data_2kij_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kij _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 111.631 0.234 . . . . 2.0800000000000001 111.631 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.9 tp -51.42 -34.24 33.93 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.706 1.602 . . . . 3.3700000000000001 114.341 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.32 -44.86 20.78 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.395 0.887 . . . . 3.1899999999999999 113.395 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -61.38 -34.51 75.46 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.587 1.155 . . . . 4.4800000000000004 113.299 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.25 -49.76 6.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.511 1.524 . . . . 2.2000000000000002 112.117 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -74.37 -30.42 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.836 1.05 . . . . 2.8500000000000001 113.836 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -67.3 -27.62 67.32 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.544 -0.722 . . . . 1.99 112.265 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.73 -14.58 59.27 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.998 1.481 . . . . 3.4300000000000002 114.998 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -63.4 129.3 39.67 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 120.55 1.523 . . . . 4.1799999999999997 112.142 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.46 158.6 33.39 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.993 1.317 . . . . 2.5699999999999998 112.159 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.1 p -98.34 -24.54 15.17 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 116.061 1.874 . . . . 3.9399999999999999 116.061 -168.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.27 159.48 37.72 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.88 1.067 . . . . 4.21 113.88 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.86 149.39 40.22 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.596 1.558 . . . . 1.5600000000000001 111.762 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 m -95.01 109.18 21.25 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.502 0.721 . . . . 2.48 112.649 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.7 mt -81.09 140.18 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.646 1.178 . . . . 2.7400000000000002 108.616 169.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.72 127.01 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.102 0.953 . . . . 3.3599999999999999 112.173 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 92.9 m . . . . . 0 N--CA 1.468 0.452 0 C-N-CA 127.67 2.388 . . . . 3.0499999999999998 109.979 -170.08 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--O 1.237 0.446 0 CA-C-O 120.432 0.158 . . . . 4.2599999999999998 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.4 t -133.04 140.05 47.51 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.725 2.01 . . . . 3.3300000000000001 110.009 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.08 149.15 39.41 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.796 0.838 . . . . 2.6699999999999999 112.506 -168.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.85 126.31 30.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.849 1.66 . . . . 2.6899999999999999 110.765 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -87.01 126.82 34.99 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.851 -1.155 . . . . 2.2400000000000002 108.761 167.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.48 162.19 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.211 1.405 . . . . 1.6299999999999999 111.763 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.97 147.53 42.95 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.29 0.567 . . . . 3.9100000000000001 111.124 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -56.26 -23.91 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 114.686 1.365 . . . . 2.1400000000000001 114.686 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.57 -13.71 60.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.549 1.315 . . . . 3.8399999999999999 114.549 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.7 mt -106.67 -13.38 15.3 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.956 1.302 . . . . 2.46 113.818 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.97 142.36 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.052 1.341 . . . . 2.0099999999999998 110.647 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -114.71 161.24 18.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.483 1.113 . . . . 2.96 113.333 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -76.27 31.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.499 1.666 . . . . 5.3499999999999996 115.499 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.7 0.21 4.96 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 127.834 2.635 . . . . 1.75 113.725 169.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -89.68 160.41 16.62 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.339 1.456 . . . . 2.1899999999999999 112.139 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.4 mt -118.77 128.55 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.583 1.553 . . . . 2.2999999999999998 108.368 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.4 mm -120.3 136.54 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.304 1.441 . . . . 1.98 113.933 -166.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -78.14 143.75 37.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.774 1.23 . . . . 3.6299999999999999 112.303 172.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.13 132.68 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.695 0.798 . . . . 1.25 110.808 167.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.47 166.97 11.07 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 125.278 1.431 . . . . 2.0099999999999998 112.282 -169.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.13 120.83 8.73 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.885 1.723 . . . . 1.6200000000000001 111.626 171.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.63 -6.17 82.18 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 126.638 2.066 . . . . 0.94999999999999996 115.159 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.18 154.4 46.24 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 119.123 1.461 . . . . 1.01 114.285 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -109.14 152.92 24.46 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.929 1.292 . . . . 2.9300000000000002 111.852 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -89.13 126.8 57.75 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.813 1.042 . . . . 3.3999999999999999 113.813 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.18 -22.24 3.45 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.028 3.152 . . . . 1.5700000000000001 114.532 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.4 m -143.64 170.54 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.206 2.202 . . . . 2.0600000000000001 109.41 -176.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.31 166.64 17.27 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.072 0.549 . . . . 2.54 110.811 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.98 -175.53 47.08 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.936 1.134 . . . . 1.28 115.936 170.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -105.29 142.33 35.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.617 1.567 . . . . 4.6799999999999997 111.277 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.08 131.17 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.367 2.267 . . . . 2.2200000000000002 110.27 -171.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.07 30.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 113.549 0.944 . . . . 2.3100000000000001 113.549 -175.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -170.62 144.97 2.45 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.119 2.568 . . . . 3.1499999999999999 107.213 168.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.48 179.61 46.51 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 116.612 1.405 . . . . 1.53 116.612 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -152.1 41.76 0.66 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.902 1.815 . . . . 3.02 115.902 -166.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.44 ' H ' HD22 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -75.88 156.53 34.25 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.409 -1.432 . . . . 1.77 113.19 -178.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 42.7 ttm -96.67 127.21 42.44 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.928 -0.767 . . . . 2.0600000000000001 108.928 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.9 t -112.95 129.05 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 124.58 1.152 . . . . 1.2 110.685 -170.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -91.66 105.64 17.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.538 0.735 . . . . 2.25 110.775 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -117.8 23.61 11.58 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.888 2.075 . . . . 2.4100000000000001 113.004 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 93.0 p -63.82 -18.58 64.26 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 116.659 2.096 . . . . 2.0299999999999998 116.659 -169.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.84 -48.86 7.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.441 1.096 . . . . 2.5 109.907 169.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.88 -58.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.82 1.248 . . . . 2.5600000000000001 111.722 -172.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.4 p -103.9 -12.35 16.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.298 1.039 . . . . 2.8399999999999999 112.66 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.63 -3.02 85.05 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.484 -1.176 . . . . 1.79 114.737 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -63.94 103.47 0.59 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.585 1.192 . . . . 3.1299999999999999 110.693 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.97 -17.51 61.46 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.815 -1.178 . . . . 2.6800000000000002 111.577 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.69 103.9 42.82 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 128.099 2.56 . . . . 6.1600000000000001 107.947 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -55.35 147.13 58.14 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.725 2.95 . . . . 3.1899999999999999 114.19 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.5 t -94.21 125.26 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.744 1.218 . . . . 2.0099999999999998 111.944 -167.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.18 141.29 38.76 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.709 -0.619 . . . . 2.25 111.72 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -115.08 169.54 9.03 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.796 1.638 . . . . 1.54 111.526 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -157.15 169.33 10.8 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 127.714 2.406 . . . . 4.79 110.727 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.18 135.1 48.93 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 CA-C-N 121.451 1.554 . . . . 1.55 108.41 165.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.88 39.37 17.13 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.28 0.943 . . . . 1.23 113.253 -168.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 t -124.76 174.26 8.02 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.624 1.57 . . . . 2.02 111.254 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 p -133.26 150.59 51.92 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.518 -1.363 . . . . 2.3199999999999998 112.566 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.06 161.84 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 125.411 1.485 . . . . 1.99 112.79 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.0 150.31 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.298 1.839 . . . . 2.46 113.435 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.67 148.33 24.86 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.038 1.335 . . . . 2.3300000000000001 112.944 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.88 -4.1 67.19 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 115.333 0.893 . . . . 0.95999999999999996 115.333 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 97.6 p -84.61 160.02 20.5 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.498 1.149 . . . . 1.6299999999999999 111.969 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mm -113.21 127.13 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.469 1.107 . . . . 2.0800000000000001 112.203 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -93.9 144.0 25.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.238 1.415 . . . . 1.9099999999999999 113.083 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -157.6 145.95 19.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.884 1.274 . . . . 4.5800000000000001 111.332 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 46.54 87.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.504 2.322 . . . . 3.8999999999999999 113.585 168.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.38 -13.42 2.28 Favored Glycine 0 CA--C 1.542 1.761 0 N-CA-C 116.251 1.26 . . . . 3.8900000000000001 116.251 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.2 m 40.1 108.61 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 130.964 3.706 . . . . 2.7999999999999998 117.322 170.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.44 HD22 ' H ' ' A' ' 62' ' ' SER . 57.4 mt -106.33 160.37 15.42 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.987 1.106 . . . . 2.9500000000000002 113.987 -169.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.68 121.28 41.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.332 1.853 . . . . 4.3700000000000001 108.476 168.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.45 126.23 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.653 0.781 . . . . 2.3900000000000001 111.167 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.81 121.51 30.31 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.375 -0.828 . . . . 2.75 109.999 168.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.65 129.95 35.04 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.2 0.6 . . . . 1.1899999999999999 112.147 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.9 p -117.77 -6.12 11.07 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.85 1.66 . . . . 3.4100000000000001 113.968 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -138.98 148.78 43.93 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.649 1.98 . . . . 2.71 110.242 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.5 m -92.42 -174.05 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.583 1.153 . . . . 2.5899999999999999 112.638 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.65 -33.16 83.58 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.857 -1.152 . . . . 2.7799999999999998 113.557 -171.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.52 -51.67 11.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.265 1.426 . . . . 3.1299999999999999 112.888 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.29 -8.13 53.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.499 1.919 . . . . 3.5800000000000001 115.551 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.6 t -48.17 146.56 2.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.974 2.109 . . . . 3.8100000000000001 114.872 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 t -62.1 -21.77 65.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.079 0.552 . . . . 3.3599999999999999 111.992 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.5 tp -59.89 -41.18 91.03 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.647 -1.283 . . . . 2.75 111.897 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.8 t -73.26 -27.38 61.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.475 1.11 . . . . 3.4300000000000002 111.564 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -70.06 -39.6 75.58 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.408 -0.807 . . . . 2.6299999999999999 112.146 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.8 mt -60.04 -44.68 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.668 1.587 . . . . 3.1499999999999999 111.657 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 115.249 1.574 . . . . 2.79 115.249 -178.07 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 119.693 -0.194 . . . . 3.1899999999999999 111.095 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.28 -32.16 47.35 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.378 1.071 . . . . 3.4100000000000001 113.405 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.51 -54.21 7.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.759 0.824 . . . . 3.3300000000000001 112.63 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -54.53 -36.98 64.84 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.463 1.505 . . . . 3.5 113.002 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.77 -38.96 67.87 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.457 1.103 . . . . 2.2400000000000002 113.491 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.8 mm -74.66 -34.07 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 118.954 0.797 . . . . 2.25 112.811 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -69.52 -25.34 63.99 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.247 -0.908 . . . . 1.8600000000000001 112.43 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.31 -15.77 63.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.36 2.264 . . . . 3.8599999999999999 114.873 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -73.56 140.72 46.47 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.692 1.197 . . . . 2.8199999999999998 112.257 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.42 165.39 15.6 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.578 1.151 . . . . 2.4199999999999999 112.47 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -93.7 -41.99 9.4 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.354 0.872 . . . . 3.4300000000000002 113.354 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -125.37 158.97 32.96 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.135 1.531 . . . . 4.29 115.135 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.55 149.83 47.02 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.646 1.578 . . . . 1.45 111.311 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.7 m -106.43 108.8 20.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.233 1.013 . . . . 1.9099999999999999 112.052 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.7 mt -90.09 132.9 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.217 1.807 . . . . 1.9299999999999999 109.576 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.23 139.55 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.609 0.719 . . . . 2.8999999999999999 112.442 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.9 m . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 126.733 2.013 . . . . 2.77 110.402 -172.772 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 109.533 -0.543 . . . . 3.2000000000000002 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 t -123.48 122.04 37.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.413 1.485 . . . . 2.5 108.991 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -116.41 141.42 48.19 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.519 1.128 . . . . 2.2799999999999998 110.012 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -136.02 132.94 36.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.903 1.281 . . . . 2.8500000000000001 110.616 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -100.1 134.56 42.85 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 119.344 0.974 . . . . 2.2599999999999998 110.506 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -138.75 163.47 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.656 1.182 . . . . 2.0299999999999998 112.104 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.19 146.63 43.23 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.9 -0.778 . . . . 3.1299999999999999 108.9 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -63.75 -1.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 114.997 1.48 . . . . 1.8100000000000001 114.997 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -83.48 -17.17 42.92 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.648 1.579 . . . . 4.21 114.855 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.4 -9.32 14.95 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.937 1.458 . . . . 2.4100000000000001 114.937 -165.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.35 151.21 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 125.677 1.591 . . . . 1.74 109.743 168.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.71 160.26 24.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.099 1.148 . . . . 3.8100000000000001 114.099 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -74.71 47.13 0.31 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.25 1.82 . . . . 5.9500000000000002 113.892 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.27 23.12 0.23 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.312 1.434 . . . . 1.3899999999999999 113.545 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -129.36 172.57 11.36 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.032 1.733 . . . . 2.8599999999999999 111.316 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 mm -108.29 123.89 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.566 1.946 . . . . 2.48 110.038 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.1 mm -117.16 126.45 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.406 1.482 . . . . 1.8899999999999999 110.1 -170.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HE3' ' CD1' ' A' ' 96' ' ' LEU . 44.7 mtpt -94.06 139.98 30.3 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.936 0.717 . . . . 3.96 112.936 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.11 153.24 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.689 1.196 . . . . 2.0299999999999998 112.133 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.94 165.52 23.42 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 125.654 1.581 . . . . 2.6800000000000002 112.693 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.5 124.16 14.89 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.069 2.513 . . . . 2.0899999999999999 112.156 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.68 -13.68 61.94 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.154 1.835 . . . . 1.6000000000000001 115.728 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.56 -8.52 76.5 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 116.992 1.557 . . . . 4.3899999999999997 116.992 -172.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.0 mttt 61.88 158.87 0.06 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 127.871 2.469 . . . . 2.4900000000000002 115.463 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -92.51 119.02 68.25 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.144 0.977 . . . . 3.6099999999999999 111.01 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -87.45 -13.16 4.33 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.914 2.409 . . . . 0.82999999999999996 114.618 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -147.47 168.26 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.496 1.918 . . . . 2.04 110.503 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.57 145.39 30.38 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.707 0.803 . . . . 1.7 113.117 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.05 -159.11 32.39 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 114.484 0.554 . . . . 0.87 114.484 -173.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -108.84 140.19 42.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.033 1.333 . . . . 4.4100000000000001 112.925 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.85 132.14 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 127.878 2.471 . . . . 1.6799999999999999 107.789 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.9 pt -140.05 29.34 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 119.378 0.99 . . . . 2.3300000000000001 112.914 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.97 137.6 3.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.06 1.344 . . . . 3.5099999999999998 108.984 169.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.83 -178.71 53.17 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 122.549 1.083 . . . . 0.81000000000000005 114.717 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.28 136.57 31.75 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.487 1.515 . . . . 3.8500000000000001 111.502 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 m -148.32 156.75 42.91 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.05 1.129 . . . . 2.0699999999999998 114.05 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 29.4 ttm -104.79 133.87 48.88 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.665 -1.235 . . . . 1.6499999999999999 107.665 167.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.1 t -126.47 138.99 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.927 1.291 . . . . 1.1100000000000001 112.48 -167.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -93.09 103.03 15.36 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.585 1.554 . . . . 2.25 109.984 173.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -128.2 3.31 5.79 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.906 1.682 . . . . 1.8700000000000001 115.115 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.6 p -47.33 -29.62 2.65 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.256 1.822 . . . . 2.04 115.399 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.86 -38.07 46.86 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.635 1.174 . . . . 2.1800000000000002 112.115 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.95 -62.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.87 2.068 . . . . 2.5 111.198 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 p -88.85 -12.73 41.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.74 1.616 . . . . 2.04 112.577 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.74 19.24 60.13 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.76 1.171 . . . . 1.75 114.209 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -74.8 -167.73 0.62 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.336 1.455 . . . . 2.9300000000000002 111.333 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.91 13.35 1.67 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.001 1.482 . . . . 3.1400000000000001 115.001 -171.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -158.23 154.24 23.5 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.672 1.589 . . . . 4.9299999999999997 111.061 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -58.97 141.26 98.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.54 2.827 . . . . 2.5 113.048 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.2 t -114.04 137.05 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.833 2.053 . . . . 1.79 111.735 -169.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.6 133.56 33.7 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.221 -0.924 . . . . 1.9299999999999999 112.746 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -129.21 140.84 51.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.127 2.171 . . . . 1.3300000000000001 109.921 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -148.82 -177.19 0.63 Allowed Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 126.223 1.809 . . . . 4.96 110.287 -169.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.31 132.96 25.19 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 122.703 2.001 . . . . 1.29 110.674 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.09 7.22 68.22 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 126.222 1.867 . . . . 1.1799999999999999 114.784 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.3 t -101.56 152.35 20.89 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.105 1.952 . . . . 1.8600000000000001 111.86 -170.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.0 p -105.22 145.91 29.99 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.877 -1.139 . . . . 1.6799999999999999 113.356 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 m -137.54 161.41 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.902 1.681 . . . . 1.8 112.183 -172.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.95 147.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.138 1.775 . . . . 1.99 113.419 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.17 150.36 30.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.701 1.2 . . . . 1.5800000000000001 112.604 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.16 -3.63 51.48 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.239 0.924 . . . . 0.77000000000000002 115.227 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.8 p -80.97 156.86 25.74 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.331 1.066 . . . . 1.6399999999999999 111.85 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mm -107.77 123.52 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.503 0.721 . . . . 1.9299999999999999 110.763 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -83.12 128.29 34.35 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.825 -0.806 . . . . 2.0 108.825 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.86 43.9 2.68 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.28 1.215 . . . . 3.8700000000000001 114.28 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -157.92 -38.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.494 2.405 . . . . 4.2699999999999996 117.494 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.38 -175.87 27.84 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 120.626 1.557 . . . . 2.25 116.743 -168.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -116.02 122.68 45.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.624 1.169 . . . . 2.4100000000000001 111.944 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.1 mt -125.78 165.4 18.72 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.047 1.339 . . . . 2.23 113.823 -170.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.423 ' CD1' ' HE3' ' A' ' 44' ' ' LYS . 8.5 mp -112.37 122.7 48.46 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.507 1.523 . . . . 3.0299999999999998 109.006 167.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.28 129.63 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.65 1.18 . . . . 2.3100000000000001 110.952 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 29.2 p -86.51 120.08 27.45 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.466 -0.771 . . . . 2.7000000000000002 109.945 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.93 131.18 37.34 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.306 -0.871 . . . . 1.1200000000000001 111.159 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.91 -12.33 11.41 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.65 0.981 . . . . 4.2599999999999998 113.65 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -141.58 143.47 33.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.372 1.469 . . . . 2.7200000000000002 109.227 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.5 p -75.93 158.99 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 107.755 -1.202 . . . . 4.6799999999999997 107.755 166.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.16 -39.64 71.43 Favored Glycine 0 N--CA 1.477 1.411 0 CA-C-N 121.231 1.832 . . . . 2.0099999999999998 115.196 -167.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -34.17 77.15 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.621 0.971 . . . . 3.3900000000000001 113.621 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -77.87 -10.33 59.51 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.759 2.424 . . . . 2.8500000000000001 115.392 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.7 p -66.49 156.19 35.51 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.355 0.872 . . . . 2.4399999999999999 113.355 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.2 t -57.62 -33.8 68.62 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.741 -0.6 . . . . 2.8900000000000001 112.174 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.1 tp -56.14 -49.56 73.59 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.937 1.295 . . . . 2.2599999999999998 111.963 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -72.98 -24.16 60.74 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.324 1.45 . . . . 2.73 113.515 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -70.69 -48.16 56.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.397 1.079 . . . . 1.51 112.04 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.2 mt -53.05 -51.97 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.909 0.883 . . . . 2.5600000000000001 111.832 -169.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 114.044 1.127 . . . . 1.8100000000000001 114.044 -177.459 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 112.927 0.714 . . . . 2.1899999999999999 112.927 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.33 -29.15 69.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.671 0.788 . . . . 2.46 112.924 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.82 -25.68 49.01 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.981 1.104 . . . . 2.6000000000000001 113.981 169.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.81 -42.97 80.71 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.864 1.266 . . . . 3.5800000000000001 112.971 -167.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -49.85 -42.48 47.6 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.195 1.398 . . . . 2.2000000000000002 112.417 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.6 mm -72.47 -35.56 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.362 1.065 . . . . 2.5499999999999998 112.564 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.3 m -70.69 -27.76 64.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.093 0.957 . . . . 1.6100000000000001 113.331 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 mp -66.39 -25.73 66.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.177 0.806 . . . . 3.0699999999999998 113.177 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -61.64 131.16 49.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.338 0.972 . . . . 2.5899999999999999 112.209 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.31 159.47 23.87 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.96 1.096 . . . . 2.29 113.96 -169.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.5 m -86.84 -30.32 21.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.72 1.208 . . . . 4.2400000000000002 112.338 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -141.88 161.0 39.07 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.712 1.745 . . . . 4.0800000000000001 115.712 -168.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.23 162.73 34.78 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.826 2.05 . . . . 2.02 111.97 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.6 m -121.89 104.55 9.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.102 1.361 . . . . 1.96 112.237 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.0 mt -83.43 133.49 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.109 1.364 . . . . 1.1599999999999999 110.503 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.7 m -126.33 144.66 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.358 1.614 . . . . 3.1499999999999999 115.358 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 125.527 1.531 . . . . 3.9199999999999999 111.432 -179.723 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 CA--C 1.546 0.823 0 CA-C-O 121.882 0.848 . . . . 3.6400000000000001 112.295 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -126.41 143.6 51.12 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.603 1.561 . . . . 1.8100000000000001 110.739 -173.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -128.17 132.58 48.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.54 1.136 . . . . 2.7799999999999998 110.843 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -108.96 132.99 53.55 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.835 1.254 . . . . 2.7999999999999998 110.392 170.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -101.54 114.92 29.38 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.687 1.13 . . . . 2.6899999999999999 110.69 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.23 159.2 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.235 1.414 . . . . 2.5699999999999998 113.567 -168.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.83 154.41 33.9 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.441 1.097 . . . . 3.6099999999999999 111.025 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.62 -21.91 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 114.145 1.165 . . . . 1.8899999999999999 114.145 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -73.29 -15.19 61.41 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.487 -1.383 . . . . 3.3300000000000001 113.587 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.4 mt -99.84 -1.08 38.41 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.512 1.525 . . . . 2.71 114.422 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.33 146.37 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.579 1.552 . . . . 1.98 111.359 173.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -120.53 165.75 14.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.848 1.659 . . . . 3.3599999999999999 112.711 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -68.69 26.03 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.224 1.935 . . . . 3.5299999999999998 116.224 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.69 14.58 1.99 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 126.565 2.031 . . . . 1.6599999999999999 114.073 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -97.91 162.75 13.09 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 119.176 1.488 . . . . 2.6099999999999999 112.845 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 87.6 mt -118.56 130.94 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.257 1.423 . . . . 2.27 109.912 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.9 mm -121.19 130.89 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.824 1.649 . . . . 1.6299999999999999 112.413 -168.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -93.68 124.26 37.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.606 0.762 . . . . 3.0 112.089 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.97 137.18 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.351 1.06 . . . . 1.8200000000000001 112.414 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.53 158.47 54.32 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.455 1.102 . . . . 2.2799999999999998 113.361 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -62.6 126.91 19.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.724 2.283 . . . . 2.4900000000000002 111.377 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.66 -5.81 72.66 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.685 1.612 . . . . 1.0900000000000001 114.786 -169.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.51 159.04 53.22 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.764 1.173 . . . . 1.04 114.431 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -112.69 141.9 45.94 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.547 1.139 . . . . 3.6899999999999999 111.745 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.07 129.99 79.24 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 119.214 -0.422 . . . . 2.8700000000000001 112.06 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -90.32 -21.7 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.391 2.727 . . . . 0.84999999999999998 114.924 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.56 166.93 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 127.405 2.282 . . . . 2.0099999999999998 109.049 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.21 140.86 29.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.081 0.855 . . . . 2.0299999999999998 111.845 173.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.61 -173.57 44.83 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 114.737 0.655 . . . . 0.91000000000000003 114.737 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -110.27 144.43 38.99 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.48 1.112 . . . . 7.4000000000000004 113.204 -170.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.11 129.13 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.574 2.35 . . . . 2.0499999999999998 109.755 -172.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.7 pt -142.86 30.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 114.225 1.194 . . . . 2.2000000000000002 114.225 -171.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -168.81 143.83 3.28 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.608 1.963 . . . . 3.1099999999999999 109.367 166.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.84 -170.91 44.31 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.08 0.792 . . . . 0.95999999999999996 115.08 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -155.11 121.62 5.32 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.361 0.664 . . . . 4.2800000000000002 112.098 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.9 t -143.57 168.79 19.03 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.633 1.173 . . . . 1.6200000000000001 112.631 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.1 ttm -115.1 137.0 52.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.817 0.847 . . . . 2.2000000000000002 111.458 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.93 142.47 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.302 1.841 . . . . 1.01 111.705 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.93 114.53 26.65 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.837 1.255 . . . . 1.8999999999999999 110.96 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -114.22 14.2 18.08 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 114.379 1.252 . . . . 2.0299999999999998 114.379 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.5 p -67.02 -3.35 6.98 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 117.922 2.564 . . . . 1.9399999999999999 117.922 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.62 -41.62 3.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.937 1.695 . . . . 2.29 109.865 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.3 mm -76.01 -58.5 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.362 1.065 . . . . 2.1499999999999999 111.453 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.1 p -102.03 -11.74 18.67 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.185 0.994 . . . . 2.4199999999999999 112.958 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.65 16.22 75.91 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.735 1.159 . . . . 1.5800000000000001 115.083 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -56.08 -38.12 70.24 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.396 1.098 . . . . 2.5800000000000001 113.393 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 63.49 19.42 11.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.263 1.425 . . . . 2.1099999999999999 114.134 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.6 ttm -148.29 134.42 9.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 129.589 3.156 . . . . 4.1799999999999997 105.213 169.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.41 161.79 43.37 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.29 1.993 . . . . 2.0899999999999999 112.81 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.5 t -124.7 122.28 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.279 1.432 . . . . 2.1000000000000001 110.911 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.5 145.21 33.34 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.705 0.802 . . . . 2.1400000000000001 112.628 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -124.32 159.74 29.62 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.021 2.128 . . . . 1.0600000000000001 111.399 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -157.14 174.26 4.2 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 126.995 2.118 . . . . 3.8900000000000001 110.732 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.25 130.1 32.69 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 CA-C-N 121.909 1.717 . . . . 1.4099999999999999 109.497 166.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.18 43.21 10.9 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.713 0.673 . . . . 1.1699999999999999 113.087 -169.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -131.76 167.03 20.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.265 1.426 . . . . 1.6100000000000001 110.85 175.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.8 p -124.41 150.55 45.49 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 120.554 1.524 . . . . 2.04 113.034 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 m -135.01 163.03 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.945 1.298 . . . . 2.1699999999999999 112.348 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.5 150.72 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.383 2.273 . . . . 2.4399999999999999 110.67 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.76 150.88 47.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.411 0.684 . . . . 1.8200000000000001 112.521 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.75 -5.94 55.9 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 115.355 0.902 . . . . 0.90000000000000002 115.355 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.88 157.64 21.91 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.255 1.528 . . . . 3.7599999999999998 111.456 169.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -110.12 131.21 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.438 1.095 . . . . 2.1800000000000002 111.025 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -96.93 132.02 43.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.309 1.444 . . . . 1.97 111.211 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -84.89 -72.96 0.45 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.128 -0.982 . . . . 3.6400000000000001 113.245 -170.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -157.85 142.95 16.75 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.556 2.343 . . . . 4.6799999999999997 107.42 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.46 11.19 1.18 Allowed Glycine 0 CA--C 1.542 1.72 0 N-CA-C 117.452 1.741 . . . . 3.2999999999999998 117.452 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.6 m 32.29 85.37 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.435 2.694 . . . . 2.54 117.036 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.8 mt -103.98 156.13 18.1 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.887 1.275 . . . . 2.5099999999999998 113.524 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 65.1 mt -108.85 123.89 49.77 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.425 1.09 . . . . 3.6200000000000001 110.492 167.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.55 124.66 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.485 1.514 . . . . 2.7999999999999998 109.542 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.7 p -82.44 120.36 25.37 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.346 -0.846 . . . . 2.4199999999999999 109.586 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.5 115.29 19.04 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.355 -0.841 . . . . 1.24 109.254 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.3 p -119.29 6.35 11.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.692 1.197 . . . . 2.9399999999999999 113.524 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -147.66 145.48 28.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.109 1.763 . . . . 1.97 110.321 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.8 m -83.64 159.6 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.74 -0.837 . . . . 2.52 108.74 164.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.18 -38.87 79.29 Favored Glycine 0 N--CA 1.475 1.262 0 O-C-N 121.025 -1.047 . . . . 1.5900000000000001 114.913 -168.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.16 90.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.355 1.077 . . . . 3.0699999999999998 112.814 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -77.26 -9.21 58.66 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.249 1.574 . . . . 2.52 115.249 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.7 p -64.47 159.04 22.35 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.336 0.865 . . . . 2.3999999999999999 113.336 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -66.1 -29.29 69.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.969 -0.56 . . . . 3.0299999999999998 111.627 170.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.12 -46.3 88.68 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.657 -1.277 . . . . 2.4100000000000001 112.255 171.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.6 m -68.41 -23.01 64.59 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.492 0.552 . . . . 2.3900000000000001 112.492 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.24 -40.39 71.08 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.995 1.271 . . . . 2.9700000000000002 112.033 169.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 82.4 mt -54.96 -50.23 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 120.26 1.391 . . . . 2.5 110.772 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 118.102 -0.951 . . . . 1.8799999999999999 113.027 175.772 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.835 0 N-CA-C 112.309 0.485 . . . . 2.3100000000000001 112.309 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.12 -33.12 71.43 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.911 1.284 . . . . 2.48 112.662 172.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.9 -29.77 58.56 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.827 0.677 . . . . 2.5 112.827 171.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.79 -41.1 77.11 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.111 -0.993 . . . . 3.3999999999999999 112.001 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.58 -30.41 65.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.284 0.947 . . . . 2.6000000000000001 113.112 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -75.25 -45.46 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.747 1.219 . . . . 2.8300000000000001 112.409 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 m -75.66 -15.51 60.31 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.508 1.123 . . . . 1.77 113.401 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.0 tp -72.88 -24.49 60.86 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.579 2.751 . . . . 4.3300000000000001 112.949 170.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -77.61 148.48 35.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.189 0.995 . . . . 3.1600000000000001 113.407 -173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 163.4 27.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.397 1.479 . . . . 2.8900000000000001 114.514 -171.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.7 p -109.0 -38.11 5.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.21 1.404 . . . . 3.1699999999999999 112.965 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.84 154.76 51.08 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.613 1.565 . . . . 3.0600000000000001 113.366 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.35 161.99 36.55 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.823 1.649 . . . . 1.5900000000000001 113.358 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -118.61 103.2 9.48 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.462 1.105 . . . . 1.6599999999999999 112.303 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.3 mt -83.56 134.71 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.888 1.275 . . . . 1.21 110.25 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.86 141.01 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.604 1.162 . . . . 2.8300000000000001 110.283 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.471 0.592 0 C-N-CA 126.381 1.872 . . . . 2.6000000000000001 110.118 -169.801 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 111.998 0.37 . . . . 3.5800000000000001 111.998 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 t -138.92 140.04 38.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.35 1.86 . . . . 1.9299999999999999 110.319 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -123.18 148.81 45.38 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.921 1.452 . . . . 2.3900000000000001 114.921 -170.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -121.36 146.66 46.63 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.509 2.324 . . . . 3.3999999999999999 110.325 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -111.83 132.09 54.92 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.422 1.01 . . . . 2.6000000000000001 111.641 171.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.2 m -135.9 161.27 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.199 1.0 . . . . 1.29 113.03 -170.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.7 148.7 36.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.479 0.711 . . . . 3.3900000000000001 109.786 168.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.22 -24.95 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 113.948 1.092 . . . . 2.3100000000000001 113.948 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -64.4 -22.86 67.09 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.45 1.1 . . . . 4.2400000000000002 113.566 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.3 mt -103.79 -6.83 21.06 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.742 1.617 . . . . 1.6299999999999999 114.747 -168.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.02 140.48 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.147 0.979 . . . . 1.6799999999999999 110.356 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.26 165.51 15.35 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.024 1.73 . . . . 3.0499999999999998 111.312 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -75.02 11.48 1.1 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.722 1.749 . . . . 4.2199999999999998 115.722 -175.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.38 6.31 16.81 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 126.562 2.029 . . . . 1.71 114.483 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -87.91 152.47 22.05 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 119.891 1.846 . . . . 2.9700000000000002 112.777 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.0 mm -111.5 128.65 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.163 1.785 . . . . 3.1400000000000001 109.813 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.8 mm -119.68 128.44 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.511 1.124 . . . . 1.99 112.903 -168.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -88.34 121.97 31.33 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 121.225 -0.922 . . . . 2.6699999999999999 112.532 170.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.21 134.33 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.293 1.437 . . . . 1.9099999999999999 111.3 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 m -97.32 163.69 19.3 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 124.61 1.164 . . . . 1.96 113.26 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.35 133.9 52.07 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.231 1.954 . . . . 1.49 111.334 167.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.46 -8.21 54.73 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.775 2.131 . . . . 0.92000000000000004 115.098 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.76 161.77 54.28 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 118.536 1.168 . . . . 1.0600000000000001 114.379 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -113.24 140.69 47.75 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.749 1.219 . . . . 2.6200000000000001 111.006 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.49 123.16 88.96 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-O 118.257 -0.878 . . . . 2.8900000000000001 111.834 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.64 -24.09 4.45 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.971 2.447 . . . . 0.83999999999999997 115.818 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.19 152.56 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 126.608 1.963 . . . . 1.8700000000000001 109.116 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 138.8 35.62 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.873 1.064 . . . . 1.8700000000000001 113.873 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.94 -157.79 20.85 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 123.728 0.68 . . . . 0.78000000000000003 114.431 -171.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ttp-105 -119.87 146.31 45.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.097 1.359 . . . . 4.9800000000000004 113.062 -170.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.6 t -98.99 130.74 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 128.247 2.619 . . . . 1.8400000000000001 109.467 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.7 31.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 114.143 1.164 . . . . 1.8300000000000001 114.143 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -167.42 139.62 3.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.427 1.491 . . . . 2.6800000000000002 110.29 169.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.61 -164.8 36.33 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 116.845 1.498 . . . . 1.0600000000000001 116.845 167.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -145.69 132.68 20.25 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.689 1.196 . . . . 4.2300000000000004 111.523 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.1 -179.21 6.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.882 0.873 . . . . 1.6799999999999999 112.831 168.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.43 135.32 54.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.793 2.037 . . . . 2.2799999999999998 110.358 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 72.4 t -126.31 142.76 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.48 1.112 . . . . 1.1699999999999999 113.071 -169.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.94 106.24 16.13 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.544 1.138 . . . . 2.4199999999999999 112.582 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -100.64 30.15 4.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.961 2.105 . . . . 1.8600000000000001 114.103 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.3 p -48.7 -28.81 3.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.016 2.598 . . . . 3.0499999999999998 118.016 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.41 -56.03 2.34 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.493 1.517 . . . . 2.6800000000000002 110.637 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.3 mm -67.77 -51.98 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.783 0.66 . . . . 2.4300000000000002 112.783 -167.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.7 p -95.52 -20.18 19.23 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.665 0.786 . . . . 2.5600000000000001 112.474 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.51 83.37 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.182 1.372 . . . . 1.3 115.374 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.43 -47.57 83.5 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.573 1.323 . . . . 2.3500000000000001 114.573 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 64.86 30.71 12.0 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.656 1.982 . . . . 2.6800000000000002 112.861 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -149.12 154.26 39.05 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 127.529 2.332 . . . . 5.5300000000000002 109.879 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.13 133.74 42.43 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.449 2.766 . . . . 2.6099999999999999 115.168 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -116.16 136.16 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 127.063 2.145 . . . . 2.0699999999999998 110.848 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.13 133.73 34.28 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.971 -1.081 . . . . 1.78 112.717 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -124.25 137.09 54.55 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.89 1.276 . . . . 1.1100000000000001 111.677 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -148.48 179.15 1.24 Allowed Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 127.52 2.328 . . . . 3.7400000000000002 108.667 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -56.3 139.38 86.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 CA-C-N 123.289 2.21 . . . . 1.02 112.319 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.05 11.73 83.37 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.456 -1.191 . . . . 0.77000000000000002 115.105 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.2 m -102.2 166.53 10.54 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.581 1.69 . . . . 1.8100000000000001 110.949 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.7 p -117.4 152.77 34.28 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.244 -1.535 . . . . 1.9099999999999999 112.855 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.15 157.06 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.763 1.625 . . . . 1.8600000000000001 112.159 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.73 143.08 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.758 1.623 . . . . 2.1899999999999999 111.675 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.68 153.99 37.93 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.47 0.915 . . . . 1.6599999999999999 113.47 -170.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.68 -1.0 59.7 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 114.893 0.717 . . . . 0.87 114.893 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 m -88.97 156.4 18.91 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.303 1.051 . . . . 2.4500000000000002 111.447 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.05 145.33 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.576 1.15 . . . . 1.75 111.117 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -115.97 137.13 52.39 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.958 2.103 . . . . 1.77 112.227 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -153.93 139.73 18.07 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.401 -1.437 . . . . 3.4500000000000002 113.084 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.314 30.1 t30 87.89 -1.48 0.49 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.285 3.434 . . . . 3.29 116.006 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.67 163.45 29.0 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 120.437 -1.414 . . . . 1.9399999999999999 115.257 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -98.95 144.01 28.6 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.121 1.769 . . . . 2.7200000000000002 112.128 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.9 mt -135.57 160.02 39.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.948 1.299 . . . . 2.1899999999999999 111.361 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.9 mt -107.99 127.63 53.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.691 0.796 . . . . 3.3399999999999999 110.435 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 mm -117.24 124.62 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.923 1.689 . . . . 2.8199999999999998 110.306 -173.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -87.19 111.22 20.77 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.424 -0.797 . . . . 2.5800000000000001 109.533 169.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.17 119.13 22.53 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.622 0.769 . . . . 1.22 109.806 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 t -119.86 8.71 11.15 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.594 0.961 . . . . 3.52 113.594 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -138.36 139.31 38.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.612 1.965 . . . . 2.0 108.058 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 m -85.98 174.58 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.737 0.815 . . . . 2.9100000000000001 111.802 170.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.25 -36.57 91.15 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 121.08 -1.012 . . . . 1.3200000000000001 114.795 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.71 -36.9 70.67 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.852 1.326 . . . . 2.1499999999999999 112.615 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -78.49 -10.25 59.64 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.798 1.777 . . . . 2.27 115.798 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -76.6 156.17 32.95 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.646 -1.283 . . . . 3.8999999999999999 112.379 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.9 t -56.88 -34.39 67.83 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.38 0.882 . . . . 2.7400000000000002 113.38 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.5 mp -56.93 -48.68 77.7 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.541 -1.349 . . . . 2.0899999999999999 112.52 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.9 m -70.74 -27.99 64.38 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.02 1.328 . . . . 2.21 112.203 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -70.76 -44.74 66.12 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.394 0.678 . . . . 2.0699999999999998 111.974 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.5 mt -56.37 -49.57 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.94 1.296 . . . . 2.1400000000000001 111.267 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 114.251 1.204 . . . . 2.46 114.251 -177.774 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 114.135 1.161 . . . . 2.3900000000000001 114.135 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.4 tp -56.41 -53.96 51.3 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.193 0.997 . . . . 3.3700000000000001 111.301 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.37 -7.99 47.2 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.436 1.643 . . . . 3.1699999999999999 115.436 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -64.88 -43.89 91.45 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 121.486 1.948 . . . . 2.8199999999999998 111.003 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -48.76 -48.96 40.51 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.281 1.432 . . . . 2.1099999999999999 111.048 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.9 mm -70.16 -34.01 57.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.79 1.236 . . . . 2.29 112.034 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 m -76.64 -24.77 53.32 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.153 1.381 . . . . 1.71 113.053 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 mp -68.22 -26.79 65.89 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.889 0.768 . . . . 2.8399999999999999 112.621 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -70.72 139.78 51.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.409 1.004 . . . . 3.8199999999999998 113.013 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.87 152.39 44.59 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.102 -0.499 . . . . 2.2400000000000002 111.188 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -106.23 -2.66 22.18 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.911 1.284 . . . . 2.77 112.128 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -142.59 153.5 43.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.326 2.25 . . . . 3.9100000000000001 112.282 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.85 162.0 36.62 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.194 1.398 . . . . 1.4399999999999999 112.991 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.8 m -115.07 108.16 16.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.929 1.292 . . . . 1.6899999999999999 111.916 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.0 mt -83.32 130.33 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.104 -0.702 . . . . 1.25 109.104 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.31 138.42 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.04 0.936 . . . . 3.4500000000000002 112.37 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.474 0.734 0 C-N-CA 124.178 0.991 . . . . 3.0299999999999998 111.747 -169.841 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 tp . . . . . 0 CA--C 1.536 0.437 0 N-CA-C 109.5 -0.556 . . . . 4.0499999999999998 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 t -135.22 129.35 33.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.637 1.175 . . . . 2.3100000000000001 110.966 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -130.74 129.44 42.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.446 1.098 . . . . 2.4100000000000001 111.822 -169.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -119.51 118.97 32.47 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.486 1.914 . . . . 2.8399999999999999 109.746 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -89.24 121.54 31.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.576 1.08 . . . . 2.6299999999999999 109.93 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.31 171.28 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.124 1.37 . . . . 2.1299999999999999 112.612 -169.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.7 146.17 32.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.634 1.174 . . . . 3.21 110.506 168.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.96 -24.05 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.608 0.966 . . . . 1.74 113.608 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.16 -22.48 61.29 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.815 -1.178 . . . . 2.9199999999999999 113.062 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.77 -15.18 42.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.305 1.042 . . . . 2.3799999999999999 113.231 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 p -86.7 93.54 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 122.715 1.245 . . . . 2.2200000000000002 109.9 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -78.32 158.3 28.89 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.42 2.288 . . . . 4.1900000000000004 109.218 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -69.74 134.26 48.41 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.015 -1.053 . . . . 3.1800000000000002 112.966 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.42 12.18 4.32 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.207 1.385 . . . . 1.6100000000000001 115.999 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -116.48 168.86 9.79 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.288 2.044 . . . . 2.71 113.861 175.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.86 129.04 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.31 1.844 . . . . 2.6400000000000001 109.607 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.1 mm -122.75 129.14 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.119 1.768 . . . . 1.9099999999999999 110.465 -171.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -83.13 135.71 34.72 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.765 1.226 . . . . 3.75 112.365 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.36 136.8 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.822 1.249 . . . . 1.3 111.949 169.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.35 159.14 65.29 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.018 0.927 . . . . 1.97 112.886 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.28 136.12 66.31 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.78 2.32 . . . . 1.74 110.757 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.18 3.79 57.87 Favored Glycine 0 CA--C 1.542 1.735 0 N-CA-C 114.914 0.726 . . . . 0.98999999999999999 114.914 -169.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.1 178.89 48.54 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 118.928 1.364 . . . . 0.97999999999999998 115.686 -174.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.81 145.26 51.24 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.419 1.888 . . . . 2.3300000000000001 111.096 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -88.07 129.5 49.79 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.863 0.69 . . . . 2.8700000000000001 112.863 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -86.27 -22.22 2.23 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.275 2.65 . . . . 0.81000000000000005 115.661 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.6 m -151.08 175.82 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 127.843 2.457 . . . . 1.79 109.147 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -99.94 140.99 33.36 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.357 0.98 . . . . 1.6799999999999999 113.474 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.51 -177.73 46.58 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 123.545 0.593 . . . . 0.76000000000000001 114.38 -169.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -103.24 138.81 39.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.838 1.255 . . . . 5.5 112.178 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.8 t -83.45 130.55 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.255 2.222 . . . . 1.76 108.657 173.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.1 pt -140.37 33.48 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-O 122.394 1.093 . . . . 1.6799999999999999 112.379 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -166.6 129.5 1.89 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.155 2.182 . . . . 2.8100000000000001 108.084 168.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.33 176.0 50.5 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 122.701 1.167 . . . . 1.03 115.03 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -153.31 120.96 5.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.417 1.487 . . . . 2.8999999999999999 112.572 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.558 ' HG ' ' ND2' ' A' ' 90' ' ' ASN . 2.8 t -141.69 159.73 41.63 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.445 1.498 . . . . 2.0800000000000001 112.024 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.4 ttm -90.67 130.18 36.7 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.761 -0.587 . . . . 1.6799999999999999 110.341 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.7 t -113.85 140.77 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.524 1.13 . . . . 2.0600000000000001 111.781 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -108.32 102.46 11.58 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.334 1.453 . . . . 1.76 111.427 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 19.86 17.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.624 1.969 . . . . 4.0 113.096 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.2 p -54.6 -29.09 50.76 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.331 1.604 . . . . 1.6000000000000001 115.331 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.59 -30.46 26.97 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.825 1.193 . . . . 2.1299999999999999 111.708 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 mm -72.76 -53.57 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.554 1.542 . . . . 1.9299999999999999 110.176 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.2 p -102.92 -22.04 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.313 1.845 . . . . 2.0499999999999998 113.691 -171.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.75 -2.23 87.7 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.277 1.418 . . . . 1.3200000000000001 114.328 -170.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -64.9 110.16 2.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.502 1.651 . . . . 2.8599999999999999 110.296 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.59 -3.38 58.44 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.983 -1.073 . . . . 2.5800000000000001 112.596 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.8 mmt -95.79 138.7 21.71 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.99 2.516 . . . . 4.4900000000000002 108.952 167.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.36 161.09 22.78 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.155 2.57 . . . . 2.6099999999999999 112.347 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.8 t -124.03 119.82 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.463 0.705 . . . . 1.5800000000000001 111.369 -168.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.57 130.79 35.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.021 0.928 . . . . 1.8 112.086 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -108.74 157.68 18.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.015 1.726 . . . . 1.1399999999999999 111.866 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -146.73 168.97 10.25 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 127.581 2.352 . . . . 4.2800000000000002 111.624 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -59.14 123.22 12.98 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 121.578 1.519 . . . . 1.1499999999999999 109.356 166.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.43 57.15 3.01 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.866 1.222 . . . . 1.21 112.426 -168.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -141.3 150.31 42.38 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.696 1.598 . . . . 1.4099999999999999 112.427 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.9 p -101.05 150.76 22.57 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 120.861 1.664 . . . . 2.04 113.522 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.05 162.61 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.464 1.506 . . . . 1.1799999999999999 111.823 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.97 150.06 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.768 2.027 . . . . 1.71 111.363 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.59 142.23 49.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.033 0.933 . . . . 1.6499999999999999 112.71 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.49 -5.77 72.07 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.125 1.345 . . . . 0.79000000000000004 116.305 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.4 p -73.93 162.22 29.3 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.711 1.256 . . . . 1.6499999999999999 111.896 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mm -110.79 143.88 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.52 1.128 . . . . 1.8 111.61 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.558 ' ND2' ' HG ' ' A' ' 62' ' ' SER . 2.4 t30 -105.45 142.62 34.89 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.467 1.907 . . . . 1.9099999999999999 112.341 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -85.73 -125.69 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.639 1.175 . . . . 3.52 112.316 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -78.99 -38.16 37.43 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.001 1.852 . . . . 3.3999999999999999 116.001 -166.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.4 128.78 13.68 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.794 0.725 . . . . 1.9299999999999999 112.538 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.2 t -83.97 121.43 27.38 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.875 -1.158 . . . . 3.2799999999999998 107.875 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.4 mt -117.99 157.73 26.23 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.715 1.206 . . . . 2.1299999999999999 111.321 -169.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -117.31 125.52 51.2 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.482 0.658 . . . . 3.0499999999999998 109.75 169.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.79 138.17 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.64 1.576 . . . . 2.3100000000000001 110.573 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.6 p -79.03 106.62 11.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.021 0.915 . . . . 2.54 111.185 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.73 82.4 4.13 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.202 1.001 . . . . 1.6799999999999999 109.097 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 t -101.51 9.32 41.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.585 1.954 . . . . 4.21 111.874 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -144.49 152.86 41.21 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.159 1.783 . . . . 2.4500000000000002 111.451 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -106.7 170.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.211 1.404 . . . . 2.5899999999999999 111.579 168.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.6 -24.24 46.56 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.366 1.306 . . . . 2.2200000000000002 116.366 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.38 96.91 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.595 1.698 . . . . 4.1200000000000001 112.529 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.18 -22.98 59.17 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.272 1.582 . . . . 3.8300000000000001 115.272 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 109' ' ' SER . 3.2 t -71.58 142.74 50.01 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.463 1.283 . . . . 4.1500000000000004 114.463 -166.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m -60.95 -27.14 68.03 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.499 -0.751 . . . . 4.6299999999999999 112.275 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.0 tp -58.4 -46.22 86.83 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.367 -0.833 . . . . 2.8599999999999999 112.093 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.403 ' H ' HG22 ' A' ' 106' ' ' THR . 75.9 p -73.03 -27.33 61.7 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.881 0.872 . . . . 2.6800000000000002 113.012 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -66.64 -40.06 88.54 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.164 -0.96 . . . . 2.0899999999999999 112.461 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 67.8 mt -53.91 -52.22 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.392 1.077 . . . . 2.5499999999999998 110.301 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 113.686 0.995 . . . . 1.45 113.686 -179.261 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 111.785 0.291 . . . . 2.3900000000000001 111.785 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 tp -55.05 -35.82 64.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.254 1.022 . . . . 2.7599999999999998 112.386 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.07 -47.34 37.26 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.359 0.527 . . . . 3.23 112.208 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.08 -32.46 70.97 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.211 1.005 . . . . 3.79 113.384 -172.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.0 -35.73 77.6 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.228 1.377 . . . . 2.0899999999999999 113.267 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.6 mm -73.99 -40.29 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.498 -0.751 . . . . 2.7000000000000002 111.591 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -66.86 -30.38 70.53 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.391 0.886 . . . . 1.6299999999999999 113.391 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.31 -17.33 62.43 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.555 1.942 . . . . 3.1299999999999999 113.941 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -86.4 147.04 26.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.538 1.135 . . . . 3.27 112.835 -170.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.23 154.41 22.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.557 1.543 . . . . 2.23 112.98 -172.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 m -100.53 -27.39 13.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.331 1.452 . . . . 3.1200000000000001 113.314 -172.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.84 150.76 50.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.228 1.411 . . . . 3.4199999999999999 113.678 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.4 172.32 12.93 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.608 1.563 . . . . 1.6000000000000001 113.37 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 93.1 m -119.4 105.3 11.15 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.501 1.52 . . . . 1.74 112.125 170.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.89 140.31 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.016 0.927 . . . . 1.8799999999999999 109.402 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.93 124.98 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.469 -0.769 . . . . 2.8399999999999999 110.551 172.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.474 0.735 0 C-N-CA 124.604 1.162 . . . . 2.6499999999999999 110.681 176.043 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 121.374 0.607 . . . . 2.9700000000000002 110.642 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 t -141.42 84.69 1.92 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.601 1.56 . . . . 1.77 109.431 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -81.02 154.15 27.03 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.033 -1.042 . . . . 2.7200000000000002 112.926 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -121.74 130.72 53.63 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.181 1.792 . . . . 2.7000000000000002 110.958 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -88.58 120.56 30.08 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.671 -0.863 . . . . 2.5299999999999998 108.671 168.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.24 159.23 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.051 0.94 . . . . 1.5700000000000001 113.13 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -78.04 143.22 37.65 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.903 -0.777 . . . . 3.1800000000000002 108.903 166.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.09 -20.24 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.609 1.164 . . . . 2.3199999999999998 113.585 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -70.24 -20.02 63.1 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.707 -1.246 . . . . 3.4300000000000002 113.637 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.83 -5.55 56.76 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.455 1.28 . . . . 2.2799999999999998 114.455 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.1 p -94.13 144.65 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.762 0.825 . . . . 2.6099999999999999 112.508 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -121.25 163.3 18.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.943 2.497 . . . . 3.1699999999999999 110.124 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 ptt85 -72.29 147.15 46.66 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.181 -0.95 . . . . 4.5 110.784 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.43 28.49 7.11 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-N 119.142 0.883 . . . . 2.71 113.93 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.5 166.34 25.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.333 1.853 . . . . 3.5299999999999998 111.523 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.4 mt -122.95 132.16 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.945 1.298 . . . . 2.8700000000000001 111.937 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 mm -118.65 129.98 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.692 1.997 . . . . 2.04 110.623 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -84.45 130.39 34.77 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.639 -0.663 . . . . 2.8199999999999998 112.19 172.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.43 136.89 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.888 1.275 . . . . 1.23 110.227 169.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.93 161.91 39.71 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.118 1.367 . . . . 1.6699999999999999 112.39 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -57.5 134.27 62.31 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.674 1.583 . . . . 1.75 108.618 166.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.64 -9.04 38.25 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 118.702 -1.054 . . . . 0.93000000000000005 115.557 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.92 177.94 37.53 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 119.645 1.723 . . . . 0.94999999999999996 114.237 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.88 151.37 38.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.684 1.593 . . . . 3.21 111.234 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -90.14 116.55 66.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 118.496 -0.764 . . . . 2.9900000000000002 109.965 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -89.16 -11.22 3.72 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.936 2.424 . . . . 0.73999999999999999 114.896 -171.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -147.8 172.82 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 128.55 2.74 . . . . 1.8300000000000001 108.834 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.2 139.39 37.88 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.164 0.893 . . . . 2.6600000000000001 112.518 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.75 -158.67 22.58 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 115.253 0.861 . . . . 0.89000000000000001 115.253 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -118.3 129.1 55.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.74 1.216 . . . . 5.2000000000000002 112.647 -170.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.3 t -88.69 127.23 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.881 1.672 . . . . 1.6299999999999999 108.93 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.7 pt -141.52 30.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 113.438 0.903 . . . . 2.1499999999999999 113.438 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -169.08 132.01 1.29 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.615 1.966 . . . . 3.1699999999999999 108.975 166.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.71 173.34 46.83 Favored Glycine 0 CA--C 1.539 1.578 0 N-CA-C 116.102 1.201 . . . . 1.1000000000000001 116.102 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -140.28 127.36 20.9 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.099 1.36 . . . . 4.4199999999999999 113.806 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 m -151.46 172.15 16.42 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.362 1.616 . . . . 1.75 115.362 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.9 ttm -106.46 133.78 50.61 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.625 1.17 . . . . 2.2599999999999998 110.497 168.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.85 132.82 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.479 1.112 . . . . 2.25 113.743 -167.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -91.23 98.7 11.88 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.269 1.828 . . . . 2.2799999999999998 111.386 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -128.98 8.61 5.68 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.135 1.774 . . . . 2.2999999999999998 115.57 -172.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.3 p -59.73 -4.81 0.75 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 116.248 1.944 . . . . 2.6499999999999999 116.248 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -94.62 -35.6 12.14 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.153 1.342 . . . . 2.25 111.449 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.8 mm -79.73 -62.88 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.797 1.239 . . . . 2.4199999999999999 111.612 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 p -84.99 -8.15 58.85 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.206 1.403 . . . . 2.6200000000000001 112.999 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.02 25.9 70.19 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.556 1.074 . . . . 2.8999999999999999 113.241 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -64.3 -177.33 0.28 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.671 1.589 . . . . 3.1699999999999999 110.876 169.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.5 -9.64 5.7 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.843 -1.161 . . . . 3.8100000000000001 113.612 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -149.26 151.25 33.55 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.099 1.36 . . . . 3.6699999999999999 110.793 169.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -48.8 153.87 3.42 Favored 'Trans proline' 0 CA--C 1.538 0.712 1 C-N-CA 125.405 4.07 . . . . 3.8300000000000001 116.245 -178.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.3 t -113.25 134.07 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.722 1.609 . . . . 1.5700000000000001 111.354 -170.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.38 137.22 38.6 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.614 0.765 . . . . 1.8500000000000001 112.188 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -130.14 143.87 51.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.167 2.187 . . . . 1.03 110.179 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -148.61 -172.61 0.32 Allowed Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 126.611 1.964 . . . . 4.2000000000000002 109.526 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.45 142.92 67.43 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 CA-C-N 123.492 2.283 . . . . 1.25 111.347 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.02 8.73 87.4 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.512 1.53 . . . . 1.0900000000000001 114.895 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.2 m -89.52 163.83 15.05 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.851 1.826 . . . . 1.6499999999999999 112.234 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.3 p -112.33 147.1 37.06 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.911 -1.118 . . . . 2.23 111.218 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 m -139.46 156.31 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.553 1.141 . . . . 1.3 112.754 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.53 150.53 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.169 1.788 . . . . 1.8700000000000001 113.225 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.02 149.59 47.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.044 0.937 . . . . 1.8899999999999999 113.168 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.3 -2.52 56.85 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.712 1.148 . . . . 0.89000000000000001 114.966 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 89.9 p -76.59 155.0 33.91 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.629 1.214 . . . . 1.8300000000000001 111.657 169.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.09 136.95 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.273 1.029 . . . . 2.0800000000000001 110.669 -171.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -93.19 149.78 20.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.853 1.661 . . . . 1.5 113.412 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -160.47 115.27 2.22 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.989 0.916 . . . . 5.6299999999999999 111.88 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.5 t30 147.79 -46.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 131.658 3.983 . . . . 3.2200000000000002 110.829 166.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.1 179.78 42.74 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 121.084 -1.01 . . . . 2.54 114.884 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -85.34 132.59 34.22 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.213 1.005 . . . . 2.6099999999999999 112.276 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.86 163.56 24.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.838 1.655 . . . . 2.9500000000000002 112.304 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.1 mt -118.46 127.29 53.51 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.209 1.004 . . . . 3.6200000000000001 112.011 172.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.95 126.99 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.11 1.364 . . . . 2.21 110.893 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 44.2 t -83.09 125.46 31.51 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.094 0.558 . . . . 4.1500000000000004 110.307 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.24 104.12 14.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.188 0.995 . . . . 1.3500000000000001 109.754 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.8 p -94.22 -3.81 50.1 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.558 1.143 . . . . 3.6800000000000002 112.13 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -136.47 136.9 39.84 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.474 1.91 . . . . 2.6299999999999999 109.856 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 p -88.69 170.08 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.573 1.149 . . . . 3.96 110.474 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.17 -35.68 85.36 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.31 -1.494 . . . . 1.8999999999999999 114.875 -171.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.79 -31.84 73.15 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.947 1.374 . . . . 2.9100000000000001 113.227 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.16 -5.92 44.67 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.118 1.367 . . . . 3.75 113.738 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.0 p -80.71 147.16 30.72 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.529 -1.357 . . . . 2.8900000000000001 112.77 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -70.67 -23.37 62.49 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.295 1.22 . . . . 3.2400000000000002 114.295 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 mp -59.37 -58.14 9.91 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 119.809 -1.807 . . . . 2.2200000000000002 115.762 -167.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.7 m -73.18 -15.22 61.46 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.859 0.754 . . . . 4.04 112.7 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.5 -42.92 64.31 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.001 0.92 . . . . 2.6600000000000001 111.461 172.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 54.9 mt -57.63 -45.76 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.067 1.347 . . . . 2.6400000000000001 112.499 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 114.514 1.301 . . . . 2.3799999999999999 114.514 -172.434 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 113.496 0.924 . . . . 3.4900000000000002 113.496 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.9 tp -64.49 -31.95 73.38 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.03 0.932 . . . . 2.7999999999999998 111.134 171.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.19 -17.3 61.94 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.122 -0.986 . . . . 2.0800000000000001 113.532 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -67.39 -28.52 68.0 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.755 0.822 . . . . 3.6000000000000001 112.207 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.8 -38.9 83.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.838 0.855 . . . . 2.0 111.319 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.3 mm -70.14 -41.28 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.275 0.63 . . . . 3.1299999999999999 110.954 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 m -67.44 -24.74 65.67 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.024 0.93 . . . . 1.46 113.256 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.5 mt -73.32 -27.8 61.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.979 1.712 . . . . 2.6899999999999999 113.889 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -64.45 140.44 58.87 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.877 0.762 . . . . 3.2999999999999998 111.003 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.51 165.26 18.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.562 1.145 . . . . 2.8599999999999999 113.475 -172.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.1 m -121.11 -29.31 4.57 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.108 1.363 . . . . 2.8199999999999998 112.411 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.21 150.05 43.68 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.227 1.411 . . . . 2.9500000000000002 112.728 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.86 145.95 38.72 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.866 1.267 . . . . 1.9399999999999999 112.507 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.5 m -98.54 100.92 12.21 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.638 1.175 . . . . 2.1000000000000001 112.323 -174.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 35.1 mt -76.72 139.58 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.83 -0.804 . . . . 2.54 108.83 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.42 125.58 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.712 0.768 . . . . 3.3500000000000001 112.254 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.471 0.621 0 C-N-CA 125.844 1.658 . . . . 3.02 111.323 -167.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt . . . . . 0 C--O 1.232 0.168 0 N-CA-C 109.0 -0.741 . . . . 3.8100000000000001 109.0 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.1 p -135.92 152.27 50.83 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.884 1.274 . . . . 3.6099999999999999 110.985 -168.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.67 149.07 40.38 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.969 0.908 . . . . 3.25 111.487 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -139.64 113.56 8.75 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.661 1.184 . . . . 2.5600000000000001 111.588 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -79.83 115.61 19.52 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.918 -1.114 . . . . 2.8300000000000001 109.303 167.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.78 166.08 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.239 1.416 . . . . 1.47 111.166 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -76.6 142.0 40.88 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.921 -0.487 . . . . 3.9500000000000002 110.342 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.41 -23.57 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.289 1.218 . . . . 2.7200000000000002 114.289 -171.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -60.68 -27.43 67.85 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.88 1.272 . . . . 4.4400000000000004 113.206 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.2 mt -101.57 -7.63 22.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.9 2.08 . . . . 2.6099999999999999 115.816 -167.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.74 144.71 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.151 0.887 . . . . 2.0899999999999999 111.151 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -121.33 154.78 35.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.204 1.802 . . . . 4.1299999999999999 112.881 -170.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -77.64 23.8 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 117.215 2.302 . . . . 4.0099999999999998 117.215 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.78 6.81 12.28 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.682 1.611 . . . . 1.8600000000000001 115.564 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -124.01 173.31 8.33 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.75 1.775 . . . . 3.5600000000000001 115.256 -168.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.4 mt -113.84 126.31 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.057 1.743 . . . . 3.1499999999999999 110.491 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.3 mm -116.08 124.14 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.495 1.918 . . . . 2.0899999999999999 110.109 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -87.07 141.36 28.72 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.737 1.215 . . . . 3.02 111.676 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -116.59 137.09 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.489 0.716 . . . . 1.24 112.287 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.13 159.25 54.33 Favored Pre-proline 0 N--CA 1.481 1.075 0 C-N-CA 124.387 1.075 . . . . 2.6000000000000001 113.234 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -60.95 136.94 68.91 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.888 1.726 . . . . 2.5299999999999998 109.772 167.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.27 26.37 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 115.429 0.932 . . . . 1.02 115.429 -171.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.66 -177.17 41.19 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 119.062 1.431 . . . . 1.0800000000000001 115.31 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -123.67 154.74 38.95 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.093 1.357 . . . . 2.9399999999999999 112.043 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -88.69 122.12 69.47 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 118.608 -0.71 . . . . 2.9500000000000002 110.34 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.18 -19.54 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.565 2.176 . . . . 0.76000000000000001 115.426 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.48 164.89 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 127.987 2.515 . . . . 1.8700000000000001 108.051 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -81.14 149.23 29.23 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.039 0.923 . . . . 2.3599999999999999 113.286 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -167.07 38.73 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.785 -0.643 . . . . 1.0 113.906 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -114.96 132.6 56.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.742 0.817 . . . . 4.6299999999999999 112.504 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.0 t -79.02 131.58 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 127.078 2.151 . . . . 1.8300000000000001 107.636 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.06 31.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.039 0.836 . . . . 1.97 112.277 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -169.07 146.71 3.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.378 2.271 . . . . 3.2400000000000002 109.258 168.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.08 -179.55 32.51 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 118.847 0.749 . . . . 0.93999999999999995 114.842 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -143.53 32.4 1.31 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.445 1.646 . . . . 4.4699999999999998 115.445 -167.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.477 ' H ' HD21 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -83.36 165.84 18.94 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.361 1.615 . . . . 1.8100000000000001 115.361 -168.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.0 ttm -110.8 138.36 47.29 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.819 0.847 . . . . 1.6299999999999999 110.95 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.33 134.66 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.092 1.357 . . . . 1.04 112.805 -168.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -86.03 108.54 18.29 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.107 1.363 . . . . 2.5299999999999998 110.924 174.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.94 -10.79 17.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.0 1.32 . . . . 2.5099999999999998 113.89 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.5 p -43.23 -35.45 1.43 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 117.995 2.591 . . . . 2.6600000000000001 117.995 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -84.86 -27.45 26.69 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.62 1.1 . . . . 1.73 112.016 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mm -89.52 -55.55 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.944 0.898 . . . . 2.1899999999999999 110.922 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.0 p -85.79 -18.35 33.2 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.191 0.996 . . . . 2.2200000000000002 113.132 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.71 9.91 80.25 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.448 1.499 . . . . 1.8700000000000001 114.439 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.02 -177.59 0.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.365 1.466 . . . . 2.8300000000000001 112.512 171.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.69 -20.68 0.59 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.148 1.379 . . . . 2.7999999999999998 114.492 -176.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.9 mtp -119.2 140.47 28.97 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.7 1.2 . . . . 5.2300000000000004 111.354 172.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -59.28 144.93 99.22 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.556 2.837 . . . . 2.96 113.973 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 t -106.72 131.99 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 127.3 2.24 . . . . 1.54 111.982 -168.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.13 134.84 37.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.267 0.627 . . . . 1.8100000000000001 111.85 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -110.37 155.47 22.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.4 1.88 . . . . 1.1399999999999999 111.652 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -151.93 172.07 5.88 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 127.343 2.257 . . . . 2.9300000000000002 108.285 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -54.9 142.08 76.3 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 CA-C-N 122.149 1.803 . . . . 0.98999999999999999 112.279 171.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.63 13.33 82.62 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-O 117.7 -1.611 . . . . 1.0900000000000001 115.635 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -96.83 144.7 26.55 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.209 2.505 . . . . 2.0299999999999998 111.392 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.5 p -90.42 157.17 17.73 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 121.305 1.866 . . . . 1.78 112.933 172.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 m -140.34 156.85 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.457 1.903 . . . . 1.27 112.035 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -113.47 151.65 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 127.573 2.349 . . . . 2.25 111.636 173.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.34 155.86 23.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.29 0.636 . . . . 1.8700000000000001 112.369 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.69 0.12 53.15 Favored Glycine 0 CA--C 1.536 1.402 0 O-C-N 121.447 -0.783 . . . . 1.1499999999999999 114.974 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.9 p -78.22 153.51 31.87 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.557 1.179 . . . . 1.99 110.899 168.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mm -113.3 131.73 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.811 0.844 . . . . 2.1899999999999999 111.011 -171.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -94.27 148.32 22.32 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.696 1.598 . . . . 1.6799999999999999 112.653 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -96.95 -88.08 0.3 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.291 1.036 . . . . 3.4199999999999999 112.712 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.471 ' C ' ' HG ' ' A' ' 62' ' ' SER . 13.1 t-20 -154.17 146.92 24.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.628 2.771 . . . . 5.6500000000000004 107.865 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.64 23.97 2.7 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 120.602 1.546 . . . . 2.9900000000000002 115.158 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 t 18.19 97.94 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 130.169 3.388 . . . . 2.4500000000000002 116.837 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.477 HD21 ' H ' ' A' ' 62' ' ' SER . 54.9 mt -102.5 154.03 19.49 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.629 1.171 . . . . 1.98 112.948 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.2 mp -117.75 126.02 51.69 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.501 1.12 . . . . 3.3100000000000001 108.566 166.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.54 125.9 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.127 1.371 . . . . 2.3599999999999999 110.086 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.2 p -81.2 119.88 24.17 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.627 -0.67 . . . . 2.73 109.538 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.95 130.92 35.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.293 0.637 . . . . 1.3200000000000001 109.665 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.46 3.55 9.05 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.897 1.073 . . . . 3.9700000000000002 113.897 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -141.18 151.5 43.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.998 1.319 . . . . 2.4399999999999999 111.86 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -89.45 173.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.769 1.628 . . . . 2.7599999999999998 111.223 171.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.94 -36.41 87.76 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 121.061 -1.024 . . . . 1.78 114.843 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.39 -28.12 69.02 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.582 1.327 . . . . 2.4900000000000002 114.582 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.71 -13.02 60.03 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.962 1.467 . . . . 3.3500000000000001 114.962 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.1 p -66.45 132.92 49.35 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.215 -0.928 . . . . 2.4500000000000002 112.608 -168.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 t -63.24 -23.77 67.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.487 1.291 . . . . 3.1699999999999999 114.487 -167.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.7 -43.74 80.84 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.917 -1.114 . . . . 2.54 111.795 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.2 p -68.03 -28.5 67.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.158 0.983 . . . . 2.3999999999999999 112.712 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -75.27 -48.65 22.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.969 1.307 . . . . 1.6899999999999999 111.91 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 53.4 mt -53.62 -49.23 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.862 1.665 . . . . 2.3199999999999998 110.5 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 114.876 1.435 . . . . 2.6499999999999999 114.876 -177.626 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 112.639 0.607 . . . . 2.3599999999999999 112.639 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.25 -40.73 86.86 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.636 1.174 . . . . 4.0899999999999999 111.205 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.32 -14.25 61.27 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.456 0.91 . . . . 2.23 113.456 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -67.3 -33.31 75.01 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.649 -1.282 . . . . 2.9500000000000002 111.505 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.91 -28.03 69.78 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.489 1.115 . . . . 2.0600000000000001 111.885 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.8 mm -74.11 -39.47 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.694 0.798 . . . . 2.5800000000000001 111.772 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -65.79 -31.52 72.54 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.803 -1.186 . . . . 2.54 112.288 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.7 mt -71.23 -11.55 60.99 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.488 1.915 . . . . 2.9300000000000002 113.685 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -87.03 158.34 19.25 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.762 1.225 . . . . 3.0299999999999998 112.873 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.13 161.3 14.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.499 1.519 . . . . 2.6499999999999999 114.326 -169.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p -90.98 -47.72 7.41 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.474 1.51 . . . . 3.2599999999999998 113.203 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -142.08 157.4 44.95 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.336 1.454 . . . . 4.1200000000000001 112.782 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.17 157.38 44.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.383 1.473 . . . . 2.2000000000000002 112.525 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.1 m -100.4 107.02 18.67 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.896 0.878 . . . . 1.6000000000000001 111.589 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.8 mt -78.84 142.26 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.684 1.193 . . . . 1.22 108.443 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.23 135.63 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.643 0.735 . . . . 3.3799999999999999 111.924 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.471 0.609 0 C-N-CA 127.747 2.419 . . . . 2.3100000000000001 110.959 -169.693 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 121.01 0.433 . . . . 3.6899999999999999 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.7 t -140.13 139.11 35.71 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.079 2.152 . . . . 1.8500000000000001 109.46 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -126.11 151.69 46.9 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.096 -1.002 . . . . 2.8399999999999999 112.183 -174.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -129.4 128.45 43.04 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.133 1.373 . . . . 2.7999999999999998 111.25 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -93.46 108.16 19.89 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.263 -0.898 . . . . 2.6800000000000002 109.571 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 m -118.95 154.55 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.179 0.992 . . . . 2.04 112.263 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -72.7 148.27 44.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.686 -0.486 . . . . 3.21 109.686 171.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.41 -17.86 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.387 1.625 . . . . 2.3399999999999999 115.387 -168.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -70.94 -20.65 62.44 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.41 -1.431 . . . . 4.2599999999999998 113.833 170.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.7 mt -98.35 -3.66 36.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.644 1.578 . . . . 1.77 114.078 -168.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -89.14 139.36 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.676 1.591 . . . . 2.1699999999999999 109.959 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -108.95 164.45 12.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.864 1.266 . . . . 4.0499999999999998 111.166 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -70.56 37.45 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.726 1.38 . . . . 3.6499999999999999 114.726 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.47 11.5 0.15 Allowed Glycine 0 CA--C 1.54 1.62 0 C-N-CA 127.824 2.63 . . . . 1.3799999999999999 114.395 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -97.3 165.4 12.05 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.829 1.815 . . . . 2.3300000000000001 112.505 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.7 mm -113.21 123.08 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.822 1.649 . . . . 2.8900000000000001 110.49 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.7 mm -116.24 128.52 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.011 1.324 . . . . 1.8500000000000001 112.174 -170.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -85.91 140.04 30.71 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.455 1.102 . . . . 2.7599999999999998 112.926 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.62 136.57 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.65 1.18 . . . . 1.3100000000000001 112.118 174.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.69 160.93 30.33 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.637 1.175 . . . . 1.8500000000000001 113.818 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.18 123.6 13.49 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.571 2.18 . . . . 1.8400000000000001 111.526 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.02 -2.36 87.7 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.619 2.057 . . . . 1.0800000000000001 115.242 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.84 171.71 54.62 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 119.246 1.523 . . . . 1.0800000000000001 114.049 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -111.24 152.44 27.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.047 1.339 . . . . 3.4700000000000002 112.235 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -76.66 131.94 73.02 Favored Pre-proline 0 CA--C 1.553 1.066 0 CA-C-O 118.629 -0.701 . . . . 3.8100000000000001 111.587 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -96.1 -17.13 0.35 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.264 2.642 . . . . 0.89000000000000001 115.787 -173.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.49 171.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 127.07 2.148 . . . . 1.78 108.976 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.6 137.38 40.9 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.935 0.789 . . . . 1.8999999999999999 112.652 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.13 -156.48 20.4 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 114.548 0.579 . . . . 0.96999999999999997 114.548 -171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.6 ttp85 -114.78 140.3 49.03 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.631 1.172 . . . . 4.9100000000000001 112.939 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.9 t -88.85 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.685 1.994 . . . . 1.8999999999999999 108.971 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.9 pt -140.92 33.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.84 0.829 . . . . 2.1699999999999999 112.376 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -166.12 137.23 3.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.22 1.808 . . . . 2.71 109.662 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.52 -176.1 51.11 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 123.691 0.662 . . . . 0.81999999999999995 114.74 171.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -156.8 92.27 1.27 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.06 0.944 . . . . 4.0300000000000002 112.13 -168.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.63 165.86 19.17 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.85 1.66 . . . . 1.8 112.675 -169.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.0 ttm -112.28 130.75 55.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.455 1.102 . . . . 2.0099999999999998 110.544 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.3 t -123.4 142.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.311 1.444 . . . . 1.1000000000000001 113.365 -167.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -104.03 107.72 18.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.835 1.254 . . . . 1.8600000000000001 112.288 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -103.01 27.21 7.32 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 126.09 1.756 . . . . 2.3799999999999999 114.109 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 p -51.53 -9.36 0.07 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 119.206 3.039 . . . . 2.4500000000000002 119.206 -169.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.36 -49.28 1.92 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.023 1.329 . . . . 2.6600000000000001 111.128 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.2 mm -67.04 -55.99 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 119.309 0.959 . . . . 1.78 111.917 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.8 p -95.59 -13.24 24.55 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.028 0.931 . . . . 2.3599999999999999 111.75 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.58 11.43 84.41 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.198 1.38 . . . . 1.45 115.569 169.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.54 -40.34 82.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.209 1.004 . . . . 2.46 113.235 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.04 43.78 8.64 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.35 1.46 . . . . 2.2999999999999998 112.246 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.0 ptm -161.98 159.4 21.88 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 128.979 2.912 . . . . 5.3399999999999999 109.602 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.82 139.25 17.48 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.577 2.185 . . . . 3.2400000000000002 112.534 172.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.49 139.09 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.871 1.669 . . . . 2.04 110.578 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.37 137.08 32.64 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.132 -0.98 . . . . 2.1099999999999999 112.499 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -117.36 157.2 26.57 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.659 1.584 . . . . 0.93999999999999995 111.027 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -160.1 172.99 5.27 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 127.536 2.335 . . . . 2.9900000000000002 110.511 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -53.57 135.2 60.93 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 CA-C-N 122.201 1.822 . . . . 1.3 111.656 167.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.31 38.87 44.95 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.356 0.503 . . . . 0.97999999999999998 113.284 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 t -125.52 139.29 53.74 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 118.088 0.944 . . . . 1.6899999999999999 111.396 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.6 p -91.05 145.02 25.04 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.902 1.228 . . . . 2.2200000000000002 112.475 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.2 m -135.88 156.45 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.63 1.572 . . . . 1.8999999999999999 112.095 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -130.01 144.02 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.487 1.515 . . . . 1.8300000000000001 112.984 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.92 147.44 50.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.757 0.823 . . . . 2.2000000000000002 112.912 -175.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.27 -6.64 63.11 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 115.245 0.858 . . . . 1.04 115.245 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.5 p -76.12 158.03 32.21 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.441 1.121 . . . . 1.5600000000000001 110.395 167.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -108.76 140.26 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.383 1.073 . . . . 2.04 110.996 -171.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -109.09 147.72 31.97 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.803 1.241 . . . . 1.6799999999999999 113.475 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -150.95 140.35 21.43 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.983 1.313 . . . . 4.0099999999999998 112.045 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 t30 43.85 88.09 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.219 2.608 . . . . 3.1499999999999999 113.708 168.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.47 -10.37 0.14 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 117.665 1.826 . . . . 3.75 117.665 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.3 m 45.31 85.48 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 127.732 2.413 . . . . 3.0499999999999998 115.946 169.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.2 mt -106.99 160.72 15.33 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.17 1.544 . . . . 1.9399999999999999 115.17 -169.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.0 135.55 51.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.332 1.053 . . . . 3.4199999999999999 110.604 165.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.56 129.72 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.257 1.823 . . . . 3.0800000000000001 110.396 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.3 p -83.1 119.27 24.29 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.484 -0.76 . . . . 2.5699999999999998 109.034 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.32 124.99 28.62 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.813 -0.554 . . . . 2.0099999999999998 110.244 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 p -118.16 -0.65 11.53 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.353 1.861 . . . . 2.77 112.884 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -142.97 136.23 28.29 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.842 2.057 . . . . 2.1499999999999999 110.054 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.38 162.93 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.404 -0.961 . . . . 2.3599999999999999 108.404 164.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.1 91.08 Favored Glycine 0 N--CA 1.479 1.562 0 O-C-N 120.4 -1.437 . . . . 1.3300000000000001 114.215 -169.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.94 -32.73 74.37 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.803 1.241 . . . . 2.2000000000000002 113.997 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -79.41 -9.76 59.66 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.962 2.105 . . . . 2.2799999999999998 115.142 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.0 p -70.1 154.69 41.62 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.067 -1.646 . . . . 2.4399999999999999 112.93 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.8 t -57.7 -30.25 65.35 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.387 -0.821 . . . . 2.5800000000000001 112.889 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.03 -49.88 75.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.931 -1.106 . . . . 2.1299999999999999 112.044 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.3 m -64.24 -34.11 77.35 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.11 0.964 . . . . 2.1899999999999999 110.922 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.19 -40.48 82.18 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.923 -0.486 . . . . 1.8999999999999999 111.882 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.0 mt -58.32 -54.69 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.478 1.111 . . . . 1.8899999999999999 110.604 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 114.178 1.177 . . . . 2.1699999999999999 114.178 -175.433 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 114.628 1.344 . . . . 2.6800000000000002 114.628 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.79 -46.28 70.98 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 117.22 2.304 . . . . 3.0699999999999998 117.22 -165.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.37 -31.81 60.62 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.721 1.146 . . . . 2.1899999999999999 113.06 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -69.0 -31.78 70.86 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.966 1.706 . . . . 3.5499999999999998 113.333 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.97 -41.77 71.57 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.295 0.952 . . . . 2.1899999999999999 111.998 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.37 -38.06 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 122.942 0.497 . . . . 3.0899999999999999 111.285 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.8 m -66.89 -24.16 66.08 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.604 -1.31 . . . . 1.8 113.639 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.02 -15.53 62.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.258 1.423 . . . . 3.4399999999999999 113.453 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -72.55 118.9 16.03 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.167 0.894 . . . . 3.8799999999999999 109.506 172.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.25 177.98 2.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.278 1.831 . . . . 3.27 115.445 -168.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.2 m -112.59 -39.37 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.967 1.707 . . . . 3.5499999999999998 113.006 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -141.18 157.14 45.67 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.49 1.293 . . . . 2.8999999999999999 114.49 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.08 170.98 14.7 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.691 1.597 . . . . 1.5900000000000001 112.822 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.7 m -131.08 112.94 13.33 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.287 1.435 . . . . 2.21 111.654 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.8 mt -85.16 142.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.317 1.447 . . . . 1.78 109.632 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -102.05 121.62 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 121.18 0.514 . . . . 3.04 111.254 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 125.252 1.421 . . . . 2.6299999999999999 110.078 -177.036 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.392 0.615 . . . . 3.2799999999999998 111.596 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -135.52 111.29 9.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.94 1.696 . . . . 2.2799999999999998 108.104 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.04 143.84 26.28 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.905 1.076 . . . . 2.5099999999999998 113.905 -169.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -113.69 126.11 54.89 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.862 1.665 . . . . 3.8500000000000001 110.141 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -98.98 122.32 42.08 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.558 1.072 . . . . 2.8300000000000001 111.535 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.19 158.0 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.931 1.085 . . . . 1.53 113.931 -168.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -78.36 145.1 35.42 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.711 -0.848 . . . . 3.5499999999999998 108.711 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 p -62.42 -18.48 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 114.386 1.254 . . . . 2.4300000000000002 114.386 -168.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -61.42 -27.67 68.71 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.589 -1.319 . . . . 3.6099999999999999 113.309 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.3 mt -93.17 -5.72 49.47 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.283 1.833 . . . . 1.99 115.008 -169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.76 140.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.831 1.652 . . . . 1.8700000000000001 109.663 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -114.98 160.47 19.53 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.394 1.478 . . . . 3.0 111.968 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -67.43 137.57 56.0 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.349 -0.982 . . . . 3.8500000000000001 108.349 167.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.69 -4.35 56.4 Favored Glycine 0 CA--C 1.543 1.803 0 C-N-CA 124.339 0.971 . . . . 2.77 114.115 -168.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -93.43 158.65 15.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.168 1.387 . . . . 2.4900000000000002 112.527 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.97 120.12 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.868 1.267 . . . . 2.7200000000000002 110.229 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 mm -122.1 132.54 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.882 1.673 . . . . 1.97 111.47 -168.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.22 130.0 34.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.623 0.769 . . . . 2.6200000000000001 112.654 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.8 p -116.33 132.99 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.106 1.362 . . . . 1.3500000000000001 111.282 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.94 161.86 42.83 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 125.479 1.511 . . . . 1.8 113.318 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.74 139.81 70.99 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.691 1.594 . . . . 1.6599999999999999 109.997 166.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.85 -14.72 41.29 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 126.164 1.84 . . . . 1.21 115.366 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.82 159.86 44.37 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.546 1.673 . . . . 1.0900000000000001 114.878 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -92.68 139.65 30.35 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.978 1.311 . . . . 4.96 111.502 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.34 130.13 94.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.396 -0.812 . . . . 3.9100000000000001 111.371 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -89.8 -13.42 2.67 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.706 2.271 . . . . 0.97999999999999998 114.908 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.11 175.2 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 127.503 2.321 . . . . 2.1299999999999999 109.903 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.255 1.2 p30 -111.55 147.23 35.85 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.159 0.8 . . . . 1.8700000000000001 113.159 172.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.25 -159.37 32.5 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 115.002 0.761 . . . . 0.68000000000000005 115.002 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 ttp-105 -111.43 140.62 45.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.229 1.412 . . . . 5.0899999999999999 112.564 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.91 128.4 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 127.436 2.294 . . . . 1.8899999999999999 108.377 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.76 32.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.234 0.827 . . . . 1.74 113.234 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -168.03 134.01 1.96 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.655 1.582 . . . . 3.3999999999999999 108.51 167.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.78 178.96 52.58 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 122.086 0.826 . . . . 0.81000000000000005 114.623 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -148.72 124.38 10.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.605 0.762 . . . . 3.2200000000000002 112.78 -172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -145.45 169.49 18.24 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.292 1.437 . . . . 1.6599999999999999 113.499 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.3 ttm -110.79 132.28 54.34 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.266 1.427 . . . . 1.5700000000000001 110.454 174.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -118.98 140.22 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.979 1.311 . . . . 1.1899999999999999 111.968 -169.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -107.19 92.89 4.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.498 1.119 . . . . 2.1299999999999999 111.068 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -87.2 22.62 2.04 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.418 1.887 . . . . 1.8799999999999999 113.999 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.9 p -55.49 -8.76 0.39 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 118.973 2.953 . . . . 2.23 118.973 -169.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -126.24 -38.12 2.17 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.916 1.686 . . . . 2.3500000000000001 111.501 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.6 mm -76.84 -61.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.211 0.604 . . . . 2.48 111.191 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.3 p -98.58 -12.97 20.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.938 0.895 . . . . 2.5099999999999998 112.616 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.04 87.29 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.329 1.442 . . . . 1.47 115.971 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -56.1 -45.15 79.52 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.34 1.056 . . . . 3.4300000000000002 111.68 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 69.81 -14.67 0.35 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.559 2.744 . . . . 3.1499999999999999 114.764 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 58.3 ttm -87.87 149.28 45.43 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.292 1.837 . . . . 3.79 110.089 168.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.09 133.83 34.61 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.324 2.683 . . . . 2.1200000000000001 112.606 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.04 135.2 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.987 1.715 . . . . 1.97 111.863 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.39 135.3 36.66 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.034 0.934 . . . . 2.5 113.494 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -128.53 144.71 51.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.016 1.726 . . . . 1.02 111.358 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -146.55 174.74 3.16 Favored Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 128.929 2.892 . . . . 3.6499999999999999 109.072 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.66 132.88 45.17 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 122.105 1.787 . . . . 0.92000000000000004 110.526 169.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.45 33.68 21.9 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.012 1.291 . . . . 0.75 114.248 -169.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 57.2 m -123.41 152.42 41.6 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.883 1.273 . . . . 2.0800000000000001 111.258 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.9 p -102.37 152.15 21.43 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.983 1.265 . . . . 2.0099999999999998 113.959 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.08 161.65 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.472 1.909 . . . . 1.8300000000000001 112.292 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.89 149.9 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.585 1.954 . . . . 1.8999999999999999 112.542 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.88 154.39 30.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.8 1.24 . . . . 1.76 114.191 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.6 -11.26 14.22 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.879 1.228 . . . . 0.80000000000000004 115.43 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 m -81.8 160.2 23.6 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.426 1.09 . . . . 2.75 111.047 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.03 145.37 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.114 0.966 . . . . 2.4199999999999999 111.655 -171.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -107.99 139.68 42.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.855 2.062 . . . . 1.8200000000000001 111.228 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -152.08 145.24 24.61 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.715 -1.241 . . . . 4.5099999999999998 112.049 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 53.2 t30 122.53 -55.81 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.099 1 C-N-CA 132.004 4.122 . . . . 3.54 111.228 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.74 175.24 41.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.568 1.08 . . . . 2.1000000000000001 114.891 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.5 m -77.71 137.97 38.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.847 1.259 . . . . 2.25 112.193 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.8 mt -127.08 162.55 25.79 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.594 1.158 . . . . 2.04 112.111 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.6 127.46 54.53 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.653 0.781 . . . . 3.6000000000000001 110.343 168.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 mm -114.05 124.51 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 125.468 1.507 . . . . 2.8599999999999999 109.981 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.1 p -91.38 121.57 33.22 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.844 0.747 . . . . 2.3100000000000001 109.412 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.25 138.02 37.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.344 0.658 . . . . 1.29 111.819 -173.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -112.35 -12.3 13.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.062 0.945 . . . . 3.1600000000000001 112.919 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -142.64 141.65 31.93 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.196 1.399 . . . . 1.8300000000000001 110.948 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.89 161.84 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.494 1.117 . . . . 2.8700000000000001 111.443 170.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.9 -35.96 91.48 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.4 -0.813 . . . . 2.3599999999999999 113.899 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.74 84.34 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.149 0.974 . . . . 3.6000000000000001 111.661 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.3 -4.69 31.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.389 1.625 . . . . 3.4900000000000002 115.389 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.4 p -59.79 147.94 36.25 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.923 1.238 . . . . 2.6800000000000002 111.704 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.7 t -57.67 -19.8 29.25 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.203 1.186 . . . . 2.6499999999999999 114.203 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -48.55 -46.08 38.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.591 1.556 . . . . 2.4399999999999999 112.438 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.6 p -69.11 -29.08 67.08 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.281 1.033 . . . . 2.4399999999999999 112.839 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -74.64 -42.5 58.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.724 1.21 . . . . 1.49 111.917 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 69.1 mt -54.72 -46.19 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.69 1.196 . . . . 2.2599999999999998 110.861 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.479 0.981 0 O-C-N 120.606 -1.309 . . . . 1.9399999999999999 114.176 178.747 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 112.454 0.539 . . . . 2.0299999999999998 112.454 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.81 -33.06 73.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.706 0.803 . . . . 2.3399999999999999 111.673 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.39 -48.02 21.28 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.701 0.682 . . . . 2.1299999999999999 111.245 168.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.32 -40.13 61.49 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.745 2.018 . . . . 3.4700000000000002 113.983 -174.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -43.42 -51.91 6.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.7 1.2 . . . . 2.1000000000000001 111.695 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.2 mm -72.69 -28.02 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.498 1.119 . . . . 3.5600000000000001 113.125 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -74.0 -24.02 59.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.405 1.082 . . . . 1.3300000000000001 112.894 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.47 -16.9 61.97 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.636 0.976 . . . . 2.79 113.636 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.4 154.43 42.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.501 1.143 . . . . 2.8799999999999999 113.466 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.58 160.79 26.3 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.638 -1.165 . . . . 2.6600000000000001 110.855 168.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.6 m -108.65 -6.43 15.99 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.507 1.523 . . . . 2.7599999999999998 112.272 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.21 159.51 41.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.199 1.8 . . . . 3.3700000000000001 113.012 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.19 156.65 44.4 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.209 1.404 . . . . 1.3600000000000001 113.092 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -109.66 108.61 19.07 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 113.279 0.844 . . . . 1.8700000000000001 113.279 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.9 mt -86.82 125.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.894 1.278 . . . . 1.3799999999999999 110.064 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.04 125.3 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 119.571 1.078 . . . . 2.9399999999999999 112.539 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 124.893 1.277 . . . . 3.7799999999999998 113.647 -172.184 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 CA--C 1.557 1.237 0 N-CA-C 114.245 1.202 . . . . 3.7599999999999998 114.245 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 m -77.64 136.02 38.18 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.943 1.297 . . . . 2.6299999999999999 111.394 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -122.39 127.27 49.51 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.065 0.946 . . . . 2.4100000000000001 110.241 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -114.45 119.86 38.34 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.959 1.303 . . . . 4.21 108.891 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -93.97 124.0 37.69 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.582 -0.896 . . . . 2.0600000000000001 108.582 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 m -137.63 170.71 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.734 1.214 . . . . 1.9399999999999999 112.265 -169.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.17 147.35 36.54 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.769 0.828 . . . . 3.3999999999999999 110.601 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.88 -17.67 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 113.734 1.013 . . . . 1.8799999999999999 113.734 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.52 -17.62 26.72 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 120.351 -1.468 . . . . 4.6799999999999997 113.511 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.62 -16.68 28.24 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.246 1.419 . . . . 2.46 113.441 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -76.53 147.54 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.289 -0.882 . . . . 1.6599999999999999 110.065 169.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -121.81 162.41 20.95 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.324 1.45 . . . . 3.21 111.852 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.4 ptt-85 -72.84 139.2 46.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.576 -0.738 . . . . 6.2800000000000002 109.931 170.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.54 -3.43 10.23 Favored Glycine 0 CA--C 1.541 1.713 0 N-CA-C 115.666 1.027 . . . . 1.8100000000000001 115.666 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -119.25 -174.42 2.72 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.592 1.696 . . . . 3.4199999999999999 112.979 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.68 130.25 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.894 1.678 . . . . 2.7599999999999998 109.933 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -115.89 129.35 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.738 2.015 . . . . 1.97 110.144 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -92.15 133.95 35.31 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 121.627 -0.671 . . . . 3.3900000000000001 112.611 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.02 133.39 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.049 1.34 . . . . 1.3700000000000001 111.44 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 m -100.67 162.2 21.47 Favored Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 124.414 1.086 . . . . 2.0499999999999998 113.095 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.25 137.61 71.13 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.064 2.51 . . . . 1.75 112.472 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.14 -7.37 4.56 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.569 0.987 . . . . 1.03 115.569 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.12 160.88 50.31 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.193 1.497 . . . . 0.93999999999999995 113.542 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -99.14 152.09 20.26 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.704 1.202 . . . . 2.73 112.146 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -81.04 125.03 80.73 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.021 0.929 . . . . 2.9900000000000002 110.823 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.35 -20.8 2.59 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.987 2.458 . . . . 0.79000000000000004 115.496 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 m -151.17 168.78 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 127.921 2.488 . . . . 1.97 108.834 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -89.32 148.03 23.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.122 0.874 . . . . 2.1899999999999999 111.793 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.8 -149.42 10.0 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 114.416 0.526 . . . . 1.01 114.416 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.3 ttm105 -132.26 144.5 50.65 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.711 1.205 . . . . 5.8300000000000001 113.058 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.93 132.77 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.185 2.194 . . . . 2.23 109.78 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.7 pt -140.67 30.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.144 1.165 . . . . 1.9399999999999999 114.144 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -168.51 140.3 2.75 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.488 -1.383 . . . . 3.3799999999999999 110.048 168.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.15 -165.12 32.66 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.604 1.097 . . . . 0.98999999999999999 114.641 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -150.27 123.22 8.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.383 1.473 . . . . 2.7599999999999998 111.423 -175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.06 171.89 15.13 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.18 1.178 . . . . 1.6200000000000001 114.18 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.0 ttm -121.05 132.93 55.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.207 1.403 . . . . 1.8100000000000001 109.643 172.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.86 134.81 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.903 1.281 . . . . 0.98999999999999999 112.0 -168.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -94.98 113.4 25.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.465 1.906 . . . . 2.1600000000000001 110.642 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -114.72 22.76 13.25 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.621 1.568 . . . . 2.2200000000000002 112.964 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.7 p -57.06 -22.92 42.9 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 118.176 2.658 . . . . 2.46 118.176 -167.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -105.04 -31.03 9.38 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.516 1.527 . . . . 1.9299999999999999 111.415 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.0 mm -74.36 -67.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.534 1.134 . . . . 2.2000000000000002 110.919 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.1 p -99.13 -4.85 31.28 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.444 1.497 . . . . 2.2400000000000002 112.306 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.13 2.79 85.56 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.801 1.191 . . . . 2.0899999999999999 114.757 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -73.81 108.23 6.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.412 1.085 . . . . 3.6099999999999999 112.263 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.94 -16.49 56.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.47 1.108 . . . . 3.2599999999999998 112.963 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.4 ttp -109.85 121.08 43.03 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.675 1.59 . . . . 4.2000000000000002 108.052 169.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.82 165.66 28.99 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.604 2.869 . . . . 2.0600000000000001 114.275 -168.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.14 130.45 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.545 1.538 . . . . 2.2799999999999998 111.02 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.58 137.4 38.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.08 0.552 . . . . 1.73 111.66 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.18 147.26 46.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.807 1.643 . . . . 1.05 110.404 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -145.63 171.65 6.26 Favored Pre-proline 0 N--CA 1.48 1.048 0 C-N-CA 127.639 2.376 . . . . 3.4900000000000002 110.248 -171.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.14 127.15 23.82 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.973 1.74 . . . . 1.21 111.556 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.01 35.29 18.88 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.539 1.066 . . . . 0.93999999999999995 113.902 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.9 t -118.47 154.7 32.07 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.427 1.613 . . . . 1.95 112.252 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -107.1 144.03 34.39 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.657 1.183 . . . . 2.1099999999999999 112.536 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 m -138.72 153.71 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.187 0.995 . . . . 1.48 113.555 -172.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -118.37 146.25 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.001 1.32 . . . . 2.3100000000000001 114.031 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.1 143.82 31.47 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.207 1.403 . . . . 1.9199999999999999 112.154 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.62 -4.04 66.21 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.845 1.098 . . . . 0.68000000000000005 115.845 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.4 p -74.25 159.38 32.56 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.074 1.437 . . . . 1.6299999999999999 111.758 169.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.58 140.58 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.397 1.079 . . . . 2.0 111.507 -173.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -81.86 139.29 34.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.502 1.121 . . . . 2.6800000000000002 111.475 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -146.35 56.88 1.18 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.5 1.296 . . . . 3.2200000000000002 114.5 168.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -160.03 -59.36 0.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.374 1.25 . . . . 3.3999999999999999 114.374 167.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -164.21 168.96 38.87 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.701 1.143 . . . . 2.0800000000000001 113.497 -168.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.8 p -84.15 148.18 26.91 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.789 1.033 . . . . 2.75 113.789 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -137.5 161.3 36.76 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.993 1.717 . . . . 2.3500000000000001 111.629 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.7 mp -108.42 119.86 40.74 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.075 1.35 . . . . 3.1699999999999999 110.348 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.9 mt -107.13 119.74 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.267 1.427 . . . . 3.5899999999999999 110.153 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.6 p -79.97 117.11 20.52 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.856 -1.153 . . . . 2.4500000000000002 110.248 170.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.63 121.83 28.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.616 0.722 . . . . 1.3200000000000001 112.701 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -115.31 -9.77 12.14 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.558 1.543 . . . . 2.6499999999999999 113.471 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -138.26 146.0 41.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.5 1.52 . . . . 2.0699999999999998 111.474 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 m -100.4 160.75 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.47 1.508 . . . . 2.4900000000000002 110.1 167.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.96 -39.13 56.33 Favored Glycine 0 N--CA 1.472 1.074 0 N-CA-C 116.556 1.382 . . . . 1.3600000000000001 116.556 -166.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.22 -36.37 71.83 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.654 1.227 . . . . 2.3599999999999999 113.346 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.66 -9.06 58.26 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.322 1.23 . . . . 2.3300000000000001 114.322 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.8 p -58.8 152.64 18.64 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.158 -0.964 . . . . 2.2400000000000002 113.148 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 t -56.82 -39.22 73.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.756 1.222 . . . . 2.8199999999999998 110.567 169.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.39 -43.36 99.01 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.014 1.726 . . . . 2.21 112.362 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.7 t -67.4 -35.14 78.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.498 0.719 . . . . 2.9900000000000002 111.839 176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.29 -43.37 70.53 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.364 0.529 . . . . 1.76 111.739 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.6 mt -54.06 -51.4 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.143 0.977 . . . . 2.9500000000000002 111.589 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.478 0.959 0 O-C-N 120.99 -1.069 . . . . 1.5900000000000001 113.04 179.37 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 111.797 0.295 . . . . 2.4700000000000002 111.797 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.39 -33.29 65.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.9 0.88 . . . . 3.71 113.25 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.36 -44.65 35.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.791 0.723 . . . . 2.3799999999999999 112.581 169.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -64.15 -34.13 77.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.317 0.858 . . . . 3.3500000000000001 113.317 -174.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.23 -36.38 73.1 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.497 1.044 . . . . 2.2599999999999998 113.047 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.0 mm -67.01 -37.24 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 118.764 0.711 . . . . 3.25 111.304 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.0 m -72.9 -23.81 60.76 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.387 -0.821 . . . . 2.1600000000000001 112.754 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.7 mt -72.38 -25.6 61.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.909 1.284 . . . . 2.8999999999999999 112.905 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -68.49 106.09 2.43 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.721 1.146 . . . . 3.4399999999999999 110.76 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 155.31 28.23 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.173 1.389 . . . . 2.3599999999999999 113.467 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.7 m -95.78 -31.14 13.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.388 1.475 . . . . 2.9900000000000002 114.281 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.35 159.83 41.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.184 0.994 . . . . 2.8500000000000001 113.33 -169.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.45 163.49 32.96 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.567 1.547 . . . . 1.5 112.776 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.5 m -119.65 97.52 5.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.559 1.544 . . . . 1.5800000000000001 110.704 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.2 mt -84.89 133.92 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.369 1.068 . . . . 1.48 110.008 -172.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -107.81 127.34 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.506 1.122 . . . . 2.75 111.111 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 125.4 1.48 . . . . 2.5499999999999998 111.388 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 120.993 0.425 . . . . 3.9700000000000002 111.015 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -142.2 145.66 34.37 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.179 1.392 . . . . 2.6400000000000001 110.959 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -118.48 149.06 41.92 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.495 1.665 . . . . 2.5099999999999998 115.495 -168.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -104.07 139.0 39.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.577 1.951 . . . . 2.9199999999999999 109.65 169.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -98.73 121.23 40.41 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.043 0.937 . . . . 2.4900000000000002 109.408 172.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.62 159.86 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 115.288 1.588 . . . . 1.3799999999999999 115.288 -167.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.09 150.74 30.17 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.434 1.093 . . . . 3.1699999999999999 109.761 166.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.05 -21.27 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.334 1.054 . . . . 1.76 113.646 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.47 -20.14 62.81 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.361 -1.462 . . . . 3.0899999999999999 112.95 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.1 mt -107.22 -8.93 16.25 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.253 1.575 . . . . 1.97 115.253 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.15 148.89 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.297 1.039 . . . . 1.9199999999999999 111.051 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -122.3 165.07 16.81 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.121 1.368 . . . . 4.0899999999999999 114.204 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -69.09 26.19 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 127.011 2.124 . . . . 3.5 116.213 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.79 9.65 2.32 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.003 1.764 . . . . 1.4099999999999999 113.776 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -89.47 165.07 14.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.126 1.37 . . . . 2.9100000000000001 112.821 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.1 mt -122.21 128.28 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.143 1.377 . . . . 2.3700000000000001 110.167 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.1 mm -118.06 130.54 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.407 1.483 . . . . 1.6699999999999999 113.348 -167.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -82.77 128.08 34.05 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.525 1.13 . . . . 3.3399999999999999 112.408 172.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.39 125.26 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.666 1.186 . . . . 2.3599999999999999 111.856 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.81 158.57 42.03 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.506 1.522 . . . . 2.1699999999999999 113.205 -175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.82 123.08 9.11 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.268 3.312 . . . . 1.78 113.489 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.72 -0.75 88.13 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.879 1.228 . . . . 0.95999999999999996 115.022 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.9 -169.03 30.21 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 118.757 1.278 . . . . 1.05 114.116 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -130.18 158.85 38.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.12 1.768 . . . . 3.4700000000000002 111.462 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -86.68 118.66 70.53 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.621 0.768 . . . . 3.8700000000000001 109.277 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -89.68 -13.84 2.61 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.04 1.827 . . . . 1.0800000000000001 115.865 -168.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.0 159.82 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 128.992 2.917 . . . . 1.8100000000000001 107.699 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.0 147.51 25.7 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.653 0.983 . . . . 2.0 113.653 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.45 -159.3 32.21 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 114.946 0.738 . . . . 1.01 114.946 -173.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -109.12 145.43 35.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.702 1.601 . . . . 6.0199999999999996 113.541 -169.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 t -106.89 119.88 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 127.396 2.279 . . . . 1.79 108.276 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 pt -136.61 34.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 119.224 0.92 . . . . 2.6299999999999999 113.399 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.15 127.97 2.21 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.024 1.73 . . . . 3.5899999999999999 107.454 167.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.88 178.03 40.76 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 122.874 1.263 . . . . 0.93999999999999995 115.402 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -154.95 110.65 3.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.279 1.032 . . . . 3.2200000000000002 112.737 -166.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.0 p -137.74 175.05 9.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.609 1.964 . . . . 3.8599999999999999 113.936 -168.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 38.6 ttm -114.72 145.13 42.41 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.321 1.048 . . . . 1.8899999999999999 109.619 165.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.37 142.91 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.067 1.347 . . . . 0.94999999999999996 111.771 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -113.13 113.23 25.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.915 1.686 . . . . 1.8799999999999999 110.747 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -134.39 14.37 3.79 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.084 1.754 . . . . 2.52 114.336 -170.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.6 p -58.49 -13.95 6.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 117.543 2.423 . . . . 1.6499999999999999 117.543 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -93.86 -33.32 13.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.999 1.32 . . . . 2.25 111.684 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.0 mm -73.79 -62.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.575 -0.703 . . . . 2.1499999999999999 110.047 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.6 p -94.23 -13.19 26.84 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.007 1.323 . . . . 2.1200000000000001 113.382 -171.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.43 10.31 78.93 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.659 1.6 . . . . 1.49 113.827 -172.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.88 98.87 0.58 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.684 1.742 . . . . 2.71 109.385 170.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.64 28.41 0.26 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.988 1.315 . . . . 2.7000000000000002 112.496 -171.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.2 ptm -155.16 145.0 15.55 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.377 2.271 . . . . 4.2000000000000002 109.301 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.42 148.92 21.22 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.111 2.541 . . . . 1.9399999999999999 112.095 -172.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.55 136.21 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.829 1.252 . . . . 2.3399999999999999 112.416 -168.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.0 150.15 29.0 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.079 0.952 . . . . 1.97 113.125 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -132.26 150.87 52.06 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.131 1.772 . . . . 2.3300000000000001 111.598 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -143.78 173.88 4.06 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 129.146 2.978 . . . . 4.2699999999999996 108.784 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -58.06 138.77 87.68 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 CA-C-N 121.058 1.414 . . . . 1.24 110.862 168.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.22 14.61 74.0 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.205 1.383 . . . . 1.1399999999999999 115.083 -170.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.8 m -97.74 164.87 12.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.391 1.596 . . . . 2.5 110.72 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.8 p -124.03 159.96 28.73 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.107 -0.996 . . . . 2.2999999999999998 113.334 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.65 161.06 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.616 1.966 . . . . 1.8300000000000001 112.151 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.84 154.86 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.847 2.059 . . . . 2.3500000000000001 112.026 172.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.2 150.45 48.29 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.37 0.878 . . . . 1.8700000000000001 113.37 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.64 -5.12 62.01 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.661 1.124 . . . . 0.79000000000000004 115.219 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.0 p -77.68 157.46 30.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.792 1.237 . . . . 1.76 111.663 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mm -108.39 137.2 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.884 0.874 . . . . 1.7 111.482 -170.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.66 155.13 21.24 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.877 1.671 . . . . 3.4500000000000002 112.905 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -129.77 124.49 33.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.642 1.577 . . . . 3.02 109.075 166.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 93' ' ' GLY . 34.4 t30 45.94 -132.37 1.03 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.101 2.161 . . . . 3.8500000000000001 110.294 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.401 ' H ' ' ND2' ' A' ' 92' ' ' ASN . . . 88.98 -60.23 3.85 Favored Glycine 0 CA--C 1.527 0.8 0 O-C-N 120.069 -1.644 . . . . 3.4199999999999999 116.488 166.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.4 m 47.44 77.16 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.398 1.479 . . . . 2.6400000000000001 111.781 -168.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.2 164.2 12.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.402 1.081 . . . . 2.5600000000000001 113.421 -166.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mp -119.54 128.7 54.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.158 0.983 . . . . 3.2799999999999998 110.527 168.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.5 mm -115.74 122.55 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.835 1.654 . . . . 2.5600000000000001 110.955 -170.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.07 103.34 16.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.756 1.222 . . . . 4.2400000000000002 110.141 176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.07 131.35 36.23 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.355 1.062 . . . . 1.1499999999999999 112.001 -174.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.35 6.01 7.0 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.01 1.485 . . . . 3.0499999999999998 115.01 -175.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -142.05 147.31 36.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.492 1.117 . . . . 1.8 111.842 170.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 p -86.64 163.25 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.442 1.097 . . . . 3.8799999999999999 110.389 170.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.05 -37.67 94.29 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 120.241 -1.537 . . . . 1.4299999999999999 114.712 -169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.67 -32.06 71.27 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.244 1.018 . . . . 2.7000000000000002 112.822 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.42 -16.74 60.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.78 1.232 . . . . 2.6400000000000001 113.946 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.9 p -68.37 159.87 30.64 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.902 1.228 . . . . 2.23 113.714 -169.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.3 t -66.27 -31.12 71.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.396 -0.82 . . . . 3.1499999999999999 111.539 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.3 mp -57.44 -53.09 62.05 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.839 -1.163 . . . . 2.3399999999999999 111.828 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.6 p -70.5 -24.69 62.88 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.196 0.998 . . . . 2.1600000000000001 111.901 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -72.76 -42.61 63.82 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.478 0.918 . . . . 2.1800000000000002 113.478 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.3 mt -56.68 -49.19 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.031 -1.043 . . . . 2.7200000000000002 110.259 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 113.379 0.881 . . . . 1.8899999999999999 113.379 178.594 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 115.149 1.537 . . . . 2.3300000000000001 115.149 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.9 tp -68.17 -31.64 71.33 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.608 -1.308 . . . . 2.5600000000000001 113.731 -169.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.89 -21.01 55.56 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.894 -1.129 . . . . 2.2599999999999998 113.532 169.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -69.39 -41.41 76.49 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.813 -1.179 . . . . 3.5800000000000001 111.366 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.19 -43.56 82.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.241 1.016 . . . . 2.0 112.162 177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.02 -33.64 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.294 -0.879 . . . . 2.3300000000000001 111.998 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.9 m -75.77 -19.62 58.87 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.285 1.034 . . . . 1.97 113.177 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mt -68.12 -32.13 72.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.585 1.954 . . . . 2.8599999999999999 113.006 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -57.11 131.76 50.88 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.853 1.206 . . . . 4.46 111.952 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.08 144.93 53.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.835 -0.621 . . . . 2.75 109.489 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 p -78.52 -20.98 49.55 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.118 1.155 . . . . 4.4199999999999999 114.118 -174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -137.76 158.65 43.91 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.61 1.337 . . . . 3.9700000000000002 114.61 -169.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.86 172.8 12.19 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.595 1.958 . . . . 1.6799999999999999 112.476 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.6 m -131.45 102.41 5.93 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.135 1.774 . . . . 1.9299999999999999 111.141 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.5 mt -80.38 128.62 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.045 1.338 . . . . 1.3700000000000001 109.387 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.51 132.97 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.804 0.842 . . . . 3.3500000000000001 112.533 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.478 0.943 0 C-N-CA 124.611 1.165 . . . . 3.5 113.403 -169.149 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 109.051 -0.722 . . . . 4.5199999999999996 109.051 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 t -124.93 144.33 50.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.138 1.375 . . . . 2.73 111.207 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -141.79 127.25 18.86 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.947 1.299 . . . . 2.3399999999999999 110.054 -171.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.4 133.35 53.43 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.723 -1.236 . . . . 3.2799999999999998 111.12 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.69 123.47 43.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.082 0.856 . . . . 3.0499999999999998 110.965 176.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -129.61 165.41 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.243 1.417 . . . . 2.3199999999999998 112.808 -168.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -80.18 151.1 29.9 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.115 1.366 . . . . 3.6899999999999999 110.165 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.35 -23.09 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 120.968 -1.083 . . . . 2.6899999999999999 113.117 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -70.05 -18.16 63.27 Favored 'General case' 0 CA--C 1.552 1.053 0 O-C-N 120.813 -1.179 . . . . 3.7799999999999998 113.741 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -110.52 -3.36 16.04 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.093 1.516 . . . . 2.9100000000000001 115.093 -169.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -94.63 145.33 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.931 1.692 . . . . 1.97 111.067 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -122.79 166.72 14.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.713 2.405 . . . . 3.3999999999999999 114.041 -175.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -73.86 16.18 0.24 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.787 2.143 . . . . 4.1900000000000004 116.787 -169.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.97 11.25 3.64 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.218 1.865 . . . . 1.6200000000000001 113.829 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -79.64 152.74 29.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.332 1.566 . . . . 3.54 112.508 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.24 120.08 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.116 1.366 . . . . 3.0800000000000001 108.922 173.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.6 mm -118.76 125.25 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.031 0.932 . . . . 1.52 113.198 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -80.03 128.69 33.78 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.378 0.671 . . . . 2.75 110.632 167.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 p -103.14 137.07 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.137 0.975 . . . . 1.8799999999999999 111.113 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -88.58 160.66 44.18 Favored Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 113.35 0.87 . . . . 1.99 113.35 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.01 136.29 64.52 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.67 2.247 . . . . 1.8200000000000001 110.41 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.64 -3.97 23.49 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.443 1.497 . . . . 0.95999999999999996 116.408 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.97 178.26 53.9 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.203 1.382 . . . . 0.97999999999999998 114.9 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -126.65 148.0 49.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.659 1.584 . . . . 3.3300000000000001 112.616 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -82.73 126.68 72.6 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.394 0.677 . . . . 3.04 112.601 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -90.89 -22.6 0.61 Allowed 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.122 3.215 . . . . 1.1200000000000001 114.713 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 m -147.67 170.3 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 128.524 2.73 . . . . 1.8600000000000001 108.721 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -99.22 156.35 17.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.106 1.15 . . . . 1.6799999999999999 114.106 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.8 -168.1 39.87 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 115.845 1.098 . . . . 0.73999999999999999 115.845 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -112.17 138.72 48.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.43 1.892 . . . . 5.2199999999999998 111.552 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.82 127.84 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 127.016 2.126 . . . . 1.72 109.399 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.2 pt -140.61 31.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.494 0.718 . . . . 1.79 112.844 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -167.3 133.59 2.2 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.415 1.486 . . . . 2.5699999999999998 109.821 169.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.41 -177.8 48.86 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.075 1.19 . . . . 0.79000000000000004 116.075 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -147.75 113.02 5.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.864 1.266 . . . . 3.8500000000000001 112.402 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.79 167.27 22.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.488 1.115 . . . . 1.8300000000000001 111.607 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.7 ttm -105.3 145.57 30.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.955 0.902 . . . . 2.0899999999999999 109.945 169.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.57 136.0 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.215 1.006 . . . . 1.0600000000000001 112.054 -170.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -100.89 132.66 46.19 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.067 1.347 . . . . 2.21 111.631 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -133.62 16.46 3.98 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.101 1.519 . . . . 1.8200000000000001 115.101 -169.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 98.0 p -44.38 -32.45 1.35 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 119.628 3.196 . . . . 2.0800000000000001 119.628 -166.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -95.09 -41.82 8.92 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.648 1.113 . . . . 2.6800000000000002 111.202 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.4 mm -69.04 -64.32 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.889 1.276 . . . . 1.8500000000000001 111.498 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.4 p -93.69 -11.3 31.85 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.202 1.401 . . . . 2.2799999999999998 112.327 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.54 2.16 87.29 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.021 1.296 . . . . 1.26 115.083 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -55.68 -46.46 77.58 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.174 0.987 . . . . 2.3300000000000001 113.542 -170.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 55.94 27.25 10.85 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.679 1.592 . . . . 3.23 113.369 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.7 ttt -152.79 136.85 10.36 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 131.158 3.783 . . . . 4.5499999999999998 105.312 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.32 153.51 35.71 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.719 2.28 . . . . 2.02 112.881 -172.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.8 t -128.39 134.38 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.735 1.614 . . . . 2.3700000000000001 112.073 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.55 134.12 36.48 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.545 1.138 . . . . 1.9199999999999999 113.488 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -117.7 143.52 46.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.635 1.974 . . . . 1.1000000000000001 110.655 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -142.93 175.34 2.94 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 127.358 2.263 . . . . 5.0 109.465 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -59.18 127.82 25.42 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 CA-C-N 122.182 1.815 . . . . 1.04 111.325 170.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.29 33.59 11.63 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.659 1.123 . . . . 1.03 114.749 -169.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -121.09 170.82 9.17 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.166 1.386 . . . . 2.5299999999999998 111.173 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.8 p -122.74 151.22 41.8 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.493 -1.379 . . . . 1.79 113.449 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.72 156.37 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.936 1.694 . . . . 2.02 112.272 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -123.97 159.06 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.213 1.805 . . . . 1.8700000000000001 112.355 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.14 149.99 49.43 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.769 -0.582 . . . . 1.6000000000000001 112.479 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.7 -2.42 83.0 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 115.293 0.877 . . . . 1.03 115.293 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.88 153.14 32.92 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 117.783 0.792 . . . . 3.3199999999999998 112.05 168.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mm -108.89 129.84 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.988 1.315 . . . . 2.0299999999999998 110.493 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -94.77 142.38 27.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.04 1.736 . . . . 1.6599999999999999 111.856 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.65 -101.33 0.11 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.242 1.201 . . . . 5.7199999999999998 114.242 -174.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -98.42 -41.36 7.84 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.324 1.602 . . . . 3.6600000000000001 115.324 -167.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.49 140.37 18.11 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 119.487 1.04 . . . . 1.8500000000000001 114.041 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t -84.93 129.35 34.82 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.735 0.814 . . . . 3.5600000000000001 110.413 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.2 mt -120.69 158.72 26.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.375 1.47 . . . . 2.0 110.902 -173.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.97 129.75 56.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.166 0.587 . . . . 2.5 109.88 168.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.31 128.19 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.596 1.558 . . . . 2.1099999999999999 110.222 -173.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 23.4 p -81.84 111.16 17.8 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.288 -1.004 . . . . 2.52 108.288 168.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.29 142.96 37.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.869 0.868 . . . . 1.3500000000000001 110.848 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -132.21 3.5 3.99 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.876 1.806 . . . . 4.04 115.876 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -145.16 150.81 37.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.842 1.257 . . . . 2.23 111.473 170.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.8 m -81.88 171.41 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.206 1.002 . . . . 2.6000000000000001 110.85 168.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.75 -28.89 73.3 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 120.756 -1.215 . . . . 1.73 114.699 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.91 -42.75 60.2 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.792 1.296 . . . . 2.79 113.572 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -78.73 -10.2 59.69 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 116.497 2.036 . . . . 2.9100000000000001 116.497 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.9 t -83.95 156.48 22.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.464 1.505 . . . . 3.7999999999999998 113.417 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.8 m -39.33 -44.28 1.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.99 2.116 . . . . 3.1499999999999999 114.308 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.17 -46.73 85.8 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.756 1.162 . . . . 2.1099999999999999 111.847 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.3 t -70.19 -35.65 74.09 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.851 0.861 . . . . 3.0099999999999998 111.088 173.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -64.25 -35.73 81.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.377 0.671 . . . . 2.1699999999999999 112.288 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.6 mt -64.69 -58.99 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.466 1.506 . . . . 2.3799999999999999 110.728 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 113.539 0.941 . . . . 2.4100000000000001 113.539 -171.737 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 114.632 1.345 . . . . 2.1099999999999999 114.632 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 35.3 tp -63.63 -42.62 98.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.903 1.229 . . . . 2.3300000000000001 113.313 -168.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.8 -21.61 57.17 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.597 -1.314 . . . . 3.1000000000000001 113.161 169.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -67.17 -39.56 86.47 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.776 1.171 . . . . 3.46 111.446 -170.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -49.47 -46.15 47.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.315 0.646 . . . . 2.4100000000000001 110.998 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.2 mm -71.52 -27.99 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.652 1.181 . . . . 3.1000000000000001 113.294 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.9 m -70.91 -37.09 72.92 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.307 1.043 . . . . 1.3 112.83 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.05 -17.34 51.88 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.092 1.145 . . . . 3.73 114.092 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.65 135.52 55.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.691 1.596 . . . . 2.8500000000000001 113.185 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.13 150.36 48.29 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.399 0.679 . . . . 2.23 112.104 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -100.56 -28.55 12.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.765 1.226 . . . . 2.7000000000000002 112.193 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -140.64 152.93 45.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.054 1.342 . . . . 3.2999999999999998 112.096 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.08 157.84 44.16 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.638 1.575 . . . . 2.2400000000000002 113.272 -169.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 m -94.5 109.67 21.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.784 0.834 . . . . 2.4500000000000002 112.849 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.7 mt -84.48 125.09 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.067 0.947 . . . . 1.5 109.55 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.72 130.17 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.986 0.914 . . . . 2.8700000000000001 110.691 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.474 0.756 0 C-N-CA 124.594 1.158 . . . . 2.6200000000000001 111.09 -177.759 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 109.108 -0.701 . . . . 4.46 109.108 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -140.59 138.44 34.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.81 0.844 . . . . 2.73 111.588 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -137.39 132.0 32.86 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.195 0.998 . . . . 3.0299999999999998 110.915 -173.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.2 140.36 48.62 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.243 1.417 . . . . 3.46 109.925 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -100.45 117.77 35.29 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.308 0.958 . . . . 2.2999999999999998 109.22 168.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.99 156.96 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.857 1.263 . . . . 1.8600000000000001 111.946 -168.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -76.84 151.62 35.8 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.46 -0.775 . . . . 3.7799999999999998 111.273 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.0 -19.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 115.037 1.495 . . . . 1.95 115.037 -172.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.95 -19.28 52.13 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 120.333 -1.479 . . . . 3.9700000000000002 113.668 173.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.8 mt -91.36 -6.85 52.32 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.107 1.763 . . . . 2.7799999999999998 113.43 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.26 143.03 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.218 1.807 . . . . 1.8600000000000001 110.255 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.32 172.73 10.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.17 0.988 . . . . 4.3899999999999997 112.316 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -65.66 21.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 117.487 2.403 . . . . 4.5700000000000003 117.487 -172.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.7 42.95 0.81 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.219 1.866 . . . . 1.6799999999999999 111.714 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -122.66 159.32 28.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.894 1.678 . . . . 2.1899999999999999 110.584 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 53.7 mt -116.22 125.79 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.18 0.992 . . . . 2.2999999999999998 109.834 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.5 mm -116.92 127.19 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.936 1.295 . . . . 1.48 112.195 -168.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -79.37 121.66 25.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.693 0.797 . . . . 4.4199999999999999 109.209 168.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.8 124.44 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.247 1.019 . . . . 1.74 109.29 170.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.8 m -85.99 156.68 57.74 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 123.323 0.649 . . . . 2.6600000000000001 112.654 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.05 130.71 35.66 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.746 2.297 . . . . 2.0800000000000001 111.848 171.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.1 -7.44 29.34 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 124.812 1.196 . . . . 1.03 115.07 -171.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.51 -177.83 50.62 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.341 1.448 . . . . 1.0900000000000001 114.234 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -125.65 158.18 35.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.22 1.408 . . . . 2.6499999999999999 112.29 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -88.78 129.08 49.97 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.901 0.881 . . . . 3.6600000000000001 111.859 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.99 -25.59 1.41 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.747 2.965 . . . . 1.0 115.207 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -147.85 167.33 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.833 2.453 . . . . 2.2599999999999998 108.749 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.21 149.11 24.83 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.023 0.828 . . . . 1.95 111.429 174.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -165.15 35.72 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 114.552 0.581 . . . . 1.05 114.552 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -111.5 144.49 40.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.473 1.509 . . . . 4.4900000000000002 112.314 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.13 134.03 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.863 2.465 . . . . 1.97 108.225 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 pt -138.35 30.31 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 122.253 1.025 . . . . 2.2000000000000002 112.42 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -168.54 144.44 3.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.582 1.953 . . . . 3.3799999999999999 109.552 167.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 177.18 38.94 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 117.268 1.667 . . . . 1.1799999999999999 117.268 167.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -143.78 37.6 1.32 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 115.619 1.711 . . . . 2.9500000000000002 115.619 -168.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.406 ' H ' HD23 ' A' ' 95' ' ' LEU . 34.7 m -77.3 157.61 30.63 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.718 -1.239 . . . . 2.0499999999999998 112.247 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.3 ttm -92.89 140.13 29.82 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.841 -0.618 . . . . 2.0699999999999998 110.083 168.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.5 t -126.24 143.48 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.355 1.462 . . . . 0.97999999999999998 111.905 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -106.22 111.09 23.55 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.014 1.725 . . . . 2.1400000000000001 111.429 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.3 16.24 5.01 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.792 1.637 . . . . 1.8999999999999999 114.662 -172.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.5 p -65.6 -26.92 68.06 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.659 1.726 . . . . 1.9299999999999999 115.659 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -79.43 -48.21 14.35 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.36 0.982 . . . . 2.6699999999999999 110.686 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.5 mm -65.73 -55.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.657 0.783 . . . . 2.5600000000000001 110.499 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.7 p -93.57 -11.63 31.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.407 1.083 . . . . 2.73 113.708 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.07 13.48 82.95 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 119.312 -0.716 . . . . 1.4399999999999999 113.785 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.58 175.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.14 2.176 . . . . 2.9100000000000001 113.581 171.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.77 6.45 1.61 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.224 1.565 . . . . 3.2000000000000002 115.224 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -149.55 148.83 27.08 Favored Pre-proline 0 C--O 1.24 0.604 0 O-C-N 120.825 -1.172 . . . . 5.0599999999999996 109.272 168.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.08 157.85 60.13 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.565 2.176 . . . . 1.79 111.395 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.8 t -117.25 127.81 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.832 1.253 . . . . 1.6799999999999999 112.353 -167.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.21 130.17 35.2 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.274 0.629 . . . . 2.0299999999999998 111.213 173.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.12 162.92 12.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.684 1.194 . . . . 1.1100000000000001 111.649 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -150.6 165.17 18.0 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 127.571 2.349 . . . . 4.7400000000000002 110.342 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.1 129.79 31.66 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 CA-C-N 121.075 1.42 . . . . 1.24 108.697 165.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.37 44.67 6.85 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.344 0.973 . . . . 1.1499999999999999 113.576 -169.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 t -131.39 151.2 51.75 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.346 1.458 . . . . 1.8799999999999999 111.698 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.0 p -101.4 147.58 26.17 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.788 1.631 . . . . 2.5 113.151 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 m -139.48 151.71 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.197 1.399 . . . . 2.0600000000000001 112.64 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -112.88 147.08 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.94 1.296 . . . . 2.5 112.736 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.66 144.31 14.24 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.864 -1.062 . . . . 1.6899999999999999 111.719 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.57 -7.58 57.49 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 116.203 1.241 . . . . 0.84999999999999998 116.203 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.6 p -68.98 160.73 30.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.398 1.599 . . . . 1.7 110.962 168.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.55 146.18 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.115 0.966 . . . . 2.1600000000000001 110.624 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -108.45 153.04 23.89 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.832 1.253 . . . . 1.6000000000000001 113.465 -174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -115.28 -167.7 1.28 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.662 1.985 . . . . 3.6099999999999999 109.805 170.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -77.66 140.5 39.6 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 119.649 -1.907 . . . . 4.79 111.574 -174.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.05 11.31 0.42 Allowed Glycine 0 CA--C 1.542 1.741 0 C-N-CA 124.978 1.275 . . . . 3.5099999999999998 114.012 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m 23.8 85.67 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 129.58 3.152 . . . . 2.46 115.846 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 62' ' ' SER . 57.7 mt -87.33 150.69 23.68 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.402 0.681 . . . . 2.3399999999999999 112.761 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.73 128.93 51.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.679 0.792 . . . . 2.8300000000000001 110.244 167.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.0 mm -111.86 126.47 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.837 1.655 . . . . 3.1800000000000002 110.449 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.2 p -79.41 104.5 10.06 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.899 0.857 . . . . 2.8199999999999998 109.718 169.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.94 113.69 14.91 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.178 -0.951 . . . . 2.0499999999999998 109.393 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.5 p -120.21 16.2 12.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.708 1.203 . . . . 3.6000000000000001 113.026 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -148.86 146.32 27.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.075 1.75 . . . . 2.1600000000000001 110.417 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 m -100.56 164.16 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.701 0.8 . . . . 2.1899999999999999 109.625 165.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -51.45 -45.09 53.63 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 114.523 0.569 . . . . 1.5800000000000001 114.523 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.2 -23.57 67.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.325 1.232 . . . . 2.2200000000000002 114.325 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -78.7 -25.96 44.81 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.986 1.476 . . . . 2.5800000000000001 114.986 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 p -52.36 143.21 15.51 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.838 1.792 . . . . 2.3599999999999999 115.838 -164.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.6 t -60.04 -32.22 70.71 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.067 0.947 . . . . 2.9500000000000002 111.499 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.3 tp -52.97 -44.62 67.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.424 1.49 . . . . 2.4900000000000002 112.195 168.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.0 p -71.87 -24.5 61.69 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.154 0.798 . . . . 3.6600000000000001 113.154 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -71.25 -39.56 71.54 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.826 -1.171 . . . . 2.7200000000000002 112.014 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 96.3 mt -53.49 -55.14 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.506 0.722 . . . . 3.0299999999999998 109.968 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 114.251 1.204 . . . . 2.96 114.251 178.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 113.797 1.036 . . . . 2.3599999999999999 113.797 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 47.3 tp -67.84 -35.05 77.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.797 1.18 . . . . 2.1000000000000001 112.507 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.63 -36.37 62.9 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.374 0.534 . . . . 2.8599999999999999 111.481 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -56.54 -36.9 69.77 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.801 1.24 . . . . 3.7599999999999998 114.255 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -48.62 -49.51 36.73 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.753 1.16 . . . . 2.1899999999999999 111.489 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.97 -29.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.625 1.17 . . . . 3.2200000000000002 112.039 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -73.01 -26.35 61.29 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.475 -0.766 . . . . 1.45 112.907 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.36 -33.01 72.44 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.239 0.927 . . . . 2.6899999999999999 112.362 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -62.02 147.1 48.24 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.167 0.894 . . . . 4.7400000000000002 111.655 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.9 -21.01 64.37 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.235 2.309 . . . . 3.79 117.235 -167.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 m 66.73 -28.17 0.13 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.233 1.813 . . . . 2.96 114.545 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -137.82 156.62 47.74 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.127 2.171 . . . . 2.7999999999999998 112.981 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.12 165.73 26.63 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.495 1.518 . . . . 2.0099999999999998 113.7 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.2 m -116.29 108.13 15.71 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.966 1.706 . . . . 1.79 111.274 170.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.8 mt -85.94 141.08 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.674 1.189 . . . . 2.0600000000000001 109.727 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 m -114.63 133.39 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.195 0.998 . . . . 2.7599999999999998 113.285 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.476 0.852 0 C-N-CA 125.985 1.714 . . . . 2.6299999999999999 110.093 -174.799 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.338 0.59 . . . . 3.3300000000000001 110.6 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -78.87 125.82 29.88 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.656 1.182 . . . . 2.4700000000000002 110.407 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -103.0 160.79 14.31 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.951 -1.093 . . . . 3.3199999999999998 113.055 -174.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.94 125.28 35.1 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.05 1.34 . . . . 4.5300000000000002 109.486 168.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -91.82 121.75 33.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.859 -1.164 . . . . 2.04 107.859 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 m -136.32 157.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.077 0.951 . . . . 1.6899999999999999 113.538 -167.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.8 145.6 32.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.775 0.83 . . . . 2.9700000000000002 110.29 167.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.63 -29.65 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 113.287 0.847 . . . . 1.8899999999999999 113.287 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -74.35 -3.77 32.35 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.895 1.278 . . . . 3.9500000000000002 113.551 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.8 -13.52 12.61 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.535 1.934 . . . . 2.5600000000000001 114.617 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.51 147.85 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 119.556 1.071 . . . . 2.02 111.246 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.76 163.76 20.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.016 1.726 . . . . 3.6600000000000001 114.298 -176.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -71.52 18.82 0.07 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 117.621 2.452 . . . . 4.5499999999999998 117.621 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.17 4.33 6.35 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.019 1.295 . . . . 1.9399999999999999 115.548 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -111.29 169.67 8.63 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.633 1.173 . . . . 2.27 112.565 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.8 mt -123.75 130.75 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.666 1.586 . . . . 2.29 110.427 -170.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -117.99 136.04 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.438 1.495 . . . . 2.0 113.871 -166.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -87.09 143.14 27.44 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.567 0.951 . . . . 3.7200000000000002 113.567 169.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.9 p -132.25 134.74 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.439 1.095 . . . . 1.74 111.479 169.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.14 170.41 5.36 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 125.339 1.456 . . . . 2.27 112.847 -170.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.33 132.07 50.02 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.785 2.323 . . . . 1.96 112.547 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.11 -8.27 39.35 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.939 1.733 . . . . 0.91000000000000003 114.992 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.78 166.56 54.57 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 118.933 1.366 . . . . 0.97999999999999998 113.813 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -119.61 153.34 35.64 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.037 1.335 . . . . 4.0 112.255 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -79.29 134.97 58.09 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.374 0.669 . . . . 2.9700000000000002 112.45 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.14 -32.58 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.983 2.456 . . . . 0.98999999999999999 115.313 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 m -145.85 171.32 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 126.984 2.114 . . . . 1.9399999999999999 109.183 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.96 144.5 25.4 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.089 0.859 . . . . 2.3900000000000001 112.399 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.62 -164.82 35.89 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.013 1.165 . . . . 0.88 116.013 -175.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -107.94 145.64 33.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.738 2.015 . . . . 6.1500000000000004 112.693 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.66 133.76 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 127.581 2.352 . . . . 2.0899999999999999 110.443 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.73 37.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.936 1.087 . . . . 2.3500000000000001 113.936 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -165.29 136.53 3.98 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.839 -1.163 . . . . 2.3700000000000001 110.159 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.41 -174.31 50.39 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.844 1.212 . . . . 0.76000000000000001 115.992 168.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -149.67 112.0 4.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.27 1.028 . . . . 2.8100000000000001 112.222 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.55 154.95 45.78 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.238 1.015 . . . . 1.7 112.814 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.4 ttm -104.32 128.87 52.19 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.689 1.195 . . . . 1.8899999999999999 108.969 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 86.1 t -115.99 136.6 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.68 1.592 . . . . 1.03 113.147 -166.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -91.04 100.68 13.49 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.348 -0.845 . . . . 1.98 111.607 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -93.65 4.74 53.48 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.318 1.447 . . . . 2.0499999999999998 113.963 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -38.97 -45.59 1.22 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.923 2.489 . . . . 2.4900000000000002 116.842 -169.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.74 -32.01 28.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.024 0.829 . . . . 2.3199999999999998 111.924 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.15 -58.13 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.796 1.639 . . . . 2.0899999999999999 111.642 -171.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.9 p -102.7 -5.5 23.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.757 1.223 . . . . 2.0 113.036 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.98 18.82 79.75 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.445 1.498 . . . . 1.1499999999999999 113.955 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -67.15 -53.29 31.96 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.782 0.833 . . . . 2.4199999999999999 112.035 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 64.18 29.26 14.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.433 1.893 . . . . 2.9100000000000001 112.882 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.2 ptp -157.77 128.77 3.68 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 130.21 3.404 . . . . 5.2400000000000002 106.489 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.98 156.95 51.87 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.032 1.821 . . . . 1.9399999999999999 114.104 -167.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.9 t -120.02 129.55 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 126.96 2.104 . . . . 2.1400000000000001 111.299 -168.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.7 134.63 36.41 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.34 -0.85 . . . . 1.75 112.809 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -120.34 151.3 39.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.302 1.841 . . . . 1.0800000000000001 110.841 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -149.24 174.66 3.27 Favored Pre-proline 0 N--CA 1.483 1.175 0 C-N-CA 127.866 2.466 . . . . 3.2400000000000002 111.491 -168.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.24 129.67 24.84 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 CA-C-N 122.045 1.766 . . . . 0.97999999999999998 110.592 167.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.24 46.77 9.78 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.59 1.09 . . . . 1.1000000000000001 111.918 -168.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.8 t -126.34 160.27 30.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.615 1.566 . . . . 1.45 111.365 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.0 p -121.0 146.09 47.06 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.887 -1.133 . . . . 1.8300000000000001 111.817 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.05 155.0 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.064 1.345 . . . . 1.3400000000000001 112.952 -171.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.76 147.81 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.575 1.95 . . . . 2.1899999999999999 112.503 169.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.66 151.46 33.54 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.902 1.281 . . . . 1.8999999999999999 113.136 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.03 -6.6 59.0 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.928 1.251 . . . . 0.75 115.715 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.5 p -76.53 159.84 30.0 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.763 1.282 . . . . 1.5800000000000001 111.758 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -110.24 125.77 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.138 0.975 . . . . 1.79 112.112 -169.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -95.5 127.53 41.61 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.251 1.82 . . . . 1.6799999999999999 112.099 -175.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -150.69 76.9 1.27 Allowed 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.087 1.884 . . . . 3.9300000000000002 116.087 -171.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -171.59 -60.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.393 1.877 . . . . 3.3500000000000001 110.592 167.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.17 175.07 24.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.076 2.274 . . . . 1.9199999999999999 112.285 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.0 m -87.15 141.37 28.7 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.672 1.189 . . . . 2.1499999999999999 112.296 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.4 mt -127.73 165.51 19.93 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.224 1.81 . . . . 1.98 112.339 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.1 tp -124.02 113.52 18.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.048 1.739 . . . . 3.79 111.573 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.87 130.04 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.113 0.965 . . . . 2.8900000000000001 112.588 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 82.8 m -86.67 106.4 17.59 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.813 0.845 . . . . 3.9900000000000002 109.939 169.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.25 116.41 19.5 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.451 -0.78 . . . . 1.03 111.108 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -115.86 10.42 15.28 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.339 1.056 . . . . 3.5499999999999998 113.384 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -141.09 138.51 33.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.694 1.598 . . . . 2.0299999999999998 110.795 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 m -84.59 162.27 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 108.903 -0.777 . . . . 2.3799999999999999 108.903 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.31 -43.33 75.59 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.009 -1.057 . . . . 1.73 114.257 -169.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.41 -31.41 72.1 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.888 1.07 . . . . 3.0499999999999998 113.888 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.18 -17.02 58.86 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.025 1.73 . . . . 2.7999999999999998 114.19 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.0 p -68.86 151.8 46.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.022 0.929 . . . . 3.1699999999999999 113.245 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.6 t -55.44 -37.45 67.72 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.281 0.632 . . . . 3.0 112.051 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.7 tp -61.57 -49.46 76.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.416 1.086 . . . . 2.9500000000000002 112.256 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 t -71.89 -25.99 62.15 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.444 0.697 . . . . 2.4399999999999999 112.2 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.83 -41.15 75.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.73 1.212 . . . . 1.79 112.778 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.69 -50.09 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.804 0.842 . . . . 2.6899999999999999 110.651 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 114.005 1.113 . . . . 1.9399999999999999 114.005 178.807 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 113.175 0.806 . . . . 1.98 113.175 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.15 -28.3 69.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.3 0.64 . . . . 2.3599999999999999 112.331 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.34 -47.51 33.92 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.693 -0.629 . . . . 2.1000000000000001 110.852 167.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -48.91 -41.48 33.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.301 1.44 . . . . 4.4199999999999999 114.779 -169.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.42 -45.33 69.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.944 0.793 . . . . 2.4900000000000002 111.992 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.7 mm -72.91 -29.24 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.551 1.14 . . . . 3.1000000000000001 112.521 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -74.29 -24.21 59.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.408 0.892 . . . . 1.48 113.408 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.31 -19.73 65.62 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.77 1.026 . . . . 2.79 113.77 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.33 157.79 36.32 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 115.178 1.547 . . . . 2.9700000000000002 115.178 -169.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.11 154.4 17.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.893 1.677 . . . . 2.1899999999999999 112.721 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -88.55 -23.29 23.2 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.552 1.141 . . . . 3.3199999999999998 112.736 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.75 168.26 20.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.779 1.232 . . . . 3.52 114.075 -169.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.65 161.3 38.08 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.408 1.483 . . . . 1.9299999999999999 112.472 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.0 m -121.55 95.95 4.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.748 1.619 . . . . 1.97 110.873 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.32 146.22 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.219 1.408 . . . . 1.5800000000000001 110.002 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.19 120.59 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.518 1.054 . . . . 2.7200000000000002 111.967 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.478 0.964 0 C-N-CA 125.17 1.388 . . . . 2.6299999999999999 111.277 178.141 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 CA--C 1.543 0.708 0 CA-C-O 120.832 0.349 . . . . 3.73 111.926 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.7 t -132.3 110.65 10.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.149 1.78 . . . . 2.1499999999999999 110.072 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -108.51 136.64 47.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.176 1.176 . . . . 2.8900000000000001 114.176 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -108.11 132.55 53.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.671 1.588 . . . . 2.6699999999999999 110.106 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -104.51 122.79 46.29 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.524 -0.917 . . . . 2.1499999999999999 108.524 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.3 m -139.68 156.66 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.974 0.91 . . . . 2.2799999999999998 113.007 -169.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -74.06 146.48 43.63 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.618 -0.512 . . . . 4.0300000000000002 109.618 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.41 -27.92 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.681 1.363 . . . . 2.04 114.681 -168.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -73.3 -7.67 52.54 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 120.495 -1.378 . . . . 3.3500000000000001 113.431 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.0 -1.04 32.68 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.258 1.823 . . . . 2.3900000000000001 114.882 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -109.76 148.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.918 1.287 . . . . 1.9199999999999999 110.736 172.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -123.65 175.9 6.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.908 2.083 . . . . 4.0599999999999996 110.811 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -68.92 156.65 38.16 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.36 -0.838 . . . . 3.5299999999999998 111.093 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.36 22.78 21.17 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 119.132 0.878 . . . . 2.1099999999999999 113.858 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.15 167.28 20.95 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.539 1.535 . . . . 2.1000000000000001 112.305 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.03 129.69 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.159 1.383 . . . . 2.3199999999999998 110.646 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 mm -120.52 129.13 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.241 1.816 . . . . 1.8500000000000001 110.499 -169.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -78.68 133.69 37.18 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.101 -1.0 . . . . 2.8700000000000001 111.171 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.96 128.09 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.008 1.323 . . . . 1.3200000000000001 110.539 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.85 171.08 5.8 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.622 1.169 . . . . 2.1699999999999999 112.48 -169.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.32 127.81 25.24 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.483 2.122 . . . . 1.5700000000000001 112.537 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.22 -1.96 73.12 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.79 1.185 . . . . 1.0 116.006 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.22 -176.82 50.3 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 118.897 1.348 . . . . 0.93999999999999995 114.064 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -124.57 159.79 29.87 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.074 1.749 . . . . 3.6600000000000001 112.152 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -84.03 118.8 72.25 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.125 0.97 . . . . 3.8300000000000001 109.554 170.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -83.49 -17.66 6.22 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.258 1.972 . . . . 0.81999999999999995 115.482 -169.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -153.04 160.93 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 127.915 2.486 . . . . 2.02 108.312 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.03 140.88 33.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.154 0.888 . . . . 1.9199999999999999 112.768 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.16 -148.75 9.39 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.642 -0.661 . . . . 0.85999999999999999 114.603 -171.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -131.85 145.57 51.62 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.896 1.278 . . . . 5.04 113.939 -170.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.5 t -96.46 125.48 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.949 2.5 . . . . 1.98 108.916 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.49 32.73 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 113.641 0.978 . . . . 1.8300000000000001 113.641 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -168.11 136.21 2.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.364 1.866 . . . . 3.5600000000000001 108.26 166.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.29 179.4 52.62 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 122.448 1.027 . . . . 0.91000000000000003 114.726 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -154.67 123.44 6.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.972 0.909 . . . . 2.9500000000000002 112.743 -170.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.9 p -137.5 -179.04 5.5 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.345 1.858 . . . . 3.7999999999999998 113.588 -168.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.9 ttm -128.4 135.14 49.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.971 1.708 . . . . 1.5700000000000001 108.888 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.76 139.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.215 1.406 . . . . 1.0700000000000001 112.076 -168.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -102.24 110.57 22.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.386 1.475 . . . . 1.9099999999999999 111.401 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.75 22.05 11.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.21 1.804 . . . . 2.4900000000000002 113.145 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.5 p -53.1 -28.18 24.17 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.7 1.741 . . . . 2.0600000000000001 115.7 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.83 -34.91 16.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.369 0.986 . . . . 2.4300000000000002 111.667 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.3 mm -70.46 -47.8 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.617 0.767 . . . . 1.97 110.687 -177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.2 p -119.92 -4.33 10.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.77 1.228 . . . . 2.3999999999999999 114.172 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.37 3.07 89.86 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.606 1.098 . . . . 1.8500000000000001 115.331 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -56.32 -52.92 62.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.298 1.221 . . . . 2.7200000000000002 114.298 -169.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.19 33.63 23.35 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 122.201 1.0 . . . . 3.1099999999999999 111.868 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -154.78 113.21 2.37 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 128.745 2.818 . . . . 4.6299999999999999 106.068 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -62.33 153.03 73.2 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.994 2.462 . . . . 2.25 114.251 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.4 t -115.96 137.27 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.99 1.316 . . . . 1.55 110.949 -171.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.95 142.05 28.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.636 0.774 . . . . 1.77 112.483 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -123.43 152.19 41.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.289 1.436 . . . . 0.94999999999999996 111.717 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -146.23 170.16 8.38 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 129.148 2.979 . . . . 4.46 107.864 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.33 132.79 54.33 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 CA-C-N 121.82 1.686 . . . . 0.97999999999999998 111.63 168.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.11 25.77 28.07 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.239 1.399 . . . . 0.76000000000000001 114.815 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.2 t -117.56 158.61 24.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.231 1.412 . . . . 1.5 111.826 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.6 p -116.6 146.95 42.32 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.005 1.275 . . . . 1.6899999999999999 113.22 -172.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.6 156.04 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.703 1.601 . . . . 1.3500000000000001 113.08 -172.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -115.24 147.35 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.702 2.001 . . . . 1.6699999999999999 112.558 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.14 148.29 44.9 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.886 1.274 . . . . 1.97 112.897 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.86 -4.96 51.06 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.617 1.103 . . . . 0.73999999999999999 115.42 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.3 p -74.61 154.49 38.52 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.477 1.638 . . . . 1.55 111.363 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.94 124.9 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.095 0.558 . . . . 1.6899999999999999 111.618 -169.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -86.73 139.64 30.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.469 1.107 . . . . 1.54 111.763 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -88.49 -70.49 0.64 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.255 -0.903 . . . . 3.5800000000000001 112.206 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -131.9 -160.66 1.06 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.746 1.618 . . . . 4.4699999999999998 109.208 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.86 -26.52 11.48 Favored Glycine 0 CA--C 1.529 0.908 0 O-C-N 119.684 -1.885 . . . . 3.4100000000000001 116.128 169.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.0 m 44.74 67.89 0.63 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.686 1.594 . . . . 2.7400000000000002 112.163 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mt -97.8 159.47 14.91 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.706 1.203 . . . . 2.02 113.115 -166.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.93 128.96 54.91 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.567 0.698 . . . . 2.8300000000000001 110.487 168.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.56 122.5 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.45 1.9 . . . . 2.6400000000000001 109.952 -169.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 21.0 p -82.46 119.29 24.01 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.936 0.789 . . . . 2.5899999999999999 110.316 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -97.45 113.96 25.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.457 1.103 . . . . 2.2400000000000002 111.195 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.1 p -108.37 4.8 24.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.24 1.816 . . . . 3.0099999999999998 112.77 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -137.69 136.52 37.48 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.922 1.289 . . . . 1.97 109.702 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -91.54 176.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.331 1.053 . . . . 3.8500000000000001 109.602 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.18 -31.95 66.55 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 120.835 1.652 . . . . 1.6499999999999999 113.952 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -45.1 65.08 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.633 1.216 . . . . 2.5299999999999998 113.353 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.32 -14.41 59.43 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.961 1.837 . . . . 2.7799999999999998 115.961 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.5 t -77.76 143.33 38.07 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.057 -1.027 . . . . 4.1900000000000004 112.829 -170.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.0 t -63.0 -31.77 72.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.917 0.71 . . . . 2.8399999999999999 112.917 -172.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.67 -51.33 65.82 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.315 1.046 . . . . 2.2200000000000002 112.491 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 p -72.92 -31.82 64.88 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.542 0.571 . . . . 2.3700000000000001 112.542 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.4 -42.13 98.78 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.428 0.558 . . . . 1.8200000000000001 111.71 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.99 -56.15 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.31 1.044 . . . . 2.73 110.153 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 114.181 1.178 . . . . 1.8500000000000001 114.181 -177.508 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 119.294 -0.384 . . . . 3.2799999999999998 111.838 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tp -52.56 -33.79 47.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.92 0.888 . . . . 2.79 112.819 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.88 -50.07 14.21 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.704 0.802 . . . . 2.02 112.919 168.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -58.73 -32.83 69.57 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.726 1.211 . . . . 4.0599999999999996 114.032 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.83 -30.24 65.58 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.947 0.721 . . . . 2.5 112.947 173.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.4 mm -72.76 -42.22 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.844 0.858 . . . . 2.8999999999999999 111.718 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.6 m -68.38 -21.56 64.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.438 1.095 . . . . 1.48 113.224 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.01 -14.02 61.34 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.961 2.104 . . . . 2.73 114.671 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -87.04 149.76 24.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.425 1.011 . . . . 2.7400000000000002 113.184 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.13 173.79 11.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.73 1.612 . . . . 2.7000000000000002 114.61 -169.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.3 m -99.91 -43.88 6.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.809 1.644 . . . . 3.9300000000000002 110.706 168.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -139.18 165.42 27.22 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.601 1.56 . . . . 3.6600000000000001 113.04 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.72 173.38 11.55 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.053 1.741 . . . . 2.0099999999999998 112.3 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.2 m -131.32 111.3 11.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.899 1.279 . . . . 1.73 111.334 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.7 mt -98.84 145.42 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.478 1.911 . . . . 2.2000000000000002 109.884 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.5 133.61 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.373 -0.829 . . . . 3.1099999999999999 112.608 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.475 0.801 0 C-N-CA 125.374 1.47 . . . . 2.7200000000000002 112.245 -172.178 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 CA--C 1.546 0.822 0 CA-C-O 122.572 1.177 . . . . 6.2300000000000004 112.88 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.6 t -139.16 154.4 48.08 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.598 1.559 . . . . 2.0600000000000001 111.562 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.81 138.76 45.86 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.127 1.371 . . . . 2.8300000000000001 111.71 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -119.74 129.31 54.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.063 1.745 . . . . 3.3500000000000001 110.051 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.8 133.86 39.43 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.45 -1.406 . . . . 2.6200000000000001 110.608 168.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -135.08 158.15 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.332 1.053 . . . . 1.3400000000000001 112.835 -171.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.94 149.04 36.03 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.478 1.111 . . . . 4.1799999999999997 109.414 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.49 -29.49 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.291 1.589 . . . . 2.6000000000000001 115.291 -168.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -76.46 -7.15 54.5 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.369 -1.457 . . . . 3.4700000000000002 113.599 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.9 mt -100.74 -6.32 25.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.096 1.758 . . . . 1.8700000000000001 113.357 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 p -95.63 129.9 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.687 1.195 . . . . 2.5 109.013 169.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -141.32 -175.21 4.26 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.229 1.011 . . . . 5.5099999999999998 112.016 -169.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -65.9 15.53 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.475 2.769 . . . . 4.0199999999999996 118.475 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.07 9.87 3.59 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.282 1.42 . . . . 1.5600000000000001 115.344 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -94.32 148.55 22.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.063 1.431 . . . . 3.1000000000000001 113.818 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.1 mm -105.26 124.67 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.24 1.016 . . . . 3.02 110.03 171.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.5 mm -99.82 162.93 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.927 2.091 . . . . 2.6800000000000002 111.276 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -132.39 129.6 39.57 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.188 1.395 . . . . 2.6299999999999999 110.328 170.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.25 144.04 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.354 1.062 . . . . 1.5800000000000001 112.554 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -99.02 163.9 17.85 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.246 1.418 . . . . 3.0699999999999998 113.104 -174.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.34 106.58 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.826 2.351 . . . . 2.4900000000000002 109.385 166.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.45 68.26 1.16 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.255 1.407 . . . . 2.9100000000000001 110.311 -168.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.86 164.08 33.51 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 127.407 2.432 . . . . 1.79 109.497 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -125.34 153.09 43.86 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.521 1.16 . . . . 2.3199999999999998 112.798 -172.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -87.46 136.71 32.92 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 123.968 0.907 . . . . 2.8300000000000001 112.29 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -98.48 -18.03 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.934 3.09 . . . . 0.76000000000000001 115.587 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.86 166.88 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 127.936 2.494 . . . . 2.2999999999999998 108.422 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.18 142.35 27.72 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.185 0.902 . . . . 2.04 113.405 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -160.33 27.67 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.581 0.61 . . . . 0.77000000000000002 114.06 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.3 ttp-105 -116.19 136.25 53.18 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.567 1.147 . . . . 4.8499999999999996 112.888 -171.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -82.74 130.36 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 126.531 1.932 . . . . 1.8100000000000001 108.26 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.69 34.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.395 0.678 . . . . 2.21 112.328 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -166.71 132.67 2.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.088 1.355 . . . . 2.8199999999999998 109.709 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.95 -170.77 50.08 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 116.363 1.305 . . . . 0.98999999999999999 116.363 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 123.43 13.21 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.804 1.642 . . . . 3.2799999999999998 112.306 -173.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.57 176.68 9.64 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.169 0.988 . . . . 1.52 112.428 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 34.0 ttm -120.98 133.72 55.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.624 1.57 . . . . 1.9199999999999999 110.126 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.06 143.45 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.792 1.237 . . . . 1.03 111.514 -169.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -106.95 86.11 2.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.064 1.346 . . . . 2.0099999999999998 111.099 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -87.74 34.01 0.71 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.955 1.702 . . . . 1.8899999999999999 113.578 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -58.92 -34.34 71.61 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 117.182 2.29 . . . . 2.1899999999999999 117.182 -168.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.75 -48.59 4.66 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.805 1.184 . . . . 2.04 111.468 -174.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.7 mm -67.63 -48.89 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.739 0.816 . . . . 1.99 111.634 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.1 m -101.15 -32.84 10.36 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.946 1.298 . . . . 2.8900000000000001 110.715 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.74 5.41 61.35 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.67 1.129 . . . . 1.3 115.541 171.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.14 -51.02 71.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.027 1.331 . . . . 2.6499999999999999 111.603 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.21 35.8 15.26 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.9 1.68 . . . . 3.2999999999999998 112.793 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -154.19 154.53 29.89 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 129.923 3.289 . . . . 5.7999999999999998 109.08 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -64.19 136.63 52.66 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.5 2.8 . . . . 2.3100000000000001 113.604 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.6 t -130.56 129.81 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 125.471 1.509 . . . . 2.0099999999999998 111.999 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.73 146.44 32.37 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.06 1.134 . . . . 1.74 114.06 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.7 152.36 45.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.886 2.074 . . . . 1.1200000000000001 111.164 175.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -141.82 -176.38 0.56 Allowed Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 128.688 2.795 . . . . 4.5 107.782 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.84 148.89 90.8 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 CA-C-N 122.141 1.8 . . . . 2.3399999999999999 114.094 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.17 25.45 74.54 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.959 1.266 . . . . 1.3400000000000001 114.455 -172.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -115.01 147.69 39.78 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.753 1.277 . . . . 1.6100000000000001 111.034 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.1 p -99.08 147.67 24.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.183 1.356 . . . . 2.1099999999999999 113.286 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.0 168.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.4 1.88 . . . . 1.25 111.152 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.7 156.32 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.448 1.499 . . . . 2.8399999999999999 111.651 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.67 157.51 32.42 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.136 1.162 . . . . 2.1600000000000001 114.136 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.87 -7.2 15.8 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.159 0.885 . . . . 0.98999999999999999 115.113 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 m -90.92 156.98 17.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.716 1.206 . . . . 2.7599999999999998 110.417 172.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mm -102.42 141.47 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.938 0.895 . . . . 2.1000000000000001 111.39 -169.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -101.59 135.74 42.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.594 1.957 . . . . 1.9399999999999999 110.84 173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -153.57 140.45 19.16 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.91 1.284 . . . . 3.77 111.143 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.321 9.0 t30 95.98 -17.61 0.07 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 129.136 2.974 . . . . 3.9500000000000002 116.832 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.25 161.83 34.97 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 120.66 1.573 . . . . 1.8600000000000001 114.629 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.2 m -87.97 133.72 33.88 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.285 1.034 . . . . 2.1400000000000001 112.979 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.1 mt -128.96 162.52 27.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.988 1.715 . . . . 2.0800000000000001 112.814 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -117.89 132.78 56.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.86 0.864 . . . . 2.9900000000000002 109.923 167.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.76 131.16 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.708 1.203 . . . . 2.6699999999999999 111.468 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 29.9 p -85.05 115.08 22.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.662 0.665 . . . . 2.6400000000000001 109.607 168.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.53 118.16 21.13 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.637 0.775 . . . . 2.1499999999999999 109.526 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.7 p -119.19 11.91 12.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.537 1.135 . . . . 3.0499999999999998 113.275 -174.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -145.44 146.96 31.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.903 1.681 . . . . 2.21 111.149 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.3 p -112.07 -175.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.717 1.607 . . . . 3.9500000000000002 111.869 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.36 -18.27 55.12 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 119.826 -1.797 . . . . 3.2000000000000002 116.329 -172.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.62 -58.01 3.87 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.314 1.046 . . . . 5.25 111.74 169.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.41 -32.11 64.24 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.769 1.396 . . . . 3.9100000000000001 114.769 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 t -50.13 126.55 14.85 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.81 1.244 . . . . 3.4199999999999999 112.789 -168.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.4 t -54.06 -35.41 62.0 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.892 1.071 . . . . 3.2799999999999998 113.892 -168.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.06 -50.47 73.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.726 -1.234 . . . . 2.3799999999999999 112.241 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -71.56 -23.17 61.7 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.354 1.062 . . . . 2.54 112.194 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -74.05 -43.91 56.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.828 1.251 . . . . 2.7599999999999998 113.077 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.7 mt -55.9 -49.17 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.405 1.482 . . . . 2.3599999999999999 110.644 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 114.324 1.231 . . . . 2.1200000000000001 114.324 -178.225 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 121.054 0.454 . . . . 2.46 110.354 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.22 -30.36 71.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.649 1.179 . . . . 2.3700000000000001 112.439 172.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.19 -26.95 59.42 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.257 -0.902 . . . . 2.0600000000000001 113.317 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.91 -41.15 87.6 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.278 1.031 . . . . 2.9300000000000002 112.228 -169.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -50.02 -44.2 51.11 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.842 1.257 . . . . 2.0699999999999998 111.992 173.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -73.08 -35.3 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.355 1.062 . . . . 2.6800000000000002 112.104 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -70.38 -22.06 62.8 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.864 -1.147 . . . . 1.55 113.313 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.33 -19.95 65.52 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.955 1.094 . . . . 2.8799999999999999 113.955 170.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -70.99 169.51 14.76 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.696 1.135 . . . . 3.73 113.843 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.02 -24.94 9.63 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.769 1.396 . . . . 3.25 114.769 -174.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 m 67.76 -11.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.283 1.833 . . . . 4.1200000000000001 115.818 175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -130.03 157.86 41.2 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.284 1.833 . . . . 2.8199999999999998 112.061 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.45 162.69 34.73 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.006 0.923 . . . . 1.97 113.166 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.4 m -123.44 100.62 6.91 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.657 1.583 . . . . 1.9199999999999999 110.364 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.6 mt -85.29 146.14 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.47 1.508 . . . . 1.79 110.615 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.45 127.56 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.955 0.902 . . . . 2.9300000000000002 110.387 166.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.5 m . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 125.285 1.434 . . . . 3.2400000000000002 111.089 -170.879 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--O 1.236 0.359 0 N-CA-C 108.14 -1.059 . . . . 4.2400000000000002 108.14 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -138.81 153.33 48.38 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.53 1.132 . . . . 2.04 110.832 -169.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.26 134.89 55.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.748 0.819 . . . . 2.3700000000000001 110.24 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -123.92 129.07 50.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.507 1.523 . . . . 3.46 110.858 -169.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.51 130.66 45.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.589 1.086 . . . . 3.2799999999999998 110.476 170.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.8 m -141.42 168.27 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.039 1.336 . . . . 2.4500000000000002 112.844 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -78.15 139.28 38.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.402 0.681 . . . . 3.1299999999999999 109.593 168.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.89 -22.67 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.708 1.744 . . . . 2.2000000000000002 115.708 -168.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -64.31 -21.06 66.48 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.609 -1.307 . . . . 5.1399999999999997 112.94 172.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.2 mt -99.2 -4.93 30.92 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.611 1.965 . . . . 3.0800000000000001 114.502 -169.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.3 m -74.35 -42.5 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.486 0.714 . . . . 4.0099999999999998 112.635 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.319 32.1 mt-30 60.54 146.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 128.248 2.619 . . . . 3.4900000000000002 116.043 -171.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -80.11 25.03 0.39 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 116.831 2.16 . . . . 3.9900000000000002 116.831 -167.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.25 8.25 12.37 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.107 1.337 . . . . 1.5800000000000001 113.662 170.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.24 169.9 8.23 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.253 1.421 . . . . 2.8999999999999999 114.173 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.7 mt -121.56 127.92 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.261 2.224 . . . . 2.29 109.69 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.1 mm -116.3 133.69 62.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.729 2.012 . . . . 1.6299999999999999 110.552 -170.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -79.52 142.7 35.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.296 1.438 . . . . 3.73 113.202 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 p -133.12 131.42 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.365 0.666 . . . . 1.8500000000000001 112.039 168.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.58 162.68 49.88 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 125.003 1.321 . . . . 2.4300000000000002 113.182 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -60.12 131.14 37.5 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.427 2.085 . . . . 1.53 110.733 166.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.37 -3.86 61.31 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.738 1.637 . . . . 0.89000000000000001 114.717 -170.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.17 170.08 53.52 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 118.48 1.14 . . . . 0.95999999999999996 113.829 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -115.25 144.4 43.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.565 1.146 . . . . 2.25 110.973 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -79.44 120.73 81.38 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-O 118.722 -0.656 . . . . 2.8199999999999998 109.868 175.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.35 -12.5 6.69 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.601 2.201 . . . . 0.81999999999999995 114.095 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -148.95 165.1 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.478 2.711 . . . . 2.0 109.446 -173.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -103.51 145.59 29.79 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.349 0.87 . . . . 2.25 113.349 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.95 -153.19 23.23 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.647 0.619 . . . . 0.78000000000000003 114.647 -172.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -117.31 132.45 56.6 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.704 1.202 . . . . 5.2699999999999996 112.734 -169.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.3 t -82.7 127.13 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.935 2.094 . . . . 1.6499999999999999 108.422 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 pt -140.71 32.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 122.745 1.26 . . . . 2.1200000000000001 113.017 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -168.21 126.66 1.17 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.746 2.419 . . . . 2.98 106.711 167.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.45 178.25 46.89 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 117.004 1.562 . . . . 1.0600000000000001 117.004 174.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -148.02 128.45 13.99 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.863 1.265 . . . . 2.9100000000000001 112.328 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 m -148.12 167.74 24.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.346 1.059 . . . . 2.04 113.133 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.3 ttm -111.4 108.39 17.94 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.822 1.249 . . . . 1.8300000000000001 109.939 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.7 t -87.64 158.35 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.465 1.906 . . . . 1.0900000000000001 112.536 -169.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -113.55 92.22 3.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.374 1.87 . . . . 1.9199999999999999 110.134 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.89 16.52 21.22 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.943 1.697 . . . . 2.1099999999999999 112.884 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -56.56 -29.39 61.96 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.252 1.821 . . . . 1.77 114.713 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -81.58 -32.18 32.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.256 1.389 . . . . 1.8600000000000001 111.866 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mm -77.76 -45.95 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.087 0.955 . . . . 2.0600000000000001 111.14 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 m -109.08 -12.58 14.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.336 1.454 . . . . 4.0599999999999996 112.751 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.28 6.47 80.15 Favored Glycine 0 CA--C 1.544 1.889 0 C-N-CA 125.219 1.39 . . . . 1.53 116.011 174.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.77 -38.22 89.75 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.693 1.197 . . . . 2.9399999999999999 113.995 -169.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 72.81 -17.77 0.38 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.949 2.5 . . . . 2.3399999999999999 113.886 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -92.08 150.07 39.81 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.14 1.776 . . . . 6.3899999999999997 110.665 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.53 153.6 30.7 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.356 2.704 . . . . 2.7200000000000002 112.243 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.73 124.85 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.586 1.154 . . . . 2.4900000000000002 111.851 -169.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.73 138.89 37.45 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.699 0.8 . . . . 2.4300000000000002 112.821 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -127.13 145.76 50.63 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.019 2.127 . . . . 1.21 110.451 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -144.04 172.31 5.69 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 128.618 2.767 . . . . 3.3100000000000001 109.605 -169.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -57.74 137.08 79.42 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.673 1.582 . . . . 1.2 110.943 168.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.0 17.81 79.83 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.954 1.264 . . . . 1.28 114.57 -172.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 t -101.79 161.02 13.97 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.006 1.903 . . . . 1.71 111.414 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 p -112.43 146.57 38.16 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.841 1.2 . . . . 2.0499999999999998 113.648 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.64 159.35 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.204 1.802 . . . . 1.77 111.964 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.35 152.1 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.896 1.678 . . . . 2.8300000000000001 112.176 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.96 149.99 39.07 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.737 -0.665 . . . . 1.72 112.52 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.69 -10.57 55.98 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.583 1.087 . . . . 0.78000000000000003 115.53 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.3 p -76.51 161.51 28.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.516 1.158 . . . . 1.6100000000000001 111.262 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -106.77 142.23 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.917 0.887 . . . . 1.77 110.913 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -99.74 143.23 30.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.714 1.606 . . . . 1.7 112.543 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -155.94 141.4 17.71 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.026 -1.046 . . . . 3.3599999999999999 112.15 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.26 17.3 t30 111.8 -42.07 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 1 C-N-CA 131.863 4.065 . . . . 3.8300000000000001 113.556 -178.279 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.16 -174.58 37.12 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 119.76 1.164 . . . . 2.0099999999999998 114.661 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.0 m -92.29 136.8 32.89 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.731 1.612 . . . . 2.3199999999999998 111.373 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 mt -130.81 160.97 32.81 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.553 1.141 . . . . 2.0 113.294 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.97 123.05 48.77 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.83 1.252 . . . . 2.6699999999999999 109.97 170.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.15 126.21 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.653 1.181 . . . . 2.1699999999999999 110.714 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 32.0 p -79.38 126.94 31.48 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.495 -0.753 . . . . 2.5 110.235 169.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.32 129.21 34.24 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.568 0.747 . . . . 1.1200000000000001 110.393 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.7 p -107.9 -8.86 15.84 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.657 0.984 . . . . 3.9399999999999999 113.657 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -145.82 150.29 35.9 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.31 1.444 . . . . 2.52 110.909 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 m -74.74 160.19 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 118.69 0.677 . . . . 2.8100000000000001 109.174 166.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.66 77.57 Favored Glycine 0 N--CA 1.475 1.242 0 N-CA-C 116.285 1.274 . . . . 2.1699999999999999 116.285 -165.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.49 -39.31 62.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.688 1.244 . . . . 3.8999999999999999 113.581 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -72.11 -6.02 39.55 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.402 1.481 . . . . 3.3100000000000001 114.106 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.0 p -51.48 151.29 3.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.381 1.473 . . . . 2.3900000000000001 114.035 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.19 -33.62 67.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.178 1.391 . . . . 3.27 111.173 169.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.82 -51.48 68.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.673 1.989 . . . . 2.5800000000000001 112.549 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.8 m -70.66 -18.19 62.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.441 0.534 . . . . 2.79 112.441 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -73.93 -39.25 63.93 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.497 -0.752 . . . . 2.0 112.613 169.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 87.4 mt -49.75 -51.9 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 119.892 1.224 . . . . 2.77 111.441 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.479 1.011 0 O-C-N 121.273 -0.892 . . . . 2.5099999999999998 113.276 178.966 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.985 0 N-CA-C 113.599 0.962 . . . . 2.6600000000000001 113.599 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 tp -59.41 -37.85 79.09 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.888 1.675 . . . . 2.6600000000000001 111.714 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.21 -18.82 63.18 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.075 0.768 . . . . 2.3599999999999999 113.075 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -61.15 -36.76 80.65 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.943 1.247 . . . . 3.6499999999999999 112.237 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.16 -42.24 96.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.877 0.871 . . . . 2.5 111.355 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -72.1 -36.29 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.167 0.587 . . . . 2.4199999999999999 111.704 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -69.02 -30.95 69.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.333 1.053 . . . . 1.8600000000000001 112.881 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -64.0 -32.84 74.52 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.695 1.998 . . . . 3.3799999999999999 112.979 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -77.48 129.89 36.3 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.94 0.791 . . . . 3.3199999999999998 112.395 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.97 156.42 36.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.124 0.97 . . . . 2.3999999999999999 112.787 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -108.75 -4.83 16.64 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.092 1.515 . . . . 3.1000000000000001 115.092 -167.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.29 160.54 39.9 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.285 -1.509 . . . . 3.9500000000000002 113.806 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.16 159.06 43.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.977 1.311 . . . . 1.96 112.988 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 90.0 m -119.08 106.15 12.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.441 1.497 . . . . 1.97 111.148 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mt -97.4 138.53 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.838 1.655 . . . . 1.4399999999999999 110.842 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -124.74 126.45 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.796 1.18 . . . . 3.1200000000000001 111.737 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 125.342 1.457 . . . . 3.6899999999999999 111.055 -175.338 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 121.333 0.587 . . . . 3.8100000000000001 111.606 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -141.0 133.62 28.66 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.016 1.726 . . . . 2.9399999999999999 109.871 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -127.41 139.28 52.94 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.265 -0.897 . . . . 3.8900000000000001 112.146 -176.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -114.61 145.82 41.54 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.277 1.431 . . . . 2.6699999999999999 112.166 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -117.23 110.73 18.48 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.0 1.32 . . . . 2.4500000000000002 108.283 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.9 m -127.86 164.65 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 114.531 1.308 . . . . 1.3 114.531 -166.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.79 146.41 37.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.549 -0.751 . . . . 3.1000000000000001 110.379 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.71 -23.61 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.26 0.837 . . . . 1.6499999999999999 113.26 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.36 -17.17 61.85 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.817 -1.177 . . . . 3.7599999999999998 112.984 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.7 mt -105.05 -12.26 16.24 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.404 1.882 . . . . 2.1400000000000001 114.525 -169.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.41 143.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.101 0.96 . . . . 2.0299999999999998 109.321 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -119.29 163.29 17.36 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.557 1.143 . . . . 3.48 112.327 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.64 135.64 50.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.67 -0.863 . . . . 3.8300000000000001 108.67 167.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.9 -10.85 32.12 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 124.86 1.219 . . . . 1.96 114.225 -169.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -88.15 152.07 22.25 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.334 1.454 . . . . 2.7999999999999998 113.773 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -105.26 118.92 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.546 1.539 . . . . 2.3799999999999999 110.321 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 mm -118.51 128.6 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.105 1.362 . . . . 1.8999999999999999 111.922 -169.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -90.99 139.97 30.27 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.209 -0.932 . . . . 2.5099999999999998 112.437 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.05 133.6 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.374 1.47 . . . . 1.4399999999999999 110.998 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 m -107.69 170.5 5.52 Favored Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 124.683 1.193 . . . . 1.96 113.751 -167.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -52.49 134.59 52.9 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.224 2.616 . . . . 1.6100000000000001 112.89 169.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.54 -13.68 3.75 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 116.017 1.167 . . . . 1.03 116.017 -175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.9 162.99 53.93 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 118.77 1.285 . . . . 0.95999999999999996 114.454 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -107.3 154.12 21.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.702 1.201 . . . . 3.1499999999999999 112.374 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -88.15 119.48 70.35 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.779 0.832 . . . . 3.5699999999999998 111.512 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.29 -15.2 5.47 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.363 2.709 . . . . 0.81999999999999995 114.924 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 m -152.45 171.47 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.988 2.515 . . . . 1.76 108.234 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.27 144.89 30.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.313 0.857 . . . . 1.72 113.313 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.16 -160.98 25.91 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 114.78 0.672 . . . . 0.79000000000000004 114.78 -173.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -115.89 140.54 49.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.156 1.382 . . . . 6.5999999999999996 112.408 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.41 127.67 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.792 2.437 . . . . 1.9299999999999999 109.198 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.5 pt -141.0 32.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.636 0.976 . . . . 2.0800000000000001 113.636 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -165.15 132.44 3.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.154 1.382 . . . . 3.7999999999999998 108.07 167.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.88 -172.71 48.28 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 116.297 1.279 . . . . 0.87 116.297 169.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -150.85 126.54 10.25 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.237 1.015 . . . . 2.6800000000000002 111.838 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.96 169.53 17.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.903 1.681 . . . . 1.8300000000000001 113.067 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.8 ttm -112.62 124.26 52.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.711 0.805 . . . . 2.3900000000000001 111.279 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.36 140.44 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.885 1.274 . . . . 0.92000000000000004 111.294 -170.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -104.93 111.96 24.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.001 1.32 . . . . 1.8600000000000001 109.461 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.47 15.25 5.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.883 2.073 . . . . 2.0 113.95 -169.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.5 p -51.73 -31.35 26.08 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.728 2.121 . . . . 1.74 116.728 -170.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.51 -34.09 35.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.265 1.393 . . . . 3.04 110.684 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.0 mm -78.4 -58.3 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.763 0.825 . . . . 2.0099999999999998 111.206 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 p -95.68 0.46 52.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.113 1.365 . . . . 2.75 113.779 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.07 20.73 79.66 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.215 1.388 . . . . 1.9299999999999999 113.983 174.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -72.65 -168.23 0.43 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.839 1.655 . . . . 2.6299999999999999 111.097 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.2 -34.19 0.17 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.232 1.813 . . . . 2.8399999999999999 110.917 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.4 mmt -85.06 157.84 59.26 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 125.494 1.517 . . . . 6.0999999999999996 110.852 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -68.68 160.49 49.3 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.246 2.631 . . . . 2.3799999999999999 112.677 167.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.4 t -125.27 130.14 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.958 1.703 . . . . 2.2000000000000002 111.728 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.59 131.35 36.7 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.964 0.906 . . . . 1.99 113.209 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -113.13 152.26 29.84 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.861 2.064 . . . . 1.01 110.855 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -141.3 177.72 1.82 Allowed Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 128.642 2.777 . . . . 4.4400000000000004 109.917 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -66.84 128.57 19.09 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 CA-C-N 121.679 1.635 . . . . 1.3799999999999999 109.703 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.65 25.27 28.16 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.457 1.503 . . . . 1.1799999999999999 114.945 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.5 m -108.12 174.56 5.83 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.903 1.351 . . . . 2.0699999999999998 110.855 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.2 p -130.75 150.37 51.96 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.081 -1.637 . . . . 2.3100000000000001 112.581 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.49 147.75 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.769 1.227 . . . . 1.3300000000000001 112.089 -172.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.87 148.28 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.837 1.655 . . . . 1.9099999999999999 112.868 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.83 144.8 54.28 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.821 0.849 . . . . 1.8999999999999999 112.484 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.31 -3.16 73.81 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.109 1.338 . . . . 0.79000000000000004 115.886 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.3 p -78.77 162.47 26.11 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.605 1.202 . . . . 1.6799999999999999 111.725 171.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.73 136.37 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.093 0.957 . . . . 1.8300000000000001 111.708 -171.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -91.01 146.12 24.12 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.814 1.646 . . . . 1.49 111.981 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -93.49 -93.36 0.16 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.325 1.05 . . . . 3.6699999999999999 111.396 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -136.83 131.43 33.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.958 1.703 . . . . 4.5800000000000001 108.935 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.13 114.41 1.63 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 108.848 -1.701 . . . . 2.1899999999999999 108.848 -167.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -94.31 114.74 26.86 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.961 0.904 . . . . 2.3300000000000001 110.108 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.9 mt -112.74 153.31 27.94 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.297 1.039 . . . . 1.9199999999999999 112.078 -169.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 tp -114.83 121.2 42.53 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.941 0.897 . . . . 3.7000000000000002 110.049 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 mm -113.62 129.09 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.646 1.578 . . . . 2.7200000000000002 110.981 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.9 p -86.79 116.67 25.03 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.064 -1.023 . . . . 3.0600000000000001 109.973 168.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.89 122.89 31.38 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.48 -0.762 . . . . 2.1099999999999999 110.111 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.8 t -124.1 10.85 8.81 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.52 0.933 . . . . 3.4399999999999999 113.52 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -137.19 140.29 41.65 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.545 1.138 . . . . 2.3700000000000001 110.929 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.5 p -97.11 170.53 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.013 1.325 . . . . 4.1299999999999999 111.212 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.33 -27.45 65.52 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 119.699 -1.876 . . . . 1.76 116.092 -169.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.86 -27.87 68.55 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.96 1.38 . . . . 2.8199999999999998 113.842 174.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.45 -16.62 60.31 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.42 1.267 . . . . 4.0300000000000002 114.42 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 74.0 p -63.01 125.02 22.6 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.66 0.985 . . . . 2.5800000000000001 113.66 -166.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.4 t -60.31 -35.66 76.12 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.238 0.615 . . . . 2.9100000000000001 111.925 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.0 mp -56.27 -50.5 71.17 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.469 1.107 . . . . 2.9300000000000002 112.298 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 91.9 p -70.78 -28.44 64.66 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.903 0.481 . . . . 2.5600000000000001 112.014 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -70.43 -43.29 70.24 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.859 -0.526 . . . . 2.3300000000000001 111.595 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 53.6 mt -54.71 -51.22 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.118 1.367 . . . . 2.7400000000000002 110.876 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 113.752 1.019 . . . . 3.0499999999999998 113.752 -179.16 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.746 0 N-CA-C 112.549 0.574 . . . . 2.4199999999999999 112.549 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.95 -28.71 70.0 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.639 0.776 . . . . 2.4300000000000002 112.153 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.12 -37.25 58.3 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.326 0.65 . . . . 2.1499999999999999 111.956 167.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -63.05 -32.92 74.4 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.589 1.556 . . . . 4.9199999999999999 114.235 -176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.3 -31.65 70.47 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.992 1.269 . . . . 2.2799999999999998 111.738 172.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.4 mm -73.6 -45.26 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.728 0.811 . . . . 2.6299999999999999 110.973 166.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 m -68.39 -16.66 64.0 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 121.052 1.751 . . . . 1.6899999999999999 114.654 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.97 -30.23 67.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.396 1.478 . . . . 4.5499999999999998 112.446 169.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -77.92 130.75 36.97 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.771 0.828 . . . . 3.0499999999999998 110.694 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.9 167.59 20.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.839 1.256 . . . . 2.21 112.661 -176.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -106.15 -25.51 11.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.601 1.334 . . . . 3.23 114.601 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.66 152.69 44.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.941 1.296 . . . . 3.5699999999999998 113.969 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.33 171.8 13.56 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.484 1.514 . . . . 1.6000000000000001 112.396 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.2 m -125.49 108.46 11.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.735 1.214 . . . . 1.75 111.856 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.2 mt -82.06 140.64 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.19 1.396 . . . . 1.22 109.349 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.1 t -127.31 123.48 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.881 0.872 . . . . 2.71 111.109 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 125.104 1.362 . . . . 2.7999999999999998 110.92 -171.14 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 120.766 0.317 . . . . 3.1299999999999999 111.179 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.4 t -142.63 128.63 19.6 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.312 1.045 . . . . 1.8 111.444 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -111.4 138.13 48.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.446 1.099 . . . . 2.9500000000000002 111.566 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -106.88 146.43 31.0 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.615 1.566 . . . . 4.0 110.958 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -113.34 126.08 54.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.809 0.731 . . . . 1.8600000000000001 109.796 169.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.8 160.12 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 115.098 1.518 . . . . 1.8999999999999999 115.098 -166.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -75.74 147.99 38.88 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.687 0.795 . . . . 3.4700000000000002 109.085 167.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.31 -9.52 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 114.536 1.31 . . . . 2.1200000000000001 114.536 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -79.79 -19.01 49.57 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.168 -1.583 . . . . 3.54 113.861 170.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.7 mt -96.48 -4.59 41.27 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.859 1.264 . . . . 2.3900000000000001 113.644 -173.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.51 141.26 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.433 1.493 . . . . 1.72 109.465 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -127.49 168.39 14.98 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.026 1.731 . . . . 2.9900000000000002 111.38 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -72.59 23.7 0.06 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.737 1.615 . . . . 3.9500000000000002 114.958 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.26 11.38 2.27 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.968 2.223 . . . . 1.3899999999999999 113.855 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -87.47 163.39 16.73 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.669 1.734 . . . . 2.6600000000000001 112.371 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 98.7 mt -118.29 126.45 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.185 1.394 . . . . 2.7799999999999998 109.216 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.2 mm -118.2 129.58 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.964 1.706 . . . . 1.97 112.044 -168.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -88.57 131.48 34.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.022 0.929 . . . . 3.0800000000000001 112.566 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 p -108.02 140.74 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.333 1.453 . . . . 1.8700000000000001 111.649 175.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 m -102.96 159.5 29.1 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 124.39 1.076 . . . . 1.8600000000000001 113.324 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.75 138.76 40.98 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.444 2.762 . . . . 1.46 112.287 169.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.08 -7.28 8.01 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.995 1.158 . . . . 1.0900000000000001 115.995 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.19 -179.38 48.79 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.423 1.487 . . . . 1.1699999999999999 115.023 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -123.43 151.98 42.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.493 1.517 . . . . 3.6800000000000002 112.62 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -78.01 122.38 85.36 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.093 0.957 . . . . 2.9900000000000002 110.179 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -88.3 -17.97 2.27 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.661 2.24 . . . . 0.92000000000000004 115.004 -170.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.72 170.83 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 128.586 2.755 . . . . 1.75 108.082 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.49 151.55 20.13 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.694 0.998 . . . . 2.1499999999999999 113.694 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.63 -160.26 33.69 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.4 0.524 . . . . 0.88 114.081 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -113.32 143.86 43.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.135 0.974 . . . . 5.4100000000000001 112.913 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.26 124.54 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 126.169 1.788 . . . . 2.4700000000000002 107.237 169.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.79 33.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.256 1.022 . . . . 2.1899999999999999 110.959 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -167.85 122.74 0.99 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.613 1.965 . . . . 3.23 108.511 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.02 177.28 43.65 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 116.22 1.248 . . . . 1.01 116.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -146.81 127.69 14.45 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.072 1.349 . . . . 2.9500000000000002 112.315 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.8 t -145.7 171.48 14.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.925 1.29 . . . . 1.96 112.685 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.7 ttm -115.68 125.56 53.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.508 1.523 . . . . 2.1400000000000001 108.88 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -122.99 140.54 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.721 1.208 . . . . 1.1000000000000001 112.443 -168.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -102.04 124.62 47.96 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.03 2.132 . . . . 2.1000000000000001 111.347 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -125.05 20.25 8.28 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.681 1.193 . . . . 2.5699999999999998 113.477 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.2 p -62.51 -3.56 1.5 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 117.742 2.497 . . . . 1.6699999999999999 117.742 -169.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.34 -45.6 4.63 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.685 1.194 . . . . 2.1400000000000001 109.403 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.7 mm -74.92 -56.77 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.567 1.147 . . . . 2.5099999999999998 112.321 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.4 p -107.64 -0.95 21.58 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.328 1.451 . . . . 2.5899999999999999 112.621 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.21 6.07 78.62 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.27 1.414 . . . . 1.78 114.937 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -71.32 106.17 3.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.207 1.003 . . . . 3.3799999999999999 111.733 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.48 -16.35 60.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.827 0.851 . . . . 2.48 112.375 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.7 ttt -113.42 136.85 21.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.041 1.736 . . . . 6.25 108.971 172.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.07 165.74 25.7 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.63 2.22 . . . . 2.3500000000000001 114.17 -168.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.06 138.68 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.142 1.777 . . . . 2.2000000000000002 111.065 -170.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.23 126.72 33.42 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.732 -0.605 . . . . 2.3700000000000001 112.017 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -98.62 151.04 21.12 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.29 1.436 . . . . 1.1299999999999999 110.067 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -137.08 175.79 3.24 Favored Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 126.112 1.765 . . . . 3.7400000000000002 109.679 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.82 65.96 4.91 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 123.395 2.73 . . . . 2.4900000000000002 111.631 172.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.02 29.98 0.02 OUTLIER Glycine 0 CA--C 1.538 1.479 0 C-N-CA 127.14 2.305 . . . . 1.9199999999999999 112.806 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -126.94 150.44 49.34 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.172 1.389 . . . . 1.8200000000000001 111.273 -170.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.1 p -98.29 148.81 23.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.793 0.837 . . . . 2.1299999999999999 112.631 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 m -140.08 148.24 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.751 1.621 . . . . 1.5700000000000001 111.796 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.64 148.66 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.253 1.421 . . . . 2.6899999999999999 112.51 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.38 142.0 55.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.141 0.976 . . . . 1.78 112.454 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.51 2.44 89.59 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 115.619 1.008 . . . . 1.23 115.619 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 76.0 p -79.22 153.37 30.02 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.012 1.406 . . . . 1.8 111.118 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 mm -112.56 132.51 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.127 0.971 . . . . 2.0800000000000001 112.796 -168.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -84.45 133.97 34.47 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.668 1.587 . . . . 2.9500000000000002 111.282 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.82 -72.66 0.44 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.437 0.637 . . . . 4.9199999999999999 110.071 168.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -143.91 155.93 44.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.425 2.29 . . . . 3.9900000000000002 107.877 172.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.93 108.04 2.88 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 127.45 2.452 . . . . 1.99 111.803 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.7 t -86.64 127.89 34.96 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.491 1.146 . . . . 3.2400000000000002 110.844 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -126.12 162.64 24.9 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.835 1.254 . . . . 2.1499999999999999 111.562 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -114.81 126.78 55.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.426 0.691 . . . . 2.7200000000000002 109.44 167.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.62 125.65 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.804 1.642 . . . . 2.3900000000000001 110.292 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.7 p -87.25 108.03 18.76 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.671 0.748 . . . . 2.9700000000000002 109.744 168.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.26 135.66 36.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.61 0.764 . . . . 1.3100000000000001 111.574 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.04 -0.14 9.54 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.586 1.328 . . . . 2.98 114.586 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -143.78 144.68 31.91 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.296 1.438 . . . . 1.78 111.827 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 m -83.6 162.92 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.024 0.93 . . . . 2.4199999999999999 110.974 169.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.63 -34.49 90.04 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 120.728 -1.233 . . . . 1.45 114.984 -168.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.25 -28.0 64.89 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.11 -1.229 . . . . 2.2799999999999998 113.056 175.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.27 -7.81 56.57 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.16 1.784 . . . . 2.7599999999999998 114.545 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.4 p -68.55 158.03 34.76 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.885 -1.135 . . . . 2.29 112.688 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 t -64.59 -33.19 75.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.19 0.596 . . . . 2.8199999999999998 111.254 170.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mp -55.66 -50.98 68.79 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.983 -1.073 . . . . 2.4500000000000002 111.107 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.0 m -69.29 -31.56 70.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.417 1.087 . . . . 1.95 111.928 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.19 -40.8 98.56 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.671 -0.643 . . . . 1.6899999999999999 111.718 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 70.0 mt -65.18 -50.7 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.843 1.657 . . . . 3.3500000000000001 111.108 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 113.52 0.933 . . . . 2.0299999999999998 113.52 -175.619 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 112.644 0.609 . . . . 2.9900000000000002 112.644 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.0 tp -65.06 -30.19 71.14 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.601 -0.687 . . . . 3.6099999999999999 111.891 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.69 61.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.583 0.753 . . . . 2.3900000000000001 112.439 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -58.84 -35.96 73.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.013 1.325 . . . . 3.7400000000000002 112.914 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -48.98 -49.97 38.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.892 0.877 . . . . 2.2599999999999998 112.236 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.8 mm -74.09 -36.84 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.672 0.789 . . . . 3.2799999999999998 112.622 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -58.91 -30.31 67.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.116 0.966 . . . . 1.51 113.053 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -22.06 61.72 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.938 1.295 . . . . 3.1600000000000001 114.308 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -62.84 162.84 10.38 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.997 1.48 . . . . 3.1000000000000001 114.997 -171.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.7 -31.08 12.86 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.97 1.308 . . . . 3.5499999999999998 114.291 -171.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m 64.32 -12.78 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 127.946 2.499 . . . . 3.27 116.437 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -140.9 149.05 41.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.212 1.805 . . . . 2.8599999999999999 111.204 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.21 173.06 11.92 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.504 1.122 . . . . 1.46 112.837 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.4 m -124.33 120.88 33.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.611 1.165 . . . . 1.75 111.967 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.9 mt -94.42 144.5 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.785 2.034 . . . . 1.9199999999999999 110.37 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.7 t -111.92 126.0 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.223 1.009 . . . . 3.48 110.878 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.483 1.216 0 C-N-CA 125.791 1.636 . . . . 2.8900000000000001 111.331 -172.366 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 120.72 0.295 . . . . 4.0999999999999996 111.594 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -136.75 145.47 44.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.729 1.612 . . . . 2.3399999999999999 110.5 169.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -109.79 130.1 55.56 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.143 0.497 . . . . 2.8199999999999998 111.68 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -118.27 132.52 56.29 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.384 2.273 . . . . 3.9199999999999999 110.19 -170.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -93.52 139.17 31.05 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.097 1.317 . . . . 2.1800000000000002 112.312 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.96 166.09 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.68 1.592 . . . . 1.45 114.02 -171.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.79 150.58 24.95 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.375 1.47 . . . . 3.21 109.621 166.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.45 -19.48 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 114.295 1.22 . . . . 2.2599999999999998 114.295 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.32 -21.73 60.5 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.703 -1.248 . . . . 3.8199999999999998 113.866 172.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.8 mt -101.87 -7.43 22.48 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.806 1.242 . . . . 1.8600000000000001 113.808 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -86.23 142.35 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.835 1.254 . . . . 1.98 109.631 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -117.19 168.36 10.37 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.471 1.108 . . . . 4.4199999999999999 113.292 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -67.62 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.98 2.112 . . . . 3.4399999999999999 115.711 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.77 12.22 0.63 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.484 1.993 . . . . 1.45 114.277 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -92.42 152.31 19.78 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.739 1.769 . . . . 2.71 112.702 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -102.0 121.99 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.716 1.206 . . . . 2.7000000000000002 110.281 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.0 mm -104.56 159.95 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.796 1.638 . . . . 1.79 112.273 -172.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -129.47 132.89 47.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.688 1.595 . . . . 2.8500000000000001 111.332 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.57 140.8 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.225 1.01 . . . . 1.5800000000000001 112.542 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -95.03 159.34 33.27 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 125.233 1.413 . . . . 2.0800000000000001 112.859 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.0 133.96 43.9 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.058 2.505 . . . . 1.6200000000000001 111.891 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.29 -12.04 61.63 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.539 1.542 . . . . 0.94999999999999996 114.7 -172.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.61 173.76 52.85 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.216 1.389 . . . . 0.98999999999999999 114.726 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -108.45 154.07 22.4 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.55 1.54 . . . . 3.8199999999999998 113.259 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -84.03 121.75 75.78 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.887 0.875 . . . . 2.9700000000000002 110.818 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.79 -21.06 2.82 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.974 2.449 . . . . 0.91000000000000003 115.816 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -152.04 163.08 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 128.08 2.552 . . . . 2.2000000000000002 108.906 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 136.78 32.84 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 112.818 0.673 . . . . 1.7 112.818 -172.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.3 -161.86 32.89 Favored Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.635 -0.666 . . . . 0.81999999999999995 114.148 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.7 ttp85 -109.91 134.01 52.54 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.204 1.801 . . . . 4.9800000000000004 112.976 -172.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.5 133.53 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.524 2.329 . . . . 1.8799999999999999 108.77 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.62 32.46 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.951 0.901 . . . . 2.1699999999999999 112.817 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -167.16 136.17 2.74 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.222 1.809 . . . . 3.04 109.005 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.18 -177.19 51.85 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 122.417 1.01 . . . . 0.95999999999999996 115.559 170.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -144.01 124.71 14.13 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.653 1.181 . . . . 2.8999999999999999 111.746 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m -149.28 166.49 28.77 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.23 1.567 . . . . 1.9399999999999999 115.23 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.6 ttm -114.67 119.57 37.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.142 1.377 . . . . 2.4500000000000002 108.884 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.39 134.37 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.882 1.673 . . . . 1.0900000000000001 112.363 -167.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -86.73 75.79 9.59 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.702 1.601 . . . . 2.2000000000000002 110.316 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.67 4.62 53.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.205 1.402 . . . . 2.2200000000000002 113.718 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.1 -23.87 66.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 115.511 1.671 . . . . 3.0099999999999998 115.511 -169.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.72 -21.13 57.82 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.434 1.015 . . . . 2.3700000000000001 112.029 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -86.94 -49.84 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.935 0.894 . . . . 2.6600000000000001 110.968 176.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.4 p -100.19 -7.7 24.43 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.436 1.273 . . . . 2.3599999999999999 114.436 -172.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.98 -1.06 56.77 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.336 1.446 . . . . 1.6100000000000001 115.186 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.94 -6.76 1.41 Allowed 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 119.822 1.811 . . . . 2.8900000000000001 115.094 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 45.24 26.37 0.25 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 130.746 3.618 . . . . 2.9700000000000002 115.537 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 ttm -166.49 135.39 2.38 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.618 1.967 . . . . 4.7999999999999998 108.779 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.88 162.84 40.58 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.215 3.277 . . . . 2.1299999999999999 114.474 -169.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.99 135.57 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 126.198 1.799 . . . . 2.6000000000000001 110.991 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.8 141.98 35.74 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.826 0.85 . . . . 2.1800000000000002 112.977 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -128.87 149.54 50.72 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.829 2.052 . . . . 1.3 111.04 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -151.46 171.67 6.25 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 128.757 2.823 . . . . 3.71 108.977 -173.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.78 134.57 63.6 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 CA-C-N 122.36 1.879 . . . . 1.1200000000000001 111.699 169.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.78 31.14 45.38 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.052 0.834 . . . . 1.1000000000000001 114.19 -170.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.2 t -122.05 159.82 26.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.835 1.254 . . . . 2.04 110.827 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.0 p -118.77 155.43 31.14 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.547 1.521 . . . . 2.0 113.732 -172.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.1 m -132.2 152.41 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.61 1.964 . . . . 2.75 111.568 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.464 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -100.71 -1.26 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.844 2.058 . . . . 4.0599999999999996 116.041 -176.279 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 70.07 159.98 0.2 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.171 1.788 . . . . 2.29 114.484 -167.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.7 -44.27 2.5 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.011 1.291 . . . . 1.6799999999999999 113.277 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.5 p -51.33 151.29 3.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.373 1.069 . . . . 1.8100000000000001 113.741 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.59 136.13 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.229 1.012 . . . . 2.2799999999999998 110.462 -172.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -83.3 129.9 35.03 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.05 0.94 . . . . 1.8999999999999999 109.121 169.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -134.49 63.6 1.62 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.911 0.708 . . . . 4.4699999999999998 112.911 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -158.31 -56.1 0.07 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.51 1.67 . . . . 4.2400000000000002 115.51 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.9 -174.43 31.77 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.247 1.259 . . . . 2.1200000000000001 116.247 -167.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.4 p -94.31 126.46 39.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.857 1.263 . . . . 3.0800000000000001 112.54 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 mt -136.0 161.79 34.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.333 1.053 . . . . 2.0800000000000001 113.255 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -120.61 139.0 53.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.291 1.036 . . . . 2.7000000000000002 111.591 168.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.36 133.07 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.209 1.404 . . . . 2.6200000000000001 111.244 -173.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.6 p -90.28 118.76 30.03 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.145 -0.972 . . . . 2.4700000000000002 111.307 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.46 121.0 24.64 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.083 -1.011 . . . . 1.22 110.782 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.4 p -125.95 11.21 7.69 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.818 1.247 . . . . 3.7000000000000002 113.612 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -139.6 135.29 33.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.163 1.785 . . . . 1.99 108.137 171.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 p -78.66 160.65 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 122.962 0.505 . . . . 3.8700000000000001 109.697 169.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.28 -32.86 68.62 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 120.819 -1.176 . . . . 1.55 115.875 -168.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.48 -40.12 73.82 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.356 1.578 . . . . 2.1400000000000001 113.243 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.33 -7.67 53.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.703 2.001 . . . . 2.4199999999999999 114.385 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 67.6 p -58.48 149.25 25.71 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.988 -1.07 . . . . 2.6699999999999999 113.547 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.0 t -60.09 -36.57 77.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.663 0.785 . . . . 3.3700000000000001 111.309 171.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.2 tp -58.48 -47.01 85.46 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.841 -1.162 . . . . 2.2799999999999998 112.792 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 t -70.9 -26.96 63.46 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.337 0.655 . . . . 2.6299999999999999 112.404 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -71.25 -42.77 68.41 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.516 1.126 . . . . 1.5600000000000001 111.818 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.4 mt -54.31 -50.68 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.158 0.983 . . . . 2.6299999999999999 110.574 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.475 0.785 0 O-C-N 120.958 -1.089 . . . . 1.6799999999999999 113.292 179.408 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 111.893 0.331 . . . . 2.0600000000000001 111.893 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.8 tp -49.25 -43.14 42.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.587 1.555 . . . . 2.73 111.797 171.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.93 -35.97 62.16 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.276 0.843 . . . . 2.0800000000000001 113.276 172.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -64.57 -31.24 72.38 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.941 0.792 . . . . 4.1200000000000001 112.801 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.44 -32.65 70.41 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.97 1.259 . . . . 2.3999999999999999 112.569 172.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.6 mm -73.08 -40.71 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.397 -0.814 . . . . 3.2400000000000002 111.725 169.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.5 m -70.83 -21.06 62.49 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.142 1.164 . . . . 1.3600000000000001 114.142 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -72.84 -9.97 59.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.653 1.581 . . . . 3.0099999999999998 113.807 173.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -89.28 132.92 34.69 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.071 0.85 . . . . 3.4300000000000002 113.094 -172.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.48 161.13 31.52 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.445 1.498 . . . . 3.6400000000000001 114.43 -169.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 p -123.6 -26.3 4.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.587 1.555 . . . . 2.8399999999999999 113.833 -179.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.58 153.19 43.3 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.438 1.095 . . . . 3.3500000000000001 113.242 177.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.63 165.66 26.88 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.211 1.404 . . . . 1.4399999999999999 112.786 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -118.61 98.41 6.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.658 1.183 . . . . 2.3700000000000001 112.159 -178.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.2 mt -83.24 129.6 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 121.252 -0.905 . . . . 1.3600000000000001 110.496 -177.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.94 109.28 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 108.478 -0.934 . . . . 2.6099999999999999 108.478 169.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.477 0.92 0 C-N-CA 125.803 1.641 . . . . 3.2200000000000002 110.144 -177.019 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 109.559 -0.534 . . . . 3.2599999999999998 109.559 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 t -137.93 127.96 25.74 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.333 1.053 . . . . 2.0600000000000001 110.476 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -102.76 146.94 27.49 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.478 -0.764 . . . . 2.6099999999999999 112.459 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -127.75 138.37 52.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.965 1.706 . . . . 3.5299999999999998 110.41 -169.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -99.69 116.75 32.53 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.487 0.715 . . . . 2.6299999999999999 109.334 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.95 166.07 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.008 0.923 . . . . 1.28 113.146 -172.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -88.13 160.82 17.61 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.582 1.553 . . . . 3.8300000000000001 112.565 169.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.55 -28.36 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 115.472 1.656 . . . . 3.0800000000000001 115.472 -171.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -75.99 -17.23 59.78 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.272 -1.517 . . . . 4.3899999999999997 112.554 172.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -94.78 -8.78 36.54 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.176 1.39 . . . . 2.0899999999999999 113.723 -172.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.73 139.02 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.945 1.698 . . . . 1.5900000000000001 109.392 168.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.63 168.04 20.26 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.281 1.432 . . . . 3.1099999999999999 112.597 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -68.91 4.84 1.32 Allowed 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 117.531 2.419 . . . . 5.0 117.531 -167.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.16 7.35 16.63 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.667 1.603 . . . . 1.7 114.21 172.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -90.04 152.78 21.01 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.058 1.429 . . . . 2.71 112.929 -177.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.1 mm -113.45 122.47 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.927 1.691 . . . . 2.6299999999999999 109.86 177.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.3 mm -113.28 125.04 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.992 1.317 . . . . 2.1800000000000002 111.562 -172.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -78.74 132.48 36.96 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.443 -0.786 . . . . 3.29 110.508 169.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 p -121.85 133.86 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.337 1.455 . . . . 1.3600000000000001 111.206 176.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 m -89.06 162.22 38.42 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.766 1.226 . . . . 2.2000000000000002 113.389 -173.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -61.28 133.7 47.95 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.695 1.597 . . . . 1.78 109.196 167.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.96 -10.69 46.05 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.515 -1.158 . . . . 1.1200000000000001 115.426 -172.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.53 175.17 44.07 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.038 1.419 . . . . 1.0600000000000001 114.403 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -111.63 153.34 26.49 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.463 1.505 . . . . 2.6499999999999999 112.055 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -84.17 128.67 61.45 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-O 118.101 -0.952 . . . . 3.8300000000000001 109.717 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -96.9 -14.46 0.4 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.912 2.408 . . . . 0.88 115.482 -173.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.37 164.62 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 127.716 2.406 . . . . 2.1600000000000001 108.336 -176.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -88.46 155.09 19.87 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.412 1.264 . . . . 2.4700000000000002 114.412 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.74 -131.26 2.4 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.362 -0.835 . . . . 1.0600000000000001 113.735 177.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -135.72 146.39 47.65 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.233 1.197 . . . . 4.7599999999999998 114.233 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.77 122.77 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 105.628 -1.99 . . . . 2.3500000000000001 105.628 166.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.2 pt -137.0 33.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.816 0.817 . . . . 2.1400000000000001 112.109 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -167.62 128.54 1.46 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.069 2.148 . . . . 2.8100000000000001 107.75 166.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.66 -178.12 54.09 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 122.842 1.246 . . . . 0.80000000000000004 115.374 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -149.13 137.04 20.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.391 1.476 . . . . 3.9700000000000002 111.414 -176.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -150.76 176.68 10.81 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.481 0.919 . . . . 2.1400000000000001 113.481 176.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.5 ttm -112.89 126.95 56.02 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.334 1.054 . . . . 1.8 110.678 171.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -114.33 140.77 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.206 1.402 . . . . 0.94999999999999996 112.774 -168.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -97.38 107.67 20.23 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.456 1.502 . . . . 1.95 109.554 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.256 11.2 pt-20 -123.75 30.15 6.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.483 1.513 . . . . 2.2200000000000002 113.063 -178.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.3 p -60.63 -24.22 65.36 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.966 1.839 . . . . 2.1699999999999999 115.966 -175.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -95.47 -33.61 12.38 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.079 1.351 . . . . 1.72 111.352 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.0 mm -76.5 -49.34 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.531 -0.731 . . . . 2.0600000000000001 110.632 178.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 m -106.85 -21.5 13.0 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.535 1.134 . . . . 3.5099999999999998 113.277 -169.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.59 -13.69 64.87 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.584 1.564 . . . . 1.26 115.78 172.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -63.86 118.31 8.19 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.475 1.138 . . . . 3.1000000000000001 110.215 174.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.25 35.05 0.32 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.187 1.395 . . . . 2.7799999999999998 112.829 -178.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 ptp -154.14 137.13 10.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.367 1.867 . . . . 5.0099999999999998 110.239 -174.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -63.23 154.93 64.69 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.861 2.374 . . . . 2.3599999999999999 115.193 -179.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.4 t -122.76 132.23 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.999 1.72 . . . . 1.74 111.04 -170.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.25 35.56 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.964 0.887 . . . . 2.3900000000000001 113.289 -175.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -125.01 150.57 46.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.539 1.936 . . . . 1.97 110.61 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -150.09 173.9 3.92 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 129.621 3.169 . . . . 3.6499999999999999 108.415 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -56.14 136.81 77.08 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 CA-C-N 121.702 1.644 . . . . 0.96999999999999997 111.573 170.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.94 25.98 72.33 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.602 1.096 . . . . 0.89000000000000001 114.465 -171.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.4 m -102.05 146.98 27.15 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 119.139 1.469 . . . . 2.0499999999999998 110.575 174.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.7 p -88.83 151.76 22.17 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.184 1.357 . . . . 1.8999999999999999 113.148 178.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -138.52 157.04 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.04 1.336 . . . . 2.0299999999999998 112.01 176.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.75 150.18 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.095 2.158 . . . . 1.8899999999999999 111.282 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.86 148.54 49.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.913 0.885 . . . . 1.75 113.334 -174.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.44 -3.46 62.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.348 0.975 . . . . 0.76000000000000001 115.106 179.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.2 p -79.5 157.2 27.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.951 1.375 . . . . 1.71 111.07 169.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mm -115.13 130.52 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.551 0.74 . . . . 1.8400000000000001 112.645 -168.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -90.07 149.26 22.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.882 1.673 . . . . 1.6599999999999999 113.669 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -157.67 142.9 16.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.403 1.081 . . . . 4.0700000000000003 112.61 171.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 t30 117.47 -40.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 131.255 3.822 . . . . 4.1100000000000003 113.514 175.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.62 -179.79 46.35 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 120.031 1.287 . . . . 2.1800000000000002 115.281 173.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.4 m -82.35 134.21 35.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.416 1.086 . . . . 2.6600000000000001 112.616 -177.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.39 165.16 20.29 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.128 1.771 . . . . 2.3300000000000001 111.619 -176.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.43 132.96 55.91 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.607 0.718 . . . . 3.04 111.026 168.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.7 mm -118.14 125.12 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.053 1.741 . . . . 2.5099999999999998 110.283 -169.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -82.73 114.65 21.23 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.383 -0.823 . . . . 2.3599999999999999 109.065 168.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.04 112.67 15.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.338 -0.986 . . . . 1.1799999999999999 108.338 174.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -104.6 2.56 30.79 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.932 0.893 . . . . 2.9900000000000002 112.746 -172.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -147.76 154.39 40.46 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.7 1.6 . . . . 2.2400000000000002 111.665 173.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.06 165.63 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.896 1.278 . . . . 2.9700000000000002 112.181 170.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 -35.21 85.42 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 120.906 -1.121 . . . . 1.6000000000000001 114.283 -172.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.91 -31.69 72.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.455 1.128 . . . . 2.3399999999999999 113.64 176.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -75.19 -17.63 60.32 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.127 -0.983 . . . . 2.9500000000000002 113.58 174.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 81.6 p -64.65 144.6 57.11 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.899 -1.126 . . . . 2.4199999999999999 112.566 -169.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -64.55 -22.85 67.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.899 0.879 . . . . 2.9199999999999999 113.065 -169.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.64 -49.33 78.19 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.68 1.192 . . . . 2.3500000000000001 113.107 -177.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.8 m -72.83 -17.34 61.56 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.533 0.938 . . . . 3.8100000000000001 113.533 173.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -76.92 -40.89 45.58 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.736 0.643 . . . . 1.5800000000000001 112.736 172.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.13 -47.31 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.6 1.56 . . . . 2.4100000000000001 110.386 177.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 114.479 1.288 . . . . 2.1299999999999999 114.479 -178.011 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 112.48 0.548 . . . . 3.1299999999999999 112.48 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.25 -44.85 84.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.253 1.421 . . . . 2.3999999999999999 111.797 176.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.82 -8.61 56.33 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.286 1.217 . . . . 2.5800000000000001 114.286 175.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -65.25 -43.01 92.71 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.818 1.19 . . . . 2.98 110.607 -177.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -45.86 -52.93 10.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.246 1.818 . . . . 2.54 112.246 172.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.1 mm -69.78 -31.32 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.11 0.964 . . . . 3.02 112.183 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.9 m -75.46 -28.3 59.23 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.01 1.324 . . . . 2.25 113.627 -175.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.32 -24.14 67.73 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.265 0.938 . . . . 3.0099999999999998 113.519 175.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -68.25 139.47 56.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.886 1.275 . . . . 2.9399999999999999 113.465 -175.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.87 157.28 29.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.604 1.161 . . . . 2.4900000000000002 112.561 173.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.54 -2.25 17.72 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.7 1.741 . . . . 3.0800000000000001 115.7 -169.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.31 156.74 48.21 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.862 1.665 . . . . 3.8999999999999999 112.526 -178.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.72 147.3 37.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.034 0.934 . . . . 1.8 113.108 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.2 m -107.98 106.45 16.71 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.597 1.159 . . . . 1.8700000000000001 111.369 175.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mt -83.48 147.22 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.178 1.791 . . . . 1.8600000000000001 109.486 176.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.16 140.24 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.636 1.347 . . . . 3.1899999999999999 114.636 169.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.479 1.016 0 C-N-CA 125.575 1.55 . . . . 3.5299999999999998 114.4 -178.732 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.8 tp . . . . . 0 CA--C 1.552 1.028 0 CA-C-O 121.612 0.72 . . . . 4.04 112.388 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -79.08 153.6 30.05 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.231 1.013 . . . . 2.3700000000000001 112.501 -172.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -116.08 131.63 56.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.111 1.364 . . . . 2.6499999999999999 110.214 176.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -126.33 136.07 52.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.214 1.806 . . . . 3.98 110.171 -176.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -110.2 130.98 55.45 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.466 -1.396 . . . . 1.99 112.252 -175.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.81 169.14 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.922 1.289 . . . . 1.95 113.62 -173.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -79.58 152.42 30.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.24 1.416 . . . . 3.3799999999999999 112.494 171.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.77 -18.76 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 115.189 1.552 . . . . 2.3799999999999999 115.189 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -85.46 -19.92 30.54 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 120.623 1.556 . . . . 3.04 113.503 169.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.16 -17.7 21.55 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.046 1.338 . . . . 2.3700000000000001 113.558 -173.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.54 138.69 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.766 0.827 . . . . 2.1899999999999999 109.235 168.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -118.82 159.27 24.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.196 0.998 . . . . 3.5299999999999998 111.123 178.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.2 ptt85 -69.59 146.6 51.62 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.899 -0.501 . . . . 3.2799999999999998 109.984 169.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.12 2.8 56.9 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-N 118.852 0.751 . . . . 2.27 114.077 -171.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -112.98 172.87 6.67 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.612 1.565 . . . . 2.3700000000000001 112.102 173.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.3 mm -112.69 122.95 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.734 1.614 . . . . 2.54 110.483 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.6 mm -119.5 132.89 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.458 1.503 . . . . 2.23 111.429 -169.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -86.74 142.24 28.3 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.322 1.449 . . . . 3.77 112.456 174.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.35 145.4 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.58 0.752 . . . . 1.3500000000000001 111.749 170.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.78 156.75 35.17 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 124.98 1.312 . . . . 2.1200000000000001 113.323 -177.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -59.64 140.18 92.41 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.352 2.035 . . . . 1.99 110.679 168.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.57 -5.34 11.21 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.748 1.166 . . . . 1.05 114.906 -172.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.64 169.99 53.81 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 118.817 1.308 . . . . 0.98999999999999999 114.241 177.032 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -123.25 152.05 41.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.07 1.748 . . . . 2.8999999999999999 110.606 -178.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -81.05 127.51 74.13 Favored Pre-proline 0 CA--C 1.551 0.988 0 O-C-N 121.629 -0.669 . . . . 3.0099999999999998 111.575 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.13 -20.66 2.76 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.581 2.854 . . . . 1.1899999999999999 113.493 177.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 m -147.99 170.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.872 2.469 . . . . 1.8899999999999999 108.978 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.84 152.47 20.48 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.059 0.763 . . . . 1.71 113.059 177.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.74 -174.61 46.17 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 115.397 0.919 . . . . 0.81000000000000005 115.397 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.0 ttt85 -102.75 139.46 38.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.66 1.184 . . . . 7.1399999999999997 111.912 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.3 t -99.91 133.96 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 127.307 2.243 . . . . 1.8899999999999999 109.268 -173.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.1 pt -139.87 28.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.017 1.117 . . . . 1.95 114.017 -177.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.73 150.18 3.95 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.941 1.697 . . . . 3.27 110.114 166.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.57 -173.92 34.35 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.704 1.145 . . . . 0.81999999999999995 115.29 169.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -151.33 121.13 7.04 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.185 1.394 . . . . 3.96 110.965 -175.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.6 m -147.5 155.2 41.66 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.111 -0.993 . . . . 2.0899999999999999 113.009 172.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.1 ttm -102.06 121.13 41.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.598 1.159 . . . . 1.8999999999999999 108.436 169.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 68.7 t -118.59 146.33 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.539 1.936 . . . . 1.1899999999999999 112.831 -165.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -108.41 115.84 30.85 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.351 1.86 . . . . 2.0099999999999998 110.541 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -127.12 26.21 6.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.611 1.564 . . . . 1.77 112.271 179.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.5 p -55.58 -31.04 61.86 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.006 1.854 . . . . 1.6799999999999999 116.006 -172.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.0 -39.44 13.7 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.607 1.094 . . . . 2.1699999999999999 111.189 176.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.6 mm -70.29 -62.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.733 1.213 . . . . 1.9099999999999999 111.332 -173.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.7 p -98.21 -7.49 29.2 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.552 1.141 . . . . 2.2999999999999998 112.946 -175.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.61 17.66 65.6 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.839 1.209 . . . . 1.4299999999999999 113.331 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -82.53 96.81 8.16 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.32 1.06 . . . . 3.0600000000000001 112.108 -176.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.88 20.18 0.26 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.27 1.028 . . . . 2.2599999999999998 113.565 177.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.5 ttt -146.69 132.54 9.4 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 128.419 2.688 . . . . 4.96 107.385 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -69.64 153.53 69.34 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.052 2.501 . . . . 2.6200000000000001 112.62 -170.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.1 t -111.87 132.5 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.971 1.708 . . . . 1.7 111.207 -168.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.09 137.68 34.0 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.435 -0.791 . . . . 1.8300000000000001 111.398 174.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -122.75 146.91 47.09 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.364 1.465 . . . . 1.1299999999999999 110.938 176.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -150.23 170.98 6.89 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 126.871 2.068 . . . . 3.8599999999999999 111.375 -170.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -59.01 118.94 5.92 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.982 1.788 . . . . 0.93999999999999995 109.634 167.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.3 48.33 4.34 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.534 1.54 . . . . 0.88 113.689 -169.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.6 m -126.44 166.62 16.89 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.861 1.33 . . . . 1.5600000000000001 112.804 173.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.7 p -111.0 149.63 30.43 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.271 0.941 . . . . 1.96 112.842 174.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.03 157.12 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.371 1.468 . . . . 1.2 111.898 175.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.34 149.42 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.839 2.056 . . . . 1.77 113.078 176.193 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.84 143.83 46.23 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.891 0.876 . . . . 1.6799999999999999 111.843 176.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.33 -7.67 60.28 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 116.272 1.269 . . . . 0.69999999999999996 116.272 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 t -73.7 157.14 37.08 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.137 1.468 . . . . 3.6499999999999999 111.329 169.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.41 136.32 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.753 1.621 . . . . 2.1299999999999999 111.697 -169.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -99.59 134.42 42.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.249 1.019 . . . . 2.23 110.745 172.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -135.9 53.65 1.94 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.041 1.126 . . . . 3.6499999999999999 114.041 175.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -153.17 -54.21 0.11 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.415 1.635 . . . . 2.98 115.415 173.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.07 -156.17 11.33 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-N 119.367 0.985 . . . . 2.7400000000000002 114.946 -169.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -83.9 155.47 22.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.223 1.009 . . . . 3.7999999999999998 112.783 177.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.1 mt -147.55 152.28 37.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.839 2.056 . . . . 2.25 107.766 167.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.58 114.86 28.21 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.189 0.995 . . . . 3.4199999999999999 109.399 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.67 126.43 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.259 1.023 . . . . 2.1899999999999999 111.397 -173.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 30.0 p -82.37 119.65 24.43 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.579 -0.701 . . . . 2.3900000000000001 109.249 169.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.8 123.53 28.32 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.275 -0.891 . . . . 1.03 110.973 -175.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.6 p -115.81 -8.14 12.0 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.736 1.013 . . . . 2.8999999999999999 113.736 -174.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -142.24 151.0 41.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.569 1.548 . . . . 1.6599999999999999 110.603 173.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 m -100.65 171.21 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.863 1.265 . . . . 2.6699999999999999 109.614 167.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.51 63.52 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.61 -1.306 . . . . 1.6499999999999999 114.663 -174.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.13 -47.06 63.34 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.27 -1.135 . . . . 2.1000000000000001 112.951 169.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -79.1 -16.73 56.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.091 2.156 . . . . 2.5299999999999998 116.174 -174.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -71.54 148.37 46.78 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.485 -1.385 . . . . 4.0099999999999998 113.614 -170.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 t -51.62 -35.89 43.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.033 1.333 . . . . 2.75 112.869 171.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.9 tp -60.29 -46.36 90.11 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.204 -0.935 . . . . 2.3599999999999999 112.128 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.1 p -73.91 -30.83 62.8 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.991 0.916 . . . . 2.1400000000000001 113.411 173.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -61.54 -43.1 99.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.18 0.9 . . . . 1.6200000000000001 111.343 175.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.83 -54.69 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.547 1.139 . . . . 2.9900000000000002 110.475 178.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.476 0.846 0 O-C-N 121.338 -0.851 . . . . 1.7 112.84 -178.949 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.721 0 N-CA-C 111.638 0.236 . . . . 2.6099999999999999 111.638 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 tp -50.2 -41.41 49.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.242 1.417 . . . . 2.6400000000000001 113.36 177.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.22 61.04 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.928 0.714 . . . . 3.1000000000000001 112.928 171.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.23 -35.18 73.19 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.029 0.931 . . . . 3.9300000000000002 112.551 178.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.32 -31.94 69.61 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.301 0.955 . . . . 2.4500000000000002 112.973 173.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.2 mm -72.17 -40.2 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.027 0.931 . . . . 3.6200000000000001 111.786 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m -71.26 -23.74 62.04 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.824 -1.173 . . . . 1.99 113.882 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.0 mt -73.4 -20.98 60.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.102 1.361 . . . . 3.1099999999999999 113.57 173.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -85.37 143.18 28.79 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.178 0.991 . . . . 3.5699999999999998 113.326 -176.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.56 165.69 12.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.746 1.619 . . . . 3.4399999999999999 114.568 -178.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -120.55 -6.3 9.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.287 1.035 . . . . 4.0300000000000002 113.041 169.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.49 155.23 45.03 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.558 -1.339 . . . . 2.79 113.725 -175.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.78 162.38 35.63 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.864 1.666 . . . . 2.3300000000000001 113.003 177.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.2 m -125.51 111.97 15.68 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.637 1.175 . . . . 2.27 112.811 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 mt -96.75 133.1 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.788 1.235 . . . . 2.1699999999999999 110.439 -175.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -126.54 115.1 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.218 1.407 . . . . 3.75 110.614 -177.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.473 0.699 0 C-N-CA 124.865 1.266 . . . . 4.0599999999999996 110.561 -169.652 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 110.404 -0.221 . . . . 4.8200000000000003 110.404 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.7 t -126.78 120.0 28.26 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.759 1.224 . . . . 1.9299999999999999 109.301 172.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -117.88 152.46 35.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.293 1.037 . . . . 3.2400000000000002 111.14 -173.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -142.09 138.39 31.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.968 1.707 . . . . 2.9300000000000002 111.18 -176.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -108.41 130.61 55.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.407 1.003 . . . . 1.9399999999999999 109.664 168.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.7 167.86 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.588 1.155 . . . . 2.1800000000000002 112.9 -168.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.88 149.87 32.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.261 1.425 . . . . 4.8899999999999997 110.712 168.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.02 -9.05 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.599 1.333 . . . . 2.0800000000000001 114.599 -173.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -96.64 -15.51 21.47 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.274 -1.516 . . . . 4.4100000000000001 112.803 169.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.01 -5.67 59.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.219 1.408 . . . . 2.1000000000000001 113.936 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -100.12 142.85 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.504 1.522 . . . . 1.8799999999999999 111.207 170.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -117.83 168.97 10.0 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.76 2.024 . . . . 3.4399999999999999 111.468 175.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -68.83 144.82 54.17 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.841 -0.537 . . . . 5.6500000000000004 110.586 169.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.0 -7.37 31.13 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.264 1.411 . . . . 2.6499999999999999 114.984 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.6 165.69 11.5 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.404 1.602 . . . . 3.0600000000000001 113.343 178.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -116.39 132.49 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.653 1.181 . . . . 3.02 112.302 -173.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.52 118.57 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 127.599 2.36 . . . . 2.4100000000000001 109.225 -169.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -94.68 115.59 27.72 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.613 -0.679 . . . . 4.0300000000000002 111.699 172.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.6 p -94.04 146.93 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.343 1.057 . . . . 1.99 112.254 -170.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.6 m -92.04 160.39 35.75 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.65 1.18 . . . . 2.3700000000000001 112.598 169.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -55.86 146.5 67.29 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.116 1.877 . . . . 2.6200000000000001 110.939 167.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.52 0.95 41.95 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.722 1.153 . . . . 1.75 115.299 -174.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.63 148.2 50.62 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.263 1.531 . . . . 1.6200000000000001 112.819 172.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -117.68 9.72 13.15 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.478 1.658 . . . . 3.9700000000000002 115.478 -169.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 51.88 115.11 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 129.095 2.958 . . . . 3.4199999999999999 116.794 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.71 -14.81 9.94 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.065 2.51 . . . . 1.0600000000000001 115.346 -176.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 m -153.11 173.72 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 128.296 2.638 . . . . 1.8300000000000001 108.639 -178.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -92.62 147.87 22.53 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.505 0.928 . . . . 2.46 113.505 173.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.56 173.78 44.44 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 115.134 0.814 . . . . 1.79 115.134 -170.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -113.28 133.16 55.25 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.125 1.37 . . . . 6.1900000000000004 111.621 -174.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.25 127.92 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 126.821 2.048 . . . . 1.6299999999999999 109.286 -169.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 pt -142.49 30.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.784 1.031 . . . . 2.2400000000000002 113.784 -173.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -169.51 143.08 2.72 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.459 1.903 . . . . 3.46 109.747 168.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -171.6 37.9 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 116.285 1.274 . . . . 1.26 116.285 169.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -142.63 123.78 14.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.142 0.977 . . . . 3.1899999999999999 111.929 177.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 m -148.22 151.41 35.45 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.862 -1.149 . . . . 2.02 113.915 169.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.8 ttm -95.24 138.42 32.97 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.638 -0.664 . . . . 2.2599999999999998 109.688 168.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.5 t -129.31 132.2 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.421 1.488 . . . . 2.1800000000000002 111.035 -170.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.76 121.14 30.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.918 1.287 . . . . 2.3100000000000001 111.651 176.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -116.12 14.21 15.93 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.054 1.742 . . . . 1.96 113.224 -178.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 86.7 p -60.74 -0.85 0.32 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 119.211 3.041 . . . . 1.5800000000000001 119.211 -167.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -115.1 -40.51 3.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.938 1.295 . . . . 2.1400000000000001 110.299 169.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.5 mm -69.46 -49.95 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.831 0.853 . . . . 2.3799999999999999 112.109 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 p -106.09 -13.47 15.44 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.3 1.04 . . . . 2.3100000000000001 113.108 175.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.68 -0.17 84.55 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 124.85 1.214 . . . . 1.3100000000000001 115.162 169.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.18 121.98 27.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.04 1.336 . . . . 3.02 111.916 179.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.01 14.52 4.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.955 1.302 . . . . 2.2599999999999998 113.301 -173.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 71.7 mtp -126.75 105.86 23.13 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 127.887 2.475 . . . . 4.3200000000000003 108.002 -174.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.33 152.97 36.22 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.222 2.615 . . . . 2.9700000000000002 114.387 -173.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.82 127.98 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 126.275 1.83 . . . . 2.0600000000000001 111.054 -167.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.83 129.07 34.18 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.713 -0.617 . . . . 1.8600000000000001 111.639 -178.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -121.65 144.88 48.51 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.454 1.902 . . . . 1.04 110.2 -177.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -155.8 -177.77 0.79 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 128.452 2.701 . . . . 4.9800000000000004 108.78 -174.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.82 133.35 54.05 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.119 1.88 . . . . 1.3200000000000001 112.308 168.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.25 28.9 59.27 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.166 1.365 . . . . 0.93000000000000005 114.567 -171.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.1 m -111.33 170.27 8.23 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.668 1.734 . . . . 1.8500000000000001 110.661 175.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.3 p -127.06 148.29 50.13 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 120.463 -1.398 . . . . 2.3599999999999999 111.986 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.0 149.05 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.371 1.069 . . . . 1.45 112.019 179.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.4 150.54 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.428 1.891 . . . . 2.0299999999999998 110.763 177.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.19 138.59 57.88 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.967 -0.56 . . . . 1.75 111.654 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.66 3.73 88.02 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.143 0.817 . . . . 1.7 115.143 -176.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.6 p -88.44 142.82 27.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.815 1.308 . . . . 1.9099999999999999 110.2 167.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.44 120.39 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.092 0.775 . . . . 2.1499999999999999 113.092 -167.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -76.16 129.32 36.58 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.445 1.098 . . . . 2.0 111.037 178.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -106.4 -29.67 9.58 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.223 1.194 . . . . 6.2000000000000002 114.223 -172.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -104.62 -45.36 4.64 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 116.521 2.045 . . . . 3.5099999999999998 116.521 -165.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.96 -142.65 5.22 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 118.204 2.042 . . . . 3.02 118.204 -167.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 t -90.09 144.28 26.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.369 1.468 . . . . 2.8300000000000001 112.412 -174.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.7 mt -147.82 159.44 43.83 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.72 1.608 . . . . 1.99 109.538 169.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 tp -116.39 123.52 47.78 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.486 1.114 . . . . 3.3399999999999999 110.331 169.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.57 129.47 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.275 1.03 . . . . 2.5600000000000001 110.845 -170.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 52.8 t -86.46 123.9 32.2 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.379 -0.826 . . . . 4.4699999999999998 109.671 168.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.89 121.83 25.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.898 0.879 . . . . 1.3100000000000001 109.424 176.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.3 t -114.73 0.23 13.79 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.93 1.085 . . . . 3.04 113.93 -169.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -146.84 150.64 35.67 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.955 2.102 . . . . 1.99 111.178 175.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.1 m -83.47 166.56 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.767 0.827 . . . . 2.8199999999999998 112.615 169.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.87 -31.4 75.88 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 120.932 -1.105 . . . . 1.6000000000000001 114.681 -174.033 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.19 -25.39 64.31 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.174 1.175 . . . . 3.0800000000000001 114.174 174.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.19 -19.92 59.57 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.269 -0.894 . . . . 3.1400000000000001 113.081 171.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.1 p -68.49 141.96 55.43 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.564 -0.71 . . . . 2.4900000000000002 111.809 -169.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 t -70.15 -18.18 63.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.097 0.777 . . . . 3.2000000000000002 113.097 -170.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.4 mp -59.42 -52.14 66.9 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.297 -1.502 . . . . 2.48 112.588 -175.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.6 p -73.76 -17.48 61.09 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.91 0.884 . . . . 3.0 113.379 174.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -72.0 -42.72 66.11 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.12 0.968 . . . . 2.0899999999999999 111.723 173.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.3 mt -61.18 -52.75 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.616 1.566 . . . . 2.5699999999999998 111.16 -177.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 115.347 1.61 . . . . 2.8500000000000001 115.347 -172.876 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 115.098 1.518 . . . . 2.29 115.098 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.0 tp -59.75 -40.81 89.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.962 1.256 . . . . 2.7200000000000002 113.928 -168.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.25 -20.7 60.78 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.3 1.222 . . . . 2.73 114.3 173.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -70.73 -42.99 69.81 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.109 1.322 . . . . 3.1800000000000002 111.426 -169.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -47.52 -50.55 23.29 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.834 1.254 . . . . 2.46 111.564 173.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.54 -28.87 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.396 1.078 . . . . 3.25 112.635 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -74.42 -25.64 59.57 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.874 -1.141 . . . . 1.8799999999999999 112.973 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.01 -22.5 63.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.036 0.835 . . . . 2.9100000000000001 112.89 169.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -68.46 135.19 51.27 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.855 1.207 . . . . 3.0099999999999998 111.469 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.26 151.13 47.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.642 0.777 . . . . 2.5600000000000001 112.422 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 p -87.36 -21.95 25.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.827 1.651 . . . . 3.5699999999999998 113.355 177.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.75 157.08 47.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.871 1.268 . . . . 3.5299999999999998 112.788 -175.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.75 157.38 45.11 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.73 1.212 . . . . 1.55 112.179 177.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 m -115.11 110.35 19.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.372 1.069 . . . . 1.8600000000000001 111.385 177.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.7 mt -91.75 135.2 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.091 1.756 . . . . 2.2400000000000002 109.495 -178.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 m -96.53 115.02 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 119.385 0.993 . . . . 3.4900000000000002 109.372 167.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 N--CA 1.471 0.603 0 C-N-CA 123.813 0.845 . . . . 3.7000000000000002 110.273 -177.441 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 113.117 0.784 . . . . 5.5700000000000003 113.117 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.0 t -92.42 111.43 23.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.939 0.896 . . . . 2.0299999999999998 109.607 176.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -81.53 138.29 35.45 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.349 0.87 . . . . 2.9399999999999999 113.349 -170.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -127.83 125.3 39.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.847 2.059 . . . . 2.7000000000000002 109.795 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -95.5 132.0 41.07 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.419 -1.425 . . . . 4.1600000000000001 109.864 174.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.81 167.79 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.768 1.627 . . . . 1.51 112.846 -169.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.9 148.95 31.07 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.217 -0.66 . . . . 3.3500000000000001 109.217 165.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.97 -7.36 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 114.954 1.465 . . . . 1.8700000000000001 114.954 -177.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.78 -30.5 56.52 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 119.791 -1.818 . . . . 3.2999999999999998 112.691 167.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -90.69 4.04 52.58 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.798 1.639 . . . . 2.1200000000000001 114.117 -168.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 p -101.1 135.75 36.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 126.416 1.886 . . . . 2.0600000000000001 110.62 173.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.82 166.58 10.91 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.219 1.808 . . . . 4.0499999999999998 111.45 178.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -65.29 -12.87 56.08 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.718 1.377 . . . . 4.9800000000000004 114.718 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.19 7.56 75.85 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.262 1.41 . . . . 2.0699999999999998 115.938 174.352 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -91.82 155.84 17.94 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.782 1.791 . . . . 2.8999999999999999 112.649 176.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.0 mm -110.9 123.83 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.753 1.621 . . . . 3.1800000000000002 109.172 176.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -120.95 133.83 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.424 1.089 . . . . 1.6399999999999999 113.375 -167.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HE3' ' CG ' ' A' ' 96' ' ' LEU . 10.9 mmmm -101.04 148.2 25.32 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.601 0.76 . . . . 5.04 112.563 178.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 p -124.22 134.53 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.424 1.089 . . . . 1.95 111.691 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.2 m -79.94 163.57 57.3 Favored Pre-proline 0 N--CA 1.482 1.15 0 N-CA-C 113.303 0.853 . . . . 2.27 113.303 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.36 120.33 7.45 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.242 1.961 . . . . 1.95 108.451 168.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.02 84.2 Favored Glycine 0 CA--C 1.54 1.655 0 C-N-CA 124.634 1.112 . . . . 1.22 115.467 -170.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.46 178.51 52.9 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 119.633 1.717 . . . . 1.0700000000000001 115.404 -177.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -120.87 145.3 47.78 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.614 1.165 . . . . 2.3599999999999999 112.211 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -81.99 124.22 79.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.763 0.825 . . . . 2.8599999999999999 111.901 -178.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -91.98 -20.14 0.66 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.194 2.596 . . . . 0.81999999999999995 115.932 -170.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.73 166.94 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 126.849 2.06 . . . . 1.75 109.79 -177.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.313 0.3 OUTLIER -88.98 142.96 27.2 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.983 0.811 . . . . 1.8999999999999999 112.698 174.327 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.61 -166.75 39.94 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.533 0.973 . . . . 0.68999999999999995 115.533 -173.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.6 ttp85 -109.76 143.54 39.44 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.68 1.592 . . . . 5.46 112.053 -171.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.2 128.87 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.1 1.76 . . . . 2.3100000000000001 109.668 -172.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.7 pt -140.27 36.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 114.001 1.111 . . . . 2.1000000000000001 114.001 -172.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -166.27 142.14 4.78 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.14 1.376 . . . . 3.1699999999999999 111.283 168.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.15 -163.84 34.74 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.049 1.309 . . . . 1.21 115.907 169.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.98 126.46 5.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.329 1.233 . . . . 3.7000000000000002 114.329 174.035 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 m -145.95 166.67 25.35 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.849 -1.157 . . . . 2.0600000000000001 112.828 174.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.9 ttm -107.73 124.44 50.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.018 0.927 . . . . 1.75 109.286 172.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.08 143.61 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.064 1.746 . . . . 0.90000000000000002 112.981 -167.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -98.25 96.28 7.96 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.22 1.408 . . . . 1.9399999999999999 111.309 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -93.01 -10.58 35.72 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.082 1.353 . . . . 1.74 113.268 177.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 t -38.12 -46.4 1.03 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.51 2.411 . . . . 2.4700000000000002 117.51 -167.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.3 -33.48 61.19 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.46 1.482 . . . . 1.98 112.167 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 mm -73.23 -47.49 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.406 1.482 . . . . 2.0499999999999998 111.075 -177.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.4 p -110.44 -13.19 14.31 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.037 1.335 . . . . 2.1899999999999999 114.125 -170.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.36 2.84 90.24 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.512 1.529 . . . . 1.1200000000000001 114.752 -177.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -51.44 -49.91 60.77 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.921 1.36 . . . . 2.4900000000000002 114.419 -172.059 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 57.76 31.53 20.59 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.334 1.454 . . . . 2.77 114.605 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.2 ttm -162.55 136.08 4.64 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 130.212 3.405 . . . . 3.9199999999999999 105.242 169.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.18 164.9 34.12 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.95 2.433 . . . . 2.0499999999999998 113.321 -170.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.3 t -120.22 129.83 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.383 1.473 . . . . 1.46 111.454 -169.427 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.27 139.7 36.54 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.479 -0.763 . . . . 1.74 111.943 177.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -125.03 150.97 46.21 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.664 1.586 . . . . 0.93999999999999995 111.449 -178.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -149.57 172.86 4.77 Favored Pre-proline 0 N--CA 1.483 1.224 0 C-N-CA 129.312 3.045 . . . . 3.98 109.053 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -59.52 140.2 92.86 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 CA-C-N 121.588 1.603 . . . . 0.96999999999999997 110.994 167.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.42 44.76 15.91 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.811 -0.555 . . . . 1.05 112.45 -170.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.9 t -126.67 170.14 12.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.69 1.596 . . . . 1.6000000000000001 111.111 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.4 p -129.69 149.43 51.45 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.777 -1.202 . . . . 2.1600000000000001 112.411 -176.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.89 159.06 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.09 1.356 . . . . 1.24 113.804 -176.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.05 152.84 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.798 2.439 . . . . 1.8799999999999999 111.46 169.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.32 152.14 44.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.774 0.829 . . . . 1.7 112.906 178.427 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.23 4.72 89.87 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.42 0.528 . . . . 0.91000000000000003 114.42 -175.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 m -82.15 153.52 25.98 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.286 -1.126 . . . . 2.02 110.563 169.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mm -108.3 143.59 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.698 1.199 . . . . 1.8600000000000001 110.236 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -108.21 139.8 42.37 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.832 1.653 . . . . 1.54 113.086 -175.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -152.22 115.73 4.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.508 1.049 . . . . 3.7799999999999998 113.808 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 51.5 t30 152.04 -51.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 131.341 3.856 . . . . 3.29 109.245 167.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.51 -178.65 36.54 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.768 1.651 . . . . 2.2999999999999998 112.454 -174.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.4 p -89.53 135.39 33.63 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.713 -0.875 . . . . 2.73 113.286 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.6 mt -122.5 165.7 15.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.454 1.101 . . . . 2.3300000000000001 112.921 -176.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.526 ' CG ' ' HE3' ' A' ' 44' ' ' LYS . 6.8 tt -116.24 117.45 30.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.367 1.467 . . . . 4.3499999999999996 111.478 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.12 120.48 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.948 1.299 . . . . 2.4700000000000002 111.49 178.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 20.4 p -84.57 120.82 26.79 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.035 -1.098 . . . . 2.2599999999999998 108.035 166.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.28 157.38 34.49 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.921 -0.487 . . . . 1.6299999999999999 110.481 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.4 t -141.46 -9.22 0.96 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.671 1.36 . . . . 3.54 114.671 176.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -140.51 144.27 35.89 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.589 1.156 . . . . 1.8899999999999999 110.451 169.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -69.97 161.02 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.641 -0.503 . . . . 2.73 109.641 167.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.48 -36.61 89.96 Favored Glycine 0 N--CA 1.476 1.355 0 O-C-N 121.114 -0.991 . . . . 1.6799999999999999 113.811 -171.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.87 -38.51 91.21 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.754 1.02 . . . . 2.54 113.754 171.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -77.31 -6.71 54.2 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.043 2.137 . . . . 2.4700000000000002 114.861 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 81.3 p -65.3 157.91 27.81 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.604 -1.31 . . . . 2.5899999999999999 113.194 178.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 90.9 m -64.48 -35.68 81.73 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.622 0.769 . . . . 4.1299999999999999 111.36 175.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.19 -47.56 68.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.866 1.266 . . . . 2.3100000000000001 111.7 171.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 m -68.41 -30.44 69.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.479 1.112 . . . . 2.4399999999999999 113.584 176.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -70.08 -41.05 74.59 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.085 0.857 . . . . 2.04 111.663 172.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.49 -48.55 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.845 0.858 . . . . 2.6400000000000001 110.904 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 113.439 0.903 . . . . 1.8100000000000001 113.439 177.732 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 113.535 0.939 . . . . 3.1299999999999999 113.535 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.5 tp -70.92 -34.31 71.38 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.641 1.177 . . . . 2.5099999999999998 113.17 170.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.07 -32.04 68.61 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.194 -0.941 . . . . 2.75 111.567 174.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -54.56 -37.9 66.01 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 124.968 1.307 . . . . 2.8100000000000001 113.354 -170.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.05 -43.79 91.74 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.346 1.058 . . . . 1.75 112.578 -178.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.3 mm -72.43 -33.18 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.25 -0.906 . . . . 2.6299999999999999 112.237 175.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m -77.43 -17.31 58.22 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.383 0.882 . . . . 1.5800000000000001 113.383 176.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mt -71.88 -43.39 65.5 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.602 2.361 . . . . 2.54 112.749 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -49.57 134.7 19.36 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.63 0.772 . . . . 4.21 110.764 175.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.59 -14.34 41.6 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.041 1.497 . . . . 3.6600000000000001 115.041 -172.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 m 69.11 -24.79 0.14 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 128.29 2.636 . . . . 3.27 115.024 173.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -125.38 152.97 44.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.176 1.39 . . . . 3.2599999999999998 111.262 169.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.84 151.35 45.62 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.716 1.206 . . . . 1.75 111.88 -177.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.2 m -111.45 104.09 12.5 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.283 1.033 . . . . 1.8999999999999999 111.876 -176.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.1 mt -91.26 134.67 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.705 1.602 . . . . 2.4100000000000001 110.795 -173.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.69 130.27 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 120.719 -1.238 . . . . 3.5600000000000001 110.483 169.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 125.726 1.61 . . . . 4.2800000000000002 110.873 178.931 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.625 0.726 . . . . 3.5899999999999999 111.502 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.1 t -134.97 95.12 3.26 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.992 2.517 . . . . 2.2999999999999998 107.406 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.78 145.21 25.74 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.121 -0.987 . . . . 3.6600000000000001 110.573 -176.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -127.49 156.53 42.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.345 2.658 . . . . 2.9300000000000002 111.274 -167.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -121.11 140.2 52.3 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.238 0.926 . . . . 2.3399999999999999 112.746 169.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.97 166.24 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.257 1.423 . . . . 2.4900000000000002 113.478 -177.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.44 147.66 32.21 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.694 1.198 . . . . 3.96 110.443 166.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.77 -13.06 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.461 1.282 . . . . 2.1000000000000001 114.461 -176.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -82.87 -12.67 57.21 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 120.141 -1.599 . . . . 5.0099999999999998 113.565 170.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.9 mt -103.75 -10.22 18.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.151 1.78 . . . . 2.8500000000000001 114.282 -172.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.63 143.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.693 1.197 . . . . 2.2200000000000002 110.664 173.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -121.23 164.63 16.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.502 1.921 . . . . 3.0899999999999999 111.067 176.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.0 ptt-85 -72.22 153.3 41.67 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.707 -1.246 . . . . 3.48 110.743 172.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.57 25.37 9.32 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 119.25 -0.75 . . . . 2.0800000000000001 114.213 -176.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -140.14 162.24 35.72 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.49 1.516 . . . . 2.7400000000000002 112.05 176.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.45 125.72 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.307 1.443 . . . . 2.21 110.199 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.8 mm -115.43 128.71 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.99 1.316 . . . . 1.9099999999999999 111.401 -171.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -80.87 146.77 30.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.339 1.055 . . . . 3.8100000000000001 112.667 175.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.8 137.0 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.524 0.729 . . . . 1.22 111.81 168.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 m -89.75 164.29 29.5 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.068 1.347 . . . . 1.78 113.38 -178.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.66 132.25 32.26 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.238 1.959 . . . . 1.6200000000000001 109.445 168.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.74 -8.8 47.47 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.183 0.897 . . . . 1.01 115.187 -169.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.74 163.9 43.32 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 118.616 1.208 . . . . 1.02 114.092 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -111.6 149.07 31.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.422 1.489 . . . . 2.4199999999999999 110.437 175.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -81.39 130.14 63.37 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 121.85 -0.531 . . . . 3.5800000000000001 111.918 177.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.96 -25.66 1.4 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.446 2.764 . . . . 0.77000000000000002 114.792 -178.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.4 176.59 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.22 2.208 . . . . 2.1000000000000001 109.323 -178.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.84 148.04 26.14 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.647 0.779 . . . . 2.3599999999999999 111.816 174.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.2 -160.14 32.87 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.521 0.568 . . . . 0.87 114.521 -172.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -116.91 135.6 53.59 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.412 1.485 . . . . 4.2699999999999996 113.268 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.47 135.36 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.111 2.164 . . . . 2.2599999999999998 108.935 170.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.4 pt -137.03 31.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 113.386 0.884 . . . . 1.8899999999999999 113.386 175.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -166.46 139.45 3.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.707 1.603 . . . . 2.8799999999999999 109.098 166.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.13 177.38 49.91 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 122.684 1.158 . . . . 0.81999999999999995 115.259 174.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -145.52 133.22 21.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.043 1.337 . . . . 2.75 112.23 -174.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.3 m -150.66 176.03 11.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.625 1.17 . . . . 1.8899999999999999 112.853 172.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.8 ttm -117.96 129.84 55.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.711 1.204 . . . . 1.6499999999999999 110.397 168.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t -117.38 136.05 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.78 1.232 . . . . 1.0700000000000001 113.223 -167.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -88.6 108.2 19.31 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.58 1.152 . . . . 1.8500000000000001 111.227 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -110.18 16.36 21.82 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.225 1.41 . . . . 1.8999999999999999 114.117 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -60.57 -19.91 58.89 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.986 1.847 . . . . 1.6100000000000001 115.986 -169.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -91.94 -40.82 10.92 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.112 0.869 . . . . 1.6299999999999999 111.663 172.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 27.5 mm -78.34 -61.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.016 0.926 . . . . 2.0299999999999998 112.246 -171.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.9 p -96.74 -7.75 33.08 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.499 1.12 . . . . 2.1499999999999999 112.651 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.35 16.03 74.97 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.446 1.498 . . . . 1.25 113.833 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -83.66 105.01 14.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.391 1.476 . . . . 2.98 111.763 -176.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.31 -13.26 59.76 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.398 -0.814 . . . . 2.23 111.643 177.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -100.06 111.92 63.05 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 126.745 2.018 . . . . 5.7800000000000002 107.889 169.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.86 148.93 35.63 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.869 3.046 . . . . 2.3599999999999999 114.162 -178.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.79 130.23 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.516 1.526 . . . . 1.4399999999999999 110.879 -169.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.2 142.89 37.63 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.271 0.629 . . . . 1.73 112.516 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.07 147.3 46.87 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.414 1.886 . . . . 1.97 110.603 177.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -147.25 170.6 7.49 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 128.504 2.721 . . . . 3.9300000000000002 109.664 -174.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -59.38 124.37 15.39 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 121.566 1.595 . . . . 1.0600000000000001 109.593 168.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.94 55.25 3.18 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.938 0.78 . . . . 1.3400000000000001 112.308 -168.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 t -139.49 141.36 37.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.417 1.087 . . . . 1.5 111.147 178.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.8 p -97.09 144.8 26.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.51 1.05 . . . . 1.6899999999999999 112.497 -178.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.58 156.59 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.323 1.849 . . . . 1.26 111.49 -173.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.29 146.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.672 1.589 . . . . 1.6499999999999999 111.92 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.47 153.12 28.14 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.81 0.844 . . . . 1.6399999999999999 113.218 -175.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.45 -5.08 17.05 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.594 0.997 . . . . 0.81999999999999995 115.594 178.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -75.79 153.03 37.2 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.787 1.294 . . . . 1.54 109.869 168.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 mm -109.14 132.3 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.658 0.783 . . . . 1.79 110.668 -169.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -91.95 151.89 20.29 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.694 1.597 . . . . 1.5800000000000001 113.198 -173.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -156.65 139.33 15.08 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.029 -1.044 . . . . 3.04 111.774 176.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.311 57.8 t30 99.23 -21.67 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.001 3.321 . . . . 3.3100000000000001 116.932 172.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.32 178.81 38.8 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 119.928 -1.733 . . . . 2.1800000000000002 114.215 -174.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.1 t -120.78 125.7 48.24 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.627 1.171 . . . . 3.3999999999999999 110.942 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.66 161.85 21.77 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.627 1.571 . . . . 2.2400000000000002 112.438 -167.298 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.21 119.58 37.54 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.944 1.298 . . . . 2.79 110.154 174.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.98 123.3 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.052 1.341 . . . . 2.7400000000000002 109.747 175.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.8 p -82.28 108.45 15.74 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.544 -0.722 . . . . 2.6499999999999999 110.077 170.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.87 113.88 17.33 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.127 -0.983 . . . . 1.3300000000000001 110.707 -172.038 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -111.34 -2.33 15.68 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.07 1.348 . . . . 3.4300000000000002 112.478 179.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -138.32 142.33 39.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.954 2.102 . . . . 1.8999999999999999 109.391 178.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.34 178.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 124.707 1.203 . . . . 2.6299999999999999 112.554 172.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.63 -39.49 97.63 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.594 -1.316 . . . . 1.3999999999999999 113.615 -178.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.01 -31.89 72.31 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 118.411 1.105 . . . . 3.1200000000000001 113.176 172.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -75.71 -4.37 39.98 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 128.132 2.573 . . . . 3.04 113.464 175.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 76.3 p -70.57 141.44 51.83 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.588 -1.945 . . . . 2.2000000000000002 114.275 -177.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -62.17 -31.93 72.49 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.71 -0.619 . . . . 2.6699999999999999 112.19 176.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -56.03 -48.05 76.7 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.777 -1.202 . . . . 1.95 111.8 171.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.8 m -64.97 -36.56 84.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.094 0.557 . . . . 2.3399999999999999 110.43 175.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.32 -40.59 85.97 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.664 -0.647 . . . . 1.77 112.303 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 67.9 mt -59.03 -51.41 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.355 1.062 . . . . 1.9199999999999999 109.945 177.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 117.903 -1.046 . . . . 2.0800000000000001 113.084 179.465 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 111.97 0.359 . . . . 3.1299999999999999 111.97 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 tp -56.56 -34.41 67.09 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.71 0.804 . . . . 2.2799999999999998 112.92 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.23 -41.76 39.94 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.915 0.709 . . . . 2.0800000000000001 112.915 168.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -60.19 -35.11 74.65 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.953 1.301 . . . . 2.9500000000000002 112.709 -175.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.72 -36.68 72.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.691 0.796 . . . . 2.23 112.866 173.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.4 mm -72.88 -38.66 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.872 0.76 . . . . 2.5699999999999998 111.621 173.13 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -65.54 -25.75 67.58 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.174 -0.954 . . . . 1.53 112.783 177.037 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.9 mt -73.33 -17.84 61.25 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.633 1.973 . . . . 3.2799999999999998 114.892 174.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -74.48 144.76 44.04 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.085 1.311 . . . . 3.3500000000000001 112.105 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.49 156.49 21.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.845 1.258 . . . . 3.4199999999999999 112.839 -176.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 p -94.76 -30.45 14.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.599 1.16 . . . . 3.27 113.7 171.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -140.47 162.13 36.08 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.245 1.818 . . . . 3.5600000000000001 113.014 -173.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.16 159.61 41.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.948 1.299 . . . . 1.8500000000000001 112.873 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.4 m -104.53 124.49 49.38 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.266 1.026 . . . . 2.3599999999999999 111.833 176.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.78 130.25 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.325 1.45 . . . . 2.2400000000000002 110.932 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -110.83 133.96 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.366 1.066 . . . . 3.6600000000000001 111.897 177.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 123.457 0.703 . . . . 2.7200000000000002 112.279 -175.829 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 tt . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.624 0.249 . . . . 5.7300000000000004 111.427 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.2 t -130.63 131.16 44.76 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.618 1.567 . . . . 2.25 109.605 -177.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.36 143.63 49.1 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.703 1.201 . . . . 3.0299999999999998 112.366 -170.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.96 143.65 50.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.954 1.302 . . . . 3.3900000000000001 111.177 -178.054 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -108.35 125.98 52.33 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.823 -0.806 . . . . 2.4700000000000002 108.823 166.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.29 161.29 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.605 1.162 . . . . 1.97 112.357 -170.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -74.06 143.3 45.53 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.025 -0.732 . . . . 4.2999999999999998 109.025 172.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.59 -2.34 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 114.463 1.283 . . . . 2.5600000000000001 114.463 -171.48 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -81.05 -23.4 38.58 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.33 2.252 . . . . 4.7699999999999996 113.13 168.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.6 mt -103.12 -10.76 18.58 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.644 1.578 . . . . 3.1000000000000001 114.009 -168.125 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.4 p -87.01 145.06 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.74 2.016 . . . . 2.6600000000000001 108.646 168.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.24 159.48 16.08 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.198 0.999 . . . . 4.7999999999999998 112.415 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -73.49 33.04 0.08 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 115.615 1.709 . . . . 5.4800000000000004 115.615 -178.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.26 15.95 1.31 Allowed Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.481 2.467 . . . . 1.97 113.756 171.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -81.96 158.37 23.91 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.968 1.384 . . . . 2.3500000000000001 113.216 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -106.91 125.85 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.418 1.487 . . . . 2.9500000000000002 112.333 -172.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.7 mm -127.3 119.1 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.899 1.28 . . . . 2.3100000000000001 111.492 -169.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HE3' ' HG ' ' A' ' 96' ' ' LEU . 21.2 mmtp -85.44 120.16 26.59 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.744 -1.223 . . . . 4.6699999999999999 110.287 169.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 p -96.97 138.41 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.758 0.708 . . . . 2.1600000000000001 111.795 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 m -87.68 150.44 48.36 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.678 1.191 . . . . 2.3700000000000001 112.886 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -59.44 142.83 99.57 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.755 2.303 . . . . 2.1800000000000002 111.07 170.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.31 -13.08 8.24 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 115.855 1.102 . . . . 1.9199999999999999 115.855 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.31 -172.64 40.62 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 119.058 1.429 . . . . 1.5900000000000001 115.214 -175.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -113.25 158.01 21.03 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.006 1.322 . . . . 2.52 111.521 171.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -91.54 125.26 58.4 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.234 1.013 . . . . 3.8999999999999999 111.437 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -92.66 -13.29 1.48 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.311 2.674 . . . . 1.49 115.444 -175.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.48 162.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 126.613 1.965 . . . . 2.6699999999999999 109.433 178.193 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.273 0.5 OUTLIER -93.51 137.67 32.56 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.684 0.754 . . . . 2.0899999999999999 112.33 175.595 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.41 177.32 41.95 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 123.975 0.798 . . . . 1.24 114.6 -169.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.7 ttm-85 -100.89 146.02 27.86 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.203 1.401 . . . . 7.5099999999999998 111.578 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.4 t -101.06 126.57 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.135 2.174 . . . . 2.6099999999999999 109.135 -174.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 pt -140.87 29.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 113.973 1.101 . . . . 1.99 113.973 -175.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -170.17 146.67 3.02 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.882 2.073 . . . . 3.8999999999999999 109.158 166.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.4 -174.24 48.63 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.43 1.014 . . . . 1.3500000000000001 115.227 169.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -150.22 118.78 6.5 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.353 1.061 . . . . 3.04 111.064 -174.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.4 t -142.71 163.98 31.36 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.282 1.433 . . . . 1.9399999999999999 112.27 -175.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.2 ttm -116.05 129.69 56.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.06 1.344 . . . . 1.9199999999999999 110.435 174.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.6 t -121.59 143.33 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.766 1.627 . . . . 0.91000000000000003 112.061 -168.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -99.45 90.4 4.51 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.281 1.832 . . . . 1.8 111.359 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -90.03 9.58 27.47 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.862 1.265 . . . . 2.3199999999999998 113.762 -175.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.8 t -50.35 -47.35 56.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.188 2.195 . . . . 2.2599999999999998 115.612 -169.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.98 -36.99 48.32 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.593 -1.317 . . . . 1.79 111.777 -175.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.3 mm -73.61 -48.28 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.727 -0.608 . . . . 2.1099999999999999 110.207 -177.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.1 p -107.33 -11.37 15.57 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.352 1.241 . . . . 2.3399999999999999 114.352 -170.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.61 -5.81 72.39 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 126.011 1.767 . . . . 1.51 115.943 174.117 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.25 -47.2 81.98 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.529 1.165 . . . . 2.8500000000000001 113.254 -169.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.268 . . 58.61 45.61 15.86 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.442 1.897 . . . . 3.1400000000000001 111.847 -176.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptp -153.02 134.95 8.81 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 128.98 2.912 . . . . 5.0199999999999996 109.068 172.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -62.2 145.64 96.19 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.712 2.275 . . . . 2.0 113.952 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.34 128.51 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.502 1.521 . . . . 1.52 111.303 -174.117 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.87 144.79 28.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.628 0.771 . . . . 1.8600000000000001 112.977 -179.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -122.23 159.44 27.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.176 1.79 . . . . 1.3100000000000001 112.274 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -151.98 171.76 6.24 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 127.791 2.437 . . . . 4.4100000000000001 110.643 -176.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.5 123.98 13.79 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 CA-C-N 121.341 1.515 . . . . 1.6200000000000001 108.84 166.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.83 44.4 5.75 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.057 0.837 . . . . 1.28 113.01 -168.367 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.9 m -124.96 169.05 12.48 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.245 1.418 . . . . 1.74 109.362 168.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.4 p -121.46 156.79 32.0 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.825 -1.172 . . . . 1.8899999999999999 112.868 169.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.28 160.48 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.884 1.674 . . . . 2.23 111.924 -178.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.62 154.51 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 126.47 1.908 . . . . 2.9399999999999999 112.514 -176.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.73 159.84 33.17 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.432 0.901 . . . . 2.3399999999999999 113.432 -177.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -6.96 11.88 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.797 1.189 . . . . 1.0700000000000001 115.113 179.037 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -84.65 162.69 19.64 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.167 1.387 . . . . 2.6699999999999999 111.601 174.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 mm -111.33 140.86 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.271 1.028 . . . . 2.04 111.547 -169.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -90.61 136.09 33.28 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.178 1.791 . . . . 2.79 109.371 169.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -83.64 -73.32 0.42 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.702 0.801 . . . . 3.6600000000000001 110.663 169.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -140.55 161.27 38.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.241 1.816 . . . . 3.6299999999999999 107.969 170.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.88 138.66 6.48 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.506 2.479 . . . . 2.5899999999999999 111.572 177.436 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.9 m -114.61 95.77 5.41 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.825 1.25 . . . . 3.54 110.167 -169.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.3 mt -104.44 152.7 22.01 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.043 1.337 . . . . 2.79 113.684 -170.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.464 ' HG ' ' HE3' ' A' ' 44' ' ' LYS . 4.2 tt -104.25 117.75 34.96 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.891 1.276 . . . . 4.6699999999999999 109.731 171.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.3 mm -113.41 129.02 69.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.022 1.329 . . . . 2.9100000000000001 111.422 -173.493 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.3 p -101.69 124.94 48.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.414 -0.804 . . . . 2.4199999999999999 110.109 168.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.96 151.02 31.88 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.692 0.627 . . . . 1.3899999999999999 112.692 -174.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -129.43 -3.23 4.89 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.775 1.398 . . . . 3.1800000000000002 114.775 169.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -140.97 141.87 34.37 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.66 1.184 . . . . 3.2200000000000002 111.09 169.067 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.85 165.8 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 109.233 -0.655 . . . . 2.9399999999999999 109.233 166.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.7 -39.74 91.67 Favored Glycine 0 N--CA 1.475 1.294 0 CA-C-N 119.528 1.058 . . . . 2.4700000000000002 114.673 -168.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.16 82.58 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.142 0.971 . . . . 3.9199999999999999 112.875 174.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -74.33 -8.34 55.9 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.213 2.605 . . . . 3.7400000000000002 114.275 176.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.0 p -64.13 159.07 21.27 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.789 -1.194 . . . . 2.8399999999999999 113.525 -174.526 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.6 t -52.21 -24.04 6.57 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.22 1.193 . . . . 3.5499999999999998 114.22 175.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.69 -44.92 93.46 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.251 -1.531 . . . . 2.6099999999999999 112.87 174.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.2 p -70.92 -21.35 62.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 117.945 0.339 . . . . 2.2999999999999998 111.785 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.02 -38.55 72.61 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.672 -0.643 . . . . 2.4100000000000001 111.149 174.024 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 94.1 mt -59.98 -54.21 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.405 0.682 . . . . 2.5899999999999999 110.829 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 113.303 0.853 . . . . 2.1600000000000001 113.303 -178.781 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 111.604 0.224 . . . . 2.6800000000000002 111.604 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.0 tp -70.56 -30.95 67.81 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.122 1.369 . . . . 2.3199999999999998 112.234 174.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.21 -34.13 61.45 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.991 0.516 . . . . 2.4700000000000002 112.343 177.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -64.31 -28.46 69.73 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.359 -0.838 . . . . 3.0 112.88 -177.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.28 -28.63 69.86 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.064 0.946 . . . . 2.23 113.237 173.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.62 -37.85 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.169 -0.957 . . . . 2.54 111.31 169.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -70.48 -31.39 68.5 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.253 1.021 . . . . 2.2200000000000002 113.138 179.322 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.72 -22.79 64.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.166 2.186 . . . . 3.2400000000000002 114.165 -178.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -76.78 155.58 33.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.21 1.404 . . . . 3.29 113.926 -169.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.78 -28.07 14.44 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.391 1.256 . . . . 3.0299999999999998 114.391 -168.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m 66.93 -29.47 0.14 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.805 2.15 . . . . 3.71 116.805 171.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.22 145.9 41.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.087 1.755 . . . . 3.5299999999999998 111.455 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.25 160.66 41.14 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.94 1.089 . . . . 1.6000000000000001 113.94 -169.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.8 m -112.43 112.64 24.35 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.309 1.044 . . . . 1.98 112.395 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.42 146.18 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 126.742 2.017 . . . . 1.9399999999999999 109.932 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.56 115.0 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.024 -1.102 . . . . 2.7200000000000002 108.024 166.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.471 0.615 0 C-N-CA 126.238 1.815 . . . . 2.8999999999999999 109.917 -176.416 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--O 1.238 0.478 0 CA-C-O 121.621 0.724 . . . . 3.5699999999999998 112.311 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.3 t -142.07 131.88 24.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.914 1.285 . . . . 1.9199999999999999 110.507 168.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -99.34 135.67 40.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.091 0.956 . . . . 2.75 110.878 -179.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -131.99 132.58 43.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.5 1.92 . . . . 3.4199999999999999 111.642 -167.088 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -104.08 130.0 51.76 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.251 -1.531 . . . . 2.1000000000000001 112.706 -172.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -142.6 -179.77 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 125.7 1.6 . . . . 2.3599999999999999 113.749 -171.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.93 147.43 23.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.671 1.188 . . . . 2.6699999999999999 110.69 166.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.38 -21.53 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.943 1.09 . . . . 2.8500000000000001 113.943 -176.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.16 -23.88 67.23 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.119 -0.988 . . . . 3.1499999999999999 112.448 168.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.4 mt -106.62 -10.23 16.26 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.838 1.655 . . . . 2.6699999999999999 114.384 -169.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.7 m -60.78 -37.34 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 119.897 1.226 . . . . 3.9300000000000002 112.415 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.306 35.3 mt-30 58.31 150.75 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.959 2.904 . . . . 4.0700000000000003 115.775 -173.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -71.12 40.89 0.06 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 117.203 2.297 . . . . 4.7999999999999998 117.203 -167.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.47 17.77 0.43 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.627 1.584 . . . . 1.5800000000000001 115.712 178.201 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.52 170.23 8.27 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.831 1.315 . . . . 3.1499999999999999 113.392 170.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.2 mt -122.02 131.8 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.454 1.502 . . . . 2.27 109.004 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.96 131.58 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.717 1.607 . . . . 1.8600000000000001 111.02 -169.44 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -84.52 125.72 32.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.913 0.779 . . . . 2.9199999999999999 112.23 171.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.79 133.04 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.233 1.413 . . . . 1.3500000000000001 110.935 172.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 m -93.2 168.26 12.5 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 124.036 0.935 . . . . 2.0 112.982 -176.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.92 132.38 47.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.583 2.188 . . . . 1.4299999999999999 110.324 168.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.77 -6.17 27.12 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.614 1.102 . . . . 1.0 115.395 -172.038 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.26 162.71 53.69 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.149 1.474 . . . . 0.98999999999999999 114.112 -179.072 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -104.84 146.34 29.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.299 1.04 . . . . 3.21 111.692 175.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -71.57 130.91 86.74 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.696 -0.669 . . . . 2.9199999999999999 109.538 169.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -94.83 -18.03 0.41 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.481 2.12 . . . . 1.03 115.065 -171.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 m -144.09 175.63 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 127.277 2.231 . . . . 2.52 110.086 -178.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -94.91 136.25 35.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.97 0.805 . . . . 1.98 112.027 168.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.46 -173.44 46.28 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 121.545 -0.722 . . . . 0.72999999999999998 114.243 -169.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -109.22 134.65 51.48 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.143 0.977 . . . . 5.8099999999999996 113.218 -175.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.8 126.88 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.907 2.083 . . . . 1.6299999999999999 108.048 174.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.8 pt -140.39 33.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 118.614 0.643 . . . . 2.1000000000000001 112.12 176.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -165.82 128.54 2.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.714 1.606 . . . . 3.8799999999999999 108.594 169.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.78 165.93 40.67 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.745 1.164 . . . . 1.3 114.697 -179.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -141.53 130.16 22.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.293 1.037 . . . . 2.7200000000000002 112.38 178.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.69 163.36 33.49 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.49 1.116 . . . . 1.6899999999999999 112.657 173.222 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.0 ttm -90.61 141.94 28.26 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.489 0.716 . . . . 1.75 109.298 168.161 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.2 t -134.55 142.56 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.997 1.319 . . . . 0.97999999999999998 112.724 -168.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -89.07 116.36 27.29 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.257 1.023 . . . . 2.1499999999999999 112.211 173.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -109.62 10.69 24.92 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.504 1.522 . . . . 2.1000000000000001 111.951 169.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 t -58.47 -39.29 79.53 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.939 1.296 . . . . 2.8399999999999999 114.043 -172.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.88 -31.47 27.91 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 120.391 1.451 . . . . 2.1600000000000001 111.576 177.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.8 mm -62.03 -57.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.028 0.931 . . . . 2.7000000000000002 110.762 178.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 p -119.58 -5.11 10.27 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.161 1.171 . . . . 2.8100000000000001 114.161 -169.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.42 11.69 77.33 Favored Glycine 0 CA--C 1.539 1.572 0 CA-C-O 118.504 -1.164 . . . . 2.0299999999999998 115.295 -179.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -49.97 -53.51 26.0 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.842 1.821 . . . . 2.7999999999999998 114.17 -175.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.256 . . 59.66 13.94 3.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.09 1.756 . . . . 2.3700000000000001 114.739 -173.498 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 52.3 ttp -132.81 131.84 22.23 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 128.308 2.643 . . . . 4.5899999999999999 106.876 169.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.98 152.33 46.11 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.161 2.574 . . . . 2.6299999999999999 112.949 -171.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -109.48 133.24 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.752 1.621 . . . . 1.49 110.632 -171.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.16 132.35 36.52 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.57 -0.706 . . . . 1.97 111.206 174.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -120.58 144.62 48.0 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.365 1.466 . . . . 1.02 110.122 173.085 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 167.28 13.51 Favored Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 127.699 2.4 . . . . 5.71 110.526 -169.873 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -58.72 132.03 45.59 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 CA-C-N 121.628 1.617 . . . . 1.04 111.354 174.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.5 29.56 35.84 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.451 1.024 . . . . 0.73999999999999999 114.21 -169.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.9 t -116.4 152.6 33.63 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.788 1.635 . . . . 1.73 111.658 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.2 p -107.15 150.15 26.9 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.931 1.241 . . . . 1.9299999999999999 113.142 178.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.4 m -140.27 163.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.448 1.499 . . . . 1.98 112.285 -174.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.93 156.78 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.535 1.534 . . . . 2.4399999999999999 112.549 173.418 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.75 148.12 49.99 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.487 0.921 . . . . 1.8899999999999999 113.487 -177.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.49 -1.62 70.88 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 115.198 0.839 . . . . 0.89000000000000001 115.198 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.8 p -78.11 151.43 33.36 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.425 1.113 . . . . 1.6599999999999999 109.433 166.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.88 132.87 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.509 0.724 . . . . 1.76 111.835 -168.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -95.28 137.65 34.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.221 1.808 . . . . 1.5600000000000001 112.671 -176.176 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -85.53 -92.94 0.09 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 115.488 1.662 . . . . 3.3199999999999998 115.488 -169.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -109.22 -30.65 7.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 117.143 2.275 . . . . 3.9399999999999999 117.143 -167.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.8 150.72 16.93 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.065 1.317 . . . . 1.96 113.379 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 t -98.15 139.65 33.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.275 1.83 . . . . 3.5899999999999999 112.443 -174.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.85 162.68 30.91 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.717 1.607 . . . . 2.3399999999999999 112.208 -168.447 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.36 127.95 54.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.073 0.949 . . . . 2.8700000000000001 112.248 172.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.53 132.21 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.326 1.451 . . . . 2.2599999999999998 111.875 -172.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.1 m -84.97 118.27 24.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.81 1.244 . . . . 2.8999999999999999 111.187 -179.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.95 117.0 21.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.45 0.7 . . . . 1.29 111.79 176.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.4 t -112.53 5.34 17.88 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.926 1.29 . . . . 3.6099999999999999 114.253 174.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -151.3 144.29 24.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.498 2.319 . . . . 2.5099999999999998 108.808 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.6 m -82.59 162.31 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.271 -1.011 . . . . 2.8500000000000001 108.271 164.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.98 -39.15 56.54 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-N 119.555 1.071 . . . . 1.5600000000000001 114.976 -168.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.71 80.63 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.265 1.026 . . . . 2.52 113.537 173.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.85 -9.46 58.7 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.563 1.545 . . . . 4.04 114.958 -179.145 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.3 p -69.7 160.94 30.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.777 1.028 . . . . 2.7200000000000002 113.777 -175.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.8 t -63.07 -33.03 74.56 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.71 0.804 . . . . 2.7200000000000002 112.112 172.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.59 -45.25 92.46 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.054 -1.029 . . . . 2.6000000000000001 111.368 176.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 64.8 m -71.46 -33.32 69.23 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.906 0.882 . . . . 2.3700000000000001 112.54 173.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -61.97 -42.23 98.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.276 1.03 . . . . 2.23 111.17 177.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.29 -55.63 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.079 1.352 . . . . 2.54 110.808 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 113.404 0.89 . . . . 1.79 113.404 -175.588 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.687 0 N-CA-C 112.367 0.506 . . . . 2.7999999999999998 112.367 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 tp -61.7 -32.55 72.76 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.572 0.749 . . . . 2.8399999999999999 111.884 175.248 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.47 -41.79 45.98 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.507 0.723 . . . . 2.54 112.391 168.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -61.06 -36.85 80.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.803 1.241 . . . . 3.3500000000000001 113.143 -174.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.45 -33.19 72.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.389 0.995 . . . . 2.0 113.449 178.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.98 -39.85 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.25 -0.906 . . . . 2.5499999999999998 111.853 168.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.2 m -63.99 -32.77 74.43 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.097 -1.002 . . . . 1.79 113.128 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.14 -24.02 67.53 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.0 2.52 . . . . 2.6099999999999999 114.132 177.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -80.24 121.48 25.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.391 0.677 . . . . 3.0800000000000001 109.291 -177.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.78 66.56 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 116.527 2.047 . . . . 2.4300000000000002 116.527 -166.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m 67.16 -21.13 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 115.613 1.709 . . . . 4.1200000000000001 115.613 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -128.05 152.19 48.26 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.146 -1.596 . . . . 3.04 114.171 176.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.7 144.62 49.25 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.086 1.355 . . . . 2.6699999999999999 111.112 -177.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.5 m -119.08 98.23 6.07 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.919 0.887 . . . . 2.79 112.049 -171.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.6 mt -81.68 136.91 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 127.013 2.125 . . . . 1.6100000000000001 111.46 -171.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.61 142.79 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.679 0.792 . . . . 3.27 112.49 168.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.0 m . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 126.388 1.875 . . . . 4.0800000000000001 111.849 -169.895 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.8 tp . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 113.258 0.836 . . . . 4.29 113.258 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.5 m -78.15 153.81 31.75 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.311 1.044 . . . . 3.6699999999999999 110.826 -178.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -124.2 146.96 48.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.51 0.724 . . . . 2.5899999999999999 112.707 176.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -137.42 139.76 40.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.789 2.036 . . . . 2.6600000000000001 110.255 -172.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -107.56 130.28 54.89 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.258 0.936 . . . . 2.9500000000000002 112.665 175.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 m -132.97 174.71 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.644 1.578 . . . . 2.5299999999999998 111.503 -177.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.87 145.58 31.28 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.939 0.895 . . . . 4.9500000000000002 111.761 169.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.31 -8.02 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 114.189 1.181 . . . . 2.54 114.189 -176.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -85.46 -28.12 25.25 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.166 -1.583 . . . . 4.5599999999999996 112.315 167.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.58 -20.06 22.07 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.441 1.496 . . . . 2.6499999999999999 113.515 -169.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.58 -46.07 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.48 1.112 . . . . 3.8199999999999998 112.352 178.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 59.56 164.94 0.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.408 1.883 . . . . 3.8500000000000001 115.863 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -74.34 27.34 0.08 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 117.002 2.223 . . . . 5.4500000000000002 117.002 -168.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.75 -8.3 5.29 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 117.012 1.565 . . . . 1.75 117.012 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.11 175.76 5.37 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.63 1.715 . . . . 3.0800000000000001 114.308 -174.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.9 mt -123.27 135.33 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.481 1.913 . . . . 2.9199999999999999 110.411 -178.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.4 mm -124.9 123.59 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.349 1.859 . . . . 1.6399999999999999 110.186 -170.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -100.01 122.0 42.24 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.273 -0.892 . . . . 4.4100000000000001 112.79 177.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.7 p -100.72 142.57 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.557 1.543 . . . . 1.4099999999999999 112.117 -173.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 m -88.95 163.58 34.29 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 124.417 1.087 . . . . 2.2799999999999998 113.136 -177.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.95 132.6 48.39 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.446 2.097 . . . . 1.8999999999999999 110.902 169.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.17 -1.99 62.62 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 115.854 1.102 . . . . 1.1000000000000001 115.854 -172.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.17 174.99 46.27 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-N 119.517 1.659 . . . . 1.1000000000000001 114.923 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -122.37 145.89 47.85 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.505 1.522 . . . . 3.5499999999999998 111.132 -177.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -86.35 129.66 52.56 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 118.697 -0.668 . . . . 3.6699999999999999 112.443 -177.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.12 -19.83 0.85 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.124 2.55 . . . . 0.96999999999999997 115.825 -172.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.7 m -148.57 165.71 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 126.87 2.068 . . . . 2.4300000000000002 109.466 -177.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -88.29 127.88 35.47 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.288 0.949 . . . . 2.1299999999999999 111.976 169.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.19 -167.83 29.41 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.592 1.091 . . . . 0.75 112.918 -169.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -117.33 135.36 53.9 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.042 0.937 . . . . 6.3300000000000001 113.326 -175.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.8 t -83.45 129.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 128.522 2.729 . . . . 1.77 109.14 176.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.17 32.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.216 1.006 . . . . 1.8500000000000001 113.165 -179.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -168.55 137.91 2.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.004 1.722 . . . . 3.52 108.675 166.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.11 -177.08 51.93 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.593 0.997 . . . . 0.81000000000000005 115.593 169.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -145.89 120.73 9.94 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.282 1.433 . . . . 5.4199999999999999 110.972 -169.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.22 171.76 14.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.462 1.105 . . . . 1.74 111.267 172.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.6 ttm -108.01 149.15 28.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.99 1.316 . . . . 1.8400000000000001 111.043 170.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.92 133.72 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.743 1.217 . . . . 0.98999999999999999 112.573 -169.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -100.45 106.06 17.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.412 1.485 . . . . 2.21 110.409 177.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.29 6.07 10.71 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.741 1.616 . . . . 2.1899999999999999 114.912 -172.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.3 p -45.69 -26.04 0.57 Allowed 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 117.127 2.269 . . . . 1.9099999999999999 117.127 -175.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.34 -42.16 19.09 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.558 1.526 . . . . 1.6899999999999999 112.664 175.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.9 mm -72.68 -60.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.974 0.91 . . . . 2.0699999999999998 110.278 -170.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 p -93.25 -11.11 33.36 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.877 2.071 . . . . 2.2200000000000002 112.455 -176.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.1 31.85 57.06 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 121.246 -0.909 . . . . 1.55 113.275 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -68.24 178.83 1.77 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.691 0.796 . . . . 2.5800000000000001 110.96 168.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.03 7.13 1.59 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.193 1.183 . . . . 3.3900000000000001 114.193 177.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 ptp -149.19 153.55 37.93 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.669 1.988 . . . . 3.8599999999999999 107.806 169.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.9 159.64 37.88 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.138 1.892 . . . . 1.8700000000000001 112.652 -177.087 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.88 138.37 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.211 1.804 . . . . 1.98 112.024 -168.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.6 150.86 36.43 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.382 -0.823 . . . . 1.8400000000000001 113.119 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -132.32 155.1 48.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.628 1.971 . . . . 1.98 112.699 175.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -153.94 -179.15 0.99 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 129.044 2.938 . . . . 3.54 109.79 178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.72 150.4 82.73 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.748 1.632 . . . . 2.48 113.788 170.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.34 19.88 70.95 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-N 114.569 -1.196 . . . . 1.1000000000000001 114.357 -171.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.7 t -107.84 153.88 22.37 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 119.324 1.562 . . . . 1.5700000000000001 111.1 -176.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.3 p -118.44 143.43 46.69 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.282 -1.511 . . . . 2.2799999999999998 112.948 -169.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 m -134.01 156.95 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.768 1.627 . . . . 1.9399999999999999 112.399 -169.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.7 153.51 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.236 1.814 . . . . 2.3999999999999999 112.816 174.669 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.38 150.45 48.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.148 0.796 . . . . 1.5900000000000001 113.148 175.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.84 -6.0 56.26 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.489 1.042 . . . . 0.78000000000000003 115.451 176.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.4 p -77.72 159.82 28.85 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.274 1.03 . . . . 1.6499999999999999 111.361 169.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mm -113.77 127.24 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.432 0.693 . . . . 1.73 111.782 -169.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -86.48 140.12 30.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.445 1.898 . . . . 1.6699999999999999 111.987 -178.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -100.46 -125.34 0.17 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.402 1.081 . . . . 3.4399999999999999 113.509 -172.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -90.13 63.61 5.89 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.983 1.265 . . . . 3.8500000000000001 113.844 -166.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.92 157.23 9.23 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.431 -0.793 . . . . 1.8999999999999999 114.989 169.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -92.36 133.3 36.0 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.475 1.11 . . . . 3.0699999999999998 112.259 -175.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.76 153.7 39.14 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.601 1.56 . . . . 1.8300000000000001 111.587 -176.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.1 tp -108.62 119.81 40.61 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.617 1.167 . . . . 3.7599999999999998 110.356 174.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mp -117.53 127.94 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.319 1.048 . . . . 2.4300000000000002 111.04 -175.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.3 p -81.52 128.65 34.13 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.722 -0.611 . . . . 2.5299999999999998 110.654 171.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.09 126.17 34.6 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.499 -0.751 . . . . 1.3999999999999999 110.864 176.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 p -133.97 -3.96 2.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.926 1.69 . . . . 3.3700000000000001 113.698 -170.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -148.03 150.3 33.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.237 2.215 . . . . 2.4900000000000002 108.887 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.74 173.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.246 1.018 . . . . 2.7999999999999998 111.416 169.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.75 -35.78 47.55 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.17 -0.956 . . . . 1.8500000000000001 115.027 -170.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.63 -31.97 71.14 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.322 1.231 . . . . 2.7200000000000002 114.322 176.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.84 -14.11 60.28 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.05 1.295 . . . . 3.8799999999999999 114.19 172.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 60.1 p -68.47 144.59 54.6 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.138 -1.601 . . . . 2.4900000000000002 113.152 -169.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 t -63.48 -33.04 74.7 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.77 0.428 . . . . 3.79 110.821 171.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.7 mp -53.3 -53.01 57.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.58 1.152 . . . . 2.1099999999999999 111.886 175.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.4 m -71.73 -26.54 62.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.022 0.929 . . . . 2.4100000000000001 111.77 177.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -70.64 -42.66 70.55 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.761 -0.587 . . . . 1.8 111.826 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.91 -53.34 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.746 1.219 . . . . 3.3399999999999999 110.287 177.65 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 113.607 0.966 . . . . 1.78 113.607 -176.561 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.081 0.771 . . . . 1.8100000000000001 113.081 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.9 tp -67.58 -28.86 68.13 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.327 -0.858 . . . . 2.6400000000000001 112.243 177.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.77 -45.31 29.48 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.019 0.528 . . . . 2.0699999999999998 111.312 167.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -53.62 -43.69 68.88 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.462 1.905 . . . . 2.9100000000000001 113.22 -175.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -48.04 -48.1 33.24 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.003 0.921 . . . . 2.0499999999999998 112.229 176.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.6 mm -73.88 -34.59 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.23 -0.919 . . . . 2.5299999999999998 113.408 177.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -77.17 -24.16 51.52 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.417 1.266 . . . . 2.7200000000000002 114.417 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.6 mt -58.63 -21.07 52.7 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.232 1.413 . . . . 3.1000000000000001 113.769 174.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -78.09 141.7 38.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.858 1.263 . . . . 2.6200000000000001 113.589 -174.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.9 154.51 33.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.283 1.033 . . . . 2.3399999999999999 112.732 175.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.61 -12.93 35.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.498 1.519 . . . . 3.2599999999999998 113.549 175.18 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -143.42 164.74 29.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.794 2.038 . . . . 3.1699999999999999 113.3 -175.497 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.15 163.59 32.31 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.343 1.457 . . . . 1.3899999999999999 111.524 171.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.4 m -114.75 106.8 14.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.017 1.327 . . . . 1.8100000000000001 110.062 170.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.52 133.12 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.084 -1.08 . . . . 1.28 108.084 174.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.61 118.43 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.519 0.728 . . . . 3.0699999999999998 110.451 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.8 m . . . . . 0 N--CA 1.466 0.349 0 C-N-CA 125.183 1.393 . . . . 3.3399999999999999 109.765 -171.711 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 120.537 0.208 . . . . 3.9700000000000002 111.128 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 t -139.5 96.81 3.15 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.678 1.191 . . . . 2.25 110.447 -177.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -91.14 150.14 21.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.769 1.025 . . . . 2.5099999999999998 113.769 -179.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -124.18 140.55 52.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.308 1.843 . . . . 2.8199999999999998 111.182 169.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -98.05 126.02 43.29 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.71 0.804 . . . . 2.5600000000000001 109.099 169.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 m -136.28 164.78 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.698 1.199 . . . . 1.28 112.625 -172.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.36 151.14 31.17 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.663 0.785 . . . . 3.4100000000000001 111.741 169.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.05 -24.87 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.385 0.883 . . . . 1.96 113.385 175.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -69.4 -27.88 65.68 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.843 -1.161 . . . . 3.1299999999999999 113.199 170.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.9 mt -100.74 -7.78 23.42 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.872 1.669 . . . . 2.4199999999999999 114.434 -168.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.67 141.83 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.631 0.773 . . . . 2.29 110.341 169.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -126.07 159.67 32.17 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.78 1.632 . . . . 3.6899999999999999 111.962 -170.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.266 16.8 ptt85 -75.53 15.82 0.43 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.957 1.836 . . . . 3.52 115.957 -174.217 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.31 -2.58 15.48 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.651 2.072 . . . . 1.78 113.539 168.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -84.02 155.84 22.54 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 118.731 1.266 . . . . 2.9900000000000002 111.735 178.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 mt -118.69 128.95 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.55 1.14 . . . . 2.2400000000000002 109.167 169.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.6 mm -107.09 168.45 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 128.018 2.527 . . . . 2.1099999999999999 111.022 -167.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -129.13 136.52 50.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.775 1.23 . . . . 2.48 109.832 170.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.07 132.69 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.393 1.077 . . . . 1.52 110.405 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.9 m -90.15 166.52 19.84 Favored Pre-proline 0 N--CA 1.482 1.127 0 N-CA-C 113.427 0.899 . . . . 2.48 113.427 -170.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -61.8 128.01 23.16 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.76 2.307 . . . . 1.51 110.598 169.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.42 8.46 59.54 Favored Glycine 0 CA--C 1.539 1.583 0 O-C-N 121.278 -0.889 . . . . 0.88 114.884 -170.573 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.47 169.02 54.9 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.636 1.588 . . . . 0.95999999999999996 114.791 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -125.61 140.35 52.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.964 1.305 . . . . 2.9199999999999999 110.979 -175.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -79.06 127.39 79.66 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 112.671 0.619 . . . . 2.8700000000000001 112.671 -173.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -87.0 -24.59 1.3 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.397 2.731 . . . . 0.69999999999999996 114.875 -174.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 m -149.86 171.45 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 127.877 2.471 . . . . 1.6799999999999999 108.988 -177.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.54 139.77 38.41 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.428 1.013 . . . . 1.79 113.111 178.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.44 -154.86 14.5 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 114.701 0.641 . . . . 0.75 114.701 -170.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -120.73 141.45 50.43 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.125 1.157 . . . . 6.5 114.125 -173.147 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.1 t -89.83 132.64 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 128.647 2.779 . . . . 1.6100000000000001 108.997 174.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 pt -139.09 35.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 113.456 0.91 . . . . 1.8999999999999999 113.456 171.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -165.75 137.4 3.92 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.673 1.189 . . . . 3.0899999999999999 111.149 166.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.1 -164.73 26.21 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 117.469 1.748 . . . . 0.94999999999999996 117.469 168.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -151.48 109.03 3.62 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.321 1.449 . . . . 2.7400000000000002 111.97 -172.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.13 170.21 16.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.726 0.774 . . . . 1.8 112.024 172.108 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 ttm -117.43 144.11 45.33 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.911 1.284 . . . . 1.8400000000000001 110.092 176.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.0 t -130.29 139.74 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.851 1.26 . . . . 1.97 111.259 -169.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -98.11 127.51 44.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.384 0.674 . . . . 2.3199999999999998 112.427 175.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -127.95 20.7 6.42 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.515 1.526 . . . . 2.0600000000000001 112.879 -173.336 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 p -64.55 -22.2 66.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.878 1.807 . . . . 1.79 115.878 -169.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.68 -42.65 11.23 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.752 0.821 . . . . 1.77 109.543 168.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.77 -59.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.802 1.241 . . . . 2.0 112.505 -171.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.0 p -106.91 -10.56 15.96 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.548 1.539 . . . . 2.1699999999999999 113.361 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.58 13.01 76.88 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 119.151 -0.805 . . . . 1.3100000000000001 114.574 176.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -58.32 -47.39 83.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.718 1.207 . . . . 2.8300000000000001 113.407 -174.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 61.75 19.76 10.82 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.507 1.299 . . . . 2.25 114.507 178.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttt -150.68 136.93 10.97 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 128.466 2.706 . . . . 5.3399999999999999 106.729 168.366 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.13 151.73 64.57 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.288 3.325 . . . . 1.9399999999999999 115.2 -176.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.23 134.38 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.555 1.942 . . . . 1.6699999999999999 111.597 -169.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.97 141.87 32.9 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.054 1.131 . . . . 2.1800000000000002 114.054 -173.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -124.72 142.35 51.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.4 1.88 . . . . 0.96999999999999997 111.496 173.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -142.03 174.71 3.51 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 128.968 2.907 . . . . 4.3200000000000003 109.84 -176.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.76 126.65 19.48 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 CA-C-N 121.577 1.599 . . . . 0.96999999999999997 110.493 167.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.39 9.55 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.045 1.307 . . . . 0.76000000000000001 114.315 -169.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.3 m -120.41 153.14 36.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 119.233 1.517 . . . . 1.5600000000000001 111.749 177.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 p -101.5 152.28 20.95 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.344 1.429 . . . . 1.76 113.358 175.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.1 m -136.41 155.03 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.803 1.641 . . . . 1.8300000000000001 111.41 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.91 143.97 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.487 1.515 . . . . 1.8799999999999999 112.802 -179.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.45 147.91 29.97 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.394 1.078 . . . . 1.6000000000000001 112.663 -178.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.98 -6.26 49.76 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.599 -1.112 . . . . 0.76000000000000001 115.705 178.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.8 p -79.26 163.37 25.0 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.964 1.382 . . . . 1.5700000000000001 111.844 169.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mm -110.93 129.93 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.351 1.06 . . . . 1.97 111.253 -173.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -92.03 135.21 34.14 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.816 1.646 . . . . 1.8600000000000001 110.858 176.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -88.77 -107.01 0.08 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.215 1.191 . . . . 3.9900000000000002 114.215 -173.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -82.24 -45.44 15.02 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 116.722 2.119 . . . . 3.1400000000000001 116.722 -166.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.41 140.72 15.19 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.069 0.849 . . . . 1.9299999999999999 113.539 -172.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.1 p -82.93 137.15 34.32 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.652 0.726 . . . . 2.8100000000000001 112.53 171.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.1 mt -130.03 156.17 44.93 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.953 1.301 . . . . 1.97 112.079 -170.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.97 122.21 42.53 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.366 1.067 . . . . 3.7599999999999998 110.82 174.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -115.6 123.02 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.799 1.239 . . . . 2.5800000000000001 111.895 -173.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 74.8 m -79.51 120.24 23.61 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.674 -1.267 . . . . 3.8199999999999998 108.956 168.258 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.88 118.24 20.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.644 -0.502 . . . . 1.1100000000000001 109.644 173.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.7 p -108.72 -0.28 20.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.39 1.076 . . . . 2.6899999999999999 113.31 175.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -137.96 139.65 39.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.093 1.357 . . . . 1.78 111.618 176.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 m -78.84 157.18 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.702 -0.851 . . . . 2.2599999999999998 108.702 165.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.74 -35.24 73.45 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 120.954 -1.091 . . . . 1.3700000000000001 115.569 -169.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.22 64.43 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.629 1.344 . . . . 2.4500000000000002 114.629 174.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -80.18 -8.18 59.31 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.814 1.646 . . . . 2.54 115.274 173.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 37.4 p -58.86 158.22 8.56 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.609 1.337 . . . . 2.2200000000000002 114.609 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.7 m -60.68 -35.65 76.79 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.711 0.804 . . . . 3.6499999999999999 111.035 170.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.63 -43.64 96.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.208 1.003 . . . . 2.1200000000000001 112.101 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.9 p -72.95 -21.84 60.81 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.901 1.074 . . . . 2.5099999999999998 113.901 170.092 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -70.44 -38.28 74.5 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.606 -1.309 . . . . 2.3399999999999999 112.01 174.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.22 -52.39 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.848 1.259 . . . . 2.4100000000000001 110.741 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.481 1.088 0 CA-C-N 119.285 0.948 . . . . 1.53 112.951 179.289 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 111.28 0.104 . . . . 2.8900000000000001 111.28 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.9 tp -42.01 -31.04 0.31 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.533 2.733 . . . . 2.6600000000000001 115.861 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.97 -32.67 65.37 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.187 1.18 . . . . 3.3999999999999999 114.187 177.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.98 -30.55 68.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.822 1.249 . . . . 6.3399999999999999 112.497 -170.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -53.16 -37.29 61.74 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.803 1.641 . . . . 1.8999999999999999 112.51 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -75.84 -35.93 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.962 1.305 . . . . 2.2000000000000002 112.821 175.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.1 m -72.82 -39.74 66.37 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.039 1.126 . . . . 1.97 114.039 -175.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.21 -18.01 65.06 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.301 1.223 . . . . 2.98 114.301 -173.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -70.09 141.33 52.77 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.273 1.029 . . . . 3.1000000000000001 112.829 -172.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.04 139.1 30.79 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.583 0.957 . . . . 2.23 113.583 -176.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -90.69 -8.18 50.61 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.565 1.546 . . . . 2.7400000000000002 113.868 -171.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.01 160.85 38.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.142 1.377 . . . . 3.6600000000000001 113.896 -179.236 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.04 166.37 24.89 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.812 1.645 . . . . 2.2200000000000002 112.005 176.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.9 m -117.62 105.38 11.98 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.624 1.17 . . . . 2.1600000000000001 111.322 169.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.0 mt -82.87 130.44 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.482 1.113 . . . . 2.0099999999999998 108.925 177.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -126.52 128.11 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 121.501 -0.749 . . . . 3.3300000000000001 112.139 -176.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 124.737 1.215 . . . . 3.79 109.56 169.67 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.548 0.881 0 N-CA-C 115.351 1.612 . . . . 4.4500000000000002 115.351 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.6 t -112.58 109.82 19.6 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.373 1.069 . . . . 2.2400000000000002 108.409 166.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -107.9 145.01 34.34 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.622 0.971 . . . . 2.7599999999999998 113.622 -168.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -124.02 128.53 49.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.511 1.924 . . . . 3.1699999999999999 109.97 173.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -91.86 124.05 35.7 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.208 -0.932 . . . . 2.3500000000000001 109.228 173.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 m -136.51 162.75 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.505 1.298 . . . . 1.7 114.505 -169.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.47 147.99 35.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.001 1.321 . . . . 2.7000000000000002 111.653 169.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -57.68 -22.81 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.694 0.998 . . . . 1.7 113.694 -178.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.52 -12.79 61.56 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.624 -1.298 . . . . 3.7400000000000002 113.258 175.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.87 -2.07 21.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.318 1.447 . . . . 2.5299999999999998 113.863 -171.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.39 148.26 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.862 1.265 . . . . 2.0699999999999998 110.571 170.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -137.56 165.68 25.74 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.176 1.391 . . . . 2.9399999999999999 113.379 -178.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.0 ptt85 -67.51 25.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 118.463 2.764 . . . . 3.3100000000000001 118.463 -168.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.32 9.7 1.28 Allowed Glycine 0 CA--C 1.54 1.629 0 C-N-CA 126.122 1.82 . . . . 1.3700000000000001 114.387 171.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -83.83 155.79 22.79 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.039 1.42 . . . . 2.7200000000000002 112.408 175.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 mt -111.8 124.99 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.51 0.724 . . . . 2.3999999999999999 110.254 172.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.1 mm -121.61 129.28 75.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 127.268 2.227 . . . . 1.96 110.452 -169.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -92.04 128.7 37.98 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.339 -0.851 . . . . 3.0299999999999998 110.536 171.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -102.76 135.4 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.837 1.255 . . . . 2.1800000000000002 110.346 -177.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.0 m -89.2 156.05 48.94 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.288 1.035 . . . . 2.3500000000000001 112.433 -178.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -59.19 143.28 99.82 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.929 1.753 . . . . 1.9199999999999999 111.641 168.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.05 -6.85 3.58 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.313 0.958 . . . . 1.3300000000000001 114.427 -169.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.7 151.16 50.28 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 119.246 1.523 . . . . 1.1499999999999999 113.054 177.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -103.03 142.8 33.49 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.826 1.25 . . . . 2.7799999999999998 110.875 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -75.49 125.25 88.92 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.881 -0.512 . . . . 3.5 112.059 -179.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.3 -25.46 3.88 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.88 2.387 . . . . 1.0900000000000001 113.922 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.3 m -151.97 171.95 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 127.711 2.404 . . . . 1.9299999999999999 109.057 -176.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.22 151.26 19.93 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.646 0.778 . . . . 2.27 112.229 177.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.74 -172.08 41.85 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 116.139 1.216 . . . . 0.91000000000000003 116.139 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -108.37 129.26 55.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.66 1.584 . . . . 5.5 111.703 -175.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.2 t -87.29 127.96 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.115 2.166 . . . . 1.8999999999999999 109.218 -176.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.4 pt -142.12 29.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 113.728 1.01 . . . . 2.3599999999999999 113.728 -172.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.22 141.45 1.61 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.784 1.634 . . . . 2.9199999999999999 109.534 165.093 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.75 -174.75 41.4 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 122.433 1.018 . . . . 0.75 114.98 170.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.43 103.96 3.19 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.135 0.974 . . . . 3.8300000000000001 111.07 -167.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -144.44 172.73 12.54 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.212 0.819 . . . . 1.6899999999999999 113.212 -172.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.5 ttm -124.71 133.64 53.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.981 1.312 . . . . 2.1899999999999999 110.04 -176.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -123.28 137.34 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.27 1.428 . . . . 2.2200000000000002 111.637 -169.063 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -95.71 103.63 15.52 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.87 1.268 . . . . 2.1800000000000002 110.682 -176.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -108.6 -1.5 19.55 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.669 1.588 . . . . 2.0600000000000001 113.677 -170.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 p -53.4 -33.06 52.41 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.552 2.056 . . . . 1.8100000000000001 116.552 -169.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.23 -44.34 22.0 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.652 1.569 . . . . 2.3599999999999999 110.775 173.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mm -62.04 -49.11 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.215 1.806 . . . . 2.23 111.621 -174.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.9 p -118.27 -2.68 11.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.009 1.114 . . . . 2.4500000000000002 114.009 -171.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.24 18.91 70.55 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.924 1.249 . . . . 1.1399999999999999 114.732 178.027 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -61.08 -179.12 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.543 1.137 . . . . 2.77 111.138 168.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.05 -20.35 0.88 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.322 1.449 . . . . 2.5899999999999999 114.141 177.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -125.58 153.22 72.73 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.827 2.051 . . . . 3.8599999999999999 110.336 167.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.0 165.83 31.43 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.237 2.625 . . . . 2.1600000000000001 114.019 -174.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.17 133.43 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 127.047 2.139 . . . . 2.2200000000000002 112.191 -168.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.88 141.03 36.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.35 1.06 . . . . 1.71 113.567 178.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -126.08 150.0 48.49 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.662 1.985 . . . . 2.0600000000000001 111.38 178.254 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -144.41 176.29 2.33 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.543 2.337 . . . . 3.48 110.257 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.47 131.01 36.02 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 CA-C-N 122.047 1.767 . . . . 1.01 110.463 167.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.05 28.68 33.48 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 118.092 -1.393 . . . . 0.83999999999999997 114.805 -171.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.3 m -108.02 174.14 6.01 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.853 1.826 . . . . 1.5800000000000001 110.959 174.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -125.79 156.44 39.5 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.437 -1.414 . . . . 2.0699999999999998 112.831 175.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.09 146.16 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.716 1.606 . . . . 1.2 112.648 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.85 152.3 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.73 2.412 . . . . 1.8 112.42 170.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.46 155.19 38.25 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.733 0.813 . . . . 1.9099999999999999 112.158 177.02 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.53 -1.37 52.05 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.519 1.057 . . . . 0.94999999999999996 115.543 176.467 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 p -76.86 162.81 27.32 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.066 1.433 . . . . 1.79 112.306 172.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.76 137.98 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.722 1.209 . . . . 1.97 111.082 -174.384 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -84.31 134.73 34.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.199 1.0 . . . . 2.52 111.152 170.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.26 50.92 1.49 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.135 1.532 . . . . 4.2300000000000004 115.135 179.214 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -163.97 -36.43 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.1 1.518 . . . . 3.3799999999999999 115.1 171.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.26 169.74 28.22 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-N 120.197 1.362 . . . . 2.8100000000000001 115.411 -171.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.0 m -69.56 137.46 52.42 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.547 1.314 . . . . 2.2799999999999998 114.547 -171.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.49 159.98 31.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.547 1.939 . . . . 2.1200000000000001 110.415 171.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.4 tp -114.07 126.51 55.18 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.037 0.935 . . . . 3.8199999999999998 110.778 173.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.36 132.43 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.842 1.257 . . . . 2.1099999999999999 111.272 -170.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 46.7 t -87.18 121.17 29.28 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.529 -0.915 . . . . 3.8199999999999998 108.529 168.008 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.93 130.48 35.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.083 0.953 . . . . 1.0800000000000001 110.604 -178.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.9 p -120.72 9.05 10.67 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.555 1.317 . . . . 2.6600000000000001 114.555 -175.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -149.04 155.15 40.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.428 1.491 . . . . 3.0099999999999998 111.575 168.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.33 164.03 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 108.71 -0.848 . . . . 2.7599999999999998 108.71 163.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 -39.66 95.55 Favored Glycine 0 N--CA 1.473 1.155 0 O-C-N 120.719 -1.238 . . . . 1.53 113.536 -170.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.72 77.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.417 1.109 . . . . 2.4399999999999999 113.27 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -77.37 -6.65 54.09 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.127 1.528 . . . . 2.6299999999999999 115.127 175.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.0 p -63.62 148.21 49.52 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.686 -1.259 . . . . 2.2400000000000002 111.182 174.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.6 m -65.27 -34.38 78.22 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.506 -0.746 . . . . 4.8700000000000001 110.312 169.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.1 tp -49.34 -51.87 31.73 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.435 1.494 . . . . 2.2799999999999998 112.565 172.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.2 m -74.37 -24.15 59.11 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.1 1.148 . . . . 2.8199999999999998 114.1 177.071 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -71.45 -40.5 70.32 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.879 1.271 . . . . 2.71 112.75 173.438 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.2 mt -51.63 -46.48 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.271 1.028 . . . . 2.4199999999999999 111.71 -178.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 113.936 1.087 . . . . 1.6599999999999999 113.936 179.488 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 113.18 0.808 . . . . 3.9500000000000002 113.18 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -82.83 -38.79 22.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.666 0.787 . . . . 4.7000000000000002 110.735 169.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.44 -42.31 87.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.357 0.663 . . . . 2.0800000000000001 111.631 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.9 tp -51.42 -34.24 33.93 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.706 1.602 . . . . 3.3700000000000001 114.341 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.32 -44.86 20.78 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.395 0.887 . . . . 3.1899999999999999 113.395 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -61.38 -34.51 75.46 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.587 1.155 . . . . 4.4800000000000004 113.299 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.25 -49.76 6.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.511 1.524 . . . . 2.2000000000000002 112.117 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -74.37 -30.42 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.836 1.05 . . . . 2.8500000000000001 113.836 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -67.3 -27.62 67.32 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.544 -0.722 . . . . 1.99 112.265 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.73 -14.58 59.27 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.998 1.481 . . . . 3.4300000000000002 114.998 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -63.4 129.3 39.67 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 120.55 1.523 . . . . 4.1799999999999997 112.142 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.46 158.6 33.39 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.993 1.317 . . . . 2.5699999999999998 112.159 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.1 p -98.34 -24.54 15.17 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 116.061 1.874 . . . . 3.9399999999999999 116.061 -168.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.27 159.48 37.72 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.88 1.067 . . . . 4.21 113.88 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.86 149.39 40.22 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.596 1.558 . . . . 1.5600000000000001 111.762 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 m -95.01 109.18 21.25 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.502 0.721 . . . . 2.48 112.649 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.7 mt -81.09 140.18 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.646 1.178 . . . . 2.7400000000000002 108.616 169.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.72 127.01 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.102 0.953 . . . . 3.3599999999999999 112.173 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 92.9 m -120.23 134.28 55.29 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.67 2.388 . . . . 3.0499999999999998 109.979 -170.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.35 145.79 28.44 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.082 1.353 . . . . 4.0800000000000001 109.926 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.11 5.13 1.29 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.638 2.088 . . . . 3.5299999999999998 116.638 -167.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.5 m -133.34 -60.11 0.85 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.116 1.367 . . . . 4.5499999999999998 110.428 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -158.7 -169.51 2.74 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.772 2.829 . . . . 4.4100000000000001 106.265 168.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -55.37 -13.98 1.67 Allowed 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 113.616 0.969 . . . . 4.6900000000000004 113.616 168.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 pt -68.46 -22.56 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 127.158 2.183 . . . . 4.4100000000000001 114.433 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 tt -116.32 128.52 55.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.374 0.988 . . . . 3.3700000000000001 111.458 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -130.25 127.66 40.05 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.787 1.235 . . . . 4.2599999999999998 111.063 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.4 t -133.04 140.05 47.51 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.725 2.01 . . . . 3.3300000000000001 110.009 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.08 149.15 39.41 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.796 0.838 . . . . 2.6699999999999999 112.506 -168.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.85 126.31 30.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.849 1.66 . . . . 2.6899999999999999 110.765 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -87.01 126.82 34.99 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.851 -1.155 . . . . 2.2400000000000002 108.761 167.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.48 162.19 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.211 1.405 . . . . 1.6299999999999999 111.763 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.97 147.53 42.95 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.29 0.567 . . . . 3.9100000000000001 111.124 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -56.26 -23.91 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 114.686 1.365 . . . . 2.1400000000000001 114.686 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.57 -13.71 60.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.549 1.315 . . . . 3.8399999999999999 114.549 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.7 mt -106.67 -13.38 15.3 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.956 1.302 . . . . 2.46 113.818 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.97 142.36 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.052 1.341 . . . . 2.0099999999999998 110.647 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -114.71 161.24 18.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.483 1.113 . . . . 2.96 113.333 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -76.27 31.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.499 1.666 . . . . 5.3499999999999996 115.499 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.7 0.21 4.96 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 127.834 2.635 . . . . 1.75 113.725 169.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -89.68 160.41 16.62 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.339 1.456 . . . . 2.1899999999999999 112.139 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.4 mt -118.77 128.55 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.583 1.553 . . . . 2.2999999999999998 108.368 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.4 mm -120.3 136.54 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.304 1.441 . . . . 1.98 113.933 -166.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -78.14 143.75 37.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.774 1.23 . . . . 3.6299999999999999 112.303 172.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.13 132.68 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.695 0.798 . . . . 1.25 110.808 167.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.47 166.97 11.07 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 125.278 1.431 . . . . 2.0099999999999998 112.282 -169.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.13 120.83 8.73 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.885 1.723 . . . . 1.6200000000000001 111.626 171.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.63 -6.17 82.18 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 126.638 2.066 . . . . 0.94999999999999996 115.159 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.18 154.4 46.24 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 119.123 1.461 . . . . 1.01 114.285 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -109.14 152.92 24.46 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.929 1.292 . . . . 2.9300000000000002 111.852 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -89.13 126.8 57.75 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.813 1.042 . . . . 3.3999999999999999 113.813 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.18 -22.24 3.45 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.028 3.152 . . . . 1.5700000000000001 114.532 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.4 m -143.64 170.54 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.206 2.202 . . . . 2.0600000000000001 109.41 -176.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.31 166.64 17.27 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.072 0.549 . . . . 2.54 110.811 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.98 -175.53 47.08 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.936 1.134 . . . . 1.28 115.936 170.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -105.29 142.33 35.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.617 1.567 . . . . 4.6799999999999997 111.277 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.08 131.17 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.367 2.267 . . . . 2.2200000000000002 110.27 -171.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.07 30.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 113.549 0.944 . . . . 2.3100000000000001 113.549 -175.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -170.62 144.97 2.45 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.119 2.568 . . . . 3.1499999999999999 107.213 168.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.48 179.61 46.51 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 116.612 1.405 . . . . 1.53 116.612 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -152.1 41.76 0.66 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.902 1.815 . . . . 3.02 115.902 -166.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.44 ' H ' HD22 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -75.88 156.53 34.25 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.409 -1.432 . . . . 1.77 113.19 -178.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 42.7 ttm -96.67 127.21 42.44 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.928 -0.767 . . . . 2.0600000000000001 108.928 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.9 t -112.95 129.05 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 124.58 1.152 . . . . 1.2 110.685 -170.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -91.66 105.64 17.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.538 0.735 . . . . 2.25 110.775 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -117.8 23.61 11.58 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.888 2.075 . . . . 2.4100000000000001 113.004 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 93.0 p -63.82 -18.58 64.26 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 116.659 2.096 . . . . 2.0299999999999998 116.659 -169.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.84 -48.86 7.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.441 1.096 . . . . 2.5 109.907 169.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.88 -58.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.82 1.248 . . . . 2.5600000000000001 111.722 -172.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.4 p -103.9 -12.35 16.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.298 1.039 . . . . 2.8399999999999999 112.66 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.63 -3.02 85.05 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.484 -1.176 . . . . 1.79 114.737 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -63.94 103.47 0.59 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.585 1.192 . . . . 3.1299999999999999 110.693 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.97 -17.51 61.46 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.815 -1.178 . . . . 2.6800000000000002 111.577 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.69 103.9 42.82 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 128.099 2.56 . . . . 6.1600000000000001 107.947 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -55.35 147.13 58.14 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.725 2.95 . . . . 3.1899999999999999 114.19 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.5 t -94.21 125.26 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.744 1.218 . . . . 2.0099999999999998 111.944 -167.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.18 141.29 38.76 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.709 -0.619 . . . . 2.25 111.72 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -115.08 169.54 9.03 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.796 1.638 . . . . 1.54 111.526 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -157.15 169.33 10.8 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 127.714 2.406 . . . . 4.79 110.727 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.18 135.1 48.93 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 CA-C-N 121.451 1.554 . . . . 1.55 108.41 165.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.88 39.37 17.13 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.28 0.943 . . . . 1.23 113.253 -168.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 t -124.76 174.26 8.02 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.624 1.57 . . . . 2.02 111.254 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 p -133.26 150.59 51.92 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.518 -1.363 . . . . 2.3199999999999998 112.566 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.06 161.84 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 125.411 1.485 . . . . 1.99 112.79 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.0 150.31 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.298 1.839 . . . . 2.46 113.435 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.67 148.33 24.86 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.038 1.335 . . . . 2.3300000000000001 112.944 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.88 -4.1 67.19 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 115.333 0.893 . . . . 0.95999999999999996 115.333 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 97.6 p -84.61 160.02 20.5 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.498 1.149 . . . . 1.6299999999999999 111.969 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mm -113.21 127.13 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.469 1.107 . . . . 2.0800000000000001 112.203 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -93.9 144.0 25.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.238 1.415 . . . . 1.9099999999999999 113.083 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -157.6 145.95 19.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.884 1.274 . . . . 4.5800000000000001 111.332 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 46.54 87.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.504 2.322 . . . . 3.8999999999999999 113.585 168.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.38 -13.42 2.28 Favored Glycine 0 CA--C 1.542 1.761 0 N-CA-C 116.251 1.26 . . . . 3.8900000000000001 116.251 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.2 m 40.1 108.61 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 130.964 3.706 . . . . 2.7999999999999998 117.322 170.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.44 HD22 ' H ' ' A' ' 62' ' ' SER . 57.4 mt -106.33 160.37 15.42 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.987 1.106 . . . . 2.9500000000000002 113.987 -169.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.68 121.28 41.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.332 1.853 . . . . 4.3700000000000001 108.476 168.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.45 126.23 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.653 0.781 . . . . 2.3900000000000001 111.167 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.81 121.51 30.31 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.375 -0.828 . . . . 2.75 109.999 168.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.65 129.95 35.04 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.2 0.6 . . . . 1.1899999999999999 112.147 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.9 p -117.77 -6.12 11.07 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.85 1.66 . . . . 3.4100000000000001 113.968 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -138.98 148.78 43.93 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.649 1.98 . . . . 2.71 110.242 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.5 m -92.42 -174.05 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.583 1.153 . . . . 2.5899999999999999 112.638 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.65 -33.16 83.58 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.857 -1.152 . . . . 2.7799999999999998 113.557 -171.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.52 -51.67 11.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.265 1.426 . . . . 3.1299999999999999 112.888 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.29 -8.13 53.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.499 1.919 . . . . 3.5800000000000001 115.551 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.6 t -48.17 146.56 2.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.974 2.109 . . . . 3.8100000000000001 114.872 -176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 t -62.1 -21.77 65.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.079 0.552 . . . . 3.3599999999999999 111.992 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.5 tp -59.89 -41.18 91.03 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.647 -1.283 . . . . 2.75 111.897 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.8 t -73.26 -27.38 61.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.475 1.11 . . . . 3.4300000000000002 111.564 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -70.06 -39.6 75.58 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.408 -0.807 . . . . 2.6299999999999999 112.146 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.8 mt -60.04 -44.68 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.668 1.587 . . . . 3.1499999999999999 111.657 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.02 -9.19 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 115.249 1.574 . . . . 2.79 115.249 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -75.19 -38.92 60.58 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.318 -0.863 . . . . 5.6600000000000001 111.617 166.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.94 -41.41 36.38 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.628 2.371 . . . . 5.1699999999999999 113.161 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.8 t -70.74 -22.44 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.325 1.45 . . . . 4.0199999999999996 112.243 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.28 -59.46 5.29 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.256 1.022 . . . . 5.4199999999999999 110.74 170.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -65.9 -5.34 8.92 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.988 1.847 . . . . 7.2699999999999996 115.988 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.63 -32.47 69.79 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.999 1.272 . . . . 7.9500000000000002 112.718 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 116.865 -1.54 . . . . 8.0399999999999991 115.105 -179.521 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.9 p . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 114.322 1.23 . . . . 4.0700000000000003 114.322 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -75.95 -36.73 59.2 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.962 0.905 . . . . 4.7400000000000002 110.042 169.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.06 77.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.552 0.741 . . . . 3.1899999999999999 111.095 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.28 -32.16 47.35 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.378 1.071 . . . . 3.4100000000000001 113.405 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.51 -54.21 7.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.759 0.824 . . . . 3.3300000000000001 112.63 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -54.53 -36.98 64.84 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.463 1.505 . . . . 3.5 113.002 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.77 -38.96 67.87 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.457 1.103 . . . . 2.2400000000000002 113.491 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.8 mm -74.66 -34.07 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 118.954 0.797 . . . . 2.25 112.811 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -69.52 -25.34 63.99 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.247 -0.908 . . . . 1.8600000000000001 112.43 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.31 -15.77 63.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.36 2.264 . . . . 3.8599999999999999 114.873 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -73.56 140.72 46.47 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.692 1.197 . . . . 2.8199999999999998 112.257 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.42 165.39 15.6 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.578 1.151 . . . . 2.4199999999999999 112.47 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -93.7 -41.99 9.4 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.354 0.872 . . . . 3.4300000000000002 113.354 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -125.37 158.97 32.96 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.135 1.531 . . . . 4.29 115.135 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.55 149.83 47.02 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.646 1.578 . . . . 1.45 111.311 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.7 m -106.43 108.8 20.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.233 1.013 . . . . 1.9099999999999999 112.052 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.7 mt -90.09 132.9 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.217 1.807 . . . . 1.9299999999999999 109.576 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.23 139.55 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.609 0.719 . . . . 2.8999999999999999 112.442 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.9 m -129.28 138.5 51.67 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.733 2.013 . . . . 2.77 110.402 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.4 mt -93.62 73.21 4.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.841 0.856 . . . . 3.4900000000000002 109.381 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.03 -12.52 39.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.62 1.168 . . . . 3.5499999999999998 113.772 -173.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.6 m -148.42 139.43 23.14 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.901 1.281 . . . . 3.7599999999999998 110.858 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 25' ' ' ILE . 22.9 t70 -8.96 58.78 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.002 1 C-N-CA 134.125 4.97 . . . . 4.5199999999999996 118.396 -171.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.38 -9.78 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 125.593 1.557 . . . . 4.5899999999999999 113.938 -167.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.443 ' H ' ' C ' ' A' ' 23' ' ' ASP . 22.6 pt -82.8 -18.01 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 130.011 3.324 . . . . 4.2400000000000002 116.123 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 tt -125.42 120.93 32.38 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.841 0.856 . . . . 3.6899999999999999 110.802 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -98.64 127.27 44.51 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.009 -0.996 . . . . 3.2000000000000002 109.533 175.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 t -123.48 122.04 37.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.413 1.485 . . . . 2.5 108.991 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -116.41 141.42 48.19 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.519 1.128 . . . . 2.2799999999999998 110.012 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -136.02 132.94 36.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.903 1.281 . . . . 2.8500000000000001 110.616 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -100.1 134.56 42.85 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 119.344 0.974 . . . . 2.2599999999999998 110.506 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -138.75 163.47 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.656 1.182 . . . . 2.0299999999999998 112.104 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.19 146.63 43.23 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.9 -0.778 . . . . 3.1299999999999999 108.9 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -63.75 -1.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 114.997 1.48 . . . . 1.8100000000000001 114.997 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -83.48 -17.17 42.92 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.648 1.579 . . . . 4.21 114.855 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.4 -9.32 14.95 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.937 1.458 . . . . 2.4100000000000001 114.937 -165.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.35 151.21 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 125.677 1.591 . . . . 1.74 109.743 168.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.71 160.26 24.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.099 1.148 . . . . 3.8100000000000001 114.099 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -74.71 47.13 0.31 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.25 1.82 . . . . 5.9500000000000002 113.892 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.27 23.12 0.23 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.312 1.434 . . . . 1.3899999999999999 113.545 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -129.36 172.57 11.36 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.032 1.733 . . . . 2.8599999999999999 111.316 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 mm -108.29 123.89 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.566 1.946 . . . . 2.48 110.038 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.1 mm -117.16 126.45 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.406 1.482 . . . . 1.8899999999999999 110.1 -170.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HE3' ' CD1' ' A' ' 96' ' ' LEU . 44.7 mtpt -94.06 139.98 30.3 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.936 0.717 . . . . 3.96 112.936 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.11 153.24 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.689 1.196 . . . . 2.0299999999999998 112.133 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.94 165.52 23.42 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 125.654 1.581 . . . . 2.6800000000000002 112.693 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.5 124.16 14.89 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.069 2.513 . . . . 2.0899999999999999 112.156 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.68 -13.68 61.94 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.154 1.835 . . . . 1.6000000000000001 115.728 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.56 -8.52 76.5 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 116.992 1.557 . . . . 4.3899999999999997 116.992 -172.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.0 mttt 61.88 158.87 0.06 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 127.871 2.469 . . . . 2.4900000000000002 115.463 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -92.51 119.02 68.25 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.144 0.977 . . . . 3.6099999999999999 111.01 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -87.45 -13.16 4.33 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.914 2.409 . . . . 0.82999999999999996 114.618 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -147.47 168.26 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.496 1.918 . . . . 2.04 110.503 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.57 145.39 30.38 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.707 0.803 . . . . 1.7 113.117 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.05 -159.11 32.39 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 114.484 0.554 . . . . 0.87 114.484 -173.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -108.84 140.19 42.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.033 1.333 . . . . 4.4100000000000001 112.925 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.85 132.14 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 127.878 2.471 . . . . 1.6799999999999999 107.789 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.9 pt -140.05 29.34 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 119.378 0.99 . . . . 2.3300000000000001 112.914 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.97 137.6 3.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.06 1.344 . . . . 3.5099999999999998 108.984 169.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.83 -178.71 53.17 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 122.549 1.083 . . . . 0.81000000000000005 114.717 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.28 136.57 31.75 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.487 1.515 . . . . 3.8500000000000001 111.502 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 m -148.32 156.75 42.91 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.05 1.129 . . . . 2.0699999999999998 114.05 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 29.4 ttm -104.79 133.87 48.88 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.665 -1.235 . . . . 1.6499999999999999 107.665 167.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.1 t -126.47 138.99 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.927 1.291 . . . . 1.1100000000000001 112.48 -167.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -93.09 103.03 15.36 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.585 1.554 . . . . 2.25 109.984 173.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -128.2 3.31 5.79 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.906 1.682 . . . . 1.8700000000000001 115.115 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.6 p -47.33 -29.62 2.65 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.256 1.822 . . . . 2.04 115.399 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.86 -38.07 46.86 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.635 1.174 . . . . 2.1800000000000002 112.115 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.95 -62.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.87 2.068 . . . . 2.5 111.198 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 p -88.85 -12.73 41.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.74 1.616 . . . . 2.04 112.577 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.74 19.24 60.13 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.76 1.171 . . . . 1.75 114.209 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -74.8 -167.73 0.62 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.336 1.455 . . . . 2.9300000000000002 111.333 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.91 13.35 1.67 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.001 1.482 . . . . 3.1400000000000001 115.001 -171.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -158.23 154.24 23.5 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.672 1.589 . . . . 4.9299999999999997 111.061 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -58.97 141.26 98.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.54 2.827 . . . . 2.5 113.048 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.2 t -114.04 137.05 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.833 2.053 . . . . 1.79 111.735 -169.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.6 133.56 33.7 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.221 -0.924 . . . . 1.9299999999999999 112.746 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -129.21 140.84 51.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.127 2.171 . . . . 1.3300000000000001 109.921 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -148.82 -177.19 0.63 Allowed Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 126.223 1.809 . . . . 4.96 110.287 -169.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.31 132.96 25.19 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 122.703 2.001 . . . . 1.29 110.674 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.09 7.22 68.22 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 126.222 1.867 . . . . 1.1799999999999999 114.784 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.3 t -101.56 152.35 20.89 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.105 1.952 . . . . 1.8600000000000001 111.86 -170.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.0 p -105.22 145.91 29.99 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.877 -1.139 . . . . 1.6799999999999999 113.356 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 m -137.54 161.41 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.902 1.681 . . . . 1.8 112.183 -172.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.95 147.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.138 1.775 . . . . 1.99 113.419 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.17 150.36 30.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.701 1.2 . . . . 1.5800000000000001 112.604 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.16 -3.63 51.48 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.239 0.924 . . . . 0.77000000000000002 115.227 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.8 p -80.97 156.86 25.74 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.331 1.066 . . . . 1.6399999999999999 111.85 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mm -107.77 123.52 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.503 0.721 . . . . 1.9299999999999999 110.763 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -83.12 128.29 34.35 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.825 -0.806 . . . . 2.0 108.825 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.86 43.9 2.68 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.28 1.215 . . . . 3.8700000000000001 114.28 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -157.92 -38.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.494 2.405 . . . . 4.2699999999999996 117.494 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.38 -175.87 27.84 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 120.626 1.557 . . . . 2.25 116.743 -168.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -116.02 122.68 45.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.624 1.169 . . . . 2.4100000000000001 111.944 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.1 mt -125.78 165.4 18.72 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.047 1.339 . . . . 2.23 113.823 -170.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.423 ' CD1' ' HE3' ' A' ' 44' ' ' LYS . 8.5 mp -112.37 122.7 48.46 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.507 1.523 . . . . 3.0299999999999998 109.006 167.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.28 129.63 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.65 1.18 . . . . 2.3100000000000001 110.952 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 29.2 p -86.51 120.08 27.45 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.466 -0.771 . . . . 2.7000000000000002 109.945 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.93 131.18 37.34 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.306 -0.871 . . . . 1.1200000000000001 111.159 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.91 -12.33 11.41 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.65 0.981 . . . . 4.2599999999999998 113.65 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -141.58 143.47 33.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.372 1.469 . . . . 2.7200000000000002 109.227 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.5 p -75.93 158.99 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 107.755 -1.202 . . . . 4.6799999999999997 107.755 166.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.16 -39.64 71.43 Favored Glycine 0 N--CA 1.477 1.411 0 CA-C-N 121.231 1.832 . . . . 2.0099999999999998 115.196 -167.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -34.17 77.15 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.621 0.971 . . . . 3.3900000000000001 113.621 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -77.87 -10.33 59.51 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.759 2.424 . . . . 2.8500000000000001 115.392 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.7 p -66.49 156.19 35.51 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.355 0.872 . . . . 2.4399999999999999 113.355 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.2 t -57.62 -33.8 68.62 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.741 -0.6 . . . . 2.8900000000000001 112.174 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.1 tp -56.14 -49.56 73.59 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.937 1.295 . . . . 2.2599999999999998 111.963 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -72.98 -24.16 60.74 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.324 1.45 . . . . 2.73 113.515 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -70.69 -48.16 56.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.397 1.079 . . . . 1.51 112.04 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.2 mt -53.05 -51.97 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.909 0.883 . . . . 2.5600000000000001 111.832 -169.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.6 m -69.66 -24.63 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.044 1.127 . . . . 1.8100000000000001 114.044 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -75.27 -34.72 61.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 118.764 -0.636 . . . . 4.9500000000000002 112.381 171.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.06 -46.17 65.52 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.047 1.339 . . . . 2.77 110.966 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.7 t -59.61 -43.37 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.519 -0.738 . . . . 2.5299999999999998 111.334 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.13 -28.85 68.48 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.551 0.945 . . . . 3.4900000000000002 113.551 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -73.9 -30.38 62.57 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.822 1.045 . . . . 4.3200000000000003 113.822 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.19 72.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.095 0.958 . . . . 4.6399999999999997 112.333 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.502 1.921 . . . . 4.7400000000000002 113.121 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.3 p . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 112.059 0.392 . . . . 3.4900000000000002 112.059 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -82.09 -30.24 31.36 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.27 -0.894 . . . . 5.2999999999999998 112.169 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.42 -29.85 68.04 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.455 -0.778 . . . . 2.1899999999999999 112.927 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.33 -29.15 69.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.671 0.788 . . . . 2.46 112.924 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.82 -25.68 49.01 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.981 1.104 . . . . 2.6000000000000001 113.981 169.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.81 -42.97 80.71 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.864 1.266 . . . . 3.5800000000000001 112.971 -167.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -49.85 -42.48 47.6 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.195 1.398 . . . . 2.2000000000000002 112.417 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.6 mm -72.47 -35.56 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.362 1.065 . . . . 2.5499999999999998 112.564 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.3 m -70.69 -27.76 64.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.093 0.957 . . . . 1.6100000000000001 113.331 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 mp -66.39 -25.73 66.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.177 0.806 . . . . 3.0699999999999998 113.177 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -61.64 131.16 49.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.338 0.972 . . . . 2.5899999999999999 112.209 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.31 159.47 23.87 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.96 1.096 . . . . 2.29 113.96 -169.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.5 m -86.84 -30.32 21.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.72 1.208 . . . . 4.2400000000000002 112.338 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -141.88 161.0 39.07 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.712 1.745 . . . . 4.0800000000000001 115.712 -168.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.23 162.73 34.78 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.826 2.05 . . . . 2.02 111.97 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.6 m -121.89 104.55 9.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.102 1.361 . . . . 1.96 112.237 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.0 mt -83.43 133.49 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.109 1.364 . . . . 1.1599999999999999 110.503 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.7 m -126.33 144.66 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.358 1.614 . . . . 3.1499999999999999 115.358 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.8 m -140.83 135.5 31.45 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.527 1.531 . . . . 3.9199999999999999 111.432 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.82 87.2 6.81 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.836 -1.165 . . . . 4.5700000000000003 109.441 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.48 -18.14 59.93 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.308 1.043 . . . . 3.9700000000000002 112.699 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -148.14 132.9 17.94 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.295 1.438 . . . . 5.4900000000000002 108.856 166.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -32.56 75.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 131.021 3.728 . . . . 6.4100000000000001 117.556 -166.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 60.19 -23.25 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.693 2.397 . . . . 6.04 114.779 -170.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.6 pt -65.1 -17.51 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 129.245 3.018 . . . . 5.6299999999999999 115.382 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -117.56 -80.19 0.6 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.108 1.363 . . . . 5.0899999999999999 110.15 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.5 tt 61.26 135.57 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.853 2.061 . . . . 3.6400000000000001 112.295 -168.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -126.41 143.6 51.12 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.603 1.561 . . . . 1.8100000000000001 110.739 -173.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -128.17 132.58 48.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.54 1.136 . . . . 2.7799999999999998 110.843 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -108.96 132.99 53.55 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.835 1.254 . . . . 2.7999999999999998 110.392 170.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -101.54 114.92 29.38 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.687 1.13 . . . . 2.6899999999999999 110.69 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.23 159.2 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.235 1.414 . . . . 2.5699999999999998 113.567 -168.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.83 154.41 33.9 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.441 1.097 . . . . 3.6099999999999999 111.025 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.62 -21.91 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 114.145 1.165 . . . . 1.8899999999999999 114.145 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -73.29 -15.19 61.41 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.487 -1.383 . . . . 3.3300000000000001 113.587 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.4 mt -99.84 -1.08 38.41 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.512 1.525 . . . . 2.71 114.422 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.33 146.37 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.579 1.552 . . . . 1.98 111.359 173.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -120.53 165.75 14.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.848 1.659 . . . . 3.3599999999999999 112.711 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -68.69 26.03 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.224 1.935 . . . . 3.5299999999999998 116.224 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.69 14.58 1.99 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 126.565 2.031 . . . . 1.6599999999999999 114.073 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -97.91 162.75 13.09 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 119.176 1.488 . . . . 2.6099999999999999 112.845 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 87.6 mt -118.56 130.94 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.257 1.423 . . . . 2.27 109.912 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.9 mm -121.19 130.89 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.824 1.649 . . . . 1.6299999999999999 112.413 -168.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -93.68 124.26 37.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.606 0.762 . . . . 3.0 112.089 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.97 137.18 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.351 1.06 . . . . 1.8200000000000001 112.414 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.53 158.47 54.32 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.455 1.102 . . . . 2.2799999999999998 113.361 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -62.6 126.91 19.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.724 2.283 . . . . 2.4900000000000002 111.377 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.66 -5.81 72.66 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.685 1.612 . . . . 1.0900000000000001 114.786 -169.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.51 159.04 53.22 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.764 1.173 . . . . 1.04 114.431 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -112.69 141.9 45.94 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.547 1.139 . . . . 3.6899999999999999 111.745 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.07 129.99 79.24 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 119.214 -0.422 . . . . 2.8700000000000001 112.06 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -90.32 -21.7 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.391 2.727 . . . . 0.84999999999999998 114.924 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.56 166.93 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 127.405 2.282 . . . . 2.0099999999999998 109.049 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.21 140.86 29.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.081 0.855 . . . . 2.0299999999999998 111.845 173.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.61 -173.57 44.83 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 114.737 0.655 . . . . 0.91000000000000003 114.737 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -110.27 144.43 38.99 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.48 1.112 . . . . 7.4000000000000004 113.204 -170.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.11 129.13 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.574 2.35 . . . . 2.0499999999999998 109.755 -172.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.7 pt -142.86 30.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 114.225 1.194 . . . . 2.2000000000000002 114.225 -171.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -168.81 143.83 3.28 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.608 1.963 . . . . 3.1099999999999999 109.367 166.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.84 -170.91 44.31 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.08 0.792 . . . . 0.95999999999999996 115.08 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -155.11 121.62 5.32 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.361 0.664 . . . . 4.2800000000000002 112.098 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.9 t -143.57 168.79 19.03 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.633 1.173 . . . . 1.6200000000000001 112.631 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.1 ttm -115.1 137.0 52.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.817 0.847 . . . . 2.2000000000000002 111.458 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.93 142.47 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.302 1.841 . . . . 1.01 111.705 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.93 114.53 26.65 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.837 1.255 . . . . 1.8999999999999999 110.96 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -114.22 14.2 18.08 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 114.379 1.252 . . . . 2.0299999999999998 114.379 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.5 p -67.02 -3.35 6.98 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 117.922 2.564 . . . . 1.9399999999999999 117.922 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.62 -41.62 3.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.937 1.695 . . . . 2.29 109.865 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.3 mm -76.01 -58.5 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.362 1.065 . . . . 2.1499999999999999 111.453 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.1 p -102.03 -11.74 18.67 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.185 0.994 . . . . 2.4199999999999999 112.958 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.65 16.22 75.91 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.735 1.159 . . . . 1.5800000000000001 115.083 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -56.08 -38.12 70.24 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.396 1.098 . . . . 2.5800000000000001 113.393 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 63.49 19.42 11.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.263 1.425 . . . . 2.1099999999999999 114.134 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.6 ttm -148.29 134.42 9.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 129.589 3.156 . . . . 4.1799999999999997 105.213 169.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.41 161.79 43.37 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.29 1.993 . . . . 2.0899999999999999 112.81 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.5 t -124.7 122.28 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.279 1.432 . . . . 2.1000000000000001 110.911 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.5 145.21 33.34 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.705 0.802 . . . . 2.1400000000000001 112.628 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -124.32 159.74 29.62 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.021 2.128 . . . . 1.0600000000000001 111.399 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -157.14 174.26 4.2 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 126.995 2.118 . . . . 3.8900000000000001 110.732 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.25 130.1 32.69 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 CA-C-N 121.909 1.717 . . . . 1.4099999999999999 109.497 166.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.18 43.21 10.9 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.713 0.673 . . . . 1.1699999999999999 113.087 -169.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -131.76 167.03 20.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.265 1.426 . . . . 1.6100000000000001 110.85 175.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.8 p -124.41 150.55 45.49 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 120.554 1.524 . . . . 2.04 113.034 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 m -135.01 163.03 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.945 1.298 . . . . 2.1699999999999999 112.348 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.5 150.72 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.383 2.273 . . . . 2.4399999999999999 110.67 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.76 150.88 47.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.411 0.684 . . . . 1.8200000000000001 112.521 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.75 -5.94 55.9 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 115.355 0.902 . . . . 0.90000000000000002 115.355 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.88 157.64 21.91 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.255 1.528 . . . . 3.7599999999999998 111.456 169.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -110.12 131.21 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.438 1.095 . . . . 2.1800000000000002 111.025 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -96.93 132.02 43.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.309 1.444 . . . . 1.97 111.211 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -84.89 -72.96 0.45 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.128 -0.982 . . . . 3.6400000000000001 113.245 -170.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -157.85 142.95 16.75 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.556 2.343 . . . . 4.6799999999999997 107.42 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.46 11.19 1.18 Allowed Glycine 0 CA--C 1.542 1.72 0 N-CA-C 117.452 1.741 . . . . 3.2999999999999998 117.452 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.6 m 32.29 85.37 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.435 2.694 . . . . 2.54 117.036 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.8 mt -103.98 156.13 18.1 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.887 1.275 . . . . 2.5099999999999998 113.524 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 65.1 mt -108.85 123.89 49.77 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.425 1.09 . . . . 3.6200000000000001 110.492 167.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.55 124.66 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.485 1.514 . . . . 2.7999999999999998 109.542 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.7 p -82.44 120.36 25.37 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.346 -0.846 . . . . 2.4199999999999999 109.586 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.5 115.29 19.04 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.355 -0.841 . . . . 1.24 109.254 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.3 p -119.29 6.35 11.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.692 1.197 . . . . 2.9399999999999999 113.524 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -147.66 145.48 28.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.109 1.763 . . . . 1.97 110.321 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.8 m -83.64 159.6 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.74 -0.837 . . . . 2.52 108.74 164.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.18 -38.87 79.29 Favored Glycine 0 N--CA 1.475 1.262 0 O-C-N 121.025 -1.047 . . . . 1.5900000000000001 114.913 -168.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.16 90.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.355 1.077 . . . . 3.0699999999999998 112.814 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -77.26 -9.21 58.66 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.249 1.574 . . . . 2.52 115.249 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.7 p -64.47 159.04 22.35 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.336 0.865 . . . . 2.3999999999999999 113.336 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -66.1 -29.29 69.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.969 -0.56 . . . . 3.0299999999999998 111.627 170.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.12 -46.3 88.68 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.657 -1.277 . . . . 2.4100000000000001 112.255 171.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.6 m -68.41 -23.01 64.59 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.492 0.552 . . . . 2.3900000000000001 112.492 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.41 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 6.4 tp-100 -71.24 -40.39 71.08 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.995 1.271 . . . . 2.9700000000000002 112.033 169.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 82.4 mt -54.96 -50.23 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 120.26 1.391 . . . . 2.5 110.772 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -64.91 -32.23 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 118.102 -0.951 . . . . 1.8799999999999999 113.027 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 110' ' ' GLN . 47.1 mtmt -70.71 -37.6 73.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.724 1.147 . . . . 4.2199999999999998 113.12 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.1 -48.13 83.02 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.951 2.1 . . . . 4.4100000000000001 110.049 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.4 -44.13 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 119.095 -0.479 . . . . 2.3700000000000001 110.962 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -58.47 -32.15 68.49 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.384 0.993 . . . . 4.3899999999999997 113.437 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.06 -24.46 62.33 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.605 1.162 . . . . 4.8600000000000003 113.935 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.92 -39.67 79.52 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.209 0.603 . . . . 3.8100000000000001 110.395 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 126.037 1.735 . . . . 4.8099999999999996 112.714 169.818 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 113.439 0.904 . . . . 3.4900000000000002 113.439 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -76.9 -26.08 53.73 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.531 1.06 . . . . 6.4900000000000002 112.542 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.97 68.91 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.56 0.744 . . . . 2.3100000000000001 112.309 171.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.12 -33.12 71.43 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.911 1.284 . . . . 2.48 112.662 172.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.9 -29.77 58.56 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.827 0.677 . . . . 2.5 112.827 171.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.79 -41.1 77.11 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.111 -0.993 . . . . 3.3999999999999999 112.001 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.58 -30.41 65.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.284 0.947 . . . . 2.6000000000000001 113.112 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -75.25 -45.46 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.747 1.219 . . . . 2.8300000000000001 112.409 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 m -75.66 -15.51 60.31 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.508 1.123 . . . . 1.77 113.401 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.0 tp -72.88 -24.49 60.86 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.579 2.751 . . . . 4.3300000000000001 112.949 170.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -77.61 148.48 35.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.189 0.995 . . . . 3.1600000000000001 113.407 -173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 163.4 27.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.397 1.479 . . . . 2.8900000000000001 114.514 -171.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.7 p -109.0 -38.11 5.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.21 1.404 . . . . 3.1699999999999999 112.965 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.84 154.76 51.08 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.613 1.565 . . . . 3.0600000000000001 113.366 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.35 161.99 36.55 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.823 1.649 . . . . 1.5900000000000001 113.358 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -118.61 103.2 9.48 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.462 1.105 . . . . 1.6599999999999999 112.303 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.3 mt -83.56 134.71 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.888 1.275 . . . . 1.21 110.25 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.86 141.01 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.604 1.162 . . . . 2.8300000000000001 110.283 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m -133.27 139.06 46.72 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.381 1.872 . . . . 2.6000000000000001 110.118 -169.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.1 mt -100.36 125.5 46.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.517 0.727 . . . . 3.73 110.097 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -118.17 6.85 12.02 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 117.343 2.349 . . . . 4.29 117.343 -166.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -135.2 -73.35 0.46 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 120.688 1.586 . . . . 4.25 113.223 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -164.25 64.39 0.15 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.42 2.288 . . . . 4.6799999999999997 106.438 174.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.283 12.1 p30 54.98 -11.11 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 128.751 2.821 . . . . 5.8899999999999997 118.145 -169.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 pt -76.09 -3.68 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.979 1.712 . . . . 5.2999999999999998 115.253 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -130.9 120.56 23.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.834 1.654 . . . . 4.3700000000000001 111.419 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 mp -111.41 129.35 56.05 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.115 1.766 . . . . 3.5800000000000001 111.998 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 t -138.92 140.04 38.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.35 1.86 . . . . 1.9299999999999999 110.319 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -123.18 148.81 45.38 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.921 1.452 . . . . 2.3900000000000001 114.921 -170.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -121.36 146.66 46.63 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.509 2.324 . . . . 3.3999999999999999 110.325 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -111.83 132.09 54.92 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.422 1.01 . . . . 2.6000000000000001 111.641 171.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.2 m -135.9 161.27 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.199 1.0 . . . . 1.29 113.03 -170.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.7 148.7 36.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.479 0.711 . . . . 3.3900000000000001 109.786 168.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.22 -24.95 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 113.948 1.092 . . . . 2.3100000000000001 113.948 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -64.4 -22.86 67.09 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.45 1.1 . . . . 4.2400000000000002 113.566 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.3 mt -103.79 -6.83 21.06 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.742 1.617 . . . . 1.6299999999999999 114.747 -168.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.02 140.48 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.147 0.979 . . . . 1.6799999999999999 110.356 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.26 165.51 15.35 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.024 1.73 . . . . 3.0499999999999998 111.312 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -75.02 11.48 1.1 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.722 1.749 . . . . 4.2199999999999998 115.722 -175.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.38 6.31 16.81 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 126.562 2.029 . . . . 1.71 114.483 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -87.91 152.47 22.05 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 119.891 1.846 . . . . 2.9700000000000002 112.777 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.0 mm -111.5 128.65 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.163 1.785 . . . . 3.1400000000000001 109.813 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.8 mm -119.68 128.44 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.511 1.124 . . . . 1.99 112.903 -168.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -88.34 121.97 31.33 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 121.225 -0.922 . . . . 2.6699999999999999 112.532 170.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.21 134.33 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.293 1.437 . . . . 1.9099999999999999 111.3 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 m -97.32 163.69 19.3 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 124.61 1.164 . . . . 1.96 113.26 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.35 133.9 52.07 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.231 1.954 . . . . 1.49 111.334 167.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.46 -8.21 54.73 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.775 2.131 . . . . 0.92000000000000004 115.098 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.76 161.77 54.28 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 118.536 1.168 . . . . 1.0600000000000001 114.379 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -113.24 140.69 47.75 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.749 1.219 . . . . 2.6200000000000001 111.006 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.49 123.16 88.96 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-O 118.257 -0.878 . . . . 2.8900000000000001 111.834 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.64 -24.09 4.45 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.971 2.447 . . . . 0.83999999999999997 115.818 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.19 152.56 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 126.608 1.963 . . . . 1.8700000000000001 109.116 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 138.8 35.62 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.873 1.064 . . . . 1.8700000000000001 113.873 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.94 -157.79 20.85 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 123.728 0.68 . . . . 0.78000000000000003 114.431 -171.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ttp-105 -119.87 146.31 45.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.097 1.359 . . . . 4.9800000000000004 113.062 -170.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.6 t -98.99 130.74 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 128.247 2.619 . . . . 1.8400000000000001 109.467 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.7 31.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 114.143 1.164 . . . . 1.8300000000000001 114.143 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -167.42 139.62 3.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.427 1.491 . . . . 2.6800000000000002 110.29 169.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.61 -164.8 36.33 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 116.845 1.498 . . . . 1.0600000000000001 116.845 167.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -145.69 132.68 20.25 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.689 1.196 . . . . 4.2300000000000004 111.523 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.1 -179.21 6.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.882 0.873 . . . . 1.6799999999999999 112.831 168.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.43 135.32 54.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.793 2.037 . . . . 2.2799999999999998 110.358 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 72.4 t -126.31 142.76 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.48 1.112 . . . . 1.1699999999999999 113.071 -169.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.94 106.24 16.13 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.544 1.138 . . . . 2.4199999999999999 112.582 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -100.64 30.15 4.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.961 2.105 . . . . 1.8600000000000001 114.103 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.3 p -48.7 -28.81 3.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.016 2.598 . . . . 3.0499999999999998 118.016 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.41 -56.03 2.34 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.493 1.517 . . . . 2.6800000000000002 110.637 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.3 mm -67.77 -51.98 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.783 0.66 . . . . 2.4300000000000002 112.783 -167.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.7 p -95.52 -20.18 19.23 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.665 0.786 . . . . 2.5600000000000001 112.474 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.51 83.37 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.182 1.372 . . . . 1.3 115.374 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.43 -47.57 83.5 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.573 1.323 . . . . 2.3500000000000001 114.573 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 64.86 30.71 12.0 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.656 1.982 . . . . 2.6800000000000002 112.861 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -149.12 154.26 39.05 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 127.529 2.332 . . . . 5.5300000000000002 109.879 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.13 133.74 42.43 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.449 2.766 . . . . 2.6099999999999999 115.168 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -116.16 136.16 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 127.063 2.145 . . . . 2.0699999999999998 110.848 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.13 133.73 34.28 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.971 -1.081 . . . . 1.78 112.717 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -124.25 137.09 54.55 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.89 1.276 . . . . 1.1100000000000001 111.677 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -148.48 179.15 1.24 Allowed Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 127.52 2.328 . . . . 3.7400000000000002 108.667 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -56.3 139.38 86.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 CA-C-N 123.289 2.21 . . . . 1.02 112.319 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.05 11.73 83.37 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.456 -1.191 . . . . 0.77000000000000002 115.105 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.2 m -102.2 166.53 10.54 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.581 1.69 . . . . 1.8100000000000001 110.949 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.7 p -117.4 152.77 34.28 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.244 -1.535 . . . . 1.9099999999999999 112.855 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.15 157.06 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.763 1.625 . . . . 1.8600000000000001 112.159 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.73 143.08 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.758 1.623 . . . . 2.1899999999999999 111.675 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.68 153.99 37.93 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.47 0.915 . . . . 1.6599999999999999 113.47 -170.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.68 -1.0 59.7 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 114.893 0.717 . . . . 0.87 114.893 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 m -88.97 156.4 18.91 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.303 1.051 . . . . 2.4500000000000002 111.447 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.05 145.33 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.576 1.15 . . . . 1.75 111.117 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -115.97 137.13 52.39 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.958 2.103 . . . . 1.77 112.227 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -153.93 139.73 18.07 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.401 -1.437 . . . . 3.4500000000000002 113.084 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.314 30.1 t30 87.89 -1.48 0.49 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.285 3.434 . . . . 3.29 116.006 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.67 163.45 29.0 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 120.437 -1.414 . . . . 1.9399999999999999 115.257 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -98.95 144.01 28.6 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.121 1.769 . . . . 2.7200000000000002 112.128 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.9 mt -135.57 160.02 39.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.948 1.299 . . . . 2.1899999999999999 111.361 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.9 mt -107.99 127.63 53.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.691 0.796 . . . . 3.3399999999999999 110.435 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 mm -117.24 124.62 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.923 1.689 . . . . 2.8199999999999998 110.306 -173.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -87.19 111.22 20.77 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.424 -0.797 . . . . 2.5800000000000001 109.533 169.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.17 119.13 22.53 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.622 0.769 . . . . 1.22 109.806 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 t -119.86 8.71 11.15 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.594 0.961 . . . . 3.52 113.594 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -138.36 139.31 38.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.612 1.965 . . . . 2.0 108.058 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 m -85.98 174.58 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.737 0.815 . . . . 2.9100000000000001 111.802 170.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.25 -36.57 91.15 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 121.08 -1.012 . . . . 1.3200000000000001 114.795 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.71 -36.9 70.67 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.852 1.326 . . . . 2.1499999999999999 112.615 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -78.49 -10.25 59.64 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.798 1.777 . . . . 2.27 115.798 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -76.6 156.17 32.95 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.646 -1.283 . . . . 3.8999999999999999 112.379 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.9 t -56.88 -34.39 67.83 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.38 0.882 . . . . 2.7400000000000002 113.38 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.5 mp -56.93 -48.68 77.7 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.541 -1.349 . . . . 2.0899999999999999 112.52 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.9 m -70.74 -27.99 64.38 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.02 1.328 . . . . 2.21 112.203 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -70.76 -44.74 66.12 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.394 0.678 . . . . 2.0699999999999998 111.974 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.5 mt -56.37 -49.57 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.94 1.296 . . . . 2.1400000000000001 111.267 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.52 -19.74 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.251 1.204 . . . . 2.46 114.251 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -72.27 -29.97 64.4 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.6 1.091 . . . . 4.0300000000000002 112.67 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tt -75.03 -58.92 2.98 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.095 1.358 . . . . 3.9900000000000002 111.328 170.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.6 t -69.66 -18.11 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.364 -0.835 . . . . 2.3199999999999998 112.885 -169.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -65.41 -30.98 71.84 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.133 -1.604 . . . . 3.4100000000000001 112.147 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -75.04 -18.86 60.25 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.187 1.395 . . . . 3.8999999999999999 113.293 172.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.06 -7.79 57.38 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.654 1.582 . . . . 4.6200000000000001 114.636 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.173 -1.394 . . . . 4.7999999999999998 114.115 179.412 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 119.088 -0.482 . . . . 3.8599999999999999 111.769 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.55 -23.91 53.58 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.221 0.919 . . . . 4.71 112.672 170.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.18 -8.27 37.27 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.135 1.161 . . . . 2.3900000000000001 114.135 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.4 tp -56.41 -53.96 51.3 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.193 0.997 . . . . 3.3700000000000001 111.301 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.37 -7.99 47.2 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.436 1.643 . . . . 3.1699999999999999 115.436 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -64.88 -43.89 91.45 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 121.486 1.948 . . . . 2.8199999999999998 111.003 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -48.76 -48.96 40.51 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.281 1.432 . . . . 2.1099999999999999 111.048 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.9 mm -70.16 -34.01 57.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.79 1.236 . . . . 2.29 112.034 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 m -76.64 -24.77 53.32 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.153 1.381 . . . . 1.71 113.053 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 mp -68.22 -26.79 65.89 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.889 0.768 . . . . 2.8399999999999999 112.621 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -70.72 139.78 51.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.409 1.004 . . . . 3.8199999999999998 113.013 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.87 152.39 44.59 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.102 -0.499 . . . . 2.2400000000000002 111.188 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -106.23 -2.66 22.18 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.911 1.284 . . . . 2.77 112.128 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -142.59 153.5 43.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.326 2.25 . . . . 3.9100000000000001 112.282 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.85 162.0 36.62 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.194 1.398 . . . . 1.4399999999999999 112.991 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.8 m -115.07 108.16 16.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.929 1.292 . . . . 1.6899999999999999 111.916 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.0 mt -83.32 130.33 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.104 -0.702 . . . . 1.25 109.104 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.31 138.42 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.04 0.936 . . . . 3.4500000000000002 112.37 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.4 m -140.19 139.29 35.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.178 0.991 . . . . 3.0299999999999998 111.747 -169.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.4 mt -104.35 141.22 36.7 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.953 1.301 . . . . 3.98 109.199 168.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.36 20.77 1.2 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.333 1.975 . . . . 4.8799999999999999 116.333 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.8 m -142.04 -73.83 0.31 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.401 -0.812 . . . . 4.2199999999999998 112.573 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -160.99 50.28 0.25 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.491 1.916 . . . . 6.79 109.052 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.7 -18.59 0.08 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.55 2.34 . . . . 7.1699999999999999 114.471 -167.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.5 pt -69.62 -33.39 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.422 1.489 . . . . 5.1699999999999999 113.284 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 tp -86.83 92.46 8.99 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.213 1.005 . . . . 3.52 108.61 168.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 tp -106.55 125.79 51.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.826 2.051 . . . . 4.0499999999999998 109.5 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 t -135.22 129.35 33.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.637 1.175 . . . . 2.3100000000000001 110.966 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -130.74 129.44 42.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.446 1.098 . . . . 2.4100000000000001 111.822 -169.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -119.51 118.97 32.47 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.486 1.914 . . . . 2.8399999999999999 109.746 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -89.24 121.54 31.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.576 1.08 . . . . 2.6299999999999999 109.93 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.31 171.28 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.124 1.37 . . . . 2.1299999999999999 112.612 -169.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.7 146.17 32.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.634 1.174 . . . . 3.21 110.506 168.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.96 -24.05 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.608 0.966 . . . . 1.74 113.608 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.16 -22.48 61.29 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.815 -1.178 . . . . 2.9199999999999999 113.062 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.77 -15.18 42.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.305 1.042 . . . . 2.3799999999999999 113.231 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 p -86.7 93.54 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 122.715 1.245 . . . . 2.2200000000000002 109.9 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -78.32 158.3 28.89 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.42 2.288 . . . . 4.1900000000000004 109.218 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -69.74 134.26 48.41 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.015 -1.053 . . . . 3.1800000000000002 112.966 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.42 12.18 4.32 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.207 1.385 . . . . 1.6100000000000001 115.999 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -116.48 168.86 9.79 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.288 2.044 . . . . 2.71 113.861 175.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.86 129.04 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.31 1.844 . . . . 2.6400000000000001 109.607 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.1 mm -122.75 129.14 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.119 1.768 . . . . 1.9099999999999999 110.465 -171.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -83.13 135.71 34.72 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.765 1.226 . . . . 3.75 112.365 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.36 136.8 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.822 1.249 . . . . 1.3 111.949 169.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.35 159.14 65.29 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.018 0.927 . . . . 1.97 112.886 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.28 136.12 66.31 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.78 2.32 . . . . 1.74 110.757 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.18 3.79 57.87 Favored Glycine 0 CA--C 1.542 1.735 0 N-CA-C 114.914 0.726 . . . . 0.98999999999999999 114.914 -169.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.1 178.89 48.54 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 118.928 1.364 . . . . 0.97999999999999998 115.686 -174.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.81 145.26 51.24 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.419 1.888 . . . . 2.3300000000000001 111.096 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -88.07 129.5 49.79 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.863 0.69 . . . . 2.8700000000000001 112.863 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -86.27 -22.22 2.23 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.275 2.65 . . . . 0.81000000000000005 115.661 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.6 m -151.08 175.82 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 127.843 2.457 . . . . 1.79 109.147 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -99.94 140.99 33.36 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.357 0.98 . . . . 1.6799999999999999 113.474 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.51 -177.73 46.58 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 123.545 0.593 . . . . 0.76000000000000001 114.38 -169.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -103.24 138.81 39.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.838 1.255 . . . . 5.5 112.178 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.8 t -83.45 130.55 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.255 2.222 . . . . 1.76 108.657 173.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.1 pt -140.37 33.48 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-O 122.394 1.093 . . . . 1.6799999999999999 112.379 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -166.6 129.5 1.89 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.155 2.182 . . . . 2.8100000000000001 108.084 168.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.33 176.0 50.5 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 122.701 1.167 . . . . 1.03 115.03 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -153.31 120.96 5.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.417 1.487 . . . . 2.8999999999999999 112.572 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.558 ' HG ' ' ND2' ' A' ' 90' ' ' ASN . 2.8 t -141.69 159.73 41.63 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.445 1.498 . . . . 2.0800000000000001 112.024 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.4 ttm -90.67 130.18 36.7 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.761 -0.587 . . . . 1.6799999999999999 110.341 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.7 t -113.85 140.77 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.524 1.13 . . . . 2.0600000000000001 111.781 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -108.32 102.46 11.58 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.334 1.453 . . . . 1.76 111.427 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 19.86 17.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.624 1.969 . . . . 4.0 113.096 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.2 p -54.6 -29.09 50.76 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.331 1.604 . . . . 1.6000000000000001 115.331 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.59 -30.46 26.97 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.825 1.193 . . . . 2.1299999999999999 111.708 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 mm -72.76 -53.57 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.554 1.542 . . . . 1.9299999999999999 110.176 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.2 p -102.92 -22.04 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.313 1.845 . . . . 2.0499999999999998 113.691 -171.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.75 -2.23 87.7 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.277 1.418 . . . . 1.3200000000000001 114.328 -170.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -64.9 110.16 2.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.502 1.651 . . . . 2.8599999999999999 110.296 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.59 -3.38 58.44 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.983 -1.073 . . . . 2.5800000000000001 112.596 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.8 mmt -95.79 138.7 21.71 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.99 2.516 . . . . 4.4900000000000002 108.952 167.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.36 161.09 22.78 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.155 2.57 . . . . 2.6099999999999999 112.347 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.8 t -124.03 119.82 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.463 0.705 . . . . 1.5800000000000001 111.369 -168.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.57 130.79 35.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.021 0.928 . . . . 1.8 112.086 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -108.74 157.68 18.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.015 1.726 . . . . 1.1399999999999999 111.866 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -146.73 168.97 10.25 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 127.581 2.352 . . . . 4.2800000000000002 111.624 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -59.14 123.22 12.98 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 121.578 1.519 . . . . 1.1499999999999999 109.356 166.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.43 57.15 3.01 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.866 1.222 . . . . 1.21 112.426 -168.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -141.3 150.31 42.38 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.696 1.598 . . . . 1.4099999999999999 112.427 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.9 p -101.05 150.76 22.57 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 120.861 1.664 . . . . 2.04 113.522 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.05 162.61 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.464 1.506 . . . . 1.1799999999999999 111.823 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.97 150.06 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.768 2.027 . . . . 1.71 111.363 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.59 142.23 49.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.033 0.933 . . . . 1.6499999999999999 112.71 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.49 -5.77 72.07 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.125 1.345 . . . . 0.79000000000000004 116.305 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.4 p -73.93 162.22 29.3 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.711 1.256 . . . . 1.6499999999999999 111.896 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mm -110.79 143.88 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.52 1.128 . . . . 1.8 111.61 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.558 ' ND2' ' HG ' ' A' ' 62' ' ' SER . 2.4 t30 -105.45 142.62 34.89 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.467 1.907 . . . . 1.9099999999999999 112.341 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -85.73 -125.69 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.639 1.175 . . . . 3.52 112.316 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -78.99 -38.16 37.43 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.001 1.852 . . . . 3.3999999999999999 116.001 -166.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.4 128.78 13.68 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.794 0.725 . . . . 1.9299999999999999 112.538 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.2 t -83.97 121.43 27.38 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.875 -1.158 . . . . 3.2799999999999998 107.875 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.4 mt -117.99 157.73 26.23 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.715 1.206 . . . . 2.1299999999999999 111.321 -169.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -117.31 125.52 51.2 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.482 0.658 . . . . 3.0499999999999998 109.75 169.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.79 138.17 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.64 1.576 . . . . 2.3100000000000001 110.573 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.6 p -79.03 106.62 11.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.021 0.915 . . . . 2.54 111.185 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.73 82.4 4.13 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.202 1.001 . . . . 1.6799999999999999 109.097 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 t -101.51 9.32 41.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.585 1.954 . . . . 4.21 111.874 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -144.49 152.86 41.21 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.159 1.783 . . . . 2.4500000000000002 111.451 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -106.7 170.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.211 1.404 . . . . 2.5899999999999999 111.579 168.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.6 -24.24 46.56 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.366 1.306 . . . . 2.2200000000000002 116.366 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.38 96.91 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.595 1.698 . . . . 4.1200000000000001 112.529 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.18 -22.98 59.17 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.272 1.582 . . . . 3.8300000000000001 115.272 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 109' ' ' SER . 3.2 t -71.58 142.74 50.01 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.463 1.283 . . . . 4.1500000000000004 114.463 -166.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m -60.95 -27.14 68.03 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.499 -0.751 . . . . 4.6299999999999999 112.275 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.0 tp -58.4 -46.22 86.83 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.367 -0.833 . . . . 2.8599999999999999 112.093 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.403 ' H ' HG22 ' A' ' 106' ' ' THR . 75.9 p -73.03 -27.33 61.7 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.881 0.872 . . . . 2.6800000000000002 113.012 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -66.64 -40.06 88.54 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.164 -0.96 . . . . 2.0899999999999999 112.461 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 67.8 mt -53.91 -52.22 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.392 1.077 . . . . 2.5499999999999998 110.301 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 m -70.01 -24.4 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 113.686 0.995 . . . . 1.45 113.686 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -70.07 -48.37 58.06 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.229 0.922 . . . . 3.4300000000000002 111.849 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mt -72.68 -37.93 67.75 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.597 0.962 . . . . 3.3500000000000001 113.597 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -70.85 -18.83 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.142 -0.974 . . . . 3.8900000000000001 112.649 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -71.96 -36.49 69.86 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.927 0.891 . . . . 3.73 111.012 168.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -73.17 -11.52 60.56 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.07 -1.019 . . . . 3.5800000000000001 113.121 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.62 -56.06 6.57 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.165 -0.96 . . . . 3.7200000000000002 110.237 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.257 0 CA-C-O 116.665 -1.636 . . . . 4.2800000000000002 114.767 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 113.681 0.993 . . . . 3.5600000000000001 113.681 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -99.06 -39.99 8.24 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.945 1.698 . . . . 5.29 111.381 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.27 90.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.158 0.983 . . . . 2.3900000000000001 111.785 172.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 tp -55.05 -35.82 64.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.254 1.022 . . . . 2.7599999999999998 112.386 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.07 -47.34 37.26 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.359 0.527 . . . . 3.23 112.208 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.08 -32.46 70.97 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.211 1.005 . . . . 3.79 113.384 -172.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.0 -35.73 77.6 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.228 1.377 . . . . 2.0899999999999999 113.267 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.6 mm -73.99 -40.29 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.498 -0.751 . . . . 2.7000000000000002 111.591 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -66.86 -30.38 70.53 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.391 0.886 . . . . 1.6299999999999999 113.391 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.31 -17.33 62.43 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.555 1.942 . . . . 3.1299999999999999 113.941 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -86.4 147.04 26.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.538 1.135 . . . . 3.27 112.835 -170.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.23 154.41 22.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.557 1.543 . . . . 2.23 112.98 -172.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 m -100.53 -27.39 13.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.331 1.452 . . . . 3.1200000000000001 113.314 -172.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.84 150.76 50.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.228 1.411 . . . . 3.4199999999999999 113.678 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.4 172.32 12.93 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.608 1.563 . . . . 1.6000000000000001 113.37 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 93.1 m -119.4 105.3 11.15 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.501 1.52 . . . . 1.74 112.125 170.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.89 140.31 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.016 0.927 . . . . 1.8799999999999999 109.402 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.93 124.98 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.469 -0.769 . . . . 2.8399999999999999 110.551 172.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -128.04 144.47 51.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.604 1.162 . . . . 2.6499999999999999 110.681 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.8 mt -112.56 123.5 50.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.183 0.993 . . . . 3.0499999999999998 110.938 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -105.79 1.57 27.09 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 117.567 2.432 . . . . 4.2000000000000002 117.567 -165.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -128.89 -93.47 0.44 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.815 1.246 . . . . 4.0899999999999999 111.454 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -142.01 58.45 1.48 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.618 1.967 . . . . 4.4699999999999998 108.995 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.337 12.7 p30 56.81 -9.55 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.649 2.779 . . . . 5.3799999999999999 117.899 -170.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.4 pt -77.33 -13.14 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.876 2.07 . . . . 4.04 115.472 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.7 tp -117.82 105.54 12.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.298 1.439 . . . . 4.0899999999999999 109.683 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.86 129.13 36.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.28 1.032 . . . . 2.9700000000000002 110.642 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 t -141.42 84.69 1.92 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.601 1.56 . . . . 1.77 109.431 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -81.02 154.15 27.03 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.033 -1.042 . . . . 2.7200000000000002 112.926 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -121.74 130.72 53.63 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.181 1.792 . . . . 2.7000000000000002 110.958 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -88.58 120.56 30.08 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.671 -0.863 . . . . 2.5299999999999998 108.671 168.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.24 159.23 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.051 0.94 . . . . 1.5700000000000001 113.13 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -78.04 143.22 37.65 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.903 -0.777 . . . . 3.1800000000000002 108.903 166.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.09 -20.24 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.609 1.164 . . . . 2.3199999999999998 113.585 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -70.24 -20.02 63.1 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.707 -1.246 . . . . 3.4300000000000002 113.637 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.83 -5.55 56.76 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.455 1.28 . . . . 2.2799999999999998 114.455 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.1 p -94.13 144.65 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.762 0.825 . . . . 2.6099999999999999 112.508 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -121.25 163.3 18.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.943 2.497 . . . . 3.1699999999999999 110.124 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 ptt85 -72.29 147.15 46.66 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.181 -0.95 . . . . 4.5 110.784 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.43 28.49 7.11 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-N 119.142 0.883 . . . . 2.71 113.93 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.5 166.34 25.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.333 1.853 . . . . 3.5299999999999998 111.523 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.4 mt -122.95 132.16 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.945 1.298 . . . . 2.8700000000000001 111.937 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 mm -118.65 129.98 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.692 1.997 . . . . 2.04 110.623 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -84.45 130.39 34.77 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.639 -0.663 . . . . 2.8199999999999998 112.19 172.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.43 136.89 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.888 1.275 . . . . 1.23 110.227 169.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.93 161.91 39.71 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.118 1.367 . . . . 1.6699999999999999 112.39 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -57.5 134.27 62.31 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.674 1.583 . . . . 1.75 108.618 166.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.64 -9.04 38.25 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 118.702 -1.054 . . . . 0.93000000000000005 115.557 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.92 177.94 37.53 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 119.645 1.723 . . . . 0.94999999999999996 114.237 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.88 151.37 38.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.684 1.593 . . . . 3.21 111.234 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -90.14 116.55 66.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 118.496 -0.764 . . . . 2.9900000000000002 109.965 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -89.16 -11.22 3.72 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.936 2.424 . . . . 0.73999999999999999 114.896 -171.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -147.8 172.82 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 128.55 2.74 . . . . 1.8300000000000001 108.834 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.2 139.39 37.88 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.164 0.893 . . . . 2.6600000000000001 112.518 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.75 -158.67 22.58 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 115.253 0.861 . . . . 0.89000000000000001 115.253 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -118.3 129.1 55.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.74 1.216 . . . . 5.2000000000000002 112.647 -170.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.3 t -88.69 127.23 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.881 1.672 . . . . 1.6299999999999999 108.93 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.7 pt -141.52 30.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 113.438 0.903 . . . . 2.1499999999999999 113.438 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -169.08 132.01 1.29 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.615 1.966 . . . . 3.1699999999999999 108.975 166.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.71 173.34 46.83 Favored Glycine 0 CA--C 1.539 1.578 0 N-CA-C 116.102 1.201 . . . . 1.1000000000000001 116.102 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -140.28 127.36 20.9 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.099 1.36 . . . . 4.4199999999999999 113.806 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 m -151.46 172.15 16.42 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.362 1.616 . . . . 1.75 115.362 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.9 ttm -106.46 133.78 50.61 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.625 1.17 . . . . 2.2599999999999998 110.497 168.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.85 132.82 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.479 1.112 . . . . 2.25 113.743 -167.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -91.23 98.7 11.88 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.269 1.828 . . . . 2.2799999999999998 111.386 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -128.98 8.61 5.68 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.135 1.774 . . . . 2.2999999999999998 115.57 -172.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.3 p -59.73 -4.81 0.75 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 116.248 1.944 . . . . 2.6499999999999999 116.248 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -94.62 -35.6 12.14 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.153 1.342 . . . . 2.25 111.449 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.8 mm -79.73 -62.88 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.797 1.239 . . . . 2.4199999999999999 111.612 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 p -84.99 -8.15 58.85 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.206 1.403 . . . . 2.6200000000000001 112.999 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.02 25.9 70.19 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.556 1.074 . . . . 2.8999999999999999 113.241 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -64.3 -177.33 0.28 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.671 1.589 . . . . 3.1699999999999999 110.876 169.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.5 -9.64 5.7 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.843 -1.161 . . . . 3.8100000000000001 113.612 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -149.26 151.25 33.55 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.099 1.36 . . . . 3.6699999999999999 110.793 169.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -48.8 153.87 3.42 Favored 'Trans proline' 0 CA--C 1.538 0.712 1 C-N-CA 125.405 4.07 . . . . 3.8300000000000001 116.245 -178.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.3 t -113.25 134.07 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.722 1.609 . . . . 1.5700000000000001 111.354 -170.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.38 137.22 38.6 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.614 0.765 . . . . 1.8500000000000001 112.188 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -130.14 143.87 51.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.167 2.187 . . . . 1.03 110.179 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -148.61 -172.61 0.32 Allowed Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 126.611 1.964 . . . . 4.2000000000000002 109.526 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.45 142.92 67.43 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 CA-C-N 123.492 2.283 . . . . 1.25 111.347 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.02 8.73 87.4 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.512 1.53 . . . . 1.0900000000000001 114.895 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.2 m -89.52 163.83 15.05 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.851 1.826 . . . . 1.6499999999999999 112.234 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.3 p -112.33 147.1 37.06 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.911 -1.118 . . . . 2.23 111.218 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 m -139.46 156.31 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.553 1.141 . . . . 1.3 112.754 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.53 150.53 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.169 1.788 . . . . 1.8700000000000001 113.225 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.02 149.59 47.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.044 0.937 . . . . 1.8899999999999999 113.168 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.3 -2.52 56.85 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.712 1.148 . . . . 0.89000000000000001 114.966 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 89.9 p -76.59 155.0 33.91 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.629 1.214 . . . . 1.8300000000000001 111.657 169.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.09 136.95 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.273 1.029 . . . . 2.0800000000000001 110.669 -171.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -93.19 149.78 20.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.853 1.661 . . . . 1.5 113.412 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -160.47 115.27 2.22 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.989 0.916 . . . . 5.6299999999999999 111.88 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.5 t30 147.79 -46.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 131.658 3.983 . . . . 3.2200000000000002 110.829 166.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.1 179.78 42.74 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 121.084 -1.01 . . . . 2.54 114.884 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -85.34 132.59 34.22 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.213 1.005 . . . . 2.6099999999999999 112.276 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.86 163.56 24.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.838 1.655 . . . . 2.9500000000000002 112.304 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.1 mt -118.46 127.29 53.51 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.209 1.004 . . . . 3.6200000000000001 112.011 172.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.95 126.99 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.11 1.364 . . . . 2.21 110.893 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 44.2 t -83.09 125.46 31.51 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.094 0.558 . . . . 4.1500000000000004 110.307 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.24 104.12 14.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.188 0.995 . . . . 1.3500000000000001 109.754 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.8 p -94.22 -3.81 50.1 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.558 1.143 . . . . 3.6800000000000002 112.13 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -136.47 136.9 39.84 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.474 1.91 . . . . 2.6299999999999999 109.856 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 p -88.69 170.08 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.573 1.149 . . . . 3.96 110.474 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.17 -35.68 85.36 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.31 -1.494 . . . . 1.8999999999999999 114.875 -171.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.79 -31.84 73.15 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.947 1.374 . . . . 2.9100000000000001 113.227 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.16 -5.92 44.67 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.118 1.367 . . . . 3.75 113.738 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.0 p -80.71 147.16 30.72 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.529 -1.357 . . . . 2.8900000000000001 112.77 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -70.67 -23.37 62.49 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.295 1.22 . . . . 3.2400000000000002 114.295 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 mp -59.37 -58.14 9.91 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 119.809 -1.807 . . . . 2.2200000000000002 115.762 -167.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.7 m -73.18 -15.22 61.46 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.859 0.754 . . . . 4.04 112.7 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.5 -42.92 64.31 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.001 0.92 . . . . 2.6600000000000001 111.461 172.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 54.9 mt -57.63 -45.76 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.067 1.347 . . . . 2.6400000000000001 112.499 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.73 -18.7 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 114.514 1.301 . . . . 2.3799999999999999 114.514 -172.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -73.34 -31.26 63.87 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.372 -0.83 . . . . 3.77 112.428 173.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -56.11 5.02 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.072 1.749 . . . . 4.4400000000000004 111.41 172.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.68 -27.24 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.614 0.766 . . . . 2.9300000000000002 112.466 -170.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.12 -30.16 71.24 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.173 -0.954 . . . . 3.8300000000000001 112.888 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.32 -19.27 58.39 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.241 -1.537 . . . . 6.04 112.722 174.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.21 -30.13 57.85 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.631 1.345 . . . . 5.5300000000000002 114.631 -169.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 124.921 1.288 . . . . 6.4400000000000004 111.371 175.055 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 112.84 0.682 . . . . 2.9199999999999999 112.84 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -73.49 -36.08 65.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.97 0.908 . . . . 5.25 111.103 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.17 -21.2 63.08 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.606 -1.309 . . . . 3.4900000000000002 113.496 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.9 tp -64.49 -31.95 73.38 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.03 0.932 . . . . 2.7999999999999998 111.134 171.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.19 -17.3 61.94 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.122 -0.986 . . . . 2.0800000000000001 113.532 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -67.39 -28.52 68.0 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.755 0.822 . . . . 3.6000000000000001 112.207 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.8 -38.9 83.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.838 0.855 . . . . 2.0 111.319 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.3 mm -70.14 -41.28 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.275 0.63 . . . . 3.1299999999999999 110.954 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 m -67.44 -24.74 65.67 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.024 0.93 . . . . 1.46 113.256 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.5 mt -73.32 -27.8 61.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.979 1.712 . . . . 2.6899999999999999 113.889 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -64.45 140.44 58.87 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.877 0.762 . . . . 3.2999999999999998 111.003 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.51 165.26 18.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.562 1.145 . . . . 2.8599999999999999 113.475 -172.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.1 m -121.11 -29.31 4.57 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.108 1.363 . . . . 2.8199999999999998 112.411 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.21 150.05 43.68 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.227 1.411 . . . . 2.9500000000000002 112.728 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.86 145.95 38.72 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.866 1.267 . . . . 1.9399999999999999 112.507 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.5 m -98.54 100.92 12.21 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.638 1.175 . . . . 2.1000000000000001 112.323 -174.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 35.1 mt -76.72 139.58 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.83 -0.804 . . . . 2.54 108.83 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.42 125.58 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.712 0.768 . . . . 3.3500000000000001 112.254 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.0 m -140.19 141.72 35.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.844 1.658 . . . . 3.02 111.323 -167.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -93.3 112.94 25.0 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.994 0.917 . . . . 6.21 109.034 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.99 -3.64 48.09 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.768 1.025 . . . . 5.1299999999999999 113.768 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.6 m -161.1 146.37 14.1 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 129.843 3.257 . . . . 5.0199999999999996 111.178 168.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' ILE . 24.2 t70 -23.88 61.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 1 C-N-CA 133.568 4.747 . . . . 6.0 118.622 -169.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 63.74 -26.64 0.08 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.083 2.153 . . . . 6.5999999999999996 114.456 -166.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 23' ' ' ASP . 33.0 pt -62.2 -13.36 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 128.639 2.776 . . . . 5.9500000000000002 115.391 175.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.2 tp -131.02 56.33 1.8 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.209 1.404 . . . . 4.46 110.841 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -65.44 116.14 6.42 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.098 -1.41 . . . . 3.8100000000000001 109.0 167.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.1 p -135.92 152.27 50.83 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.884 1.274 . . . . 3.6099999999999999 110.985 -168.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.67 149.07 40.38 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.969 0.908 . . . . 3.25 111.487 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -139.64 113.56 8.75 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.661 1.184 . . . . 2.5600000000000001 111.588 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -79.83 115.61 19.52 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.918 -1.114 . . . . 2.8300000000000001 109.303 167.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.78 166.08 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.239 1.416 . . . . 1.47 111.166 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -76.6 142.0 40.88 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.921 -0.487 . . . . 3.9500000000000002 110.342 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.41 -23.57 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.289 1.218 . . . . 2.7200000000000002 114.289 -171.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -60.68 -27.43 67.85 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.88 1.272 . . . . 4.4400000000000004 113.206 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.2 mt -101.57 -7.63 22.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.9 2.08 . . . . 2.6099999999999999 115.816 -167.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.74 144.71 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.151 0.887 . . . . 2.0899999999999999 111.151 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -121.33 154.78 35.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.204 1.802 . . . . 4.1299999999999999 112.881 -170.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -77.64 23.8 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 117.215 2.302 . . . . 4.0099999999999998 117.215 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.78 6.81 12.28 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.682 1.611 . . . . 1.8600000000000001 115.564 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -124.01 173.31 8.33 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.75 1.775 . . . . 3.5600000000000001 115.256 -168.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.4 mt -113.84 126.31 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.057 1.743 . . . . 3.1499999999999999 110.491 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.3 mm -116.08 124.14 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.495 1.918 . . . . 2.0899999999999999 110.109 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -87.07 141.36 28.72 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.737 1.215 . . . . 3.02 111.676 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -116.59 137.09 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.489 0.716 . . . . 1.24 112.287 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.13 159.25 54.33 Favored Pre-proline 0 N--CA 1.481 1.075 0 C-N-CA 124.387 1.075 . . . . 2.6000000000000001 113.234 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -60.95 136.94 68.91 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.888 1.726 . . . . 2.5299999999999998 109.772 167.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.27 26.37 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 115.429 0.932 . . . . 1.02 115.429 -171.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.66 -177.17 41.19 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 119.062 1.431 . . . . 1.0800000000000001 115.31 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -123.67 154.74 38.95 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.093 1.357 . . . . 2.9399999999999999 112.043 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -88.69 122.12 69.47 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 118.608 -0.71 . . . . 2.9500000000000002 110.34 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.18 -19.54 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.565 2.176 . . . . 0.76000000000000001 115.426 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.48 164.89 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 127.987 2.515 . . . . 1.8700000000000001 108.051 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -81.14 149.23 29.23 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.039 0.923 . . . . 2.3599999999999999 113.286 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -167.07 38.73 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.785 -0.643 . . . . 1.0 113.906 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -114.96 132.6 56.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.742 0.817 . . . . 4.6299999999999999 112.504 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.0 t -79.02 131.58 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 127.078 2.151 . . . . 1.8300000000000001 107.636 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.06 31.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.039 0.836 . . . . 1.97 112.277 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -169.07 146.71 3.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.378 2.271 . . . . 3.2400000000000002 109.258 168.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.08 -179.55 32.51 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 118.847 0.749 . . . . 0.93999999999999995 114.842 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -143.53 32.4 1.31 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.445 1.646 . . . . 4.4699999999999998 115.445 -167.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.477 ' H ' HD21 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -83.36 165.84 18.94 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.361 1.615 . . . . 1.8100000000000001 115.361 -168.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.0 ttm -110.8 138.36 47.29 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.819 0.847 . . . . 1.6299999999999999 110.95 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.33 134.66 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.092 1.357 . . . . 1.04 112.805 -168.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -86.03 108.54 18.29 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.107 1.363 . . . . 2.5299999999999998 110.924 174.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.94 -10.79 17.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.0 1.32 . . . . 2.5099999999999998 113.89 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.5 p -43.23 -35.45 1.43 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 117.995 2.591 . . . . 2.6600000000000001 117.995 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -84.86 -27.45 26.69 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.62 1.1 . . . . 1.73 112.016 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mm -89.52 -55.55 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.944 0.898 . . . . 2.1899999999999999 110.922 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.0 p -85.79 -18.35 33.2 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.191 0.996 . . . . 2.2200000000000002 113.132 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.71 9.91 80.25 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.448 1.499 . . . . 1.8700000000000001 114.439 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.02 -177.59 0.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.365 1.466 . . . . 2.8300000000000001 112.512 171.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.69 -20.68 0.59 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.148 1.379 . . . . 2.7999999999999998 114.492 -176.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.9 mtp -119.2 140.47 28.97 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.7 1.2 . . . . 5.2300000000000004 111.354 172.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -59.28 144.93 99.22 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.556 2.837 . . . . 2.96 113.973 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 t -106.72 131.99 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 127.3 2.24 . . . . 1.54 111.982 -168.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.13 134.84 37.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.267 0.627 . . . . 1.8100000000000001 111.85 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -110.37 155.47 22.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.4 1.88 . . . . 1.1399999999999999 111.652 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -151.93 172.07 5.88 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 127.343 2.257 . . . . 2.9300000000000002 108.285 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -54.9 142.08 76.3 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 CA-C-N 122.149 1.803 . . . . 0.98999999999999999 112.279 171.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.63 13.33 82.62 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-O 117.7 -1.611 . . . . 1.0900000000000001 115.635 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -96.83 144.7 26.55 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.209 2.505 . . . . 2.0299999999999998 111.392 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.5 p -90.42 157.17 17.73 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 121.305 1.866 . . . . 1.78 112.933 172.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 m -140.34 156.85 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.457 1.903 . . . . 1.27 112.035 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -113.47 151.65 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 127.573 2.349 . . . . 2.25 111.636 173.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.34 155.86 23.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.29 0.636 . . . . 1.8700000000000001 112.369 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.69 0.12 53.15 Favored Glycine 0 CA--C 1.536 1.402 0 O-C-N 121.447 -0.783 . . . . 1.1499999999999999 114.974 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.9 p -78.22 153.51 31.87 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.557 1.179 . . . . 1.99 110.899 168.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mm -113.3 131.73 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.811 0.844 . . . . 2.1899999999999999 111.011 -171.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -94.27 148.32 22.32 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.696 1.598 . . . . 1.6799999999999999 112.653 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -96.95 -88.08 0.3 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.291 1.036 . . . . 3.4199999999999999 112.712 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.471 ' C ' ' HG ' ' A' ' 62' ' ' SER . 13.1 t-20 -154.17 146.92 24.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.628 2.771 . . . . 5.6500000000000004 107.865 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.64 23.97 2.7 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 120.602 1.546 . . . . 2.9900000000000002 115.158 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 t 18.19 97.94 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 130.169 3.388 . . . . 2.4500000000000002 116.837 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.477 HD21 ' H ' ' A' ' 62' ' ' SER . 54.9 mt -102.5 154.03 19.49 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.629 1.171 . . . . 1.98 112.948 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.2 mp -117.75 126.02 51.69 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.501 1.12 . . . . 3.3100000000000001 108.566 166.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.54 125.9 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.127 1.371 . . . . 2.3599999999999999 110.086 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.2 p -81.2 119.88 24.17 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.627 -0.67 . . . . 2.73 109.538 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.95 130.92 35.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.293 0.637 . . . . 1.3200000000000001 109.665 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.46 3.55 9.05 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.897 1.073 . . . . 3.9700000000000002 113.897 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -141.18 151.5 43.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.998 1.319 . . . . 2.4399999999999999 111.86 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -89.45 173.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.769 1.628 . . . . 2.7599999999999998 111.223 171.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.94 -36.41 87.76 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 121.061 -1.024 . . . . 1.78 114.843 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.39 -28.12 69.02 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.582 1.327 . . . . 2.4900000000000002 114.582 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.71 -13.02 60.03 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.962 1.467 . . . . 3.3500000000000001 114.962 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.1 p -66.45 132.92 49.35 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.215 -0.928 . . . . 2.4500000000000002 112.608 -168.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 t -63.24 -23.77 67.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.487 1.291 . . . . 3.1699999999999999 114.487 -167.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.7 -43.74 80.84 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.917 -1.114 . . . . 2.54 111.795 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.2 p -68.03 -28.5 67.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.158 0.983 . . . . 2.3999999999999999 112.712 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -75.27 -48.65 22.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.969 1.307 . . . . 1.6899999999999999 111.91 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 53.4 mt -53.62 -49.23 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.862 1.665 . . . . 2.3199999999999998 110.5 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.55 -20.08 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.876 1.435 . . . . 2.6499999999999999 114.876 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -74.86 -38.52 61.92 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.888 1.222 . . . . 3.6899999999999999 112.842 170.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.38 -52.71 8.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.198 2.199 . . . . 3.9199999999999999 112.656 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -71.32 -21.71 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.65 1.18 . . . . 3.1000000000000001 111.819 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.83 -34.13 71.2 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.419 -1.426 . . . . 5.3300000000000001 112.18 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.89 -17.51 59.76 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.974 0.91 . . . . 6.21 113.349 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.54 -26.4 50.97 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.7 1.37 . . . . 6.5999999999999996 114.7 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 127.033 2.133 . . . . 7.6699999999999999 113.685 179.664 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 111.481 0.178 . . . . 4.1600000000000001 111.481 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -76.69 -31.21 57.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.757 1.223 . . . . 4.29 111.699 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.26 61.96 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.277 -0.889 . . . . 2.3599999999999999 112.639 170.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.25 -40.73 86.86 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.636 1.174 . . . . 4.0899999999999999 111.205 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.32 -14.25 61.27 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.456 0.91 . . . . 2.23 113.456 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -67.3 -33.31 75.01 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.649 -1.282 . . . . 2.9500000000000002 111.505 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.91 -28.03 69.78 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.489 1.115 . . . . 2.0600000000000001 111.885 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.8 mm -74.11 -39.47 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.694 0.798 . . . . 2.5800000000000001 111.772 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -65.79 -31.52 72.54 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.803 -1.186 . . . . 2.54 112.288 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.7 mt -71.23 -11.55 60.99 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.488 1.915 . . . . 2.9300000000000002 113.685 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -87.03 158.34 19.25 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.762 1.225 . . . . 3.0299999999999998 112.873 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.13 161.3 14.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.499 1.519 . . . . 2.6499999999999999 114.326 -169.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p -90.98 -47.72 7.41 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.474 1.51 . . . . 3.2599999999999998 113.203 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -142.08 157.4 44.95 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.336 1.454 . . . . 4.1200000000000001 112.782 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.17 157.38 44.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.383 1.473 . . . . 2.2000000000000002 112.525 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.1 m -100.4 107.02 18.67 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.896 0.878 . . . . 1.6000000000000001 111.589 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.8 mt -78.84 142.26 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.684 1.193 . . . . 1.22 108.443 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.23 135.63 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.643 0.735 . . . . 3.3799999999999999 111.924 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.0 m -128.83 141.26 51.35 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.747 2.419 . . . . 2.3100000000000001 110.959 -169.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.6 mt -99.54 130.7 45.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.886 0.874 . . . . 3.3399999999999999 109.783 168.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.04 23.01 6.6 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.287 1.035 . . . . 3.3900000000000001 113.457 -169.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -151.1 -82.13 0.1 Allowed 'General case' 0 N--CA 1.484 1.233 0 O-C-N 119.733 -1.854 . . . . 3.7999999999999998 114.541 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -160.91 55.38 0.3 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.574 1.549 . . . . 5.29 108.941 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.67 -26.33 0.07 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.828 2.451 . . . . 5.3200000000000003 115.463 -169.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.7 pt -63.02 -5.56 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.422 1.889 . . . . 4.4100000000000001 115.717 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.24 126.37 26.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.367 1.467 . . . . 3.3100000000000001 111.62 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.6 mp -114.73 137.5 51.85 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.063 2.145 . . . . 3.6899999999999999 111.149 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.7 t -140.13 139.11 35.71 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.079 2.152 . . . . 1.8500000000000001 109.46 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -126.11 151.69 46.9 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.096 -1.002 . . . . 2.8399999999999999 112.183 -174.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -129.4 128.45 43.04 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.133 1.373 . . . . 2.7999999999999998 111.25 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -93.46 108.16 19.89 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.263 -0.898 . . . . 2.6800000000000002 109.571 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 m -118.95 154.55 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.179 0.992 . . . . 2.04 112.263 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -72.7 148.27 44.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.686 -0.486 . . . . 3.21 109.686 171.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.41 -17.86 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.387 1.625 . . . . 2.3399999999999999 115.387 -168.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -70.94 -20.65 62.44 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.41 -1.431 . . . . 4.2599999999999998 113.833 170.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.7 mt -98.35 -3.66 36.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.644 1.578 . . . . 1.77 114.078 -168.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -89.14 139.36 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.676 1.591 . . . . 2.1699999999999999 109.959 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -108.95 164.45 12.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.864 1.266 . . . . 4.0499999999999998 111.166 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -70.56 37.45 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.726 1.38 . . . . 3.6499999999999999 114.726 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.47 11.5 0.15 Allowed Glycine 0 CA--C 1.54 1.62 0 C-N-CA 127.824 2.63 . . . . 1.3799999999999999 114.395 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -97.3 165.4 12.05 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.829 1.815 . . . . 2.3300000000000001 112.505 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.7 mm -113.21 123.08 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.822 1.649 . . . . 2.8900000000000001 110.49 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.7 mm -116.24 128.52 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.011 1.324 . . . . 1.8500000000000001 112.174 -170.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -85.91 140.04 30.71 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.455 1.102 . . . . 2.7599999999999998 112.926 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.62 136.57 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.65 1.18 . . . . 1.3100000000000001 112.118 174.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.69 160.93 30.33 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.637 1.175 . . . . 1.8500000000000001 113.818 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.18 123.6 13.49 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.571 2.18 . . . . 1.8400000000000001 111.526 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.02 -2.36 87.7 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.619 2.057 . . . . 1.0800000000000001 115.242 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.84 171.71 54.62 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 119.246 1.523 . . . . 1.0800000000000001 114.049 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -111.24 152.44 27.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.047 1.339 . . . . 3.4700000000000002 112.235 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -76.66 131.94 73.02 Favored Pre-proline 0 CA--C 1.553 1.066 0 CA-C-O 118.629 -0.701 . . . . 3.8100000000000001 111.587 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -96.1 -17.13 0.35 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.264 2.642 . . . . 0.89000000000000001 115.787 -173.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.49 171.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 127.07 2.148 . . . . 1.78 108.976 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.6 137.38 40.9 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.935 0.789 . . . . 1.8999999999999999 112.652 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.13 -156.48 20.4 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 114.548 0.579 . . . . 0.96999999999999997 114.548 -171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.6 ttp85 -114.78 140.3 49.03 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.631 1.172 . . . . 4.9100000000000001 112.939 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.9 t -88.85 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.685 1.994 . . . . 1.8999999999999999 108.971 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.9 pt -140.92 33.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.84 0.829 . . . . 2.1699999999999999 112.376 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -166.12 137.23 3.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.22 1.808 . . . . 2.71 109.662 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.52 -176.1 51.11 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 123.691 0.662 . . . . 0.81999999999999995 114.74 171.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -156.8 92.27 1.27 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.06 0.944 . . . . 4.0300000000000002 112.13 -168.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.63 165.86 19.17 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.85 1.66 . . . . 1.8 112.675 -169.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.0 ttm -112.28 130.75 55.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.455 1.102 . . . . 2.0099999999999998 110.544 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.3 t -123.4 142.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.311 1.444 . . . . 1.1000000000000001 113.365 -167.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -104.03 107.72 18.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.835 1.254 . . . . 1.8600000000000001 112.288 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -103.01 27.21 7.32 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 126.09 1.756 . . . . 2.3799999999999999 114.109 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 p -51.53 -9.36 0.07 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 119.206 3.039 . . . . 2.4500000000000002 119.206 -169.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.36 -49.28 1.92 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.023 1.329 . . . . 2.6600000000000001 111.128 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.2 mm -67.04 -55.99 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 119.309 0.959 . . . . 1.78 111.917 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.8 p -95.59 -13.24 24.55 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.028 0.931 . . . . 2.3599999999999999 111.75 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.58 11.43 84.41 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.198 1.38 . . . . 1.45 115.569 169.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.54 -40.34 82.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.209 1.004 . . . . 2.46 113.235 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.04 43.78 8.64 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.35 1.46 . . . . 2.2999999999999998 112.246 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.0 ptm -161.98 159.4 21.88 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 128.979 2.912 . . . . 5.3399999999999999 109.602 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.82 139.25 17.48 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.577 2.185 . . . . 3.2400000000000002 112.534 172.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.49 139.09 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.871 1.669 . . . . 2.04 110.578 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.37 137.08 32.64 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.132 -0.98 . . . . 2.1099999999999999 112.499 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -117.36 157.2 26.57 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.659 1.584 . . . . 0.93999999999999995 111.027 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -160.1 172.99 5.27 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 127.536 2.335 . . . . 2.9900000000000002 110.511 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -53.57 135.2 60.93 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 CA-C-N 122.201 1.822 . . . . 1.3 111.656 167.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.31 38.87 44.95 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.356 0.503 . . . . 0.97999999999999998 113.284 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 t -125.52 139.29 53.74 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 118.088 0.944 . . . . 1.6899999999999999 111.396 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.6 p -91.05 145.02 25.04 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.902 1.228 . . . . 2.2200000000000002 112.475 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.2 m -135.88 156.45 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.63 1.572 . . . . 1.8999999999999999 112.095 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -130.01 144.02 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.487 1.515 . . . . 1.8300000000000001 112.984 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.92 147.44 50.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.757 0.823 . . . . 2.2000000000000002 112.912 -175.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.27 -6.64 63.11 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 115.245 0.858 . . . . 1.04 115.245 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.5 p -76.12 158.03 32.21 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.441 1.121 . . . . 1.5600000000000001 110.395 167.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -108.76 140.26 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.383 1.073 . . . . 2.04 110.996 -171.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -109.09 147.72 31.97 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.803 1.241 . . . . 1.6799999999999999 113.475 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -150.95 140.35 21.43 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.983 1.313 . . . . 4.0099999999999998 112.045 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 t30 43.85 88.09 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.219 2.608 . . . . 3.1499999999999999 113.708 168.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.47 -10.37 0.14 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 117.665 1.826 . . . . 3.75 117.665 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.3 m 45.31 85.48 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 127.732 2.413 . . . . 3.0499999999999998 115.946 169.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.2 mt -106.99 160.72 15.33 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.17 1.544 . . . . 1.9399999999999999 115.17 -169.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.0 135.55 51.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.332 1.053 . . . . 3.4199999999999999 110.604 165.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.56 129.72 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.257 1.823 . . . . 3.0800000000000001 110.396 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.3 p -83.1 119.27 24.29 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.484 -0.76 . . . . 2.5699999999999998 109.034 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.32 124.99 28.62 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.813 -0.554 . . . . 2.0099999999999998 110.244 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 p -118.16 -0.65 11.53 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.353 1.861 . . . . 2.77 112.884 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -142.97 136.23 28.29 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.842 2.057 . . . . 2.1499999999999999 110.054 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.38 162.93 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.404 -0.961 . . . . 2.3599999999999999 108.404 164.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.1 91.08 Favored Glycine 0 N--CA 1.479 1.562 0 O-C-N 120.4 -1.437 . . . . 1.3300000000000001 114.215 -169.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.94 -32.73 74.37 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.803 1.241 . . . . 2.2000000000000002 113.997 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -79.41 -9.76 59.66 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.962 2.105 . . . . 2.2799999999999998 115.142 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.0 p -70.1 154.69 41.62 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.067 -1.646 . . . . 2.4399999999999999 112.93 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.8 t -57.7 -30.25 65.35 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.387 -0.821 . . . . 2.5800000000000001 112.889 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.03 -49.88 75.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.931 -1.106 . . . . 2.1299999999999999 112.044 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.3 m -64.24 -34.11 77.35 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.11 0.964 . . . . 2.1899999999999999 110.922 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.19 -40.48 82.18 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.923 -0.486 . . . . 1.8999999999999999 111.882 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.0 mt -58.32 -54.69 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.478 1.111 . . . . 1.8899999999999999 110.604 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.11 -22.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.178 1.177 . . . . 2.1699999999999999 114.178 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -71.68 -46.4 58.98 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.842 0.857 . . . . 3.23 112.116 172.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.72 -43.73 65.39 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.786 0.834 . . . . 3.2799999999999998 112.217 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.42 -17.87 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 120.557 -1.34 . . . . 3.6499999999999999 113.53 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -67.97 -28.75 67.72 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.854 1.262 . . . . 4.0499999999999998 112.012 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -70.38 -19.81 62.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.518 1.127 . . . . 3.6400000000000001 113.471 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.98 -58.97 2.93 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.171 1.388 . . . . 4.3099999999999996 111.821 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 125.438 1.495 . . . . 4.3799999999999999 113.453 179.666 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.5 p . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 114.007 1.114 . . . . 6.0300000000000002 114.007 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -99.51 -10.44 22.12 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.298 1.039 . . . . 5.3899999999999997 113.052 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.4 -38.07 35.71 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.628 1.344 . . . . 2.6800000000000002 114.628 169.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.79 -46.28 70.98 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 117.22 2.304 . . . . 3.0699999999999998 117.22 -165.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.37 -31.81 60.62 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.721 1.146 . . . . 2.1899999999999999 113.06 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -69.0 -31.78 70.86 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.966 1.706 . . . . 3.5499999999999998 113.333 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.97 -41.77 71.57 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.295 0.952 . . . . 2.1899999999999999 111.998 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.37 -38.06 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 122.942 0.497 . . . . 3.0899999999999999 111.285 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.8 m -66.89 -24.16 66.08 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.604 -1.31 . . . . 1.8 113.639 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.02 -15.53 62.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.258 1.423 . . . . 3.4399999999999999 113.453 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -72.55 118.9 16.03 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.167 0.894 . . . . 3.8799999999999999 109.506 172.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.25 177.98 2.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.278 1.831 . . . . 3.27 115.445 -168.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.2 m -112.59 -39.37 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.967 1.707 . . . . 3.5499999999999998 113.006 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -141.18 157.14 45.67 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.49 1.293 . . . . 2.8999999999999999 114.49 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.08 170.98 14.7 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.691 1.597 . . . . 1.5900000000000001 112.822 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.7 m -131.08 112.94 13.33 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.287 1.435 . . . . 2.21 111.654 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.8 mt -85.16 142.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.317 1.447 . . . . 1.78 109.632 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -102.05 121.62 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 121.18 0.514 . . . . 3.04 111.254 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.4 m -121.93 144.34 48.92 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.252 1.421 . . . . 2.6299999999999999 110.078 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.7 mt -109.88 150.57 28.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.122 1.369 . . . . 3.3399999999999999 112.828 -168.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.53 -22.34 0.81 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 116.184 1.92 . . . . 4.3799999999999999 116.184 -174.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.3 m -109.93 3.76 20.84 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.847 1.203 . . . . 4.6900000000000004 113.994 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t0 88.94 78.46 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 129.841 3.256 . . . . 5.2300000000000004 111.704 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.317 14.6 p30 54.98 -6.12 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.979 2.912 . . . . 5.04 118.24 -169.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.0 pt -91.27 -8.1 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 115.796 1.776 . . . . 5.8399999999999999 115.796 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 tt -129.6 137.43 50.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.738 1.215 . . . . 4.3799999999999999 111.046 169.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.41 136.94 52.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.814 1.646 . . . . 3.2799999999999998 111.596 174.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -135.52 111.29 9.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.94 1.696 . . . . 2.2799999999999998 108.104 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.04 143.84 26.28 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.905 1.076 . . . . 2.5099999999999998 113.905 -169.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -113.69 126.11 54.89 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.862 1.665 . . . . 3.8500000000000001 110.141 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -98.98 122.32 42.08 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.558 1.072 . . . . 2.8300000000000001 111.535 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.19 158.0 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.931 1.085 . . . . 1.53 113.931 -168.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -78.36 145.1 35.42 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.711 -0.848 . . . . 3.5499999999999998 108.711 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 p -62.42 -18.48 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 114.386 1.254 . . . . 2.4300000000000002 114.386 -168.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -61.42 -27.67 68.71 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.589 -1.319 . . . . 3.6099999999999999 113.309 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.3 mt -93.17 -5.72 49.47 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.283 1.833 . . . . 1.99 115.008 -169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.76 140.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.831 1.652 . . . . 1.8700000000000001 109.663 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -114.98 160.47 19.53 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.394 1.478 . . . . 3.0 111.968 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -67.43 137.57 56.0 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.349 -0.982 . . . . 3.8500000000000001 108.349 167.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.69 -4.35 56.4 Favored Glycine 0 CA--C 1.543 1.803 0 C-N-CA 124.339 0.971 . . . . 2.77 114.115 -168.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -93.43 158.65 15.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.168 1.387 . . . . 2.4900000000000002 112.527 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.97 120.12 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.868 1.267 . . . . 2.7200000000000002 110.229 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 mm -122.1 132.54 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.882 1.673 . . . . 1.97 111.47 -168.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.22 130.0 34.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.623 0.769 . . . . 2.6200000000000001 112.654 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.8 p -116.33 132.99 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.106 1.362 . . . . 1.3500000000000001 111.282 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.94 161.86 42.83 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 125.479 1.511 . . . . 1.8 113.318 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.74 139.81 70.99 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.691 1.594 . . . . 1.6599999999999999 109.997 166.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.85 -14.72 41.29 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 126.164 1.84 . . . . 1.21 115.366 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.82 159.86 44.37 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.546 1.673 . . . . 1.0900000000000001 114.878 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -92.68 139.65 30.35 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.978 1.311 . . . . 4.96 111.502 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.34 130.13 94.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.396 -0.812 . . . . 3.9100000000000001 111.371 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -89.8 -13.42 2.67 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.706 2.271 . . . . 0.97999999999999998 114.908 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.11 175.2 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 127.503 2.321 . . . . 2.1299999999999999 109.903 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.255 1.2 p30 -111.55 147.23 35.85 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.159 0.8 . . . . 1.8700000000000001 113.159 172.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.25 -159.37 32.5 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 115.002 0.761 . . . . 0.68000000000000005 115.002 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 ttp-105 -111.43 140.62 45.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.229 1.412 . . . . 5.0899999999999999 112.564 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.91 128.4 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 127.436 2.294 . . . . 1.8899999999999999 108.377 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.76 32.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.234 0.827 . . . . 1.74 113.234 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -168.03 134.01 1.96 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.655 1.582 . . . . 3.3999999999999999 108.51 167.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.78 178.96 52.58 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 122.086 0.826 . . . . 0.81000000000000005 114.623 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -148.72 124.38 10.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.605 0.762 . . . . 3.2200000000000002 112.78 -172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -145.45 169.49 18.24 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.292 1.437 . . . . 1.6599999999999999 113.499 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.3 ttm -110.79 132.28 54.34 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.266 1.427 . . . . 1.5700000000000001 110.454 174.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -118.98 140.22 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.979 1.311 . . . . 1.1899999999999999 111.968 -169.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -107.19 92.89 4.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.498 1.119 . . . . 2.1299999999999999 111.068 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -87.2 22.62 2.04 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.418 1.887 . . . . 1.8799999999999999 113.999 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.9 p -55.49 -8.76 0.39 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 118.973 2.953 . . . . 2.23 118.973 -169.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -126.24 -38.12 2.17 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.916 1.686 . . . . 2.3500000000000001 111.501 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.6 mm -76.84 -61.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.211 0.604 . . . . 2.48 111.191 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.3 p -98.58 -12.97 20.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.938 0.895 . . . . 2.5099999999999998 112.616 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.04 87.29 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.329 1.442 . . . . 1.47 115.971 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -56.1 -45.15 79.52 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.34 1.056 . . . . 3.4300000000000002 111.68 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 69.81 -14.67 0.35 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.559 2.744 . . . . 3.1499999999999999 114.764 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 58.3 ttm -87.87 149.28 45.43 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.292 1.837 . . . . 3.79 110.089 168.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.09 133.83 34.61 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.324 2.683 . . . . 2.1200000000000001 112.606 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.04 135.2 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.987 1.715 . . . . 1.97 111.863 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.39 135.3 36.66 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.034 0.934 . . . . 2.5 113.494 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -128.53 144.71 51.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.016 1.726 . . . . 1.02 111.358 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -146.55 174.74 3.16 Favored Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 128.929 2.892 . . . . 3.6499999999999999 109.072 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.66 132.88 45.17 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 122.105 1.787 . . . . 0.92000000000000004 110.526 169.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.45 33.68 21.9 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.012 1.291 . . . . 0.75 114.248 -169.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 57.2 m -123.41 152.42 41.6 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.883 1.273 . . . . 2.0800000000000001 111.258 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.9 p -102.37 152.15 21.43 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.983 1.265 . . . . 2.0099999999999998 113.959 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.08 161.65 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.472 1.909 . . . . 1.8300000000000001 112.292 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.89 149.9 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.585 1.954 . . . . 1.8999999999999999 112.542 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.88 154.39 30.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.8 1.24 . . . . 1.76 114.191 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.6 -11.26 14.22 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.879 1.228 . . . . 0.80000000000000004 115.43 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 m -81.8 160.2 23.6 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.426 1.09 . . . . 2.75 111.047 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.03 145.37 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.114 0.966 . . . . 2.4199999999999999 111.655 -171.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -107.99 139.68 42.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.855 2.062 . . . . 1.8200000000000001 111.228 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -152.08 145.24 24.61 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.715 -1.241 . . . . 4.5099999999999998 112.049 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 53.2 t30 122.53 -55.81 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.099 1 C-N-CA 132.004 4.122 . . . . 3.54 111.228 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.74 175.24 41.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.568 1.08 . . . . 2.1000000000000001 114.891 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.5 m -77.71 137.97 38.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.847 1.259 . . . . 2.25 112.193 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.8 mt -127.08 162.55 25.79 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.594 1.158 . . . . 2.04 112.111 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.6 127.46 54.53 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.653 0.781 . . . . 3.6000000000000001 110.343 168.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 mm -114.05 124.51 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 125.468 1.507 . . . . 2.8599999999999999 109.981 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.1 p -91.38 121.57 33.22 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.844 0.747 . . . . 2.3100000000000001 109.412 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.25 138.02 37.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.344 0.658 . . . . 1.29 111.819 -173.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -112.35 -12.3 13.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.062 0.945 . . . . 3.1600000000000001 112.919 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -142.64 141.65 31.93 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.196 1.399 . . . . 1.8300000000000001 110.948 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.89 161.84 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.494 1.117 . . . . 2.8700000000000001 111.443 170.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.9 -35.96 91.48 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.4 -0.813 . . . . 2.3599999999999999 113.899 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.74 84.34 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.149 0.974 . . . . 3.6000000000000001 111.661 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.3 -4.69 31.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.389 1.625 . . . . 3.4900000000000002 115.389 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.4 p -59.79 147.94 36.25 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.923 1.238 . . . . 2.6800000000000002 111.704 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.7 t -57.67 -19.8 29.25 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.203 1.186 . . . . 2.6499999999999999 114.203 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -48.55 -46.08 38.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.591 1.556 . . . . 2.4399999999999999 112.438 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.6 p -69.11 -29.08 67.08 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.281 1.033 . . . . 2.4399999999999999 112.839 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -74.64 -42.5 58.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.724 1.21 . . . . 1.49 111.917 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 69.1 mt -54.72 -46.19 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.69 1.196 . . . . 2.2599999999999998 110.861 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m -70.03 -20.89 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.606 -1.309 . . . . 1.9399999999999999 114.176 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -75.2 -29.1 60.24 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.13 0.972 . . . . 3.4100000000000001 113.235 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.0 mt -73.74 -58.32 3.38 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.921 1.288 . . . . 3.6200000000000001 111.479 168.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 85.4 t -65.73 -22.08 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.862 0.865 . . . . 2.4900000000000002 112.775 -169.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.8 -33.97 75.84 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.041 -1.662 . . . . 3.4500000000000002 112.912 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.87 -14.31 60.28 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.36 -1.462 . . . . 5.7400000000000002 113.376 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.02 -36.65 64.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.152 0.981 . . . . 5.6500000000000004 112.778 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 124.746 1.218 . . . . 6.0199999999999996 110.776 169.189 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.481 0.549 . . . . 3.1600000000000001 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -70.97 -43.4 68.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.376 0.67 . . . . 4.4199999999999999 109.723 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.65 74.37 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.723 1.209 . . . . 2.0299999999999998 112.454 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.81 -33.06 73.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.706 0.803 . . . . 2.3399999999999999 111.673 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.39 -48.02 21.28 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.701 0.682 . . . . 2.1299999999999999 111.245 168.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.32 -40.13 61.49 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.745 2.018 . . . . 3.4700000000000002 113.983 -174.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -43.42 -51.91 6.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.7 1.2 . . . . 2.1000000000000001 111.695 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.2 mm -72.69 -28.02 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.498 1.119 . . . . 3.5600000000000001 113.125 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -74.0 -24.02 59.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.405 1.082 . . . . 1.3300000000000001 112.894 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.47 -16.9 61.97 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.636 0.976 . . . . 2.79 113.636 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.4 154.43 42.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.501 1.143 . . . . 2.8799999999999999 113.466 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.58 160.79 26.3 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.638 -1.165 . . . . 2.6600000000000001 110.855 168.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.6 m -108.65 -6.43 15.99 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.507 1.523 . . . . 2.7599999999999998 112.272 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.21 159.51 41.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.199 1.8 . . . . 3.3700000000000001 113.012 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.19 156.65 44.4 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.209 1.404 . . . . 1.3600000000000001 113.092 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -109.66 108.61 19.07 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 113.279 0.844 . . . . 1.8700000000000001 113.279 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.9 mt -86.82 125.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.894 1.278 . . . . 1.3799999999999999 110.064 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.04 125.3 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 119.571 1.078 . . . . 2.9399999999999999 112.539 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 m -142.26 149.21 39.28 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.893 1.277 . . . . 3.7799999999999998 113.647 -172.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.69 148.67 49.83 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.729 1.611 . . . . 3.6400000000000001 112.792 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -147.44 16.75 1.16 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.071 1.508 . . . . 6.0999999999999996 115.071 -173.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 m -130.11 -120.61 0.22 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.322 1.449 . . . . 3.9100000000000001 109.135 -175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -117.8 60.1 0.78 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.245 1.818 . . . . 7.7699999999999996 109.266 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t30 66.72 -39.55 0.35 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 128.734 2.814 . . . . 7.1200000000000001 114.865 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.6 pt -45.85 -30.33 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 127.862 2.465 . . . . 5.9699999999999998 117.143 -174.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.02 -39.71 79.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.054 1.341 . . . . 4.6100000000000003 113.509 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.7 tp 12.46 63.43 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 129.379 3.072 . . . . 3.7599999999999998 114.245 -173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 m -77.64 136.02 38.18 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.943 1.297 . . . . 2.6299999999999999 111.394 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -122.39 127.27 49.51 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.065 0.946 . . . . 2.4100000000000001 110.241 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -114.45 119.86 38.34 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.959 1.303 . . . . 4.21 108.891 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -93.97 124.0 37.69 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.582 -0.896 . . . . 2.0600000000000001 108.582 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 m -137.63 170.71 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.734 1.214 . . . . 1.9399999999999999 112.265 -169.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.17 147.35 36.54 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.769 0.828 . . . . 3.3999999999999999 110.601 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.88 -17.67 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 113.734 1.013 . . . . 1.8799999999999999 113.734 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.52 -17.62 26.72 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 120.351 -1.468 . . . . 4.6799999999999997 113.511 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.62 -16.68 28.24 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.246 1.419 . . . . 2.46 113.441 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -76.53 147.54 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.289 -0.882 . . . . 1.6599999999999999 110.065 169.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -121.81 162.41 20.95 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.324 1.45 . . . . 3.21 111.852 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.4 ptt-85 -72.84 139.2 46.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.576 -0.738 . . . . 6.2800000000000002 109.931 170.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.54 -3.43 10.23 Favored Glycine 0 CA--C 1.541 1.713 0 N-CA-C 115.666 1.027 . . . . 1.8100000000000001 115.666 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -119.25 -174.42 2.72 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.592 1.696 . . . . 3.4199999999999999 112.979 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.68 130.25 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.894 1.678 . . . . 2.7599999999999998 109.933 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -115.89 129.35 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.738 2.015 . . . . 1.97 110.144 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -92.15 133.95 35.31 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 121.627 -0.671 . . . . 3.3900000000000001 112.611 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.02 133.39 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.049 1.34 . . . . 1.3700000000000001 111.44 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 m -100.67 162.2 21.47 Favored Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 124.414 1.086 . . . . 2.0499999999999998 113.095 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.25 137.61 71.13 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.064 2.51 . . . . 1.75 112.472 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.14 -7.37 4.56 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.569 0.987 . . . . 1.03 115.569 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.12 160.88 50.31 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.193 1.497 . . . . 0.93999999999999995 113.542 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -99.14 152.09 20.26 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.704 1.202 . . . . 2.73 112.146 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -81.04 125.03 80.73 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.021 0.929 . . . . 2.9900000000000002 110.823 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.35 -20.8 2.59 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.987 2.458 . . . . 0.79000000000000004 115.496 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 m -151.17 168.78 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 127.921 2.488 . . . . 1.97 108.834 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -89.32 148.03 23.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.122 0.874 . . . . 2.1899999999999999 111.793 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.8 -149.42 10.0 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 114.416 0.526 . . . . 1.01 114.416 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.3 ttm105 -132.26 144.5 50.65 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.711 1.205 . . . . 5.8300000000000001 113.058 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.93 132.77 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.185 2.194 . . . . 2.23 109.78 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.7 pt -140.67 30.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.144 1.165 . . . . 1.9399999999999999 114.144 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -168.51 140.3 2.75 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.488 -1.383 . . . . 3.3799999999999999 110.048 168.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.15 -165.12 32.66 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.604 1.097 . . . . 0.98999999999999999 114.641 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -150.27 123.22 8.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.383 1.473 . . . . 2.7599999999999998 111.423 -175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.06 171.89 15.13 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.18 1.178 . . . . 1.6200000000000001 114.18 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.0 ttm -121.05 132.93 55.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.207 1.403 . . . . 1.8100000000000001 109.643 172.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.86 134.81 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.903 1.281 . . . . 0.98999999999999999 112.0 -168.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -94.98 113.4 25.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.465 1.906 . . . . 2.1600000000000001 110.642 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -114.72 22.76 13.25 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.621 1.568 . . . . 2.2200000000000002 112.964 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.7 p -57.06 -22.92 42.9 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 118.176 2.658 . . . . 2.46 118.176 -167.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -105.04 -31.03 9.38 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.516 1.527 . . . . 1.9299999999999999 111.415 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.0 mm -74.36 -67.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.534 1.134 . . . . 2.2000000000000002 110.919 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.1 p -99.13 -4.85 31.28 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.444 1.497 . . . . 2.2400000000000002 112.306 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.13 2.79 85.56 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.801 1.191 . . . . 2.0899999999999999 114.757 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -73.81 108.23 6.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.412 1.085 . . . . 3.6099999999999999 112.263 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.94 -16.49 56.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.47 1.108 . . . . 3.2599999999999998 112.963 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.4 ttp -109.85 121.08 43.03 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.675 1.59 . . . . 4.2000000000000002 108.052 169.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.82 165.66 28.99 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.604 2.869 . . . . 2.0600000000000001 114.275 -168.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.14 130.45 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.545 1.538 . . . . 2.2799999999999998 111.02 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.58 137.4 38.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.08 0.552 . . . . 1.73 111.66 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.18 147.26 46.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.807 1.643 . . . . 1.05 110.404 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -145.63 171.65 6.26 Favored Pre-proline 0 N--CA 1.48 1.048 0 C-N-CA 127.639 2.376 . . . . 3.4900000000000002 110.248 -171.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.14 127.15 23.82 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.973 1.74 . . . . 1.21 111.556 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.01 35.29 18.88 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.539 1.066 . . . . 0.93999999999999995 113.902 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.9 t -118.47 154.7 32.07 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.427 1.613 . . . . 1.95 112.252 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -107.1 144.03 34.39 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.657 1.183 . . . . 2.1099999999999999 112.536 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 m -138.72 153.71 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.187 0.995 . . . . 1.48 113.555 -172.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -118.37 146.25 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.001 1.32 . . . . 2.3100000000000001 114.031 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.1 143.82 31.47 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.207 1.403 . . . . 1.9199999999999999 112.154 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.62 -4.04 66.21 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.845 1.098 . . . . 0.68000000000000005 115.845 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.4 p -74.25 159.38 32.56 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.074 1.437 . . . . 1.6299999999999999 111.758 169.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.58 140.58 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.397 1.079 . . . . 2.0 111.507 -173.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -81.86 139.29 34.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.502 1.121 . . . . 2.6800000000000002 111.475 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -146.35 56.88 1.18 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.5 1.296 . . . . 3.2200000000000002 114.5 168.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -160.03 -59.36 0.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.374 1.25 . . . . 3.3999999999999999 114.374 167.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -164.21 168.96 38.87 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.701 1.143 . . . . 2.0800000000000001 113.497 -168.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.8 p -84.15 148.18 26.91 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.789 1.033 . . . . 2.75 113.789 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -137.5 161.3 36.76 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.993 1.717 . . . . 2.3500000000000001 111.629 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.7 mp -108.42 119.86 40.74 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.075 1.35 . . . . 3.1699999999999999 110.348 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.9 mt -107.13 119.74 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.267 1.427 . . . . 3.5899999999999999 110.153 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.6 p -79.97 117.11 20.52 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.856 -1.153 . . . . 2.4500000000000002 110.248 170.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.63 121.83 28.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.616 0.722 . . . . 1.3200000000000001 112.701 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -115.31 -9.77 12.14 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.558 1.543 . . . . 2.6499999999999999 113.471 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -138.26 146.0 41.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.5 1.52 . . . . 2.0699999999999998 111.474 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 m -100.4 160.75 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.47 1.508 . . . . 2.4900000000000002 110.1 167.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.96 -39.13 56.33 Favored Glycine 0 N--CA 1.472 1.074 0 N-CA-C 116.556 1.382 . . . . 1.3600000000000001 116.556 -166.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.22 -36.37 71.83 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.654 1.227 . . . . 2.3599999999999999 113.346 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.66 -9.06 58.26 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.322 1.23 . . . . 2.3300000000000001 114.322 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.8 p -58.8 152.64 18.64 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.158 -0.964 . . . . 2.2400000000000002 113.148 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 t -56.82 -39.22 73.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.756 1.222 . . . . 2.8199999999999998 110.567 169.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.39 -43.36 99.01 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.014 1.726 . . . . 2.21 112.362 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.7 t -67.4 -35.14 78.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.498 0.719 . . . . 2.9900000000000002 111.839 176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.29 -43.37 70.53 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.364 0.529 . . . . 1.76 111.739 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.6 mt -54.06 -51.4 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.143 0.977 . . . . 2.9500000000000002 111.589 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.8 m -66.45 -32.14 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 120.99 -1.069 . . . . 1.5900000000000001 113.04 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -73.61 -27.09 61.1 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.413 1.085 . . . . 3.5699999999999998 112.633 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.6 mt -70.41 -53.23 17.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.722 1.209 . . . . 4.2800000000000002 110.654 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.23 -50.38 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.76 0.824 . . . . 2.5099999999999998 111.777 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -54.47 -41.14 69.15 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.754 1.02 . . . . 3.79 113.754 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.33 -30.91 54.19 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.731 1.012 . . . . 4.0300000000000002 113.731 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.27 -25.03 62.28 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 115.284 1.587 . . . . 4.5499999999999998 115.284 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.777 1.631 . . . . 4.8899999999999997 111.865 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 114.337 1.236 . . . . 2.8999999999999999 114.337 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.99 -43.58 24.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.771 0.714 . . . . 5.5 109.947 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.98 -42.9 81.07 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.753 -0.592 . . . . 2.4700000000000002 111.797 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.39 -33.29 65.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.9 0.88 . . . . 3.71 113.25 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.36 -44.65 35.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.791 0.723 . . . . 2.3799999999999999 112.581 169.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -64.15 -34.13 77.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.317 0.858 . . . . 3.3500000000000001 113.317 -174.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.23 -36.38 73.1 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.497 1.044 . . . . 2.2599999999999998 113.047 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.0 mm -67.01 -37.24 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 118.764 0.711 . . . . 3.25 111.304 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.0 m -72.9 -23.81 60.76 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.387 -0.821 . . . . 2.1600000000000001 112.754 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.7 mt -72.38 -25.6 61.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.909 1.284 . . . . 2.8999999999999999 112.905 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -68.49 106.09 2.43 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.721 1.146 . . . . 3.4399999999999999 110.76 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 155.31 28.23 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.173 1.389 . . . . 2.3599999999999999 113.467 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.7 m -95.78 -31.14 13.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.388 1.475 . . . . 2.9900000000000002 114.281 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.35 159.83 41.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.184 0.994 . . . . 2.8500000000000001 113.33 -169.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.45 163.49 32.96 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.567 1.547 . . . . 1.5 112.776 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.5 m -119.65 97.52 5.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.559 1.544 . . . . 1.5800000000000001 110.704 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.2 mt -84.89 133.92 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.369 1.068 . . . . 1.48 110.008 -172.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -107.81 127.34 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.506 1.122 . . . . 2.75 111.111 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.6 m -121.8 146.22 47.28 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.4 1.48 . . . . 2.5499999999999998 111.388 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.5 mt -77.11 113.75 15.17 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.718 0.807 . . . . 4.1600000000000001 110.625 171.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -99.23 -5.83 29.18 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.349 1.24 . . . . 5.4000000000000004 114.349 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 m -133.3 -58.7 0.89 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.499 1.52 . . . . 3.8900000000000001 110.755 169.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -163.1 -158.7 0.49 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.958 2.903 . . . . 4.6799999999999997 104.728 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -61.26 -1.3 0.47 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.353 1.861 . . . . 6.3600000000000003 114.588 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.4 pt -91.84 -16.59 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 128.433 2.693 . . . . 4.5599999999999996 113.747 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -135.34 123.48 22.94 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.736 1.214 . . . . 5.0700000000000003 111.711 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.97 132.23 56.04 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.621 1.568 . . . . 3.9700000000000002 111.015 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -142.2 145.66 34.37 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.179 1.392 . . . . 2.6400000000000001 110.959 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -118.48 149.06 41.92 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.495 1.665 . . . . 2.5099999999999998 115.495 -168.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -104.07 139.0 39.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.577 1.951 . . . . 2.9199999999999999 109.65 169.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -98.73 121.23 40.41 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.043 0.937 . . . . 2.4900000000000002 109.408 172.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.62 159.86 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 115.288 1.588 . . . . 1.3799999999999999 115.288 -167.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.09 150.74 30.17 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.434 1.093 . . . . 3.1699999999999999 109.761 166.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.05 -21.27 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.334 1.054 . . . . 1.76 113.646 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.47 -20.14 62.81 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.361 -1.462 . . . . 3.0899999999999999 112.95 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.1 mt -107.22 -8.93 16.25 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.253 1.575 . . . . 1.97 115.253 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.15 148.89 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.297 1.039 . . . . 1.9199999999999999 111.051 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -122.3 165.07 16.81 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.121 1.368 . . . . 4.0899999999999999 114.204 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -69.09 26.19 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 127.011 2.124 . . . . 3.5 116.213 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.79 9.65 2.32 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.003 1.764 . . . . 1.4099999999999999 113.776 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -89.47 165.07 14.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.126 1.37 . . . . 2.9100000000000001 112.821 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.1 mt -122.21 128.28 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.143 1.377 . . . . 2.3700000000000001 110.167 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.1 mm -118.06 130.54 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.407 1.483 . . . . 1.6699999999999999 113.348 -167.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -82.77 128.08 34.05 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.525 1.13 . . . . 3.3399999999999999 112.408 172.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.39 125.26 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.666 1.186 . . . . 2.3599999999999999 111.856 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.81 158.57 42.03 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.506 1.522 . . . . 2.1699999999999999 113.205 -175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.82 123.08 9.11 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.268 3.312 . . . . 1.78 113.489 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.72 -0.75 88.13 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.879 1.228 . . . . 0.95999999999999996 115.022 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.9 -169.03 30.21 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 118.757 1.278 . . . . 1.05 114.116 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -130.18 158.85 38.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.12 1.768 . . . . 3.4700000000000002 111.462 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -86.68 118.66 70.53 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.621 0.768 . . . . 3.8700000000000001 109.277 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -89.68 -13.84 2.61 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.04 1.827 . . . . 1.0800000000000001 115.865 -168.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.0 159.82 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 128.992 2.917 . . . . 1.8100000000000001 107.699 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.0 147.51 25.7 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.653 0.983 . . . . 2.0 113.653 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.45 -159.3 32.21 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 114.946 0.738 . . . . 1.01 114.946 -173.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -109.12 145.43 35.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.702 1.601 . . . . 6.0199999999999996 113.541 -169.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 t -106.89 119.88 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 127.396 2.279 . . . . 1.79 108.276 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 pt -136.61 34.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 119.224 0.92 . . . . 2.6299999999999999 113.399 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.15 127.97 2.21 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.024 1.73 . . . . 3.5899999999999999 107.454 167.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.88 178.03 40.76 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 122.874 1.263 . . . . 0.93999999999999995 115.402 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -154.95 110.65 3.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.279 1.032 . . . . 3.2200000000000002 112.737 -166.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.0 p -137.74 175.05 9.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.609 1.964 . . . . 3.8599999999999999 113.936 -168.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 38.6 ttm -114.72 145.13 42.41 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.321 1.048 . . . . 1.8899999999999999 109.619 165.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.37 142.91 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.067 1.347 . . . . 0.94999999999999996 111.771 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -113.13 113.23 25.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.915 1.686 . . . . 1.8799999999999999 110.747 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -134.39 14.37 3.79 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.084 1.754 . . . . 2.52 114.336 -170.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.6 p -58.49 -13.95 6.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 117.543 2.423 . . . . 1.6499999999999999 117.543 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -93.86 -33.32 13.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.999 1.32 . . . . 2.25 111.684 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.0 mm -73.79 -62.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.575 -0.703 . . . . 2.1499999999999999 110.047 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.6 p -94.23 -13.19 26.84 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.007 1.323 . . . . 2.1200000000000001 113.382 -171.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.43 10.31 78.93 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.659 1.6 . . . . 1.49 113.827 -172.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.88 98.87 0.58 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.684 1.742 . . . . 2.71 109.385 170.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.64 28.41 0.26 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.988 1.315 . . . . 2.7000000000000002 112.496 -171.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.2 ptm -155.16 145.0 15.55 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.377 2.271 . . . . 4.2000000000000002 109.301 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.42 148.92 21.22 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.111 2.541 . . . . 1.9399999999999999 112.095 -172.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.55 136.21 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.829 1.252 . . . . 2.3399999999999999 112.416 -168.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.0 150.15 29.0 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.079 0.952 . . . . 1.97 113.125 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -132.26 150.87 52.06 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.131 1.772 . . . . 2.3300000000000001 111.598 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -143.78 173.88 4.06 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 129.146 2.978 . . . . 4.2699999999999996 108.784 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -58.06 138.77 87.68 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 CA-C-N 121.058 1.414 . . . . 1.24 110.862 168.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.22 14.61 74.0 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.205 1.383 . . . . 1.1399999999999999 115.083 -170.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.8 m -97.74 164.87 12.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.391 1.596 . . . . 2.5 110.72 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.8 p -124.03 159.96 28.73 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.107 -0.996 . . . . 2.2999999999999998 113.334 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.65 161.06 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.616 1.966 . . . . 1.8300000000000001 112.151 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.84 154.86 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.847 2.059 . . . . 2.3500000000000001 112.026 172.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.2 150.45 48.29 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.37 0.878 . . . . 1.8700000000000001 113.37 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.64 -5.12 62.01 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.661 1.124 . . . . 0.79000000000000004 115.219 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.0 p -77.68 157.46 30.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.792 1.237 . . . . 1.76 111.663 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mm -108.39 137.2 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.884 0.874 . . . . 1.7 111.482 -170.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.66 155.13 21.24 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.877 1.671 . . . . 3.4500000000000002 112.905 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -129.77 124.49 33.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.642 1.577 . . . . 3.02 109.075 166.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 93' ' ' GLY . 34.4 t30 45.94 -132.37 1.03 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.101 2.161 . . . . 3.8500000000000001 110.294 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.401 ' H ' ' ND2' ' A' ' 92' ' ' ASN . . . 88.98 -60.23 3.85 Favored Glycine 0 CA--C 1.527 0.8 0 O-C-N 120.069 -1.644 . . . . 3.4199999999999999 116.488 166.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.4 m 47.44 77.16 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.398 1.479 . . . . 2.6400000000000001 111.781 -168.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.2 164.2 12.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.402 1.081 . . . . 2.5600000000000001 113.421 -166.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mp -119.54 128.7 54.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.158 0.983 . . . . 3.2799999999999998 110.527 168.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.5 mm -115.74 122.55 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.835 1.654 . . . . 2.5600000000000001 110.955 -170.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.07 103.34 16.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.756 1.222 . . . . 4.2400000000000002 110.141 176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.07 131.35 36.23 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.355 1.062 . . . . 1.1499999999999999 112.001 -174.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.35 6.01 7.0 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.01 1.485 . . . . 3.0499999999999998 115.01 -175.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -142.05 147.31 36.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.492 1.117 . . . . 1.8 111.842 170.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 p -86.64 163.25 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.442 1.097 . . . . 3.8799999999999999 110.389 170.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.05 -37.67 94.29 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 120.241 -1.537 . . . . 1.4299999999999999 114.712 -169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.67 -32.06 71.27 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.244 1.018 . . . . 2.7000000000000002 112.822 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.42 -16.74 60.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.78 1.232 . . . . 2.6400000000000001 113.946 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.9 p -68.37 159.87 30.64 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.902 1.228 . . . . 2.23 113.714 -169.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.3 t -66.27 -31.12 71.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.396 -0.82 . . . . 3.1499999999999999 111.539 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.3 mp -57.44 -53.09 62.05 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.839 -1.163 . . . . 2.3399999999999999 111.828 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.6 p -70.5 -24.69 62.88 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.196 0.998 . . . . 2.1600000000000001 111.901 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -72.76 -42.61 63.82 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.478 0.918 . . . . 2.1800000000000002 113.478 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.3 mt -56.68 -49.19 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.031 -1.043 . . . . 2.7200000000000002 110.259 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 m -65.92 -25.16 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.379 0.881 . . . . 1.8899999999999999 113.379 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -71.88 -46.44 57.81 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.81 0.844 . . . . 2.98 112.056 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.0 mt -70.07 -36.49 74.98 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.521 1.528 . . . . 3.0800000000000001 113.65 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.32 -52.14 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.776 -0.453 . . . . 2.6699999999999999 109.776 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.22 -23.49 63.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.571 1.323 . . . . 4.4199999999999999 114.571 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.53 -25.48 59.36 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.039 -1.038 . . . . 3.7000000000000002 113.024 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.14 -50.6 21.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.44 1.018 . . . . 3.9300000000000002 112.136 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.183 0 C-N-CA 124.943 1.297 . . . . 4.1600000000000001 113.728 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 112.05 0.389 . . . . 3.52 112.05 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -76.28 -49.15 17.78 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.225 -0.922 . . . . 4.9100000000000001 110.136 168.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.45 -15.25 62.8 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.149 1.537 . . . . 2.3300000000000001 115.149 -170.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.9 tp -68.17 -31.64 71.33 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.608 -1.308 . . . . 2.5600000000000001 113.731 -169.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.89 -21.01 55.56 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.894 -1.129 . . . . 2.2599999999999998 113.532 169.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -69.39 -41.41 76.49 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.813 -1.179 . . . . 3.5800000000000001 111.366 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.19 -43.56 82.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.241 1.016 . . . . 2.0 112.162 177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.02 -33.64 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.294 -0.879 . . . . 2.3300000000000001 111.998 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.9 m -75.77 -19.62 58.87 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.285 1.034 . . . . 1.97 113.177 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mt -68.12 -32.13 72.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.585 1.954 . . . . 2.8599999999999999 113.006 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -57.11 131.76 50.88 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.853 1.206 . . . . 4.46 111.952 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.08 144.93 53.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.835 -0.621 . . . . 2.75 109.489 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 p -78.52 -20.98 49.55 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.118 1.155 . . . . 4.4199999999999999 114.118 -174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -137.76 158.65 43.91 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.61 1.337 . . . . 3.9700000000000002 114.61 -169.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.86 172.8 12.19 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.595 1.958 . . . . 1.6799999999999999 112.476 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.6 m -131.45 102.41 5.93 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.135 1.774 . . . . 1.9299999999999999 111.141 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.5 mt -80.38 128.62 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.045 1.338 . . . . 1.3700000000000001 109.387 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.51 132.97 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.804 0.842 . . . . 3.3500000000000001 112.533 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.4 m -140.52 150.98 44.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.611 1.165 . . . . 3.5 113.403 -169.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mt -104.07 132.54 50.22 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.861 0.864 . . . . 3.6699999999999999 108.784 166.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.66 174.44 10.12 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.276 1.431 . . . . 4.0899999999999999 112.74 -168.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t 68.26 -61.53 0.39 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.155 2.582 . . . . 6.7000000000000002 113.801 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -164.82 46.61 0.1 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.685 3.194 . . . . 6.3399999999999999 107.026 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.277 0.6 OUTLIER 59.21 -8.54 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 128.453 2.701 . . . . 6.8300000000000001 115.919 -165.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.5 pt -68.73 -19.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.322 1.849 . . . . 5.9699999999999998 115.425 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.7 tp -107.84 98.92 8.44 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.085 1.354 . . . . 4.1699999999999999 109.074 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mp -81.35 121.93 26.83 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.42 -0.8 . . . . 4.5199999999999996 109.051 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 t -124.93 144.33 50.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.138 1.375 . . . . 2.73 111.207 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -141.79 127.25 18.86 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.947 1.299 . . . . 2.3399999999999999 110.054 -171.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.4 133.35 53.43 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.723 -1.236 . . . . 3.2799999999999998 111.12 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.69 123.47 43.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.082 0.856 . . . . 3.0499999999999998 110.965 176.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -129.61 165.41 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.243 1.417 . . . . 2.3199999999999998 112.808 -168.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -80.18 151.1 29.9 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.115 1.366 . . . . 3.6899999999999999 110.165 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.35 -23.09 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 120.968 -1.083 . . . . 2.6899999999999999 113.117 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -70.05 -18.16 63.27 Favored 'General case' 0 CA--C 1.552 1.053 0 O-C-N 120.813 -1.179 . . . . 3.7799999999999998 113.741 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -110.52 -3.36 16.04 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.093 1.516 . . . . 2.9100000000000001 115.093 -169.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -94.63 145.33 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.931 1.692 . . . . 1.97 111.067 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -122.79 166.72 14.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.713 2.405 . . . . 3.3999999999999999 114.041 -175.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -73.86 16.18 0.24 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.787 2.143 . . . . 4.1900000000000004 116.787 -169.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.97 11.25 3.64 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.218 1.865 . . . . 1.6200000000000001 113.829 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -79.64 152.74 29.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.332 1.566 . . . . 3.54 112.508 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.24 120.08 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.116 1.366 . . . . 3.0800000000000001 108.922 173.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.6 mm -118.76 125.25 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.031 0.932 . . . . 1.52 113.198 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -80.03 128.69 33.78 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.378 0.671 . . . . 2.75 110.632 167.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 p -103.14 137.07 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.137 0.975 . . . . 1.8799999999999999 111.113 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -88.58 160.66 44.18 Favored Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 113.35 0.87 . . . . 1.99 113.35 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.01 136.29 64.52 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.67 2.247 . . . . 1.8200000000000001 110.41 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.64 -3.97 23.49 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.443 1.497 . . . . 0.95999999999999996 116.408 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.97 178.26 53.9 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.203 1.382 . . . . 0.97999999999999998 114.9 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -126.65 148.0 49.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.659 1.584 . . . . 3.3300000000000001 112.616 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -82.73 126.68 72.6 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.394 0.677 . . . . 3.04 112.601 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -90.89 -22.6 0.61 Allowed 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.122 3.215 . . . . 1.1200000000000001 114.713 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 m -147.67 170.3 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 128.524 2.73 . . . . 1.8600000000000001 108.721 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -99.22 156.35 17.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.106 1.15 . . . . 1.6799999999999999 114.106 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.8 -168.1 39.87 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 115.845 1.098 . . . . 0.73999999999999999 115.845 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -112.17 138.72 48.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.43 1.892 . . . . 5.2199999999999998 111.552 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.82 127.84 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 127.016 2.126 . . . . 1.72 109.399 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.2 pt -140.61 31.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.494 0.718 . . . . 1.79 112.844 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -167.3 133.59 2.2 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.415 1.486 . . . . 2.5699999999999998 109.821 169.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.41 -177.8 48.86 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.075 1.19 . . . . 0.79000000000000004 116.075 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -147.75 113.02 5.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.864 1.266 . . . . 3.8500000000000001 112.402 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.79 167.27 22.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.488 1.115 . . . . 1.8300000000000001 111.607 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.7 ttm -105.3 145.57 30.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.955 0.902 . . . . 2.0899999999999999 109.945 169.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.57 136.0 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.215 1.006 . . . . 1.0600000000000001 112.054 -170.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -100.89 132.66 46.19 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.067 1.347 . . . . 2.21 111.631 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -133.62 16.46 3.98 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.101 1.519 . . . . 1.8200000000000001 115.101 -169.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 98.0 p -44.38 -32.45 1.35 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 119.628 3.196 . . . . 2.0800000000000001 119.628 -166.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -95.09 -41.82 8.92 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.648 1.113 . . . . 2.6800000000000002 111.202 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.4 mm -69.04 -64.32 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.889 1.276 . . . . 1.8500000000000001 111.498 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.4 p -93.69 -11.3 31.85 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.202 1.401 . . . . 2.2799999999999998 112.327 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.54 2.16 87.29 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.021 1.296 . . . . 1.26 115.083 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -55.68 -46.46 77.58 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.174 0.987 . . . . 2.3300000000000001 113.542 -170.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 55.94 27.25 10.85 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.679 1.592 . . . . 3.23 113.369 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.7 ttt -152.79 136.85 10.36 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 131.158 3.783 . . . . 4.5499999999999998 105.312 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.32 153.51 35.71 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.719 2.28 . . . . 2.02 112.881 -172.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.8 t -128.39 134.38 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.735 1.614 . . . . 2.3700000000000001 112.073 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.55 134.12 36.48 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.545 1.138 . . . . 1.9199999999999999 113.488 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -117.7 143.52 46.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.635 1.974 . . . . 1.1000000000000001 110.655 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -142.93 175.34 2.94 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 127.358 2.263 . . . . 5.0 109.465 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -59.18 127.82 25.42 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 CA-C-N 122.182 1.815 . . . . 1.04 111.325 170.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.29 33.59 11.63 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.659 1.123 . . . . 1.03 114.749 -169.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -121.09 170.82 9.17 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.166 1.386 . . . . 2.5299999999999998 111.173 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.8 p -122.74 151.22 41.8 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.493 -1.379 . . . . 1.79 113.449 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.72 156.37 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.936 1.694 . . . . 2.02 112.272 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -123.97 159.06 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.213 1.805 . . . . 1.8700000000000001 112.355 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.14 149.99 49.43 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.769 -0.582 . . . . 1.6000000000000001 112.479 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.7 -2.42 83.0 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 115.293 0.877 . . . . 1.03 115.293 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.88 153.14 32.92 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 117.783 0.792 . . . . 3.3199999999999998 112.05 168.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mm -108.89 129.84 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.988 1.315 . . . . 2.0299999999999998 110.493 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -94.77 142.38 27.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.04 1.736 . . . . 1.6599999999999999 111.856 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.65 -101.33 0.11 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.242 1.201 . . . . 5.7199999999999998 114.242 -174.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -98.42 -41.36 7.84 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.324 1.602 . . . . 3.6600000000000001 115.324 -167.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.49 140.37 18.11 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 119.487 1.04 . . . . 1.8500000000000001 114.041 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t -84.93 129.35 34.82 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.735 0.814 . . . . 3.5600000000000001 110.413 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.2 mt -120.69 158.72 26.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.375 1.47 . . . . 2.0 110.902 -173.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.97 129.75 56.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.166 0.587 . . . . 2.5 109.88 168.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.31 128.19 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.596 1.558 . . . . 2.1099999999999999 110.222 -173.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 23.4 p -81.84 111.16 17.8 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.288 -1.004 . . . . 2.52 108.288 168.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.29 142.96 37.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.869 0.868 . . . . 1.3500000000000001 110.848 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -132.21 3.5 3.99 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.876 1.806 . . . . 4.04 115.876 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -145.16 150.81 37.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.842 1.257 . . . . 2.23 111.473 170.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.8 m -81.88 171.41 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.206 1.002 . . . . 2.6000000000000001 110.85 168.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.75 -28.89 73.3 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 120.756 -1.215 . . . . 1.73 114.699 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.91 -42.75 60.2 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.792 1.296 . . . . 2.79 113.572 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -78.73 -10.2 59.69 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 116.497 2.036 . . . . 2.9100000000000001 116.497 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.9 t -83.95 156.48 22.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.464 1.505 . . . . 3.7999999999999998 113.417 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.8 m -39.33 -44.28 1.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.99 2.116 . . . . 3.1499999999999999 114.308 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.17 -46.73 85.8 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.756 1.162 . . . . 2.1099999999999999 111.847 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.3 t -70.19 -35.65 74.09 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.851 0.861 . . . . 3.0099999999999998 111.088 173.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -64.25 -35.73 81.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.377 0.671 . . . . 2.1699999999999999 112.288 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.6 mt -64.69 -58.99 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.466 1.506 . . . . 2.3799999999999999 110.728 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m -65.37 -20.99 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 113.539 0.941 . . . . 2.4100000000000001 113.539 -171.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -69.58 -55.53 9.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.171 0.988 . . . . 3.2599999999999998 111.744 169.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -30.24 56.06 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 115.151 1.538 . . . . 3.8300000000000001 115.151 -173.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.73 -54.46 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.952 -0.759 . . . . 2.48 108.952 171.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -59.96 -14.71 17.22 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.383 1.994 . . . . 4.3499999999999996 116.383 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -72.41 -37.28 68.68 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.423 1.465 . . . . 4.5499999999999998 112.636 169.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.08 -65.1 1.05 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.362 0.665 . . . . 4.1200000000000001 111.552 169.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 128.348 2.659 . . . . 5.3700000000000001 112.268 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 112.161 0.43 . . . . 2.96 112.161 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -57.33 -33.21 67.5 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.475 1.51 . . . . 4.46 113.211 173.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.48 -17.79 60.03 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.632 1.345 . . . . 2.1099999999999999 114.632 172.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 35.3 tp -63.63 -42.62 98.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.903 1.229 . . . . 2.3300000000000001 113.313 -168.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.8 -21.61 57.17 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.597 -1.314 . . . . 3.1000000000000001 113.161 169.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -67.17 -39.56 86.47 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.776 1.171 . . . . 3.46 111.446 -170.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -49.47 -46.15 47.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.315 0.646 . . . . 2.4100000000000001 110.998 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.2 mm -71.52 -27.99 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.652 1.181 . . . . 3.1000000000000001 113.294 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.9 m -70.91 -37.09 72.92 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.307 1.043 . . . . 1.3 112.83 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.05 -17.34 51.88 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.092 1.145 . . . . 3.73 114.092 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.65 135.52 55.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.691 1.596 . . . . 2.8500000000000001 113.185 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.13 150.36 48.29 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.399 0.679 . . . . 2.23 112.104 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -100.56 -28.55 12.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.765 1.226 . . . . 2.7000000000000002 112.193 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -140.64 152.93 45.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.054 1.342 . . . . 3.2999999999999998 112.096 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.08 157.84 44.16 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.638 1.575 . . . . 2.2400000000000002 113.272 -169.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 m -94.5 109.67 21.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.784 0.834 . . . . 2.4500000000000002 112.849 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.7 mt -84.48 125.09 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.067 0.947 . . . . 1.5 109.55 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.72 130.17 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.986 0.914 . . . . 2.8700000000000001 110.691 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -140.21 136.24 33.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.594 1.158 . . . . 2.6200000000000001 111.09 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.3 mt -81.32 92.08 6.33 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.297 -1.001 . . . . 3.9100000000000001 108.297 169.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.84 -5.38 40.6 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.952 0.901 . . . . 3.6000000000000001 113.259 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.2 m -158.72 142.46 15.23 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.838 2.055 . . . . 3.9900000000000002 111.655 167.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -3.6 50.49 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.266 1 C-N-CA 134.995 5.318 . . . . 5.8600000000000003 117.725 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.4 -22.61 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 126.737 2.015 . . . . 5.9299999999999997 113.339 -166.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.7 pt -61.55 -11.44 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 129.106 2.962 . . . . 4.6500000000000004 116.332 175.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.5 tp -136.49 103.88 5.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.693 1.197 . . . . 3.5 110.988 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.85 127.65 33.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.081 0.952 . . . . 4.46 109.108 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -140.59 138.44 34.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.81 0.844 . . . . 2.73 111.588 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -137.39 132.0 32.86 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.195 0.998 . . . . 3.0299999999999998 110.915 -173.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.2 140.36 48.62 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.243 1.417 . . . . 3.46 109.925 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -100.45 117.77 35.29 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.308 0.958 . . . . 2.2999999999999998 109.22 168.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.99 156.96 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.857 1.263 . . . . 1.8600000000000001 111.946 -168.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -76.84 151.62 35.8 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.46 -0.775 . . . . 3.7799999999999998 111.273 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.0 -19.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 115.037 1.495 . . . . 1.95 115.037 -172.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.95 -19.28 52.13 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 120.333 -1.479 . . . . 3.9700000000000002 113.668 173.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.8 mt -91.36 -6.85 52.32 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.107 1.763 . . . . 2.7799999999999998 113.43 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.26 143.03 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.218 1.807 . . . . 1.8600000000000001 110.255 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.32 172.73 10.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.17 0.988 . . . . 4.3899999999999997 112.316 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -65.66 21.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 117.487 2.403 . . . . 4.5700000000000003 117.487 -172.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.7 42.95 0.81 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.219 1.866 . . . . 1.6799999999999999 111.714 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -122.66 159.32 28.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.894 1.678 . . . . 2.1899999999999999 110.584 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 53.7 mt -116.22 125.79 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.18 0.992 . . . . 2.2999999999999998 109.834 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.5 mm -116.92 127.19 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.936 1.295 . . . . 1.48 112.195 -168.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -79.37 121.66 25.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.693 0.797 . . . . 4.4199999999999999 109.209 168.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.8 124.44 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.247 1.019 . . . . 1.74 109.29 170.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.8 m -85.99 156.68 57.74 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 123.323 0.649 . . . . 2.6600000000000001 112.654 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.05 130.71 35.66 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.746 2.297 . . . . 2.0800000000000001 111.848 171.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.1 -7.44 29.34 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 124.812 1.196 . . . . 1.03 115.07 -171.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.51 -177.83 50.62 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.341 1.448 . . . . 1.0900000000000001 114.234 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -125.65 158.18 35.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.22 1.408 . . . . 2.6499999999999999 112.29 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -88.78 129.08 49.97 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.901 0.881 . . . . 3.6600000000000001 111.859 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.99 -25.59 1.41 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.747 2.965 . . . . 1.0 115.207 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -147.85 167.33 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.833 2.453 . . . . 2.2599999999999998 108.749 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.21 149.11 24.83 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.023 0.828 . . . . 1.95 111.429 174.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -165.15 35.72 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 114.552 0.581 . . . . 1.05 114.552 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -111.5 144.49 40.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.473 1.509 . . . . 4.4900000000000002 112.314 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.13 134.03 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.863 2.465 . . . . 1.97 108.225 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 pt -138.35 30.31 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 122.253 1.025 . . . . 2.2000000000000002 112.42 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -168.54 144.44 3.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.582 1.953 . . . . 3.3799999999999999 109.552 167.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 177.18 38.94 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 117.268 1.667 . . . . 1.1799999999999999 117.268 167.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -143.78 37.6 1.32 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 115.619 1.711 . . . . 2.9500000000000002 115.619 -168.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.406 ' H ' HD23 ' A' ' 95' ' ' LEU . 34.7 m -77.3 157.61 30.63 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.718 -1.239 . . . . 2.0499999999999998 112.247 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.3 ttm -92.89 140.13 29.82 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.841 -0.618 . . . . 2.0699999999999998 110.083 168.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.5 t -126.24 143.48 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.355 1.462 . . . . 0.97999999999999998 111.905 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -106.22 111.09 23.55 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.014 1.725 . . . . 2.1400000000000001 111.429 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.3 16.24 5.01 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.792 1.637 . . . . 1.8999999999999999 114.662 -172.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.5 p -65.6 -26.92 68.06 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.659 1.726 . . . . 1.9299999999999999 115.659 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -79.43 -48.21 14.35 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.36 0.982 . . . . 2.6699999999999999 110.686 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.5 mm -65.73 -55.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.657 0.783 . . . . 2.5600000000000001 110.499 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.7 p -93.57 -11.63 31.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.407 1.083 . . . . 2.73 113.708 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.07 13.48 82.95 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 119.312 -0.716 . . . . 1.4399999999999999 113.785 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.58 175.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.14 2.176 . . . . 2.9100000000000001 113.581 171.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.77 6.45 1.61 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.224 1.565 . . . . 3.2000000000000002 115.224 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -149.55 148.83 27.08 Favored Pre-proline 0 C--O 1.24 0.604 0 O-C-N 120.825 -1.172 . . . . 5.0599999999999996 109.272 168.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.08 157.85 60.13 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.565 2.176 . . . . 1.79 111.395 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.8 t -117.25 127.81 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.832 1.253 . . . . 1.6799999999999999 112.353 -167.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.21 130.17 35.2 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.274 0.629 . . . . 2.0299999999999998 111.213 173.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.12 162.92 12.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.684 1.194 . . . . 1.1100000000000001 111.649 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -150.6 165.17 18.0 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 127.571 2.349 . . . . 4.7400000000000002 110.342 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.1 129.79 31.66 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 CA-C-N 121.075 1.42 . . . . 1.24 108.697 165.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.37 44.67 6.85 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.344 0.973 . . . . 1.1499999999999999 113.576 -169.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 t -131.39 151.2 51.75 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.346 1.458 . . . . 1.8799999999999999 111.698 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.0 p -101.4 147.58 26.17 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.788 1.631 . . . . 2.5 113.151 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 m -139.48 151.71 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.197 1.399 . . . . 2.0600000000000001 112.64 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -112.88 147.08 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.94 1.296 . . . . 2.5 112.736 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.66 144.31 14.24 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.864 -1.062 . . . . 1.6899999999999999 111.719 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.57 -7.58 57.49 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 116.203 1.241 . . . . 0.84999999999999998 116.203 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.6 p -68.98 160.73 30.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.398 1.599 . . . . 1.7 110.962 168.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.55 146.18 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.115 0.966 . . . . 2.1600000000000001 110.624 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -108.45 153.04 23.89 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.832 1.253 . . . . 1.6000000000000001 113.465 -174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -115.28 -167.7 1.28 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.662 1.985 . . . . 3.6099999999999999 109.805 170.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -77.66 140.5 39.6 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 119.649 -1.907 . . . . 4.79 111.574 -174.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.05 11.31 0.42 Allowed Glycine 0 CA--C 1.542 1.741 0 C-N-CA 124.978 1.275 . . . . 3.5099999999999998 114.012 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m 23.8 85.67 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 129.58 3.152 . . . . 2.46 115.846 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 62' ' ' SER . 57.7 mt -87.33 150.69 23.68 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.402 0.681 . . . . 2.3399999999999999 112.761 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.73 128.93 51.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.679 0.792 . . . . 2.8300000000000001 110.244 167.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.0 mm -111.86 126.47 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.837 1.655 . . . . 3.1800000000000002 110.449 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.2 p -79.41 104.5 10.06 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.899 0.857 . . . . 2.8199999999999998 109.718 169.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.94 113.69 14.91 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.178 -0.951 . . . . 2.0499999999999998 109.393 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.5 p -120.21 16.2 12.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.708 1.203 . . . . 3.6000000000000001 113.026 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -148.86 146.32 27.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.075 1.75 . . . . 2.1600000000000001 110.417 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 m -100.56 164.16 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.701 0.8 . . . . 2.1899999999999999 109.625 165.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -51.45 -45.09 53.63 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 114.523 0.569 . . . . 1.5800000000000001 114.523 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.2 -23.57 67.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.325 1.232 . . . . 2.2200000000000002 114.325 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -78.7 -25.96 44.81 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.986 1.476 . . . . 2.5800000000000001 114.986 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 p -52.36 143.21 15.51 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.838 1.792 . . . . 2.3599999999999999 115.838 -164.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.6 t -60.04 -32.22 70.71 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.067 0.947 . . . . 2.9500000000000002 111.499 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.3 tp -52.97 -44.62 67.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.424 1.49 . . . . 2.4900000000000002 112.195 168.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.0 p -71.87 -24.5 61.69 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.154 0.798 . . . . 3.6600000000000001 113.154 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -71.25 -39.56 71.54 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.826 -1.171 . . . . 2.7200000000000002 112.014 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 96.3 mt -53.49 -55.14 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.506 0.722 . . . . 3.0299999999999998 109.968 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.77 -18.9 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 114.251 1.204 . . . . 2.96 114.251 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -71.12 -41.45 70.51 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.837 -1.164 . . . . 4.6299999999999999 110.764 168.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.7 mt -70.86 -40.68 72.19 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.78 1.232 . . . . 3.5099999999999998 113.646 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.94 -28.75 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.44 1.018 . . . . 2.6200000000000001 111.368 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -73.83 -30.89 62.95 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.575 1.15 . . . . 4.2000000000000002 112.94 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.66 -29.1 63.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.433 1.093 . . . . 4.4100000000000001 113.884 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.07 -52.42 42.33 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.917 0.78 . . . . 3.7000000000000002 110.881 -173.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 126.274 1.829 . . . . 3.9199999999999999 114.366 169.668 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 113.899 1.074 . . . . 3.4199999999999999 113.899 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -70.56 -39.06 74.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.358 1.435 . . . . 5.2800000000000002 109.054 167.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.64 56.11 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.797 1.036 . . . . 2.3599999999999999 113.797 173.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 47.3 tp -67.84 -35.05 77.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.797 1.18 . . . . 2.1000000000000001 112.507 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.63 -36.37 62.9 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.374 0.534 . . . . 2.8599999999999999 111.481 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -56.54 -36.9 69.77 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.801 1.24 . . . . 3.7599999999999998 114.255 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -48.62 -49.51 36.73 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.753 1.16 . . . . 2.1899999999999999 111.489 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.97 -29.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.625 1.17 . . . . 3.2200000000000002 112.039 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -73.01 -26.35 61.29 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.475 -0.766 . . . . 1.45 112.907 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.36 -33.01 72.44 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.239 0.927 . . . . 2.6899999999999999 112.362 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -62.02 147.1 48.24 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.167 0.894 . . . . 4.7400000000000002 111.655 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.9 -21.01 64.37 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.235 2.309 . . . . 3.79 117.235 -167.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 m 66.73 -28.17 0.13 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.233 1.813 . . . . 2.96 114.545 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -137.82 156.62 47.74 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.127 2.171 . . . . 2.7999999999999998 112.981 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.12 165.73 26.63 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.495 1.518 . . . . 2.0099999999999998 113.7 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.2 m -116.29 108.13 15.71 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.966 1.706 . . . . 1.79 111.274 170.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.8 mt -85.94 141.08 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.674 1.189 . . . . 2.0600000000000001 109.727 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 m -114.63 133.39 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.195 0.998 . . . . 2.7599999999999998 113.285 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.3 m -134.19 136.42 43.72 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.985 1.714 . . . . 2.6299999999999999 110.093 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.3 mt -91.5 86.69 6.12 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.214 0.606 . . . . 3.29 110.632 -174.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.69 -3.37 34.3 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.052 0.941 . . . . 3.79 112.821 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.9 m -160.76 142.05 11.97 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 128.029 2.532 . . . . 3.8199999999999998 110.803 167.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 25' ' ' ILE . 23.9 t70 -20.99 66.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 1 C-N-CA 132.552 4.341 . . . . 4.3200000000000003 117.917 -168.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.33 11.2 p30 49.39 2.73 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.642 2.377 . . . . 5.04 116.442 -167.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.411 ' H ' ' C ' ' A' ' 23' ' ' ASP . 14.0 pt -82.38 -11.45 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 129.262 3.025 . . . . 4.0599999999999996 114.603 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.7 tp -135.58 95.14 3.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.181 1.392 . . . . 3.46 111.625 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.89 78.78 7.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.026 1.73 . . . . 3.3300000000000001 110.6 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -78.87 125.82 29.88 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.656 1.182 . . . . 2.4700000000000002 110.407 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -103.0 160.79 14.31 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.951 -1.093 . . . . 3.3199999999999998 113.055 -174.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.94 125.28 35.1 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.05 1.34 . . . . 4.5300000000000002 109.486 168.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -91.82 121.75 33.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.859 -1.164 . . . . 2.04 107.859 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 m -136.32 157.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.077 0.951 . . . . 1.6899999999999999 113.538 -167.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.8 145.6 32.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.775 0.83 . . . . 2.9700000000000002 110.29 167.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.63 -29.65 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 113.287 0.847 . . . . 1.8899999999999999 113.287 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -74.35 -3.77 32.35 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.895 1.278 . . . . 3.9500000000000002 113.551 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.8 -13.52 12.61 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.535 1.934 . . . . 2.5600000000000001 114.617 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.51 147.85 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 119.556 1.071 . . . . 2.02 111.246 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.76 163.76 20.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.016 1.726 . . . . 3.6600000000000001 114.298 -176.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -71.52 18.82 0.07 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 117.621 2.452 . . . . 4.5499999999999998 117.621 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.17 4.33 6.35 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.019 1.295 . . . . 1.9399999999999999 115.548 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -111.29 169.67 8.63 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.633 1.173 . . . . 2.27 112.565 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.8 mt -123.75 130.75 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.666 1.586 . . . . 2.29 110.427 -170.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -117.99 136.04 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.438 1.495 . . . . 2.0 113.871 -166.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -87.09 143.14 27.44 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.567 0.951 . . . . 3.7200000000000002 113.567 169.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.9 p -132.25 134.74 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.439 1.095 . . . . 1.74 111.479 169.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.14 170.41 5.36 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 125.339 1.456 . . . . 2.27 112.847 -170.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.33 132.07 50.02 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.785 2.323 . . . . 1.96 112.547 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.11 -8.27 39.35 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.939 1.733 . . . . 0.91000000000000003 114.992 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.78 166.56 54.57 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 118.933 1.366 . . . . 0.97999999999999998 113.813 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -119.61 153.34 35.64 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.037 1.335 . . . . 4.0 112.255 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -79.29 134.97 58.09 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.374 0.669 . . . . 2.9700000000000002 112.45 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.14 -32.58 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.983 2.456 . . . . 0.98999999999999999 115.313 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 m -145.85 171.32 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 126.984 2.114 . . . . 1.9399999999999999 109.183 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.96 144.5 25.4 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.089 0.859 . . . . 2.3900000000000001 112.399 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.62 -164.82 35.89 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.013 1.165 . . . . 0.88 116.013 -175.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -107.94 145.64 33.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.738 2.015 . . . . 6.1500000000000004 112.693 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.66 133.76 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 127.581 2.352 . . . . 2.0899999999999999 110.443 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.73 37.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.936 1.087 . . . . 2.3500000000000001 113.936 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -165.29 136.53 3.98 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.839 -1.163 . . . . 2.3700000000000001 110.159 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.41 -174.31 50.39 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.844 1.212 . . . . 0.76000000000000001 115.992 168.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -149.67 112.0 4.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.27 1.028 . . . . 2.8100000000000001 112.222 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.55 154.95 45.78 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.238 1.015 . . . . 1.7 112.814 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.4 ttm -104.32 128.87 52.19 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.689 1.195 . . . . 1.8899999999999999 108.969 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 86.1 t -115.99 136.6 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.68 1.592 . . . . 1.03 113.147 -166.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -91.04 100.68 13.49 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.348 -0.845 . . . . 1.98 111.607 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -93.65 4.74 53.48 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.318 1.447 . . . . 2.0499999999999998 113.963 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -38.97 -45.59 1.22 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.923 2.489 . . . . 2.4900000000000002 116.842 -169.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.74 -32.01 28.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.024 0.829 . . . . 2.3199999999999998 111.924 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.15 -58.13 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.796 1.639 . . . . 2.0899999999999999 111.642 -171.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.9 p -102.7 -5.5 23.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.757 1.223 . . . . 2.0 113.036 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.98 18.82 79.75 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.445 1.498 . . . . 1.1499999999999999 113.955 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -67.15 -53.29 31.96 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.782 0.833 . . . . 2.4199999999999999 112.035 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 64.18 29.26 14.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.433 1.893 . . . . 2.9100000000000001 112.882 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.2 ptp -157.77 128.77 3.68 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 130.21 3.404 . . . . 5.2400000000000002 106.489 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.98 156.95 51.87 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.032 1.821 . . . . 1.9399999999999999 114.104 -167.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.9 t -120.02 129.55 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 126.96 2.104 . . . . 2.1400000000000001 111.299 -168.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.7 134.63 36.41 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.34 -0.85 . . . . 1.75 112.809 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -120.34 151.3 39.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.302 1.841 . . . . 1.0800000000000001 110.841 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -149.24 174.66 3.27 Favored Pre-proline 0 N--CA 1.483 1.175 0 C-N-CA 127.866 2.466 . . . . 3.2400000000000002 111.491 -168.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.24 129.67 24.84 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 CA-C-N 122.045 1.766 . . . . 0.97999999999999998 110.592 167.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.24 46.77 9.78 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.59 1.09 . . . . 1.1000000000000001 111.918 -168.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.8 t -126.34 160.27 30.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.615 1.566 . . . . 1.45 111.365 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.0 p -121.0 146.09 47.06 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.887 -1.133 . . . . 1.8300000000000001 111.817 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.05 155.0 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.064 1.345 . . . . 1.3400000000000001 112.952 -171.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.76 147.81 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.575 1.95 . . . . 2.1899999999999999 112.503 169.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.66 151.46 33.54 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.902 1.281 . . . . 1.8999999999999999 113.136 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.03 -6.6 59.0 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.928 1.251 . . . . 0.75 115.715 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.5 p -76.53 159.84 30.0 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.763 1.282 . . . . 1.5800000000000001 111.758 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -110.24 125.77 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.138 0.975 . . . . 1.79 112.112 -169.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -95.5 127.53 41.61 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.251 1.82 . . . . 1.6799999999999999 112.099 -175.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -150.69 76.9 1.27 Allowed 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.087 1.884 . . . . 3.9300000000000002 116.087 -171.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -171.59 -60.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.393 1.877 . . . . 3.3500000000000001 110.592 167.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.17 175.07 24.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.076 2.274 . . . . 1.9199999999999999 112.285 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.0 m -87.15 141.37 28.7 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.672 1.189 . . . . 2.1499999999999999 112.296 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.4 mt -127.73 165.51 19.93 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.224 1.81 . . . . 1.98 112.339 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.1 tp -124.02 113.52 18.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.048 1.739 . . . . 3.79 111.573 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.87 130.04 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.113 0.965 . . . . 2.8900000000000001 112.588 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 82.8 m -86.67 106.4 17.59 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.813 0.845 . . . . 3.9900000000000002 109.939 169.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.25 116.41 19.5 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.451 -0.78 . . . . 1.03 111.108 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -115.86 10.42 15.28 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.339 1.056 . . . . 3.5499999999999998 113.384 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -141.09 138.51 33.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.694 1.598 . . . . 2.0299999999999998 110.795 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 m -84.59 162.27 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 108.903 -0.777 . . . . 2.3799999999999999 108.903 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.31 -43.33 75.59 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.009 -1.057 . . . . 1.73 114.257 -169.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.41 -31.41 72.1 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.888 1.07 . . . . 3.0499999999999998 113.888 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.18 -17.02 58.86 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.025 1.73 . . . . 2.7999999999999998 114.19 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.0 p -68.86 151.8 46.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.022 0.929 . . . . 3.1699999999999999 113.245 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.6 t -55.44 -37.45 67.72 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.281 0.632 . . . . 3.0 112.051 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.7 tp -61.57 -49.46 76.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.416 1.086 . . . . 2.9500000000000002 112.256 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 t -71.89 -25.99 62.15 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.444 0.697 . . . . 2.4399999999999999 112.2 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.83 -41.15 75.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.73 1.212 . . . . 1.79 112.778 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.69 -50.09 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.804 0.842 . . . . 2.6899999999999999 110.651 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.14 -18.27 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 114.005 1.113 . . . . 1.9399999999999999 114.005 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.84 -45.95 73.19 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.768 1.167 . . . . 3.1899999999999999 110.448 167.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -41.72 99.07 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.819 1.247 . . . . 3.1800000000000002 112.57 -177.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.76 -33.13 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.901 0.88 . . . . 2.3799999999999999 112.467 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -71.14 -27.52 63.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.774 0.829 . . . . 3.8100000000000001 112.538 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -67.26 -32.25 73.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.986 0.914 . . . . 4.2400000000000002 112.453 172.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.78 -43.44 46.45 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.425 1.09 . . . . 4.8799999999999999 113.474 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.714 1.606 . . . . 5.5 113.264 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 112.609 0.596 . . . . 3.48 112.609 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -73.94 -46.15 45.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.771 1.228 . . . . 4.1200000000000001 109.818 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.4 -33.06 74.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.794 1.238 . . . . 1.98 113.175 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.15 -28.3 69.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.3 0.64 . . . . 2.3599999999999999 112.331 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.34 -47.51 33.92 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.693 -0.629 . . . . 2.1000000000000001 110.852 167.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -48.91 -41.48 33.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.301 1.44 . . . . 4.4199999999999999 114.779 -169.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.42 -45.33 69.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.944 0.793 . . . . 2.4900000000000002 111.992 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.7 mm -72.91 -29.24 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.551 1.14 . . . . 3.1000000000000001 112.521 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -74.29 -24.21 59.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.408 0.892 . . . . 1.48 113.408 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.31 -19.73 65.62 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.77 1.026 . . . . 2.79 113.77 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.33 157.79 36.32 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 115.178 1.547 . . . . 2.9700000000000002 115.178 -169.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.11 154.4 17.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.893 1.677 . . . . 2.1899999999999999 112.721 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -88.55 -23.29 23.2 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.552 1.141 . . . . 3.3199999999999998 112.736 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.75 168.26 20.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.779 1.232 . . . . 3.52 114.075 -169.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.65 161.3 38.08 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.408 1.483 . . . . 1.9299999999999999 112.472 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.0 m -121.55 95.95 4.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.748 1.619 . . . . 1.97 110.873 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.32 146.22 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.219 1.408 . . . . 1.5800000000000001 110.002 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.19 120.59 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.518 1.054 . . . . 2.7200000000000002 111.967 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.1 m -122.1 146.97 46.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.17 1.388 . . . . 2.6299999999999999 111.277 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 mp -110.48 88.9 2.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.635 1.174 . . . . 4.1900000000000004 110.607 -171.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.03 -7.93 20.14 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.767 1.765 . . . . 3.75 115.767 -169.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.6 m -113.36 -96.0 0.45 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.083 1.353 . . . . 4.0999999999999996 111.594 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -152.72 56.38 0.8 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.994 1.717 . . . . 4.5999999999999996 109.873 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 60.9 -7.68 0.08 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 129.623 3.169 . . . . 5.7999999999999998 118.095 -172.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.4 pt -80.15 -9.05 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.559 1.543 . . . . 4.7000000000000002 114.103 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tt -127.69 140.58 51.99 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.303 2.241 . . . . 3.9100000000000001 110.99 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.14 127.16 47.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.934 1.693 . . . . 3.73 111.926 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.7 t -132.3 110.65 10.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.149 1.78 . . . . 2.1499999999999999 110.072 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -108.51 136.64 47.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.176 1.176 . . . . 2.8900000000000001 114.176 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -108.11 132.55 53.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.671 1.588 . . . . 2.6699999999999999 110.106 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -104.51 122.79 46.29 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.524 -0.917 . . . . 2.1499999999999999 108.524 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.3 m -139.68 156.66 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.974 0.91 . . . . 2.2799999999999998 113.007 -169.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -74.06 146.48 43.63 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.618 -0.512 . . . . 4.0300000000000002 109.618 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.41 -27.92 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.681 1.363 . . . . 2.04 114.681 -168.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -73.3 -7.67 52.54 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 120.495 -1.378 . . . . 3.3500000000000001 113.431 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.0 -1.04 32.68 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.258 1.823 . . . . 2.3900000000000001 114.882 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -109.76 148.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.918 1.287 . . . . 1.9199999999999999 110.736 172.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -123.65 175.9 6.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.908 2.083 . . . . 4.0599999999999996 110.811 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -68.92 156.65 38.16 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.36 -0.838 . . . . 3.5299999999999998 111.093 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.36 22.78 21.17 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 119.132 0.878 . . . . 2.1099999999999999 113.858 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.15 167.28 20.95 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.539 1.535 . . . . 2.1000000000000001 112.305 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.03 129.69 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.159 1.383 . . . . 2.3199999999999998 110.646 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 mm -120.52 129.13 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.241 1.816 . . . . 1.8500000000000001 110.499 -169.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -78.68 133.69 37.18 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.101 -1.0 . . . . 2.8700000000000001 111.171 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.96 128.09 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.008 1.323 . . . . 1.3200000000000001 110.539 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.85 171.08 5.8 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.622 1.169 . . . . 2.1699999999999999 112.48 -169.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.32 127.81 25.24 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.483 2.122 . . . . 1.5700000000000001 112.537 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.22 -1.96 73.12 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.79 1.185 . . . . 1.0 116.006 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.22 -176.82 50.3 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 118.897 1.348 . . . . 0.93999999999999995 114.064 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -124.57 159.79 29.87 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.074 1.749 . . . . 3.6600000000000001 112.152 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -84.03 118.8 72.25 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.125 0.97 . . . . 3.8300000000000001 109.554 170.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -83.49 -17.66 6.22 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.258 1.972 . . . . 0.81999999999999995 115.482 -169.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -153.04 160.93 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 127.915 2.486 . . . . 2.02 108.312 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.03 140.88 33.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.154 0.888 . . . . 1.9199999999999999 112.768 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.16 -148.75 9.39 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.642 -0.661 . . . . 0.85999999999999999 114.603 -171.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -131.85 145.57 51.62 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.896 1.278 . . . . 5.04 113.939 -170.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.5 t -96.46 125.48 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.949 2.5 . . . . 1.98 108.916 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.49 32.73 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 113.641 0.978 . . . . 1.8300000000000001 113.641 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -168.11 136.21 2.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.364 1.866 . . . . 3.5600000000000001 108.26 166.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.29 179.4 52.62 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 122.448 1.027 . . . . 0.91000000000000003 114.726 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -154.67 123.44 6.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.972 0.909 . . . . 2.9500000000000002 112.743 -170.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.9 p -137.5 -179.04 5.5 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.345 1.858 . . . . 3.7999999999999998 113.588 -168.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.9 ttm -128.4 135.14 49.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.971 1.708 . . . . 1.5700000000000001 108.888 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.76 139.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.215 1.406 . . . . 1.0700000000000001 112.076 -168.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -102.24 110.57 22.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.386 1.475 . . . . 1.9099999999999999 111.401 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.75 22.05 11.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.21 1.804 . . . . 2.4900000000000002 113.145 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.5 p -53.1 -28.18 24.17 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.7 1.741 . . . . 2.0600000000000001 115.7 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.83 -34.91 16.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.369 0.986 . . . . 2.4300000000000002 111.667 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.3 mm -70.46 -47.8 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.617 0.767 . . . . 1.97 110.687 -177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.2 p -119.92 -4.33 10.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.77 1.228 . . . . 2.3999999999999999 114.172 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.37 3.07 89.86 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.606 1.098 . . . . 1.8500000000000001 115.331 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -56.32 -52.92 62.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.298 1.221 . . . . 2.7200000000000002 114.298 -169.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.19 33.63 23.35 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 122.201 1.0 . . . . 3.1099999999999999 111.868 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -154.78 113.21 2.37 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 128.745 2.818 . . . . 4.6299999999999999 106.068 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -62.33 153.03 73.2 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.994 2.462 . . . . 2.25 114.251 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.4 t -115.96 137.27 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.99 1.316 . . . . 1.55 110.949 -171.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.95 142.05 28.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.636 0.774 . . . . 1.77 112.483 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -123.43 152.19 41.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.289 1.436 . . . . 0.94999999999999996 111.717 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -146.23 170.16 8.38 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 129.148 2.979 . . . . 4.46 107.864 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.33 132.79 54.33 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 CA-C-N 121.82 1.686 . . . . 0.97999999999999998 111.63 168.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.11 25.77 28.07 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.239 1.399 . . . . 0.76000000000000001 114.815 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.2 t -117.56 158.61 24.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.231 1.412 . . . . 1.5 111.826 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.6 p -116.6 146.95 42.32 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.005 1.275 . . . . 1.6899999999999999 113.22 -172.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.6 156.04 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.703 1.601 . . . . 1.3500000000000001 113.08 -172.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -115.24 147.35 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.702 2.001 . . . . 1.6699999999999999 112.558 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.14 148.29 44.9 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.886 1.274 . . . . 1.97 112.897 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.86 -4.96 51.06 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.617 1.103 . . . . 0.73999999999999999 115.42 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.3 p -74.61 154.49 38.52 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.477 1.638 . . . . 1.55 111.363 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.94 124.9 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.095 0.558 . . . . 1.6899999999999999 111.618 -169.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -86.73 139.64 30.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.469 1.107 . . . . 1.54 111.763 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -88.49 -70.49 0.64 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.255 -0.903 . . . . 3.5800000000000001 112.206 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -131.9 -160.66 1.06 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.746 1.618 . . . . 4.4699999999999998 109.208 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.86 -26.52 11.48 Favored Glycine 0 CA--C 1.529 0.908 0 O-C-N 119.684 -1.885 . . . . 3.4100000000000001 116.128 169.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.0 m 44.74 67.89 0.63 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.686 1.594 . . . . 2.7400000000000002 112.163 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mt -97.8 159.47 14.91 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.706 1.203 . . . . 2.02 113.115 -166.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.93 128.96 54.91 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.567 0.698 . . . . 2.8300000000000001 110.487 168.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.56 122.5 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.45 1.9 . . . . 2.6400000000000001 109.952 -169.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 21.0 p -82.46 119.29 24.01 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.936 0.789 . . . . 2.5899999999999999 110.316 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -97.45 113.96 25.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.457 1.103 . . . . 2.2400000000000002 111.195 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.1 p -108.37 4.8 24.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.24 1.816 . . . . 3.0099999999999998 112.77 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -137.69 136.52 37.48 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.922 1.289 . . . . 1.97 109.702 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -91.54 176.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.331 1.053 . . . . 3.8500000000000001 109.602 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.18 -31.95 66.55 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 120.835 1.652 . . . . 1.6499999999999999 113.952 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -45.1 65.08 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.633 1.216 . . . . 2.5299999999999998 113.353 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.32 -14.41 59.43 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.961 1.837 . . . . 2.7799999999999998 115.961 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.5 t -77.76 143.33 38.07 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.057 -1.027 . . . . 4.1900000000000004 112.829 -170.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.0 t -63.0 -31.77 72.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.917 0.71 . . . . 2.8399999999999999 112.917 -172.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.67 -51.33 65.82 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.315 1.046 . . . . 2.2200000000000002 112.491 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 p -72.92 -31.82 64.88 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.542 0.571 . . . . 2.3700000000000001 112.542 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.4 -42.13 98.78 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.428 0.558 . . . . 1.8200000000000001 111.71 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.99 -56.15 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.31 1.044 . . . . 2.73 110.153 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.34 -21.78 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 114.181 1.178 . . . . 1.8500000000000001 114.181 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -71.85 -43.5 65.39 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.218 0.917 . . . . 5.4900000000000002 111.917 170.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.35 -34.25 72.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.399 0.68 . . . . 3.98 111.713 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.19 -24.93 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.009 -1.057 . . . . 2.96 111.917 171.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.88 -27.72 65.05 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.853 -1.154 . . . . 3.25 111.874 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -72.37 -16.23 61.86 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.953 1.094 . . . . 4.9699999999999998 113.953 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.57 -60.6 2.14 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.977 -1.077 . . . . 4.3499999999999996 110.612 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 126.389 1.876 . . . . 5.2199999999999998 114.537 176.115 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 112.208 0.447 . . . . 3.04 112.208 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -72.11 -38.59 69.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.353 1.061 . . . . 5.6100000000000003 110.953 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.73 94.24 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.102 1.361 . . . . 3.2799999999999998 111.838 169.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tp -52.56 -33.79 47.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.92 0.888 . . . . 2.79 112.819 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.88 -50.07 14.21 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.704 0.802 . . . . 2.02 112.919 168.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -58.73 -32.83 69.57 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.726 1.211 . . . . 4.0599999999999996 114.032 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.83 -30.24 65.58 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.947 0.721 . . . . 2.5 112.947 173.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.4 mm -72.76 -42.22 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.844 0.858 . . . . 2.8999999999999999 111.718 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.6 m -68.38 -21.56 64.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.438 1.095 . . . . 1.48 113.224 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.01 -14.02 61.34 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.961 2.104 . . . . 2.73 114.671 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -87.04 149.76 24.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.425 1.011 . . . . 2.7400000000000002 113.184 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.13 173.79 11.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.73 1.612 . . . . 2.7000000000000002 114.61 -169.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.3 m -99.91 -43.88 6.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.809 1.644 . . . . 3.9300000000000002 110.706 168.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -139.18 165.42 27.22 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.601 1.56 . . . . 3.6600000000000001 113.04 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.72 173.38 11.55 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.053 1.741 . . . . 2.0099999999999998 112.3 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.2 m -131.32 111.3 11.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.899 1.279 . . . . 1.73 111.334 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.7 mt -98.84 145.42 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.478 1.911 . . . . 2.2000000000000002 109.884 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.5 133.61 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.373 -0.829 . . . . 3.1099999999999999 112.608 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.7 m -113.26 135.76 53.48 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.374 1.47 . . . . 2.7200000000000002 112.245 -172.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.9 mt -129.32 91.83 3.25 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.486 -1.301 . . . . 3.4300000000000002 107.486 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.69 4.94 45.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.81 1.244 . . . . 5.2800000000000002 111.67 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.2 m -149.86 127.6 11.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.822 3.249 . . . . 4.0700000000000003 106.988 176.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -35.24 68.56 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.196 1 C-N-CA 133.021 4.528 . . . . 6.29 118.484 -167.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.63 30.3 19.91 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.236 2.214 . . . . 5.2199999999999998 114.062 -174.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.5 pt -122.63 -23.07 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.247 1.819 . . . . 5.7599999999999998 113.927 -174.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.66 -60.27 3.31 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.883 1.068 . . . . 4.5 113.883 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 63.26 91.38 0.07 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.326 1.45 . . . . 6.2300000000000004 112.88 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.6 t -139.16 154.4 48.08 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.598 1.559 . . . . 2.0600000000000001 111.562 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.81 138.76 45.86 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.127 1.371 . . . . 2.8300000000000001 111.71 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -119.74 129.31 54.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.063 1.745 . . . . 3.3500000000000001 110.051 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.8 133.86 39.43 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.45 -1.406 . . . . 2.6200000000000001 110.608 168.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -135.08 158.15 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.332 1.053 . . . . 1.3400000000000001 112.835 -171.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.94 149.04 36.03 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.478 1.111 . . . . 4.1799999999999997 109.414 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.49 -29.49 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.291 1.589 . . . . 2.6000000000000001 115.291 -168.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -76.46 -7.15 54.5 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.369 -1.457 . . . . 3.4700000000000002 113.599 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.9 mt -100.74 -6.32 25.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.096 1.758 . . . . 1.8700000000000001 113.357 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 p -95.63 129.9 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.687 1.195 . . . . 2.5 109.013 169.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -141.32 -175.21 4.26 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.229 1.011 . . . . 5.5099999999999998 112.016 -169.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -65.9 15.53 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.475 2.769 . . . . 4.0199999999999996 118.475 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.07 9.87 3.59 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.282 1.42 . . . . 1.5600000000000001 115.344 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -94.32 148.55 22.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.063 1.431 . . . . 3.1000000000000001 113.818 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.1 mm -105.26 124.67 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.24 1.016 . . . . 3.02 110.03 171.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.5 mm -99.82 162.93 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.927 2.091 . . . . 2.6800000000000002 111.276 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -132.39 129.6 39.57 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.188 1.395 . . . . 2.6299999999999999 110.328 170.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.25 144.04 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.354 1.062 . . . . 1.5800000000000001 112.554 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -99.02 163.9 17.85 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.246 1.418 . . . . 3.0699999999999998 113.104 -174.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.34 106.58 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.826 2.351 . . . . 2.4900000000000002 109.385 166.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.45 68.26 1.16 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.255 1.407 . . . . 2.9100000000000001 110.311 -168.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.86 164.08 33.51 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 127.407 2.432 . . . . 1.79 109.497 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -125.34 153.09 43.86 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.521 1.16 . . . . 2.3199999999999998 112.798 -172.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -87.46 136.71 32.92 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 123.968 0.907 . . . . 2.8300000000000001 112.29 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -98.48 -18.03 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.934 3.09 . . . . 0.76000000000000001 115.587 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.86 166.88 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 127.936 2.494 . . . . 2.2999999999999998 108.422 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.18 142.35 27.72 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.185 0.902 . . . . 2.04 113.405 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -160.33 27.67 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.581 0.61 . . . . 0.77000000000000002 114.06 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.3 ttp-105 -116.19 136.25 53.18 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.567 1.147 . . . . 4.8499999999999996 112.888 -171.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -82.74 130.36 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 126.531 1.932 . . . . 1.8100000000000001 108.26 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.69 34.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.395 0.678 . . . . 2.21 112.328 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -166.71 132.67 2.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.088 1.355 . . . . 2.8199999999999998 109.709 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.95 -170.77 50.08 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 116.363 1.305 . . . . 0.98999999999999999 116.363 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 123.43 13.21 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.804 1.642 . . . . 3.2799999999999998 112.306 -173.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.57 176.68 9.64 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.169 0.988 . . . . 1.52 112.428 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 34.0 ttm -120.98 133.72 55.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.624 1.57 . . . . 1.9199999999999999 110.126 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.06 143.45 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.792 1.237 . . . . 1.03 111.514 -169.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -106.95 86.11 2.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.064 1.346 . . . . 2.0099999999999998 111.099 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -87.74 34.01 0.71 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.955 1.702 . . . . 1.8899999999999999 113.578 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -58.92 -34.34 71.61 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 117.182 2.29 . . . . 2.1899999999999999 117.182 -168.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.75 -48.59 4.66 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.805 1.184 . . . . 2.04 111.468 -174.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.7 mm -67.63 -48.89 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.739 0.816 . . . . 1.99 111.634 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.1 m -101.15 -32.84 10.36 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.946 1.298 . . . . 2.8900000000000001 110.715 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.74 5.41 61.35 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.67 1.129 . . . . 1.3 115.541 171.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.14 -51.02 71.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.027 1.331 . . . . 2.6499999999999999 111.603 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.21 35.8 15.26 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.9 1.68 . . . . 3.2999999999999998 112.793 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -154.19 154.53 29.89 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 129.923 3.289 . . . . 5.7999999999999998 109.08 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -64.19 136.63 52.66 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.5 2.8 . . . . 2.3100000000000001 113.604 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.6 t -130.56 129.81 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 125.471 1.509 . . . . 2.0099999999999998 111.999 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.73 146.44 32.37 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.06 1.134 . . . . 1.74 114.06 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.7 152.36 45.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.886 2.074 . . . . 1.1200000000000001 111.164 175.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -141.82 -176.38 0.56 Allowed Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 128.688 2.795 . . . . 4.5 107.782 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.84 148.89 90.8 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 CA-C-N 122.141 1.8 . . . . 2.3399999999999999 114.094 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.17 25.45 74.54 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.959 1.266 . . . . 1.3400000000000001 114.455 -172.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -115.01 147.69 39.78 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.753 1.277 . . . . 1.6100000000000001 111.034 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.1 p -99.08 147.67 24.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.183 1.356 . . . . 2.1099999999999999 113.286 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.0 168.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.4 1.88 . . . . 1.25 111.152 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.7 156.32 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.448 1.499 . . . . 2.8399999999999999 111.651 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.67 157.51 32.42 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.136 1.162 . . . . 2.1600000000000001 114.136 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.87 -7.2 15.8 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.159 0.885 . . . . 0.98999999999999999 115.113 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 m -90.92 156.98 17.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.716 1.206 . . . . 2.7599999999999998 110.417 172.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mm -102.42 141.47 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.938 0.895 . . . . 2.1000000000000001 111.39 -169.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -101.59 135.74 42.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.594 1.957 . . . . 1.9399999999999999 110.84 173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -153.57 140.45 19.16 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.91 1.284 . . . . 3.77 111.143 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.321 9.0 t30 95.98 -17.61 0.07 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 129.136 2.974 . . . . 3.9500000000000002 116.832 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.25 161.83 34.97 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 120.66 1.573 . . . . 1.8600000000000001 114.629 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.2 m -87.97 133.72 33.88 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.285 1.034 . . . . 2.1400000000000001 112.979 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.1 mt -128.96 162.52 27.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.988 1.715 . . . . 2.0800000000000001 112.814 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -117.89 132.78 56.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.86 0.864 . . . . 2.9900000000000002 109.923 167.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.76 131.16 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.708 1.203 . . . . 2.6699999999999999 111.468 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 29.9 p -85.05 115.08 22.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.662 0.665 . . . . 2.6400000000000001 109.607 168.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.53 118.16 21.13 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.637 0.775 . . . . 2.1499999999999999 109.526 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.7 p -119.19 11.91 12.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.537 1.135 . . . . 3.0499999999999998 113.275 -174.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -145.44 146.96 31.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.903 1.681 . . . . 2.21 111.149 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.3 p -112.07 -175.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.717 1.607 . . . . 3.9500000000000002 111.869 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.36 -18.27 55.12 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 119.826 -1.797 . . . . 3.2000000000000002 116.329 -172.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.62 -58.01 3.87 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.314 1.046 . . . . 5.25 111.74 169.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.41 -32.11 64.24 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.769 1.396 . . . . 3.9100000000000001 114.769 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 t -50.13 126.55 14.85 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.81 1.244 . . . . 3.4199999999999999 112.789 -168.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.4 t -54.06 -35.41 62.0 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.892 1.071 . . . . 3.2799999999999998 113.892 -168.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.06 -50.47 73.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.726 -1.234 . . . . 2.3799999999999999 112.241 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -71.56 -23.17 61.7 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.354 1.062 . . . . 2.54 112.194 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -74.05 -43.91 56.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.828 1.251 . . . . 2.7599999999999998 113.077 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.7 mt -55.9 -49.17 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.405 1.482 . . . . 2.3599999999999999 110.644 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.67 -18.65 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 114.324 1.231 . . . . 2.1200000000000001 114.324 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -72.55 -42.61 64.49 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.753 -0.642 . . . . 3.2400000000000002 111.28 168.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -54.04 10.7 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.411 1.484 . . . . 3.5600000000000001 112.382 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.92 -21.97 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.451 1.1 . . . . 2.4100000000000001 112.25 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.14 -30.94 67.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.006 1.322 . . . . 3.3300000000000001 113.027 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -77.32 -9.6 58.93 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.817 -1.177 . . . . 4.5999999999999996 114.041 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.16 -63.4 1.23 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.479 1.036 . . . . 3.5499999999999998 110.568 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.256 1.397 0 C-N-CA 125.796 1.638 . . . . 3.9500000000000002 114.133 -178.205 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 112.905 0.705 . . . . 5.0499999999999998 112.905 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -82.9 -26.91 31.06 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.313 -0.867 . . . . 6.3300000000000001 112.236 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.42 68.28 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.959 -1.088 . . . . 2.46 110.354 168.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.22 -30.36 71.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.649 1.179 . . . . 2.3700000000000001 112.439 172.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.19 -26.95 59.42 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.257 -0.902 . . . . 2.0600000000000001 113.317 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.91 -41.15 87.6 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.278 1.031 . . . . 2.9300000000000002 112.228 -169.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -50.02 -44.2 51.11 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.842 1.257 . . . . 2.0699999999999998 111.992 173.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -73.08 -35.3 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.355 1.062 . . . . 2.6800000000000002 112.104 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -70.38 -22.06 62.8 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.864 -1.147 . . . . 1.55 113.313 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.33 -19.95 65.52 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.955 1.094 . . . . 2.8799999999999999 113.955 170.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -70.99 169.51 14.76 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.696 1.135 . . . . 3.73 113.843 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.02 -24.94 9.63 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.769 1.396 . . . . 3.25 114.769 -174.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 m 67.76 -11.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.283 1.833 . . . . 4.1200000000000001 115.818 175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -130.03 157.86 41.2 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.284 1.833 . . . . 2.8199999999999998 112.061 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.45 162.69 34.73 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.006 0.923 . . . . 1.97 113.166 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.4 m -123.44 100.62 6.91 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.657 1.583 . . . . 1.9199999999999999 110.364 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.6 mt -85.29 146.14 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.47 1.508 . . . . 1.79 110.615 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.45 127.56 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.955 0.902 . . . . 2.9300000000000002 110.387 166.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.5 m -134.38 139.54 45.67 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.285 1.434 . . . . 3.2400000000000002 111.089 -170.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.47 114.17 23.83 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.362 -0.836 . . . . 4.5099999999999998 108.776 167.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -94.76 -11.17 29.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.681 1.192 . . . . 4.9900000000000002 111.378 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.8 m -156.4 140.63 16.54 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.662 1.985 . . . . 5.2699999999999996 110.248 167.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -42.87 69.42 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 130.61 3.564 . . . . 5.4299999999999997 119.493 -166.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 63.65 23.58 13.59 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.198 1.799 . . . . 5.9900000000000002 112.643 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 pt -124.61 -16.34 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 126.82 2.048 . . . . 6.3300000000000001 112.104 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.8 tp -136.97 80.5 1.82 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.725 2.01 . . . . 4.4199999999999999 108.767 169.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -85.41 123.68 31.14 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.14 -1.059 . . . . 4.2400000000000002 108.14 169.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -138.81 153.33 48.38 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.53 1.132 . . . . 2.04 110.832 -169.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.26 134.89 55.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.748 0.819 . . . . 2.3700000000000001 110.24 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -123.92 129.07 50.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.507 1.523 . . . . 3.46 110.858 -169.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.51 130.66 45.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.589 1.086 . . . . 3.2799999999999998 110.476 170.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.8 m -141.42 168.27 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.039 1.336 . . . . 2.4500000000000002 112.844 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -78.15 139.28 38.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.402 0.681 . . . . 3.1299999999999999 109.593 168.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.89 -22.67 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.708 1.744 . . . . 2.2000000000000002 115.708 -168.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -64.31 -21.06 66.48 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.609 -1.307 . . . . 5.1399999999999997 112.94 172.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.2 mt -99.2 -4.93 30.92 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.611 1.965 . . . . 3.0800000000000001 114.502 -169.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.3 m -74.35 -42.5 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.486 0.714 . . . . 4.0099999999999998 112.635 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.319 32.1 mt-30 60.54 146.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 128.248 2.619 . . . . 3.4900000000000002 116.043 -171.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -80.11 25.03 0.39 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 116.831 2.16 . . . . 3.9900000000000002 116.831 -167.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.25 8.25 12.37 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.107 1.337 . . . . 1.5800000000000001 113.662 170.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.24 169.9 8.23 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.253 1.421 . . . . 2.8999999999999999 114.173 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.7 mt -121.56 127.92 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.261 2.224 . . . . 2.29 109.69 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.1 mm -116.3 133.69 62.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.729 2.012 . . . . 1.6299999999999999 110.552 -170.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -79.52 142.7 35.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.296 1.438 . . . . 3.73 113.202 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 p -133.12 131.42 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.365 0.666 . . . . 1.8500000000000001 112.039 168.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.58 162.68 49.88 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 125.003 1.321 . . . . 2.4300000000000002 113.182 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -60.12 131.14 37.5 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.427 2.085 . . . . 1.53 110.733 166.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.37 -3.86 61.31 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.738 1.637 . . . . 0.89000000000000001 114.717 -170.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.17 170.08 53.52 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 118.48 1.14 . . . . 0.95999999999999996 113.829 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -115.25 144.4 43.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.565 1.146 . . . . 2.25 110.973 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -79.44 120.73 81.38 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-O 118.722 -0.656 . . . . 2.8199999999999998 109.868 175.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.35 -12.5 6.69 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.601 2.201 . . . . 0.81999999999999995 114.095 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -148.95 165.1 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.478 2.711 . . . . 2.0 109.446 -173.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -103.51 145.59 29.79 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.349 0.87 . . . . 2.25 113.349 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.95 -153.19 23.23 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.647 0.619 . . . . 0.78000000000000003 114.647 -172.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -117.31 132.45 56.6 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.704 1.202 . . . . 5.2699999999999996 112.734 -169.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.3 t -82.7 127.13 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.935 2.094 . . . . 1.6499999999999999 108.422 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 pt -140.71 32.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 122.745 1.26 . . . . 2.1200000000000001 113.017 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -168.21 126.66 1.17 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.746 2.419 . . . . 2.98 106.711 167.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.45 178.25 46.89 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 117.004 1.562 . . . . 1.0600000000000001 117.004 174.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -148.02 128.45 13.99 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.863 1.265 . . . . 2.9100000000000001 112.328 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 m -148.12 167.74 24.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.346 1.059 . . . . 2.04 113.133 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.3 ttm -111.4 108.39 17.94 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.822 1.249 . . . . 1.8300000000000001 109.939 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.7 t -87.64 158.35 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.465 1.906 . . . . 1.0900000000000001 112.536 -169.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -113.55 92.22 3.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.374 1.87 . . . . 1.9199999999999999 110.134 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.89 16.52 21.22 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.943 1.697 . . . . 2.1099999999999999 112.884 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -56.56 -29.39 61.96 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.252 1.821 . . . . 1.77 114.713 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -81.58 -32.18 32.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.256 1.389 . . . . 1.8600000000000001 111.866 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mm -77.76 -45.95 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.087 0.955 . . . . 2.0600000000000001 111.14 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 m -109.08 -12.58 14.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.336 1.454 . . . . 4.0599999999999996 112.751 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.28 6.47 80.15 Favored Glycine 0 CA--C 1.544 1.889 0 C-N-CA 125.219 1.39 . . . . 1.53 116.011 174.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.77 -38.22 89.75 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.693 1.197 . . . . 2.9399999999999999 113.995 -169.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 72.81 -17.77 0.38 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.949 2.5 . . . . 2.3399999999999999 113.886 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -92.08 150.07 39.81 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.14 1.776 . . . . 6.3899999999999997 110.665 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.53 153.6 30.7 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.356 2.704 . . . . 2.7200000000000002 112.243 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.73 124.85 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.586 1.154 . . . . 2.4900000000000002 111.851 -169.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.73 138.89 37.45 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.699 0.8 . . . . 2.4300000000000002 112.821 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -127.13 145.76 50.63 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.019 2.127 . . . . 1.21 110.451 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -144.04 172.31 5.69 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 128.618 2.767 . . . . 3.3100000000000001 109.605 -169.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -57.74 137.08 79.42 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.673 1.582 . . . . 1.2 110.943 168.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.0 17.81 79.83 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.954 1.264 . . . . 1.28 114.57 -172.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 t -101.79 161.02 13.97 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.006 1.903 . . . . 1.71 111.414 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 p -112.43 146.57 38.16 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.841 1.2 . . . . 2.0499999999999998 113.648 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.64 159.35 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.204 1.802 . . . . 1.77 111.964 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.35 152.1 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.896 1.678 . . . . 2.8300000000000001 112.176 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.96 149.99 39.07 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.737 -0.665 . . . . 1.72 112.52 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.69 -10.57 55.98 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.583 1.087 . . . . 0.78000000000000003 115.53 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.3 p -76.51 161.51 28.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.516 1.158 . . . . 1.6100000000000001 111.262 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -106.77 142.23 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.917 0.887 . . . . 1.77 110.913 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -99.74 143.23 30.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.714 1.606 . . . . 1.7 112.543 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -155.94 141.4 17.71 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.026 -1.046 . . . . 3.3599999999999999 112.15 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.26 17.3 t30 111.8 -42.07 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 1 C-N-CA 131.863 4.065 . . . . 3.8300000000000001 113.556 -178.279 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.16 -174.58 37.12 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 119.76 1.164 . . . . 2.0099999999999998 114.661 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.0 m -92.29 136.8 32.89 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.731 1.612 . . . . 2.3199999999999998 111.373 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 mt -130.81 160.97 32.81 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.553 1.141 . . . . 2.0 113.294 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.97 123.05 48.77 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.83 1.252 . . . . 2.6699999999999999 109.97 170.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.15 126.21 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.653 1.181 . . . . 2.1699999999999999 110.714 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 32.0 p -79.38 126.94 31.48 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.495 -0.753 . . . . 2.5 110.235 169.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.32 129.21 34.24 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.568 0.747 . . . . 1.1200000000000001 110.393 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.7 p -107.9 -8.86 15.84 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.657 0.984 . . . . 3.9399999999999999 113.657 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -145.82 150.29 35.9 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.31 1.444 . . . . 2.52 110.909 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 m -74.74 160.19 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 118.69 0.677 . . . . 2.8100000000000001 109.174 166.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.66 77.57 Favored Glycine 0 N--CA 1.475 1.242 0 N-CA-C 116.285 1.274 . . . . 2.1699999999999999 116.285 -165.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.49 -39.31 62.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.688 1.244 . . . . 3.8999999999999999 113.581 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -72.11 -6.02 39.55 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.402 1.481 . . . . 3.3100000000000001 114.106 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.0 p -51.48 151.29 3.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.381 1.473 . . . . 2.3900000000000001 114.035 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.19 -33.62 67.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.178 1.391 . . . . 3.27 111.173 169.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.82 -51.48 68.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.673 1.989 . . . . 2.5800000000000001 112.549 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.8 m -70.66 -18.19 62.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.441 0.534 . . . . 2.79 112.441 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -73.93 -39.25 63.93 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.497 -0.752 . . . . 2.0 112.613 169.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 87.4 mt -49.75 -51.9 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 119.892 1.224 . . . . 2.77 111.441 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.3 m -63.39 -29.41 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.273 -0.892 . . . . 2.5099999999999998 113.276 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -74.73 -33.52 62.38 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.838 0.855 . . . . 5.3399999999999999 112.556 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -39.47 75.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.978 1.711 . . . . 3.4399999999999999 110.528 174.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.4 t -61.18 -45.68 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.027 0.931 . . . . 2.5099999999999998 110.404 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.58 -9.97 40.74 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 116.293 1.96 . . . . 4.1500000000000004 116.293 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -71.13 -26.58 63.07 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 121.107 1.776 . . . . 6.79 111.848 168.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.28 -57.62 3.78 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.588 -0.695 . . . . 3.5899999999999999 111.463 173.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 C--O 1.252 1.192 0 N-CA-C 113.427 0.899 . . . . 4.9699999999999998 113.427 178.447 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 112.882 0.697 . . . . 4.2300000000000004 112.882 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 68.61 -49.33 0.57 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 128.224 2.609 . . . . 4.9400000000000004 112.818 -167.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.35 -11.82 60.86 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 121.134 -0.979 . . . . 2.6600000000000001 113.599 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 tp -59.41 -37.85 79.09 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.888 1.675 . . . . 2.6600000000000001 111.714 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.21 -18.82 63.18 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.075 0.768 . . . . 2.3599999999999999 113.075 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -61.15 -36.76 80.65 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.943 1.247 . . . . 3.6499999999999999 112.237 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.16 -42.24 96.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.877 0.871 . . . . 2.5 111.355 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -72.1 -36.29 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.167 0.587 . . . . 2.4199999999999999 111.704 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -69.02 -30.95 69.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.333 1.053 . . . . 1.8600000000000001 112.881 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -64.0 -32.84 74.52 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.695 1.998 . . . . 3.3799999999999999 112.979 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -77.48 129.89 36.3 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.94 0.791 . . . . 3.3199999999999998 112.395 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.97 156.42 36.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.124 0.97 . . . . 2.3999999999999999 112.787 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -108.75 -4.83 16.64 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.092 1.515 . . . . 3.1000000000000001 115.092 -167.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.29 160.54 39.9 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.285 -1.509 . . . . 3.9500000000000002 113.806 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.16 159.06 43.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.977 1.311 . . . . 1.96 112.988 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 90.0 m -119.08 106.15 12.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.441 1.497 . . . . 1.97 111.148 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mt -97.4 138.53 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.838 1.655 . . . . 1.4399999999999999 110.842 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -124.74 126.45 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.796 1.18 . . . . 3.1200000000000001 111.737 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 m -138.25 150.14 46.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.342 1.457 . . . . 3.6899999999999999 111.055 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -89.25 146.41 24.76 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.112 -0.992 . . . . 4.1500000000000004 112.181 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.87 -8.47 9.4 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.481 1.112 . . . . 3.8799999999999999 112.639 169.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -150.82 135.11 16.96 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.113 2.165 . . . . 3.3100000000000001 107.989 168.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -51.6 84.79 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 117.61 2.448 . . . . 4.6399999999999997 117.61 -165.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 62.48 23.58 14.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.508 2.323 . . . . 4.6900000000000004 113.557 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.8 pt -128.96 -19.88 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.883 1.673 . . . . 4.5300000000000002 112.359 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 tt -136.26 115.56 12.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.779 1.231 . . . . 3.8700000000000001 110.393 165.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 mp -98.83 148.63 23.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.257 1.423 . . . . 3.8100000000000001 111.606 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -141.0 133.62 28.66 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.016 1.726 . . . . 2.9399999999999999 109.871 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -127.41 139.28 52.94 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.265 -0.897 . . . . 3.8900000000000001 112.146 -176.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -114.61 145.82 41.54 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.277 1.431 . . . . 2.6699999999999999 112.166 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -117.23 110.73 18.48 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.0 1.32 . . . . 2.4500000000000002 108.283 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.9 m -127.86 164.65 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 114.531 1.308 . . . . 1.3 114.531 -166.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.79 146.41 37.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.549 -0.751 . . . . 3.1000000000000001 110.379 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.71 -23.61 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.26 0.837 . . . . 1.6499999999999999 113.26 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.36 -17.17 61.85 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.817 -1.177 . . . . 3.7599999999999998 112.984 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.7 mt -105.05 -12.26 16.24 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.404 1.882 . . . . 2.1400000000000001 114.525 -169.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.41 143.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.101 0.96 . . . . 2.0299999999999998 109.321 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -119.29 163.29 17.36 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.557 1.143 . . . . 3.48 112.327 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.64 135.64 50.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.67 -0.863 . . . . 3.8300000000000001 108.67 167.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.9 -10.85 32.12 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 124.86 1.219 . . . . 1.96 114.225 -169.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -88.15 152.07 22.25 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.334 1.454 . . . . 2.7999999999999998 113.773 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -105.26 118.92 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.546 1.539 . . . . 2.3799999999999999 110.321 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 mm -118.51 128.6 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.105 1.362 . . . . 1.8999999999999999 111.922 -169.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -90.99 139.97 30.27 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.209 -0.932 . . . . 2.5099999999999998 112.437 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.05 133.6 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.374 1.47 . . . . 1.4399999999999999 110.998 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 m -107.69 170.5 5.52 Favored Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 124.683 1.193 . . . . 1.96 113.751 -167.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -52.49 134.59 52.9 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.224 2.616 . . . . 1.6100000000000001 112.89 169.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.54 -13.68 3.75 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 116.017 1.167 . . . . 1.03 116.017 -175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.9 162.99 53.93 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 118.77 1.285 . . . . 0.95999999999999996 114.454 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -107.3 154.12 21.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.702 1.201 . . . . 3.1499999999999999 112.374 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -88.15 119.48 70.35 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.779 0.832 . . . . 3.5699999999999998 111.512 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.29 -15.2 5.47 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.363 2.709 . . . . 0.81999999999999995 114.924 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 m -152.45 171.47 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.988 2.515 . . . . 1.76 108.234 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.27 144.89 30.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.313 0.857 . . . . 1.72 113.313 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.16 -160.98 25.91 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 114.78 0.672 . . . . 0.79000000000000004 114.78 -173.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -115.89 140.54 49.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.156 1.382 . . . . 6.5999999999999996 112.408 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.41 127.67 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.792 2.437 . . . . 1.9299999999999999 109.198 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.5 pt -141.0 32.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.636 0.976 . . . . 2.0800000000000001 113.636 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -165.15 132.44 3.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.154 1.382 . . . . 3.7999999999999998 108.07 167.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.88 -172.71 48.28 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 116.297 1.279 . . . . 0.87 116.297 169.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -150.85 126.54 10.25 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.237 1.015 . . . . 2.6800000000000002 111.838 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.96 169.53 17.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.903 1.681 . . . . 1.8300000000000001 113.067 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.8 ttm -112.62 124.26 52.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.711 0.805 . . . . 2.3900000000000001 111.279 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.36 140.44 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.885 1.274 . . . . 0.92000000000000004 111.294 -170.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -104.93 111.96 24.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.001 1.32 . . . . 1.8600000000000001 109.461 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.47 15.25 5.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.883 2.073 . . . . 2.0 113.95 -169.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.5 p -51.73 -31.35 26.08 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.728 2.121 . . . . 1.74 116.728 -170.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.51 -34.09 35.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.265 1.393 . . . . 3.04 110.684 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.0 mm -78.4 -58.3 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.763 0.825 . . . . 2.0099999999999998 111.206 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 p -95.68 0.46 52.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.113 1.365 . . . . 2.75 113.779 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.07 20.73 79.66 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.215 1.388 . . . . 1.9299999999999999 113.983 174.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -72.65 -168.23 0.43 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.839 1.655 . . . . 2.6299999999999999 111.097 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.2 -34.19 0.17 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.232 1.813 . . . . 2.8399999999999999 110.917 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.4 mmt -85.06 157.84 59.26 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 125.494 1.517 . . . . 6.0999999999999996 110.852 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -68.68 160.49 49.3 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.246 2.631 . . . . 2.3799999999999999 112.677 167.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.4 t -125.27 130.14 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.958 1.703 . . . . 2.2000000000000002 111.728 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.59 131.35 36.7 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.964 0.906 . . . . 1.99 113.209 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -113.13 152.26 29.84 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.861 2.064 . . . . 1.01 110.855 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -141.3 177.72 1.82 Allowed Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 128.642 2.777 . . . . 4.4400000000000004 109.917 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -66.84 128.57 19.09 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 CA-C-N 121.679 1.635 . . . . 1.3799999999999999 109.703 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.65 25.27 28.16 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.457 1.503 . . . . 1.1799999999999999 114.945 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.5 m -108.12 174.56 5.83 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.903 1.351 . . . . 2.0699999999999998 110.855 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.2 p -130.75 150.37 51.96 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.081 -1.637 . . . . 2.3100000000000001 112.581 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.49 147.75 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.769 1.227 . . . . 1.3300000000000001 112.089 -172.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.87 148.28 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.837 1.655 . . . . 1.9099999999999999 112.868 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.83 144.8 54.28 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.821 0.849 . . . . 1.8999999999999999 112.484 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.31 -3.16 73.81 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.109 1.338 . . . . 0.79000000000000004 115.886 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.3 p -78.77 162.47 26.11 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.605 1.202 . . . . 1.6799999999999999 111.725 171.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.73 136.37 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.093 0.957 . . . . 1.8300000000000001 111.708 -171.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -91.01 146.12 24.12 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.814 1.646 . . . . 1.49 111.981 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -93.49 -93.36 0.16 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.325 1.05 . . . . 3.6699999999999999 111.396 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -136.83 131.43 33.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.958 1.703 . . . . 4.5800000000000001 108.935 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.13 114.41 1.63 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 108.848 -1.701 . . . . 2.1899999999999999 108.848 -167.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -94.31 114.74 26.86 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.961 0.904 . . . . 2.3300000000000001 110.108 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.9 mt -112.74 153.31 27.94 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.297 1.039 . . . . 1.9199999999999999 112.078 -169.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 tp -114.83 121.2 42.53 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.941 0.897 . . . . 3.7000000000000002 110.049 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 mm -113.62 129.09 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.646 1.578 . . . . 2.7200000000000002 110.981 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.9 p -86.79 116.67 25.03 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.064 -1.023 . . . . 3.0600000000000001 109.973 168.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.89 122.89 31.38 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.48 -0.762 . . . . 2.1099999999999999 110.111 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.8 t -124.1 10.85 8.81 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.52 0.933 . . . . 3.4399999999999999 113.52 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -137.19 140.29 41.65 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.545 1.138 . . . . 2.3700000000000001 110.929 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.5 p -97.11 170.53 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.013 1.325 . . . . 4.1299999999999999 111.212 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.33 -27.45 65.52 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 119.699 -1.876 . . . . 1.76 116.092 -169.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.86 -27.87 68.55 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.96 1.38 . . . . 2.8199999999999998 113.842 174.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.45 -16.62 60.31 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.42 1.267 . . . . 4.0300000000000002 114.42 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 74.0 p -63.01 125.02 22.6 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.66 0.985 . . . . 2.5800000000000001 113.66 -166.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.4 t -60.31 -35.66 76.12 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.238 0.615 . . . . 2.9100000000000001 111.925 -174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.0 mp -56.27 -50.5 71.17 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.469 1.107 . . . . 2.9300000000000002 112.298 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 91.9 p -70.78 -28.44 64.66 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.903 0.481 . . . . 2.5600000000000001 112.014 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -70.43 -43.29 70.24 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.859 -0.526 . . . . 2.3300000000000001 111.595 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 53.6 mt -54.71 -51.22 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.118 1.367 . . . . 2.7400000000000002 110.876 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.03 -25.21 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 113.752 1.019 . . . . 3.0499999999999998 113.752 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -73.34 -36.76 66.22 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.745 0.702 . . . . 3.9700000000000002 112.281 169.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.1 -33.33 73.32 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.637 0.775 . . . . 3.5 112.111 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.32 -59.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.839 1.256 . . . . 3.4900000000000002 112.089 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -68.22 -25.1 65.04 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.505 1.298 . . . . 4.46 114.505 -170.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.52 -12.62 61.15 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.417 1.462 . . . . 5.2699999999999996 114.492 170.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.86 -49.01 50.75 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.372 0.987 . . . . 5.6799999999999997 110.996 170.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.214 0 C-N-CA 126.203 1.801 . . . . 5.6299999999999999 113.239 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 113.0 0.741 . . . . 3.21 113.0 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -74.19 -31.01 62.48 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.012 1.278 . . . . 4.3499999999999996 112.193 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.33 88.17 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.184 0.994 . . . . 2.4199999999999999 112.549 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.95 -28.71 70.0 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.639 0.776 . . . . 2.4300000000000002 112.153 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.12 -37.25 58.3 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.326 0.65 . . . . 2.1499999999999999 111.956 167.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -63.05 -32.92 74.4 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.589 1.556 . . . . 4.9199999999999999 114.235 -176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.3 -31.65 70.47 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.992 1.269 . . . . 2.2799999999999998 111.738 172.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.4 mm -73.6 -45.26 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.728 0.811 . . . . 2.6299999999999999 110.973 166.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 m -68.39 -16.66 64.0 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 121.052 1.751 . . . . 1.6899999999999999 114.654 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.97 -30.23 67.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.396 1.478 . . . . 4.5499999999999998 112.446 169.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -77.92 130.75 36.97 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.771 0.828 . . . . 3.0499999999999998 110.694 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.9 167.59 20.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.839 1.256 . . . . 2.21 112.661 -176.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -106.15 -25.51 11.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.601 1.334 . . . . 3.23 114.601 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.66 152.69 44.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.941 1.296 . . . . 3.5699999999999998 113.969 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.33 171.8 13.56 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.484 1.514 . . . . 1.6000000000000001 112.396 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.2 m -125.49 108.46 11.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.735 1.214 . . . . 1.75 111.856 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.2 mt -82.06 140.64 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.19 1.396 . . . . 1.22 109.349 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.1 t -127.31 123.48 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.881 0.872 . . . . 2.71 111.109 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.1 m -136.83 151.27 48.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.104 1.362 . . . . 2.7999999999999998 110.92 -171.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.4 mt -94.89 127.24 40.78 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.722 0.809 . . . . 3.6200000000000001 110.42 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.47 -12.23 19.51 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.272 1.029 . . . . 3.4100000000000001 111.983 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -146.15 135.89 23.3 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.085 2.154 . . . . 3.7799999999999998 107.975 169.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.94 84.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 127.58 2.352 . . . . 5.0300000000000002 116.681 -166.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 57.87 35.55 25.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.74 1.616 . . . . 4.6600000000000001 112.732 -175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.5 pt -141.96 -22.21 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.819 1.648 . . . . 4.2400000000000002 113.121 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.9 tp -130.31 124.79 33.16 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.774 1.229 . . . . 3.5499999999999998 111.297 169.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.5 mp -107.94 138.79 43.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.896 1.679 . . . . 3.1299999999999999 111.179 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.4 t -142.63 128.63 19.6 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.312 1.045 . . . . 1.8 111.444 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -111.4 138.13 48.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.446 1.099 . . . . 2.9500000000000002 111.566 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -106.88 146.43 31.0 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.615 1.566 . . . . 4.0 110.958 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -113.34 126.08 54.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.809 0.731 . . . . 1.8600000000000001 109.796 169.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.8 160.12 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 115.098 1.518 . . . . 1.8999999999999999 115.098 -166.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -75.74 147.99 38.88 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.687 0.795 . . . . 3.4700000000000002 109.085 167.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.31 -9.52 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 114.536 1.31 . . . . 2.1200000000000001 114.536 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -79.79 -19.01 49.57 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.168 -1.583 . . . . 3.54 113.861 170.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.7 mt -96.48 -4.59 41.27 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.859 1.264 . . . . 2.3900000000000001 113.644 -173.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.51 141.26 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.433 1.493 . . . . 1.72 109.465 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -127.49 168.39 14.98 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.026 1.731 . . . . 2.9900000000000002 111.38 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -72.59 23.7 0.06 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.737 1.615 . . . . 3.9500000000000002 114.958 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.26 11.38 2.27 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.968 2.223 . . . . 1.3899999999999999 113.855 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -87.47 163.39 16.73 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.669 1.734 . . . . 2.6600000000000001 112.371 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 98.7 mt -118.29 126.45 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.185 1.394 . . . . 2.7799999999999998 109.216 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.2 mm -118.2 129.58 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.964 1.706 . . . . 1.97 112.044 -168.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -88.57 131.48 34.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.022 0.929 . . . . 3.0800000000000001 112.566 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 p -108.02 140.74 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.333 1.453 . . . . 1.8700000000000001 111.649 175.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 m -102.96 159.5 29.1 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 124.39 1.076 . . . . 1.8600000000000001 113.324 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.75 138.76 40.98 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.444 2.762 . . . . 1.46 112.287 169.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.08 -7.28 8.01 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.995 1.158 . . . . 1.0900000000000001 115.995 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.19 -179.38 48.79 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.423 1.487 . . . . 1.1699999999999999 115.023 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -123.43 151.98 42.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.493 1.517 . . . . 3.6800000000000002 112.62 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -78.01 122.38 85.36 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.093 0.957 . . . . 2.9900000000000002 110.179 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -88.3 -17.97 2.27 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.661 2.24 . . . . 0.92000000000000004 115.004 -170.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.72 170.83 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 128.586 2.755 . . . . 1.75 108.082 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.49 151.55 20.13 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.694 0.998 . . . . 2.1499999999999999 113.694 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.63 -160.26 33.69 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.4 0.524 . . . . 0.88 114.081 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -113.32 143.86 43.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.135 0.974 . . . . 5.4100000000000001 112.913 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.26 124.54 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 126.169 1.788 . . . . 2.4700000000000002 107.237 169.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.79 33.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.256 1.022 . . . . 2.1899999999999999 110.959 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -167.85 122.74 0.99 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.613 1.965 . . . . 3.23 108.511 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.02 177.28 43.65 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 116.22 1.248 . . . . 1.01 116.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -146.81 127.69 14.45 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.072 1.349 . . . . 2.9500000000000002 112.315 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.8 t -145.7 171.48 14.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.925 1.29 . . . . 1.96 112.685 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.7 ttm -115.68 125.56 53.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.508 1.523 . . . . 2.1400000000000001 108.88 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -122.99 140.54 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.721 1.208 . . . . 1.1000000000000001 112.443 -168.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -102.04 124.62 47.96 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.03 2.132 . . . . 2.1000000000000001 111.347 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -125.05 20.25 8.28 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.681 1.193 . . . . 2.5699999999999998 113.477 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.2 p -62.51 -3.56 1.5 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 117.742 2.497 . . . . 1.6699999999999999 117.742 -169.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.34 -45.6 4.63 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.685 1.194 . . . . 2.1400000000000001 109.403 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.7 mm -74.92 -56.77 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.567 1.147 . . . . 2.5099999999999998 112.321 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.4 p -107.64 -0.95 21.58 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.328 1.451 . . . . 2.5899999999999999 112.621 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.21 6.07 78.62 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.27 1.414 . . . . 1.78 114.937 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -71.32 106.17 3.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.207 1.003 . . . . 3.3799999999999999 111.733 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.48 -16.35 60.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.827 0.851 . . . . 2.48 112.375 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.7 ttt -113.42 136.85 21.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.041 1.736 . . . . 6.25 108.971 172.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.07 165.74 25.7 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.63 2.22 . . . . 2.3500000000000001 114.17 -168.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.06 138.68 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.142 1.777 . . . . 2.2000000000000002 111.065 -170.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.23 126.72 33.42 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.732 -0.605 . . . . 2.3700000000000001 112.017 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -98.62 151.04 21.12 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.29 1.436 . . . . 1.1299999999999999 110.067 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -137.08 175.79 3.24 Favored Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 126.112 1.765 . . . . 3.7400000000000002 109.679 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.82 65.96 4.91 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 123.395 2.73 . . . . 2.4900000000000002 111.631 172.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.02 29.98 0.02 OUTLIER Glycine 0 CA--C 1.538 1.479 0 C-N-CA 127.14 2.305 . . . . 1.9199999999999999 112.806 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -126.94 150.44 49.34 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.172 1.389 . . . . 1.8200000000000001 111.273 -170.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.1 p -98.29 148.81 23.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.793 0.837 . . . . 2.1299999999999999 112.631 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 m -140.08 148.24 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.751 1.621 . . . . 1.5700000000000001 111.796 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.64 148.66 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.253 1.421 . . . . 2.6899999999999999 112.51 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.38 142.0 55.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.141 0.976 . . . . 1.78 112.454 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.51 2.44 89.59 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 115.619 1.008 . . . . 1.23 115.619 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 76.0 p -79.22 153.37 30.02 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.012 1.406 . . . . 1.8 111.118 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 mm -112.56 132.51 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.127 0.971 . . . . 2.0800000000000001 112.796 -168.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -84.45 133.97 34.47 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.668 1.587 . . . . 2.9500000000000002 111.282 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.82 -72.66 0.44 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.437 0.637 . . . . 4.9199999999999999 110.071 168.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -143.91 155.93 44.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.425 2.29 . . . . 3.9900000000000002 107.877 172.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.93 108.04 2.88 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 127.45 2.452 . . . . 1.99 111.803 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.7 t -86.64 127.89 34.96 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.491 1.146 . . . . 3.2400000000000002 110.844 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -126.12 162.64 24.9 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.835 1.254 . . . . 2.1499999999999999 111.562 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -114.81 126.78 55.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.426 0.691 . . . . 2.7200000000000002 109.44 167.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.62 125.65 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.804 1.642 . . . . 2.3900000000000001 110.292 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.7 p -87.25 108.03 18.76 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.671 0.748 . . . . 2.9700000000000002 109.744 168.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.26 135.66 36.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.61 0.764 . . . . 1.3100000000000001 111.574 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.04 -0.14 9.54 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.586 1.328 . . . . 2.98 114.586 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -143.78 144.68 31.91 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.296 1.438 . . . . 1.78 111.827 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 m -83.6 162.92 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.024 0.93 . . . . 2.4199999999999999 110.974 169.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.63 -34.49 90.04 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 120.728 -1.233 . . . . 1.45 114.984 -168.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.25 -28.0 64.89 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.11 -1.229 . . . . 2.2799999999999998 113.056 175.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.27 -7.81 56.57 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.16 1.784 . . . . 2.7599999999999998 114.545 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.4 p -68.55 158.03 34.76 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.885 -1.135 . . . . 2.29 112.688 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 t -64.59 -33.19 75.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.19 0.596 . . . . 2.8199999999999998 111.254 170.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mp -55.66 -50.98 68.79 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.983 -1.073 . . . . 2.4500000000000002 111.107 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.0 m -69.29 -31.56 70.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.417 1.087 . . . . 1.95 111.928 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.19 -40.8 98.56 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.671 -0.643 . . . . 1.6899999999999999 111.718 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 70.0 mt -65.18 -50.7 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.843 1.657 . . . . 3.3500000000000001 111.108 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.2 m -65.21 -25.46 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 113.52 0.933 . . . . 2.0299999999999998 113.52 -175.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -72.72 -38.46 67.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.12 0.873 . . . . 5.2199999999999998 113.197 169.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.25 -52.12 13.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.459 1.904 . . . . 3.9300000000000002 113.482 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.8 t -69.47 -22.98 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.627 -1.295 . . . . 2.7599999999999998 111.762 -176.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.56 -24.58 64.63 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.556 1.142 . . . . 4.0199999999999996 112.642 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.86 -27.62 63.97 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.915 -1.116 . . . . 4.4199999999999999 113.775 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.74 -50.72 48.38 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.622 1.101 . . . . 5.0 110.298 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 125.045 1.338 . . . . 5.2199999999999998 113.088 170.028 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.131 1.16 . . . . 2.9100000000000001 114.131 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -74.16 -39.34 63.32 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.9 0.88 . . . . 4.4199999999999999 109.737 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.68 83.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.871 1.268 . . . . 2.9900000000000002 112.644 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.0 tp -65.06 -30.19 71.14 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.601 -0.687 . . . . 3.6099999999999999 111.891 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.69 61.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.583 0.753 . . . . 2.3900000000000001 112.439 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -58.84 -35.96 73.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.013 1.325 . . . . 3.7400000000000002 112.914 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -48.98 -49.97 38.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.892 0.877 . . . . 2.2599999999999998 112.236 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.8 mm -74.09 -36.84 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.672 0.789 . . . . 3.2799999999999998 112.622 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -58.91 -30.31 67.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.116 0.966 . . . . 1.51 113.053 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -22.06 61.72 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.938 1.295 . . . . 3.1600000000000001 114.308 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -62.84 162.84 10.38 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.997 1.48 . . . . 3.1000000000000001 114.997 -171.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.7 -31.08 12.86 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.97 1.308 . . . . 3.5499999999999998 114.291 -171.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m 64.32 -12.78 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 127.946 2.499 . . . . 3.27 116.437 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -140.9 149.05 41.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.212 1.805 . . . . 2.8599999999999999 111.204 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.21 173.06 11.92 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.504 1.122 . . . . 1.46 112.837 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.4 m -124.33 120.88 33.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.611 1.165 . . . . 1.75 111.967 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.9 mt -94.42 144.5 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.785 2.034 . . . . 1.9199999999999999 110.37 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.7 t -111.92 126.0 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.223 1.009 . . . . 3.48 110.878 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.6 m -135.88 152.77 51.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.791 1.636 . . . . 2.8900000000000001 111.331 -172.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -78.71 141.31 38.0 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.122 0.874 . . . . 5.46 111.493 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.46 -9.39 10.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.746 1.218 . . . . 4.7300000000000004 113.143 172.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.1 m -152.7 145.53 24.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.495 1.918 . . . . 3.6200000000000001 110.528 169.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 25' ' ' ILE . 37.4 t70 -39.29 78.8 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 130.713 3.605 . . . . 6.4800000000000004 116.725 -167.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 66.05 -22.71 0.09 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.812 2.445 . . . . 8.0399999999999991 114.563 -170.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.432 ' H ' ' C ' ' A' ' 23' ' ' ASP . 43.5 pt -82.24 -15.57 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 128.586 2.755 . . . . 5.3099999999999996 115.138 -170.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tt -138.3 132.6 31.89 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.048 1.129 . . . . 3.5499999999999998 114.048 170.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mp -106.14 147.76 28.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.337 2.255 . . . . 4.0999999999999996 111.594 172.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -136.75 145.47 44.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.729 1.612 . . . . 2.3399999999999999 110.5 169.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -109.79 130.1 55.56 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.143 0.497 . . . . 2.8199999999999998 111.68 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -118.27 132.52 56.29 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.384 2.273 . . . . 3.9199999999999999 110.19 -170.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -93.52 139.17 31.05 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.097 1.317 . . . . 2.1800000000000002 112.312 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.96 166.09 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.68 1.592 . . . . 1.45 114.02 -171.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.79 150.58 24.95 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.375 1.47 . . . . 3.21 109.621 166.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.45 -19.48 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 114.295 1.22 . . . . 2.2599999999999998 114.295 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.32 -21.73 60.5 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.703 -1.248 . . . . 3.8199999999999998 113.866 172.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.8 mt -101.87 -7.43 22.48 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.806 1.242 . . . . 1.8600000000000001 113.808 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -86.23 142.35 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.835 1.254 . . . . 1.98 109.631 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -117.19 168.36 10.37 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.471 1.108 . . . . 4.4199999999999999 113.292 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -67.62 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.98 2.112 . . . . 3.4399999999999999 115.711 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.77 12.22 0.63 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.484 1.993 . . . . 1.45 114.277 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -92.42 152.31 19.78 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.739 1.769 . . . . 2.71 112.702 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -102.0 121.99 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.716 1.206 . . . . 2.7000000000000002 110.281 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.0 mm -104.56 159.95 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.796 1.638 . . . . 1.79 112.273 -172.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -129.47 132.89 47.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.688 1.595 . . . . 2.8500000000000001 111.332 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.57 140.8 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.225 1.01 . . . . 1.5800000000000001 112.542 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -95.03 159.34 33.27 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 125.233 1.413 . . . . 2.0800000000000001 112.859 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.0 133.96 43.9 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.058 2.505 . . . . 1.6200000000000001 111.891 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.29 -12.04 61.63 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.539 1.542 . . . . 0.94999999999999996 114.7 -172.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.61 173.76 52.85 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.216 1.389 . . . . 0.98999999999999999 114.726 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -108.45 154.07 22.4 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.55 1.54 . . . . 3.8199999999999998 113.259 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -84.03 121.75 75.78 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.887 0.875 . . . . 2.9700000000000002 110.818 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.79 -21.06 2.82 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.974 2.449 . . . . 0.91000000000000003 115.816 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -152.04 163.08 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 128.08 2.552 . . . . 2.2000000000000002 108.906 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 136.78 32.84 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 112.818 0.673 . . . . 1.7 112.818 -172.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.3 -161.86 32.89 Favored Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.635 -0.666 . . . . 0.81999999999999995 114.148 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.7 ttp85 -109.91 134.01 52.54 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.204 1.801 . . . . 4.9800000000000004 112.976 -172.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.5 133.53 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.524 2.329 . . . . 1.8799999999999999 108.77 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.62 32.46 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.951 0.901 . . . . 2.1699999999999999 112.817 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -167.16 136.17 2.74 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.222 1.809 . . . . 3.04 109.005 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.18 -177.19 51.85 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 122.417 1.01 . . . . 0.95999999999999996 115.559 170.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -144.01 124.71 14.13 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.653 1.181 . . . . 2.8999999999999999 111.746 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m -149.28 166.49 28.77 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.23 1.567 . . . . 1.9399999999999999 115.23 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.6 ttm -114.67 119.57 37.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.142 1.377 . . . . 2.4500000000000002 108.884 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.39 134.37 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.882 1.673 . . . . 1.0900000000000001 112.363 -167.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -86.73 75.79 9.59 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.702 1.601 . . . . 2.2000000000000002 110.316 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.67 4.62 53.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.205 1.402 . . . . 2.2200000000000002 113.718 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.1 -23.87 66.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 115.511 1.671 . . . . 3.0099999999999998 115.511 -169.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.72 -21.13 57.82 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.434 1.015 . . . . 2.3700000000000001 112.029 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -86.94 -49.84 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.935 0.894 . . . . 2.6600000000000001 110.968 176.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.4 p -100.19 -7.7 24.43 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.436 1.273 . . . . 2.3599999999999999 114.436 -172.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.98 -1.06 56.77 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.336 1.446 . . . . 1.6100000000000001 115.186 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.94 -6.76 1.41 Allowed 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 119.822 1.811 . . . . 2.8900000000000001 115.094 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 45.24 26.37 0.25 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 130.746 3.618 . . . . 2.9700000000000002 115.537 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 ttm -166.49 135.39 2.38 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.618 1.967 . . . . 4.7999999999999998 108.779 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.88 162.84 40.58 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.215 3.277 . . . . 2.1299999999999999 114.474 -169.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.99 135.57 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 126.198 1.799 . . . . 2.6000000000000001 110.991 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.8 141.98 35.74 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.826 0.85 . . . . 2.1800000000000002 112.977 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -128.87 149.54 50.72 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.829 2.052 . . . . 1.3 111.04 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -151.46 171.67 6.25 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 128.757 2.823 . . . . 3.71 108.977 -173.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.78 134.57 63.6 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 CA-C-N 122.36 1.879 . . . . 1.1200000000000001 111.699 169.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.78 31.14 45.38 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.052 0.834 . . . . 1.1000000000000001 114.19 -170.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.2 t -122.05 159.82 26.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.835 1.254 . . . . 2.04 110.827 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.0 p -118.77 155.43 31.14 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.547 1.521 . . . . 2.0 113.732 -172.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.1 m -132.2 152.41 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.61 1.964 . . . . 2.75 111.568 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.464 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -100.71 -1.26 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.844 2.058 . . . . 4.0599999999999996 116.041 -176.279 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 70.07 159.98 0.2 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.171 1.788 . . . . 2.29 114.484 -167.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.7 -44.27 2.5 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.011 1.291 . . . . 1.6799999999999999 113.277 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.5 p -51.33 151.29 3.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.373 1.069 . . . . 1.8100000000000001 113.741 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.59 136.13 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.229 1.012 . . . . 2.2799999999999998 110.462 -172.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -83.3 129.9 35.03 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.05 0.94 . . . . 1.8999999999999999 109.121 169.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -134.49 63.6 1.62 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.911 0.708 . . . . 4.4699999999999998 112.911 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -158.31 -56.1 0.07 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.51 1.67 . . . . 4.2400000000000002 115.51 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.9 -174.43 31.77 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.247 1.259 . . . . 2.1200000000000001 116.247 -167.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.4 p -94.31 126.46 39.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.857 1.263 . . . . 3.0800000000000001 112.54 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 mt -136.0 161.79 34.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.333 1.053 . . . . 2.0800000000000001 113.255 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -120.61 139.0 53.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.291 1.036 . . . . 2.7000000000000002 111.591 168.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.36 133.07 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.209 1.404 . . . . 2.6200000000000001 111.244 -173.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.6 p -90.28 118.76 30.03 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.145 -0.972 . . . . 2.4700000000000002 111.307 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.46 121.0 24.64 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.083 -1.011 . . . . 1.22 110.782 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.4 p -125.95 11.21 7.69 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.818 1.247 . . . . 3.7000000000000002 113.612 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -139.6 135.29 33.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.163 1.785 . . . . 1.99 108.137 171.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 p -78.66 160.65 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 122.962 0.505 . . . . 3.8700000000000001 109.697 169.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.28 -32.86 68.62 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 120.819 -1.176 . . . . 1.55 115.875 -168.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.48 -40.12 73.82 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.356 1.578 . . . . 2.1400000000000001 113.243 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.33 -7.67 53.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.703 2.001 . . . . 2.4199999999999999 114.385 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 67.6 p -58.48 149.25 25.71 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.988 -1.07 . . . . 2.6699999999999999 113.547 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.0 t -60.09 -36.57 77.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.663 0.785 . . . . 3.3700000000000001 111.309 171.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.2 tp -58.48 -47.01 85.46 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.841 -1.162 . . . . 2.2799999999999998 112.792 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 t -70.9 -26.96 63.46 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.337 0.655 . . . . 2.6299999999999999 112.404 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -71.25 -42.77 68.41 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.516 1.126 . . . . 1.5600000000000001 111.818 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.4 mt -54.31 -50.68 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.158 0.983 . . . . 2.6299999999999999 110.574 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.7 m -68.62 -29.47 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 120.958 -1.089 . . . . 1.6799999999999999 113.292 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -70.81 -29.28 65.41 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.286 -0.884 . . . . 2.9100000000000001 112.285 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.0 mt -76.56 -51.77 11.01 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.73 1.612 . . . . 3.9900000000000002 112.649 168.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.65 -28.19 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.317 1.047 . . . . 2.9900000000000002 112.507 -171.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -65.08 -34.47 78.48 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.701 -1.25 . . . . 4.0999999999999996 111.636 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -80.73 -14.0 58.5 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.134 1.161 . . . . 3.75 114.134 173.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.26 -24.26 59.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.543 1.137 . . . . 5.3499999999999996 113.586 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 128.436 2.694 . . . . 5.21 114.249 177.896 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.9 p . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 113.763 1.023 . . . . 3.8300000000000001 113.763 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -77.03 -33.79 57.34 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.714 -1.242 . . . . 4.3700000000000001 110.946 168.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.93 -35.78 80.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.514 0.725 . . . . 2.0600000000000001 111.893 176.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.8 tp -49.25 -43.14 42.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.587 1.555 . . . . 2.73 111.797 171.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.93 -35.97 62.16 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.276 0.843 . . . . 2.0800000000000001 113.276 172.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -64.57 -31.24 72.38 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.941 0.792 . . . . 4.1200000000000001 112.801 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.44 -32.65 70.41 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.97 1.259 . . . . 2.3999999999999999 112.569 172.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.6 mm -73.08 -40.71 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.397 -0.814 . . . . 3.2400000000000002 111.725 169.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.5 m -70.83 -21.06 62.49 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.142 1.164 . . . . 1.3600000000000001 114.142 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -72.84 -9.97 59.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.653 1.581 . . . . 3.0099999999999998 113.807 173.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -89.28 132.92 34.69 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.071 0.85 . . . . 3.4300000000000002 113.094 -172.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.48 161.13 31.52 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.445 1.498 . . . . 3.6400000000000001 114.43 -169.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 p -123.6 -26.3 4.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.587 1.555 . . . . 2.8399999999999999 113.833 -179.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.58 153.19 43.3 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.438 1.095 . . . . 3.3500000000000001 113.242 177.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.63 165.66 26.88 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.211 1.404 . . . . 1.4399999999999999 112.786 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -118.61 98.41 6.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.658 1.183 . . . . 2.3700000000000001 112.159 -178.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.2 mt -83.24 129.6 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 121.252 -0.905 . . . . 1.3600000000000001 110.496 -177.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.94 109.28 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 108.478 -0.934 . . . . 2.6099999999999999 108.478 169.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -104.41 149.94 24.97 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.803 1.641 . . . . 3.2200000000000002 110.144 -177.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.44 103.49 14.85 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.387 -0.82 . . . . 4.0099999999999998 109.971 178.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.81 -1.53 58.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.454 1.502 . . . . 4.4400000000000004 113.68 -174.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.6 m -156.13 133.21 10.59 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.496 1.918 . . . . 3.5600000000000001 107.933 167.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 t70 18.04 -117.09 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 130.025 3.33 . . . . 6.2300000000000004 110.667 -166.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.01 12.44 34.16 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.565 1.146 . . . . 5.4800000000000004 110.201 163.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.5 pt -94.78 -29.83 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.931 2.492 . . . . 5.3899999999999997 116.939 -167.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.44 108.82 17.38 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.935 1.243 . . . . 3.7400000000000002 111.417 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 mp -88.29 120.16 29.39 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.998 1.319 . . . . 3.2599999999999998 109.559 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 t -137.93 127.96 25.74 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.333 1.053 . . . . 2.0600000000000001 110.476 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -102.76 146.94 27.49 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.478 -0.764 . . . . 2.6099999999999999 112.459 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -127.75 138.37 52.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.965 1.706 . . . . 3.5299999999999998 110.41 -169.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -99.69 116.75 32.53 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.487 0.715 . . . . 2.6299999999999999 109.334 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.95 166.07 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.008 0.923 . . . . 1.28 113.146 -172.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -88.13 160.82 17.61 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.582 1.553 . . . . 3.8300000000000001 112.565 169.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.55 -28.36 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 115.472 1.656 . . . . 3.0800000000000001 115.472 -171.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -75.99 -17.23 59.78 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.272 -1.517 . . . . 4.3899999999999997 112.554 172.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -94.78 -8.78 36.54 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.176 1.39 . . . . 2.0899999999999999 113.723 -172.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.73 139.02 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.945 1.698 . . . . 1.5900000000000001 109.392 168.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.63 168.04 20.26 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.281 1.432 . . . . 3.1099999999999999 112.597 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -68.91 4.84 1.32 Allowed 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 117.531 2.419 . . . . 5.0 117.531 -167.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.16 7.35 16.63 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.667 1.603 . . . . 1.7 114.21 172.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -90.04 152.78 21.01 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.058 1.429 . . . . 2.71 112.929 -177.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.1 mm -113.45 122.47 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.927 1.691 . . . . 2.6299999999999999 109.86 177.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.3 mm -113.28 125.04 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.992 1.317 . . . . 2.1800000000000002 111.562 -172.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -78.74 132.48 36.96 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.443 -0.786 . . . . 3.29 110.508 169.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 p -121.85 133.86 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.337 1.455 . . . . 1.3600000000000001 111.206 176.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 m -89.06 162.22 38.42 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.766 1.226 . . . . 2.2000000000000002 113.389 -173.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -61.28 133.7 47.95 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.695 1.597 . . . . 1.78 109.196 167.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.96 -10.69 46.05 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.515 -1.158 . . . . 1.1200000000000001 115.426 -172.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.53 175.17 44.07 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.038 1.419 . . . . 1.0600000000000001 114.403 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -111.63 153.34 26.49 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.463 1.505 . . . . 2.6499999999999999 112.055 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -84.17 128.67 61.45 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-O 118.101 -0.952 . . . . 3.8300000000000001 109.717 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -96.9 -14.46 0.4 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.912 2.408 . . . . 0.88 115.482 -173.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.37 164.62 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 127.716 2.406 . . . . 2.1600000000000001 108.336 -176.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -88.46 155.09 19.87 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.412 1.264 . . . . 2.4700000000000002 114.412 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.74 -131.26 2.4 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.362 -0.835 . . . . 1.0600000000000001 113.735 177.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -135.72 146.39 47.65 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.233 1.197 . . . . 4.7599999999999998 114.233 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.77 122.77 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 105.628 -1.99 . . . . 2.3500000000000001 105.628 166.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.2 pt -137.0 33.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.816 0.817 . . . . 2.1400000000000001 112.109 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -167.62 128.54 1.46 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.069 2.148 . . . . 2.8100000000000001 107.75 166.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.66 -178.12 54.09 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 122.842 1.246 . . . . 0.80000000000000004 115.374 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -149.13 137.04 20.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.391 1.476 . . . . 3.9700000000000002 111.414 -176.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -150.76 176.68 10.81 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.481 0.919 . . . . 2.1400000000000001 113.481 176.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.5 ttm -112.89 126.95 56.02 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.334 1.054 . . . . 1.8 110.678 171.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -114.33 140.77 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.206 1.402 . . . . 0.94999999999999996 112.774 -168.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -97.38 107.67 20.23 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.456 1.502 . . . . 1.95 109.554 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.256 11.2 pt-20 -123.75 30.15 6.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.483 1.513 . . . . 2.2200000000000002 113.063 -178.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.3 p -60.63 -24.22 65.36 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.966 1.839 . . . . 2.1699999999999999 115.966 -175.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -95.47 -33.61 12.38 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.079 1.351 . . . . 1.72 111.352 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.0 mm -76.5 -49.34 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.531 -0.731 . . . . 2.0600000000000001 110.632 178.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 m -106.85 -21.5 13.0 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.535 1.134 . . . . 3.5099999999999998 113.277 -169.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.59 -13.69 64.87 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.584 1.564 . . . . 1.26 115.78 172.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -63.86 118.31 8.19 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.475 1.138 . . . . 3.1000000000000001 110.215 174.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.25 35.05 0.32 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.187 1.395 . . . . 2.7799999999999998 112.829 -178.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 ptp -154.14 137.13 10.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.367 1.867 . . . . 5.0099999999999998 110.239 -174.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -63.23 154.93 64.69 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.861 2.374 . . . . 2.3599999999999999 115.193 -179.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.4 t -122.76 132.23 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.999 1.72 . . . . 1.74 111.04 -170.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.25 35.56 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.964 0.887 . . . . 2.3900000000000001 113.289 -175.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -125.01 150.57 46.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.539 1.936 . . . . 1.97 110.61 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -150.09 173.9 3.92 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 129.621 3.169 . . . . 3.6499999999999999 108.415 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -56.14 136.81 77.08 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 CA-C-N 121.702 1.644 . . . . 0.96999999999999997 111.573 170.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.94 25.98 72.33 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.602 1.096 . . . . 0.89000000000000001 114.465 -171.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.4 m -102.05 146.98 27.15 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 119.139 1.469 . . . . 2.0499999999999998 110.575 174.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.7 p -88.83 151.76 22.17 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.184 1.357 . . . . 1.8999999999999999 113.148 178.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -138.52 157.04 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.04 1.336 . . . . 2.0299999999999998 112.01 176.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.75 150.18 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.095 2.158 . . . . 1.8899999999999999 111.282 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.86 148.54 49.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.913 0.885 . . . . 1.75 113.334 -174.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.44 -3.46 62.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.348 0.975 . . . . 0.76000000000000001 115.106 179.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.2 p -79.5 157.2 27.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.951 1.375 . . . . 1.71 111.07 169.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mm -115.13 130.52 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.551 0.74 . . . . 1.8400000000000001 112.645 -168.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -90.07 149.26 22.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.882 1.673 . . . . 1.6599999999999999 113.669 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -157.67 142.9 16.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.403 1.081 . . . . 4.0700000000000003 112.61 171.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 t30 117.47 -40.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 131.255 3.822 . . . . 4.1100000000000003 113.514 175.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.62 -179.79 46.35 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 120.031 1.287 . . . . 2.1800000000000002 115.281 173.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.4 m -82.35 134.21 35.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.416 1.086 . . . . 2.6600000000000001 112.616 -177.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.39 165.16 20.29 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.128 1.771 . . . . 2.3300000000000001 111.619 -176.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.43 132.96 55.91 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.607 0.718 . . . . 3.04 111.026 168.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.7 mm -118.14 125.12 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.053 1.741 . . . . 2.5099999999999998 110.283 -169.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -82.73 114.65 21.23 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.383 -0.823 . . . . 2.3599999999999999 109.065 168.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.04 112.67 15.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.338 -0.986 . . . . 1.1799999999999999 108.338 174.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -104.6 2.56 30.79 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.932 0.893 . . . . 2.9900000000000002 112.746 -172.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -147.76 154.39 40.46 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.7 1.6 . . . . 2.2400000000000002 111.665 173.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.06 165.63 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.896 1.278 . . . . 2.9700000000000002 112.181 170.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 -35.21 85.42 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 120.906 -1.121 . . . . 1.6000000000000001 114.283 -172.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.91 -31.69 72.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.455 1.128 . . . . 2.3399999999999999 113.64 176.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -75.19 -17.63 60.32 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.127 -0.983 . . . . 2.9500000000000002 113.58 174.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 81.6 p -64.65 144.6 57.11 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.899 -1.126 . . . . 2.4199999999999999 112.566 -169.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -64.55 -22.85 67.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.899 0.879 . . . . 2.9199999999999999 113.065 -169.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.64 -49.33 78.19 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.68 1.192 . . . . 2.3500000000000001 113.107 -177.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.8 m -72.83 -17.34 61.56 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.533 0.938 . . . . 3.8100000000000001 113.533 173.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -76.92 -40.89 45.58 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.736 0.643 . . . . 1.5800000000000001 112.736 172.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.13 -47.31 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.6 1.56 . . . . 2.4100000000000001 110.386 177.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.13 -18.7 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 114.479 1.288 . . . . 2.1299999999999999 114.479 -178.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -72.03 -33.25 67.87 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.562 1.074 . . . . 4.9000000000000004 112.504 171.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 mt -75.32 -50.73 15.11 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.405 1.082 . . . . 3.9700000000000002 111.603 170.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -66.44 -29.1 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.03 0.932 . . . . 2.79 112.122 -174.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -60.16 -38.85 84.41 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.417 -1.427 . . . . 4.5199999999999996 112.524 173.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.04 -13.54 59.71 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.52 -1.363 . . . . 6.54 114.478 171.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.43 -27.43 62.33 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.704 1.001 . . . . 6.3399999999999999 113.704 -176.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 124.523 1.129 . . . . 5.5599999999999996 111.268 169.249 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 114.174 1.175 . . . . 4.5700000000000003 114.174 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -87.17 -24.49 24.45 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.795 1.238 . . . . 6.5700000000000003 111.741 168.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.9 -27.15 60.11 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.011 0.924 . . . . 3.1299999999999999 112.48 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.25 -44.85 84.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.253 1.421 . . . . 2.3999999999999999 111.797 176.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.82 -8.61 56.33 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.286 1.217 . . . . 2.5800000000000001 114.286 175.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -65.25 -43.01 92.71 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.818 1.19 . . . . 2.98 110.607 -177.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -45.86 -52.93 10.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.246 1.818 . . . . 2.54 112.246 172.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.1 mm -69.78 -31.32 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.11 0.964 . . . . 3.02 112.183 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.9 m -75.46 -28.3 59.23 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.01 1.324 . . . . 2.25 113.627 -175.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.32 -24.14 67.73 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.265 0.938 . . . . 3.0099999999999998 113.519 175.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -68.25 139.47 56.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.886 1.275 . . . . 2.9399999999999999 113.465 -175.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.87 157.28 29.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.604 1.161 . . . . 2.4900000000000002 112.561 173.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.54 -2.25 17.72 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.7 1.741 . . . . 3.0800000000000001 115.7 -169.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.31 156.74 48.21 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.862 1.665 . . . . 3.8999999999999999 112.526 -178.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.72 147.3 37.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.034 0.934 . . . . 1.8 113.108 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.2 m -107.98 106.45 16.71 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.597 1.159 . . . . 1.8700000000000001 111.369 175.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mt -83.48 147.22 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.178 1.791 . . . . 1.8600000000000001 109.486 176.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.16 140.24 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.636 1.347 . . . . 3.1899999999999999 114.636 169.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 p -126.22 142.49 51.51 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.575 1.55 . . . . 3.5299999999999998 114.4 -178.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.55 82.81 8.11 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.287 1.042 . . . . 4.3099999999999996 108.268 169.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -78.15 -33.65 50.22 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.869 1.268 . . . . 4.6600000000000001 112.07 178.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -142.59 125.04 15.65 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.577 1.951 . . . . 4.3300000000000001 109.502 170.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -10.51 62.43 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.219 1 C-N-CA 135.942 5.697 . . . . 5.7599999999999998 117.168 -178.958 . . . . . . . . 4 4 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 59.19 -21.16 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.349 2.26 . . . . 4.6100000000000003 115.41 -168.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.419 ' H ' ' C ' ' A' ' 23' ' ' ASP . 8.0 pt -58.45 -27.53 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 128.751 2.82 . . . . 4.8099999999999996 115.499 177.048 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 tp -105.65 -55.96 2.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.586 0.754 . . . . 4.1100000000000003 112.495 177.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.8 tp 40.61 80.9 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.08 2.152 . . . . 4.04 112.388 -173.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -79.08 153.6 30.05 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.231 1.013 . . . . 2.3700000000000001 112.501 -172.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -116.08 131.63 56.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.111 1.364 . . . . 2.6499999999999999 110.214 176.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -126.33 136.07 52.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.214 1.806 . . . . 3.98 110.171 -176.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -110.2 130.98 55.45 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.466 -1.396 . . . . 1.99 112.252 -175.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.81 169.14 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.922 1.289 . . . . 1.95 113.62 -173.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -79.58 152.42 30.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.24 1.416 . . . . 3.3799999999999999 112.494 171.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.77 -18.76 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 115.189 1.552 . . . . 2.3799999999999999 115.189 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -85.46 -19.92 30.54 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 120.623 1.556 . . . . 3.04 113.503 169.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.16 -17.7 21.55 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.046 1.338 . . . . 2.3700000000000001 113.558 -173.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.54 138.69 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.766 0.827 . . . . 2.1899999999999999 109.235 168.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -118.82 159.27 24.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.196 0.998 . . . . 3.5299999999999998 111.123 178.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.2 ptt85 -69.59 146.6 51.62 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.899 -0.501 . . . . 3.2799999999999998 109.984 169.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.12 2.8 56.9 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-N 118.852 0.751 . . . . 2.27 114.077 -171.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -112.98 172.87 6.67 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.612 1.565 . . . . 2.3700000000000001 112.102 173.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.3 mm -112.69 122.95 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.734 1.614 . . . . 2.54 110.483 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.6 mm -119.5 132.89 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.458 1.503 . . . . 2.23 111.429 -169.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -86.74 142.24 28.3 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.322 1.449 . . . . 3.77 112.456 174.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.35 145.4 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.58 0.752 . . . . 1.3500000000000001 111.749 170.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.78 156.75 35.17 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 124.98 1.312 . . . . 2.1200000000000001 113.323 -177.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -59.64 140.18 92.41 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.352 2.035 . . . . 1.99 110.679 168.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.57 -5.34 11.21 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.748 1.166 . . . . 1.05 114.906 -172.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.64 169.99 53.81 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 118.817 1.308 . . . . 0.98999999999999999 114.241 177.032 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -123.25 152.05 41.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.07 1.748 . . . . 2.8999999999999999 110.606 -178.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -81.05 127.51 74.13 Favored Pre-proline 0 CA--C 1.551 0.988 0 O-C-N 121.629 -0.669 . . . . 3.0099999999999998 111.575 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.13 -20.66 2.76 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.581 2.854 . . . . 1.1899999999999999 113.493 177.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 m -147.99 170.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.872 2.469 . . . . 1.8899999999999999 108.978 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.84 152.47 20.48 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.059 0.763 . . . . 1.71 113.059 177.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.74 -174.61 46.17 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 115.397 0.919 . . . . 0.81000000000000005 115.397 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.0 ttt85 -102.75 139.46 38.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.66 1.184 . . . . 7.1399999999999997 111.912 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.3 t -99.91 133.96 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 127.307 2.243 . . . . 1.8899999999999999 109.268 -173.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.1 pt -139.87 28.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.017 1.117 . . . . 1.95 114.017 -177.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.73 150.18 3.95 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.941 1.697 . . . . 3.27 110.114 166.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.57 -173.92 34.35 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.704 1.145 . . . . 0.81999999999999995 115.29 169.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -151.33 121.13 7.04 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.185 1.394 . . . . 3.96 110.965 -175.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.6 m -147.5 155.2 41.66 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.111 -0.993 . . . . 2.0899999999999999 113.009 172.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.1 ttm -102.06 121.13 41.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.598 1.159 . . . . 1.8999999999999999 108.436 169.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 68.7 t -118.59 146.33 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.539 1.936 . . . . 1.1899999999999999 112.831 -165.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -108.41 115.84 30.85 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.351 1.86 . . . . 2.0099999999999998 110.541 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -127.12 26.21 6.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.611 1.564 . . . . 1.77 112.271 179.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.5 p -55.58 -31.04 61.86 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.006 1.854 . . . . 1.6799999999999999 116.006 -172.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.0 -39.44 13.7 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.607 1.094 . . . . 2.1699999999999999 111.189 176.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.6 mm -70.29 -62.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.733 1.213 . . . . 1.9099999999999999 111.332 -173.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.7 p -98.21 -7.49 29.2 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.552 1.141 . . . . 2.2999999999999998 112.946 -175.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.61 17.66 65.6 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.839 1.209 . . . . 1.4299999999999999 113.331 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -82.53 96.81 8.16 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.32 1.06 . . . . 3.0600000000000001 112.108 -176.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.88 20.18 0.26 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.27 1.028 . . . . 2.2599999999999998 113.565 177.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.5 ttt -146.69 132.54 9.4 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 128.419 2.688 . . . . 4.96 107.385 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -69.64 153.53 69.34 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.052 2.501 . . . . 2.6200000000000001 112.62 -170.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.1 t -111.87 132.5 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.971 1.708 . . . . 1.7 111.207 -168.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.09 137.68 34.0 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.435 -0.791 . . . . 1.8300000000000001 111.398 174.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -122.75 146.91 47.09 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.364 1.465 . . . . 1.1299999999999999 110.938 176.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -150.23 170.98 6.89 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 126.871 2.068 . . . . 3.8599999999999999 111.375 -170.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -59.01 118.94 5.92 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.982 1.788 . . . . 0.93999999999999995 109.634 167.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.3 48.33 4.34 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.534 1.54 . . . . 0.88 113.689 -169.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.6 m -126.44 166.62 16.89 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.861 1.33 . . . . 1.5600000000000001 112.804 173.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.7 p -111.0 149.63 30.43 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.271 0.941 . . . . 1.96 112.842 174.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.03 157.12 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.371 1.468 . . . . 1.2 111.898 175.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.34 149.42 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.839 2.056 . . . . 1.77 113.078 176.193 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.84 143.83 46.23 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.891 0.876 . . . . 1.6799999999999999 111.843 176.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.33 -7.67 60.28 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 116.272 1.269 . . . . 0.69999999999999996 116.272 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 t -73.7 157.14 37.08 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.137 1.468 . . . . 3.6499999999999999 111.329 169.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.41 136.32 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.753 1.621 . . . . 2.1299999999999999 111.697 -169.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -99.59 134.42 42.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.249 1.019 . . . . 2.23 110.745 172.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -135.9 53.65 1.94 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.041 1.126 . . . . 3.6499999999999999 114.041 175.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -153.17 -54.21 0.11 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.415 1.635 . . . . 2.98 115.415 173.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.07 -156.17 11.33 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-N 119.367 0.985 . . . . 2.7400000000000002 114.946 -169.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -83.9 155.47 22.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.223 1.009 . . . . 3.7999999999999998 112.783 177.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.1 mt -147.55 152.28 37.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.839 2.056 . . . . 2.25 107.766 167.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.58 114.86 28.21 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.189 0.995 . . . . 3.4199999999999999 109.399 175.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.67 126.43 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.259 1.023 . . . . 2.1899999999999999 111.397 -173.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 30.0 p -82.37 119.65 24.43 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.579 -0.701 . . . . 2.3900000000000001 109.249 169.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.8 123.53 28.32 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.275 -0.891 . . . . 1.03 110.973 -175.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.6 p -115.81 -8.14 12.0 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.736 1.013 . . . . 2.8999999999999999 113.736 -174.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -142.24 151.0 41.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.569 1.548 . . . . 1.6599999999999999 110.603 173.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 m -100.65 171.21 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.863 1.265 . . . . 2.6699999999999999 109.614 167.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.51 63.52 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.61 -1.306 . . . . 1.6499999999999999 114.663 -174.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.13 -47.06 63.34 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.27 -1.135 . . . . 2.1000000000000001 112.951 169.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -79.1 -16.73 56.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.091 2.156 . . . . 2.5299999999999998 116.174 -174.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -71.54 148.37 46.78 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.485 -1.385 . . . . 4.0099999999999998 113.614 -170.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 t -51.62 -35.89 43.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.033 1.333 . . . . 2.75 112.869 171.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.9 tp -60.29 -46.36 90.11 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.204 -0.935 . . . . 2.3599999999999999 112.128 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.1 p -73.91 -30.83 62.8 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.991 0.916 . . . . 2.1400000000000001 113.411 173.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -61.54 -43.1 99.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.18 0.9 . . . . 1.6200000000000001 111.343 175.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.83 -54.69 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.547 1.139 . . . . 2.9900000000000002 110.475 178.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.21 -29.75 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.338 -0.851 . . . . 1.7 112.84 -178.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -66.1 -39.62 90.11 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.288 0.949 . . . . 3.4100000000000001 112.006 174.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.15 -35.84 74.31 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.569 1.148 . . . . 4.0999999999999996 113.385 174.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.2 t -69.41 -42.52 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.427 0.691 . . . . 2.3399999999999999 111.113 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -65.29 -36.16 83.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.193 1.397 . . . . 3.8300000000000001 112.999 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -69.49 -30.06 67.85 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.994 -1.066 . . . . 4.6900000000000004 112.927 171.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.05 -59.73 2.57 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.66 0.784 . . . . 4.3099999999999996 112.491 173.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.202 0 C-N-CA 127.402 2.281 . . . . 4.8399999999999999 114.008 -173.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 113.537 0.94 . . . . 4.1200000000000001 113.537 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -89.23 -26.54 21.15 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.032 0.933 . . . . 6.1399999999999997 111.523 170.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.77 -33.47 75.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.816 0.846 . . . . 2.6099999999999999 111.638 169.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 tp -50.2 -41.41 49.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.242 1.417 . . . . 2.6400000000000001 113.36 177.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.22 61.04 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.928 0.714 . . . . 3.1000000000000001 112.928 171.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.23 -35.18 73.19 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.029 0.931 . . . . 3.9300000000000002 112.551 178.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.32 -31.94 69.61 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.301 0.955 . . . . 2.4500000000000002 112.973 173.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.2 mm -72.17 -40.2 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.027 0.931 . . . . 3.6200000000000001 111.786 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m -71.26 -23.74 62.04 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.824 -1.173 . . . . 1.99 113.882 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.0 mt -73.4 -20.98 60.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.102 1.361 . . . . 3.1099999999999999 113.57 173.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -85.37 143.18 28.79 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.178 0.991 . . . . 3.5699999999999998 113.326 -176.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.56 165.69 12.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.746 1.619 . . . . 3.4399999999999999 114.568 -178.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -120.55 -6.3 9.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.287 1.035 . . . . 4.0300000000000002 113.041 169.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.49 155.23 45.03 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.558 -1.339 . . . . 2.79 113.725 -175.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.78 162.38 35.63 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.864 1.666 . . . . 2.3300000000000001 113.003 177.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.2 m -125.51 111.97 15.68 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.637 1.175 . . . . 2.27 112.811 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 mt -96.75 133.1 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.788 1.235 . . . . 2.1699999999999999 110.439 -175.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -126.54 115.1 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.218 1.407 . . . . 3.75 110.614 -177.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 m -133.51 149.21 51.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.865 1.266 . . . . 4.0599999999999996 110.561 -169.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.09 143.87 25.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.781 0.833 . . . . 4.0599999999999996 111.197 175.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.04 -12.03 8.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.481 1.112 . . . . 3.6800000000000002 113.686 170.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.5 m -144.42 139.77 28.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.224 1.41 . . . . 5.0199999999999996 109.998 168.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -32.96 72.58 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 131.288 3.835 . . . . 5.8899999999999997 118.203 -166.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 61.48 -17.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.439 2.296 . . . . 7.4199999999999999 114.589 -168.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.0 pt -72.83 -18.18 18.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 127.324 2.249 . . . . 5.3200000000000003 115.696 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 tt -130.06 124.98 34.13 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.515 1.052 . . . . 3.4399999999999999 112.851 175.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -102.58 131.89 49.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.047 1.739 . . . . 4.8200000000000003 110.404 177.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.7 t -126.78 120.0 28.26 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.759 1.224 . . . . 1.9299999999999999 109.301 172.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -117.88 152.46 35.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.293 1.037 . . . . 3.2400000000000002 111.14 -173.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -142.09 138.39 31.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.968 1.707 . . . . 2.9300000000000002 111.18 -176.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -108.41 130.61 55.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.407 1.003 . . . . 1.9399999999999999 109.664 168.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.7 167.86 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.588 1.155 . . . . 2.1800000000000002 112.9 -168.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.88 149.87 32.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.261 1.425 . . . . 4.8899999999999997 110.712 168.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.02 -9.05 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.599 1.333 . . . . 2.0800000000000001 114.599 -173.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -96.64 -15.51 21.47 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.274 -1.516 . . . . 4.4100000000000001 112.803 169.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.01 -5.67 59.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.219 1.408 . . . . 2.1000000000000001 113.936 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -100.12 142.85 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.504 1.522 . . . . 1.8799999999999999 111.207 170.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -117.83 168.97 10.0 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.76 2.024 . . . . 3.4399999999999999 111.468 175.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -68.83 144.82 54.17 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.841 -0.537 . . . . 5.6500000000000004 110.586 169.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.0 -7.37 31.13 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.264 1.411 . . . . 2.6499999999999999 114.984 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.6 165.69 11.5 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.404 1.602 . . . . 3.0600000000000001 113.343 178.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -116.39 132.49 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.653 1.181 . . . . 3.02 112.302 -173.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.52 118.57 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 127.599 2.36 . . . . 2.4100000000000001 109.225 -169.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -94.68 115.59 27.72 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.613 -0.679 . . . . 4.0300000000000002 111.699 172.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.6 p -94.04 146.93 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.343 1.057 . . . . 1.99 112.254 -170.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.6 m -92.04 160.39 35.75 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.65 1.18 . . . . 2.3700000000000001 112.598 169.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -55.86 146.5 67.29 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.116 1.877 . . . . 2.6200000000000001 110.939 167.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.52 0.95 41.95 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.722 1.153 . . . . 1.75 115.299 -174.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.63 148.2 50.62 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.263 1.531 . . . . 1.6200000000000001 112.819 172.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -117.68 9.72 13.15 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.478 1.658 . . . . 3.9700000000000002 115.478 -169.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 51.88 115.11 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 129.095 2.958 . . . . 3.4199999999999999 116.794 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.71 -14.81 9.94 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.065 2.51 . . . . 1.0600000000000001 115.346 -176.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 m -153.11 173.72 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 128.296 2.638 . . . . 1.8300000000000001 108.639 -178.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -92.62 147.87 22.53 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.505 0.928 . . . . 2.46 113.505 173.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.56 173.78 44.44 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 115.134 0.814 . . . . 1.79 115.134 -170.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -113.28 133.16 55.25 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.125 1.37 . . . . 6.1900000000000004 111.621 -174.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.25 127.92 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 126.821 2.048 . . . . 1.6299999999999999 109.286 -169.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 pt -142.49 30.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.784 1.031 . . . . 2.2400000000000002 113.784 -173.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -169.51 143.08 2.72 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.459 1.903 . . . . 3.46 109.747 168.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -171.6 37.9 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 116.285 1.274 . . . . 1.26 116.285 169.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -142.63 123.78 14.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.142 0.977 . . . . 3.1899999999999999 111.929 177.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 m -148.22 151.41 35.45 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.862 -1.149 . . . . 2.02 113.915 169.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.8 ttm -95.24 138.42 32.97 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.638 -0.664 . . . . 2.2599999999999998 109.688 168.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.5 t -129.31 132.2 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.421 1.488 . . . . 2.1800000000000002 111.035 -170.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.76 121.14 30.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.918 1.287 . . . . 2.3100000000000001 111.651 176.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -116.12 14.21 15.93 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.054 1.742 . . . . 1.96 113.224 -178.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 86.7 p -60.74 -0.85 0.32 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 119.211 3.041 . . . . 1.5800000000000001 119.211 -167.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -115.1 -40.51 3.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.938 1.295 . . . . 2.1400000000000001 110.299 169.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.5 mm -69.46 -49.95 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.831 0.853 . . . . 2.3799999999999999 112.109 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 p -106.09 -13.47 15.44 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.3 1.04 . . . . 2.3100000000000001 113.108 175.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.68 -0.17 84.55 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 124.85 1.214 . . . . 1.3100000000000001 115.162 169.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.18 121.98 27.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.04 1.336 . . . . 3.02 111.916 179.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.01 14.52 4.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.955 1.302 . . . . 2.2599999999999998 113.301 -173.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 71.7 mtp -126.75 105.86 23.13 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 127.887 2.475 . . . . 4.3200000000000003 108.002 -174.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.33 152.97 36.22 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.222 2.615 . . . . 2.9700000000000002 114.387 -173.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.82 127.98 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 126.275 1.83 . . . . 2.0600000000000001 111.054 -167.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.83 129.07 34.18 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.713 -0.617 . . . . 1.8600000000000001 111.639 -178.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -121.65 144.88 48.51 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.454 1.902 . . . . 1.04 110.2 -177.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -155.8 -177.77 0.79 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 128.452 2.701 . . . . 4.9800000000000004 108.78 -174.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.82 133.35 54.05 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.119 1.88 . . . . 1.3200000000000001 112.308 168.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.25 28.9 59.27 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.166 1.365 . . . . 0.93000000000000005 114.567 -171.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.1 m -111.33 170.27 8.23 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.668 1.734 . . . . 1.8500000000000001 110.661 175.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.3 p -127.06 148.29 50.13 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 120.463 -1.398 . . . . 2.3599999999999999 111.986 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.0 149.05 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.371 1.069 . . . . 1.45 112.019 179.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.4 150.54 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.428 1.891 . . . . 2.0299999999999998 110.763 177.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.19 138.59 57.88 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.967 -0.56 . . . . 1.75 111.654 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.66 3.73 88.02 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.143 0.817 . . . . 1.7 115.143 -176.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.6 p -88.44 142.82 27.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.815 1.308 . . . . 1.9099999999999999 110.2 167.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.44 120.39 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.092 0.775 . . . . 2.1499999999999999 113.092 -167.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -76.16 129.32 36.58 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.445 1.098 . . . . 2.0 111.037 178.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -106.4 -29.67 9.58 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.223 1.194 . . . . 6.2000000000000002 114.223 -172.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -104.62 -45.36 4.64 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 116.521 2.045 . . . . 3.5099999999999998 116.521 -165.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.96 -142.65 5.22 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 118.204 2.042 . . . . 3.02 118.204 -167.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 t -90.09 144.28 26.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.369 1.468 . . . . 2.8300000000000001 112.412 -174.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.7 mt -147.82 159.44 43.83 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.72 1.608 . . . . 1.99 109.538 169.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 tp -116.39 123.52 47.78 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.486 1.114 . . . . 3.3399999999999999 110.331 169.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.57 129.47 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.275 1.03 . . . . 2.5600000000000001 110.845 -170.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 52.8 t -86.46 123.9 32.2 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.379 -0.826 . . . . 4.4699999999999998 109.671 168.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.89 121.83 25.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.898 0.879 . . . . 1.3100000000000001 109.424 176.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.3 t -114.73 0.23 13.79 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.93 1.085 . . . . 3.04 113.93 -169.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -146.84 150.64 35.67 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.955 2.102 . . . . 1.99 111.178 175.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.1 m -83.47 166.56 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.767 0.827 . . . . 2.8199999999999998 112.615 169.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.87 -31.4 75.88 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 120.932 -1.105 . . . . 1.6000000000000001 114.681 -174.033 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.19 -25.39 64.31 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.174 1.175 . . . . 3.0800000000000001 114.174 174.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.19 -19.92 59.57 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.269 -0.894 . . . . 3.1400000000000001 113.081 171.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.1 p -68.49 141.96 55.43 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.564 -0.71 . . . . 2.4900000000000002 111.809 -169.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 t -70.15 -18.18 63.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.097 0.777 . . . . 3.2000000000000002 113.097 -170.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.4 mp -59.42 -52.14 66.9 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.297 -1.502 . . . . 2.48 112.588 -175.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.6 p -73.76 -17.48 61.09 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.91 0.884 . . . . 3.0 113.379 174.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -72.0 -42.72 66.11 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.12 0.968 . . . . 2.0899999999999999 111.723 173.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.3 mt -61.18 -52.75 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.616 1.566 . . . . 2.5699999999999998 111.16 -177.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m -63.92 -15.26 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.347 1.61 . . . . 2.8500000000000001 115.347 -172.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -71.15 -42.57 68.96 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.186 0.995 . . . . 3.2599999999999998 111.697 169.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.54 -47.62 22.03 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.853 1.661 . . . . 4.3799999999999999 111.306 177.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.9 t -68.66 -21.81 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 118.631 -0.699 . . . . 2.8199999999999998 112.225 -176.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -53.4 -36.81 61.87 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 120.743 1.611 . . . . 4.1200000000000001 111.328 167.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.84 -8.32 55.6 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.428 -1.42 . . . . 5.1299999999999999 113.565 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.99 -27.86 57.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.397 1.079 . . . . 6.3099999999999996 113.7 171.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.609 1.564 . . . . 5.5599999999999996 113.141 -178.749 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 111.975 0.361 . . . . 3.3799999999999999 111.975 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -72.72 -39.44 66.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.006 1.323 . . . . 4.3899999999999997 111.181 175.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.56 -11.33 60.61 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.098 1.518 . . . . 2.29 115.098 174.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.0 tp -59.75 -40.81 89.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.962 1.256 . . . . 2.7200000000000002 113.928 -168.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.25 -20.7 60.78 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.3 1.222 . . . . 2.73 114.3 173.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -70.73 -42.99 69.81 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.109 1.322 . . . . 3.1800000000000002 111.426 -169.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -47.52 -50.55 23.29 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.834 1.254 . . . . 2.46 111.564 173.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.54 -28.87 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.396 1.078 . . . . 3.25 112.635 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -74.42 -25.64 59.57 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.874 -1.141 . . . . 1.8799999999999999 112.973 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.01 -22.5 63.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.036 0.835 . . . . 2.9100000000000001 112.89 169.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -68.46 135.19 51.27 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.855 1.207 . . . . 3.0099999999999998 111.469 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.26 151.13 47.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.642 0.777 . . . . 2.5600000000000001 112.422 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 p -87.36 -21.95 25.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.827 1.651 . . . . 3.5699999999999998 113.355 177.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.75 157.08 47.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.871 1.268 . . . . 3.5299999999999998 112.788 -175.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.75 157.38 45.11 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.73 1.212 . . . . 1.55 112.179 177.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 m -115.11 110.35 19.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.372 1.069 . . . . 1.8600000000000001 111.385 177.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.7 mt -91.75 135.2 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.091 1.756 . . . . 2.2400000000000002 109.495 -178.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 m -96.53 115.02 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 119.385 0.993 . . . . 3.4900000000000002 109.372 167.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.0 m -78.99 135.37 36.89 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.813 0.845 . . . . 3.7000000000000002 110.273 -177.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 mt -120.51 59.15 0.91 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.42 1.488 . . . . 5.8899999999999997 109.195 179.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.65 -8.04 44.19 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.544 -0.722 . . . . 6.0800000000000001 112.291 177.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.4 m -136.45 128.44 29.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.91 2.884 . . . . 6.1299999999999999 108.006 176.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -19.96 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 1 C-N-CA 134.403 5.081 . . . . 8.0299999999999994 116.705 -169.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.277 16.7 p30 46.74 21.56 0.14 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.852 1.797 . . . . 8.0600000000000005 115.852 -170.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.8 pt -110.05 -26.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 127.204 2.201 . . . . 6.8899999999999997 114.256 -175.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.92 -53.9 52.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.199 0.908 . . . . 6.54 113.285 -169.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 mp 53.77 43.42 31.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.033 1.333 . . . . 5.5700000000000003 113.117 178.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.0 t -92.42 111.43 23.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.939 0.896 . . . . 2.0299999999999998 109.607 176.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -81.53 138.29 35.45 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.349 0.87 . . . . 2.9399999999999999 113.349 -170.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -127.83 125.3 39.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.847 2.059 . . . . 2.7000000000000002 109.795 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -95.5 132.0 41.07 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.419 -1.425 . . . . 4.1600000000000001 109.864 174.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.81 167.79 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.768 1.627 . . . . 1.51 112.846 -169.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.9 148.95 31.07 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.217 -0.66 . . . . 3.3500000000000001 109.217 165.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.97 -7.36 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 114.954 1.465 . . . . 1.8700000000000001 114.954 -177.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.78 -30.5 56.52 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 119.791 -1.818 . . . . 3.2999999999999998 112.691 167.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -90.69 4.04 52.58 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.798 1.639 . . . . 2.1200000000000001 114.117 -168.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 p -101.1 135.75 36.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 126.416 1.886 . . . . 2.0600000000000001 110.62 173.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.82 166.58 10.91 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.219 1.808 . . . . 4.0499999999999998 111.45 178.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -65.29 -12.87 56.08 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.718 1.377 . . . . 4.9800000000000004 114.718 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.19 7.56 75.85 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.262 1.41 . . . . 2.0699999999999998 115.938 174.352 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -91.82 155.84 17.94 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.782 1.791 . . . . 2.8999999999999999 112.649 176.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.0 mm -110.9 123.83 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.753 1.621 . . . . 3.1800000000000002 109.172 176.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -120.95 133.83 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.424 1.089 . . . . 1.6399999999999999 113.375 -167.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HE3' ' CG ' ' A' ' 96' ' ' LEU . 10.9 mmmm -101.04 148.2 25.32 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.601 0.76 . . . . 5.04 112.563 178.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 p -124.22 134.53 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.424 1.089 . . . . 1.95 111.691 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.2 m -79.94 163.57 57.3 Favored Pre-proline 0 N--CA 1.482 1.15 0 N-CA-C 113.303 0.853 . . . . 2.27 113.303 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.36 120.33 7.45 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.242 1.961 . . . . 1.95 108.451 168.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.02 84.2 Favored Glycine 0 CA--C 1.54 1.655 0 C-N-CA 124.634 1.112 . . . . 1.22 115.467 -170.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.46 178.51 52.9 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 119.633 1.717 . . . . 1.0700000000000001 115.404 -177.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -120.87 145.3 47.78 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.614 1.165 . . . . 2.3599999999999999 112.211 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -81.99 124.22 79.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.763 0.825 . . . . 2.8599999999999999 111.901 -178.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -91.98 -20.14 0.66 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.194 2.596 . . . . 0.81999999999999995 115.932 -170.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.73 166.94 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 126.849 2.06 . . . . 1.75 109.79 -177.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.313 0.3 OUTLIER -88.98 142.96 27.2 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.983 0.811 . . . . 1.8999999999999999 112.698 174.327 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.61 -166.75 39.94 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.533 0.973 . . . . 0.68999999999999995 115.533 -173.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.6 ttp85 -109.76 143.54 39.44 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.68 1.592 . . . . 5.46 112.053 -171.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.2 128.87 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.1 1.76 . . . . 2.3100000000000001 109.668 -172.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.7 pt -140.27 36.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 114.001 1.111 . . . . 2.1000000000000001 114.001 -172.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -166.27 142.14 4.78 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.14 1.376 . . . . 3.1699999999999999 111.283 168.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.15 -163.84 34.74 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.049 1.309 . . . . 1.21 115.907 169.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.98 126.46 5.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.329 1.233 . . . . 3.7000000000000002 114.329 174.035 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 m -145.95 166.67 25.35 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.849 -1.157 . . . . 2.0600000000000001 112.828 174.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.9 ttm -107.73 124.44 50.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.018 0.927 . . . . 1.75 109.286 172.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.08 143.61 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.064 1.746 . . . . 0.90000000000000002 112.981 -167.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -98.25 96.28 7.96 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.22 1.408 . . . . 1.9399999999999999 111.309 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -93.01 -10.58 35.72 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.082 1.353 . . . . 1.74 113.268 177.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 t -38.12 -46.4 1.03 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.51 2.411 . . . . 2.4700000000000002 117.51 -167.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.3 -33.48 61.19 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.46 1.482 . . . . 1.98 112.167 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 mm -73.23 -47.49 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.406 1.482 . . . . 2.0499999999999998 111.075 -177.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.4 p -110.44 -13.19 14.31 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.037 1.335 . . . . 2.1899999999999999 114.125 -170.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.36 2.84 90.24 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.512 1.529 . . . . 1.1200000000000001 114.752 -177.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -51.44 -49.91 60.77 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.921 1.36 . . . . 2.4900000000000002 114.419 -172.059 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 57.76 31.53 20.59 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.334 1.454 . . . . 2.77 114.605 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.2 ttm -162.55 136.08 4.64 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 130.212 3.405 . . . . 3.9199999999999999 105.242 169.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.18 164.9 34.12 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.95 2.433 . . . . 2.0499999999999998 113.321 -170.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.3 t -120.22 129.83 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.383 1.473 . . . . 1.46 111.454 -169.427 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.27 139.7 36.54 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.479 -0.763 . . . . 1.74 111.943 177.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -125.03 150.97 46.21 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.664 1.586 . . . . 0.93999999999999995 111.449 -178.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -149.57 172.86 4.77 Favored Pre-proline 0 N--CA 1.483 1.224 0 C-N-CA 129.312 3.045 . . . . 3.98 109.053 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -59.52 140.2 92.86 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 CA-C-N 121.588 1.603 . . . . 0.96999999999999997 110.994 167.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.42 44.76 15.91 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.811 -0.555 . . . . 1.05 112.45 -170.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.9 t -126.67 170.14 12.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.69 1.596 . . . . 1.6000000000000001 111.111 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.4 p -129.69 149.43 51.45 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.777 -1.202 . . . . 2.1600000000000001 112.411 -176.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.89 159.06 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.09 1.356 . . . . 1.24 113.804 -176.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.05 152.84 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.798 2.439 . . . . 1.8799999999999999 111.46 169.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.32 152.14 44.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.774 0.829 . . . . 1.7 112.906 178.427 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.23 4.72 89.87 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.42 0.528 . . . . 0.91000000000000003 114.42 -175.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 m -82.15 153.52 25.98 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.286 -1.126 . . . . 2.02 110.563 169.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mm -108.3 143.59 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.698 1.199 . . . . 1.8600000000000001 110.236 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -108.21 139.8 42.37 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.832 1.653 . . . . 1.54 113.086 -175.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -152.22 115.73 4.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.508 1.049 . . . . 3.7799999999999998 113.808 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 51.5 t30 152.04 -51.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 131.341 3.856 . . . . 3.29 109.245 167.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.51 -178.65 36.54 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.768 1.651 . . . . 2.2999999999999998 112.454 -174.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.4 p -89.53 135.39 33.63 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.713 -0.875 . . . . 2.73 113.286 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.6 mt -122.5 165.7 15.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.454 1.101 . . . . 2.3300000000000001 112.921 -176.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.526 ' CG ' ' HE3' ' A' ' 44' ' ' LYS . 6.8 tt -116.24 117.45 30.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.367 1.467 . . . . 4.3499999999999996 111.478 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.12 120.48 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.948 1.299 . . . . 2.4700000000000002 111.49 178.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 20.4 p -84.57 120.82 26.79 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.035 -1.098 . . . . 2.2599999999999998 108.035 166.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.28 157.38 34.49 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.921 -0.487 . . . . 1.6299999999999999 110.481 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.4 t -141.46 -9.22 0.96 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.671 1.36 . . . . 3.54 114.671 176.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -140.51 144.27 35.89 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.589 1.156 . . . . 1.8899999999999999 110.451 169.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -69.97 161.02 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.641 -0.503 . . . . 2.73 109.641 167.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.48 -36.61 89.96 Favored Glycine 0 N--CA 1.476 1.355 0 O-C-N 121.114 -0.991 . . . . 1.6799999999999999 113.811 -171.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.87 -38.51 91.21 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.754 1.02 . . . . 2.54 113.754 171.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -77.31 -6.71 54.2 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.043 2.137 . . . . 2.4700000000000002 114.861 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 81.3 p -65.3 157.91 27.81 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.604 -1.31 . . . . 2.5899999999999999 113.194 178.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 90.9 m -64.48 -35.68 81.73 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.622 0.769 . . . . 4.1299999999999999 111.36 175.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.19 -47.56 68.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.866 1.266 . . . . 2.3100000000000001 111.7 171.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 m -68.41 -30.44 69.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.479 1.112 . . . . 2.4399999999999999 113.584 176.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -70.08 -41.05 74.59 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.085 0.857 . . . . 2.04 111.663 172.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.49 -48.55 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.845 0.858 . . . . 2.6400000000000001 110.904 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.21 -27.11 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 113.439 0.903 . . . . 1.8100000000000001 113.439 177.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -71.72 -48.74 45.09 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.726 1.148 . . . . 3.2999999999999998 111.691 171.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.16 -40.99 82.82 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.436 1.094 . . . . 3.9399999999999999 112.954 178.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -75.36 -33.87 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 113.981 1.104 . . . . 3.5899999999999999 113.981 176.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -74.63 -46.58 37.37 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.007 0.822 . . . . 4.2199999999999998 112.071 179.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -74.76 -9.98 59.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 5.5899999999999999 113.9 -179.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.12 -52.95 43.78 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.578 0.751 . . . . 4.54 111.163 170.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.29 -1.338 . . . . 4.46 114.185 178.091 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 112.233 0.457 . . . . 4.8899999999999997 112.233 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.97 -47.56 79.89 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.412 1.885 . . . . 4.8300000000000001 109.791 169.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.35 76.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.075 1.35 . . . . 3.1299999999999999 113.535 174.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.5 tp -70.92 -34.31 71.38 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.641 1.177 . . . . 2.5099999999999998 113.17 170.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.07 -32.04 68.61 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.194 -0.941 . . . . 2.75 111.567 174.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -54.56 -37.9 66.01 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 124.968 1.307 . . . . 2.8100000000000001 113.354 -170.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.05 -43.79 91.74 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.346 1.058 . . . . 1.75 112.578 -178.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.3 mm -72.43 -33.18 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.25 -0.906 . . . . 2.6299999999999999 112.237 175.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m -77.43 -17.31 58.22 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.383 0.882 . . . . 1.5800000000000001 113.383 176.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mt -71.88 -43.39 65.5 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.602 2.361 . . . . 2.54 112.749 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -49.57 134.7 19.36 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.63 0.772 . . . . 4.21 110.764 175.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.59 -14.34 41.6 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.041 1.497 . . . . 3.6600000000000001 115.041 -172.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 m 69.11 -24.79 0.14 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 128.29 2.636 . . . . 3.27 115.024 173.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -125.38 152.97 44.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.176 1.39 . . . . 3.2599999999999998 111.262 169.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.84 151.35 45.62 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.716 1.206 . . . . 1.75 111.88 -177.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.2 m -111.45 104.09 12.5 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.283 1.033 . . . . 1.8999999999999999 111.876 -176.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.1 mt -91.26 134.67 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.705 1.602 . . . . 2.4100000000000001 110.795 -173.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.69 130.27 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 120.719 -1.238 . . . . 3.5600000000000001 110.483 169.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m -125.78 153.9 43.34 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.726 1.61 . . . . 4.2800000000000002 110.873 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.3 mt -111.85 108.25 17.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.624 1.17 . . . . 5.6900000000000004 110.044 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.13 3.1 38.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 116.372 1.989 . . . . 5.21 116.372 -168.375 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.4 m -128.71 -63.13 0.99 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.134 1.374 . . . . 6.7599999999999998 110.163 169.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -157.89 -170.12 3.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 130.111 3.364 . . . . 8.2899999999999991 105.829 169.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -15.77 1.72 Allowed 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 114.178 1.177 . . . . 6.3600000000000003 114.178 173.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.6 pt -67.93 -29.87 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 126.194 1.797 . . . . 5.9900000000000002 114.078 175.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tt -115.2 118.27 32.86 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.12 0.968 . . . . 3.7599999999999998 110.891 -171.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mp -91.98 130.75 37.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.625 0.726 . . . . 3.5899999999999999 111.502 173.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.1 t -134.97 95.12 3.26 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.992 2.517 . . . . 2.2999999999999998 107.406 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.78 145.21 25.74 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.121 -0.987 . . . . 3.6600000000000001 110.573 -176.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -127.49 156.53 42.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.345 2.658 . . . . 2.9300000000000002 111.274 -167.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -121.11 140.2 52.3 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.238 0.926 . . . . 2.3399999999999999 112.746 169.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.97 166.24 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.257 1.423 . . . . 2.4900000000000002 113.478 -177.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.44 147.66 32.21 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.694 1.198 . . . . 3.96 110.443 166.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.77 -13.06 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.461 1.282 . . . . 2.1000000000000001 114.461 -176.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -82.87 -12.67 57.21 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 120.141 -1.599 . . . . 5.0099999999999998 113.565 170.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.9 mt -103.75 -10.22 18.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.151 1.78 . . . . 2.8500000000000001 114.282 -172.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.63 143.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.693 1.197 . . . . 2.2200000000000002 110.664 173.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -121.23 164.63 16.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.502 1.921 . . . . 3.0899999999999999 111.067 176.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.0 ptt-85 -72.22 153.3 41.67 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.707 -1.246 . . . . 3.48 110.743 172.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.57 25.37 9.32 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 119.25 -0.75 . . . . 2.0800000000000001 114.213 -176.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -140.14 162.24 35.72 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.49 1.516 . . . . 2.7400000000000002 112.05 176.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.45 125.72 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.307 1.443 . . . . 2.21 110.199 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.8 mm -115.43 128.71 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.99 1.316 . . . . 1.9099999999999999 111.401 -171.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -80.87 146.77 30.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.339 1.055 . . . . 3.8100000000000001 112.667 175.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.8 137.0 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.524 0.729 . . . . 1.22 111.81 168.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 m -89.75 164.29 29.5 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.068 1.347 . . . . 1.78 113.38 -178.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.66 132.25 32.26 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.238 1.959 . . . . 1.6200000000000001 109.445 168.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.74 -8.8 47.47 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.183 0.897 . . . . 1.01 115.187 -169.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.74 163.9 43.32 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 118.616 1.208 . . . . 1.02 114.092 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -111.6 149.07 31.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.422 1.489 . . . . 2.4199999999999999 110.437 175.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -81.39 130.14 63.37 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 121.85 -0.531 . . . . 3.5800000000000001 111.918 177.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.96 -25.66 1.4 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.446 2.764 . . . . 0.77000000000000002 114.792 -178.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.4 176.59 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.22 2.208 . . . . 2.1000000000000001 109.323 -178.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.84 148.04 26.14 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.647 0.779 . . . . 2.3599999999999999 111.816 174.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.2 -160.14 32.87 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.521 0.568 . . . . 0.87 114.521 -172.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -116.91 135.6 53.59 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.412 1.485 . . . . 4.2699999999999996 113.268 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.47 135.36 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.111 2.164 . . . . 2.2599999999999998 108.935 170.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.4 pt -137.03 31.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 113.386 0.884 . . . . 1.8899999999999999 113.386 175.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -166.46 139.45 3.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.707 1.603 . . . . 2.8799999999999999 109.098 166.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.13 177.38 49.91 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 122.684 1.158 . . . . 0.81999999999999995 115.259 174.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -145.52 133.22 21.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.043 1.337 . . . . 2.75 112.23 -174.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.3 m -150.66 176.03 11.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.625 1.17 . . . . 1.8899999999999999 112.853 172.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.8 ttm -117.96 129.84 55.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.711 1.204 . . . . 1.6499999999999999 110.397 168.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t -117.38 136.05 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.78 1.232 . . . . 1.0700000000000001 113.223 -167.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -88.6 108.2 19.31 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.58 1.152 . . . . 1.8500000000000001 111.227 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -110.18 16.36 21.82 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.225 1.41 . . . . 1.8999999999999999 114.117 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -60.57 -19.91 58.89 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.986 1.847 . . . . 1.6100000000000001 115.986 -169.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -91.94 -40.82 10.92 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.112 0.869 . . . . 1.6299999999999999 111.663 172.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 27.5 mm -78.34 -61.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.016 0.926 . . . . 2.0299999999999998 112.246 -171.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.9 p -96.74 -7.75 33.08 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.499 1.12 . . . . 2.1499999999999999 112.651 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.35 16.03 74.97 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.446 1.498 . . . . 1.25 113.833 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -83.66 105.01 14.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.391 1.476 . . . . 2.98 111.763 -176.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.31 -13.26 59.76 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.398 -0.814 . . . . 2.23 111.643 177.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -100.06 111.92 63.05 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 126.745 2.018 . . . . 5.7800000000000002 107.889 169.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.86 148.93 35.63 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.869 3.046 . . . . 2.3599999999999999 114.162 -178.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.79 130.23 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.516 1.526 . . . . 1.4399999999999999 110.879 -169.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.2 142.89 37.63 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.271 0.629 . . . . 1.73 112.516 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.07 147.3 46.87 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.414 1.886 . . . . 1.97 110.603 177.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -147.25 170.6 7.49 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 128.504 2.721 . . . . 3.9300000000000002 109.664 -174.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -59.38 124.37 15.39 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 121.566 1.595 . . . . 1.0600000000000001 109.593 168.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.94 55.25 3.18 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.938 0.78 . . . . 1.3400000000000001 112.308 -168.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 t -139.49 141.36 37.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.417 1.087 . . . . 1.5 111.147 178.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.8 p -97.09 144.8 26.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.51 1.05 . . . . 1.6899999999999999 112.497 -178.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.58 156.59 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.323 1.849 . . . . 1.26 111.49 -173.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.29 146.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.672 1.589 . . . . 1.6499999999999999 111.92 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.47 153.12 28.14 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.81 0.844 . . . . 1.6399999999999999 113.218 -175.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.45 -5.08 17.05 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.594 0.997 . . . . 0.81999999999999995 115.594 178.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -75.79 153.03 37.2 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.787 1.294 . . . . 1.54 109.869 168.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 mm -109.14 132.3 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.658 0.783 . . . . 1.79 110.668 -169.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -91.95 151.89 20.29 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.694 1.597 . . . . 1.5800000000000001 113.198 -173.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -156.65 139.33 15.08 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.029 -1.044 . . . . 3.04 111.774 176.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.311 57.8 t30 99.23 -21.67 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.001 3.321 . . . . 3.3100000000000001 116.932 172.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.32 178.81 38.8 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 119.928 -1.733 . . . . 2.1800000000000002 114.215 -174.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.1 t -120.78 125.7 48.24 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.627 1.171 . . . . 3.3999999999999999 110.942 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.66 161.85 21.77 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.627 1.571 . . . . 2.2400000000000002 112.438 -167.298 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.21 119.58 37.54 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.944 1.298 . . . . 2.79 110.154 174.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.98 123.3 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.052 1.341 . . . . 2.7400000000000002 109.747 175.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.8 p -82.28 108.45 15.74 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.544 -0.722 . . . . 2.6499999999999999 110.077 170.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.87 113.88 17.33 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.127 -0.983 . . . . 1.3300000000000001 110.707 -172.038 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -111.34 -2.33 15.68 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.07 1.348 . . . . 3.4300000000000002 112.478 179.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -138.32 142.33 39.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.954 2.102 . . . . 1.8999999999999999 109.391 178.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.34 178.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 124.707 1.203 . . . . 2.6299999999999999 112.554 172.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.63 -39.49 97.63 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.594 -1.316 . . . . 1.3999999999999999 113.615 -178.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.01 -31.89 72.31 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 118.411 1.105 . . . . 3.1200000000000001 113.176 172.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -75.71 -4.37 39.98 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 128.132 2.573 . . . . 3.04 113.464 175.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 76.3 p -70.57 141.44 51.83 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.588 -1.945 . . . . 2.2000000000000002 114.275 -177.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -62.17 -31.93 72.49 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.71 -0.619 . . . . 2.6699999999999999 112.19 176.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -56.03 -48.05 76.7 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.777 -1.202 . . . . 1.95 111.8 171.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.8 m -64.97 -36.56 84.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.094 0.557 . . . . 2.3399999999999999 110.43 175.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.32 -40.59 85.97 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.664 -0.647 . . . . 1.77 112.303 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 67.9 mt -59.03 -51.41 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.355 1.062 . . . . 1.9199999999999999 109.945 177.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 m -71.19 -32.35 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 117.903 -1.046 . . . . 2.0800000000000001 113.084 179.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -56.21 -46.69 79.38 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.59 1.086 . . . . 3.9300000000000002 110.9 171.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.67 -41.07 88.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.591 1.157 . . . . 3.27 113.499 178.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.4 t -65.16 -46.98 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 118.97 0.804 . . . . 2.7000000000000002 110.405 175.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -59.23 -37.87 78.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.829 1.252 . . . . 4.04 112.065 -178.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.38 -26.83 64.84 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.374 1.25 . . . . 4.3700000000000001 114.374 176.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.7 86.92 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.517 0.599 . . . . 4.7199999999999998 111.199 -171.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.253 1.243 0 C-N-CA 126.148 1.779 . . . . 5.2300000000000004 112.691 172.013 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 114.112 1.152 . . . . 4.8099999999999996 114.112 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -84.91 -27.83 26.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 5.4100000000000001 112.181 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.38 -39.0 93.32 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.069 0.948 . . . . 3.1299999999999999 111.97 171.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 tp -56.56 -34.41 67.09 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.71 0.804 . . . . 2.2799999999999998 112.92 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.23 -41.76 39.94 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.915 0.709 . . . . 2.0800000000000001 112.915 168.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -60.19 -35.11 74.65 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.953 1.301 . . . . 2.9500000000000002 112.709 -175.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.72 -36.68 72.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.691 0.796 . . . . 2.23 112.866 173.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.4 mm -72.88 -38.66 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.872 0.76 . . . . 2.5699999999999998 111.621 173.13 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -65.54 -25.75 67.58 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.174 -0.954 . . . . 1.53 112.783 177.037 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.9 mt -73.33 -17.84 61.25 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.633 1.973 . . . . 3.2799999999999998 114.892 174.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -74.48 144.76 44.04 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.085 1.311 . . . . 3.3500000000000001 112.105 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.49 156.49 21.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.845 1.258 . . . . 3.4199999999999999 112.839 -176.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 p -94.76 -30.45 14.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.599 1.16 . . . . 3.27 113.7 171.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -140.47 162.13 36.08 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.245 1.818 . . . . 3.5600000000000001 113.014 -173.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.16 159.61 41.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.948 1.299 . . . . 1.8500000000000001 112.873 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.4 m -104.53 124.49 49.38 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.266 1.026 . . . . 2.3599999999999999 111.833 176.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.78 130.25 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.325 1.45 . . . . 2.2400000000000002 110.932 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -110.83 133.96 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.366 1.066 . . . . 3.6600000000000001 111.897 177.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -140.39 133.43 29.39 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.457 0.703 . . . . 2.7200000000000002 112.279 -175.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.82 143.73 32.73 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.306 1.442 . . . . 5.9199999999999999 111.217 175.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -145.2 19.33 1.57 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.652 2.093 . . . . 4.6200000000000001 116.652 -171.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 m -144.04 -74.38 0.26 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.856 1.058 . . . . 4.0300000000000002 113.856 175.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -157.63 37.92 0.27 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.659 1.984 . . . . 7.3099999999999996 109.229 -168.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.42 -17.27 0.1 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 127.194 2.197 . . . . 6.8899999999999997 114.168 -166.214 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 pt -66.77 -37.56 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 O-C-N 119.975 -1.703 . . . . 5.4000000000000004 113.438 176.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.1 tp -84.17 76.87 10.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.545 1.538 . . . . 3.6400000000000001 111.19 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 tt -97.24 120.5 37.72 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.734 1.613 . . . . 5.7300000000000004 111.427 176.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.2 t -130.63 131.16 44.76 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.618 1.567 . . . . 2.25 109.605 -177.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.36 143.63 49.1 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.703 1.201 . . . . 3.0299999999999998 112.366 -170.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.96 143.65 50.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.954 1.302 . . . . 3.3900000000000001 111.177 -178.054 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -108.35 125.98 52.33 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.823 -0.806 . . . . 2.4700000000000002 108.823 166.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.29 161.29 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.605 1.162 . . . . 1.97 112.357 -170.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -74.06 143.3 45.53 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.025 -0.732 . . . . 4.2999999999999998 109.025 172.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.59 -2.34 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 114.463 1.283 . . . . 2.5600000000000001 114.463 -171.48 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -81.05 -23.4 38.58 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.33 2.252 . . . . 4.7699999999999996 113.13 168.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.6 mt -103.12 -10.76 18.58 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.644 1.578 . . . . 3.1000000000000001 114.009 -168.125 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.4 p -87.01 145.06 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.74 2.016 . . . . 2.6600000000000001 108.646 168.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.24 159.48 16.08 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.198 0.999 . . . . 4.7999999999999998 112.415 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -73.49 33.04 0.08 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 115.615 1.709 . . . . 5.4800000000000004 115.615 -178.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.26 15.95 1.31 Allowed Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.481 2.467 . . . . 1.97 113.756 171.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -81.96 158.37 23.91 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.968 1.384 . . . . 2.3500000000000001 113.216 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -106.91 125.85 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.418 1.487 . . . . 2.9500000000000002 112.333 -172.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.7 mm -127.3 119.1 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.899 1.28 . . . . 2.3100000000000001 111.492 -169.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HE3' ' HG ' ' A' ' 96' ' ' LEU . 21.2 mmtp -85.44 120.16 26.59 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.744 -1.223 . . . . 4.6699999999999999 110.287 169.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 p -96.97 138.41 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.758 0.708 . . . . 2.1600000000000001 111.795 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 m -87.68 150.44 48.36 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.678 1.191 . . . . 2.3700000000000001 112.886 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -59.44 142.83 99.57 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.755 2.303 . . . . 2.1800000000000002 111.07 170.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.31 -13.08 8.24 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 115.855 1.102 . . . . 1.9199999999999999 115.855 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.31 -172.64 40.62 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 119.058 1.429 . . . . 1.5900000000000001 115.214 -175.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -113.25 158.01 21.03 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.006 1.322 . . . . 2.52 111.521 171.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -91.54 125.26 58.4 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.234 1.013 . . . . 3.8999999999999999 111.437 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -92.66 -13.29 1.48 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.311 2.674 . . . . 1.49 115.444 -175.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.48 162.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 126.613 1.965 . . . . 2.6699999999999999 109.433 178.193 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.273 0.5 OUTLIER -93.51 137.67 32.56 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.684 0.754 . . . . 2.0899999999999999 112.33 175.595 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.41 177.32 41.95 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 123.975 0.798 . . . . 1.24 114.6 -169.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.7 ttm-85 -100.89 146.02 27.86 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.203 1.401 . . . . 7.5099999999999998 111.578 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.4 t -101.06 126.57 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.135 2.174 . . . . 2.6099999999999999 109.135 -174.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 pt -140.87 29.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 113.973 1.101 . . . . 1.99 113.973 -175.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -170.17 146.67 3.02 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.882 2.073 . . . . 3.8999999999999999 109.158 166.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.4 -174.24 48.63 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.43 1.014 . . . . 1.3500000000000001 115.227 169.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -150.22 118.78 6.5 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.353 1.061 . . . . 3.04 111.064 -174.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.4 t -142.71 163.98 31.36 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.282 1.433 . . . . 1.9399999999999999 112.27 -175.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.2 ttm -116.05 129.69 56.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.06 1.344 . . . . 1.9199999999999999 110.435 174.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.6 t -121.59 143.33 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.766 1.627 . . . . 0.91000000000000003 112.061 -168.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -99.45 90.4 4.51 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.281 1.832 . . . . 1.8 111.359 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -90.03 9.58 27.47 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.862 1.265 . . . . 2.3199999999999998 113.762 -175.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.8 t -50.35 -47.35 56.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.188 2.195 . . . . 2.2599999999999998 115.612 -169.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.98 -36.99 48.32 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.593 -1.317 . . . . 1.79 111.777 -175.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.3 mm -73.61 -48.28 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.727 -0.608 . . . . 2.1099999999999999 110.207 -177.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.1 p -107.33 -11.37 15.57 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.352 1.241 . . . . 2.3399999999999999 114.352 -170.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.61 -5.81 72.39 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 126.011 1.767 . . . . 1.51 115.943 174.117 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.25 -47.2 81.98 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.529 1.165 . . . . 2.8500000000000001 113.254 -169.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.268 . . 58.61 45.61 15.86 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.442 1.897 . . . . 3.1400000000000001 111.847 -176.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptp -153.02 134.95 8.81 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 128.98 2.912 . . . . 5.0199999999999996 109.068 172.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -62.2 145.64 96.19 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.712 2.275 . . . . 2.0 113.952 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.34 128.51 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.502 1.521 . . . . 1.52 111.303 -174.117 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.87 144.79 28.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.628 0.771 . . . . 1.8600000000000001 112.977 -179.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -122.23 159.44 27.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.176 1.79 . . . . 1.3100000000000001 112.274 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -151.98 171.76 6.24 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 127.791 2.437 . . . . 4.4100000000000001 110.643 -176.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.5 123.98 13.79 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 CA-C-N 121.341 1.515 . . . . 1.6200000000000001 108.84 166.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.83 44.4 5.75 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.057 0.837 . . . . 1.28 113.01 -168.367 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.9 m -124.96 169.05 12.48 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.245 1.418 . . . . 1.74 109.362 168.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.4 p -121.46 156.79 32.0 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.825 -1.172 . . . . 1.8899999999999999 112.868 169.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.28 160.48 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.884 1.674 . . . . 2.23 111.924 -178.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.62 154.51 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 126.47 1.908 . . . . 2.9399999999999999 112.514 -176.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.73 159.84 33.17 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.432 0.901 . . . . 2.3399999999999999 113.432 -177.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -6.96 11.88 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.797 1.189 . . . . 1.0700000000000001 115.113 179.037 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -84.65 162.69 19.64 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.167 1.387 . . . . 2.6699999999999999 111.601 174.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 mm -111.33 140.86 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.271 1.028 . . . . 2.04 111.547 -169.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -90.61 136.09 33.28 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.178 1.791 . . . . 2.79 109.371 169.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -83.64 -73.32 0.42 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.702 0.801 . . . . 3.6600000000000001 110.663 169.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -140.55 161.27 38.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.241 1.816 . . . . 3.6299999999999999 107.969 170.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.88 138.66 6.48 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.506 2.479 . . . . 2.5899999999999999 111.572 177.436 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.9 m -114.61 95.77 5.41 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.825 1.25 . . . . 3.54 110.167 -169.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.3 mt -104.44 152.7 22.01 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.043 1.337 . . . . 2.79 113.684 -170.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.464 ' HG ' ' HE3' ' A' ' 44' ' ' LYS . 4.2 tt -104.25 117.75 34.96 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.891 1.276 . . . . 4.6699999999999999 109.731 171.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.3 mm -113.41 129.02 69.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.022 1.329 . . . . 2.9100000000000001 111.422 -173.493 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.3 p -101.69 124.94 48.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.414 -0.804 . . . . 2.4199999999999999 110.109 168.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.96 151.02 31.88 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.692 0.627 . . . . 1.3899999999999999 112.692 -174.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -129.43 -3.23 4.89 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.775 1.398 . . . . 3.1800000000000002 114.775 169.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -140.97 141.87 34.37 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.66 1.184 . . . . 3.2200000000000002 111.09 169.067 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.85 165.8 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 109.233 -0.655 . . . . 2.9399999999999999 109.233 166.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.7 -39.74 91.67 Favored Glycine 0 N--CA 1.475 1.294 0 CA-C-N 119.528 1.058 . . . . 2.4700000000000002 114.673 -168.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.16 82.58 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.142 0.971 . . . . 3.9199999999999999 112.875 174.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -74.33 -8.34 55.9 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.213 2.605 . . . . 3.7400000000000002 114.275 176.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.0 p -64.13 159.07 21.27 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.789 -1.194 . . . . 2.8399999999999999 113.525 -174.526 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.6 t -52.21 -24.04 6.57 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.22 1.193 . . . . 3.5499999999999998 114.22 175.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.69 -44.92 93.46 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.251 -1.531 . . . . 2.6099999999999999 112.87 174.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.2 p -70.92 -21.35 62.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 117.945 0.339 . . . . 2.2999999999999998 111.785 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.02 -38.55 72.61 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.672 -0.643 . . . . 2.4100000000000001 111.149 174.024 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 94.1 mt -59.98 -54.21 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.405 0.682 . . . . 2.5899999999999999 110.829 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.37 -23.49 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 113.303 0.853 . . . . 2.1600000000000001 113.303 -178.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -74.45 -39.94 62.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.803 0.841 . . . . 3.8399999999999999 113.215 170.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.5 mt -65.25 -36.91 85.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.612 1.096 . . . . 4.5099999999999998 112.606 178.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.82 -52.25 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.991 0.516 . . . . 2.3700000000000001 110.627 174.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.49 -19.4 62.21 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.493 1.664 . . . . 4.7699999999999996 115.493 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -71.55 -33.93 69.55 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.51 1.505 . . . . 4.8099999999999996 111.906 168.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.03 -54.82 9.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.105 0.962 . . . . 4.3700000000000001 111.755 176.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.104 0 C-N-CA 127.079 2.152 . . . . 5.1399999999999997 115.451 177.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 112.137 0.421 . . . . 3.5099999999999998 112.137 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -67.37 -39.53 85.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.067 1.347 . . . . 4.4000000000000004 112.005 175.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.05 73.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.764 0.426 . . . . 2.6800000000000002 111.604 176.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.0 tp -70.56 -30.95 67.81 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.122 1.369 . . . . 2.3199999999999998 112.234 174.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.21 -34.13 61.45 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.991 0.516 . . . . 2.4700000000000002 112.343 177.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -64.31 -28.46 69.73 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.359 -0.838 . . . . 3.0 112.88 -177.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.28 -28.63 69.86 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.064 0.946 . . . . 2.23 113.237 173.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.62 -37.85 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.169 -0.957 . . . . 2.54 111.31 169.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -70.48 -31.39 68.5 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.253 1.021 . . . . 2.2200000000000002 113.138 179.322 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.72 -22.79 64.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.166 2.186 . . . . 3.2400000000000002 114.165 -178.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -76.78 155.58 33.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.21 1.404 . . . . 3.29 113.926 -169.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.78 -28.07 14.44 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.391 1.256 . . . . 3.0299999999999998 114.391 -168.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m 66.93 -29.47 0.14 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.805 2.15 . . . . 3.71 116.805 171.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.22 145.9 41.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.087 1.755 . . . . 3.5299999999999998 111.455 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.25 160.66 41.14 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.94 1.089 . . . . 1.6000000000000001 113.94 -169.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.8 m -112.43 112.64 24.35 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.309 1.044 . . . . 1.98 112.395 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.42 146.18 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 126.742 2.017 . . . . 1.9399999999999999 109.932 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.56 115.0 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.024 -1.102 . . . . 2.7200000000000002 108.024 166.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m -107.2 139.85 41.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.238 1.815 . . . . 2.8999999999999999 109.917 -176.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.45 95.25 8.73 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.739 -0.837 . . . . 4.5099999999999998 108.739 174.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -15.58 60.64 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.526 0.935 . . . . 4.0700000000000003 113.526 -173.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.9 m -150.51 146.12 26.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.979 2.112 . . . . 3.77 111.509 168.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 25' ' ' ILE . 25.6 t0 -19.63 64.49 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 1 C-N-CA 133.814 4.846 . . . . 6.1900000000000004 118.108 -169.799 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.26 -14.27 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 127.157 2.183 . . . . 5.4800000000000004 114.329 -168.426 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.433 ' H ' ' C ' ' A' ' 23' ' ' ASP . 16.8 pt -75.66 -26.25 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 128.09 2.556 . . . . 5.5999999999999996 115.221 -178.367 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.1 tp -125.41 128.63 48.41 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.851 1.26 . . . . 3.3300000000000001 111.793 -172.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -108.4 137.83 45.72 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.697 1.199 . . . . 3.5699999999999998 112.311 177.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.3 t -142.07 131.88 24.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.914 1.285 . . . . 1.9199999999999999 110.507 168.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -99.34 135.67 40.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.091 0.956 . . . . 2.75 110.878 -179.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -131.99 132.58 43.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.5 1.92 . . . . 3.4199999999999999 111.642 -167.088 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -104.08 130.0 51.76 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.251 -1.531 . . . . 2.1000000000000001 112.706 -172.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -142.6 -179.77 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 125.7 1.6 . . . . 2.3599999999999999 113.749 -171.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.93 147.43 23.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.671 1.188 . . . . 2.6699999999999999 110.69 166.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.38 -21.53 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.943 1.09 . . . . 2.8500000000000001 113.943 -176.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.16 -23.88 67.23 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.119 -0.988 . . . . 3.1499999999999999 112.448 168.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.4 mt -106.62 -10.23 16.26 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.838 1.655 . . . . 2.6699999999999999 114.384 -169.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.7 m -60.78 -37.34 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 119.897 1.226 . . . . 3.9300000000000002 112.415 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.306 35.3 mt-30 58.31 150.75 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.959 2.904 . . . . 4.0700000000000003 115.775 -173.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -71.12 40.89 0.06 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 117.203 2.297 . . . . 4.7999999999999998 117.203 -167.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.47 17.77 0.43 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.627 1.584 . . . . 1.5800000000000001 115.712 178.201 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.52 170.23 8.27 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.831 1.315 . . . . 3.1499999999999999 113.392 170.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.2 mt -122.02 131.8 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.454 1.502 . . . . 2.27 109.004 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.96 131.58 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.717 1.607 . . . . 1.8600000000000001 111.02 -169.44 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -84.52 125.72 32.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.913 0.779 . . . . 2.9199999999999999 112.23 171.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.79 133.04 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.233 1.413 . . . . 1.3500000000000001 110.935 172.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 m -93.2 168.26 12.5 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 124.036 0.935 . . . . 2.0 112.982 -176.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.92 132.38 47.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.583 2.188 . . . . 1.4299999999999999 110.324 168.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.77 -6.17 27.12 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.614 1.102 . . . . 1.0 115.395 -172.038 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.26 162.71 53.69 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.149 1.474 . . . . 0.98999999999999999 114.112 -179.072 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -104.84 146.34 29.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.299 1.04 . . . . 3.21 111.692 175.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -71.57 130.91 86.74 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.696 -0.669 . . . . 2.9199999999999999 109.538 169.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -94.83 -18.03 0.41 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.481 2.12 . . . . 1.03 115.065 -171.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 m -144.09 175.63 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 127.277 2.231 . . . . 2.52 110.086 -178.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -94.91 136.25 35.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.97 0.805 . . . . 1.98 112.027 168.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.46 -173.44 46.28 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 121.545 -0.722 . . . . 0.72999999999999998 114.243 -169.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -109.22 134.65 51.48 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.143 0.977 . . . . 5.8099999999999996 113.218 -175.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.8 126.88 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.907 2.083 . . . . 1.6299999999999999 108.048 174.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.8 pt -140.39 33.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 118.614 0.643 . . . . 2.1000000000000001 112.12 176.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -165.82 128.54 2.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.714 1.606 . . . . 3.8799999999999999 108.594 169.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.78 165.93 40.67 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.745 1.164 . . . . 1.3 114.697 -179.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -141.53 130.16 22.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.293 1.037 . . . . 2.7200000000000002 112.38 178.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.69 163.36 33.49 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.49 1.116 . . . . 1.6899999999999999 112.657 173.222 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.0 ttm -90.61 141.94 28.26 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.489 0.716 . . . . 1.75 109.298 168.161 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.2 t -134.55 142.56 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.997 1.319 . . . . 0.97999999999999998 112.724 -168.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -89.07 116.36 27.29 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.257 1.023 . . . . 2.1499999999999999 112.211 173.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -109.62 10.69 24.92 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.504 1.522 . . . . 2.1000000000000001 111.951 169.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 t -58.47 -39.29 79.53 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.939 1.296 . . . . 2.8399999999999999 114.043 -172.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.88 -31.47 27.91 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 120.391 1.451 . . . . 2.1600000000000001 111.576 177.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.8 mm -62.03 -57.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.028 0.931 . . . . 2.7000000000000002 110.762 178.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 p -119.58 -5.11 10.27 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.161 1.171 . . . . 2.8100000000000001 114.161 -169.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.42 11.69 77.33 Favored Glycine 0 CA--C 1.539 1.572 0 CA-C-O 118.504 -1.164 . . . . 2.0299999999999998 115.295 -179.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -49.97 -53.51 26.0 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.842 1.821 . . . . 2.7999999999999998 114.17 -175.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.256 . . 59.66 13.94 3.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.09 1.756 . . . . 2.3700000000000001 114.739 -173.498 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 52.3 ttp -132.81 131.84 22.23 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 128.308 2.643 . . . . 4.5899999999999999 106.876 169.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.98 152.33 46.11 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.161 2.574 . . . . 2.6299999999999999 112.949 -171.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -109.48 133.24 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.752 1.621 . . . . 1.49 110.632 -171.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.16 132.35 36.52 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.57 -0.706 . . . . 1.97 111.206 174.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -120.58 144.62 48.0 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.365 1.466 . . . . 1.02 110.122 173.085 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 167.28 13.51 Favored Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 127.699 2.4 . . . . 5.71 110.526 -169.873 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -58.72 132.03 45.59 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 CA-C-N 121.628 1.617 . . . . 1.04 111.354 174.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.5 29.56 35.84 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.451 1.024 . . . . 0.73999999999999999 114.21 -169.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.9 t -116.4 152.6 33.63 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.788 1.635 . . . . 1.73 111.658 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.2 p -107.15 150.15 26.9 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.931 1.241 . . . . 1.9299999999999999 113.142 178.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.4 m -140.27 163.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.448 1.499 . . . . 1.98 112.285 -174.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.93 156.78 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.535 1.534 . . . . 2.4399999999999999 112.549 173.418 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.75 148.12 49.99 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.487 0.921 . . . . 1.8899999999999999 113.487 -177.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.49 -1.62 70.88 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 115.198 0.839 . . . . 0.89000000000000001 115.198 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.8 p -78.11 151.43 33.36 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.425 1.113 . . . . 1.6599999999999999 109.433 166.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.88 132.87 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.509 0.724 . . . . 1.76 111.835 -168.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -95.28 137.65 34.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.221 1.808 . . . . 1.5600000000000001 112.671 -176.176 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -85.53 -92.94 0.09 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 115.488 1.662 . . . . 3.3199999999999998 115.488 -169.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -109.22 -30.65 7.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 117.143 2.275 . . . . 3.9399999999999999 117.143 -167.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.8 150.72 16.93 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.065 1.317 . . . . 1.96 113.379 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 t -98.15 139.65 33.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.275 1.83 . . . . 3.5899999999999999 112.443 -174.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.85 162.68 30.91 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.717 1.607 . . . . 2.3399999999999999 112.208 -168.447 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.36 127.95 54.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.073 0.949 . . . . 2.8700000000000001 112.248 172.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.53 132.21 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.326 1.451 . . . . 2.2599999999999998 111.875 -172.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.1 m -84.97 118.27 24.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.81 1.244 . . . . 2.8999999999999999 111.187 -179.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.95 117.0 21.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.45 0.7 . . . . 1.29 111.79 176.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.4 t -112.53 5.34 17.88 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.926 1.29 . . . . 3.6099999999999999 114.253 174.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -151.3 144.29 24.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.498 2.319 . . . . 2.5099999999999998 108.808 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.6 m -82.59 162.31 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.271 -1.011 . . . . 2.8500000000000001 108.271 164.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.98 -39.15 56.54 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-N 119.555 1.071 . . . . 1.5600000000000001 114.976 -168.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.71 80.63 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.265 1.026 . . . . 2.52 113.537 173.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.85 -9.46 58.7 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.563 1.545 . . . . 4.04 114.958 -179.145 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.3 p -69.7 160.94 30.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.777 1.028 . . . . 2.7200000000000002 113.777 -175.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.8 t -63.07 -33.03 74.56 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.71 0.804 . . . . 2.7200000000000002 112.112 172.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.59 -45.25 92.46 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.054 -1.029 . . . . 2.6000000000000001 111.368 176.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 64.8 m -71.46 -33.32 69.23 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.906 0.882 . . . . 2.3700000000000001 112.54 173.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -61.97 -42.23 98.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.276 1.03 . . . . 2.23 111.17 177.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.29 -55.63 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.079 1.352 . . . . 2.54 110.808 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.0 m -66.92 -24.01 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 113.404 0.89 . . . . 1.79 113.404 -175.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -72.71 -49.09 33.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.88 1.272 . . . . 3.4399999999999999 112.241 170.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.4 mt -66.24 -27.88 68.3 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.37 0.878 . . . . 4.3300000000000001 113.37 179.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.53 -53.63 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.279 0.632 . . . . 2.52 109.727 169.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.54 -33.04 67.69 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.492 1.293 . . . . 3.8500000000000001 114.492 -177.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.85 -29.79 69.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.154 0.982 . . . . 4.8600000000000003 112.866 175.261 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.95 -59.02 2.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.798 0.839 . . . . 4.4400000000000004 112.529 -169.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--O 1.255 1.386 0 C-N-CA 125.033 1.333 . . . . 4.0899999999999999 113.698 -176.629 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 114.417 1.266 . . . . 4.0700000000000003 114.417 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.0 -32.51 24.9 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.493 1.042 . . . . 4.0999999999999996 110.678 169.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.88 71.51 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.516 -0.74 . . . . 2.7999999999999998 112.367 170.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 tp -61.7 -32.55 72.76 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.572 0.749 . . . . 2.8399999999999999 111.884 175.248 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.47 -41.79 45.98 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.507 0.723 . . . . 2.54 112.391 168.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -61.06 -36.85 80.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.803 1.241 . . . . 3.3500000000000001 113.143 -174.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.45 -33.19 72.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.389 0.995 . . . . 2.0 113.449 178.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.98 -39.85 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.25 -0.906 . . . . 2.5499999999999998 111.853 168.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.2 m -63.99 -32.77 74.43 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.097 -1.002 . . . . 1.79 113.128 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.14 -24.02 67.53 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.0 2.52 . . . . 2.6099999999999999 114.132 177.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -80.24 121.48 25.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.391 0.677 . . . . 3.0800000000000001 109.291 -177.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.78 66.56 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 116.527 2.047 . . . . 2.4300000000000002 116.527 -166.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m 67.16 -21.13 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 115.613 1.709 . . . . 4.1200000000000001 115.613 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -128.05 152.19 48.26 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.146 -1.596 . . . . 3.04 114.171 176.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.7 144.62 49.25 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.086 1.355 . . . . 2.6699999999999999 111.112 -177.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.5 m -119.08 98.23 6.07 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.919 0.887 . . . . 2.79 112.049 -171.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.6 mt -81.68 136.91 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 127.013 2.125 . . . . 1.6100000000000001 111.46 -171.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.61 142.79 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.679 0.792 . . . . 3.27 112.49 168.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.0 m -138.58 115.84 11.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.388 1.875 . . . . 4.0800000000000001 111.849 -169.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mp -102.62 77.56 1.62 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.558 1.143 . . . . 5.0 110.004 177.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -17.34 62.59 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.91 0.707 . . . . 4.2800000000000002 112.91 176.558 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.9 m -144.79 131.48 20.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.377 2.271 . . . . 5.2699999999999996 110.078 176.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 25' ' ' ILE . 2.5 t70 -21.06 63.65 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.424 1 C-N-CA 133.875 4.87 . . . . 5.8600000000000003 117.649 -169.907 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 60.73 -25.47 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.825 2.45 . . . . 5.7300000000000004 114.473 -167.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 23' ' ' ASP . 26.7 pt -58.74 5.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 131.6 3.96 . . . . 5.79 117.08 179.076 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.51 -40.67 1.41 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.364 1.866 . . . . 5.4400000000000004 113.249 179.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.8 tp 22.57 68.05 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 128.687 2.795 . . . . 4.29 113.258 -176.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.5 m -78.15 153.81 31.75 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.311 1.044 . . . . 3.6699999999999999 110.826 -178.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -124.2 146.96 48.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.51 0.724 . . . . 2.5899999999999999 112.707 176.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -137.42 139.76 40.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.789 2.036 . . . . 2.6600000000000001 110.255 -172.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -107.56 130.28 54.89 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.258 0.936 . . . . 2.9500000000000002 112.665 175.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 m -132.97 174.71 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.644 1.578 . . . . 2.5299999999999998 111.503 -177.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.87 145.58 31.28 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.939 0.895 . . . . 4.9500000000000002 111.761 169.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.31 -8.02 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 114.189 1.181 . . . . 2.54 114.189 -176.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -85.46 -28.12 25.25 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.166 -1.583 . . . . 4.5599999999999996 112.315 167.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.58 -20.06 22.07 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.441 1.496 . . . . 2.6499999999999999 113.515 -169.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.58 -46.07 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.48 1.112 . . . . 3.8199999999999998 112.352 178.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 59.56 164.94 0.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.408 1.883 . . . . 3.8500000000000001 115.863 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -74.34 27.34 0.08 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 117.002 2.223 . . . . 5.4500000000000002 117.002 -168.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.75 -8.3 5.29 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 117.012 1.565 . . . . 1.75 117.012 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.11 175.76 5.37 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.63 1.715 . . . . 3.0800000000000001 114.308 -174.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.9 mt -123.27 135.33 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.481 1.913 . . . . 2.9199999999999999 110.411 -178.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.4 mm -124.9 123.59 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.349 1.859 . . . . 1.6399999999999999 110.186 -170.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -100.01 122.0 42.24 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.273 -0.892 . . . . 4.4100000000000001 112.79 177.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.7 p -100.72 142.57 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.557 1.543 . . . . 1.4099999999999999 112.117 -173.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 m -88.95 163.58 34.29 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 124.417 1.087 . . . . 2.2799999999999998 113.136 -177.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.95 132.6 48.39 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.446 2.097 . . . . 1.8999999999999999 110.902 169.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.17 -1.99 62.62 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 115.854 1.102 . . . . 1.1000000000000001 115.854 -172.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.17 174.99 46.27 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-N 119.517 1.659 . . . . 1.1000000000000001 114.923 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -122.37 145.89 47.85 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.505 1.522 . . . . 3.5499999999999998 111.132 -177.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -86.35 129.66 52.56 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 118.697 -0.668 . . . . 3.6699999999999999 112.443 -177.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.12 -19.83 0.85 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.124 2.55 . . . . 0.96999999999999997 115.825 -172.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.7 m -148.57 165.71 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 126.87 2.068 . . . . 2.4300000000000002 109.466 -177.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -88.29 127.88 35.47 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.288 0.949 . . . . 2.1299999999999999 111.976 169.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.19 -167.83 29.41 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.592 1.091 . . . . 0.75 112.918 -169.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -117.33 135.36 53.9 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.042 0.937 . . . . 6.3300000000000001 113.326 -175.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.8 t -83.45 129.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 128.522 2.729 . . . . 1.77 109.14 176.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.17 32.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.216 1.006 . . . . 1.8500000000000001 113.165 -179.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -168.55 137.91 2.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.004 1.722 . . . . 3.52 108.675 166.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.11 -177.08 51.93 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.593 0.997 . . . . 0.81000000000000005 115.593 169.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -145.89 120.73 9.94 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.282 1.433 . . . . 5.4199999999999999 110.972 -169.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.22 171.76 14.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.462 1.105 . . . . 1.74 111.267 172.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.6 ttm -108.01 149.15 28.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.99 1.316 . . . . 1.8400000000000001 111.043 170.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.92 133.72 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.743 1.217 . . . . 0.98999999999999999 112.573 -169.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -100.45 106.06 17.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.412 1.485 . . . . 2.21 110.409 177.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.29 6.07 10.71 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.741 1.616 . . . . 2.1899999999999999 114.912 -172.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.3 p -45.69 -26.04 0.57 Allowed 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 117.127 2.269 . . . . 1.9099999999999999 117.127 -175.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.34 -42.16 19.09 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.558 1.526 . . . . 1.6899999999999999 112.664 175.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.9 mm -72.68 -60.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.974 0.91 . . . . 2.0699999999999998 110.278 -170.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 p -93.25 -11.11 33.36 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.877 2.071 . . . . 2.2200000000000002 112.455 -176.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.1 31.85 57.06 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 121.246 -0.909 . . . . 1.55 113.275 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -68.24 178.83 1.77 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.691 0.796 . . . . 2.5800000000000001 110.96 168.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.03 7.13 1.59 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.193 1.183 . . . . 3.3900000000000001 114.193 177.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 ptp -149.19 153.55 37.93 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.669 1.988 . . . . 3.8599999999999999 107.806 169.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.9 159.64 37.88 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.138 1.892 . . . . 1.8700000000000001 112.652 -177.087 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.88 138.37 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.211 1.804 . . . . 1.98 112.024 -168.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.6 150.86 36.43 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.382 -0.823 . . . . 1.8400000000000001 113.119 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -132.32 155.1 48.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.628 1.971 . . . . 1.98 112.699 175.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -153.94 -179.15 0.99 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 129.044 2.938 . . . . 3.54 109.79 178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.72 150.4 82.73 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.748 1.632 . . . . 2.48 113.788 170.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.34 19.88 70.95 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-N 114.569 -1.196 . . . . 1.1000000000000001 114.357 -171.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.7 t -107.84 153.88 22.37 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 119.324 1.562 . . . . 1.5700000000000001 111.1 -176.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.3 p -118.44 143.43 46.69 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.282 -1.511 . . . . 2.2799999999999998 112.948 -169.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 m -134.01 156.95 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.768 1.627 . . . . 1.9399999999999999 112.399 -169.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.7 153.51 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.236 1.814 . . . . 2.3999999999999999 112.816 174.669 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.38 150.45 48.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.148 0.796 . . . . 1.5900000000000001 113.148 175.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.84 -6.0 56.26 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.489 1.042 . . . . 0.78000000000000003 115.451 176.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.4 p -77.72 159.82 28.85 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.274 1.03 . . . . 1.6499999999999999 111.361 169.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mm -113.77 127.24 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.432 0.693 . . . . 1.73 111.782 -169.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -86.48 140.12 30.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.445 1.898 . . . . 1.6699999999999999 111.987 -178.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -100.46 -125.34 0.17 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.402 1.081 . . . . 3.4399999999999999 113.509 -172.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -90.13 63.61 5.89 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.983 1.265 . . . . 3.8500000000000001 113.844 -166.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.92 157.23 9.23 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.431 -0.793 . . . . 1.8999999999999999 114.989 169.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -92.36 133.3 36.0 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.475 1.11 . . . . 3.0699999999999998 112.259 -175.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.76 153.7 39.14 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.601 1.56 . . . . 1.8300000000000001 111.587 -176.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.1 tp -108.62 119.81 40.61 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.617 1.167 . . . . 3.7599999999999998 110.356 174.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mp -117.53 127.94 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.319 1.048 . . . . 2.4300000000000002 111.04 -175.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.3 p -81.52 128.65 34.13 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.722 -0.611 . . . . 2.5299999999999998 110.654 171.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.09 126.17 34.6 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.499 -0.751 . . . . 1.3999999999999999 110.864 176.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 p -133.97 -3.96 2.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.926 1.69 . . . . 3.3700000000000001 113.698 -170.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -148.03 150.3 33.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.237 2.215 . . . . 2.4900000000000002 108.887 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.74 173.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.246 1.018 . . . . 2.7999999999999998 111.416 169.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.75 -35.78 47.55 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.17 -0.956 . . . . 1.8500000000000001 115.027 -170.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.63 -31.97 71.14 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.322 1.231 . . . . 2.7200000000000002 114.322 176.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.84 -14.11 60.28 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.05 1.295 . . . . 3.8799999999999999 114.19 172.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 60.1 p -68.47 144.59 54.6 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.138 -1.601 . . . . 2.4900000000000002 113.152 -169.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 t -63.48 -33.04 74.7 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.77 0.428 . . . . 3.79 110.821 171.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.7 mp -53.3 -53.01 57.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.58 1.152 . . . . 2.1099999999999999 111.886 175.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.4 m -71.73 -26.54 62.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.022 0.929 . . . . 2.4100000000000001 111.77 177.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -70.64 -42.66 70.55 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.761 -0.587 . . . . 1.8 111.826 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.91 -53.34 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.746 1.219 . . . . 3.3399999999999999 110.287 177.65 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.5 m -67.47 -23.25 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 113.607 0.966 . . . . 1.78 113.607 -176.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -73.35 -51.96 15.56 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.908 0.776 . . . . 3.46 112.068 168.596 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.0 mt -62.22 -43.17 99.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.146 0.978 . . . . 3.8300000000000001 112.925 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.39 -50.75 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.492 0.717 . . . . 2.7799999999999998 110.517 178.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -56.95 -37.25 71.26 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.72 1.007 . . . . 3.8199999999999998 113.72 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -74.65 -21.56 59.37 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.104 1.15 . . . . 5.6100000000000003 114.104 176.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.98 -44.33 63.69 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.84 0.856 . . . . 4.5499999999999998 112.093 -174.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.691 1.196 . . . . 5.04 113.409 170.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 119.163 -0.446 . . . . 3.0299999999999998 110.249 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.34 -42.47 98.74 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.015 0.825 . . . . 4.5899999999999999 109.979 167.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.81 -34.91 65.76 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.252 -0.905 . . . . 1.8100000000000001 113.081 175.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.9 tp -67.58 -28.86 68.13 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.327 -0.858 . . . . 2.6400000000000001 112.243 177.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.77 -45.31 29.48 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.019 0.528 . . . . 2.0699999999999998 111.312 167.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -53.62 -43.69 68.88 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.462 1.905 . . . . 2.9100000000000001 113.22 -175.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -48.04 -48.1 33.24 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.003 0.921 . . . . 2.0499999999999998 112.229 176.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.6 mm -73.88 -34.59 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.23 -0.919 . . . . 2.5299999999999998 113.408 177.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -77.17 -24.16 51.52 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.417 1.266 . . . . 2.7200000000000002 114.417 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.6 mt -58.63 -21.07 52.7 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.232 1.413 . . . . 3.1000000000000001 113.769 174.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -78.09 141.7 38.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.858 1.263 . . . . 2.6200000000000001 113.589 -174.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.9 154.51 33.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.283 1.033 . . . . 2.3399999999999999 112.732 175.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.61 -12.93 35.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.498 1.519 . . . . 3.2599999999999998 113.549 175.18 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -143.42 164.74 29.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.794 2.038 . . . . 3.1699999999999999 113.3 -175.497 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.15 163.59 32.31 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.343 1.457 . . . . 1.3899999999999999 111.524 171.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.4 m -114.75 106.8 14.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.017 1.327 . . . . 1.8100000000000001 110.062 170.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.52 133.12 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.084 -1.08 . . . . 1.28 108.084 174.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.61 118.43 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.519 0.728 . . . . 3.0699999999999998 110.451 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.8 m -131.85 144.16 50.69 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.183 1.393 . . . . 3.3399999999999999 109.765 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.7 mt -105.23 124.23 49.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.187 0.995 . . . . 4.3499999999999996 108.701 -176.27 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.39 10.77 23.37 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.772 2.138 . . . . 3.7200000000000002 116.772 -166.58 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.0 m -125.77 -96.97 0.43 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.024 0.929 . . . . 3.8799999999999999 109.789 175.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -139.4 56.39 1.67 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.878 2.071 . . . . 5.21 107.572 -179.343 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 65.0 -23.78 0.08 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.615 2.766 . . . . 4.8799999999999999 116.711 -168.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.0 pt -71.84 -8.32 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 115.735 1.754 . . . . 5.0800000000000001 115.735 -172.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tt -119.42 125.35 48.75 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.329 1.852 . . . . 3.6299999999999999 110.292 -177.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -101.52 131.86 47.45 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.246 1.418 . . . . 3.9700000000000002 111.128 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 t -139.5 96.81 3.15 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.678 1.191 . . . . 2.25 110.447 -177.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -91.14 150.14 21.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.769 1.025 . . . . 2.5099999999999998 113.769 -179.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -124.18 140.55 52.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.308 1.843 . . . . 2.8199999999999998 111.182 169.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -98.05 126.02 43.29 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.71 0.804 . . . . 2.5600000000000001 109.099 169.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 m -136.28 164.78 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.698 1.199 . . . . 1.28 112.625 -172.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.36 151.14 31.17 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.663 0.785 . . . . 3.4100000000000001 111.741 169.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.05 -24.87 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.385 0.883 . . . . 1.96 113.385 175.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -69.4 -27.88 65.68 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.843 -1.161 . . . . 3.1299999999999999 113.199 170.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.9 mt -100.74 -7.78 23.42 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.872 1.669 . . . . 2.4199999999999999 114.434 -168.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.67 141.83 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.631 0.773 . . . . 2.29 110.341 169.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -126.07 159.67 32.17 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.78 1.632 . . . . 3.6899999999999999 111.962 -170.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.266 16.8 ptt85 -75.53 15.82 0.43 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.957 1.836 . . . . 3.52 115.957 -174.217 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.31 -2.58 15.48 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.651 2.072 . . . . 1.78 113.539 168.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -84.02 155.84 22.54 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 118.731 1.266 . . . . 2.9900000000000002 111.735 178.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 mt -118.69 128.95 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.55 1.14 . . . . 2.2400000000000002 109.167 169.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.6 mm -107.09 168.45 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 128.018 2.527 . . . . 2.1099999999999999 111.022 -167.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -129.13 136.52 50.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.775 1.23 . . . . 2.48 109.832 170.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.07 132.69 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.393 1.077 . . . . 1.52 110.405 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.9 m -90.15 166.52 19.84 Favored Pre-proline 0 N--CA 1.482 1.127 0 N-CA-C 113.427 0.899 . . . . 2.48 113.427 -170.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -61.8 128.01 23.16 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.76 2.307 . . . . 1.51 110.598 169.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.42 8.46 59.54 Favored Glycine 0 CA--C 1.539 1.583 0 O-C-N 121.278 -0.889 . . . . 0.88 114.884 -170.573 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.47 169.02 54.9 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.636 1.588 . . . . 0.95999999999999996 114.791 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -125.61 140.35 52.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.964 1.305 . . . . 2.9199999999999999 110.979 -175.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -79.06 127.39 79.66 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 112.671 0.619 . . . . 2.8700000000000001 112.671 -173.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -87.0 -24.59 1.3 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.397 2.731 . . . . 0.69999999999999996 114.875 -174.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 m -149.86 171.45 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 127.877 2.471 . . . . 1.6799999999999999 108.988 -177.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.54 139.77 38.41 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.428 1.013 . . . . 1.79 113.111 178.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.44 -154.86 14.5 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 114.701 0.641 . . . . 0.75 114.701 -170.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -120.73 141.45 50.43 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.125 1.157 . . . . 6.5 114.125 -173.147 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.1 t -89.83 132.64 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 128.647 2.779 . . . . 1.6100000000000001 108.997 174.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 pt -139.09 35.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 113.456 0.91 . . . . 1.8999999999999999 113.456 171.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -165.75 137.4 3.92 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.673 1.189 . . . . 3.0899999999999999 111.149 166.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.1 -164.73 26.21 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 117.469 1.748 . . . . 0.94999999999999996 117.469 168.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -151.48 109.03 3.62 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.321 1.449 . . . . 2.7400000000000002 111.97 -172.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.13 170.21 16.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.726 0.774 . . . . 1.8 112.024 172.108 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 ttm -117.43 144.11 45.33 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.911 1.284 . . . . 1.8400000000000001 110.092 176.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.0 t -130.29 139.74 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.851 1.26 . . . . 1.97 111.259 -169.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -98.11 127.51 44.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.384 0.674 . . . . 2.3199999999999998 112.427 175.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -127.95 20.7 6.42 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.515 1.526 . . . . 2.0600000000000001 112.879 -173.336 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 p -64.55 -22.2 66.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.878 1.807 . . . . 1.79 115.878 -169.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.68 -42.65 11.23 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.752 0.821 . . . . 1.77 109.543 168.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.77 -59.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.802 1.241 . . . . 2.0 112.505 -171.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.0 p -106.91 -10.56 15.96 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.548 1.539 . . . . 2.1699999999999999 113.361 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.58 13.01 76.88 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 119.151 -0.805 . . . . 1.3100000000000001 114.574 176.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -58.32 -47.39 83.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.718 1.207 . . . . 2.8300000000000001 113.407 -174.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 61.75 19.76 10.82 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.507 1.299 . . . . 2.25 114.507 178.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttt -150.68 136.93 10.97 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 128.466 2.706 . . . . 5.3399999999999999 106.729 168.366 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.13 151.73 64.57 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.288 3.325 . . . . 1.9399999999999999 115.2 -176.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.23 134.38 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.555 1.942 . . . . 1.6699999999999999 111.597 -169.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.97 141.87 32.9 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.054 1.131 . . . . 2.1800000000000002 114.054 -173.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -124.72 142.35 51.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.4 1.88 . . . . 0.96999999999999997 111.496 173.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -142.03 174.71 3.51 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 128.968 2.907 . . . . 4.3200000000000003 109.84 -176.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.76 126.65 19.48 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 CA-C-N 121.577 1.599 . . . . 0.96999999999999997 110.493 167.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.39 9.55 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.045 1.307 . . . . 0.76000000000000001 114.315 -169.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.3 m -120.41 153.14 36.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 119.233 1.517 . . . . 1.5600000000000001 111.749 177.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 p -101.5 152.28 20.95 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.344 1.429 . . . . 1.76 113.358 175.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.1 m -136.41 155.03 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.803 1.641 . . . . 1.8300000000000001 111.41 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.91 143.97 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.487 1.515 . . . . 1.8799999999999999 112.802 -179.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.45 147.91 29.97 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.394 1.078 . . . . 1.6000000000000001 112.663 -178.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.98 -6.26 49.76 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.599 -1.112 . . . . 0.76000000000000001 115.705 178.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.8 p -79.26 163.37 25.0 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.964 1.382 . . . . 1.5700000000000001 111.844 169.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mm -110.93 129.93 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.351 1.06 . . . . 1.97 111.253 -173.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -92.03 135.21 34.14 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.816 1.646 . . . . 1.8600000000000001 110.858 176.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -88.77 -107.01 0.08 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.215 1.191 . . . . 3.9900000000000002 114.215 -173.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -82.24 -45.44 15.02 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 116.722 2.119 . . . . 3.1400000000000001 116.722 -166.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.41 140.72 15.19 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.069 0.849 . . . . 1.9299999999999999 113.539 -172.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.1 p -82.93 137.15 34.32 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.652 0.726 . . . . 2.8100000000000001 112.53 171.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.1 mt -130.03 156.17 44.93 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.953 1.301 . . . . 1.97 112.079 -170.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.97 122.21 42.53 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.366 1.067 . . . . 3.7599999999999998 110.82 174.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -115.6 123.02 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.799 1.239 . . . . 2.5800000000000001 111.895 -173.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 74.8 m -79.51 120.24 23.61 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.674 -1.267 . . . . 3.8199999999999998 108.956 168.258 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.88 118.24 20.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.644 -0.502 . . . . 1.1100000000000001 109.644 173.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.7 p -108.72 -0.28 20.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.39 1.076 . . . . 2.6899999999999999 113.31 175.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -137.96 139.65 39.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.093 1.357 . . . . 1.78 111.618 176.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 m -78.84 157.18 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.702 -0.851 . . . . 2.2599999999999998 108.702 165.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.74 -35.24 73.45 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 120.954 -1.091 . . . . 1.3700000000000001 115.569 -169.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.22 64.43 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.629 1.344 . . . . 2.4500000000000002 114.629 174.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -80.18 -8.18 59.31 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.814 1.646 . . . . 2.54 115.274 173.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 37.4 p -58.86 158.22 8.56 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.609 1.337 . . . . 2.2200000000000002 114.609 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.7 m -60.68 -35.65 76.79 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.711 0.804 . . . . 3.6499999999999999 111.035 170.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.63 -43.64 96.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.208 1.003 . . . . 2.1200000000000001 112.101 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.9 p -72.95 -21.84 60.81 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.901 1.074 . . . . 2.5099999999999998 113.901 170.092 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -70.44 -38.28 74.5 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.606 -1.309 . . . . 2.3399999999999999 112.01 174.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.22 -52.39 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.848 1.259 . . . . 2.4100000000000001 110.741 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -65.63 -28.28 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.285 0.948 . . . . 1.53 112.951 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -63.17 -40.75 98.44 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.281 0.946 . . . . 4.1699999999999999 111.019 172.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.19 -46.28 61.62 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.672 1.189 . . . . 3.7200000000000002 112.718 178.697 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.91 -26.44 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.239 -0.913 . . . . 2.4700000000000002 113.096 -178.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.63 -25.9 63.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.003 -1.061 . . . . 3.77 112.167 175.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -71.8 -19.93 61.92 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.258 1.023 . . . . 4.2699999999999996 113.327 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.95 -57.17 4.24 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.842 -1.162 . . . . 3.5899999999999999 112.711 -176.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 124.265 1.026 . . . . 4.3399999999999999 112.483 -177.477 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 117.249 2.314 . . . . 4.7800000000000002 117.249 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -98.21 -36.2 10.12 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 120.174 -1.579 . . . . 5.5599999999999996 111.961 173.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.06 86.24 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.795 0.838 . . . . 2.8900000000000001 111.28 168.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.9 tp -42.01 -31.04 0.31 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.533 2.733 . . . . 2.6600000000000001 115.861 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.97 -32.67 65.37 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.187 1.18 . . . . 3.3999999999999999 114.187 177.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.98 -30.55 68.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.822 1.249 . . . . 6.3399999999999999 112.497 -170.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -53.16 -37.29 61.74 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.803 1.641 . . . . 1.8999999999999999 112.51 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -75.84 -35.93 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.962 1.305 . . . . 2.2000000000000002 112.821 175.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.1 m -72.82 -39.74 66.37 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.039 1.126 . . . . 1.97 114.039 -175.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.21 -18.01 65.06 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.301 1.223 . . . . 2.98 114.301 -173.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -70.09 141.33 52.77 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.273 1.029 . . . . 3.1000000000000001 112.829 -172.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.04 139.1 30.79 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.583 0.957 . . . . 2.23 113.583 -176.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -90.69 -8.18 50.61 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.565 1.546 . . . . 2.7400000000000002 113.868 -171.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.01 160.85 38.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.142 1.377 . . . . 3.6600000000000001 113.896 -179.236 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.04 166.37 24.89 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.812 1.645 . . . . 2.2200000000000002 112.005 176.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.9 m -117.62 105.38 11.98 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.624 1.17 . . . . 2.1600000000000001 111.322 169.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.0 mt -82.87 130.44 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.482 1.113 . . . . 2.0099999999999998 108.925 177.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -126.52 128.11 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 121.501 -0.749 . . . . 3.3300000000000001 112.139 -176.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.4 m -91.16 130.48 37.05 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.737 1.215 . . . . 3.79 109.56 169.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.91 3.01 8.08 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.545 1.313 . . . . 6.3499999999999996 114.545 -169.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 t70 20.77 -92.61 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 130.65 3.58 . . . . 8.7200000000000006 114.252 -177.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 m -29.61 -52.63 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.288 2.635 . . . . 7.8200000000000003 115.853 178.465 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -164.92 -85.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.191 1.396 . . . . 11.02 107.848 176.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -130.99 10.31 4.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.092 1.757 . . . . 9.0500000000000007 112.073 175.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 pt -111.71 -11.27 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 117.942 2.571 . . . . 9.3699999999999992 117.942 -164.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -69.23 -32.18 71.25 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.164 1.347 . . . . 5.75 114.074 -172.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.4 mp 53.49 66.18 1.3 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.351 1.612 . . . . 4.4500000000000002 115.351 174.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.6 t -112.58 109.82 19.6 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.373 1.069 . . . . 2.2400000000000002 108.409 166.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -107.9 145.01 34.34 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.622 0.971 . . . . 2.7599999999999998 113.622 -168.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -124.02 128.53 49.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.511 1.924 . . . . 3.1699999999999999 109.97 173.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -91.86 124.05 35.7 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.208 -0.932 . . . . 2.3500000000000001 109.228 173.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 m -136.51 162.75 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.505 1.298 . . . . 1.7 114.505 -169.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.47 147.99 35.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.001 1.321 . . . . 2.7000000000000002 111.653 169.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -57.68 -22.81 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.694 0.998 . . . . 1.7 113.694 -178.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.52 -12.79 61.56 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.624 -1.298 . . . . 3.7400000000000002 113.258 175.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.87 -2.07 21.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.318 1.447 . . . . 2.5299999999999998 113.863 -171.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.39 148.26 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.862 1.265 . . . . 2.0699999999999998 110.571 170.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -137.56 165.68 25.74 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.176 1.391 . . . . 2.9399999999999999 113.379 -178.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.0 ptt85 -67.51 25.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 118.463 2.764 . . . . 3.3100000000000001 118.463 -168.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.32 9.7 1.28 Allowed Glycine 0 CA--C 1.54 1.629 0 C-N-CA 126.122 1.82 . . . . 1.3700000000000001 114.387 171.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -83.83 155.79 22.79 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.039 1.42 . . . . 2.7200000000000002 112.408 175.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 mt -111.8 124.99 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.51 0.724 . . . . 2.3999999999999999 110.254 172.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.1 mm -121.61 129.28 75.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 127.268 2.227 . . . . 1.96 110.452 -169.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -92.04 128.7 37.98 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.339 -0.851 . . . . 3.0299999999999998 110.536 171.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -102.76 135.4 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.837 1.255 . . . . 2.1800000000000002 110.346 -177.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.0 m -89.2 156.05 48.94 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.288 1.035 . . . . 2.3500000000000001 112.433 -178.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -59.19 143.28 99.82 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.929 1.753 . . . . 1.9199999999999999 111.641 168.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.05 -6.85 3.58 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.313 0.958 . . . . 1.3300000000000001 114.427 -169.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.7 151.16 50.28 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 119.246 1.523 . . . . 1.1499999999999999 113.054 177.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -103.03 142.8 33.49 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.826 1.25 . . . . 2.7799999999999998 110.875 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -75.49 125.25 88.92 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.881 -0.512 . . . . 3.5 112.059 -179.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.3 -25.46 3.88 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.88 2.387 . . . . 1.0900000000000001 113.922 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.3 m -151.97 171.95 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 127.711 2.404 . . . . 1.9299999999999999 109.057 -176.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.22 151.26 19.93 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.646 0.778 . . . . 2.27 112.229 177.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.74 -172.08 41.85 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 116.139 1.216 . . . . 0.91000000000000003 116.139 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -108.37 129.26 55.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.66 1.584 . . . . 5.5 111.703 -175.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.2 t -87.29 127.96 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.115 2.166 . . . . 1.8999999999999999 109.218 -176.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.4 pt -142.12 29.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 113.728 1.01 . . . . 2.3599999999999999 113.728 -172.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.22 141.45 1.61 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.784 1.634 . . . . 2.9199999999999999 109.534 165.093 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.75 -174.75 41.4 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 122.433 1.018 . . . . 0.75 114.98 170.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.43 103.96 3.19 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.135 0.974 . . . . 3.8300000000000001 111.07 -167.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -144.44 172.73 12.54 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.212 0.819 . . . . 1.6899999999999999 113.212 -172.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.5 ttm -124.71 133.64 53.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.981 1.312 . . . . 2.1899999999999999 110.04 -176.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -123.28 137.34 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.27 1.428 . . . . 2.2200000000000002 111.637 -169.063 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -95.71 103.63 15.52 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.87 1.268 . . . . 2.1800000000000002 110.682 -176.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -108.6 -1.5 19.55 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.669 1.588 . . . . 2.0600000000000001 113.677 -170.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 p -53.4 -33.06 52.41 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.552 2.056 . . . . 1.8100000000000001 116.552 -169.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.23 -44.34 22.0 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.652 1.569 . . . . 2.3599999999999999 110.775 173.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mm -62.04 -49.11 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.215 1.806 . . . . 2.23 111.621 -174.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.9 p -118.27 -2.68 11.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.009 1.114 . . . . 2.4500000000000002 114.009 -171.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.24 18.91 70.55 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.924 1.249 . . . . 1.1399999999999999 114.732 178.027 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -61.08 -179.12 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.543 1.137 . . . . 2.77 111.138 168.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.05 -20.35 0.88 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.322 1.449 . . . . 2.5899999999999999 114.141 177.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -125.58 153.22 72.73 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.827 2.051 . . . . 3.8599999999999999 110.336 167.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.0 165.83 31.43 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.237 2.625 . . . . 2.1600000000000001 114.019 -174.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.17 133.43 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 127.047 2.139 . . . . 2.2200000000000002 112.191 -168.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.88 141.03 36.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.35 1.06 . . . . 1.71 113.567 178.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -126.08 150.0 48.49 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.662 1.985 . . . . 2.0600000000000001 111.38 178.254 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -144.41 176.29 2.33 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.543 2.337 . . . . 3.48 110.257 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.47 131.01 36.02 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 CA-C-N 122.047 1.767 . . . . 1.01 110.463 167.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.05 28.68 33.48 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 118.092 -1.393 . . . . 0.83999999999999997 114.805 -171.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.3 m -108.02 174.14 6.01 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.853 1.826 . . . . 1.5800000000000001 110.959 174.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -125.79 156.44 39.5 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.437 -1.414 . . . . 2.0699999999999998 112.831 175.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.09 146.16 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.716 1.606 . . . . 1.2 112.648 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.85 152.3 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.73 2.412 . . . . 1.8 112.42 170.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.46 155.19 38.25 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.733 0.813 . . . . 1.9099999999999999 112.158 177.02 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.53 -1.37 52.05 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.519 1.057 . . . . 0.94999999999999996 115.543 176.467 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 p -76.86 162.81 27.32 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.066 1.433 . . . . 1.79 112.306 172.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.76 137.98 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.722 1.209 . . . . 1.97 111.082 -174.384 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -84.31 134.73 34.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.199 1.0 . . . . 2.52 111.152 170.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.26 50.92 1.49 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.135 1.532 . . . . 4.2300000000000004 115.135 179.214 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -163.97 -36.43 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.1 1.518 . . . . 3.3799999999999999 115.1 171.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.26 169.74 28.22 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-N 120.197 1.362 . . . . 2.8100000000000001 115.411 -171.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.0 m -69.56 137.46 52.42 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.547 1.314 . . . . 2.2799999999999998 114.547 -171.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.49 159.98 31.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.547 1.939 . . . . 2.1200000000000001 110.415 171.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.4 tp -114.07 126.51 55.18 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.037 0.935 . . . . 3.8199999999999998 110.778 173.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.36 132.43 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.842 1.257 . . . . 2.1099999999999999 111.272 -170.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 46.7 t -87.18 121.17 29.28 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.529 -0.915 . . . . 3.8199999999999998 108.529 168.008 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.93 130.48 35.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.083 0.953 . . . . 1.0800000000000001 110.604 -178.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.9 p -120.72 9.05 10.67 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.555 1.317 . . . . 2.6600000000000001 114.555 -175.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -149.04 155.15 40.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.428 1.491 . . . . 3.0099999999999998 111.575 168.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.33 164.03 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 108.71 -0.848 . . . . 2.7599999999999998 108.71 163.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 -39.66 95.55 Favored Glycine 0 N--CA 1.473 1.155 0 O-C-N 120.719 -1.238 . . . . 1.53 113.536 -170.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.72 77.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.417 1.109 . . . . 2.4399999999999999 113.27 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -77.37 -6.65 54.09 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.127 1.528 . . . . 2.6299999999999999 115.127 175.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.0 p -63.62 148.21 49.52 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.686 -1.259 . . . . 2.2400000000000002 111.182 174.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.6 m -65.27 -34.38 78.22 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.506 -0.746 . . . . 4.8700000000000001 110.312 169.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.1 tp -49.34 -51.87 31.73 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.435 1.494 . . . . 2.2799999999999998 112.565 172.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.2 m -74.37 -24.15 59.11 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.1 1.148 . . . . 2.8199999999999998 114.1 177.071 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -71.45 -40.5 70.32 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.879 1.271 . . . . 2.71 112.75 173.438 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.2 mt -51.63 -46.48 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.271 1.028 . . . . 2.4199999999999999 111.71 -178.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m -66.49 -22.93 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.936 1.087 . . . . 1.6599999999999999 113.936 179.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -74.17 -44.85 51.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.104 0.962 . . . . 3.73 112.006 169.014 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.8 mt -70.16 -46.47 64.61 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.849 1.66 . . . . 4.5499999999999998 112.74 -173.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.32 -48.17 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.029 0.532 . . . . 2.48 109.901 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.18 -31.05 68.65 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.018 1.118 . . . . 3.0600000000000001 114.018 179.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -76.23 -36.37 58.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.966 1.099 . . . . 3.77 113.966 169.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.32 -17.21 62.46 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.281 1.586 . . . . 4.5899999999999999 115.281 -169.374 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 126.241 1.817 . . . . 5.8700000000000001 111.951 175.877 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 111.631 0.234 . . . . 1.6000000000000001 111.631 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.9 tp -51.42 -34.24 33.93 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.706 1.602 . . . . 2.5800000000000001 114.341 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.32 -44.86 20.78 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.395 0.887 . . . . 2.1400000000000001 113.395 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -61.38 -34.51 75.46 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.587 1.155 . . . . 3.1000000000000001 113.299 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.25 -49.76 6.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.511 1.524 . . . . 0.96999999999999997 112.117 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -74.37 -30.42 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.836 1.05 . . . . 2.2200000000000002 113.836 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -67.3 -27.62 67.32 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.544 -0.722 . . . . 1.99 112.265 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.73 -14.58 59.27 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.998 1.481 . . . . 2.6000000000000001 114.998 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -63.4 129.3 39.67 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 120.55 1.523 . . . . 3.0899999999999999 112.142 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.46 158.6 33.39 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.993 1.317 . . . . 1.8700000000000001 112.159 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.1 p -98.34 -24.54 15.17 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 116.061 1.874 . . . . 3.1499999999999999 116.061 -168.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.27 159.48 37.72 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.88 1.067 . . . . 4.21 113.88 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.86 149.39 40.22 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.596 1.558 . . . . 1.0700000000000001 111.762 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 m -95.01 109.18 21.25 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.502 0.721 . . . . 1.5700000000000001 112.649 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.7 mt -81.09 140.18 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.646 1.178 . . . . 1.3300000000000001 108.616 169.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.72 127.01 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.102 0.953 . . . . 2.0499999999999998 112.173 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 92.9 m . . . . . 0 N--CA 1.468 0.452 0 C-N-CA 127.67 2.388 . . . . 2.1299999999999999 109.979 -170.08 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--O 1.237 0.446 0 CA-C-O 120.432 0.158 . . . . 3.1699999999999999 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.4 t -133.04 140.05 47.51 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.725 2.01 . . . . 2.0 110.009 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.08 149.15 39.41 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.796 0.838 . . . . 2.6699999999999999 112.506 -168.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.85 126.31 30.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.849 1.66 . . . . 2.6899999999999999 110.765 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -87.01 126.82 34.99 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.851 -1.155 . . . . 2.0499999999999998 108.761 167.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.48 162.19 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.211 1.405 . . . . 1.21 111.763 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.97 147.53 42.95 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.29 0.567 . . . . 3.9100000000000001 111.124 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -56.26 -23.91 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 114.686 1.365 . . . . 1.3999999999999999 114.686 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.57 -13.71 60.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.549 1.315 . . . . 3.8399999999999999 114.549 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.7 mt -106.67 -13.38 15.3 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.956 1.302 . . . . 1.47 113.818 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.97 142.36 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.052 1.341 . . . . 1.5600000000000001 110.647 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -114.71 161.24 18.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.483 1.113 . . . . 2.96 113.333 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -76.27 31.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.499 1.666 . . . . 4.3099999999999996 115.499 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.7 0.21 4.96 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 127.834 2.635 . . . . 1.1100000000000001 113.725 169.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -89.68 160.41 16.62 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.339 1.456 . . . . 2.1899999999999999 112.139 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.4 mt -118.77 128.55 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.583 1.553 . . . . 1.22 108.368 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.4 mm -120.3 136.54 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.304 1.441 . . . . 0.84999999999999998 113.933 -166.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -78.14 143.75 37.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.774 1.23 . . . . 2.3599999999999999 112.303 172.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.13 132.68 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.695 0.798 . . . . 0.78000000000000003 110.808 167.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.436 ' HB ' ' HD2' ' A' ' 47' ' ' PRO . 10.9 m -102.47 166.97 11.07 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 125.278 1.431 . . . . 1.1699999999999999 112.282 -169.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 46' ' ' VAL . 36.3 Cg_endo -61.13 120.83 8.73 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.885 1.723 . . . . 0.96999999999999997 111.626 171.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.63 -6.17 82.18 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 126.638 2.066 . . . . 0.94999999999999996 115.159 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.18 154.4 46.24 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 119.123 1.461 . . . . 1.01 114.285 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -109.14 152.92 24.46 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.929 1.292 . . . . 1.99 111.852 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -89.13 126.8 57.75 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.813 1.042 . . . . 2.29 113.813 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.18 -22.24 3.45 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.028 3.152 . . . . 1.47 114.532 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.4 m -143.64 170.54 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.206 2.202 . . . . 1.3200000000000001 109.41 -176.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.31 166.64 17.27 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.072 0.549 . . . . 2.54 110.811 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.98 -175.53 47.08 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.936 1.134 . . . . 1.0700000000000001 115.936 170.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -105.29 142.33 35.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.617 1.567 . . . . 3.7200000000000002 111.277 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.08 131.17 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.367 2.267 . . . . 1.1699999999999999 110.27 -171.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.07 30.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 113.549 0.944 . . . . 1.0 113.549 -175.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -170.62 144.97 2.45 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.119 2.568 . . . . 3.1499999999999999 107.213 168.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.48 179.61 46.51 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 116.612 1.405 . . . . 1.53 116.612 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -152.1 41.76 0.66 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.902 1.815 . . . . 2.98 115.902 -166.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.683 ' H ' HD21 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -75.88 156.53 34.25 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.409 -1.432 . . . . 1.2 113.19 -178.463 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 42.7 ttm -96.67 127.21 42.44 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.928 -0.767 . . . . 1.3100000000000001 108.928 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.9 t -112.95 129.05 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 124.58 1.152 . . . . 1.05 110.685 -170.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -91.66 105.64 17.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.538 0.735 . . . . 2.25 110.775 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -117.8 23.61 11.58 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.888 2.075 . . . . 2.4100000000000001 113.004 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 93.0 p -63.82 -18.58 64.26 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 116.659 2.096 . . . . 1.6799999999999999 116.659 -169.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.84 -48.86 7.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.441 1.096 . . . . 1.4199999999999999 109.907 169.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.88 -58.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.82 1.248 . . . . 1.6399999999999999 111.722 -172.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.4 p -103.9 -12.35 16.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.298 1.039 . . . . 1.75 112.66 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.63 -3.02 85.05 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.484 -1.176 . . . . 1.79 114.737 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -63.94 103.47 0.59 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.585 1.192 . . . . 3.1299999999999999 110.693 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.97 -17.51 61.46 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.815 -1.178 . . . . 1.6200000000000001 111.577 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.69 103.9 42.82 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 128.099 2.56 . . . . 5.1200000000000001 107.947 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -55.35 147.13 58.14 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.725 2.95 . . . . 2.3500000000000001 114.19 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.5 t -94.21 125.26 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.744 1.218 . . . . 1.24 111.944 -167.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.18 141.29 38.76 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.709 -0.619 . . . . 1.1299999999999999 111.72 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -115.08 169.54 9.03 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.796 1.638 . . . . 1.54 111.526 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -157.15 169.33 10.8 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 127.714 2.406 . . . . 3.8900000000000001 110.727 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.18 135.1 48.93 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 CA-C-N 121.451 1.554 . . . . 1.3500000000000001 108.41 165.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.88 39.37 17.13 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.28 0.943 . . . . 1.1699999999999999 113.253 -168.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 t -124.76 174.26 8.02 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.624 1.57 . . . . 1.95 111.254 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 p -133.26 150.59 51.92 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.518 -1.363 . . . . 1.27 112.566 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.06 161.84 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 125.411 1.485 . . . . 0.93999999999999995 112.79 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.0 150.31 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.298 1.839 . . . . 1.3200000000000001 113.435 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.67 148.33 24.86 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.038 1.335 . . . . 1.0600000000000001 112.944 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.88 -4.1 67.19 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 115.333 0.893 . . . . 0.95999999999999996 115.333 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 97.6 p -84.61 160.02 20.5 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.498 1.149 . . . . 1.3400000000000001 111.969 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mm -113.21 127.13 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.469 1.107 . . . . 0.94999999999999996 112.203 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -93.9 144.0 25.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.238 1.415 . . . . 1.9099999999999999 113.083 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -157.6 145.95 19.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.884 1.274 . . . . 3.8599999999999999 111.332 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 46.54 87.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.504 2.322 . . . . 3.8999999999999999 113.585 168.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.38 -13.42 2.28 Favored Glycine 0 CA--C 1.542 1.761 0 N-CA-C 116.251 1.26 . . . . 3.8900000000000001 116.251 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.2 m 40.1 108.61 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 130.964 3.706 . . . . 2.6099999999999999 117.322 170.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.683 HD21 ' H ' ' A' ' 62' ' ' SER . 57.4 mt -106.33 160.37 15.42 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.987 1.106 . . . . 1.8799999999999999 113.987 -169.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.68 121.28 41.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.332 1.853 . . . . 3.1099999999999999 108.476 168.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.45 126.23 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.653 0.781 . . . . 1.4099999999999999 111.167 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.81 121.51 30.31 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.375 -0.828 . . . . 1.6100000000000001 109.999 168.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.65 129.95 35.04 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.2 0.6 . . . . 0.95999999999999996 112.147 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.9 p -117.77 -6.12 11.07 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.85 1.66 . . . . 2.3500000000000001 113.968 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -138.98 148.78 43.93 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.649 1.98 . . . . 2.29 110.242 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.5 m -92.42 -174.05 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.583 1.153 . . . . 1.9399999999999999 112.638 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.65 -33.16 83.58 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.857 -1.152 . . . . 2.7799999999999998 113.557 -171.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.52 -51.67 11.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.265 1.426 . . . . 2.5099999999999998 112.888 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.29 -8.13 53.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.499 1.919 . . . . 3.5800000000000001 115.551 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 109' ' ' SER . 4.6 t -48.17 146.56 2.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.974 2.109 . . . . 2.7999999999999998 114.872 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 t -62.1 -21.77 65.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.079 0.552 . . . . 2.6600000000000001 111.992 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.5 tp -59.89 -41.18 91.03 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.647 -1.283 . . . . 1.71 111.897 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.515 ' H ' HG23 ' A' ' 106' ' ' THR . 8.8 t -73.26 -27.38 61.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.475 1.11 . . . . 2.6800000000000002 111.564 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -70.06 -39.6 75.58 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.408 -0.807 . . . . 2.4300000000000002 112.146 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.8 mt -60.04 -44.68 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.668 1.587 . . . . 2.27 111.657 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 115.249 1.574 . . . . 2.1200000000000001 115.249 -178.07 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 119.693 -0.194 . . . . 2.1400000000000001 111.095 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.28 -32.16 47.35 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.378 1.071 . . . . 2.0499999999999998 113.405 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.51 -54.21 7.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.759 0.824 . . . . 2.1000000000000001 112.63 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -54.53 -36.98 64.84 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.463 1.505 . . . . 2.52 113.002 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.77 -38.96 67.87 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.457 1.103 . . . . 1.24 113.491 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.8 mm -74.66 -34.07 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 118.954 0.797 . . . . 1.49 112.811 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -69.52 -25.34 63.99 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.247 -0.908 . . . . 1.3500000000000001 112.43 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.31 -15.77 63.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.36 2.264 . . . . 2.4300000000000002 114.873 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -73.56 140.72 46.47 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.692 1.197 . . . . 2.2200000000000002 112.257 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.42 165.39 15.6 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.578 1.151 . . . . 1.79 112.47 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -93.7 -41.99 9.4 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.354 0.872 . . . . 2.5299999999999998 113.354 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -125.37 158.97 32.96 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.135 1.531 . . . . 4.29 115.135 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.55 149.83 47.02 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.646 1.578 . . . . 0.92000000000000004 111.311 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.7 m -106.43 108.8 20.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.233 1.013 . . . . 0.93999999999999995 112.052 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.7 mt -90.09 132.9 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.217 1.807 . . . . 0.92000000000000004 109.576 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.23 139.55 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.609 0.719 . . . . 1.98 112.442 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.9 m . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 126.733 2.013 . . . . 1.8600000000000001 110.402 -172.772 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 109.533 -0.543 . . . . 2.29 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 t -123.48 122.04 37.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.413 1.485 . . . . 1.95 108.991 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -116.41 141.42 48.19 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.519 1.128 . . . . 2.2799999999999998 110.012 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -136.02 132.94 36.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.903 1.281 . . . . 2.8500000000000001 110.616 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -100.1 134.56 42.85 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 119.344 0.974 . . . . 1.6599999999999999 110.506 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -138.75 163.47 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.656 1.182 . . . . 0.85999999999999999 112.104 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.19 146.63 43.23 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.9 -0.778 . . . . 3.1299999999999999 108.9 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -63.75 -1.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 114.997 1.48 . . . . 1.1899999999999999 114.997 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -83.48 -17.17 42.92 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.648 1.579 . . . . 3.9500000000000002 114.855 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.4 -9.32 14.95 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.937 1.458 . . . . 1.3300000000000001 114.937 -165.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.35 151.21 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 125.677 1.591 . . . . 1.46 109.743 168.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.71 160.26 24.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.099 1.148 . . . . 3.8100000000000001 114.099 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -74.71 47.13 0.31 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.25 1.82 . . . . 4.8600000000000003 113.892 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.27 23.12 0.23 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.312 1.434 . . . . 1.1799999999999999 113.545 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -129.36 172.57 11.36 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.032 1.733 . . . . 2.8599999999999999 111.316 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 mm -108.29 123.89 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.566 1.946 . . . . 1.4199999999999999 110.038 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.1 mm -117.16 126.45 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.406 1.482 . . . . 0.90000000000000002 110.1 -170.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HE3' HD11 ' A' ' 96' ' ' LEU . 44.7 mtpt -94.06 139.98 30.3 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.936 0.717 . . . . 2.8999999999999999 112.936 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.11 153.24 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.689 1.196 . . . . 1.1599999999999999 112.133 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.94 165.52 23.42 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 125.654 1.581 . . . . 1.8300000000000001 112.693 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.5 124.16 14.89 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.069 2.513 . . . . 1.4099999999999999 112.156 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.68 -13.68 61.94 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.154 1.835 . . . . 1.6000000000000001 115.728 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.56 -8.52 76.5 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 116.992 1.557 . . . . 4.3899999999999997 116.992 -172.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.0 mttt 61.88 158.87 0.06 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 127.871 2.469 . . . . 1.6299999999999999 115.463 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -92.51 119.02 68.25 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.144 0.977 . . . . 2.1299999999999999 111.01 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -87.45 -13.16 4.33 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.914 2.409 . . . . 0.77000000000000002 114.618 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -147.47 168.26 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.496 1.918 . . . . 1.0900000000000001 110.503 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.57 145.39 30.38 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.707 0.803 . . . . 1.7 113.117 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.05 -159.11 32.39 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 114.484 0.554 . . . . 0.69999999999999996 114.484 -173.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -108.84 140.19 42.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.033 1.333 . . . . 3.6000000000000001 112.925 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.85 132.14 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 127.878 2.471 . . . . 0.68999999999999995 107.789 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.9 pt -140.05 29.34 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 119.378 0.99 . . . . 1.1599999999999999 112.914 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.97 137.6 3.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.06 1.344 . . . . 3.5099999999999998 108.984 169.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.83 -178.71 53.17 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 122.549 1.083 . . . . 0.81000000000000005 114.717 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.28 136.57 31.75 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.487 1.515 . . . . 2.52 111.502 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 m -148.32 156.75 42.91 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.05 1.129 . . . . 1.6499999999999999 114.05 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 29.4 ttm -104.79 133.87 48.88 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.665 -1.235 . . . . 0.98999999999999999 107.665 167.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.1 t -126.47 138.99 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.927 1.291 . . . . 0.81999999999999995 112.48 -167.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -93.09 103.03 15.36 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.585 1.554 . . . . 2.25 109.984 173.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -128.2 3.31 5.79 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.906 1.682 . . . . 1.8200000000000001 115.115 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.6 p -47.33 -29.62 2.65 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.256 1.822 . . . . 1.6299999999999999 115.399 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.86 -38.07 46.86 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.635 1.174 . . . . 1.4399999999999999 112.115 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.95 -62.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.87 2.068 . . . . 1.23 111.198 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 p -88.85 -12.73 41.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.74 1.616 . . . . 1.3700000000000001 112.577 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.74 19.24 60.13 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.76 1.171 . . . . 1.75 114.209 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -74.8 -167.73 0.62 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.336 1.455 . . . . 2.9300000000000002 111.333 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.91 13.35 1.67 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.001 1.482 . . . . 2.29 115.001 -171.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -158.23 154.24 23.5 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.672 1.589 . . . . 3.7999999999999998 111.061 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -58.97 141.26 98.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.54 2.827 . . . . 1.72 113.048 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.2 t -114.04 137.05 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.833 2.053 . . . . 1.0900000000000001 111.735 -169.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.6 133.56 33.7 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.221 -0.924 . . . . 0.85999999999999999 112.746 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -129.21 140.84 51.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.127 2.171 . . . . 1.1699999999999999 109.921 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 15.1 ptpt -148.82 -177.19 0.63 Allowed Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 126.223 1.809 . . . . 3.96 110.287 -169.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 59.5 Cg_endo -69.31 132.96 25.19 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 122.703 2.001 . . . . 1.04 110.674 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.09 7.22 68.22 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 126.222 1.867 . . . . 1.1799999999999999 114.784 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.3 t -101.56 152.35 20.89 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.105 1.952 . . . . 1.6599999999999999 111.86 -170.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.0 p -105.22 145.91 29.99 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.877 -1.139 . . . . 0.73999999999999999 113.356 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 m -137.54 161.41 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.902 1.681 . . . . 0.53000000000000003 112.183 -172.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.95 147.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.138 1.775 . . . . 0.93000000000000005 113.419 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.17 150.36 30.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.701 1.2 . . . . 0.58999999999999997 112.604 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.16 -3.63 51.48 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.239 0.924 . . . . 0.77000000000000002 115.227 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.8 p -80.97 156.86 25.74 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.331 1.066 . . . . 1.3799999999999999 111.85 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mm -107.77 123.52 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.503 0.721 . . . . 0.81000000000000005 110.763 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -83.12 128.29 34.35 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.825 -0.806 . . . . 2.0 108.825 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.86 43.9 2.68 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.28 1.215 . . . . 3.6800000000000002 114.28 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -157.92 -38.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.494 2.405 . . . . 3.6899999999999999 117.494 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.38 -175.87 27.84 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 120.626 1.557 . . . . 2.25 116.743 -168.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -116.02 122.68 45.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.624 1.169 . . . . 1.6899999999999999 111.944 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.1 mt -125.78 165.4 18.72 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.047 1.339 . . . . 0.96999999999999997 113.823 -170.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.467 HD11 ' HE3' ' A' ' 44' ' ' LYS . 8.5 mp -112.37 122.7 48.46 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.507 1.523 . . . . 2.3399999999999999 109.006 167.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.28 129.63 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.65 1.18 . . . . 1.28 110.952 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 29.2 p -86.51 120.08 27.45 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.466 -0.771 . . . . 1.6499999999999999 109.945 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.93 131.18 37.34 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.306 -0.871 . . . . 1.03 111.159 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.91 -12.33 11.41 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.65 0.981 . . . . 3.2999999999999998 113.65 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -141.58 143.47 33.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.372 1.469 . . . . 2.2200000000000002 109.227 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.5 p -75.93 158.99 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 107.755 -1.202 . . . . 3.4300000000000002 107.755 166.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.16 -39.64 71.43 Favored Glycine 0 N--CA 1.477 1.411 0 CA-C-N 121.231 1.832 . . . . 1.8400000000000001 115.196 -167.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -34.17 77.15 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.621 0.971 . . . . 2.6699999999999999 113.621 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -77.87 -10.33 59.51 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.759 2.424 . . . . 2.8500000000000001 115.392 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.7 p -66.49 156.19 35.51 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.355 0.872 . . . . 1.5900000000000001 113.355 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.2 t -57.62 -33.8 68.62 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.741 -0.6 . . . . 1.98 112.174 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.1 tp -56.14 -49.56 73.59 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.937 1.295 . . . . 1.5800000000000001 111.963 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -72.98 -24.16 60.74 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.324 1.45 . . . . 2.5699999999999998 113.515 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -70.69 -48.16 56.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.397 1.079 . . . . 1.3700000000000001 112.04 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.2 mt -53.05 -51.97 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.909 0.883 . . . . 1.4199999999999999 111.832 -169.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 114.044 1.127 . . . . 1.3100000000000001 114.044 -177.459 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 112.927 0.714 . . . . 1.6799999999999999 112.927 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.33 -29.15 69.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.671 0.788 . . . . 1.6599999999999999 112.924 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.82 -25.68 49.01 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.981 1.104 . . . . 1.5900000000000001 113.981 169.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.81 -42.97 80.71 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.864 1.266 . . . . 2.6699999999999999 112.971 -167.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -49.85 -42.48 47.6 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.195 1.398 . . . . 1.0600000000000001 112.417 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.6 mm -72.47 -35.56 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.362 1.065 . . . . 1.8200000000000001 112.564 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.3 m -70.69 -27.76 64.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.093 0.957 . . . . 1.4399999999999999 113.331 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 mp -66.39 -25.73 66.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.177 0.806 . . . . 2.2799999999999998 113.177 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -61.64 131.16 49.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.338 0.972 . . . . 2.5899999999999999 112.209 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.31 159.47 23.87 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.96 1.096 . . . . 1.8200000000000001 113.96 -169.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.5 m -86.84 -30.32 21.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.72 1.208 . . . . 3.1099999999999999 112.338 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -141.88 161.0 39.07 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.712 1.745 . . . . 4.0800000000000001 115.712 -168.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.23 162.73 34.78 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.826 2.05 . . . . 1.0800000000000001 111.97 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.6 m -121.89 104.55 9.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.102 1.361 . . . . 1.05 112.237 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.0 mt -83.43 133.49 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.109 1.364 . . . . 0.67000000000000004 110.503 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.7 m -126.33 144.66 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.358 1.614 . . . . 2.0299999999999998 115.358 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 125.527 1.531 . . . . 2.73 111.432 -179.723 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 CA--C 1.546 0.823 0 CA-C-O 121.882 0.848 . . . . 2.9300000000000002 112.295 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -126.41 143.6 51.12 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.603 1.561 . . . . 1.6100000000000001 110.739 -173.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -128.17 132.58 48.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.54 1.136 . . . . 2.7799999999999998 110.843 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -108.96 132.99 53.55 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.835 1.254 . . . . 2.7999999999999998 110.392 170.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -101.54 114.92 29.38 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.687 1.13 . . . . 2.6899999999999999 110.69 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.23 159.2 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.235 1.414 . . . . 1.46 113.567 -168.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.83 154.41 33.9 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.441 1.097 . . . . 3.6099999999999999 111.025 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.62 -21.91 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 114.145 1.165 . . . . 1.46 114.145 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -73.29 -15.19 61.41 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.487 -1.383 . . . . 3.3300000000000001 113.587 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.4 mt -99.84 -1.08 38.41 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.512 1.525 . . . . 2.1699999999999999 114.422 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.33 146.37 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.579 1.552 . . . . 1.5900000000000001 111.359 173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -120.53 165.75 14.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.848 1.659 . . . . 3.3599999999999999 112.711 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -68.69 26.03 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.224 1.935 . . . . 2.7000000000000002 116.224 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.69 14.58 1.99 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 126.565 2.031 . . . . 1.1000000000000001 114.073 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -97.91 162.75 13.09 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 119.176 1.488 . . . . 2.6099999999999999 112.845 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 87.6 mt -118.56 130.94 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.257 1.423 . . . . 1.21 109.912 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.9 mm -121.19 130.89 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.824 1.649 . . . . 0.65000000000000002 112.413 -168.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HE3' HD21 ' A' ' 96' ' ' LEU . 32.2 ttmt -93.68 124.26 37.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.606 0.762 . . . . 2.1600000000000001 112.089 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.97 137.18 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.351 1.06 . . . . 0.72999999999999998 112.414 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.53 158.47 54.32 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.455 1.102 . . . . 1.27 113.361 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -62.6 126.91 19.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.724 2.283 . . . . 1.8300000000000001 111.377 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.66 -5.81 72.66 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.685 1.612 . . . . 1.0900000000000001 114.786 -169.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.51 159.04 53.22 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.764 1.173 . . . . 1.04 114.431 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -112.69 141.9 45.94 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.547 1.139 . . . . 2.5099999999999998 111.745 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.07 129.99 79.24 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 119.214 -0.422 . . . . 1.78 112.06 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -90.32 -21.7 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.391 2.727 . . . . 0.80000000000000004 114.924 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.56 166.93 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 127.405 2.282 . . . . 0.95999999999999996 109.049 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.21 140.86 29.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.081 0.855 . . . . 2.0299999999999998 111.845 173.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.61 -173.57 44.83 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 114.737 0.655 . . . . 0.83999999999999997 114.737 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -110.27 144.43 38.99 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.48 1.112 . . . . 6.4299999999999997 113.204 -170.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.11 129.13 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.574 2.35 . . . . 0.93000000000000005 109.755 -172.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.7 pt -142.86 30.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 114.225 1.194 . . . . 1.2 114.225 -171.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -168.81 143.83 3.28 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.608 1.963 . . . . 3.1099999999999999 109.367 166.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.84 -170.91 44.31 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.08 0.792 . . . . 0.95999999999999996 115.08 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -155.11 121.62 5.32 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.361 0.664 . . . . 2.9399999999999999 112.098 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.9 t -143.57 168.79 19.03 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.633 1.173 . . . . 1.1399999999999999 112.631 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.1 ttm -115.1 137.0 52.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.817 0.847 . . . . 1.2 111.458 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.93 142.47 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.302 1.841 . . . . 0.75 111.705 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.93 114.53 26.65 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.837 1.255 . . . . 1.8999999999999999 110.96 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -114.22 14.2 18.08 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 114.379 1.252 . . . . 2.0299999999999998 114.379 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.5 p -67.02 -3.35 6.98 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 117.922 2.564 . . . . 1.6899999999999999 117.922 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.62 -41.62 3.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.937 1.695 . . . . 1.24 109.865 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.3 mm -76.01 -58.5 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.362 1.065 . . . . 1.1699999999999999 111.453 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.1 p -102.03 -11.74 18.67 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.185 0.994 . . . . 1.3300000000000001 112.958 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.65 16.22 75.91 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.735 1.159 . . . . 1.3899999999999999 115.083 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -56.08 -38.12 70.24 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.396 1.098 . . . . 2.5800000000000001 113.393 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 63.49 19.42 11.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.263 1.425 . . . . 1.3200000000000001 114.134 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.6 ttm -148.29 134.42 9.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 129.589 3.156 . . . . 3.2200000000000002 105.213 169.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.41 161.79 43.37 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.29 1.993 . . . . 1.4299999999999999 112.81 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.5 t -124.7 122.28 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.279 1.432 . . . . 0.89000000000000001 110.911 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.5 145.21 33.34 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.705 0.802 . . . . 1.04 112.628 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -124.32 159.74 29.62 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.021 2.128 . . . . 0.85999999999999999 111.399 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -157.14 174.26 4.2 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 126.995 2.118 . . . . 2.73 110.732 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.25 130.1 32.69 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 CA-C-N 121.909 1.717 . . . . 1.23 109.497 166.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.18 43.21 10.9 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.713 0.673 . . . . 1.03 113.087 -169.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -131.76 167.03 20.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.265 1.426 . . . . 1.5600000000000001 110.85 175.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.8 p -124.41 150.55 45.49 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 120.554 1.524 . . . . 1.26 113.034 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 m -135.01 163.03 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.945 1.298 . . . . 0.81000000000000005 112.348 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.5 150.72 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.383 2.273 . . . . 1.03 110.67 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.76 150.88 47.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.411 0.684 . . . . 0.82999999999999996 112.521 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.75 -5.94 55.9 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 115.355 0.902 . . . . 0.90000000000000002 115.355 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.88 157.64 21.91 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.255 1.528 . . . . 2.73 111.456 169.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -110.12 131.21 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.438 1.095 . . . . 0.93000000000000005 111.025 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -96.93 132.02 43.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.309 1.444 . . . . 1.97 111.211 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -84.89 -72.96 0.45 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.128 -0.982 . . . . 3.6400000000000001 113.245 -170.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -157.85 142.95 16.75 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.556 2.343 . . . . 4.6799999999999997 107.42 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.46 11.19 1.18 Allowed Glycine 0 CA--C 1.542 1.72 0 N-CA-C 117.452 1.741 . . . . 3.2999999999999998 117.452 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.6 m 32.29 85.37 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.435 2.694 . . . . 1.8 117.036 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.8 mt -103.98 156.13 18.1 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.887 1.275 . . . . 1.3799999999999999 113.524 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.477 HD21 ' HE3' ' A' ' 44' ' ' LYS . 65.1 mt -108.85 123.89 49.77 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.425 1.09 . . . . 2.54 110.492 167.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.55 124.66 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.485 1.514 . . . . 1.5 109.542 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.7 p -82.44 120.36 25.37 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.346 -0.846 . . . . 1.77 109.586 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.5 115.29 19.04 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.355 -0.841 . . . . 1.05 109.254 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.3 p -119.29 6.35 11.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.692 1.197 . . . . 2.0800000000000001 113.524 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -147.66 145.48 28.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.109 1.763 . . . . 1.5800000000000001 110.321 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.8 m -83.64 159.6 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.74 -0.837 . . . . 1.73 108.74 164.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.18 -38.87 79.29 Favored Glycine 0 N--CA 1.475 1.262 0 O-C-N 121.025 -1.047 . . . . 1.54 114.913 -168.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.16 90.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.355 1.077 . . . . 1.9399999999999999 112.814 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -77.26 -9.21 58.66 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.249 1.574 . . . . 2.52 115.249 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.7 p -64.47 159.04 22.35 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.336 0.865 . . . . 1.6599999999999999 113.336 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -66.1 -29.29 69.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.969 -0.56 . . . . 2.04 111.627 170.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.12 -46.3 88.68 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.657 -1.277 . . . . 1.6499999999999999 112.255 171.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.6 m -68.41 -23.01 64.59 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.492 0.552 . . . . 1.6299999999999999 112.492 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.24 -40.39 71.08 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.995 1.271 . . . . 2.5 112.033 169.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 82.4 mt -54.96 -50.23 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 120.26 1.391 . . . . 1.51 110.772 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 118.102 -0.951 . . . . 1.6100000000000001 113.027 175.772 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.835 0 N-CA-C 112.309 0.485 . . . . 1.6499999999999999 112.309 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.12 -33.12 71.43 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.911 1.284 . . . . 1.6000000000000001 112.662 172.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.9 -29.77 58.56 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.827 0.677 . . . . 1.3799999999999999 112.827 171.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.79 -41.1 77.11 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.111 -0.993 . . . . 2.4500000000000002 112.001 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.58 -30.41 65.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.284 0.947 . . . . 1.6000000000000001 113.112 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -75.25 -45.46 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.747 1.219 . . . . 2.0499999999999998 112.409 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 m -75.66 -15.51 60.31 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.508 1.123 . . . . 1.52 113.401 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.0 tp -72.88 -24.49 60.86 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.579 2.751 . . . . 2.8900000000000001 112.949 170.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -77.61 148.48 35.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.189 0.995 . . . . 2.4500000000000002 113.407 -173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 163.4 27.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.397 1.479 . . . . 2.4100000000000001 114.514 -171.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.7 p -109.0 -38.11 5.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.21 1.404 . . . . 2.4700000000000002 112.965 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.84 154.76 51.08 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.613 1.565 . . . . 3.0600000000000001 113.366 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.35 161.99 36.55 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.823 1.649 . . . . 0.72999999999999998 113.358 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -118.61 103.2 9.48 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.462 1.105 . . . . 0.93000000000000005 112.303 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.3 mt -83.56 134.71 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.888 1.275 . . . . 0.58999999999999997 110.25 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.86 141.01 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.604 1.162 . . . . 1.71 110.283 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.471 0.592 0 C-N-CA 126.381 1.872 . . . . 1.74 110.118 -169.801 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 111.998 0.37 . . . . 3.0499999999999998 111.998 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 t -138.92 140.04 38.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.35 1.86 . . . . 1.6299999999999999 110.319 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -123.18 148.81 45.38 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.921 1.452 . . . . 2.3900000000000001 114.921 -170.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -121.36 146.66 46.63 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.509 2.324 . . . . 3.3999999999999999 110.325 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -111.83 132.09 54.92 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.422 1.01 . . . . 1.6799999999999999 111.641 171.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.2 m -135.9 161.27 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.199 1.0 . . . . 0.73999999999999999 113.03 -170.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.7 148.7 36.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.479 0.711 . . . . 3.3900000000000001 109.786 168.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.22 -24.95 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 113.948 1.092 . . . . 1.1699999999999999 113.948 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -64.4 -22.86 67.09 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.45 1.1 . . . . 4.2400000000000002 113.566 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.3 mt -103.79 -6.83 21.06 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.742 1.617 . . . . 1.1299999999999999 114.747 -168.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.02 140.48 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.147 0.979 . . . . 1.5 110.356 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.26 165.51 15.35 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.024 1.73 . . . . 3.0499999999999998 111.312 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -75.02 11.48 1.1 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.722 1.749 . . . . 3.2400000000000002 115.722 -175.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.38 6.31 16.81 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 126.562 2.029 . . . . 0.97999999999999998 114.483 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -87.91 152.47 22.05 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 119.891 1.846 . . . . 2.9700000000000002 112.777 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.0 mm -111.5 128.65 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.163 1.785 . . . . 1.74 109.813 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.8 mm -119.68 128.44 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.511 1.124 . . . . 0.67000000000000004 112.903 -168.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -88.34 121.97 31.33 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 121.225 -0.922 . . . . 1.8899999999999999 112.532 170.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.21 134.33 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.293 1.437 . . . . 0.68000000000000005 111.3 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 m -97.32 163.69 19.3 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 124.61 1.164 . . . . 0.92000000000000004 113.26 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.35 133.9 52.07 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.231 1.954 . . . . 0.91000000000000003 111.334 167.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.46 -8.21 54.73 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.775 2.131 . . . . 0.92000000000000004 115.098 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.76 161.77 54.28 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 118.536 1.168 . . . . 1.0600000000000001 114.379 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -113.24 140.69 47.75 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.749 1.219 . . . . 1.6899999999999999 111.006 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.49 123.16 88.96 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-O 118.257 -0.878 . . . . 1.79 111.834 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.64 -24.09 4.45 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.971 2.447 . . . . 0.77000000000000002 115.818 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.19 152.56 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 126.608 1.963 . . . . 0.95999999999999996 109.116 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 138.8 35.62 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.873 1.064 . . . . 1.8700000000000001 113.873 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.94 -157.79 20.85 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 123.728 0.68 . . . . 0.66000000000000003 114.431 -171.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ttp-105 -119.87 146.31 45.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.097 1.359 . . . . 4.0099999999999998 113.062 -170.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.6 t -98.99 130.74 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 128.247 2.619 . . . . 0.79000000000000004 109.467 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.7 31.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 114.143 1.164 . . . . 0.78000000000000003 114.143 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -167.42 139.62 3.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.427 1.491 . . . . 2.6800000000000002 110.29 169.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.61 -164.8 36.33 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 116.845 1.498 . . . . 1.0600000000000001 116.845 167.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -145.69 132.68 20.25 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.689 1.196 . . . . 2.8700000000000001 111.523 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.1 -179.21 6.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.882 0.873 . . . . 1.1899999999999999 112.831 168.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.43 135.32 54.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.793 2.037 . . . . 1.22 110.358 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 72.4 t -126.31 142.76 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.48 1.112 . . . . 0.81999999999999995 113.071 -169.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.94 106.24 16.13 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.544 1.138 . . . . 2.4199999999999999 112.582 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -100.64 30.15 4.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.961 2.105 . . . . 1.78 114.103 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.3 p -48.7 -28.81 3.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.016 2.598 . . . . 2.3500000000000001 118.016 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.41 -56.03 2.34 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.493 1.517 . . . . 2.1200000000000001 110.637 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.3 mm -67.77 -51.98 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.783 0.66 . . . . 1.6699999999999999 112.783 -167.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.7 p -95.52 -20.18 19.23 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.665 0.786 . . . . 1.49 112.474 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.51 83.37 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.182 1.372 . . . . 1.28 115.374 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.43 -47.57 83.5 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.573 1.323 . . . . 2.3500000000000001 114.573 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 64.86 30.71 12.0 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.656 1.982 . . . . 1.8200000000000001 112.861 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -149.12 154.26 39.05 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 127.529 2.332 . . . . 4.7000000000000002 109.879 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.13 133.74 42.43 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.449 2.766 . . . . 2.0299999999999998 115.168 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -116.16 136.16 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 127.063 2.145 . . . . 0.87 110.848 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.13 133.73 34.28 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.971 -1.081 . . . . 0.84999999999999998 112.717 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -124.25 137.09 54.55 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.89 1.276 . . . . 0.95999999999999996 111.677 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -148.48 179.15 1.24 Allowed Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 127.52 2.328 . . . . 2.7400000000000002 108.667 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -56.3 139.38 86.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 CA-C-N 123.289 2.21 . . . . 0.81999999999999995 112.319 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.05 11.73 83.37 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.456 -1.191 . . . . 0.77000000000000002 115.105 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.2 m -102.2 166.53 10.54 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.581 1.69 . . . . 1.71 110.949 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.7 p -117.4 152.77 34.28 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.244 -1.535 . . . . 0.79000000000000004 112.855 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.15 157.06 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.763 1.625 . . . . 0.60999999999999999 112.159 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.73 143.08 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.758 1.623 . . . . 1.1699999999999999 111.675 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.68 153.99 37.93 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.47 0.915 . . . . 0.75 113.47 -170.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.68 -1.0 59.7 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 114.893 0.717 . . . . 0.87 114.893 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 m -88.97 156.4 18.91 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.303 1.051 . . . . 2.4500000000000002 111.447 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.05 145.33 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.576 1.15 . . . . 0.83999999999999997 111.117 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -115.97 137.13 52.39 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.958 2.103 . . . . 1.77 112.227 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -153.93 139.73 18.07 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.401 -1.437 . . . . 3.0099999999999998 113.084 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.314 30.1 t30 87.89 -1.48 0.49 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.285 3.434 . . . . 3.1400000000000001 116.006 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.67 163.45 29.0 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 120.437 -1.414 . . . . 1.9399999999999999 115.257 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -98.95 144.01 28.6 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.121 1.769 . . . . 1.98 112.128 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.9 mt -135.57 160.02 39.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.948 1.299 . . . . 1.0700000000000001 111.361 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.9 mt -107.99 127.63 53.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.691 0.796 . . . . 2.2599999999999998 110.435 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 mm -117.24 124.62 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.923 1.689 . . . . 1.7 110.306 -173.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -87.19 111.22 20.77 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.424 -0.797 . . . . 1.5700000000000001 109.533 169.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.17 119.13 22.53 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.622 0.769 . . . . 0.92000000000000004 109.806 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 t -119.86 8.71 11.15 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.594 0.961 . . . . 2.5600000000000001 113.594 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -138.36 139.31 38.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.612 1.965 . . . . 1.73 108.058 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 m -85.98 174.58 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.737 0.815 . . . . 1.6399999999999999 111.802 170.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.25 -36.57 91.15 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 121.08 -1.012 . . . . 1.3 114.795 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.71 -36.9 70.67 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.852 1.326 . . . . 1.6299999999999999 112.615 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -78.49 -10.25 59.64 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.798 1.777 . . . . 2.27 115.798 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -76.6 156.17 32.95 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.646 -1.283 . . . . 2.8700000000000001 112.379 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.9 t -56.88 -34.39 67.83 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.38 0.882 . . . . 1.9399999999999999 113.38 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.5 mp -56.93 -48.68 77.7 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.541 -1.349 . . . . 1.4399999999999999 112.52 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.9 m -70.74 -27.99 64.38 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.02 1.328 . . . . 1.8999999999999999 112.203 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -70.76 -44.74 66.12 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.394 0.678 . . . . 2.0699999999999998 111.974 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.5 mt -56.37 -49.57 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.94 1.296 . . . . 1.22 111.267 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 114.251 1.204 . . . . 1.3300000000000001 114.251 -177.774 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 114.135 1.161 . . . . 2.0299999999999998 114.135 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.4 tp -56.41 -53.96 51.3 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.193 0.997 . . . . 2.6200000000000001 111.301 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.37 -7.99 47.2 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.436 1.643 . . . . 2.1499999999999999 115.436 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -64.88 -43.89 91.45 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 121.486 1.948 . . . . 2.1200000000000001 111.003 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -48.76 -48.96 40.51 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.281 1.432 . . . . 1.24 111.048 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.9 mm -70.16 -34.01 57.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.79 1.236 . . . . 1.52 112.034 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 m -76.64 -24.77 53.32 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.153 1.381 . . . . 1.1399999999999999 113.053 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 mp -68.22 -26.79 65.89 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.889 0.768 . . . . 2.04 112.621 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -70.72 139.78 51.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.409 1.004 . . . . 2.6800000000000002 113.013 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.87 152.39 44.59 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.102 -0.499 . . . . 2.02 111.188 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -106.23 -2.66 22.18 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.911 1.284 . . . . 1.9399999999999999 112.128 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -142.59 153.5 43.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.326 2.25 . . . . 3.9100000000000001 112.282 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.85 162.0 36.62 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.194 1.398 . . . . 0.70999999999999996 112.991 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.8 m -115.07 108.16 16.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.929 1.292 . . . . 0.85999999999999999 111.916 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.0 mt -83.32 130.33 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.104 -0.702 . . . . 0.67000000000000004 109.104 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.31 138.42 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.04 0.936 . . . . 2.5099999999999998 112.37 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.474 0.734 0 C-N-CA 124.178 0.991 . . . . 1.99 111.747 -169.841 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 tp . . . . . 0 CA--C 1.536 0.437 0 N-CA-C 109.5 -0.556 . . . . 3.3199999999999998 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 t -135.22 129.35 33.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.637 1.175 . . . . 1.71 110.966 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -130.74 129.44 42.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.446 1.098 . . . . 2.4100000000000001 111.822 -169.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -119.51 118.97 32.47 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.486 1.914 . . . . 2.8399999999999999 109.746 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -89.24 121.54 31.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.576 1.08 . . . . 2.1299999999999999 109.93 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.31 171.28 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.124 1.37 . . . . 0.96999999999999997 112.612 -169.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.7 146.17 32.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.634 1.174 . . . . 3.21 110.506 168.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.96 -24.05 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.608 0.966 . . . . 1.0700000000000001 113.608 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.16 -22.48 61.29 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.815 -1.178 . . . . 2.9199999999999999 113.062 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.77 -15.18 42.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.305 1.042 . . . . 1.24 113.231 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 p -86.7 93.54 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 122.715 1.245 . . . . 1.8899999999999999 109.9 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -78.32 158.3 28.89 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.42 2.288 . . . . 4.1900000000000004 109.218 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -69.74 134.26 48.41 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.015 -1.053 . . . . 2.73 112.966 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.42 12.18 4.32 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.207 1.385 . . . . 0.88 115.999 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -116.48 168.86 9.79 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.288 2.044 . . . . 2.71 113.861 175.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.86 129.04 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.31 1.844 . . . . 1.55 109.607 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.1 mm -122.75 129.14 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.119 1.768 . . . . 0.80000000000000004 110.465 -171.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -83.13 135.71 34.72 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.765 1.226 . . . . 2.8500000000000001 112.365 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.36 136.8 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.822 1.249 . . . . 0.81999999999999995 111.949 169.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.35 159.14 65.29 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.018 0.927 . . . . 1.1599999999999999 112.886 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.28 136.12 66.31 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.78 2.32 . . . . 1.24 110.757 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.18 3.79 57.87 Favored Glycine 0 CA--C 1.542 1.735 0 N-CA-C 114.914 0.726 . . . . 0.98999999999999999 114.914 -169.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.1 178.89 48.54 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 118.928 1.364 . . . . 0.97999999999999998 115.686 -174.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.81 145.26 51.24 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.419 1.888 . . . . 1.6399999999999999 111.096 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -88.07 129.5 49.79 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.863 0.69 . . . . 1.73 112.863 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -86.27 -22.22 2.23 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.275 2.65 . . . . 0.72999999999999998 115.661 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.6 m -151.08 175.82 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 127.843 2.457 . . . . 0.76000000000000001 109.147 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -99.94 140.99 33.36 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.357 0.98 . . . . 1.6799999999999999 113.474 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.51 -177.73 46.58 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 123.545 0.593 . . . . 0.62 114.38 -169.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -103.24 138.81 39.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.838 1.255 . . . . 4.4699999999999998 112.178 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.8 t -83.45 130.55 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.255 2.222 . . . . 0.75 108.657 173.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.1 pt -140.37 33.48 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-O 122.394 1.093 . . . . 0.77000000000000002 112.379 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -166.6 129.5 1.89 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.155 2.182 . . . . 2.8100000000000001 108.084 168.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.33 176.0 50.5 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 122.701 1.167 . . . . 1.03 115.03 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -153.31 120.96 5.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.417 1.487 . . . . 2.0699999999999998 112.572 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.8 t -141.69 159.73 41.63 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.445 1.498 . . . . 1.46 112.024 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.4 ttm -90.67 130.18 36.7 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.761 -0.587 . . . . 0.88 110.341 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.7 t -113.85 140.77 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.524 1.13 . . . . 0.60999999999999999 111.781 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -108.32 102.46 11.58 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.334 1.453 . . . . 1.76 111.427 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 19.86 17.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.624 1.969 . . . . 4.0 113.096 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.2 p -54.6 -29.09 50.76 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.331 1.604 . . . . 1.3 115.331 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.59 -30.46 26.97 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.825 1.193 . . . . 1.02 111.708 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 mm -72.76 -53.57 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.554 1.542 . . . . 1.0600000000000001 110.176 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.2 p -102.92 -22.04 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.313 1.845 . . . . 1.6599999999999999 113.691 -171.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.75 -2.23 87.7 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.277 1.418 . . . . 1.28 114.328 -170.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -64.9 110.16 2.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.502 1.651 . . . . 2.8599999999999999 110.296 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.59 -3.38 58.44 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.983 -1.073 . . . . 1.47 112.596 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.8 mmt -95.79 138.7 21.71 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.99 2.516 . . . . 3.6299999999999999 108.952 167.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.36 161.09 22.78 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.155 2.57 . . . . 1.9299999999999999 112.347 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.8 t -124.03 119.82 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.463 0.705 . . . . 0.81999999999999995 111.369 -168.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.57 130.79 35.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.021 0.928 . . . . 0.87 112.086 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -108.74 157.68 18.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.015 1.726 . . . . 0.76000000000000001 111.866 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -146.73 168.97 10.25 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 127.581 2.352 . . . . 3.5 111.624 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -59.14 123.22 12.98 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 121.578 1.519 . . . . 0.93000000000000005 109.356 166.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.43 57.15 3.01 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.866 1.222 . . . . 1.21 112.426 -168.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -141.3 150.31 42.38 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.696 1.598 . . . . 1.28 112.427 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.9 p -101.05 150.76 22.57 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 120.861 1.664 . . . . 0.84999999999999998 113.522 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.05 162.61 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.464 1.506 . . . . 0.53000000000000003 111.823 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -126.97 150.06 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.768 2.027 . . . . 0.93000000000000005 111.363 176.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.59 142.23 49.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.033 0.933 . . . . 0.66000000000000003 112.71 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.49 -5.77 72.07 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.125 1.345 . . . . 0.79000000000000004 116.305 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.4 p -73.93 162.22 29.3 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.711 1.256 . . . . 1.3899999999999999 111.896 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mm -110.79 143.88 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.52 1.128 . . . . 0.64000000000000001 111.61 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -105.45 142.62 34.89 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.467 1.907 . . . . 1.9099999999999999 112.341 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -85.73 -125.69 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.639 1.175 . . . . 3.52 112.316 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -78.99 -38.16 37.43 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.001 1.852 . . . . 3.3999999999999999 116.001 -166.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.4 128.78 13.68 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.794 0.725 . . . . 1.9299999999999999 112.538 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.2 t -83.97 121.43 27.38 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.875 -1.158 . . . . 2.2799999999999998 107.875 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.4 mt -117.99 157.73 26.23 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.715 1.206 . . . . 1.1200000000000001 111.321 -169.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -117.31 125.52 51.2 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.482 0.658 . . . . 2.0600000000000001 109.75 169.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.79 138.17 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.64 1.576 . . . . 1.3100000000000001 110.573 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.6 p -79.03 106.62 11.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.021 0.915 . . . . 1.8500000000000001 111.185 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.73 82.4 4.13 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.202 1.001 . . . . 1.6799999999999999 109.097 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 t -101.51 9.32 41.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.585 1.954 . . . . 3.04 111.874 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -144.49 152.86 41.21 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.159 1.783 . . . . 2.1499999999999999 111.451 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -106.7 170.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.211 1.404 . . . . 1.77 111.579 168.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.6 -24.24 46.56 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.366 1.306 . . . . 2.2200000000000002 116.366 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.38 96.91 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.595 1.698 . . . . 2.8500000000000001 112.529 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.18 -22.98 59.17 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.272 1.582 . . . . 3.8300000000000001 115.272 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 109' ' ' SER . 3.2 t -71.58 142.74 50.01 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.463 1.283 . . . . 2.96 114.463 -166.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m -60.95 -27.14 68.03 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.499 -0.751 . . . . 3.52 112.275 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.0 tp -58.4 -46.22 86.83 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.367 -0.833 . . . . 1.5 112.093 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.474 ' H ' HG23 ' A' ' 106' ' ' THR . 75.9 p -73.03 -27.33 61.7 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.881 0.872 . . . . 2.6000000000000001 113.012 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -66.64 -40.06 88.54 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.164 -0.96 . . . . 1.8799999999999999 112.461 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 67.8 mt -53.91 -52.22 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.392 1.077 . . . . 1.3999999999999999 110.301 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 113.686 0.995 . . . . 1.1299999999999999 113.686 -179.261 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 111.785 0.291 . . . . 1.9099999999999999 111.785 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 tp -55.05 -35.82 64.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.254 1.022 . . . . 2.1000000000000001 112.386 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.07 -47.34 37.26 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.359 0.527 . . . . 2.0600000000000001 112.208 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.08 -32.46 70.97 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.211 1.005 . . . . 3.04 113.384 -172.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.0 -35.73 77.6 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.228 1.377 . . . . 1.3100000000000001 113.267 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.6 mm -73.99 -40.29 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.498 -0.751 . . . . 1.8899999999999999 111.591 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -66.86 -30.38 70.53 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.391 0.886 . . . . 1.6299999999999999 113.391 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.31 -17.33 62.43 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.555 1.942 . . . . 2.3799999999999999 113.941 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -86.4 147.04 26.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.538 1.135 . . . . 2.46 112.835 -170.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.23 154.41 22.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.557 1.543 . . . . 2.04 112.98 -172.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 m -100.53 -27.39 13.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.331 1.452 . . . . 2.1299999999999999 113.314 -172.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.84 150.76 50.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.228 1.411 . . . . 3.4199999999999999 113.678 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.4 172.32 12.93 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.608 1.563 . . . . 1.02 113.37 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 93.1 m -119.4 105.3 11.15 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.501 1.52 . . . . 0.98999999999999999 112.125 170.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.89 140.31 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.016 0.927 . . . . 0.59999999999999998 109.402 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.93 124.98 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.469 -0.769 . . . . 1.8899999999999999 110.551 172.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.474 0.735 0 C-N-CA 124.604 1.162 . . . . 1.78 110.681 176.043 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 121.374 0.607 . . . . 2.3500000000000001 110.642 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 t -141.42 84.69 1.92 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.601 1.56 . . . . 1.5600000000000001 109.431 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -81.02 154.15 27.03 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.033 -1.042 . . . . 2.7200000000000002 112.926 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -121.74 130.72 53.63 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.181 1.792 . . . . 2.7000000000000002 110.958 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -88.58 120.56 30.08 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.671 -0.863 . . . . 2.1000000000000001 108.671 168.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.24 159.23 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.051 0.94 . . . . 0.98999999999999999 113.13 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -78.04 143.22 37.65 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.903 -0.777 . . . . 3.1800000000000002 108.903 166.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.09 -20.24 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.609 1.164 . . . . 1.1200000000000001 113.585 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -70.24 -20.02 63.1 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.707 -1.246 . . . . 3.4300000000000002 113.637 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.83 -5.55 56.76 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.455 1.28 . . . . 1.72 114.455 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.1 p -94.13 144.65 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.762 0.825 . . . . 1.6899999999999999 112.508 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -121.25 163.3 18.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.943 2.497 . . . . 3.1699999999999999 110.124 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 ptt85 -72.29 147.15 46.66 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.181 -0.95 . . . . 3.77 110.784 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.43 28.49 7.11 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-N 119.142 0.883 . . . . 1.76 113.93 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.5 166.34 25.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.333 1.853 . . . . 3.5299999999999998 111.523 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.4 mt -122.95 132.16 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.945 1.298 . . . . 1.8400000000000001 111.937 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 mm -118.65 129.98 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.692 1.997 . . . . 0.71999999999999997 110.623 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -84.45 130.39 34.77 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.639 -0.663 . . . . 2.0899999999999999 112.19 172.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.43 136.89 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.888 1.275 . . . . 0.60999999999999999 110.227 169.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.93 161.91 39.71 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.118 1.367 . . . . 0.87 112.39 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -57.5 134.27 62.31 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.674 1.583 . . . . 1.0800000000000001 108.618 166.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.64 -9.04 38.25 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 118.702 -1.054 . . . . 0.93000000000000005 115.557 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.92 177.94 37.53 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 119.645 1.723 . . . . 0.94999999999999996 114.237 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.88 151.37 38.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.684 1.593 . . . . 2.0899999999999999 111.234 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -90.14 116.55 66.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 118.496 -0.764 . . . . 1.8300000000000001 109.965 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -89.16 -11.22 3.72 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.936 2.424 . . . . 0.73999999999999999 114.896 -171.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -147.8 172.82 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 128.55 2.74 . . . . 0.89000000000000001 108.834 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.2 139.39 37.88 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.164 0.893 . . . . 2.6600000000000001 112.518 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.75 -158.67 22.58 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 115.253 0.861 . . . . 0.79000000000000004 115.253 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -118.3 129.1 55.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.74 1.216 . . . . 4.3399999999999999 112.647 -170.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.3 t -88.69 127.23 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.881 1.672 . . . . 0.89000000000000001 108.93 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.7 pt -141.52 30.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 113.438 0.903 . . . . 0.95999999999999996 113.438 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -169.08 132.01 1.29 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.615 1.966 . . . . 3.1699999999999999 108.975 166.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.71 173.34 46.83 Favored Glycine 0 CA--C 1.539 1.578 0 N-CA-C 116.102 1.201 . . . . 1.1000000000000001 116.102 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -140.28 127.36 20.9 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.099 1.36 . . . . 3.0299999999999998 113.806 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 m -151.46 172.15 16.42 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.362 1.616 . . . . 1.22 115.362 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.9 ttm -106.46 133.78 50.61 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.625 1.17 . . . . 1.46 110.497 168.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.85 132.82 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.479 1.112 . . . . 1.1599999999999999 113.743 -167.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -91.23 98.7 11.88 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.269 1.828 . . . . 2.2799999999999998 111.386 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -128.98 8.61 5.68 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.135 1.774 . . . . 1.77 115.57 -172.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.3 p -59.73 -4.81 0.75 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 116.248 1.944 . . . . 2.1000000000000001 116.248 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -94.62 -35.6 12.14 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.153 1.342 . . . . 1.6299999999999999 111.449 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.8 mm -79.73 -62.88 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.797 1.239 . . . . 1.6100000000000001 111.612 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 p -84.99 -8.15 58.85 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.206 1.403 . . . . 2.2400000000000002 112.999 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.02 25.9 70.19 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.556 1.074 . . . . 2.8999999999999999 113.241 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -64.3 -177.33 0.28 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.671 1.589 . . . . 3.1699999999999999 110.876 169.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.5 -9.64 5.7 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.843 -1.161 . . . . 2.8300000000000001 113.612 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -149.26 151.25 33.55 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.099 1.36 . . . . 2.9300000000000002 110.793 169.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -48.8 153.87 3.42 Favored 'Trans proline' 0 CA--C 1.538 0.712 1 C-N-CA 125.405 4.07 . . . . 2.9500000000000002 116.245 -178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.3 t -113.25 134.07 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.722 1.609 . . . . 1.1599999999999999 111.354 -170.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.38 137.22 38.6 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.614 0.765 . . . . 0.87 112.188 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -130.14 143.87 51.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.167 2.187 . . . . 1.03 110.179 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 16.5 ptmt -148.61 -172.61 0.32 Allowed Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 126.611 1.964 . . . . 3.4100000000000001 109.526 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 74.1 Cg_endo -66.45 142.92 67.43 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 CA-C-N 123.492 2.283 . . . . 1.1599999999999999 111.347 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.02 8.73 87.4 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.512 1.53 . . . . 0.97999999999999998 114.895 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.2 m -89.52 163.83 15.05 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.851 1.826 . . . . 1.6499999999999999 112.234 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.3 p -112.33 147.1 37.06 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.911 -1.118 . . . . 1.1599999999999999 111.218 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 m -139.46 156.31 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.553 1.141 . . . . 0.69999999999999996 112.754 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.53 150.53 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.169 1.788 . . . . 1.23 113.225 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.02 149.59 47.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.044 0.937 . . . . 0.84999999999999998 113.168 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.3 -2.52 56.85 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.712 1.148 . . . . 0.89000000000000001 114.966 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 89.9 p -76.59 155.0 33.91 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.629 1.214 . . . . 1.54 111.657 169.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.09 136.95 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.273 1.029 . . . . 1.1399999999999999 110.669 -171.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -93.19 149.78 20.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.853 1.661 . . . . 1.5 113.412 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -160.47 115.27 2.22 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.989 0.916 . . . . 3.9700000000000002 111.88 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.5 t30 147.79 -46.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 131.658 3.983 . . . . 3.2200000000000002 110.829 166.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.1 179.78 42.74 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 121.084 -1.01 . . . . 2.1099999999999999 114.884 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -85.34 132.59 34.22 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.213 1.005 . . . . 2.25 112.276 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.86 163.56 24.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.838 1.655 . . . . 1.76 112.304 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.1 mt -118.46 127.29 53.51 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.209 1.004 . . . . 2.52 112.011 172.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.95 126.99 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.11 1.364 . . . . 1.25 110.893 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 44.2 t -83.09 125.46 31.51 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.094 0.558 . . . . 2.75 110.307 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.24 104.12 14.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.188 0.995 . . . . 1.1599999999999999 109.754 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.8 p -94.22 -3.81 50.1 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.558 1.143 . . . . 2.73 112.13 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -136.47 136.9 39.84 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.474 1.91 . . . . 2.5699999999999998 109.856 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 p -88.69 170.08 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.573 1.149 . . . . 2.4900000000000002 110.474 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.17 -35.68 85.36 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.31 -1.494 . . . . 1.8999999999999999 114.875 -171.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.79 -31.84 73.15 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.947 1.374 . . . . 2.5 113.227 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.16 -5.92 44.67 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.118 1.367 . . . . 3.75 113.738 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.0 p -80.71 147.16 30.72 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.529 -1.357 . . . . 1.72 112.77 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -70.67 -23.37 62.49 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.295 1.22 . . . . 2.6899999999999999 114.295 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 mp -59.37 -58.14 9.91 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 119.809 -1.807 . . . . 1.54 115.762 -167.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.7 m -73.18 -15.22 61.46 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.859 0.754 . . . . 3.3999999999999999 112.7 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.5 -42.92 64.31 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.001 0.92 . . . . 2.3799999999999999 111.461 172.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 54.9 mt -57.63 -45.76 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.067 1.347 . . . . 1.77 112.499 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 114.514 1.301 . . . . 1.98 114.514 -172.434 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 113.496 0.924 . . . . 2.6800000000000002 113.496 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.9 tp -64.49 -31.95 73.38 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.03 0.932 . . . . 1.98 111.134 171.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.19 -17.3 61.94 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.122 -0.986 . . . . 1.27 113.532 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -67.39 -28.52 68.0 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.755 0.822 . . . . 2.5499999999999998 112.207 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.8 -38.9 83.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.838 0.855 . . . . 1.27 111.319 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.3 mm -70.14 -41.28 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.275 0.63 . . . . 2.1499999999999999 110.954 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 m -67.44 -24.74 65.67 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.024 0.93 . . . . 1.1399999999999999 113.256 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.5 mt -73.32 -27.8 61.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.979 1.712 . . . . 1.6599999999999999 113.889 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -64.45 140.44 58.87 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.877 0.762 . . . . 3.2999999999999998 111.003 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.51 165.26 18.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.562 1.145 . . . . 2.5299999999999998 113.475 -172.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.1 m -121.11 -29.31 4.57 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.108 1.363 . . . . 2.0800000000000001 112.411 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.21 150.05 43.68 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.227 1.411 . . . . 2.9500000000000002 112.728 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.86 145.95 38.72 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.866 1.267 . . . . 1.0600000000000001 112.507 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.5 m -98.54 100.92 12.21 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.638 1.175 . . . . 1.3999999999999999 112.323 -174.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 35.1 mt -76.72 139.58 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.83 -0.804 . . . . 1.0900000000000001 108.83 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.42 125.58 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.712 0.768 . . . . 2.3799999999999999 112.254 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.471 0.621 0 C-N-CA 125.844 1.658 . . . . 2.0299999999999998 111.323 -167.926 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt . . . . . 0 C--O 1.232 0.168 0 N-CA-C 109.0 -0.741 . . . . 2.8599999999999999 109.0 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.1 p -135.92 152.27 50.83 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.884 1.274 . . . . 2.46 110.985 -168.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.67 149.07 40.38 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.969 0.908 . . . . 3.25 111.487 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -139.64 113.56 8.75 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.661 1.184 . . . . 2.5600000000000001 111.588 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -79.83 115.61 19.52 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.918 -1.114 . . . . 2.7000000000000002 109.303 167.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.78 166.08 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.239 1.416 . . . . 0.92000000000000004 111.166 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -76.6 142.0 40.88 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.921 -0.487 . . . . 3.9500000000000002 110.342 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.41 -23.57 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.289 1.218 . . . . 1.29 114.289 -171.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -60.68 -27.43 67.85 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.88 1.272 . . . . 4.4400000000000004 113.206 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.2 mt -101.57 -7.63 22.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.9 2.08 . . . . 1.3600000000000001 115.816 -167.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.74 144.71 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.151 0.887 . . . . 1.5600000000000001 111.151 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -121.33 154.78 35.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.204 1.802 . . . . 4.1299999999999999 112.881 -170.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -77.64 23.8 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 117.215 2.302 . . . . 3.2799999999999998 117.215 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.78 6.81 12.28 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.682 1.611 . . . . 1.47 115.564 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -124.01 173.31 8.33 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.75 1.775 . . . . 3.5600000000000001 115.256 -168.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.4 mt -113.84 126.31 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.057 1.743 . . . . 2.1299999999999999 110.491 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.3 mm -116.08 124.14 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.495 1.918 . . . . 0.72999999999999998 110.109 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.489 ' HE3' HD11 ' A' ' 96' ' ' LEU . 65.2 tttt -87.07 141.36 28.72 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.737 1.215 . . . . 2.1699999999999999 111.676 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -116.59 137.09 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.489 0.716 . . . . 0.72999999999999998 112.287 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.13 159.25 54.33 Favored Pre-proline 0 N--CA 1.481 1.075 0 C-N-CA 124.387 1.075 . . . . 1.3200000000000001 113.234 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -60.95 136.94 68.91 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.888 1.726 . . . . 1.8 109.772 167.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.27 26.37 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 115.429 0.932 . . . . 1.02 115.429 -171.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.66 -177.17 41.19 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 119.062 1.431 . . . . 1.0800000000000001 115.31 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -123.67 154.74 38.95 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.093 1.357 . . . . 2.04 112.043 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -88.69 122.12 69.47 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 118.608 -0.71 . . . . 1.79 110.34 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.18 -19.54 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.565 2.176 . . . . 0.76000000000000001 115.426 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.48 164.89 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 127.987 2.515 . . . . 0.90000000000000002 108.051 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -81.14 149.23 29.23 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.039 0.923 . . . . 2.3599999999999999 113.286 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -167.07 38.73 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.785 -0.643 . . . . 0.85999999999999999 113.906 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -114.96 132.6 56.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.742 0.817 . . . . 3.8399999999999999 112.504 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.0 t -79.02 131.58 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 127.078 2.151 . . . . 0.65000000000000002 107.636 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.06 31.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.039 0.836 . . . . 0.76000000000000001 112.277 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -169.07 146.71 3.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.378 2.271 . . . . 3.2400000000000002 109.258 168.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.08 -179.55 32.51 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 118.847 0.749 . . . . 0.93999999999999995 114.842 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -143.53 32.4 1.31 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.445 1.646 . . . . 3.1499999999999999 115.445 -167.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.806 ' H ' HD21 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -83.36 165.84 18.94 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.361 1.615 . . . . 1.28 115.361 -168.629 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.0 ttm -110.8 138.36 47.29 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.819 0.847 . . . . 1.0600000000000001 110.95 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.33 134.66 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.092 1.357 . . . . 0.88 112.805 -168.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -86.03 108.54 18.29 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.107 1.363 . . . . 2.5299999999999998 110.924 174.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.94 -10.79 17.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.0 1.32 . . . . 2.5099999999999998 113.89 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.5 p -43.23 -35.45 1.43 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 117.995 2.591 . . . . 1.79 117.995 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -84.86 -27.45 26.69 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.62 1.1 . . . . 1.4099999999999999 112.016 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mm -89.52 -55.55 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.944 0.898 . . . . 1.3899999999999999 110.922 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.0 p -85.79 -18.35 33.2 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.191 0.996 . . . . 1.8 113.132 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.71 9.91 80.25 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.448 1.499 . . . . 1.79 114.439 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.02 -177.59 0.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.365 1.466 . . . . 2.8300000000000001 112.512 171.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.69 -20.68 0.59 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.148 1.379 . . . . 1.8999999999999999 114.492 -176.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.9 mtp -119.2 140.47 28.97 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.7 1.2 . . . . 4.2300000000000004 111.354 172.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -59.28 144.93 99.22 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.556 2.837 . . . . 2.1800000000000002 113.973 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 t -106.72 131.99 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 127.3 2.24 . . . . 0.82999999999999996 111.982 -168.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.13 134.84 37.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.267 0.627 . . . . 0.82999999999999996 111.85 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -110.37 155.47 22.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.4 1.88 . . . . 0.87 111.652 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -151.93 172.07 5.88 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 127.343 2.257 . . . . 2.2799999999999998 108.285 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -54.9 142.08 76.3 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 CA-C-N 122.149 1.803 . . . . 0.82999999999999996 112.279 171.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.63 13.33 82.62 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-O 117.7 -1.611 . . . . 1.0900000000000001 115.635 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -96.83 144.7 26.55 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.209 2.505 . . . . 1.4199999999999999 111.392 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.5 p -90.42 157.17 17.73 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 121.305 1.866 . . . . 1.01 112.933 172.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 m -140.34 156.85 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.457 1.903 . . . . 0.79000000000000004 112.035 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -113.47 151.65 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 127.573 2.349 . . . . 1.1000000000000001 111.636 173.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.34 155.86 23.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.29 0.636 . . . . 0.88 112.369 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.69 0.12 53.15 Favored Glycine 0 CA--C 1.536 1.402 0 O-C-N 121.447 -0.783 . . . . 1.1499999999999999 114.974 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.9 p -78.22 153.51 31.87 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.557 1.179 . . . . 1.72 110.899 168.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mm -113.3 131.73 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.811 0.844 . . . . 1.3200000000000001 111.011 -171.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -94.27 148.32 22.32 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.696 1.598 . . . . 1.6799999999999999 112.653 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -96.95 -88.08 0.3 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.291 1.036 . . . . 3.4199999999999999 112.712 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -154.17 146.92 24.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.628 2.771 . . . . 4.4100000000000001 107.865 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.64 23.97 2.7 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 120.602 1.546 . . . . 2.9900000000000002 115.158 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 t 18.19 97.94 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 130.169 3.388 . . . . 1.74 116.837 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.806 HD21 ' H ' ' A' ' 62' ' ' SER . 54.9 mt -102.5 154.03 19.49 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.629 1.171 . . . . 1.0700000000000001 112.948 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.489 HD11 ' HE3' ' A' ' 44' ' ' LYS . 7.2 mp -117.75 126.02 51.69 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.501 1.12 . . . . 2.3399999999999999 108.566 166.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.54 125.9 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.127 1.371 . . . . 1.1399999999999999 110.086 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.2 p -81.2 119.88 24.17 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.627 -0.67 . . . . 1.53 109.538 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.95 130.92 35.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.293 0.637 . . . . 1.27 109.665 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.46 3.55 9.05 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.897 1.073 . . . . 3.04 113.897 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -141.18 151.5 43.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.998 1.319 . . . . 2.1600000000000001 111.86 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -89.45 173.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.769 1.628 . . . . 2.1499999999999999 111.223 171.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.94 -36.41 87.76 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 121.061 -1.024 . . . . 1.6000000000000001 114.843 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.39 -28.12 69.02 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.582 1.327 . . . . 2.0899999999999999 114.582 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.71 -13.02 60.03 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.962 1.467 . . . . 3.3500000000000001 114.962 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.1 p -66.45 132.92 49.35 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.215 -0.928 . . . . 2.1000000000000001 112.608 -168.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 t -63.24 -23.77 67.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.487 1.291 . . . . 2.23 114.487 -167.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.7 -43.74 80.84 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.917 -1.114 . . . . 1.8300000000000001 111.795 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.2 p -68.03 -28.5 67.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.158 0.983 . . . . 2.02 112.712 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -75.27 -48.65 22.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.969 1.307 . . . . 1.55 111.91 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 53.4 mt -53.62 -49.23 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.862 1.665 . . . . 1.45 110.5 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 114.876 1.435 . . . . 1.6100000000000001 114.876 -177.626 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 112.639 0.607 . . . . 1.79 112.639 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.25 -40.73 86.86 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.636 1.174 . . . . 2.98 111.205 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.32 -14.25 61.27 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.456 0.91 . . . . 1.1799999999999999 113.456 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -67.3 -33.31 75.01 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.649 -1.282 . . . . 2.3900000000000001 111.505 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.91 -28.03 69.78 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.489 1.115 . . . . 1.1299999999999999 111.885 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.8 mm -74.11 -39.47 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.694 0.798 . . . . 1.74 111.772 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -65.79 -31.52 72.54 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.803 -1.186 . . . . 1.79 112.288 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.7 mt -71.23 -11.55 60.99 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.488 1.915 . . . . 2.1600000000000001 113.685 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -87.03 158.34 19.25 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.762 1.225 . . . . 2.29 112.873 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.13 161.3 14.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.499 1.519 . . . . 2.2799999999999998 114.326 -169.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p -90.98 -47.72 7.41 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.474 1.51 . . . . 2.7599999999999998 113.203 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -142.08 157.4 44.95 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.336 1.454 . . . . 4.1200000000000001 112.782 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.17 157.38 44.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.383 1.473 . . . . 0.88 112.525 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.1 m -100.4 107.02 18.67 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.896 0.878 . . . . 0.87 111.589 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.8 mt -78.84 142.26 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.684 1.193 . . . . 0.71999999999999997 108.443 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.23 135.63 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.643 0.735 . . . . 2.02 111.924 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.471 0.609 0 C-N-CA 127.747 2.419 . . . . 1.6599999999999999 110.959 -169.693 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 121.01 0.433 . . . . 2.4900000000000002 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.7 t -140.13 139.11 35.71 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.079 2.152 . . . . 1.3400000000000001 109.46 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -126.11 151.69 46.9 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.096 -1.002 . . . . 2.8399999999999999 112.183 -174.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -129.4 128.45 43.04 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.133 1.373 . . . . 2.7999999999999998 111.25 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -93.46 108.16 19.89 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.263 -0.898 . . . . 2.1299999999999999 109.571 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 m -118.95 154.55 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.179 0.992 . . . . 0.94999999999999996 112.263 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -72.7 148.27 44.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.686 -0.486 . . . . 3.21 109.686 171.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.41 -17.86 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.387 1.625 . . . . 1.0800000000000001 115.387 -168.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -70.94 -20.65 62.44 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.41 -1.431 . . . . 4.2599999999999998 113.833 170.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.7 mt -98.35 -3.66 36.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.644 1.578 . . . . 1.23 114.078 -168.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -89.14 139.36 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.676 1.591 . . . . 1.54 109.959 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -108.95 164.45 12.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.864 1.266 . . . . 3.8500000000000001 111.166 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -70.56 37.45 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.726 1.38 . . . . 2.8500000000000001 114.726 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.47 11.5 0.15 Allowed Glycine 0 CA--C 1.54 1.62 0 C-N-CA 127.824 2.63 . . . . 0.87 114.395 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -97.3 165.4 12.05 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.829 1.815 . . . . 2.3300000000000001 112.505 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.7 mm -113.21 123.08 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.822 1.649 . . . . 1.55 110.49 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.7 mm -116.24 128.52 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.011 1.324 . . . . 0.77000000000000002 112.174 -170.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -85.91 140.04 30.71 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.455 1.102 . . . . 2.0600000000000001 112.926 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.62 136.57 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.65 1.18 . . . . 0.66000000000000003 112.118 174.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.69 160.93 30.33 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.637 1.175 . . . . 0.90000000000000002 113.818 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.18 123.6 13.49 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.571 2.18 . . . . 1.1699999999999999 111.526 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.02 -2.36 87.7 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.619 2.057 . . . . 1.0800000000000001 115.242 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.84 171.71 54.62 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 119.246 1.523 . . . . 1.0800000000000001 114.049 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -111.24 152.44 27.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.047 1.339 . . . . 2.4100000000000001 112.235 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -76.66 131.94 73.02 Favored Pre-proline 0 CA--C 1.553 1.066 0 CA-C-O 118.629 -0.701 . . . . 2.2999999999999998 111.587 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -96.1 -17.13 0.35 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.264 2.642 . . . . 0.80000000000000004 115.787 -173.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.49 171.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 127.07 2.148 . . . . 0.75 108.976 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.6 137.38 40.9 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.935 0.789 . . . . 1.8999999999999999 112.652 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.13 -156.48 20.4 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 114.548 0.579 . . . . 0.80000000000000004 114.548 -171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.6 ttp85 -114.78 140.3 49.03 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.631 1.172 . . . . 3.8500000000000001 112.939 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.9 t -88.85 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.685 1.994 . . . . 0.72999999999999998 108.971 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.9 pt -140.92 33.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.84 0.829 . . . . 0.95999999999999996 112.376 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -166.12 137.23 3.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.22 1.808 . . . . 2.71 109.662 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.52 -176.1 51.11 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 123.691 0.662 . . . . 0.81999999999999995 114.74 171.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -156.8 92.27 1.27 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.06 0.944 . . . . 3.1099999999999999 112.13 -168.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.63 165.86 19.17 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.85 1.66 . . . . 1.1799999999999999 112.675 -169.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.0 ttm -112.28 130.75 55.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.455 1.102 . . . . 1.48 110.544 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.3 t -123.4 142.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.311 1.444 . . . . 0.90000000000000002 113.365 -167.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -104.03 107.72 18.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.835 1.254 . . . . 1.8600000000000001 112.288 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -103.01 27.21 7.32 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 126.09 1.756 . . . . 2.3799999999999999 114.109 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 p -51.53 -9.36 0.07 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 119.206 3.039 . . . . 2.1400000000000001 119.206 -169.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.36 -49.28 1.92 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.023 1.329 . . . . 1.3999999999999999 111.128 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.2 mm -67.04 -55.99 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 119.309 0.959 . . . . 1.2 111.917 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.8 p -95.59 -13.24 24.55 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.028 0.931 . . . . 1.3700000000000001 111.75 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.58 11.43 84.41 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.198 1.38 . . . . 1.3100000000000001 115.569 169.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.54 -40.34 82.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.209 1.004 . . . . 2.46 113.235 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.04 43.78 8.64 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.35 1.46 . . . . 1.52 112.246 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.0 ptm -161.98 159.4 21.88 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 128.979 2.912 . . . . 4.4000000000000004 109.602 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.82 139.25 17.48 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.577 2.185 . . . . 2.3100000000000001 112.534 172.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.49 139.09 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.871 1.669 . . . . 1.1200000000000001 110.578 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.37 137.08 32.64 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.132 -0.98 . . . . 0.81999999999999995 112.499 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -117.36 157.2 26.57 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.659 1.584 . . . . 0.71999999999999997 111.027 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -160.1 172.99 5.27 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 127.536 2.335 . . . . 2.2599999999999998 110.511 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -53.57 135.2 60.93 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 CA-C-N 122.201 1.822 . . . . 1.04 111.656 167.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.31 38.87 44.95 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.356 0.503 . . . . 0.88 113.284 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 t -125.52 139.29 53.74 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 118.088 0.944 . . . . 1.46 111.396 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.6 p -91.05 145.02 25.04 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.902 1.228 . . . . 0.97999999999999998 112.475 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.2 m -135.88 156.45 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.63 1.572 . . . . 0.60999999999999999 112.095 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -130.01 144.02 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.487 1.515 . . . . 1.1299999999999999 112.984 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.92 147.44 50.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.757 0.823 . . . . 0.90000000000000002 112.912 -175.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.27 -6.64 63.11 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 115.245 0.858 . . . . 1.04 115.245 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.5 p -76.12 158.03 32.21 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.441 1.121 . . . . 1.4099999999999999 110.395 167.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -108.76 140.26 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.383 1.073 . . . . 1.1100000000000001 110.996 -171.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -109.09 147.72 31.97 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.803 1.241 . . . . 1.6799999999999999 113.475 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -150.95 140.35 21.43 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.983 1.313 . . . . 3.4900000000000002 112.045 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 t30 43.85 88.09 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.219 2.608 . . . . 3.1499999999999999 113.708 168.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.47 -10.37 0.14 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 117.665 1.826 . . . . 3.75 117.665 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.3 m 45.31 85.48 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 127.732 2.413 . . . . 2.52 115.946 169.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.2 mt -106.99 160.72 15.33 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.17 1.544 . . . . 0.93000000000000005 115.17 -169.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.0 135.55 51.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.332 1.053 . . . . 2.4300000000000002 110.604 165.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.56 129.72 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.257 1.823 . . . . 1.6599999999999999 110.396 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.3 p -83.1 119.27 24.29 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.484 -0.76 . . . . 1.52 109.034 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.32 124.99 28.62 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.813 -0.554 . . . . 0.80000000000000004 110.244 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 p -118.16 -0.65 11.53 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.353 1.861 . . . . 2.3799999999999999 112.884 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -142.97 136.23 28.29 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.842 2.057 . . . . 1.8700000000000001 110.054 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.38 162.93 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.404 -0.961 . . . . 1.6399999999999999 108.404 164.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.1 91.08 Favored Glycine 0 N--CA 1.479 1.562 0 O-C-N 120.4 -1.437 . . . . 1.3300000000000001 114.215 -169.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.94 -32.73 74.37 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.803 1.241 . . . . 1.6299999999999999 113.997 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -79.41 -9.76 59.66 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.962 2.105 . . . . 2.2799999999999998 115.142 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.0 p -70.1 154.69 41.62 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.067 -1.646 . . . . 1.47 112.93 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.8 t -57.7 -30.25 65.35 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.387 -0.821 . . . . 1.8600000000000001 112.889 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.03 -49.88 75.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.931 -1.106 . . . . 1.6000000000000001 112.044 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.3 m -64.24 -34.11 77.35 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.11 0.964 . . . . 1.72 110.922 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.19 -40.48 82.18 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.923 -0.486 . . . . 1.6799999999999999 111.882 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.0 mt -58.32 -54.69 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.478 1.111 . . . . 1.1799999999999999 110.604 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 114.178 1.177 . . . . 1.45 114.178 -175.433 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 114.628 1.344 . . . . 2.0600000000000001 114.628 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.79 -46.28 70.98 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 117.22 2.304 . . . . 1.77 117.22 -165.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.37 -31.81 60.62 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.721 1.146 . . . . 1.3500000000000001 113.06 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -69.0 -31.78 70.86 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.966 1.706 . . . . 2.8399999999999999 113.333 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.97 -41.77 71.57 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.295 0.952 . . . . 1.47 111.998 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.37 -38.06 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 122.942 0.497 . . . . 2.0699999999999998 111.285 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.8 m -66.89 -24.16 66.08 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.604 -1.31 . . . . 1.8 113.639 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.02 -15.53 62.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.258 1.423 . . . . 2.3599999999999999 113.453 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -72.55 118.9 16.03 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.167 0.894 . . . . 3.3799999999999999 109.506 172.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.25 177.98 2.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.278 1.831 . . . . 2.5899999999999999 115.445 -168.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.2 m -112.59 -39.37 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.967 1.707 . . . . 2.4500000000000002 113.006 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -141.18 157.14 45.67 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.49 1.293 . . . . 2.8999999999999999 114.49 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.08 170.98 14.7 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.691 1.597 . . . . 0.93000000000000005 112.822 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.7 m -131.08 112.94 13.33 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.287 1.435 . . . . 1.3 111.654 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.8 mt -85.16 142.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.317 1.447 . . . . 1.1000000000000001 109.632 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -102.05 121.62 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 121.18 0.514 . . . . 2.0899999999999999 111.254 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 125.252 1.421 . . . . 1.8 110.078 -177.036 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.392 0.615 . . . . 2.7599999999999998 111.596 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -135.52 111.29 9.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.94 1.696 . . . . 2.0499999999999998 108.104 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.04 143.84 26.28 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.905 1.076 . . . . 2.5099999999999998 113.905 -169.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -113.69 126.11 54.89 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.862 1.665 . . . . 3.8500000000000001 110.141 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -98.98 122.32 42.08 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.558 1.072 . . . . 2.4100000000000001 111.535 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.19 158.0 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.931 1.085 . . . . 0.93000000000000005 113.931 -168.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -78.36 145.1 35.42 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.711 -0.848 . . . . 3.5499999999999998 108.711 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 p -62.42 -18.48 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 114.386 1.254 . . . . 1.55 114.386 -168.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -61.42 -27.67 68.71 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.589 -1.319 . . . . 3.6099999999999999 113.309 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.3 mt -93.17 -5.72 49.47 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.283 1.833 . . . . 1.4399999999999999 115.008 -169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.76 140.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.831 1.652 . . . . 1.45 109.663 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -114.98 160.47 19.53 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.394 1.478 . . . . 3.0 111.968 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -67.43 137.57 56.0 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.349 -0.982 . . . . 3.21 108.349 167.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.69 -4.35 56.4 Favored Glycine 0 CA--C 1.543 1.803 0 C-N-CA 124.339 0.971 . . . . 1.6100000000000001 114.115 -168.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -93.43 158.65 15.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.168 1.387 . . . . 2.4900000000000002 112.527 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.97 120.12 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.868 1.267 . . . . 1.55 110.229 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 mm -122.1 132.54 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.882 1.673 . . . . 0.85999999999999999 111.47 -168.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.22 130.0 34.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.623 0.769 . . . . 1.8799999999999999 112.654 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.8 p -116.33 132.99 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.106 1.362 . . . . 0.75 111.282 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.94 161.86 42.83 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 125.479 1.511 . . . . 0.90000000000000002 113.318 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.74 139.81 70.99 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.691 1.594 . . . . 1.1299999999999999 109.997 166.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.85 -14.72 41.29 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 126.164 1.84 . . . . 1.21 115.366 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.82 159.86 44.37 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.546 1.673 . . . . 1.0700000000000001 114.878 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -92.68 139.65 30.35 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.978 1.311 . . . . 4.0199999999999996 111.502 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.34 130.13 94.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.396 -0.812 . . . . 2.3900000000000001 111.371 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -89.8 -13.42 2.67 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.706 2.271 . . . . 0.87 114.908 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.11 175.2 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 127.503 2.321 . . . . 1.47 109.903 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.255 1.2 p30 -111.55 147.23 35.85 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.159 0.8 . . . . 1.8700000000000001 113.159 172.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.25 -159.37 32.5 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 115.002 0.761 . . . . 0.57999999999999996 115.002 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 ttp-105 -111.43 140.62 45.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.229 1.412 . . . . 4.25 112.564 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.91 128.4 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 127.436 2.294 . . . . 0.72999999999999998 108.377 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.76 32.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.234 0.827 . . . . 0.68000000000000005 113.234 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -168.03 134.01 1.96 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.655 1.582 . . . . 3.3999999999999999 108.51 167.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.78 178.96 52.58 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 122.086 0.826 . . . . 0.81000000000000005 114.623 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -148.72 124.38 10.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.605 0.762 . . . . 2.5499999999999998 112.78 -172.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -145.45 169.49 18.24 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.292 1.437 . . . . 1.1399999999999999 113.499 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.3 ttm -110.79 132.28 54.34 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.266 1.427 . . . . 0.88 110.454 174.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -118.98 140.22 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.979 1.311 . . . . 0.84999999999999998 111.968 -169.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -107.19 92.89 4.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.498 1.119 . . . . 2.1299999999999999 111.068 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -87.2 22.62 2.04 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.418 1.887 . . . . 1.8799999999999999 113.999 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.9 p -55.49 -8.76 0.39 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 118.973 2.953 . . . . 2.1000000000000001 118.973 -169.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -126.24 -38.12 2.17 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.916 1.686 . . . . 1.49 111.501 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.6 mm -76.84 -61.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.211 0.604 . . . . 1.5600000000000001 111.191 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.3 p -98.58 -12.97 20.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.938 0.895 . . . . 1.6299999999999999 112.616 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.04 87.29 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.329 1.442 . . . . 1.4299999999999999 115.971 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -56.1 -45.15 79.52 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.34 1.056 . . . . 3.4300000000000002 111.68 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 69.81 -14.67 0.35 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.559 2.744 . . . . 2.2200000000000002 114.764 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 58.3 ttm -87.87 149.28 45.43 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.292 1.837 . . . . 3.0600000000000001 110.089 168.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.09 133.83 34.61 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.324 2.683 . . . . 1.48 112.606 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.04 135.2 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.987 1.715 . . . . 0.85999999999999999 111.863 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.39 135.3 36.66 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.034 0.934 . . . . 1.0800000000000001 113.494 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -128.53 144.71 51.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.016 1.726 . . . . 0.75 111.358 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -146.55 174.74 3.16 Favored Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 128.929 2.892 . . . . 2.6400000000000001 109.072 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.66 132.88 45.17 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 122.105 1.787 . . . . 0.77000000000000002 110.526 169.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.45 33.68 21.9 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.012 1.291 . . . . 0.75 114.248 -169.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 57.2 m -123.41 152.42 41.6 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.883 1.273 . . . . 1.4399999999999999 111.258 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.9 p -102.37 152.15 21.43 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.983 1.265 . . . . 0.83999999999999997 113.959 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.08 161.65 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.472 1.909 . . . . 0.5 112.292 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.89 149.9 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.585 1.954 . . . . 1.1200000000000001 112.542 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.88 154.39 30.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.8 1.24 . . . . 0.69999999999999996 114.191 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.6 -11.26 14.22 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.879 1.228 . . . . 0.80000000000000004 115.43 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 m -81.8 160.2 23.6 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.426 1.09 . . . . 2.75 111.047 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.03 145.37 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.114 0.966 . . . . 1.26 111.655 -171.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -107.99 139.68 42.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.855 2.062 . . . . 1.8200000000000001 111.228 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -152.08 145.24 24.61 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.715 -1.241 . . . . 4.5099999999999998 112.049 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 53.2 t30 122.53 -55.81 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.099 1 C-N-CA 132.004 4.122 . . . . 3.4399999999999999 111.228 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.74 175.24 41.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.568 1.08 . . . . 1.8200000000000001 114.891 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.5 m -77.71 137.97 38.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.847 1.259 . . . . 1.8700000000000001 112.193 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.8 mt -127.08 162.55 25.79 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.594 1.158 . . . . 1.05 112.111 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.6 127.46 54.53 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.653 0.781 . . . . 2.5800000000000001 110.343 168.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 mm -114.05 124.51 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 125.468 1.507 . . . . 1.5900000000000001 109.981 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.1 p -91.38 121.57 33.22 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.844 0.747 . . . . 1.46 109.412 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.25 138.02 37.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.344 0.658 . . . . 1.29 111.819 -173.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -112.35 -12.3 13.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.062 0.945 . . . . 2.75 112.919 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -142.64 141.65 31.93 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.196 1.399 . . . . 1.6399999999999999 110.948 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.89 161.84 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.494 1.117 . . . . 1.75 111.443 170.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.9 -35.96 91.48 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.4 -0.813 . . . . 2.3100000000000001 113.899 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.74 84.34 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.149 0.974 . . . . 2.9300000000000002 111.661 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.3 -4.69 31.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.389 1.625 . . . . 3.4900000000000002 115.389 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.4 p -59.79 147.94 36.25 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.923 1.238 . . . . 2.0299999999999998 111.704 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.7 t -57.67 -19.8 29.25 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.203 1.186 . . . . 1.8999999999999999 114.203 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -48.55 -46.08 38.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.591 1.556 . . . . 1.6499999999999999 112.438 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.6 p -69.11 -29.08 67.08 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.281 1.033 . . . . 2.2200000000000002 112.839 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -74.64 -42.5 58.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.724 1.21 . . . . 1.3300000000000001 111.917 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 69.1 mt -54.72 -46.19 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.69 1.196 . . . . 1.3400000000000001 110.861 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.479 0.981 0 O-C-N 120.606 -1.309 . . . . 1.46 114.176 178.747 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 112.454 0.539 . . . . 1.3799999999999999 112.454 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.81 -33.06 73.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.706 0.803 . . . . 1.6599999999999999 111.673 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.39 -48.02 21.28 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.701 0.682 . . . . 1.28 111.245 168.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.32 -40.13 61.49 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.745 2.018 . . . . 2.6299999999999999 113.983 -174.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -43.42 -51.91 6.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.7 1.2 . . . . 1.74 111.695 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.2 mm -72.69 -28.02 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.498 1.119 . . . . 2.6600000000000001 113.125 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -74.0 -24.02 59.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.405 1.082 . . . . 1.1899999999999999 112.894 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.47 -16.9 61.97 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.636 0.976 . . . . 2.04 113.636 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.4 154.43 42.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.501 1.143 . . . . 2.8799999999999999 113.466 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.58 160.79 26.3 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.638 -1.165 . . . . 1.8999999999999999 110.855 168.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.6 m -108.65 -6.43 15.99 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.507 1.523 . . . . 1.8999999999999999 112.272 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.21 159.51 41.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.199 1.8 . . . . 3.3700000000000001 113.012 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.19 156.65 44.4 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.209 1.404 . . . . 0.68999999999999995 113.092 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -109.66 108.61 19.07 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 113.279 0.844 . . . . 0.88 113.279 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.9 mt -86.82 125.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.894 1.278 . . . . 0.77000000000000002 110.064 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.04 125.3 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 119.571 1.078 . . . . 2.1800000000000002 112.539 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 124.893 1.277 . . . . 2.7599999999999998 113.647 -172.184 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 CA--C 1.557 1.237 0 N-CA-C 114.245 1.202 . . . . 2.79 114.245 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 m -77.64 136.02 38.18 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.943 1.297 . . . . 1.8500000000000001 111.394 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -122.39 127.27 49.51 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.065 0.946 . . . . 2.4100000000000001 110.241 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -114.45 119.86 38.34 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.959 1.303 . . . . 4.21 108.891 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -93.97 124.0 37.69 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.582 -0.896 . . . . 1.9099999999999999 108.582 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 m -137.63 170.71 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.734 1.214 . . . . 0.72999999999999998 112.265 -169.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.17 147.35 36.54 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.769 0.828 . . . . 3.3999999999999999 110.601 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.88 -17.67 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 113.734 1.013 . . . . 1.1299999999999999 113.734 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.52 -17.62 26.72 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 120.351 -1.468 . . . . 4.6799999999999997 113.511 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.62 -16.68 28.24 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.246 1.419 . . . . 1.4299999999999999 113.441 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -76.53 147.54 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.289 -0.882 . . . . 1.6299999999999999 110.065 169.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -121.81 162.41 20.95 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.324 1.45 . . . . 3.21 111.852 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.4 ptt-85 -72.84 139.2 46.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.576 -0.738 . . . . 5.0 109.931 170.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.54 -3.43 10.23 Favored Glycine 0 CA--C 1.541 1.713 0 N-CA-C 115.666 1.027 . . . . 1.0900000000000001 115.666 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -119.25 -174.42 2.72 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.592 1.696 . . . . 3.4199999999999999 112.979 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.68 130.25 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.894 1.678 . . . . 1.8 109.933 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -115.89 129.35 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.738 2.015 . . . . 0.70999999999999996 110.144 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HE3' HD11 ' A' ' 96' ' ' LEU . 41.9 mtpt -92.15 133.95 35.31 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 121.627 -0.671 . . . . 2.1499999999999999 112.611 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.02 133.39 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.049 1.34 . . . . 0.69999999999999996 111.44 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 m -100.67 162.2 21.47 Favored Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 124.414 1.086 . . . . 0.87 113.095 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.25 137.61 71.13 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.064 2.51 . . . . 1.0700000000000001 112.472 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.14 -7.37 4.56 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.569 0.987 . . . . 1.03 115.569 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.12 160.88 50.31 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.193 1.497 . . . . 0.93999999999999995 113.542 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -99.14 152.09 20.26 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.704 1.202 . . . . 1.96 112.146 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -81.04 125.03 80.73 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.021 0.929 . . . . 1.78 110.823 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.35 -20.8 2.59 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.987 2.458 . . . . 0.69999999999999996 115.496 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 m -151.17 168.78 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 127.921 2.488 . . . . 0.84999999999999998 108.834 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -89.32 148.03 23.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.122 0.874 . . . . 2.1899999999999999 111.793 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.8 -149.42 10.0 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 114.416 0.526 . . . . 1.01 114.416 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.3 ttm105 -132.26 144.5 50.65 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.711 1.205 . . . . 5.0199999999999996 113.058 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.93 132.77 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.185 2.194 . . . . 0.85999999999999999 109.78 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.7 pt -140.67 30.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.144 1.165 . . . . 0.85999999999999999 114.144 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -168.51 140.3 2.75 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.488 -1.383 . . . . 3.3799999999999999 110.048 168.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.15 -165.12 32.66 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.604 1.097 . . . . 0.98999999999999999 114.641 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -150.27 123.22 8.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.383 1.473 . . . . 1.8700000000000001 111.423 -175.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.06 171.89 15.13 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.18 1.178 . . . . 1.1000000000000001 114.18 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.0 ttm -121.05 132.93 55.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.207 1.403 . . . . 0.83999999999999997 109.643 172.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.86 134.81 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.903 1.281 . . . . 0.63 112.0 -168.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -94.98 113.4 25.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.465 1.906 . . . . 2.1600000000000001 110.642 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -114.72 22.76 13.25 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.621 1.568 . . . . 2.2200000000000002 112.964 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.7 p -57.06 -22.92 42.9 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 118.176 2.658 . . . . 2.0299999999999998 118.176 -167.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -105.04 -31.03 9.38 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.516 1.527 . . . . 1.3 111.415 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.0 mm -74.36 -67.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.534 1.134 . . . . 1.3 110.919 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.1 p -99.13 -4.85 31.28 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.444 1.497 . . . . 1.52 112.306 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.13 2.79 85.56 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.801 1.191 . . . . 2.0899999999999999 114.757 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -73.81 108.23 6.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.412 1.085 . . . . 3.6099999999999999 112.263 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.94 -16.49 56.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.47 1.108 . . . . 2.1200000000000001 112.963 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.4 ttp -109.85 121.08 43.03 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.675 1.59 . . . . 3.3999999999999999 108.052 169.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.82 165.66 28.99 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.604 2.869 . . . . 1.5 114.275 -168.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.14 130.45 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.545 1.538 . . . . 0.80000000000000004 111.02 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.58 137.4 38.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.08 0.552 . . . . 0.69999999999999996 111.66 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.18 147.26 46.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.807 1.643 . . . . 0.84999999999999998 110.404 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -145.63 171.65 6.26 Favored Pre-proline 0 N--CA 1.48 1.048 0 C-N-CA 127.639 2.376 . . . . 2.7999999999999998 110.248 -171.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.14 127.15 23.82 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.973 1.74 . . . . 1.02 111.556 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.01 35.29 18.88 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.539 1.066 . . . . 0.90000000000000002 113.902 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.9 t -118.47 154.7 32.07 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.427 1.613 . . . . 1.55 112.252 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -107.1 144.03 34.39 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.657 1.183 . . . . 1.02 112.536 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 m -138.72 153.71 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.187 0.995 . . . . 0.72999999999999998 113.555 -172.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -118.37 146.25 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.001 1.32 . . . . 0.90000000000000002 114.031 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.1 143.82 31.47 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.207 1.403 . . . . 0.76000000000000001 112.154 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.62 -4.04 66.21 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.845 1.098 . . . . 0.68000000000000005 115.845 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.4 p -74.25 159.38 32.56 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.074 1.437 . . . . 1.3999999999999999 111.758 169.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.58 140.58 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.397 1.079 . . . . 0.80000000000000004 111.507 -173.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -81.86 139.29 34.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.502 1.121 . . . . 2.6800000000000002 111.475 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -146.35 56.88 1.18 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.5 1.296 . . . . 3.2200000000000002 114.5 168.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -160.03 -59.36 0.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.374 1.25 . . . . 3.3999999999999999 114.374 167.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -164.21 168.96 38.87 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.701 1.143 . . . . 1.99 113.497 -168.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.8 p -84.15 148.18 26.91 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.789 1.033 . . . . 1.79 113.789 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -137.5 161.3 36.76 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.993 1.717 . . . . 1.29 111.629 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.479 HD11 ' HE3' ' A' ' 44' ' ' LYS . 9.7 mp -108.42 119.86 40.74 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.075 1.35 . . . . 2.04 110.348 174.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.9 mt -107.13 119.74 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.267 1.427 . . . . 2.1200000000000001 110.153 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.6 p -79.97 117.11 20.52 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.856 -1.153 . . . . 1.49 110.248 170.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.63 121.83 28.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.616 0.722 . . . . 0.93000000000000005 112.701 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -115.31 -9.77 12.14 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.558 1.543 . . . . 2.1299999999999999 113.471 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -138.26 146.0 41.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.5 1.52 . . . . 1.6100000000000001 111.474 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 m -100.4 160.75 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.47 1.508 . . . . 1.78 110.1 167.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.96 -39.13 56.33 Favored Glycine 0 N--CA 1.472 1.074 0 N-CA-C 116.556 1.382 . . . . 1.28 116.556 -166.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.22 -36.37 71.83 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.654 1.227 . . . . 1.73 113.346 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.66 -9.06 58.26 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.322 1.23 . . . . 2.3300000000000001 114.322 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.8 p -58.8 152.64 18.64 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.158 -0.964 . . . . 1.6499999999999999 113.148 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 t -56.82 -39.22 73.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.756 1.222 . . . . 1.8899999999999999 110.567 169.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.39 -43.36 99.01 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.014 1.726 . . . . 1.47 112.362 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.7 t -67.4 -35.14 78.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.498 0.719 . . . . 2.1400000000000001 111.839 176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.29 -43.37 70.53 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.364 0.529 . . . . 1.5700000000000001 111.739 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.6 mt -54.06 -51.4 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.143 0.977 . . . . 1.73 111.589 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.478 0.959 0 O-C-N 120.99 -1.069 . . . . 1.4099999999999999 113.04 179.37 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 111.797 0.295 . . . . 1.8700000000000001 111.797 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.39 -33.29 65.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.9 0.88 . . . . 2.25 113.25 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.36 -44.65 35.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.791 0.723 . . . . 1.6100000000000001 112.581 169.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -64.15 -34.13 77.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.317 0.858 . . . . 2.5 113.317 -174.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.23 -36.38 73.1 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.497 1.044 . . . . 1.25 113.047 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.0 mm -67.01 -37.24 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 118.764 0.711 . . . . 2.3799999999999999 111.304 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.0 m -72.9 -23.81 60.76 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.387 -0.821 . . . . 1.23 112.754 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.7 mt -72.38 -25.6 61.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.909 1.284 . . . . 2.0899999999999999 112.905 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -68.49 106.09 2.43 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.721 1.146 . . . . 3.2599999999999998 110.76 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 155.31 28.23 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.173 1.389 . . . . 2.2000000000000002 113.467 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.7 m -95.78 -31.14 13.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.388 1.475 . . . . 1.95 114.281 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.35 159.83 41.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.184 0.994 . . . . 2.8500000000000001 113.33 -169.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.45 163.49 32.96 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.567 1.547 . . . . 0.72999999999999998 112.776 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.5 m -119.65 97.52 5.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.559 1.544 . . . . 0.80000000000000004 110.704 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.2 mt -84.89 133.92 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.369 1.068 . . . . 0.79000000000000004 110.008 -172.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -107.81 127.34 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.506 1.122 . . . . 1.78 111.111 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 125.4 1.48 . . . . 1.6299999999999999 111.388 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 120.993 0.425 . . . . 3.3999999999999999 111.015 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -142.2 145.66 34.37 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.179 1.392 . . . . 2.0600000000000001 110.959 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -118.48 149.06 41.92 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.495 1.665 . . . . 2.5099999999999998 115.495 -168.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -104.07 139.0 39.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.577 1.951 . . . . 2.9199999999999999 109.65 169.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -98.73 121.23 40.41 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.043 0.937 . . . . 2.23 109.408 172.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.62 159.86 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 115.288 1.588 . . . . 0.81999999999999995 115.288 -167.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.09 150.74 30.17 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.434 1.093 . . . . 3.1699999999999999 109.761 166.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.05 -21.27 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.334 1.054 . . . . 1.03 113.646 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.47 -20.14 62.81 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.361 -1.462 . . . . 2.8799999999999999 112.95 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.1 mt -107.22 -8.93 16.25 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.253 1.575 . . . . 1.4199999999999999 115.253 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.15 148.89 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.297 1.039 . . . . 1.49 111.051 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -122.3 165.07 16.81 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.121 1.368 . . . . 4.0899999999999999 114.204 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -69.09 26.19 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 127.011 2.124 . . . . 2.7799999999999998 116.213 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.79 9.65 2.32 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.003 1.764 . . . . 1.01 113.776 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -89.47 165.07 14.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.126 1.37 . . . . 2.9100000000000001 112.821 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.1 mt -122.21 128.28 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.143 1.377 . . . . 1.1699999999999999 110.167 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.1 mm -118.06 130.54 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.407 1.483 . . . . 0.75 113.348 -167.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -82.77 128.08 34.05 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.525 1.13 . . . . 2.5800000000000001 112.408 172.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.39 125.26 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.666 1.186 . . . . 0.78000000000000003 111.856 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.81 158.57 42.03 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.506 1.522 . . . . 1.1599999999999999 113.205 -175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.82 123.08 9.11 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.268 3.312 . . . . 1.1399999999999999 113.489 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.72 -0.75 88.13 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.879 1.228 . . . . 0.95999999999999996 115.022 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.9 -169.03 30.21 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 118.757 1.278 . . . . 1.05 114.116 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -130.18 158.85 38.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.12 1.768 . . . . 2.4500000000000002 111.462 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -86.68 118.66 70.53 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.621 0.768 . . . . 2.3900000000000001 109.277 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -89.68 -13.84 2.61 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.04 1.827 . . . . 1.01 115.865 -168.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.0 159.82 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 128.992 2.917 . . . . 1.0700000000000001 107.699 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.0 147.51 25.7 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.653 0.983 . . . . 2.0 113.653 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.45 -159.3 32.21 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 114.946 0.738 . . . . 0.87 114.946 -173.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -109.12 145.43 35.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.702 1.601 . . . . 5.1200000000000001 113.541 -169.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 t -106.89 119.88 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 127.396 2.279 . . . . 1.1200000000000001 108.276 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 pt -136.61 34.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 119.224 0.92 . . . . 1.52 113.399 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.15 127.97 2.21 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.024 1.73 . . . . 3.5899999999999999 107.454 167.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.88 178.03 40.76 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 122.874 1.263 . . . . 0.89000000000000001 115.402 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -154.95 110.65 3.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.279 1.032 . . . . 2.3999999999999999 112.737 -166.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.0 p -137.74 175.05 9.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.609 1.964 . . . . 2.8999999999999999 113.936 -168.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 38.6 ttm -114.72 145.13 42.41 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.321 1.048 . . . . 1.04 109.619 165.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.37 142.91 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.067 1.347 . . . . 0.64000000000000001 111.771 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -113.13 113.23 25.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.915 1.686 . . . . 1.8799999999999999 110.747 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -134.39 14.37 3.79 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.084 1.754 . . . . 2.52 114.336 -170.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.6 p -58.49 -13.95 6.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 117.543 2.423 . . . . 1.3400000000000001 117.543 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -93.86 -33.32 13.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.999 1.32 . . . . 1.1000000000000001 111.684 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.0 mm -73.79 -62.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.575 -0.703 . . . . 1.0800000000000001 110.047 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.6 p -94.23 -13.19 26.84 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.007 1.323 . . . . 1.3799999999999999 113.382 -171.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.43 10.31 78.93 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.659 1.6 . . . . 1.49 113.827 -172.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.88 98.87 0.58 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.684 1.742 . . . . 2.71 109.385 170.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.64 28.41 0.26 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.988 1.315 . . . . 1.8899999999999999 112.496 -171.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.2 ptm -155.16 145.0 15.55 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.377 2.271 . . . . 3.27 109.301 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.42 148.92 21.22 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.111 2.541 . . . . 1.3500000000000001 112.095 -172.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.55 136.21 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.829 1.252 . . . . 0.98999999999999999 112.416 -168.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.0 150.15 29.0 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.079 0.952 . . . . 0.78000000000000003 113.125 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -132.26 150.87 52.06 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.131 1.772 . . . . 1.1599999999999999 111.598 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -143.78 173.88 4.06 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 129.146 2.978 . . . . 3.25 108.784 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -58.06 138.77 87.68 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 CA-C-N 121.058 1.414 . . . . 1.1200000000000001 110.862 168.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.22 14.61 74.0 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.205 1.383 . . . . 1.04 115.083 -170.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.8 m -97.74 164.87 12.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.391 1.596 . . . . 1.8100000000000001 110.72 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.8 p -124.03 159.96 28.73 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.107 -0.996 . . . . 1.48 113.334 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.65 161.06 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.616 1.966 . . . . 0.69999999999999996 112.151 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.537 HD13 ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -116.84 154.86 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.847 2.059 . . . . 1.29 112.026 172.226 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.2 150.45 48.29 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.37 0.878 . . . . 0.78000000000000003 113.37 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.64 -5.12 62.01 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.661 1.124 . . . . 0.79000000000000004 115.219 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.0 p -77.68 157.46 30.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.792 1.237 . . . . 1.51 111.663 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mm -108.39 137.2 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.884 0.874 . . . . 0.73999999999999999 111.482 -170.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.66 155.13 21.24 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.877 1.671 . . . . 3.4500000000000002 112.905 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -129.77 124.49 33.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.642 1.577 . . . . 3.02 109.075 166.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 45.94 -132.37 1.03 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.101 2.161 . . . . 3.8500000000000001 110.294 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.98 -60.23 3.85 Favored Glycine 0 CA--C 1.527 0.8 0 O-C-N 120.069 -1.644 . . . . 3.4199999999999999 116.488 166.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.4 m 47.44 77.16 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.398 1.479 . . . . 2.3199999999999998 111.781 -168.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.2 164.2 12.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.402 1.081 . . . . 1.3600000000000001 113.421 -166.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mp -119.54 128.7 54.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.158 0.983 . . . . 2.0 110.527 168.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.5 mm -115.74 122.55 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.835 1.654 . . . . 1.4299999999999999 110.955 -170.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.07 103.34 16.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.756 1.222 . . . . 3.02 110.141 176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.07 131.35 36.23 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.355 1.062 . . . . 0.87 112.001 -174.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.35 6.01 7.0 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.01 1.485 . . . . 2.21 115.01 -175.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -142.05 147.31 36.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.492 1.117 . . . . 1.53 111.842 170.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 p -86.64 163.25 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.442 1.097 . . . . 3.02 110.389 170.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.05 -37.67 94.29 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 120.241 -1.537 . . . . 1.4299999999999999 114.712 -169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.67 -32.06 71.27 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.244 1.018 . . . . 1.6799999999999999 112.822 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.42 -16.74 60.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.78 1.232 . . . . 2.6400000000000001 113.946 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.9 p -68.37 159.87 30.64 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.902 1.228 . . . . 1.72 113.714 -169.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.3 t -66.27 -31.12 71.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.396 -0.82 . . . . 2.3199999999999998 111.539 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.3 mp -57.44 -53.09 62.05 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.839 -1.163 . . . . 1.6200000000000001 111.828 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.6 p -70.5 -24.69 62.88 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.196 0.998 . . . . 1.8100000000000001 111.901 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -72.76 -42.61 63.82 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.478 0.918 . . . . 2.1499999999999999 113.478 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.3 mt -56.68 -49.19 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.031 -1.043 . . . . 1.71 110.259 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 113.379 0.881 . . . . 1.5800000000000001 113.379 178.594 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 115.149 1.537 . . . . 1.71 115.149 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.9 tp -68.17 -31.64 71.33 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.608 -1.308 . . . . 1.9299999999999999 113.731 -169.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.89 -21.01 55.56 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.894 -1.129 . . . . 1.3400000000000001 113.532 169.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -69.39 -41.41 76.49 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.813 -1.179 . . . . 2.6299999999999999 111.366 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.19 -43.56 82.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.241 1.016 . . . . 1.02 112.162 177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.02 -33.64 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.294 -0.879 . . . . 1.6000000000000001 111.998 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.9 m -75.77 -19.62 58.87 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.285 1.034 . . . . 1.1200000000000001 113.177 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mt -68.12 -32.13 72.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.585 1.954 . . . . 2.0699999999999998 113.006 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -57.11 131.76 50.88 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.853 1.206 . . . . 3.4300000000000002 111.952 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.08 144.93 53.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.835 -0.621 . . . . 2.2999999999999998 109.489 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 p -78.52 -20.98 49.55 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.118 1.155 . . . . 3.1499999999999999 114.118 -174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -137.76 158.65 43.91 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.61 1.337 . . . . 3.9700000000000002 114.61 -169.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.86 172.8 12.19 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.595 1.958 . . . . 1.1699999999999999 112.476 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.6 m -131.45 102.41 5.93 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.135 1.774 . . . . 1.2 111.141 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.5 mt -80.38 128.62 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.045 1.338 . . . . 0.76000000000000001 109.387 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.51 132.97 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.804 0.842 . . . . 2.1800000000000002 112.533 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.478 0.943 0 C-N-CA 124.611 1.165 . . . . 2.1499999999999999 113.403 -169.149 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 109.051 -0.722 . . . . 3.6200000000000001 109.051 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 t -124.93 144.33 50.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.138 1.375 . . . . 2.0299999999999998 111.207 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -141.79 127.25 18.86 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.947 1.299 . . . . 2.3399999999999999 110.054 -171.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.4 133.35 53.43 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.723 -1.236 . . . . 3.2799999999999998 111.12 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.69 123.47 43.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.082 0.856 . . . . 2.8999999999999999 110.965 176.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -129.61 165.41 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.243 1.417 . . . . 1.28 112.808 -168.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -80.18 151.1 29.9 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.115 1.366 . . . . 3.6899999999999999 110.165 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.35 -23.09 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 120.968 -1.083 . . . . 1.76 113.117 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -70.05 -18.16 63.27 Favored 'General case' 0 CA--C 1.552 1.053 0 O-C-N 120.813 -1.179 . . . . 3.7799999999999998 113.741 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -110.52 -3.36 16.04 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.093 1.516 . . . . 1.73 115.093 -169.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -94.63 145.33 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.931 1.692 . . . . 1.97 111.067 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -122.79 166.72 14.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.713 2.405 . . . . 3.3999999999999999 114.041 -175.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -73.86 16.18 0.24 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.787 2.143 . . . . 3.4500000000000002 116.787 -169.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.97 11.25 3.64 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.218 1.865 . . . . 1.3300000000000001 113.829 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -79.64 152.74 29.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.332 1.566 . . . . 3.54 112.508 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.24 120.08 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.116 1.366 . . . . 1.8 108.922 173.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.6 mm -118.76 125.25 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.031 0.932 . . . . 0.62 113.198 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.563 ' HE3' HD11 ' A' ' 96' ' ' LEU . 17.7 ttmt -80.03 128.69 33.78 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.378 0.671 . . . . 1.9299999999999999 110.632 167.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 p -103.14 137.07 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.137 0.975 . . . . 0.66000000000000003 111.113 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -88.58 160.66 44.18 Favored Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 113.35 0.87 . . . . 1.1599999999999999 113.35 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.01 136.29 64.52 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.67 2.247 . . . . 1.3100000000000001 110.41 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.64 -3.97 23.49 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.443 1.497 . . . . 0.95999999999999996 116.408 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.97 178.26 53.9 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.203 1.382 . . . . 0.97999999999999998 114.9 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -126.65 148.0 49.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.659 1.584 . . . . 2.3799999999999999 112.616 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -82.73 126.68 72.6 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.394 0.677 . . . . 1.8600000000000001 112.601 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -90.89 -22.6 0.61 Allowed 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.122 3.215 . . . . 1.0 114.713 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 m -147.67 170.3 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 128.524 2.73 . . . . 0.80000000000000004 108.721 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -99.22 156.35 17.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.106 1.15 . . . . 1.6799999999999999 114.106 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.8 -168.1 39.87 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 115.845 1.098 . . . . 0.65000000000000002 115.845 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -112.17 138.72 48.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.43 1.892 . . . . 4.1500000000000004 111.552 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.82 127.84 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 127.016 2.126 . . . . 0.67000000000000004 109.399 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.2 pt -140.61 31.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.494 0.718 . . . . 0.69999999999999996 112.844 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -167.3 133.59 2.2 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.415 1.486 . . . . 2.5699999999999998 109.821 169.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.41 -177.8 48.86 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.075 1.19 . . . . 0.79000000000000004 116.075 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -147.75 113.02 5.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.864 1.266 . . . . 2.3100000000000001 112.402 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.79 167.27 22.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.488 1.115 . . . . 1.28 111.607 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.7 ttm -105.3 145.57 30.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.955 0.902 . . . . 0.95999999999999996 109.945 169.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.57 136.0 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.215 1.006 . . . . 0.69999999999999996 112.054 -170.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -100.89 132.66 46.19 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.067 1.347 . . . . 2.21 111.631 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -133.62 16.46 3.98 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.101 1.519 . . . . 1.8200000000000001 115.101 -169.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' A' ' 73' ' ' ALA . 98.0 p -44.38 -32.45 1.35 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 119.628 3.196 . . . . 1.8 119.628 -166.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -95.09 -41.82 8.92 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.648 1.113 . . . . 1.51 111.202 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.4 mm -69.04 -64.32 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.889 1.276 . . . . 1.05 111.498 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.4 p -93.69 -11.3 31.85 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.202 1.401 . . . . 1.3200000000000001 112.327 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.54 2.16 87.29 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.021 1.296 . . . . 1.23 115.083 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -55.68 -46.46 77.58 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.174 0.987 . . . . 2.3300000000000001 113.542 -170.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' A' ' 67' ' ' SER . . . 55.94 27.25 10.85 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.679 1.592 . . . . 2.0699999999999998 113.369 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.7 ttt -152.79 136.85 10.36 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 131.158 3.783 . . . . 3.6800000000000002 105.312 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.32 153.51 35.71 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.719 2.28 . . . . 1.3500000000000001 112.881 -172.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.8 t -128.39 134.38 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.735 1.614 . . . . 1.01 112.073 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.55 134.12 36.48 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.545 1.138 . . . . 0.90000000000000002 113.488 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -117.7 143.52 46.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.635 1.974 . . . . 0.87 110.655 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -142.93 175.34 2.94 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 127.358 2.263 . . . . 3.5899999999999999 109.465 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -59.18 127.82 25.42 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 CA-C-N 122.182 1.815 . . . . 0.98999999999999999 111.325 170.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.29 33.59 11.63 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.659 1.123 . . . . 1.03 114.749 -169.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -121.09 170.82 9.17 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.166 1.386 . . . . 1.76 111.173 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.8 p -122.74 151.22 41.8 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.493 -1.379 . . . . 0.81000000000000005 113.449 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.72 156.37 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.936 1.694 . . . . 0.68999999999999995 112.272 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -123.97 159.06 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.213 1.805 . . . . 0.96999999999999997 112.355 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.14 149.99 49.43 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.769 -0.582 . . . . 0.65000000000000002 112.479 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.7 -2.42 83.0 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 115.293 0.877 . . . . 1.03 115.293 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.88 153.14 32.92 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 117.783 0.792 . . . . 1.96 112.05 168.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mm -108.89 129.84 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.988 1.315 . . . . 0.72999999999999998 110.493 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -94.77 142.38 27.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.04 1.736 . . . . 1.6599999999999999 111.856 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.65 -101.33 0.11 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.242 1.201 . . . . 5.0999999999999996 114.242 -174.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -98.42 -41.36 7.84 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.324 1.602 . . . . 3.6600000000000001 115.324 -167.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.49 140.37 18.11 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 119.487 1.04 . . . . 1.8500000000000001 114.041 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t -84.93 129.35 34.82 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.735 0.814 . . . . 2.6200000000000001 110.413 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.2 mt -120.69 158.72 26.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.375 1.47 . . . . 0.95999999999999996 110.902 -173.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.563 HD11 ' HE3' ' A' ' 44' ' ' LYS . 7.8 mp -112.97 129.75 56.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.166 0.587 . . . . 1.76 109.88 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.31 128.19 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.596 1.558 . . . . 1.1200000000000001 110.222 -173.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 23.4 p -81.84 111.16 17.8 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.288 -1.004 . . . . 1.51 108.288 168.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.29 142.96 37.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.869 0.868 . . . . 1.0600000000000001 110.848 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -132.21 3.5 3.99 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.876 1.806 . . . . 2.9900000000000002 115.876 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -145.16 150.81 37.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.842 1.257 . . . . 1.98 111.473 170.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.8 m -81.88 171.41 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.206 1.002 . . . . 1.8100000000000001 110.85 168.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.75 -28.89 73.3 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 120.756 -1.215 . . . . 1.73 114.699 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.91 -42.75 60.2 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.792 1.296 . . . . 1.79 113.572 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -78.73 -10.2 59.69 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 116.497 2.036 . . . . 2.9100000000000001 116.497 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.9 t -83.95 156.48 22.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.464 1.505 . . . . 2.5699999999999998 113.417 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.8 m -39.33 -44.28 1.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.99 2.116 . . . . 2.3100000000000001 114.308 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.17 -46.73 85.8 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.756 1.162 . . . . 1.4099999999999999 111.847 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.3 t -70.19 -35.65 74.09 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.851 0.861 . . . . 2.3799999999999999 111.088 173.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -64.25 -35.73 81.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.377 0.671 . . . . 1.9199999999999999 112.288 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.6 mt -64.69 -58.99 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.466 1.506 . . . . 1.4299999999999999 110.728 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 113.539 0.941 . . . . 1.48 113.539 -171.737 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 114.632 1.345 . . . . 1.51 114.632 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 35.3 tp -63.63 -42.62 98.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.903 1.229 . . . . 1.4099999999999999 113.313 -168.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.8 -21.61 57.17 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.597 -1.314 . . . . 2.1899999999999999 113.161 169.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -67.17 -39.56 86.47 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.776 1.171 . . . . 2.5800000000000001 111.446 -170.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -49.47 -46.15 47.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.315 0.646 . . . . 1.4299999999999999 110.998 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.2 mm -71.52 -27.99 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.652 1.181 . . . . 2.3599999999999999 113.294 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.9 m -70.91 -37.09 72.92 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.307 1.043 . . . . 1.24 112.83 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.05 -17.34 51.88 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.092 1.145 . . . . 2.3900000000000001 114.092 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.65 135.52 55.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.691 1.596 . . . . 2.1899999999999999 113.185 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.13 150.36 48.29 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.399 0.679 . . . . 1.97 112.104 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -100.56 -28.55 12.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.765 1.226 . . . . 1.8700000000000001 112.193 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -140.64 152.93 45.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.054 1.342 . . . . 3.2999999999999998 112.096 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.08 157.84 44.16 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.638 1.575 . . . . 1.2 113.272 -169.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 m -94.5 109.67 21.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.784 0.834 . . . . 1.48 112.849 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.7 mt -84.48 125.09 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.067 0.947 . . . . 0.81000000000000005 109.55 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.72 130.17 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.986 0.914 . . . . 1.8300000000000001 110.691 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.474 0.756 0 C-N-CA 124.594 1.158 . . . . 1.98 111.09 -177.759 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 109.108 -0.701 . . . . 3.5 109.108 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -140.59 138.44 34.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.81 0.844 . . . . 1.6499999999999999 111.588 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -137.39 132.0 32.86 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.195 0.998 . . . . 3.0299999999999998 110.915 -173.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.2 140.36 48.62 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.243 1.417 . . . . 3.46 109.925 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -100.45 117.77 35.29 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.308 0.958 . . . . 2.0499999999999998 109.22 168.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.99 156.96 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.857 1.263 . . . . 1.4299999999999999 111.946 -168.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -76.84 151.62 35.8 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.46 -0.775 . . . . 3.7799999999999998 111.273 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.0 -19.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 115.037 1.495 . . . . 1.1499999999999999 115.037 -172.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.95 -19.28 52.13 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 120.333 -1.479 . . . . 3.9700000000000002 113.668 173.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.8 mt -91.36 -6.85 52.32 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.107 1.763 . . . . 1.72 113.43 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.26 143.03 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.218 1.807 . . . . 1.49 110.255 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.32 172.73 10.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.17 0.988 . . . . 4.3899999999999997 112.316 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -65.66 21.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 117.487 2.403 . . . . 3.7400000000000002 117.487 -172.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.7 42.95 0.81 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.219 1.866 . . . . 1.3999999999999999 111.714 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -122.66 159.32 28.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.894 1.678 . . . . 2.1899999999999999 110.584 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 53.7 mt -116.22 125.79 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.18 0.992 . . . . 1.2 109.834 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.5 mm -116.92 127.19 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.936 1.295 . . . . 0.69999999999999996 112.195 -168.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -79.37 121.66 25.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.693 0.797 . . . . 3.2000000000000002 109.209 168.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.8 124.44 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.247 1.019 . . . . 1.1399999999999999 109.29 170.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.8 m -85.99 156.68 57.74 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 123.323 0.649 . . . . 1.3 112.654 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.05 130.71 35.66 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.746 2.297 . . . . 1.3500000000000001 111.848 171.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.1 -7.44 29.34 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 124.812 1.196 . . . . 1.03 115.07 -171.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.51 -177.83 50.62 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.341 1.448 . . . . 1.0900000000000001 114.234 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -125.65 158.18 35.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.22 1.408 . . . . 1.8100000000000001 112.29 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -88.78 129.08 49.97 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.901 0.881 . . . . 2.2200000000000002 111.859 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.99 -25.59 1.41 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.747 2.965 . . . . 0.88 115.207 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -147.85 167.33 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.833 2.453 . . . . 0.98999999999999999 108.749 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.21 149.11 24.83 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.023 0.828 . . . . 1.95 111.429 174.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -165.15 35.72 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 114.552 0.581 . . . . 0.95999999999999996 114.552 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -111.5 144.49 40.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.473 1.509 . . . . 3.5600000000000001 112.314 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.13 134.03 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.863 2.465 . . . . 1.04 108.225 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 pt -138.35 30.31 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 122.253 1.025 . . . . 1.1399999999999999 112.42 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -168.54 144.44 3.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.582 1.953 . . . . 3.3799999999999999 109.552 167.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 177.18 38.94 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 117.268 1.667 . . . . 1.0600000000000001 117.268 167.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -143.78 37.6 1.32 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 115.619 1.711 . . . . 2.21 115.619 -168.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.645 ' H ' HD21 ' A' ' 95' ' ' LEU . 34.7 m -77.3 157.61 30.63 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.718 -1.239 . . . . 1.72 112.247 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.3 ttm -92.89 140.13 29.82 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.841 -0.618 . . . . 1.1599999999999999 110.083 168.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.5 t -126.24 143.48 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.355 1.462 . . . . 0.72999999999999998 111.905 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -106.22 111.09 23.55 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.014 1.725 . . . . 2.1400000000000001 111.429 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.3 16.24 5.01 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.792 1.637 . . . . 1.8999999999999999 114.662 -172.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.5 p -65.6 -26.92 68.06 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.659 1.726 . . . . 1.46 115.659 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -79.43 -48.21 14.35 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.36 0.982 . . . . 1.51 110.686 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.5 mm -65.73 -55.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.657 0.783 . . . . 1.6299999999999999 110.499 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.7 p -93.57 -11.63 31.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.407 1.083 . . . . 1.6799999999999999 113.708 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.07 13.48 82.95 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 119.312 -0.716 . . . . 1.4299999999999999 113.785 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.58 175.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.14 2.176 . . . . 2.9100000000000001 113.581 171.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.77 6.45 1.61 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.224 1.565 . . . . 2.2400000000000002 115.224 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -149.55 148.83 27.08 Favored Pre-proline 0 C--O 1.24 0.604 0 O-C-N 120.825 -1.172 . . . . 4.0899999999999999 109.272 168.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.08 157.85 60.13 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.565 2.176 . . . . 1.27 111.395 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.8 t -117.25 127.81 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.832 1.253 . . . . 0.93999999999999995 112.353 -167.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.21 130.17 35.2 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.274 0.629 . . . . 1.01 111.213 173.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.12 162.92 12.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.684 1.194 . . . . 0.81000000000000005 111.649 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -150.6 165.17 18.0 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 127.571 2.349 . . . . 3.7000000000000002 110.342 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.1 129.79 31.66 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 CA-C-N 121.075 1.42 . . . . 1.0800000000000001 108.697 165.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.37 44.67 6.85 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.344 0.973 . . . . 1.01 113.576 -169.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 t -131.39 151.2 51.75 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.346 1.458 . . . . 1.74 111.698 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.0 p -101.4 147.58 26.17 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.788 1.631 . . . . 1.45 113.151 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 m -139.48 151.71 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.197 1.399 . . . . 0.76000000000000001 112.64 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -112.88 147.08 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.94 1.296 . . . . 1.21 112.736 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.66 144.31 14.24 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.864 -1.062 . . . . 0.73999999999999999 111.719 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.57 -7.58 57.49 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 116.203 1.241 . . . . 0.84999999999999998 116.203 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.6 p -68.98 160.73 30.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.398 1.599 . . . . 1.48 110.962 168.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.55 146.18 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.115 0.966 . . . . 0.87 110.624 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -108.45 153.04 23.89 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.832 1.253 . . . . 1.6000000000000001 113.465 -174.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -115.28 -167.7 1.28 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.662 1.985 . . . . 3.6099999999999999 109.805 170.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -77.66 140.5 39.6 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 119.649 -1.907 . . . . 4.79 111.574 -174.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.05 11.31 0.42 Allowed Glycine 0 CA--C 1.542 1.741 0 C-N-CA 124.978 1.275 . . . . 3.5099999999999998 114.012 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m 23.8 85.67 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 129.58 3.152 . . . . 1.6399999999999999 115.846 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.645 HD21 ' H ' ' A' ' 62' ' ' SER . 57.7 mt -87.33 150.69 23.68 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.402 0.681 . . . . 1.3799999999999999 112.761 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.73 128.93 51.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.679 0.792 . . . . 1.95 110.244 167.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.0 mm -111.86 126.47 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.837 1.655 . . . . 1.75 110.449 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.2 p -79.41 104.5 10.06 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.899 0.857 . . . . 1.6899999999999999 109.718 169.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.94 113.69 14.91 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.178 -0.951 . . . . 1.1200000000000001 109.393 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.5 p -120.21 16.2 12.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.708 1.203 . . . . 2.4399999999999999 113.026 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -148.86 146.32 27.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.075 1.75 . . . . 1.78 110.417 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 m -100.56 164.16 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.701 0.8 . . . . 1.55 109.625 165.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -51.45 -45.09 53.63 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 114.523 0.569 . . . . 1.49 114.523 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.2 -23.57 67.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.325 1.232 . . . . 1.77 114.325 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -78.7 -25.96 44.81 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.986 1.476 . . . . 2.5800000000000001 114.986 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 p -52.36 143.21 15.51 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.838 1.792 . . . . 1.72 115.838 -164.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.6 t -60.04 -32.22 70.71 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.067 0.947 . . . . 2.0299999999999998 111.499 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.3 tp -52.97 -44.62 67.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.424 1.49 . . . . 1.6299999999999999 112.195 168.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.0 p -71.87 -24.5 61.69 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.154 0.798 . . . . 2.9399999999999999 113.154 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -71.25 -39.56 71.54 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.826 -1.171 . . . . 2.7200000000000002 112.014 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 96.3 mt -53.49 -55.14 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.506 0.722 . . . . 1.71 109.968 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 114.251 1.204 . . . . 1.53 114.251 178.994 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 113.797 1.036 . . . . 1.8 113.797 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 47.3 tp -67.84 -35.05 77.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.797 1.18 . . . . 1.4099999999999999 112.507 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.63 -36.37 62.9 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.374 0.534 . . . . 1.74 111.481 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -56.54 -36.9 69.77 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.801 1.24 . . . . 2.8500000000000001 114.255 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -48.62 -49.51 36.73 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.753 1.16 . . . . 1.6599999999999999 111.489 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.97 -29.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.625 1.17 . . . . 2.3500000000000001 112.039 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -73.01 -26.35 61.29 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.475 -0.766 . . . . 1.28 112.907 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.36 -33.01 72.44 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.239 0.927 . . . . 1.9399999999999999 112.362 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -62.02 147.1 48.24 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.167 0.894 . . . . 3.6499999999999999 111.655 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.9 -21.01 64.37 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.235 2.309 . . . . 3.79 117.235 -167.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 m 66.73 -28.17 0.13 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.233 1.813 . . . . 2.6499999999999999 114.545 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -137.82 156.62 47.74 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.127 2.171 . . . . 2.7999999999999998 112.981 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.12 165.73 26.63 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.495 1.518 . . . . 0.88 113.7 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.2 m -116.29 108.13 15.71 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.966 1.706 . . . . 0.82999999999999996 111.274 170.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.8 mt -85.94 141.08 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.674 1.189 . . . . 0.72999999999999998 109.727 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 m -114.63 133.39 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.195 0.998 . . . . 1.75 113.285 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.476 0.852 0 C-N-CA 125.985 1.714 . . . . 1.8600000000000001 110.093 -174.799 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.338 0.59 . . . . 2.3700000000000001 110.6 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -78.87 125.82 29.88 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.656 1.182 . . . . 1.75 110.407 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -103.0 160.79 14.31 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.951 -1.093 . . . . 3.3199999999999998 113.055 -174.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.94 125.28 35.1 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.05 1.34 . . . . 4.5300000000000002 109.486 168.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -91.82 121.75 33.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.859 -1.164 . . . . 1.6699999999999999 107.859 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 m -136.32 157.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.077 0.951 . . . . 1.1200000000000001 113.538 -167.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.8 145.6 32.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.775 0.83 . . . . 2.9700000000000002 110.29 167.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.63 -29.65 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 113.287 0.847 . . . . 1.27 113.287 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -74.35 -3.77 32.35 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.895 1.278 . . . . 3.9500000000000002 113.551 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.8 -13.52 12.61 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.535 1.934 . . . . 1.9299999999999999 114.617 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.51 147.85 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 119.556 1.071 . . . . 1.77 111.246 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.76 163.76 20.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.016 1.726 . . . . 3.6600000000000001 114.298 -176.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -71.52 18.82 0.07 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 117.621 2.452 . . . . 3.5099999999999998 117.621 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.17 4.33 6.35 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.019 1.295 . . . . 1.22 115.548 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -111.29 169.67 8.63 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.633 1.173 . . . . 2.27 112.565 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.8 mt -123.75 130.75 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.666 1.586 . . . . 1.1699999999999999 110.427 -170.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -117.99 136.04 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.438 1.495 . . . . 0.69999999999999996 113.871 -166.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -87.09 143.14 27.44 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.567 0.951 . . . . 2.6099999999999999 113.567 169.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.9 p -132.25 134.74 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.439 1.095 . . . . 0.81999999999999995 111.479 169.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.14 170.41 5.36 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 125.339 1.456 . . . . 1.3400000000000001 112.847 -170.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.33 132.07 50.02 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.785 2.323 . . . . 1.3 112.547 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.11 -8.27 39.35 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.939 1.733 . . . . 0.91000000000000003 114.992 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.78 166.56 54.57 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 118.933 1.366 . . . . 0.97999999999999998 113.813 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -119.61 153.34 35.64 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.037 1.335 . . . . 2.77 112.255 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -79.29 134.97 58.09 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.374 0.669 . . . . 1.8100000000000001 112.45 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.14 -32.58 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.983 2.456 . . . . 0.90000000000000002 115.313 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 m -145.85 171.32 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 126.984 2.114 . . . . 0.90000000000000002 109.183 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.96 144.5 25.4 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.089 0.859 . . . . 2.3900000000000001 112.399 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.62 -164.82 35.89 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.013 1.165 . . . . 0.78000000000000003 116.013 -175.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -107.94 145.64 33.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.738 2.015 . . . . 5.1900000000000004 112.693 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.66 133.76 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 127.581 2.352 . . . . 0.96999999999999997 110.443 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.73 37.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.936 1.087 . . . . 1.21 113.936 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -165.29 136.53 3.98 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.839 -1.163 . . . . 2.3700000000000001 110.159 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.41 -174.31 50.39 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.844 1.212 . . . . 0.76000000000000001 115.992 168.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -149.67 112.0 4.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.27 1.028 . . . . 1.99 112.222 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.55 154.95 45.78 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.238 1.015 . . . . 1.25 112.814 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.4 ttm -104.32 128.87 52.19 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.689 1.195 . . . . 0.83999999999999997 108.969 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 86.1 t -115.99 136.6 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.68 1.592 . . . . 0.62 113.147 -166.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -91.04 100.68 13.49 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.348 -0.845 . . . . 1.98 111.607 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -93.65 4.74 53.48 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.318 1.447 . . . . 2.0499999999999998 113.963 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -38.97 -45.59 1.22 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.923 2.489 . . . . 1.8999999999999999 116.842 -169.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.74 -32.01 28.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.024 0.829 . . . . 1.0900000000000001 111.924 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.15 -58.13 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.796 1.639 . . . . 1.0700000000000001 111.642 -171.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.9 p -102.7 -5.5 23.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.757 1.223 . . . . 1.22 113.036 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.98 18.82 79.75 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.445 1.498 . . . . 1.1499999999999999 113.955 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -67.15 -53.29 31.96 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.782 0.833 . . . . 2.4199999999999999 112.035 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 64.18 29.26 14.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.433 1.893 . . . . 1.8500000000000001 112.882 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.2 ptp -157.77 128.77 3.68 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 130.21 3.404 . . . . 4.0999999999999996 106.489 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.98 156.95 51.87 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.032 1.821 . . . . 1.3200000000000001 114.104 -167.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.9 t -120.02 129.55 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 126.96 2.104 . . . . 0.69999999999999996 111.299 -168.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.7 134.63 36.41 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.34 -0.85 . . . . 0.66000000000000003 112.809 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -120.34 151.3 39.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.302 1.841 . . . . 0.73999999999999999 110.841 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -149.24 174.66 3.27 Favored Pre-proline 0 N--CA 1.483 1.175 0 C-N-CA 127.866 2.466 . . . . 2.3999999999999999 111.491 -168.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.24 129.67 24.84 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 CA-C-N 122.045 1.766 . . . . 0.83999999999999997 110.592 167.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.24 46.77 9.78 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.59 1.09 . . . . 1.1000000000000001 111.918 -168.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.8 t -126.34 160.27 30.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.615 1.566 . . . . 1.3300000000000001 111.365 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.0 p -121.0 146.09 47.06 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.887 -1.133 . . . . 0.93000000000000005 111.817 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.05 155.0 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.064 1.345 . . . . 0.67000000000000004 112.952 -171.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.434 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -114.76 147.81 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.575 1.95 . . . . 1.03 112.503 169.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.66 151.46 33.54 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.902 1.281 . . . . 0.70999999999999996 113.136 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.03 -6.6 59.0 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.928 1.251 . . . . 0.75 115.715 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.5 p -76.53 159.84 30.0 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.763 1.282 . . . . 1.3700000000000001 111.758 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -110.24 125.77 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.138 0.975 . . . . 0.70999999999999996 112.112 -169.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -95.5 127.53 41.61 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.251 1.82 . . . . 1.6799999999999999 112.099 -175.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -150.69 76.9 1.27 Allowed 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.087 1.884 . . . . 3.4399999999999999 116.087 -171.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -171.59 -60.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.393 1.877 . . . . 3.3500000000000001 110.592 167.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.17 175.07 24.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.076 2.274 . . . . 1.8999999999999999 112.285 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.0 m -87.15 141.37 28.7 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.672 1.189 . . . . 1.8200000000000001 112.296 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.4 mt -127.73 165.51 19.93 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.224 1.81 . . . . 0.90000000000000002 112.339 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.1 tp -124.02 113.52 18.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.048 1.739 . . . . 2.8100000000000001 111.573 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.87 130.04 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.113 0.965 . . . . 1.6699999999999999 112.588 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 82.8 m -86.67 106.4 17.59 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.813 0.845 . . . . 2.52 109.939 169.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.25 116.41 19.5 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.451 -0.78 . . . . 0.93999999999999995 111.108 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -115.86 10.42 15.28 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.339 1.056 . . . . 3.2999999999999998 113.384 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -141.09 138.51 33.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.694 1.598 . . . . 1.6899999999999999 110.795 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 m -84.59 162.27 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 108.903 -0.777 . . . . 1.6299999999999999 108.903 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.31 -43.33 75.59 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.009 -1.057 . . . . 1.73 114.257 -169.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.41 -31.41 72.1 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.888 1.07 . . . . 1.79 113.888 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.18 -17.02 58.86 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.025 1.73 . . . . 2.7999999999999998 114.19 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.0 p -68.86 151.8 46.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.022 0.929 . . . . 1.8100000000000001 113.245 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.6 t -55.44 -37.45 67.72 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.281 0.632 . . . . 2.0699999999999998 112.051 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.7 tp -61.57 -49.46 76.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.416 1.086 . . . . 1.73 112.256 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 t -71.89 -25.99 62.15 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.444 0.697 . . . . 1.6299999999999999 112.2 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.83 -41.15 75.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.73 1.212 . . . . 1.6299999999999999 112.778 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.69 -50.09 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.804 0.842 . . . . 1.6599999999999999 110.651 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 114.005 1.113 . . . . 1.48 114.005 178.807 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 113.175 0.806 . . . . 1.51 113.175 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.15 -28.3 69.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.3 0.64 . . . . 1.6299999999999999 112.331 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.34 -47.51 33.92 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.693 -0.629 . . . . 1.4199999999999999 110.852 167.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -48.91 -41.48 33.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.301 1.44 . . . . 3.46 114.779 -169.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.42 -45.33 69.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.944 0.793 . . . . 1.5700000000000001 111.992 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.7 mm -72.91 -29.24 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.551 1.14 . . . . 2.0099999999999998 112.521 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -74.29 -24.21 59.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.408 0.892 . . . . 1.47 113.408 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.31 -19.73 65.62 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.77 1.026 . . . . 2.0699999999999998 113.77 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.33 157.79 36.32 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 115.178 1.547 . . . . 2.3300000000000001 115.178 -169.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.11 154.4 17.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.893 1.677 . . . . 1.8100000000000001 112.721 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -88.55 -23.29 23.2 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.552 1.141 . . . . 2.2999999999999998 112.736 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.75 168.26 20.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.779 1.232 . . . . 3.52 114.075 -169.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.65 161.3 38.08 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.408 1.483 . . . . 0.72999999999999998 112.472 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.0 m -121.55 95.95 4.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.748 1.619 . . . . 0.81999999999999995 110.873 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.32 146.22 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.219 1.408 . . . . 0.82999999999999996 110.002 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.19 120.59 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.518 1.054 . . . . 1.72 111.967 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.478 0.964 0 C-N-CA 125.17 1.388 . . . . 1.9399999999999999 111.277 178.141 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 CA--C 1.543 0.708 0 CA-C-O 120.832 0.349 . . . . 2.8500000000000001 111.926 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.7 t -132.3 110.65 10.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.149 1.78 . . . . 1.6100000000000001 110.072 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -108.51 136.64 47.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.176 1.176 . . . . 2.8900000000000001 114.176 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -108.11 132.55 53.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.671 1.588 . . . . 2.6699999999999999 110.106 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -104.51 122.79 46.29 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.524 -0.917 . . . . 2.0299999999999998 108.524 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.3 m -139.68 156.66 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.974 0.91 . . . . 0.93000000000000005 113.007 -169.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -74.06 146.48 43.63 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.618 -0.512 . . . . 4.0300000000000002 109.618 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.41 -27.92 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.681 1.363 . . . . 1.28 114.681 -168.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -73.3 -7.67 52.54 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 120.495 -1.378 . . . . 3.3500000000000001 113.431 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.0 -1.04 32.68 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.258 1.823 . . . . 1.6899999999999999 114.882 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -109.76 148.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.918 1.287 . . . . 1.9199999999999999 110.736 172.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -123.65 175.9 6.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.908 2.083 . . . . 3.4100000000000001 110.811 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -68.92 156.65 38.16 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.36 -0.838 . . . . 2.8399999999999999 111.093 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.36 22.78 21.17 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 119.132 0.878 . . . . 1.2 113.858 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.15 167.28 20.95 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.539 1.535 . . . . 2.1000000000000001 112.305 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.03 129.69 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.159 1.383 . . . . 1.2 110.646 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 mm -120.52 129.13 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.241 1.816 . . . . 0.67000000000000004 110.499 -169.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -78.68 133.69 37.18 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.101 -1.0 . . . . 2.1200000000000001 111.171 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.96 128.09 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.008 1.323 . . . . 0.80000000000000004 110.539 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.85 171.08 5.8 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.622 1.169 . . . . 1.1000000000000001 112.48 -169.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.32 127.81 25.24 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.483 2.122 . . . . 1.04 112.537 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.22 -1.96 73.12 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.79 1.185 . . . . 1.0 116.006 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.22 -176.82 50.3 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 118.897 1.348 . . . . 0.93999999999999995 114.064 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -124.57 159.79 29.87 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.074 1.749 . . . . 2.5699999999999998 112.152 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -84.03 118.8 72.25 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.125 0.97 . . . . 2.3100000000000001 109.554 170.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -83.49 -17.66 6.22 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.258 1.972 . . . . 0.80000000000000004 115.482 -169.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -153.04 160.93 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 127.915 2.486 . . . . 1.2 108.312 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.03 140.88 33.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.154 0.888 . . . . 1.9199999999999999 112.768 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.16 -148.75 9.39 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.642 -0.661 . . . . 0.81000000000000005 114.603 -171.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -131.85 145.57 51.62 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.896 1.278 . . . . 4.0199999999999996 113.939 -170.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.5 t -96.46 125.48 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.949 2.5 . . . . 0.75 108.916 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.49 32.73 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 113.641 0.978 . . . . 0.78000000000000003 113.641 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -168.11 136.21 2.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.364 1.866 . . . . 3.5600000000000001 108.26 166.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.29 179.4 52.62 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 122.448 1.027 . . . . 0.91000000000000003 114.726 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -154.67 123.44 6.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.972 0.909 . . . . 2.04 112.743 -170.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.9 p -137.5 -179.04 5.5 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.345 1.858 . . . . 3.1800000000000002 113.588 -168.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.9 ttm -128.4 135.14 49.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.971 1.708 . . . . 0.81000000000000005 108.888 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.76 139.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.215 1.406 . . . . 0.67000000000000004 112.076 -168.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -102.24 110.57 22.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.386 1.475 . . . . 1.9099999999999999 111.401 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.75 22.05 11.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.21 1.804 . . . . 2.4900000000000002 113.145 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.5 p -53.1 -28.18 24.17 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.7 1.741 . . . . 1.6000000000000001 115.7 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.83 -34.91 16.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.369 0.986 . . . . 1.2 111.667 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.3 mm -70.46 -47.8 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.617 0.767 . . . . 1.25 110.687 -177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.2 p -119.92 -4.33 10.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.77 1.228 . . . . 1.74 114.172 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.37 3.07 89.86 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.606 1.098 . . . . 1.8500000000000001 115.331 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -56.32 -52.92 62.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.298 1.221 . . . . 2.7200000000000002 114.298 -169.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.19 33.63 23.35 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 122.201 1.0 . . . . 1.8999999999999999 111.868 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -154.78 113.21 2.37 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 128.745 2.818 . . . . 3.8199999999999998 106.068 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -62.33 153.03 73.2 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.994 2.462 . . . . 1.48 114.251 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.4 t -115.96 137.27 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.99 1.316 . . . . 0.71999999999999997 110.949 -171.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.95 142.05 28.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.636 0.774 . . . . 0.64000000000000001 112.483 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -123.43 152.19 41.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.289 1.436 . . . . 0.68000000000000005 111.717 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -146.23 170.16 8.38 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 129.148 2.979 . . . . 3.5 107.864 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.33 132.79 54.33 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 CA-C-N 121.82 1.686 . . . . 0.78000000000000003 111.63 168.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.11 25.77 28.07 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.239 1.399 . . . . 0.76000000000000001 114.815 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.2 t -117.56 158.61 24.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.231 1.412 . . . . 1.3700000000000001 111.826 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.6 p -116.6 146.95 42.32 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.005 1.275 . . . . 0.83999999999999997 113.22 -172.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.6 156.04 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.703 1.601 . . . . 0.73999999999999999 113.08 -172.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -115.24 147.35 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.702 2.001 . . . . 1.03 112.558 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.14 148.29 44.9 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.886 1.274 . . . . 0.83999999999999997 112.897 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.86 -4.96 51.06 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.617 1.103 . . . . 0.73999999999999999 115.42 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.3 p -74.61 154.49 38.52 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.477 1.638 . . . . 1.29 111.363 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.94 124.9 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.095 0.558 . . . . 0.73999999999999999 111.618 -169.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -86.73 139.64 30.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.469 1.107 . . . . 1.54 111.763 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -88.49 -70.49 0.64 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.255 -0.903 . . . . 3.46 112.206 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -131.9 -160.66 1.06 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.746 1.618 . . . . 4.4699999999999998 109.208 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.86 -26.52 11.48 Favored Glycine 0 CA--C 1.529 0.908 0 O-C-N 119.684 -1.885 . . . . 3.4100000000000001 116.128 169.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.0 m 44.74 67.89 0.63 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.686 1.594 . . . . 1.97 112.163 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mt -97.8 159.47 14.91 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.706 1.203 . . . . 0.98999999999999999 113.115 -166.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.93 128.96 54.91 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.567 0.698 . . . . 2.0 110.487 168.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.56 122.5 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.45 1.9 . . . . 1.52 109.952 -169.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 21.0 p -82.46 119.29 24.01 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.936 0.789 . . . . 1.6499999999999999 110.316 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -97.45 113.96 25.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.457 1.103 . . . . 0.91000000000000003 111.195 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.1 p -108.37 4.8 24.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.24 1.816 . . . . 1.8700000000000001 112.77 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -137.69 136.52 37.48 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.922 1.289 . . . . 1.6200000000000001 109.702 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -91.54 176.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.331 1.053 . . . . 2.5299999999999998 109.602 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.18 -31.95 66.55 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 120.835 1.652 . . . . 1.6499999999999999 113.952 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -45.1 65.08 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.633 1.216 . . . . 2.1400000000000001 113.353 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.32 -14.41 59.43 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.961 1.837 . . . . 2.7799999999999998 115.961 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.5 t -77.76 143.33 38.07 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.057 -1.027 . . . . 3.0600000000000001 112.829 -170.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.0 t -63.0 -31.77 72.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.917 0.71 . . . . 1.8999999999999999 112.917 -172.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.67 -51.33 65.82 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.315 1.046 . . . . 1.4399999999999999 112.491 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 p -72.92 -31.82 64.88 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.542 0.571 . . . . 2.1299999999999999 112.542 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.4 -42.13 98.78 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.428 0.558 . . . . 1.6499999999999999 111.71 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.99 -56.15 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.31 1.044 . . . . 1.72 110.153 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 114.181 1.178 . . . . 1.3600000000000001 114.181 -177.508 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 119.294 -0.384 . . . . 2.23 111.838 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tp -52.56 -33.79 47.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.92 0.888 . . . . 1.6699999999999999 112.819 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.88 -50.07 14.21 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.704 0.802 . . . . 1.23 112.919 168.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -58.73 -32.83 69.57 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.726 1.211 . . . . 3.0099999999999998 114.032 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.83 -30.24 65.58 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.947 0.721 . . . . 1.3799999999999999 112.947 173.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.4 mm -72.76 -42.22 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.844 0.858 . . . . 2.02 111.718 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.6 m -68.38 -21.56 64.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.438 1.095 . . . . 1.1100000000000001 113.224 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.01 -14.02 61.34 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.961 2.104 . . . . 1.8600000000000001 114.671 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -87.04 149.76 24.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.425 1.011 . . . . 2.3300000000000001 113.184 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.13 173.79 11.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.73 1.612 . . . . 2.6299999999999999 114.61 -169.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.3 m -99.91 -43.88 6.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.809 1.644 . . . . 3.1000000000000001 110.706 168.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -139.18 165.42 27.22 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.601 1.56 . . . . 3.6600000000000001 113.04 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.72 173.38 11.55 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.053 1.741 . . . . 1.03 112.3 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.2 m -131.32 111.3 11.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.899 1.279 . . . . 0.94999999999999996 111.334 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.7 mt -98.84 145.42 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.478 1.911 . . . . 0.97999999999999998 109.884 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.5 133.61 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.373 -0.829 . . . . 2.02 112.608 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.475 0.801 0 C-N-CA 125.374 1.47 . . . . 1.77 112.245 -172.178 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 CA--C 1.546 0.822 0 CA-C-O 122.572 1.177 . . . . 4.96 112.88 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.6 t -139.16 154.4 48.08 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.598 1.559 . . . . 1.51 111.562 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.81 138.76 45.86 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.127 1.371 . . . . 2.8300000000000001 111.71 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -119.74 129.31 54.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.063 1.745 . . . . 3.3500000000000001 110.051 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.8 133.86 39.43 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.45 -1.406 . . . . 2.1299999999999999 110.608 168.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -135.08 158.15 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.332 1.053 . . . . 0.87 112.835 -171.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.94 149.04 36.03 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.478 1.111 . . . . 4.1799999999999997 109.414 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.49 -29.49 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.291 1.589 . . . . 1.5700000000000001 115.291 -168.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -76.46 -7.15 54.5 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.369 -1.457 . . . . 3.4700000000000002 113.599 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.9 mt -100.74 -6.32 25.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.096 1.758 . . . . 1.29 113.357 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 p -95.63 129.9 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.687 1.195 . . . . 2.3300000000000001 109.013 169.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -141.32 -175.21 4.26 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.229 1.011 . . . . 5.5099999999999998 112.016 -169.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -65.9 15.53 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.475 2.769 . . . . 3.2000000000000002 118.475 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.07 9.87 3.59 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.282 1.42 . . . . 1.1699999999999999 115.344 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -94.32 148.55 22.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.063 1.431 . . . . 3.1000000000000001 113.818 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.1 mm -105.26 124.67 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.24 1.016 . . . . 1.6200000000000001 110.03 171.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.5 mm -99.82 162.93 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.927 2.091 . . . . 1.4099999999999999 111.276 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HE2' HD11 ' A' ' 96' ' ' LEU . 37.5 ttmt -132.39 129.6 39.57 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.188 1.395 . . . . 2.0099999999999998 110.328 170.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.25 144.04 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.354 1.062 . . . . 1.0600000000000001 112.554 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -99.02 163.9 17.85 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.246 1.418 . . . . 1.97 113.104 -174.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.34 106.58 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.826 2.351 . . . . 2.2799999999999998 109.385 166.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.45 68.26 1.16 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.255 1.407 . . . . 2.9100000000000001 110.311 -168.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.86 164.08 33.51 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 127.407 2.432 . . . . 1.0600000000000001 109.497 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -125.34 153.09 43.86 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.521 1.16 . . . . 1.6000000000000001 112.798 -172.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -87.46 136.71 32.92 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 123.968 0.907 . . . . 1.6799999999999999 112.29 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -98.48 -18.03 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.934 3.09 . . . . 0.71999999999999997 115.587 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.86 166.88 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 127.936 2.494 . . . . 1.0800000000000001 108.422 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.18 142.35 27.72 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.185 0.902 . . . . 2.04 113.405 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -160.33 27.67 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.581 0.61 . . . . 0.67000000000000004 114.06 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.3 ttp-105 -116.19 136.25 53.18 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.567 1.147 . . . . 3.8199999999999998 112.888 -171.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -82.74 130.36 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 126.531 1.932 . . . . 0.80000000000000004 108.26 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.69 34.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.395 0.678 . . . . 0.84999999999999998 112.328 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -166.71 132.67 2.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.088 1.355 . . . . 2.8199999999999998 109.709 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.95 -170.77 50.08 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 116.363 1.305 . . . . 0.81999999999999995 116.363 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 123.43 13.21 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.804 1.642 . . . . 2.0800000000000001 112.306 -173.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.57 176.68 9.64 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.169 0.988 . . . . 1.1100000000000001 112.428 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 34.0 ttm -120.98 133.72 55.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.624 1.57 . . . . 1.0900000000000001 110.126 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.06 143.45 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.792 1.237 . . . . 0.69999999999999996 111.514 -169.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -106.95 86.11 2.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.064 1.346 . . . . 2.0099999999999998 111.099 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -87.74 34.01 0.71 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.955 1.702 . . . . 1.8899999999999999 113.578 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -58.92 -34.34 71.61 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 117.182 2.29 . . . . 2.0499999999999998 117.182 -168.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.75 -48.59 4.66 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.805 1.184 . . . . 1.1200000000000001 111.468 -174.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.7 mm -67.63 -48.89 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.739 0.816 . . . . 1.1399999999999999 111.634 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.1 m -101.15 -32.84 10.36 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.946 1.298 . . . . 2.71 110.715 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.74 5.41 61.35 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.67 1.129 . . . . 1.22 115.541 171.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.14 -51.02 71.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.027 1.331 . . . . 2.6499999999999999 111.603 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.21 35.8 15.26 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.9 1.68 . . . . 2.3100000000000001 112.793 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -154.19 154.53 29.89 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 129.923 3.289 . . . . 4.9000000000000004 109.08 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -64.19 136.63 52.66 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.5 2.8 . . . . 1.71 113.604 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.6 t -130.56 129.81 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 125.471 1.509 . . . . 1.3600000000000001 111.999 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.73 146.44 32.37 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.06 1.134 . . . . 0.78000000000000003 114.06 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.7 152.36 45.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.886 2.074 . . . . 0.81999999999999995 111.164 175.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -141.82 -176.38 0.56 Allowed Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 128.688 2.795 . . . . 3.1899999999999999 107.782 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.84 148.89 90.8 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 CA-C-N 122.141 1.8 . . . . 1.27 114.094 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.17 25.45 74.54 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.959 1.266 . . . . 1.3400000000000001 114.455 -172.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -115.01 147.69 39.78 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.753 1.277 . . . . 1.5700000000000001 111.034 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.1 p -99.08 147.67 24.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.183 1.356 . . . . 1.0 113.286 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.0 168.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.4 1.88 . . . . 0.60999999999999999 111.152 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.7 156.32 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.448 1.499 . . . . 1.55 111.651 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.67 157.51 32.42 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.136 1.162 . . . . 1.02 114.136 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.87 -7.2 15.8 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.159 0.885 . . . . 0.98999999999999999 115.113 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 m -90.92 156.98 17.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.716 1.206 . . . . 2.73 110.417 172.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mm -102.42 141.47 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.938 0.895 . . . . 1.0700000000000001 111.39 -169.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -101.59 135.74 42.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.594 1.957 . . . . 1.9399999999999999 110.84 173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -153.57 140.45 19.16 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.91 1.284 . . . . 3.2200000000000002 111.143 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.321 9.0 t30 95.98 -17.61 0.07 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 129.136 2.974 . . . . 3.8599999999999999 116.832 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.25 161.83 34.97 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 120.66 1.573 . . . . 1.8600000000000001 114.629 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.2 m -87.97 133.72 33.88 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.285 1.034 . . . . 1.9099999999999999 112.979 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.1 mt -128.96 162.52 27.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.988 1.715 . . . . 0.97999999999999998 112.814 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.522 HD11 ' HE2' ' A' ' 44' ' ' LYS . 7.4 mp -117.89 132.78 56.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.86 0.864 . . . . 2.0099999999999998 109.923 167.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.76 131.16 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.708 1.203 . . . . 1.6200000000000001 111.468 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 29.9 p -85.05 115.08 22.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.662 0.665 . . . . 1.5800000000000001 109.607 168.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.53 118.16 21.13 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.637 0.775 . . . . 0.95999999999999996 109.526 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.7 p -119.19 11.91 12.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.537 1.135 . . . . 2.04 113.275 -174.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -145.44 146.96 31.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.903 1.681 . . . . 1.8400000000000001 111.149 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 103' ' ' GLY . 1.3 p -112.07 -175.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.717 1.607 . . . . 3.0 111.869 176.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.452 ' H ' HG22 ' A' ' 102' ' ' VAL . . . -61.36 -18.27 55.12 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 119.826 -1.797 . . . . 2.8799999999999999 116.329 -172.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.62 -58.01 3.87 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.314 1.046 . . . . 3.7200000000000002 111.74 169.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.41 -32.11 64.24 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.769 1.396 . . . . 3.9100000000000001 114.769 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 t -50.13 126.55 14.85 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.81 1.244 . . . . 2.4700000000000002 112.789 -168.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.4 t -54.06 -35.41 62.0 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.892 1.071 . . . . 2.48 113.892 -168.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.06 -50.47 73.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.726 -1.234 . . . . 1.78 112.241 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -71.56 -23.17 61.7 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.354 1.062 . . . . 2.1699999999999999 112.194 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -74.05 -43.91 56.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.828 1.251 . . . . 2.3999999999999999 113.077 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.7 mt -55.9 -49.17 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.405 1.482 . . . . 1.45 110.644 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 114.324 1.231 . . . . 1.23 114.324 -178.225 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 121.054 0.454 . . . . 1.8600000000000001 110.354 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.22 -30.36 71.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.649 1.179 . . . . 1.5900000000000001 112.439 172.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.19 -26.95 59.42 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.257 -0.902 . . . . 1.1899999999999999 113.317 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.91 -41.15 87.6 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.278 1.031 . . . . 2.3300000000000001 112.228 -169.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -50.02 -44.2 51.11 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.842 1.257 . . . . 1.3999999999999999 111.992 173.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -73.08 -35.3 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.355 1.062 . . . . 1.74 112.104 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -70.38 -22.06 62.8 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.864 -1.147 . . . . 1.3300000000000001 113.313 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.33 -19.95 65.52 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.955 1.094 . . . . 2.0600000000000001 113.955 170.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -70.99 169.51 14.76 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.696 1.135 . . . . 2.6499999999999999 113.843 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.02 -24.94 9.63 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.769 1.396 . . . . 3.25 114.769 -174.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 m 67.76 -11.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.283 1.833 . . . . 2.8399999999999999 115.818 175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -130.03 157.86 41.2 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.284 1.833 . . . . 2.8199999999999998 112.061 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.45 162.69 34.73 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.006 0.923 . . . . 0.78000000000000003 113.166 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.4 m -123.44 100.62 6.91 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.657 1.583 . . . . 0.94999999999999996 110.364 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.6 mt -85.29 146.14 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.47 1.508 . . . . 0.82999999999999996 110.615 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.412 HG12 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -107.45 127.56 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.955 0.902 . . . . 1.99 110.387 166.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.5 m . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 125.285 1.434 . . . . 2.1600000000000001 111.089 -170.879 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--O 1.236 0.359 0 N-CA-C 108.14 -1.059 . . . . 3.3900000000000001 108.14 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -138.81 153.33 48.38 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.53 1.132 . . . . 1.54 110.832 -169.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HG2' HG12 ' A' ' 18' ' ' VAL . 29.4 mt-10 -121.26 134.89 55.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.748 0.819 . . . . 2.3700000000000001 110.24 -170.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -123.92 129.07 50.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.507 1.523 . . . . 3.46 110.858 -169.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.51 130.66 45.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.589 1.086 . . . . 2.7799999999999998 110.476 170.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.8 m -141.42 168.27 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.039 1.336 . . . . 1.1100000000000001 112.844 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -78.15 139.28 38.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.402 0.681 . . . . 3.1299999999999999 109.593 168.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.89 -22.67 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.708 1.744 . . . . 1.5700000000000001 115.708 -168.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -64.31 -21.06 66.48 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.609 -1.307 . . . . 5.1399999999999997 112.94 172.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.2 mt -99.2 -4.93 30.92 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.611 1.965 . . . . 1.72 114.502 -169.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.3 m -74.35 -42.5 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.486 0.714 . . . . 4.0099999999999998 112.635 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.319 32.1 mt-30 60.54 146.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 128.248 2.619 . . . . 3.4900000000000002 116.043 -171.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -80.11 25.03 0.39 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 116.831 2.16 . . . . 3.1600000000000001 116.831 -167.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.25 8.25 12.37 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.107 1.337 . . . . 1.03 113.662 170.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.24 169.9 8.23 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.253 1.421 . . . . 2.8999999999999999 114.173 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.7 mt -121.56 127.92 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.261 2.224 . . . . 1.26 109.69 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.1 mm -116.3 133.69 62.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.729 2.012 . . . . 0.77000000000000002 110.552 -170.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HE3' HD11 ' A' ' 96' ' ' LEU . 14.0 mmmm -79.52 142.7 35.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.296 1.438 . . . . 2.5299999999999998 113.202 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 p -133.12 131.42 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.365 0.666 . . . . 0.68000000000000005 112.039 168.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.58 162.68 49.88 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 125.003 1.321 . . . . 1.25 113.182 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -60.12 131.14 37.5 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.427 2.085 . . . . 1.04 110.733 166.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.37 -3.86 61.31 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.738 1.637 . . . . 0.89000000000000001 114.717 -170.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.17 170.08 53.52 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 118.48 1.14 . . . . 0.95999999999999996 113.829 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -115.25 144.4 43.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.565 1.146 . . . . 1.5700000000000001 110.973 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -79.44 120.73 81.38 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-O 118.722 -0.656 . . . . 1.6599999999999999 109.868 175.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.35 -12.5 6.69 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.601 2.201 . . . . 0.76000000000000001 114.095 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -148.95 165.1 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.478 2.711 . . . . 1.26 109.446 -173.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -103.51 145.59 29.79 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.349 0.87 . . . . 2.25 113.349 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.95 -153.19 23.23 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.647 0.619 . . . . 0.62 114.647 -172.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -117.31 132.45 56.6 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.704 1.202 . . . . 4.2300000000000004 112.734 -169.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.3 t -82.7 127.13 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.935 2.094 . . . . 0.66000000000000003 108.422 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 pt -140.71 32.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 122.745 1.26 . . . . 0.93999999999999995 113.017 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -168.21 126.66 1.17 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.746 2.419 . . . . 2.98 106.711 167.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.45 178.25 46.89 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 117.004 1.562 . . . . 1.0600000000000001 117.004 174.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -148.02 128.45 13.99 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.863 1.265 . . . . 2.1499999999999999 112.328 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 m -148.12 167.74 24.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.346 1.059 . . . . 1.21 113.133 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.3 ttm -111.4 108.39 17.94 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.822 1.249 . . . . 1.3200000000000001 109.939 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.7 t -87.64 158.35 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.465 1.906 . . . . 0.81000000000000005 112.536 -169.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -113.55 92.22 3.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.374 1.87 . . . . 1.9199999999999999 110.134 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.89 16.52 21.22 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.943 1.697 . . . . 2.1099999999999999 112.884 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -56.56 -29.39 61.96 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.252 1.821 . . . . 1.3700000000000001 114.713 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -81.58 -32.18 32.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.256 1.389 . . . . 1.25 111.866 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mm -77.76 -45.95 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.087 0.955 . . . . 1.27 111.14 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 m -109.08 -12.58 14.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.336 1.454 . . . . 2.6499999999999999 112.751 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.28 6.47 80.15 Favored Glycine 0 CA--C 1.544 1.889 0 C-N-CA 125.219 1.39 . . . . 1.53 116.011 174.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.77 -38.22 89.75 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.693 1.197 . . . . 2.9399999999999999 113.995 -169.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 72.81 -17.77 0.38 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.949 2.5 . . . . 1.45 113.886 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -92.08 150.07 39.81 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.14 1.776 . . . . 5.6699999999999999 110.665 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.53 153.6 30.7 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.356 2.704 . . . . 2.02 112.243 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.73 124.85 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.586 1.154 . . . . 1.1000000000000001 111.851 -169.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.73 138.89 37.45 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.699 0.8 . . . . 1.05 112.821 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -127.13 145.76 50.63 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.019 2.127 . . . . 0.88 110.451 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -144.04 172.31 5.69 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 128.618 2.767 . . . . 2.4399999999999999 109.605 -169.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -57.74 137.08 79.42 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.673 1.582 . . . . 0.98999999999999999 110.943 168.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.0 17.81 79.83 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.954 1.264 . . . . 1.28 114.57 -172.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 t -101.79 161.02 13.97 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.006 1.903 . . . . 1.6000000000000001 111.414 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 p -112.43 146.57 38.16 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.841 1.2 . . . . 0.79000000000000004 113.648 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.64 159.35 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.204 1.802 . . . . 0.55000000000000004 111.964 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -117.35 152.1 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.896 1.678 . . . . 1.6200000000000001 112.176 173.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.96 149.99 39.07 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.737 -0.665 . . . . 0.66000000000000003 112.52 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.69 -10.57 55.98 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.583 1.087 . . . . 0.78000000000000003 115.53 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.3 p -76.51 161.51 28.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.516 1.158 . . . . 1.3500000000000001 111.262 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -106.77 142.23 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.917 0.887 . . . . 0.69999999999999996 110.913 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -99.74 143.23 30.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.714 1.606 . . . . 1.7 112.543 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -155.94 141.4 17.71 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.026 -1.046 . . . . 3.3199999999999998 112.15 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.26 17.3 t30 111.8 -42.07 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 1 C-N-CA 131.863 4.065 . . . . 3.8300000000000001 113.556 -178.279 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.16 -174.58 37.12 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 119.76 1.164 . . . . 2.0099999999999998 114.661 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.0 m -92.29 136.8 32.89 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.731 1.612 . . . . 1.8500000000000001 111.373 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 mt -130.81 160.97 32.81 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.553 1.141 . . . . 1.05 113.294 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.427 HD11 ' HE3' ' A' ' 44' ' ' LYS . 7.0 mp -113.97 123.05 48.77 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.83 1.252 . . . . 1.9299999999999999 109.97 170.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.15 126.21 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.653 1.181 . . . . 1.22 110.714 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 32.0 p -79.38 126.94 31.48 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.495 -0.753 . . . . 1.5800000000000001 110.235 169.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.32 129.21 34.24 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.568 0.747 . . . . 1.03 110.393 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.7 p -107.9 -8.86 15.84 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.657 0.984 . . . . 3.1000000000000001 113.657 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -145.82 150.29 35.9 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.31 1.444 . . . . 2.1899999999999999 110.909 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 m -74.74 160.19 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 118.69 0.677 . . . . 2.1499999999999999 109.174 166.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.66 77.57 Favored Glycine 0 N--CA 1.475 1.242 0 N-CA-C 116.285 1.274 . . . . 2.1699999999999999 116.285 -165.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.49 -39.31 62.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.688 1.244 . . . . 3.1699999999999999 113.581 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -72.11 -6.02 39.55 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.402 1.481 . . . . 3.3100000000000001 114.106 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.0 p -51.48 151.29 3.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.381 1.473 . . . . 1.73 114.035 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.19 -33.62 67.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.178 1.391 . . . . 2.6899999999999999 111.173 169.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.82 -51.48 68.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.673 1.989 . . . . 1.6000000000000001 112.549 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.8 m -70.66 -18.19 62.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.441 0.534 . . . . 2.5 112.441 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -73.93 -39.25 63.93 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.497 -0.752 . . . . 1.75 112.613 169.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 87.4 mt -49.75 -51.9 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 119.892 1.224 . . . . 1.6699999999999999 111.441 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.479 1.011 0 O-C-N 121.273 -0.892 . . . . 1.5 113.276 178.966 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.985 0 N-CA-C 113.599 0.962 . . . . 2.0099999999999998 113.599 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 tp -59.41 -37.85 79.09 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.888 1.675 . . . . 1.8999999999999999 111.714 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.21 -18.82 63.18 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.075 0.768 . . . . 1.3400000000000001 113.075 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -61.15 -36.76 80.65 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.943 1.247 . . . . 3.0 112.237 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.16 -42.24 96.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.877 0.871 . . . . 1.26 111.355 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -72.1 -36.29 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.167 0.587 . . . . 1.51 111.704 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -69.02 -30.95 69.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.333 1.053 . . . . 1.3100000000000001 112.881 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -64.0 -32.84 74.52 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.695 1.998 . . . . 2.3300000000000001 112.979 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -77.48 129.89 36.3 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.94 0.791 . . . . 3.3199999999999998 112.395 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.97 156.42 36.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.124 0.97 . . . . 2.25 112.787 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -108.75 -4.83 16.64 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.092 1.515 . . . . 2.1000000000000001 115.092 -167.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.29 160.54 39.9 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.285 -1.509 . . . . 3.9500000000000002 113.806 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.16 159.06 43.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.977 1.311 . . . . 0.80000000000000004 112.988 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 90.0 m -119.08 106.15 12.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.441 1.497 . . . . 0.88 111.148 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mt -97.4 138.53 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.838 1.655 . . . . 0.81999999999999995 110.842 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -124.74 126.45 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.796 1.18 . . . . 1.97 111.737 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 125.342 1.457 . . . . 2.3999999999999999 111.055 -175.338 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 121.333 0.587 . . . . 2.9900000000000002 111.606 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -141.0 133.62 28.66 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.016 1.726 . . . . 2.4500000000000002 109.871 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -127.41 139.28 52.94 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.265 -0.897 . . . . 3.8900000000000001 112.146 -176.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -114.61 145.82 41.54 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.277 1.431 . . . . 2.6699999999999999 112.166 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -117.23 110.73 18.48 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.0 1.32 . . . . 2.4500000000000002 108.283 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.9 m -127.86 164.65 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 114.531 1.308 . . . . 0.78000000000000003 114.531 -166.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.79 146.41 37.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.549 -0.751 . . . . 3.1000000000000001 110.379 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.71 -23.61 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.26 0.837 . . . . 1.05 113.26 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.36 -17.17 61.85 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.817 -1.177 . . . . 3.7599999999999998 112.984 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.7 mt -105.05 -12.26 16.24 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.404 1.882 . . . . 1.28 114.525 -169.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.41 143.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.101 0.96 . . . . 1.5 109.321 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -119.29 163.29 17.36 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.557 1.143 . . . . 3.2400000000000002 112.327 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.64 135.64 50.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.67 -0.863 . . . . 3.0600000000000001 108.67 167.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.9 -10.85 32.12 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 124.86 1.219 . . . . 0.90000000000000002 114.225 -169.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -88.15 152.07 22.25 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.334 1.454 . . . . 2.7999999999999998 113.773 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -105.26 118.92 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.546 1.539 . . . . 1.2 110.321 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 mm -118.51 128.6 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.105 1.362 . . . . 0.67000000000000004 111.922 -169.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -90.99 139.97 30.27 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.209 -0.932 . . . . 1.8700000000000001 112.437 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.05 133.6 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.374 1.47 . . . . 0.71999999999999997 110.998 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 m -107.69 170.5 5.52 Favored Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 124.683 1.193 . . . . 1.0900000000000001 113.751 -167.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -52.49 134.59 52.9 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.224 2.616 . . . . 1.0 112.89 169.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.54 -13.68 3.75 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 116.017 1.167 . . . . 1.03 116.017 -175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.9 162.99 53.93 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 118.77 1.285 . . . . 0.95999999999999996 114.454 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -107.3 154.12 21.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.702 1.201 . . . . 2.1499999999999999 112.374 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -88.15 119.48 70.35 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.779 0.832 . . . . 2.0899999999999999 111.512 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.29 -15.2 5.47 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.363 2.709 . . . . 0.72999999999999998 114.924 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 m -152.45 171.47 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.988 2.515 . . . . 0.70999999999999996 108.234 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.27 144.89 30.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.313 0.857 . . . . 1.72 113.313 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.16 -160.98 25.91 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 114.78 0.672 . . . . 0.70999999999999996 114.78 -173.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -115.89 140.54 49.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.156 1.382 . . . . 5.54 112.408 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.41 127.67 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.792 2.437 . . . . 0.87 109.198 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.5 pt -141.0 32.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.636 0.976 . . . . 0.91000000000000003 113.636 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -165.15 132.44 3.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.154 1.382 . . . . 3.7999999999999998 108.07 167.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.88 -172.71 48.28 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 116.297 1.279 . . . . 0.81999999999999995 116.297 169.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -150.85 126.54 10.25 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.237 1.015 . . . . 1.9099999999999999 111.838 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.96 169.53 17.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.903 1.681 . . . . 1.27 113.067 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.8 ttm -112.62 124.26 52.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.711 0.805 . . . . 1.23 111.279 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.36 140.44 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.885 1.274 . . . . 0.68000000000000005 111.294 -170.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -104.93 111.96 24.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.001 1.32 . . . . 1.8600000000000001 109.461 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.47 15.25 5.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.883 2.073 . . . . 2.0 113.95 -169.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.5 p -51.73 -31.35 26.08 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.728 2.121 . . . . 1.6799999999999999 116.728 -170.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.51 -34.09 35.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.265 1.393 . . . . 1.72 110.684 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 108' ' ' LEU . 9.0 mm -78.4 -58.3 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.763 0.825 . . . . 1.7 111.206 -175.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 p -95.68 0.46 52.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.113 1.365 . . . . 2.0699999999999998 113.779 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.07 20.73 79.66 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.215 1.388 . . . . 1.8100000000000001 113.983 174.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -72.65 -168.23 0.43 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.839 1.655 . . . . 2.6299999999999999 111.097 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.2 -34.19 0.17 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.232 1.813 . . . . 1.72 110.917 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.4 mmt -85.06 157.84 59.26 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 125.494 1.517 . . . . 4.8600000000000003 110.852 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -68.68 160.49 49.3 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.246 2.631 . . . . 1.6000000000000001 112.677 167.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.4 t -125.27 130.14 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.958 1.703 . . . . 1.03 111.728 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.59 131.35 36.7 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.964 0.906 . . . . 1.0700000000000001 113.209 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -113.13 152.26 29.84 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.861 2.064 . . . . 0.85999999999999999 110.855 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -141.3 177.72 1.82 Allowed Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 128.642 2.777 . . . . 3.0800000000000001 109.917 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -66.84 128.57 19.09 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 CA-C-N 121.679 1.635 . . . . 1.27 109.703 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.65 25.27 28.16 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.457 1.503 . . . . 1.1100000000000001 114.945 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.5 m -108.12 174.56 5.83 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.903 1.351 . . . . 2.0699999999999998 110.855 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.2 p -130.75 150.37 51.96 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.081 -1.637 . . . . 1.23 112.581 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.49 147.75 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.769 1.227 . . . . 0.73999999999999999 112.089 -172.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -112.87 148.28 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.837 1.655 . . . . 1.23 112.868 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.83 144.8 54.28 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.821 0.849 . . . . 0.90000000000000002 112.484 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.31 -3.16 73.81 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.109 1.338 . . . . 0.77000000000000002 115.886 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.3 p -78.77 162.47 26.11 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.605 1.202 . . . . 1.4299999999999999 111.725 171.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.73 136.37 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.093 0.957 . . . . 0.79000000000000004 111.708 -171.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -91.01 146.12 24.12 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.814 1.646 . . . . 1.49 111.981 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -93.49 -93.36 0.16 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.325 1.05 . . . . 3.6699999999999999 111.396 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -136.83 131.43 33.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.958 1.703 . . . . 4.5800000000000001 108.935 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.13 114.41 1.63 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 108.848 -1.701 . . . . 1.8500000000000001 108.848 -167.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -94.31 114.74 26.86 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.961 0.904 . . . . 1.98 110.108 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.9 mt -112.74 153.31 27.94 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.297 1.039 . . . . 0.97999999999999998 112.078 -169.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 tp -114.83 121.2 42.53 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.941 0.897 . . . . 2.5800000000000001 110.049 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 mm -113.62 129.09 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.646 1.578 . . . . 1.6799999999999999 110.981 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.9 p -86.79 116.67 25.03 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.064 -1.023 . . . . 1.48 109.973 168.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.89 122.89 31.38 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.48 -0.762 . . . . 0.93000000000000005 110.111 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.8 t -124.1 10.85 8.81 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.52 0.933 . . . . 3.0299999999999998 113.52 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -137.19 140.29 41.65 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.545 1.138 . . . . 2.0299999999999998 110.929 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.5 p -97.11 170.53 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.013 1.325 . . . . 2.7599999999999998 111.212 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.33 -27.45 65.52 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 119.699 -1.876 . . . . 1.5700000000000001 116.092 -169.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.86 -27.87 68.55 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.96 1.38 . . . . 2.4399999999999999 113.842 174.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.45 -16.62 60.31 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.42 1.267 . . . . 4.0300000000000002 114.42 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 74.0 p -63.01 125.02 22.6 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.66 0.985 . . . . 2.2400000000000002 113.66 -166.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.405 HG23 HD12 ' A' ' 108' ' ' LEU . 11.4 t -60.31 -35.66 76.12 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.238 0.615 . . . . 2.3199999999999998 111.925 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.484 HD11 HD12 ' A' ' 69' ' ' ILE . 8.0 mp -56.27 -50.5 71.17 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.469 1.107 . . . . 1.77 112.298 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 91.9 p -70.78 -28.44 64.66 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.903 0.481 . . . . 1.7 112.014 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -70.43 -43.29 70.24 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.859 -0.526 . . . . 2.0099999999999998 111.595 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 53.6 mt -54.71 -51.22 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.118 1.367 . . . . 1.6599999999999999 110.876 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 113.752 1.019 . . . . 1.51 113.752 -179.16 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.746 0 N-CA-C 112.549 0.574 . . . . 1.3899999999999999 112.549 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.95 -28.71 70.0 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.639 0.776 . . . . 1.5 112.153 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.12 -37.25 58.3 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.326 0.65 . . . . 1.21 111.956 167.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -63.05 -32.92 74.4 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.589 1.556 . . . . 3.7200000000000002 114.235 -176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 10' ' ' LEU . 4.2 mm? -60.3 -31.65 70.47 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.992 1.269 . . . . 1.5 111.738 172.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.4 mm -73.6 -45.26 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.728 0.811 . . . . 1.71 110.973 166.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 m -68.39 -16.66 64.0 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 121.052 1.751 . . . . 1.48 114.654 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 7' ' ' LEU . 22.5 mt -69.97 -30.23 67.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.396 1.478 . . . . 3.2000000000000002 112.446 169.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -77.92 130.75 36.97 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.771 0.828 . . . . 2.3199999999999998 110.694 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.9 167.59 20.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.839 1.256 . . . . 2.21 112.661 -176.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -106.15 -25.51 11.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.601 1.334 . . . . 2.2200000000000002 114.601 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.66 152.69 44.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.941 1.296 . . . . 3.5699999999999998 113.969 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.33 171.8 13.56 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.484 1.514 . . . . 0.82999999999999996 112.396 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.2 m -125.49 108.46 11.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.735 1.214 . . . . 0.90000000000000002 111.856 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.2 mt -82.06 140.64 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.19 1.396 . . . . 0.63 109.349 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.1 t -127.31 123.48 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.881 0.872 . . . . 1.9199999999999999 111.109 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 125.104 1.362 . . . . 1.99 110.92 -171.14 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 120.766 0.317 . . . . 2.48 111.179 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.4 t -142.63 128.63 19.6 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.312 1.045 . . . . 1.3799999999999999 111.444 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -111.4 138.13 48.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.446 1.099 . . . . 2.9500000000000002 111.566 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -106.88 146.43 31.0 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.615 1.566 . . . . 4.0 110.958 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -113.34 126.08 54.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.809 0.731 . . . . 1.6299999999999999 109.796 169.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.8 160.12 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 115.098 1.518 . . . . 0.76000000000000001 115.098 -166.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -75.74 147.99 38.88 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.687 0.795 . . . . 3.4700000000000002 109.085 167.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.31 -9.52 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 114.536 1.31 . . . . 1.01 114.536 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -79.79 -19.01 49.57 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.168 -1.583 . . . . 3.54 113.861 170.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.7 mt -96.48 -4.59 41.27 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.859 1.264 . . . . 1.24 113.644 -173.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.51 141.26 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.433 1.493 . . . . 1.52 109.465 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -127.49 168.39 14.98 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.026 1.731 . . . . 2.9900000000000002 111.38 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -72.59 23.7 0.06 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.737 1.615 . . . . 3.1600000000000001 114.958 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.26 11.38 2.27 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.968 2.223 . . . . 0.89000000000000001 113.855 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -87.47 163.39 16.73 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.669 1.734 . . . . 2.6600000000000001 112.371 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 98.7 mt -118.29 126.45 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.185 1.394 . . . . 1.45 109.216 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.2 mm -118.2 129.58 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.964 1.706 . . . . 0.68000000000000005 112.044 -168.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -88.57 131.48 34.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.022 0.929 . . . . 2.1200000000000001 112.566 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 p -108.02 140.74 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.333 1.453 . . . . 0.66000000000000003 111.649 175.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 m -102.96 159.5 29.1 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 124.39 1.076 . . . . 0.83999999999999997 113.324 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.75 138.76 40.98 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.444 2.762 . . . . 0.96999999999999997 112.287 169.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.08 -7.28 8.01 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.995 1.158 . . . . 1.0900000000000001 115.995 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.19 -179.38 48.79 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.423 1.487 . . . . 1.1699999999999999 115.023 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -123.43 151.98 42.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.493 1.517 . . . . 2.5600000000000001 112.62 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -78.01 122.38 85.36 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.093 0.957 . . . . 1.8700000000000001 110.179 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -88.3 -17.97 2.27 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.661 2.24 . . . . 0.81999999999999995 115.004 -170.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.72 170.83 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 128.586 2.755 . . . . 0.70999999999999996 108.082 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.49 151.55 20.13 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.694 0.998 . . . . 2.1499999999999999 113.694 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.63 -160.26 33.69 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.4 0.524 . . . . 0.79000000000000004 114.081 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -113.32 143.86 43.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.135 0.974 . . . . 4.2000000000000002 112.913 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.26 124.54 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 126.169 1.788 . . . . 1.1000000000000001 107.237 169.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.79 33.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.256 1.022 . . . . 1.1200000000000001 110.959 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -167.85 122.74 0.99 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.613 1.965 . . . . 2.9100000000000001 108.511 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.02 177.28 43.65 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 116.22 1.248 . . . . 0.93999999999999995 116.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -146.81 127.69 14.45 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.072 1.349 . . . . 2.0299999999999998 112.315 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.8 t -145.7 171.48 14.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.925 1.29 . . . . 1.45 112.685 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.7 ttm -115.68 125.56 53.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.508 1.523 . . . . 1.3500000000000001 108.88 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -122.99 140.54 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.721 1.208 . . . . 0.96999999999999997 112.443 -168.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -102.04 124.62 47.96 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.03 2.132 . . . . 2.1000000000000001 111.347 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -125.05 20.25 8.28 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.681 1.193 . . . . 2.5699999999999998 113.477 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.2 p -62.51 -3.56 1.5 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 117.742 2.497 . . . . 1.3200000000000001 117.742 -169.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.34 -45.6 4.63 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.685 1.194 . . . . 1.4399999999999999 109.403 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.7 mm -74.92 -56.77 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.567 1.147 . . . . 1.5800000000000001 112.321 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.4 p -107.64 -0.95 21.58 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.328 1.451 . . . . 2.02 112.621 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.21 6.07 78.62 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.27 1.414 . . . . 1.78 114.937 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -71.32 106.17 3.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.207 1.003 . . . . 3.3799999999999999 111.733 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.48 -16.35 60.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.827 0.851 . . . . 1.8200000000000001 112.375 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.7 ttt -113.42 136.85 21.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.041 1.736 . . . . 5.4000000000000004 108.971 172.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.07 165.74 25.7 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.63 2.22 . . . . 1.78 114.17 -168.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.06 138.68 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.142 1.777 . . . . 1.5800000000000001 111.065 -170.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.23 126.72 33.42 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.732 -0.605 . . . . 1.48 112.017 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -98.62 151.04 21.12 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.29 1.436 . . . . 0.93999999999999995 110.067 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -137.08 175.79 3.24 Favored Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 126.112 1.765 . . . . 2.8799999999999999 109.679 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.82 65.96 4.91 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 123.395 2.73 . . . . 2.4900000000000002 111.631 172.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.02 29.98 0.02 OUTLIER Glycine 0 CA--C 1.538 1.479 0 C-N-CA 127.14 2.305 . . . . 1.3500000000000001 112.806 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -126.94 150.44 49.34 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.172 1.389 . . . . 1.8200000000000001 111.273 -170.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.1 p -98.29 148.81 23.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.793 0.837 . . . . 1.1499999999999999 112.631 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 m -140.08 148.24 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.751 1.621 . . . . 0.93000000000000005 111.796 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.64 148.66 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.253 1.421 . . . . 1.3799999999999999 112.51 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.38 142.0 55.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.141 0.976 . . . . 0.75 112.454 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.51 2.44 89.59 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 115.619 1.008 . . . . 1.23 115.619 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 76.0 p -79.22 153.37 30.02 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.012 1.406 . . . . 1.6399999999999999 111.118 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 mm -112.56 132.51 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.127 0.971 . . . . 1.01 112.796 -168.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -84.45 133.97 34.47 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.668 1.587 . . . . 2.9500000000000002 111.282 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.82 -72.66 0.44 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.437 0.637 . . . . 3.98 110.071 168.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -143.91 155.93 44.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.425 2.29 . . . . 3.9900000000000002 107.877 172.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.93 108.04 2.88 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 127.45 2.452 . . . . 1.98 111.803 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.7 t -86.64 127.89 34.96 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.491 1.146 . . . . 2.2000000000000002 110.844 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -126.12 162.64 24.9 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.835 1.254 . . . . 0.96999999999999997 111.562 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -114.81 126.78 55.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.426 0.691 . . . . 1.95 109.44 167.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.62 125.65 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.804 1.642 . . . . 1.28 110.292 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.7 p -87.25 108.03 18.76 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.671 0.748 . . . . 1.52 109.744 168.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.26 135.66 36.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.61 0.764 . . . . 0.87 111.574 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.04 -0.14 9.54 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.586 1.328 . . . . 2.1499999999999999 114.586 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -143.78 144.68 31.91 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.296 1.438 . . . . 1.52 111.827 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 m -83.6 162.92 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.024 0.93 . . . . 1.6799999999999999 110.974 169.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.63 -34.49 90.04 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 120.728 -1.233 . . . . 1.3700000000000001 114.984 -168.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.25 -28.0 64.89 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.11 -1.229 . . . . 1.71 113.056 175.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.27 -7.81 56.57 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.16 1.784 . . . . 2.7599999999999998 114.545 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.4 p -68.55 158.03 34.76 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.885 -1.135 . . . . 1.9399999999999999 112.688 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 t -64.59 -33.19 75.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.19 0.596 . . . . 2.4300000000000002 111.254 170.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mp -55.66 -50.98 68.79 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.983 -1.073 . . . . 1.95 111.107 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.0 m -69.29 -31.56 70.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.417 1.087 . . . . 1.71 111.928 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.19 -40.8 98.56 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.671 -0.643 . . . . 1.6899999999999999 111.718 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 70.0 mt -65.18 -50.7 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.843 1.657 . . . . 2.04 111.108 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 113.52 0.933 . . . . 1.97 113.52 -175.619 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 112.644 0.609 . . . . 2.0 112.644 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.0 tp -65.06 -30.19 71.14 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.601 -0.687 . . . . 2.3700000000000001 111.891 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.69 61.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.583 0.753 . . . . 1.3300000000000001 112.439 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -58.84 -35.96 73.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.013 1.325 . . . . 2.73 112.914 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -48.98 -49.97 38.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.892 0.877 . . . . 1.53 112.236 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.8 mm -74.09 -36.84 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.672 0.789 . . . . 2.1600000000000001 112.622 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -58.91 -30.31 67.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.116 0.966 . . . . 1.1599999999999999 113.053 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -22.06 61.72 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.938 1.295 . . . . 2.3100000000000001 114.308 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -62.84 162.84 10.38 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.997 1.48 . . . . 2.3599999999999999 114.997 -171.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.7 -31.08 12.86 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.97 1.308 . . . . 3.5499999999999998 114.291 -171.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m 64.32 -12.78 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 127.946 2.499 . . . . 2.48 116.437 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -140.9 149.05 41.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.212 1.805 . . . . 2.8599999999999999 111.204 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.21 173.06 11.92 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.504 1.122 . . . . 0.75 112.837 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.4 m -124.33 120.88 33.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.611 1.165 . . . . 0.83999999999999997 111.967 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.9 mt -94.42 144.5 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.785 2.034 . . . . 0.59999999999999998 110.37 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.7 t -111.92 126.0 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.223 1.009 . . . . 2.0600000000000001 110.878 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.483 1.216 0 C-N-CA 125.791 1.636 . . . . 1.8700000000000001 111.331 -172.366 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 120.72 0.295 . . . . 3.3900000000000001 111.594 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -136.75 145.47 44.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.729 1.612 . . . . 1.8200000000000001 110.5 169.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -109.79 130.1 55.56 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.143 0.497 . . . . 2.8199999999999998 111.68 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -118.27 132.52 56.29 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.384 2.273 . . . . 3.9199999999999999 110.19 -170.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -93.52 139.17 31.05 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.097 1.317 . . . . 1.6100000000000001 112.312 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.96 166.09 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.68 1.592 . . . . 0.88 114.02 -171.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.79 150.58 24.95 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.375 1.47 . . . . 3.21 109.621 166.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.45 -19.48 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 114.295 1.22 . . . . 1.1100000000000001 114.295 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.32 -21.73 60.5 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.703 -1.248 . . . . 3.8199999999999998 113.866 172.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.8 mt -101.87 -7.43 22.48 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.806 1.242 . . . . 1.3100000000000001 113.808 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -86.23 142.35 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.835 1.254 . . . . 1.4299999999999999 109.631 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -117.19 168.36 10.37 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.471 1.108 . . . . 4.4199999999999999 113.292 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -67.62 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.98 2.112 . . . . 2.6899999999999999 115.711 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.77 12.22 0.63 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.484 1.993 . . . . 0.83999999999999997 114.277 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -92.42 152.31 19.78 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.739 1.769 . . . . 2.71 112.702 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -102.0 121.99 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.716 1.206 . . . . 1.3999999999999999 110.281 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.0 mm -104.56 159.95 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.796 1.638 . . . . 1.3700000000000001 112.273 -172.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HE2' HD11 ' A' ' 96' ' ' LEU . 34.3 ttmt -129.47 132.89 47.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.688 1.595 . . . . 2.0299999999999998 111.332 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.57 140.8 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.225 1.01 . . . . 0.79000000000000004 112.542 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -95.03 159.34 33.27 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 125.233 1.413 . . . . 0.97999999999999998 112.859 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.0 133.96 43.9 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.058 2.505 . . . . 1.0600000000000001 111.891 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.29 -12.04 61.63 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.539 1.542 . . . . 0.94999999999999996 114.7 -172.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.61 173.76 52.85 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.216 1.389 . . . . 0.98999999999999999 114.726 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -108.45 154.07 22.4 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.55 1.54 . . . . 2.7000000000000002 113.259 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -84.03 121.75 75.78 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.887 0.875 . . . . 1.8100000000000001 110.818 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.79 -21.06 2.82 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.974 2.449 . . . . 0.82999999999999996 115.816 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -152.04 163.08 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 128.08 2.552 . . . . 0.95999999999999996 108.906 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 136.78 32.84 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 112.818 0.673 . . . . 1.7 112.818 -172.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.3 -161.86 32.89 Favored Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.635 -0.666 . . . . 0.71999999999999997 114.148 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.7 ttp85 -109.91 134.01 52.54 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.204 1.801 . . . . 4.0599999999999996 112.976 -172.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.5 133.53 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.524 2.329 . . . . 0.93999999999999995 108.77 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.62 32.46 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.951 0.901 . . . . 0.98999999999999999 112.817 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -167.16 136.17 2.74 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.222 1.809 . . . . 3.04 109.005 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.18 -177.19 51.85 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 122.417 1.01 . . . . 0.95999999999999996 115.559 170.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -144.01 124.71 14.13 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.653 1.181 . . . . 1.95 111.746 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m -149.28 166.49 28.77 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.23 1.567 . . . . 1.1499999999999999 115.23 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.6 ttm -114.67 119.57 37.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.142 1.377 . . . . 1.3100000000000001 108.884 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.39 134.37 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.882 1.673 . . . . 1.0900000000000001 112.363 -167.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -86.73 75.79 9.59 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.702 1.601 . . . . 2.2000000000000002 110.316 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.67 4.62 53.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.205 1.402 . . . . 1.98 113.718 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.1 -23.87 66.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 115.511 1.671 . . . . 3.0099999999999998 115.511 -169.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.72 -21.13 57.82 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.434 1.015 . . . . 1.5800000000000001 112.029 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -86.94 -49.84 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.935 0.894 . . . . 1.3999999999999999 110.968 176.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.4 p -100.19 -7.7 24.43 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.436 1.273 . . . . 1.4199999999999999 114.436 -172.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.98 -1.06 56.77 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.336 1.446 . . . . 1.6100000000000001 115.186 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.94 -6.76 1.41 Allowed 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 119.822 1.811 . . . . 2.8900000000000001 115.094 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 45.24 26.37 0.25 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 130.746 3.618 . . . . 1.97 115.537 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 ttm -166.49 135.39 2.38 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.618 1.967 . . . . 3.8700000000000001 108.779 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.88 162.84 40.58 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.215 3.277 . . . . 1.75 114.474 -169.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.99 135.57 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 126.198 1.799 . . . . 1.3400000000000001 110.991 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.8 141.98 35.74 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.826 0.85 . . . . 1.3 112.977 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -128.87 149.54 50.72 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.829 2.052 . . . . 1.05 111.04 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -151.46 171.67 6.25 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 128.757 2.823 . . . . 2.8399999999999999 108.977 -173.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.78 134.57 63.6 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 CA-C-N 122.36 1.879 . . . . 1.1200000000000001 111.699 169.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.78 31.14 45.38 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.052 0.834 . . . . 1.1000000000000001 114.19 -170.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.2 t -122.05 159.82 26.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.835 1.254 . . . . 1.8999999999999999 110.827 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.0 p -118.77 155.43 31.14 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.547 1.521 . . . . 1.1899999999999999 113.732 -172.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.1 m -132.2 152.41 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.61 1.964 . . . . 1.26 111.568 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.637 HD13 ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -100.71 -1.26 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.844 2.058 . . . . 4.0599999999999996 116.041 -176.279 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 70.07 159.98 0.2 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.171 1.788 . . . . 0.87 114.484 -167.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.7 -44.27 2.5 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.011 1.291 . . . . 1.6799999999999999 113.277 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.5 p -51.33 151.29 3.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.373 1.069 . . . . 1.3 113.741 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.59 136.13 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.229 1.012 . . . . 1.04 110.462 -172.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -83.3 129.9 35.03 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.05 0.94 . . . . 1.8999999999999999 109.121 169.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -134.49 63.6 1.62 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.911 0.708 . . . . 3.5499999999999998 112.911 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -158.31 -56.1 0.07 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.51 1.67 . . . . 4.2400000000000002 115.51 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.9 -174.43 31.77 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.247 1.259 . . . . 2.1200000000000001 116.247 -167.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.4 p -94.31 126.46 39.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.857 1.263 . . . . 2.52 112.54 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 mt -136.0 161.79 34.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.333 1.053 . . . . 1.05 113.255 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.503 HD11 ' HE2' ' A' ' 44' ' ' LYS . 7.5 mp -120.61 139.0 53.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.291 1.036 . . . . 1.9299999999999999 111.591 168.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.36 133.07 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.209 1.404 . . . . 1.5600000000000001 111.244 -173.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.6 p -90.28 118.76 30.03 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.145 -0.972 . . . . 1.4199999999999999 111.307 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.46 121.0 24.64 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.083 -1.011 . . . . 0.92000000000000004 110.782 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.4 p -125.95 11.21 7.69 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.818 1.247 . . . . 2.4300000000000002 113.612 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -139.6 135.29 33.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.163 1.785 . . . . 1.6100000000000001 108.137 171.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 p -78.66 160.65 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 122.962 0.505 . . . . 2.73 109.697 169.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.28 -32.86 68.62 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 120.819 -1.176 . . . . 1.3999999999999999 115.875 -168.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.48 -40.12 73.82 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.356 1.578 . . . . 1.6299999999999999 113.243 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.33 -7.67 53.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.703 2.001 . . . . 2.4199999999999999 114.385 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 67.6 p -58.48 149.25 25.71 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.988 -1.07 . . . . 1.7 113.547 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.0 t -60.09 -36.57 77.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.663 0.785 . . . . 2.3399999999999999 111.309 171.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.2 tp -58.48 -47.01 85.46 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.841 -1.162 . . . . 1.49 112.792 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 t -70.9 -26.96 63.46 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.337 0.655 . . . . 1.9199999999999999 112.404 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -71.25 -42.77 68.41 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.516 1.126 . . . . 1.5600000000000001 111.818 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.4 mt -54.31 -50.68 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.158 0.983 . . . . 1.79 110.574 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.475 0.785 0 O-C-N 120.958 -1.089 . . . . 1.6799999999999999 113.292 179.408 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 111.893 0.331 . . . . 1.52 111.893 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.8 tp -49.25 -43.14 42.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.587 1.555 . . . . 1.6399999999999999 111.797 171.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.93 -35.97 62.16 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.276 0.843 . . . . 1.27 113.276 172.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -64.57 -31.24 72.38 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.941 0.792 . . . . 3.0699999999999998 112.801 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.44 -32.65 70.41 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.97 1.259 . . . . 1.75 112.569 172.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.6 mm -73.08 -40.71 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.397 -0.814 . . . . 2.2999999999999998 111.725 169.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.5 m -70.83 -21.06 62.49 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.142 1.164 . . . . 1.1699999999999999 114.142 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -72.84 -9.97 59.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.653 1.581 . . . . 2.1200000000000001 113.807 173.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -89.28 132.92 34.69 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.071 0.85 . . . . 2.7599999999999998 113.094 -172.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.48 161.13 31.52 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.445 1.498 . . . . 2.8599999999999999 114.43 -169.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 p -123.6 -26.3 4.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.587 1.555 . . . . 2.0499999999999998 113.833 -179.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.58 153.19 43.3 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.438 1.095 . . . . 3.3500000000000001 113.242 177.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.63 165.66 26.88 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.211 1.404 . . . . 0.78000000000000003 112.786 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -118.61 98.41 6.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.658 1.183 . . . . 1.04 112.159 -178.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.2 mt -83.24 129.6 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 121.252 -0.905 . . . . 0.66000000000000003 110.496 -177.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.94 109.28 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 108.478 -0.934 . . . . 1.76 108.478 169.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.477 0.92 0 C-N-CA 125.803 1.641 . . . . 2.1699999999999999 110.144 -177.019 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 109.559 -0.534 . . . . 2.6299999999999999 109.559 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 t -137.93 127.96 25.74 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.333 1.053 . . . . 1.79 110.476 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -102.76 146.94 27.49 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.478 -0.764 . . . . 2.6099999999999999 112.459 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -127.75 138.37 52.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.965 1.706 . . . . 3.5299999999999998 110.41 -169.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -99.69 116.75 32.53 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.487 0.715 . . . . 2.5099999999999998 109.334 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.95 166.07 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.008 0.923 . . . . 0.87 113.146 -172.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -88.13 160.82 17.61 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.582 1.553 . . . . 3.8300000000000001 112.565 169.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.55 -28.36 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 115.472 1.656 . . . . 1.6699999999999999 115.472 -171.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -75.99 -17.23 59.78 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.272 -1.517 . . . . 4.3899999999999997 112.554 172.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -94.78 -8.78 36.54 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.176 1.39 . . . . 1.54 113.723 -172.01 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.73 139.02 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.945 1.698 . . . . 1.45 109.392 168.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.63 168.04 20.26 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.281 1.432 . . . . 2.8799999999999999 112.597 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -68.91 4.84 1.32 Allowed 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 117.531 2.419 . . . . 4.3799999999999999 117.531 -167.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.16 7.35 16.63 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.667 1.603 . . . . 1.3700000000000001 114.21 172.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -90.04 152.78 21.01 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.058 1.429 . . . . 2.71 112.929 -177.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.1 mm -113.45 122.47 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.927 1.691 . . . . 1.3200000000000001 109.86 177.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.3 mm -113.28 125.04 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.992 1.317 . . . . 0.88 111.562 -172.213 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -78.74 132.48 36.96 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.443 -0.786 . . . . 2.4300000000000002 110.508 169.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 p -121.85 133.86 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.337 1.455 . . . . 0.66000000000000003 111.206 176.505 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 m -89.06 162.22 38.42 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.766 1.226 . . . . 1.05 113.389 -173.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -61.28 133.7 47.95 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.695 1.597 . . . . 1.21 109.196 167.284 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.96 -10.69 46.05 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.515 -1.158 . . . . 1.1200000000000001 115.426 -172.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.53 175.17 44.07 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.038 1.419 . . . . 1.0600000000000001 114.403 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -111.63 153.34 26.49 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.463 1.505 . . . . 1.74 112.055 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -84.17 128.67 61.45 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-O 118.101 -0.952 . . . . 2.3100000000000001 109.717 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -96.9 -14.46 0.4 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.912 2.408 . . . . 0.80000000000000004 115.482 -173.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.37 164.62 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 127.716 2.406 . . . . 1.03 108.336 -176.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -88.46 155.09 19.87 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.412 1.264 . . . . 2.4700000000000002 114.412 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.74 -131.26 2.4 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.362 -0.835 . . . . 1.0600000000000001 113.735 177.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -135.72 146.39 47.65 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.233 1.197 . . . . 3.6000000000000001 114.233 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.77 122.77 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 105.628 -1.99 . . . . 1.21 105.628 166.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.2 pt -137.0 33.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.816 0.817 . . . . 0.88 112.109 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -167.62 128.54 1.46 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.069 2.148 . . . . 2.8100000000000001 107.75 166.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.66 -178.12 54.09 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 122.842 1.246 . . . . 0.80000000000000004 115.374 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -149.13 137.04 20.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.391 1.476 . . . . 2.5699999999999998 111.414 -176.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -150.76 176.68 10.81 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.481 0.919 . . . . 1.3300000000000001 113.481 176.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.5 ttm -112.89 126.95 56.02 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.334 1.054 . . . . 1.27 110.678 171.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -114.33 140.77 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.206 1.402 . . . . 0.72999999999999998 112.774 -168.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -97.38 107.67 20.23 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.456 1.502 . . . . 1.95 109.554 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.256 11.2 pt-20 -123.75 30.15 6.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.483 1.513 . . . . 1.8600000000000001 113.063 -178.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.3 p -60.63 -24.22 65.36 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.966 1.839 . . . . 1.51 115.966 -175.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -95.47 -33.61 12.38 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.079 1.351 . . . . 1.3200000000000001 111.352 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.0 mm -76.5 -49.34 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.531 -0.731 . . . . 1.23 110.632 178.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 m -106.85 -21.5 13.0 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.535 1.134 . . . . 2.2000000000000002 113.277 -169.278 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.59 -13.69 64.87 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.584 1.564 . . . . 1.22 115.78 172.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -63.86 118.31 8.19 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.475 1.138 . . . . 3.1000000000000001 110.215 174.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.25 35.05 0.32 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.187 1.395 . . . . 1.54 112.829 -178.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 ptp -154.14 137.13 10.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.367 1.867 . . . . 4.04 110.239 -174.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -63.23 154.93 64.69 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.861 2.374 . . . . 1.5800000000000001 115.193 -179.332 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.4 t -122.76 132.23 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.999 1.72 . . . . 0.98999999999999999 111.04 -170.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.25 35.56 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.964 0.887 . . . . 1.01 113.289 -175.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -125.01 150.57 46.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.539 1.936 . . . . 0.76000000000000001 110.61 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -150.09 173.9 3.92 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 129.621 3.169 . . . . 2.5699999999999998 108.415 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -56.14 136.81 77.08 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 CA-C-N 121.702 1.644 . . . . 0.80000000000000004 111.573 170.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.94 25.98 72.33 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.602 1.096 . . . . 0.89000000000000001 114.465 -171.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.4 m -102.05 146.98 27.15 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 119.139 1.469 . . . . 1.45 110.575 174.584 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.7 p -88.83 151.76 22.17 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.184 1.357 . . . . 0.80000000000000004 113.148 178.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -138.52 157.04 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.04 1.336 . . . . 0.69999999999999996 112.01 176.281 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.75 150.18 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.095 2.158 . . . . 1.3 111.282 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.86 148.54 49.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.913 0.885 . . . . 0.66000000000000003 113.334 -174.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.44 -3.46 62.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.348 0.975 . . . . 0.76000000000000001 115.106 179.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.2 p -79.5 157.2 27.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.951 1.375 . . . . 1.4299999999999999 111.07 169.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mm -115.13 130.52 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.551 0.74 . . . . 0.81000000000000005 112.645 -168.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -90.07 149.26 22.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.882 1.673 . . . . 1.6599999999999999 113.669 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -157.67 142.9 16.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.403 1.081 . . . . 4.0700000000000003 112.61 171.438 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 t30 117.47 -40.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 131.255 3.822 . . . . 4.1100000000000003 113.514 175.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.62 -179.79 46.35 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 120.031 1.287 . . . . 1.8899999999999999 115.281 173.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.4 m -82.35 134.21 35.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.416 1.086 . . . . 2.1299999999999999 112.616 -177.18 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.39 165.16 20.29 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.128 1.771 . . . . 1.3400000000000001 111.619 -176.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.43 132.96 55.91 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.607 0.718 . . . . 2.1499999999999999 111.026 168.105 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.7 mm -118.14 125.12 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.053 1.741 . . . . 1.54 110.283 -169.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -82.73 114.65 21.23 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.383 -0.823 . . . . 1.5 109.065 168.142 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.04 112.67 15.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.338 -0.986 . . . . 1.01 108.338 174.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -104.6 2.56 30.79 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.932 0.893 . . . . 2.4500000000000002 112.746 -172.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -147.76 154.39 40.46 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.7 1.6 . . . . 2.0600000000000001 111.665 173.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.06 165.63 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.896 1.278 . . . . 1.96 112.181 170.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 -35.21 85.42 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 120.906 -1.121 . . . . 1.5 114.283 -172.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.91 -31.69 72.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.455 1.128 . . . . 1.8899999999999999 113.64 176.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -75.19 -17.63 60.32 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.127 -0.983 . . . . 2.9500000000000002 113.58 174.361 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 81.6 p -64.65 144.6 57.11 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.899 -1.126 . . . . 1.8300000000000001 112.566 -169.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -64.55 -22.85 67.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.899 0.879 . . . . 1.9399999999999999 113.065 -169.44 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.64 -49.33 78.19 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.68 1.192 . . . . 1.5900000000000001 113.107 -177.182 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.8 m -72.83 -17.34 61.56 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.533 0.938 . . . . 2.75 113.533 173.59 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -76.92 -40.89 45.58 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.736 0.643 . . . . 1.48 112.736 172.359 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.13 -47.31 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.6 1.56 . . . . 1.46 110.386 177.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 114.479 1.288 . . . . 1.5 114.479 -178.011 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 112.48 0.548 . . . . 2.3700000000000001 112.48 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.25 -44.85 84.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.253 1.421 . . . . 1.54 111.797 176.427 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.82 -8.61 56.33 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.286 1.217 . . . . 1.5900000000000001 114.286 175.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -65.25 -43.01 92.71 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.818 1.19 . . . . 2.4900000000000002 110.607 -177.243 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -45.86 -52.93 10.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.246 1.818 . . . . 1.6799999999999999 112.246 172.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.1 mm -69.78 -31.32 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.11 0.964 . . . . 2.1400000000000001 112.183 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.9 m -75.46 -28.3 59.23 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.01 1.324 . . . . 1.27 113.627 -175.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.32 -24.14 67.73 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.265 0.938 . . . . 2.0 113.519 175.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -68.25 139.47 56.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.886 1.275 . . . . 2.4900000000000002 113.465 -175.033 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.87 157.28 29.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.604 1.161 . . . . 2.21 112.561 173.517 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.54 -2.25 17.72 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.7 1.741 . . . . 1.97 115.7 -169.369 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.31 156.74 48.21 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.862 1.665 . . . . 3.8999999999999999 112.526 -178.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.72 147.3 37.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.034 0.934 . . . . 0.81999999999999995 113.108 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.2 m -107.98 106.45 16.71 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.597 1.159 . . . . 0.81000000000000005 111.369 175.225 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mt -83.48 147.22 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.178 1.791 . . . . 0.58999999999999997 109.486 176.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.16 140.24 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.636 1.347 . . . . 2.1099999999999999 114.636 169.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.479 1.016 0 C-N-CA 125.575 1.55 . . . . 2.6600000000000001 114.4 -178.732 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.8 tp . . . . . 0 CA--C 1.552 1.028 0 CA-C-O 121.612 0.72 . . . . 3.2799999999999998 112.388 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -79.08 153.6 30.05 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.231 1.013 . . . . 1.6699999999999999 112.501 -172.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -116.08 131.63 56.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.111 1.364 . . . . 2.6499999999999999 110.214 176.006 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -126.33 136.07 52.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.214 1.806 . . . . 3.98 110.171 -176.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -110.2 130.98 55.45 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.466 -1.396 . . . . 1.97 112.252 -175.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.81 169.14 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.922 1.289 . . . . 0.76000000000000001 113.62 -173.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -79.58 152.42 30.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.24 1.416 . . . . 3.3799999999999999 112.494 171.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.77 -18.76 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 115.189 1.552 . . . . 1.1599999999999999 115.189 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -85.46 -19.92 30.54 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 120.623 1.556 . . . . 3.04 113.503 169.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.16 -17.7 21.55 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.046 1.338 . . . . 1.21 113.558 -173.27 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.54 138.69 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.766 0.827 . . . . 1.6000000000000001 109.235 168.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -118.82 159.27 24.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.196 0.998 . . . . 3.5299999999999998 111.123 178.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.2 ptt85 -69.59 146.6 51.62 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.899 -0.501 . . . . 2.7000000000000002 109.984 169.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.12 2.8 56.9 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-N 118.852 0.751 . . . . 1.0800000000000001 114.077 -171.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -112.98 172.87 6.67 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.612 1.565 . . . . 2.3700000000000001 112.102 173.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.3 mm -112.69 122.95 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.734 1.614 . . . . 1.3 110.483 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.6 mm -119.5 132.89 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.458 1.503 . . . . 0.87 111.429 -169.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HE3' HD11 ' A' ' 96' ' ' LEU . 13.7 mmmm -86.74 142.24 28.3 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.322 1.449 . . . . 2.4399999999999999 112.456 174.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.35 145.4 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.58 0.752 . . . . 0.71999999999999997 111.749 170.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.78 156.75 35.17 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 124.98 1.312 . . . . 1.0900000000000001 113.323 -177.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -59.64 140.18 92.41 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.352 2.035 . . . . 1.27 110.679 168.104 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.57 -5.34 11.21 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.748 1.166 . . . . 1.05 114.906 -172.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.64 169.99 53.81 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 118.817 1.308 . . . . 0.98999999999999999 114.241 177.032 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -123.25 152.05 41.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.07 1.748 . . . . 1.95 110.606 -178.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -81.05 127.51 74.13 Favored Pre-proline 0 CA--C 1.551 0.988 0 O-C-N 121.629 -0.669 . . . . 1.8999999999999999 111.575 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.13 -20.66 2.76 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.581 2.854 . . . . 1.1200000000000001 113.493 177.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 m -147.99 170.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.872 2.469 . . . . 0.92000000000000004 108.978 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.84 152.47 20.48 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.059 0.763 . . . . 1.71 113.059 177.264 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.74 -174.61 46.17 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 115.397 0.919 . . . . 0.72999999999999998 115.397 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.0 ttt85 -102.75 139.46 38.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.66 1.184 . . . . 5.9000000000000004 111.912 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.3 t -99.91 133.96 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 127.307 2.243 . . . . 0.80000000000000004 109.268 -173.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.1 pt -139.87 28.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.017 1.117 . . . . 0.76000000000000001 114.017 -177.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.73 150.18 3.95 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.941 1.697 . . . . 3.27 110.114 166.404 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.57 -173.92 34.35 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.704 1.145 . . . . 0.81999999999999995 115.29 169.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -151.33 121.13 7.04 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.185 1.394 . . . . 2.52 110.965 -175.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.6 m -147.5 155.2 41.66 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.111 -0.993 . . . . 1.4099999999999999 113.009 172.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.1 ttm -102.06 121.13 41.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.598 1.159 . . . . 1.1499999999999999 108.436 169.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 68.7 t -118.59 146.33 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.539 1.936 . . . . 1.0 112.831 -165.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -108.41 115.84 30.85 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.351 1.86 . . . . 2.0099999999999998 110.541 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -127.12 26.21 6.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.611 1.564 . . . . 1.74 112.271 179.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.5 p -55.58 -31.04 61.86 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.006 1.854 . . . . 1.4299999999999999 116.006 -172.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.0 -39.44 13.7 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.607 1.094 . . . . 1.1000000000000001 111.189 176.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.6 mm -70.29 -62.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.733 1.213 . . . . 1.05 111.332 -173.321 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.7 p -98.21 -7.49 29.2 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.552 1.141 . . . . 1.25 112.946 -175.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.61 17.66 65.6 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.839 1.209 . . . . 1.4299999999999999 113.331 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -82.53 96.81 8.16 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.32 1.06 . . . . 3.0600000000000001 112.108 -176.558 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.88 20.18 0.26 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.27 1.028 . . . . 1.48 113.565 177.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.5 ttt -146.69 132.54 9.4 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 128.419 2.688 . . . . 4.21 107.385 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -69.64 153.53 69.34 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.052 2.501 . . . . 1.8999999999999999 112.62 -170.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.1 t -111.87 132.5 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.971 1.708 . . . . 0.97999999999999998 111.207 -168.14 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.09 137.68 34.0 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.435 -0.791 . . . . 0.78000000000000003 111.398 174.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -122.75 146.91 47.09 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.364 1.465 . . . . 0.80000000000000004 110.938 176.451 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -150.23 170.98 6.89 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 126.871 2.068 . . . . 2.8599999999999999 111.375 -170.676 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -59.01 118.94 5.92 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.982 1.788 . . . . 0.87 109.634 167.334 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.3 48.33 4.34 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.534 1.54 . . . . 0.88 113.689 -169.306 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.6 m -126.44 166.62 16.89 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.861 1.33 . . . . 1.4399999999999999 112.804 173.514 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.7 p -111.0 149.63 30.43 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.271 0.941 . . . . 0.87 112.842 174.358 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.03 157.12 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.371 1.468 . . . . 0.54000000000000004 111.898 175.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -119.34 149.42 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.839 2.056 . . . . 0.91000000000000003 113.078 176.193 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.84 143.83 46.23 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.891 0.876 . . . . 0.63 111.843 176.035 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.33 -7.67 60.28 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 116.272 1.269 . . . . 0.69999999999999996 116.272 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 t -73.7 157.14 37.08 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.137 1.468 . . . . 2.1899999999999999 111.329 169.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.41 136.32 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.753 1.621 . . . . 0.98999999999999999 111.697 -169.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -99.59 134.42 42.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.249 1.019 . . . . 2.23 110.745 172.299 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -135.9 53.65 1.94 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.041 1.126 . . . . 3.4199999999999999 114.041 175.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -153.17 -54.21 0.11 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.415 1.635 . . . . 2.98 115.415 173.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.07 -156.17 11.33 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-N 119.367 0.985 . . . . 2.5 114.946 -169.314 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -83.9 155.47 22.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.223 1.009 . . . . 3.0600000000000001 112.783 177.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.1 mt -147.55 152.28 37.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.839 2.056 . . . . 1.1200000000000001 107.766 167.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.421 HD11 ' HE3' ' A' ' 44' ' ' LYS . 10.1 mp -111.58 114.86 28.21 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.189 0.995 . . . . 2.1299999999999999 109.399 175.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.67 126.43 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.259 1.023 . . . . 1.1799999999999999 111.397 -173.473 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 30.0 p -82.37 119.65 24.43 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.579 -0.701 . . . . 1.55 109.249 169.044 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.8 123.53 28.32 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.275 -0.891 . . . . 0.88 110.973 -175.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.6 p -115.81 -8.14 12.0 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.736 1.013 . . . . 2.5600000000000001 113.736 -174.46 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -142.24 151.0 41.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.569 1.548 . . . . 1.48 110.603 173.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 m -100.65 171.21 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.863 1.265 . . . . 1.8799999999999999 109.614 167.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.51 63.52 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.61 -1.306 . . . . 1.6399999999999999 114.663 -174.388 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.13 -47.06 63.34 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.27 -1.135 . . . . 1.6200000000000001 112.951 169.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -79.1 -16.73 56.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.091 2.156 . . . . 2.5299999999999998 116.174 -174.337 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 109' ' ' SER . 10.0 t -71.54 148.37 46.78 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.485 -1.385 . . . . 2.7799999999999998 113.614 -170.035 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 t -51.62 -35.89 43.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.033 1.333 . . . . 1.9199999999999999 112.869 171.026 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.9 tp -60.29 -46.36 90.11 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.204 -0.935 . . . . 1.72 112.128 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.403 ' H ' HG23 ' A' ' 106' ' ' THR . 53.1 p -73.91 -30.83 62.8 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.991 0.916 . . . . 2.1299999999999999 113.411 173.224 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -61.54 -43.1 99.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.18 0.9 . . . . 1.5900000000000001 111.343 175.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.83 -54.69 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.547 1.139 . . . . 1.8 110.475 178.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.476 0.846 0 O-C-N 121.338 -0.851 . . . . 1.3 112.84 -178.949 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.721 0 N-CA-C 111.638 0.236 . . . . 2.1400000000000001 111.638 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 tp -50.2 -41.41 49.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.242 1.417 . . . . 1.9199999999999999 113.36 177.107 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.22 61.04 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.928 0.714 . . . . 1.9299999999999999 112.928 171.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.23 -35.18 73.19 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.029 0.931 . . . . 3.0600000000000001 112.551 178.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.32 -31.94 69.61 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.301 0.955 . . . . 1.3600000000000001 112.973 173.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.2 mm -72.17 -40.2 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.027 0.931 . . . . 2.8300000000000001 111.786 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m -71.26 -23.74 62.04 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.824 -1.173 . . . . 1.9099999999999999 113.882 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.0 mt -73.4 -20.98 60.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.102 1.361 . . . . 2.3999999999999999 113.57 173.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -85.37 143.18 28.79 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.178 0.991 . . . . 2.9199999999999999 113.326 -176.226 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.56 165.69 12.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.746 1.619 . . . . 3.1499999999999999 114.568 -178.242 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -120.55 -6.3 9.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.287 1.035 . . . . 3.5899999999999999 113.041 169.165 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.49 155.23 45.03 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.558 -1.339 . . . . 2.79 113.725 -175.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.78 162.38 35.63 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.864 1.666 . . . . 1.28 113.003 177.66 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.2 m -125.51 111.97 15.68 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.637 1.175 . . . . 1.4199999999999999 112.811 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 mt -96.75 133.1 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.788 1.235 . . . . 0.73999999999999999 110.439 -175.175 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -126.54 115.1 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.218 1.407 . . . . 2.6499999999999999 110.614 -177.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.473 0.699 0 C-N-CA 124.865 1.266 . . . . 2.5899999999999999 110.561 -169.652 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 110.404 -0.221 . . . . 4.0999999999999996 110.404 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.7 t -126.78 120.0 28.26 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.759 1.224 . . . . 1.6100000000000001 109.301 172.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -117.88 152.46 35.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.293 1.037 . . . . 3.2400000000000002 111.14 -173.094 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -142.09 138.39 31.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.968 1.707 . . . . 2.9300000000000002 111.18 -176.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -108.41 130.61 55.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.407 1.003 . . . . 1.9399999999999999 109.664 168.308 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.7 167.86 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.588 1.155 . . . . 1.1699999999999999 112.9 -168.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.88 149.87 32.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.261 1.425 . . . . 4.8899999999999997 110.712 168.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.02 -9.05 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.599 1.333 . . . . 1.6299999999999999 114.599 -173.299 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -96.64 -15.51 21.47 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.274 -1.516 . . . . 4.4100000000000001 112.803 169.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.01 -5.67 59.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.219 1.408 . . . . 1.6599999999999999 113.936 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -100.12 142.85 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.504 1.522 . . . . 1.55 111.207 170.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -117.83 168.97 10.0 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.76 2.024 . . . . 3.4399999999999999 111.468 175.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -68.83 144.82 54.17 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.841 -0.537 . . . . 4.7400000000000002 110.586 169.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.0 -7.37 31.13 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.264 1.411 . . . . 1.8 114.984 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.6 165.69 11.5 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.404 1.602 . . . . 3.0600000000000001 113.343 178.288 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -116.39 132.49 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.653 1.181 . . . . 1.9299999999999999 112.302 -173.039 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.52 118.57 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 127.599 2.36 . . . . 1.0900000000000001 109.225 -169.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -94.68 115.59 27.72 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.613 -0.679 . . . . 3.1400000000000001 111.699 172.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.6 p -94.04 146.93 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.343 1.057 . . . . 1.02 112.254 -170.109 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.6 m -92.04 160.39 35.75 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.65 1.18 . . . . 1.1100000000000001 112.598 169.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -55.86 146.5 67.29 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.116 1.877 . . . . 1.8400000000000001 110.939 167.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.52 0.95 41.95 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.722 1.153 . . . . 1.75 115.299 -174.357 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.63 148.2 50.62 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.263 1.531 . . . . 1.53 112.819 172.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -117.68 9.72 13.15 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.478 1.658 . . . . 3.9700000000000002 115.478 -169.345 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 51.88 115.11 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 129.095 2.958 . . . . 2.27 116.794 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.71 -14.81 9.94 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.065 2.51 . . . . 0.95999999999999996 115.346 -176.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 m -153.11 173.72 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 128.296 2.638 . . . . 0.88 108.639 -178.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -92.62 147.87 22.53 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.505 0.928 . . . . 2.46 113.505 173.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.56 173.78 44.44 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 115.134 0.814 . . . . 1.3999999999999999 115.134 -170.181 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -113.28 133.16 55.25 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.125 1.37 . . . . 5.1699999999999999 111.621 -174.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.25 127.92 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 126.821 2.048 . . . . 0.85999999999999999 109.286 -169.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 pt -142.49 30.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.784 1.031 . . . . 1.0600000000000001 113.784 -173.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -169.51 143.08 2.72 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.459 1.903 . . . . 3.46 109.747 168.165 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -171.6 37.9 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 116.285 1.274 . . . . 1.26 116.285 169.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -142.63 123.78 14.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.142 0.977 . . . . 2.77 111.929 177.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 m -148.22 151.41 35.45 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.862 -1.149 . . . . 1.3100000000000001 113.915 169.469 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.8 ttm -95.24 138.42 32.97 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.638 -0.664 . . . . 1.0700000000000001 109.688 168.319 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.5 t -129.31 132.2 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.421 1.488 . . . . 1.03 111.035 -170.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.76 121.14 30.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.918 1.287 . . . . 2.3100000000000001 111.651 176.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -116.12 14.21 15.93 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.054 1.742 . . . . 1.96 113.224 -178.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 86.7 p -60.74 -0.85 0.32 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 119.211 3.041 . . . . 1.4099999999999999 119.211 -167.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -115.1 -40.51 3.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.938 1.295 . . . . 1.5700000000000001 110.299 169.319 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.5 mm -69.46 -49.95 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.831 0.853 . . . . 1.6100000000000001 112.109 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 p -106.09 -13.47 15.44 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.3 1.04 . . . . 1.4399999999999999 113.108 175.561 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.68 -0.17 84.55 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 124.85 1.214 . . . . 1.25 115.162 169.444 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.18 121.98 27.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.04 1.336 . . . . 3.02 111.916 179.166 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.01 14.52 4.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.955 1.302 . . . . 1.3200000000000001 113.301 -173.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 71.7 mtp -126.75 105.86 23.13 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 127.887 2.475 . . . . 3.25 108.002 -174.427 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.33 152.97 36.22 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.222 2.615 . . . . 1.96 114.387 -173.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.82 127.98 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 126.275 1.83 . . . . 0.98999999999999999 111.054 -167.549 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.83 129.07 34.18 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.713 -0.617 . . . . 0.81000000000000005 111.639 -178.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -121.65 144.88 48.51 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.454 1.902 . . . . 0.85999999999999999 110.2 -177.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -155.8 -177.77 0.79 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 128.452 2.701 . . . . 3.7999999999999998 108.78 -174.251 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.82 133.35 54.05 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.119 1.88 . . . . 1.04 112.308 168.193 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.25 28.9 59.27 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.166 1.365 . . . . 0.91000000000000003 114.567 -171.26 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.1 m -111.33 170.27 8.23 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.668 1.734 . . . . 1.8500000000000001 110.661 175.635 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.3 p -127.06 148.29 50.13 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 120.463 -1.398 . . . . 1.0900000000000001 111.986 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.0 149.05 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.371 1.069 . . . . 1.0600000000000001 112.019 179.302 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -119.4 150.54 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.428 1.891 . . . . 1.4299999999999999 110.763 177.975 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.19 138.59 57.88 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.967 -0.56 . . . . 0.81999999999999995 111.654 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.66 3.73 88.02 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.143 0.817 . . . . 1.7 115.143 -176.25 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.6 p -88.44 142.82 27.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.815 1.308 . . . . 1.75 110.2 167.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.44 120.39 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.092 0.775 . . . . 1.1799999999999999 113.092 -167.133 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -76.16 129.32 36.58 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.445 1.098 . . . . 2.0 111.037 178.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -106.4 -29.67 9.58 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.223 1.194 . . . . 5.4400000000000004 114.223 -172.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -104.62 -45.36 4.64 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 116.521 2.045 . . . . 3.1499999999999999 116.521 -165.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.96 -142.65 5.22 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 118.204 2.042 . . . . 2.52 118.204 -167.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 t -90.09 144.28 26.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.369 1.468 . . . . 2.04 112.412 -174.243 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.7 mt -147.82 159.44 43.83 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.72 1.608 . . . . 1.1100000000000001 109.538 169.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 tp -116.39 123.52 47.78 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.486 1.114 . . . . 2.3599999999999999 110.331 169.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.57 129.47 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.275 1.03 . . . . 1.6000000000000001 110.845 -170.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 52.8 t -86.46 123.9 32.2 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.379 -0.826 . . . . 3.1099999999999999 109.671 168.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.89 121.83 25.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.898 0.879 . . . . 1.1000000000000001 109.424 176.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.3 t -114.73 0.23 13.79 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.93 1.085 . . . . 2.46 113.93 -169.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -146.84 150.64 35.67 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.955 2.102 . . . . 1.8500000000000001 111.178 175.525 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.1 m -83.47 166.56 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.767 0.827 . . . . 1.95 112.615 169.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.87 -31.4 75.88 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 120.932 -1.105 . . . . 1.49 114.681 -174.033 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.19 -25.39 64.31 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.174 1.175 . . . . 1.98 114.174 174.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.19 -19.92 59.57 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.269 -0.894 . . . . 3.1400000000000001 113.081 171.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.1 p -68.49 141.96 55.43 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.564 -0.71 . . . . 1.71 111.809 -169.52 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 t -70.15 -18.18 63.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.097 0.777 . . . . 2.4700000000000002 113.097 -170.026 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.4 mp -59.42 -52.14 66.9 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.297 -1.502 . . . . 1.76 112.588 -175.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.6 p -73.76 -17.48 61.09 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.91 0.884 . . . . 1.8799999999999999 113.379 174.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -72.0 -42.72 66.11 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.12 0.968 . . . . 2.0899999999999999 111.723 173.466 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.3 mt -61.18 -52.75 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.616 1.566 . . . . 1.6299999999999999 111.16 -177.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 115.347 1.61 . . . . 1.8999999999999999 115.347 -172.876 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 115.098 1.518 . . . . 1.5600000000000001 115.098 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.0 tp -59.75 -40.81 89.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.962 1.256 . . . . 1.98 113.928 -168.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.25 -20.7 60.78 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.3 1.222 . . . . 1.75 114.3 173.047 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -70.73 -42.99 69.81 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.109 1.322 . . . . 2.4199999999999999 111.426 -169.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -47.52 -50.55 23.29 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.834 1.254 . . . . 1.52 111.564 173.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.54 -28.87 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.396 1.078 . . . . 2.23 112.635 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -74.42 -25.64 59.57 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.874 -1.141 . . . . 1.0600000000000001 112.973 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.01 -22.5 63.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.036 0.835 . . . . 2.1299999999999999 112.89 169.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -68.46 135.19 51.27 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.855 1.207 . . . . 3.0099999999999998 111.469 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.26 151.13 47.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.642 0.777 . . . . 1.8600000000000001 112.422 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 p -87.36 -21.95 25.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.827 1.651 . . . . 2.5299999999999998 113.355 177.364 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.75 157.08 47.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.871 1.268 . . . . 3.5299999999999998 112.788 -175.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.75 157.38 45.11 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.73 1.212 . . . . 0.70999999999999996 112.179 177.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 m -115.11 110.35 19.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.372 1.069 . . . . 0.82999999999999996 111.385 177.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.7 mt -91.75 135.2 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.091 1.756 . . . . 0.77000000000000002 109.495 -178.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 m -96.53 115.02 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 119.385 0.993 . . . . 2.4700000000000002 109.372 167.478 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 N--CA 1.471 0.603 0 C-N-CA 123.813 0.845 . . . . 2.71 110.273 -177.441 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 113.117 0.784 . . . . 3.8799999999999999 113.117 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.0 t -92.42 111.43 23.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.939 0.896 . . . . 1.8300000000000001 109.607 176.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -81.53 138.29 35.45 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.349 0.87 . . . . 2.9399999999999999 113.349 -170.564 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -127.83 125.3 39.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.847 2.059 . . . . 2.7000000000000002 109.795 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -95.5 132.0 41.07 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.419 -1.425 . . . . 3.6499999999999999 109.864 174.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.81 167.79 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.768 1.627 . . . . 0.87 112.846 -169.353 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.9 148.95 31.07 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.217 -0.66 . . . . 3.3500000000000001 109.217 165.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.97 -7.36 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 114.954 1.465 . . . . 1.1499999999999999 114.954 -177.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.78 -30.5 56.52 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 119.791 -1.818 . . . . 3.2999999999999998 112.691 167.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -90.69 4.04 52.58 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.798 1.639 . . . . 1.3 114.117 -168.258 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 p -101.1 135.75 36.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 126.416 1.886 . . . . 1.6699999999999999 110.62 173.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.82 166.58 10.91 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.219 1.808 . . . . 4.0499999999999998 111.45 178.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -65.29 -12.87 56.08 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.718 1.377 . . . . 3.9300000000000002 114.718 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.19 7.56 75.85 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.262 1.41 . . . . 1.2 115.938 174.352 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -91.82 155.84 17.94 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.782 1.791 . . . . 2.8999999999999999 112.649 176.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.0 mm -110.9 123.83 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.753 1.621 . . . . 1.8300000000000001 109.172 176.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -120.95 133.83 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.424 1.089 . . . . 0.70999999999999996 113.375 -167.222 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.529 ' HE3' ' CG ' ' A' ' 96' ' ' LEU . 10.9 mmmm -101.04 148.2 25.32 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.601 0.76 . . . . 3.6499999999999999 112.563 178.293 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 p -124.22 134.53 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.424 1.089 . . . . 0.59999999999999998 111.691 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.2 m -79.94 163.57 57.3 Favored Pre-proline 0 N--CA 1.482 1.15 0 N-CA-C 113.303 0.853 . . . . 0.96999999999999997 113.303 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.36 120.33 7.45 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.242 1.961 . . . . 1.4299999999999999 108.451 168.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.02 84.2 Favored Glycine 0 CA--C 1.54 1.655 0 C-N-CA 124.634 1.112 . . . . 1.22 115.467 -170.456 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.46 178.51 52.9 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 119.633 1.717 . . . . 1.0700000000000001 115.404 -177.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -120.87 145.3 47.78 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.614 1.165 . . . . 1.76 112.211 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -81.99 124.22 79.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.763 0.825 . . . . 1.72 111.901 -178.237 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -91.98 -20.14 0.66 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.194 2.596 . . . . 0.77000000000000002 115.932 -170.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.73 166.94 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 126.849 2.06 . . . . 0.70999999999999996 109.79 -177.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.313 0.3 OUTLIER -88.98 142.96 27.2 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.983 0.811 . . . . 1.8999999999999999 112.698 174.327 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' A' ' 100' ' ' THR . . . 170.61 -166.75 39.94 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.533 0.973 . . . . 0.59999999999999998 115.533 -173.671 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.6 ttp85 -109.76 143.54 39.44 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.68 1.592 . . . . 4.3700000000000001 112.053 -171.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.2 128.87 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.1 1.76 . . . . 0.92000000000000004 109.668 -172.544 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.7 pt -140.27 36.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 114.001 1.111 . . . . 0.96999999999999997 114.001 -172.315 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -166.27 142.14 4.78 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.14 1.376 . . . . 3.1699999999999999 111.283 168.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.15 -163.84 34.74 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.049 1.309 . . . . 1.21 115.907 169.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.98 126.46 5.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.329 1.233 . . . . 2.5899999999999999 114.329 174.035 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 m -145.95 166.67 25.35 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.849 -1.157 . . . . 1.3700000000000001 112.828 174.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.9 ttm -107.73 124.44 50.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.018 0.927 . . . . 0.95999999999999996 109.286 172.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.08 143.61 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.064 1.746 . . . . 0.58999999999999997 112.981 -167.045 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -98.25 96.28 7.96 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.22 1.408 . . . . 1.9399999999999999 111.309 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -93.01 -10.58 35.72 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.082 1.353 . . . . 1.74 113.268 177.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 t -38.12 -46.4 1.03 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.51 2.411 . . . . 2.3399999999999999 117.51 -167.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.3 -33.48 61.19 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.46 1.482 . . . . 1.2 112.167 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 mm -73.23 -47.49 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.406 1.482 . . . . 1.03 111.075 -177.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.4 p -110.44 -13.19 14.31 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.037 1.335 . . . . 1.2 114.125 -170.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.36 2.84 90.24 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.512 1.529 . . . . 1.1200000000000001 114.752 -177.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -51.44 -49.91 60.77 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.921 1.36 . . . . 2.4900000000000002 114.419 -172.059 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 57.76 31.53 20.59 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.334 1.454 . . . . 1.5900000000000001 114.605 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.2 ttm -162.55 136.08 4.64 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 130.212 3.405 . . . . 3.1400000000000001 105.242 169.069 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.18 164.9 34.12 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.95 2.433 . . . . 1.3799999999999999 113.321 -170.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.3 t -120.22 129.83 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.383 1.473 . . . . 0.72999999999999998 111.454 -169.427 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.27 139.7 36.54 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.479 -0.763 . . . . 0.81000000000000005 111.943 177.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -125.03 150.97 46.21 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.664 1.586 . . . . 0.88 111.449 -178.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -149.57 172.86 4.77 Favored Pre-proline 0 N--CA 1.483 1.224 0 C-N-CA 129.312 3.045 . . . . 3.21 109.053 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -59.52 140.2 92.86 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 CA-C-N 121.588 1.603 . . . . 0.91000000000000003 110.994 167.442 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.42 44.76 15.91 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.811 -0.555 . . . . 1.05 112.45 -170.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.9 t -126.67 170.14 12.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.69 1.596 . . . . 1.47 111.111 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.4 p -129.69 149.43 51.45 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.777 -1.202 . . . . 0.81999999999999995 112.411 -176.419 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.89 159.06 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.09 1.356 . . . . 0.54000000000000004 113.804 -176.044 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -120.05 152.84 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.798 2.439 . . . . 1.1699999999999999 111.46 169.922 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.32 152.14 44.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.774 0.829 . . . . 0.63 112.906 178.427 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.23 4.72 89.87 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.42 0.528 . . . . 0.91000000000000003 114.42 -175.705 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 m -82.15 153.52 25.98 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.286 -1.126 . . . . 1.49 110.563 169.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mm -108.3 143.59 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.698 1.199 . . . . 0.84999999999999998 110.236 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -108.21 139.8 42.37 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.832 1.653 . . . . 1.54 113.086 -175.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -152.22 115.73 4.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.508 1.049 . . . . 3.7799999999999998 113.808 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 51.5 t30 152.04 -51.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 131.341 3.856 . . . . 3.1200000000000001 109.245 167.311 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.51 -178.65 36.54 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.768 1.651 . . . . 2.0 112.454 -174.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.4 p -89.53 135.39 33.63 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.713 -0.875 . . . . 1.8600000000000001 113.286 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.6 mt -122.5 165.7 15.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.454 1.101 . . . . 1.29 112.921 -176.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.529 ' CG ' ' HE3' ' A' ' 44' ' ' LYS . 6.8 tt -116.24 117.45 30.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.367 1.467 . . . . 3.6200000000000001 111.478 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.12 120.48 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.948 1.299 . . . . 1.3400000000000001 111.49 178.267 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 20.4 p -84.57 120.82 26.79 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.035 -1.098 . . . . 1.48 108.035 166.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.28 157.38 34.49 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.921 -0.487 . . . . 1.6299999999999999 110.481 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.418 HG22 ' HA2' ' A' ' 55' ' ' GLY . 8.4 t -141.46 -9.22 0.96 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.671 1.36 . . . . 2.54 114.671 176.578 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -140.51 144.27 35.89 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.589 1.156 . . . . 1.6200000000000001 110.451 169.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -69.97 161.02 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.641 -0.503 . . . . 1.52 109.641 167.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.48 -36.61 89.96 Favored Glycine 0 N--CA 1.476 1.355 0 O-C-N 121.114 -0.991 . . . . 1.52 113.811 -171.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.87 -38.51 91.21 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.754 1.02 . . . . 1.8799999999999999 113.754 171.175 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -77.31 -6.71 54.2 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.043 2.137 . . . . 2.4700000000000002 114.861 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 81.3 p -65.3 157.91 27.81 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.604 -1.31 . . . . 1.55 113.194 178.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 90.9 m -64.48 -35.68 81.73 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.622 0.769 . . . . 2.9500000000000002 111.36 175.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.19 -47.56 68.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.866 1.266 . . . . 1.6299999999999999 111.7 171.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 m -68.41 -30.44 69.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.479 1.112 . . . . 1.9399999999999999 113.584 176.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -70.08 -41.05 74.59 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.085 0.857 . . . . 1.77 111.663 172.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.49 -48.55 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.845 0.858 . . . . 1.6000000000000001 110.904 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 113.439 0.903 . . . . 1.3100000000000001 113.439 177.732 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 113.535 0.939 . . . . 1.9399999999999999 113.535 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.5 tp -70.92 -34.31 71.38 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.641 1.177 . . . . 1.47 113.17 170.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.07 -32.04 68.61 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.194 -0.941 . . . . 1.46 111.567 174.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -54.56 -37.9 66.01 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 124.968 1.307 . . . . 2.04 113.354 -170.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.05 -43.79 91.74 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.346 1.058 . . . . 1.1799999999999999 112.578 -178.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.3 mm -72.43 -33.18 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.25 -0.906 . . . . 1.8 112.237 175.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m -77.43 -17.31 58.22 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.383 0.882 . . . . 1.5700000000000001 113.383 176.192 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mt -71.88 -43.39 65.5 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.602 2.361 . . . . 1.77 112.749 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -49.57 134.7 19.36 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.63 0.772 . . . . 3.0099999999999998 110.764 175.155 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.59 -14.34 41.6 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.041 1.497 . . . . 3.6600000000000001 115.041 -172.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 m 69.11 -24.79 0.14 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 128.29 2.636 . . . . 3.0099999999999998 115.024 173.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -125.38 152.97 44.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.176 1.39 . . . . 3.2599999999999998 111.262 169.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.84 151.35 45.62 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.716 1.206 . . . . 1.02 111.88 -177.423 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.2 m -111.45 104.09 12.5 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.283 1.033 . . . . 1.0700000000000001 111.876 -176.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.1 mt -91.26 134.67 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.705 1.602 . . . . 1.04 110.795 -173.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.69 130.27 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 120.719 -1.238 . . . . 2.54 110.483 169.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 125.726 1.61 . . . . 3.1800000000000002 110.873 178.931 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.625 0.726 . . . . 2.8399999999999999 111.502 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.1 t -134.97 95.12 3.26 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.992 2.517 . . . . 1.95 107.406 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.78 145.21 25.74 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.121 -0.987 . . . . 3.6600000000000001 110.573 -176.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -127.49 156.53 42.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.345 2.658 . . . . 2.9300000000000002 111.274 -167.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -121.11 140.2 52.3 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.238 0.926 . . . . 2.0299999999999998 112.746 169.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.97 166.24 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.257 1.423 . . . . 1.3600000000000001 113.478 -177.157 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.44 147.66 32.21 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.694 1.198 . . . . 3.96 110.443 166.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.77 -13.06 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.461 1.282 . . . . 1.5700000000000001 114.461 -176.117 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -82.87 -12.67 57.21 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 120.141 -1.599 . . . . 5.0099999999999998 113.565 170.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.9 mt -103.75 -10.22 18.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.151 1.78 . . . . 1.95 114.282 -172.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.63 143.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.693 1.197 . . . . 1.79 110.664 173.224 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -121.23 164.63 16.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.502 1.921 . . . . 3.0899999999999999 111.067 176.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.0 ptt-85 -72.22 153.3 41.67 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.707 -1.246 . . . . 2.8199999999999998 110.743 172.56 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.57 25.37 9.32 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 119.25 -0.75 . . . . 1.28 114.213 -176.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -140.14 162.24 35.72 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.49 1.516 . . . . 2.7400000000000002 112.05 176.733 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.45 125.72 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.307 1.443 . . . . 1.1299999999999999 110.199 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.8 mm -115.43 128.71 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.99 1.316 . . . . 0.87 111.401 -171.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -80.87 146.77 30.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.339 1.055 . . . . 2.4700000000000002 112.667 175.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.8 137.0 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.524 0.729 . . . . 0.56000000000000005 111.81 168.081 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 m -89.75 164.29 29.5 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.068 1.347 . . . . 0.89000000000000001 113.38 -178.491 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.66 132.25 32.26 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.238 1.959 . . . . 1.0700000000000001 109.445 168.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.74 -8.8 47.47 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.183 0.897 . . . . 1.01 115.187 -169.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.74 163.9 43.32 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 118.616 1.208 . . . . 1.02 114.092 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -111.6 149.07 31.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.422 1.489 . . . . 1.6699999999999999 110.437 175.083 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -81.39 130.14 63.37 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 121.85 -0.531 . . . . 2.0800000000000001 111.918 177.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.96 -25.66 1.4 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.446 2.764 . . . . 0.71999999999999997 114.792 -178.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.4 176.59 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.22 2.208 . . . . 0.88 109.323 -178.155 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.84 148.04 26.14 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.647 0.779 . . . . 2.3599999999999999 111.816 174.122 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.2 -160.14 32.87 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.521 0.568 . . . . 0.76000000000000001 114.521 -172.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -116.91 135.6 53.59 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.412 1.485 . . . . 3.4500000000000002 113.268 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.47 135.36 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.111 2.164 . . . . 1.03 108.935 170.585 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.4 pt -137.03 31.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 113.386 0.884 . . . . 0.81999999999999995 113.386 175.081 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -166.46 139.45 3.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.707 1.603 . . . . 2.8799999999999999 109.098 166.506 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.13 177.38 49.91 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 122.684 1.158 . . . . 0.81999999999999995 115.259 174.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -145.52 133.22 21.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.043 1.337 . . . . 1.8300000000000001 112.23 -174.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.3 m -150.66 176.03 11.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.625 1.17 . . . . 1.1799999999999999 112.853 172.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.8 ttm -117.96 129.84 55.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.711 1.204 . . . . 0.93999999999999995 110.397 168.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t -117.38 136.05 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.78 1.232 . . . . 0.66000000000000003 113.223 -167.27 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -88.6 108.2 19.31 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.58 1.152 . . . . 1.8500000000000001 111.227 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -110.18 16.36 21.82 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.225 1.41 . . . . 1.6799999999999999 114.117 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -60.57 -19.91 58.89 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.986 1.847 . . . . 1.6000000000000001 115.986 -169.04 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -91.94 -40.82 10.92 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.112 0.869 . . . . 0.98999999999999999 111.663 172.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 27.5 mm -78.34 -61.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.016 0.926 . . . . 1.02 112.246 -171.473 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.9 p -96.74 -7.75 33.08 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.499 1.12 . . . . 1.2 112.651 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.35 16.03 74.97 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.446 1.498 . . . . 1.25 113.833 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -83.66 105.01 14.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.391 1.476 . . . . 2.98 111.763 -176.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.31 -13.26 59.76 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.398 -0.814 . . . . 1.53 111.643 177.381 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -100.06 111.92 63.05 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 126.745 2.018 . . . . 4.5300000000000002 107.889 169.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.86 148.93 35.63 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.869 3.046 . . . . 1.55 114.162 -178.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.79 130.23 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.516 1.526 . . . . 0.71999999999999997 110.879 -169.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.2 142.89 37.63 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.271 0.629 . . . . 0.65000000000000002 112.516 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.07 147.3 46.87 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.414 1.886 . . . . 0.73999999999999999 110.603 177.492 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -147.25 170.6 7.49 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 128.504 2.721 . . . . 2.6899999999999999 109.664 -174.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -59.38 124.37 15.39 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 121.566 1.595 . . . . 0.87 109.593 168.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.94 55.25 3.18 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.938 0.78 . . . . 1.3400000000000001 112.308 -168.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 t -139.49 141.36 37.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.417 1.087 . . . . 1.3799999999999999 111.147 178.404 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.8 p -97.09 144.8 26.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.51 1.05 . . . . 0.71999999999999997 112.497 -178.207 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.58 156.59 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.323 1.849 . . . . 0.58999999999999997 111.49 -173.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.29 146.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.672 1.589 . . . . 1.01 111.92 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.47 153.12 28.14 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.81 0.844 . . . . 0.71999999999999997 113.218 -175.549 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.45 -5.08 17.05 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.594 0.997 . . . . 0.81999999999999995 115.594 178.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -75.79 153.03 37.2 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.787 1.294 . . . . 1.3300000000000001 109.869 168.384 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 mm -109.14 132.3 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.658 0.783 . . . . 0.66000000000000003 110.668 -169.841 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -91.95 151.89 20.29 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.694 1.597 . . . . 1.5800000000000001 113.198 -173.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -156.65 139.33 15.08 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.029 -1.044 . . . . 3.04 111.774 176.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.311 57.8 t30 99.23 -21.67 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.001 3.321 . . . . 3.0 116.932 172.395 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.32 178.81 38.8 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 119.928 -1.733 . . . . 2.1800000000000002 114.215 -174.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.1 t -120.78 125.7 48.24 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.627 1.171 . . . . 2.3599999999999999 110.942 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.66 161.85 21.77 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.627 1.571 . . . . 1.1699999999999999 112.438 -167.298 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.21 119.58 37.54 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.944 1.298 . . . . 1.75 110.154 174.156 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.98 123.3 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.052 1.341 . . . . 1.54 109.747 175.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.8 p -82.28 108.45 15.74 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.544 -0.722 . . . . 1.5700000000000001 110.077 170.02 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.87 113.88 17.33 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.127 -0.983 . . . . 1.02 110.707 -172.038 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -111.34 -2.33 15.68 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.07 1.348 . . . . 2.9199999999999999 112.478 179.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -138.32 142.33 39.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.954 2.102 . . . . 1.72 109.391 178.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.34 178.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 124.707 1.203 . . . . 1.8500000000000001 112.554 172.185 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.63 -39.49 97.63 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.594 -1.316 . . . . 1.3899999999999999 113.615 -178.549 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.01 -31.89 72.31 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 118.411 1.105 . . . . 1.8300000000000001 113.176 172.489 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -75.71 -4.37 39.98 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 128.132 2.573 . . . . 3.04 113.464 175.101 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 76.3 p -70.57 141.44 51.83 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.588 -1.945 . . . . 1.6399999999999999 114.275 -177.452 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -62.17 -31.93 72.49 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.71 -0.619 . . . . 1.8999999999999999 112.19 176.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -56.03 -48.05 76.7 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.777 -1.202 . . . . 1.47 111.8 171.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.8 m -64.97 -36.56 84.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.094 0.557 . . . . 1.8200000000000001 110.43 175.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.32 -40.59 85.97 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.664 -0.647 . . . . 1.6000000000000001 112.303 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 67.9 mt -59.03 -51.41 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.355 1.062 . . . . 1.26 109.945 177.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 117.903 -1.046 . . . . 1.1799999999999999 113.084 179.465 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 111.97 0.359 . . . . 1.77 111.97 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 tp -56.56 -34.41 67.09 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.71 0.804 . . . . 1.5600000000000001 112.92 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.23 -41.76 39.94 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.915 0.709 . . . . 1.3300000000000001 112.915 168.555 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -60.19 -35.11 74.65 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.953 1.301 . . . . 2.1800000000000002 112.709 -175.678 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.72 -36.68 72.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.691 0.796 . . . . 1.26 112.866 173.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.4 mm -72.88 -38.66 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.872 0.76 . . . . 1.8500000000000001 111.621 173.13 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -65.54 -25.75 67.58 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.174 -0.954 . . . . 1.23 112.783 177.037 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.9 mt -73.33 -17.84 61.25 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.633 1.973 . . . . 1.8700000000000001 114.892 174.666 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -74.48 144.76 44.04 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.085 1.311 . . . . 3.3199999999999998 112.105 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.49 156.49 21.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.845 1.258 . . . . 2.98 112.839 -176.249 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 p -94.76 -30.45 14.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.599 1.16 . . . . 2.73 113.7 171.403 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -140.47 162.13 36.08 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.245 1.818 . . . . 3.5600000000000001 113.014 -173.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.16 159.61 41.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.948 1.299 . . . . 1.5600000000000001 112.873 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.4 m -104.53 124.49 49.38 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.266 1.026 . . . . 1.3200000000000001 111.833 176.16 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.78 130.25 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.325 1.45 . . . . 0.95999999999999996 110.932 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -110.83 133.96 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.366 1.066 . . . . 2.48 111.897 177.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 123.457 0.703 . . . . 1.6200000000000001 112.279 -175.829 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 tt . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.624 0.249 . . . . 4.2699999999999996 111.427 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.2 t -130.63 131.16 44.76 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.618 1.567 . . . . 1.8799999999999999 109.605 -177.829 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.36 143.63 49.1 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.703 1.201 . . . . 3.0299999999999998 112.366 -170.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.96 143.65 50.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.954 1.302 . . . . 3.3900000000000001 111.177 -178.054 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -108.35 125.98 52.33 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.823 -0.806 . . . . 2.4199999999999999 108.823 166.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.29 161.29 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.605 1.162 . . . . 1.6799999999999999 112.357 -170.333 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -74.06 143.3 45.53 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.025 -0.732 . . . . 4.2999999999999998 109.025 172.662 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.59 -2.34 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 114.463 1.283 . . . . 1.74 114.463 -171.48 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -81.05 -23.4 38.58 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.33 2.252 . . . . 4.7699999999999996 113.13 168.632 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.6 mt -103.12 -10.76 18.58 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.644 1.578 . . . . 1.9399999999999999 114.009 -168.125 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.4 p -87.01 145.06 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.74 2.016 . . . . 1.75 108.646 168.243 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.24 159.48 16.08 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.198 0.999 . . . . 4.7999999999999998 112.415 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -73.49 33.04 0.08 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 115.615 1.709 . . . . 4.5499999999999998 115.615 -178.146 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.26 15.95 1.31 Allowed Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.481 2.467 . . . . 1.55 113.756 171.337 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -81.96 158.37 23.91 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.968 1.384 . . . . 2.3500000000000001 113.216 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -106.91 125.85 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.418 1.487 . . . . 1.6899999999999999 112.333 -172.616 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.7 mm -127.3 119.1 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.899 1.28 . . . . 0.91000000000000003 111.492 -169.788 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HE3' ' HG ' ' A' ' 96' ' ' LEU . 21.2 mmtp -85.44 120.16 26.59 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.744 -1.223 . . . . 3.6299999999999999 110.287 169.801 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 p -96.97 138.41 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.758 0.708 . . . . 1.1200000000000001 111.795 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 m -87.68 150.44 48.36 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.678 1.191 . . . . 1.1000000000000001 112.886 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -59.44 142.83 99.57 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.755 2.303 . . . . 1.72 111.07 170.348 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.31 -13.08 8.24 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 115.855 1.102 . . . . 1.9099999999999999 115.855 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.31 -172.64 40.62 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 119.058 1.429 . . . . 1.4399999999999999 115.214 -175.392 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -113.25 158.01 21.03 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.006 1.322 . . . . 1.75 111.521 171.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -91.54 125.26 58.4 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.234 1.013 . . . . 2.4300000000000002 111.437 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -92.66 -13.29 1.48 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.311 2.674 . . . . 1.4099999999999999 115.444 -175.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.48 162.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 126.613 1.965 . . . . 1.5 109.433 178.193 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.273 0.5 OUTLIER -93.51 137.67 32.56 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.684 0.754 . . . . 2.0899999999999999 112.33 175.595 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.41 177.32 41.95 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 123.975 0.798 . . . . 1.01 114.6 -169.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.7 ttm-85 -100.89 146.02 27.86 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.203 1.401 . . . . 6.2800000000000002 111.578 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.4 t -101.06 126.57 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.135 2.174 . . . . 1.1699999999999999 109.135 -174.317 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 pt -140.87 29.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 113.973 1.101 . . . . 1.1699999999999999 113.973 -175.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -170.17 146.67 3.02 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.882 2.073 . . . . 3.8999999999999999 109.158 166.171 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.4 -174.24 48.63 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.43 1.014 . . . . 1.3300000000000001 115.227 169.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -150.22 118.78 6.5 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.353 1.061 . . . . 2.2400000000000002 111.064 -174.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.4 t -142.71 163.98 31.36 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.282 1.433 . . . . 1.5900000000000001 112.27 -175.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.2 ttm -116.05 129.69 56.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.06 1.344 . . . . 0.79000000000000004 110.435 174.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.6 t -121.59 143.33 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.766 1.627 . . . . 0.60999999999999999 112.061 -168.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -99.45 90.4 4.51 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.281 1.832 . . . . 1.8 111.359 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -90.03 9.58 27.47 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.862 1.265 . . . . 2.3199999999999998 113.762 -175.441 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.8 t -50.35 -47.35 56.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.188 2.195 . . . . 1.8799999999999999 115.612 -169.061 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.98 -36.99 48.32 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.593 -1.317 . . . . 1.1399999999999999 111.777 -175.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.3 mm -73.61 -48.28 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.727 -0.608 . . . . 1.03 110.207 -177.309 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.1 p -107.33 -11.37 15.57 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.352 1.241 . . . . 1.26 114.352 -170.428 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.61 -5.81 72.39 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 126.011 1.767 . . . . 1.51 115.943 174.117 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.25 -47.2 81.98 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.529 1.165 . . . . 2.8500000000000001 113.254 -169.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.268 . . 58.61 45.61 15.86 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.442 1.897 . . . . 1.9299999999999999 111.847 -176.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptp -153.02 134.95 8.81 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 128.98 2.912 . . . . 4.0700000000000003 109.068 172.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -62.2 145.64 96.19 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.712 2.275 . . . . 1.3500000000000001 113.952 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.34 128.51 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.502 1.521 . . . . 0.76000000000000001 111.303 -174.117 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.87 144.79 28.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.628 0.771 . . . . 0.76000000000000001 112.977 -179.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -122.23 159.44 27.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.176 1.79 . . . . 1.3100000000000001 112.274 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -151.98 171.76 6.24 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 127.791 2.437 . . . . 3.6400000000000001 110.643 -176.485 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.5 123.98 13.79 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 CA-C-N 121.341 1.515 . . . . 1.4199999999999999 108.84 166.206 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.83 44.4 5.75 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.057 0.837 . . . . 1.27 113.01 -168.367 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.9 m -124.96 169.05 12.48 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.245 1.418 . . . . 1.3600000000000001 109.362 168.558 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.4 p -121.46 156.79 32.0 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.825 -1.172 . . . . 0.97999999999999998 112.868 169.81 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.28 160.48 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.884 1.674 . . . . 0.76000000000000001 111.924 -178.78 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -127.62 154.51 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 126.47 1.908 . . . . 1.6000000000000001 112.514 -176.952 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.73 159.84 33.17 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.432 0.901 . . . . 1.1699999999999999 113.432 -177.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -6.96 11.88 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.797 1.189 . . . . 1.0700000000000001 115.113 179.037 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -84.65 162.69 19.64 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.167 1.387 . . . . 2.46 111.601 174.575 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 mm -111.33 140.86 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.271 1.028 . . . . 0.96999999999999997 111.547 -169.437 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -90.61 136.09 33.28 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.178 1.791 . . . . 2.79 109.371 169.331 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -83.64 -73.32 0.42 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.702 0.801 . . . . 3.52 110.663 169.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -140.55 161.27 38.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.241 1.816 . . . . 3.6299999999999999 107.969 170.093 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.88 138.66 6.48 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.506 2.479 . . . . 1.8300000000000001 111.572 177.436 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.9 m -114.61 95.77 5.41 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.825 1.25 . . . . 2.5600000000000001 110.167 -169.475 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.3 mt -104.44 152.7 22.01 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.043 1.337 . . . . 1.6799999999999999 113.684 -170.774 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.416 ' HG ' ' HE3' ' A' ' 44' ' ' LYS . 4.2 tt -104.25 117.75 34.96 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.891 1.276 . . . . 3.5800000000000001 109.731 171.943 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.3 mm -113.41 129.02 69.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.022 1.329 . . . . 1.96 111.422 -173.493 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.3 p -101.69 124.94 48.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.414 -0.804 . . . . 1.45 110.109 168.381 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.96 151.02 31.88 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.692 0.627 . . . . 1.3899999999999999 112.692 -174.18 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -129.43 -3.23 4.89 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.775 1.398 . . . . 2.7999999999999998 114.775 169.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -140.97 141.87 34.37 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.66 1.184 . . . . 2.73 111.09 169.067 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.85 165.8 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 109.233 -0.655 . . . . 2.21 109.233 166.437 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.7 -39.74 91.67 Favored Glycine 0 N--CA 1.475 1.294 0 CA-C-N 119.528 1.058 . . . . 2.4500000000000002 114.673 -168.139 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.16 82.58 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.142 0.971 . . . . 3.2400000000000002 112.875 174.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -74.33 -8.34 55.9 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.213 2.605 . . . . 3.7400000000000002 114.275 176.363 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.0 p -64.13 159.07 21.27 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.789 -1.194 . . . . 2.0499999999999998 113.525 -174.526 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.6 t -52.21 -24.04 6.57 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.22 1.193 . . . . 2.5299999999999998 114.22 175.648 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.69 -44.92 93.46 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.251 -1.531 . . . . 1.9299999999999999 112.87 174.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.2 p -70.92 -21.35 62.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 117.945 0.339 . . . . 2.1400000000000001 111.785 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.02 -38.55 72.61 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.672 -0.643 . . . . 2.4100000000000001 111.149 174.024 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 94.1 mt -59.98 -54.21 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.405 0.682 . . . . 1.72 110.829 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 113.303 0.853 . . . . 1.3100000000000001 113.303 -178.781 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 111.604 0.224 . . . . 1.6699999999999999 111.604 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.0 tp -70.56 -30.95 67.81 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.122 1.369 . . . . 1.6000000000000001 112.234 174.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.21 -34.13 61.45 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.991 0.516 . . . . 1.45 112.343 177.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -64.31 -28.46 69.73 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.359 -0.838 . . . . 2.4100000000000001 112.88 -177.608 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.28 -28.63 69.86 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.064 0.946 . . . . 1.25 113.237 173.137 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.62 -37.85 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.169 -0.957 . . . . 1.8100000000000001 111.31 169.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -70.48 -31.39 68.5 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.253 1.021 . . . . 1.52 113.138 179.322 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.72 -22.79 64.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.166 2.186 . . . . 2.23 114.165 -178.29 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -76.78 155.58 33.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.21 1.404 . . . . 2.4900000000000002 113.926 -169.163 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.78 -28.07 14.44 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.391 1.256 . . . . 3.0299999999999998 114.391 -168.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m 66.93 -29.47 0.14 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.805 2.15 . . . . 2.9900000000000002 116.805 171.094 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.22 145.9 41.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.087 1.755 . . . . 3.5299999999999998 111.455 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.25 160.66 41.14 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.94 1.089 . . . . 0.77000000000000002 113.94 -169.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.8 m -112.43 112.64 24.35 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.309 1.044 . . . . 1.1899999999999999 112.395 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.42 146.18 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 126.742 2.017 . . . . 0.69999999999999996 109.932 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.56 115.0 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.024 -1.102 . . . . 1.76 108.024 166.34 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.471 0.615 0 C-N-CA 126.238 1.815 . . . . 1.8899999999999999 109.917 -176.416 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--O 1.238 0.478 0 CA-C-O 121.621 0.724 . . . . 2.7400000000000002 112.311 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.3 t -142.07 131.88 24.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.914 1.285 . . . . 1.46 110.507 168.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -99.34 135.67 40.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.091 0.956 . . . . 2.75 110.878 -179.035 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -131.99 132.58 43.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.5 1.92 . . . . 3.4199999999999999 111.642 -167.088 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -104.08 130.0 51.76 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.251 -1.531 . . . . 1.9299999999999999 112.706 -172.563 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -142.6 -179.77 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 125.7 1.6 . . . . 0.93000000000000005 113.749 -171.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.93 147.43 23.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.671 1.188 . . . . 2.6699999999999999 110.69 166.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.38 -21.53 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.943 1.09 . . . . 2.0699999999999998 113.943 -176.348 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.16 -23.88 67.23 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.119 -0.988 . . . . 3.1499999999999999 112.448 168.564 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.4 mt -106.62 -10.23 16.26 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.838 1.655 . . . . 2.0499999999999998 114.384 -169.092 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.7 m -60.78 -37.34 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 119.897 1.226 . . . . 3.9300000000000002 112.415 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.306 35.3 mt-30 58.31 150.75 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.959 2.904 . . . . 4.0700000000000003 115.775 -173.63 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -71.12 40.89 0.06 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 117.203 2.297 . . . . 3.8199999999999998 117.203 -167.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.47 17.77 0.43 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.627 1.584 . . . . 1.01 115.712 178.201 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.52 170.23 8.27 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.831 1.315 . . . . 3.1499999999999999 113.392 170.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.2 mt -122.02 131.8 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.454 1.502 . . . . 1.1899999999999999 109.004 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.96 131.58 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.717 1.607 . . . . 0.73999999999999999 111.02 -169.44 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -84.52 125.72 32.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.913 0.779 . . . . 2.1699999999999999 112.23 171.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.79 133.04 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.233 1.413 . . . . 0.68000000000000005 110.935 172.784 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 m -93.2 168.26 12.5 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 124.036 0.935 . . . . 0.90000000000000002 112.982 -176.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.92 132.38 47.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.583 2.188 . . . . 1.02 110.324 168.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.77 -6.17 27.12 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.614 1.102 . . . . 1.0 115.395 -172.038 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.26 162.71 53.69 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.149 1.474 . . . . 0.98999999999999999 114.112 -179.072 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -104.84 146.34 29.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.299 1.04 . . . . 2.21 111.692 175.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -71.57 130.91 86.74 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.696 -0.669 . . . . 1.8 109.538 169.703 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -94.83 -18.03 0.41 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.481 2.12 . . . . 0.93999999999999995 115.065 -171.329 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 m -144.09 175.63 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 127.277 2.231 . . . . 1.2 110.086 -178.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -94.91 136.25 35.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.97 0.805 . . . . 1.98 112.027 168.847 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.46 -173.44 46.28 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 121.545 -0.722 . . . . 0.68000000000000005 114.243 -169.733 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -109.22 134.65 51.48 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.143 0.977 . . . . 4.9299999999999997 113.218 -175.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.8 126.88 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.907 2.083 . . . . 0.81000000000000005 108.048 174.676 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.8 pt -140.39 33.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 118.614 0.643 . . . . 1.01 112.12 176.401 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -165.82 128.54 2.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.714 1.606 . . . . 3.8799999999999999 108.594 169.274 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.78 165.93 40.67 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.745 1.164 . . . . 1.3 114.697 -179.195 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -141.53 130.16 22.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.293 1.037 . . . . 1.9299999999999999 112.38 178.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.46 ' HB2' HD21 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -143.69 163.36 33.49 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.49 1.116 . . . . 1.3700000000000001 112.657 173.222 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.0 ttm -90.61 141.94 28.26 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.489 0.716 . . . . 0.93000000000000005 109.298 168.161 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.2 t -134.55 142.56 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.997 1.319 . . . . 0.64000000000000001 112.724 -168.551 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -89.07 116.36 27.29 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.257 1.023 . . . . 2.1499999999999999 112.211 173.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -109.62 10.69 24.92 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.504 1.522 . . . . 1.75 111.951 169.489 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 t -58.47 -39.29 79.53 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.939 1.296 . . . . 2.4700000000000002 114.043 -172.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.88 -31.47 27.91 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 120.391 1.451 . . . . 1.6200000000000001 111.576 177.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.8 mm -62.03 -57.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.028 0.931 . . . . 1.5800000000000001 110.762 178.206 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 p -119.58 -5.11 10.27 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.161 1.171 . . . . 2.1099999999999999 114.161 -169.683 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.42 11.69 77.33 Favored Glycine 0 CA--C 1.539 1.572 0 CA-C-O 118.504 -1.164 . . . . 1.79 115.295 -179.361 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -49.97 -53.51 26.0 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.842 1.821 . . . . 2.7999999999999998 114.17 -175.564 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.256 . . 59.66 13.94 3.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.09 1.756 . . . . 1.5700000000000001 114.739 -173.498 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 52.3 ttp -132.81 131.84 22.23 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 128.308 2.643 . . . . 3.79 106.876 169.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.98 152.33 46.11 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.161 2.574 . . . . 1.9199999999999999 112.949 -171.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -109.48 133.24 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.752 1.621 . . . . 0.71999999999999997 110.632 -171.626 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.16 132.35 36.52 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.57 -0.706 . . . . 0.78000000000000003 111.206 174.727 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -120.58 144.62 48.0 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.365 1.466 . . . . 0.79000000000000004 110.122 173.085 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 167.28 13.51 Favored Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 127.699 2.4 . . . . 4.4500000000000002 110.526 -169.873 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -58.72 132.03 45.59 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 CA-C-N 121.628 1.617 . . . . 0.84999999999999998 111.354 174.644 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.5 29.56 35.84 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.451 1.024 . . . . 0.73999999999999999 114.21 -169.235 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.9 t -116.4 152.6 33.63 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.788 1.635 . . . . 1.5700000000000001 111.658 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.2 p -107.15 150.15 26.9 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.931 1.241 . . . . 0.79000000000000004 113.142 178.738 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.4 m -140.27 163.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.448 1.499 . . . . 0.59999999999999998 112.285 -174.703 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.93 156.78 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.535 1.534 . . . . 1.26 112.549 173.418 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.75 148.12 49.99 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.487 0.921 . . . . 0.57999999999999996 113.487 -177.783 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.49 -1.62 70.88 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 115.198 0.839 . . . . 0.89000000000000001 115.198 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.8 p -78.11 151.43 33.36 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.425 1.113 . . . . 1.4399999999999999 109.433 166.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.88 132.87 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.509 0.724 . . . . 0.72999999999999998 111.835 -168.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -95.28 137.65 34.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.221 1.808 . . . . 1.5600000000000001 112.671 -176.176 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -85.53 -92.94 0.09 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 115.488 1.662 . . . . 3.3199999999999998 115.488 -169.788 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -109.22 -30.65 7.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 117.143 2.275 . . . . 3.9399999999999999 117.143 -167.342 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.8 150.72 16.93 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.065 1.317 . . . . 1.96 113.379 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 t -98.15 139.65 33.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.275 1.83 . . . . 2.5 112.443 -174.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 62' ' ' SER . 1.0 OUTLIER -132.85 162.68 30.91 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.717 1.607 . . . . 1.3200000000000001 112.208 -168.447 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.36 127.95 54.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.073 0.949 . . . . 1.96 112.248 172.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.53 132.21 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.326 1.451 . . . . 1.21 111.875 -172.361 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.1 m -84.97 118.27 24.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.81 1.244 . . . . 2.0800000000000001 111.187 -179.196 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.95 117.0 21.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.45 0.7 . . . . 0.98999999999999999 111.79 176.515 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.4 t -112.53 5.34 17.88 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.926 1.29 . . . . 2.8199999999999998 114.253 174.24 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -151.3 144.29 24.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.498 2.319 . . . . 2.1800000000000002 108.808 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.6 m -82.59 162.31 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.271 -1.011 . . . . 2.0800000000000001 108.271 164.033 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.98 -39.15 56.54 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-N 119.555 1.071 . . . . 1.3899999999999999 114.976 -168.568 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.71 80.63 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.265 1.026 . . . . 1.8600000000000001 113.537 173.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.85 -9.46 58.7 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.563 1.545 . . . . 4.04 114.958 -179.145 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.3 p -69.7 160.94 30.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.777 1.028 . . . . 1.6599999999999999 113.777 -175.595 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.8 t -63.07 -33.03 74.56 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.71 0.804 . . . . 1.8899999999999999 112.112 172.574 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.59 -45.25 92.46 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.054 -1.029 . . . . 1.45 111.368 176.694 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 64.8 m -71.46 -33.32 69.23 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.906 0.882 . . . . 2.1400000000000001 112.54 173.115 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -61.97 -42.23 98.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.276 1.03 . . . . 2.0099999999999998 111.17 177.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.29 -55.63 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.079 1.352 . . . . 1.3799999999999999 110.808 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 113.404 0.89 . . . . 1.3899999999999999 113.404 -175.588 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.687 0 N-CA-C 112.367 0.506 . . . . 1.55 112.367 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 tp -61.7 -32.55 72.76 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.572 0.749 . . . . 1.6899999999999999 111.884 175.248 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.47 -41.79 45.98 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.507 0.723 . . . . 1.47 112.391 168.49 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -61.06 -36.85 80.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.803 1.241 . . . . 2.5699999999999998 113.143 -174.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.45 -33.19 72.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.389 0.995 . . . . 1.1599999999999999 113.449 178.502 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.98 -39.85 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.25 -0.906 . . . . 1.6100000000000001 111.853 168.694 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.2 m -63.99 -32.77 74.43 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.097 -1.002 . . . . 1.0700000000000001 113.128 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.14 -24.02 67.53 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.0 2.52 . . . . 1.8700000000000001 114.132 177.872 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -80.24 121.48 25.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.391 0.677 . . . . 2.3700000000000001 109.291 -177.024 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.78 66.56 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 116.527 2.047 . . . . 2.4300000000000002 116.527 -166.281 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m 67.16 -21.13 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 115.613 1.709 . . . . 3.4900000000000002 115.613 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -128.05 152.19 48.26 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.146 -1.596 . . . . 3.04 114.171 176.612 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.7 144.62 49.25 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.086 1.355 . . . . 1.6799999999999999 111.112 -177.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.5 m -119.08 98.23 6.07 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.919 0.887 . . . . 1.97 112.049 -171.423 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.6 mt -81.68 136.91 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 127.013 2.125 . . . . 0.93999999999999995 111.46 -171.419 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.61 142.79 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.679 0.792 . . . . 1.99 112.49 168.616 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.0 m . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 126.388 1.875 . . . . 3.29 111.849 -169.895 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.8 tp . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 113.258 0.836 . . . . 3.3700000000000001 113.258 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.5 m -78.15 153.81 31.75 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.311 1.044 . . . . 2.5899999999999999 110.826 -178.642 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -124.2 146.96 48.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.51 0.724 . . . . 2.5899999999999999 112.707 176.225 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -137.42 139.76 40.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.789 2.036 . . . . 2.6600000000000001 110.255 -172.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -107.56 130.28 54.89 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.258 0.936 . . . . 2.8399999999999999 112.665 175.42 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 m -132.97 174.71 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.644 1.578 . . . . 1.45 111.503 -177.681 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.87 145.58 31.28 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.939 0.895 . . . . 4.9500000000000002 111.761 169.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.31 -8.02 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 114.189 1.181 . . . . 1.8400000000000001 114.189 -176.135 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -85.46 -28.12 25.25 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.166 -1.583 . . . . 4.5599999999999996 112.315 167.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.58 -20.06 22.07 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.441 1.496 . . . . 2.1299999999999999 113.515 -169.067 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.58 -46.07 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.48 1.112 . . . . 3.8199999999999998 112.352 178.165 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 59.56 164.94 0.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.408 1.883 . . . . 3.8500000000000001 115.863 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -74.34 27.34 0.08 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 117.002 2.223 . . . . 4.1900000000000004 117.002 -168.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.75 -8.3 5.29 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 117.012 1.565 . . . . 1.1699999999999999 117.012 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.11 175.76 5.37 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.63 1.715 . . . . 3.0800000000000001 114.308 -174.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.9 mt -123.27 135.33 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.481 1.913 . . . . 1.6399999999999999 110.411 -178.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.4 mm -124.9 123.59 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.349 1.859 . . . . 0.76000000000000001 110.186 -170.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -100.01 122.0 42.24 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.273 -0.892 . . . . 3.2400000000000002 112.79 177.707 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.7 p -100.72 142.57 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.557 1.543 . . . . 0.70999999999999996 112.117 -173.374 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 m -88.95 163.58 34.29 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 124.417 1.087 . . . . 1.03 113.136 -177.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.95 132.6 48.39 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.446 2.097 . . . . 1.25 110.902 169.124 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.17 -1.99 62.62 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 115.854 1.102 . . . . 1.1000000000000001 115.854 -172.282 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.17 174.99 46.27 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-N 119.517 1.659 . . . . 1.1000000000000001 114.923 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -122.37 145.89 47.85 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.505 1.522 . . . . 2.4100000000000001 111.132 -177.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -86.35 129.66 52.56 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 118.697 -0.668 . . . . 2.21 112.443 -177.135 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.12 -19.83 0.85 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.124 2.55 . . . . 0.91000000000000003 115.825 -172.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.7 m -148.57 165.71 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 126.87 2.068 . . . . 1.21 109.466 -177.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -88.29 127.88 35.47 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.288 0.949 . . . . 2.1299999999999999 111.976 169.681 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.19 -167.83 29.41 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.592 1.091 . . . . 0.65000000000000002 112.918 -169.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -117.33 135.36 53.9 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.042 0.937 . . . . 5.1200000000000001 113.326 -175.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.8 t -83.45 129.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 128.522 2.729 . . . . 0.76000000000000001 109.14 176.323 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.17 32.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.216 1.006 . . . . 0.88 113.165 -179.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -168.55 137.91 2.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.004 1.722 . . . . 3.52 108.675 166.334 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.11 -177.08 51.93 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.593 0.997 . . . . 0.79000000000000004 115.593 169.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -145.89 120.73 9.94 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.282 1.433 . . . . 5.4199999999999999 110.972 -169.841 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.22 171.76 14.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.462 1.105 . . . . 1.3100000000000001 111.267 172.881 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.6 ttm -108.01 149.15 28.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.99 1.316 . . . . 0.81000000000000005 111.043 170.219 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.92 133.72 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.743 1.217 . . . . 0.68999999999999995 112.573 -169.669 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -100.45 106.06 17.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.412 1.485 . . . . 2.21 110.409 177.789 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.29 6.07 10.71 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.741 1.616 . . . . 2.1699999999999999 114.912 -172.883 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.3 p -45.69 -26.04 0.57 Allowed 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 117.127 2.269 . . . . 1.3600000000000001 117.127 -175.853 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.34 -42.16 19.09 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.558 1.526 . . . . 0.98999999999999999 112.664 175.337 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.9 mm -72.68 -60.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.974 0.91 . . . . 1.01 110.278 -170.448 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 p -93.25 -11.11 33.36 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.877 2.071 . . . . 1.1599999999999999 112.455 -176.304 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.1 31.85 57.06 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 121.246 -0.909 . . . . 1.55 113.275 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -68.24 178.83 1.77 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.691 0.796 . . . . 2.5800000000000001 110.96 168.688 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.03 7.13 1.59 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.193 1.183 . . . . 2.1099999999999999 114.193 177.17 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 ptp -149.19 153.55 37.93 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.669 1.988 . . . . 3.0699999999999998 107.806 169.7 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.9 159.64 37.88 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.138 1.892 . . . . 1.3400000000000001 112.652 -177.087 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.88 138.37 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.211 1.804 . . . . 1.1899999999999999 112.024 -168.333 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.6 150.86 36.43 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.382 -0.823 . . . . 0.82999999999999996 113.119 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -132.32 155.1 48.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.628 1.971 . . . . 1.5600000000000001 112.699 175.745 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -153.94 -179.15 0.99 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 129.044 2.938 . . . . 2.6200000000000001 109.79 178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.72 150.4 82.73 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.748 1.632 . . . . 1.46 113.788 170.468 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.34 19.88 70.95 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-N 114.569 -1.196 . . . . 1.1000000000000001 114.357 -171.683 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.7 t -107.84 153.88 22.37 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 119.324 1.562 . . . . 1.1799999999999999 111.1 -176.206 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.3 p -118.44 143.43 46.69 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.282 -1.511 . . . . 1.23 112.948 -169.493 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 m -134.01 156.95 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.768 1.627 . . . . 0.64000000000000001 112.399 -169.628 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.526 HD13 ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -112.7 153.51 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.236 1.814 . . . . 1.4399999999999999 112.816 174.669 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.38 150.45 48.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.148 0.796 . . . . 0.68000000000000005 113.148 175.592 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.84 -6.0 56.26 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.489 1.042 . . . . 0.78000000000000003 115.451 176.793 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.4 p -77.72 159.82 28.85 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.274 1.03 . . . . 1.4299999999999999 111.361 169.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mm -113.77 127.24 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.432 0.693 . . . . 0.81999999999999995 111.782 -169.223 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -86.48 140.12 30.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.445 1.898 . . . . 1.6699999999999999 111.987 -178.039 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -100.46 -125.34 0.17 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.402 1.081 . . . . 3.4399999999999999 113.509 -172.701 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -90.13 63.61 5.89 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.983 1.265 . . . . 3.71 113.844 -166.495 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.92 157.23 9.23 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.431 -0.793 . . . . 1.8999999999999999 114.989 169.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -92.36 133.3 36.0 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.475 1.11 . . . . 2.1200000000000001 112.259 -175.586 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.76 153.7 39.14 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.601 1.56 . . . . 0.92000000000000004 111.587 -176.183 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.1 tp -108.62 119.81 40.61 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.617 1.167 . . . . 2.3399999999999999 110.356 174.855 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mp -117.53 127.94 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.319 1.048 . . . . 1.23 111.04 -175.665 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.3 p -81.52 128.65 34.13 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.722 -0.611 . . . . 1.3899999999999999 110.654 171.325 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.09 126.17 34.6 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.499 -0.751 . . . . 1.0700000000000001 110.864 176.461 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 p -133.97 -3.96 2.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.926 1.69 . . . . 2.27 113.698 -170.554 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -148.03 150.3 33.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.237 2.215 . . . . 2.0899999999999999 108.887 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.74 173.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.246 1.018 . . . . 1.6499999999999999 111.416 169.301 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.75 -35.78 47.55 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.17 -0.956 . . . . 1.8500000000000001 115.027 -170.604 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.63 -31.97 71.14 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.322 1.231 . . . . 2.3100000000000001 114.322 176.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.84 -14.11 60.28 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.05 1.295 . . . . 3.8799999999999999 114.19 172.457 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 60.1 p -68.47 144.59 54.6 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.138 -1.601 . . . . 2.04 113.152 -169.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 t -63.48 -33.04 74.7 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.77 0.428 . . . . 2.8599999999999999 110.821 171.872 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.7 mp -53.3 -53.01 57.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.58 1.152 . . . . 1.6100000000000001 111.886 175.396 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.4 m -71.73 -26.54 62.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.022 0.929 . . . . 2.02 111.77 177.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -70.64 -42.66 70.55 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.761 -0.587 . . . . 1.6100000000000001 111.826 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.91 -53.34 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.746 1.219 . . . . 2.1099999999999999 110.287 177.65 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 113.607 0.966 . . . . 1.78 113.607 -176.561 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.081 0.771 . . . . 1.3999999999999999 113.081 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.9 tp -67.58 -28.86 68.13 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.327 -0.858 . . . . 1.45 112.243 177.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.77 -45.31 29.48 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.019 0.528 . . . . 1.23 111.312 167.441 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -53.62 -43.69 68.88 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.462 1.905 . . . . 2.2799999999999998 113.22 -175.249 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -48.04 -48.1 33.24 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.003 0.921 . . . . 0.97999999999999998 112.229 176.677 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.6 mm -73.88 -34.59 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.23 -0.919 . . . . 1.8100000000000001 113.408 177.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -77.17 -24.16 51.52 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.417 1.266 . . . . 1.96 114.417 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.6 mt -58.63 -21.07 52.7 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.232 1.413 . . . . 1.95 113.769 174.057 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -78.09 141.7 38.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.858 1.263 . . . . 2.54 113.589 -174.273 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.9 154.51 33.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.283 1.033 . . . . 1.78 112.732 175.493 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.61 -12.93 35.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.498 1.519 . . . . 2.5800000000000001 113.549 175.18 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -143.42 164.74 29.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.794 2.038 . . . . 3.1699999999999999 113.3 -175.497 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.15 163.59 32.31 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.343 1.457 . . . . 0.72999999999999998 111.524 171.616 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.4 m -114.75 106.8 14.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.017 1.327 . . . . 0.80000000000000004 110.062 170.962 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.52 133.12 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.084 -1.08 . . . . 0.65000000000000002 108.084 174.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.61 118.43 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.519 0.728 . . . . 2.2799999999999998 110.451 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.8 m . . . . . 0 N--CA 1.466 0.349 0 C-N-CA 125.183 1.393 . . . . 2.4199999999999999 109.765 -171.711 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 120.537 0.208 . . . . 3.0899999999999999 111.128 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 t -139.5 96.81 3.15 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.678 1.191 . . . . 1.6899999999999999 110.447 -177.275 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -91.14 150.14 21.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.769 1.025 . . . . 2.5099999999999998 113.769 -179.724 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -124.18 140.55 52.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.308 1.843 . . . . 2.8199999999999998 111.182 169.685 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -98.05 126.02 43.29 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.71 0.804 . . . . 1.9399999999999999 109.099 169.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 m -136.28 164.78 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.698 1.199 . . . . 0.80000000000000004 112.625 -172.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.36 151.14 31.17 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.663 0.785 . . . . 3.4100000000000001 111.741 169.714 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.05 -24.87 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.385 0.883 . . . . 1.0900000000000001 113.385 175.474 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -69.4 -27.88 65.68 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.843 -1.161 . . . . 3.1299999999999999 113.199 170.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.9 mt -100.74 -7.78 23.42 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.872 1.669 . . . . 1.29 114.434 -168.792 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.67 141.83 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.631 0.773 . . . . 1.55 110.341 169.131 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -126.07 159.67 32.17 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.78 1.632 . . . . 3.6899999999999999 111.962 -170.018 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.266 16.8 ptt85 -75.53 15.82 0.43 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.957 1.836 . . . . 2.7799999999999998 115.957 -174.217 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.31 -2.58 15.48 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.651 2.072 . . . . 1.04 113.539 168.847 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -84.02 155.84 22.54 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 118.731 1.266 . . . . 2.9900000000000002 111.735 178.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 mt -118.69 128.95 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.55 1.14 . . . . 1.1699999999999999 109.167 169.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.6 mm -107.09 168.45 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 128.018 2.527 . . . . 1.26 111.022 -167.757 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -129.13 136.52 50.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.775 1.23 . . . . 1.78 109.832 170.068 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.07 132.69 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.393 1.077 . . . . 0.72999999999999998 110.405 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.9 m -90.15 166.52 19.84 Favored Pre-proline 0 N--CA 1.482 1.127 0 N-CA-C 113.427 0.899 . . . . 1.24 113.427 -170.13 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -61.8 128.01 23.16 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.76 2.307 . . . . 1.03 110.598 169.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.42 8.46 59.54 Favored Glycine 0 CA--C 1.539 1.583 0 O-C-N 121.278 -0.889 . . . . 0.88 114.884 -170.573 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.47 169.02 54.9 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.636 1.588 . . . . 0.95999999999999996 114.791 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -125.61 140.35 52.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.964 1.305 . . . . 1.96 110.979 -175.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -79.06 127.39 79.66 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 112.671 0.619 . . . . 1.74 112.671 -173.218 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -87.0 -24.59 1.3 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.397 2.731 . . . . 0.64000000000000001 114.875 -174.856 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 m -149.86 171.45 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 127.877 2.471 . . . . 0.71999999999999997 108.988 -177.924 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.54 139.77 38.41 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.428 1.013 . . . . 1.79 113.111 178.86 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.44 -154.86 14.5 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 114.701 0.641 . . . . 0.65000000000000002 114.701 -170.597 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -120.73 141.45 50.43 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.125 1.157 . . . . 5.2000000000000002 114.125 -173.147 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.1 t -89.83 132.64 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 128.647 2.779 . . . . 0.65000000000000002 108.997 174.582 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 pt -139.09 35.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 113.456 0.91 . . . . 0.83999999999999997 113.456 171.419 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -165.75 137.4 3.92 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.673 1.189 . . . . 3.0899999999999999 111.149 166.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.1 -164.73 26.21 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 117.469 1.748 . . . . 0.94999999999999996 117.469 168.215 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -151.48 109.03 3.62 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.321 1.449 . . . . 2.0600000000000001 111.97 -172.601 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.13 170.21 16.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.726 0.774 . . . . 1.24 112.024 172.108 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 ttm -117.43 144.11 45.33 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.911 1.284 . . . . 1.1899999999999999 110.092 176.203 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.0 t -130.29 139.74 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.851 1.26 . . . . 0.63 111.259 -169.791 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -98.11 127.51 44.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.384 0.674 . . . . 2.3199999999999998 112.427 175.173 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -127.95 20.7 6.42 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.515 1.526 . . . . 2.0600000000000001 112.879 -173.336 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 p -64.55 -22.2 66.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.878 1.807 . . . . 1.4299999999999999 115.878 -169.57 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.68 -42.65 11.23 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.752 0.821 . . . . 1.0600000000000001 109.543 168.654 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.77 -59.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.802 1.241 . . . . 1.0900000000000001 112.505 -171.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.0 p -106.91 -10.56 15.96 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.548 1.539 . . . . 1.23 113.361 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.58 13.01 76.88 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 119.151 -0.805 . . . . 1.3100000000000001 114.574 176.693 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -58.32 -47.39 83.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.718 1.207 . . . . 2.8300000000000001 113.407 -174.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 61.75 19.76 10.82 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.507 1.299 . . . . 1.3400000000000001 114.507 178.569 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.4 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 28.6 ttt -150.68 136.93 10.97 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 128.466 2.706 . . . . 4.4900000000000002 106.729 168.366 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 74' ' ' MET . 46.0 Cg_exo -59.13 151.73 64.57 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.288 3.325 . . . . 1.29 115.2 -176.038 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.23 134.38 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.555 1.942 . . . . 0.85999999999999999 111.597 -169.332 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.97 141.87 32.9 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.054 1.131 . . . . 0.94999999999999996 114.054 -173.234 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -124.72 142.35 51.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.4 1.88 . . . . 0.76000000000000001 111.496 173.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -142.03 174.71 3.51 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 128.968 2.907 . . . . 3.48 109.84 -176.637 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.76 126.65 19.48 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 CA-C-N 121.577 1.599 . . . . 0.84999999999999998 110.493 167.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.39 9.55 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.045 1.307 . . . . 0.76000000000000001 114.315 -169.757 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.3 m -120.41 153.14 36.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 119.233 1.517 . . . . 1.45 111.749 177.387 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 p -101.5 152.28 20.95 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.344 1.429 . . . . 0.89000000000000001 113.358 175.034 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.1 m -136.41 155.03 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.803 1.641 . . . . 0.54000000000000004 111.41 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.91 143.97 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.487 1.515 . . . . 0.91000000000000003 112.802 -179.285 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.45 147.91 29.97 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.394 1.078 . . . . 0.59999999999999998 112.663 -178.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.98 -6.26 49.76 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.599 -1.112 . . . . 0.76000000000000001 115.705 178.081 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.8 p -79.26 163.37 25.0 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.964 1.382 . . . . 1.29 111.844 169.267 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mm -110.93 129.93 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.351 1.06 . . . . 0.68000000000000005 111.253 -173.185 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -92.03 135.21 34.14 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.816 1.646 . . . . 1.8600000000000001 110.858 176.303 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -88.77 -107.01 0.08 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.215 1.191 . . . . 3.4399999999999999 114.215 -173.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -82.24 -45.44 15.02 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 116.722 2.119 . . . . 3.1400000000000001 116.722 -166.827 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.41 140.72 15.19 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.069 0.849 . . . . 1.9299999999999999 113.539 -172.655 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.1 p -82.93 137.15 34.32 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.652 0.726 . . . . 1.6000000000000001 112.53 171.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.1 mt -130.03 156.17 44.93 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.953 1.301 . . . . 0.93999999999999995 112.079 -170.392 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.97 122.21 42.53 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.366 1.067 . . . . 2.6699999999999999 110.82 174.757 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -115.6 123.02 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.799 1.239 . . . . 1.48 111.895 -173.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 74.8 m -79.51 120.24 23.61 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.674 -1.267 . . . . 2.2799999999999998 108.956 168.258 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.88 118.24 20.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.644 -0.502 . . . . 0.78000000000000003 109.644 173.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.7 p -108.72 -0.28 20.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.39 1.076 . . . . 2.1499999999999999 113.31 175.226 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -137.96 139.65 39.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.093 1.357 . . . . 1.6499999999999999 111.618 176.437 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 m -78.84 157.18 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.702 -0.851 . . . . 1.5600000000000001 108.702 165.52 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.74 -35.24 73.45 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 120.954 -1.091 . . . . 1.3600000000000001 115.569 -169.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.22 64.43 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.629 1.344 . . . . 1.8 114.629 174.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -80.18 -8.18 59.31 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.814 1.646 . . . . 2.54 115.274 173.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 37.4 p -58.86 158.22 8.56 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.609 1.337 . . . . 1.6100000000000001 114.609 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.7 m -60.68 -35.65 76.79 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.711 0.804 . . . . 3.25 111.035 170.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.63 -43.64 96.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.208 1.003 . . . . 1.47 112.101 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.9 p -72.95 -21.84 60.81 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.901 1.074 . . . . 2.1699999999999999 113.901 170.092 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -70.44 -38.28 74.5 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.606 -1.309 . . . . 2.04 112.01 174.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.22 -52.39 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.848 1.259 . . . . 1.3500000000000001 110.741 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.481 1.088 0 CA-C-N 119.285 0.948 . . . . 1.3899999999999999 112.951 179.289 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 111.28 0.104 . . . . 2.2799999999999998 111.28 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.9 tp -42.01 -31.04 0.31 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.533 2.733 . . . . 1.8899999999999999 115.861 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.97 -32.67 65.37 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.187 1.18 . . . . 2.0499999999999998 114.187 177.566 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.98 -30.55 68.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.822 1.249 . . . . 5.6500000000000004 112.497 -170.14 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -53.16 -37.29 61.74 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.803 1.641 . . . . 0.96999999999999997 112.51 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -75.84 -35.93 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.962 1.305 . . . . 1.52 112.821 175.358 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.1 m -72.82 -39.74 66.37 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.039 1.126 . . . . 1.29 114.039 -175.464 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.21 -18.01 65.06 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.301 1.223 . . . . 2.1899999999999999 114.301 -173.056 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -70.09 141.33 52.77 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.273 1.029 . . . . 2.2799999999999998 112.829 -172.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.04 139.1 30.79 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.583 0.957 . . . . 2.23 113.583 -176.013 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -90.69 -8.18 50.61 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.565 1.546 . . . . 1.78 113.868 -171.364 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.01 160.85 38.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.142 1.377 . . . . 3.6600000000000001 113.896 -179.236 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.04 166.37 24.89 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.812 1.645 . . . . 0.93999999999999995 112.005 176.03 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.9 m -117.62 105.38 11.98 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.624 1.17 . . . . 1.1200000000000001 111.322 169.956 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.0 mt -82.87 130.44 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.482 1.113 . . . . 0.81000000000000005 108.925 177.034 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -126.52 128.11 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 121.501 -0.749 . . . . 1.8600000000000001 112.139 -176.314 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 124.737 1.215 . . . . 2.98 109.56 169.67 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.548 0.881 0 N-CA-C 115.351 1.612 . . . . 3.8700000000000001 115.351 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.6 t -112.58 109.82 19.6 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.373 1.069 . . . . 1.7 108.409 166.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -107.9 145.01 34.34 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.622 0.971 . . . . 2.7599999999999998 113.622 -168.849 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -124.02 128.53 49.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.511 1.924 . . . . 3.1699999999999999 109.97 173.626 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -91.86 124.05 35.7 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.208 -0.932 . . . . 2.1200000000000001 109.228 173.576 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 m -136.51 162.75 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.505 1.298 . . . . 1.1200000000000001 114.505 -169.667 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.47 147.99 35.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.001 1.321 . . . . 2.7000000000000002 111.653 169.412 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -57.68 -22.81 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.694 0.998 . . . . 1.25 113.694 -178.75 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.52 -12.79 61.56 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.624 -1.298 . . . . 3.7400000000000002 113.258 175.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.87 -2.07 21.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.318 1.447 . . . . 1.55 113.863 -171.009 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.39 148.26 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.862 1.265 . . . . 1.47 110.571 170.109 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -137.56 165.68 25.74 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.176 1.391 . . . . 2.8500000000000001 113.379 -178.538 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.0 ptt85 -67.51 25.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 118.463 2.764 . . . . 2.6099999999999999 118.463 -168.178 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.32 9.7 1.28 Allowed Glycine 0 CA--C 1.54 1.629 0 C-N-CA 126.122 1.82 . . . . 1.0600000000000001 114.387 171.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -83.83 155.79 22.79 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.039 1.42 . . . . 2.7200000000000002 112.408 175.134 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 mt -111.8 124.99 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.51 0.724 . . . . 1.3300000000000001 110.254 172.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.1 mm -121.61 129.28 75.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 127.268 2.227 . . . . 0.78000000000000003 110.452 -169.38 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -92.04 128.7 37.98 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.339 -0.851 . . . . 2.21 110.536 171.3 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -102.76 135.4 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.837 1.255 . . . . 0.76000000000000001 110.346 -177.867 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.0 m -89.2 156.05 48.94 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.288 1.035 . . . . 1.24 112.433 -178.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -59.19 143.28 99.82 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.929 1.753 . . . . 1.27 111.641 168.796 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.05 -6.85 3.58 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.313 0.958 . . . . 1.3300000000000001 114.427 -169.173 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.7 151.16 50.28 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 119.246 1.523 . . . . 1.1499999999999999 113.054 177.342 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -103.03 142.8 33.49 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.826 1.25 . . . . 1.97 110.875 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -75.49 125.25 88.92 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.881 -0.512 . . . . 2.3199999999999998 112.059 -179.352 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.3 -25.46 3.88 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.88 2.387 . . . . 0.93999999999999995 113.922 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.3 m -151.97 171.95 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 127.711 2.404 . . . . 0.80000000000000004 109.057 -176.476 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.22 151.26 19.93 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.646 0.778 . . . . 2.27 112.229 177.109 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.74 -172.08 41.85 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 116.139 1.216 . . . . 0.75 116.139 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -108.37 129.26 55.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.66 1.584 . . . . 4.3300000000000001 111.703 -175.324 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.2 t -87.29 127.96 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.115 2.166 . . . . 0.76000000000000001 109.218 -176.005 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.4 pt -142.12 29.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 113.728 1.01 . . . . 1.01 113.728 -172.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.22 141.45 1.61 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.784 1.634 . . . . 2.9199999999999999 109.534 165.093 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.75 -174.75 41.4 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 122.433 1.018 . . . . 0.75 114.98 170.162 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.43 103.96 3.19 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.135 0.974 . . . . 2.9100000000000001 111.07 -167.845 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -144.44 172.73 12.54 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.212 0.819 . . . . 1.0700000000000001 113.212 -172.697 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.5 ttm -124.71 133.64 53.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.981 1.312 . . . . 1.03 110.04 -176.647 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -123.28 137.34 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.27 1.428 . . . . 0.81999999999999995 111.637 -169.063 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -95.71 103.63 15.52 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.87 1.268 . . . . 2.1800000000000002 110.682 -176.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -108.6 -1.5 19.55 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.669 1.588 . . . . 2.0600000000000001 113.677 -170.343 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 p -53.4 -33.06 52.41 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.552 2.056 . . . . 1.4199999999999999 116.552 -169.28 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.23 -44.34 22.0 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.652 1.569 . . . . 1.1399999999999999 110.775 173.853 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mm -62.04 -49.11 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.215 1.806 . . . . 1.2 111.621 -174.311 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.9 p -118.27 -2.68 11.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.009 1.114 . . . . 1.3700000000000001 114.009 -171.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.24 18.91 70.55 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.924 1.249 . . . . 1.1299999999999999 114.732 178.027 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -61.08 -179.12 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.543 1.137 . . . . 2.77 111.138 168.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.05 -20.35 0.88 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.322 1.449 . . . . 1.72 114.141 177.637 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -125.58 153.22 72.73 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.827 2.051 . . . . 3.04 110.336 167.763 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.0 165.83 31.43 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.237 2.625 . . . . 1.6699999999999999 114.019 -174.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.17 133.43 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 127.047 2.139 . . . . 0.94999999999999996 112.191 -168.596 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.88 141.03 36.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.35 1.06 . . . . 0.72999999999999998 113.567 178.796 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -126.08 150.0 48.49 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.662 1.985 . . . . 0.81999999999999995 111.38 178.254 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 17.5 ptpt -144.41 176.29 2.33 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.543 2.337 . . . . 2.3599999999999999 110.257 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 37.5 Cg_endo -60.47 131.01 36.02 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 CA-C-N 122.047 1.767 . . . . 0.83999999999999997 110.463 167.619 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.05 28.68 33.48 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 118.092 -1.393 . . . . 0.83999999999999997 114.805 -171.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.3 m -108.02 174.14 6.01 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.853 1.826 . . . . 1.5800000000000001 110.959 174.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -125.79 156.44 39.5 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.437 -1.414 . . . . 0.89000000000000001 112.831 175.198 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.09 146.16 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.716 1.606 . . . . 0.57999999999999996 112.648 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.85 152.3 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.73 2.412 . . . . 0.98999999999999999 112.42 170.288 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.46 155.19 38.25 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.733 0.813 . . . . 0.90000000000000002 112.158 177.02 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.53 -1.37 52.05 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.519 1.057 . . . . 0.94999999999999996 115.543 176.467 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 p -76.86 162.81 27.32 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.066 1.433 . . . . 1.6100000000000001 112.306 172.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.76 137.98 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.722 1.209 . . . . 0.77000000000000002 111.082 -174.384 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -84.31 134.73 34.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.199 1.0 . . . . 2.52 111.152 170.119 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.26 50.92 1.49 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.135 1.532 . . . . 3.7400000000000002 115.135 179.214 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -163.97 -36.43 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.1 1.518 . . . . 3.3799999999999999 115.1 171.12 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.26 169.74 28.22 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-N 120.197 1.362 . . . . 1.97 115.411 -171.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.0 m -69.56 137.46 52.42 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.547 1.314 . . . . 1.9399999999999999 114.547 -171.192 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.49 159.98 31.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.547 1.939 . . . . 1.0800000000000001 110.415 171.622 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.4 tp -114.07 126.51 55.18 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.037 0.935 . . . . 2.77 110.778 173.193 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.36 132.43 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.842 1.257 . . . . 1.1399999999999999 111.272 -170.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 46.7 t -87.18 121.17 29.28 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.529 -0.915 . . . . 3.3199999999999998 108.529 168.008 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.93 130.48 35.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.083 0.953 . . . . 0.82999999999999996 110.604 -178.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.9 p -120.72 9.05 10.67 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.555 1.317 . . . . 2.1299999999999999 114.555 -175.523 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -149.04 155.15 40.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.428 1.491 . . . . 2.4100000000000001 111.575 168.499 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.33 164.03 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 108.71 -0.848 . . . . 1.5800000000000001 108.71 163.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 -39.66 95.55 Favored Glycine 0 N--CA 1.473 1.155 0 O-C-N 120.719 -1.238 . . . . 1.3999999999999999 113.536 -170.664 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.72 77.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.417 1.109 . . . . 1.8200000000000001 113.27 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -77.37 -6.65 54.09 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.127 1.528 . . . . 2.6299999999999999 115.127 175.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.0 p -63.62 148.21 49.52 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.686 -1.259 . . . . 1.6699999999999999 111.182 174.543 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.6 m -65.27 -34.38 78.22 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.506 -0.746 . . . . 3.6499999999999999 110.312 169.857 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.1 tp -49.34 -51.87 31.73 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.435 1.494 . . . . 1.6799999999999999 112.565 172.485 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.2 m -74.37 -24.15 59.11 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.1 1.148 . . . . 2.4700000000000002 114.1 177.071 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -71.45 -40.5 70.32 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.879 1.271 . . . . 2.4399999999999999 112.75 173.438 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.2 mt -51.63 -46.48 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.271 1.028 . . . . 1.47 111.71 -178.033 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 113.936 1.087 . . . . 1.3 113.936 179.488 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 113.18 0.808 . . . . 2.73 113.18 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -82.83 -38.79 22.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.666 0.787 . . . . 4.7000000000000002 110.735 169.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.44 -42.31 87.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.357 0.663 . . . . 1.6000000000000001 111.631 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.9 tp -51.42 -34.24 33.93 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.706 1.602 . . . . 2.5800000000000001 114.341 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.32 -44.86 20.78 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.395 0.887 . . . . 2.1400000000000001 113.395 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -61.38 -34.51 75.46 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.587 1.155 . . . . 3.1000000000000001 113.299 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.25 -49.76 6.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.511 1.524 . . . . 0.96999999999999997 112.117 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -74.37 -30.42 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.836 1.05 . . . . 2.2200000000000002 113.836 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -67.3 -27.62 67.32 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.544 -0.722 . . . . 1.99 112.265 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.73 -14.58 59.27 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.998 1.481 . . . . 2.6000000000000001 114.998 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -63.4 129.3 39.67 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 120.55 1.523 . . . . 3.0899999999999999 112.142 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.46 158.6 33.39 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.993 1.317 . . . . 1.8700000000000001 112.159 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.1 p -98.34 -24.54 15.17 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 116.061 1.874 . . . . 3.1499999999999999 116.061 -168.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.27 159.48 37.72 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.88 1.067 . . . . 4.21 113.88 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.86 149.39 40.22 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.596 1.558 . . . . 1.0700000000000001 111.762 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 m -95.01 109.18 21.25 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.502 0.721 . . . . 1.5700000000000001 112.649 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.7 mt -81.09 140.18 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.646 1.178 . . . . 1.3300000000000001 108.616 169.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.72 127.01 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.102 0.953 . . . . 2.0499999999999998 112.173 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 92.9 m -120.23 134.28 55.29 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.67 2.388 . . . . 2.1299999999999999 109.979 -170.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.35 145.79 28.44 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.082 1.353 . . . . 2.9900000000000002 109.926 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.11 5.13 1.29 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.638 2.088 . . . . 3.5299999999999998 116.638 -167.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.5 m -133.34 -60.11 0.85 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.116 1.367 . . . . 4.5499999999999998 110.428 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -158.7 -169.51 2.74 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.772 2.829 . . . . 4.4100000000000001 106.265 168.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -55.37 -13.98 1.67 Allowed 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 113.616 0.969 . . . . 4.2999999999999998 113.616 168.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 pt -68.46 -22.56 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 127.158 2.183 . . . . 3.8300000000000001 114.433 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 tt -116.32 128.52 55.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.374 0.988 . . . . 3.0600000000000001 111.458 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -130.25 127.66 40.05 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.787 1.235 . . . . 3.1699999999999999 111.063 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.4 t -133.04 140.05 47.51 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.725 2.01 . . . . 2.0 110.009 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.08 149.15 39.41 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.796 0.838 . . . . 2.6699999999999999 112.506 -168.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.85 126.31 30.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.849 1.66 . . . . 2.6899999999999999 110.765 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -87.01 126.82 34.99 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.851 -1.155 . . . . 2.0499999999999998 108.761 167.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.48 162.19 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.211 1.405 . . . . 1.21 111.763 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.97 147.53 42.95 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.29 0.567 . . . . 3.9100000000000001 111.124 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -56.26 -23.91 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 114.686 1.365 . . . . 1.3999999999999999 114.686 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.57 -13.71 60.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.549 1.315 . . . . 3.8399999999999999 114.549 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.7 mt -106.67 -13.38 15.3 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.956 1.302 . . . . 1.47 113.818 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.97 142.36 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.052 1.341 . . . . 1.5600000000000001 110.647 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -114.71 161.24 18.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.483 1.113 . . . . 2.96 113.333 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -76.27 31.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.499 1.666 . . . . 4.3099999999999996 115.499 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.7 0.21 4.96 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 127.834 2.635 . . . . 1.1100000000000001 113.725 169.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -89.68 160.41 16.62 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.339 1.456 . . . . 2.1899999999999999 112.139 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.4 mt -118.77 128.55 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.583 1.553 . . . . 1.22 108.368 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.4 mm -120.3 136.54 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.304 1.441 . . . . 0.84999999999999998 113.933 -166.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -78.14 143.75 37.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.774 1.23 . . . . 2.3599999999999999 112.303 172.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.13 132.68 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.695 0.798 . . . . 0.78000000000000003 110.808 167.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.436 ' HB ' ' HD2' ' A' ' 47' ' ' PRO . 10.9 m -102.47 166.97 11.07 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 125.278 1.431 . . . . 1.1699999999999999 112.282 -169.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 46' ' ' VAL . 36.3 Cg_endo -61.13 120.83 8.73 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.885 1.723 . . . . 0.96999999999999997 111.626 171.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.63 -6.17 82.18 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 126.638 2.066 . . . . 0.94999999999999996 115.159 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.18 154.4 46.24 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 119.123 1.461 . . . . 1.01 114.285 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -109.14 152.92 24.46 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.929 1.292 . . . . 1.99 111.852 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -89.13 126.8 57.75 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.813 1.042 . . . . 2.29 113.813 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.18 -22.24 3.45 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.028 3.152 . . . . 1.47 114.532 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.4 m -143.64 170.54 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.206 2.202 . . . . 1.3200000000000001 109.41 -176.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.31 166.64 17.27 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.072 0.549 . . . . 2.54 110.811 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.98 -175.53 47.08 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.936 1.134 . . . . 1.0700000000000001 115.936 170.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -105.29 142.33 35.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.617 1.567 . . . . 3.7200000000000002 111.277 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.08 131.17 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.367 2.267 . . . . 1.1699999999999999 110.27 -171.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.07 30.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 113.549 0.944 . . . . 1.0 113.549 -175.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -170.62 144.97 2.45 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.119 2.568 . . . . 3.1499999999999999 107.213 168.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.48 179.61 46.51 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 116.612 1.405 . . . . 1.53 116.612 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -152.1 41.76 0.66 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.902 1.815 . . . . 2.98 115.902 -166.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.683 ' H ' HD21 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -75.88 156.53 34.25 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.409 -1.432 . . . . 1.2 113.19 -178.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 42.7 ttm -96.67 127.21 42.44 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.928 -0.767 . . . . 1.3100000000000001 108.928 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.9 t -112.95 129.05 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 124.58 1.152 . . . . 1.05 110.685 -170.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -91.66 105.64 17.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.538 0.735 . . . . 2.25 110.775 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -117.8 23.61 11.58 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.888 2.075 . . . . 2.4100000000000001 113.004 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 93.0 p -63.82 -18.58 64.26 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 116.659 2.096 . . . . 1.6799999999999999 116.659 -169.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.84 -48.86 7.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.441 1.096 . . . . 1.4199999999999999 109.907 169.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.88 -58.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.82 1.248 . . . . 1.6399999999999999 111.722 -172.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.4 p -103.9 -12.35 16.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.298 1.039 . . . . 1.75 112.66 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.63 -3.02 85.05 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.484 -1.176 . . . . 1.79 114.737 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -63.94 103.47 0.59 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.585 1.192 . . . . 3.1299999999999999 110.693 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.97 -17.51 61.46 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.815 -1.178 . . . . 1.6200000000000001 111.577 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.69 103.9 42.82 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 128.099 2.56 . . . . 5.1200000000000001 107.947 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -55.35 147.13 58.14 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.725 2.95 . . . . 2.3500000000000001 114.19 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.5 t -94.21 125.26 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.744 1.218 . . . . 1.24 111.944 -167.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.18 141.29 38.76 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.709 -0.619 . . . . 1.1299999999999999 111.72 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -115.08 169.54 9.03 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.796 1.638 . . . . 1.54 111.526 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -157.15 169.33 10.8 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 127.714 2.406 . . . . 3.8900000000000001 110.727 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.18 135.1 48.93 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 CA-C-N 121.451 1.554 . . . . 1.3500000000000001 108.41 165.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.88 39.37 17.13 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.28 0.943 . . . . 1.1699999999999999 113.253 -168.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 t -124.76 174.26 8.02 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.624 1.57 . . . . 1.95 111.254 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 p -133.26 150.59 51.92 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.518 -1.363 . . . . 1.27 112.566 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.06 161.84 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 125.411 1.485 . . . . 0.93999999999999995 112.79 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.0 150.31 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.298 1.839 . . . . 1.3200000000000001 113.435 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.67 148.33 24.86 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.038 1.335 . . . . 1.0600000000000001 112.944 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.88 -4.1 67.19 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 115.333 0.893 . . . . 0.95999999999999996 115.333 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 97.6 p -84.61 160.02 20.5 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.498 1.149 . . . . 1.3400000000000001 111.969 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mm -113.21 127.13 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.469 1.107 . . . . 0.94999999999999996 112.203 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -93.9 144.0 25.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.238 1.415 . . . . 1.9099999999999999 113.083 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -157.6 145.95 19.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.884 1.274 . . . . 3.8599999999999999 111.332 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 46.54 87.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.504 2.322 . . . . 3.8999999999999999 113.585 168.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.38 -13.42 2.28 Favored Glycine 0 CA--C 1.542 1.761 0 N-CA-C 116.251 1.26 . . . . 3.8900000000000001 116.251 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.2 m 40.1 108.61 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 130.964 3.706 . . . . 2.6099999999999999 117.322 170.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.683 HD21 ' H ' ' A' ' 62' ' ' SER . 57.4 mt -106.33 160.37 15.42 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.987 1.106 . . . . 1.8799999999999999 113.987 -169.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.68 121.28 41.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.332 1.853 . . . . 3.1099999999999999 108.476 168.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.45 126.23 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.653 0.781 . . . . 1.4099999999999999 111.167 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.81 121.51 30.31 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.375 -0.828 . . . . 1.6100000000000001 109.999 168.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.65 129.95 35.04 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.2 0.6 . . . . 0.95999999999999996 112.147 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.9 p -117.77 -6.12 11.07 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.85 1.66 . . . . 2.3500000000000001 113.968 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -138.98 148.78 43.93 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.649 1.98 . . . . 2.29 110.242 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.5 m -92.42 -174.05 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.583 1.153 . . . . 1.9399999999999999 112.638 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.65 -33.16 83.58 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.857 -1.152 . . . . 2.7799999999999998 113.557 -171.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.52 -51.67 11.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.265 1.426 . . . . 2.5099999999999998 112.888 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.29 -8.13 53.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.499 1.919 . . . . 3.5800000000000001 115.551 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 109' ' ' SER . 4.6 t -48.17 146.56 2.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.974 2.109 . . . . 2.7999999999999998 114.872 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 t -62.1 -21.77 65.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.079 0.552 . . . . 2.6600000000000001 111.992 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.5 tp -59.89 -41.18 91.03 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.647 -1.283 . . . . 1.71 111.897 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.515 ' H ' HG23 ' A' ' 106' ' ' THR . 8.8 t -73.26 -27.38 61.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.475 1.11 . . . . 2.6800000000000002 111.564 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -70.06 -39.6 75.58 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.408 -0.807 . . . . 2.4300000000000002 112.146 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.8 mt -60.04 -44.68 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.668 1.587 . . . . 2.27 111.657 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.02 -9.19 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 115.249 1.574 . . . . 2.1200000000000001 115.249 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -75.19 -38.92 60.58 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.318 -0.863 . . . . 4.8799999999999999 111.617 166.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.94 -41.41 36.38 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.628 2.371 . . . . 4.4500000000000002 113.161 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.8 t -70.74 -22.44 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.325 1.45 . . . . 3.8599999999999999 112.243 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.28 -59.46 5.29 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.256 1.022 . . . . 5.4199999999999999 110.74 170.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -65.9 -5.34 8.92 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.988 1.847 . . . . 7.2699999999999996 115.988 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.63 -32.47 69.79 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.999 1.272 . . . . 7.9500000000000002 112.718 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 116.865 -1.54 . . . . 8.0399999999999991 115.105 -179.521 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.9 p . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 114.322 1.23 . . . . 3.77 114.322 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -75.95 -36.73 59.2 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.962 0.905 . . . . 4.7400000000000002 110.042 169.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.06 77.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.552 0.741 . . . . 2.1400000000000001 111.095 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.28 -32.16 47.35 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.378 1.071 . . . . 2.0499999999999998 113.405 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.51 -54.21 7.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.759 0.824 . . . . 2.1000000000000001 112.63 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -54.53 -36.98 64.84 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.463 1.505 . . . . 2.52 113.002 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.77 -38.96 67.87 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.457 1.103 . . . . 1.24 113.491 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.8 mm -74.66 -34.07 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 118.954 0.797 . . . . 1.49 112.811 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -69.52 -25.34 63.99 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.247 -0.908 . . . . 1.3500000000000001 112.43 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.31 -15.77 63.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.36 2.264 . . . . 2.4300000000000002 114.873 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -73.56 140.72 46.47 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.692 1.197 . . . . 2.2200000000000002 112.257 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.42 165.39 15.6 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.578 1.151 . . . . 1.79 112.47 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -93.7 -41.99 9.4 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.354 0.872 . . . . 2.5299999999999998 113.354 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -125.37 158.97 32.96 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.135 1.531 . . . . 4.29 115.135 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.55 149.83 47.02 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.646 1.578 . . . . 0.92000000000000004 111.311 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.7 m -106.43 108.8 20.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.233 1.013 . . . . 0.93999999999999995 112.052 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.7 mt -90.09 132.9 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.217 1.807 . . . . 0.92000000000000004 109.576 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.23 139.55 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.609 0.719 . . . . 1.98 112.442 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.9 m -129.28 138.5 51.67 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.733 2.013 . . . . 1.8600000000000001 110.402 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.4 mt -93.62 73.21 4.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.841 0.856 . . . . 2.8900000000000001 109.381 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.03 -12.52 39.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.62 1.168 . . . . 3.5499999999999998 113.772 -173.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.6 m -148.42 139.43 23.14 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.901 1.281 . . . . 3.3700000000000001 110.858 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 25' ' ' ILE . 22.9 t70 -8.96 58.78 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.002 1 C-N-CA 134.125 4.97 . . . . 4.5199999999999996 118.396 -171.144 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.38 -9.78 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 125.593 1.557 . . . . 4.0099999999999998 113.938 -167.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 23' ' ' ASP . 22.6 pt -82.8 -18.01 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 130.011 3.324 . . . . 3.4700000000000002 116.123 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 tt -125.42 120.93 32.38 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.841 0.856 . . . . 2.7599999999999998 110.802 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -98.64 127.27 44.51 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.009 -0.996 . . . . 2.29 109.533 175.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 t -123.48 122.04 37.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.413 1.485 . . . . 1.95 108.991 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -116.41 141.42 48.19 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.519 1.128 . . . . 2.2799999999999998 110.012 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -136.02 132.94 36.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.903 1.281 . . . . 2.8500000000000001 110.616 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -100.1 134.56 42.85 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 119.344 0.974 . . . . 1.6599999999999999 110.506 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -138.75 163.47 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.656 1.182 . . . . 0.85999999999999999 112.104 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.19 146.63 43.23 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.9 -0.778 . . . . 3.1299999999999999 108.9 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -63.75 -1.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 114.997 1.48 . . . . 1.1899999999999999 114.997 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -83.48 -17.17 42.92 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.648 1.579 . . . . 3.9500000000000002 114.855 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.4 -9.32 14.95 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.937 1.458 . . . . 1.3300000000000001 114.937 -165.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.35 151.21 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 125.677 1.591 . . . . 1.46 109.743 168.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.71 160.26 24.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.099 1.148 . . . . 3.8100000000000001 114.099 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -74.71 47.13 0.31 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.25 1.82 . . . . 4.8600000000000003 113.892 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.27 23.12 0.23 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.312 1.434 . . . . 1.1799999999999999 113.545 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -129.36 172.57 11.36 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.032 1.733 . . . . 2.8599999999999999 111.316 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 mm -108.29 123.89 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.566 1.946 . . . . 1.4199999999999999 110.038 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.1 mm -117.16 126.45 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.406 1.482 . . . . 0.90000000000000002 110.1 -170.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HE3' HD11 ' A' ' 96' ' ' LEU . 44.7 mtpt -94.06 139.98 30.3 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.936 0.717 . . . . 2.8999999999999999 112.936 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.11 153.24 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.689 1.196 . . . . 1.1599999999999999 112.133 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.94 165.52 23.42 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 125.654 1.581 . . . . 1.8300000000000001 112.693 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.5 124.16 14.89 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.069 2.513 . . . . 1.4099999999999999 112.156 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.68 -13.68 61.94 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.154 1.835 . . . . 1.6000000000000001 115.728 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.56 -8.52 76.5 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 116.992 1.557 . . . . 4.3899999999999997 116.992 -172.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.0 mttt 61.88 158.87 0.06 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 127.871 2.469 . . . . 1.6299999999999999 115.463 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -92.51 119.02 68.25 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.144 0.977 . . . . 2.1299999999999999 111.01 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -87.45 -13.16 4.33 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.914 2.409 . . . . 0.77000000000000002 114.618 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -147.47 168.26 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.496 1.918 . . . . 1.0900000000000001 110.503 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.57 145.39 30.38 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.707 0.803 . . . . 1.7 113.117 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.05 -159.11 32.39 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 114.484 0.554 . . . . 0.69999999999999996 114.484 -173.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -108.84 140.19 42.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.033 1.333 . . . . 3.6000000000000001 112.925 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.85 132.14 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 127.878 2.471 . . . . 0.68999999999999995 107.789 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.9 pt -140.05 29.34 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 119.378 0.99 . . . . 1.1599999999999999 112.914 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.97 137.6 3.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.06 1.344 . . . . 3.5099999999999998 108.984 169.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.83 -178.71 53.17 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 122.549 1.083 . . . . 0.81000000000000005 114.717 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.28 136.57 31.75 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.487 1.515 . . . . 2.52 111.502 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 m -148.32 156.75 42.91 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.05 1.129 . . . . 1.6499999999999999 114.05 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 29.4 ttm -104.79 133.87 48.88 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.665 -1.235 . . . . 0.98999999999999999 107.665 167.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.1 t -126.47 138.99 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.927 1.291 . . . . 0.81999999999999995 112.48 -167.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -93.09 103.03 15.36 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.585 1.554 . . . . 2.25 109.984 173.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -128.2 3.31 5.79 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.906 1.682 . . . . 1.8200000000000001 115.115 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.6 p -47.33 -29.62 2.65 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.256 1.822 . . . . 1.6299999999999999 115.399 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.86 -38.07 46.86 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.635 1.174 . . . . 1.4399999999999999 112.115 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.95 -62.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.87 2.068 . . . . 1.23 111.198 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 p -88.85 -12.73 41.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.74 1.616 . . . . 1.3700000000000001 112.577 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.74 19.24 60.13 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.76 1.171 . . . . 1.75 114.209 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -74.8 -167.73 0.62 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.336 1.455 . . . . 2.9300000000000002 111.333 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.91 13.35 1.67 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.001 1.482 . . . . 2.29 115.001 -171.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -158.23 154.24 23.5 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.672 1.589 . . . . 3.7999999999999998 111.061 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -58.97 141.26 98.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.54 2.827 . . . . 1.72 113.048 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.2 t -114.04 137.05 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.833 2.053 . . . . 1.0900000000000001 111.735 -169.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.6 133.56 33.7 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.221 -0.924 . . . . 0.85999999999999999 112.746 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -129.21 140.84 51.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.127 2.171 . . . . 1.1699999999999999 109.921 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 15.1 ptpt -148.82 -177.19 0.63 Allowed Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 126.223 1.809 . . . . 3.96 110.287 -169.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 59.5 Cg_endo -69.31 132.96 25.19 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 122.703 2.001 . . . . 1.04 110.674 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.09 7.22 68.22 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 126.222 1.867 . . . . 1.1799999999999999 114.784 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.3 t -101.56 152.35 20.89 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.105 1.952 . . . . 1.6599999999999999 111.86 -170.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.0 p -105.22 145.91 29.99 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.877 -1.139 . . . . 0.73999999999999999 113.356 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 m -137.54 161.41 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.902 1.681 . . . . 0.53000000000000003 112.183 -172.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.95 147.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.138 1.775 . . . . 0.93000000000000005 113.419 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.17 150.36 30.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.701 1.2 . . . . 0.58999999999999997 112.604 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.16 -3.63 51.48 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.239 0.924 . . . . 0.77000000000000002 115.227 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.8 p -80.97 156.86 25.74 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.331 1.066 . . . . 1.3799999999999999 111.85 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mm -107.77 123.52 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.503 0.721 . . . . 0.81000000000000005 110.763 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -83.12 128.29 34.35 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.825 -0.806 . . . . 2.0 108.825 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.86 43.9 2.68 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.28 1.215 . . . . 3.6800000000000002 114.28 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -157.92 -38.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.494 2.405 . . . . 3.6899999999999999 117.494 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.38 -175.87 27.84 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 120.626 1.557 . . . . 2.25 116.743 -168.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -116.02 122.68 45.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.624 1.169 . . . . 1.6899999999999999 111.944 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.1 mt -125.78 165.4 18.72 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.047 1.339 . . . . 0.96999999999999997 113.823 -170.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.467 HD11 ' HE3' ' A' ' 44' ' ' LYS . 8.5 mp -112.37 122.7 48.46 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.507 1.523 . . . . 2.3399999999999999 109.006 167.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.28 129.63 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.65 1.18 . . . . 1.28 110.952 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 29.2 p -86.51 120.08 27.45 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.466 -0.771 . . . . 1.6499999999999999 109.945 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.93 131.18 37.34 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.306 -0.871 . . . . 1.03 111.159 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.91 -12.33 11.41 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.65 0.981 . . . . 3.2999999999999998 113.65 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -141.58 143.47 33.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.372 1.469 . . . . 2.2200000000000002 109.227 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.5 p -75.93 158.99 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 107.755 -1.202 . . . . 3.4300000000000002 107.755 166.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.16 -39.64 71.43 Favored Glycine 0 N--CA 1.477 1.411 0 CA-C-N 121.231 1.832 . . . . 1.8400000000000001 115.196 -167.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -34.17 77.15 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.621 0.971 . . . . 2.6699999999999999 113.621 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -77.87 -10.33 59.51 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.759 2.424 . . . . 2.8500000000000001 115.392 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.7 p -66.49 156.19 35.51 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.355 0.872 . . . . 1.5900000000000001 113.355 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.2 t -57.62 -33.8 68.62 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.741 -0.6 . . . . 1.98 112.174 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.1 tp -56.14 -49.56 73.59 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.937 1.295 . . . . 1.5800000000000001 111.963 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -72.98 -24.16 60.74 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.324 1.45 . . . . 2.5699999999999998 113.515 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -70.69 -48.16 56.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.397 1.079 . . . . 1.3700000000000001 112.04 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.2 mt -53.05 -51.97 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.909 0.883 . . . . 1.4199999999999999 111.832 -169.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.6 m -69.66 -24.63 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.044 1.127 . . . . 1.3100000000000001 114.044 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -75.27 -34.72 61.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 118.764 -0.636 . . . . 4.21 112.381 171.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.06 -46.17 65.52 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.047 1.339 . . . . 2.2000000000000002 110.966 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.7 t -59.61 -43.37 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.519 -0.738 . . . . 2.25 111.334 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.13 -28.85 68.48 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.551 0.945 . . . . 3.4900000000000002 113.551 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -73.9 -30.38 62.57 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.822 1.045 . . . . 4.3200000000000003 113.822 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.19 72.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.095 0.958 . . . . 4.6399999999999997 112.333 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.502 1.921 . . . . 4.7400000000000002 113.121 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.3 p . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 112.059 0.392 . . . . 3.0699999999999998 112.059 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -82.09 -30.24 31.36 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.27 -0.894 . . . . 5.2999999999999998 112.169 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.42 -29.85 68.04 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.455 -0.778 . . . . 1.6799999999999999 112.927 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.33 -29.15 69.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.671 0.788 . . . . 1.6599999999999999 112.924 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.82 -25.68 49.01 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.981 1.104 . . . . 1.5900000000000001 113.981 169.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.81 -42.97 80.71 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.864 1.266 . . . . 2.6699999999999999 112.971 -167.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -49.85 -42.48 47.6 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.195 1.398 . . . . 1.0600000000000001 112.417 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.6 mm -72.47 -35.56 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.362 1.065 . . . . 1.8200000000000001 112.564 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.3 m -70.69 -27.76 64.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.093 0.957 . . . . 1.4399999999999999 113.331 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 mp -66.39 -25.73 66.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.177 0.806 . . . . 2.2799999999999998 113.177 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -61.64 131.16 49.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.338 0.972 . . . . 2.5899999999999999 112.209 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.31 159.47 23.87 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.96 1.096 . . . . 1.8200000000000001 113.96 -169.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.5 m -86.84 -30.32 21.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.72 1.208 . . . . 3.1099999999999999 112.338 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -141.88 161.0 39.07 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.712 1.745 . . . . 4.0800000000000001 115.712 -168.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.23 162.73 34.78 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.826 2.05 . . . . 1.0800000000000001 111.97 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.6 m -121.89 104.55 9.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.102 1.361 . . . . 1.05 112.237 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.0 mt -83.43 133.49 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.109 1.364 . . . . 0.67000000000000004 110.503 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.7 m -126.33 144.66 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.358 1.614 . . . . 2.0299999999999998 115.358 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.8 m -140.83 135.5 31.45 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.527 1.531 . . . . 2.73 111.432 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.82 87.2 6.81 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.836 -1.165 . . . . 3.77 109.441 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.48 -18.14 59.93 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.308 1.043 . . . . 3.9700000000000002 112.699 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -148.14 132.9 17.94 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.295 1.438 . . . . 5.4900000000000002 108.856 166.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 25' ' ' ILE . 44.3 t0 -32.56 75.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 131.021 3.728 . . . . 6.4100000000000001 117.556 -166.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 60.19 -23.25 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.693 2.397 . . . . 5.3200000000000003 114.779 -170.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.405 ' H ' ' C ' ' A' ' 23' ' ' ASP . 19.6 pt -65.1 -17.51 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 129.245 3.018 . . . . 4.75 115.382 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -117.56 -80.19 0.6 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.108 1.363 . . . . 5.0899999999999999 110.15 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.5 tt 61.26 135.57 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.853 2.061 . . . . 2.9300000000000002 112.295 -168.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -126.41 143.6 51.12 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.603 1.561 . . . . 1.6100000000000001 110.739 -173.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -128.17 132.58 48.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.54 1.136 . . . . 2.7799999999999998 110.843 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -108.96 132.99 53.55 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.835 1.254 . . . . 2.7999999999999998 110.392 170.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -101.54 114.92 29.38 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.687 1.13 . . . . 2.6899999999999999 110.69 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.23 159.2 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.235 1.414 . . . . 1.46 113.567 -168.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.83 154.41 33.9 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.441 1.097 . . . . 3.6099999999999999 111.025 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.62 -21.91 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 114.145 1.165 . . . . 1.46 114.145 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -73.29 -15.19 61.41 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.487 -1.383 . . . . 3.3300000000000001 113.587 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.4 mt -99.84 -1.08 38.41 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.512 1.525 . . . . 2.1699999999999999 114.422 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.33 146.37 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.579 1.552 . . . . 1.5900000000000001 111.359 173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -120.53 165.75 14.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.848 1.659 . . . . 3.3599999999999999 112.711 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -68.69 26.03 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.224 1.935 . . . . 2.7000000000000002 116.224 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.69 14.58 1.99 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 126.565 2.031 . . . . 1.1000000000000001 114.073 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -97.91 162.75 13.09 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 119.176 1.488 . . . . 2.6099999999999999 112.845 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 87.6 mt -118.56 130.94 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.257 1.423 . . . . 1.21 109.912 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.9 mm -121.19 130.89 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.824 1.649 . . . . 0.65000000000000002 112.413 -168.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HE3' HD21 ' A' ' 96' ' ' LEU . 32.2 ttmt -93.68 124.26 37.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.606 0.762 . . . . 2.1600000000000001 112.089 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.97 137.18 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.351 1.06 . . . . 0.72999999999999998 112.414 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.53 158.47 54.32 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.455 1.102 . . . . 1.27 113.361 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -62.6 126.91 19.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.724 2.283 . . . . 1.8300000000000001 111.377 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.66 -5.81 72.66 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.685 1.612 . . . . 1.0900000000000001 114.786 -169.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.51 159.04 53.22 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.764 1.173 . . . . 1.04 114.431 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -112.69 141.9 45.94 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.547 1.139 . . . . 2.5099999999999998 111.745 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.07 129.99 79.24 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 119.214 -0.422 . . . . 1.78 112.06 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -90.32 -21.7 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.391 2.727 . . . . 0.80000000000000004 114.924 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.56 166.93 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 127.405 2.282 . . . . 0.95999999999999996 109.049 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.21 140.86 29.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.081 0.855 . . . . 2.0299999999999998 111.845 173.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.61 -173.57 44.83 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 114.737 0.655 . . . . 0.83999999999999997 114.737 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -110.27 144.43 38.99 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.48 1.112 . . . . 6.4299999999999997 113.204 -170.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.11 129.13 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.574 2.35 . . . . 0.93000000000000005 109.755 -172.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.7 pt -142.86 30.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 114.225 1.194 . . . . 1.2 114.225 -171.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -168.81 143.83 3.28 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.608 1.963 . . . . 3.1099999999999999 109.367 166.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.84 -170.91 44.31 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.08 0.792 . . . . 0.95999999999999996 115.08 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -155.11 121.62 5.32 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.361 0.664 . . . . 2.9399999999999999 112.098 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.9 t -143.57 168.79 19.03 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.633 1.173 . . . . 1.1399999999999999 112.631 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.1 ttm -115.1 137.0 52.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.817 0.847 . . . . 1.2 111.458 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.93 142.47 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.302 1.841 . . . . 0.75 111.705 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.93 114.53 26.65 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.837 1.255 . . . . 1.8999999999999999 110.96 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -114.22 14.2 18.08 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 114.379 1.252 . . . . 2.0299999999999998 114.379 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.5 p -67.02 -3.35 6.98 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 117.922 2.564 . . . . 1.6899999999999999 117.922 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.62 -41.62 3.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.937 1.695 . . . . 1.24 109.865 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.3 mm -76.01 -58.5 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.362 1.065 . . . . 1.1699999999999999 111.453 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.1 p -102.03 -11.74 18.67 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.185 0.994 . . . . 1.3300000000000001 112.958 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.65 16.22 75.91 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.735 1.159 . . . . 1.3899999999999999 115.083 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -56.08 -38.12 70.24 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.396 1.098 . . . . 2.5800000000000001 113.393 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 63.49 19.42 11.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.263 1.425 . . . . 1.3200000000000001 114.134 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.6 ttm -148.29 134.42 9.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 129.589 3.156 . . . . 3.2200000000000002 105.213 169.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.41 161.79 43.37 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.29 1.993 . . . . 1.4299999999999999 112.81 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.5 t -124.7 122.28 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.279 1.432 . . . . 0.89000000000000001 110.911 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.5 145.21 33.34 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.705 0.802 . . . . 1.04 112.628 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -124.32 159.74 29.62 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.021 2.128 . . . . 0.85999999999999999 111.399 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -157.14 174.26 4.2 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 126.995 2.118 . . . . 2.73 110.732 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.25 130.1 32.69 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 CA-C-N 121.909 1.717 . . . . 1.23 109.497 166.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.18 43.21 10.9 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.713 0.673 . . . . 1.03 113.087 -169.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -131.76 167.03 20.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.265 1.426 . . . . 1.5600000000000001 110.85 175.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.8 p -124.41 150.55 45.49 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 120.554 1.524 . . . . 1.26 113.034 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 m -135.01 163.03 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.945 1.298 . . . . 0.81000000000000005 112.348 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.5 150.72 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.383 2.273 . . . . 1.03 110.67 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.76 150.88 47.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.411 0.684 . . . . 0.82999999999999996 112.521 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.75 -5.94 55.9 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 115.355 0.902 . . . . 0.90000000000000002 115.355 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.88 157.64 21.91 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.255 1.528 . . . . 2.73 111.456 169.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -110.12 131.21 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.438 1.095 . . . . 0.93000000000000005 111.025 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -96.93 132.02 43.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.309 1.444 . . . . 1.97 111.211 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -84.89 -72.96 0.45 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.128 -0.982 . . . . 3.6400000000000001 113.245 -170.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -157.85 142.95 16.75 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.556 2.343 . . . . 4.6799999999999997 107.42 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.46 11.19 1.18 Allowed Glycine 0 CA--C 1.542 1.72 0 N-CA-C 117.452 1.741 . . . . 3.2999999999999998 117.452 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.6 m 32.29 85.37 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.435 2.694 . . . . 1.8 117.036 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.8 mt -103.98 156.13 18.1 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.887 1.275 . . . . 1.3799999999999999 113.524 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.477 HD21 ' HE3' ' A' ' 44' ' ' LYS . 65.1 mt -108.85 123.89 49.77 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.425 1.09 . . . . 2.54 110.492 167.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.55 124.66 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.485 1.514 . . . . 1.5 109.542 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.7 p -82.44 120.36 25.37 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.346 -0.846 . . . . 1.77 109.586 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.5 115.29 19.04 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.355 -0.841 . . . . 1.05 109.254 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.3 p -119.29 6.35 11.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.692 1.197 . . . . 2.0800000000000001 113.524 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -147.66 145.48 28.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.109 1.763 . . . . 1.5800000000000001 110.321 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.8 m -83.64 159.6 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.74 -0.837 . . . . 1.73 108.74 164.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.18 -38.87 79.29 Favored Glycine 0 N--CA 1.475 1.262 0 O-C-N 121.025 -1.047 . . . . 1.54 114.913 -168.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.16 90.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.355 1.077 . . . . 1.9399999999999999 112.814 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -77.26 -9.21 58.66 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.249 1.574 . . . . 2.52 115.249 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.7 p -64.47 159.04 22.35 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.336 0.865 . . . . 1.6599999999999999 113.336 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -66.1 -29.29 69.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.969 -0.56 . . . . 2.04 111.627 170.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.12 -46.3 88.68 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.657 -1.277 . . . . 1.6499999999999999 112.255 171.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.6 m -68.41 -23.01 64.59 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.492 0.552 . . . . 1.6299999999999999 112.492 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.429 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 6.4 tp-100 -71.24 -40.39 71.08 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.995 1.271 . . . . 2.5 112.033 169.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 82.4 mt -54.96 -50.23 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 120.26 1.391 . . . . 1.51 110.772 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -64.91 -32.23 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 118.102 -0.951 . . . . 1.6100000000000001 113.027 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 110' ' ' GLN . 47.1 mtmt -70.71 -37.6 73.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.724 1.147 . . . . 3.23 113.12 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.1 -48.13 83.02 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.951 2.1 . . . . 3.3999999999999999 110.049 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.4 -44.13 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 119.095 -0.479 . . . . 1.97 110.962 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -58.47 -32.15 68.49 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.384 0.993 . . . . 4.3899999999999997 113.437 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.06 -24.46 62.33 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.605 1.162 . . . . 4.8600000000000003 113.935 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.92 -39.67 79.52 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.209 0.603 . . . . 3.8100000000000001 110.395 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 126.037 1.735 . . . . 4.8099999999999996 112.714 169.818 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 113.439 0.904 . . . . 2.6899999999999999 113.439 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -76.9 -26.08 53.73 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.531 1.06 . . . . 6.4900000000000002 112.542 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.97 68.91 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.56 0.744 . . . . 1.6499999999999999 112.309 171.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.12 -33.12 71.43 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.911 1.284 . . . . 1.6000000000000001 112.662 172.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.9 -29.77 58.56 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.827 0.677 . . . . 1.3799999999999999 112.827 171.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.79 -41.1 77.11 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.111 -0.993 . . . . 2.4500000000000002 112.001 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.58 -30.41 65.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.284 0.947 . . . . 1.6000000000000001 113.112 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -75.25 -45.46 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.747 1.219 . . . . 2.0499999999999998 112.409 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 m -75.66 -15.51 60.31 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.508 1.123 . . . . 1.52 113.401 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.0 tp -72.88 -24.49 60.86 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.579 2.751 . . . . 2.8900000000000001 112.949 170.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -77.61 148.48 35.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.189 0.995 . . . . 2.4500000000000002 113.407 -173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 163.4 27.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.397 1.479 . . . . 2.4100000000000001 114.514 -171.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.7 p -109.0 -38.11 5.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.21 1.404 . . . . 2.4700000000000002 112.965 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.84 154.76 51.08 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.613 1.565 . . . . 3.0600000000000001 113.366 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.35 161.99 36.55 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.823 1.649 . . . . 0.72999999999999998 113.358 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -118.61 103.2 9.48 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.462 1.105 . . . . 0.93000000000000005 112.303 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.3 mt -83.56 134.71 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.888 1.275 . . . . 0.58999999999999997 110.25 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.86 141.01 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.604 1.162 . . . . 1.71 110.283 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m -133.27 139.06 46.72 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.381 1.872 . . . . 1.74 110.118 -169.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.1 mt -100.36 125.5 46.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.517 0.727 . . . . 2.98 110.097 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -118.17 6.85 12.02 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 117.343 2.349 . . . . 4.29 117.343 -166.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -135.2 -73.35 0.46 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 120.688 1.586 . . . . 4.04 113.223 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -164.25 64.39 0.15 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.42 2.288 . . . . 4.6799999999999997 106.438 174.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.283 12.1 p30 54.98 -11.11 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 128.751 2.821 . . . . 5.0700000000000003 118.145 -169.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 pt -76.09 -3.68 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.979 1.712 . . . . 4.4400000000000004 115.253 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -130.9 120.56 23.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.834 1.654 . . . . 3.5800000000000001 111.419 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 mp -111.41 129.35 56.05 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.115 1.766 . . . . 3.0499999999999998 111.998 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 t -138.92 140.04 38.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.35 1.86 . . . . 1.6299999999999999 110.319 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -123.18 148.81 45.38 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.921 1.452 . . . . 2.3900000000000001 114.921 -170.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -121.36 146.66 46.63 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.509 2.324 . . . . 3.3999999999999999 110.325 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -111.83 132.09 54.92 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.422 1.01 . . . . 1.6799999999999999 111.641 171.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.2 m -135.9 161.27 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.199 1.0 . . . . 0.73999999999999999 113.03 -170.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.7 148.7 36.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.479 0.711 . . . . 3.3900000000000001 109.786 168.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.22 -24.95 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 113.948 1.092 . . . . 1.1699999999999999 113.948 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -64.4 -22.86 67.09 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.45 1.1 . . . . 4.2400000000000002 113.566 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.3 mt -103.79 -6.83 21.06 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.742 1.617 . . . . 1.1299999999999999 114.747 -168.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.02 140.48 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.147 0.979 . . . . 1.5 110.356 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.26 165.51 15.35 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.024 1.73 . . . . 3.0499999999999998 111.312 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -75.02 11.48 1.1 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.722 1.749 . . . . 3.2400000000000002 115.722 -175.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.38 6.31 16.81 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 126.562 2.029 . . . . 0.97999999999999998 114.483 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -87.91 152.47 22.05 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 119.891 1.846 . . . . 2.9700000000000002 112.777 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.0 mm -111.5 128.65 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.163 1.785 . . . . 1.74 109.813 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.8 mm -119.68 128.44 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.511 1.124 . . . . 0.67000000000000004 112.903 -168.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -88.34 121.97 31.33 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 121.225 -0.922 . . . . 1.8899999999999999 112.532 170.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.21 134.33 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.293 1.437 . . . . 0.68000000000000005 111.3 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 m -97.32 163.69 19.3 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 124.61 1.164 . . . . 0.92000000000000004 113.26 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.35 133.9 52.07 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.231 1.954 . . . . 0.91000000000000003 111.334 167.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.46 -8.21 54.73 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.775 2.131 . . . . 0.92000000000000004 115.098 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.76 161.77 54.28 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 118.536 1.168 . . . . 1.0600000000000001 114.379 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -113.24 140.69 47.75 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.749 1.219 . . . . 1.6899999999999999 111.006 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.49 123.16 88.96 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-O 118.257 -0.878 . . . . 1.79 111.834 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.64 -24.09 4.45 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.971 2.447 . . . . 0.77000000000000002 115.818 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.19 152.56 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 126.608 1.963 . . . . 0.95999999999999996 109.116 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 138.8 35.62 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.873 1.064 . . . . 1.8700000000000001 113.873 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.94 -157.79 20.85 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 123.728 0.68 . . . . 0.66000000000000003 114.431 -171.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ttp-105 -119.87 146.31 45.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.097 1.359 . . . . 4.0099999999999998 113.062 -170.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.6 t -98.99 130.74 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 128.247 2.619 . . . . 0.79000000000000004 109.467 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.7 31.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 114.143 1.164 . . . . 0.78000000000000003 114.143 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -167.42 139.62 3.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.427 1.491 . . . . 2.6800000000000002 110.29 169.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.61 -164.8 36.33 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 116.845 1.498 . . . . 1.0600000000000001 116.845 167.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -145.69 132.68 20.25 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.689 1.196 . . . . 2.8700000000000001 111.523 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.1 -179.21 6.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.882 0.873 . . . . 1.1899999999999999 112.831 168.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.43 135.32 54.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.793 2.037 . . . . 1.22 110.358 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 72.4 t -126.31 142.76 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.48 1.112 . . . . 0.81999999999999995 113.071 -169.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.94 106.24 16.13 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.544 1.138 . . . . 2.4199999999999999 112.582 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -100.64 30.15 4.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.961 2.105 . . . . 1.78 114.103 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.3 p -48.7 -28.81 3.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.016 2.598 . . . . 2.3500000000000001 118.016 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.41 -56.03 2.34 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.493 1.517 . . . . 2.1200000000000001 110.637 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.3 mm -67.77 -51.98 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.783 0.66 . . . . 1.6699999999999999 112.783 -167.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.7 p -95.52 -20.18 19.23 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.665 0.786 . . . . 1.49 112.474 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.51 83.37 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.182 1.372 . . . . 1.28 115.374 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.43 -47.57 83.5 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.573 1.323 . . . . 2.3500000000000001 114.573 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 64.86 30.71 12.0 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.656 1.982 . . . . 1.8200000000000001 112.861 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -149.12 154.26 39.05 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 127.529 2.332 . . . . 4.7000000000000002 109.879 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.13 133.74 42.43 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.449 2.766 . . . . 2.0299999999999998 115.168 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -116.16 136.16 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 127.063 2.145 . . . . 0.87 110.848 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.13 133.73 34.28 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.971 -1.081 . . . . 0.84999999999999998 112.717 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -124.25 137.09 54.55 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.89 1.276 . . . . 0.95999999999999996 111.677 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -148.48 179.15 1.24 Allowed Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 127.52 2.328 . . . . 2.7400000000000002 108.667 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -56.3 139.38 86.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 CA-C-N 123.289 2.21 . . . . 0.81999999999999995 112.319 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.05 11.73 83.37 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.456 -1.191 . . . . 0.77000000000000002 115.105 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.2 m -102.2 166.53 10.54 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.581 1.69 . . . . 1.71 110.949 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.7 p -117.4 152.77 34.28 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.244 -1.535 . . . . 0.79000000000000004 112.855 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.15 157.06 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.763 1.625 . . . . 0.60999999999999999 112.159 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.73 143.08 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.758 1.623 . . . . 1.1699999999999999 111.675 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.68 153.99 37.93 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.47 0.915 . . . . 0.75 113.47 -170.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.68 -1.0 59.7 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 114.893 0.717 . . . . 0.87 114.893 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 m -88.97 156.4 18.91 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.303 1.051 . . . . 2.4500000000000002 111.447 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.05 145.33 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.576 1.15 . . . . 0.83999999999999997 111.117 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -115.97 137.13 52.39 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.958 2.103 . . . . 1.77 112.227 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -153.93 139.73 18.07 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.401 -1.437 . . . . 3.0099999999999998 113.084 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.314 30.1 t30 87.89 -1.48 0.49 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.285 3.434 . . . . 3.1400000000000001 116.006 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.67 163.45 29.0 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 120.437 -1.414 . . . . 1.9399999999999999 115.257 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -98.95 144.01 28.6 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.121 1.769 . . . . 1.98 112.128 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.9 mt -135.57 160.02 39.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.948 1.299 . . . . 1.0700000000000001 111.361 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.9 mt -107.99 127.63 53.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.691 0.796 . . . . 2.2599999999999998 110.435 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 mm -117.24 124.62 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.923 1.689 . . . . 1.7 110.306 -173.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -87.19 111.22 20.77 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.424 -0.797 . . . . 1.5700000000000001 109.533 169.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.17 119.13 22.53 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.622 0.769 . . . . 0.92000000000000004 109.806 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 t -119.86 8.71 11.15 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.594 0.961 . . . . 2.5600000000000001 113.594 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -138.36 139.31 38.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.612 1.965 . . . . 1.73 108.058 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 m -85.98 174.58 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.737 0.815 . . . . 1.6399999999999999 111.802 170.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.25 -36.57 91.15 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 121.08 -1.012 . . . . 1.3 114.795 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.71 -36.9 70.67 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.852 1.326 . . . . 1.6299999999999999 112.615 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -78.49 -10.25 59.64 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.798 1.777 . . . . 2.27 115.798 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -76.6 156.17 32.95 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.646 -1.283 . . . . 2.8700000000000001 112.379 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.9 t -56.88 -34.39 67.83 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.38 0.882 . . . . 1.9399999999999999 113.38 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.5 mp -56.93 -48.68 77.7 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.541 -1.349 . . . . 1.4399999999999999 112.52 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.9 m -70.74 -27.99 64.38 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.02 1.328 . . . . 1.8999999999999999 112.203 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -70.76 -44.74 66.12 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.394 0.678 . . . . 2.0699999999999998 111.974 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.5 mt -56.37 -49.57 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.94 1.296 . . . . 1.22 111.267 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.52 -19.74 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.251 1.204 . . . . 1.3300000000000001 114.251 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -72.27 -29.97 64.4 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.6 1.091 . . . . 3.1400000000000001 112.67 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tt -75.03 -58.92 2.98 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.095 1.358 . . . . 2.8500000000000001 111.328 170.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.6 t -69.66 -18.11 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.364 -0.835 . . . . 1.8799999999999999 112.885 -169.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -65.41 -30.98 71.84 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.133 -1.604 . . . . 3.4100000000000001 112.147 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -75.04 -18.86 60.25 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.187 1.395 . . . . 3.8999999999999999 113.293 172.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.06 -7.79 57.38 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.654 1.582 . . . . 4.6200000000000001 114.636 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.173 -1.394 . . . . 4.7999999999999998 114.115 179.412 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 119.088 -0.482 . . . . 3.1600000000000001 111.769 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.55 -23.91 53.58 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.221 0.919 . . . . 4.6299999999999999 112.672 170.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.18 -8.27 37.27 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.135 1.161 . . . . 2.0299999999999998 114.135 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.4 tp -56.41 -53.96 51.3 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.193 0.997 . . . . 2.6200000000000001 111.301 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.37 -7.99 47.2 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.436 1.643 . . . . 2.1499999999999999 115.436 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -64.88 -43.89 91.45 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 121.486 1.948 . . . . 2.1200000000000001 111.003 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -48.76 -48.96 40.51 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.281 1.432 . . . . 1.24 111.048 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.9 mm -70.16 -34.01 57.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.79 1.236 . . . . 1.52 112.034 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 m -76.64 -24.77 53.32 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.153 1.381 . . . . 1.1399999999999999 113.053 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 mp -68.22 -26.79 65.89 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.889 0.768 . . . . 2.04 112.621 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -70.72 139.78 51.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.409 1.004 . . . . 2.6800000000000002 113.013 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.87 152.39 44.59 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.102 -0.499 . . . . 2.02 111.188 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -106.23 -2.66 22.18 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.911 1.284 . . . . 1.9399999999999999 112.128 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -142.59 153.5 43.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.326 2.25 . . . . 3.9100000000000001 112.282 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.85 162.0 36.62 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.194 1.398 . . . . 0.70999999999999996 112.991 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.8 m -115.07 108.16 16.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.929 1.292 . . . . 0.85999999999999999 111.916 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.0 mt -83.32 130.33 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.104 -0.702 . . . . 0.67000000000000004 109.104 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.31 138.42 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.04 0.936 . . . . 2.5099999999999998 112.37 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.4 m -140.19 139.29 35.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.178 0.991 . . . . 1.99 111.747 -169.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.4 mt -104.35 141.22 36.7 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.953 1.301 . . . . 3.4500000000000002 109.199 168.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.36 20.77 1.2 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.333 1.975 . . . . 4.8799999999999999 116.333 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.8 m -142.04 -73.83 0.31 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.401 -0.812 . . . . 4.2199999999999998 112.573 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -160.99 50.28 0.25 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.491 1.916 . . . . 6.79 109.052 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.7 -18.59 0.08 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.55 2.34 . . . . 6.4100000000000001 114.471 -167.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.5 pt -69.62 -33.39 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.422 1.489 . . . . 4.6200000000000001 113.284 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 tp -86.83 92.46 8.99 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.213 1.005 . . . . 2.9900000000000002 108.61 168.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 tp -106.55 125.79 51.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.826 2.051 . . . . 3.3199999999999998 109.5 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 t -135.22 129.35 33.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.637 1.175 . . . . 1.71 110.966 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -130.74 129.44 42.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.446 1.098 . . . . 2.4100000000000001 111.822 -169.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -119.51 118.97 32.47 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.486 1.914 . . . . 2.8399999999999999 109.746 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -89.24 121.54 31.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.576 1.08 . . . . 2.1299999999999999 109.93 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.31 171.28 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.124 1.37 . . . . 0.96999999999999997 112.612 -169.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.7 146.17 32.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.634 1.174 . . . . 3.21 110.506 168.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.96 -24.05 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.608 0.966 . . . . 1.0700000000000001 113.608 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.16 -22.48 61.29 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.815 -1.178 . . . . 2.9199999999999999 113.062 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.77 -15.18 42.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.305 1.042 . . . . 1.24 113.231 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 p -86.7 93.54 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 122.715 1.245 . . . . 1.8899999999999999 109.9 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -78.32 158.3 28.89 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.42 2.288 . . . . 4.1900000000000004 109.218 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -69.74 134.26 48.41 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.015 -1.053 . . . . 2.73 112.966 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.42 12.18 4.32 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.207 1.385 . . . . 0.88 115.999 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -116.48 168.86 9.79 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.288 2.044 . . . . 2.71 113.861 175.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.86 129.04 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.31 1.844 . . . . 1.55 109.607 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.1 mm -122.75 129.14 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.119 1.768 . . . . 0.80000000000000004 110.465 -171.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -83.13 135.71 34.72 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.765 1.226 . . . . 2.8500000000000001 112.365 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.36 136.8 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.822 1.249 . . . . 0.81999999999999995 111.949 169.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.35 159.14 65.29 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.018 0.927 . . . . 1.1599999999999999 112.886 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.28 136.12 66.31 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.78 2.32 . . . . 1.24 110.757 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.18 3.79 57.87 Favored Glycine 0 CA--C 1.542 1.735 0 N-CA-C 114.914 0.726 . . . . 0.98999999999999999 114.914 -169.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.1 178.89 48.54 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 118.928 1.364 . . . . 0.97999999999999998 115.686 -174.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.81 145.26 51.24 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.419 1.888 . . . . 1.6399999999999999 111.096 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -88.07 129.5 49.79 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.863 0.69 . . . . 1.73 112.863 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -86.27 -22.22 2.23 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.275 2.65 . . . . 0.72999999999999998 115.661 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.6 m -151.08 175.82 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 127.843 2.457 . . . . 0.76000000000000001 109.147 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -99.94 140.99 33.36 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.357 0.98 . . . . 1.6799999999999999 113.474 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.51 -177.73 46.58 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 123.545 0.593 . . . . 0.62 114.38 -169.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -103.24 138.81 39.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.838 1.255 . . . . 4.4699999999999998 112.178 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.8 t -83.45 130.55 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.255 2.222 . . . . 0.75 108.657 173.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.1 pt -140.37 33.48 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-O 122.394 1.093 . . . . 0.77000000000000002 112.379 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -166.6 129.5 1.89 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.155 2.182 . . . . 2.8100000000000001 108.084 168.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.33 176.0 50.5 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 122.701 1.167 . . . . 1.03 115.03 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -153.31 120.96 5.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.417 1.487 . . . . 2.0699999999999998 112.572 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.8 t -141.69 159.73 41.63 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.445 1.498 . . . . 1.46 112.024 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.4 ttm -90.67 130.18 36.7 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.761 -0.587 . . . . 0.88 110.341 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.7 t -113.85 140.77 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.524 1.13 . . . . 0.60999999999999999 111.781 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -108.32 102.46 11.58 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.334 1.453 . . . . 1.76 111.427 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 19.86 17.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.624 1.969 . . . . 4.0 113.096 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.2 p -54.6 -29.09 50.76 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.331 1.604 . . . . 1.3 115.331 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.59 -30.46 26.97 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.825 1.193 . . . . 1.02 111.708 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 mm -72.76 -53.57 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.554 1.542 . . . . 1.0600000000000001 110.176 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.2 p -102.92 -22.04 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.313 1.845 . . . . 1.6599999999999999 113.691 -171.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.75 -2.23 87.7 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.277 1.418 . . . . 1.28 114.328 -170.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -64.9 110.16 2.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.502 1.651 . . . . 2.8599999999999999 110.296 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.59 -3.38 58.44 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.983 -1.073 . . . . 1.47 112.596 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.8 mmt -95.79 138.7 21.71 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.99 2.516 . . . . 3.6299999999999999 108.952 167.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.36 161.09 22.78 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.155 2.57 . . . . 1.9299999999999999 112.347 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.8 t -124.03 119.82 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.463 0.705 . . . . 0.81999999999999995 111.369 -168.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.57 130.79 35.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.021 0.928 . . . . 0.87 112.086 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -108.74 157.68 18.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.015 1.726 . . . . 0.76000000000000001 111.866 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -146.73 168.97 10.25 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 127.581 2.352 . . . . 3.5 111.624 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -59.14 123.22 12.98 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 121.578 1.519 . . . . 0.93000000000000005 109.356 166.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.43 57.15 3.01 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.866 1.222 . . . . 1.21 112.426 -168.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -141.3 150.31 42.38 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.696 1.598 . . . . 1.28 112.427 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.9 p -101.05 150.76 22.57 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 120.861 1.664 . . . . 0.84999999999999998 113.522 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.05 162.61 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.464 1.506 . . . . 0.53000000000000003 111.823 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -126.97 150.06 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.768 2.027 . . . . 0.93000000000000005 111.363 176.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.59 142.23 49.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.033 0.933 . . . . 0.66000000000000003 112.71 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.49 -5.77 72.07 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.125 1.345 . . . . 0.79000000000000004 116.305 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.4 p -73.93 162.22 29.3 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.711 1.256 . . . . 1.3899999999999999 111.896 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mm -110.79 143.88 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.52 1.128 . . . . 0.64000000000000001 111.61 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -105.45 142.62 34.89 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.467 1.907 . . . . 1.9099999999999999 112.341 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -85.73 -125.69 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.639 1.175 . . . . 3.52 112.316 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -78.99 -38.16 37.43 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.001 1.852 . . . . 3.3999999999999999 116.001 -166.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.4 128.78 13.68 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.794 0.725 . . . . 1.9299999999999999 112.538 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.2 t -83.97 121.43 27.38 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.875 -1.158 . . . . 2.2799999999999998 107.875 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.4 mt -117.99 157.73 26.23 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.715 1.206 . . . . 1.1200000000000001 111.321 -169.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -117.31 125.52 51.2 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.482 0.658 . . . . 2.0600000000000001 109.75 169.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.79 138.17 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.64 1.576 . . . . 1.3100000000000001 110.573 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.6 p -79.03 106.62 11.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.021 0.915 . . . . 1.8500000000000001 111.185 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.73 82.4 4.13 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.202 1.001 . . . . 1.6799999999999999 109.097 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 t -101.51 9.32 41.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.585 1.954 . . . . 3.04 111.874 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -144.49 152.86 41.21 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.159 1.783 . . . . 2.1499999999999999 111.451 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -106.7 170.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.211 1.404 . . . . 1.77 111.579 168.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.6 -24.24 46.56 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.366 1.306 . . . . 2.2200000000000002 116.366 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.38 96.91 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.595 1.698 . . . . 2.8500000000000001 112.529 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.18 -22.98 59.17 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.272 1.582 . . . . 3.8300000000000001 115.272 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 109' ' ' SER . 3.2 t -71.58 142.74 50.01 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.463 1.283 . . . . 2.96 114.463 -166.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m -60.95 -27.14 68.03 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.499 -0.751 . . . . 3.52 112.275 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.0 tp -58.4 -46.22 86.83 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.367 -0.833 . . . . 1.5 112.093 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.474 ' H ' HG23 ' A' ' 106' ' ' THR . 75.9 p -73.03 -27.33 61.7 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.881 0.872 . . . . 2.6000000000000001 113.012 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -66.64 -40.06 88.54 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.164 -0.96 . . . . 1.8799999999999999 112.461 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 67.8 mt -53.91 -52.22 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.392 1.077 . . . . 1.3999999999999999 110.301 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.404 ' HA ' HG12 ' A' ' 115' ' ' VAL . 21.9 m -70.01 -24.4 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 113.686 0.995 . . . . 1.1299999999999999 113.686 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -70.07 -48.37 58.06 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.229 0.922 . . . . 2.8100000000000001 111.849 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mt -72.68 -37.93 67.75 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.597 0.962 . . . . 2.4500000000000002 113.597 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 112' ' ' VAL . 2.3 p -70.85 -18.83 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.142 -0.974 . . . . 2.7200000000000002 112.649 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -71.96 -36.49 69.86 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.927 0.891 . . . . 3.73 111.012 168.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -73.17 -11.52 60.56 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.07 -1.019 . . . . 3.5800000000000001 113.121 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.62 -56.06 6.57 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.165 -0.96 . . . . 3.6499999999999999 110.237 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.257 0 CA-C-O 116.665 -1.636 . . . . 4.2800000000000002 114.767 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 113.681 0.993 . . . . 2.6699999999999999 113.681 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -99.06 -39.99 8.24 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.945 1.698 . . . . 5.29 111.381 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.27 90.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.158 0.983 . . . . 1.9099999999999999 111.785 172.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 tp -55.05 -35.82 64.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.254 1.022 . . . . 2.1000000000000001 112.386 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.07 -47.34 37.26 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.359 0.527 . . . . 2.0600000000000001 112.208 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.08 -32.46 70.97 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.211 1.005 . . . . 3.04 113.384 -172.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.0 -35.73 77.6 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.228 1.377 . . . . 1.3100000000000001 113.267 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.6 mm -73.99 -40.29 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.498 -0.751 . . . . 1.8899999999999999 111.591 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -66.86 -30.38 70.53 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.391 0.886 . . . . 1.6299999999999999 113.391 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.31 -17.33 62.43 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.555 1.942 . . . . 2.3799999999999999 113.941 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -86.4 147.04 26.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.538 1.135 . . . . 2.46 112.835 -170.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.23 154.41 22.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.557 1.543 . . . . 2.04 112.98 -172.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 m -100.53 -27.39 13.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.331 1.452 . . . . 2.1299999999999999 113.314 -172.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.84 150.76 50.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.228 1.411 . . . . 3.4199999999999999 113.678 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.4 172.32 12.93 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.608 1.563 . . . . 1.02 113.37 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 93.1 m -119.4 105.3 11.15 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.501 1.52 . . . . 0.98999999999999999 112.125 170.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.89 140.31 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.016 0.927 . . . . 0.59999999999999998 109.402 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.93 124.98 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.469 -0.769 . . . . 1.8899999999999999 110.551 172.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -128.04 144.47 51.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.604 1.162 . . . . 1.78 110.681 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.8 mt -112.56 123.5 50.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.183 0.993 . . . . 2.54 110.938 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -105.79 1.57 27.09 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 117.567 2.432 . . . . 4.2000000000000002 117.567 -165.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -128.89 -93.47 0.44 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.815 1.246 . . . . 4.0899999999999999 111.454 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -142.01 58.45 1.48 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.618 1.967 . . . . 4.4699999999999998 108.995 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.337 12.7 p30 56.81 -9.55 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.649 2.779 . . . . 4.5499999999999998 117.899 -170.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.4 pt -77.33 -13.14 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.876 2.07 . . . . 3.3599999999999999 115.472 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.7 tp -117.82 105.54 12.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.298 1.439 . . . . 2.9100000000000001 109.683 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.86 129.13 36.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.28 1.032 . . . . 2.3500000000000001 110.642 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 t -141.42 84.69 1.92 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.601 1.56 . . . . 1.5600000000000001 109.431 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -81.02 154.15 27.03 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.033 -1.042 . . . . 2.7200000000000002 112.926 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -121.74 130.72 53.63 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.181 1.792 . . . . 2.7000000000000002 110.958 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -88.58 120.56 30.08 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.671 -0.863 . . . . 2.1000000000000001 108.671 168.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.24 159.23 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.051 0.94 . . . . 0.98999999999999999 113.13 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -78.04 143.22 37.65 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.903 -0.777 . . . . 3.1800000000000002 108.903 166.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.09 -20.24 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.609 1.164 . . . . 1.1200000000000001 113.585 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -70.24 -20.02 63.1 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.707 -1.246 . . . . 3.4300000000000002 113.637 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.83 -5.55 56.76 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.455 1.28 . . . . 1.72 114.455 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.1 p -94.13 144.65 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.762 0.825 . . . . 1.6899999999999999 112.508 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -121.25 163.3 18.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.943 2.497 . . . . 3.1699999999999999 110.124 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 ptt85 -72.29 147.15 46.66 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.181 -0.95 . . . . 3.77 110.784 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.43 28.49 7.11 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-N 119.142 0.883 . . . . 1.76 113.93 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.5 166.34 25.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.333 1.853 . . . . 3.5299999999999998 111.523 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.4 mt -122.95 132.16 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.945 1.298 . . . . 1.8400000000000001 111.937 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 mm -118.65 129.98 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.692 1.997 . . . . 0.71999999999999997 110.623 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -84.45 130.39 34.77 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.639 -0.663 . . . . 2.0899999999999999 112.19 172.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.43 136.89 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.888 1.275 . . . . 0.60999999999999999 110.227 169.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.93 161.91 39.71 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.118 1.367 . . . . 0.87 112.39 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -57.5 134.27 62.31 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.674 1.583 . . . . 1.0800000000000001 108.618 166.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.64 -9.04 38.25 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 118.702 -1.054 . . . . 0.93000000000000005 115.557 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.92 177.94 37.53 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 119.645 1.723 . . . . 0.94999999999999996 114.237 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.88 151.37 38.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.684 1.593 . . . . 2.0899999999999999 111.234 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -90.14 116.55 66.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 118.496 -0.764 . . . . 1.8300000000000001 109.965 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -89.16 -11.22 3.72 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.936 2.424 . . . . 0.73999999999999999 114.896 -171.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -147.8 172.82 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 128.55 2.74 . . . . 0.89000000000000001 108.834 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.2 139.39 37.88 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.164 0.893 . . . . 2.6600000000000001 112.518 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.75 -158.67 22.58 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 115.253 0.861 . . . . 0.79000000000000004 115.253 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -118.3 129.1 55.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.74 1.216 . . . . 4.3399999999999999 112.647 -170.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.3 t -88.69 127.23 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.881 1.672 . . . . 0.89000000000000001 108.93 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.7 pt -141.52 30.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 113.438 0.903 . . . . 0.95999999999999996 113.438 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -169.08 132.01 1.29 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.615 1.966 . . . . 3.1699999999999999 108.975 166.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.71 173.34 46.83 Favored Glycine 0 CA--C 1.539 1.578 0 N-CA-C 116.102 1.201 . . . . 1.1000000000000001 116.102 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -140.28 127.36 20.9 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.099 1.36 . . . . 3.0299999999999998 113.806 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 m -151.46 172.15 16.42 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.362 1.616 . . . . 1.22 115.362 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.9 ttm -106.46 133.78 50.61 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.625 1.17 . . . . 1.46 110.497 168.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.85 132.82 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.479 1.112 . . . . 1.1599999999999999 113.743 -167.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -91.23 98.7 11.88 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.269 1.828 . . . . 2.2799999999999998 111.386 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -128.98 8.61 5.68 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.135 1.774 . . . . 1.77 115.57 -172.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.3 p -59.73 -4.81 0.75 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 116.248 1.944 . . . . 2.1000000000000001 116.248 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -94.62 -35.6 12.14 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.153 1.342 . . . . 1.6299999999999999 111.449 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.8 mm -79.73 -62.88 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.797 1.239 . . . . 1.6100000000000001 111.612 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 p -84.99 -8.15 58.85 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.206 1.403 . . . . 2.2400000000000002 112.999 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.02 25.9 70.19 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.556 1.074 . . . . 2.8999999999999999 113.241 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -64.3 -177.33 0.28 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.671 1.589 . . . . 3.1699999999999999 110.876 169.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.5 -9.64 5.7 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.843 -1.161 . . . . 2.8300000000000001 113.612 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -149.26 151.25 33.55 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.099 1.36 . . . . 2.9300000000000002 110.793 169.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -48.8 153.87 3.42 Favored 'Trans proline' 0 CA--C 1.538 0.712 1 C-N-CA 125.405 4.07 . . . . 2.9500000000000002 116.245 -178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.3 t -113.25 134.07 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.722 1.609 . . . . 1.1599999999999999 111.354 -170.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.38 137.22 38.6 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.614 0.765 . . . . 0.87 112.188 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -130.14 143.87 51.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.167 2.187 . . . . 1.03 110.179 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 16.5 ptmt -148.61 -172.61 0.32 Allowed Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 126.611 1.964 . . . . 3.4100000000000001 109.526 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 74.1 Cg_endo -66.45 142.92 67.43 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 CA-C-N 123.492 2.283 . . . . 1.1599999999999999 111.347 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.02 8.73 87.4 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.512 1.53 . . . . 0.97999999999999998 114.895 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.2 m -89.52 163.83 15.05 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.851 1.826 . . . . 1.6499999999999999 112.234 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.3 p -112.33 147.1 37.06 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.911 -1.118 . . . . 1.1599999999999999 111.218 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 m -139.46 156.31 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.553 1.141 . . . . 0.69999999999999996 112.754 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.53 150.53 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.169 1.788 . . . . 1.23 113.225 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.02 149.59 47.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.044 0.937 . . . . 0.84999999999999998 113.168 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.3 -2.52 56.85 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.712 1.148 . . . . 0.89000000000000001 114.966 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 89.9 p -76.59 155.0 33.91 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.629 1.214 . . . . 1.54 111.657 169.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.09 136.95 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.273 1.029 . . . . 1.1399999999999999 110.669 -171.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -93.19 149.78 20.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.853 1.661 . . . . 1.5 113.412 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -160.47 115.27 2.22 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.989 0.916 . . . . 3.9700000000000002 111.88 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.5 t30 147.79 -46.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 131.658 3.983 . . . . 3.2200000000000002 110.829 166.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.1 179.78 42.74 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 121.084 -1.01 . . . . 2.1099999999999999 114.884 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -85.34 132.59 34.22 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.213 1.005 . . . . 2.25 112.276 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.86 163.56 24.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.838 1.655 . . . . 1.76 112.304 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.1 mt -118.46 127.29 53.51 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.209 1.004 . . . . 2.52 112.011 172.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.95 126.99 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.11 1.364 . . . . 1.25 110.893 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 44.2 t -83.09 125.46 31.51 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.094 0.558 . . . . 2.75 110.307 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.24 104.12 14.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.188 0.995 . . . . 1.1599999999999999 109.754 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.8 p -94.22 -3.81 50.1 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.558 1.143 . . . . 2.73 112.13 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -136.47 136.9 39.84 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.474 1.91 . . . . 2.5699999999999998 109.856 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 p -88.69 170.08 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.573 1.149 . . . . 2.4900000000000002 110.474 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.17 -35.68 85.36 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.31 -1.494 . . . . 1.8999999999999999 114.875 -171.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.79 -31.84 73.15 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.947 1.374 . . . . 2.5 113.227 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.16 -5.92 44.67 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.118 1.367 . . . . 3.75 113.738 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.0 p -80.71 147.16 30.72 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.529 -1.357 . . . . 1.72 112.77 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -70.67 -23.37 62.49 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.295 1.22 . . . . 2.6899999999999999 114.295 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 mp -59.37 -58.14 9.91 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 119.809 -1.807 . . . . 1.54 115.762 -167.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.7 m -73.18 -15.22 61.46 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.859 0.754 . . . . 3.3999999999999999 112.7 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.5 -42.92 64.31 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.001 0.92 . . . . 2.3799999999999999 111.461 172.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 54.9 mt -57.63 -45.76 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.067 1.347 . . . . 1.77 112.499 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.73 -18.7 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 114.514 1.301 . . . . 1.98 114.514 -172.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -73.34 -31.26 63.87 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.372 -0.83 . . . . 2.79 112.428 173.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -56.11 5.02 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.072 1.749 . . . . 3.9199999999999999 111.41 172.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.68 -27.24 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.614 0.766 . . . . 2.9300000000000002 112.466 -170.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.12 -30.16 71.24 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.173 -0.954 . . . . 3.8300000000000001 112.888 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.32 -19.27 58.39 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.241 -1.537 . . . . 6.04 112.722 174.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.21 -30.13 57.85 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.631 1.345 . . . . 5.5300000000000002 114.631 -169.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 124.921 1.288 . . . . 6.4400000000000004 111.371 175.055 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 112.84 0.682 . . . . 2.3700000000000001 112.84 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -73.49 -36.08 65.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.97 0.908 . . . . 5.25 111.103 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.17 -21.2 63.08 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.606 -1.309 . . . . 2.6800000000000002 113.496 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.9 tp -64.49 -31.95 73.38 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.03 0.932 . . . . 1.98 111.134 171.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.19 -17.3 61.94 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.122 -0.986 . . . . 1.27 113.532 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -67.39 -28.52 68.0 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.755 0.822 . . . . 2.5499999999999998 112.207 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.8 -38.9 83.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.838 0.855 . . . . 1.27 111.319 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.3 mm -70.14 -41.28 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.275 0.63 . . . . 2.1499999999999999 110.954 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 m -67.44 -24.74 65.67 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.024 0.93 . . . . 1.1399999999999999 113.256 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.5 mt -73.32 -27.8 61.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.979 1.712 . . . . 1.6599999999999999 113.889 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -64.45 140.44 58.87 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.877 0.762 . . . . 3.2999999999999998 111.003 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.51 165.26 18.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.562 1.145 . . . . 2.5299999999999998 113.475 -172.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.1 m -121.11 -29.31 4.57 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.108 1.363 . . . . 2.0800000000000001 112.411 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.21 150.05 43.68 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.227 1.411 . . . . 2.9500000000000002 112.728 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.86 145.95 38.72 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.866 1.267 . . . . 1.0600000000000001 112.507 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.5 m -98.54 100.92 12.21 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.638 1.175 . . . . 1.3999999999999999 112.323 -174.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 35.1 mt -76.72 139.58 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.83 -0.804 . . . . 1.0900000000000001 108.83 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.42 125.58 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.712 0.768 . . . . 2.3799999999999999 112.254 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.0 m -140.19 141.72 35.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.844 1.658 . . . . 2.0299999999999998 111.323 -167.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 24' ' ' ASN . 2.9 mm? -93.3 112.94 25.0 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.994 0.917 . . . . 4.8399999999999999 109.034 173.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.99 -3.64 48.09 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.768 1.025 . . . . 5.1299999999999999 113.768 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.6 m -161.1 146.37 14.1 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 129.843 3.257 . . . . 5.0199999999999996 111.178 168.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 25' ' ' ILE . 24.2 t70 -23.88 61.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 1 C-N-CA 133.568 4.747 . . . . 6.0 118.622 -169.262 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.514 ' HA ' HD12 ' A' ' 20' ' ' LEU . 28.8 t-20 63.74 -26.64 0.08 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.083 2.153 . . . . 6.5999999999999996 114.456 -166.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.409 ' H ' ' C ' ' A' ' 23' ' ' ASP . 33.0 pt -62.2 -13.36 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 128.639 2.776 . . . . 5.04 115.391 175.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.2 tp -131.02 56.33 1.8 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.209 1.404 . . . . 3.7799999999999998 110.841 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.51 ' HA ' HD13 ' A' ' 20' ' ' LEU . 6.9 tt -65.44 116.14 6.42 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.098 -1.41 . . . . 2.8599999999999999 109.0 167.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.1 p -135.92 152.27 50.83 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.884 1.274 . . . . 2.46 110.985 -168.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.67 149.07 40.38 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.969 0.908 . . . . 3.25 111.487 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -139.64 113.56 8.75 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.661 1.184 . . . . 2.5600000000000001 111.588 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -79.83 115.61 19.52 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.918 -1.114 . . . . 2.7000000000000002 109.303 167.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.78 166.08 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.239 1.416 . . . . 0.92000000000000004 111.166 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -76.6 142.0 40.88 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.921 -0.487 . . . . 3.9500000000000002 110.342 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.41 -23.57 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.289 1.218 . . . . 1.29 114.289 -171.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -60.68 -27.43 67.85 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.88 1.272 . . . . 4.4400000000000004 113.206 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.2 mt -101.57 -7.63 22.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.9 2.08 . . . . 1.3600000000000001 115.816 -167.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.74 144.71 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.151 0.887 . . . . 1.5600000000000001 111.151 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -121.33 154.78 35.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.204 1.802 . . . . 4.1299999999999999 112.881 -170.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -77.64 23.8 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 117.215 2.302 . . . . 3.2799999999999998 117.215 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.78 6.81 12.28 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.682 1.611 . . . . 1.47 115.564 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -124.01 173.31 8.33 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.75 1.775 . . . . 3.5600000000000001 115.256 -168.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.4 mt -113.84 126.31 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.057 1.743 . . . . 2.1299999999999999 110.491 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.3 mm -116.08 124.14 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.495 1.918 . . . . 0.72999999999999998 110.109 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.489 ' HE3' HD11 ' A' ' 96' ' ' LEU . 65.2 tttt -87.07 141.36 28.72 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.737 1.215 . . . . 2.1699999999999999 111.676 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -116.59 137.09 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.489 0.716 . . . . 0.72999999999999998 112.287 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.13 159.25 54.33 Favored Pre-proline 0 N--CA 1.481 1.075 0 C-N-CA 124.387 1.075 . . . . 1.3200000000000001 113.234 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -60.95 136.94 68.91 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.888 1.726 . . . . 1.8 109.772 167.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.27 26.37 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 115.429 0.932 . . . . 1.02 115.429 -171.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.66 -177.17 41.19 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 119.062 1.431 . . . . 1.0800000000000001 115.31 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -123.67 154.74 38.95 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.093 1.357 . . . . 2.04 112.043 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -88.69 122.12 69.47 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 118.608 -0.71 . . . . 1.79 110.34 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.18 -19.54 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.565 2.176 . . . . 0.76000000000000001 115.426 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.48 164.89 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 127.987 2.515 . . . . 0.90000000000000002 108.051 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -81.14 149.23 29.23 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.039 0.923 . . . . 2.3599999999999999 113.286 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -167.07 38.73 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.785 -0.643 . . . . 0.85999999999999999 113.906 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -114.96 132.6 56.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.742 0.817 . . . . 3.8399999999999999 112.504 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.0 t -79.02 131.58 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 127.078 2.151 . . . . 0.65000000000000002 107.636 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.06 31.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.039 0.836 . . . . 0.76000000000000001 112.277 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -169.07 146.71 3.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.378 2.271 . . . . 3.2400000000000002 109.258 168.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.08 -179.55 32.51 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 118.847 0.749 . . . . 0.93999999999999995 114.842 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -143.53 32.4 1.31 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.445 1.646 . . . . 3.1499999999999999 115.445 -167.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.806 ' H ' HD21 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -83.36 165.84 18.94 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.361 1.615 . . . . 1.28 115.361 -168.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.0 ttm -110.8 138.36 47.29 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.819 0.847 . . . . 1.0600000000000001 110.95 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.33 134.66 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.092 1.357 . . . . 0.88 112.805 -168.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -86.03 108.54 18.29 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.107 1.363 . . . . 2.5299999999999998 110.924 174.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.94 -10.79 17.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.0 1.32 . . . . 2.5099999999999998 113.89 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.5 p -43.23 -35.45 1.43 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 117.995 2.591 . . . . 1.79 117.995 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -84.86 -27.45 26.69 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.62 1.1 . . . . 1.4099999999999999 112.016 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mm -89.52 -55.55 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.944 0.898 . . . . 1.3899999999999999 110.922 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.0 p -85.79 -18.35 33.2 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.191 0.996 . . . . 1.8 113.132 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.71 9.91 80.25 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.448 1.499 . . . . 1.79 114.439 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.02 -177.59 0.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.365 1.466 . . . . 2.8300000000000001 112.512 171.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.69 -20.68 0.59 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.148 1.379 . . . . 1.8999999999999999 114.492 -176.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.9 mtp -119.2 140.47 28.97 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.7 1.2 . . . . 4.2300000000000004 111.354 172.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -59.28 144.93 99.22 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.556 2.837 . . . . 2.1800000000000002 113.973 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 t -106.72 131.99 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 127.3 2.24 . . . . 0.82999999999999996 111.982 -168.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.13 134.84 37.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.267 0.627 . . . . 0.82999999999999996 111.85 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -110.37 155.47 22.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.4 1.88 . . . . 0.87 111.652 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -151.93 172.07 5.88 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 127.343 2.257 . . . . 2.2799999999999998 108.285 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -54.9 142.08 76.3 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 CA-C-N 122.149 1.803 . . . . 0.82999999999999996 112.279 171.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.63 13.33 82.62 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-O 117.7 -1.611 . . . . 1.0900000000000001 115.635 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -96.83 144.7 26.55 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.209 2.505 . . . . 1.4199999999999999 111.392 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.5 p -90.42 157.17 17.73 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 121.305 1.866 . . . . 1.01 112.933 172.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 m -140.34 156.85 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.457 1.903 . . . . 0.79000000000000004 112.035 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -113.47 151.65 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 127.573 2.349 . . . . 1.1000000000000001 111.636 173.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.34 155.86 23.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.29 0.636 . . . . 0.88 112.369 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.69 0.12 53.15 Favored Glycine 0 CA--C 1.536 1.402 0 O-C-N 121.447 -0.783 . . . . 1.1499999999999999 114.974 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.9 p -78.22 153.51 31.87 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.557 1.179 . . . . 1.72 110.899 168.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mm -113.3 131.73 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.811 0.844 . . . . 1.3200000000000001 111.011 -171.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -94.27 148.32 22.32 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.696 1.598 . . . . 1.6799999999999999 112.653 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -96.95 -88.08 0.3 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.291 1.036 . . . . 3.4199999999999999 112.712 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -154.17 146.92 24.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.628 2.771 . . . . 4.4100000000000001 107.865 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.64 23.97 2.7 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 120.602 1.546 . . . . 2.9900000000000002 115.158 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 t 18.19 97.94 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 130.169 3.388 . . . . 1.74 116.837 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.806 HD21 ' H ' ' A' ' 62' ' ' SER . 54.9 mt -102.5 154.03 19.49 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.629 1.171 . . . . 1.0700000000000001 112.948 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.489 HD11 ' HE3' ' A' ' 44' ' ' LYS . 7.2 mp -117.75 126.02 51.69 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.501 1.12 . . . . 2.3399999999999999 108.566 166.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.54 125.9 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.127 1.371 . . . . 1.1399999999999999 110.086 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.2 p -81.2 119.88 24.17 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.627 -0.67 . . . . 1.53 109.538 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.95 130.92 35.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.293 0.637 . . . . 1.27 109.665 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.46 3.55 9.05 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.897 1.073 . . . . 3.04 113.897 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -141.18 151.5 43.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.998 1.319 . . . . 2.1600000000000001 111.86 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -89.45 173.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.769 1.628 . . . . 2.1499999999999999 111.223 171.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.94 -36.41 87.76 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 121.061 -1.024 . . . . 1.6000000000000001 114.843 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.39 -28.12 69.02 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.582 1.327 . . . . 2.0899999999999999 114.582 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.71 -13.02 60.03 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.962 1.467 . . . . 3.3500000000000001 114.962 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.1 p -66.45 132.92 49.35 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.215 -0.928 . . . . 2.1000000000000001 112.608 -168.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 t -63.24 -23.77 67.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.487 1.291 . . . . 2.23 114.487 -167.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.7 -43.74 80.84 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.917 -1.114 . . . . 1.8300000000000001 111.795 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.2 p -68.03 -28.5 67.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.158 0.983 . . . . 2.02 112.712 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -75.27 -48.65 22.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.969 1.307 . . . . 1.55 111.91 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 53.4 mt -53.62 -49.23 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.862 1.665 . . . . 1.45 110.5 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.55 -20.08 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.876 1.435 . . . . 1.6100000000000001 114.876 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -74.86 -38.52 61.92 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.888 1.222 . . . . 3.0 112.842 170.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.38 -52.71 8.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.198 2.199 . . . . 3.27 112.656 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -71.32 -21.71 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.65 1.18 . . . . 3.1000000000000001 111.819 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.83 -34.13 71.2 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.419 -1.426 . . . . 5.3300000000000001 112.18 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.89 -17.51 59.76 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.974 0.91 . . . . 6.21 113.349 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.54 -26.4 50.97 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.7 1.37 . . . . 6.5999999999999996 114.7 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 127.033 2.133 . . . . 7.6699999999999999 113.685 179.664 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 111.481 0.178 . . . . 3.5899999999999999 111.481 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -76.69 -31.21 57.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.757 1.223 . . . . 4.29 111.699 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.26 61.96 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.277 -0.889 . . . . 1.79 112.639 170.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.25 -40.73 86.86 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.636 1.174 . . . . 2.98 111.205 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.32 -14.25 61.27 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.456 0.91 . . . . 1.1799999999999999 113.456 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -67.3 -33.31 75.01 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.649 -1.282 . . . . 2.3900000000000001 111.505 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.91 -28.03 69.78 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.489 1.115 . . . . 1.1299999999999999 111.885 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.8 mm -74.11 -39.47 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.694 0.798 . . . . 1.74 111.772 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -65.79 -31.52 72.54 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.803 -1.186 . . . . 1.79 112.288 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.7 mt -71.23 -11.55 60.99 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.488 1.915 . . . . 2.1600000000000001 113.685 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -87.03 158.34 19.25 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.762 1.225 . . . . 2.29 112.873 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.13 161.3 14.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.499 1.519 . . . . 2.2799999999999998 114.326 -169.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p -90.98 -47.72 7.41 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.474 1.51 . . . . 2.7599999999999998 113.203 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -142.08 157.4 44.95 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.336 1.454 . . . . 4.1200000000000001 112.782 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.17 157.38 44.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.383 1.473 . . . . 0.88 112.525 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.1 m -100.4 107.02 18.67 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.896 0.878 . . . . 0.87 111.589 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.8 mt -78.84 142.26 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.684 1.193 . . . . 0.71999999999999997 108.443 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.23 135.63 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.643 0.735 . . . . 2.02 111.924 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.0 m -128.83 141.26 51.35 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.747 2.419 . . . . 1.6599999999999999 110.959 -169.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.6 mt -99.54 130.7 45.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.886 0.874 . . . . 2.8199999999999998 109.783 168.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.04 23.01 6.6 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.287 1.035 . . . . 3.3900000000000001 113.457 -169.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -151.1 -82.13 0.1 Allowed 'General case' 0 N--CA 1.484 1.233 0 O-C-N 119.733 -1.854 . . . . 3.7999999999999998 114.541 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -160.91 55.38 0.3 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.574 1.549 . . . . 5.29 108.941 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.67 -26.33 0.07 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.828 2.451 . . . . 5.1799999999999997 115.463 -169.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.7 pt -63.02 -5.56 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.422 1.889 . . . . 3.71 115.717 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.24 126.37 26.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.367 1.467 . . . . 2.6000000000000001 111.62 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.6 mp -114.73 137.5 51.85 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.063 2.145 . . . . 2.4900000000000002 111.149 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.7 t -140.13 139.11 35.71 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.079 2.152 . . . . 1.3400000000000001 109.46 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -126.11 151.69 46.9 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.096 -1.002 . . . . 2.8399999999999999 112.183 -174.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -129.4 128.45 43.04 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.133 1.373 . . . . 2.7999999999999998 111.25 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -93.46 108.16 19.89 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.263 -0.898 . . . . 2.1299999999999999 109.571 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 m -118.95 154.55 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.179 0.992 . . . . 0.94999999999999996 112.263 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -72.7 148.27 44.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.686 -0.486 . . . . 3.21 109.686 171.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.41 -17.86 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.387 1.625 . . . . 1.0800000000000001 115.387 -168.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -70.94 -20.65 62.44 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.41 -1.431 . . . . 4.2599999999999998 113.833 170.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.7 mt -98.35 -3.66 36.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.644 1.578 . . . . 1.23 114.078 -168.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -89.14 139.36 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.676 1.591 . . . . 1.54 109.959 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -108.95 164.45 12.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.864 1.266 . . . . 3.8500000000000001 111.166 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -70.56 37.45 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.726 1.38 . . . . 2.8500000000000001 114.726 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.47 11.5 0.15 Allowed Glycine 0 CA--C 1.54 1.62 0 C-N-CA 127.824 2.63 . . . . 0.87 114.395 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -97.3 165.4 12.05 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.829 1.815 . . . . 2.3300000000000001 112.505 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.7 mm -113.21 123.08 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.822 1.649 . . . . 1.55 110.49 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.7 mm -116.24 128.52 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.011 1.324 . . . . 0.77000000000000002 112.174 -170.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -85.91 140.04 30.71 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.455 1.102 . . . . 2.0600000000000001 112.926 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.62 136.57 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.65 1.18 . . . . 0.66000000000000003 112.118 174.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.69 160.93 30.33 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.637 1.175 . . . . 0.90000000000000002 113.818 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.18 123.6 13.49 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.571 2.18 . . . . 1.1699999999999999 111.526 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.02 -2.36 87.7 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.619 2.057 . . . . 1.0800000000000001 115.242 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.84 171.71 54.62 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 119.246 1.523 . . . . 1.0800000000000001 114.049 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -111.24 152.44 27.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.047 1.339 . . . . 2.4100000000000001 112.235 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -76.66 131.94 73.02 Favored Pre-proline 0 CA--C 1.553 1.066 0 CA-C-O 118.629 -0.701 . . . . 2.2999999999999998 111.587 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -96.1 -17.13 0.35 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.264 2.642 . . . . 0.80000000000000004 115.787 -173.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.49 171.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 127.07 2.148 . . . . 0.75 108.976 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.6 137.38 40.9 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.935 0.789 . . . . 1.8999999999999999 112.652 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.13 -156.48 20.4 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 114.548 0.579 . . . . 0.80000000000000004 114.548 -171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.6 ttp85 -114.78 140.3 49.03 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.631 1.172 . . . . 3.8500000000000001 112.939 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.9 t -88.85 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.685 1.994 . . . . 0.72999999999999998 108.971 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.9 pt -140.92 33.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.84 0.829 . . . . 0.95999999999999996 112.376 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -166.12 137.23 3.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.22 1.808 . . . . 2.71 109.662 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.52 -176.1 51.11 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 123.691 0.662 . . . . 0.81999999999999995 114.74 171.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -156.8 92.27 1.27 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.06 0.944 . . . . 3.1099999999999999 112.13 -168.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.63 165.86 19.17 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.85 1.66 . . . . 1.1799999999999999 112.675 -169.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.0 ttm -112.28 130.75 55.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.455 1.102 . . . . 1.48 110.544 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.3 t -123.4 142.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.311 1.444 . . . . 0.90000000000000002 113.365 -167.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -104.03 107.72 18.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.835 1.254 . . . . 1.8600000000000001 112.288 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -103.01 27.21 7.32 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 126.09 1.756 . . . . 2.3799999999999999 114.109 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 p -51.53 -9.36 0.07 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 119.206 3.039 . . . . 2.1400000000000001 119.206 -169.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.36 -49.28 1.92 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.023 1.329 . . . . 1.3999999999999999 111.128 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.2 mm -67.04 -55.99 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 119.309 0.959 . . . . 1.2 111.917 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.8 p -95.59 -13.24 24.55 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.028 0.931 . . . . 1.3700000000000001 111.75 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.58 11.43 84.41 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.198 1.38 . . . . 1.3100000000000001 115.569 169.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.54 -40.34 82.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.209 1.004 . . . . 2.46 113.235 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.04 43.78 8.64 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.35 1.46 . . . . 1.52 112.246 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.0 ptm -161.98 159.4 21.88 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 128.979 2.912 . . . . 4.4000000000000004 109.602 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.82 139.25 17.48 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.577 2.185 . . . . 2.3100000000000001 112.534 172.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.49 139.09 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.871 1.669 . . . . 1.1200000000000001 110.578 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.37 137.08 32.64 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.132 -0.98 . . . . 0.81999999999999995 112.499 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -117.36 157.2 26.57 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.659 1.584 . . . . 0.71999999999999997 111.027 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -160.1 172.99 5.27 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 127.536 2.335 . . . . 2.2599999999999998 110.511 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -53.57 135.2 60.93 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 CA-C-N 122.201 1.822 . . . . 1.04 111.656 167.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.31 38.87 44.95 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.356 0.503 . . . . 0.88 113.284 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 t -125.52 139.29 53.74 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 118.088 0.944 . . . . 1.46 111.396 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.6 p -91.05 145.02 25.04 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.902 1.228 . . . . 0.97999999999999998 112.475 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.2 m -135.88 156.45 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.63 1.572 . . . . 0.60999999999999999 112.095 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -130.01 144.02 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.487 1.515 . . . . 1.1299999999999999 112.984 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.92 147.44 50.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.757 0.823 . . . . 0.90000000000000002 112.912 -175.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.27 -6.64 63.11 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 115.245 0.858 . . . . 1.04 115.245 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.5 p -76.12 158.03 32.21 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.441 1.121 . . . . 1.4099999999999999 110.395 167.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -108.76 140.26 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.383 1.073 . . . . 1.1100000000000001 110.996 -171.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -109.09 147.72 31.97 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.803 1.241 . . . . 1.6799999999999999 113.475 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -150.95 140.35 21.43 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.983 1.313 . . . . 3.4900000000000002 112.045 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 t30 43.85 88.09 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.219 2.608 . . . . 3.1499999999999999 113.708 168.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.47 -10.37 0.14 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 117.665 1.826 . . . . 3.75 117.665 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.3 m 45.31 85.48 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 127.732 2.413 . . . . 2.52 115.946 169.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.2 mt -106.99 160.72 15.33 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.17 1.544 . . . . 0.93000000000000005 115.17 -169.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.0 135.55 51.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.332 1.053 . . . . 2.4300000000000002 110.604 165.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.56 129.72 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.257 1.823 . . . . 1.6599999999999999 110.396 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.3 p -83.1 119.27 24.29 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.484 -0.76 . . . . 1.52 109.034 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.32 124.99 28.62 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.813 -0.554 . . . . 0.80000000000000004 110.244 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 p -118.16 -0.65 11.53 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.353 1.861 . . . . 2.3799999999999999 112.884 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -142.97 136.23 28.29 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.842 2.057 . . . . 1.8700000000000001 110.054 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.38 162.93 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.404 -0.961 . . . . 1.6399999999999999 108.404 164.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.1 91.08 Favored Glycine 0 N--CA 1.479 1.562 0 O-C-N 120.4 -1.437 . . . . 1.3300000000000001 114.215 -169.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.94 -32.73 74.37 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.803 1.241 . . . . 1.6299999999999999 113.997 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -79.41 -9.76 59.66 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.962 2.105 . . . . 2.2799999999999998 115.142 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.0 p -70.1 154.69 41.62 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.067 -1.646 . . . . 1.47 112.93 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.8 t -57.7 -30.25 65.35 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.387 -0.821 . . . . 1.8600000000000001 112.889 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.03 -49.88 75.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.931 -1.106 . . . . 1.6000000000000001 112.044 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.3 m -64.24 -34.11 77.35 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.11 0.964 . . . . 1.72 110.922 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.19 -40.48 82.18 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.923 -0.486 . . . . 1.6799999999999999 111.882 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.0 mt -58.32 -54.69 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.478 1.111 . . . . 1.1799999999999999 110.604 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.11 -22.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.178 1.177 . . . . 1.45 114.178 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -71.68 -46.4 58.98 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.842 0.857 . . . . 2.6499999999999999 112.116 172.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.72 -43.73 65.39 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.786 0.834 . . . . 2.3500000000000001 112.217 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.42 -17.87 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 120.557 -1.34 . . . . 2.71 113.53 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -67.97 -28.75 67.72 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.854 1.262 . . . . 4.0499999999999998 112.012 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -70.38 -19.81 62.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.518 1.127 . . . . 3.6400000000000001 113.471 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.98 -58.97 2.93 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.171 1.388 . . . . 4.3099999999999996 111.821 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 125.438 1.495 . . . . 4.3799999999999999 113.453 179.666 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.5 p . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 114.007 1.114 . . . . 5.2999999999999998 114.007 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -99.51 -10.44 22.12 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.298 1.039 . . . . 5.3899999999999997 113.052 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.4 -38.07 35.71 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.628 1.344 . . . . 2.0600000000000001 114.628 169.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.79 -46.28 70.98 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 117.22 2.304 . . . . 1.77 117.22 -165.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.37 -31.81 60.62 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.721 1.146 . . . . 1.3500000000000001 113.06 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -69.0 -31.78 70.86 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.966 1.706 . . . . 2.8399999999999999 113.333 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.97 -41.77 71.57 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.295 0.952 . . . . 1.47 111.998 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.37 -38.06 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 122.942 0.497 . . . . 2.0699999999999998 111.285 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.8 m -66.89 -24.16 66.08 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.604 -1.31 . . . . 1.8 113.639 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.02 -15.53 62.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.258 1.423 . . . . 2.3599999999999999 113.453 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -72.55 118.9 16.03 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.167 0.894 . . . . 3.3799999999999999 109.506 172.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.25 177.98 2.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.278 1.831 . . . . 2.5899999999999999 115.445 -168.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.2 m -112.59 -39.37 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.967 1.707 . . . . 2.4500000000000002 113.006 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -141.18 157.14 45.67 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.49 1.293 . . . . 2.8999999999999999 114.49 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.08 170.98 14.7 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.691 1.597 . . . . 0.93000000000000005 112.822 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.7 m -131.08 112.94 13.33 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.287 1.435 . . . . 1.3 111.654 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.8 mt -85.16 142.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.317 1.447 . . . . 1.1000000000000001 109.632 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -102.05 121.62 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 121.18 0.514 . . . . 2.0899999999999999 111.254 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.4 m -121.93 144.34 48.92 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.252 1.421 . . . . 1.8 110.078 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.7 mt -109.88 150.57 28.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.122 1.369 . . . . 2.5699999999999998 112.828 -168.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.53 -22.34 0.81 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 116.184 1.92 . . . . 4.3799999999999999 116.184 -174.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.3 m -109.93 3.76 20.84 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.847 1.203 . . . . 4.6900000000000004 113.994 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t0 88.94 78.46 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 129.841 3.256 . . . . 5.2300000000000004 111.704 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.317 14.6 p30 54.98 -6.12 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.979 2.912 . . . . 4.2599999999999998 118.24 -169.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.0 pt -91.27 -8.1 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 115.796 1.776 . . . . 4.71 115.796 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 tt -129.6 137.43 50.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.738 1.215 . . . . 3.6099999999999999 111.046 169.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.41 136.94 52.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.814 1.646 . . . . 2.7599999999999998 111.596 174.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -135.52 111.29 9.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.94 1.696 . . . . 2.0499999999999998 108.104 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.04 143.84 26.28 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.905 1.076 . . . . 2.5099999999999998 113.905 -169.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -113.69 126.11 54.89 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.862 1.665 . . . . 3.8500000000000001 110.141 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -98.98 122.32 42.08 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.558 1.072 . . . . 2.4100000000000001 111.535 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.19 158.0 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.931 1.085 . . . . 0.93000000000000005 113.931 -168.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -78.36 145.1 35.42 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.711 -0.848 . . . . 3.5499999999999998 108.711 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 p -62.42 -18.48 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 114.386 1.254 . . . . 1.55 114.386 -168.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -61.42 -27.67 68.71 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.589 -1.319 . . . . 3.6099999999999999 113.309 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.3 mt -93.17 -5.72 49.47 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.283 1.833 . . . . 1.4399999999999999 115.008 -169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.76 140.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.831 1.652 . . . . 1.45 109.663 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -114.98 160.47 19.53 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.394 1.478 . . . . 3.0 111.968 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -67.43 137.57 56.0 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.349 -0.982 . . . . 3.21 108.349 167.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.69 -4.35 56.4 Favored Glycine 0 CA--C 1.543 1.803 0 C-N-CA 124.339 0.971 . . . . 1.6100000000000001 114.115 -168.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -93.43 158.65 15.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.168 1.387 . . . . 2.4900000000000002 112.527 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.97 120.12 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.868 1.267 . . . . 1.55 110.229 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 mm -122.1 132.54 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.882 1.673 . . . . 0.85999999999999999 111.47 -168.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.22 130.0 34.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.623 0.769 . . . . 1.8799999999999999 112.654 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.8 p -116.33 132.99 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.106 1.362 . . . . 0.75 111.282 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.94 161.86 42.83 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 125.479 1.511 . . . . 0.90000000000000002 113.318 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.74 139.81 70.99 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.691 1.594 . . . . 1.1299999999999999 109.997 166.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.85 -14.72 41.29 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 126.164 1.84 . . . . 1.21 115.366 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.82 159.86 44.37 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.546 1.673 . . . . 1.0700000000000001 114.878 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -92.68 139.65 30.35 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.978 1.311 . . . . 4.0199999999999996 111.502 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.34 130.13 94.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.396 -0.812 . . . . 2.3900000000000001 111.371 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -89.8 -13.42 2.67 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.706 2.271 . . . . 0.87 114.908 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.11 175.2 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 127.503 2.321 . . . . 1.47 109.903 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.255 1.2 p30 -111.55 147.23 35.85 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.159 0.8 . . . . 1.8700000000000001 113.159 172.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.25 -159.37 32.5 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 115.002 0.761 . . . . 0.57999999999999996 115.002 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 ttp-105 -111.43 140.62 45.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.229 1.412 . . . . 4.25 112.564 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.91 128.4 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 127.436 2.294 . . . . 0.72999999999999998 108.377 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.76 32.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.234 0.827 . . . . 0.68000000000000005 113.234 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -168.03 134.01 1.96 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.655 1.582 . . . . 3.3999999999999999 108.51 167.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.78 178.96 52.58 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 122.086 0.826 . . . . 0.81000000000000005 114.623 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -148.72 124.38 10.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.605 0.762 . . . . 2.5499999999999998 112.78 -172.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -145.45 169.49 18.24 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.292 1.437 . . . . 1.1399999999999999 113.499 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.3 ttm -110.79 132.28 54.34 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.266 1.427 . . . . 0.88 110.454 174.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -118.98 140.22 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.979 1.311 . . . . 0.84999999999999998 111.968 -169.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -107.19 92.89 4.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.498 1.119 . . . . 2.1299999999999999 111.068 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -87.2 22.62 2.04 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.418 1.887 . . . . 1.8799999999999999 113.999 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.9 p -55.49 -8.76 0.39 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 118.973 2.953 . . . . 2.1000000000000001 118.973 -169.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -126.24 -38.12 2.17 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.916 1.686 . . . . 1.49 111.501 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.6 mm -76.84 -61.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.211 0.604 . . . . 1.5600000000000001 111.191 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.3 p -98.58 -12.97 20.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.938 0.895 . . . . 1.6299999999999999 112.616 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.04 87.29 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.329 1.442 . . . . 1.4299999999999999 115.971 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -56.1 -45.15 79.52 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.34 1.056 . . . . 3.4300000000000002 111.68 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 69.81 -14.67 0.35 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.559 2.744 . . . . 2.2200000000000002 114.764 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 58.3 ttm -87.87 149.28 45.43 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.292 1.837 . . . . 3.0600000000000001 110.089 168.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.09 133.83 34.61 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.324 2.683 . . . . 1.48 112.606 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.04 135.2 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.987 1.715 . . . . 0.85999999999999999 111.863 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.39 135.3 36.66 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.034 0.934 . . . . 1.0800000000000001 113.494 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -128.53 144.71 51.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.016 1.726 . . . . 0.75 111.358 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -146.55 174.74 3.16 Favored Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 128.929 2.892 . . . . 2.6400000000000001 109.072 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.66 132.88 45.17 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 122.105 1.787 . . . . 0.77000000000000002 110.526 169.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.45 33.68 21.9 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.012 1.291 . . . . 0.75 114.248 -169.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 57.2 m -123.41 152.42 41.6 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.883 1.273 . . . . 1.4399999999999999 111.258 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.9 p -102.37 152.15 21.43 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.983 1.265 . . . . 0.83999999999999997 113.959 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.08 161.65 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.472 1.909 . . . . 0.5 112.292 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.89 149.9 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.585 1.954 . . . . 1.1200000000000001 112.542 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.88 154.39 30.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.8 1.24 . . . . 0.69999999999999996 114.191 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.6 -11.26 14.22 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.879 1.228 . . . . 0.80000000000000004 115.43 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 m -81.8 160.2 23.6 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.426 1.09 . . . . 2.75 111.047 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.03 145.37 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.114 0.966 . . . . 1.26 111.655 -171.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -107.99 139.68 42.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.855 2.062 . . . . 1.8200000000000001 111.228 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -152.08 145.24 24.61 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.715 -1.241 . . . . 4.5099999999999998 112.049 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 53.2 t30 122.53 -55.81 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.099 1 C-N-CA 132.004 4.122 . . . . 3.4399999999999999 111.228 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.74 175.24 41.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.568 1.08 . . . . 1.8200000000000001 114.891 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.5 m -77.71 137.97 38.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.847 1.259 . . . . 1.8700000000000001 112.193 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.8 mt -127.08 162.55 25.79 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.594 1.158 . . . . 1.05 112.111 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.6 127.46 54.53 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.653 0.781 . . . . 2.5800000000000001 110.343 168.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 mm -114.05 124.51 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 125.468 1.507 . . . . 1.5900000000000001 109.981 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.1 p -91.38 121.57 33.22 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.844 0.747 . . . . 1.46 109.412 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.25 138.02 37.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.344 0.658 . . . . 1.29 111.819 -173.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -112.35 -12.3 13.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.062 0.945 . . . . 2.75 112.919 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -142.64 141.65 31.93 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.196 1.399 . . . . 1.6399999999999999 110.948 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.89 161.84 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.494 1.117 . . . . 1.75 111.443 170.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.9 -35.96 91.48 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.4 -0.813 . . . . 2.3100000000000001 113.899 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.74 84.34 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.149 0.974 . . . . 2.9300000000000002 111.661 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.3 -4.69 31.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.389 1.625 . . . . 3.4900000000000002 115.389 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.4 p -59.79 147.94 36.25 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.923 1.238 . . . . 2.0299999999999998 111.704 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.7 t -57.67 -19.8 29.25 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.203 1.186 . . . . 1.8999999999999999 114.203 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -48.55 -46.08 38.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.591 1.556 . . . . 1.6499999999999999 112.438 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.6 p -69.11 -29.08 67.08 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.281 1.033 . . . . 2.2200000000000002 112.839 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -74.64 -42.5 58.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.724 1.21 . . . . 1.3300000000000001 111.917 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 69.1 mt -54.72 -46.19 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.69 1.196 . . . . 1.3400000000000001 110.861 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m -70.03 -20.89 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.606 -1.309 . . . . 1.46 114.176 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -75.2 -29.1 60.24 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.13 0.972 . . . . 2.3900000000000001 113.235 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.0 mt -73.74 -58.32 3.38 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.921 1.288 . . . . 2.6000000000000001 111.479 168.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 85.4 t -65.73 -22.08 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.862 0.865 . . . . 2.48 112.775 -169.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.8 -33.97 75.84 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.041 -1.662 . . . . 3.4500000000000002 112.912 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.87 -14.31 60.28 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.36 -1.462 . . . . 5.7400000000000002 113.376 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.02 -36.65 64.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.152 0.981 . . . . 5.6500000000000004 112.778 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 124.746 1.218 . . . . 6.0199999999999996 110.776 169.189 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.481 0.549 . . . . 2.4300000000000002 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -70.97 -43.4 68.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.376 0.67 . . . . 4.4199999999999999 109.723 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.65 74.37 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.723 1.209 . . . . 1.3799999999999999 112.454 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.81 -33.06 73.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.706 0.803 . . . . 1.6599999999999999 111.673 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.39 -48.02 21.28 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.701 0.682 . . . . 1.28 111.245 168.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.32 -40.13 61.49 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.745 2.018 . . . . 2.6299999999999999 113.983 -174.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -43.42 -51.91 6.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.7 1.2 . . . . 1.74 111.695 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.2 mm -72.69 -28.02 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.498 1.119 . . . . 2.6600000000000001 113.125 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -74.0 -24.02 59.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.405 1.082 . . . . 1.1899999999999999 112.894 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.47 -16.9 61.97 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.636 0.976 . . . . 2.04 113.636 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.4 154.43 42.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.501 1.143 . . . . 2.8799999999999999 113.466 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.58 160.79 26.3 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.638 -1.165 . . . . 1.8999999999999999 110.855 168.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.6 m -108.65 -6.43 15.99 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.507 1.523 . . . . 1.8999999999999999 112.272 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.21 159.51 41.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.199 1.8 . . . . 3.3700000000000001 113.012 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.19 156.65 44.4 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.209 1.404 . . . . 0.68999999999999995 113.092 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -109.66 108.61 19.07 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 113.279 0.844 . . . . 0.88 113.279 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.9 mt -86.82 125.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.894 1.278 . . . . 0.77000000000000002 110.064 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.04 125.3 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 119.571 1.078 . . . . 2.1800000000000002 112.539 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 m -142.26 149.21 39.28 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.893 1.277 . . . . 2.7599999999999998 113.647 -172.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.69 148.67 49.83 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.729 1.611 . . . . 2.6499999999999999 112.792 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -147.44 16.75 1.16 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.071 1.508 . . . . 6.0999999999999996 115.071 -173.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 m -130.11 -120.61 0.22 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.322 1.449 . . . . 3.9100000000000001 109.135 -175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -117.8 60.1 0.78 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.245 1.818 . . . . 7.7699999999999996 109.266 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t30 66.72 -39.55 0.35 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 128.734 2.814 . . . . 6.4100000000000001 114.865 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.6 pt -45.85 -30.33 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 127.862 2.465 . . . . 5.3099999999999996 117.143 -174.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.02 -39.71 79.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.054 1.341 . . . . 3.79 113.509 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.7 tp 12.46 63.43 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 129.379 3.072 . . . . 2.79 114.245 -173.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 m -77.64 136.02 38.18 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.943 1.297 . . . . 1.8500000000000001 111.394 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -122.39 127.27 49.51 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.065 0.946 . . . . 2.4100000000000001 110.241 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -114.45 119.86 38.34 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.959 1.303 . . . . 4.21 108.891 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -93.97 124.0 37.69 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.582 -0.896 . . . . 1.9099999999999999 108.582 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 m -137.63 170.71 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.734 1.214 . . . . 0.72999999999999998 112.265 -169.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.17 147.35 36.54 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.769 0.828 . . . . 3.3999999999999999 110.601 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.88 -17.67 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 113.734 1.013 . . . . 1.1299999999999999 113.734 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.52 -17.62 26.72 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 120.351 -1.468 . . . . 4.6799999999999997 113.511 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.62 -16.68 28.24 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.246 1.419 . . . . 1.4299999999999999 113.441 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -76.53 147.54 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.289 -0.882 . . . . 1.6299999999999999 110.065 169.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -121.81 162.41 20.95 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.324 1.45 . . . . 3.21 111.852 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.4 ptt-85 -72.84 139.2 46.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.576 -0.738 . . . . 5.0 109.931 170.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.54 -3.43 10.23 Favored Glycine 0 CA--C 1.541 1.713 0 N-CA-C 115.666 1.027 . . . . 1.0900000000000001 115.666 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -119.25 -174.42 2.72 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.592 1.696 . . . . 3.4199999999999999 112.979 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.68 130.25 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.894 1.678 . . . . 1.8 109.933 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -115.89 129.35 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.738 2.015 . . . . 0.70999999999999996 110.144 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HE3' HD11 ' A' ' 96' ' ' LEU . 41.9 mtpt -92.15 133.95 35.31 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 121.627 -0.671 . . . . 2.1499999999999999 112.611 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.02 133.39 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.049 1.34 . . . . 0.69999999999999996 111.44 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 m -100.67 162.2 21.47 Favored Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 124.414 1.086 . . . . 0.87 113.095 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.25 137.61 71.13 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.064 2.51 . . . . 1.0700000000000001 112.472 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.14 -7.37 4.56 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.569 0.987 . . . . 1.03 115.569 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.12 160.88 50.31 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.193 1.497 . . . . 0.93999999999999995 113.542 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -99.14 152.09 20.26 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.704 1.202 . . . . 1.96 112.146 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -81.04 125.03 80.73 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.021 0.929 . . . . 1.78 110.823 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.35 -20.8 2.59 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.987 2.458 . . . . 0.69999999999999996 115.496 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 m -151.17 168.78 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 127.921 2.488 . . . . 0.84999999999999998 108.834 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -89.32 148.03 23.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.122 0.874 . . . . 2.1899999999999999 111.793 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.8 -149.42 10.0 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 114.416 0.526 . . . . 1.01 114.416 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.3 ttm105 -132.26 144.5 50.65 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.711 1.205 . . . . 5.0199999999999996 113.058 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.93 132.77 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.185 2.194 . . . . 0.85999999999999999 109.78 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.7 pt -140.67 30.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.144 1.165 . . . . 0.85999999999999999 114.144 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -168.51 140.3 2.75 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.488 -1.383 . . . . 3.3799999999999999 110.048 168.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.15 -165.12 32.66 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.604 1.097 . . . . 0.98999999999999999 114.641 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -150.27 123.22 8.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.383 1.473 . . . . 1.8700000000000001 111.423 -175.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.06 171.89 15.13 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.18 1.178 . . . . 1.1000000000000001 114.18 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.0 ttm -121.05 132.93 55.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.207 1.403 . . . . 0.83999999999999997 109.643 172.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.86 134.81 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.903 1.281 . . . . 0.63 112.0 -168.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -94.98 113.4 25.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.465 1.906 . . . . 2.1600000000000001 110.642 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -114.72 22.76 13.25 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.621 1.568 . . . . 2.2200000000000002 112.964 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.7 p -57.06 -22.92 42.9 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 118.176 2.658 . . . . 2.0299999999999998 118.176 -167.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -105.04 -31.03 9.38 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.516 1.527 . . . . 1.3 111.415 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.0 mm -74.36 -67.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.534 1.134 . . . . 1.3 110.919 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.1 p -99.13 -4.85 31.28 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.444 1.497 . . . . 1.52 112.306 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.13 2.79 85.56 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.801 1.191 . . . . 2.0899999999999999 114.757 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -73.81 108.23 6.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.412 1.085 . . . . 3.6099999999999999 112.263 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.94 -16.49 56.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.47 1.108 . . . . 2.1200000000000001 112.963 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.4 ttp -109.85 121.08 43.03 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.675 1.59 . . . . 3.3999999999999999 108.052 169.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.82 165.66 28.99 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.604 2.869 . . . . 1.5 114.275 -168.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.14 130.45 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.545 1.538 . . . . 0.80000000000000004 111.02 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.58 137.4 38.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.08 0.552 . . . . 0.69999999999999996 111.66 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.18 147.26 46.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.807 1.643 . . . . 0.84999999999999998 110.404 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -145.63 171.65 6.26 Favored Pre-proline 0 N--CA 1.48 1.048 0 C-N-CA 127.639 2.376 . . . . 2.7999999999999998 110.248 -171.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.14 127.15 23.82 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.973 1.74 . . . . 1.02 111.556 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.01 35.29 18.88 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.539 1.066 . . . . 0.90000000000000002 113.902 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.9 t -118.47 154.7 32.07 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.427 1.613 . . . . 1.55 112.252 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -107.1 144.03 34.39 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.657 1.183 . . . . 1.02 112.536 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 m -138.72 153.71 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.187 0.995 . . . . 0.72999999999999998 113.555 -172.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -118.37 146.25 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.001 1.32 . . . . 0.90000000000000002 114.031 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.1 143.82 31.47 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.207 1.403 . . . . 0.76000000000000001 112.154 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.62 -4.04 66.21 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.845 1.098 . . . . 0.68000000000000005 115.845 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.4 p -74.25 159.38 32.56 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.074 1.437 . . . . 1.3999999999999999 111.758 169.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.58 140.58 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.397 1.079 . . . . 0.80000000000000004 111.507 -173.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -81.86 139.29 34.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.502 1.121 . . . . 2.6800000000000002 111.475 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -146.35 56.88 1.18 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.5 1.296 . . . . 3.2200000000000002 114.5 168.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -160.03 -59.36 0.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.374 1.25 . . . . 3.3999999999999999 114.374 167.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -164.21 168.96 38.87 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.701 1.143 . . . . 1.99 113.497 -168.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.8 p -84.15 148.18 26.91 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.789 1.033 . . . . 1.79 113.789 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -137.5 161.3 36.76 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.993 1.717 . . . . 1.29 111.629 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.479 HD11 ' HE3' ' A' ' 44' ' ' LYS . 9.7 mp -108.42 119.86 40.74 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.075 1.35 . . . . 2.04 110.348 174.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.9 mt -107.13 119.74 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.267 1.427 . . . . 2.1200000000000001 110.153 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.6 p -79.97 117.11 20.52 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.856 -1.153 . . . . 1.49 110.248 170.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.63 121.83 28.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.616 0.722 . . . . 0.93000000000000005 112.701 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -115.31 -9.77 12.14 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.558 1.543 . . . . 2.1299999999999999 113.471 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -138.26 146.0 41.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.5 1.52 . . . . 1.6100000000000001 111.474 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 m -100.4 160.75 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.47 1.508 . . . . 1.78 110.1 167.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.96 -39.13 56.33 Favored Glycine 0 N--CA 1.472 1.074 0 N-CA-C 116.556 1.382 . . . . 1.28 116.556 -166.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.22 -36.37 71.83 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.654 1.227 . . . . 1.73 113.346 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.66 -9.06 58.26 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.322 1.23 . . . . 2.3300000000000001 114.322 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.8 p -58.8 152.64 18.64 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.158 -0.964 . . . . 1.6499999999999999 113.148 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 t -56.82 -39.22 73.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.756 1.222 . . . . 1.8899999999999999 110.567 169.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.39 -43.36 99.01 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.014 1.726 . . . . 1.47 112.362 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.7 t -67.4 -35.14 78.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.498 0.719 . . . . 2.1400000000000001 111.839 176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.29 -43.37 70.53 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.364 0.529 . . . . 1.5700000000000001 111.739 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.6 mt -54.06 -51.4 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.143 0.977 . . . . 1.73 111.589 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.8 m -66.45 -32.14 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 120.99 -1.069 . . . . 1.4099999999999999 113.04 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -73.61 -27.09 61.1 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.413 1.085 . . . . 2.8399999999999999 112.633 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.6 mt -70.41 -53.23 17.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.722 1.209 . . . . 3.21 110.654 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.23 -50.38 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.76 0.824 . . . . 2.0099999999999998 111.777 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -54.47 -41.14 69.15 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.754 1.02 . . . . 3.79 113.754 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.33 -30.91 54.19 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.731 1.012 . . . . 4.0300000000000002 113.731 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.27 -25.03 62.28 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 115.284 1.587 . . . . 4.3700000000000001 115.284 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.777 1.631 . . . . 4.8899999999999997 111.865 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 114.337 1.236 . . . . 2.3799999999999999 114.337 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.99 -43.58 24.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.771 0.714 . . . . 5.5 109.947 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.98 -42.9 81.07 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.753 -0.592 . . . . 1.8700000000000001 111.797 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.39 -33.29 65.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.9 0.88 . . . . 2.25 113.25 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.36 -44.65 35.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.791 0.723 . . . . 1.6100000000000001 112.581 169.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -64.15 -34.13 77.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.317 0.858 . . . . 2.5 113.317 -174.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.23 -36.38 73.1 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.497 1.044 . . . . 1.25 113.047 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.0 mm -67.01 -37.24 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 118.764 0.711 . . . . 2.3799999999999999 111.304 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.0 m -72.9 -23.81 60.76 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.387 -0.821 . . . . 1.23 112.754 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.7 mt -72.38 -25.6 61.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.909 1.284 . . . . 2.0899999999999999 112.905 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -68.49 106.09 2.43 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.721 1.146 . . . . 3.2599999999999998 110.76 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 155.31 28.23 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.173 1.389 . . . . 2.2000000000000002 113.467 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.7 m -95.78 -31.14 13.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.388 1.475 . . . . 1.95 114.281 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.35 159.83 41.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.184 0.994 . . . . 2.8500000000000001 113.33 -169.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.45 163.49 32.96 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.567 1.547 . . . . 0.72999999999999998 112.776 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.5 m -119.65 97.52 5.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.559 1.544 . . . . 0.80000000000000004 110.704 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.2 mt -84.89 133.92 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.369 1.068 . . . . 0.79000000000000004 110.008 -172.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -107.81 127.34 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.506 1.122 . . . . 1.78 111.111 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.6 m -121.8 146.22 47.28 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.4 1.48 . . . . 1.6299999999999999 111.388 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.5 mt -77.11 113.75 15.17 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.718 0.807 . . . . 3.4900000000000002 110.625 171.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -99.23 -5.83 29.18 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.349 1.24 . . . . 5.4000000000000004 114.349 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 m -133.3 -58.7 0.89 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.499 1.52 . . . . 3.8900000000000001 110.755 169.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -163.1 -158.7 0.49 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.958 2.903 . . . . 4.6799999999999997 104.728 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -61.26 -1.3 0.47 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.353 1.861 . . . . 5.4299999999999997 114.588 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.4 pt -91.84 -16.59 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 128.433 2.693 . . . . 4.1299999999999999 113.747 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -135.34 123.48 22.94 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.736 1.214 . . . . 3.73 111.711 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.97 132.23 56.04 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.621 1.568 . . . . 3.3999999999999999 111.015 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -142.2 145.66 34.37 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.179 1.392 . . . . 2.0600000000000001 110.959 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -118.48 149.06 41.92 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.495 1.665 . . . . 2.5099999999999998 115.495 -168.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -104.07 139.0 39.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.577 1.951 . . . . 2.9199999999999999 109.65 169.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -98.73 121.23 40.41 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.043 0.937 . . . . 2.23 109.408 172.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.62 159.86 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 115.288 1.588 . . . . 0.81999999999999995 115.288 -167.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.09 150.74 30.17 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.434 1.093 . . . . 3.1699999999999999 109.761 166.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.05 -21.27 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.334 1.054 . . . . 1.03 113.646 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.47 -20.14 62.81 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.361 -1.462 . . . . 2.8799999999999999 112.95 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.1 mt -107.22 -8.93 16.25 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.253 1.575 . . . . 1.4199999999999999 115.253 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.15 148.89 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.297 1.039 . . . . 1.49 111.051 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -122.3 165.07 16.81 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.121 1.368 . . . . 4.0899999999999999 114.204 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -69.09 26.19 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 127.011 2.124 . . . . 2.7799999999999998 116.213 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.79 9.65 2.32 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.003 1.764 . . . . 1.01 113.776 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -89.47 165.07 14.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.126 1.37 . . . . 2.9100000000000001 112.821 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.1 mt -122.21 128.28 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.143 1.377 . . . . 1.1699999999999999 110.167 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.1 mm -118.06 130.54 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.407 1.483 . . . . 0.75 113.348 -167.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -82.77 128.08 34.05 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.525 1.13 . . . . 2.5800000000000001 112.408 172.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.39 125.26 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.666 1.186 . . . . 0.78000000000000003 111.856 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.81 158.57 42.03 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.506 1.522 . . . . 1.1599999999999999 113.205 -175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.82 123.08 9.11 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.268 3.312 . . . . 1.1399999999999999 113.489 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.72 -0.75 88.13 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.879 1.228 . . . . 0.95999999999999996 115.022 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.9 -169.03 30.21 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 118.757 1.278 . . . . 1.05 114.116 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -130.18 158.85 38.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.12 1.768 . . . . 2.4500000000000002 111.462 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -86.68 118.66 70.53 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.621 0.768 . . . . 2.3900000000000001 109.277 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -89.68 -13.84 2.61 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.04 1.827 . . . . 1.01 115.865 -168.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.0 159.82 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 128.992 2.917 . . . . 1.0700000000000001 107.699 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.0 147.51 25.7 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.653 0.983 . . . . 2.0 113.653 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.45 -159.3 32.21 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 114.946 0.738 . . . . 0.87 114.946 -173.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -109.12 145.43 35.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.702 1.601 . . . . 5.1200000000000001 113.541 -169.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 t -106.89 119.88 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 127.396 2.279 . . . . 1.1200000000000001 108.276 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 pt -136.61 34.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 119.224 0.92 . . . . 1.52 113.399 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.15 127.97 2.21 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.024 1.73 . . . . 3.5899999999999999 107.454 167.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.88 178.03 40.76 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 122.874 1.263 . . . . 0.89000000000000001 115.402 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -154.95 110.65 3.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.279 1.032 . . . . 2.3999999999999999 112.737 -166.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.0 p -137.74 175.05 9.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.609 1.964 . . . . 2.8999999999999999 113.936 -168.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 38.6 ttm -114.72 145.13 42.41 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.321 1.048 . . . . 1.04 109.619 165.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.37 142.91 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.067 1.347 . . . . 0.64000000000000001 111.771 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -113.13 113.23 25.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.915 1.686 . . . . 1.8799999999999999 110.747 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -134.39 14.37 3.79 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.084 1.754 . . . . 2.52 114.336 -170.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.6 p -58.49 -13.95 6.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 117.543 2.423 . . . . 1.3400000000000001 117.543 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -93.86 -33.32 13.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.999 1.32 . . . . 1.1000000000000001 111.684 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.0 mm -73.79 -62.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.575 -0.703 . . . . 1.0800000000000001 110.047 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.6 p -94.23 -13.19 26.84 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.007 1.323 . . . . 1.3799999999999999 113.382 -171.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.43 10.31 78.93 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.659 1.6 . . . . 1.49 113.827 -172.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.88 98.87 0.58 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.684 1.742 . . . . 2.71 109.385 170.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.64 28.41 0.26 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.988 1.315 . . . . 1.8899999999999999 112.496 -171.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.2 ptm -155.16 145.0 15.55 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.377 2.271 . . . . 3.27 109.301 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.42 148.92 21.22 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.111 2.541 . . . . 1.3500000000000001 112.095 -172.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.55 136.21 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.829 1.252 . . . . 0.98999999999999999 112.416 -168.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.0 150.15 29.0 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.079 0.952 . . . . 0.78000000000000003 113.125 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -132.26 150.87 52.06 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.131 1.772 . . . . 1.1599999999999999 111.598 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -143.78 173.88 4.06 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 129.146 2.978 . . . . 3.25 108.784 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -58.06 138.77 87.68 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 CA-C-N 121.058 1.414 . . . . 1.1200000000000001 110.862 168.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.22 14.61 74.0 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.205 1.383 . . . . 1.04 115.083 -170.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.8 m -97.74 164.87 12.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.391 1.596 . . . . 1.8100000000000001 110.72 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.8 p -124.03 159.96 28.73 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.107 -0.996 . . . . 1.48 113.334 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.65 161.06 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.616 1.966 . . . . 0.69999999999999996 112.151 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.537 HD13 ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -116.84 154.86 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.847 2.059 . . . . 1.29 112.026 172.226 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.2 150.45 48.29 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.37 0.878 . . . . 0.78000000000000003 113.37 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.64 -5.12 62.01 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.661 1.124 . . . . 0.79000000000000004 115.219 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.0 p -77.68 157.46 30.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.792 1.237 . . . . 1.51 111.663 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mm -108.39 137.2 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.884 0.874 . . . . 0.73999999999999999 111.482 -170.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.66 155.13 21.24 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.877 1.671 . . . . 3.4500000000000002 112.905 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -129.77 124.49 33.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.642 1.577 . . . . 3.02 109.075 166.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 45.94 -132.37 1.03 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.101 2.161 . . . . 3.8500000000000001 110.294 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.98 -60.23 3.85 Favored Glycine 0 CA--C 1.527 0.8 0 O-C-N 120.069 -1.644 . . . . 3.4199999999999999 116.488 166.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.4 m 47.44 77.16 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.398 1.479 . . . . 2.3199999999999998 111.781 -168.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.2 164.2 12.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.402 1.081 . . . . 1.3600000000000001 113.421 -166.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mp -119.54 128.7 54.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.158 0.983 . . . . 2.0 110.527 168.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.5 mm -115.74 122.55 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.835 1.654 . . . . 1.4299999999999999 110.955 -170.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.07 103.34 16.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.756 1.222 . . . . 3.02 110.141 176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.07 131.35 36.23 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.355 1.062 . . . . 0.87 112.001 -174.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.35 6.01 7.0 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.01 1.485 . . . . 2.21 115.01 -175.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -142.05 147.31 36.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.492 1.117 . . . . 1.53 111.842 170.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 p -86.64 163.25 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.442 1.097 . . . . 3.02 110.389 170.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.05 -37.67 94.29 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 120.241 -1.537 . . . . 1.4299999999999999 114.712 -169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.67 -32.06 71.27 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.244 1.018 . . . . 1.6799999999999999 112.822 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.42 -16.74 60.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.78 1.232 . . . . 2.6400000000000001 113.946 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.9 p -68.37 159.87 30.64 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.902 1.228 . . . . 1.72 113.714 -169.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.3 t -66.27 -31.12 71.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.396 -0.82 . . . . 2.3199999999999998 111.539 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.3 mp -57.44 -53.09 62.05 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.839 -1.163 . . . . 1.6200000000000001 111.828 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.6 p -70.5 -24.69 62.88 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.196 0.998 . . . . 1.8100000000000001 111.901 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -72.76 -42.61 63.82 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.478 0.918 . . . . 2.1499999999999999 113.478 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.3 mt -56.68 -49.19 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.031 -1.043 . . . . 1.71 110.259 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 m -65.92 -25.16 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.379 0.881 . . . . 1.5800000000000001 113.379 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -71.88 -46.44 57.81 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.81 0.844 . . . . 2.3999999999999999 112.056 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.0 mt -70.07 -36.49 74.98 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.521 1.528 . . . . 2.3599999999999999 113.65 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.32 -52.14 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.776 -0.453 . . . . 2.29 109.776 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.22 -23.49 63.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.571 1.323 . . . . 4.4199999999999999 114.571 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.53 -25.48 59.36 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.039 -1.038 . . . . 3.7000000000000002 113.024 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.14 -50.6 21.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.44 1.018 . . . . 3.9300000000000002 112.136 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.183 0 C-N-CA 124.943 1.297 . . . . 4.1600000000000001 113.728 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 112.05 0.389 . . . . 2.98 112.05 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -76.28 -49.15 17.78 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.225 -0.922 . . . . 4.9100000000000001 110.136 168.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.45 -15.25 62.8 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.149 1.537 . . . . 1.71 115.149 -170.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.9 tp -68.17 -31.64 71.33 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.608 -1.308 . . . . 1.9299999999999999 113.731 -169.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.89 -21.01 55.56 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.894 -1.129 . . . . 1.3400000000000001 113.532 169.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -69.39 -41.41 76.49 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.813 -1.179 . . . . 2.6299999999999999 111.366 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.19 -43.56 82.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.241 1.016 . . . . 1.02 112.162 177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.02 -33.64 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.294 -0.879 . . . . 1.6000000000000001 111.998 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.9 m -75.77 -19.62 58.87 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.285 1.034 . . . . 1.1200000000000001 113.177 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mt -68.12 -32.13 72.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.585 1.954 . . . . 2.0699999999999998 113.006 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -57.11 131.76 50.88 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.853 1.206 . . . . 3.4300000000000002 111.952 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.08 144.93 53.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.835 -0.621 . . . . 2.2999999999999998 109.489 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 p -78.52 -20.98 49.55 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.118 1.155 . . . . 3.1499999999999999 114.118 -174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -137.76 158.65 43.91 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.61 1.337 . . . . 3.9700000000000002 114.61 -169.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.86 172.8 12.19 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.595 1.958 . . . . 1.1699999999999999 112.476 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.6 m -131.45 102.41 5.93 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.135 1.774 . . . . 1.2 111.141 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.5 mt -80.38 128.62 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.045 1.338 . . . . 0.76000000000000001 109.387 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.51 132.97 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.804 0.842 . . . . 2.1800000000000002 112.533 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.4 m -140.52 150.98 44.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.611 1.165 . . . . 2.1499999999999999 113.403 -169.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mt -104.07 132.54 50.22 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.861 0.864 . . . . 3.1000000000000001 108.784 166.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.66 174.44 10.12 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.276 1.431 . . . . 4.0899999999999999 112.74 -168.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t 68.26 -61.53 0.39 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.155 2.582 . . . . 6.7000000000000002 113.801 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -164.82 46.61 0.1 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.685 3.194 . . . . 6.3399999999999999 107.026 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.277 0.6 OUTLIER 59.21 -8.54 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 128.453 2.701 . . . . 6.8300000000000001 115.919 -165.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.5 pt -68.73 -19.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.322 1.849 . . . . 5.29 115.425 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.7 tp -107.84 98.92 8.44 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.085 1.354 . . . . 3.7799999999999998 109.074 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mp -81.35 121.93 26.83 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.42 -0.8 . . . . 3.6200000000000001 109.051 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 t -124.93 144.33 50.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.138 1.375 . . . . 2.0299999999999998 111.207 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -141.79 127.25 18.86 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.947 1.299 . . . . 2.3399999999999999 110.054 -171.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.4 133.35 53.43 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.723 -1.236 . . . . 3.2799999999999998 111.12 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.69 123.47 43.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.082 0.856 . . . . 2.8999999999999999 110.965 176.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -129.61 165.41 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.243 1.417 . . . . 1.28 112.808 -168.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -80.18 151.1 29.9 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.115 1.366 . . . . 3.6899999999999999 110.165 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.35 -23.09 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 120.968 -1.083 . . . . 1.76 113.117 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -70.05 -18.16 63.27 Favored 'General case' 0 CA--C 1.552 1.053 0 O-C-N 120.813 -1.179 . . . . 3.7799999999999998 113.741 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -110.52 -3.36 16.04 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.093 1.516 . . . . 1.73 115.093 -169.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -94.63 145.33 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.931 1.692 . . . . 1.97 111.067 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -122.79 166.72 14.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.713 2.405 . . . . 3.3999999999999999 114.041 -175.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -73.86 16.18 0.24 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.787 2.143 . . . . 3.4500000000000002 116.787 -169.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.97 11.25 3.64 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.218 1.865 . . . . 1.3300000000000001 113.829 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -79.64 152.74 29.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.332 1.566 . . . . 3.54 112.508 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.24 120.08 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.116 1.366 . . . . 1.8 108.922 173.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.6 mm -118.76 125.25 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.031 0.932 . . . . 0.62 113.198 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.563 ' HE3' HD11 ' A' ' 96' ' ' LEU . 17.7 ttmt -80.03 128.69 33.78 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.378 0.671 . . . . 1.9299999999999999 110.632 167.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 p -103.14 137.07 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.137 0.975 . . . . 0.66000000000000003 111.113 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -88.58 160.66 44.18 Favored Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 113.35 0.87 . . . . 1.1599999999999999 113.35 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.01 136.29 64.52 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.67 2.247 . . . . 1.3100000000000001 110.41 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.64 -3.97 23.49 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.443 1.497 . . . . 0.95999999999999996 116.408 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.97 178.26 53.9 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.203 1.382 . . . . 0.97999999999999998 114.9 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -126.65 148.0 49.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.659 1.584 . . . . 2.3799999999999999 112.616 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -82.73 126.68 72.6 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.394 0.677 . . . . 1.8600000000000001 112.601 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -90.89 -22.6 0.61 Allowed 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.122 3.215 . . . . 1.0 114.713 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 m -147.67 170.3 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 128.524 2.73 . . . . 0.80000000000000004 108.721 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -99.22 156.35 17.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.106 1.15 . . . . 1.6799999999999999 114.106 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.8 -168.1 39.87 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 115.845 1.098 . . . . 0.65000000000000002 115.845 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -112.17 138.72 48.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.43 1.892 . . . . 4.1500000000000004 111.552 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.82 127.84 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 127.016 2.126 . . . . 0.67000000000000004 109.399 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.2 pt -140.61 31.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.494 0.718 . . . . 0.69999999999999996 112.844 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -167.3 133.59 2.2 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.415 1.486 . . . . 2.5699999999999998 109.821 169.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.41 -177.8 48.86 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.075 1.19 . . . . 0.79000000000000004 116.075 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -147.75 113.02 5.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.864 1.266 . . . . 2.3100000000000001 112.402 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.79 167.27 22.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.488 1.115 . . . . 1.28 111.607 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.7 ttm -105.3 145.57 30.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.955 0.902 . . . . 0.95999999999999996 109.945 169.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.57 136.0 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.215 1.006 . . . . 0.69999999999999996 112.054 -170.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -100.89 132.66 46.19 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.067 1.347 . . . . 2.21 111.631 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -133.62 16.46 3.98 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.101 1.519 . . . . 1.8200000000000001 115.101 -169.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' A' ' 73' ' ' ALA . 98.0 p -44.38 -32.45 1.35 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 119.628 3.196 . . . . 1.8 119.628 -166.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -95.09 -41.82 8.92 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.648 1.113 . . . . 1.51 111.202 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.4 mm -69.04 -64.32 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.889 1.276 . . . . 1.05 111.498 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.4 p -93.69 -11.3 31.85 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.202 1.401 . . . . 1.3200000000000001 112.327 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.54 2.16 87.29 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.021 1.296 . . . . 1.23 115.083 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -55.68 -46.46 77.58 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.174 0.987 . . . . 2.3300000000000001 113.542 -170.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' A' ' 67' ' ' SER . . . 55.94 27.25 10.85 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.679 1.592 . . . . 2.0699999999999998 113.369 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.7 ttt -152.79 136.85 10.36 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 131.158 3.783 . . . . 3.6800000000000002 105.312 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.32 153.51 35.71 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.719 2.28 . . . . 1.3500000000000001 112.881 -172.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.8 t -128.39 134.38 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.735 1.614 . . . . 1.01 112.073 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.55 134.12 36.48 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.545 1.138 . . . . 0.90000000000000002 113.488 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -117.7 143.52 46.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.635 1.974 . . . . 0.87 110.655 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -142.93 175.34 2.94 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 127.358 2.263 . . . . 3.5899999999999999 109.465 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -59.18 127.82 25.42 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 CA-C-N 122.182 1.815 . . . . 0.98999999999999999 111.325 170.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.29 33.59 11.63 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.659 1.123 . . . . 1.03 114.749 -169.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -121.09 170.82 9.17 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.166 1.386 . . . . 1.76 111.173 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.8 p -122.74 151.22 41.8 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.493 -1.379 . . . . 0.81000000000000005 113.449 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.72 156.37 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.936 1.694 . . . . 0.68999999999999995 112.272 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -123.97 159.06 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.213 1.805 . . . . 0.96999999999999997 112.355 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.14 149.99 49.43 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.769 -0.582 . . . . 0.65000000000000002 112.479 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.7 -2.42 83.0 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 115.293 0.877 . . . . 1.03 115.293 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.88 153.14 32.92 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 117.783 0.792 . . . . 1.96 112.05 168.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mm -108.89 129.84 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.988 1.315 . . . . 0.72999999999999998 110.493 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -94.77 142.38 27.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.04 1.736 . . . . 1.6599999999999999 111.856 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.65 -101.33 0.11 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.242 1.201 . . . . 5.0999999999999996 114.242 -174.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -98.42 -41.36 7.84 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.324 1.602 . . . . 3.6600000000000001 115.324 -167.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.49 140.37 18.11 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 119.487 1.04 . . . . 1.8500000000000001 114.041 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t -84.93 129.35 34.82 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.735 0.814 . . . . 2.6200000000000001 110.413 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.2 mt -120.69 158.72 26.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.375 1.47 . . . . 0.95999999999999996 110.902 -173.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.563 HD11 ' HE3' ' A' ' 44' ' ' LYS . 7.8 mp -112.97 129.75 56.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.166 0.587 . . . . 1.76 109.88 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.31 128.19 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.596 1.558 . . . . 1.1200000000000001 110.222 -173.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 23.4 p -81.84 111.16 17.8 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.288 -1.004 . . . . 1.51 108.288 168.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.29 142.96 37.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.869 0.868 . . . . 1.0600000000000001 110.848 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -132.21 3.5 3.99 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.876 1.806 . . . . 2.9900000000000002 115.876 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -145.16 150.81 37.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.842 1.257 . . . . 1.98 111.473 170.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.8 m -81.88 171.41 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.206 1.002 . . . . 1.8100000000000001 110.85 168.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.75 -28.89 73.3 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 120.756 -1.215 . . . . 1.73 114.699 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.91 -42.75 60.2 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.792 1.296 . . . . 1.79 113.572 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -78.73 -10.2 59.69 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 116.497 2.036 . . . . 2.9100000000000001 116.497 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.9 t -83.95 156.48 22.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.464 1.505 . . . . 2.5699999999999998 113.417 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.8 m -39.33 -44.28 1.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.99 2.116 . . . . 2.3100000000000001 114.308 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.17 -46.73 85.8 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.756 1.162 . . . . 1.4099999999999999 111.847 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.3 t -70.19 -35.65 74.09 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.851 0.861 . . . . 2.3799999999999999 111.088 173.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -64.25 -35.73 81.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.377 0.671 . . . . 1.9199999999999999 112.288 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.6 mt -64.69 -58.99 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.466 1.506 . . . . 1.4299999999999999 110.728 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m -65.37 -20.99 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 113.539 0.941 . . . . 1.48 113.539 -171.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -69.58 -55.53 9.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.171 0.988 . . . . 2.6800000000000002 111.744 169.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -30.24 56.06 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 115.151 1.538 . . . . 3.2200000000000002 115.151 -173.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.73 -54.46 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.952 -0.759 . . . . 2.3999999999999999 108.952 171.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -59.96 -14.71 17.22 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.383 1.994 . . . . 4.3499999999999996 116.383 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -72.41 -37.28 68.68 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.423 1.465 . . . . 4.5499999999999998 112.636 169.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.08 -65.1 1.05 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.362 0.665 . . . . 3.8100000000000001 111.552 169.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 128.348 2.659 . . . . 5.3700000000000001 112.268 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 112.161 0.43 . . . . 2.7000000000000002 112.161 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -57.33 -33.21 67.5 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.475 1.51 . . . . 4.46 113.211 173.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.48 -17.79 60.03 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.632 1.345 . . . . 1.51 114.632 172.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 35.3 tp -63.63 -42.62 98.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.903 1.229 . . . . 1.4099999999999999 113.313 -168.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.8 -21.61 57.17 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.597 -1.314 . . . . 2.1899999999999999 113.161 169.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -67.17 -39.56 86.47 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.776 1.171 . . . . 2.5800000000000001 111.446 -170.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -49.47 -46.15 47.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.315 0.646 . . . . 1.4299999999999999 110.998 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.2 mm -71.52 -27.99 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.652 1.181 . . . . 2.3599999999999999 113.294 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.9 m -70.91 -37.09 72.92 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.307 1.043 . . . . 1.24 112.83 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.05 -17.34 51.88 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.092 1.145 . . . . 2.3900000000000001 114.092 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.65 135.52 55.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.691 1.596 . . . . 2.1899999999999999 113.185 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.13 150.36 48.29 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.399 0.679 . . . . 1.97 112.104 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -100.56 -28.55 12.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.765 1.226 . . . . 1.8700000000000001 112.193 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -140.64 152.93 45.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.054 1.342 . . . . 3.2999999999999998 112.096 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.08 157.84 44.16 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.638 1.575 . . . . 1.2 113.272 -169.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 m -94.5 109.67 21.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.784 0.834 . . . . 1.48 112.849 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.7 mt -84.48 125.09 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.067 0.947 . . . . 0.81000000000000005 109.55 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.72 130.17 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.986 0.914 . . . . 1.8300000000000001 110.691 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -140.21 136.24 33.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.594 1.158 . . . . 1.98 111.09 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.3 mt -81.32 92.08 6.33 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.297 -1.001 . . . . 3.3300000000000001 108.297 169.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.84 -5.38 40.6 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.952 0.901 . . . . 3.6000000000000001 113.259 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.2 m -158.72 142.46 15.23 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.838 2.055 . . . . 3.9900000000000002 111.655 167.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 25' ' ' ILE . 1.5 m-20 -3.6 50.49 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.266 1 C-N-CA 134.995 5.318 . . . . 5.8600000000000003 117.725 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.4 -22.61 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 126.737 2.015 . . . . 5.25 113.339 -166.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.432 ' H ' ' C ' ' A' ' 23' ' ' ASP . 44.7 pt -61.55 -11.44 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 129.106 2.962 . . . . 3.9700000000000002 116.332 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.5 tp -136.49 103.88 5.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.693 1.197 . . . . 2.6800000000000002 110.988 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.85 127.65 33.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.081 0.952 . . . . 3.5 109.108 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -140.59 138.44 34.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.81 0.844 . . . . 1.6499999999999999 111.588 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -137.39 132.0 32.86 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.195 0.998 . . . . 3.0299999999999998 110.915 -173.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.2 140.36 48.62 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.243 1.417 . . . . 3.46 109.925 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -100.45 117.77 35.29 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.308 0.958 . . . . 2.0499999999999998 109.22 168.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.99 156.96 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.857 1.263 . . . . 1.4299999999999999 111.946 -168.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -76.84 151.62 35.8 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.46 -0.775 . . . . 3.7799999999999998 111.273 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.0 -19.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 115.037 1.495 . . . . 1.1499999999999999 115.037 -172.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.95 -19.28 52.13 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 120.333 -1.479 . . . . 3.9700000000000002 113.668 173.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.8 mt -91.36 -6.85 52.32 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.107 1.763 . . . . 1.72 113.43 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.26 143.03 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.218 1.807 . . . . 1.49 110.255 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.32 172.73 10.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.17 0.988 . . . . 4.3899999999999997 112.316 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -65.66 21.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 117.487 2.403 . . . . 3.7400000000000002 117.487 -172.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.7 42.95 0.81 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.219 1.866 . . . . 1.3999999999999999 111.714 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -122.66 159.32 28.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.894 1.678 . . . . 2.1899999999999999 110.584 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 53.7 mt -116.22 125.79 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.18 0.992 . . . . 1.2 109.834 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.5 mm -116.92 127.19 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.936 1.295 . . . . 0.69999999999999996 112.195 -168.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -79.37 121.66 25.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.693 0.797 . . . . 3.2000000000000002 109.209 168.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.8 124.44 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.247 1.019 . . . . 1.1399999999999999 109.29 170.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.8 m -85.99 156.68 57.74 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 123.323 0.649 . . . . 1.3 112.654 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.05 130.71 35.66 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.746 2.297 . . . . 1.3500000000000001 111.848 171.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.1 -7.44 29.34 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 124.812 1.196 . . . . 1.03 115.07 -171.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.51 -177.83 50.62 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.341 1.448 . . . . 1.0900000000000001 114.234 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -125.65 158.18 35.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.22 1.408 . . . . 1.8100000000000001 112.29 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -88.78 129.08 49.97 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.901 0.881 . . . . 2.2200000000000002 111.859 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.99 -25.59 1.41 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.747 2.965 . . . . 0.88 115.207 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -147.85 167.33 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.833 2.453 . . . . 0.98999999999999999 108.749 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.21 149.11 24.83 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.023 0.828 . . . . 1.95 111.429 174.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -165.15 35.72 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 114.552 0.581 . . . . 0.95999999999999996 114.552 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -111.5 144.49 40.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.473 1.509 . . . . 3.5600000000000001 112.314 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.13 134.03 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.863 2.465 . . . . 1.04 108.225 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 pt -138.35 30.31 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 122.253 1.025 . . . . 1.1399999999999999 112.42 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -168.54 144.44 3.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.582 1.953 . . . . 3.3799999999999999 109.552 167.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 177.18 38.94 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 117.268 1.667 . . . . 1.0600000000000001 117.268 167.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -143.78 37.6 1.32 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 115.619 1.711 . . . . 2.21 115.619 -168.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.645 ' H ' HD21 ' A' ' 95' ' ' LEU . 34.7 m -77.3 157.61 30.63 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.718 -1.239 . . . . 1.72 112.247 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.3 ttm -92.89 140.13 29.82 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.841 -0.618 . . . . 1.1599999999999999 110.083 168.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.5 t -126.24 143.48 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.355 1.462 . . . . 0.72999999999999998 111.905 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -106.22 111.09 23.55 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.014 1.725 . . . . 2.1400000000000001 111.429 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.3 16.24 5.01 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.792 1.637 . . . . 1.8999999999999999 114.662 -172.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.5 p -65.6 -26.92 68.06 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.659 1.726 . . . . 1.46 115.659 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -79.43 -48.21 14.35 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.36 0.982 . . . . 1.51 110.686 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.5 mm -65.73 -55.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.657 0.783 . . . . 1.6299999999999999 110.499 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.7 p -93.57 -11.63 31.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.407 1.083 . . . . 1.6799999999999999 113.708 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.07 13.48 82.95 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 119.312 -0.716 . . . . 1.4299999999999999 113.785 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.58 175.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.14 2.176 . . . . 2.9100000000000001 113.581 171.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.77 6.45 1.61 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.224 1.565 . . . . 2.2400000000000002 115.224 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -149.55 148.83 27.08 Favored Pre-proline 0 C--O 1.24 0.604 0 O-C-N 120.825 -1.172 . . . . 4.0899999999999999 109.272 168.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.08 157.85 60.13 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.565 2.176 . . . . 1.27 111.395 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.8 t -117.25 127.81 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.832 1.253 . . . . 0.93999999999999995 112.353 -167.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.21 130.17 35.2 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.274 0.629 . . . . 1.01 111.213 173.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.12 162.92 12.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.684 1.194 . . . . 0.81000000000000005 111.649 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -150.6 165.17 18.0 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 127.571 2.349 . . . . 3.7000000000000002 110.342 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.1 129.79 31.66 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 CA-C-N 121.075 1.42 . . . . 1.0800000000000001 108.697 165.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.37 44.67 6.85 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.344 0.973 . . . . 1.01 113.576 -169.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 t -131.39 151.2 51.75 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.346 1.458 . . . . 1.74 111.698 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.0 p -101.4 147.58 26.17 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.788 1.631 . . . . 1.45 113.151 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 m -139.48 151.71 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.197 1.399 . . . . 0.76000000000000001 112.64 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -112.88 147.08 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.94 1.296 . . . . 1.21 112.736 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.66 144.31 14.24 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.864 -1.062 . . . . 0.73999999999999999 111.719 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.57 -7.58 57.49 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 116.203 1.241 . . . . 0.84999999999999998 116.203 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.6 p -68.98 160.73 30.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.398 1.599 . . . . 1.48 110.962 168.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.55 146.18 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.115 0.966 . . . . 0.87 110.624 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -108.45 153.04 23.89 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.832 1.253 . . . . 1.6000000000000001 113.465 -174.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -115.28 -167.7 1.28 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.662 1.985 . . . . 3.6099999999999999 109.805 170.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -77.66 140.5 39.6 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 119.649 -1.907 . . . . 4.79 111.574 -174.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.05 11.31 0.42 Allowed Glycine 0 CA--C 1.542 1.741 0 C-N-CA 124.978 1.275 . . . . 3.5099999999999998 114.012 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m 23.8 85.67 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 129.58 3.152 . . . . 1.6399999999999999 115.846 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.645 HD21 ' H ' ' A' ' 62' ' ' SER . 57.7 mt -87.33 150.69 23.68 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.402 0.681 . . . . 1.3799999999999999 112.761 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.73 128.93 51.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.679 0.792 . . . . 1.95 110.244 167.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.0 mm -111.86 126.47 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.837 1.655 . . . . 1.75 110.449 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.2 p -79.41 104.5 10.06 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.899 0.857 . . . . 1.6899999999999999 109.718 169.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.94 113.69 14.91 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.178 -0.951 . . . . 1.1200000000000001 109.393 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.5 p -120.21 16.2 12.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.708 1.203 . . . . 2.4399999999999999 113.026 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -148.86 146.32 27.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.075 1.75 . . . . 1.78 110.417 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 m -100.56 164.16 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.701 0.8 . . . . 1.55 109.625 165.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -51.45 -45.09 53.63 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 114.523 0.569 . . . . 1.49 114.523 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.2 -23.57 67.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.325 1.232 . . . . 1.77 114.325 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -78.7 -25.96 44.81 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.986 1.476 . . . . 2.5800000000000001 114.986 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 p -52.36 143.21 15.51 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.838 1.792 . . . . 1.72 115.838 -164.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.6 t -60.04 -32.22 70.71 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.067 0.947 . . . . 2.0299999999999998 111.499 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.3 tp -52.97 -44.62 67.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.424 1.49 . . . . 1.6299999999999999 112.195 168.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.0 p -71.87 -24.5 61.69 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.154 0.798 . . . . 2.9399999999999999 113.154 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -71.25 -39.56 71.54 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.826 -1.171 . . . . 2.7200000000000002 112.014 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 96.3 mt -53.49 -55.14 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.506 0.722 . . . . 1.71 109.968 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.77 -18.9 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 114.251 1.204 . . . . 1.53 114.251 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -71.12 -41.45 70.51 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.837 -1.164 . . . . 3.5 110.764 168.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.7 mt -70.86 -40.68 72.19 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.78 1.232 . . . . 2.5099999999999998 113.646 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.94 -28.75 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.44 1.018 . . . . 1.9199999999999999 111.368 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -73.83 -30.89 62.95 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.575 1.15 . . . . 4.2000000000000002 112.94 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.66 -29.1 63.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.433 1.093 . . . . 4.4100000000000001 113.884 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.07 -52.42 42.33 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.917 0.78 . . . . 3.7000000000000002 110.881 -173.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 126.274 1.829 . . . . 3.9199999999999999 114.366 169.668 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 113.899 1.074 . . . . 3.4199999999999999 113.899 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -70.56 -39.06 74.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.358 1.435 . . . . 5.2800000000000002 109.054 167.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.64 56.11 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.797 1.036 . . . . 1.8 113.797 173.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 47.3 tp -67.84 -35.05 77.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.797 1.18 . . . . 1.4099999999999999 112.507 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.63 -36.37 62.9 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.374 0.534 . . . . 1.74 111.481 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -56.54 -36.9 69.77 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.801 1.24 . . . . 2.8500000000000001 114.255 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -48.62 -49.51 36.73 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.753 1.16 . . . . 1.6599999999999999 111.489 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.97 -29.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.625 1.17 . . . . 2.3500000000000001 112.039 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -73.01 -26.35 61.29 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.475 -0.766 . . . . 1.28 112.907 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.36 -33.01 72.44 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.239 0.927 . . . . 1.9399999999999999 112.362 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -62.02 147.1 48.24 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.167 0.894 . . . . 3.6499999999999999 111.655 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.9 -21.01 64.37 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.235 2.309 . . . . 3.79 117.235 -167.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 m 66.73 -28.17 0.13 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.233 1.813 . . . . 2.6499999999999999 114.545 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -137.82 156.62 47.74 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.127 2.171 . . . . 2.7999999999999998 112.981 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.12 165.73 26.63 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.495 1.518 . . . . 0.88 113.7 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.2 m -116.29 108.13 15.71 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.966 1.706 . . . . 0.82999999999999996 111.274 170.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.8 mt -85.94 141.08 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.674 1.189 . . . . 0.72999999999999998 109.727 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 m -114.63 133.39 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.195 0.998 . . . . 1.75 113.285 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.3 m -134.19 136.42 43.72 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.985 1.714 . . . . 1.8600000000000001 110.093 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.3 mt -91.5 86.69 6.12 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.214 0.606 . . . . 2.6400000000000001 110.632 -174.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.69 -3.37 34.3 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.052 0.941 . . . . 3.79 112.821 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.9 m -160.76 142.05 11.97 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 128.029 2.532 . . . . 3.8199999999999998 110.803 167.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -20.99 66.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 1 C-N-CA 132.552 4.341 . . . . 4.3200000000000003 117.917 -168.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.33 11.2 p30 49.39 2.73 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.642 2.377 . . . . 4.3399999999999999 116.442 -167.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 pt -82.38 -11.45 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 129.262 3.025 . . . . 3.5 114.603 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.7 tp -135.58 95.14 3.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.181 1.392 . . . . 2.8700000000000001 111.625 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.89 78.78 7.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.026 1.73 . . . . 2.3700000000000001 110.6 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -78.87 125.82 29.88 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.656 1.182 . . . . 1.75 110.407 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -103.0 160.79 14.31 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.951 -1.093 . . . . 3.3199999999999998 113.055 -174.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.94 125.28 35.1 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.05 1.34 . . . . 4.5300000000000002 109.486 168.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -91.82 121.75 33.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.859 -1.164 . . . . 1.6699999999999999 107.859 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 m -136.32 157.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.077 0.951 . . . . 1.1200000000000001 113.538 -167.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.8 145.6 32.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.775 0.83 . . . . 2.9700000000000002 110.29 167.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.63 -29.65 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 113.287 0.847 . . . . 1.27 113.287 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -74.35 -3.77 32.35 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.895 1.278 . . . . 3.9500000000000002 113.551 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.8 -13.52 12.61 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.535 1.934 . . . . 1.9299999999999999 114.617 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.51 147.85 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 119.556 1.071 . . . . 1.77 111.246 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.76 163.76 20.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.016 1.726 . . . . 3.6600000000000001 114.298 -176.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -71.52 18.82 0.07 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 117.621 2.452 . . . . 3.5099999999999998 117.621 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.17 4.33 6.35 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.019 1.295 . . . . 1.22 115.548 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -111.29 169.67 8.63 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.633 1.173 . . . . 2.27 112.565 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.8 mt -123.75 130.75 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.666 1.586 . . . . 1.1699999999999999 110.427 -170.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -117.99 136.04 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.438 1.495 . . . . 0.69999999999999996 113.871 -166.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -87.09 143.14 27.44 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.567 0.951 . . . . 2.6099999999999999 113.567 169.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.9 p -132.25 134.74 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.439 1.095 . . . . 0.81999999999999995 111.479 169.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.14 170.41 5.36 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 125.339 1.456 . . . . 1.3400000000000001 112.847 -170.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.33 132.07 50.02 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.785 2.323 . . . . 1.3 112.547 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.11 -8.27 39.35 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.939 1.733 . . . . 0.91000000000000003 114.992 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.78 166.56 54.57 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 118.933 1.366 . . . . 0.97999999999999998 113.813 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -119.61 153.34 35.64 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.037 1.335 . . . . 2.77 112.255 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -79.29 134.97 58.09 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.374 0.669 . . . . 1.8100000000000001 112.45 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.14 -32.58 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.983 2.456 . . . . 0.90000000000000002 115.313 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 m -145.85 171.32 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 126.984 2.114 . . . . 0.90000000000000002 109.183 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.96 144.5 25.4 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.089 0.859 . . . . 2.3900000000000001 112.399 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.62 -164.82 35.89 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.013 1.165 . . . . 0.78000000000000003 116.013 -175.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -107.94 145.64 33.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.738 2.015 . . . . 5.1900000000000004 112.693 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.66 133.76 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 127.581 2.352 . . . . 0.96999999999999997 110.443 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.73 37.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.936 1.087 . . . . 1.21 113.936 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -165.29 136.53 3.98 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.839 -1.163 . . . . 2.3700000000000001 110.159 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.41 -174.31 50.39 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.844 1.212 . . . . 0.76000000000000001 115.992 168.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -149.67 112.0 4.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.27 1.028 . . . . 1.99 112.222 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.55 154.95 45.78 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.238 1.015 . . . . 1.25 112.814 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.4 ttm -104.32 128.87 52.19 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.689 1.195 . . . . 0.83999999999999997 108.969 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 86.1 t -115.99 136.6 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.68 1.592 . . . . 0.62 113.147 -166.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -91.04 100.68 13.49 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.348 -0.845 . . . . 1.98 111.607 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -93.65 4.74 53.48 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.318 1.447 . . . . 2.0499999999999998 113.963 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -38.97 -45.59 1.22 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.923 2.489 . . . . 1.8999999999999999 116.842 -169.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.74 -32.01 28.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.024 0.829 . . . . 1.0900000000000001 111.924 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.15 -58.13 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.796 1.639 . . . . 1.0700000000000001 111.642 -171.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.9 p -102.7 -5.5 23.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.757 1.223 . . . . 1.22 113.036 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.98 18.82 79.75 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.445 1.498 . . . . 1.1499999999999999 113.955 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -67.15 -53.29 31.96 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.782 0.833 . . . . 2.4199999999999999 112.035 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 64.18 29.26 14.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.433 1.893 . . . . 1.8500000000000001 112.882 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.2 ptp -157.77 128.77 3.68 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 130.21 3.404 . . . . 4.0999999999999996 106.489 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.98 156.95 51.87 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.032 1.821 . . . . 1.3200000000000001 114.104 -167.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.9 t -120.02 129.55 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 126.96 2.104 . . . . 0.69999999999999996 111.299 -168.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.7 134.63 36.41 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.34 -0.85 . . . . 0.66000000000000003 112.809 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -120.34 151.3 39.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.302 1.841 . . . . 0.73999999999999999 110.841 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -149.24 174.66 3.27 Favored Pre-proline 0 N--CA 1.483 1.175 0 C-N-CA 127.866 2.466 . . . . 2.3999999999999999 111.491 -168.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.24 129.67 24.84 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 CA-C-N 122.045 1.766 . . . . 0.83999999999999997 110.592 167.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.24 46.77 9.78 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.59 1.09 . . . . 1.1000000000000001 111.918 -168.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.8 t -126.34 160.27 30.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.615 1.566 . . . . 1.3300000000000001 111.365 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.0 p -121.0 146.09 47.06 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.887 -1.133 . . . . 0.93000000000000005 111.817 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.05 155.0 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.064 1.345 . . . . 0.67000000000000004 112.952 -171.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.434 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -114.76 147.81 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.575 1.95 . . . . 1.03 112.503 169.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.66 151.46 33.54 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.902 1.281 . . . . 0.70999999999999996 113.136 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.03 -6.6 59.0 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.928 1.251 . . . . 0.75 115.715 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.5 p -76.53 159.84 30.0 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.763 1.282 . . . . 1.3700000000000001 111.758 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -110.24 125.77 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.138 0.975 . . . . 0.70999999999999996 112.112 -169.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -95.5 127.53 41.61 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.251 1.82 . . . . 1.6799999999999999 112.099 -175.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -150.69 76.9 1.27 Allowed 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.087 1.884 . . . . 3.4399999999999999 116.087 -171.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -171.59 -60.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.393 1.877 . . . . 3.3500000000000001 110.592 167.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.17 175.07 24.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.076 2.274 . . . . 1.8999999999999999 112.285 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.0 m -87.15 141.37 28.7 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.672 1.189 . . . . 1.8200000000000001 112.296 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.4 mt -127.73 165.51 19.93 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.224 1.81 . . . . 0.90000000000000002 112.339 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.1 tp -124.02 113.52 18.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.048 1.739 . . . . 2.8100000000000001 111.573 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.87 130.04 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.113 0.965 . . . . 1.6699999999999999 112.588 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 82.8 m -86.67 106.4 17.59 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.813 0.845 . . . . 2.52 109.939 169.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.25 116.41 19.5 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.451 -0.78 . . . . 0.93999999999999995 111.108 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -115.86 10.42 15.28 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.339 1.056 . . . . 3.2999999999999998 113.384 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -141.09 138.51 33.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.694 1.598 . . . . 1.6899999999999999 110.795 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 m -84.59 162.27 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 108.903 -0.777 . . . . 1.6299999999999999 108.903 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.31 -43.33 75.59 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.009 -1.057 . . . . 1.73 114.257 -169.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.41 -31.41 72.1 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.888 1.07 . . . . 1.79 113.888 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.18 -17.02 58.86 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.025 1.73 . . . . 2.7999999999999998 114.19 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.0 p -68.86 151.8 46.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.022 0.929 . . . . 1.8100000000000001 113.245 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.6 t -55.44 -37.45 67.72 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.281 0.632 . . . . 2.0699999999999998 112.051 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.7 tp -61.57 -49.46 76.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.416 1.086 . . . . 1.73 112.256 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 t -71.89 -25.99 62.15 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.444 0.697 . . . . 1.6299999999999999 112.2 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.83 -41.15 75.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.73 1.212 . . . . 1.6299999999999999 112.778 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.69 -50.09 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.804 0.842 . . . . 1.6599999999999999 110.651 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.14 -18.27 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 114.005 1.113 . . . . 1.48 114.005 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.84 -45.95 73.19 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.768 1.167 . . . . 2.6699999999999999 110.448 167.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -41.72 99.07 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.819 1.247 . . . . 2.3500000000000001 112.57 -177.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.76 -33.13 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.901 0.88 . . . . 2.3300000000000001 112.467 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -71.14 -27.52 63.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.774 0.829 . . . . 3.8100000000000001 112.538 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -67.26 -32.25 73.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.986 0.914 . . . . 4.2400000000000002 112.453 172.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.78 -43.44 46.45 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.425 1.09 . . . . 4.8799999999999999 113.474 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.714 1.606 . . . . 5.5 113.264 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 112.609 0.596 . . . . 2.6400000000000001 112.609 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -73.94 -46.15 45.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.771 1.228 . . . . 4.1200000000000001 109.818 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.4 -33.06 74.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.794 1.238 . . . . 1.51 113.175 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.15 -28.3 69.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.3 0.64 . . . . 1.6299999999999999 112.331 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.34 -47.51 33.92 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.693 -0.629 . . . . 1.4199999999999999 110.852 167.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -48.91 -41.48 33.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.301 1.44 . . . . 3.46 114.779 -169.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.42 -45.33 69.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.944 0.793 . . . . 1.5700000000000001 111.992 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.7 mm -72.91 -29.24 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.551 1.14 . . . . 2.0099999999999998 112.521 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -74.29 -24.21 59.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.408 0.892 . . . . 1.47 113.408 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.31 -19.73 65.62 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.77 1.026 . . . . 2.0699999999999998 113.77 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.33 157.79 36.32 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 115.178 1.547 . . . . 2.3300000000000001 115.178 -169.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.11 154.4 17.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.893 1.677 . . . . 1.8100000000000001 112.721 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -88.55 -23.29 23.2 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.552 1.141 . . . . 2.2999999999999998 112.736 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.75 168.26 20.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.779 1.232 . . . . 3.52 114.075 -169.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.65 161.3 38.08 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.408 1.483 . . . . 0.72999999999999998 112.472 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.0 m -121.55 95.95 4.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.748 1.619 . . . . 0.81999999999999995 110.873 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.32 146.22 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.219 1.408 . . . . 0.82999999999999996 110.002 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.19 120.59 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.518 1.054 . . . . 1.72 111.967 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.1 m -122.1 146.97 46.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.17 1.388 . . . . 1.9399999999999999 111.277 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 mp -110.48 88.9 2.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.635 1.174 . . . . 3.2200000000000002 110.607 -171.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.03 -7.93 20.14 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.767 1.765 . . . . 3.75 115.767 -169.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.6 m -113.36 -96.0 0.45 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.083 1.353 . . . . 4.0999999999999996 111.594 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -152.72 56.38 0.8 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.994 1.717 . . . . 4.5999999999999996 109.873 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 60.9 -7.68 0.08 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 129.623 3.169 . . . . 5.0700000000000003 118.095 -172.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.4 pt -80.15 -9.05 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.559 1.543 . . . . 4.2599999999999998 114.103 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tt -127.69 140.58 51.99 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.303 2.241 . . . . 3.1899999999999999 110.99 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.14 127.16 47.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.934 1.693 . . . . 2.8500000000000001 111.926 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.7 t -132.3 110.65 10.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.149 1.78 . . . . 1.6100000000000001 110.072 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -108.51 136.64 47.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.176 1.176 . . . . 2.8900000000000001 114.176 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -108.11 132.55 53.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.671 1.588 . . . . 2.6699999999999999 110.106 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -104.51 122.79 46.29 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.524 -0.917 . . . . 2.0299999999999998 108.524 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.3 m -139.68 156.66 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.974 0.91 . . . . 0.93000000000000005 113.007 -169.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -74.06 146.48 43.63 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.618 -0.512 . . . . 4.0300000000000002 109.618 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.41 -27.92 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.681 1.363 . . . . 1.28 114.681 -168.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -73.3 -7.67 52.54 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 120.495 -1.378 . . . . 3.3500000000000001 113.431 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.0 -1.04 32.68 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.258 1.823 . . . . 1.6899999999999999 114.882 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -109.76 148.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.918 1.287 . . . . 1.9199999999999999 110.736 172.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -123.65 175.9 6.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.908 2.083 . . . . 3.4100000000000001 110.811 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -68.92 156.65 38.16 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.36 -0.838 . . . . 2.8399999999999999 111.093 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.36 22.78 21.17 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 119.132 0.878 . . . . 1.2 113.858 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.15 167.28 20.95 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.539 1.535 . . . . 2.1000000000000001 112.305 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.03 129.69 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.159 1.383 . . . . 1.2 110.646 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 mm -120.52 129.13 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.241 1.816 . . . . 0.67000000000000004 110.499 -169.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -78.68 133.69 37.18 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.101 -1.0 . . . . 2.1200000000000001 111.171 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.96 128.09 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.008 1.323 . . . . 0.80000000000000004 110.539 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.85 171.08 5.8 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.622 1.169 . . . . 1.1000000000000001 112.48 -169.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.32 127.81 25.24 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.483 2.122 . . . . 1.04 112.537 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.22 -1.96 73.12 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.79 1.185 . . . . 1.0 116.006 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.22 -176.82 50.3 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 118.897 1.348 . . . . 0.93999999999999995 114.064 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -124.57 159.79 29.87 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.074 1.749 . . . . 2.5699999999999998 112.152 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -84.03 118.8 72.25 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.125 0.97 . . . . 2.3100000000000001 109.554 170.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -83.49 -17.66 6.22 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.258 1.972 . . . . 0.80000000000000004 115.482 -169.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -153.04 160.93 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 127.915 2.486 . . . . 1.2 108.312 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.03 140.88 33.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.154 0.888 . . . . 1.9199999999999999 112.768 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.16 -148.75 9.39 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.642 -0.661 . . . . 0.81000000000000005 114.603 -171.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -131.85 145.57 51.62 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.896 1.278 . . . . 4.0199999999999996 113.939 -170.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.5 t -96.46 125.48 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.949 2.5 . . . . 0.75 108.916 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.49 32.73 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 113.641 0.978 . . . . 0.78000000000000003 113.641 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -168.11 136.21 2.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.364 1.866 . . . . 3.5600000000000001 108.26 166.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.29 179.4 52.62 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 122.448 1.027 . . . . 0.91000000000000003 114.726 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -154.67 123.44 6.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.972 0.909 . . . . 2.04 112.743 -170.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.9 p -137.5 -179.04 5.5 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.345 1.858 . . . . 3.1800000000000002 113.588 -168.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.9 ttm -128.4 135.14 49.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.971 1.708 . . . . 0.81000000000000005 108.888 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.76 139.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.215 1.406 . . . . 0.67000000000000004 112.076 -168.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -102.24 110.57 22.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.386 1.475 . . . . 1.9099999999999999 111.401 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.75 22.05 11.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.21 1.804 . . . . 2.4900000000000002 113.145 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.5 p -53.1 -28.18 24.17 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.7 1.741 . . . . 1.6000000000000001 115.7 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.83 -34.91 16.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.369 0.986 . . . . 1.2 111.667 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.3 mm -70.46 -47.8 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.617 0.767 . . . . 1.25 110.687 -177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.2 p -119.92 -4.33 10.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.77 1.228 . . . . 1.74 114.172 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.37 3.07 89.86 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.606 1.098 . . . . 1.8500000000000001 115.331 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -56.32 -52.92 62.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.298 1.221 . . . . 2.7200000000000002 114.298 -169.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.19 33.63 23.35 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 122.201 1.0 . . . . 1.8999999999999999 111.868 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -154.78 113.21 2.37 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 128.745 2.818 . . . . 3.8199999999999998 106.068 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -62.33 153.03 73.2 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.994 2.462 . . . . 1.48 114.251 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.4 t -115.96 137.27 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.99 1.316 . . . . 0.71999999999999997 110.949 -171.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.95 142.05 28.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.636 0.774 . . . . 0.64000000000000001 112.483 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -123.43 152.19 41.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.289 1.436 . . . . 0.68000000000000005 111.717 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -146.23 170.16 8.38 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 129.148 2.979 . . . . 3.5 107.864 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.33 132.79 54.33 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 CA-C-N 121.82 1.686 . . . . 0.78000000000000003 111.63 168.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.11 25.77 28.07 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.239 1.399 . . . . 0.76000000000000001 114.815 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.2 t -117.56 158.61 24.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.231 1.412 . . . . 1.3700000000000001 111.826 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.6 p -116.6 146.95 42.32 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.005 1.275 . . . . 0.83999999999999997 113.22 -172.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.6 156.04 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.703 1.601 . . . . 0.73999999999999999 113.08 -172.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -115.24 147.35 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.702 2.001 . . . . 1.03 112.558 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.14 148.29 44.9 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.886 1.274 . . . . 0.83999999999999997 112.897 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.86 -4.96 51.06 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.617 1.103 . . . . 0.73999999999999999 115.42 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.3 p -74.61 154.49 38.52 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.477 1.638 . . . . 1.29 111.363 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.94 124.9 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.095 0.558 . . . . 0.73999999999999999 111.618 -169.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -86.73 139.64 30.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.469 1.107 . . . . 1.54 111.763 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -88.49 -70.49 0.64 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.255 -0.903 . . . . 3.46 112.206 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -131.9 -160.66 1.06 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.746 1.618 . . . . 4.4699999999999998 109.208 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.86 -26.52 11.48 Favored Glycine 0 CA--C 1.529 0.908 0 O-C-N 119.684 -1.885 . . . . 3.4100000000000001 116.128 169.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.0 m 44.74 67.89 0.63 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.686 1.594 . . . . 1.97 112.163 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mt -97.8 159.47 14.91 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.706 1.203 . . . . 0.98999999999999999 113.115 -166.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.93 128.96 54.91 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.567 0.698 . . . . 2.0 110.487 168.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.56 122.5 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.45 1.9 . . . . 1.52 109.952 -169.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 21.0 p -82.46 119.29 24.01 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.936 0.789 . . . . 1.6499999999999999 110.316 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -97.45 113.96 25.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.457 1.103 . . . . 0.91000000000000003 111.195 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.1 p -108.37 4.8 24.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.24 1.816 . . . . 1.8700000000000001 112.77 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -137.69 136.52 37.48 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.922 1.289 . . . . 1.6200000000000001 109.702 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -91.54 176.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.331 1.053 . . . . 2.5299999999999998 109.602 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.18 -31.95 66.55 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 120.835 1.652 . . . . 1.6499999999999999 113.952 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -45.1 65.08 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.633 1.216 . . . . 2.1400000000000001 113.353 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.32 -14.41 59.43 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.961 1.837 . . . . 2.7799999999999998 115.961 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.5 t -77.76 143.33 38.07 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.057 -1.027 . . . . 3.0600000000000001 112.829 -170.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.0 t -63.0 -31.77 72.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.917 0.71 . . . . 1.8999999999999999 112.917 -172.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.67 -51.33 65.82 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.315 1.046 . . . . 1.4399999999999999 112.491 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 p -72.92 -31.82 64.88 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.542 0.571 . . . . 2.1299999999999999 112.542 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.4 -42.13 98.78 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.428 0.558 . . . . 1.6499999999999999 111.71 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.99 -56.15 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.31 1.044 . . . . 1.72 110.153 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.34 -21.78 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 114.181 1.178 . . . . 1.3600000000000001 114.181 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -71.85 -43.5 65.39 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.218 0.917 . . . . 4.4699999999999998 111.917 170.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.35 -34.25 72.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.399 0.68 . . . . 2.8900000000000001 111.713 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.19 -24.93 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.009 -1.057 . . . . 2.1699999999999999 111.917 171.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.88 -27.72 65.05 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.853 -1.154 . . . . 3.0 111.874 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -72.37 -16.23 61.86 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.953 1.094 . . . . 4.9699999999999998 113.953 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.57 -60.6 2.14 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.977 -1.077 . . . . 4.3499999999999996 110.612 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 126.389 1.876 . . . . 5.2199999999999998 114.537 176.115 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 112.208 0.447 . . . . 2.8799999999999999 112.208 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -72.11 -38.59 69.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.353 1.061 . . . . 5.6100000000000003 110.953 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.73 94.24 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.102 1.361 . . . . 2.23 111.838 169.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tp -52.56 -33.79 47.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.92 0.888 . . . . 1.6699999999999999 112.819 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.88 -50.07 14.21 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.704 0.802 . . . . 1.23 112.919 168.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -58.73 -32.83 69.57 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.726 1.211 . . . . 3.0099999999999998 114.032 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.83 -30.24 65.58 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.947 0.721 . . . . 1.3799999999999999 112.947 173.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.4 mm -72.76 -42.22 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.844 0.858 . . . . 2.02 111.718 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.6 m -68.38 -21.56 64.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.438 1.095 . . . . 1.1100000000000001 113.224 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.01 -14.02 61.34 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.961 2.104 . . . . 1.8600000000000001 114.671 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -87.04 149.76 24.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.425 1.011 . . . . 2.3300000000000001 113.184 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.13 173.79 11.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.73 1.612 . . . . 2.6299999999999999 114.61 -169.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.3 m -99.91 -43.88 6.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.809 1.644 . . . . 3.1000000000000001 110.706 168.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -139.18 165.42 27.22 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.601 1.56 . . . . 3.6600000000000001 113.04 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.72 173.38 11.55 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.053 1.741 . . . . 1.03 112.3 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.2 m -131.32 111.3 11.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.899 1.279 . . . . 0.94999999999999996 111.334 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.7 mt -98.84 145.42 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.478 1.911 . . . . 0.97999999999999998 109.884 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.5 133.61 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.373 -0.829 . . . . 2.02 112.608 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.7 m -113.26 135.76 53.48 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.374 1.47 . . . . 1.77 112.245 -172.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.9 mt -129.32 91.83 3.25 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.486 -1.301 . . . . 3.0099999999999998 107.486 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.69 4.94 45.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.81 1.244 . . . . 5.2800000000000002 111.67 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.2 m -149.86 127.6 11.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.822 3.249 . . . . 4.0199999999999996 106.988 176.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -35.24 68.56 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.196 1 C-N-CA 133.021 4.528 . . . . 6.29 118.484 -167.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.63 30.3 19.91 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.236 2.214 . . . . 4.4400000000000004 114.062 -174.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.5 pt -122.63 -23.07 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.247 1.819 . . . . 4.6399999999999997 113.927 -174.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.66 -60.27 3.31 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.883 1.068 . . . . 3.8799999999999999 113.883 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 63.26 91.38 0.07 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.326 1.45 . . . . 4.96 112.88 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.6 t -139.16 154.4 48.08 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.598 1.559 . . . . 1.51 111.562 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.81 138.76 45.86 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.127 1.371 . . . . 2.8300000000000001 111.71 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -119.74 129.31 54.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.063 1.745 . . . . 3.3500000000000001 110.051 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.8 133.86 39.43 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.45 -1.406 . . . . 2.1299999999999999 110.608 168.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -135.08 158.15 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.332 1.053 . . . . 0.87 112.835 -171.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.94 149.04 36.03 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.478 1.111 . . . . 4.1799999999999997 109.414 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.49 -29.49 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.291 1.589 . . . . 1.5700000000000001 115.291 -168.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -76.46 -7.15 54.5 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.369 -1.457 . . . . 3.4700000000000002 113.599 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.9 mt -100.74 -6.32 25.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.096 1.758 . . . . 1.29 113.357 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 p -95.63 129.9 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.687 1.195 . . . . 2.3300000000000001 109.013 169.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -141.32 -175.21 4.26 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.229 1.011 . . . . 5.5099999999999998 112.016 -169.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -65.9 15.53 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.475 2.769 . . . . 3.2000000000000002 118.475 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.07 9.87 3.59 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.282 1.42 . . . . 1.1699999999999999 115.344 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -94.32 148.55 22.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.063 1.431 . . . . 3.1000000000000001 113.818 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.1 mm -105.26 124.67 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.24 1.016 . . . . 1.6200000000000001 110.03 171.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.5 mm -99.82 162.93 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.927 2.091 . . . . 1.4099999999999999 111.276 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HE2' HD11 ' A' ' 96' ' ' LEU . 37.5 ttmt -132.39 129.6 39.57 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.188 1.395 . . . . 2.0099999999999998 110.328 170.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.25 144.04 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.354 1.062 . . . . 1.0600000000000001 112.554 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -99.02 163.9 17.85 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.246 1.418 . . . . 1.97 113.104 -174.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.34 106.58 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.826 2.351 . . . . 2.2799999999999998 109.385 166.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.45 68.26 1.16 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.255 1.407 . . . . 2.9100000000000001 110.311 -168.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.86 164.08 33.51 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 127.407 2.432 . . . . 1.0600000000000001 109.497 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -125.34 153.09 43.86 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.521 1.16 . . . . 1.6000000000000001 112.798 -172.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -87.46 136.71 32.92 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 123.968 0.907 . . . . 1.6799999999999999 112.29 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -98.48 -18.03 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.934 3.09 . . . . 0.71999999999999997 115.587 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.86 166.88 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 127.936 2.494 . . . . 1.0800000000000001 108.422 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.18 142.35 27.72 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.185 0.902 . . . . 2.04 113.405 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -160.33 27.67 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.581 0.61 . . . . 0.67000000000000004 114.06 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.3 ttp-105 -116.19 136.25 53.18 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.567 1.147 . . . . 3.8199999999999998 112.888 -171.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -82.74 130.36 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 126.531 1.932 . . . . 0.80000000000000004 108.26 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.69 34.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.395 0.678 . . . . 0.84999999999999998 112.328 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -166.71 132.67 2.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.088 1.355 . . . . 2.8199999999999998 109.709 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.95 -170.77 50.08 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 116.363 1.305 . . . . 0.81999999999999995 116.363 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 123.43 13.21 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.804 1.642 . . . . 2.0800000000000001 112.306 -173.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.57 176.68 9.64 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.169 0.988 . . . . 1.1100000000000001 112.428 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 34.0 ttm -120.98 133.72 55.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.624 1.57 . . . . 1.0900000000000001 110.126 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.06 143.45 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.792 1.237 . . . . 0.69999999999999996 111.514 -169.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -106.95 86.11 2.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.064 1.346 . . . . 2.0099999999999998 111.099 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -87.74 34.01 0.71 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.955 1.702 . . . . 1.8899999999999999 113.578 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -58.92 -34.34 71.61 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 117.182 2.29 . . . . 2.0499999999999998 117.182 -168.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.75 -48.59 4.66 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.805 1.184 . . . . 1.1200000000000001 111.468 -174.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.7 mm -67.63 -48.89 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.739 0.816 . . . . 1.1399999999999999 111.634 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.1 m -101.15 -32.84 10.36 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.946 1.298 . . . . 2.71 110.715 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.74 5.41 61.35 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.67 1.129 . . . . 1.22 115.541 171.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.14 -51.02 71.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.027 1.331 . . . . 2.6499999999999999 111.603 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.21 35.8 15.26 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.9 1.68 . . . . 2.3100000000000001 112.793 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -154.19 154.53 29.89 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 129.923 3.289 . . . . 4.9000000000000004 109.08 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -64.19 136.63 52.66 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.5 2.8 . . . . 1.71 113.604 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.6 t -130.56 129.81 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 125.471 1.509 . . . . 1.3600000000000001 111.999 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.73 146.44 32.37 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.06 1.134 . . . . 0.78000000000000003 114.06 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.7 152.36 45.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.886 2.074 . . . . 0.81999999999999995 111.164 175.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -141.82 -176.38 0.56 Allowed Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 128.688 2.795 . . . . 3.1899999999999999 107.782 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.84 148.89 90.8 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 CA-C-N 122.141 1.8 . . . . 1.27 114.094 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.17 25.45 74.54 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.959 1.266 . . . . 1.3400000000000001 114.455 -172.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -115.01 147.69 39.78 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.753 1.277 . . . . 1.5700000000000001 111.034 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.1 p -99.08 147.67 24.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.183 1.356 . . . . 1.0 113.286 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.0 168.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.4 1.88 . . . . 0.60999999999999999 111.152 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.7 156.32 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.448 1.499 . . . . 1.55 111.651 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.67 157.51 32.42 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.136 1.162 . . . . 1.02 114.136 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.87 -7.2 15.8 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.159 0.885 . . . . 0.98999999999999999 115.113 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 m -90.92 156.98 17.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.716 1.206 . . . . 2.73 110.417 172.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mm -102.42 141.47 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.938 0.895 . . . . 1.0700000000000001 111.39 -169.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -101.59 135.74 42.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.594 1.957 . . . . 1.9399999999999999 110.84 173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -153.57 140.45 19.16 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.91 1.284 . . . . 3.2200000000000002 111.143 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.321 9.0 t30 95.98 -17.61 0.07 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 129.136 2.974 . . . . 3.8599999999999999 116.832 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.25 161.83 34.97 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 120.66 1.573 . . . . 1.8600000000000001 114.629 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.2 m -87.97 133.72 33.88 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.285 1.034 . . . . 1.9099999999999999 112.979 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.1 mt -128.96 162.52 27.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.988 1.715 . . . . 0.97999999999999998 112.814 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.522 HD11 ' HE2' ' A' ' 44' ' ' LYS . 7.4 mp -117.89 132.78 56.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.86 0.864 . . . . 2.0099999999999998 109.923 167.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.76 131.16 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.708 1.203 . . . . 1.6200000000000001 111.468 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 29.9 p -85.05 115.08 22.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.662 0.665 . . . . 1.5800000000000001 109.607 168.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.53 118.16 21.13 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.637 0.775 . . . . 0.95999999999999996 109.526 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.7 p -119.19 11.91 12.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.537 1.135 . . . . 2.04 113.275 -174.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -145.44 146.96 31.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.903 1.681 . . . . 1.8400000000000001 111.149 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 103' ' ' GLY . 1.3 p -112.07 -175.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.717 1.607 . . . . 3.0 111.869 176.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.452 ' H ' HG22 ' A' ' 102' ' ' VAL . . . -61.36 -18.27 55.12 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 119.826 -1.797 . . . . 2.8799999999999999 116.329 -172.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.62 -58.01 3.87 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.314 1.046 . . . . 3.7200000000000002 111.74 169.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.41 -32.11 64.24 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.769 1.396 . . . . 3.9100000000000001 114.769 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 t -50.13 126.55 14.85 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.81 1.244 . . . . 2.4700000000000002 112.789 -168.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.4 t -54.06 -35.41 62.0 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.892 1.071 . . . . 2.48 113.892 -168.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.06 -50.47 73.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.726 -1.234 . . . . 1.78 112.241 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -71.56 -23.17 61.7 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.354 1.062 . . . . 2.1699999999999999 112.194 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -74.05 -43.91 56.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.828 1.251 . . . . 2.3999999999999999 113.077 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.7 mt -55.9 -49.17 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.405 1.482 . . . . 1.45 110.644 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.67 -18.65 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 114.324 1.231 . . . . 1.23 114.324 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -72.55 -42.61 64.49 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.753 -0.642 . . . . 2.6000000000000001 111.28 168.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -54.04 10.7 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.411 1.484 . . . . 2.48 112.382 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.92 -21.97 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.451 1.1 . . . . 1.97 112.25 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.14 -30.94 67.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.006 1.322 . . . . 3.3300000000000001 113.027 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -77.32 -9.6 58.93 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.817 -1.177 . . . . 4.5999999999999996 114.041 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.16 -63.4 1.23 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.479 1.036 . . . . 3.5499999999999998 110.568 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.256 1.397 0 C-N-CA 125.796 1.638 . . . . 3.9500000000000002 114.133 -178.205 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 112.905 0.705 . . . . 4.1900000000000004 112.905 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -82.9 -26.91 31.06 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.313 -0.867 . . . . 6.3300000000000001 112.236 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.42 68.28 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.959 -1.088 . . . . 1.8600000000000001 110.354 168.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.22 -30.36 71.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.649 1.179 . . . . 1.5900000000000001 112.439 172.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.19 -26.95 59.42 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.257 -0.902 . . . . 1.1899999999999999 113.317 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.91 -41.15 87.6 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.278 1.031 . . . . 2.3300000000000001 112.228 -169.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -50.02 -44.2 51.11 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.842 1.257 . . . . 1.3999999999999999 111.992 173.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -73.08 -35.3 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.355 1.062 . . . . 1.74 112.104 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -70.38 -22.06 62.8 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.864 -1.147 . . . . 1.3300000000000001 113.313 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.33 -19.95 65.52 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.955 1.094 . . . . 2.0600000000000001 113.955 170.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -70.99 169.51 14.76 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.696 1.135 . . . . 2.6499999999999999 113.843 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.02 -24.94 9.63 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.769 1.396 . . . . 3.25 114.769 -174.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 m 67.76 -11.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.283 1.833 . . . . 2.8399999999999999 115.818 175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -130.03 157.86 41.2 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.284 1.833 . . . . 2.8199999999999998 112.061 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.45 162.69 34.73 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.006 0.923 . . . . 0.78000000000000003 113.166 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.4 m -123.44 100.62 6.91 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.657 1.583 . . . . 0.94999999999999996 110.364 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.6 mt -85.29 146.14 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.47 1.508 . . . . 0.82999999999999996 110.615 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.412 HG12 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -107.45 127.56 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.955 0.902 . . . . 1.99 110.387 166.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.5 m -134.38 139.54 45.67 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.285 1.434 . . . . 2.1600000000000001 111.089 -170.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.47 114.17 23.83 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.362 -0.836 . . . . 3.6499999999999999 108.776 167.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -94.76 -11.17 29.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.681 1.192 . . . . 4.9900000000000002 111.378 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.8 m -156.4 140.63 16.54 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.662 1.985 . . . . 4.5199999999999996 110.248 167.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -42.87 69.42 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 130.61 3.564 . . . . 5.4299999999999997 119.493 -166.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 63.65 23.58 13.59 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.198 1.799 . . . . 5.4299999999999997 112.643 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 pt -124.61 -16.34 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 126.82 2.048 . . . . 5.4900000000000002 112.104 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.8 tp -136.97 80.5 1.82 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.725 2.01 . . . . 3.9900000000000002 108.767 169.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -85.41 123.68 31.14 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.14 -1.059 . . . . 3.3900000000000001 108.14 169.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -138.81 153.33 48.38 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.53 1.132 . . . . 1.54 110.832 -169.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HG2' HG12 ' A' ' 18' ' ' VAL . 29.4 mt-10 -121.26 134.89 55.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.748 0.819 . . . . 2.3700000000000001 110.24 -170.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -123.92 129.07 50.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.507 1.523 . . . . 3.46 110.858 -169.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.51 130.66 45.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.589 1.086 . . . . 2.7799999999999998 110.476 170.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.8 m -141.42 168.27 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.039 1.336 . . . . 1.1100000000000001 112.844 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -78.15 139.28 38.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.402 0.681 . . . . 3.1299999999999999 109.593 168.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.89 -22.67 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.708 1.744 . . . . 1.5700000000000001 115.708 -168.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -64.31 -21.06 66.48 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.609 -1.307 . . . . 5.1399999999999997 112.94 172.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.2 mt -99.2 -4.93 30.92 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.611 1.965 . . . . 1.72 114.502 -169.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.3 m -74.35 -42.5 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.486 0.714 . . . . 4.0099999999999998 112.635 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.319 32.1 mt-30 60.54 146.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 128.248 2.619 . . . . 3.4900000000000002 116.043 -171.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -80.11 25.03 0.39 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 116.831 2.16 . . . . 3.1600000000000001 116.831 -167.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.25 8.25 12.37 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.107 1.337 . . . . 1.03 113.662 170.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.24 169.9 8.23 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.253 1.421 . . . . 2.8999999999999999 114.173 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.7 mt -121.56 127.92 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.261 2.224 . . . . 1.26 109.69 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.1 mm -116.3 133.69 62.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.729 2.012 . . . . 0.77000000000000002 110.552 -170.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HE3' HD11 ' A' ' 96' ' ' LEU . 14.0 mmmm -79.52 142.7 35.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.296 1.438 . . . . 2.5299999999999998 113.202 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 p -133.12 131.42 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.365 0.666 . . . . 0.68000000000000005 112.039 168.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.58 162.68 49.88 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 125.003 1.321 . . . . 1.25 113.182 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -60.12 131.14 37.5 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.427 2.085 . . . . 1.04 110.733 166.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.37 -3.86 61.31 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.738 1.637 . . . . 0.89000000000000001 114.717 -170.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.17 170.08 53.52 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 118.48 1.14 . . . . 0.95999999999999996 113.829 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -115.25 144.4 43.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.565 1.146 . . . . 1.5700000000000001 110.973 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -79.44 120.73 81.38 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-O 118.722 -0.656 . . . . 1.6599999999999999 109.868 175.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.35 -12.5 6.69 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.601 2.201 . . . . 0.76000000000000001 114.095 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -148.95 165.1 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.478 2.711 . . . . 1.26 109.446 -173.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -103.51 145.59 29.79 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.349 0.87 . . . . 2.25 113.349 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.95 -153.19 23.23 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.647 0.619 . . . . 0.62 114.647 -172.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -117.31 132.45 56.6 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.704 1.202 . . . . 4.2300000000000004 112.734 -169.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.3 t -82.7 127.13 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.935 2.094 . . . . 0.66000000000000003 108.422 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 pt -140.71 32.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 122.745 1.26 . . . . 0.93999999999999995 113.017 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -168.21 126.66 1.17 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.746 2.419 . . . . 2.98 106.711 167.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.45 178.25 46.89 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 117.004 1.562 . . . . 1.0600000000000001 117.004 174.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -148.02 128.45 13.99 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.863 1.265 . . . . 2.1499999999999999 112.328 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 m -148.12 167.74 24.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.346 1.059 . . . . 1.21 113.133 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.3 ttm -111.4 108.39 17.94 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.822 1.249 . . . . 1.3200000000000001 109.939 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.7 t -87.64 158.35 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.465 1.906 . . . . 0.81000000000000005 112.536 -169.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -113.55 92.22 3.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.374 1.87 . . . . 1.9199999999999999 110.134 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.89 16.52 21.22 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.943 1.697 . . . . 2.1099999999999999 112.884 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -56.56 -29.39 61.96 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.252 1.821 . . . . 1.3700000000000001 114.713 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -81.58 -32.18 32.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.256 1.389 . . . . 1.25 111.866 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mm -77.76 -45.95 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.087 0.955 . . . . 1.27 111.14 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 m -109.08 -12.58 14.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.336 1.454 . . . . 2.6499999999999999 112.751 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.28 6.47 80.15 Favored Glycine 0 CA--C 1.544 1.889 0 C-N-CA 125.219 1.39 . . . . 1.53 116.011 174.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.77 -38.22 89.75 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.693 1.197 . . . . 2.9399999999999999 113.995 -169.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 72.81 -17.77 0.38 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.949 2.5 . . . . 1.45 113.886 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -92.08 150.07 39.81 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.14 1.776 . . . . 5.6699999999999999 110.665 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.53 153.6 30.7 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.356 2.704 . . . . 2.02 112.243 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.73 124.85 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.586 1.154 . . . . 1.1000000000000001 111.851 -169.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.73 138.89 37.45 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.699 0.8 . . . . 1.05 112.821 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -127.13 145.76 50.63 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.019 2.127 . . . . 0.88 110.451 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -144.04 172.31 5.69 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 128.618 2.767 . . . . 2.4399999999999999 109.605 -169.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -57.74 137.08 79.42 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.673 1.582 . . . . 0.98999999999999999 110.943 168.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.0 17.81 79.83 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.954 1.264 . . . . 1.28 114.57 -172.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 t -101.79 161.02 13.97 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.006 1.903 . . . . 1.6000000000000001 111.414 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 p -112.43 146.57 38.16 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.841 1.2 . . . . 0.79000000000000004 113.648 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.64 159.35 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.204 1.802 . . . . 0.55000000000000004 111.964 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -117.35 152.1 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.896 1.678 . . . . 1.6200000000000001 112.176 173.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.96 149.99 39.07 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.737 -0.665 . . . . 0.66000000000000003 112.52 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.69 -10.57 55.98 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.583 1.087 . . . . 0.78000000000000003 115.53 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.3 p -76.51 161.51 28.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.516 1.158 . . . . 1.3500000000000001 111.262 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -106.77 142.23 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.917 0.887 . . . . 0.69999999999999996 110.913 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -99.74 143.23 30.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.714 1.606 . . . . 1.7 112.543 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -155.94 141.4 17.71 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.026 -1.046 . . . . 3.3199999999999998 112.15 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.26 17.3 t30 111.8 -42.07 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 1 C-N-CA 131.863 4.065 . . . . 3.8300000000000001 113.556 -178.279 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.16 -174.58 37.12 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 119.76 1.164 . . . . 2.0099999999999998 114.661 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.0 m -92.29 136.8 32.89 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.731 1.612 . . . . 1.8500000000000001 111.373 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 mt -130.81 160.97 32.81 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.553 1.141 . . . . 1.05 113.294 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.427 HD11 ' HE3' ' A' ' 44' ' ' LYS . 7.0 mp -113.97 123.05 48.77 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.83 1.252 . . . . 1.9299999999999999 109.97 170.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.15 126.21 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.653 1.181 . . . . 1.22 110.714 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 32.0 p -79.38 126.94 31.48 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.495 -0.753 . . . . 1.5800000000000001 110.235 169.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.32 129.21 34.24 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.568 0.747 . . . . 1.03 110.393 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.7 p -107.9 -8.86 15.84 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.657 0.984 . . . . 3.1000000000000001 113.657 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -145.82 150.29 35.9 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.31 1.444 . . . . 2.1899999999999999 110.909 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 m -74.74 160.19 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 118.69 0.677 . . . . 2.1499999999999999 109.174 166.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.66 77.57 Favored Glycine 0 N--CA 1.475 1.242 0 N-CA-C 116.285 1.274 . . . . 2.1699999999999999 116.285 -165.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.49 -39.31 62.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.688 1.244 . . . . 3.1699999999999999 113.581 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -72.11 -6.02 39.55 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.402 1.481 . . . . 3.3100000000000001 114.106 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.0 p -51.48 151.29 3.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.381 1.473 . . . . 1.73 114.035 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.19 -33.62 67.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.178 1.391 . . . . 2.6899999999999999 111.173 169.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.82 -51.48 68.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.673 1.989 . . . . 1.6000000000000001 112.549 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.8 m -70.66 -18.19 62.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.441 0.534 . . . . 2.5 112.441 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -73.93 -39.25 63.93 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.497 -0.752 . . . . 1.75 112.613 169.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 87.4 mt -49.75 -51.9 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 119.892 1.224 . . . . 1.6699999999999999 111.441 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.3 m -63.39 -29.41 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.273 -0.892 . . . . 1.5 113.276 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -74.73 -33.52 62.38 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.838 0.855 . . . . 4.1900000000000004 112.556 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -39.47 75.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.978 1.711 . . . . 2.79 110.528 174.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.4 t -61.18 -45.68 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.027 0.931 . . . . 2.2400000000000002 110.404 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.58 -9.97 40.74 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 116.293 1.96 . . . . 4.1500000000000004 116.293 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -71.13 -26.58 63.07 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 121.107 1.776 . . . . 6.79 111.848 168.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.28 -57.62 3.78 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.588 -0.695 . . . . 3.5899999999999999 111.463 173.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 C--O 1.252 1.192 0 N-CA-C 113.427 0.899 . . . . 4.9699999999999998 113.427 178.447 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 112.882 0.697 . . . . 4.2300000000000004 112.882 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 68.61 -49.33 0.57 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 128.224 2.609 . . . . 4.9400000000000004 112.818 -167.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.35 -11.82 60.86 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 121.134 -0.979 . . . . 2.0099999999999998 113.599 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 tp -59.41 -37.85 79.09 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.888 1.675 . . . . 1.8999999999999999 111.714 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.21 -18.82 63.18 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.075 0.768 . . . . 1.3400000000000001 113.075 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -61.15 -36.76 80.65 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.943 1.247 . . . . 3.0 112.237 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.16 -42.24 96.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.877 0.871 . . . . 1.26 111.355 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -72.1 -36.29 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.167 0.587 . . . . 1.51 111.704 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -69.02 -30.95 69.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.333 1.053 . . . . 1.3100000000000001 112.881 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -64.0 -32.84 74.52 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.695 1.998 . . . . 2.3300000000000001 112.979 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -77.48 129.89 36.3 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.94 0.791 . . . . 3.3199999999999998 112.395 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.97 156.42 36.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.124 0.97 . . . . 2.25 112.787 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -108.75 -4.83 16.64 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.092 1.515 . . . . 2.1000000000000001 115.092 -167.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.29 160.54 39.9 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.285 -1.509 . . . . 3.9500000000000002 113.806 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.16 159.06 43.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.977 1.311 . . . . 0.80000000000000004 112.988 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 90.0 m -119.08 106.15 12.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.441 1.497 . . . . 0.88 111.148 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mt -97.4 138.53 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.838 1.655 . . . . 0.81999999999999995 110.842 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -124.74 126.45 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.796 1.18 . . . . 1.97 111.737 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 m -138.25 150.14 46.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.342 1.457 . . . . 2.3999999999999999 111.055 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -89.25 146.41 24.76 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.112 -0.992 . . . . 3.21 112.181 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.87 -8.47 9.4 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.481 1.112 . . . . 3.8799999999999999 112.639 169.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -150.82 135.11 16.96 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.113 2.165 . . . . 3.3100000000000001 107.989 168.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -51.6 84.79 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 117.61 2.448 . . . . 4.6399999999999997 117.61 -165.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 62.48 23.58 14.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.508 2.323 . . . . 4.1200000000000001 113.557 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.8 pt -128.96 -19.88 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.883 1.673 . . . . 3.8100000000000001 112.359 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 tt -136.26 115.56 12.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.779 1.231 . . . . 3.2999999999999998 110.393 165.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 mp -98.83 148.63 23.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.257 1.423 . . . . 2.9900000000000002 111.606 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -141.0 133.62 28.66 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.016 1.726 . . . . 2.4500000000000002 109.871 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -127.41 139.28 52.94 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.265 -0.897 . . . . 3.8900000000000001 112.146 -176.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -114.61 145.82 41.54 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.277 1.431 . . . . 2.6699999999999999 112.166 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -117.23 110.73 18.48 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.0 1.32 . . . . 2.4500000000000002 108.283 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.9 m -127.86 164.65 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 114.531 1.308 . . . . 0.78000000000000003 114.531 -166.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.79 146.41 37.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.549 -0.751 . . . . 3.1000000000000001 110.379 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.71 -23.61 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.26 0.837 . . . . 1.05 113.26 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.36 -17.17 61.85 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.817 -1.177 . . . . 3.7599999999999998 112.984 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.7 mt -105.05 -12.26 16.24 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.404 1.882 . . . . 1.28 114.525 -169.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.41 143.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.101 0.96 . . . . 1.5 109.321 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -119.29 163.29 17.36 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.557 1.143 . . . . 3.2400000000000002 112.327 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.64 135.64 50.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.67 -0.863 . . . . 3.0600000000000001 108.67 167.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.9 -10.85 32.12 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 124.86 1.219 . . . . 0.90000000000000002 114.225 -169.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -88.15 152.07 22.25 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.334 1.454 . . . . 2.7999999999999998 113.773 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -105.26 118.92 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.546 1.539 . . . . 1.2 110.321 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 mm -118.51 128.6 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.105 1.362 . . . . 0.67000000000000004 111.922 -169.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -90.99 139.97 30.27 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.209 -0.932 . . . . 1.8700000000000001 112.437 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.05 133.6 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.374 1.47 . . . . 0.71999999999999997 110.998 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 m -107.69 170.5 5.52 Favored Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 124.683 1.193 . . . . 1.0900000000000001 113.751 -167.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -52.49 134.59 52.9 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.224 2.616 . . . . 1.0 112.89 169.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.54 -13.68 3.75 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 116.017 1.167 . . . . 1.03 116.017 -175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.9 162.99 53.93 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 118.77 1.285 . . . . 0.95999999999999996 114.454 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -107.3 154.12 21.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.702 1.201 . . . . 2.1499999999999999 112.374 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -88.15 119.48 70.35 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.779 0.832 . . . . 2.0899999999999999 111.512 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.29 -15.2 5.47 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.363 2.709 . . . . 0.72999999999999998 114.924 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 m -152.45 171.47 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.988 2.515 . . . . 0.70999999999999996 108.234 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.27 144.89 30.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.313 0.857 . . . . 1.72 113.313 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.16 -160.98 25.91 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 114.78 0.672 . . . . 0.70999999999999996 114.78 -173.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -115.89 140.54 49.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.156 1.382 . . . . 5.54 112.408 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.41 127.67 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.792 2.437 . . . . 0.87 109.198 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.5 pt -141.0 32.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.636 0.976 . . . . 0.91000000000000003 113.636 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -165.15 132.44 3.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.154 1.382 . . . . 3.7999999999999998 108.07 167.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.88 -172.71 48.28 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 116.297 1.279 . . . . 0.81999999999999995 116.297 169.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -150.85 126.54 10.25 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.237 1.015 . . . . 1.9099999999999999 111.838 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.96 169.53 17.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.903 1.681 . . . . 1.27 113.067 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.8 ttm -112.62 124.26 52.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.711 0.805 . . . . 1.23 111.279 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.36 140.44 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.885 1.274 . . . . 0.68000000000000005 111.294 -170.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -104.93 111.96 24.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.001 1.32 . . . . 1.8600000000000001 109.461 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.47 15.25 5.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.883 2.073 . . . . 2.0 113.95 -169.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.5 p -51.73 -31.35 26.08 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.728 2.121 . . . . 1.6799999999999999 116.728 -170.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.51 -34.09 35.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.265 1.393 . . . . 1.72 110.684 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 108' ' ' LEU . 9.0 mm -78.4 -58.3 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.763 0.825 . . . . 1.7 111.206 -175.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 p -95.68 0.46 52.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.113 1.365 . . . . 2.0699999999999998 113.779 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.07 20.73 79.66 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.215 1.388 . . . . 1.8100000000000001 113.983 174.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -72.65 -168.23 0.43 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.839 1.655 . . . . 2.6299999999999999 111.097 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.2 -34.19 0.17 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.232 1.813 . . . . 1.72 110.917 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.4 mmt -85.06 157.84 59.26 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 125.494 1.517 . . . . 4.8600000000000003 110.852 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -68.68 160.49 49.3 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.246 2.631 . . . . 1.6000000000000001 112.677 167.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.4 t -125.27 130.14 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.958 1.703 . . . . 1.03 111.728 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.59 131.35 36.7 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.964 0.906 . . . . 1.0700000000000001 113.209 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -113.13 152.26 29.84 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.861 2.064 . . . . 0.85999999999999999 110.855 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -141.3 177.72 1.82 Allowed Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 128.642 2.777 . . . . 3.0800000000000001 109.917 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -66.84 128.57 19.09 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 CA-C-N 121.679 1.635 . . . . 1.27 109.703 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.65 25.27 28.16 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.457 1.503 . . . . 1.1100000000000001 114.945 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.5 m -108.12 174.56 5.83 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.903 1.351 . . . . 2.0699999999999998 110.855 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.2 p -130.75 150.37 51.96 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.081 -1.637 . . . . 1.23 112.581 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.49 147.75 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.769 1.227 . . . . 0.73999999999999999 112.089 -172.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -112.87 148.28 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.837 1.655 . . . . 1.23 112.868 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.83 144.8 54.28 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.821 0.849 . . . . 0.90000000000000002 112.484 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.31 -3.16 73.81 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.109 1.338 . . . . 0.77000000000000002 115.886 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.3 p -78.77 162.47 26.11 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.605 1.202 . . . . 1.4299999999999999 111.725 171.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.73 136.37 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.093 0.957 . . . . 0.79000000000000004 111.708 -171.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -91.01 146.12 24.12 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.814 1.646 . . . . 1.49 111.981 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -93.49 -93.36 0.16 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.325 1.05 . . . . 3.6699999999999999 111.396 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -136.83 131.43 33.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.958 1.703 . . . . 4.5800000000000001 108.935 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.13 114.41 1.63 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 108.848 -1.701 . . . . 1.8500000000000001 108.848 -167.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -94.31 114.74 26.86 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.961 0.904 . . . . 1.98 110.108 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.9 mt -112.74 153.31 27.94 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.297 1.039 . . . . 0.97999999999999998 112.078 -169.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 tp -114.83 121.2 42.53 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.941 0.897 . . . . 2.5800000000000001 110.049 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 mm -113.62 129.09 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.646 1.578 . . . . 1.6799999999999999 110.981 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.9 p -86.79 116.67 25.03 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.064 -1.023 . . . . 1.48 109.973 168.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.89 122.89 31.38 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.48 -0.762 . . . . 0.93000000000000005 110.111 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.8 t -124.1 10.85 8.81 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.52 0.933 . . . . 3.0299999999999998 113.52 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -137.19 140.29 41.65 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.545 1.138 . . . . 2.0299999999999998 110.929 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.5 p -97.11 170.53 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.013 1.325 . . . . 2.7599999999999998 111.212 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.33 -27.45 65.52 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 119.699 -1.876 . . . . 1.5700000000000001 116.092 -169.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.86 -27.87 68.55 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.96 1.38 . . . . 2.4399999999999999 113.842 174.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.45 -16.62 60.31 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.42 1.267 . . . . 4.0300000000000002 114.42 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 74.0 p -63.01 125.02 22.6 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.66 0.985 . . . . 2.2400000000000002 113.66 -166.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.405 HG23 HD12 ' A' ' 108' ' ' LEU . 11.4 t -60.31 -35.66 76.12 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.238 0.615 . . . . 2.3199999999999998 111.925 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.484 HD11 HD12 ' A' ' 69' ' ' ILE . 8.0 mp -56.27 -50.5 71.17 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.469 1.107 . . . . 1.77 112.298 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 91.9 p -70.78 -28.44 64.66 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.903 0.481 . . . . 1.7 112.014 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -70.43 -43.29 70.24 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.859 -0.526 . . . . 2.0099999999999998 111.595 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 53.6 mt -54.71 -51.22 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.118 1.367 . . . . 1.6599999999999999 110.876 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.03 -25.21 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 113.752 1.019 . . . . 1.51 113.752 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -73.34 -36.76 66.22 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.745 0.702 . . . . 3.1400000000000001 112.281 169.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.1 -33.33 73.32 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.637 0.775 . . . . 2.54 112.111 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.32 -59.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.839 1.256 . . . . 2.8700000000000001 112.089 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -68.22 -25.1 65.04 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.505 1.298 . . . . 4.46 114.505 -170.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.52 -12.62 61.15 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.417 1.462 . . . . 5.2699999999999996 114.492 170.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.86 -49.01 50.75 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.372 0.987 . . . . 5.6799999999999997 110.996 170.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.214 0 C-N-CA 126.203 1.801 . . . . 5.6299999999999999 113.239 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 113.0 0.741 . . . . 2.54 113.0 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -74.19 -31.01 62.48 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.012 1.278 . . . . 4.3499999999999996 112.193 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.33 88.17 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.184 0.994 . . . . 1.3899999999999999 112.549 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.95 -28.71 70.0 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.639 0.776 . . . . 1.5 112.153 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.12 -37.25 58.3 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.326 0.65 . . . . 1.21 111.956 167.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -63.05 -32.92 74.4 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.589 1.556 . . . . 3.7200000000000002 114.235 -176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 10' ' ' LEU . 4.2 mm? -60.3 -31.65 70.47 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.992 1.269 . . . . 1.5 111.738 172.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.4 mm -73.6 -45.26 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.728 0.811 . . . . 1.71 110.973 166.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 m -68.39 -16.66 64.0 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 121.052 1.751 . . . . 1.48 114.654 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 7' ' ' LEU . 22.5 mt -69.97 -30.23 67.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.396 1.478 . . . . 3.2000000000000002 112.446 169.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -77.92 130.75 36.97 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.771 0.828 . . . . 2.3199999999999998 110.694 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.9 167.59 20.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.839 1.256 . . . . 2.21 112.661 -176.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -106.15 -25.51 11.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.601 1.334 . . . . 2.2200000000000002 114.601 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.66 152.69 44.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.941 1.296 . . . . 3.5699999999999998 113.969 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.33 171.8 13.56 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.484 1.514 . . . . 0.82999999999999996 112.396 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.2 m -125.49 108.46 11.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.735 1.214 . . . . 0.90000000000000002 111.856 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.2 mt -82.06 140.64 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.19 1.396 . . . . 0.63 109.349 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.1 t -127.31 123.48 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.881 0.872 . . . . 1.9199999999999999 111.109 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.1 m -136.83 151.27 48.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.104 1.362 . . . . 1.99 110.92 -171.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.4 mt -94.89 127.24 40.78 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.722 0.809 . . . . 2.77 110.42 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB3' HD23 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -100.47 -12.23 19.51 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.272 1.029 . . . . 3.4100000000000001 111.983 177.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -146.15 135.89 23.3 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.085 2.154 . . . . 3.7799999999999998 107.975 169.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.94 84.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 127.58 2.352 . . . . 5.0300000000000002 116.681 -166.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 57.87 35.55 25.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.74 1.616 . . . . 4.0499999999999998 112.732 -175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.5 pt -141.96 -22.21 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.819 1.648 . . . . 3.3999999999999999 113.121 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' A' ' 21' ' ' ASP . 48.9 tp -130.31 124.79 33.16 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.774 1.229 . . . . 2.7200000000000002 111.297 169.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.5 mp -107.94 138.79 43.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.896 1.679 . . . . 2.48 111.179 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.4 t -142.63 128.63 19.6 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.312 1.045 . . . . 1.3799999999999999 111.444 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -111.4 138.13 48.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.446 1.099 . . . . 2.9500000000000002 111.566 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -106.88 146.43 31.0 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.615 1.566 . . . . 4.0 110.958 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -113.34 126.08 54.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.809 0.731 . . . . 1.6299999999999999 109.796 169.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.8 160.12 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 115.098 1.518 . . . . 0.76000000000000001 115.098 -166.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -75.74 147.99 38.88 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.687 0.795 . . . . 3.4700000000000002 109.085 167.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.31 -9.52 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 114.536 1.31 . . . . 1.01 114.536 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -79.79 -19.01 49.57 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.168 -1.583 . . . . 3.54 113.861 170.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.7 mt -96.48 -4.59 41.27 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.859 1.264 . . . . 1.24 113.644 -173.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.51 141.26 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.433 1.493 . . . . 1.52 109.465 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -127.49 168.39 14.98 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.026 1.731 . . . . 2.9900000000000002 111.38 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -72.59 23.7 0.06 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.737 1.615 . . . . 3.1600000000000001 114.958 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.26 11.38 2.27 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.968 2.223 . . . . 0.89000000000000001 113.855 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -87.47 163.39 16.73 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.669 1.734 . . . . 2.6600000000000001 112.371 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 98.7 mt -118.29 126.45 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.185 1.394 . . . . 1.45 109.216 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.2 mm -118.2 129.58 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.964 1.706 . . . . 0.68000000000000005 112.044 -168.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -88.57 131.48 34.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.022 0.929 . . . . 2.1200000000000001 112.566 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 p -108.02 140.74 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.333 1.453 . . . . 0.66000000000000003 111.649 175.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 m -102.96 159.5 29.1 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 124.39 1.076 . . . . 0.83999999999999997 113.324 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.75 138.76 40.98 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.444 2.762 . . . . 0.96999999999999997 112.287 169.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.08 -7.28 8.01 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.995 1.158 . . . . 1.0900000000000001 115.995 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.19 -179.38 48.79 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.423 1.487 . . . . 1.1699999999999999 115.023 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -123.43 151.98 42.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.493 1.517 . . . . 2.5600000000000001 112.62 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -78.01 122.38 85.36 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.093 0.957 . . . . 1.8700000000000001 110.179 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -88.3 -17.97 2.27 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.661 2.24 . . . . 0.81999999999999995 115.004 -170.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.72 170.83 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 128.586 2.755 . . . . 0.70999999999999996 108.082 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.49 151.55 20.13 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.694 0.998 . . . . 2.1499999999999999 113.694 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.63 -160.26 33.69 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.4 0.524 . . . . 0.79000000000000004 114.081 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -113.32 143.86 43.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.135 0.974 . . . . 4.2000000000000002 112.913 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.26 124.54 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 126.169 1.788 . . . . 1.1000000000000001 107.237 169.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.79 33.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.256 1.022 . . . . 1.1200000000000001 110.959 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -167.85 122.74 0.99 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.613 1.965 . . . . 2.9100000000000001 108.511 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.02 177.28 43.65 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 116.22 1.248 . . . . 0.93999999999999995 116.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -146.81 127.69 14.45 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.072 1.349 . . . . 2.0299999999999998 112.315 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.8 t -145.7 171.48 14.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.925 1.29 . . . . 1.45 112.685 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.7 ttm -115.68 125.56 53.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.508 1.523 . . . . 1.3500000000000001 108.88 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -122.99 140.54 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.721 1.208 . . . . 0.96999999999999997 112.443 -168.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -102.04 124.62 47.96 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.03 2.132 . . . . 2.1000000000000001 111.347 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -125.05 20.25 8.28 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.681 1.193 . . . . 2.5699999999999998 113.477 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.2 p -62.51 -3.56 1.5 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 117.742 2.497 . . . . 1.3200000000000001 117.742 -169.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.34 -45.6 4.63 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.685 1.194 . . . . 1.4399999999999999 109.403 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.7 mm -74.92 -56.77 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.567 1.147 . . . . 1.5800000000000001 112.321 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.4 p -107.64 -0.95 21.58 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.328 1.451 . . . . 2.02 112.621 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.21 6.07 78.62 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.27 1.414 . . . . 1.78 114.937 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -71.32 106.17 3.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.207 1.003 . . . . 3.3799999999999999 111.733 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.48 -16.35 60.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.827 0.851 . . . . 1.8200000000000001 112.375 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.7 ttt -113.42 136.85 21.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.041 1.736 . . . . 5.4000000000000004 108.971 172.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.07 165.74 25.7 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.63 2.22 . . . . 1.78 114.17 -168.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.06 138.68 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.142 1.777 . . . . 1.5800000000000001 111.065 -170.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.23 126.72 33.42 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.732 -0.605 . . . . 1.48 112.017 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -98.62 151.04 21.12 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.29 1.436 . . . . 0.93999999999999995 110.067 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -137.08 175.79 3.24 Favored Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 126.112 1.765 . . . . 2.8799999999999999 109.679 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.82 65.96 4.91 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 123.395 2.73 . . . . 2.4900000000000002 111.631 172.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.02 29.98 0.02 OUTLIER Glycine 0 CA--C 1.538 1.479 0 C-N-CA 127.14 2.305 . . . . 1.3500000000000001 112.806 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -126.94 150.44 49.34 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.172 1.389 . . . . 1.8200000000000001 111.273 -170.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.1 p -98.29 148.81 23.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.793 0.837 . . . . 1.1499999999999999 112.631 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 m -140.08 148.24 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.751 1.621 . . . . 0.93000000000000005 111.796 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.64 148.66 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.253 1.421 . . . . 1.3799999999999999 112.51 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.38 142.0 55.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.141 0.976 . . . . 0.75 112.454 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.51 2.44 89.59 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 115.619 1.008 . . . . 1.23 115.619 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 76.0 p -79.22 153.37 30.02 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.012 1.406 . . . . 1.6399999999999999 111.118 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 mm -112.56 132.51 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.127 0.971 . . . . 1.01 112.796 -168.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -84.45 133.97 34.47 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.668 1.587 . . . . 2.9500000000000002 111.282 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.82 -72.66 0.44 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.437 0.637 . . . . 3.98 110.071 168.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -143.91 155.93 44.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.425 2.29 . . . . 3.9900000000000002 107.877 172.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.93 108.04 2.88 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 127.45 2.452 . . . . 1.98 111.803 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.7 t -86.64 127.89 34.96 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.491 1.146 . . . . 2.2000000000000002 110.844 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -126.12 162.64 24.9 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.835 1.254 . . . . 0.96999999999999997 111.562 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -114.81 126.78 55.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.426 0.691 . . . . 1.95 109.44 167.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.62 125.65 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.804 1.642 . . . . 1.28 110.292 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.7 p -87.25 108.03 18.76 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.671 0.748 . . . . 1.52 109.744 168.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.26 135.66 36.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.61 0.764 . . . . 0.87 111.574 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.04 -0.14 9.54 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.586 1.328 . . . . 2.1499999999999999 114.586 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -143.78 144.68 31.91 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.296 1.438 . . . . 1.52 111.827 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 m -83.6 162.92 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.024 0.93 . . . . 1.6799999999999999 110.974 169.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.63 -34.49 90.04 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 120.728 -1.233 . . . . 1.3700000000000001 114.984 -168.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.25 -28.0 64.89 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.11 -1.229 . . . . 1.71 113.056 175.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.27 -7.81 56.57 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.16 1.784 . . . . 2.7599999999999998 114.545 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.4 p -68.55 158.03 34.76 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.885 -1.135 . . . . 1.9399999999999999 112.688 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 t -64.59 -33.19 75.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.19 0.596 . . . . 2.4300000000000002 111.254 170.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mp -55.66 -50.98 68.79 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.983 -1.073 . . . . 1.95 111.107 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.0 m -69.29 -31.56 70.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.417 1.087 . . . . 1.71 111.928 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.19 -40.8 98.56 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.671 -0.643 . . . . 1.6899999999999999 111.718 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 70.0 mt -65.18 -50.7 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.843 1.657 . . . . 2.04 111.108 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.2 m -65.21 -25.46 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 113.52 0.933 . . . . 1.97 113.52 -175.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -72.72 -38.46 67.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.12 0.873 . . . . 4.1600000000000001 113.197 169.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.25 -52.12 13.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.459 1.904 . . . . 3.1400000000000001 113.482 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.8 t -69.47 -22.98 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.627 -1.295 . . . . 2.3399999999999999 111.762 -176.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.56 -24.58 64.63 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.556 1.142 . . . . 4.0199999999999996 112.642 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.86 -27.62 63.97 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.915 -1.116 . . . . 4.4199999999999999 113.775 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.74 -50.72 48.38 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.622 1.101 . . . . 5.0 110.298 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 125.045 1.338 . . . . 5.2199999999999998 113.088 170.028 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.131 1.16 . . . . 2.3799999999999999 114.131 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -74.16 -39.34 63.32 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.9 0.88 . . . . 4.4199999999999999 109.737 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.68 83.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.871 1.268 . . . . 2.0 112.644 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.0 tp -65.06 -30.19 71.14 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.601 -0.687 . . . . 2.3700000000000001 111.891 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.69 61.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.583 0.753 . . . . 1.3300000000000001 112.439 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -58.84 -35.96 73.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.013 1.325 . . . . 2.73 112.914 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -48.98 -49.97 38.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.892 0.877 . . . . 1.53 112.236 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.8 mm -74.09 -36.84 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.672 0.789 . . . . 2.1600000000000001 112.622 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -58.91 -30.31 67.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.116 0.966 . . . . 1.1599999999999999 113.053 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -22.06 61.72 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.938 1.295 . . . . 2.3100000000000001 114.308 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -62.84 162.84 10.38 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.997 1.48 . . . . 2.3599999999999999 114.997 -171.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.7 -31.08 12.86 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.97 1.308 . . . . 3.5499999999999998 114.291 -171.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m 64.32 -12.78 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 127.946 2.499 . . . . 2.48 116.437 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -140.9 149.05 41.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.212 1.805 . . . . 2.8599999999999999 111.204 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.21 173.06 11.92 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.504 1.122 . . . . 0.75 112.837 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.4 m -124.33 120.88 33.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.611 1.165 . . . . 0.83999999999999997 111.967 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.9 mt -94.42 144.5 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.785 2.034 . . . . 0.59999999999999998 110.37 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.7 t -111.92 126.0 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.223 1.009 . . . . 2.0600000000000001 110.878 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.6 m -135.88 152.77 51.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.791 1.636 . . . . 1.8700000000000001 111.331 -172.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -78.71 141.31 38.0 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.122 0.874 . . . . 4.7699999999999996 111.493 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.46 -9.39 10.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.746 1.218 . . . . 4.7300000000000004 113.143 172.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.1 m -152.7 145.53 24.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.495 1.918 . . . . 3.5099999999999998 110.528 169.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -39.29 78.8 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 130.713 3.605 . . . . 6.4800000000000004 116.725 -167.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 66.05 -22.71 0.09 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.812 2.445 . . . . 8.0399999999999991 114.563 -170.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 pt -82.24 -15.57 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 128.586 2.755 . . . . 4.6600000000000001 115.138 -170.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tt -138.3 132.6 31.89 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.048 1.129 . . . . 2.9500000000000002 114.048 170.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mp -106.14 147.76 28.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.337 2.255 . . . . 3.3900000000000001 111.594 172.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -136.75 145.47 44.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.729 1.612 . . . . 1.8200000000000001 110.5 169.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -109.79 130.1 55.56 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.143 0.497 . . . . 2.8199999999999998 111.68 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -118.27 132.52 56.29 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.384 2.273 . . . . 3.9199999999999999 110.19 -170.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -93.52 139.17 31.05 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.097 1.317 . . . . 1.6100000000000001 112.312 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.96 166.09 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.68 1.592 . . . . 0.88 114.02 -171.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.79 150.58 24.95 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.375 1.47 . . . . 3.21 109.621 166.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.45 -19.48 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 114.295 1.22 . . . . 1.1100000000000001 114.295 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.32 -21.73 60.5 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.703 -1.248 . . . . 3.8199999999999998 113.866 172.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.8 mt -101.87 -7.43 22.48 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.806 1.242 . . . . 1.3100000000000001 113.808 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -86.23 142.35 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.835 1.254 . . . . 1.4299999999999999 109.631 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -117.19 168.36 10.37 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.471 1.108 . . . . 4.4199999999999999 113.292 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -67.62 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.98 2.112 . . . . 2.6899999999999999 115.711 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.77 12.22 0.63 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.484 1.993 . . . . 0.83999999999999997 114.277 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -92.42 152.31 19.78 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.739 1.769 . . . . 2.71 112.702 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -102.0 121.99 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.716 1.206 . . . . 1.3999999999999999 110.281 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.0 mm -104.56 159.95 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.796 1.638 . . . . 1.3700000000000001 112.273 -172.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HE2' HD11 ' A' ' 96' ' ' LEU . 34.3 ttmt -129.47 132.89 47.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.688 1.595 . . . . 2.0299999999999998 111.332 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.57 140.8 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.225 1.01 . . . . 0.79000000000000004 112.542 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -95.03 159.34 33.27 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 125.233 1.413 . . . . 0.97999999999999998 112.859 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.0 133.96 43.9 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.058 2.505 . . . . 1.0600000000000001 111.891 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.29 -12.04 61.63 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.539 1.542 . . . . 0.94999999999999996 114.7 -172.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.61 173.76 52.85 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.216 1.389 . . . . 0.98999999999999999 114.726 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -108.45 154.07 22.4 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.55 1.54 . . . . 2.7000000000000002 113.259 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -84.03 121.75 75.78 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.887 0.875 . . . . 1.8100000000000001 110.818 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.79 -21.06 2.82 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.974 2.449 . . . . 0.82999999999999996 115.816 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -152.04 163.08 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 128.08 2.552 . . . . 0.95999999999999996 108.906 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 136.78 32.84 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 112.818 0.673 . . . . 1.7 112.818 -172.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.3 -161.86 32.89 Favored Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.635 -0.666 . . . . 0.71999999999999997 114.148 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.7 ttp85 -109.91 134.01 52.54 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.204 1.801 . . . . 4.0599999999999996 112.976 -172.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.5 133.53 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.524 2.329 . . . . 0.93999999999999995 108.77 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.62 32.46 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.951 0.901 . . . . 0.98999999999999999 112.817 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -167.16 136.17 2.74 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.222 1.809 . . . . 3.04 109.005 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.18 -177.19 51.85 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 122.417 1.01 . . . . 0.95999999999999996 115.559 170.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -144.01 124.71 14.13 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.653 1.181 . . . . 1.95 111.746 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m -149.28 166.49 28.77 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.23 1.567 . . . . 1.1499999999999999 115.23 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.6 ttm -114.67 119.57 37.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.142 1.377 . . . . 1.3100000000000001 108.884 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.39 134.37 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.882 1.673 . . . . 1.0900000000000001 112.363 -167.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -86.73 75.79 9.59 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.702 1.601 . . . . 2.2000000000000002 110.316 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.67 4.62 53.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.205 1.402 . . . . 1.98 113.718 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.1 -23.87 66.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 115.511 1.671 . . . . 3.0099999999999998 115.511 -169.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.72 -21.13 57.82 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.434 1.015 . . . . 1.5800000000000001 112.029 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -86.94 -49.84 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.935 0.894 . . . . 1.3999999999999999 110.968 176.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.4 p -100.19 -7.7 24.43 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.436 1.273 . . . . 1.4199999999999999 114.436 -172.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.98 -1.06 56.77 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.336 1.446 . . . . 1.6100000000000001 115.186 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.94 -6.76 1.41 Allowed 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 119.822 1.811 . . . . 2.8900000000000001 115.094 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 45.24 26.37 0.25 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 130.746 3.618 . . . . 1.97 115.537 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 ttm -166.49 135.39 2.38 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.618 1.967 . . . . 3.8700000000000001 108.779 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.88 162.84 40.58 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.215 3.277 . . . . 1.75 114.474 -169.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.99 135.57 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 126.198 1.799 . . . . 1.3400000000000001 110.991 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.8 141.98 35.74 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.826 0.85 . . . . 1.3 112.977 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -128.87 149.54 50.72 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.829 2.052 . . . . 1.05 111.04 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -151.46 171.67 6.25 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 128.757 2.823 . . . . 2.8399999999999999 108.977 -173.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.78 134.57 63.6 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 CA-C-N 122.36 1.879 . . . . 1.1200000000000001 111.699 169.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.78 31.14 45.38 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.052 0.834 . . . . 1.1000000000000001 114.19 -170.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.2 t -122.05 159.82 26.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.835 1.254 . . . . 1.8999999999999999 110.827 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.0 p -118.77 155.43 31.14 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.547 1.521 . . . . 1.1899999999999999 113.732 -172.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.1 m -132.2 152.41 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.61 1.964 . . . . 1.26 111.568 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.637 HD13 ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -100.71 -1.26 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.844 2.058 . . . . 4.0599999999999996 116.041 -176.279 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 70.07 159.98 0.2 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.171 1.788 . . . . 0.87 114.484 -167.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.7 -44.27 2.5 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.011 1.291 . . . . 1.6799999999999999 113.277 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.5 p -51.33 151.29 3.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.373 1.069 . . . . 1.3 113.741 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.59 136.13 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.229 1.012 . . . . 1.04 110.462 -172.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -83.3 129.9 35.03 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.05 0.94 . . . . 1.8999999999999999 109.121 169.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -134.49 63.6 1.62 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.911 0.708 . . . . 3.5499999999999998 112.911 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -158.31 -56.1 0.07 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.51 1.67 . . . . 4.2400000000000002 115.51 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.9 -174.43 31.77 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.247 1.259 . . . . 2.1200000000000001 116.247 -167.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.4 p -94.31 126.46 39.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.857 1.263 . . . . 2.52 112.54 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 mt -136.0 161.79 34.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.333 1.053 . . . . 1.05 113.255 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.503 HD11 ' HE2' ' A' ' 44' ' ' LYS . 7.5 mp -120.61 139.0 53.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.291 1.036 . . . . 1.9299999999999999 111.591 168.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.36 133.07 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.209 1.404 . . . . 1.5600000000000001 111.244 -173.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.6 p -90.28 118.76 30.03 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.145 -0.972 . . . . 1.4199999999999999 111.307 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.46 121.0 24.64 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.083 -1.011 . . . . 0.92000000000000004 110.782 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.4 p -125.95 11.21 7.69 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.818 1.247 . . . . 2.4300000000000002 113.612 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -139.6 135.29 33.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.163 1.785 . . . . 1.6100000000000001 108.137 171.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 p -78.66 160.65 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 122.962 0.505 . . . . 2.73 109.697 169.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.28 -32.86 68.62 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 120.819 -1.176 . . . . 1.3999999999999999 115.875 -168.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.48 -40.12 73.82 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.356 1.578 . . . . 1.6299999999999999 113.243 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.33 -7.67 53.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.703 2.001 . . . . 2.4199999999999999 114.385 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 67.6 p -58.48 149.25 25.71 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.988 -1.07 . . . . 1.7 113.547 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.0 t -60.09 -36.57 77.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.663 0.785 . . . . 2.3399999999999999 111.309 171.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.2 tp -58.48 -47.01 85.46 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.841 -1.162 . . . . 1.49 112.792 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 t -70.9 -26.96 63.46 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.337 0.655 . . . . 1.9199999999999999 112.404 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -71.25 -42.77 68.41 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.516 1.126 . . . . 1.5600000000000001 111.818 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.4 mt -54.31 -50.68 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.158 0.983 . . . . 1.79 110.574 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.7 m -68.62 -29.47 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 120.958 -1.089 . . . . 1.6799999999999999 113.292 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -70.81 -29.28 65.41 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.286 -0.884 . . . . 2.3500000000000001 112.285 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.0 mt -76.56 -51.77 11.01 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.73 1.612 . . . . 2.7799999999999998 112.649 168.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.65 -28.19 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.317 1.047 . . . . 2.7000000000000002 112.507 -171.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -65.08 -34.47 78.48 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.701 -1.25 . . . . 4.0999999999999996 111.636 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -80.73 -14.0 58.5 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.134 1.161 . . . . 3.75 114.134 173.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.26 -24.26 59.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.543 1.137 . . . . 5.3499999999999996 113.586 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 128.436 2.694 . . . . 5.21 114.249 177.896 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.9 p . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 113.763 1.023 . . . . 3.1800000000000002 113.763 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -77.03 -33.79 57.34 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.714 -1.242 . . . . 4.3700000000000001 110.946 168.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.93 -35.78 80.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.514 0.725 . . . . 1.52 111.893 176.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.8 tp -49.25 -43.14 42.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.587 1.555 . . . . 1.6399999999999999 111.797 171.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.93 -35.97 62.16 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.276 0.843 . . . . 1.27 113.276 172.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -64.57 -31.24 72.38 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.941 0.792 . . . . 3.0699999999999998 112.801 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.44 -32.65 70.41 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.97 1.259 . . . . 1.75 112.569 172.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.6 mm -73.08 -40.71 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.397 -0.814 . . . . 2.2999999999999998 111.725 169.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.5 m -70.83 -21.06 62.49 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.142 1.164 . . . . 1.1699999999999999 114.142 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -72.84 -9.97 59.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.653 1.581 . . . . 2.1200000000000001 113.807 173.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -89.28 132.92 34.69 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.071 0.85 . . . . 2.7599999999999998 113.094 -172.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.48 161.13 31.52 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.445 1.498 . . . . 2.8599999999999999 114.43 -169.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 p -123.6 -26.3 4.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.587 1.555 . . . . 2.0499999999999998 113.833 -179.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.58 153.19 43.3 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.438 1.095 . . . . 3.3500000000000001 113.242 177.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.63 165.66 26.88 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.211 1.404 . . . . 0.78000000000000003 112.786 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -118.61 98.41 6.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.658 1.183 . . . . 1.04 112.159 -178.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.2 mt -83.24 129.6 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 121.252 -0.905 . . . . 0.66000000000000003 110.496 -177.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.94 109.28 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 108.478 -0.934 . . . . 1.76 108.478 169.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -104.41 149.94 24.97 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.803 1.641 . . . . 2.1699999999999999 110.144 -177.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.44 103.49 14.85 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.387 -0.82 . . . . 3.2200000000000002 109.971 178.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.81 -1.53 58.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.454 1.502 . . . . 4.4400000000000004 113.68 -174.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.6 m -156.13 133.21 10.59 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.496 1.918 . . . . 3.5099999999999998 107.933 167.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 t70 18.04 -117.09 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 130.025 3.33 . . . . 6.2300000000000004 110.667 -166.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.01 12.44 34.16 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.565 1.146 . . . . 5.4800000000000004 110.201 163.552 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.5 pt -94.78 -29.83 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.931 2.492 . . . . 4.3300000000000001 116.939 -167.046 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.44 108.82 17.38 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.935 1.243 . . . . 2.6899999999999999 111.417 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 mp -88.29 120.16 29.39 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.998 1.319 . . . . 2.6299999999999999 109.559 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 t -137.93 127.96 25.74 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.333 1.053 . . . . 1.79 110.476 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -102.76 146.94 27.49 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.478 -0.764 . . . . 2.6099999999999999 112.459 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -127.75 138.37 52.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.965 1.706 . . . . 3.5299999999999998 110.41 -169.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -99.69 116.75 32.53 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.487 0.715 . . . . 2.5099999999999998 109.334 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.95 166.07 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.008 0.923 . . . . 0.87 113.146 -172.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -88.13 160.82 17.61 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.582 1.553 . . . . 3.8300000000000001 112.565 169.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.55 -28.36 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 115.472 1.656 . . . . 1.6699999999999999 115.472 -171.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -75.99 -17.23 59.78 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.272 -1.517 . . . . 4.3899999999999997 112.554 172.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -94.78 -8.78 36.54 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.176 1.39 . . . . 1.54 113.723 -172.01 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.73 139.02 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.945 1.698 . . . . 1.45 109.392 168.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.63 168.04 20.26 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.281 1.432 . . . . 2.8799999999999999 112.597 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -68.91 4.84 1.32 Allowed 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 117.531 2.419 . . . . 4.3799999999999999 117.531 -167.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.16 7.35 16.63 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.667 1.603 . . . . 1.3700000000000001 114.21 172.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -90.04 152.78 21.01 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.058 1.429 . . . . 2.71 112.929 -177.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.1 mm -113.45 122.47 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.927 1.691 . . . . 1.3200000000000001 109.86 177.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.3 mm -113.28 125.04 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.992 1.317 . . . . 0.88 111.562 -172.213 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -78.74 132.48 36.96 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.443 -0.786 . . . . 2.4300000000000002 110.508 169.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 p -121.85 133.86 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.337 1.455 . . . . 0.66000000000000003 111.206 176.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 m -89.06 162.22 38.42 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.766 1.226 . . . . 1.05 113.389 -173.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -61.28 133.7 47.95 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.695 1.597 . . . . 1.21 109.196 167.284 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.96 -10.69 46.05 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.515 -1.158 . . . . 1.1200000000000001 115.426 -172.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.53 175.17 44.07 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.038 1.419 . . . . 1.0600000000000001 114.403 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -111.63 153.34 26.49 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.463 1.505 . . . . 1.74 112.055 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -84.17 128.67 61.45 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-O 118.101 -0.952 . . . . 2.3100000000000001 109.717 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -96.9 -14.46 0.4 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.912 2.408 . . . . 0.80000000000000004 115.482 -173.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.37 164.62 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 127.716 2.406 . . . . 1.03 108.336 -176.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -88.46 155.09 19.87 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.412 1.264 . . . . 2.4700000000000002 114.412 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.74 -131.26 2.4 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.362 -0.835 . . . . 1.0600000000000001 113.735 177.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -135.72 146.39 47.65 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.233 1.197 . . . . 3.6000000000000001 114.233 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.77 122.77 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 105.628 -1.99 . . . . 1.21 105.628 166.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.2 pt -137.0 33.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.816 0.817 . . . . 0.88 112.109 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -167.62 128.54 1.46 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.069 2.148 . . . . 2.8100000000000001 107.75 166.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.66 -178.12 54.09 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 122.842 1.246 . . . . 0.80000000000000004 115.374 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -149.13 137.04 20.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.391 1.476 . . . . 2.5699999999999998 111.414 -176.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -150.76 176.68 10.81 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.481 0.919 . . . . 1.3300000000000001 113.481 176.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.5 ttm -112.89 126.95 56.02 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.334 1.054 . . . . 1.27 110.678 171.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -114.33 140.77 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.206 1.402 . . . . 0.72999999999999998 112.774 -168.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -97.38 107.67 20.23 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.456 1.502 . . . . 1.95 109.554 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.256 11.2 pt-20 -123.75 30.15 6.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.483 1.513 . . . . 1.8600000000000001 113.063 -178.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.3 p -60.63 -24.22 65.36 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.966 1.839 . . . . 1.51 115.966 -175.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -95.47 -33.61 12.38 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.079 1.351 . . . . 1.3200000000000001 111.352 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.0 mm -76.5 -49.34 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.531 -0.731 . . . . 1.23 110.632 178.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 m -106.85 -21.5 13.0 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.535 1.134 . . . . 2.2000000000000002 113.277 -169.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.59 -13.69 64.87 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.584 1.564 . . . . 1.22 115.78 172.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -63.86 118.31 8.19 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.475 1.138 . . . . 3.1000000000000001 110.215 174.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.25 35.05 0.32 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.187 1.395 . . . . 1.54 112.829 -178.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 ptp -154.14 137.13 10.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.367 1.867 . . . . 4.04 110.239 -174.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -63.23 154.93 64.69 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.861 2.374 . . . . 1.5800000000000001 115.193 -179.332 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.4 t -122.76 132.23 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.999 1.72 . . . . 0.98999999999999999 111.04 -170.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.25 35.56 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.964 0.887 . . . . 1.01 113.289 -175.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -125.01 150.57 46.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.539 1.936 . . . . 0.76000000000000001 110.61 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -150.09 173.9 3.92 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 129.621 3.169 . . . . 2.5699999999999998 108.415 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -56.14 136.81 77.08 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 CA-C-N 121.702 1.644 . . . . 0.80000000000000004 111.573 170.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.94 25.98 72.33 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.602 1.096 . . . . 0.89000000000000001 114.465 -171.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.4 m -102.05 146.98 27.15 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 119.139 1.469 . . . . 1.45 110.575 174.584 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.7 p -88.83 151.76 22.17 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.184 1.357 . . . . 0.80000000000000004 113.148 178.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -138.52 157.04 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.04 1.336 . . . . 0.69999999999999996 112.01 176.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.75 150.18 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.095 2.158 . . . . 1.3 111.282 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.86 148.54 49.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.913 0.885 . . . . 0.66000000000000003 113.334 -174.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.44 -3.46 62.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.348 0.975 . . . . 0.76000000000000001 115.106 179.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.2 p -79.5 157.2 27.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.951 1.375 . . . . 1.4299999999999999 111.07 169.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mm -115.13 130.52 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.551 0.74 . . . . 0.81000000000000005 112.645 -168.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -90.07 149.26 22.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.882 1.673 . . . . 1.6599999999999999 113.669 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -157.67 142.9 16.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.403 1.081 . . . . 4.0700000000000003 112.61 171.438 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 t30 117.47 -40.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 131.255 3.822 . . . . 4.1100000000000003 113.514 175.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.62 -179.79 46.35 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 120.031 1.287 . . . . 1.8899999999999999 115.281 173.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.4 m -82.35 134.21 35.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.416 1.086 . . . . 2.1299999999999999 112.616 -177.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.39 165.16 20.29 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.128 1.771 . . . . 1.3400000000000001 111.619 -176.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.43 132.96 55.91 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.607 0.718 . . . . 2.1499999999999999 111.026 168.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.7 mm -118.14 125.12 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.053 1.741 . . . . 1.54 110.283 -169.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -82.73 114.65 21.23 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.383 -0.823 . . . . 1.5 109.065 168.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.04 112.67 15.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.338 -0.986 . . . . 1.01 108.338 174.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -104.6 2.56 30.79 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.932 0.893 . . . . 2.4500000000000002 112.746 -172.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -147.76 154.39 40.46 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.7 1.6 . . . . 2.0600000000000001 111.665 173.297 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.06 165.63 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.896 1.278 . . . . 1.96 112.181 170.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 -35.21 85.42 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 120.906 -1.121 . . . . 1.5 114.283 -172.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.91 -31.69 72.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.455 1.128 . . . . 1.8899999999999999 113.64 176.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -75.19 -17.63 60.32 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.127 -0.983 . . . . 2.9500000000000002 113.58 174.361 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 81.6 p -64.65 144.6 57.11 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.899 -1.126 . . . . 1.8300000000000001 112.566 -169.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -64.55 -22.85 67.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.899 0.879 . . . . 1.9399999999999999 113.065 -169.44 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.64 -49.33 78.19 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.68 1.192 . . . . 1.5900000000000001 113.107 -177.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.8 m -72.83 -17.34 61.56 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.533 0.938 . . . . 2.75 113.533 173.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -76.92 -40.89 45.58 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.736 0.643 . . . . 1.48 112.736 172.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.13 -47.31 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.6 1.56 . . . . 1.46 110.386 177.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.13 -18.7 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 114.479 1.288 . . . . 1.5 114.479 -178.011 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -72.03 -33.25 67.87 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.562 1.074 . . . . 4.0300000000000002 112.504 171.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 mt -75.32 -50.73 15.11 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.405 1.082 . . . . 3.1899999999999999 111.603 170.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -66.44 -29.1 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.03 0.932 . . . . 2.79 112.122 -174.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -60.16 -38.85 84.41 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.417 -1.427 . . . . 4.5199999999999996 112.524 173.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.04 -13.54 59.71 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.52 -1.363 . . . . 6.54 114.478 171.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.43 -27.43 62.33 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.704 1.001 . . . . 6.3399999999999999 113.704 -176.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 124.523 1.129 . . . . 5.5599999999999996 111.268 169.249 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 114.174 1.175 . . . . 3.6699999999999999 114.174 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -87.17 -24.49 24.45 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.795 1.238 . . . . 6.5700000000000003 111.741 168.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.9 -27.15 60.11 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.011 0.924 . . . . 2.3700000000000001 112.48 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.25 -44.85 84.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.253 1.421 . . . . 1.54 111.797 176.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.82 -8.61 56.33 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.286 1.217 . . . . 1.5900000000000001 114.286 175.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -65.25 -43.01 92.71 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.818 1.19 . . . . 2.4900000000000002 110.607 -177.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -45.86 -52.93 10.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.246 1.818 . . . . 1.6799999999999999 112.246 172.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.1 mm -69.78 -31.32 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.11 0.964 . . . . 2.1400000000000001 112.183 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.9 m -75.46 -28.3 59.23 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.01 1.324 . . . . 1.27 113.627 -175.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.32 -24.14 67.73 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.265 0.938 . . . . 2.0 113.519 175.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -68.25 139.47 56.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.886 1.275 . . . . 2.4900000000000002 113.465 -175.033 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.87 157.28 29.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.604 1.161 . . . . 2.21 112.561 173.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.54 -2.25 17.72 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.7 1.741 . . . . 1.97 115.7 -169.369 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.31 156.74 48.21 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.862 1.665 . . . . 3.8999999999999999 112.526 -178.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.72 147.3 37.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.034 0.934 . . . . 0.81999999999999995 113.108 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.2 m -107.98 106.45 16.71 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.597 1.159 . . . . 0.81000000000000005 111.369 175.225 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mt -83.48 147.22 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.178 1.791 . . . . 0.58999999999999997 109.486 176.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.16 140.24 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.636 1.347 . . . . 2.1099999999999999 114.636 169.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 p -126.22 142.49 51.51 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.575 1.55 . . . . 2.6600000000000001 114.4 -178.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.55 82.81 8.11 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.287 1.042 . . . . 3.0 108.268 169.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.401 ' HB2' HD23 ' A' ' 26' ' ' LEU . 15.0 m-20 -78.15 -33.65 50.22 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.869 1.268 . . . . 4.6600000000000001 112.07 178.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -142.59 125.04 15.65 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.577 1.951 . . . . 4.3300000000000001 109.502 170.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -10.51 62.43 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.219 1 C-N-CA 135.942 5.697 . . . . 5.7599999999999998 117.168 -178.958 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 59.19 -21.16 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.349 2.26 . . . . 4.0700000000000003 115.41 -168.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.404 ' H ' ' C ' ' A' ' 23' ' ' ASP . 8.0 pt -58.45 -27.53 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 128.751 2.82 . . . . 4.0199999999999996 115.499 177.048 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 21' ' ' ASP . 2.4 tp -105.65 -55.96 2.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.586 0.754 . . . . 4.1100000000000003 112.495 177.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.8 tp 40.61 80.9 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.08 2.152 . . . . 3.2799999999999998 112.388 -173.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -79.08 153.6 30.05 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.231 1.013 . . . . 1.6699999999999999 112.501 -172.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -116.08 131.63 56.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.111 1.364 . . . . 2.6499999999999999 110.214 176.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -126.33 136.07 52.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.214 1.806 . . . . 3.98 110.171 -176.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -110.2 130.98 55.45 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.466 -1.396 . . . . 1.97 112.252 -175.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.81 169.14 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.922 1.289 . . . . 0.76000000000000001 113.62 -173.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -79.58 152.42 30.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.24 1.416 . . . . 3.3799999999999999 112.494 171.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.77 -18.76 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 115.189 1.552 . . . . 1.1599999999999999 115.189 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -85.46 -19.92 30.54 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 120.623 1.556 . . . . 3.04 113.503 169.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.16 -17.7 21.55 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.046 1.338 . . . . 1.21 113.558 -173.27 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.54 138.69 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.766 0.827 . . . . 1.6000000000000001 109.235 168.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -118.82 159.27 24.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.196 0.998 . . . . 3.5299999999999998 111.123 178.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.2 ptt85 -69.59 146.6 51.62 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.899 -0.501 . . . . 2.7000000000000002 109.984 169.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.12 2.8 56.9 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-N 118.852 0.751 . . . . 1.0800000000000001 114.077 -171.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -112.98 172.87 6.67 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.612 1.565 . . . . 2.3700000000000001 112.102 173.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.3 mm -112.69 122.95 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.734 1.614 . . . . 1.3 110.483 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.6 mm -119.5 132.89 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.458 1.503 . . . . 0.87 111.429 -169.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HE3' HD11 ' A' ' 96' ' ' LEU . 13.7 mmmm -86.74 142.24 28.3 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.322 1.449 . . . . 2.4399999999999999 112.456 174.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.35 145.4 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.58 0.752 . . . . 0.71999999999999997 111.749 170.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.78 156.75 35.17 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 124.98 1.312 . . . . 1.0900000000000001 113.323 -177.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -59.64 140.18 92.41 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.352 2.035 . . . . 1.27 110.679 168.104 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.57 -5.34 11.21 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.748 1.166 . . . . 1.05 114.906 -172.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.64 169.99 53.81 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 118.817 1.308 . . . . 0.98999999999999999 114.241 177.032 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -123.25 152.05 41.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.07 1.748 . . . . 1.95 110.606 -178.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -81.05 127.51 74.13 Favored Pre-proline 0 CA--C 1.551 0.988 0 O-C-N 121.629 -0.669 . . . . 1.8999999999999999 111.575 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.13 -20.66 2.76 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.581 2.854 . . . . 1.1200000000000001 113.493 177.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 m -147.99 170.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.872 2.469 . . . . 0.92000000000000004 108.978 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.84 152.47 20.48 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.059 0.763 . . . . 1.71 113.059 177.264 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.74 -174.61 46.17 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 115.397 0.919 . . . . 0.72999999999999998 115.397 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.0 ttt85 -102.75 139.46 38.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.66 1.184 . . . . 5.9000000000000004 111.912 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.3 t -99.91 133.96 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 127.307 2.243 . . . . 0.80000000000000004 109.268 -173.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.1 pt -139.87 28.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.017 1.117 . . . . 0.76000000000000001 114.017 -177.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.73 150.18 3.95 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.941 1.697 . . . . 3.27 110.114 166.404 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.57 -173.92 34.35 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.704 1.145 . . . . 0.81999999999999995 115.29 169.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -151.33 121.13 7.04 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.185 1.394 . . . . 2.52 110.965 -175.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.6 m -147.5 155.2 41.66 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.111 -0.993 . . . . 1.4099999999999999 113.009 172.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.1 ttm -102.06 121.13 41.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.598 1.159 . . . . 1.1499999999999999 108.436 169.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 68.7 t -118.59 146.33 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.539 1.936 . . . . 1.0 112.831 -165.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -108.41 115.84 30.85 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.351 1.86 . . . . 2.0099999999999998 110.541 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -127.12 26.21 6.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.611 1.564 . . . . 1.74 112.271 179.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.5 p -55.58 -31.04 61.86 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.006 1.854 . . . . 1.4299999999999999 116.006 -172.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.0 -39.44 13.7 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.607 1.094 . . . . 1.1000000000000001 111.189 176.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.6 mm -70.29 -62.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.733 1.213 . . . . 1.05 111.332 -173.321 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.7 p -98.21 -7.49 29.2 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.552 1.141 . . . . 1.25 112.946 -175.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.61 17.66 65.6 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.839 1.209 . . . . 1.4299999999999999 113.331 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -82.53 96.81 8.16 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.32 1.06 . . . . 3.0600000000000001 112.108 -176.558 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.88 20.18 0.26 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.27 1.028 . . . . 1.48 113.565 177.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.5 ttt -146.69 132.54 9.4 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 128.419 2.688 . . . . 4.21 107.385 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -69.64 153.53 69.34 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.052 2.501 . . . . 1.8999999999999999 112.62 -170.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.1 t -111.87 132.5 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.971 1.708 . . . . 0.97999999999999998 111.207 -168.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.09 137.68 34.0 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.435 -0.791 . . . . 0.78000000000000003 111.398 174.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -122.75 146.91 47.09 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.364 1.465 . . . . 0.80000000000000004 110.938 176.451 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -150.23 170.98 6.89 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 126.871 2.068 . . . . 2.8599999999999999 111.375 -170.676 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -59.01 118.94 5.92 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.982 1.788 . . . . 0.87 109.634 167.334 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.3 48.33 4.34 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.534 1.54 . . . . 0.88 113.689 -169.306 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.6 m -126.44 166.62 16.89 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.861 1.33 . . . . 1.4399999999999999 112.804 173.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.7 p -111.0 149.63 30.43 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.271 0.941 . . . . 0.87 112.842 174.358 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.03 157.12 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.371 1.468 . . . . 0.54000000000000004 111.898 175.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -119.34 149.42 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.839 2.056 . . . . 0.91000000000000003 113.078 176.193 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.84 143.83 46.23 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.891 0.876 . . . . 0.63 111.843 176.035 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.33 -7.67 60.28 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 116.272 1.269 . . . . 0.69999999999999996 116.272 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 t -73.7 157.14 37.08 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.137 1.468 . . . . 2.1899999999999999 111.329 169.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.41 136.32 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.753 1.621 . . . . 0.98999999999999999 111.697 -169.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -99.59 134.42 42.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.249 1.019 . . . . 2.23 110.745 172.299 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -135.9 53.65 1.94 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.041 1.126 . . . . 3.4199999999999999 114.041 175.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -153.17 -54.21 0.11 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.415 1.635 . . . . 2.98 115.415 173.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.07 -156.17 11.33 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-N 119.367 0.985 . . . . 2.5 114.946 -169.314 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -83.9 155.47 22.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.223 1.009 . . . . 3.0600000000000001 112.783 177.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.1 mt -147.55 152.28 37.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.839 2.056 . . . . 1.1200000000000001 107.766 167.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD11 ' HE3' ' A' ' 44' ' ' LYS . 10.1 mp -111.58 114.86 28.21 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.189 0.995 . . . . 2.1299999999999999 109.399 175.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.67 126.43 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.259 1.023 . . . . 1.1799999999999999 111.397 -173.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 30.0 p -82.37 119.65 24.43 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.579 -0.701 . . . . 1.55 109.249 169.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.8 123.53 28.32 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.275 -0.891 . . . . 0.88 110.973 -175.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.6 p -115.81 -8.14 12.0 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.736 1.013 . . . . 2.5600000000000001 113.736 -174.46 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -142.24 151.0 41.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.569 1.548 . . . . 1.48 110.603 173.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 m -100.65 171.21 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.863 1.265 . . . . 1.8799999999999999 109.614 167.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.51 63.52 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.61 -1.306 . . . . 1.6399999999999999 114.663 -174.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.13 -47.06 63.34 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.27 -1.135 . . . . 1.6200000000000001 112.951 169.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -79.1 -16.73 56.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.091 2.156 . . . . 2.5299999999999998 116.174 -174.337 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 109' ' ' SER . 10.0 t -71.54 148.37 46.78 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.485 -1.385 . . . . 2.7799999999999998 113.614 -170.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 t -51.62 -35.89 43.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.033 1.333 . . . . 1.9199999999999999 112.869 171.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.9 tp -60.29 -46.36 90.11 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.204 -0.935 . . . . 1.72 112.128 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.403 ' H ' HG23 ' A' ' 106' ' ' THR . 53.1 p -73.91 -30.83 62.8 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.991 0.916 . . . . 2.1299999999999999 113.411 173.224 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -61.54 -43.1 99.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.18 0.9 . . . . 1.5900000000000001 111.343 175.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.83 -54.69 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.547 1.139 . . . . 1.8 110.475 178.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.21 -29.75 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.338 -0.851 . . . . 1.3 112.84 -178.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -66.1 -39.62 90.11 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.288 0.949 . . . . 2.5699999999999998 112.006 174.128 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.15 -35.84 74.31 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.569 1.148 . . . . 3.27 113.385 174.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.2 t -69.41 -42.52 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.427 0.691 . . . . 2.0699999999999998 111.113 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -65.29 -36.16 83.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.193 1.397 . . . . 3.8300000000000001 112.999 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -69.49 -30.06 67.85 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.994 -1.066 . . . . 4.6900000000000004 112.927 171.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.05 -59.73 2.57 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.66 0.784 . . . . 4.3099999999999996 112.491 173.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.202 0 C-N-CA 127.402 2.281 . . . . 4.8399999999999999 114.008 -173.114 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 113.537 0.94 . . . . 3.79 113.537 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -89.23 -26.54 21.15 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.032 0.933 . . . . 6.1399999999999997 111.523 170.156 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.77 -33.47 75.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.816 0.846 . . . . 2.1400000000000001 111.638 169.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 tp -50.2 -41.41 49.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.242 1.417 . . . . 1.9199999999999999 113.36 177.107 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.22 61.04 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.928 0.714 . . . . 1.9299999999999999 112.928 171.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.23 -35.18 73.19 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.029 0.931 . . . . 3.0600000000000001 112.551 178.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.32 -31.94 69.61 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.301 0.955 . . . . 1.3600000000000001 112.973 173.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.2 mm -72.17 -40.2 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.027 0.931 . . . . 2.8300000000000001 111.786 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m -71.26 -23.74 62.04 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.824 -1.173 . . . . 1.9099999999999999 113.882 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.0 mt -73.4 -20.98 60.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.102 1.361 . . . . 2.3999999999999999 113.57 173.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -85.37 143.18 28.79 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.178 0.991 . . . . 2.9199999999999999 113.326 -176.226 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.56 165.69 12.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.746 1.619 . . . . 3.1499999999999999 114.568 -178.242 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -120.55 -6.3 9.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.287 1.035 . . . . 3.5899999999999999 113.041 169.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.49 155.23 45.03 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.558 -1.339 . . . . 2.79 113.725 -175.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.78 162.38 35.63 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.864 1.666 . . . . 1.28 113.003 177.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.2 m -125.51 111.97 15.68 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.637 1.175 . . . . 1.4199999999999999 112.811 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 mt -96.75 133.1 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.788 1.235 . . . . 0.73999999999999999 110.439 -175.175 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -126.54 115.1 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.218 1.407 . . . . 2.6499999999999999 110.614 -177.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 m -133.51 149.21 51.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.865 1.266 . . . . 2.5899999999999999 110.561 -169.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.09 143.87 25.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.781 0.833 . . . . 3.5 111.197 175.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.04 -12.03 8.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.481 1.112 . . . . 3.6800000000000002 113.686 170.531 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.5 m -144.42 139.77 28.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.224 1.41 . . . . 5.0199999999999996 109.998 168.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -32.96 72.58 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 131.288 3.835 . . . . 5.8899999999999997 118.203 -166.371 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 61.48 -17.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.439 2.296 . . . . 7.0199999999999996 114.589 -168.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.0 pt -72.83 -18.18 18.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 127.324 2.249 . . . . 4.6200000000000001 115.696 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 tt -130.06 124.98 34.13 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.515 1.052 . . . . 3.0499999999999998 112.851 175.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -102.58 131.89 49.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.047 1.739 . . . . 4.0999999999999996 110.404 177.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.7 t -126.78 120.0 28.26 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.759 1.224 . . . . 1.6100000000000001 109.301 172.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -117.88 152.46 35.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.293 1.037 . . . . 3.2400000000000002 111.14 -173.094 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -142.09 138.39 31.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.968 1.707 . . . . 2.9300000000000002 111.18 -176.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -108.41 130.61 55.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.407 1.003 . . . . 1.9399999999999999 109.664 168.308 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.7 167.86 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.588 1.155 . . . . 1.1699999999999999 112.9 -168.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.88 149.87 32.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.261 1.425 . . . . 4.8899999999999997 110.712 168.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.02 -9.05 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.599 1.333 . . . . 1.6299999999999999 114.599 -173.299 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -96.64 -15.51 21.47 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.274 -1.516 . . . . 4.4100000000000001 112.803 169.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.01 -5.67 59.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.219 1.408 . . . . 1.6599999999999999 113.936 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -100.12 142.85 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.504 1.522 . . . . 1.55 111.207 170.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -117.83 168.97 10.0 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.76 2.024 . . . . 3.4399999999999999 111.468 175.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -68.83 144.82 54.17 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.841 -0.537 . . . . 4.7400000000000002 110.586 169.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.0 -7.37 31.13 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.264 1.411 . . . . 1.8 114.984 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.6 165.69 11.5 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.404 1.602 . . . . 3.0600000000000001 113.343 178.288 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -116.39 132.49 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.653 1.181 . . . . 1.9299999999999999 112.302 -173.039 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.52 118.57 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 127.599 2.36 . . . . 1.0900000000000001 109.225 -169.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -94.68 115.59 27.72 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.613 -0.679 . . . . 3.1400000000000001 111.699 172.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.6 p -94.04 146.93 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.343 1.057 . . . . 1.02 112.254 -170.109 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.6 m -92.04 160.39 35.75 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.65 1.18 . . . . 1.1100000000000001 112.598 169.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -55.86 146.5 67.29 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.116 1.877 . . . . 1.8400000000000001 110.939 167.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.52 0.95 41.95 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.722 1.153 . . . . 1.75 115.299 -174.357 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.63 148.2 50.62 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.263 1.531 . . . . 1.53 112.819 172.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -117.68 9.72 13.15 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.478 1.658 . . . . 3.9700000000000002 115.478 -169.345 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 51.88 115.11 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 129.095 2.958 . . . . 2.27 116.794 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.71 -14.81 9.94 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.065 2.51 . . . . 0.95999999999999996 115.346 -176.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 m -153.11 173.72 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 128.296 2.638 . . . . 0.88 108.639 -178.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -92.62 147.87 22.53 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.505 0.928 . . . . 2.46 113.505 173.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.56 173.78 44.44 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 115.134 0.814 . . . . 1.3999999999999999 115.134 -170.181 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -113.28 133.16 55.25 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.125 1.37 . . . . 5.1699999999999999 111.621 -174.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.25 127.92 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 126.821 2.048 . . . . 0.85999999999999999 109.286 -169.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 pt -142.49 30.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.784 1.031 . . . . 1.0600000000000001 113.784 -173.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -169.51 143.08 2.72 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.459 1.903 . . . . 3.46 109.747 168.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -171.6 37.9 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 116.285 1.274 . . . . 1.26 116.285 169.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -142.63 123.78 14.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.142 0.977 . . . . 2.77 111.929 177.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 m -148.22 151.41 35.45 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.862 -1.149 . . . . 1.3100000000000001 113.915 169.469 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.8 ttm -95.24 138.42 32.97 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.638 -0.664 . . . . 1.0700000000000001 109.688 168.319 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.5 t -129.31 132.2 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.421 1.488 . . . . 1.03 111.035 -170.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.76 121.14 30.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.918 1.287 . . . . 2.3100000000000001 111.651 176.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -116.12 14.21 15.93 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.054 1.742 . . . . 1.96 113.224 -178.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 86.7 p -60.74 -0.85 0.32 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 119.211 3.041 . . . . 1.4099999999999999 119.211 -167.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -115.1 -40.51 3.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.938 1.295 . . . . 1.5700000000000001 110.299 169.319 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.5 mm -69.46 -49.95 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.831 0.853 . . . . 1.6100000000000001 112.109 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 p -106.09 -13.47 15.44 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.3 1.04 . . . . 1.4399999999999999 113.108 175.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.68 -0.17 84.55 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 124.85 1.214 . . . . 1.25 115.162 169.444 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.18 121.98 27.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.04 1.336 . . . . 3.02 111.916 179.166 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.01 14.52 4.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.955 1.302 . . . . 1.3200000000000001 113.301 -173.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 71.7 mtp -126.75 105.86 23.13 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 127.887 2.475 . . . . 3.25 108.002 -174.427 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.33 152.97 36.22 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.222 2.615 . . . . 1.96 114.387 -173.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.82 127.98 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 126.275 1.83 . . . . 0.98999999999999999 111.054 -167.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.83 129.07 34.18 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.713 -0.617 . . . . 0.81000000000000005 111.639 -178.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -121.65 144.88 48.51 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.454 1.902 . . . . 0.85999999999999999 110.2 -177.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -155.8 -177.77 0.79 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 128.452 2.701 . . . . 3.7999999999999998 108.78 -174.251 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.82 133.35 54.05 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.119 1.88 . . . . 1.04 112.308 168.193 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.25 28.9 59.27 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.166 1.365 . . . . 0.91000000000000003 114.567 -171.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.1 m -111.33 170.27 8.23 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.668 1.734 . . . . 1.8500000000000001 110.661 175.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.3 p -127.06 148.29 50.13 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 120.463 -1.398 . . . . 1.0900000000000001 111.986 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.0 149.05 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.371 1.069 . . . . 1.0600000000000001 112.019 179.302 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -119.4 150.54 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.428 1.891 . . . . 1.4299999999999999 110.763 177.975 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.19 138.59 57.88 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.967 -0.56 . . . . 0.81999999999999995 111.654 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.66 3.73 88.02 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.143 0.817 . . . . 1.7 115.143 -176.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.6 p -88.44 142.82 27.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.815 1.308 . . . . 1.75 110.2 167.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.44 120.39 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.092 0.775 . . . . 1.1799999999999999 113.092 -167.133 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -76.16 129.32 36.58 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.445 1.098 . . . . 2.0 111.037 178.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -106.4 -29.67 9.58 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.223 1.194 . . . . 5.4400000000000004 114.223 -172.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -104.62 -45.36 4.64 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 116.521 2.045 . . . . 3.1499999999999999 116.521 -165.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.96 -142.65 5.22 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 118.204 2.042 . . . . 2.52 118.204 -167.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 t -90.09 144.28 26.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.369 1.468 . . . . 2.04 112.412 -174.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.7 mt -147.82 159.44 43.83 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.72 1.608 . . . . 1.1100000000000001 109.538 169.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 tp -116.39 123.52 47.78 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.486 1.114 . . . . 2.3599999999999999 110.331 169.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.57 129.47 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.275 1.03 . . . . 1.6000000000000001 110.845 -170.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 52.8 t -86.46 123.9 32.2 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.379 -0.826 . . . . 3.1099999999999999 109.671 168.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.89 121.83 25.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.898 0.879 . . . . 1.1000000000000001 109.424 176.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.3 t -114.73 0.23 13.79 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.93 1.085 . . . . 2.46 113.93 -169.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -146.84 150.64 35.67 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.955 2.102 . . . . 1.8500000000000001 111.178 175.525 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.1 m -83.47 166.56 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.767 0.827 . . . . 1.95 112.615 169.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.87 -31.4 75.88 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 120.932 -1.105 . . . . 1.49 114.681 -174.033 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.19 -25.39 64.31 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.174 1.175 . . . . 1.98 114.174 174.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.19 -19.92 59.57 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.269 -0.894 . . . . 3.1400000000000001 113.081 171.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.1 p -68.49 141.96 55.43 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.564 -0.71 . . . . 1.71 111.809 -169.52 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 t -70.15 -18.18 63.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.097 0.777 . . . . 2.4700000000000002 113.097 -170.026 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.4 mp -59.42 -52.14 66.9 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.297 -1.502 . . . . 1.76 112.588 -175.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.6 p -73.76 -17.48 61.09 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.91 0.884 . . . . 1.8799999999999999 113.379 174.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -72.0 -42.72 66.11 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.12 0.968 . . . . 2.0899999999999999 111.723 173.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.3 mt -61.18 -52.75 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.616 1.566 . . . . 1.6299999999999999 111.16 -177.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m -63.92 -15.26 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.347 1.61 . . . . 1.8999999999999999 115.347 -172.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -71.15 -42.57 68.96 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.186 0.995 . . . . 2.6200000000000001 111.697 169.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.54 -47.62 22.03 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.853 1.661 . . . . 3.71 111.306 177.307 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.9 t -68.66 -21.81 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 118.631 -0.699 . . . . 2.8199999999999998 112.225 -176.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -53.4 -36.81 61.87 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 120.743 1.611 . . . . 4.1200000000000001 111.328 167.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.84 -8.32 55.6 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.428 -1.42 . . . . 5.1299999999999999 113.565 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.99 -27.86 57.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.397 1.079 . . . . 6.3099999999999996 113.7 171.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.609 1.564 . . . . 5.5599999999999996 113.141 -178.749 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 111.975 0.361 . . . . 3.21 111.975 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -72.72 -39.44 66.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.006 1.323 . . . . 4.3899999999999997 111.181 175.44 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.56 -11.33 60.61 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.098 1.518 . . . . 1.5600000000000001 115.098 174.417 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.0 tp -59.75 -40.81 89.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.962 1.256 . . . . 1.98 113.928 -168.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.25 -20.7 60.78 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.3 1.222 . . . . 1.75 114.3 173.047 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -70.73 -42.99 69.81 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.109 1.322 . . . . 2.4199999999999999 111.426 -169.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -47.52 -50.55 23.29 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.834 1.254 . . . . 1.52 111.564 173.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.54 -28.87 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.396 1.078 . . . . 2.23 112.635 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -74.42 -25.64 59.57 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.874 -1.141 . . . . 1.0600000000000001 112.973 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.01 -22.5 63.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.036 0.835 . . . . 2.1299999999999999 112.89 169.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -68.46 135.19 51.27 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.855 1.207 . . . . 3.0099999999999998 111.469 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.26 151.13 47.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.642 0.777 . . . . 1.8600000000000001 112.422 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 p -87.36 -21.95 25.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.827 1.651 . . . . 2.5299999999999998 113.355 177.364 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.75 157.08 47.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.871 1.268 . . . . 3.5299999999999998 112.788 -175.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.75 157.38 45.11 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.73 1.212 . . . . 0.70999999999999996 112.179 177.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 m -115.11 110.35 19.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.372 1.069 . . . . 0.82999999999999996 111.385 177.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.7 mt -91.75 135.2 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.091 1.756 . . . . 0.77000000000000002 109.495 -178.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 m -96.53 115.02 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 119.385 0.993 . . . . 2.4700000000000002 109.372 167.478 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.0 m -78.99 135.37 36.89 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.813 0.845 . . . . 2.71 110.273 -177.441 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 mt -120.51 59.15 0.91 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.42 1.488 . . . . 5.0999999999999996 109.195 179.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.65 -8.04 44.19 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.544 -0.722 . . . . 6.0800000000000001 112.291 177.374 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.4 m -136.45 128.44 29.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.91 2.884 . . . . 5.4400000000000004 108.006 176.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -19.96 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 1 C-N-CA 134.403 5.081 . . . . 8.0299999999999994 116.705 -169.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.277 16.7 p30 46.74 21.56 0.14 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.852 1.797 . . . . 7.0800000000000001 115.852 -170.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.8 pt -110.05 -26.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 127.204 2.201 . . . . 6.2199999999999998 114.256 -175.474 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.92 -53.9 52.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.199 0.908 . . . . 5.29 113.285 -169.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 mp 53.77 43.42 31.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.033 1.333 . . . . 3.8799999999999999 113.117 178.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.0 t -92.42 111.43 23.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.939 0.896 . . . . 1.8300000000000001 109.607 176.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -81.53 138.29 35.45 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.349 0.87 . . . . 2.9399999999999999 113.349 -170.564 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -127.83 125.3 39.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.847 2.059 . . . . 2.7000000000000002 109.795 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -95.5 132.0 41.07 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.419 -1.425 . . . . 3.6499999999999999 109.864 174.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.81 167.79 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.768 1.627 . . . . 0.87 112.846 -169.353 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.9 148.95 31.07 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.217 -0.66 . . . . 3.3500000000000001 109.217 165.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.97 -7.36 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 114.954 1.465 . . . . 1.1499999999999999 114.954 -177.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.78 -30.5 56.52 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 119.791 -1.818 . . . . 3.2999999999999998 112.691 167.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -90.69 4.04 52.58 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.798 1.639 . . . . 1.3 114.117 -168.258 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 p -101.1 135.75 36.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 126.416 1.886 . . . . 1.6699999999999999 110.62 173.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.82 166.58 10.91 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.219 1.808 . . . . 4.0499999999999998 111.45 178.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -65.29 -12.87 56.08 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.718 1.377 . . . . 3.9300000000000002 114.718 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.19 7.56 75.85 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.262 1.41 . . . . 1.2 115.938 174.352 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -91.82 155.84 17.94 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.782 1.791 . . . . 2.8999999999999999 112.649 176.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.0 mm -110.9 123.83 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.753 1.621 . . . . 1.8300000000000001 109.172 176.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -120.95 133.83 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.424 1.089 . . . . 0.70999999999999996 113.375 -167.222 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.529 ' HE3' ' CG ' ' A' ' 96' ' ' LEU . 10.9 mmmm -101.04 148.2 25.32 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.601 0.76 . . . . 3.6499999999999999 112.563 178.293 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 p -124.22 134.53 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.424 1.089 . . . . 0.59999999999999998 111.691 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.2 m -79.94 163.57 57.3 Favored Pre-proline 0 N--CA 1.482 1.15 0 N-CA-C 113.303 0.853 . . . . 0.96999999999999997 113.303 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.36 120.33 7.45 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.242 1.961 . . . . 1.4299999999999999 108.451 168.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.02 84.2 Favored Glycine 0 CA--C 1.54 1.655 0 C-N-CA 124.634 1.112 . . . . 1.22 115.467 -170.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.46 178.51 52.9 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 119.633 1.717 . . . . 1.0700000000000001 115.404 -177.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -120.87 145.3 47.78 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.614 1.165 . . . . 1.76 112.211 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -81.99 124.22 79.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.763 0.825 . . . . 1.72 111.901 -178.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -91.98 -20.14 0.66 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.194 2.596 . . . . 0.77000000000000002 115.932 -170.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.73 166.94 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 126.849 2.06 . . . . 0.70999999999999996 109.79 -177.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.313 0.3 OUTLIER -88.98 142.96 27.2 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.983 0.811 . . . . 1.8999999999999999 112.698 174.327 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' A' ' 100' ' ' THR . . . 170.61 -166.75 39.94 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.533 0.973 . . . . 0.59999999999999998 115.533 -173.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.6 ttp85 -109.76 143.54 39.44 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.68 1.592 . . . . 4.3700000000000001 112.053 -171.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.2 128.87 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.1 1.76 . . . . 0.92000000000000004 109.668 -172.544 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.7 pt -140.27 36.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 114.001 1.111 . . . . 0.96999999999999997 114.001 -172.315 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -166.27 142.14 4.78 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.14 1.376 . . . . 3.1699999999999999 111.283 168.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.15 -163.84 34.74 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.049 1.309 . . . . 1.21 115.907 169.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.98 126.46 5.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.329 1.233 . . . . 2.5899999999999999 114.329 174.035 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 m -145.95 166.67 25.35 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.849 -1.157 . . . . 1.3700000000000001 112.828 174.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.9 ttm -107.73 124.44 50.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.018 0.927 . . . . 0.95999999999999996 109.286 172.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.08 143.61 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.064 1.746 . . . . 0.58999999999999997 112.981 -167.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -98.25 96.28 7.96 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.22 1.408 . . . . 1.9399999999999999 111.309 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -93.01 -10.58 35.72 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.082 1.353 . . . . 1.74 113.268 177.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 t -38.12 -46.4 1.03 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.51 2.411 . . . . 2.3399999999999999 117.51 -167.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.3 -33.48 61.19 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.46 1.482 . . . . 1.2 112.167 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 mm -73.23 -47.49 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.406 1.482 . . . . 1.03 111.075 -177.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.4 p -110.44 -13.19 14.31 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.037 1.335 . . . . 1.2 114.125 -170.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.36 2.84 90.24 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.512 1.529 . . . . 1.1200000000000001 114.752 -177.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -51.44 -49.91 60.77 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.921 1.36 . . . . 2.4900000000000002 114.419 -172.059 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 57.76 31.53 20.59 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.334 1.454 . . . . 1.5900000000000001 114.605 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.2 ttm -162.55 136.08 4.64 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 130.212 3.405 . . . . 3.1400000000000001 105.242 169.069 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.18 164.9 34.12 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.95 2.433 . . . . 1.3799999999999999 113.321 -170.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.3 t -120.22 129.83 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.383 1.473 . . . . 0.72999999999999998 111.454 -169.427 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.27 139.7 36.54 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.479 -0.763 . . . . 0.81000000000000005 111.943 177.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -125.03 150.97 46.21 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.664 1.586 . . . . 0.88 111.449 -178.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -149.57 172.86 4.77 Favored Pre-proline 0 N--CA 1.483 1.224 0 C-N-CA 129.312 3.045 . . . . 3.21 109.053 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -59.52 140.2 92.86 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 CA-C-N 121.588 1.603 . . . . 0.91000000000000003 110.994 167.442 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.42 44.76 15.91 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.811 -0.555 . . . . 1.05 112.45 -170.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.9 t -126.67 170.14 12.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.69 1.596 . . . . 1.47 111.111 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.4 p -129.69 149.43 51.45 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.777 -1.202 . . . . 0.81999999999999995 112.411 -176.419 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.89 159.06 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.09 1.356 . . . . 0.54000000000000004 113.804 -176.044 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -120.05 152.84 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.798 2.439 . . . . 1.1699999999999999 111.46 169.922 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.32 152.14 44.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.774 0.829 . . . . 0.63 112.906 178.427 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.23 4.72 89.87 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.42 0.528 . . . . 0.91000000000000003 114.42 -175.705 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 m -82.15 153.52 25.98 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.286 -1.126 . . . . 1.49 110.563 169.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mm -108.3 143.59 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.698 1.199 . . . . 0.84999999999999998 110.236 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -108.21 139.8 42.37 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.832 1.653 . . . . 1.54 113.086 -175.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -152.22 115.73 4.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.508 1.049 . . . . 3.7799999999999998 113.808 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 51.5 t30 152.04 -51.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 131.341 3.856 . . . . 3.1200000000000001 109.245 167.311 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.51 -178.65 36.54 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.768 1.651 . . . . 2.0 112.454 -174.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.4 p -89.53 135.39 33.63 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.713 -0.875 . . . . 1.8600000000000001 113.286 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.6 mt -122.5 165.7 15.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.454 1.101 . . . . 1.29 112.921 -176.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.529 ' CG ' ' HE3' ' A' ' 44' ' ' LYS . 6.8 tt -116.24 117.45 30.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.367 1.467 . . . . 3.6200000000000001 111.478 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.12 120.48 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.948 1.299 . . . . 1.3400000000000001 111.49 178.267 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 20.4 p -84.57 120.82 26.79 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.035 -1.098 . . . . 1.48 108.035 166.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.28 157.38 34.49 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.921 -0.487 . . . . 1.6299999999999999 110.481 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.418 HG22 ' HA2' ' A' ' 55' ' ' GLY . 8.4 t -141.46 -9.22 0.96 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.671 1.36 . . . . 2.54 114.671 176.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -140.51 144.27 35.89 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.589 1.156 . . . . 1.6200000000000001 110.451 169.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -69.97 161.02 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.641 -0.503 . . . . 1.52 109.641 167.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.48 -36.61 89.96 Favored Glycine 0 N--CA 1.476 1.355 0 O-C-N 121.114 -0.991 . . . . 1.52 113.811 -171.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.87 -38.51 91.21 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.754 1.02 . . . . 1.8799999999999999 113.754 171.175 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -77.31 -6.71 54.2 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.043 2.137 . . . . 2.4700000000000002 114.861 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 81.3 p -65.3 157.91 27.81 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.604 -1.31 . . . . 1.55 113.194 178.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 90.9 m -64.48 -35.68 81.73 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.622 0.769 . . . . 2.9500000000000002 111.36 175.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.19 -47.56 68.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.866 1.266 . . . . 1.6299999999999999 111.7 171.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 m -68.41 -30.44 69.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.479 1.112 . . . . 1.9399999999999999 113.584 176.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -70.08 -41.05 74.59 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.085 0.857 . . . . 1.77 111.663 172.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.49 -48.55 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.845 0.858 . . . . 1.6000000000000001 110.904 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.21 -27.11 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 113.439 0.903 . . . . 1.3100000000000001 113.439 177.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -71.72 -48.74 45.09 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.726 1.148 . . . . 2.6000000000000001 111.691 171.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.16 -40.99 82.82 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.436 1.094 . . . . 2.77 112.954 178.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -75.36 -33.87 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 113.981 1.104 . . . . 2.5600000000000001 113.981 176.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -74.63 -46.58 37.37 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.007 0.822 . . . . 4.2199999999999998 112.071 179.328 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -74.76 -9.98 59.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 5.5899999999999999 113.9 -179.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.12 -52.95 43.78 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.578 0.751 . . . . 4.54 111.163 170.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.29 -1.338 . . . . 4.46 114.185 178.091 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 112.233 0.457 . . . . 3.9900000000000002 112.233 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.97 -47.56 79.89 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.412 1.885 . . . . 4.8300000000000001 109.791 169.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.35 76.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.075 1.35 . . . . 1.9399999999999999 113.535 174.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.5 tp -70.92 -34.31 71.38 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.641 1.177 . . . . 1.47 113.17 170.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.07 -32.04 68.61 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.194 -0.941 . . . . 1.46 111.567 174.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -54.56 -37.9 66.01 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 124.968 1.307 . . . . 2.04 113.354 -170.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.05 -43.79 91.74 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.346 1.058 . . . . 1.1799999999999999 112.578 -178.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.3 mm -72.43 -33.18 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.25 -0.906 . . . . 1.8 112.237 175.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m -77.43 -17.31 58.22 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.383 0.882 . . . . 1.5700000000000001 113.383 176.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mt -71.88 -43.39 65.5 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.602 2.361 . . . . 1.77 112.749 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -49.57 134.7 19.36 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.63 0.772 . . . . 3.0099999999999998 110.764 175.155 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.59 -14.34 41.6 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.041 1.497 . . . . 3.6600000000000001 115.041 -172.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 m 69.11 -24.79 0.14 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 128.29 2.636 . . . . 3.0099999999999998 115.024 173.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -125.38 152.97 44.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.176 1.39 . . . . 3.2599999999999998 111.262 169.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.84 151.35 45.62 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.716 1.206 . . . . 1.02 111.88 -177.423 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.2 m -111.45 104.09 12.5 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.283 1.033 . . . . 1.0700000000000001 111.876 -176.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.1 mt -91.26 134.67 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.705 1.602 . . . . 1.04 110.795 -173.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.69 130.27 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 120.719 -1.238 . . . . 2.54 110.483 169.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m -125.78 153.9 43.34 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.726 1.61 . . . . 3.1800000000000002 110.873 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.3 mt -111.85 108.25 17.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.624 1.17 . . . . 4.4400000000000004 110.044 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.13 3.1 38.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 116.372 1.989 . . . . 5.21 116.372 -168.375 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.4 m -128.71 -63.13 0.99 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.134 1.374 . . . . 6.7599999999999998 110.163 169.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -157.89 -170.12 3.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 130.111 3.364 . . . . 8.2899999999999991 105.829 169.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -15.77 1.72 Allowed 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 114.178 1.177 . . . . 6.3300000000000001 114.178 173.226 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.6 pt -67.93 -29.87 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 126.194 1.797 . . . . 5.1799999999999997 114.078 175.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tt -115.2 118.27 32.86 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.12 0.968 . . . . 3.0899999999999999 110.891 -171.376 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mp -91.98 130.75 37.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.625 0.726 . . . . 2.8399999999999999 111.502 173.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.1 t -134.97 95.12 3.26 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.992 2.517 . . . . 1.95 107.406 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.78 145.21 25.74 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.121 -0.987 . . . . 3.6600000000000001 110.573 -176.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -127.49 156.53 42.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.345 2.658 . . . . 2.9300000000000002 111.274 -167.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -121.11 140.2 52.3 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.238 0.926 . . . . 2.0299999999999998 112.746 169.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.97 166.24 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.257 1.423 . . . . 1.3600000000000001 113.478 -177.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.44 147.66 32.21 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.694 1.198 . . . . 3.96 110.443 166.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.77 -13.06 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.461 1.282 . . . . 1.5700000000000001 114.461 -176.117 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -82.87 -12.67 57.21 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 120.141 -1.599 . . . . 5.0099999999999998 113.565 170.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.9 mt -103.75 -10.22 18.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.151 1.78 . . . . 1.95 114.282 -172.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.63 143.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.693 1.197 . . . . 1.79 110.664 173.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -121.23 164.63 16.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.502 1.921 . . . . 3.0899999999999999 111.067 176.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.0 ptt-85 -72.22 153.3 41.67 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.707 -1.246 . . . . 2.8199999999999998 110.743 172.56 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.57 25.37 9.32 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 119.25 -0.75 . . . . 1.28 114.213 -176.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -140.14 162.24 35.72 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.49 1.516 . . . . 2.7400000000000002 112.05 176.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.45 125.72 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.307 1.443 . . . . 1.1299999999999999 110.199 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.8 mm -115.43 128.71 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.99 1.316 . . . . 0.87 111.401 -171.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -80.87 146.77 30.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.339 1.055 . . . . 2.4700000000000002 112.667 175.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.8 137.0 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.524 0.729 . . . . 0.56000000000000005 111.81 168.081 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 m -89.75 164.29 29.5 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.068 1.347 . . . . 0.89000000000000001 113.38 -178.491 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.66 132.25 32.26 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.238 1.959 . . . . 1.0700000000000001 109.445 168.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.74 -8.8 47.47 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.183 0.897 . . . . 1.01 115.187 -169.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.74 163.9 43.32 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 118.616 1.208 . . . . 1.02 114.092 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -111.6 149.07 31.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.422 1.489 . . . . 1.6699999999999999 110.437 175.083 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -81.39 130.14 63.37 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 121.85 -0.531 . . . . 2.0800000000000001 111.918 177.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.96 -25.66 1.4 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.446 2.764 . . . . 0.71999999999999997 114.792 -178.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.4 176.59 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.22 2.208 . . . . 0.88 109.323 -178.155 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.84 148.04 26.14 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.647 0.779 . . . . 2.3599999999999999 111.816 174.122 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.2 -160.14 32.87 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.521 0.568 . . . . 0.76000000000000001 114.521 -172.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -116.91 135.6 53.59 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.412 1.485 . . . . 3.4500000000000002 113.268 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.47 135.36 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.111 2.164 . . . . 1.03 108.935 170.585 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.4 pt -137.03 31.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 113.386 0.884 . . . . 0.81999999999999995 113.386 175.081 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -166.46 139.45 3.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.707 1.603 . . . . 2.8799999999999999 109.098 166.506 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.13 177.38 49.91 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 122.684 1.158 . . . . 0.81999999999999995 115.259 174.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -145.52 133.22 21.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.043 1.337 . . . . 1.8300000000000001 112.23 -174.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.3 m -150.66 176.03 11.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.625 1.17 . . . . 1.1799999999999999 112.853 172.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.8 ttm -117.96 129.84 55.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.711 1.204 . . . . 0.93999999999999995 110.397 168.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t -117.38 136.05 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.78 1.232 . . . . 0.66000000000000003 113.223 -167.27 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -88.6 108.2 19.31 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.58 1.152 . . . . 1.8500000000000001 111.227 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -110.18 16.36 21.82 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.225 1.41 . . . . 1.6799999999999999 114.117 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -60.57 -19.91 58.89 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.986 1.847 . . . . 1.6000000000000001 115.986 -169.04 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -91.94 -40.82 10.92 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.112 0.869 . . . . 0.98999999999999999 111.663 172.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 27.5 mm -78.34 -61.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.016 0.926 . . . . 1.02 112.246 -171.473 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.9 p -96.74 -7.75 33.08 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.499 1.12 . . . . 1.2 112.651 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.35 16.03 74.97 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.446 1.498 . . . . 1.25 113.833 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -83.66 105.01 14.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.391 1.476 . . . . 2.98 111.763 -176.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.31 -13.26 59.76 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.398 -0.814 . . . . 1.53 111.643 177.381 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -100.06 111.92 63.05 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 126.745 2.018 . . . . 4.5300000000000002 107.889 169.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.86 148.93 35.63 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.869 3.046 . . . . 1.55 114.162 -178.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.79 130.23 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.516 1.526 . . . . 0.71999999999999997 110.879 -169.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.2 142.89 37.63 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.271 0.629 . . . . 0.65000000000000002 112.516 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.07 147.3 46.87 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.414 1.886 . . . . 0.73999999999999999 110.603 177.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -147.25 170.6 7.49 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 128.504 2.721 . . . . 2.6899999999999999 109.664 -174.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -59.38 124.37 15.39 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 121.566 1.595 . . . . 0.87 109.593 168.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.94 55.25 3.18 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.938 0.78 . . . . 1.3400000000000001 112.308 -168.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 t -139.49 141.36 37.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.417 1.087 . . . . 1.3799999999999999 111.147 178.404 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.8 p -97.09 144.8 26.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.51 1.05 . . . . 0.71999999999999997 112.497 -178.207 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.58 156.59 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.323 1.849 . . . . 0.58999999999999997 111.49 -173.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.29 146.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.672 1.589 . . . . 1.01 111.92 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.47 153.12 28.14 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.81 0.844 . . . . 0.71999999999999997 113.218 -175.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.45 -5.08 17.05 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.594 0.997 . . . . 0.81999999999999995 115.594 178.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -75.79 153.03 37.2 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.787 1.294 . . . . 1.3300000000000001 109.869 168.384 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 mm -109.14 132.3 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.658 0.783 . . . . 0.66000000000000003 110.668 -169.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -91.95 151.89 20.29 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.694 1.597 . . . . 1.5800000000000001 113.198 -173.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -156.65 139.33 15.08 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.029 -1.044 . . . . 3.04 111.774 176.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.311 57.8 t30 99.23 -21.67 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.001 3.321 . . . . 3.0 116.932 172.395 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.32 178.81 38.8 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 119.928 -1.733 . . . . 2.1800000000000002 114.215 -174.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.1 t -120.78 125.7 48.24 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.627 1.171 . . . . 2.3599999999999999 110.942 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.66 161.85 21.77 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.627 1.571 . . . . 1.1699999999999999 112.438 -167.298 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.21 119.58 37.54 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.944 1.298 . . . . 1.75 110.154 174.156 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.98 123.3 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.052 1.341 . . . . 1.54 109.747 175.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.8 p -82.28 108.45 15.74 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.544 -0.722 . . . . 1.5700000000000001 110.077 170.02 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.87 113.88 17.33 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.127 -0.983 . . . . 1.02 110.707 -172.038 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -111.34 -2.33 15.68 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.07 1.348 . . . . 2.9199999999999999 112.478 179.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -138.32 142.33 39.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.954 2.102 . . . . 1.72 109.391 178.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.34 178.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 124.707 1.203 . . . . 1.8500000000000001 112.554 172.185 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.63 -39.49 97.63 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.594 -1.316 . . . . 1.3899999999999999 113.615 -178.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.01 -31.89 72.31 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 118.411 1.105 . . . . 1.8300000000000001 113.176 172.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -75.71 -4.37 39.98 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 128.132 2.573 . . . . 3.04 113.464 175.101 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 76.3 p -70.57 141.44 51.83 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.588 -1.945 . . . . 1.6399999999999999 114.275 -177.452 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -62.17 -31.93 72.49 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.71 -0.619 . . . . 1.8999999999999999 112.19 176.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -56.03 -48.05 76.7 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.777 -1.202 . . . . 1.47 111.8 171.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.8 m -64.97 -36.56 84.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.094 0.557 . . . . 1.8200000000000001 110.43 175.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.32 -40.59 85.97 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.664 -0.647 . . . . 1.6000000000000001 112.303 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 67.9 mt -59.03 -51.41 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.355 1.062 . . . . 1.26 109.945 177.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 m -71.19 -32.35 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 117.903 -1.046 . . . . 1.1799999999999999 113.084 179.465 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -56.21 -46.69 79.38 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.59 1.086 . . . . 3.1400000000000001 110.9 171.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.67 -41.07 88.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.591 1.157 . . . . 2.4900000000000002 113.499 178.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.4 t -65.16 -46.98 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 118.97 0.804 . . . . 2.5299999999999998 110.405 175.072 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -59.23 -37.87 78.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.829 1.252 . . . . 4.04 112.065 -178.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.38 -26.83 64.84 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.374 1.25 . . . . 4.3700000000000001 114.374 176.219 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.7 86.92 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.517 0.599 . . . . 4.7199999999999998 111.199 -171.605 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.253 1.243 0 C-N-CA 126.148 1.779 . . . . 5.2300000000000004 112.691 172.013 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 114.112 1.152 . . . . 4.3399999999999999 114.112 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -84.91 -27.83 26.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 5.4100000000000001 112.181 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.38 -39.0 93.32 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.069 0.948 . . . . 1.77 111.97 171.311 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 tp -56.56 -34.41 67.09 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.71 0.804 . . . . 1.5600000000000001 112.92 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.23 -41.76 39.94 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.915 0.709 . . . . 1.3300000000000001 112.915 168.555 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -60.19 -35.11 74.65 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.953 1.301 . . . . 2.1800000000000002 112.709 -175.678 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.72 -36.68 72.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.691 0.796 . . . . 1.26 112.866 173.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.4 mm -72.88 -38.66 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.872 0.76 . . . . 1.8500000000000001 111.621 173.13 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -65.54 -25.75 67.58 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.174 -0.954 . . . . 1.23 112.783 177.037 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.9 mt -73.33 -17.84 61.25 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.633 1.973 . . . . 1.8700000000000001 114.892 174.666 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -74.48 144.76 44.04 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.085 1.311 . . . . 3.3199999999999998 112.105 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.49 156.49 21.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.845 1.258 . . . . 2.98 112.839 -176.249 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 p -94.76 -30.45 14.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.599 1.16 . . . . 2.73 113.7 171.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -140.47 162.13 36.08 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.245 1.818 . . . . 3.5600000000000001 113.014 -173.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.16 159.61 41.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.948 1.299 . . . . 1.5600000000000001 112.873 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.4 m -104.53 124.49 49.38 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.266 1.026 . . . . 1.3200000000000001 111.833 176.16 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.78 130.25 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.325 1.45 . . . . 0.95999999999999996 110.932 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -110.83 133.96 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.366 1.066 . . . . 2.48 111.897 177.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -140.39 133.43 29.39 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.457 0.703 . . . . 1.6200000000000001 112.279 -175.829 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.82 143.73 32.73 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.306 1.442 . . . . 4.8499999999999996 111.217 175.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -145.2 19.33 1.57 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.652 2.093 . . . . 4.6200000000000001 116.652 -171.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 m -144.04 -74.38 0.26 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.856 1.058 . . . . 4.0300000000000002 113.856 175.479 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -157.63 37.92 0.27 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.659 1.984 . . . . 7.3099999999999996 109.229 -168.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.42 -17.27 0.1 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 127.194 2.197 . . . . 6.1600000000000001 114.168 -166.214 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 pt -66.77 -37.56 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 O-C-N 119.975 -1.703 . . . . 4.8099999999999996 113.438 176.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.1 tp -84.17 76.87 10.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.545 1.538 . . . . 3.1099999999999999 111.19 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 tt -97.24 120.5 37.72 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.734 1.613 . . . . 4.2699999999999996 111.427 176.058 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.2 t -130.63 131.16 44.76 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.618 1.567 . . . . 1.8799999999999999 109.605 -177.829 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.36 143.63 49.1 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.703 1.201 . . . . 3.0299999999999998 112.366 -170.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.96 143.65 50.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.954 1.302 . . . . 3.3900000000000001 111.177 -178.054 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -108.35 125.98 52.33 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.823 -0.806 . . . . 2.4199999999999999 108.823 166.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.29 161.29 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.605 1.162 . . . . 1.6799999999999999 112.357 -170.333 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -74.06 143.3 45.53 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.025 -0.732 . . . . 4.2999999999999998 109.025 172.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.59 -2.34 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 114.463 1.283 . . . . 1.74 114.463 -171.48 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -81.05 -23.4 38.58 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.33 2.252 . . . . 4.7699999999999996 113.13 168.632 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.6 mt -103.12 -10.76 18.58 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.644 1.578 . . . . 1.9399999999999999 114.009 -168.125 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.4 p -87.01 145.06 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.74 2.016 . . . . 1.75 108.646 168.243 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.24 159.48 16.08 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.198 0.999 . . . . 4.7999999999999998 112.415 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -73.49 33.04 0.08 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 115.615 1.709 . . . . 4.5499999999999998 115.615 -178.146 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.26 15.95 1.31 Allowed Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.481 2.467 . . . . 1.55 113.756 171.337 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -81.96 158.37 23.91 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.968 1.384 . . . . 2.3500000000000001 113.216 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -106.91 125.85 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.418 1.487 . . . . 1.6899999999999999 112.333 -172.616 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.7 mm -127.3 119.1 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.899 1.28 . . . . 0.91000000000000003 111.492 -169.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HE3' ' HG ' ' A' ' 96' ' ' LEU . 21.2 mmtp -85.44 120.16 26.59 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.744 -1.223 . . . . 3.6299999999999999 110.287 169.801 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 p -96.97 138.41 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.758 0.708 . . . . 1.1200000000000001 111.795 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 m -87.68 150.44 48.36 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.678 1.191 . . . . 1.1000000000000001 112.886 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -59.44 142.83 99.57 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.755 2.303 . . . . 1.72 111.07 170.348 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.31 -13.08 8.24 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 115.855 1.102 . . . . 1.9099999999999999 115.855 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.31 -172.64 40.62 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 119.058 1.429 . . . . 1.4399999999999999 115.214 -175.392 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -113.25 158.01 21.03 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.006 1.322 . . . . 1.75 111.521 171.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -91.54 125.26 58.4 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.234 1.013 . . . . 2.4300000000000002 111.437 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -92.66 -13.29 1.48 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.311 2.674 . . . . 1.4099999999999999 115.444 -175.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.48 162.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 126.613 1.965 . . . . 1.5 109.433 178.193 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.273 0.5 OUTLIER -93.51 137.67 32.56 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.684 0.754 . . . . 2.0899999999999999 112.33 175.595 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.41 177.32 41.95 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 123.975 0.798 . . . . 1.01 114.6 -169.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.7 ttm-85 -100.89 146.02 27.86 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.203 1.401 . . . . 6.2800000000000002 111.578 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.4 t -101.06 126.57 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.135 2.174 . . . . 1.1699999999999999 109.135 -174.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 pt -140.87 29.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 113.973 1.101 . . . . 1.1699999999999999 113.973 -175.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -170.17 146.67 3.02 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.882 2.073 . . . . 3.8999999999999999 109.158 166.171 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.4 -174.24 48.63 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.43 1.014 . . . . 1.3300000000000001 115.227 169.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -150.22 118.78 6.5 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.353 1.061 . . . . 2.2400000000000002 111.064 -174.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.4 t -142.71 163.98 31.36 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.282 1.433 . . . . 1.5900000000000001 112.27 -175.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.2 ttm -116.05 129.69 56.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.06 1.344 . . . . 0.79000000000000004 110.435 174.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.6 t -121.59 143.33 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.766 1.627 . . . . 0.60999999999999999 112.061 -168.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -99.45 90.4 4.51 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.281 1.832 . . . . 1.8 111.359 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -90.03 9.58 27.47 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.862 1.265 . . . . 2.3199999999999998 113.762 -175.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.8 t -50.35 -47.35 56.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.188 2.195 . . . . 1.8799999999999999 115.612 -169.061 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.98 -36.99 48.32 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.593 -1.317 . . . . 1.1399999999999999 111.777 -175.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.3 mm -73.61 -48.28 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.727 -0.608 . . . . 1.03 110.207 -177.309 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.1 p -107.33 -11.37 15.57 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.352 1.241 . . . . 1.26 114.352 -170.428 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.61 -5.81 72.39 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 126.011 1.767 . . . . 1.51 115.943 174.117 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.25 -47.2 81.98 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.529 1.165 . . . . 2.8500000000000001 113.254 -169.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.268 . . 58.61 45.61 15.86 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.442 1.897 . . . . 1.9299999999999999 111.847 -176.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptp -153.02 134.95 8.81 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 128.98 2.912 . . . . 4.0700000000000003 109.068 172.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -62.2 145.64 96.19 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.712 2.275 . . . . 1.3500000000000001 113.952 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.34 128.51 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.502 1.521 . . . . 0.76000000000000001 111.303 -174.117 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.87 144.79 28.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.628 0.771 . . . . 0.76000000000000001 112.977 -179.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -122.23 159.44 27.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.176 1.79 . . . . 1.3100000000000001 112.274 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -151.98 171.76 6.24 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 127.791 2.437 . . . . 3.6400000000000001 110.643 -176.485 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.5 123.98 13.79 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 CA-C-N 121.341 1.515 . . . . 1.4199999999999999 108.84 166.206 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.83 44.4 5.75 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.057 0.837 . . . . 1.27 113.01 -168.367 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.9 m -124.96 169.05 12.48 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.245 1.418 . . . . 1.3600000000000001 109.362 168.558 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.4 p -121.46 156.79 32.0 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.825 -1.172 . . . . 0.97999999999999998 112.868 169.81 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.28 160.48 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.884 1.674 . . . . 0.76000000000000001 111.924 -178.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -127.62 154.51 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 126.47 1.908 . . . . 1.6000000000000001 112.514 -176.952 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.73 159.84 33.17 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.432 0.901 . . . . 1.1699999999999999 113.432 -177.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -6.96 11.88 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.797 1.189 . . . . 1.0700000000000001 115.113 179.037 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -84.65 162.69 19.64 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.167 1.387 . . . . 2.46 111.601 174.575 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 mm -111.33 140.86 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.271 1.028 . . . . 0.96999999999999997 111.547 -169.437 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -90.61 136.09 33.28 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.178 1.791 . . . . 2.79 109.371 169.331 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -83.64 -73.32 0.42 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.702 0.801 . . . . 3.52 110.663 169.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -140.55 161.27 38.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.241 1.816 . . . . 3.6299999999999999 107.969 170.093 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.88 138.66 6.48 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.506 2.479 . . . . 1.8300000000000001 111.572 177.436 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.9 m -114.61 95.77 5.41 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.825 1.25 . . . . 2.5600000000000001 110.167 -169.475 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.3 mt -104.44 152.7 22.01 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.043 1.337 . . . . 1.6799999999999999 113.684 -170.774 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.416 ' HG ' ' HE3' ' A' ' 44' ' ' LYS . 4.2 tt -104.25 117.75 34.96 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.891 1.276 . . . . 3.5800000000000001 109.731 171.943 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.3 mm -113.41 129.02 69.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.022 1.329 . . . . 1.96 111.422 -173.493 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.3 p -101.69 124.94 48.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.414 -0.804 . . . . 1.45 110.109 168.381 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.96 151.02 31.88 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.692 0.627 . . . . 1.3899999999999999 112.692 -174.18 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -129.43 -3.23 4.89 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.775 1.398 . . . . 2.7999999999999998 114.775 169.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -140.97 141.87 34.37 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.66 1.184 . . . . 2.73 111.09 169.067 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.85 165.8 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 109.233 -0.655 . . . . 2.21 109.233 166.437 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.7 -39.74 91.67 Favored Glycine 0 N--CA 1.475 1.294 0 CA-C-N 119.528 1.058 . . . . 2.4500000000000002 114.673 -168.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.16 82.58 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.142 0.971 . . . . 3.2400000000000002 112.875 174.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -74.33 -8.34 55.9 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.213 2.605 . . . . 3.7400000000000002 114.275 176.363 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.0 p -64.13 159.07 21.27 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.789 -1.194 . . . . 2.0499999999999998 113.525 -174.526 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.6 t -52.21 -24.04 6.57 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.22 1.193 . . . . 2.5299999999999998 114.22 175.648 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.69 -44.92 93.46 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.251 -1.531 . . . . 1.9299999999999999 112.87 174.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.2 p -70.92 -21.35 62.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 117.945 0.339 . . . . 2.1400000000000001 111.785 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.02 -38.55 72.61 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.672 -0.643 . . . . 2.4100000000000001 111.149 174.024 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 94.1 mt -59.98 -54.21 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.405 0.682 . . . . 1.72 110.829 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.37 -23.49 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 113.303 0.853 . . . . 1.3100000000000001 113.303 -178.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -74.45 -39.94 62.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.803 0.841 . . . . 2.7799999999999998 113.215 170.052 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.5 mt -65.25 -36.91 85.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.612 1.096 . . . . 3.1800000000000002 112.606 178.262 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.82 -52.25 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.991 0.516 . . . . 2.3700000000000001 110.627 174.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.49 -19.4 62.21 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.493 1.664 . . . . 4.7699999999999996 115.493 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -71.55 -33.93 69.55 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.51 1.505 . . . . 4.8099999999999996 111.906 168.045 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.03 -54.82 9.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.105 0.962 . . . . 4.3700000000000001 111.755 176.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.104 0 C-N-CA 127.079 2.152 . . . . 5.1399999999999997 115.451 177.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 112.137 0.421 . . . . 2.71 112.137 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -67.37 -39.53 85.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.067 1.347 . . . . 4.4000000000000004 112.005 175.386 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.05 73.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.764 0.426 . . . . 1.6699999999999999 111.604 176.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.0 tp -70.56 -30.95 67.81 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.122 1.369 . . . . 1.6000000000000001 112.234 174.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.21 -34.13 61.45 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.991 0.516 . . . . 1.45 112.343 177.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -64.31 -28.46 69.73 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.359 -0.838 . . . . 2.4100000000000001 112.88 -177.608 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.28 -28.63 69.86 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.064 0.946 . . . . 1.25 113.237 173.137 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.62 -37.85 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.169 -0.957 . . . . 1.8100000000000001 111.31 169.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -70.48 -31.39 68.5 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.253 1.021 . . . . 1.52 113.138 179.322 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.72 -22.79 64.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.166 2.186 . . . . 2.23 114.165 -178.29 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -76.78 155.58 33.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.21 1.404 . . . . 2.4900000000000002 113.926 -169.163 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.78 -28.07 14.44 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.391 1.256 . . . . 3.0299999999999998 114.391 -168.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m 66.93 -29.47 0.14 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.805 2.15 . . . . 2.9900000000000002 116.805 171.094 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.22 145.9 41.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.087 1.755 . . . . 3.5299999999999998 111.455 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.25 160.66 41.14 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.94 1.089 . . . . 0.77000000000000002 113.94 -169.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.8 m -112.43 112.64 24.35 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.309 1.044 . . . . 1.1899999999999999 112.395 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.42 146.18 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 126.742 2.017 . . . . 0.69999999999999996 109.932 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.56 115.0 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.024 -1.102 . . . . 1.76 108.024 166.34 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m -107.2 139.85 41.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.238 1.815 . . . . 1.8899999999999999 109.917 -176.416 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.45 95.25 8.73 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.739 -0.837 . . . . 3.75 108.739 174.324 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -15.58 60.64 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.526 0.935 . . . . 4.0700000000000003 113.526 -173.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.9 m -150.51 146.12 26.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.979 2.112 . . . . 3.6800000000000002 111.509 168.097 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -19.63 64.49 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 1 C-N-CA 133.814 4.846 . . . . 6.1900000000000004 118.108 -169.799 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.26 -14.27 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 127.157 2.183 . . . . 5.4500000000000002 114.329 -168.426 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 pt -75.66 -26.25 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 128.09 2.556 . . . . 4.9400000000000004 115.221 -178.367 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.1 tp -125.41 128.63 48.41 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.851 1.26 . . . . 3.1600000000000001 111.793 -172.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -108.4 137.83 45.72 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.697 1.199 . . . . 2.7400000000000002 112.311 177.562 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.3 t -142.07 131.88 24.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.914 1.285 . . . . 1.46 110.507 168.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -99.34 135.67 40.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.091 0.956 . . . . 2.75 110.878 -179.035 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -131.99 132.58 43.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.5 1.92 . . . . 3.4199999999999999 111.642 -167.088 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -104.08 130.0 51.76 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.251 -1.531 . . . . 1.9299999999999999 112.706 -172.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -142.6 -179.77 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 125.7 1.6 . . . . 0.93000000000000005 113.749 -171.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.93 147.43 23.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.671 1.188 . . . . 2.6699999999999999 110.69 166.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.38 -21.53 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.943 1.09 . . . . 2.0699999999999998 113.943 -176.348 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.16 -23.88 67.23 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.119 -0.988 . . . . 3.1499999999999999 112.448 168.564 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.4 mt -106.62 -10.23 16.26 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.838 1.655 . . . . 2.0499999999999998 114.384 -169.092 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.7 m -60.78 -37.34 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 119.897 1.226 . . . . 3.9300000000000002 112.415 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.306 35.3 mt-30 58.31 150.75 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.959 2.904 . . . . 4.0700000000000003 115.775 -173.63 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -71.12 40.89 0.06 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 117.203 2.297 . . . . 3.8199999999999998 117.203 -167.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.47 17.77 0.43 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.627 1.584 . . . . 1.01 115.712 178.201 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.52 170.23 8.27 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.831 1.315 . . . . 3.1499999999999999 113.392 170.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.2 mt -122.02 131.8 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.454 1.502 . . . . 1.1899999999999999 109.004 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.96 131.58 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.717 1.607 . . . . 0.73999999999999999 111.02 -169.44 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -84.52 125.72 32.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.913 0.779 . . . . 2.1699999999999999 112.23 171.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.79 133.04 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.233 1.413 . . . . 0.68000000000000005 110.935 172.784 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 m -93.2 168.26 12.5 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 124.036 0.935 . . . . 0.90000000000000002 112.982 -176.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.92 132.38 47.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.583 2.188 . . . . 1.02 110.324 168.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.77 -6.17 27.12 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.614 1.102 . . . . 1.0 115.395 -172.038 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.26 162.71 53.69 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.149 1.474 . . . . 0.98999999999999999 114.112 -179.072 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -104.84 146.34 29.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.299 1.04 . . . . 2.21 111.692 175.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -71.57 130.91 86.74 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.696 -0.669 . . . . 1.8 109.538 169.703 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -94.83 -18.03 0.41 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.481 2.12 . . . . 0.93999999999999995 115.065 -171.329 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 m -144.09 175.63 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 127.277 2.231 . . . . 1.2 110.086 -178.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -94.91 136.25 35.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.97 0.805 . . . . 1.98 112.027 168.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.46 -173.44 46.28 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 121.545 -0.722 . . . . 0.68000000000000005 114.243 -169.733 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -109.22 134.65 51.48 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.143 0.977 . . . . 4.9299999999999997 113.218 -175.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.8 126.88 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.907 2.083 . . . . 0.81000000000000005 108.048 174.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.8 pt -140.39 33.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 118.614 0.643 . . . . 1.01 112.12 176.401 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -165.82 128.54 2.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.714 1.606 . . . . 3.8799999999999999 108.594 169.274 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.78 165.93 40.67 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.745 1.164 . . . . 1.3 114.697 -179.195 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -141.53 130.16 22.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.293 1.037 . . . . 1.9299999999999999 112.38 178.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.46 ' HB2' HD21 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -143.69 163.36 33.49 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.49 1.116 . . . . 1.3700000000000001 112.657 173.222 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.0 ttm -90.61 141.94 28.26 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.489 0.716 . . . . 0.93000000000000005 109.298 168.161 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.2 t -134.55 142.56 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.997 1.319 . . . . 0.64000000000000001 112.724 -168.551 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -89.07 116.36 27.29 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.257 1.023 . . . . 2.1499999999999999 112.211 173.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -109.62 10.69 24.92 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.504 1.522 . . . . 1.75 111.951 169.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 t -58.47 -39.29 79.53 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.939 1.296 . . . . 2.4700000000000002 114.043 -172.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.88 -31.47 27.91 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 120.391 1.451 . . . . 1.6200000000000001 111.576 177.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.8 mm -62.03 -57.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.028 0.931 . . . . 1.5800000000000001 110.762 178.206 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 p -119.58 -5.11 10.27 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.161 1.171 . . . . 2.1099999999999999 114.161 -169.683 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.42 11.69 77.33 Favored Glycine 0 CA--C 1.539 1.572 0 CA-C-O 118.504 -1.164 . . . . 1.79 115.295 -179.361 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -49.97 -53.51 26.0 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.842 1.821 . . . . 2.7999999999999998 114.17 -175.564 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.256 . . 59.66 13.94 3.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.09 1.756 . . . . 1.5700000000000001 114.739 -173.498 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 52.3 ttp -132.81 131.84 22.23 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 128.308 2.643 . . . . 3.79 106.876 169.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.98 152.33 46.11 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.161 2.574 . . . . 1.9199999999999999 112.949 -171.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -109.48 133.24 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.752 1.621 . . . . 0.71999999999999997 110.632 -171.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.16 132.35 36.52 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.57 -0.706 . . . . 0.78000000000000003 111.206 174.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -120.58 144.62 48.0 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.365 1.466 . . . . 0.79000000000000004 110.122 173.085 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 167.28 13.51 Favored Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 127.699 2.4 . . . . 4.4500000000000002 110.526 -169.873 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -58.72 132.03 45.59 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 CA-C-N 121.628 1.617 . . . . 0.84999999999999998 111.354 174.644 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.5 29.56 35.84 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.451 1.024 . . . . 0.73999999999999999 114.21 -169.235 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.9 t -116.4 152.6 33.63 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.788 1.635 . . . . 1.5700000000000001 111.658 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.2 p -107.15 150.15 26.9 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.931 1.241 . . . . 0.79000000000000004 113.142 178.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.4 m -140.27 163.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.448 1.499 . . . . 0.59999999999999998 112.285 -174.703 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.93 156.78 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.535 1.534 . . . . 1.26 112.549 173.418 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.75 148.12 49.99 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.487 0.921 . . . . 0.57999999999999996 113.487 -177.783 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.49 -1.62 70.88 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 115.198 0.839 . . . . 0.89000000000000001 115.198 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.8 p -78.11 151.43 33.36 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.425 1.113 . . . . 1.4399999999999999 109.433 166.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.88 132.87 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.509 0.724 . . . . 0.72999999999999998 111.835 -168.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -95.28 137.65 34.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.221 1.808 . . . . 1.5600000000000001 112.671 -176.176 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -85.53 -92.94 0.09 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 115.488 1.662 . . . . 3.3199999999999998 115.488 -169.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -109.22 -30.65 7.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 117.143 2.275 . . . . 3.9399999999999999 117.143 -167.342 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.8 150.72 16.93 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.065 1.317 . . . . 1.96 113.379 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 t -98.15 139.65 33.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.275 1.83 . . . . 2.5 112.443 -174.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 62' ' ' SER . 1.0 OUTLIER -132.85 162.68 30.91 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.717 1.607 . . . . 1.3200000000000001 112.208 -168.447 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.36 127.95 54.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.073 0.949 . . . . 1.96 112.248 172.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.53 132.21 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.326 1.451 . . . . 1.21 111.875 -172.361 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.1 m -84.97 118.27 24.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.81 1.244 . . . . 2.0800000000000001 111.187 -179.196 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.95 117.0 21.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.45 0.7 . . . . 0.98999999999999999 111.79 176.515 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.4 t -112.53 5.34 17.88 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.926 1.29 . . . . 2.8199999999999998 114.253 174.24 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -151.3 144.29 24.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.498 2.319 . . . . 2.1800000000000002 108.808 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.6 m -82.59 162.31 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.271 -1.011 . . . . 2.0800000000000001 108.271 164.033 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.98 -39.15 56.54 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-N 119.555 1.071 . . . . 1.3899999999999999 114.976 -168.568 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.71 80.63 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.265 1.026 . . . . 1.8600000000000001 113.537 173.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.85 -9.46 58.7 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.563 1.545 . . . . 4.04 114.958 -179.145 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.3 p -69.7 160.94 30.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.777 1.028 . . . . 1.6599999999999999 113.777 -175.595 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.8 t -63.07 -33.03 74.56 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.71 0.804 . . . . 1.8899999999999999 112.112 172.574 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.59 -45.25 92.46 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.054 -1.029 . . . . 1.45 111.368 176.694 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 64.8 m -71.46 -33.32 69.23 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.906 0.882 . . . . 2.1400000000000001 112.54 173.115 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -61.97 -42.23 98.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.276 1.03 . . . . 2.0099999999999998 111.17 177.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.29 -55.63 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.079 1.352 . . . . 1.3799999999999999 110.808 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.0 m -66.92 -24.01 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 113.404 0.89 . . . . 1.3899999999999999 113.404 -175.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -72.71 -49.09 33.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.88 1.272 . . . . 2.7799999999999998 112.241 170.136 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.4 mt -66.24 -27.88 68.3 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.37 0.878 . . . . 3.4500000000000002 113.37 179.357 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.53 -53.63 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.279 0.632 . . . . 2.2999999999999998 109.727 169.383 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.54 -33.04 67.69 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.492 1.293 . . . . 3.8500000000000001 114.492 -177.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.85 -29.79 69.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.154 0.982 . . . . 4.8600000000000003 112.866 175.261 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.95 -59.02 2.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.798 0.839 . . . . 4.4400000000000004 112.529 -169.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--O 1.255 1.386 0 C-N-CA 125.033 1.333 . . . . 4.0899999999999999 113.698 -176.629 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 114.417 1.266 . . . . 3.7000000000000002 114.417 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.0 -32.51 24.9 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.493 1.042 . . . . 4.0999999999999996 110.678 169.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.88 71.51 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.516 -0.74 . . . . 1.55 112.367 170.633 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 tp -61.7 -32.55 72.76 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.572 0.749 . . . . 1.6899999999999999 111.884 175.248 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.47 -41.79 45.98 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.507 0.723 . . . . 1.47 112.391 168.49 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -61.06 -36.85 80.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.803 1.241 . . . . 2.5699999999999998 113.143 -174.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.45 -33.19 72.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.389 0.995 . . . . 1.1599999999999999 113.449 178.502 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.98 -39.85 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.25 -0.906 . . . . 1.6100000000000001 111.853 168.694 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.2 m -63.99 -32.77 74.43 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.097 -1.002 . . . . 1.0700000000000001 113.128 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.14 -24.02 67.53 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.0 2.52 . . . . 1.8700000000000001 114.132 177.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -80.24 121.48 25.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.391 0.677 . . . . 2.3700000000000001 109.291 -177.024 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.78 66.56 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 116.527 2.047 . . . . 2.4300000000000002 116.527 -166.281 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m 67.16 -21.13 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 115.613 1.709 . . . . 3.4900000000000002 115.613 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -128.05 152.19 48.26 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.146 -1.596 . . . . 3.04 114.171 176.612 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.7 144.62 49.25 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.086 1.355 . . . . 1.6799999999999999 111.112 -177.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.5 m -119.08 98.23 6.07 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.919 0.887 . . . . 1.97 112.049 -171.423 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.6 mt -81.68 136.91 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 127.013 2.125 . . . . 0.93999999999999995 111.46 -171.419 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.61 142.79 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.679 0.792 . . . . 1.99 112.49 168.616 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.0 m -138.58 115.84 11.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.388 1.875 . . . . 3.29 111.849 -169.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mp -102.62 77.56 1.62 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.558 1.143 . . . . 3.8199999999999998 110.004 177.4 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -17.34 62.59 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.91 0.707 . . . . 4.2800000000000002 112.91 176.558 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.9 m -144.79 131.48 20.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.377 2.271 . . . . 5.2699999999999996 110.078 176.378 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 25' ' ' ILE . 2.5 t70 -21.06 63.65 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.424 1 C-N-CA 133.875 4.87 . . . . 5.8600000000000003 117.649 -169.907 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 60.73 -25.47 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.825 2.45 . . . . 4.9400000000000004 114.473 -167.529 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 23' ' ' ASP . 26.7 pt -58.74 5.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 131.6 3.96 . . . . 5.0499999999999998 117.08 179.076 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.51 -40.67 1.41 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.364 1.866 . . . . 5.4400000000000004 113.249 179.298 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.8 tp 22.57 68.05 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 128.687 2.795 . . . . 3.3700000000000001 113.258 -176.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.5 m -78.15 153.81 31.75 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.311 1.044 . . . . 2.5899999999999999 110.826 -178.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -124.2 146.96 48.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.51 0.724 . . . . 2.5899999999999999 112.707 176.225 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -137.42 139.76 40.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.789 2.036 . . . . 2.6600000000000001 110.255 -172.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -107.56 130.28 54.89 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.258 0.936 . . . . 2.8399999999999999 112.665 175.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 m -132.97 174.71 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.644 1.578 . . . . 1.45 111.503 -177.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.87 145.58 31.28 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.939 0.895 . . . . 4.9500000000000002 111.761 169.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.31 -8.02 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 114.189 1.181 . . . . 1.8400000000000001 114.189 -176.135 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -85.46 -28.12 25.25 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.166 -1.583 . . . . 4.5599999999999996 112.315 167.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.58 -20.06 22.07 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.441 1.496 . . . . 2.1299999999999999 113.515 -169.067 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.58 -46.07 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.48 1.112 . . . . 3.8199999999999998 112.352 178.165 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 59.56 164.94 0.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.408 1.883 . . . . 3.8500000000000001 115.863 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -74.34 27.34 0.08 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 117.002 2.223 . . . . 4.1900000000000004 117.002 -168.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.75 -8.3 5.29 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 117.012 1.565 . . . . 1.1699999999999999 117.012 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.11 175.76 5.37 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.63 1.715 . . . . 3.0800000000000001 114.308 -174.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.9 mt -123.27 135.33 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.481 1.913 . . . . 1.6399999999999999 110.411 -178.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.4 mm -124.9 123.59 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.349 1.859 . . . . 0.76000000000000001 110.186 -170.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -100.01 122.0 42.24 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.273 -0.892 . . . . 3.2400000000000002 112.79 177.707 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.7 p -100.72 142.57 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.557 1.543 . . . . 0.70999999999999996 112.117 -173.374 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 m -88.95 163.58 34.29 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 124.417 1.087 . . . . 1.03 113.136 -177.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.95 132.6 48.39 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.446 2.097 . . . . 1.25 110.902 169.124 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.17 -1.99 62.62 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 115.854 1.102 . . . . 1.1000000000000001 115.854 -172.282 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.17 174.99 46.27 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-N 119.517 1.659 . . . . 1.1000000000000001 114.923 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -122.37 145.89 47.85 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.505 1.522 . . . . 2.4100000000000001 111.132 -177.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -86.35 129.66 52.56 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 118.697 -0.668 . . . . 2.21 112.443 -177.135 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.12 -19.83 0.85 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.124 2.55 . . . . 0.91000000000000003 115.825 -172.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.7 m -148.57 165.71 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 126.87 2.068 . . . . 1.21 109.466 -177.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -88.29 127.88 35.47 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.288 0.949 . . . . 2.1299999999999999 111.976 169.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.19 -167.83 29.41 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.592 1.091 . . . . 0.65000000000000002 112.918 -169.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -117.33 135.36 53.9 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.042 0.937 . . . . 5.1200000000000001 113.326 -175.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.8 t -83.45 129.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 128.522 2.729 . . . . 0.76000000000000001 109.14 176.323 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.17 32.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.216 1.006 . . . . 0.88 113.165 -179.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -168.55 137.91 2.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.004 1.722 . . . . 3.52 108.675 166.334 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.11 -177.08 51.93 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.593 0.997 . . . . 0.79000000000000004 115.593 169.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -145.89 120.73 9.94 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.282 1.433 . . . . 5.4199999999999999 110.972 -169.841 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.22 171.76 14.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.462 1.105 . . . . 1.3100000000000001 111.267 172.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.6 ttm -108.01 149.15 28.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.99 1.316 . . . . 0.81000000000000005 111.043 170.219 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.92 133.72 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.743 1.217 . . . . 0.68999999999999995 112.573 -169.669 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -100.45 106.06 17.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.412 1.485 . . . . 2.21 110.409 177.789 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.29 6.07 10.71 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.741 1.616 . . . . 2.1699999999999999 114.912 -172.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.3 p -45.69 -26.04 0.57 Allowed 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 117.127 2.269 . . . . 1.3600000000000001 117.127 -175.853 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.34 -42.16 19.09 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.558 1.526 . . . . 0.98999999999999999 112.664 175.337 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.9 mm -72.68 -60.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.974 0.91 . . . . 1.01 110.278 -170.448 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 p -93.25 -11.11 33.36 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.877 2.071 . . . . 1.1599999999999999 112.455 -176.304 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.1 31.85 57.06 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 121.246 -0.909 . . . . 1.55 113.275 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -68.24 178.83 1.77 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.691 0.796 . . . . 2.5800000000000001 110.96 168.688 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.03 7.13 1.59 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.193 1.183 . . . . 2.1099999999999999 114.193 177.17 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 ptp -149.19 153.55 37.93 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.669 1.988 . . . . 3.0699999999999998 107.806 169.7 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.9 159.64 37.88 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.138 1.892 . . . . 1.3400000000000001 112.652 -177.087 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.88 138.37 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.211 1.804 . . . . 1.1899999999999999 112.024 -168.333 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.6 150.86 36.43 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.382 -0.823 . . . . 0.82999999999999996 113.119 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -132.32 155.1 48.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.628 1.971 . . . . 1.5600000000000001 112.699 175.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -153.94 -179.15 0.99 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 129.044 2.938 . . . . 2.6200000000000001 109.79 178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.72 150.4 82.73 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.748 1.632 . . . . 1.46 113.788 170.468 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.34 19.88 70.95 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-N 114.569 -1.196 . . . . 1.1000000000000001 114.357 -171.683 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.7 t -107.84 153.88 22.37 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 119.324 1.562 . . . . 1.1799999999999999 111.1 -176.206 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.3 p -118.44 143.43 46.69 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.282 -1.511 . . . . 1.23 112.948 -169.493 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 m -134.01 156.95 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.768 1.627 . . . . 0.64000000000000001 112.399 -169.628 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.526 HD13 ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -112.7 153.51 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.236 1.814 . . . . 1.4399999999999999 112.816 174.669 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.38 150.45 48.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.148 0.796 . . . . 0.68000000000000005 113.148 175.592 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.84 -6.0 56.26 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.489 1.042 . . . . 0.78000000000000003 115.451 176.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.4 p -77.72 159.82 28.85 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.274 1.03 . . . . 1.4299999999999999 111.361 169.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mm -113.77 127.24 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.432 0.693 . . . . 0.81999999999999995 111.782 -169.223 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -86.48 140.12 30.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.445 1.898 . . . . 1.6699999999999999 111.987 -178.039 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -100.46 -125.34 0.17 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.402 1.081 . . . . 3.4399999999999999 113.509 -172.701 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -90.13 63.61 5.89 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.983 1.265 . . . . 3.71 113.844 -166.495 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.92 157.23 9.23 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.431 -0.793 . . . . 1.8999999999999999 114.989 169.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -92.36 133.3 36.0 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.475 1.11 . . . . 2.1200000000000001 112.259 -175.586 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.76 153.7 39.14 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.601 1.56 . . . . 0.92000000000000004 111.587 -176.183 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.1 tp -108.62 119.81 40.61 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.617 1.167 . . . . 2.3399999999999999 110.356 174.855 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mp -117.53 127.94 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.319 1.048 . . . . 1.23 111.04 -175.665 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.3 p -81.52 128.65 34.13 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.722 -0.611 . . . . 1.3899999999999999 110.654 171.325 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.09 126.17 34.6 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.499 -0.751 . . . . 1.0700000000000001 110.864 176.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 p -133.97 -3.96 2.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.926 1.69 . . . . 2.27 113.698 -170.554 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -148.03 150.3 33.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.237 2.215 . . . . 2.0899999999999999 108.887 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.74 173.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.246 1.018 . . . . 1.6499999999999999 111.416 169.301 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.75 -35.78 47.55 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.17 -0.956 . . . . 1.8500000000000001 115.027 -170.604 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.63 -31.97 71.14 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.322 1.231 . . . . 2.3100000000000001 114.322 176.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.84 -14.11 60.28 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.05 1.295 . . . . 3.8799999999999999 114.19 172.457 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 60.1 p -68.47 144.59 54.6 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.138 -1.601 . . . . 2.04 113.152 -169.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 t -63.48 -33.04 74.7 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.77 0.428 . . . . 2.8599999999999999 110.821 171.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.7 mp -53.3 -53.01 57.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.58 1.152 . . . . 1.6100000000000001 111.886 175.396 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.4 m -71.73 -26.54 62.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.022 0.929 . . . . 2.02 111.77 177.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -70.64 -42.66 70.55 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.761 -0.587 . . . . 1.6100000000000001 111.826 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.91 -53.34 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.746 1.219 . . . . 2.1099999999999999 110.287 177.65 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.5 m -67.47 -23.25 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 113.607 0.966 . . . . 1.78 113.607 -176.561 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -73.35 -51.96 15.56 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.908 0.776 . . . . 2.6699999999999999 112.068 168.596 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.0 mt -62.22 -43.17 99.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.146 0.978 . . . . 2.9500000000000002 112.925 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.39 -50.75 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.492 0.717 . . . . 2.6200000000000001 110.517 178.573 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -56.95 -37.25 71.26 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.72 1.007 . . . . 3.8199999999999998 113.72 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -74.65 -21.56 59.37 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.104 1.15 . . . . 5.6100000000000003 114.104 176.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.98 -44.33 63.69 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.84 0.856 . . . . 4.5499999999999998 112.093 -174.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.691 1.196 . . . . 5.04 113.409 170.902 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 119.163 -0.446 . . . . 2.3399999999999999 110.249 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.34 -42.47 98.74 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.015 0.825 . . . . 4.5899999999999999 109.979 167.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.81 -34.91 65.76 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.252 -0.905 . . . . 1.3999999999999999 113.081 175.278 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.9 tp -67.58 -28.86 68.13 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.327 -0.858 . . . . 1.45 112.243 177.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.77 -45.31 29.48 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.019 0.528 . . . . 1.23 111.312 167.441 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -53.62 -43.69 68.88 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.462 1.905 . . . . 2.2799999999999998 113.22 -175.249 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -48.04 -48.1 33.24 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.003 0.921 . . . . 0.97999999999999998 112.229 176.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.6 mm -73.88 -34.59 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.23 -0.919 . . . . 1.8100000000000001 113.408 177.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -77.17 -24.16 51.52 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.417 1.266 . . . . 1.96 114.417 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.6 mt -58.63 -21.07 52.7 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.232 1.413 . . . . 1.95 113.769 174.057 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -78.09 141.7 38.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.858 1.263 . . . . 2.54 113.589 -174.273 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.9 154.51 33.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.283 1.033 . . . . 1.78 112.732 175.493 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.61 -12.93 35.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.498 1.519 . . . . 2.5800000000000001 113.549 175.18 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -143.42 164.74 29.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.794 2.038 . . . . 3.1699999999999999 113.3 -175.497 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.15 163.59 32.31 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.343 1.457 . . . . 0.72999999999999998 111.524 171.616 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.4 m -114.75 106.8 14.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.017 1.327 . . . . 0.80000000000000004 110.062 170.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.52 133.12 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.084 -1.08 . . . . 0.65000000000000002 108.084 174.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.61 118.43 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.519 0.728 . . . . 2.2799999999999998 110.451 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.8 m -131.85 144.16 50.69 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.183 1.393 . . . . 2.4199999999999999 109.765 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.7 mt -105.23 124.23 49.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.187 0.995 . . . . 3.75 108.701 -176.27 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.39 10.77 23.37 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.772 2.138 . . . . 3.7200000000000002 116.772 -166.58 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.0 m -125.77 -96.97 0.43 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.024 0.929 . . . . 3.8799999999999999 109.789 175.076 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -139.4 56.39 1.67 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.878 2.071 . . . . 5.21 107.572 -179.343 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 65.0 -23.78 0.08 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.615 2.766 . . . . 4.2300000000000004 116.711 -168.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.0 pt -71.84 -8.32 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 115.735 1.754 . . . . 4.1799999999999997 115.735 -172.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tt -119.42 125.35 48.75 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.329 1.852 . . . . 2.8300000000000001 110.292 -177.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -101.52 131.86 47.45 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.246 1.418 . . . . 3.0899999999999999 111.128 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 t -139.5 96.81 3.15 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.678 1.191 . . . . 1.6899999999999999 110.447 -177.275 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -91.14 150.14 21.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.769 1.025 . . . . 2.5099999999999998 113.769 -179.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -124.18 140.55 52.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.308 1.843 . . . . 2.8199999999999998 111.182 169.685 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -98.05 126.02 43.29 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.71 0.804 . . . . 1.9399999999999999 109.099 169.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 m -136.28 164.78 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.698 1.199 . . . . 0.80000000000000004 112.625 -172.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.36 151.14 31.17 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.663 0.785 . . . . 3.4100000000000001 111.741 169.714 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.05 -24.87 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.385 0.883 . . . . 1.0900000000000001 113.385 175.474 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -69.4 -27.88 65.68 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.843 -1.161 . . . . 3.1299999999999999 113.199 170.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.9 mt -100.74 -7.78 23.42 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.872 1.669 . . . . 1.29 114.434 -168.792 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.67 141.83 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.631 0.773 . . . . 1.55 110.341 169.131 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -126.07 159.67 32.17 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.78 1.632 . . . . 3.6899999999999999 111.962 -170.018 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.266 16.8 ptt85 -75.53 15.82 0.43 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.957 1.836 . . . . 2.7799999999999998 115.957 -174.217 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.31 -2.58 15.48 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.651 2.072 . . . . 1.04 113.539 168.847 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -84.02 155.84 22.54 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 118.731 1.266 . . . . 2.9900000000000002 111.735 178.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 mt -118.69 128.95 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.55 1.14 . . . . 1.1699999999999999 109.167 169.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.6 mm -107.09 168.45 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 128.018 2.527 . . . . 1.26 111.022 -167.757 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -129.13 136.52 50.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.775 1.23 . . . . 1.78 109.832 170.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.07 132.69 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.393 1.077 . . . . 0.72999999999999998 110.405 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.9 m -90.15 166.52 19.84 Favored Pre-proline 0 N--CA 1.482 1.127 0 N-CA-C 113.427 0.899 . . . . 1.24 113.427 -170.13 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -61.8 128.01 23.16 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.76 2.307 . . . . 1.03 110.598 169.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.42 8.46 59.54 Favored Glycine 0 CA--C 1.539 1.583 0 O-C-N 121.278 -0.889 . . . . 0.88 114.884 -170.573 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.47 169.02 54.9 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.636 1.588 . . . . 0.95999999999999996 114.791 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -125.61 140.35 52.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.964 1.305 . . . . 1.96 110.979 -175.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -79.06 127.39 79.66 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 112.671 0.619 . . . . 1.74 112.671 -173.218 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -87.0 -24.59 1.3 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.397 2.731 . . . . 0.64000000000000001 114.875 -174.856 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 m -149.86 171.45 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 127.877 2.471 . . . . 0.71999999999999997 108.988 -177.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.54 139.77 38.41 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.428 1.013 . . . . 1.79 113.111 178.86 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.44 -154.86 14.5 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 114.701 0.641 . . . . 0.65000000000000002 114.701 -170.597 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -120.73 141.45 50.43 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.125 1.157 . . . . 5.2000000000000002 114.125 -173.147 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.1 t -89.83 132.64 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 128.647 2.779 . . . . 0.65000000000000002 108.997 174.582 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 pt -139.09 35.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 113.456 0.91 . . . . 0.83999999999999997 113.456 171.419 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -165.75 137.4 3.92 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.673 1.189 . . . . 3.0899999999999999 111.149 166.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.1 -164.73 26.21 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 117.469 1.748 . . . . 0.94999999999999996 117.469 168.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -151.48 109.03 3.62 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.321 1.449 . . . . 2.0600000000000001 111.97 -172.601 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.13 170.21 16.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.726 0.774 . . . . 1.24 112.024 172.108 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 ttm -117.43 144.11 45.33 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.911 1.284 . . . . 1.1899999999999999 110.092 176.203 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.0 t -130.29 139.74 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.851 1.26 . . . . 0.63 111.259 -169.791 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -98.11 127.51 44.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.384 0.674 . . . . 2.3199999999999998 112.427 175.173 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -127.95 20.7 6.42 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.515 1.526 . . . . 2.0600000000000001 112.879 -173.336 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 p -64.55 -22.2 66.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.878 1.807 . . . . 1.4299999999999999 115.878 -169.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.68 -42.65 11.23 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.752 0.821 . . . . 1.0600000000000001 109.543 168.654 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.77 -59.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.802 1.241 . . . . 1.0900000000000001 112.505 -171.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.0 p -106.91 -10.56 15.96 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.548 1.539 . . . . 1.23 113.361 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.58 13.01 76.88 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 119.151 -0.805 . . . . 1.3100000000000001 114.574 176.693 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -58.32 -47.39 83.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.718 1.207 . . . . 2.8300000000000001 113.407 -174.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 61.75 19.76 10.82 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.507 1.299 . . . . 1.3400000000000001 114.507 178.569 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.4 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 28.6 ttt -150.68 136.93 10.97 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 128.466 2.706 . . . . 4.4900000000000002 106.729 168.366 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 74' ' ' MET . 46.0 Cg_exo -59.13 151.73 64.57 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.288 3.325 . . . . 1.29 115.2 -176.038 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.23 134.38 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.555 1.942 . . . . 0.85999999999999999 111.597 -169.332 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.97 141.87 32.9 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.054 1.131 . . . . 0.94999999999999996 114.054 -173.234 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -124.72 142.35 51.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.4 1.88 . . . . 0.76000000000000001 111.496 173.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -142.03 174.71 3.51 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 128.968 2.907 . . . . 3.48 109.84 -176.637 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.76 126.65 19.48 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 CA-C-N 121.577 1.599 . . . . 0.84999999999999998 110.493 167.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.39 9.55 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.045 1.307 . . . . 0.76000000000000001 114.315 -169.757 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.3 m -120.41 153.14 36.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 119.233 1.517 . . . . 1.45 111.749 177.387 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 p -101.5 152.28 20.95 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.344 1.429 . . . . 0.89000000000000001 113.358 175.034 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.1 m -136.41 155.03 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.803 1.641 . . . . 0.54000000000000004 111.41 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.91 143.97 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.487 1.515 . . . . 0.91000000000000003 112.802 -179.285 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.45 147.91 29.97 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.394 1.078 . . . . 0.59999999999999998 112.663 -178.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.98 -6.26 49.76 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.599 -1.112 . . . . 0.76000000000000001 115.705 178.081 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.8 p -79.26 163.37 25.0 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.964 1.382 . . . . 1.29 111.844 169.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mm -110.93 129.93 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.351 1.06 . . . . 0.68000000000000005 111.253 -173.185 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -92.03 135.21 34.14 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.816 1.646 . . . . 1.8600000000000001 110.858 176.303 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -88.77 -107.01 0.08 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.215 1.191 . . . . 3.4399999999999999 114.215 -173.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -82.24 -45.44 15.02 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 116.722 2.119 . . . . 3.1400000000000001 116.722 -166.827 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.41 140.72 15.19 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.069 0.849 . . . . 1.9299999999999999 113.539 -172.655 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.1 p -82.93 137.15 34.32 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.652 0.726 . . . . 1.6000000000000001 112.53 171.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.1 mt -130.03 156.17 44.93 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.953 1.301 . . . . 0.93999999999999995 112.079 -170.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.97 122.21 42.53 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.366 1.067 . . . . 2.6699999999999999 110.82 174.757 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -115.6 123.02 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.799 1.239 . . . . 1.48 111.895 -173.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 74.8 m -79.51 120.24 23.61 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.674 -1.267 . . . . 2.2799999999999998 108.956 168.258 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.88 118.24 20.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.644 -0.502 . . . . 0.78000000000000003 109.644 173.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.7 p -108.72 -0.28 20.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.39 1.076 . . . . 2.1499999999999999 113.31 175.226 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -137.96 139.65 39.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.093 1.357 . . . . 1.6499999999999999 111.618 176.437 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 m -78.84 157.18 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.702 -0.851 . . . . 1.5600000000000001 108.702 165.52 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.74 -35.24 73.45 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 120.954 -1.091 . . . . 1.3600000000000001 115.569 -169.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.22 64.43 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.629 1.344 . . . . 1.8 114.629 174.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -80.18 -8.18 59.31 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.814 1.646 . . . . 2.54 115.274 173.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 37.4 p -58.86 158.22 8.56 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.609 1.337 . . . . 1.6100000000000001 114.609 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.7 m -60.68 -35.65 76.79 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.711 0.804 . . . . 3.25 111.035 170.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.63 -43.64 96.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.208 1.003 . . . . 1.47 112.101 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.9 p -72.95 -21.84 60.81 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.901 1.074 . . . . 2.1699999999999999 113.901 170.092 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -70.44 -38.28 74.5 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.606 -1.309 . . . . 2.04 112.01 174.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.22 -52.39 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.848 1.259 . . . . 1.3500000000000001 110.741 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -65.63 -28.28 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.285 0.948 . . . . 1.3899999999999999 112.951 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -63.17 -40.75 98.44 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.281 0.946 . . . . 3.2799999999999998 111.019 172.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.19 -46.28 61.62 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.672 1.189 . . . . 2.6499999999999999 112.718 178.697 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.91 -26.44 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.239 -0.913 . . . . 1.8200000000000001 113.096 -178.493 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.63 -25.9 63.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.003 -1.061 . . . . 3.77 112.167 175.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -71.8 -19.93 61.92 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.258 1.023 . . . . 4.2699999999999996 113.327 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.95 -57.17 4.24 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.842 -1.162 . . . . 3.5899999999999999 112.711 -176.641 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 124.265 1.026 . . . . 4.3399999999999999 112.483 -177.477 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 117.249 2.314 . . . . 4.0199999999999996 117.249 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -98.21 -36.2 10.12 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 120.174 -1.579 . . . . 5.5599999999999996 111.961 173.196 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.06 86.24 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.795 0.838 . . . . 2.2799999999999998 111.28 168.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.9 tp -42.01 -31.04 0.31 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.533 2.733 . . . . 1.8899999999999999 115.861 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.97 -32.67 65.37 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.187 1.18 . . . . 2.0499999999999998 114.187 177.566 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.98 -30.55 68.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.822 1.249 . . . . 5.6500000000000004 112.497 -170.14 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -53.16 -37.29 61.74 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.803 1.641 . . . . 0.96999999999999997 112.51 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -75.84 -35.93 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.962 1.305 . . . . 1.52 112.821 175.358 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.1 m -72.82 -39.74 66.37 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.039 1.126 . . . . 1.29 114.039 -175.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.21 -18.01 65.06 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.301 1.223 . . . . 2.1899999999999999 114.301 -173.056 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -70.09 141.33 52.77 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.273 1.029 . . . . 2.2799999999999998 112.829 -172.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.04 139.1 30.79 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.583 0.957 . . . . 2.23 113.583 -176.013 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -90.69 -8.18 50.61 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.565 1.546 . . . . 1.78 113.868 -171.364 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.01 160.85 38.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.142 1.377 . . . . 3.6600000000000001 113.896 -179.236 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.04 166.37 24.89 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.812 1.645 . . . . 0.93999999999999995 112.005 176.03 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.9 m -117.62 105.38 11.98 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.624 1.17 . . . . 1.1200000000000001 111.322 169.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.0 mt -82.87 130.44 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.482 1.113 . . . . 0.81000000000000005 108.925 177.034 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -126.52 128.11 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 121.501 -0.749 . . . . 1.8600000000000001 112.139 -176.314 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.4 m -91.16 130.48 37.05 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.737 1.215 . . . . 2.98 109.56 169.67 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.91 3.01 8.08 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.545 1.313 . . . . 6.0599999999999996 114.545 -169.376 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 t70 20.77 -92.61 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 130.65 3.58 . . . . 8.7200000000000006 114.252 -177.343 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 m -29.61 -52.63 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.288 2.635 . . . . 7.71 115.853 178.465 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -164.92 -85.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.191 1.396 . . . . 11.02 107.848 176.141 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.99 10.31 4.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.092 1.757 . . . . 8.3100000000000005 112.073 175.808 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 pt -111.71 -11.27 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 117.942 2.571 . . . . 8.1300000000000008 117.942 -164.348 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -69.23 -32.18 71.25 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.164 1.347 . . . . 4.8099999999999996 114.074 -172.157 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.4 mp 53.49 66.18 1.3 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.351 1.612 . . . . 3.8700000000000001 115.351 174.157 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.6 t -112.58 109.82 19.6 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.373 1.069 . . . . 1.7 108.409 166.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -107.9 145.01 34.34 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.622 0.971 . . . . 2.7599999999999998 113.622 -168.849 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -124.02 128.53 49.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.511 1.924 . . . . 3.1699999999999999 109.97 173.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -91.86 124.05 35.7 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.208 -0.932 . . . . 2.1200000000000001 109.228 173.576 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 m -136.51 162.75 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.505 1.298 . . . . 1.1200000000000001 114.505 -169.667 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.47 147.99 35.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.001 1.321 . . . . 2.7000000000000002 111.653 169.412 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -57.68 -22.81 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.694 0.998 . . . . 1.25 113.694 -178.75 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.52 -12.79 61.56 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.624 -1.298 . . . . 3.7400000000000002 113.258 175.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.87 -2.07 21.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.318 1.447 . . . . 1.55 113.863 -171.009 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.39 148.26 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.862 1.265 . . . . 1.47 110.571 170.109 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -137.56 165.68 25.74 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.176 1.391 . . . . 2.8500000000000001 113.379 -178.538 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.0 ptt85 -67.51 25.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 118.463 2.764 . . . . 2.6099999999999999 118.463 -168.178 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.32 9.7 1.28 Allowed Glycine 0 CA--C 1.54 1.629 0 C-N-CA 126.122 1.82 . . . . 1.0600000000000001 114.387 171.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -83.83 155.79 22.79 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.039 1.42 . . . . 2.7200000000000002 112.408 175.134 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 mt -111.8 124.99 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.51 0.724 . . . . 1.3300000000000001 110.254 172.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.1 mm -121.61 129.28 75.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 127.268 2.227 . . . . 0.78000000000000003 110.452 -169.38 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -92.04 128.7 37.98 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.339 -0.851 . . . . 2.21 110.536 171.3 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -102.76 135.4 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.837 1.255 . . . . 0.76000000000000001 110.346 -177.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.0 m -89.2 156.05 48.94 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.288 1.035 . . . . 1.24 112.433 -178.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -59.19 143.28 99.82 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.929 1.753 . . . . 1.27 111.641 168.796 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.05 -6.85 3.58 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.313 0.958 . . . . 1.3300000000000001 114.427 -169.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.7 151.16 50.28 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 119.246 1.523 . . . . 1.1499999999999999 113.054 177.342 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -103.03 142.8 33.49 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.826 1.25 . . . . 1.97 110.875 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -75.49 125.25 88.92 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.881 -0.512 . . . . 2.3199999999999998 112.059 -179.352 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.3 -25.46 3.88 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.88 2.387 . . . . 0.93999999999999995 113.922 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.3 m -151.97 171.95 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 127.711 2.404 . . . . 0.80000000000000004 109.057 -176.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.22 151.26 19.93 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.646 0.778 . . . . 2.27 112.229 177.109 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.74 -172.08 41.85 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 116.139 1.216 . . . . 0.75 116.139 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -108.37 129.26 55.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.66 1.584 . . . . 4.3300000000000001 111.703 -175.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.2 t -87.29 127.96 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.115 2.166 . . . . 0.76000000000000001 109.218 -176.005 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.4 pt -142.12 29.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 113.728 1.01 . . . . 1.01 113.728 -172.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.22 141.45 1.61 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.784 1.634 . . . . 2.9199999999999999 109.534 165.093 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.75 -174.75 41.4 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 122.433 1.018 . . . . 0.75 114.98 170.162 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.43 103.96 3.19 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.135 0.974 . . . . 2.9100000000000001 111.07 -167.845 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -144.44 172.73 12.54 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.212 0.819 . . . . 1.0700000000000001 113.212 -172.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.5 ttm -124.71 133.64 53.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.981 1.312 . . . . 1.03 110.04 -176.647 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -123.28 137.34 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.27 1.428 . . . . 0.81999999999999995 111.637 -169.063 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -95.71 103.63 15.52 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.87 1.268 . . . . 2.1800000000000002 110.682 -176.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -108.6 -1.5 19.55 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.669 1.588 . . . . 2.0600000000000001 113.677 -170.343 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 p -53.4 -33.06 52.41 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.552 2.056 . . . . 1.4199999999999999 116.552 -169.28 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.23 -44.34 22.0 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.652 1.569 . . . . 1.1399999999999999 110.775 173.853 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mm -62.04 -49.11 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.215 1.806 . . . . 1.2 111.621 -174.311 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.9 p -118.27 -2.68 11.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.009 1.114 . . . . 1.3700000000000001 114.009 -171.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.24 18.91 70.55 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.924 1.249 . . . . 1.1299999999999999 114.732 178.027 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -61.08 -179.12 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.543 1.137 . . . . 2.77 111.138 168.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.05 -20.35 0.88 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.322 1.449 . . . . 1.72 114.141 177.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -125.58 153.22 72.73 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.827 2.051 . . . . 3.04 110.336 167.763 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.0 165.83 31.43 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.237 2.625 . . . . 1.6699999999999999 114.019 -174.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.17 133.43 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 127.047 2.139 . . . . 0.94999999999999996 112.191 -168.596 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.88 141.03 36.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.35 1.06 . . . . 0.72999999999999998 113.567 178.796 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -126.08 150.0 48.49 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.662 1.985 . . . . 0.81999999999999995 111.38 178.254 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 17.5 ptpt -144.41 176.29 2.33 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.543 2.337 . . . . 2.3599999999999999 110.257 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 37.5 Cg_endo -60.47 131.01 36.02 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 CA-C-N 122.047 1.767 . . . . 0.83999999999999997 110.463 167.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.05 28.68 33.48 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 118.092 -1.393 . . . . 0.83999999999999997 114.805 -171.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.3 m -108.02 174.14 6.01 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.853 1.826 . . . . 1.5800000000000001 110.959 174.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -125.79 156.44 39.5 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.437 -1.414 . . . . 0.89000000000000001 112.831 175.198 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.09 146.16 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.716 1.606 . . . . 0.57999999999999996 112.648 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.85 152.3 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.73 2.412 . . . . 0.98999999999999999 112.42 170.288 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.46 155.19 38.25 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.733 0.813 . . . . 0.90000000000000002 112.158 177.02 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.53 -1.37 52.05 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.519 1.057 . . . . 0.94999999999999996 115.543 176.467 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 p -76.86 162.81 27.32 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.066 1.433 . . . . 1.6100000000000001 112.306 172.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.76 137.98 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.722 1.209 . . . . 0.77000000000000002 111.082 -174.384 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -84.31 134.73 34.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.199 1.0 . . . . 2.52 111.152 170.119 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.26 50.92 1.49 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.135 1.532 . . . . 3.7400000000000002 115.135 179.214 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -163.97 -36.43 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.1 1.518 . . . . 3.3799999999999999 115.1 171.12 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.26 169.74 28.22 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-N 120.197 1.362 . . . . 1.97 115.411 -171.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.0 m -69.56 137.46 52.42 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.547 1.314 . . . . 1.9399999999999999 114.547 -171.192 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.49 159.98 31.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.547 1.939 . . . . 1.0800000000000001 110.415 171.622 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.4 tp -114.07 126.51 55.18 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.037 0.935 . . . . 2.77 110.778 173.193 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.36 132.43 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.842 1.257 . . . . 1.1399999999999999 111.272 -170.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 46.7 t -87.18 121.17 29.28 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.529 -0.915 . . . . 3.3199999999999998 108.529 168.008 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.93 130.48 35.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.083 0.953 . . . . 0.82999999999999996 110.604 -178.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.9 p -120.72 9.05 10.67 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.555 1.317 . . . . 2.1299999999999999 114.555 -175.523 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -149.04 155.15 40.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.428 1.491 . . . . 2.4100000000000001 111.575 168.499 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.33 164.03 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 108.71 -0.848 . . . . 1.5800000000000001 108.71 163.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 -39.66 95.55 Favored Glycine 0 N--CA 1.473 1.155 0 O-C-N 120.719 -1.238 . . . . 1.3999999999999999 113.536 -170.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.72 77.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.417 1.109 . . . . 1.8200000000000001 113.27 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -77.37 -6.65 54.09 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.127 1.528 . . . . 2.6299999999999999 115.127 175.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.0 p -63.62 148.21 49.52 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.686 -1.259 . . . . 1.6699999999999999 111.182 174.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.6 m -65.27 -34.38 78.22 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.506 -0.746 . . . . 3.6499999999999999 110.312 169.857 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.1 tp -49.34 -51.87 31.73 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.435 1.494 . . . . 1.6799999999999999 112.565 172.485 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.2 m -74.37 -24.15 59.11 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.1 1.148 . . . . 2.4700000000000002 114.1 177.071 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -71.45 -40.5 70.32 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.879 1.271 . . . . 2.4399999999999999 112.75 173.438 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.2 mt -51.63 -46.48 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.271 1.028 . . . . 1.47 111.71 -178.033 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m -66.49 -22.93 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.936 1.087 . . . . 1.3 113.936 179.488 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -74.17 -44.85 51.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.104 0.962 . . . . 2.9900000000000002 112.006 169.014 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.8 mt -70.16 -46.47 64.61 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.849 1.66 . . . . 3.3799999999999999 112.74 -173.23 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.32 -48.17 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.029 0.532 . . . . 2.25 109.901 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.18 -31.05 68.65 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.018 1.118 . . . . 3.0600000000000001 114.018 179.453 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -76.23 -36.37 58.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.966 1.099 . . . . 3.77 113.966 169.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.32 -17.21 62.46 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.281 1.586 . . . . 4.5899999999999999 115.281 -169.374 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 126.241 1.817 . . . . 5.8700000000000001 111.951 175.877 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 111.631 0.234 . . . . 1.6 111.631 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.9 tp -51.42 -34.24 33.93 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.706 1.602 . . . . 2.58 114.341 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.32 -44.86 20.78 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.395 0.887 . . . . 2.14 113.395 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -61.38 -34.51 75.46 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.587 1.155 . . . . 3.1 113.299 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.25 -49.76 6.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.511 1.524 . . . . 0.97 112.117 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -74.37 -30.42 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.836 1.05 . . . . 2.22 113.836 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -67.3 -27.62 67.32 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.544 -0.722 . . . . 1.99 112.265 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.73 -14.58 59.27 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.998 1.481 . . . . 2.6 114.998 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -63.4 129.3 39.67 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 120.55 1.523 . . . . 3.09 112.142 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.46 158.6 33.39 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.993 1.317 . . . . 1.87 112.159 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.1 p -98.34 -24.54 15.17 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 116.061 1.874 . . . . 3.15 116.061 -168.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.27 159.48 37.72 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.88 1.067 . . . . 4.21 113.88 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.86 149.39 40.22 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.596 1.558 . . . . 1.07 111.762 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 m -95.01 109.18 21.25 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.502 0.721 . . . . 1.57 112.649 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.7 mt -81.09 140.18 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.646 1.178 . . . . 1.33 108.616 169.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.72 127.01 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.102 0.953 . . . . 2.05 112.173 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 92.9 m . . . . . 0 N--CA 1.468 0.452 0 C-N-CA 127.67 2.388 . . . . 2.13 109.979 -170.08 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--O 1.237 0.446 0 CA-C-O 120.432 0.158 . . . . 3.17 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.4 t -133.04 140.05 47.51 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.725 2.01 . . . . 2.0 110.009 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.08 149.15 39.41 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.796 0.838 . . . . 2.67 112.506 -168.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.85 126.31 30.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.849 1.66 . . . . 2.69 110.765 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -87.01 126.82 34.99 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.851 -1.155 . . . . 2.05 108.761 167.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.48 162.19 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.211 1.405 . . . . 1.21 111.763 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.97 147.53 42.95 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.29 0.567 . . . . 3.91 111.124 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -56.26 -23.91 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 114.686 1.365 . . . . 1.4 114.686 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.57 -13.71 60.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.549 1.315 . . . . 3.84 114.549 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.7 mt -106.67 -13.38 15.3 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.956 1.302 . . . . 1.47 113.818 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.97 142.36 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.052 1.341 . . . . 1.56 110.647 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -114.71 161.24 18.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.483 1.113 . . . . 2.96 113.333 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -76.27 31.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.499 1.666 . . . . 4.31 115.499 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.7 0.21 4.96 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 127.834 2.635 . . . . 1.11 113.725 169.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -89.68 160.41 16.62 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.339 1.456 . . . . 2.19 112.139 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.4 mt -118.77 128.55 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.583 1.553 . . . . 1.22 108.368 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.4 mm -120.3 136.54 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.304 1.441 . . . . 0.85 113.933 -166.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -78.14 143.75 37.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.774 1.23 . . . . 2.36 112.303 172.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.13 132.68 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.695 0.798 . . . . 0.78 110.808 167.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.436 ' HB ' ' HD2' ' A' ' 47' ' ' PRO . 10.9 m -102.47 166.97 11.07 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 125.278 1.431 . . . . 1.17 112.282 -169.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 46' ' ' VAL . 36.3 Cg_endo -61.13 120.83 8.73 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.885 1.723 . . . . 0.97 111.626 171.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.63 -6.17 82.18 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 126.638 2.066 . . . . 0.95 115.159 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.18 154.4 46.24 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 119.123 1.461 . . . . 1.01 114.285 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -109.14 152.92 24.46 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.929 1.292 . . . . 1.99 111.852 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -89.13 126.8 57.75 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.813 1.042 . . . . 2.29 113.813 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.18 -22.24 3.45 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.028 3.152 . . . . 1.47 114.532 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.4 m -143.64 170.54 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.206 2.202 . . . . 1.32 109.41 -176.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.31 166.64 17.27 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.072 0.549 . . . . 2.54 110.811 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.98 -175.53 47.08 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.936 1.134 . . . . 1.07 115.936 170.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -105.29 142.33 35.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.617 1.567 . . . . 3.72 111.277 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.08 131.17 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.367 2.267 . . . . 1.17 110.27 -171.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.07 30.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 113.549 0.944 . . . . 1.0 113.549 -175.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -170.62 144.97 2.45 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.119 2.568 . . . . 3.15 107.213 168.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.48 179.61 46.51 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 116.612 1.405 . . . . 1.53 116.612 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -152.1 41.76 0.66 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.902 1.815 . . . . 2.98 115.902 -166.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.683 ' H ' HD21 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -75.88 156.53 34.25 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.409 -1.432 . . . . 1.2 113.19 -178.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 42.7 ttm -96.67 127.21 42.44 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.928 -0.767 . . . . 1.31 108.928 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.9 t -112.95 129.05 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 124.58 1.152 . . . . 1.05 110.685 -170.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -91.66 105.64 17.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.538 0.735 . . . . 2.25 110.775 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -117.8 23.61 11.58 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.888 2.075 . . . . 2.41 113.004 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 93.0 p -63.82 -18.58 64.26 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 116.659 2.096 . . . . 1.68 116.659 -169.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.84 -48.86 7.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.441 1.096 . . . . 1.42 109.907 169.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.88 -58.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.82 1.248 . . . . 1.64 111.722 -172.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.4 p -103.9 -12.35 16.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.298 1.039 . . . . 1.75 112.66 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.63 -3.02 85.05 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.484 -1.176 . . . . 1.79 114.737 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -63.94 103.47 0.59 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.585 1.192 . . . . 3.13 110.693 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.97 -17.51 61.46 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.815 -1.178 . . . . 1.62 111.577 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.69 103.9 42.82 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 128.099 2.56 . . . . 5.12 107.947 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -55.35 147.13 58.14 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.725 2.95 . . . . 2.35 114.19 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.5 t -94.21 125.26 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.744 1.218 . . . . 1.24 111.944 -167.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.18 141.29 38.76 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.709 -0.619 . . . . 1.13 111.72 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -115.08 169.54 9.03 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.796 1.638 . . . . 1.54 111.526 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -157.15 169.33 10.8 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 127.714 2.406 . . . . 3.89 110.727 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.18 135.1 48.93 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 CA-C-N 121.451 1.554 . . . . 1.35 108.41 165.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.88 39.37 17.13 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.28 0.943 . . . . 1.17 113.253 -168.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 t -124.76 174.26 8.02 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.624 1.57 . . . . 1.95 111.254 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 p -133.26 150.59 51.92 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.518 -1.363 . . . . 1.27 112.566 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.06 161.84 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 125.411 1.485 . . . . 0.94 112.79 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.0 150.31 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.298 1.839 . . . . 1.32 113.435 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.67 148.33 24.86 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.038 1.335 . . . . 1.06 112.944 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.88 -4.1 67.19 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 115.333 0.893 . . . . 0.96 115.333 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 97.6 p -84.61 160.02 20.5 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.498 1.149 . . . . 1.34 111.969 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mm -113.21 127.13 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.469 1.107 . . . . 0.95 112.203 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -93.9 144.0 25.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.238 1.415 . . . . 1.91 113.083 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -157.6 145.95 19.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.884 1.274 . . . . 3.86 111.332 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 46.54 87.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.504 2.322 . . . . 3.9 113.585 168.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.38 -13.42 2.28 Favored Glycine 0 CA--C 1.542 1.761 0 N-CA-C 116.251 1.26 . . . . 3.89 116.251 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.2 m 40.1 108.61 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 130.964 3.706 . . . . 2.61 117.322 170.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.683 HD21 ' H ' ' A' ' 62' ' ' SER . 57.4 mt -106.33 160.37 15.42 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.987 1.106 . . . . 1.88 113.987 -169.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.68 121.28 41.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.332 1.853 . . . . 3.11 108.476 168.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.45 126.23 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.653 0.781 . . . . 1.41 111.167 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.81 121.51 30.31 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.375 -0.828 . . . . 1.61 109.999 168.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.65 129.95 35.04 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.2 0.6 . . . . 0.96 112.147 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.9 p -117.77 -6.12 11.07 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.85 1.66 . . . . 2.35 113.968 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -138.98 148.78 43.93 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.649 1.98 . . . . 2.29 110.242 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.5 m -92.42 -174.05 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.583 1.153 . . . . 1.94 112.638 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.65 -33.16 83.58 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.857 -1.152 . . . . 2.78 113.557 -171.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.52 -51.67 11.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.265 1.426 . . . . 2.51 112.888 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.29 -8.13 53.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.499 1.919 . . . . 3.58 115.551 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 109' ' ' SER . 4.6 t -48.17 146.56 2.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.974 2.109 . . . . 2.8 114.872 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 t -62.1 -21.77 65.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.079 0.552 . . . . 2.66 111.992 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.5 tp -59.89 -41.18 91.03 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.647 -1.283 . . . . 1.71 111.897 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.515 ' H ' HG23 ' A' ' 106' ' ' THR . 8.8 t -73.26 -27.38 61.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.475 1.11 . . . . 2.68 111.564 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -70.06 -39.6 75.58 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.408 -0.807 . . . . 2.43 112.146 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.8 mt -60.04 -44.68 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.668 1.587 . . . . 2.27 111.657 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 115.249 1.574 . . . . 2.12 115.249 -178.07 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 119.693 -0.194 . . . . 2.14 111.095 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.28 -32.16 47.35 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.378 1.071 . . . . 2.05 113.405 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.51 -54.21 7.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.759 0.824 . . . . 2.1 112.63 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -54.53 -36.98 64.84 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.463 1.505 . . . . 2.52 113.002 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.77 -38.96 67.87 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.457 1.103 . . . . 1.24 113.491 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.8 mm -74.66 -34.07 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 118.954 0.797 . . . . 1.49 112.811 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -69.52 -25.34 63.99 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.247 -0.908 . . . . 1.35 112.43 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.31 -15.77 63.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.36 2.264 . . . . 2.43 114.873 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -73.56 140.72 46.47 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.692 1.197 . . . . 2.22 112.257 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.42 165.39 15.6 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.578 1.151 . . . . 1.79 112.47 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -93.7 -41.99 9.4 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.354 0.872 . . . . 2.53 113.354 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -125.37 158.97 32.96 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.135 1.531 . . . . 4.29 115.135 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.55 149.83 47.02 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.646 1.578 . . . . 0.92 111.311 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.7 m -106.43 108.8 20.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.233 1.013 . . . . 0.94 112.052 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.7 mt -90.09 132.9 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.217 1.807 . . . . 0.92 109.576 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.23 139.55 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.609 0.719 . . . . 1.98 112.442 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.9 m . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 126.733 2.013 . . . . 1.86 110.402 -172.772 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 109.533 -0.543 . . . . 2.29 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 t -123.48 122.04 37.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.413 1.485 . . . . 1.95 108.991 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -116.41 141.42 48.19 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.519 1.128 . . . . 2.28 110.012 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -136.02 132.94 36.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.903 1.281 . . . . 2.85 110.616 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -100.1 134.56 42.85 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 119.344 0.974 . . . . 1.66 110.506 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -138.75 163.47 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.656 1.182 . . . . 0.86 112.104 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.19 146.63 43.23 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.9 -0.778 . . . . 3.13 108.9 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -63.75 -1.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 114.997 1.48 . . . . 1.19 114.997 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -83.48 -17.17 42.92 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.648 1.579 . . . . 3.95 114.855 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.4 -9.32 14.95 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.937 1.458 . . . . 1.33 114.937 -165.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.35 151.21 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 125.677 1.591 . . . . 1.46 109.743 168.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.71 160.26 24.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.099 1.148 . . . . 3.81 114.099 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -74.71 47.13 0.31 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.25 1.82 . . . . 4.86 113.892 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.27 23.12 0.23 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.312 1.434 . . . . 1.18 113.545 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -129.36 172.57 11.36 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.032 1.733 . . . . 2.86 111.316 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 mm -108.29 123.89 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.566 1.946 . . . . 1.42 110.038 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.1 mm -117.16 126.45 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.406 1.482 . . . . 0.9 110.1 -170.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HE3' HD11 ' A' ' 96' ' ' LEU . 44.7 mtpt -94.06 139.98 30.3 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.936 0.717 . . . . 2.9 112.936 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.11 153.24 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.689 1.196 . . . . 1.16 112.133 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.94 165.52 23.42 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 125.654 1.581 . . . . 1.83 112.693 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.5 124.16 14.89 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.069 2.513 . . . . 1.41 112.156 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.68 -13.68 61.94 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.154 1.835 . . . . 1.6 115.728 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.56 -8.52 76.5 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 116.992 1.557 . . . . 4.39 116.992 -172.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.0 mttt 61.88 158.87 0.06 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 127.871 2.469 . . . . 1.63 115.463 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -92.51 119.02 68.25 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.144 0.977 . . . . 2.13 111.01 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -87.45 -13.16 4.33 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.914 2.409 . . . . 0.77 114.618 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -147.47 168.26 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.496 1.918 . . . . 1.09 110.503 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.57 145.39 30.38 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.707 0.803 . . . . 1.7 113.117 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.05 -159.11 32.39 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 114.484 0.554 . . . . 0.7 114.484 -173.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -108.84 140.19 42.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.033 1.333 . . . . 3.6 112.925 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.85 132.14 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 127.878 2.471 . . . . 0.69 107.789 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.9 pt -140.05 29.34 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 119.378 0.99 . . . . 1.16 112.914 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.97 137.6 3.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.06 1.344 . . . . 3.51 108.984 169.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.83 -178.71 53.17 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 122.549 1.083 . . . . 0.81 114.717 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.28 136.57 31.75 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.487 1.515 . . . . 2.52 111.502 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 m -148.32 156.75 42.91 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.05 1.129 . . . . 1.65 114.05 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 29.4 ttm -104.79 133.87 48.88 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.665 -1.235 . . . . 0.99 107.665 167.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.1 t -126.47 138.99 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.927 1.291 . . . . 0.82 112.48 -167.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -93.09 103.03 15.36 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.585 1.554 . . . . 2.25 109.984 173.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -128.2 3.31 5.79 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.906 1.682 . . . . 1.82 115.115 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.6 p -47.33 -29.62 2.65 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.256 1.822 . . . . 1.63 115.399 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.86 -38.07 46.86 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.635 1.174 . . . . 1.44 112.115 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.95 -62.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.87 2.068 . . . . 1.23 111.198 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 p -88.85 -12.73 41.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.74 1.616 . . . . 1.37 112.577 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.74 19.24 60.13 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.76 1.171 . . . . 1.75 114.209 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -74.8 -167.73 0.62 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.336 1.455 . . . . 2.93 111.333 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.91 13.35 1.67 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.001 1.482 . . . . 2.29 115.001 -171.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -158.23 154.24 23.5 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.672 1.589 . . . . 3.8 111.061 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -58.97 141.26 98.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.54 2.827 . . . . 1.72 113.048 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.2 t -114.04 137.05 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.833 2.053 . . . . 1.09 111.735 -169.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.6 133.56 33.7 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.221 -0.924 . . . . 0.86 112.746 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -129.21 140.84 51.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.127 2.171 . . . . 1.17 109.921 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 15.1 ptpt -148.82 -177.19 0.63 Allowed Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 126.223 1.809 . . . . 3.96 110.287 -169.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 59.5 Cg_endo -69.31 132.96 25.19 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 122.703 2.001 . . . . 1.04 110.674 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.09 7.22 68.22 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 126.222 1.867 . . . . 1.18 114.784 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.3 t -101.56 152.35 20.89 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.105 1.952 . . . . 1.66 111.86 -170.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.0 p -105.22 145.91 29.99 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.877 -1.139 . . . . 0.74 113.356 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 m -137.54 161.41 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.902 1.681 . . . . 0.53 112.183 -172.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.95 147.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.138 1.775 . . . . 0.93 113.419 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.17 150.36 30.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.701 1.2 . . . . 0.59 112.604 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.16 -3.63 51.48 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.239 0.924 . . . . 0.77 115.227 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.8 p -80.97 156.86 25.74 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.331 1.066 . . . . 1.38 111.85 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mm -107.77 123.52 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.503 0.721 . . . . 0.81 110.763 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -83.12 128.29 34.35 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.825 -0.806 . . . . 2.0 108.825 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.86 43.9 2.68 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.28 1.215 . . . . 3.68 114.28 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -157.92 -38.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.494 2.405 . . . . 3.69 117.494 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.38 -175.87 27.84 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 120.626 1.557 . . . . 2.25 116.743 -168.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -116.02 122.68 45.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.624 1.169 . . . . 1.69 111.944 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.1 mt -125.78 165.4 18.72 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.047 1.339 . . . . 0.97 113.823 -170.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.467 HD11 ' HE3' ' A' ' 44' ' ' LYS . 8.5 mp -112.37 122.7 48.46 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.507 1.523 . . . . 2.34 109.006 167.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.28 129.63 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.65 1.18 . . . . 1.28 110.952 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 29.2 p -86.51 120.08 27.45 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.466 -0.771 . . . . 1.65 109.945 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.93 131.18 37.34 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.306 -0.871 . . . . 1.03 111.159 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.91 -12.33 11.41 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.65 0.981 . . . . 3.3 113.65 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -141.58 143.47 33.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.372 1.469 . . . . 2.22 109.227 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.5 p -75.93 158.99 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 107.755 -1.202 . . . . 3.43 107.755 166.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.16 -39.64 71.43 Favored Glycine 0 N--CA 1.477 1.411 0 CA-C-N 121.231 1.832 . . . . 1.84 115.196 -167.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -34.17 77.15 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.621 0.971 . . . . 2.67 113.621 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -77.87 -10.33 59.51 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.759 2.424 . . . . 2.85 115.392 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.7 p -66.49 156.19 35.51 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.355 0.872 . . . . 1.59 113.355 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.2 t -57.62 -33.8 68.62 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.741 -0.6 . . . . 1.98 112.174 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.1 tp -56.14 -49.56 73.59 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.937 1.295 . . . . 1.58 111.963 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -72.98 -24.16 60.74 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.324 1.45 . . . . 2.57 113.515 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -70.69 -48.16 56.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.397 1.079 . . . . 1.37 112.04 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.2 mt -53.05 -51.97 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.909 0.883 . . . . 1.42 111.832 -169.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 114.044 1.127 . . . . 1.31 114.044 -177.459 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 112.927 0.714 . . . . 1.68 112.927 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.33 -29.15 69.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.671 0.788 . . . . 1.66 112.924 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.82 -25.68 49.01 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.981 1.104 . . . . 1.59 113.981 169.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.81 -42.97 80.71 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.864 1.266 . . . . 2.67 112.971 -167.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -49.85 -42.48 47.6 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.195 1.398 . . . . 1.06 112.417 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.6 mm -72.47 -35.56 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.362 1.065 . . . . 1.82 112.564 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.3 m -70.69 -27.76 64.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.093 0.957 . . . . 1.44 113.331 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 mp -66.39 -25.73 66.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.177 0.806 . . . . 2.28 113.177 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -61.64 131.16 49.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.338 0.972 . . . . 2.59 112.209 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.31 159.47 23.87 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.96 1.096 . . . . 1.82 113.96 -169.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.5 m -86.84 -30.32 21.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.72 1.208 . . . . 3.11 112.338 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -141.88 161.0 39.07 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.712 1.745 . . . . 4.08 115.712 -168.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.23 162.73 34.78 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.826 2.05 . . . . 1.08 111.97 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.6 m -121.89 104.55 9.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.102 1.361 . . . . 1.05 112.237 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.0 mt -83.43 133.49 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.109 1.364 . . . . 0.67 110.503 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.7 m -126.33 144.66 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.358 1.614 . . . . 2.03 115.358 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 125.527 1.531 . . . . 2.73 111.432 -179.723 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 CA--C 1.546 0.823 0 CA-C-O 121.882 0.848 . . . . 2.93 112.295 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -126.41 143.6 51.12 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.603 1.561 . . . . 1.61 110.739 -173.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -128.17 132.58 48.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.54 1.136 . . . . 2.78 110.843 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -108.96 132.99 53.55 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.835 1.254 . . . . 2.8 110.392 170.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -101.54 114.92 29.38 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.687 1.13 . . . . 2.69 110.69 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.23 159.2 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.235 1.414 . . . . 1.46 113.567 -168.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.83 154.41 33.9 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.441 1.097 . . . . 3.61 111.025 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.62 -21.91 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 114.145 1.165 . . . . 1.46 114.145 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -73.29 -15.19 61.41 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.487 -1.383 . . . . 3.33 113.587 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.4 mt -99.84 -1.08 38.41 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.512 1.525 . . . . 2.17 114.422 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.33 146.37 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.579 1.552 . . . . 1.59 111.359 173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -120.53 165.75 14.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.848 1.659 . . . . 3.36 112.711 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -68.69 26.03 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.224 1.935 . . . . 2.7 116.224 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.69 14.58 1.99 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 126.565 2.031 . . . . 1.1 114.073 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -97.91 162.75 13.09 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 119.176 1.488 . . . . 2.61 112.845 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 87.6 mt -118.56 130.94 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.257 1.423 . . . . 1.21 109.912 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.9 mm -121.19 130.89 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.824 1.649 . . . . 0.65 112.413 -168.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HE3' HD21 ' A' ' 96' ' ' LEU . 32.2 ttmt -93.68 124.26 37.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.606 0.762 . . . . 2.16 112.089 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.97 137.18 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.351 1.06 . . . . 0.73 112.414 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.53 158.47 54.32 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.455 1.102 . . . . 1.27 113.361 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -62.6 126.91 19.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.724 2.283 . . . . 1.83 111.377 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.66 -5.81 72.66 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.685 1.612 . . . . 1.09 114.786 -169.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.51 159.04 53.22 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.764 1.173 . . . . 1.04 114.431 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -112.69 141.9 45.94 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.547 1.139 . . . . 2.51 111.745 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.07 129.99 79.24 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 119.214 -0.422 . . . . 1.78 112.06 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -90.32 -21.7 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.391 2.727 . . . . 0.8 114.924 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.56 166.93 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 127.405 2.282 . . . . 0.96 109.049 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.21 140.86 29.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.081 0.855 . . . . 2.03 111.845 173.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.61 -173.57 44.83 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 114.737 0.655 . . . . 0.84 114.737 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -110.27 144.43 38.99 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.48 1.112 . . . . 6.43 113.204 -170.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.11 129.13 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.574 2.35 . . . . 0.93 109.755 -172.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.7 pt -142.86 30.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 114.225 1.194 . . . . 1.2 114.225 -171.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -168.81 143.83 3.28 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.608 1.963 . . . . 3.11 109.367 166.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.84 -170.91 44.31 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.08 0.792 . . . . 0.96 115.08 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -155.11 121.62 5.32 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.361 0.664 . . . . 2.94 112.098 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.9 t -143.57 168.79 19.03 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.633 1.173 . . . . 1.14 112.631 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.1 ttm -115.1 137.0 52.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.817 0.847 . . . . 1.2 111.458 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.93 142.47 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.302 1.841 . . . . 0.75 111.705 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.93 114.53 26.65 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.837 1.255 . . . . 1.9 110.96 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -114.22 14.2 18.08 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 114.379 1.252 . . . . 2.03 114.379 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.5 p -67.02 -3.35 6.98 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 117.922 2.564 . . . . 1.69 117.922 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.62 -41.62 3.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.937 1.695 . . . . 1.24 109.865 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.3 mm -76.01 -58.5 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.362 1.065 . . . . 1.17 111.453 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.1 p -102.03 -11.74 18.67 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.185 0.994 . . . . 1.33 112.958 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.65 16.22 75.91 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.735 1.159 . . . . 1.39 115.083 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -56.08 -38.12 70.24 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.396 1.098 . . . . 2.58 113.393 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 63.49 19.42 11.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.263 1.425 . . . . 1.32 114.134 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.6 ttm -148.29 134.42 9.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 129.589 3.156 . . . . 3.22 105.213 169.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.41 161.79 43.37 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.29 1.993 . . . . 1.43 112.81 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.5 t -124.7 122.28 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.279 1.432 . . . . 0.89 110.911 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.5 145.21 33.34 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.705 0.802 . . . . 1.04 112.628 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -124.32 159.74 29.62 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.021 2.128 . . . . 0.86 111.399 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -157.14 174.26 4.2 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 126.995 2.118 . . . . 2.73 110.732 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.25 130.1 32.69 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 CA-C-N 121.909 1.717 . . . . 1.23 109.497 166.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.18 43.21 10.9 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.713 0.673 . . . . 1.03 113.087 -169.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -131.76 167.03 20.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.265 1.426 . . . . 1.56 110.85 175.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.8 p -124.41 150.55 45.49 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 120.554 1.524 . . . . 1.26 113.034 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 m -135.01 163.03 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.945 1.298 . . . . 0.81 112.348 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.5 150.72 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.383 2.273 . . . . 1.03 110.67 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.76 150.88 47.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.411 0.684 . . . . 0.83 112.521 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.75 -5.94 55.9 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 115.355 0.902 . . . . 0.9 115.355 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.88 157.64 21.91 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.255 1.528 . . . . 2.73 111.456 169.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -110.12 131.21 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.438 1.095 . . . . 0.93 111.025 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -96.93 132.02 43.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.309 1.444 . . . . 1.97 111.211 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -84.89 -72.96 0.45 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.128 -0.982 . . . . 3.64 113.245 -170.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -157.85 142.95 16.75 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.556 2.343 . . . . 4.68 107.42 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.46 11.19 1.18 Allowed Glycine 0 CA--C 1.542 1.72 0 N-CA-C 117.452 1.741 . . . . 3.3 117.452 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.6 m 32.29 85.37 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.435 2.694 . . . . 1.8 117.036 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.8 mt -103.98 156.13 18.1 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.887 1.275 . . . . 1.38 113.524 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.477 HD21 ' HE3' ' A' ' 44' ' ' LYS . 65.1 mt -108.85 123.89 49.77 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.425 1.09 . . . . 2.54 110.492 167.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.55 124.66 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.485 1.514 . . . . 1.5 109.542 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.7 p -82.44 120.36 25.37 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.346 -0.846 . . . . 1.77 109.586 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.5 115.29 19.04 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.355 -0.841 . . . . 1.05 109.254 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.3 p -119.29 6.35 11.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.692 1.197 . . . . 2.08 113.524 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -147.66 145.48 28.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.109 1.763 . . . . 1.58 110.321 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.8 m -83.64 159.6 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.74 -0.837 . . . . 1.73 108.74 164.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.18 -38.87 79.29 Favored Glycine 0 N--CA 1.475 1.262 0 O-C-N 121.025 -1.047 . . . . 1.54 114.913 -168.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.16 90.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.355 1.077 . . . . 1.94 112.814 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -77.26 -9.21 58.66 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.249 1.574 . . . . 2.52 115.249 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.7 p -64.47 159.04 22.35 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.336 0.865 . . . . 1.66 113.336 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -66.1 -29.29 69.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.969 -0.56 . . . . 2.04 111.627 170.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.12 -46.3 88.68 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.657 -1.277 . . . . 1.65 112.255 171.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.6 m -68.41 -23.01 64.59 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.492 0.552 . . . . 1.63 112.492 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.24 -40.39 71.08 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.995 1.271 . . . . 2.5 112.033 169.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 82.4 mt -54.96 -50.23 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 120.26 1.391 . . . . 1.51 110.772 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 118.102 -0.951 . . . . 1.61 113.027 175.772 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.835 0 N-CA-C 112.309 0.485 . . . . 1.65 112.309 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.12 -33.12 71.43 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.911 1.284 . . . . 1.6 112.662 172.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.9 -29.77 58.56 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.827 0.677 . . . . 1.38 112.827 171.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.79 -41.1 77.11 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.111 -0.993 . . . . 2.45 112.001 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.58 -30.41 65.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.284 0.947 . . . . 1.6 113.112 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -75.25 -45.46 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.747 1.219 . . . . 2.05 112.409 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 m -75.66 -15.51 60.31 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.508 1.123 . . . . 1.52 113.401 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.0 tp -72.88 -24.49 60.86 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.579 2.751 . . . . 2.89 112.949 170.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -77.61 148.48 35.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.189 0.995 . . . . 2.45 113.407 -173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 163.4 27.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.397 1.479 . . . . 2.41 114.514 -171.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.7 p -109.0 -38.11 5.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.21 1.404 . . . . 2.47 112.965 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.84 154.76 51.08 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.613 1.565 . . . . 3.06 113.366 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.35 161.99 36.55 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.823 1.649 . . . . 0.73 113.358 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -118.61 103.2 9.48 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.462 1.105 . . . . 0.93 112.303 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.3 mt -83.56 134.71 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.888 1.275 . . . . 0.59 110.25 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.86 141.01 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.604 1.162 . . . . 1.71 110.283 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.471 0.592 0 C-N-CA 126.381 1.872 . . . . 1.74 110.118 -169.801 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 111.998 0.37 . . . . 3.05 111.998 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 t -138.92 140.04 38.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.35 1.86 . . . . 1.63 110.319 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -123.18 148.81 45.38 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.921 1.452 . . . . 2.39 114.921 -170.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -121.36 146.66 46.63 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.509 2.324 . . . . 3.4 110.325 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -111.83 132.09 54.92 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.422 1.01 . . . . 1.68 111.641 171.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.2 m -135.9 161.27 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.199 1.0 . . . . 0.74 113.03 -170.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.7 148.7 36.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.479 0.711 . . . . 3.39 109.786 168.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.22 -24.95 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 113.948 1.092 . . . . 1.17 113.948 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -64.4 -22.86 67.09 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.45 1.1 . . . . 4.24 113.566 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.3 mt -103.79 -6.83 21.06 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.742 1.617 . . . . 1.13 114.747 -168.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.02 140.48 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.147 0.979 . . . . 1.5 110.356 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.26 165.51 15.35 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.024 1.73 . . . . 3.05 111.312 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -75.02 11.48 1.1 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.722 1.749 . . . . 3.24 115.722 -175.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.38 6.31 16.81 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 126.562 2.029 . . . . 0.98 114.483 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -87.91 152.47 22.05 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 119.891 1.846 . . . . 2.97 112.777 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.0 mm -111.5 128.65 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.163 1.785 . . . . 1.74 109.813 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.8 mm -119.68 128.44 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.511 1.124 . . . . 0.67 112.903 -168.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -88.34 121.97 31.33 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 121.225 -0.922 . . . . 1.89 112.532 170.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.21 134.33 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.293 1.437 . . . . 0.68 111.3 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 m -97.32 163.69 19.3 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 124.61 1.164 . . . . 0.92 113.26 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.35 133.9 52.07 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.231 1.954 . . . . 0.91 111.334 167.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.46 -8.21 54.73 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.775 2.131 . . . . 0.92 115.098 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.76 161.77 54.28 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 118.536 1.168 . . . . 1.06 114.379 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -113.24 140.69 47.75 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.749 1.219 . . . . 1.69 111.006 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.49 123.16 88.96 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-O 118.257 -0.878 . . . . 1.79 111.834 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.64 -24.09 4.45 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.971 2.447 . . . . 0.77 115.818 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.19 152.56 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 126.608 1.963 . . . . 0.96 109.116 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 138.8 35.62 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.873 1.064 . . . . 1.87 113.873 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.94 -157.79 20.85 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 123.728 0.68 . . . . 0.66 114.431 -171.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ttp-105 -119.87 146.31 45.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.097 1.359 . . . . 4.01 113.062 -170.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.6 t -98.99 130.74 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 128.247 2.619 . . . . 0.79 109.467 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.7 31.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 114.143 1.164 . . . . 0.78 114.143 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -167.42 139.62 3.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.427 1.491 . . . . 2.68 110.29 169.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.61 -164.8 36.33 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 116.845 1.498 . . . . 1.06 116.845 167.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -145.69 132.68 20.25 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.689 1.196 . . . . 2.87 111.523 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.1 -179.21 6.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.882 0.873 . . . . 1.19 112.831 168.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.43 135.32 54.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.793 2.037 . . . . 1.22 110.358 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 72.4 t -126.31 142.76 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.48 1.112 . . . . 0.82 113.071 -169.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.94 106.24 16.13 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.544 1.138 . . . . 2.42 112.582 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -100.64 30.15 4.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.961 2.105 . . . . 1.78 114.103 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.3 p -48.7 -28.81 3.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.016 2.598 . . . . 2.35 118.016 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.41 -56.03 2.34 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.493 1.517 . . . . 2.12 110.637 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.3 mm -67.77 -51.98 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.783 0.66 . . . . 1.67 112.783 -167.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.7 p -95.52 -20.18 19.23 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.665 0.786 . . . . 1.49 112.474 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.51 83.37 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.182 1.372 . . . . 1.28 115.374 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.43 -47.57 83.5 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.573 1.323 . . . . 2.35 114.573 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 64.86 30.71 12.0 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.656 1.982 . . . . 1.82 112.861 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -149.12 154.26 39.05 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 127.529 2.332 . . . . 4.7 109.879 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.13 133.74 42.43 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.449 2.766 . . . . 2.03 115.168 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -116.16 136.16 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 127.063 2.145 . . . . 0.87 110.848 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.13 133.73 34.28 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.971 -1.081 . . . . 0.85 112.717 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -124.25 137.09 54.55 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.89 1.276 . . . . 0.96 111.677 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -148.48 179.15 1.24 Allowed Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 127.52 2.328 . . . . 2.74 108.667 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -56.3 139.38 86.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 CA-C-N 123.289 2.21 . . . . 0.82 112.319 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.05 11.73 83.37 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.456 -1.191 . . . . 0.77 115.105 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.2 m -102.2 166.53 10.54 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.581 1.69 . . . . 1.71 110.949 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.7 p -117.4 152.77 34.28 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.244 -1.535 . . . . 0.79 112.855 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.15 157.06 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.763 1.625 . . . . 0.61 112.159 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.73 143.08 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.758 1.623 . . . . 1.17 111.675 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.68 153.99 37.93 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.47 0.915 . . . . 0.75 113.47 -170.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.68 -1.0 59.7 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 114.893 0.717 . . . . 0.87 114.893 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 m -88.97 156.4 18.91 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.303 1.051 . . . . 2.45 111.447 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.05 145.33 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.576 1.15 . . . . 0.84 111.117 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -115.97 137.13 52.39 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.958 2.103 . . . . 1.77 112.227 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -153.93 139.73 18.07 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.401 -1.437 . . . . 3.01 113.084 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.314 30.1 t30 87.89 -1.48 0.49 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.285 3.434 . . . . 3.14 116.006 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.67 163.45 29.0 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 120.437 -1.414 . . . . 1.94 115.257 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -98.95 144.01 28.6 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.121 1.769 . . . . 1.98 112.128 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.9 mt -135.57 160.02 39.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.948 1.299 . . . . 1.07 111.361 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.9 mt -107.99 127.63 53.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.691 0.796 . . . . 2.26 110.435 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 mm -117.24 124.62 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.923 1.689 . . . . 1.7 110.306 -173.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -87.19 111.22 20.77 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.424 -0.797 . . . . 1.57 109.533 169.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.17 119.13 22.53 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.622 0.769 . . . . 0.92 109.806 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 t -119.86 8.71 11.15 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.594 0.961 . . . . 2.56 113.594 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -138.36 139.31 38.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.612 1.965 . . . . 1.73 108.058 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 m -85.98 174.58 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.737 0.815 . . . . 1.64 111.802 170.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.25 -36.57 91.15 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 121.08 -1.012 . . . . 1.3 114.795 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.71 -36.9 70.67 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.852 1.326 . . . . 1.63 112.615 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -78.49 -10.25 59.64 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.798 1.777 . . . . 2.27 115.798 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -76.6 156.17 32.95 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.646 -1.283 . . . . 2.87 112.379 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.9 t -56.88 -34.39 67.83 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.38 0.882 . . . . 1.94 113.38 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.5 mp -56.93 -48.68 77.7 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.541 -1.349 . . . . 1.44 112.52 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.9 m -70.74 -27.99 64.38 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.02 1.328 . . . . 1.9 112.203 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -70.76 -44.74 66.12 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.394 0.678 . . . . 2.07 111.974 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.5 mt -56.37 -49.57 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.94 1.296 . . . . 1.22 111.267 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 114.251 1.204 . . . . 1.33 114.251 -177.774 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 114.135 1.161 . . . . 2.03 114.135 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.4 tp -56.41 -53.96 51.3 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.193 0.997 . . . . 2.62 111.301 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.37 -7.99 47.2 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.436 1.643 . . . . 2.15 115.436 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -64.88 -43.89 91.45 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 121.486 1.948 . . . . 2.12 111.003 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -48.76 -48.96 40.51 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.281 1.432 . . . . 1.24 111.048 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.9 mm -70.16 -34.01 57.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.79 1.236 . . . . 1.52 112.034 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 m -76.64 -24.77 53.32 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.153 1.381 . . . . 1.14 113.053 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 mp -68.22 -26.79 65.89 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.889 0.768 . . . . 2.04 112.621 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -70.72 139.78 51.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.409 1.004 . . . . 2.68 113.013 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.87 152.39 44.59 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.102 -0.499 . . . . 2.02 111.188 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -106.23 -2.66 22.18 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.911 1.284 . . . . 1.94 112.128 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -142.59 153.5 43.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.326 2.25 . . . . 3.91 112.282 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.85 162.0 36.62 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.194 1.398 . . . . 0.71 112.991 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.8 m -115.07 108.16 16.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.929 1.292 . . . . 0.86 111.916 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.0 mt -83.32 130.33 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.104 -0.702 . . . . 0.67 109.104 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.31 138.42 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.04 0.936 . . . . 2.51 112.37 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.474 0.734 0 C-N-CA 124.178 0.991 . . . . 1.99 111.747 -169.841 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 tp . . . . . 0 CA--C 1.536 0.437 0 N-CA-C 109.5 -0.556 . . . . 3.32 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 t -135.22 129.35 33.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.637 1.175 . . . . 1.71 110.966 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -130.74 129.44 42.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.446 1.098 . . . . 2.41 111.822 -169.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -119.51 118.97 32.47 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.486 1.914 . . . . 2.84 109.746 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -89.24 121.54 31.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.576 1.08 . . . . 2.13 109.93 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.31 171.28 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.124 1.37 . . . . 0.97 112.612 -169.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.7 146.17 32.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.634 1.174 . . . . 3.21 110.506 168.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.96 -24.05 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.608 0.966 . . . . 1.07 113.608 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.16 -22.48 61.29 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.815 -1.178 . . . . 2.92 113.062 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.77 -15.18 42.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.305 1.042 . . . . 1.24 113.231 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 p -86.7 93.54 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 122.715 1.245 . . . . 1.89 109.9 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -78.32 158.3 28.89 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.42 2.288 . . . . 4.19 109.218 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -69.74 134.26 48.41 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.015 -1.053 . . . . 2.73 112.966 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.42 12.18 4.32 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.207 1.385 . . . . 0.88 115.999 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -116.48 168.86 9.79 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.288 2.044 . . . . 2.71 113.861 175.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.86 129.04 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.31 1.844 . . . . 1.55 109.607 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.1 mm -122.75 129.14 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.119 1.768 . . . . 0.8 110.465 -171.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -83.13 135.71 34.72 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.765 1.226 . . . . 2.85 112.365 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.36 136.8 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.822 1.249 . . . . 0.82 111.949 169.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.35 159.14 65.29 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.018 0.927 . . . . 1.16 112.886 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.28 136.12 66.31 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.78 2.32 . . . . 1.24 110.757 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.18 3.79 57.87 Favored Glycine 0 CA--C 1.542 1.735 0 N-CA-C 114.914 0.726 . . . . 0.99 114.914 -169.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.1 178.89 48.54 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 118.928 1.364 . . . . 0.98 115.686 -174.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.81 145.26 51.24 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.419 1.888 . . . . 1.64 111.096 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -88.07 129.5 49.79 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.863 0.69 . . . . 1.73 112.863 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -86.27 -22.22 2.23 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.275 2.65 . . . . 0.73 115.661 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.6 m -151.08 175.82 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 127.843 2.457 . . . . 0.76 109.147 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -99.94 140.99 33.36 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.357 0.98 . . . . 1.68 113.474 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.51 -177.73 46.58 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 123.545 0.593 . . . . 0.62 114.38 -169.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -103.24 138.81 39.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.838 1.255 . . . . 4.47 112.178 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.8 t -83.45 130.55 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.255 2.222 . . . . 0.75 108.657 173.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.1 pt -140.37 33.48 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-O 122.394 1.093 . . . . 0.77 112.379 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -166.6 129.5 1.89 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.155 2.182 . . . . 2.81 108.084 168.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.33 176.0 50.5 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 122.701 1.167 . . . . 1.03 115.03 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -153.31 120.96 5.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.417 1.487 . . . . 2.07 112.572 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.8 t -141.69 159.73 41.63 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.445 1.498 . . . . 1.46 112.024 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.4 ttm -90.67 130.18 36.7 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.761 -0.587 . . . . 0.88 110.341 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.7 t -113.85 140.77 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.524 1.13 . . . . 0.61 111.781 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -108.32 102.46 11.58 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.334 1.453 . . . . 1.76 111.427 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 19.86 17.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.624 1.969 . . . . 4.0 113.096 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.2 p -54.6 -29.09 50.76 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.331 1.604 . . . . 1.3 115.331 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.59 -30.46 26.97 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.825 1.193 . . . . 1.02 111.708 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 mm -72.76 -53.57 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.554 1.542 . . . . 1.06 110.176 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.2 p -102.92 -22.04 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.313 1.845 . . . . 1.66 113.691 -171.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.75 -2.23 87.7 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.277 1.418 . . . . 1.28 114.328 -170.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -64.9 110.16 2.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.502 1.651 . . . . 2.86 110.296 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.59 -3.38 58.44 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.983 -1.073 . . . . 1.47 112.596 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.8 mmt -95.79 138.7 21.71 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.99 2.516 . . . . 3.63 108.952 167.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.36 161.09 22.78 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.155 2.57 . . . . 1.93 112.347 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.8 t -124.03 119.82 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.463 0.705 . . . . 0.82 111.369 -168.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.57 130.79 35.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.021 0.928 . . . . 0.87 112.086 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -108.74 157.68 18.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.015 1.726 . . . . 0.76 111.866 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -146.73 168.97 10.25 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 127.581 2.352 . . . . 3.5 111.624 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -59.14 123.22 12.98 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 121.578 1.519 . . . . 0.93 109.356 166.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.43 57.15 3.01 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.866 1.222 . . . . 1.21 112.426 -168.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -141.3 150.31 42.38 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.696 1.598 . . . . 1.28 112.427 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.9 p -101.05 150.76 22.57 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 120.861 1.664 . . . . 0.85 113.522 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.05 162.61 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.464 1.506 . . . . 0.53 111.823 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -126.97 150.06 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.768 2.027 . . . . 0.93 111.363 176.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.59 142.23 49.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.033 0.933 . . . . 0.66 112.71 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.49 -5.77 72.07 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.125 1.345 . . . . 0.79 116.305 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.4 p -73.93 162.22 29.3 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.711 1.256 . . . . 1.39 111.896 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mm -110.79 143.88 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.52 1.128 . . . . 0.64 111.61 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -105.45 142.62 34.89 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.467 1.907 . . . . 1.91 112.341 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -85.73 -125.69 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.639 1.175 . . . . 3.52 112.316 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -78.99 -38.16 37.43 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.001 1.852 . . . . 3.4 116.001 -166.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.4 128.78 13.68 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.794 0.725 . . . . 1.93 112.538 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.2 t -83.97 121.43 27.38 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.875 -1.158 . . . . 2.28 107.875 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.4 mt -117.99 157.73 26.23 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.715 1.206 . . . . 1.12 111.321 -169.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -117.31 125.52 51.2 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.482 0.658 . . . . 2.06 109.75 169.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.79 138.17 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.64 1.576 . . . . 1.31 110.573 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.6 p -79.03 106.62 11.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.021 0.915 . . . . 1.85 111.185 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.73 82.4 4.13 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.202 1.001 . . . . 1.68 109.097 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 t -101.51 9.32 41.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.585 1.954 . . . . 3.04 111.874 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -144.49 152.86 41.21 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.159 1.783 . . . . 2.15 111.451 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -106.7 170.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.211 1.404 . . . . 1.77 111.579 168.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.6 -24.24 46.56 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.366 1.306 . . . . 2.22 116.366 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.38 96.91 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.595 1.698 . . . . 2.85 112.529 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.18 -22.98 59.17 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.272 1.582 . . . . 3.83 115.272 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 109' ' ' SER . 3.2 t -71.58 142.74 50.01 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.463 1.283 . . . . 2.96 114.463 -166.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m -60.95 -27.14 68.03 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.499 -0.751 . . . . 3.52 112.275 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.0 tp -58.4 -46.22 86.83 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.367 -0.833 . . . . 1.5 112.093 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.474 ' H ' HG23 ' A' ' 106' ' ' THR . 75.9 p -73.03 -27.33 61.7 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.881 0.872 . . . . 2.6 113.012 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -66.64 -40.06 88.54 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.164 -0.96 . . . . 1.88 112.461 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 67.8 mt -53.91 -52.22 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.392 1.077 . . . . 1.4 110.301 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 113.686 0.995 . . . . 1.13 113.686 -179.261 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 111.785 0.291 . . . . 1.91 111.785 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 tp -55.05 -35.82 64.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.254 1.022 . . . . 2.1 112.386 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.07 -47.34 37.26 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.359 0.527 . . . . 2.06 112.208 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.08 -32.46 70.97 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.211 1.005 . . . . 3.04 113.384 -172.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.0 -35.73 77.6 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.228 1.377 . . . . 1.31 113.267 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.6 mm -73.99 -40.29 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.498 -0.751 . . . . 1.89 111.591 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -66.86 -30.38 70.53 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.391 0.886 . . . . 1.63 113.391 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.31 -17.33 62.43 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.555 1.942 . . . . 2.38 113.941 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -86.4 147.04 26.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.538 1.135 . . . . 2.46 112.835 -170.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.23 154.41 22.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.557 1.543 . . . . 2.04 112.98 -172.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 m -100.53 -27.39 13.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.331 1.452 . . . . 2.13 113.314 -172.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.84 150.76 50.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.228 1.411 . . . . 3.42 113.678 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.4 172.32 12.93 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.608 1.563 . . . . 1.02 113.37 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 93.1 m -119.4 105.3 11.15 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.501 1.52 . . . . 0.99 112.125 170.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.89 140.31 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.016 0.927 . . . . 0.6 109.402 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.93 124.98 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.469 -0.769 . . . . 1.89 110.551 172.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.474 0.735 0 C-N-CA 124.604 1.162 . . . . 1.78 110.681 176.043 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 121.374 0.607 . . . . 2.35 110.642 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 t -141.42 84.69 1.92 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.601 1.56 . . . . 1.56 109.431 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -81.02 154.15 27.03 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.033 -1.042 . . . . 2.72 112.926 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -121.74 130.72 53.63 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.181 1.792 . . . . 2.7 110.958 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -88.58 120.56 30.08 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.671 -0.863 . . . . 2.1 108.671 168.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.24 159.23 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.051 0.94 . . . . 0.99 113.13 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -78.04 143.22 37.65 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.903 -0.777 . . . . 3.18 108.903 166.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.09 -20.24 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.609 1.164 . . . . 1.12 113.585 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -70.24 -20.02 63.1 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.707 -1.246 . . . . 3.43 113.637 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.83 -5.55 56.76 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.455 1.28 . . . . 1.72 114.455 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.1 p -94.13 144.65 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.762 0.825 . . . . 1.69 112.508 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -121.25 163.3 18.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.943 2.497 . . . . 3.17 110.124 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 ptt85 -72.29 147.15 46.66 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.181 -0.95 . . . . 3.77 110.784 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.43 28.49 7.11 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-N 119.142 0.883 . . . . 1.76 113.93 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.5 166.34 25.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.333 1.853 . . . . 3.53 111.523 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.4 mt -122.95 132.16 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.945 1.298 . . . . 1.84 111.937 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 mm -118.65 129.98 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.692 1.997 . . . . 0.72 110.623 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -84.45 130.39 34.77 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.639 -0.663 . . . . 2.09 112.19 172.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.43 136.89 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.888 1.275 . . . . 0.61 110.227 169.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.93 161.91 39.71 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.118 1.367 . . . . 0.87 112.39 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -57.5 134.27 62.31 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.674 1.583 . . . . 1.08 108.618 166.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.64 -9.04 38.25 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 118.702 -1.054 . . . . 0.93 115.557 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.92 177.94 37.53 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 119.645 1.723 . . . . 0.95 114.237 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.88 151.37 38.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.684 1.593 . . . . 2.09 111.234 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -90.14 116.55 66.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 118.496 -0.764 . . . . 1.83 109.965 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -89.16 -11.22 3.72 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.936 2.424 . . . . 0.74 114.896 -171.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -147.8 172.82 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 128.55 2.74 . . . . 0.89 108.834 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.2 139.39 37.88 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.164 0.893 . . . . 2.66 112.518 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.75 -158.67 22.58 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 115.253 0.861 . . . . 0.79 115.253 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -118.3 129.1 55.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.74 1.216 . . . . 4.34 112.647 -170.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.3 t -88.69 127.23 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.881 1.672 . . . . 0.89 108.93 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.7 pt -141.52 30.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 113.438 0.903 . . . . 0.96 113.438 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -169.08 132.01 1.29 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.615 1.966 . . . . 3.17 108.975 166.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.71 173.34 46.83 Favored Glycine 0 CA--C 1.539 1.578 0 N-CA-C 116.102 1.201 . . . . 1.1 116.102 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -140.28 127.36 20.9 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.099 1.36 . . . . 3.03 113.806 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 m -151.46 172.15 16.42 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.362 1.616 . . . . 1.22 115.362 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.9 ttm -106.46 133.78 50.61 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.625 1.17 . . . . 1.46 110.497 168.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.85 132.82 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.479 1.112 . . . . 1.16 113.743 -167.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -91.23 98.7 11.88 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.269 1.828 . . . . 2.28 111.386 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -128.98 8.61 5.68 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.135 1.774 . . . . 1.77 115.57 -172.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.3 p -59.73 -4.81 0.75 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 116.248 1.944 . . . . 2.1 116.248 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -94.62 -35.6 12.14 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.153 1.342 . . . . 1.63 111.449 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.8 mm -79.73 -62.88 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.797 1.239 . . . . 1.61 111.612 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 p -84.99 -8.15 58.85 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.206 1.403 . . . . 2.24 112.999 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.02 25.9 70.19 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.556 1.074 . . . . 2.9 113.241 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -64.3 -177.33 0.28 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.671 1.589 . . . . 3.17 110.876 169.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.5 -9.64 5.7 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.843 -1.161 . . . . 2.83 113.612 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -149.26 151.25 33.55 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.099 1.36 . . . . 2.93 110.793 169.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -48.8 153.87 3.42 Favored 'Trans proline' 0 CA--C 1.538 0.712 1 C-N-CA 125.405 4.07 . . . . 2.95 116.245 -178.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.3 t -113.25 134.07 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.722 1.609 . . . . 1.16 111.354 -170.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.38 137.22 38.6 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.614 0.765 . . . . 0.87 112.188 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -130.14 143.87 51.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.167 2.187 . . . . 1.03 110.179 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 16.5 ptmt -148.61 -172.61 0.32 Allowed Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 126.611 1.964 . . . . 3.41 109.526 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 74.1 Cg_endo -66.45 142.92 67.43 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 CA-C-N 123.492 2.283 . . . . 1.16 111.347 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.02 8.73 87.4 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.512 1.53 . . . . 0.98 114.895 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.2 m -89.52 163.83 15.05 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.851 1.826 . . . . 1.65 112.234 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.3 p -112.33 147.1 37.06 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.911 -1.118 . . . . 1.16 111.218 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 m -139.46 156.31 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.553 1.141 . . . . 0.7 112.754 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.53 150.53 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.169 1.788 . . . . 1.23 113.225 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.02 149.59 47.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.044 0.937 . . . . 0.85 113.168 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.3 -2.52 56.85 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.712 1.148 . . . . 0.89 114.966 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 89.9 p -76.59 155.0 33.91 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.629 1.214 . . . . 1.54 111.657 169.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.09 136.95 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.273 1.029 . . . . 1.14 110.669 -171.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -93.19 149.78 20.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.853 1.661 . . . . 1.5 113.412 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -160.47 115.27 2.22 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.989 0.916 . . . . 3.97 111.88 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.5 t30 147.79 -46.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 131.658 3.983 . . . . 3.22 110.829 166.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.1 179.78 42.74 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 121.084 -1.01 . . . . 2.11 114.884 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -85.34 132.59 34.22 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.213 1.005 . . . . 2.25 112.276 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.86 163.56 24.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.838 1.655 . . . . 1.76 112.304 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.1 mt -118.46 127.29 53.51 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.209 1.004 . . . . 2.52 112.011 172.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.95 126.99 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.11 1.364 . . . . 1.25 110.893 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 44.2 t -83.09 125.46 31.51 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.094 0.558 . . . . 2.75 110.307 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.24 104.12 14.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.188 0.995 . . . . 1.16 109.754 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.8 p -94.22 -3.81 50.1 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.558 1.143 . . . . 2.73 112.13 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -136.47 136.9 39.84 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.474 1.91 . . . . 2.57 109.856 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 p -88.69 170.08 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.573 1.149 . . . . 2.49 110.474 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.17 -35.68 85.36 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.31 -1.494 . . . . 1.9 114.875 -171.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.79 -31.84 73.15 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.947 1.374 . . . . 2.5 113.227 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.16 -5.92 44.67 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.118 1.367 . . . . 3.75 113.738 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.0 p -80.71 147.16 30.72 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.529 -1.357 . . . . 1.72 112.77 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -70.67 -23.37 62.49 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.295 1.22 . . . . 2.69 114.295 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 mp -59.37 -58.14 9.91 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 119.809 -1.807 . . . . 1.54 115.762 -167.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.7 m -73.18 -15.22 61.46 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.859 0.754 . . . . 3.4 112.7 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.5 -42.92 64.31 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.001 0.92 . . . . 2.38 111.461 172.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 54.9 mt -57.63 -45.76 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.067 1.347 . . . . 1.77 112.499 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 114.514 1.301 . . . . 1.98 114.514 -172.434 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 113.496 0.924 . . . . 2.68 113.496 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.9 tp -64.49 -31.95 73.38 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.03 0.932 . . . . 1.98 111.134 171.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.19 -17.3 61.94 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.122 -0.986 . . . . 1.27 113.532 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -67.39 -28.52 68.0 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.755 0.822 . . . . 2.55 112.207 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.8 -38.9 83.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.838 0.855 . . . . 1.27 111.319 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.3 mm -70.14 -41.28 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.275 0.63 . . . . 2.15 110.954 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 m -67.44 -24.74 65.67 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.024 0.93 . . . . 1.14 113.256 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.5 mt -73.32 -27.8 61.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.979 1.712 . . . . 1.66 113.889 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -64.45 140.44 58.87 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.877 0.762 . . . . 3.3 111.003 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.51 165.26 18.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.562 1.145 . . . . 2.53 113.475 -172.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.1 m -121.11 -29.31 4.57 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.108 1.363 . . . . 2.08 112.411 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.21 150.05 43.68 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.227 1.411 . . . . 2.95 112.728 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.86 145.95 38.72 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.866 1.267 . . . . 1.06 112.507 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.5 m -98.54 100.92 12.21 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.638 1.175 . . . . 1.4 112.323 -174.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 35.1 mt -76.72 139.58 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.83 -0.804 . . . . 1.09 108.83 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.42 125.58 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.712 0.768 . . . . 2.38 112.254 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.471 0.621 0 C-N-CA 125.844 1.658 . . . . 2.03 111.323 -167.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt . . . . . 0 C--O 1.232 0.168 0 N-CA-C 109.0 -0.741 . . . . 2.86 109.0 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.1 p -135.92 152.27 50.83 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.884 1.274 . . . . 2.46 110.985 -168.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.67 149.07 40.38 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.969 0.908 . . . . 3.25 111.487 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -139.64 113.56 8.75 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.661 1.184 . . . . 2.56 111.588 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -79.83 115.61 19.52 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.918 -1.114 . . . . 2.7 109.303 167.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.78 166.08 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.239 1.416 . . . . 0.92 111.166 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -76.6 142.0 40.88 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.921 -0.487 . . . . 3.95 110.342 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.41 -23.57 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.289 1.218 . . . . 1.29 114.289 -171.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -60.68 -27.43 67.85 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.88 1.272 . . . . 4.44 113.206 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.2 mt -101.57 -7.63 22.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.9 2.08 . . . . 1.36 115.816 -167.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.74 144.71 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.151 0.887 . . . . 1.56 111.151 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -121.33 154.78 35.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.204 1.802 . . . . 4.13 112.881 -170.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -77.64 23.8 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 117.215 2.302 . . . . 3.28 117.215 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.78 6.81 12.28 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.682 1.611 . . . . 1.47 115.564 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -124.01 173.31 8.33 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.75 1.775 . . . . 3.56 115.256 -168.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.4 mt -113.84 126.31 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.057 1.743 . . . . 2.13 110.491 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.3 mm -116.08 124.14 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.495 1.918 . . . . 0.73 110.109 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.489 ' HE3' HD11 ' A' ' 96' ' ' LEU . 65.2 tttt -87.07 141.36 28.72 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.737 1.215 . . . . 2.17 111.676 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -116.59 137.09 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.489 0.716 . . . . 0.73 112.287 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.13 159.25 54.33 Favored Pre-proline 0 N--CA 1.481 1.075 0 C-N-CA 124.387 1.075 . . . . 1.32 113.234 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -60.95 136.94 68.91 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.888 1.726 . . . . 1.8 109.772 167.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.27 26.37 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 115.429 0.932 . . . . 1.02 115.429 -171.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.66 -177.17 41.19 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 119.062 1.431 . . . . 1.08 115.31 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -123.67 154.74 38.95 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.093 1.357 . . . . 2.04 112.043 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -88.69 122.12 69.47 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 118.608 -0.71 . . . . 1.79 110.34 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.18 -19.54 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.565 2.176 . . . . 0.76 115.426 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.48 164.89 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 127.987 2.515 . . . . 0.9 108.051 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -81.14 149.23 29.23 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.039 0.923 . . . . 2.36 113.286 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -167.07 38.73 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.785 -0.643 . . . . 0.86 113.906 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -114.96 132.6 56.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.742 0.817 . . . . 3.84 112.504 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.0 t -79.02 131.58 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 127.078 2.151 . . . . 0.65 107.636 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.06 31.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.039 0.836 . . . . 0.76 112.277 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -169.07 146.71 3.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.378 2.271 . . . . 3.24 109.258 168.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.08 -179.55 32.51 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 118.847 0.749 . . . . 0.94 114.842 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -143.53 32.4 1.31 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.445 1.646 . . . . 3.15 115.445 -167.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.806 ' H ' HD21 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -83.36 165.84 18.94 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.361 1.615 . . . . 1.28 115.361 -168.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.0 ttm -110.8 138.36 47.29 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.819 0.847 . . . . 1.06 110.95 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.33 134.66 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.092 1.357 . . . . 0.88 112.805 -168.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -86.03 108.54 18.29 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.107 1.363 . . . . 2.53 110.924 174.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.94 -10.79 17.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.0 1.32 . . . . 2.51 113.89 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.5 p -43.23 -35.45 1.43 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 117.995 2.591 . . . . 1.79 117.995 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -84.86 -27.45 26.69 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.62 1.1 . . . . 1.41 112.016 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mm -89.52 -55.55 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.944 0.898 . . . . 1.39 110.922 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.0 p -85.79 -18.35 33.2 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.191 0.996 . . . . 1.8 113.132 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.71 9.91 80.25 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.448 1.499 . . . . 1.79 114.439 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.02 -177.59 0.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.365 1.466 . . . . 2.83 112.512 171.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.69 -20.68 0.59 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.148 1.379 . . . . 1.9 114.492 -176.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.9 mtp -119.2 140.47 28.97 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.7 1.2 . . . . 4.23 111.354 172.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -59.28 144.93 99.22 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.556 2.837 . . . . 2.18 113.973 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 t -106.72 131.99 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 127.3 2.24 . . . . 0.83 111.982 -168.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.13 134.84 37.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.267 0.627 . . . . 0.83 111.85 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -110.37 155.47 22.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.4 1.88 . . . . 0.87 111.652 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -151.93 172.07 5.88 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 127.343 2.257 . . . . 2.28 108.285 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -54.9 142.08 76.3 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 CA-C-N 122.149 1.803 . . . . 0.83 112.279 171.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.63 13.33 82.62 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-O 117.7 -1.611 . . . . 1.09 115.635 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -96.83 144.7 26.55 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.209 2.505 . . . . 1.42 111.392 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.5 p -90.42 157.17 17.73 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 121.305 1.866 . . . . 1.01 112.933 172.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 m -140.34 156.85 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.457 1.903 . . . . 0.79 112.035 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -113.47 151.65 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 127.573 2.349 . . . . 1.1 111.636 173.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.34 155.86 23.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.29 0.636 . . . . 0.88 112.369 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.69 0.12 53.15 Favored Glycine 0 CA--C 1.536 1.402 0 O-C-N 121.447 -0.783 . . . . 1.15 114.974 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.9 p -78.22 153.51 31.87 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.557 1.179 . . . . 1.72 110.899 168.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mm -113.3 131.73 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.811 0.844 . . . . 1.32 111.011 -171.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -94.27 148.32 22.32 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.696 1.598 . . . . 1.68 112.653 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -96.95 -88.08 0.3 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.291 1.036 . . . . 3.42 112.712 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -154.17 146.92 24.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.628 2.771 . . . . 4.41 107.865 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.64 23.97 2.7 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 120.602 1.546 . . . . 2.99 115.158 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 t 18.19 97.94 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 130.169 3.388 . . . . 1.74 116.837 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.806 HD21 ' H ' ' A' ' 62' ' ' SER . 54.9 mt -102.5 154.03 19.49 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.629 1.171 . . . . 1.07 112.948 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.489 HD11 ' HE3' ' A' ' 44' ' ' LYS . 7.2 mp -117.75 126.02 51.69 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.501 1.12 . . . . 2.34 108.566 166.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.54 125.9 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.127 1.371 . . . . 1.14 110.086 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.2 p -81.2 119.88 24.17 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.627 -0.67 . . . . 1.53 109.538 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.95 130.92 35.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.293 0.637 . . . . 1.27 109.665 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.46 3.55 9.05 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.897 1.073 . . . . 3.04 113.897 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -141.18 151.5 43.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.998 1.319 . . . . 2.16 111.86 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -89.45 173.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.769 1.628 . . . . 2.15 111.223 171.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.94 -36.41 87.76 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 121.061 -1.024 . . . . 1.6 114.843 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.39 -28.12 69.02 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.582 1.327 . . . . 2.09 114.582 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.71 -13.02 60.03 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.962 1.467 . . . . 3.35 114.962 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.1 p -66.45 132.92 49.35 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.215 -0.928 . . . . 2.1 112.608 -168.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 t -63.24 -23.77 67.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.487 1.291 . . . . 2.23 114.487 -167.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.7 -43.74 80.84 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.917 -1.114 . . . . 1.83 111.795 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.2 p -68.03 -28.5 67.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.158 0.983 . . . . 2.02 112.712 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -75.27 -48.65 22.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.969 1.307 . . . . 1.55 111.91 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 53.4 mt -53.62 -49.23 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.862 1.665 . . . . 1.45 110.5 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 114.876 1.435 . . . . 1.61 114.876 -177.626 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 112.639 0.607 . . . . 1.79 112.639 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.25 -40.73 86.86 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.636 1.174 . . . . 2.98 111.205 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.32 -14.25 61.27 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.456 0.91 . . . . 1.18 113.456 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -67.3 -33.31 75.01 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.649 -1.282 . . . . 2.39 111.505 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.91 -28.03 69.78 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.489 1.115 . . . . 1.13 111.885 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.8 mm -74.11 -39.47 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.694 0.798 . . . . 1.74 111.772 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -65.79 -31.52 72.54 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.803 -1.186 . . . . 1.79 112.288 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.7 mt -71.23 -11.55 60.99 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.488 1.915 . . . . 2.16 113.685 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -87.03 158.34 19.25 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.762 1.225 . . . . 2.29 112.873 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.13 161.3 14.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.499 1.519 . . . . 2.28 114.326 -169.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p -90.98 -47.72 7.41 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.474 1.51 . . . . 2.76 113.203 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -142.08 157.4 44.95 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.336 1.454 . . . . 4.12 112.782 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.17 157.38 44.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.383 1.473 . . . . 0.88 112.525 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.1 m -100.4 107.02 18.67 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.896 0.878 . . . . 0.87 111.589 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.8 mt -78.84 142.26 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.684 1.193 . . . . 0.72 108.443 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.23 135.63 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.643 0.735 . . . . 2.02 111.924 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.471 0.609 0 C-N-CA 127.747 2.419 . . . . 1.66 110.959 -169.693 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 121.01 0.433 . . . . 2.49 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.7 t -140.13 139.11 35.71 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.079 2.152 . . . . 1.34 109.46 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -126.11 151.69 46.9 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.096 -1.002 . . . . 2.84 112.183 -174.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -129.4 128.45 43.04 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.133 1.373 . . . . 2.8 111.25 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -93.46 108.16 19.89 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.263 -0.898 . . . . 2.13 109.571 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 m -118.95 154.55 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.179 0.992 . . . . 0.95 112.263 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -72.7 148.27 44.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.686 -0.486 . . . . 3.21 109.686 171.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.41 -17.86 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.387 1.625 . . . . 1.08 115.387 -168.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -70.94 -20.65 62.44 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.41 -1.431 . . . . 4.26 113.833 170.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.7 mt -98.35 -3.66 36.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.644 1.578 . . . . 1.23 114.078 -168.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -89.14 139.36 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.676 1.591 . . . . 1.54 109.959 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -108.95 164.45 12.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.864 1.266 . . . . 3.85 111.166 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -70.56 37.45 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.726 1.38 . . . . 2.85 114.726 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.47 11.5 0.15 Allowed Glycine 0 CA--C 1.54 1.62 0 C-N-CA 127.824 2.63 . . . . 0.87 114.395 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -97.3 165.4 12.05 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.829 1.815 . . . . 2.33 112.505 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.7 mm -113.21 123.08 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.822 1.649 . . . . 1.55 110.49 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.7 mm -116.24 128.52 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.011 1.324 . . . . 0.77 112.174 -170.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -85.91 140.04 30.71 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.455 1.102 . . . . 2.06 112.926 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.62 136.57 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.65 1.18 . . . . 0.66 112.118 174.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.69 160.93 30.33 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.637 1.175 . . . . 0.9 113.818 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.18 123.6 13.49 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.571 2.18 . . . . 1.17 111.526 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.02 -2.36 87.7 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.619 2.057 . . . . 1.08 115.242 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.84 171.71 54.62 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 119.246 1.523 . . . . 1.08 114.049 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -111.24 152.44 27.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.047 1.339 . . . . 2.41 112.235 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -76.66 131.94 73.02 Favored Pre-proline 0 CA--C 1.553 1.066 0 CA-C-O 118.629 -0.701 . . . . 2.3 111.587 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -96.1 -17.13 0.35 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.264 2.642 . . . . 0.8 115.787 -173.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.49 171.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 127.07 2.148 . . . . 0.75 108.976 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.6 137.38 40.9 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.935 0.789 . . . . 1.9 112.652 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.13 -156.48 20.4 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 114.548 0.579 . . . . 0.8 114.548 -171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.6 ttp85 -114.78 140.3 49.03 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.631 1.172 . . . . 3.85 112.939 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.9 t -88.85 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.685 1.994 . . . . 0.73 108.971 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.9 pt -140.92 33.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.84 0.829 . . . . 0.96 112.376 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -166.12 137.23 3.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.22 1.808 . . . . 2.71 109.662 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.52 -176.1 51.11 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 123.691 0.662 . . . . 0.82 114.74 171.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -156.8 92.27 1.27 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.06 0.944 . . . . 3.11 112.13 -168.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.63 165.86 19.17 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.85 1.66 . . . . 1.18 112.675 -169.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.0 ttm -112.28 130.75 55.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.455 1.102 . . . . 1.48 110.544 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.3 t -123.4 142.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.311 1.444 . . . . 0.9 113.365 -167.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -104.03 107.72 18.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.835 1.254 . . . . 1.86 112.288 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -103.01 27.21 7.32 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 126.09 1.756 . . . . 2.38 114.109 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 p -51.53 -9.36 0.07 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 119.206 3.039 . . . . 2.14 119.206 -169.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.36 -49.28 1.92 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.023 1.329 . . . . 1.4 111.128 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.2 mm -67.04 -55.99 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 119.309 0.959 . . . . 1.2 111.917 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.8 p -95.59 -13.24 24.55 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.028 0.931 . . . . 1.37 111.75 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.58 11.43 84.41 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.198 1.38 . . . . 1.31 115.569 169.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.54 -40.34 82.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.209 1.004 . . . . 2.46 113.235 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.04 43.78 8.64 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.35 1.46 . . . . 1.52 112.246 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.0 ptm -161.98 159.4 21.88 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 128.979 2.912 . . . . 4.4 109.602 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.82 139.25 17.48 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.577 2.185 . . . . 2.31 112.534 172.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.49 139.09 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.871 1.669 . . . . 1.12 110.578 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.37 137.08 32.64 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.132 -0.98 . . . . 0.82 112.499 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -117.36 157.2 26.57 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.659 1.584 . . . . 0.72 111.027 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -160.1 172.99 5.27 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 127.536 2.335 . . . . 2.26 110.511 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -53.57 135.2 60.93 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 CA-C-N 122.201 1.822 . . . . 1.04 111.656 167.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.31 38.87 44.95 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.356 0.503 . . . . 0.88 113.284 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 t -125.52 139.29 53.74 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 118.088 0.944 . . . . 1.46 111.396 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.6 p -91.05 145.02 25.04 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.902 1.228 . . . . 0.98 112.475 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.2 m -135.88 156.45 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.63 1.572 . . . . 0.61 112.095 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -130.01 144.02 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.487 1.515 . . . . 1.13 112.984 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.92 147.44 50.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.757 0.823 . . . . 0.9 112.912 -175.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.27 -6.64 63.11 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 115.245 0.858 . . . . 1.04 115.245 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.5 p -76.12 158.03 32.21 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.441 1.121 . . . . 1.41 110.395 167.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -108.76 140.26 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.383 1.073 . . . . 1.11 110.996 -171.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -109.09 147.72 31.97 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.803 1.241 . . . . 1.68 113.475 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -150.95 140.35 21.43 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.983 1.313 . . . . 3.49 112.045 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 t30 43.85 88.09 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.219 2.608 . . . . 3.15 113.708 168.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.47 -10.37 0.14 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 117.665 1.826 . . . . 3.75 117.665 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.3 m 45.31 85.48 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 127.732 2.413 . . . . 2.52 115.946 169.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.2 mt -106.99 160.72 15.33 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.17 1.544 . . . . 0.93 115.17 -169.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.0 135.55 51.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.332 1.053 . . . . 2.43 110.604 165.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.56 129.72 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.257 1.823 . . . . 1.66 110.396 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.3 p -83.1 119.27 24.29 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.484 -0.76 . . . . 1.52 109.034 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.32 124.99 28.62 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.813 -0.554 . . . . 0.8 110.244 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 p -118.16 -0.65 11.53 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.353 1.861 . . . . 2.38 112.884 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -142.97 136.23 28.29 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.842 2.057 . . . . 1.87 110.054 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.38 162.93 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.404 -0.961 . . . . 1.64 108.404 164.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.1 91.08 Favored Glycine 0 N--CA 1.479 1.562 0 O-C-N 120.4 -1.437 . . . . 1.33 114.215 -169.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.94 -32.73 74.37 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.803 1.241 . . . . 1.63 113.997 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -79.41 -9.76 59.66 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.962 2.105 . . . . 2.28 115.142 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.0 p -70.1 154.69 41.62 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.067 -1.646 . . . . 1.47 112.93 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.8 t -57.7 -30.25 65.35 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.387 -0.821 . . . . 1.86 112.889 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.03 -49.88 75.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.931 -1.106 . . . . 1.6 112.044 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.3 m -64.24 -34.11 77.35 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.11 0.964 . . . . 1.72 110.922 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.19 -40.48 82.18 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.923 -0.486 . . . . 1.68 111.882 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.0 mt -58.32 -54.69 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.478 1.111 . . . . 1.18 110.604 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 114.178 1.177 . . . . 1.45 114.178 -175.433 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 114.628 1.344 . . . . 2.06 114.628 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.79 -46.28 70.98 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 117.22 2.304 . . . . 1.77 117.22 -165.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.37 -31.81 60.62 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.721 1.146 . . . . 1.35 113.06 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -69.0 -31.78 70.86 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.966 1.706 . . . . 2.84 113.333 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.97 -41.77 71.57 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.295 0.952 . . . . 1.47 111.998 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.37 -38.06 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 122.942 0.497 . . . . 2.07 111.285 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.8 m -66.89 -24.16 66.08 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.604 -1.31 . . . . 1.8 113.639 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.02 -15.53 62.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.258 1.423 . . . . 2.36 113.453 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -72.55 118.9 16.03 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.167 0.894 . . . . 3.38 109.506 172.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.25 177.98 2.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.278 1.831 . . . . 2.59 115.445 -168.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.2 m -112.59 -39.37 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.967 1.707 . . . . 2.45 113.006 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -141.18 157.14 45.67 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.49 1.293 . . . . 2.9 114.49 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.08 170.98 14.7 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.691 1.597 . . . . 0.93 112.822 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.7 m -131.08 112.94 13.33 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.287 1.435 . . . . 1.3 111.654 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.8 mt -85.16 142.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.317 1.447 . . . . 1.1 109.632 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -102.05 121.62 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 121.18 0.514 . . . . 2.09 111.254 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 125.252 1.421 . . . . 1.8 110.078 -177.036 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.392 0.615 . . . . 2.76 111.596 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -135.52 111.29 9.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.94 1.696 . . . . 2.05 108.104 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.04 143.84 26.28 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.905 1.076 . . . . 2.51 113.905 -169.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -113.69 126.11 54.89 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.862 1.665 . . . . 3.85 110.141 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -98.98 122.32 42.08 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.558 1.072 . . . . 2.41 111.535 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.19 158.0 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.931 1.085 . . . . 0.93 113.931 -168.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -78.36 145.1 35.42 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.711 -0.848 . . . . 3.55 108.711 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 p -62.42 -18.48 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 114.386 1.254 . . . . 1.55 114.386 -168.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -61.42 -27.67 68.71 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.589 -1.319 . . . . 3.61 113.309 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.3 mt -93.17 -5.72 49.47 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.283 1.833 . . . . 1.44 115.008 -169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.76 140.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.831 1.652 . . . . 1.45 109.663 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -114.98 160.47 19.53 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.394 1.478 . . . . 3.0 111.968 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -67.43 137.57 56.0 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.349 -0.982 . . . . 3.21 108.349 167.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.69 -4.35 56.4 Favored Glycine 0 CA--C 1.543 1.803 0 C-N-CA 124.339 0.971 . . . . 1.61 114.115 -168.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -93.43 158.65 15.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.168 1.387 . . . . 2.49 112.527 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.97 120.12 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.868 1.267 . . . . 1.55 110.229 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 mm -122.1 132.54 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.882 1.673 . . . . 0.86 111.47 -168.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.22 130.0 34.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.623 0.769 . . . . 1.88 112.654 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.8 p -116.33 132.99 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.106 1.362 . . . . 0.75 111.282 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.94 161.86 42.83 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 125.479 1.511 . . . . 0.9 113.318 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.74 139.81 70.99 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.691 1.594 . . . . 1.13 109.997 166.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.85 -14.72 41.29 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 126.164 1.84 . . . . 1.21 115.366 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.82 159.86 44.37 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.546 1.673 . . . . 1.07 114.878 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -92.68 139.65 30.35 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.978 1.311 . . . . 4.02 111.502 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.34 130.13 94.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.396 -0.812 . . . . 2.39 111.371 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -89.8 -13.42 2.67 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.706 2.271 . . . . 0.87 114.908 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.11 175.2 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 127.503 2.321 . . . . 1.47 109.903 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.255 1.2 p30 -111.55 147.23 35.85 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.159 0.8 . . . . 1.87 113.159 172.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.25 -159.37 32.5 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 115.002 0.761 . . . . 0.58 115.002 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 ttp-105 -111.43 140.62 45.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.229 1.412 . . . . 4.25 112.564 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.91 128.4 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 127.436 2.294 . . . . 0.73 108.377 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.76 32.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.234 0.827 . . . . 0.68 113.234 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -168.03 134.01 1.96 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.655 1.582 . . . . 3.4 108.51 167.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.78 178.96 52.58 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 122.086 0.826 . . . . 0.81 114.623 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -148.72 124.38 10.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.605 0.762 . . . . 2.55 112.78 -172.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -145.45 169.49 18.24 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.292 1.437 . . . . 1.14 113.499 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.3 ttm -110.79 132.28 54.34 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.266 1.427 . . . . 0.88 110.454 174.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -118.98 140.22 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.979 1.311 . . . . 0.85 111.968 -169.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -107.19 92.89 4.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.498 1.119 . . . . 2.13 111.068 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -87.2 22.62 2.04 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.418 1.887 . . . . 1.88 113.999 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.9 p -55.49 -8.76 0.39 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 118.973 2.953 . . . . 2.1 118.973 -169.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -126.24 -38.12 2.17 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.916 1.686 . . . . 1.49 111.501 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.6 mm -76.84 -61.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.211 0.604 . . . . 1.56 111.191 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.3 p -98.58 -12.97 20.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.938 0.895 . . . . 1.63 112.616 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.04 87.29 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.329 1.442 . . . . 1.43 115.971 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -56.1 -45.15 79.52 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.34 1.056 . . . . 3.43 111.68 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 69.81 -14.67 0.35 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.559 2.744 . . . . 2.22 114.764 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 58.3 ttm -87.87 149.28 45.43 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.292 1.837 . . . . 3.06 110.089 168.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.09 133.83 34.61 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.324 2.683 . . . . 1.48 112.606 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.04 135.2 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.987 1.715 . . . . 0.86 111.863 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.39 135.3 36.66 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.034 0.934 . . . . 1.08 113.494 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -128.53 144.71 51.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.016 1.726 . . . . 0.75 111.358 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -146.55 174.74 3.16 Favored Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 128.929 2.892 . . . . 2.64 109.072 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.66 132.88 45.17 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 122.105 1.787 . . . . 0.77 110.526 169.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.45 33.68 21.9 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.012 1.291 . . . . 0.75 114.248 -169.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 57.2 m -123.41 152.42 41.6 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.883 1.273 . . . . 1.44 111.258 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.9 p -102.37 152.15 21.43 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.983 1.265 . . . . 0.84 113.959 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.08 161.65 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.472 1.909 . . . . 0.5 112.292 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.89 149.9 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.585 1.954 . . . . 1.12 112.542 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.88 154.39 30.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.8 1.24 . . . . 0.7 114.191 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.6 -11.26 14.22 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.879 1.228 . . . . 0.8 115.43 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 m -81.8 160.2 23.6 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.426 1.09 . . . . 2.75 111.047 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.03 145.37 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.114 0.966 . . . . 1.26 111.655 -171.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -107.99 139.68 42.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.855 2.062 . . . . 1.82 111.228 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -152.08 145.24 24.61 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.715 -1.241 . . . . 4.51 112.049 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 53.2 t30 122.53 -55.81 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.099 1 C-N-CA 132.004 4.122 . . . . 3.44 111.228 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.74 175.24 41.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.568 1.08 . . . . 1.82 114.891 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.5 m -77.71 137.97 38.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.847 1.259 . . . . 1.87 112.193 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.8 mt -127.08 162.55 25.79 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.594 1.158 . . . . 1.05 112.111 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.6 127.46 54.53 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.653 0.781 . . . . 2.58 110.343 168.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 mm -114.05 124.51 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 125.468 1.507 . . . . 1.59 109.981 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.1 p -91.38 121.57 33.22 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.844 0.747 . . . . 1.46 109.412 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.25 138.02 37.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.344 0.658 . . . . 1.29 111.819 -173.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -112.35 -12.3 13.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.062 0.945 . . . . 2.75 112.919 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -142.64 141.65 31.93 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.196 1.399 . . . . 1.64 110.948 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.89 161.84 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.494 1.117 . . . . 1.75 111.443 170.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.9 -35.96 91.48 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.4 -0.813 . . . . 2.31 113.899 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.74 84.34 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.149 0.974 . . . . 2.93 111.661 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.3 -4.69 31.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.389 1.625 . . . . 3.49 115.389 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.4 p -59.79 147.94 36.25 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.923 1.238 . . . . 2.03 111.704 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.7 t -57.67 -19.8 29.25 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.203 1.186 . . . . 1.9 114.203 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -48.55 -46.08 38.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.591 1.556 . . . . 1.65 112.438 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.6 p -69.11 -29.08 67.08 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.281 1.033 . . . . 2.22 112.839 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -74.64 -42.5 58.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.724 1.21 . . . . 1.33 111.917 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 69.1 mt -54.72 -46.19 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.69 1.196 . . . . 1.34 110.861 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.479 0.981 0 O-C-N 120.606 -1.309 . . . . 1.46 114.176 178.747 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 112.454 0.539 . . . . 1.38 112.454 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.81 -33.06 73.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.706 0.803 . . . . 1.66 111.673 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.39 -48.02 21.28 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.701 0.682 . . . . 1.28 111.245 168.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.32 -40.13 61.49 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.745 2.018 . . . . 2.63 113.983 -174.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -43.42 -51.91 6.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.7 1.2 . . . . 1.74 111.695 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.2 mm -72.69 -28.02 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.498 1.119 . . . . 2.66 113.125 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -74.0 -24.02 59.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.405 1.082 . . . . 1.19 112.894 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.47 -16.9 61.97 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.636 0.976 . . . . 2.04 113.636 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.4 154.43 42.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.501 1.143 . . . . 2.88 113.466 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.58 160.79 26.3 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.638 -1.165 . . . . 1.9 110.855 168.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.6 m -108.65 -6.43 15.99 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.507 1.523 . . . . 1.9 112.272 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.21 159.51 41.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.199 1.8 . . . . 3.37 113.012 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.19 156.65 44.4 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.209 1.404 . . . . 0.69 113.092 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -109.66 108.61 19.07 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 113.279 0.844 . . . . 0.88 113.279 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.9 mt -86.82 125.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.894 1.278 . . . . 0.77 110.064 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.04 125.3 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 119.571 1.078 . . . . 2.18 112.539 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 124.893 1.277 . . . . 2.76 113.647 -172.184 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 CA--C 1.557 1.237 0 N-CA-C 114.245 1.202 . . . . 2.79 114.245 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 m -77.64 136.02 38.18 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.943 1.297 . . . . 1.85 111.394 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -122.39 127.27 49.51 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.065 0.946 . . . . 2.41 110.241 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -114.45 119.86 38.34 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.959 1.303 . . . . 4.21 108.891 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -93.97 124.0 37.69 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.582 -0.896 . . . . 1.91 108.582 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 m -137.63 170.71 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.734 1.214 . . . . 0.73 112.265 -169.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.17 147.35 36.54 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.769 0.828 . . . . 3.4 110.601 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.88 -17.67 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 113.734 1.013 . . . . 1.13 113.734 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.52 -17.62 26.72 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 120.351 -1.468 . . . . 4.68 113.511 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.62 -16.68 28.24 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.246 1.419 . . . . 1.43 113.441 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -76.53 147.54 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.289 -0.882 . . . . 1.63 110.065 169.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -121.81 162.41 20.95 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.324 1.45 . . . . 3.21 111.852 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.4 ptt-85 -72.84 139.2 46.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.576 -0.738 . . . . 5.0 109.931 170.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.54 -3.43 10.23 Favored Glycine 0 CA--C 1.541 1.713 0 N-CA-C 115.666 1.027 . . . . 1.09 115.666 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -119.25 -174.42 2.72 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.592 1.696 . . . . 3.42 112.979 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.68 130.25 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.894 1.678 . . . . 1.8 109.933 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -115.89 129.35 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.738 2.015 . . . . 0.71 110.144 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HE3' HD11 ' A' ' 96' ' ' LEU . 41.9 mtpt -92.15 133.95 35.31 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 121.627 -0.671 . . . . 2.15 112.611 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.02 133.39 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.049 1.34 . . . . 0.7 111.44 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 m -100.67 162.2 21.47 Favored Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 124.414 1.086 . . . . 0.87 113.095 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.25 137.61 71.13 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.064 2.51 . . . . 1.07 112.472 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.14 -7.37 4.56 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.569 0.987 . . . . 1.03 115.569 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.12 160.88 50.31 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.193 1.497 . . . . 0.94 113.542 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -99.14 152.09 20.26 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.704 1.202 . . . . 1.96 112.146 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -81.04 125.03 80.73 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.021 0.929 . . . . 1.78 110.823 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.35 -20.8 2.59 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.987 2.458 . . . . 0.7 115.496 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 m -151.17 168.78 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 127.921 2.488 . . . . 0.85 108.834 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -89.32 148.03 23.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.122 0.874 . . . . 2.19 111.793 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.8 -149.42 10.0 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 114.416 0.526 . . . . 1.01 114.416 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.3 ttm105 -132.26 144.5 50.65 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.711 1.205 . . . . 5.02 113.058 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.93 132.77 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.185 2.194 . . . . 0.86 109.78 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.7 pt -140.67 30.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.144 1.165 . . . . 0.86 114.144 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -168.51 140.3 2.75 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.488 -1.383 . . . . 3.38 110.048 168.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.15 -165.12 32.66 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.604 1.097 . . . . 0.99 114.641 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -150.27 123.22 8.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.383 1.473 . . . . 1.87 111.423 -175.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.06 171.89 15.13 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.18 1.178 . . . . 1.1 114.18 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.0 ttm -121.05 132.93 55.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.207 1.403 . . . . 0.84 109.643 172.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.86 134.81 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.903 1.281 . . . . 0.63 112.0 -168.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -94.98 113.4 25.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.465 1.906 . . . . 2.16 110.642 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -114.72 22.76 13.25 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.621 1.568 . . . . 2.22 112.964 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.7 p -57.06 -22.92 42.9 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 118.176 2.658 . . . . 2.03 118.176 -167.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -105.04 -31.03 9.38 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.516 1.527 . . . . 1.3 111.415 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.0 mm -74.36 -67.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.534 1.134 . . . . 1.3 110.919 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.1 p -99.13 -4.85 31.28 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.444 1.497 . . . . 1.52 112.306 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.13 2.79 85.56 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.801 1.191 . . . . 2.09 114.757 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -73.81 108.23 6.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.412 1.085 . . . . 3.61 112.263 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.94 -16.49 56.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.47 1.108 . . . . 2.12 112.963 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.4 ttp -109.85 121.08 43.03 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.675 1.59 . . . . 3.4 108.052 169.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.82 165.66 28.99 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.604 2.869 . . . . 1.5 114.275 -168.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.14 130.45 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.545 1.538 . . . . 0.8 111.02 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.58 137.4 38.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.08 0.552 . . . . 0.7 111.66 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.18 147.26 46.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.807 1.643 . . . . 0.85 110.404 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -145.63 171.65 6.26 Favored Pre-proline 0 N--CA 1.48 1.048 0 C-N-CA 127.639 2.376 . . . . 2.8 110.248 -171.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.14 127.15 23.82 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.973 1.74 . . . . 1.02 111.556 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.01 35.29 18.88 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.539 1.066 . . . . 0.9 113.902 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.9 t -118.47 154.7 32.07 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.427 1.613 . . . . 1.55 112.252 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -107.1 144.03 34.39 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.657 1.183 . . . . 1.02 112.536 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 m -138.72 153.71 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.187 0.995 . . . . 0.73 113.555 -172.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -118.37 146.25 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.001 1.32 . . . . 0.9 114.031 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.1 143.82 31.47 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.207 1.403 . . . . 0.76 112.154 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.62 -4.04 66.21 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.845 1.098 . . . . 0.68 115.845 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.4 p -74.25 159.38 32.56 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.074 1.437 . . . . 1.4 111.758 169.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.58 140.58 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.397 1.079 . . . . 0.8 111.507 -173.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -81.86 139.29 34.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.502 1.121 . . . . 2.68 111.475 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -146.35 56.88 1.18 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.5 1.296 . . . . 3.22 114.5 168.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -160.03 -59.36 0.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.374 1.25 . . . . 3.4 114.374 167.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -164.21 168.96 38.87 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.701 1.143 . . . . 1.99 113.497 -168.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.8 p -84.15 148.18 26.91 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.789 1.033 . . . . 1.79 113.789 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -137.5 161.3 36.76 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.993 1.717 . . . . 1.29 111.629 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.479 HD11 ' HE3' ' A' ' 44' ' ' LYS . 9.7 mp -108.42 119.86 40.74 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.075 1.35 . . . . 2.04 110.348 174.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.9 mt -107.13 119.74 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.267 1.427 . . . . 2.12 110.153 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.6 p -79.97 117.11 20.52 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.856 -1.153 . . . . 1.49 110.248 170.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.63 121.83 28.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.616 0.722 . . . . 0.93 112.701 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -115.31 -9.77 12.14 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.558 1.543 . . . . 2.13 113.471 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -138.26 146.0 41.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.5 1.52 . . . . 1.61 111.474 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 m -100.4 160.75 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.47 1.508 . . . . 1.78 110.1 167.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.96 -39.13 56.33 Favored Glycine 0 N--CA 1.472 1.074 0 N-CA-C 116.556 1.382 . . . . 1.28 116.556 -166.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.22 -36.37 71.83 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.654 1.227 . . . . 1.73 113.346 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.66 -9.06 58.26 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.322 1.23 . . . . 2.33 114.322 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.8 p -58.8 152.64 18.64 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.158 -0.964 . . . . 1.65 113.148 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 t -56.82 -39.22 73.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.756 1.222 . . . . 1.89 110.567 169.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.39 -43.36 99.01 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.014 1.726 . . . . 1.47 112.362 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.7 t -67.4 -35.14 78.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.498 0.719 . . . . 2.14 111.839 176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.29 -43.37 70.53 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.364 0.529 . . . . 1.57 111.739 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.6 mt -54.06 -51.4 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.143 0.977 . . . . 1.73 111.589 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.478 0.959 0 O-C-N 120.99 -1.069 . . . . 1.41 113.04 179.37 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 111.797 0.295 . . . . 1.87 111.797 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.39 -33.29 65.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.9 0.88 . . . . 2.25 113.25 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.36 -44.65 35.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.791 0.723 . . . . 1.61 112.581 169.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -64.15 -34.13 77.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.317 0.858 . . . . 2.5 113.317 -174.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.23 -36.38 73.1 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.497 1.044 . . . . 1.25 113.047 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.0 mm -67.01 -37.24 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 118.764 0.711 . . . . 2.38 111.304 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.0 m -72.9 -23.81 60.76 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.387 -0.821 . . . . 1.23 112.754 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.7 mt -72.38 -25.6 61.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.909 1.284 . . . . 2.09 112.905 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -68.49 106.09 2.43 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.721 1.146 . . . . 3.26 110.76 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 155.31 28.23 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.173 1.389 . . . . 2.2 113.467 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.7 m -95.78 -31.14 13.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.388 1.475 . . . . 1.95 114.281 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.35 159.83 41.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.184 0.994 . . . . 2.85 113.33 -169.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.45 163.49 32.96 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.567 1.547 . . . . 0.73 112.776 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.5 m -119.65 97.52 5.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.559 1.544 . . . . 0.8 110.704 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.2 mt -84.89 133.92 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.369 1.068 . . . . 0.79 110.008 -172.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -107.81 127.34 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.506 1.122 . . . . 1.78 111.111 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 125.4 1.48 . . . . 1.63 111.388 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 120.993 0.425 . . . . 3.4 111.015 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -142.2 145.66 34.37 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.179 1.392 . . . . 2.06 110.959 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -118.48 149.06 41.92 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.495 1.665 . . . . 2.51 115.495 -168.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -104.07 139.0 39.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.577 1.951 . . . . 2.92 109.65 169.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -98.73 121.23 40.41 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.043 0.937 . . . . 2.23 109.408 172.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.62 159.86 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 115.288 1.588 . . . . 0.82 115.288 -167.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.09 150.74 30.17 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.434 1.093 . . . . 3.17 109.761 166.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.05 -21.27 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.334 1.054 . . . . 1.03 113.646 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.47 -20.14 62.81 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.361 -1.462 . . . . 2.88 112.95 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.1 mt -107.22 -8.93 16.25 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.253 1.575 . . . . 1.42 115.253 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.15 148.89 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.297 1.039 . . . . 1.49 111.051 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -122.3 165.07 16.81 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.121 1.368 . . . . 4.09 114.204 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -69.09 26.19 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 127.011 2.124 . . . . 2.78 116.213 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.79 9.65 2.32 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.003 1.764 . . . . 1.01 113.776 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -89.47 165.07 14.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.126 1.37 . . . . 2.91 112.821 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.1 mt -122.21 128.28 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.143 1.377 . . . . 1.17 110.167 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.1 mm -118.06 130.54 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.407 1.483 . . . . 0.75 113.348 -167.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -82.77 128.08 34.05 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.525 1.13 . . . . 2.58 112.408 172.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.39 125.26 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.666 1.186 . . . . 0.78 111.856 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.81 158.57 42.03 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.506 1.522 . . . . 1.16 113.205 -175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.82 123.08 9.11 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.268 3.312 . . . . 1.14 113.489 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.72 -0.75 88.13 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.879 1.228 . . . . 0.96 115.022 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.9 -169.03 30.21 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 118.757 1.278 . . . . 1.05 114.116 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -130.18 158.85 38.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.12 1.768 . . . . 2.45 111.462 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -86.68 118.66 70.53 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.621 0.768 . . . . 2.39 109.277 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -89.68 -13.84 2.61 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.04 1.827 . . . . 1.01 115.865 -168.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.0 159.82 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 128.992 2.917 . . . . 1.07 107.699 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.0 147.51 25.7 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.653 0.983 . . . . 2.0 113.653 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.45 -159.3 32.21 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 114.946 0.738 . . . . 0.87 114.946 -173.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -109.12 145.43 35.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.702 1.601 . . . . 5.12 113.541 -169.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 t -106.89 119.88 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 127.396 2.279 . . . . 1.12 108.276 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 pt -136.61 34.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 119.224 0.92 . . . . 1.52 113.399 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.15 127.97 2.21 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.024 1.73 . . . . 3.59 107.454 167.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.88 178.03 40.76 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 122.874 1.263 . . . . 0.89 115.402 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -154.95 110.65 3.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.279 1.032 . . . . 2.4 112.737 -166.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.0 p -137.74 175.05 9.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.609 1.964 . . . . 2.9 113.936 -168.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 38.6 ttm -114.72 145.13 42.41 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.321 1.048 . . . . 1.04 109.619 165.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.37 142.91 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.067 1.347 . . . . 0.64 111.771 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -113.13 113.23 25.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.915 1.686 . . . . 1.88 110.747 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -134.39 14.37 3.79 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.084 1.754 . . . . 2.52 114.336 -170.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.6 p -58.49 -13.95 6.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 117.543 2.423 . . . . 1.34 117.543 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -93.86 -33.32 13.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.999 1.32 . . . . 1.1 111.684 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.0 mm -73.79 -62.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.575 -0.703 . . . . 1.08 110.047 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.6 p -94.23 -13.19 26.84 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.007 1.323 . . . . 1.38 113.382 -171.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.43 10.31 78.93 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.659 1.6 . . . . 1.49 113.827 -172.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.88 98.87 0.58 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.684 1.742 . . . . 2.71 109.385 170.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.64 28.41 0.26 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.988 1.315 . . . . 1.89 112.496 -171.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.2 ptm -155.16 145.0 15.55 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.377 2.271 . . . . 3.27 109.301 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.42 148.92 21.22 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.111 2.541 . . . . 1.35 112.095 -172.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.55 136.21 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.829 1.252 . . . . 0.99 112.416 -168.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.0 150.15 29.0 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.079 0.952 . . . . 0.78 113.125 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -132.26 150.87 52.06 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.131 1.772 . . . . 1.16 111.598 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -143.78 173.88 4.06 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 129.146 2.978 . . . . 3.25 108.784 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -58.06 138.77 87.68 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 CA-C-N 121.058 1.414 . . . . 1.12 110.862 168.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.22 14.61 74.0 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.205 1.383 . . . . 1.04 115.083 -170.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.8 m -97.74 164.87 12.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.391 1.596 . . . . 1.81 110.72 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.8 p -124.03 159.96 28.73 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.107 -0.996 . . . . 1.48 113.334 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.65 161.06 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.616 1.966 . . . . 0.7 112.151 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.537 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -116.84 154.86 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.847 2.059 . . . . 1.29 112.026 172.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.2 150.45 48.29 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.37 0.878 . . . . 0.78 113.37 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.64 -5.12 62.01 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.661 1.124 . . . . 0.79 115.219 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.0 p -77.68 157.46 30.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.792 1.237 . . . . 1.51 111.663 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mm -108.39 137.2 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.884 0.874 . . . . 0.74 111.482 -170.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.66 155.13 21.24 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.877 1.671 . . . . 3.45 112.905 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -129.77 124.49 33.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.642 1.577 . . . . 3.02 109.075 166.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.465 ' ND2' ' H ' ' A' ' 93' ' ' GLY . 34.4 t30 45.94 -132.37 1.03 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.101 2.161 . . . . 3.85 110.294 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.465 ' H ' ' ND2' ' A' ' 92' ' ' ASN . . . 88.98 -60.23 3.85 Favored Glycine 0 CA--C 1.527 0.8 0 O-C-N 120.069 -1.644 . . . . 3.42 116.488 166.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.4 m 47.44 77.16 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.398 1.479 . . . . 2.32 111.781 -168.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.2 164.2 12.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.402 1.081 . . . . 1.36 113.421 -166.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mp -119.54 128.7 54.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.158 0.983 . . . . 2.0 110.527 168.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.5 mm -115.74 122.55 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.835 1.654 . . . . 1.43 110.955 -170.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.07 103.34 16.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.756 1.222 . . . . 3.02 110.141 176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.07 131.35 36.23 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.355 1.062 . . . . 0.87 112.001 -174.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.35 6.01 7.0 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.01 1.485 . . . . 2.21 115.01 -175.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -142.05 147.31 36.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.492 1.117 . . . . 1.53 111.842 170.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 p -86.64 163.25 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.442 1.097 . . . . 3.02 110.389 170.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.05 -37.67 94.29 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 120.241 -1.537 . . . . 1.43 114.712 -169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.67 -32.06 71.27 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.244 1.018 . . . . 1.68 112.822 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.42 -16.74 60.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.78 1.232 . . . . 2.64 113.946 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.9 p -68.37 159.87 30.64 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.902 1.228 . . . . 1.72 113.714 -169.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.3 t -66.27 -31.12 71.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.396 -0.82 . . . . 2.32 111.539 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.3 mp -57.44 -53.09 62.05 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.839 -1.163 . . . . 1.62 111.828 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.6 p -70.5 -24.69 62.88 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.196 0.998 . . . . 1.81 111.901 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -72.76 -42.61 63.82 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.478 0.918 . . . . 2.15 113.478 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.3 mt -56.68 -49.19 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.031 -1.043 . . . . 1.71 110.259 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 113.379 0.881 . . . . 1.58 113.379 178.594 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 115.149 1.537 . . . . 1.71 115.149 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.9 tp -68.17 -31.64 71.33 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.608 -1.308 . . . . 1.93 113.731 -169.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.89 -21.01 55.56 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.894 -1.129 . . . . 1.34 113.532 169.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -69.39 -41.41 76.49 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.813 -1.179 . . . . 2.63 111.366 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.19 -43.56 82.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.241 1.016 . . . . 1.02 112.162 177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.02 -33.64 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.294 -0.879 . . . . 1.6 111.998 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.9 m -75.77 -19.62 58.87 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.285 1.034 . . . . 1.12 113.177 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mt -68.12 -32.13 72.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.585 1.954 . . . . 2.07 113.006 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -57.11 131.76 50.88 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.853 1.206 . . . . 3.43 111.952 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.08 144.93 53.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.835 -0.621 . . . . 2.3 109.489 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 p -78.52 -20.98 49.55 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.118 1.155 . . . . 3.15 114.118 -174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -137.76 158.65 43.91 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.61 1.337 . . . . 3.97 114.61 -169.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.86 172.8 12.19 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.595 1.958 . . . . 1.17 112.476 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.6 m -131.45 102.41 5.93 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.135 1.774 . . . . 1.2 111.141 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.5 mt -80.38 128.62 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.045 1.338 . . . . 0.76 109.387 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.51 132.97 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.804 0.842 . . . . 2.18 112.533 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.478 0.943 0 C-N-CA 124.611 1.165 . . . . 2.15 113.403 -169.149 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 109.051 -0.722 . . . . 3.62 109.051 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 t -124.93 144.33 50.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.138 1.375 . . . . 2.03 111.207 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -141.79 127.25 18.86 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.947 1.299 . . . . 2.34 110.054 -171.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.4 133.35 53.43 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.723 -1.236 . . . . 3.28 111.12 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.69 123.47 43.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.082 0.856 . . . . 2.9 110.965 176.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -129.61 165.41 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.243 1.417 . . . . 1.28 112.808 -168.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -80.18 151.1 29.9 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.115 1.366 . . . . 3.69 110.165 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.35 -23.09 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 120.968 -1.083 . . . . 1.76 113.117 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -70.05 -18.16 63.27 Favored 'General case' 0 CA--C 1.552 1.053 0 O-C-N 120.813 -1.179 . . . . 3.78 113.741 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -110.52 -3.36 16.04 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.093 1.516 . . . . 1.73 115.093 -169.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -94.63 145.33 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.931 1.692 . . . . 1.97 111.067 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -122.79 166.72 14.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.713 2.405 . . . . 3.4 114.041 -175.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -73.86 16.18 0.24 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.787 2.143 . . . . 3.45 116.787 -169.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.97 11.25 3.64 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.218 1.865 . . . . 1.33 113.829 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -79.64 152.74 29.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.332 1.566 . . . . 3.54 112.508 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.24 120.08 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.116 1.366 . . . . 1.8 108.922 173.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.6 mm -118.76 125.25 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.031 0.932 . . . . 0.62 113.198 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.563 ' HE3' HD11 ' A' ' 96' ' ' LEU . 17.7 ttmt -80.03 128.69 33.78 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.378 0.671 . . . . 1.93 110.632 167.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 p -103.14 137.07 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.137 0.975 . . . . 0.66 111.113 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -88.58 160.66 44.18 Favored Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 113.35 0.87 . . . . 1.16 113.35 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.01 136.29 64.52 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.67 2.247 . . . . 1.31 110.41 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.64 -3.97 23.49 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.443 1.497 . . . . 0.96 116.408 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.97 178.26 53.9 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.203 1.382 . . . . 0.98 114.9 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -126.65 148.0 49.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.659 1.584 . . . . 2.38 112.616 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -82.73 126.68 72.6 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.394 0.677 . . . . 1.86 112.601 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -90.89 -22.6 0.61 Allowed 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.122 3.215 . . . . 1.0 114.713 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 m -147.67 170.3 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 128.524 2.73 . . . . 0.8 108.721 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -99.22 156.35 17.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.106 1.15 . . . . 1.68 114.106 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.8 -168.1 39.87 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 115.845 1.098 . . . . 0.65 115.845 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -112.17 138.72 48.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.43 1.892 . . . . 4.15 111.552 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.82 127.84 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 127.016 2.126 . . . . 0.67 109.399 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.2 pt -140.61 31.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.494 0.718 . . . . 0.7 112.844 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -167.3 133.59 2.2 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.415 1.486 . . . . 2.57 109.821 169.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.41 -177.8 48.86 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.075 1.19 . . . . 0.79 116.075 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -147.75 113.02 5.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.864 1.266 . . . . 2.31 112.402 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.79 167.27 22.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.488 1.115 . . . . 1.28 111.607 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.7 ttm -105.3 145.57 30.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.955 0.902 . . . . 0.96 109.945 169.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.57 136.0 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.215 1.006 . . . . 0.7 112.054 -170.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -100.89 132.66 46.19 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.067 1.347 . . . . 2.21 111.631 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -133.62 16.46 3.98 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.101 1.519 . . . . 1.82 115.101 -169.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' A' ' 73' ' ' ALA . 98.0 p -44.38 -32.45 1.35 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 119.628 3.196 . . . . 1.8 119.628 -166.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -95.09 -41.82 8.92 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.648 1.113 . . . . 1.51 111.202 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.4 mm -69.04 -64.32 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.889 1.276 . . . . 1.05 111.498 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.4 p -93.69 -11.3 31.85 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.202 1.401 . . . . 1.32 112.327 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.54 2.16 87.29 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.021 1.296 . . . . 1.23 115.083 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -55.68 -46.46 77.58 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.174 0.987 . . . . 2.33 113.542 -170.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' A' ' 67' ' ' SER . . . 55.94 27.25 10.85 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.679 1.592 . . . . 2.07 113.369 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.7 ttt -152.79 136.85 10.36 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 131.158 3.783 . . . . 3.68 105.312 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.32 153.51 35.71 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.719 2.28 . . . . 1.35 112.881 -172.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.8 t -128.39 134.38 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.735 1.614 . . . . 1.01 112.073 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.55 134.12 36.48 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.545 1.138 . . . . 0.9 113.488 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -117.7 143.52 46.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.635 1.974 . . . . 0.87 110.655 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -142.93 175.34 2.94 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 127.358 2.263 . . . . 3.59 109.465 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -59.18 127.82 25.42 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 CA-C-N 122.182 1.815 . . . . 0.99 111.325 170.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.29 33.59 11.63 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.659 1.123 . . . . 1.03 114.749 -169.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -121.09 170.82 9.17 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.166 1.386 . . . . 1.76 111.173 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.8 p -122.74 151.22 41.8 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.493 -1.379 . . . . 0.81 113.449 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.72 156.37 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.936 1.694 . . . . 0.69 112.272 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -123.97 159.06 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.213 1.805 . . . . 0.97 112.355 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.14 149.99 49.43 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.769 -0.582 . . . . 0.65 112.479 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.7 -2.42 83.0 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 115.293 0.877 . . . . 1.03 115.293 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.88 153.14 32.92 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 117.783 0.792 . . . . 1.96 112.05 168.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mm -108.89 129.84 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.988 1.315 . . . . 0.73 110.493 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -94.77 142.38 27.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.04 1.736 . . . . 1.66 111.856 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.65 -101.33 0.11 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.242 1.201 . . . . 5.1 114.242 -174.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -98.42 -41.36 7.84 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.324 1.602 . . . . 3.66 115.324 -167.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.49 140.37 18.11 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 119.487 1.04 . . . . 1.85 114.041 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t -84.93 129.35 34.82 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.735 0.814 . . . . 2.62 110.413 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.2 mt -120.69 158.72 26.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.375 1.47 . . . . 0.96 110.902 -173.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.563 HD11 ' HE3' ' A' ' 44' ' ' LYS . 7.8 mp -112.97 129.75 56.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.166 0.587 . . . . 1.76 109.88 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.31 128.19 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.596 1.558 . . . . 1.12 110.222 -173.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 23.4 p -81.84 111.16 17.8 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.288 -1.004 . . . . 1.51 108.288 168.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.29 142.96 37.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.869 0.868 . . . . 1.06 110.848 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -132.21 3.5 3.99 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.876 1.806 . . . . 2.99 115.876 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -145.16 150.81 37.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.842 1.257 . . . . 1.98 111.473 170.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.8 m -81.88 171.41 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.206 1.002 . . . . 1.81 110.85 168.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.75 -28.89 73.3 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 120.756 -1.215 . . . . 1.73 114.699 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.91 -42.75 60.2 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.792 1.296 . . . . 1.79 113.572 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -78.73 -10.2 59.69 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 116.497 2.036 . . . . 2.91 116.497 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.9 t -83.95 156.48 22.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.464 1.505 . . . . 2.57 113.417 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.8 m -39.33 -44.28 1.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.99 2.116 . . . . 2.31 114.308 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.17 -46.73 85.8 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.756 1.162 . . . . 1.41 111.847 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.3 t -70.19 -35.65 74.09 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.851 0.861 . . . . 2.38 111.088 173.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -64.25 -35.73 81.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.377 0.671 . . . . 1.92 112.288 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.6 mt -64.69 -58.99 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.466 1.506 . . . . 1.43 110.728 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 113.539 0.941 . . . . 1.48 113.539 -171.737 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 114.632 1.345 . . . . 1.51 114.632 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 35.3 tp -63.63 -42.62 98.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.903 1.229 . . . . 1.41 113.313 -168.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.8 -21.61 57.17 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.597 -1.314 . . . . 2.19 113.161 169.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -67.17 -39.56 86.47 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.776 1.171 . . . . 2.58 111.446 -170.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -49.47 -46.15 47.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.315 0.646 . . . . 1.43 110.998 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.2 mm -71.52 -27.99 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.652 1.181 . . . . 2.36 113.294 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.9 m -70.91 -37.09 72.92 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.307 1.043 . . . . 1.24 112.83 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.05 -17.34 51.88 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.092 1.145 . . . . 2.39 114.092 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.65 135.52 55.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.691 1.596 . . . . 2.19 113.185 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.13 150.36 48.29 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.399 0.679 . . . . 1.97 112.104 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -100.56 -28.55 12.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.765 1.226 . . . . 1.87 112.193 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -140.64 152.93 45.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.054 1.342 . . . . 3.3 112.096 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.08 157.84 44.16 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.638 1.575 . . . . 1.2 113.272 -169.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 m -94.5 109.67 21.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.784 0.834 . . . . 1.48 112.849 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.7 mt -84.48 125.09 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.067 0.947 . . . . 0.81 109.55 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.72 130.17 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.986 0.914 . . . . 1.83 110.691 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.474 0.756 0 C-N-CA 124.594 1.158 . . . . 1.98 111.09 -177.759 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 109.108 -0.701 . . . . 3.5 109.108 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -140.59 138.44 34.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.81 0.844 . . . . 1.65 111.588 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -137.39 132.0 32.86 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.195 0.998 . . . . 3.03 110.915 -173.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.2 140.36 48.62 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.243 1.417 . . . . 3.46 109.925 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -100.45 117.77 35.29 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.308 0.958 . . . . 2.05 109.22 168.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.99 156.96 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.857 1.263 . . . . 1.43 111.946 -168.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -76.84 151.62 35.8 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.46 -0.775 . . . . 3.78 111.273 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.0 -19.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 115.037 1.495 . . . . 1.15 115.037 -172.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.95 -19.28 52.13 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 120.333 -1.479 . . . . 3.97 113.668 173.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.8 mt -91.36 -6.85 52.32 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.107 1.763 . . . . 1.72 113.43 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.26 143.03 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.218 1.807 . . . . 1.49 110.255 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.32 172.73 10.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.17 0.988 . . . . 4.39 112.316 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -65.66 21.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 117.487 2.403 . . . . 3.74 117.487 -172.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.7 42.95 0.81 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.219 1.866 . . . . 1.4 111.714 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -122.66 159.32 28.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.894 1.678 . . . . 2.19 110.584 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 53.7 mt -116.22 125.79 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.18 0.992 . . . . 1.2 109.834 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.5 mm -116.92 127.19 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.936 1.295 . . . . 0.7 112.195 -168.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -79.37 121.66 25.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.693 0.797 . . . . 3.2 109.209 168.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.8 124.44 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.247 1.019 . . . . 1.14 109.29 170.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.8 m -85.99 156.68 57.74 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 123.323 0.649 . . . . 1.3 112.654 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.05 130.71 35.66 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.746 2.297 . . . . 1.35 111.848 171.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.1 -7.44 29.34 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 124.812 1.196 . . . . 1.03 115.07 -171.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.51 -177.83 50.62 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.341 1.448 . . . . 1.09 114.234 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -125.65 158.18 35.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.22 1.408 . . . . 1.81 112.29 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -88.78 129.08 49.97 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.901 0.881 . . . . 2.22 111.859 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.99 -25.59 1.41 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.747 2.965 . . . . 0.88 115.207 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -147.85 167.33 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.833 2.453 . . . . 0.99 108.749 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.21 149.11 24.83 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.023 0.828 . . . . 1.95 111.429 174.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -165.15 35.72 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 114.552 0.581 . . . . 0.96 114.552 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -111.5 144.49 40.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.473 1.509 . . . . 3.56 112.314 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.13 134.03 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.863 2.465 . . . . 1.04 108.225 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 pt -138.35 30.31 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 122.253 1.025 . . . . 1.14 112.42 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -168.54 144.44 3.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.582 1.953 . . . . 3.38 109.552 167.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 177.18 38.94 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 117.268 1.667 . . . . 1.06 117.268 167.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -143.78 37.6 1.32 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 115.619 1.711 . . . . 2.21 115.619 -168.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.645 ' H ' HD21 ' A' ' 95' ' ' LEU . 34.7 m -77.3 157.61 30.63 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.718 -1.239 . . . . 1.72 112.247 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.3 ttm -92.89 140.13 29.82 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.841 -0.618 . . . . 1.16 110.083 168.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.5 t -126.24 143.48 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.355 1.462 . . . . 0.73 111.905 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -106.22 111.09 23.55 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.014 1.725 . . . . 2.14 111.429 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.3 16.24 5.01 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.792 1.637 . . . . 1.9 114.662 -172.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.5 p -65.6 -26.92 68.06 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.659 1.726 . . . . 1.46 115.659 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -79.43 -48.21 14.35 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.36 0.982 . . . . 1.51 110.686 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.5 mm -65.73 -55.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.657 0.783 . . . . 1.63 110.499 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.7 p -93.57 -11.63 31.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.407 1.083 . . . . 1.68 113.708 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.07 13.48 82.95 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 119.312 -0.716 . . . . 1.43 113.785 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.58 175.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.14 2.176 . . . . 2.91 113.581 171.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.77 6.45 1.61 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.224 1.565 . . . . 2.24 115.224 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -149.55 148.83 27.08 Favored Pre-proline 0 C--O 1.24 0.604 0 O-C-N 120.825 -1.172 . . . . 4.09 109.272 168.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.08 157.85 60.13 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.565 2.176 . . . . 1.27 111.395 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.8 t -117.25 127.81 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.832 1.253 . . . . 0.94 112.353 -167.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.21 130.17 35.2 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.274 0.629 . . . . 1.01 111.213 173.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.12 162.92 12.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.684 1.194 . . . . 0.81 111.649 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -150.6 165.17 18.0 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 127.571 2.349 . . . . 3.7 110.342 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.1 129.79 31.66 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 CA-C-N 121.075 1.42 . . . . 1.08 108.697 165.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.37 44.67 6.85 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.344 0.973 . . . . 1.01 113.576 -169.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 t -131.39 151.2 51.75 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.346 1.458 . . . . 1.74 111.698 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.0 p -101.4 147.58 26.17 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.788 1.631 . . . . 1.45 113.151 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 m -139.48 151.71 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.197 1.399 . . . . 0.76 112.64 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -112.88 147.08 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.94 1.296 . . . . 1.21 112.736 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.66 144.31 14.24 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.864 -1.062 . . . . 0.74 111.719 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.57 -7.58 57.49 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 116.203 1.241 . . . . 0.85 116.203 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.6 p -68.98 160.73 30.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.398 1.599 . . . . 1.48 110.962 168.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.55 146.18 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.115 0.966 . . . . 0.87 110.624 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -108.45 153.04 23.89 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.832 1.253 . . . . 1.6 113.465 -174.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -115.28 -167.7 1.28 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.662 1.985 . . . . 3.61 109.805 170.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -77.66 140.5 39.6 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 119.649 -1.907 . . . . 4.79 111.574 -174.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.05 11.31 0.42 Allowed Glycine 0 CA--C 1.542 1.741 0 C-N-CA 124.978 1.275 . . . . 3.51 114.012 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m 23.8 85.67 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 129.58 3.152 . . . . 1.64 115.846 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.645 HD21 ' H ' ' A' ' 62' ' ' SER . 57.7 mt -87.33 150.69 23.68 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.402 0.681 . . . . 1.38 112.761 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.73 128.93 51.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.679 0.792 . . . . 1.95 110.244 167.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.0 mm -111.86 126.47 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.837 1.655 . . . . 1.75 110.449 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.2 p -79.41 104.5 10.06 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.899 0.857 . . . . 1.69 109.718 169.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.94 113.69 14.91 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.178 -0.951 . . . . 1.12 109.393 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.5 p -120.21 16.2 12.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.708 1.203 . . . . 2.44 113.026 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -148.86 146.32 27.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.075 1.75 . . . . 1.78 110.417 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 m -100.56 164.16 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.701 0.8 . . . . 1.55 109.625 165.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -51.45 -45.09 53.63 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 114.523 0.569 . . . . 1.49 114.523 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.2 -23.57 67.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.325 1.232 . . . . 1.77 114.325 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -78.7 -25.96 44.81 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.986 1.476 . . . . 2.58 114.986 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 p -52.36 143.21 15.51 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.838 1.792 . . . . 1.72 115.838 -164.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.6 t -60.04 -32.22 70.71 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.067 0.947 . . . . 2.03 111.499 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.3 tp -52.97 -44.62 67.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.424 1.49 . . . . 1.63 112.195 168.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.0 p -71.87 -24.5 61.69 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.154 0.798 . . . . 2.94 113.154 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -71.25 -39.56 71.54 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.826 -1.171 . . . . 2.72 112.014 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 96.3 mt -53.49 -55.14 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.506 0.722 . . . . 1.71 109.968 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 114.251 1.204 . . . . 1.53 114.251 178.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 113.797 1.036 . . . . 1.8 113.797 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 47.3 tp -67.84 -35.05 77.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.797 1.18 . . . . 1.41 112.507 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.63 -36.37 62.9 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.374 0.534 . . . . 1.74 111.481 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -56.54 -36.9 69.77 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.801 1.24 . . . . 2.85 114.255 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -48.62 -49.51 36.73 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.753 1.16 . . . . 1.66 111.489 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.97 -29.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.625 1.17 . . . . 2.35 112.039 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -73.01 -26.35 61.29 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.475 -0.766 . . . . 1.28 112.907 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.36 -33.01 72.44 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.239 0.927 . . . . 1.94 112.362 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -62.02 147.1 48.24 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.167 0.894 . . . . 3.65 111.655 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.9 -21.01 64.37 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.235 2.309 . . . . 3.79 117.235 -167.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 m 66.73 -28.17 0.13 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.233 1.813 . . . . 2.65 114.545 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -137.82 156.62 47.74 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.127 2.171 . . . . 2.8 112.981 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.12 165.73 26.63 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.495 1.518 . . . . 0.88 113.7 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.2 m -116.29 108.13 15.71 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.966 1.706 . . . . 0.83 111.274 170.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.8 mt -85.94 141.08 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.674 1.189 . . . . 0.73 109.727 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 m -114.63 133.39 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.195 0.998 . . . . 1.75 113.285 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.476 0.852 0 C-N-CA 125.985 1.714 . . . . 1.86 110.093 -174.799 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.338 0.59 . . . . 2.37 110.6 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -78.87 125.82 29.88 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.656 1.182 . . . . 1.75 110.407 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -103.0 160.79 14.31 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.951 -1.093 . . . . 3.32 113.055 -174.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.94 125.28 35.1 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.05 1.34 . . . . 4.53 109.486 168.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -91.82 121.75 33.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.859 -1.164 . . . . 1.67 107.859 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 m -136.32 157.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.077 0.951 . . . . 1.12 113.538 -167.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.8 145.6 32.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.775 0.83 . . . . 2.97 110.29 167.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.63 -29.65 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 113.287 0.847 . . . . 1.27 113.287 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -74.35 -3.77 32.35 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.895 1.278 . . . . 3.95 113.551 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.8 -13.52 12.61 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.535 1.934 . . . . 1.93 114.617 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.51 147.85 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 119.556 1.071 . . . . 1.77 111.246 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.76 163.76 20.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.016 1.726 . . . . 3.66 114.298 -176.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -71.52 18.82 0.07 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 117.621 2.452 . . . . 3.51 117.621 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.17 4.33 6.35 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.019 1.295 . . . . 1.22 115.548 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -111.29 169.67 8.63 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.633 1.173 . . . . 2.27 112.565 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.8 mt -123.75 130.75 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.666 1.586 . . . . 1.17 110.427 -170.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -117.99 136.04 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.438 1.495 . . . . 0.7 113.871 -166.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -87.09 143.14 27.44 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.567 0.951 . . . . 2.61 113.567 169.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.9 p -132.25 134.74 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.439 1.095 . . . . 0.82 111.479 169.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.14 170.41 5.36 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 125.339 1.456 . . . . 1.34 112.847 -170.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.33 132.07 50.02 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.785 2.323 . . . . 1.3 112.547 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.11 -8.27 39.35 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.939 1.733 . . . . 0.91 114.992 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.78 166.56 54.57 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 118.933 1.366 . . . . 0.98 113.813 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -119.61 153.34 35.64 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.037 1.335 . . . . 2.77 112.255 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -79.29 134.97 58.09 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.374 0.669 . . . . 1.81 112.45 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.14 -32.58 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.983 2.456 . . . . 0.9 115.313 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 m -145.85 171.32 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 126.984 2.114 . . . . 0.9 109.183 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.96 144.5 25.4 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.089 0.859 . . . . 2.39 112.399 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.62 -164.82 35.89 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.013 1.165 . . . . 0.78 116.013 -175.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -107.94 145.64 33.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.738 2.015 . . . . 5.19 112.693 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.66 133.76 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 127.581 2.352 . . . . 0.97 110.443 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.73 37.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.936 1.087 . . . . 1.21 113.936 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -165.29 136.53 3.98 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.839 -1.163 . . . . 2.37 110.159 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.41 -174.31 50.39 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.844 1.212 . . . . 0.76 115.992 168.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -149.67 112.0 4.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.27 1.028 . . . . 1.99 112.222 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.55 154.95 45.78 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.238 1.015 . . . . 1.25 112.814 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.4 ttm -104.32 128.87 52.19 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.689 1.195 . . . . 0.84 108.969 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 86.1 t -115.99 136.6 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.68 1.592 . . . . 0.62 113.147 -166.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -91.04 100.68 13.49 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.348 -0.845 . . . . 1.98 111.607 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -93.65 4.74 53.48 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.318 1.447 . . . . 2.05 113.963 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -38.97 -45.59 1.22 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.923 2.489 . . . . 1.9 116.842 -169.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.74 -32.01 28.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.024 0.829 . . . . 1.09 111.924 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.15 -58.13 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.796 1.639 . . . . 1.07 111.642 -171.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.9 p -102.7 -5.5 23.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.757 1.223 . . . . 1.22 113.036 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.98 18.82 79.75 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.445 1.498 . . . . 1.15 113.955 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -67.15 -53.29 31.96 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.782 0.833 . . . . 2.42 112.035 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 64.18 29.26 14.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.433 1.893 . . . . 1.85 112.882 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.2 ptp -157.77 128.77 3.68 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 130.21 3.404 . . . . 4.1 106.489 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.98 156.95 51.87 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.032 1.821 . . . . 1.32 114.104 -167.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.9 t -120.02 129.55 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 126.96 2.104 . . . . 0.7 111.299 -168.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.7 134.63 36.41 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.34 -0.85 . . . . 0.66 112.809 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -120.34 151.3 39.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.302 1.841 . . . . 0.74 110.841 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -149.24 174.66 3.27 Favored Pre-proline 0 N--CA 1.483 1.175 0 C-N-CA 127.866 2.466 . . . . 2.4 111.491 -168.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.24 129.67 24.84 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 CA-C-N 122.045 1.766 . . . . 0.84 110.592 167.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.24 46.77 9.78 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.59 1.09 . . . . 1.1 111.918 -168.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.8 t -126.34 160.27 30.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.615 1.566 . . . . 1.33 111.365 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.0 p -121.0 146.09 47.06 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.887 -1.133 . . . . 0.93 111.817 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.05 155.0 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.064 1.345 . . . . 0.67 112.952 -171.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.434 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -114.76 147.81 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.575 1.95 . . . . 1.03 112.503 169.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.66 151.46 33.54 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.902 1.281 . . . . 0.71 113.136 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.03 -6.6 59.0 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.928 1.251 . . . . 0.75 115.715 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.5 p -76.53 159.84 30.0 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.763 1.282 . . . . 1.37 111.758 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -110.24 125.77 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.138 0.975 . . . . 0.71 112.112 -169.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -95.5 127.53 41.61 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.251 1.82 . . . . 1.68 112.099 -175.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -150.69 76.9 1.27 Allowed 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.087 1.884 . . . . 3.44 116.087 -171.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -171.59 -60.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.393 1.877 . . . . 3.35 110.592 167.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.17 175.07 24.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.076 2.274 . . . . 1.9 112.285 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.0 m -87.15 141.37 28.7 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.672 1.189 . . . . 1.82 112.296 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.4 mt -127.73 165.51 19.93 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.224 1.81 . . . . 0.9 112.339 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.1 tp -124.02 113.52 18.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.048 1.739 . . . . 2.81 111.573 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.87 130.04 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.113 0.965 . . . . 1.67 112.588 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 82.8 m -86.67 106.4 17.59 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.813 0.845 . . . . 2.52 109.939 169.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.25 116.41 19.5 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.451 -0.78 . . . . 0.94 111.108 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -115.86 10.42 15.28 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.339 1.056 . . . . 3.3 113.384 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -141.09 138.51 33.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.694 1.598 . . . . 1.69 110.795 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 m -84.59 162.27 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 108.903 -0.777 . . . . 1.63 108.903 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.31 -43.33 75.59 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.009 -1.057 . . . . 1.73 114.257 -169.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.41 -31.41 72.1 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.888 1.07 . . . . 1.79 113.888 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.18 -17.02 58.86 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.025 1.73 . . . . 2.8 114.19 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.0 p -68.86 151.8 46.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.022 0.929 . . . . 1.81 113.245 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.6 t -55.44 -37.45 67.72 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.281 0.632 . . . . 2.07 112.051 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.7 tp -61.57 -49.46 76.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.416 1.086 . . . . 1.73 112.256 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 t -71.89 -25.99 62.15 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.444 0.697 . . . . 1.63 112.2 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.83 -41.15 75.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.73 1.212 . . . . 1.63 112.778 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.69 -50.09 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.804 0.842 . . . . 1.66 110.651 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 114.005 1.113 . . . . 1.48 114.005 178.807 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 113.175 0.806 . . . . 1.51 113.175 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.15 -28.3 69.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.3 0.64 . . . . 1.63 112.331 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.34 -47.51 33.92 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.693 -0.629 . . . . 1.42 110.852 167.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -48.91 -41.48 33.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.301 1.44 . . . . 3.46 114.779 -169.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.42 -45.33 69.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.944 0.793 . . . . 1.57 111.992 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.7 mm -72.91 -29.24 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.551 1.14 . . . . 2.01 112.521 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -74.29 -24.21 59.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.408 0.892 . . . . 1.47 113.408 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.31 -19.73 65.62 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.77 1.026 . . . . 2.07 113.77 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.33 157.79 36.32 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 115.178 1.547 . . . . 2.33 115.178 -169.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.11 154.4 17.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.893 1.677 . . . . 1.81 112.721 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -88.55 -23.29 23.2 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.552 1.141 . . . . 2.3 112.736 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.75 168.26 20.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.779 1.232 . . . . 3.52 114.075 -169.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.65 161.3 38.08 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.408 1.483 . . . . 0.73 112.472 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.0 m -121.55 95.95 4.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.748 1.619 . . . . 0.82 110.873 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.32 146.22 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.219 1.408 . . . . 0.83 110.002 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.19 120.59 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.518 1.054 . . . . 1.72 111.967 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.478 0.964 0 C-N-CA 125.17 1.388 . . . . 1.94 111.277 178.141 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 CA--C 1.543 0.708 0 CA-C-O 120.832 0.349 . . . . 2.85 111.926 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.7 t -132.3 110.65 10.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.149 1.78 . . . . 1.61 110.072 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -108.51 136.64 47.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.176 1.176 . . . . 2.89 114.176 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -108.11 132.55 53.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.671 1.588 . . . . 2.67 110.106 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -104.51 122.79 46.29 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.524 -0.917 . . . . 2.03 108.524 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.3 m -139.68 156.66 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.974 0.91 . . . . 0.93 113.007 -169.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -74.06 146.48 43.63 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.618 -0.512 . . . . 4.03 109.618 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.41 -27.92 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.681 1.363 . . . . 1.28 114.681 -168.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -73.3 -7.67 52.54 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 120.495 -1.378 . . . . 3.35 113.431 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.0 -1.04 32.68 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.258 1.823 . . . . 1.69 114.882 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -109.76 148.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.918 1.287 . . . . 1.92 110.736 172.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -123.65 175.9 6.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.908 2.083 . . . . 3.41 110.811 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -68.92 156.65 38.16 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.36 -0.838 . . . . 2.84 111.093 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.36 22.78 21.17 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 119.132 0.878 . . . . 1.2 113.858 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.15 167.28 20.95 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.539 1.535 . . . . 2.1 112.305 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.03 129.69 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.159 1.383 . . . . 1.2 110.646 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 mm -120.52 129.13 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.241 1.816 . . . . 0.67 110.499 -169.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -78.68 133.69 37.18 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.101 -1.0 . . . . 2.12 111.171 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.96 128.09 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.008 1.323 . . . . 0.8 110.539 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.85 171.08 5.8 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.622 1.169 . . . . 1.1 112.48 -169.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.32 127.81 25.24 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.483 2.122 . . . . 1.04 112.537 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.22 -1.96 73.12 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.79 1.185 . . . . 1.0 116.006 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.22 -176.82 50.3 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 118.897 1.348 . . . . 0.94 114.064 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -124.57 159.79 29.87 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.074 1.749 . . . . 2.57 112.152 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -84.03 118.8 72.25 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.125 0.97 . . . . 2.31 109.554 170.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -83.49 -17.66 6.22 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.258 1.972 . . . . 0.8 115.482 -169.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -153.04 160.93 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 127.915 2.486 . . . . 1.2 108.312 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.03 140.88 33.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.154 0.888 . . . . 1.92 112.768 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.16 -148.75 9.39 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.642 -0.661 . . . . 0.81 114.603 -171.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -131.85 145.57 51.62 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.896 1.278 . . . . 4.02 113.939 -170.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.5 t -96.46 125.48 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.949 2.5 . . . . 0.75 108.916 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.49 32.73 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 113.641 0.978 . . . . 0.78 113.641 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -168.11 136.21 2.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.364 1.866 . . . . 3.56 108.26 166.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.29 179.4 52.62 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 122.448 1.027 . . . . 0.91 114.726 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -154.67 123.44 6.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.972 0.909 . . . . 2.04 112.743 -170.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.9 p -137.5 -179.04 5.5 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.345 1.858 . . . . 3.18 113.588 -168.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.9 ttm -128.4 135.14 49.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.971 1.708 . . . . 0.81 108.888 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.76 139.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.215 1.406 . . . . 0.67 112.076 -168.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -102.24 110.57 22.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.386 1.475 . . . . 1.91 111.401 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.75 22.05 11.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.21 1.804 . . . . 2.49 113.145 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.5 p -53.1 -28.18 24.17 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.7 1.741 . . . . 1.6 115.7 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.83 -34.91 16.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.369 0.986 . . . . 1.2 111.667 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.3 mm -70.46 -47.8 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.617 0.767 . . . . 1.25 110.687 -177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.2 p -119.92 -4.33 10.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.77 1.228 . . . . 1.74 114.172 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.37 3.07 89.86 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.606 1.098 . . . . 1.85 115.331 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -56.32 -52.92 62.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.298 1.221 . . . . 2.72 114.298 -169.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.19 33.63 23.35 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 122.201 1.0 . . . . 1.9 111.868 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -154.78 113.21 2.37 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 128.745 2.818 . . . . 3.82 106.068 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -62.33 153.03 73.2 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.994 2.462 . . . . 1.48 114.251 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.4 t -115.96 137.27 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.99 1.316 . . . . 0.72 110.949 -171.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.95 142.05 28.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.636 0.774 . . . . 0.64 112.483 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -123.43 152.19 41.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.289 1.436 . . . . 0.68 111.717 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -146.23 170.16 8.38 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 129.148 2.979 . . . . 3.5 107.864 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.33 132.79 54.33 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 CA-C-N 121.82 1.686 . . . . 0.78 111.63 168.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.11 25.77 28.07 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.239 1.399 . . . . 0.76 114.815 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.2 t -117.56 158.61 24.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.231 1.412 . . . . 1.37 111.826 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.6 p -116.6 146.95 42.32 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.005 1.275 . . . . 0.84 113.22 -172.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.6 156.04 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.703 1.601 . . . . 0.74 113.08 -172.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -115.24 147.35 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.702 2.001 . . . . 1.03 112.558 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.14 148.29 44.9 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.886 1.274 . . . . 0.84 112.897 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.86 -4.96 51.06 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.617 1.103 . . . . 0.74 115.42 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.3 p -74.61 154.49 38.52 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.477 1.638 . . . . 1.29 111.363 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.94 124.9 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.095 0.558 . . . . 0.74 111.618 -169.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -86.73 139.64 30.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.469 1.107 . . . . 1.54 111.763 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -88.49 -70.49 0.64 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.255 -0.903 . . . . 3.46 112.206 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -131.9 -160.66 1.06 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.746 1.618 . . . . 4.47 109.208 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.86 -26.52 11.48 Favored Glycine 0 CA--C 1.529 0.908 0 O-C-N 119.684 -1.885 . . . . 3.41 116.128 169.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.0 m 44.74 67.89 0.63 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.686 1.594 . . . . 1.97 112.163 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mt -97.8 159.47 14.91 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.706 1.203 . . . . 0.99 113.115 -166.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.93 128.96 54.91 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.567 0.698 . . . . 2.0 110.487 168.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.56 122.5 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.45 1.9 . . . . 1.52 109.952 -169.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 21.0 p -82.46 119.29 24.01 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.936 0.789 . . . . 1.65 110.316 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -97.45 113.96 25.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.457 1.103 . . . . 0.91 111.195 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.1 p -108.37 4.8 24.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.24 1.816 . . . . 1.87 112.77 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -137.69 136.52 37.48 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.922 1.289 . . . . 1.62 109.702 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -91.54 176.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.331 1.053 . . . . 2.53 109.602 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.18 -31.95 66.55 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 120.835 1.652 . . . . 1.65 113.952 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -45.1 65.08 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.633 1.216 . . . . 2.14 113.353 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.32 -14.41 59.43 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.961 1.837 . . . . 2.78 115.961 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.5 t -77.76 143.33 38.07 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.057 -1.027 . . . . 3.06 112.829 -170.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.0 t -63.0 -31.77 72.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.917 0.71 . . . . 1.9 112.917 -172.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.67 -51.33 65.82 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.315 1.046 . . . . 1.44 112.491 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 p -72.92 -31.82 64.88 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.542 0.571 . . . . 2.13 112.542 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.4 -42.13 98.78 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.428 0.558 . . . . 1.65 111.71 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.99 -56.15 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.31 1.044 . . . . 1.72 110.153 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 114.181 1.178 . . . . 1.36 114.181 -177.508 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 119.294 -0.384 . . . . 2.23 111.838 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tp -52.56 -33.79 47.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.92 0.888 . . . . 1.67 112.819 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.88 -50.07 14.21 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.704 0.802 . . . . 1.23 112.919 168.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -58.73 -32.83 69.57 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.726 1.211 . . . . 3.01 114.032 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.83 -30.24 65.58 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.947 0.721 . . . . 1.38 112.947 173.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.4 mm -72.76 -42.22 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.844 0.858 . . . . 2.02 111.718 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.6 m -68.38 -21.56 64.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.438 1.095 . . . . 1.11 113.224 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.01 -14.02 61.34 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.961 2.104 . . . . 1.86 114.671 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -87.04 149.76 24.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.425 1.011 . . . . 2.33 113.184 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.13 173.79 11.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.73 1.612 . . . . 2.63 114.61 -169.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.3 m -99.91 -43.88 6.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.809 1.644 . . . . 3.1 110.706 168.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -139.18 165.42 27.22 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.601 1.56 . . . . 3.66 113.04 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.72 173.38 11.55 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.053 1.741 . . . . 1.03 112.3 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.2 m -131.32 111.3 11.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.899 1.279 . . . . 0.95 111.334 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.7 mt -98.84 145.42 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.478 1.911 . . . . 0.98 109.884 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.5 133.61 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.373 -0.829 . . . . 2.02 112.608 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.475 0.801 0 C-N-CA 125.374 1.47 . . . . 1.77 112.245 -172.178 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 CA--C 1.546 0.822 0 CA-C-O 122.572 1.177 . . . . 4.96 112.88 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.6 t -139.16 154.4 48.08 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.598 1.559 . . . . 1.51 111.562 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.81 138.76 45.86 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.127 1.371 . . . . 2.83 111.71 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -119.74 129.31 54.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.063 1.745 . . . . 3.35 110.051 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.8 133.86 39.43 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.45 -1.406 . . . . 2.13 110.608 168.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -135.08 158.15 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.332 1.053 . . . . 0.87 112.835 -171.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.94 149.04 36.03 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.478 1.111 . . . . 4.18 109.414 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.49 -29.49 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.291 1.589 . . . . 1.57 115.291 -168.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -76.46 -7.15 54.5 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.369 -1.457 . . . . 3.47 113.599 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.9 mt -100.74 -6.32 25.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.096 1.758 . . . . 1.29 113.357 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 p -95.63 129.9 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.687 1.195 . . . . 2.33 109.013 169.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -141.32 -175.21 4.26 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.229 1.011 . . . . 5.51 112.016 -169.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -65.9 15.53 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.475 2.769 . . . . 3.2 118.475 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.07 9.87 3.59 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.282 1.42 . . . . 1.17 115.344 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -94.32 148.55 22.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.063 1.431 . . . . 3.1 113.818 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.1 mm -105.26 124.67 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.24 1.016 . . . . 1.62 110.03 171.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.5 mm -99.82 162.93 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.927 2.091 . . . . 1.41 111.276 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HE2' HD11 ' A' ' 96' ' ' LEU . 37.5 ttmt -132.39 129.6 39.57 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.188 1.395 . . . . 2.01 110.328 170.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.25 144.04 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.354 1.062 . . . . 1.06 112.554 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -99.02 163.9 17.85 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.246 1.418 . . . . 1.97 113.104 -174.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.34 106.58 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.826 2.351 . . . . 2.28 109.385 166.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.45 68.26 1.16 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.255 1.407 . . . . 2.91 110.311 -168.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.86 164.08 33.51 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 127.407 2.432 . . . . 1.06 109.497 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -125.34 153.09 43.86 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.521 1.16 . . . . 1.6 112.798 -172.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -87.46 136.71 32.92 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 123.968 0.907 . . . . 1.68 112.29 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -98.48 -18.03 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.934 3.09 . . . . 0.72 115.587 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.86 166.88 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 127.936 2.494 . . . . 1.08 108.422 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.18 142.35 27.72 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.185 0.902 . . . . 2.04 113.405 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -160.33 27.67 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.581 0.61 . . . . 0.67 114.06 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.3 ttp-105 -116.19 136.25 53.18 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.567 1.147 . . . . 3.82 112.888 -171.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -82.74 130.36 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 126.531 1.932 . . . . 0.8 108.26 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.69 34.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.395 0.678 . . . . 0.85 112.328 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -166.71 132.67 2.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.088 1.355 . . . . 2.82 109.709 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.95 -170.77 50.08 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 116.363 1.305 . . . . 0.82 116.363 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 123.43 13.21 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.804 1.642 . . . . 2.08 112.306 -173.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.57 176.68 9.64 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.169 0.988 . . . . 1.11 112.428 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 34.0 ttm -120.98 133.72 55.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.624 1.57 . . . . 1.09 110.126 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.06 143.45 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.792 1.237 . . . . 0.7 111.514 -169.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -106.95 86.11 2.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.064 1.346 . . . . 2.01 111.099 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -87.74 34.01 0.71 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.955 1.702 . . . . 1.89 113.578 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -58.92 -34.34 71.61 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 117.182 2.29 . . . . 2.05 117.182 -168.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.75 -48.59 4.66 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.805 1.184 . . . . 1.12 111.468 -174.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.7 mm -67.63 -48.89 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.739 0.816 . . . . 1.14 111.634 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.1 m -101.15 -32.84 10.36 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.946 1.298 . . . . 2.71 110.715 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.74 5.41 61.35 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.67 1.129 . . . . 1.22 115.541 171.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.14 -51.02 71.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.027 1.331 . . . . 2.65 111.603 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.21 35.8 15.26 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.9 1.68 . . . . 2.31 112.793 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -154.19 154.53 29.89 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 129.923 3.289 . . . . 4.9 109.08 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -64.19 136.63 52.66 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.5 2.8 . . . . 1.71 113.604 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.6 t -130.56 129.81 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 125.471 1.509 . . . . 1.36 111.999 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.73 146.44 32.37 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.06 1.134 . . . . 0.78 114.06 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.7 152.36 45.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.886 2.074 . . . . 0.82 111.164 175.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -141.82 -176.38 0.56 Allowed Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 128.688 2.795 . . . . 3.19 107.782 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.84 148.89 90.8 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 CA-C-N 122.141 1.8 . . . . 1.27 114.094 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.17 25.45 74.54 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.959 1.266 . . . . 1.34 114.455 -172.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -115.01 147.69 39.78 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.753 1.277 . . . . 1.57 111.034 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.1 p -99.08 147.67 24.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.183 1.356 . . . . 1.0 113.286 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.0 168.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.4 1.88 . . . . 0.61 111.152 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.7 156.32 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.448 1.499 . . . . 1.55 111.651 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.67 157.51 32.42 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.136 1.162 . . . . 1.02 114.136 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.87 -7.2 15.8 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.159 0.885 . . . . 0.99 115.113 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 m -90.92 156.98 17.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.716 1.206 . . . . 2.73 110.417 172.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mm -102.42 141.47 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.938 0.895 . . . . 1.07 111.39 -169.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -101.59 135.74 42.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.594 1.957 . . . . 1.94 110.84 173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -153.57 140.45 19.16 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.91 1.284 . . . . 3.22 111.143 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.321 9.0 t30 95.98 -17.61 0.07 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 129.136 2.974 . . . . 3.86 116.832 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.25 161.83 34.97 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 120.66 1.573 . . . . 1.86 114.629 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.2 m -87.97 133.72 33.88 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.285 1.034 . . . . 1.91 112.979 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.1 mt -128.96 162.52 27.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.988 1.715 . . . . 0.98 112.814 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.522 HD11 ' HE2' ' A' ' 44' ' ' LYS . 7.4 mp -117.89 132.78 56.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.86 0.864 . . . . 2.01 109.923 167.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.76 131.16 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.708 1.203 . . . . 1.62 111.468 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 29.9 p -85.05 115.08 22.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.662 0.665 . . . . 1.58 109.607 168.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.53 118.16 21.13 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.637 0.775 . . . . 0.96 109.526 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.7 p -119.19 11.91 12.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.537 1.135 . . . . 2.04 113.275 -174.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -145.44 146.96 31.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.903 1.681 . . . . 1.84 111.149 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 103' ' ' GLY . 1.3 p -112.07 -175.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.717 1.607 . . . . 3.0 111.869 176.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.452 ' H ' HG22 ' A' ' 102' ' ' VAL . . . -61.36 -18.27 55.12 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 119.826 -1.797 . . . . 2.88 116.329 -172.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.62 -58.01 3.87 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.314 1.046 . . . . 3.72 111.74 169.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.41 -32.11 64.24 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.769 1.396 . . . . 3.91 114.769 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 t -50.13 126.55 14.85 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.81 1.244 . . . . 2.47 112.789 -168.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.4 t -54.06 -35.41 62.0 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.892 1.071 . . . . 2.48 113.892 -168.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.06 -50.47 73.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.726 -1.234 . . . . 1.78 112.241 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -71.56 -23.17 61.7 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.354 1.062 . . . . 2.17 112.194 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -74.05 -43.91 56.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.828 1.251 . . . . 2.4 113.077 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.7 mt -55.9 -49.17 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.405 1.482 . . . . 1.45 110.644 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 114.324 1.231 . . . . 1.23 114.324 -178.225 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 121.054 0.454 . . . . 1.86 110.354 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.22 -30.36 71.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.649 1.179 . . . . 1.59 112.439 172.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.19 -26.95 59.42 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.257 -0.902 . . . . 1.19 113.317 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.91 -41.15 87.6 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.278 1.031 . . . . 2.33 112.228 -169.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -50.02 -44.2 51.11 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.842 1.257 . . . . 1.4 111.992 173.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -73.08 -35.3 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.355 1.062 . . . . 1.74 112.104 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -70.38 -22.06 62.8 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.864 -1.147 . . . . 1.33 113.313 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.33 -19.95 65.52 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.955 1.094 . . . . 2.06 113.955 170.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -70.99 169.51 14.76 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.696 1.135 . . . . 2.65 113.843 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.02 -24.94 9.63 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.769 1.396 . . . . 3.25 114.769 -174.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 m 67.76 -11.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.283 1.833 . . . . 2.84 115.818 175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -130.03 157.86 41.2 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.284 1.833 . . . . 2.82 112.061 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.45 162.69 34.73 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.006 0.923 . . . . 0.78 113.166 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.4 m -123.44 100.62 6.91 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.657 1.583 . . . . 0.95 110.364 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.6 mt -85.29 146.14 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.47 1.508 . . . . 0.83 110.615 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.412 HG12 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -107.45 127.56 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.955 0.902 . . . . 1.99 110.387 166.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.5 m . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 125.285 1.434 . . . . 2.16 111.089 -170.879 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--O 1.236 0.359 0 N-CA-C 108.14 -1.059 . . . . 3.39 108.14 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -138.81 153.33 48.38 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.53 1.132 . . . . 1.54 110.832 -169.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HG2' HG12 ' A' ' 18' ' ' VAL . 29.4 mt-10 -121.26 134.89 55.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.748 0.819 . . . . 2.37 110.24 -170.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -123.92 129.07 50.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.507 1.523 . . . . 3.46 110.858 -169.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.51 130.66 45.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.589 1.086 . . . . 2.78 110.476 170.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.8 m -141.42 168.27 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.039 1.336 . . . . 1.11 112.844 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -78.15 139.28 38.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.402 0.681 . . . . 3.13 109.593 168.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.89 -22.67 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.708 1.744 . . . . 1.57 115.708 -168.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -64.31 -21.06 66.48 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.609 -1.307 . . . . 5.14 112.94 172.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.2 mt -99.2 -4.93 30.92 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.611 1.965 . . . . 1.72 114.502 -169.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.3 m -74.35 -42.5 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.486 0.714 . . . . 4.01 112.635 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.319 32.1 mt-30 60.54 146.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 128.248 2.619 . . . . 3.49 116.043 -171.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -80.11 25.03 0.39 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 116.831 2.16 . . . . 3.16 116.831 -167.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.25 8.25 12.37 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.107 1.337 . . . . 1.03 113.662 170.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.24 169.9 8.23 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.253 1.421 . . . . 2.9 114.173 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.7 mt -121.56 127.92 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.261 2.224 . . . . 1.26 109.69 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.1 mm -116.3 133.69 62.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.729 2.012 . . . . 0.77 110.552 -170.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HE3' HD11 ' A' ' 96' ' ' LEU . 14.0 mmmm -79.52 142.7 35.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.296 1.438 . . . . 2.53 113.202 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 p -133.12 131.42 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.365 0.666 . . . . 0.68 112.039 168.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.58 162.68 49.88 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 125.003 1.321 . . . . 1.25 113.182 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -60.12 131.14 37.5 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.427 2.085 . . . . 1.04 110.733 166.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.37 -3.86 61.31 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.738 1.637 . . . . 0.89 114.717 -170.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.17 170.08 53.52 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 118.48 1.14 . . . . 0.96 113.829 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -115.25 144.4 43.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.565 1.146 . . . . 1.57 110.973 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -79.44 120.73 81.38 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-O 118.722 -0.656 . . . . 1.66 109.868 175.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.35 -12.5 6.69 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.601 2.201 . . . . 0.76 114.095 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -148.95 165.1 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.478 2.711 . . . . 1.26 109.446 -173.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -103.51 145.59 29.79 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.349 0.87 . . . . 2.25 113.349 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.95 -153.19 23.23 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.647 0.619 . . . . 0.62 114.647 -172.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -117.31 132.45 56.6 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.704 1.202 . . . . 4.23 112.734 -169.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.3 t -82.7 127.13 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.935 2.094 . . . . 0.66 108.422 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 pt -140.71 32.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 122.745 1.26 . . . . 0.94 113.017 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -168.21 126.66 1.17 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.746 2.419 . . . . 2.98 106.711 167.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.45 178.25 46.89 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 117.004 1.562 . . . . 1.06 117.004 174.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -148.02 128.45 13.99 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.863 1.265 . . . . 2.15 112.328 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 m -148.12 167.74 24.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.346 1.059 . . . . 1.21 113.133 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.3 ttm -111.4 108.39 17.94 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.822 1.249 . . . . 1.32 109.939 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.7 t -87.64 158.35 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.465 1.906 . . . . 0.81 112.536 -169.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -113.55 92.22 3.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.374 1.87 . . . . 1.92 110.134 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.89 16.52 21.22 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.943 1.697 . . . . 2.11 112.884 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -56.56 -29.39 61.96 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.252 1.821 . . . . 1.37 114.713 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -81.58 -32.18 32.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.256 1.389 . . . . 1.25 111.866 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mm -77.76 -45.95 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.087 0.955 . . . . 1.27 111.14 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 m -109.08 -12.58 14.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.336 1.454 . . . . 2.65 112.751 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.28 6.47 80.15 Favored Glycine 0 CA--C 1.544 1.889 0 C-N-CA 125.219 1.39 . . . . 1.53 116.011 174.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.77 -38.22 89.75 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.693 1.197 . . . . 2.94 113.995 -169.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 72.81 -17.77 0.38 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.949 2.5 . . . . 1.45 113.886 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -92.08 150.07 39.81 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.14 1.776 . . . . 5.67 110.665 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.53 153.6 30.7 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.356 2.704 . . . . 2.02 112.243 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.73 124.85 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.586 1.154 . . . . 1.1 111.851 -169.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.73 138.89 37.45 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.699 0.8 . . . . 1.05 112.821 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -127.13 145.76 50.63 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.019 2.127 . . . . 0.88 110.451 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -144.04 172.31 5.69 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 128.618 2.767 . . . . 2.44 109.605 -169.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -57.74 137.08 79.42 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.673 1.582 . . . . 0.99 110.943 168.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.0 17.81 79.83 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.954 1.264 . . . . 1.28 114.57 -172.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 t -101.79 161.02 13.97 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.006 1.903 . . . . 1.6 111.414 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 p -112.43 146.57 38.16 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.841 1.2 . . . . 0.79 113.648 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.64 159.35 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.204 1.802 . . . . 0.55 111.964 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.474 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -117.35 152.1 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.896 1.678 . . . . 1.62 112.176 173.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.96 149.99 39.07 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.737 -0.665 . . . . 0.66 112.52 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.69 -10.57 55.98 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.583 1.087 . . . . 0.78 115.53 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.3 p -76.51 161.51 28.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.516 1.158 . . . . 1.35 111.262 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -106.77 142.23 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.917 0.887 . . . . 0.7 110.913 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -99.74 143.23 30.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.714 1.606 . . . . 1.7 112.543 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -155.94 141.4 17.71 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.026 -1.046 . . . . 3.32 112.15 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.26 17.3 t30 111.8 -42.07 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 1 C-N-CA 131.863 4.065 . . . . 3.83 113.556 -178.279 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.16 -174.58 37.12 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 119.76 1.164 . . . . 2.01 114.661 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.0 m -92.29 136.8 32.89 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.731 1.612 . . . . 1.85 111.373 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 mt -130.81 160.97 32.81 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.553 1.141 . . . . 1.05 113.294 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.427 HD11 ' HE3' ' A' ' 44' ' ' LYS . 7.0 mp -113.97 123.05 48.77 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.83 1.252 . . . . 1.93 109.97 170.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.15 126.21 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.653 1.181 . . . . 1.22 110.714 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 32.0 p -79.38 126.94 31.48 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.495 -0.753 . . . . 1.58 110.235 169.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.32 129.21 34.24 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.568 0.747 . . . . 1.03 110.393 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.7 p -107.9 -8.86 15.84 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.657 0.984 . . . . 3.1 113.657 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -145.82 150.29 35.9 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.31 1.444 . . . . 2.19 110.909 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 m -74.74 160.19 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 118.69 0.677 . . . . 2.15 109.174 166.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.66 77.57 Favored Glycine 0 N--CA 1.475 1.242 0 N-CA-C 116.285 1.274 . . . . 2.17 116.285 -165.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.49 -39.31 62.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.688 1.244 . . . . 3.17 113.581 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -72.11 -6.02 39.55 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.402 1.481 . . . . 3.31 114.106 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.0 p -51.48 151.29 3.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.381 1.473 . . . . 1.73 114.035 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.19 -33.62 67.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.178 1.391 . . . . 2.69 111.173 169.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.82 -51.48 68.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.673 1.989 . . . . 1.6 112.549 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.8 m -70.66 -18.19 62.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.441 0.534 . . . . 2.5 112.441 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -73.93 -39.25 63.93 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.497 -0.752 . . . . 1.75 112.613 169.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 87.4 mt -49.75 -51.9 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 119.892 1.224 . . . . 1.67 111.441 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.479 1.011 0 O-C-N 121.273 -0.892 . . . . 1.5 113.276 178.966 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.985 0 N-CA-C 113.599 0.962 . . . . 2.01 113.599 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 tp -59.41 -37.85 79.09 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.888 1.675 . . . . 1.9 111.714 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.21 -18.82 63.18 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.075 0.768 . . . . 1.34 113.075 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -61.15 -36.76 80.65 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.943 1.247 . . . . 3.0 112.237 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.16 -42.24 96.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.877 0.871 . . . . 1.26 111.355 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -72.1 -36.29 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.167 0.587 . . . . 1.51 111.704 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -69.02 -30.95 69.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.333 1.053 . . . . 1.31 112.881 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -64.0 -32.84 74.52 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.695 1.998 . . . . 2.33 112.979 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -77.48 129.89 36.3 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.94 0.791 . . . . 3.32 112.395 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.97 156.42 36.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.124 0.97 . . . . 2.25 112.787 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -108.75 -4.83 16.64 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.092 1.515 . . . . 2.1 115.092 -167.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.29 160.54 39.9 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.285 -1.509 . . . . 3.95 113.806 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.16 159.06 43.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.977 1.311 . . . . 0.8 112.988 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 90.0 m -119.08 106.15 12.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.441 1.497 . . . . 0.88 111.148 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mt -97.4 138.53 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.838 1.655 . . . . 0.82 110.842 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -124.74 126.45 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.796 1.18 . . . . 1.97 111.737 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 125.342 1.457 . . . . 2.4 111.055 -175.338 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 121.333 0.587 . . . . 2.99 111.606 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -141.0 133.62 28.66 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.016 1.726 . . . . 2.45 109.871 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -127.41 139.28 52.94 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.265 -0.897 . . . . 3.89 112.146 -176.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -114.61 145.82 41.54 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.277 1.431 . . . . 2.67 112.166 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -117.23 110.73 18.48 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.0 1.32 . . . . 2.45 108.283 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.9 m -127.86 164.65 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 114.531 1.308 . . . . 0.78 114.531 -166.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.79 146.41 37.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.549 -0.751 . . . . 3.1 110.379 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.71 -23.61 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.26 0.837 . . . . 1.05 113.26 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.36 -17.17 61.85 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.817 -1.177 . . . . 3.76 112.984 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.7 mt -105.05 -12.26 16.24 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.404 1.882 . . . . 1.28 114.525 -169.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.41 143.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.101 0.96 . . . . 1.5 109.321 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -119.29 163.29 17.36 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.557 1.143 . . . . 3.24 112.327 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.64 135.64 50.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.67 -0.863 . . . . 3.06 108.67 167.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.9 -10.85 32.12 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 124.86 1.219 . . . . 0.9 114.225 -169.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -88.15 152.07 22.25 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.334 1.454 . . . . 2.8 113.773 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -105.26 118.92 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.546 1.539 . . . . 1.2 110.321 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 mm -118.51 128.6 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.105 1.362 . . . . 0.67 111.922 -169.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -90.99 139.97 30.27 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.209 -0.932 . . . . 1.87 112.437 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.05 133.6 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.374 1.47 . . . . 0.72 110.998 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 m -107.69 170.5 5.52 Favored Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 124.683 1.193 . . . . 1.09 113.751 -167.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -52.49 134.59 52.9 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.224 2.616 . . . . 1.0 112.89 169.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.54 -13.68 3.75 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 116.017 1.167 . . . . 1.03 116.017 -175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.9 162.99 53.93 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 118.77 1.285 . . . . 0.96 114.454 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -107.3 154.12 21.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.702 1.201 . . . . 2.15 112.374 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -88.15 119.48 70.35 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.779 0.832 . . . . 2.09 111.512 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.29 -15.2 5.47 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.363 2.709 . . . . 0.73 114.924 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 m -152.45 171.47 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.988 2.515 . . . . 0.71 108.234 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.27 144.89 30.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.313 0.857 . . . . 1.72 113.313 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.16 -160.98 25.91 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 114.78 0.672 . . . . 0.71 114.78 -173.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -115.89 140.54 49.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.156 1.382 . . . . 5.54 112.408 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.41 127.67 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.792 2.437 . . . . 0.87 109.198 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.5 pt -141.0 32.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.636 0.976 . . . . 0.91 113.636 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -165.15 132.44 3.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.154 1.382 . . . . 3.8 108.07 167.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.88 -172.71 48.28 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 116.297 1.279 . . . . 0.82 116.297 169.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -150.85 126.54 10.25 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.237 1.015 . . . . 1.91 111.838 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.96 169.53 17.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.903 1.681 . . . . 1.27 113.067 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.8 ttm -112.62 124.26 52.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.711 0.805 . . . . 1.23 111.279 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.36 140.44 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.885 1.274 . . . . 0.68 111.294 -170.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -104.93 111.96 24.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.001 1.32 . . . . 1.86 109.461 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.47 15.25 5.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.883 2.073 . . . . 2.0 113.95 -169.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.5 p -51.73 -31.35 26.08 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.728 2.121 . . . . 1.68 116.728 -170.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.51 -34.09 35.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.265 1.393 . . . . 1.72 110.684 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 108' ' ' LEU . 9.0 mm -78.4 -58.3 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.763 0.825 . . . . 1.7 111.206 -175.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 p -95.68 0.46 52.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.113 1.365 . . . . 2.07 113.779 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.07 20.73 79.66 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.215 1.388 . . . . 1.81 113.983 174.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -72.65 -168.23 0.43 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.839 1.655 . . . . 2.63 111.097 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.2 -34.19 0.17 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.232 1.813 . . . . 1.72 110.917 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.4 mmt -85.06 157.84 59.26 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 125.494 1.517 . . . . 4.86 110.852 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -68.68 160.49 49.3 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.246 2.631 . . . . 1.6 112.677 167.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.4 t -125.27 130.14 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.958 1.703 . . . . 1.03 111.728 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.59 131.35 36.7 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.964 0.906 . . . . 1.07 113.209 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -113.13 152.26 29.84 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.861 2.064 . . . . 0.86 110.855 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -141.3 177.72 1.82 Allowed Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 128.642 2.777 . . . . 3.08 109.917 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -66.84 128.57 19.09 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 CA-C-N 121.679 1.635 . . . . 1.27 109.703 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.65 25.27 28.16 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.457 1.503 . . . . 1.11 114.945 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.5 m -108.12 174.56 5.83 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.903 1.351 . . . . 2.07 110.855 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.2 p -130.75 150.37 51.96 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.081 -1.637 . . . . 1.23 112.581 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.49 147.75 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.769 1.227 . . . . 0.74 112.089 -172.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -112.87 148.28 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.837 1.655 . . . . 1.23 112.868 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.83 144.8 54.28 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.821 0.849 . . . . 0.9 112.484 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.31 -3.16 73.81 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.109 1.338 . . . . 0.77 115.886 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.3 p -78.77 162.47 26.11 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.605 1.202 . . . . 1.43 111.725 171.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.73 136.37 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.093 0.957 . . . . 0.79 111.708 -171.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -91.01 146.12 24.12 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.814 1.646 . . . . 1.49 111.981 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -93.49 -93.36 0.16 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.325 1.05 . . . . 3.67 111.396 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -136.83 131.43 33.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.958 1.703 . . . . 4.58 108.935 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.13 114.41 1.63 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 108.848 -1.701 . . . . 1.85 108.848 -167.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -94.31 114.74 26.86 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.961 0.904 . . . . 1.98 110.108 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.9 mt -112.74 153.31 27.94 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.297 1.039 . . . . 0.98 112.078 -169.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 tp -114.83 121.2 42.53 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.941 0.897 . . . . 2.58 110.049 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 mm -113.62 129.09 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.646 1.578 . . . . 1.68 110.981 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.9 p -86.79 116.67 25.03 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.064 -1.023 . . . . 1.48 109.973 168.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.89 122.89 31.38 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.48 -0.762 . . . . 0.93 110.111 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.8 t -124.1 10.85 8.81 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.52 0.933 . . . . 3.03 113.52 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -137.19 140.29 41.65 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.545 1.138 . . . . 2.03 110.929 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.5 p -97.11 170.53 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.013 1.325 . . . . 2.76 111.212 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.33 -27.45 65.52 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 119.699 -1.876 . . . . 1.57 116.092 -169.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.86 -27.87 68.55 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.96 1.38 . . . . 2.44 113.842 174.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.45 -16.62 60.31 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.42 1.267 . . . . 4.03 114.42 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 74.0 p -63.01 125.02 22.6 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.66 0.985 . . . . 2.24 113.66 -166.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.405 HG23 HD12 ' A' ' 108' ' ' LEU . 11.4 t -60.31 -35.66 76.12 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.238 0.615 . . . . 2.32 111.925 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.484 HD11 HD12 ' A' ' 69' ' ' ILE . 8.0 mp -56.27 -50.5 71.17 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.469 1.107 . . . . 1.77 112.298 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 91.9 p -70.78 -28.44 64.66 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.903 0.481 . . . . 1.7 112.014 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -70.43 -43.29 70.24 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.859 -0.526 . . . . 2.01 111.595 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 53.6 mt -54.71 -51.22 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.118 1.367 . . . . 1.66 110.876 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 113.752 1.019 . . . . 1.51 113.752 -179.16 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.746 0 N-CA-C 112.549 0.574 . . . . 1.39 112.549 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.95 -28.71 70.0 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.639 0.776 . . . . 1.5 112.153 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.12 -37.25 58.3 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.326 0.65 . . . . 1.21 111.956 167.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -63.05 -32.92 74.4 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.589 1.556 . . . . 3.72 114.235 -176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 10' ' ' LEU . 4.2 mm? -60.3 -31.65 70.47 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.992 1.269 . . . . 1.5 111.738 172.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.4 mm -73.6 -45.26 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.728 0.811 . . . . 1.71 110.973 166.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 m -68.39 -16.66 64.0 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 121.052 1.751 . . . . 1.48 114.654 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 7' ' ' LEU . 22.5 mt -69.97 -30.23 67.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.396 1.478 . . . . 3.2 112.446 169.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -77.92 130.75 36.97 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.771 0.828 . . . . 2.32 110.694 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.9 167.59 20.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.839 1.256 . . . . 2.21 112.661 -176.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -106.15 -25.51 11.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.601 1.334 . . . . 2.22 114.601 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.66 152.69 44.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.941 1.296 . . . . 3.57 113.969 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.33 171.8 13.56 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.484 1.514 . . . . 0.83 112.396 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.2 m -125.49 108.46 11.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.735 1.214 . . . . 0.9 111.856 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.2 mt -82.06 140.64 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.19 1.396 . . . . 0.63 109.349 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.1 t -127.31 123.48 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.881 0.872 . . . . 1.92 111.109 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 125.104 1.362 . . . . 1.99 110.92 -171.14 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 120.766 0.317 . . . . 2.48 111.179 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.4 t -142.63 128.63 19.6 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.312 1.045 . . . . 1.38 111.444 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -111.4 138.13 48.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.446 1.099 . . . . 2.95 111.566 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -106.88 146.43 31.0 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.615 1.566 . . . . 4.0 110.958 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -113.34 126.08 54.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.809 0.731 . . . . 1.63 109.796 169.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.8 160.12 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 115.098 1.518 . . . . 0.76 115.098 -166.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -75.74 147.99 38.88 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.687 0.795 . . . . 3.47 109.085 167.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.31 -9.52 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 114.536 1.31 . . . . 1.01 114.536 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -79.79 -19.01 49.57 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.168 -1.583 . . . . 3.54 113.861 170.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.7 mt -96.48 -4.59 41.27 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.859 1.264 . . . . 1.24 113.644 -173.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.51 141.26 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.433 1.493 . . . . 1.52 109.465 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -127.49 168.39 14.98 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.026 1.731 . . . . 2.99 111.38 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -72.59 23.7 0.06 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.737 1.615 . . . . 3.16 114.958 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.26 11.38 2.27 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.968 2.223 . . . . 0.89 113.855 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -87.47 163.39 16.73 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.669 1.734 . . . . 2.66 112.371 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 98.7 mt -118.29 126.45 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.185 1.394 . . . . 1.45 109.216 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.2 mm -118.2 129.58 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.964 1.706 . . . . 0.68 112.044 -168.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -88.57 131.48 34.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.022 0.929 . . . . 2.12 112.566 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 p -108.02 140.74 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.333 1.453 . . . . 0.66 111.649 175.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 m -102.96 159.5 29.1 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 124.39 1.076 . . . . 0.84 113.324 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.75 138.76 40.98 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.444 2.762 . . . . 0.97 112.287 169.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.08 -7.28 8.01 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.995 1.158 . . . . 1.09 115.995 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.19 -179.38 48.79 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.423 1.487 . . . . 1.17 115.023 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -123.43 151.98 42.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.493 1.517 . . . . 2.56 112.62 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -78.01 122.38 85.36 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.093 0.957 . . . . 1.87 110.179 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -88.3 -17.97 2.27 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.661 2.24 . . . . 0.82 115.004 -170.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.72 170.83 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 128.586 2.755 . . . . 0.71 108.082 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.49 151.55 20.13 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.694 0.998 . . . . 2.15 113.694 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.63 -160.26 33.69 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.4 0.524 . . . . 0.79 114.081 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -113.32 143.86 43.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.135 0.974 . . . . 4.2 112.913 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.26 124.54 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 126.169 1.788 . . . . 1.1 107.237 169.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.79 33.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.256 1.022 . . . . 1.12 110.959 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -167.85 122.74 0.99 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.613 1.965 . . . . 2.91 108.511 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.02 177.28 43.65 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 116.22 1.248 . . . . 0.94 116.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -146.81 127.69 14.45 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.072 1.349 . . . . 2.03 112.315 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.8 t -145.7 171.48 14.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.925 1.29 . . . . 1.45 112.685 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.7 ttm -115.68 125.56 53.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.508 1.523 . . . . 1.35 108.88 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -122.99 140.54 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.721 1.208 . . . . 0.97 112.443 -168.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -102.04 124.62 47.96 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.03 2.132 . . . . 2.1 111.347 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -125.05 20.25 8.28 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.681 1.193 . . . . 2.57 113.477 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.2 p -62.51 -3.56 1.5 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 117.742 2.497 . . . . 1.32 117.742 -169.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.34 -45.6 4.63 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.685 1.194 . . . . 1.44 109.403 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.7 mm -74.92 -56.77 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.567 1.147 . . . . 1.58 112.321 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.4 p -107.64 -0.95 21.58 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.328 1.451 . . . . 2.02 112.621 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.21 6.07 78.62 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.27 1.414 . . . . 1.78 114.937 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -71.32 106.17 3.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.207 1.003 . . . . 3.38 111.733 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.48 -16.35 60.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.827 0.851 . . . . 1.82 112.375 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.7 ttt -113.42 136.85 21.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.041 1.736 . . . . 5.4 108.971 172.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.07 165.74 25.7 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.63 2.22 . . . . 1.78 114.17 -168.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.06 138.68 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.142 1.777 . . . . 1.58 111.065 -170.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.23 126.72 33.42 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.732 -0.605 . . . . 1.48 112.017 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -98.62 151.04 21.12 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.29 1.436 . . . . 0.94 110.067 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -137.08 175.79 3.24 Favored Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 126.112 1.765 . . . . 2.88 109.679 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.82 65.96 4.91 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 123.395 2.73 . . . . 2.49 111.631 172.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.02 29.98 0.02 OUTLIER Glycine 0 CA--C 1.538 1.479 0 C-N-CA 127.14 2.305 . . . . 1.35 112.806 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -126.94 150.44 49.34 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.172 1.389 . . . . 1.82 111.273 -170.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.1 p -98.29 148.81 23.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.793 0.837 . . . . 1.15 112.631 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 m -140.08 148.24 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.751 1.621 . . . . 0.93 111.796 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.64 148.66 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.253 1.421 . . . . 1.38 112.51 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.38 142.0 55.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.141 0.976 . . . . 0.75 112.454 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.51 2.44 89.59 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 115.619 1.008 . . . . 1.23 115.619 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 76.0 p -79.22 153.37 30.02 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.012 1.406 . . . . 1.64 111.118 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 mm -112.56 132.51 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.127 0.971 . . . . 1.01 112.796 -168.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -84.45 133.97 34.47 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.668 1.587 . . . . 2.95 111.282 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.82 -72.66 0.44 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.437 0.637 . . . . 3.98 110.071 168.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -143.91 155.93 44.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.425 2.29 . . . . 3.99 107.877 172.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.93 108.04 2.88 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 127.45 2.452 . . . . 1.98 111.803 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.7 t -86.64 127.89 34.96 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.491 1.146 . . . . 2.2 110.844 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -126.12 162.64 24.9 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.835 1.254 . . . . 0.97 111.562 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -114.81 126.78 55.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.426 0.691 . . . . 1.95 109.44 167.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.62 125.65 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.804 1.642 . . . . 1.28 110.292 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.7 p -87.25 108.03 18.76 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.671 0.748 . . . . 1.52 109.744 168.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.26 135.66 36.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.61 0.764 . . . . 0.87 111.574 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.04 -0.14 9.54 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.586 1.328 . . . . 2.15 114.586 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -143.78 144.68 31.91 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.296 1.438 . . . . 1.52 111.827 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 m -83.6 162.92 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.024 0.93 . . . . 1.68 110.974 169.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.63 -34.49 90.04 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 120.728 -1.233 . . . . 1.37 114.984 -168.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.25 -28.0 64.89 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.11 -1.229 . . . . 1.71 113.056 175.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.27 -7.81 56.57 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.16 1.784 . . . . 2.76 114.545 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.4 p -68.55 158.03 34.76 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.885 -1.135 . . . . 1.94 112.688 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 t -64.59 -33.19 75.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.19 0.596 . . . . 2.43 111.254 170.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mp -55.66 -50.98 68.79 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.983 -1.073 . . . . 1.95 111.107 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.0 m -69.29 -31.56 70.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.417 1.087 . . . . 1.71 111.928 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.19 -40.8 98.56 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.671 -0.643 . . . . 1.69 111.718 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 70.0 mt -65.18 -50.7 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.843 1.657 . . . . 2.04 111.108 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 113.52 0.933 . . . . 1.97 113.52 -175.619 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 112.644 0.609 . . . . 2.0 112.644 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.0 tp -65.06 -30.19 71.14 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.601 -0.687 . . . . 2.37 111.891 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.69 61.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.583 0.753 . . . . 1.33 112.439 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -58.84 -35.96 73.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.013 1.325 . . . . 2.73 112.914 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -48.98 -49.97 38.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.892 0.877 . . . . 1.53 112.236 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.8 mm -74.09 -36.84 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.672 0.789 . . . . 2.16 112.622 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -58.91 -30.31 67.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.116 0.966 . . . . 1.16 113.053 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -22.06 61.72 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.938 1.295 . . . . 2.31 114.308 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -62.84 162.84 10.38 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.997 1.48 . . . . 2.36 114.997 -171.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.7 -31.08 12.86 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.97 1.308 . . . . 3.55 114.291 -171.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m 64.32 -12.78 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 127.946 2.499 . . . . 2.48 116.437 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -140.9 149.05 41.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.212 1.805 . . . . 2.86 111.204 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.21 173.06 11.92 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.504 1.122 . . . . 0.75 112.837 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.4 m -124.33 120.88 33.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.611 1.165 . . . . 0.84 111.967 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.9 mt -94.42 144.5 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.785 2.034 . . . . 0.6 110.37 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.7 t -111.92 126.0 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.223 1.009 . . . . 2.06 110.878 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.483 1.216 0 C-N-CA 125.791 1.636 . . . . 1.87 111.331 -172.366 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 120.72 0.295 . . . . 3.39 111.594 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -136.75 145.47 44.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.729 1.612 . . . . 1.82 110.5 169.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -109.79 130.1 55.56 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.143 0.497 . . . . 2.82 111.68 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -118.27 132.52 56.29 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.384 2.273 . . . . 3.92 110.19 -170.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -93.52 139.17 31.05 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.097 1.317 . . . . 1.61 112.312 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.96 166.09 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.68 1.592 . . . . 0.88 114.02 -171.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.79 150.58 24.95 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.375 1.47 . . . . 3.21 109.621 166.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.45 -19.48 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 114.295 1.22 . . . . 1.11 114.295 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.32 -21.73 60.5 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.703 -1.248 . . . . 3.82 113.866 172.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.8 mt -101.87 -7.43 22.48 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.806 1.242 . . . . 1.31 113.808 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -86.23 142.35 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.835 1.254 . . . . 1.43 109.631 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -117.19 168.36 10.37 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.471 1.108 . . . . 4.42 113.292 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -67.62 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.98 2.112 . . . . 2.69 115.711 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.77 12.22 0.63 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.484 1.993 . . . . 0.84 114.277 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -92.42 152.31 19.78 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.739 1.769 . . . . 2.71 112.702 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -102.0 121.99 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.716 1.206 . . . . 1.4 110.281 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.0 mm -104.56 159.95 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.796 1.638 . . . . 1.37 112.273 -172.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HE2' HD11 ' A' ' 96' ' ' LEU . 34.3 ttmt -129.47 132.89 47.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.688 1.595 . . . . 2.03 111.332 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.57 140.8 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.225 1.01 . . . . 0.79 112.542 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -95.03 159.34 33.27 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 125.233 1.413 . . . . 0.98 112.859 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.0 133.96 43.9 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.058 2.505 . . . . 1.06 111.891 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.29 -12.04 61.63 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.539 1.542 . . . . 0.95 114.7 -172.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.61 173.76 52.85 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.216 1.389 . . . . 0.99 114.726 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -108.45 154.07 22.4 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.55 1.54 . . . . 2.7 113.259 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -84.03 121.75 75.78 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.887 0.875 . . . . 1.81 110.818 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.79 -21.06 2.82 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.974 2.449 . . . . 0.83 115.816 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -152.04 163.08 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 128.08 2.552 . . . . 0.96 108.906 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 136.78 32.84 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 112.818 0.673 . . . . 1.7 112.818 -172.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.3 -161.86 32.89 Favored Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.635 -0.666 . . . . 0.72 114.148 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.7 ttp85 -109.91 134.01 52.54 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.204 1.801 . . . . 4.06 112.976 -172.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.5 133.53 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.524 2.329 . . . . 0.94 108.77 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.62 32.46 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.951 0.901 . . . . 0.99 112.817 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -167.16 136.17 2.74 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.222 1.809 . . . . 3.04 109.005 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.18 -177.19 51.85 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 122.417 1.01 . . . . 0.96 115.559 170.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -144.01 124.71 14.13 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.653 1.181 . . . . 1.95 111.746 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m -149.28 166.49 28.77 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.23 1.567 . . . . 1.15 115.23 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.6 ttm -114.67 119.57 37.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.142 1.377 . . . . 1.31 108.884 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.39 134.37 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.882 1.673 . . . . 1.09 112.363 -167.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -86.73 75.79 9.59 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.702 1.601 . . . . 2.2 110.316 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.67 4.62 53.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.205 1.402 . . . . 1.98 113.718 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.1 -23.87 66.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 115.511 1.671 . . . . 3.01 115.511 -169.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.72 -21.13 57.82 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.434 1.015 . . . . 1.58 112.029 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -86.94 -49.84 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.935 0.894 . . . . 1.4 110.968 176.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.4 p -100.19 -7.7 24.43 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.436 1.273 . . . . 1.42 114.436 -172.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.98 -1.06 56.77 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.336 1.446 . . . . 1.61 115.186 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.94 -6.76 1.41 Allowed 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 119.822 1.811 . . . . 2.89 115.094 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 45.24 26.37 0.25 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 130.746 3.618 . . . . 1.97 115.537 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 ttm -166.49 135.39 2.38 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.618 1.967 . . . . 3.87 108.779 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.88 162.84 40.58 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.215 3.277 . . . . 1.75 114.474 -169.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.99 135.57 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 126.198 1.799 . . . . 1.34 110.991 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.8 141.98 35.74 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.826 0.85 . . . . 1.3 112.977 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -128.87 149.54 50.72 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.829 2.052 . . . . 1.05 111.04 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -151.46 171.67 6.25 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 128.757 2.823 . . . . 2.84 108.977 -173.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.78 134.57 63.6 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 CA-C-N 122.36 1.879 . . . . 1.12 111.699 169.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.78 31.14 45.38 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.052 0.834 . . . . 1.1 114.19 -170.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.2 t -122.05 159.82 26.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.835 1.254 . . . . 1.9 110.827 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.0 p -118.77 155.43 31.14 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.547 1.521 . . . . 1.19 113.732 -172.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.1 m -132.2 152.41 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.61 1.964 . . . . 1.26 111.568 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.637 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -100.71 -1.26 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.844 2.058 . . . . 4.06 116.041 -176.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 70.07 159.98 0.2 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.171 1.788 . . . . 0.87 114.484 -167.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.7 -44.27 2.5 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.011 1.291 . . . . 1.68 113.277 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.5 p -51.33 151.29 3.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.373 1.069 . . . . 1.3 113.741 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.59 136.13 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.229 1.012 . . . . 1.04 110.462 -172.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -83.3 129.9 35.03 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.05 0.94 . . . . 1.9 109.121 169.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -134.49 63.6 1.62 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.911 0.708 . . . . 3.55 112.911 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -158.31 -56.1 0.07 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.51 1.67 . . . . 4.24 115.51 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.9 -174.43 31.77 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.247 1.259 . . . . 2.12 116.247 -167.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.4 p -94.31 126.46 39.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.857 1.263 . . . . 2.52 112.54 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 mt -136.0 161.79 34.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.333 1.053 . . . . 1.05 113.255 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.503 HD11 ' HE2' ' A' ' 44' ' ' LYS . 7.5 mp -120.61 139.0 53.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.291 1.036 . . . . 1.93 111.591 168.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.36 133.07 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.209 1.404 . . . . 1.56 111.244 -173.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.6 p -90.28 118.76 30.03 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.145 -0.972 . . . . 1.42 111.307 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.46 121.0 24.64 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.083 -1.011 . . . . 0.92 110.782 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.4 p -125.95 11.21 7.69 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.818 1.247 . . . . 2.43 113.612 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -139.6 135.29 33.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.163 1.785 . . . . 1.61 108.137 171.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 p -78.66 160.65 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 122.962 0.505 . . . . 2.73 109.697 169.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.28 -32.86 68.62 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 120.819 -1.176 . . . . 1.4 115.875 -168.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.48 -40.12 73.82 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.356 1.578 . . . . 1.63 113.243 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.33 -7.67 53.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.703 2.001 . . . . 2.42 114.385 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 67.6 p -58.48 149.25 25.71 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.988 -1.07 . . . . 1.7 113.547 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.0 t -60.09 -36.57 77.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.663 0.785 . . . . 2.34 111.309 171.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.2 tp -58.48 -47.01 85.46 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.841 -1.162 . . . . 1.49 112.792 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 t -70.9 -26.96 63.46 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.337 0.655 . . . . 1.92 112.404 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -71.25 -42.77 68.41 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.516 1.126 . . . . 1.56 111.818 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.4 mt -54.31 -50.68 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.158 0.983 . . . . 1.79 110.574 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.475 0.785 0 O-C-N 120.958 -1.089 . . . . 1.68 113.292 179.408 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 111.893 0.331 . . . . 1.52 111.893 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.8 tp -49.25 -43.14 42.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.587 1.555 . . . . 1.64 111.797 171.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.93 -35.97 62.16 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.276 0.843 . . . . 1.27 113.276 172.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -64.57 -31.24 72.38 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.941 0.792 . . . . 3.07 112.801 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.44 -32.65 70.41 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.97 1.259 . . . . 1.75 112.569 172.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.6 mm -73.08 -40.71 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.397 -0.814 . . . . 2.3 111.725 169.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.5 m -70.83 -21.06 62.49 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.142 1.164 . . . . 1.17 114.142 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -72.84 -9.97 59.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.653 1.581 . . . . 2.12 113.807 173.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -89.28 132.92 34.69 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.071 0.85 . . . . 2.76 113.094 -172.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.48 161.13 31.52 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.445 1.498 . . . . 2.86 114.43 -169.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 p -123.6 -26.3 4.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.587 1.555 . . . . 2.05 113.833 -179.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.58 153.19 43.3 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.438 1.095 . . . . 3.35 113.242 177.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.63 165.66 26.88 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.211 1.404 . . . . 0.78 112.786 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -118.61 98.41 6.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.658 1.183 . . . . 1.04 112.159 -178.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.2 mt -83.24 129.6 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 121.252 -0.905 . . . . 0.66 110.496 -177.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.94 109.28 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 108.478 -0.934 . . . . 1.76 108.478 169.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.477 0.92 0 C-N-CA 125.803 1.641 . . . . 2.17 110.144 -177.019 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 109.559 -0.534 . . . . 2.63 109.559 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 t -137.93 127.96 25.74 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.333 1.053 . . . . 1.79 110.476 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -102.76 146.94 27.49 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.478 -0.764 . . . . 2.61 112.459 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -127.75 138.37 52.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.965 1.706 . . . . 3.53 110.41 -169.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -99.69 116.75 32.53 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.487 0.715 . . . . 2.51 109.334 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.95 166.07 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.008 0.923 . . . . 0.87 113.146 -172.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -88.13 160.82 17.61 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.582 1.553 . . . . 3.83 112.565 169.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.55 -28.36 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 115.472 1.656 . . . . 1.67 115.472 -171.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -75.99 -17.23 59.78 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.272 -1.517 . . . . 4.39 112.554 172.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -94.78 -8.78 36.54 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.176 1.39 . . . . 1.54 113.723 -172.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.73 139.02 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.945 1.698 . . . . 1.45 109.392 168.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.63 168.04 20.26 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.281 1.432 . . . . 2.88 112.597 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -68.91 4.84 1.32 Allowed 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 117.531 2.419 . . . . 4.38 117.531 -167.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.16 7.35 16.63 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.667 1.603 . . . . 1.37 114.21 172.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -90.04 152.78 21.01 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.058 1.429 . . . . 2.71 112.929 -177.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.1 mm -113.45 122.47 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.927 1.691 . . . . 1.32 109.86 177.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.3 mm -113.28 125.04 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.992 1.317 . . . . 0.88 111.562 -172.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -78.74 132.48 36.96 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.443 -0.786 . . . . 2.43 110.508 169.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 p -121.85 133.86 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.337 1.455 . . . . 0.66 111.206 176.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 m -89.06 162.22 38.42 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.766 1.226 . . . . 1.05 113.389 -173.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -61.28 133.7 47.95 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.695 1.597 . . . . 1.21 109.196 167.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.96 -10.69 46.05 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.515 -1.158 . . . . 1.12 115.426 -172.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.53 175.17 44.07 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.038 1.419 . . . . 1.06 114.403 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -111.63 153.34 26.49 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.463 1.505 . . . . 1.74 112.055 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -84.17 128.67 61.45 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-O 118.101 -0.952 . . . . 2.31 109.717 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -96.9 -14.46 0.4 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.912 2.408 . . . . 0.8 115.482 -173.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.37 164.62 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 127.716 2.406 . . . . 1.03 108.336 -176.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -88.46 155.09 19.87 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.412 1.264 . . . . 2.47 114.412 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.74 -131.26 2.4 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.362 -0.835 . . . . 1.06 113.735 177.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -135.72 146.39 47.65 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.233 1.197 . . . . 3.6 114.233 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.77 122.77 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 105.628 -1.99 . . . . 1.21 105.628 166.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.2 pt -137.0 33.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.816 0.817 . . . . 0.88 112.109 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -167.62 128.54 1.46 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.069 2.148 . . . . 2.81 107.75 166.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.66 -178.12 54.09 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 122.842 1.246 . . . . 0.8 115.374 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -149.13 137.04 20.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.391 1.476 . . . . 2.57 111.414 -176.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -150.76 176.68 10.81 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.481 0.919 . . . . 1.33 113.481 176.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.5 ttm -112.89 126.95 56.02 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.334 1.054 . . . . 1.27 110.678 171.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -114.33 140.77 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.206 1.402 . . . . 0.73 112.774 -168.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -97.38 107.67 20.23 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.456 1.502 . . . . 1.95 109.554 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.256 11.2 pt-20 -123.75 30.15 6.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.483 1.513 . . . . 1.86 113.063 -178.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.3 p -60.63 -24.22 65.36 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.966 1.839 . . . . 1.51 115.966 -175.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -95.47 -33.61 12.38 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.079 1.351 . . . . 1.32 111.352 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.0 mm -76.5 -49.34 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.531 -0.731 . . . . 1.23 110.632 178.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 m -106.85 -21.5 13.0 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.535 1.134 . . . . 2.2 113.277 -169.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.59 -13.69 64.87 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.584 1.564 . . . . 1.22 115.78 172.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -63.86 118.31 8.19 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.475 1.138 . . . . 3.1 110.215 174.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.25 35.05 0.32 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.187 1.395 . . . . 1.54 112.829 -178.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 ptp -154.14 137.13 10.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.367 1.867 . . . . 4.04 110.239 -174.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -63.23 154.93 64.69 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.861 2.374 . . . . 1.58 115.193 -179.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.4 t -122.76 132.23 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.999 1.72 . . . . 0.99 111.04 -170.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.25 35.56 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.964 0.887 . . . . 1.01 113.289 -175.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -125.01 150.57 46.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.539 1.936 . . . . 0.76 110.61 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -150.09 173.9 3.92 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 129.621 3.169 . . . . 2.57 108.415 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -56.14 136.81 77.08 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 CA-C-N 121.702 1.644 . . . . 0.8 111.573 170.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.94 25.98 72.33 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.602 1.096 . . . . 0.89 114.465 -171.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.4 m -102.05 146.98 27.15 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 119.139 1.469 . . . . 1.45 110.575 174.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.7 p -88.83 151.76 22.17 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.184 1.357 . . . . 0.8 113.148 178.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -138.52 157.04 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.04 1.336 . . . . 0.7 112.01 176.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.75 150.18 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.095 2.158 . . . . 1.3 111.282 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.86 148.54 49.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.913 0.885 . . . . 0.66 113.334 -174.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.44 -3.46 62.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.348 0.975 . . . . 0.76 115.106 179.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.2 p -79.5 157.2 27.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.951 1.375 . . . . 1.43 111.07 169.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mm -115.13 130.52 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.551 0.74 . . . . 0.81 112.645 -168.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -90.07 149.26 22.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.882 1.673 . . . . 1.66 113.669 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -157.67 142.9 16.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.403 1.081 . . . . 4.07 112.61 171.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 t30 117.47 -40.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 131.255 3.822 . . . . 4.11 113.514 175.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.62 -179.79 46.35 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 120.031 1.287 . . . . 1.89 115.281 173.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.4 m -82.35 134.21 35.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.416 1.086 . . . . 2.13 112.616 -177.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.39 165.16 20.29 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.128 1.771 . . . . 1.34 111.619 -176.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.43 132.96 55.91 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.607 0.718 . . . . 2.15 111.026 168.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.7 mm -118.14 125.12 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.053 1.741 . . . . 1.54 110.283 -169.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -82.73 114.65 21.23 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.383 -0.823 . . . . 1.5 109.065 168.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.04 112.67 15.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.338 -0.986 . . . . 1.01 108.338 174.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -104.6 2.56 30.79 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.932 0.893 . . . . 2.45 112.746 -172.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -147.76 154.39 40.46 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.7 1.6 . . . . 2.06 111.665 173.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.06 165.63 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.896 1.278 . . . . 1.96 112.181 170.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 -35.21 85.42 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 120.906 -1.121 . . . . 1.5 114.283 -172.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.91 -31.69 72.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.455 1.128 . . . . 1.89 113.64 176.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -75.19 -17.63 60.32 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.127 -0.983 . . . . 2.95 113.58 174.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 81.6 p -64.65 144.6 57.11 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.899 -1.126 . . . . 1.83 112.566 -169.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -64.55 -22.85 67.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.899 0.879 . . . . 1.94 113.065 -169.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.64 -49.33 78.19 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.68 1.192 . . . . 1.59 113.107 -177.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.8 m -72.83 -17.34 61.56 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.533 0.938 . . . . 2.75 113.533 173.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -76.92 -40.89 45.58 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.736 0.643 . . . . 1.48 112.736 172.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.13 -47.31 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.6 1.56 . . . . 1.46 110.386 177.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 114.479 1.288 . . . . 1.5 114.479 -178.011 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 112.48 0.548 . . . . 2.37 112.48 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.25 -44.85 84.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.253 1.421 . . . . 1.54 111.797 176.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.82 -8.61 56.33 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.286 1.217 . . . . 1.59 114.286 175.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -65.25 -43.01 92.71 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.818 1.19 . . . . 2.49 110.607 -177.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -45.86 -52.93 10.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.246 1.818 . . . . 1.68 112.246 172.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.1 mm -69.78 -31.32 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.11 0.964 . . . . 2.14 112.183 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.9 m -75.46 -28.3 59.23 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.01 1.324 . . . . 1.27 113.627 -175.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.32 -24.14 67.73 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.265 0.938 . . . . 2.0 113.519 175.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -68.25 139.47 56.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.886 1.275 . . . . 2.49 113.465 -175.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.87 157.28 29.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.604 1.161 . . . . 2.21 112.561 173.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.54 -2.25 17.72 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.7 1.741 . . . . 1.97 115.7 -169.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.31 156.74 48.21 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.862 1.665 . . . . 3.9 112.526 -178.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.72 147.3 37.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.034 0.934 . . . . 0.82 113.108 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.2 m -107.98 106.45 16.71 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.597 1.159 . . . . 0.81 111.369 175.225 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mt -83.48 147.22 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.178 1.791 . . . . 0.59 109.486 176.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.16 140.24 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.636 1.347 . . . . 2.11 114.636 169.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.479 1.016 0 C-N-CA 125.575 1.55 . . . . 2.66 114.4 -178.732 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.8 tp . . . . . 0 CA--C 1.552 1.028 0 CA-C-O 121.612 0.72 . . . . 3.28 112.388 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -79.08 153.6 30.05 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.231 1.013 . . . . 1.67 112.501 -172.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -116.08 131.63 56.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.111 1.364 . . . . 2.65 110.214 176.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -126.33 136.07 52.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.214 1.806 . . . . 3.98 110.171 -176.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -110.2 130.98 55.45 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.466 -1.396 . . . . 1.97 112.252 -175.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.81 169.14 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.922 1.289 . . . . 0.76 113.62 -173.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -79.58 152.42 30.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.24 1.416 . . . . 3.38 112.494 171.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.77 -18.76 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 115.189 1.552 . . . . 1.16 115.189 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -85.46 -19.92 30.54 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 120.623 1.556 . . . . 3.04 113.503 169.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.16 -17.7 21.55 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.046 1.338 . . . . 1.21 113.558 -173.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.54 138.69 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.766 0.827 . . . . 1.6 109.235 168.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -118.82 159.27 24.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.196 0.998 . . . . 3.53 111.123 178.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.2 ptt85 -69.59 146.6 51.62 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.899 -0.501 . . . . 2.7 109.984 169.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.12 2.8 56.9 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-N 118.852 0.751 . . . . 1.08 114.077 -171.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -112.98 172.87 6.67 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.612 1.565 . . . . 2.37 112.102 173.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.3 mm -112.69 122.95 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.734 1.614 . . . . 1.3 110.483 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.6 mm -119.5 132.89 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.458 1.503 . . . . 0.87 111.429 -169.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HE3' HD11 ' A' ' 96' ' ' LEU . 13.7 mmmm -86.74 142.24 28.3 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.322 1.449 . . . . 2.44 112.456 174.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.35 145.4 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.58 0.752 . . . . 0.72 111.749 170.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.78 156.75 35.17 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 124.98 1.312 . . . . 1.09 113.323 -177.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -59.64 140.18 92.41 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.352 2.035 . . . . 1.27 110.679 168.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.57 -5.34 11.21 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.748 1.166 . . . . 1.05 114.906 -172.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.64 169.99 53.81 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 118.817 1.308 . . . . 0.99 114.241 177.032 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -123.25 152.05 41.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.07 1.748 . . . . 1.95 110.606 -178.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -81.05 127.51 74.13 Favored Pre-proline 0 CA--C 1.551 0.988 0 O-C-N 121.629 -0.669 . . . . 1.9 111.575 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.13 -20.66 2.76 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.581 2.854 . . . . 1.12 113.493 177.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 m -147.99 170.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.872 2.469 . . . . 0.92 108.978 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.84 152.47 20.48 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.059 0.763 . . . . 1.71 113.059 177.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.74 -174.61 46.17 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 115.397 0.919 . . . . 0.73 115.397 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.0 ttt85 -102.75 139.46 38.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.66 1.184 . . . . 5.9 111.912 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.3 t -99.91 133.96 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 127.307 2.243 . . . . 0.8 109.268 -173.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.1 pt -139.87 28.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.017 1.117 . . . . 0.76 114.017 -177.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.73 150.18 3.95 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.941 1.697 . . . . 3.27 110.114 166.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.57 -173.92 34.35 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.704 1.145 . . . . 0.82 115.29 169.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -151.33 121.13 7.04 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.185 1.394 . . . . 2.52 110.965 -175.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.6 m -147.5 155.2 41.66 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.111 -0.993 . . . . 1.41 113.009 172.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.1 ttm -102.06 121.13 41.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.598 1.159 . . . . 1.15 108.436 169.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 68.7 t -118.59 146.33 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.539 1.936 . . . . 1.0 112.831 -165.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -108.41 115.84 30.85 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.351 1.86 . . . . 2.01 110.541 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -127.12 26.21 6.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.611 1.564 . . . . 1.74 112.271 179.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.5 p -55.58 -31.04 61.86 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.006 1.854 . . . . 1.43 116.006 -172.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.0 -39.44 13.7 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.607 1.094 . . . . 1.1 111.189 176.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.6 mm -70.29 -62.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.733 1.213 . . . . 1.05 111.332 -173.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.7 p -98.21 -7.49 29.2 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.552 1.141 . . . . 1.25 112.946 -175.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.61 17.66 65.6 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.839 1.209 . . . . 1.43 113.331 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -82.53 96.81 8.16 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.32 1.06 . . . . 3.06 112.108 -176.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.88 20.18 0.26 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.27 1.028 . . . . 1.48 113.565 177.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.5 ttt -146.69 132.54 9.4 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 128.419 2.688 . . . . 4.21 107.385 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -69.64 153.53 69.34 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.052 2.501 . . . . 1.9 112.62 -170.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.1 t -111.87 132.5 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.971 1.708 . . . . 0.98 111.207 -168.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.09 137.68 34.0 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.435 -0.791 . . . . 0.78 111.398 174.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -122.75 146.91 47.09 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.364 1.465 . . . . 0.8 110.938 176.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -150.23 170.98 6.89 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 126.871 2.068 . . . . 2.86 111.375 -170.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -59.01 118.94 5.92 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.982 1.788 . . . . 0.87 109.634 167.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.3 48.33 4.34 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.534 1.54 . . . . 0.88 113.689 -169.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.6 m -126.44 166.62 16.89 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.861 1.33 . . . . 1.44 112.804 173.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.7 p -111.0 149.63 30.43 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.271 0.941 . . . . 0.87 112.842 174.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.03 157.12 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.371 1.468 . . . . 0.54 111.898 175.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -119.34 149.42 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.839 2.056 . . . . 0.91 113.078 176.193 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.84 143.83 46.23 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.891 0.876 . . . . 0.63 111.843 176.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.33 -7.67 60.28 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 116.272 1.269 . . . . 0.7 116.272 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 t -73.7 157.14 37.08 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.137 1.468 . . . . 2.19 111.329 169.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.41 136.32 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.753 1.621 . . . . 0.99 111.697 -169.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -99.59 134.42 42.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.249 1.019 . . . . 2.23 110.745 172.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -135.9 53.65 1.94 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.041 1.126 . . . . 3.42 114.041 175.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -153.17 -54.21 0.11 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.415 1.635 . . . . 2.98 115.415 173.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.07 -156.17 11.33 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-N 119.367 0.985 . . . . 2.5 114.946 -169.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -83.9 155.47 22.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.223 1.009 . . . . 3.06 112.783 177.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.1 mt -147.55 152.28 37.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.839 2.056 . . . . 1.12 107.766 167.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.421 HD11 ' HE3' ' A' ' 44' ' ' LYS . 10.1 mp -111.58 114.86 28.21 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.189 0.995 . . . . 2.13 109.399 175.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.67 126.43 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.259 1.023 . . . . 1.18 111.397 -173.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 30.0 p -82.37 119.65 24.43 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.579 -0.701 . . . . 1.55 109.249 169.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.8 123.53 28.32 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.275 -0.891 . . . . 0.88 110.973 -175.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.6 p -115.81 -8.14 12.0 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.736 1.013 . . . . 2.56 113.736 -174.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -142.24 151.0 41.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.569 1.548 . . . . 1.48 110.603 173.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 m -100.65 171.21 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.863 1.265 . . . . 1.88 109.614 167.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.51 63.52 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.61 -1.306 . . . . 1.64 114.663 -174.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.13 -47.06 63.34 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.27 -1.135 . . . . 1.62 112.951 169.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -79.1 -16.73 56.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.091 2.156 . . . . 2.53 116.174 -174.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 109' ' ' SER . 10.0 t -71.54 148.37 46.78 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.485 -1.385 . . . . 2.78 113.614 -170.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 t -51.62 -35.89 43.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.033 1.333 . . . . 1.92 112.869 171.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.9 tp -60.29 -46.36 90.11 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.204 -0.935 . . . . 1.72 112.128 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.403 ' H ' HG23 ' A' ' 106' ' ' THR . 53.1 p -73.91 -30.83 62.8 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.991 0.916 . . . . 2.13 113.411 173.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -61.54 -43.1 99.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.18 0.9 . . . . 1.59 111.343 175.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.83 -54.69 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.547 1.139 . . . . 1.8 110.475 178.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.476 0.846 0 O-C-N 121.338 -0.851 . . . . 1.3 112.84 -178.949 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.721 0 N-CA-C 111.638 0.236 . . . . 2.14 111.638 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 tp -50.2 -41.41 49.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.242 1.417 . . . . 1.92 113.36 177.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.22 61.04 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.928 0.714 . . . . 1.93 112.928 171.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.23 -35.18 73.19 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.029 0.931 . . . . 3.06 112.551 178.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.32 -31.94 69.61 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.301 0.955 . . . . 1.36 112.973 173.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.2 mm -72.17 -40.2 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.027 0.931 . . . . 2.83 111.786 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m -71.26 -23.74 62.04 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.824 -1.173 . . . . 1.91 113.882 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.0 mt -73.4 -20.98 60.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.102 1.361 . . . . 2.4 113.57 173.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -85.37 143.18 28.79 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.178 0.991 . . . . 2.92 113.326 -176.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.56 165.69 12.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.746 1.619 . . . . 3.15 114.568 -178.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -120.55 -6.3 9.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.287 1.035 . . . . 3.59 113.041 169.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.49 155.23 45.03 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.558 -1.339 . . . . 2.79 113.725 -175.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.78 162.38 35.63 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.864 1.666 . . . . 1.28 113.003 177.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.2 m -125.51 111.97 15.68 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.637 1.175 . . . . 1.42 112.811 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 mt -96.75 133.1 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.788 1.235 . . . . 0.74 110.439 -175.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -126.54 115.1 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.218 1.407 . . . . 2.65 110.614 -177.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.473 0.699 0 C-N-CA 124.865 1.266 . . . . 2.59 110.561 -169.652 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 110.404 -0.221 . . . . 4.1 110.404 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.7 t -126.78 120.0 28.26 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.759 1.224 . . . . 1.61 109.301 172.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -117.88 152.46 35.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.293 1.037 . . . . 3.24 111.14 -173.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -142.09 138.39 31.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.968 1.707 . . . . 2.93 111.18 -176.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -108.41 130.61 55.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.407 1.003 . . . . 1.94 109.664 168.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.7 167.86 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.588 1.155 . . . . 1.17 112.9 -168.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.88 149.87 32.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.261 1.425 . . . . 4.89 110.712 168.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.02 -9.05 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.599 1.333 . . . . 1.63 114.599 -173.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -96.64 -15.51 21.47 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.274 -1.516 . . . . 4.41 112.803 169.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.01 -5.67 59.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.219 1.408 . . . . 1.66 113.936 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -100.12 142.85 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.504 1.522 . . . . 1.55 111.207 170.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -117.83 168.97 10.0 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.76 2.024 . . . . 3.44 111.468 175.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -68.83 144.82 54.17 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.841 -0.537 . . . . 4.74 110.586 169.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.0 -7.37 31.13 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.264 1.411 . . . . 1.8 114.984 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.6 165.69 11.5 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.404 1.602 . . . . 3.06 113.343 178.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -116.39 132.49 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.653 1.181 . . . . 1.93 112.302 -173.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.52 118.57 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 127.599 2.36 . . . . 1.09 109.225 -169.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -94.68 115.59 27.72 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.613 -0.679 . . . . 3.14 111.699 172.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.6 p -94.04 146.93 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.343 1.057 . . . . 1.02 112.254 -170.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.6 m -92.04 160.39 35.75 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.65 1.18 . . . . 1.11 112.598 169.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -55.86 146.5 67.29 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.116 1.877 . . . . 1.84 110.939 167.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.52 0.95 41.95 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.722 1.153 . . . . 1.75 115.299 -174.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.63 148.2 50.62 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.263 1.531 . . . . 1.53 112.819 172.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -117.68 9.72 13.15 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.478 1.658 . . . . 3.97 115.478 -169.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 51.88 115.11 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 129.095 2.958 . . . . 2.27 116.794 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.71 -14.81 9.94 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.065 2.51 . . . . 0.96 115.346 -176.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 m -153.11 173.72 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 128.296 2.638 . . . . 0.88 108.639 -178.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -92.62 147.87 22.53 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.505 0.928 . . . . 2.46 113.505 173.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.56 173.78 44.44 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 115.134 0.814 . . . . 1.4 115.134 -170.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -113.28 133.16 55.25 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.125 1.37 . . . . 5.17 111.621 -174.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.25 127.92 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 126.821 2.048 . . . . 0.86 109.286 -169.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 pt -142.49 30.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.784 1.031 . . . . 1.06 113.784 -173.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -169.51 143.08 2.72 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.459 1.903 . . . . 3.46 109.747 168.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -171.6 37.9 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 116.285 1.274 . . . . 1.26 116.285 169.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -142.63 123.78 14.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.142 0.977 . . . . 2.77 111.929 177.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 m -148.22 151.41 35.45 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.862 -1.149 . . . . 1.31 113.915 169.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.8 ttm -95.24 138.42 32.97 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.638 -0.664 . . . . 1.07 109.688 168.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.5 t -129.31 132.2 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.421 1.488 . . . . 1.03 111.035 -170.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.76 121.14 30.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.918 1.287 . . . . 2.31 111.651 176.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -116.12 14.21 15.93 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.054 1.742 . . . . 1.96 113.224 -178.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 86.7 p -60.74 -0.85 0.32 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 119.211 3.041 . . . . 1.41 119.211 -167.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -115.1 -40.51 3.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.938 1.295 . . . . 1.57 110.299 169.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.5 mm -69.46 -49.95 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.831 0.853 . . . . 1.61 112.109 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 p -106.09 -13.47 15.44 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.3 1.04 . . . . 1.44 113.108 175.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.68 -0.17 84.55 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 124.85 1.214 . . . . 1.25 115.162 169.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.18 121.98 27.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.04 1.336 . . . . 3.02 111.916 179.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.01 14.52 4.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.955 1.302 . . . . 1.32 113.301 -173.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 71.7 mtp -126.75 105.86 23.13 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 127.887 2.475 . . . . 3.25 108.002 -174.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.33 152.97 36.22 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.222 2.615 . . . . 1.96 114.387 -173.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.82 127.98 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 126.275 1.83 . . . . 0.99 111.054 -167.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.83 129.07 34.18 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.713 -0.617 . . . . 0.81 111.639 -178.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -121.65 144.88 48.51 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.454 1.902 . . . . 0.86 110.2 -177.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -155.8 -177.77 0.79 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 128.452 2.701 . . . . 3.8 108.78 -174.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.82 133.35 54.05 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.119 1.88 . . . . 1.04 112.308 168.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.25 28.9 59.27 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.166 1.365 . . . . 0.91 114.567 -171.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.1 m -111.33 170.27 8.23 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.668 1.734 . . . . 1.85 110.661 175.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.3 p -127.06 148.29 50.13 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 120.463 -1.398 . . . . 1.09 111.986 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.0 149.05 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.371 1.069 . . . . 1.06 112.019 179.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -119.4 150.54 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.428 1.891 . . . . 1.43 110.763 177.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.19 138.59 57.88 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.967 -0.56 . . . . 0.82 111.654 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.66 3.73 88.02 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.143 0.817 . . . . 1.7 115.143 -176.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.6 p -88.44 142.82 27.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.815 1.308 . . . . 1.75 110.2 167.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.44 120.39 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.092 0.775 . . . . 1.18 113.092 -167.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -76.16 129.32 36.58 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.445 1.098 . . . . 2.0 111.037 178.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -106.4 -29.67 9.58 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.223 1.194 . . . . 5.44 114.223 -172.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -104.62 -45.36 4.64 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 116.521 2.045 . . . . 3.15 116.521 -165.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.96 -142.65 5.22 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 118.204 2.042 . . . . 2.52 118.204 -167.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 t -90.09 144.28 26.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.369 1.468 . . . . 2.04 112.412 -174.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.7 mt -147.82 159.44 43.83 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.72 1.608 . . . . 1.11 109.538 169.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 tp -116.39 123.52 47.78 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.486 1.114 . . . . 2.36 110.331 169.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.57 129.47 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.275 1.03 . . . . 1.6 110.845 -170.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 52.8 t -86.46 123.9 32.2 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.379 -0.826 . . . . 3.11 109.671 168.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.89 121.83 25.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.898 0.879 . . . . 1.1 109.424 176.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.3 t -114.73 0.23 13.79 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.93 1.085 . . . . 2.46 113.93 -169.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -146.84 150.64 35.67 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.955 2.102 . . . . 1.85 111.178 175.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.1 m -83.47 166.56 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.767 0.827 . . . . 1.95 112.615 169.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.87 -31.4 75.88 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 120.932 -1.105 . . . . 1.49 114.681 -174.033 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.19 -25.39 64.31 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.174 1.175 . . . . 1.98 114.174 174.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.19 -19.92 59.57 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.269 -0.894 . . . . 3.14 113.081 171.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.1 p -68.49 141.96 55.43 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.564 -0.71 . . . . 1.71 111.809 -169.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 t -70.15 -18.18 63.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.097 0.777 . . . . 2.47 113.097 -170.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.4 mp -59.42 -52.14 66.9 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.297 -1.502 . . . . 1.76 112.588 -175.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.6 p -73.76 -17.48 61.09 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.91 0.884 . . . . 1.88 113.379 174.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -72.0 -42.72 66.11 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.12 0.968 . . . . 2.09 111.723 173.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.3 mt -61.18 -52.75 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.616 1.566 . . . . 1.63 111.16 -177.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 115.347 1.61 . . . . 1.9 115.347 -172.876 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 115.098 1.518 . . . . 1.56 115.098 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.0 tp -59.75 -40.81 89.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.962 1.256 . . . . 1.98 113.928 -168.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.25 -20.7 60.78 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.3 1.222 . . . . 1.75 114.3 173.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -70.73 -42.99 69.81 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.109 1.322 . . . . 2.42 111.426 -169.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -47.52 -50.55 23.29 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.834 1.254 . . . . 1.52 111.564 173.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.54 -28.87 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.396 1.078 . . . . 2.23 112.635 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -74.42 -25.64 59.57 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.874 -1.141 . . . . 1.06 112.973 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.01 -22.5 63.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.036 0.835 . . . . 2.13 112.89 169.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -68.46 135.19 51.27 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.855 1.207 . . . . 3.01 111.469 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.26 151.13 47.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.642 0.777 . . . . 1.86 112.422 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 p -87.36 -21.95 25.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.827 1.651 . . . . 2.53 113.355 177.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.75 157.08 47.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.871 1.268 . . . . 3.53 112.788 -175.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.75 157.38 45.11 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.73 1.212 . . . . 0.71 112.179 177.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 m -115.11 110.35 19.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.372 1.069 . . . . 0.83 111.385 177.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.7 mt -91.75 135.2 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.091 1.756 . . . . 0.77 109.495 -178.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 m -96.53 115.02 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 119.385 0.993 . . . . 2.47 109.372 167.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 N--CA 1.471 0.603 0 C-N-CA 123.813 0.845 . . . . 2.71 110.273 -177.441 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 113.117 0.784 . . . . 3.88 113.117 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.0 t -92.42 111.43 23.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.939 0.896 . . . . 1.83 109.607 176.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -81.53 138.29 35.45 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.349 0.87 . . . . 2.94 113.349 -170.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -127.83 125.3 39.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.847 2.059 . . . . 2.7 109.795 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -95.5 132.0 41.07 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.419 -1.425 . . . . 3.65 109.864 174.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.81 167.79 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.768 1.627 . . . . 0.87 112.846 -169.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.9 148.95 31.07 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.217 -0.66 . . . . 3.35 109.217 165.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.97 -7.36 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 114.954 1.465 . . . . 1.15 114.954 -177.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.78 -30.5 56.52 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 119.791 -1.818 . . . . 3.3 112.691 167.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -90.69 4.04 52.58 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.798 1.639 . . . . 1.3 114.117 -168.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 p -101.1 135.75 36.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 126.416 1.886 . . . . 1.67 110.62 173.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.82 166.58 10.91 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.219 1.808 . . . . 4.05 111.45 178.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -65.29 -12.87 56.08 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.718 1.377 . . . . 3.93 114.718 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.19 7.56 75.85 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.262 1.41 . . . . 1.2 115.938 174.352 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -91.82 155.84 17.94 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.782 1.791 . . . . 2.9 112.649 176.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.0 mm -110.9 123.83 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.753 1.621 . . . . 1.83 109.172 176.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -120.95 133.83 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.424 1.089 . . . . 0.71 113.375 -167.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.529 ' HE3' ' CG ' ' A' ' 96' ' ' LEU . 10.9 mmmm -101.04 148.2 25.32 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.601 0.76 . . . . 3.65 112.563 178.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 p -124.22 134.53 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.424 1.089 . . . . 0.6 111.691 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.2 m -79.94 163.57 57.3 Favored Pre-proline 0 N--CA 1.482 1.15 0 N-CA-C 113.303 0.853 . . . . 0.97 113.303 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.36 120.33 7.45 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.242 1.961 . . . . 1.43 108.451 168.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.02 84.2 Favored Glycine 0 CA--C 1.54 1.655 0 C-N-CA 124.634 1.112 . . . . 1.22 115.467 -170.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.46 178.51 52.9 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 119.633 1.717 . . . . 1.07 115.404 -177.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -120.87 145.3 47.78 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.614 1.165 . . . . 1.76 112.211 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -81.99 124.22 79.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.763 0.825 . . . . 1.72 111.901 -178.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -91.98 -20.14 0.66 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.194 2.596 . . . . 0.77 115.932 -170.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.73 166.94 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 126.849 2.06 . . . . 0.71 109.79 -177.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.313 0.3 OUTLIER -88.98 142.96 27.2 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.983 0.811 . . . . 1.9 112.698 174.327 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' A' ' 100' ' ' THR . . . 170.61 -166.75 39.94 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.533 0.973 . . . . 0.6 115.533 -173.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.6 ttp85 -109.76 143.54 39.44 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.68 1.592 . . . . 4.37 112.053 -171.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.2 128.87 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.1 1.76 . . . . 0.92 109.668 -172.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.7 pt -140.27 36.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 114.001 1.111 . . . . 0.97 114.001 -172.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -166.27 142.14 4.78 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.14 1.376 . . . . 3.17 111.283 168.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.15 -163.84 34.74 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.049 1.309 . . . . 1.21 115.907 169.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.98 126.46 5.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.329 1.233 . . . . 2.59 114.329 174.035 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 m -145.95 166.67 25.35 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.849 -1.157 . . . . 1.37 112.828 174.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.9 ttm -107.73 124.44 50.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.018 0.927 . . . . 0.96 109.286 172.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.08 143.61 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.064 1.746 . . . . 0.59 112.981 -167.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -98.25 96.28 7.96 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.22 1.408 . . . . 1.94 111.309 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -93.01 -10.58 35.72 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.082 1.353 . . . . 1.74 113.268 177.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 t -38.12 -46.4 1.03 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.51 2.411 . . . . 2.34 117.51 -167.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.3 -33.48 61.19 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.46 1.482 . . . . 1.2 112.167 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 mm -73.23 -47.49 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.406 1.482 . . . . 1.03 111.075 -177.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.4 p -110.44 -13.19 14.31 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.037 1.335 . . . . 1.2 114.125 -170.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.36 2.84 90.24 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.512 1.529 . . . . 1.12 114.752 -177.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -51.44 -49.91 60.77 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.921 1.36 . . . . 2.49 114.419 -172.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 57.76 31.53 20.59 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.334 1.454 . . . . 1.59 114.605 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.2 ttm -162.55 136.08 4.64 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 130.212 3.405 . . . . 3.14 105.242 169.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.18 164.9 34.12 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.95 2.433 . . . . 1.38 113.321 -170.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.3 t -120.22 129.83 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.383 1.473 . . . . 0.73 111.454 -169.427 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.27 139.7 36.54 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.479 -0.763 . . . . 0.81 111.943 177.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -125.03 150.97 46.21 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.664 1.586 . . . . 0.88 111.449 -178.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -149.57 172.86 4.77 Favored Pre-proline 0 N--CA 1.483 1.224 0 C-N-CA 129.312 3.045 . . . . 3.21 109.053 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -59.52 140.2 92.86 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 CA-C-N 121.588 1.603 . . . . 0.91 110.994 167.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.42 44.76 15.91 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.811 -0.555 . . . . 1.05 112.45 -170.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.9 t -126.67 170.14 12.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.69 1.596 . . . . 1.47 111.111 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.4 p -129.69 149.43 51.45 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.777 -1.202 . . . . 0.82 112.411 -176.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.89 159.06 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.09 1.356 . . . . 0.54 113.804 -176.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -120.05 152.84 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.798 2.439 . . . . 1.17 111.46 169.922 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.32 152.14 44.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.774 0.829 . . . . 0.63 112.906 178.427 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.23 4.72 89.87 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.42 0.528 . . . . 0.91 114.42 -175.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 m -82.15 153.52 25.98 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.286 -1.126 . . . . 1.49 110.563 169.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mm -108.3 143.59 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.698 1.199 . . . . 0.85 110.236 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -108.21 139.8 42.37 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.832 1.653 . . . . 1.54 113.086 -175.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -152.22 115.73 4.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.508 1.049 . . . . 3.78 113.808 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 51.5 t30 152.04 -51.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 131.341 3.856 . . . . 3.12 109.245 167.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.51 -178.65 36.54 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.768 1.651 . . . . 2.0 112.454 -174.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.4 p -89.53 135.39 33.63 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.713 -0.875 . . . . 1.86 113.286 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.6 mt -122.5 165.7 15.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.454 1.101 . . . . 1.29 112.921 -176.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.529 ' CG ' ' HE3' ' A' ' 44' ' ' LYS . 6.8 tt -116.24 117.45 30.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.367 1.467 . . . . 3.62 111.478 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.12 120.48 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.948 1.299 . . . . 1.34 111.49 178.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 20.4 p -84.57 120.82 26.79 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.035 -1.098 . . . . 1.48 108.035 166.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.28 157.38 34.49 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.921 -0.487 . . . . 1.63 110.481 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.418 HG22 ' HA2' ' A' ' 55' ' ' GLY . 8.4 t -141.46 -9.22 0.96 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.671 1.36 . . . . 2.54 114.671 176.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -140.51 144.27 35.89 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.589 1.156 . . . . 1.62 110.451 169.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -69.97 161.02 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.641 -0.503 . . . . 1.52 109.641 167.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.48 -36.61 89.96 Favored Glycine 0 N--CA 1.476 1.355 0 O-C-N 121.114 -0.991 . . . . 1.52 113.811 -171.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.87 -38.51 91.21 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.754 1.02 . . . . 1.88 113.754 171.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -77.31 -6.71 54.2 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.043 2.137 . . . . 2.47 114.861 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 81.3 p -65.3 157.91 27.81 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.604 -1.31 . . . . 1.55 113.194 178.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 90.9 m -64.48 -35.68 81.73 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.622 0.769 . . . . 2.95 111.36 175.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.19 -47.56 68.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.866 1.266 . . . . 1.63 111.7 171.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 m -68.41 -30.44 69.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.479 1.112 . . . . 1.94 113.584 176.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -70.08 -41.05 74.59 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.085 0.857 . . . . 1.77 111.663 172.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.49 -48.55 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.845 0.858 . . . . 1.6 110.904 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 113.439 0.903 . . . . 1.31 113.439 177.732 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 113.535 0.939 . . . . 1.94 113.535 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.5 tp -70.92 -34.31 71.38 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.641 1.177 . . . . 1.47 113.17 170.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.07 -32.04 68.61 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.194 -0.941 . . . . 1.46 111.567 174.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -54.56 -37.9 66.01 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 124.968 1.307 . . . . 2.04 113.354 -170.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.05 -43.79 91.74 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.346 1.058 . . . . 1.18 112.578 -178.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.3 mm -72.43 -33.18 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.25 -0.906 . . . . 1.8 112.237 175.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m -77.43 -17.31 58.22 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.383 0.882 . . . . 1.57 113.383 176.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mt -71.88 -43.39 65.5 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.602 2.361 . . . . 1.77 112.749 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -49.57 134.7 19.36 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.63 0.772 . . . . 3.01 110.764 175.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.59 -14.34 41.6 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.041 1.497 . . . . 3.66 115.041 -172.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 m 69.11 -24.79 0.14 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 128.29 2.636 . . . . 3.01 115.024 173.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -125.38 152.97 44.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.176 1.39 . . . . 3.26 111.262 169.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.84 151.35 45.62 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.716 1.206 . . . . 1.02 111.88 -177.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.2 m -111.45 104.09 12.5 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.283 1.033 . . . . 1.07 111.876 -176.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.1 mt -91.26 134.67 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.705 1.602 . . . . 1.04 110.795 -173.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.69 130.27 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 120.719 -1.238 . . . . 2.54 110.483 169.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 125.726 1.61 . . . . 3.18 110.873 178.931 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.625 0.726 . . . . 2.84 111.502 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.1 t -134.97 95.12 3.26 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.992 2.517 . . . . 1.95 107.406 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.78 145.21 25.74 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.121 -0.987 . . . . 3.66 110.573 -176.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -127.49 156.53 42.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.345 2.658 . . . . 2.93 111.274 -167.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -121.11 140.2 52.3 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.238 0.926 . . . . 2.03 112.746 169.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.97 166.24 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.257 1.423 . . . . 1.36 113.478 -177.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.44 147.66 32.21 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.694 1.198 . . . . 3.96 110.443 166.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.77 -13.06 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.461 1.282 . . . . 1.57 114.461 -176.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -82.87 -12.67 57.21 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 120.141 -1.599 . . . . 5.01 113.565 170.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.9 mt -103.75 -10.22 18.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.151 1.78 . . . . 1.95 114.282 -172.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.63 143.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.693 1.197 . . . . 1.79 110.664 173.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -121.23 164.63 16.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.502 1.921 . . . . 3.09 111.067 176.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.0 ptt-85 -72.22 153.3 41.67 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.707 -1.246 . . . . 2.82 110.743 172.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.57 25.37 9.32 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 119.25 -0.75 . . . . 1.28 114.213 -176.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -140.14 162.24 35.72 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.49 1.516 . . . . 2.74 112.05 176.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.45 125.72 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.307 1.443 . . . . 1.13 110.199 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.8 mm -115.43 128.71 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.99 1.316 . . . . 0.87 111.401 -171.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -80.87 146.77 30.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.339 1.055 . . . . 2.47 112.667 175.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.8 137.0 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.524 0.729 . . . . 0.56 111.81 168.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 m -89.75 164.29 29.5 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.068 1.347 . . . . 0.89 113.38 -178.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.66 132.25 32.26 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.238 1.959 . . . . 1.07 109.445 168.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.74 -8.8 47.47 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.183 0.897 . . . . 1.01 115.187 -169.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.74 163.9 43.32 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 118.616 1.208 . . . . 1.02 114.092 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -111.6 149.07 31.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.422 1.489 . . . . 1.67 110.437 175.083 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -81.39 130.14 63.37 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 121.85 -0.531 . . . . 2.08 111.918 177.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.96 -25.66 1.4 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.446 2.764 . . . . 0.72 114.792 -178.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.4 176.59 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.22 2.208 . . . . 0.88 109.323 -178.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.84 148.04 26.14 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.647 0.779 . . . . 2.36 111.816 174.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.2 -160.14 32.87 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.521 0.568 . . . . 0.76 114.521 -172.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -116.91 135.6 53.59 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.412 1.485 . . . . 3.45 113.268 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.47 135.36 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.111 2.164 . . . . 1.03 108.935 170.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.4 pt -137.03 31.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 113.386 0.884 . . . . 0.82 113.386 175.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -166.46 139.45 3.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.707 1.603 . . . . 2.88 109.098 166.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.13 177.38 49.91 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 122.684 1.158 . . . . 0.82 115.259 174.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -145.52 133.22 21.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.043 1.337 . . . . 1.83 112.23 -174.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.3 m -150.66 176.03 11.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.625 1.17 . . . . 1.18 112.853 172.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.8 ttm -117.96 129.84 55.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.711 1.204 . . . . 0.94 110.397 168.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t -117.38 136.05 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.78 1.232 . . . . 0.66 113.223 -167.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -88.6 108.2 19.31 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.58 1.152 . . . . 1.85 111.227 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -110.18 16.36 21.82 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.225 1.41 . . . . 1.68 114.117 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -60.57 -19.91 58.89 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.986 1.847 . . . . 1.6 115.986 -169.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -91.94 -40.82 10.92 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.112 0.869 . . . . 0.99 111.663 172.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 27.5 mm -78.34 -61.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.016 0.926 . . . . 1.02 112.246 -171.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.9 p -96.74 -7.75 33.08 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.499 1.12 . . . . 1.2 112.651 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.35 16.03 74.97 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.446 1.498 . . . . 1.25 113.833 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -83.66 105.01 14.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.391 1.476 . . . . 2.98 111.763 -176.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.31 -13.26 59.76 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.398 -0.814 . . . . 1.53 111.643 177.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -100.06 111.92 63.05 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 126.745 2.018 . . . . 4.53 107.889 169.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.86 148.93 35.63 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.869 3.046 . . . . 1.55 114.162 -178.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.79 130.23 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.516 1.526 . . . . 0.72 110.879 -169.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.2 142.89 37.63 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.271 0.629 . . . . 0.65 112.516 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.07 147.3 46.87 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.414 1.886 . . . . 0.74 110.603 177.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -147.25 170.6 7.49 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 128.504 2.721 . . . . 2.69 109.664 -174.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -59.38 124.37 15.39 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 121.566 1.595 . . . . 0.87 109.593 168.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.94 55.25 3.18 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.938 0.78 . . . . 1.34 112.308 -168.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 t -139.49 141.36 37.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.417 1.087 . . . . 1.38 111.147 178.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.8 p -97.09 144.8 26.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.51 1.05 . . . . 0.72 112.497 -178.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.58 156.59 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.323 1.849 . . . . 0.59 111.49 -173.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.29 146.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.672 1.589 . . . . 1.01 111.92 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.47 153.12 28.14 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.81 0.844 . . . . 0.72 113.218 -175.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.45 -5.08 17.05 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.594 0.997 . . . . 0.82 115.594 178.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -75.79 153.03 37.2 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.787 1.294 . . . . 1.33 109.869 168.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 mm -109.14 132.3 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.658 0.783 . . . . 0.66 110.668 -169.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -91.95 151.89 20.29 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.694 1.597 . . . . 1.58 113.198 -173.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -156.65 139.33 15.08 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.029 -1.044 . . . . 3.04 111.774 176.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.311 57.8 t30 99.23 -21.67 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.001 3.321 . . . . 3.0 116.932 172.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.32 178.81 38.8 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 119.928 -1.733 . . . . 2.18 114.215 -174.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.1 t -120.78 125.7 48.24 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.627 1.171 . . . . 2.36 110.942 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.66 161.85 21.77 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.627 1.571 . . . . 1.17 112.438 -167.298 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.21 119.58 37.54 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.944 1.298 . . . . 1.75 110.154 174.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.98 123.3 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.052 1.341 . . . . 1.54 109.747 175.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.8 p -82.28 108.45 15.74 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.544 -0.722 . . . . 1.57 110.077 170.02 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.87 113.88 17.33 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.127 -0.983 . . . . 1.02 110.707 -172.038 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -111.34 -2.33 15.68 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.07 1.348 . . . . 2.92 112.478 179.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -138.32 142.33 39.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.954 2.102 . . . . 1.72 109.391 178.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.34 178.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 124.707 1.203 . . . . 1.85 112.554 172.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.63 -39.49 97.63 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.594 -1.316 . . . . 1.39 113.615 -178.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.01 -31.89 72.31 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 118.411 1.105 . . . . 1.83 113.176 172.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -75.71 -4.37 39.98 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 128.132 2.573 . . . . 3.04 113.464 175.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 76.3 p -70.57 141.44 51.83 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.588 -1.945 . . . . 1.64 114.275 -177.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -62.17 -31.93 72.49 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.71 -0.619 . . . . 1.9 112.19 176.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -56.03 -48.05 76.7 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.777 -1.202 . . . . 1.47 111.8 171.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.8 m -64.97 -36.56 84.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.094 0.557 . . . . 1.82 110.43 175.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.32 -40.59 85.97 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.664 -0.647 . . . . 1.6 112.303 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 67.9 mt -59.03 -51.41 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.355 1.062 . . . . 1.26 109.945 177.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 117.903 -1.046 . . . . 1.18 113.084 179.465 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 111.97 0.359 . . . . 1.77 111.97 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 tp -56.56 -34.41 67.09 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.71 0.804 . . . . 1.56 112.92 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.23 -41.76 39.94 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.915 0.709 . . . . 1.33 112.915 168.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -60.19 -35.11 74.65 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.953 1.301 . . . . 2.18 112.709 -175.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.72 -36.68 72.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.691 0.796 . . . . 1.26 112.866 173.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.4 mm -72.88 -38.66 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.872 0.76 . . . . 1.85 111.621 173.13 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -65.54 -25.75 67.58 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.174 -0.954 . . . . 1.23 112.783 177.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.9 mt -73.33 -17.84 61.25 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.633 1.973 . . . . 1.87 114.892 174.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -74.48 144.76 44.04 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.085 1.311 . . . . 3.32 112.105 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.49 156.49 21.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.845 1.258 . . . . 2.98 112.839 -176.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 p -94.76 -30.45 14.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.599 1.16 . . . . 2.73 113.7 171.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -140.47 162.13 36.08 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.245 1.818 . . . . 3.56 113.014 -173.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.16 159.61 41.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.948 1.299 . . . . 1.56 112.873 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.4 m -104.53 124.49 49.38 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.266 1.026 . . . . 1.32 111.833 176.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.78 130.25 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.325 1.45 . . . . 0.96 110.932 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -110.83 133.96 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.366 1.066 . . . . 2.48 111.897 177.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 123.457 0.703 . . . . 1.62 112.279 -175.829 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 tt . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.624 0.249 . . . . 4.27 111.427 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.2 t -130.63 131.16 44.76 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.618 1.567 . . . . 1.88 109.605 -177.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.36 143.63 49.1 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.703 1.201 . . . . 3.03 112.366 -170.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.96 143.65 50.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.954 1.302 . . . . 3.39 111.177 -178.054 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -108.35 125.98 52.33 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.823 -0.806 . . . . 2.42 108.823 166.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.29 161.29 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.605 1.162 . . . . 1.68 112.357 -170.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -74.06 143.3 45.53 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.025 -0.732 . . . . 4.3 109.025 172.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.59 -2.34 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 114.463 1.283 . . . . 1.74 114.463 -171.48 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -81.05 -23.4 38.58 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.33 2.252 . . . . 4.77 113.13 168.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.6 mt -103.12 -10.76 18.58 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.644 1.578 . . . . 1.94 114.009 -168.125 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.4 p -87.01 145.06 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.74 2.016 . . . . 1.75 108.646 168.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.24 159.48 16.08 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.198 0.999 . . . . 4.8 112.415 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -73.49 33.04 0.08 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 115.615 1.709 . . . . 4.55 115.615 -178.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.26 15.95 1.31 Allowed Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.481 2.467 . . . . 1.55 113.756 171.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -81.96 158.37 23.91 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.968 1.384 . . . . 2.35 113.216 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -106.91 125.85 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.418 1.487 . . . . 1.69 112.333 -172.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.7 mm -127.3 119.1 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.899 1.28 . . . . 0.91 111.492 -169.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HE3' ' HG ' ' A' ' 96' ' ' LEU . 21.2 mmtp -85.44 120.16 26.59 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.744 -1.223 . . . . 3.63 110.287 169.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 p -96.97 138.41 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.758 0.708 . . . . 1.12 111.795 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 m -87.68 150.44 48.36 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.678 1.191 . . . . 1.1 112.886 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -59.44 142.83 99.57 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.755 2.303 . . . . 1.72 111.07 170.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.31 -13.08 8.24 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 115.855 1.102 . . . . 1.91 115.855 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.31 -172.64 40.62 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 119.058 1.429 . . . . 1.44 115.214 -175.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -113.25 158.01 21.03 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.006 1.322 . . . . 1.75 111.521 171.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -91.54 125.26 58.4 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.234 1.013 . . . . 2.43 111.437 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -92.66 -13.29 1.48 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.311 2.674 . . . . 1.41 115.444 -175.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.48 162.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 126.613 1.965 . . . . 1.5 109.433 178.193 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.273 0.5 OUTLIER -93.51 137.67 32.56 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.684 0.754 . . . . 2.09 112.33 175.595 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.41 177.32 41.95 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 123.975 0.798 . . . . 1.01 114.6 -169.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.7 ttm-85 -100.89 146.02 27.86 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.203 1.401 . . . . 6.28 111.578 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.4 t -101.06 126.57 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.135 2.174 . . . . 1.17 109.135 -174.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 pt -140.87 29.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 113.973 1.101 . . . . 1.17 113.973 -175.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -170.17 146.67 3.02 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.882 2.073 . . . . 3.9 109.158 166.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.4 -174.24 48.63 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.43 1.014 . . . . 1.33 115.227 169.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -150.22 118.78 6.5 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.353 1.061 . . . . 2.24 111.064 -174.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.4 t -142.71 163.98 31.36 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.282 1.433 . . . . 1.59 112.27 -175.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.2 ttm -116.05 129.69 56.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.06 1.344 . . . . 0.79 110.435 174.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.6 t -121.59 143.33 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.766 1.627 . . . . 0.61 112.061 -168.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -99.45 90.4 4.51 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.281 1.832 . . . . 1.8 111.359 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -90.03 9.58 27.47 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.862 1.265 . . . . 2.32 113.762 -175.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.8 t -50.35 -47.35 56.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.188 2.195 . . . . 1.88 115.612 -169.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.98 -36.99 48.32 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.593 -1.317 . . . . 1.14 111.777 -175.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.3 mm -73.61 -48.28 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.727 -0.608 . . . . 1.03 110.207 -177.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.1 p -107.33 -11.37 15.57 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.352 1.241 . . . . 1.26 114.352 -170.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.61 -5.81 72.39 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 126.011 1.767 . . . . 1.51 115.943 174.117 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.25 -47.2 81.98 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.529 1.165 . . . . 2.85 113.254 -169.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.268 . . 58.61 45.61 15.86 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.442 1.897 . . . . 1.93 111.847 -176.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptp -153.02 134.95 8.81 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 128.98 2.912 . . . . 4.07 109.068 172.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -62.2 145.64 96.19 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.712 2.275 . . . . 1.35 113.952 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.34 128.51 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.502 1.521 . . . . 0.76 111.303 -174.117 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.87 144.79 28.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.628 0.771 . . . . 0.76 112.977 -179.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -122.23 159.44 27.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.176 1.79 . . . . 1.31 112.274 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -151.98 171.76 6.24 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 127.791 2.437 . . . . 3.64 110.643 -176.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.5 123.98 13.79 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 CA-C-N 121.341 1.515 . . . . 1.42 108.84 166.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.83 44.4 5.75 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.057 0.837 . . . . 1.27 113.01 -168.367 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.9 m -124.96 169.05 12.48 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.245 1.418 . . . . 1.36 109.362 168.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.4 p -121.46 156.79 32.0 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.825 -1.172 . . . . 0.98 112.868 169.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.28 160.48 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.884 1.674 . . . . 0.76 111.924 -178.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.466 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -127.62 154.51 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 126.47 1.908 . . . . 1.6 112.514 -176.952 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.73 159.84 33.17 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.432 0.901 . . . . 1.17 113.432 -177.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -6.96 11.88 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.797 1.189 . . . . 1.07 115.113 179.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -84.65 162.69 19.64 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.167 1.387 . . . . 2.46 111.601 174.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 mm -111.33 140.86 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.271 1.028 . . . . 0.97 111.547 -169.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -90.61 136.09 33.28 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.178 1.791 . . . . 2.79 109.371 169.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -83.64 -73.32 0.42 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.702 0.801 . . . . 3.52 110.663 169.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -140.55 161.27 38.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.241 1.816 . . . . 3.63 107.969 170.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.88 138.66 6.48 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.506 2.479 . . . . 1.83 111.572 177.436 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.9 m -114.61 95.77 5.41 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.825 1.25 . . . . 2.56 110.167 -169.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.3 mt -104.44 152.7 22.01 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.043 1.337 . . . . 1.68 113.684 -170.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.416 ' HG ' ' HE3' ' A' ' 44' ' ' LYS . 4.2 tt -104.25 117.75 34.96 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.891 1.276 . . . . 3.58 109.731 171.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.3 mm -113.41 129.02 69.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.022 1.329 . . . . 1.96 111.422 -173.493 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.3 p -101.69 124.94 48.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.414 -0.804 . . . . 1.45 110.109 168.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.96 151.02 31.88 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.692 0.627 . . . . 1.39 112.692 -174.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -129.43 -3.23 4.89 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.775 1.398 . . . . 2.8 114.775 169.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -140.97 141.87 34.37 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.66 1.184 . . . . 2.73 111.09 169.067 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.85 165.8 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 109.233 -0.655 . . . . 2.21 109.233 166.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.7 -39.74 91.67 Favored Glycine 0 N--CA 1.475 1.294 0 CA-C-N 119.528 1.058 . . . . 2.45 114.673 -168.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.16 82.58 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.142 0.971 . . . . 3.24 112.875 174.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -74.33 -8.34 55.9 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.213 2.605 . . . . 3.74 114.275 176.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.0 p -64.13 159.07 21.27 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.789 -1.194 . . . . 2.05 113.525 -174.526 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.6 t -52.21 -24.04 6.57 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.22 1.193 . . . . 2.53 114.22 175.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.69 -44.92 93.46 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.251 -1.531 . . . . 1.93 112.87 174.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.2 p -70.92 -21.35 62.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 117.945 0.339 . . . . 2.14 111.785 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.02 -38.55 72.61 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.672 -0.643 . . . . 2.41 111.149 174.024 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 94.1 mt -59.98 -54.21 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.405 0.682 . . . . 1.72 110.829 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 113.303 0.853 . . . . 1.31 113.303 -178.781 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 111.604 0.224 . . . . 1.67 111.604 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.0 tp -70.56 -30.95 67.81 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.122 1.369 . . . . 1.6 112.234 174.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.21 -34.13 61.45 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.991 0.516 . . . . 1.45 112.343 177.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -64.31 -28.46 69.73 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.359 -0.838 . . . . 2.41 112.88 -177.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.28 -28.63 69.86 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.064 0.946 . . . . 1.25 113.237 173.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.62 -37.85 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.169 -0.957 . . . . 1.81 111.31 169.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -70.48 -31.39 68.5 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.253 1.021 . . . . 1.52 113.138 179.322 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.72 -22.79 64.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.166 2.186 . . . . 2.23 114.165 -178.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -76.78 155.58 33.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.21 1.404 . . . . 2.49 113.926 -169.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.78 -28.07 14.44 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.391 1.256 . . . . 3.03 114.391 -168.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m 66.93 -29.47 0.14 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.805 2.15 . . . . 2.99 116.805 171.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.22 145.9 41.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.087 1.755 . . . . 3.53 111.455 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.25 160.66 41.14 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.94 1.089 . . . . 0.77 113.94 -169.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.8 m -112.43 112.64 24.35 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.309 1.044 . . . . 1.19 112.395 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.42 146.18 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 126.742 2.017 . . . . 0.7 109.932 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.56 115.0 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.024 -1.102 . . . . 1.76 108.024 166.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.471 0.615 0 C-N-CA 126.238 1.815 . . . . 1.89 109.917 -176.416 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--O 1.238 0.478 0 CA-C-O 121.621 0.724 . . . . 2.74 112.311 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.3 t -142.07 131.88 24.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.914 1.285 . . . . 1.46 110.507 168.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -99.34 135.67 40.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.091 0.956 . . . . 2.75 110.878 -179.035 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -131.99 132.58 43.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.5 1.92 . . . . 3.42 111.642 -167.088 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -104.08 130.0 51.76 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.251 -1.531 . . . . 1.93 112.706 -172.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -142.6 -179.77 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 125.7 1.6 . . . . 0.93 113.749 -171.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.93 147.43 23.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.671 1.188 . . . . 2.67 110.69 166.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.38 -21.53 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.943 1.09 . . . . 2.07 113.943 -176.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.16 -23.88 67.23 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.119 -0.988 . . . . 3.15 112.448 168.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.4 mt -106.62 -10.23 16.26 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.838 1.655 . . . . 2.05 114.384 -169.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.7 m -60.78 -37.34 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 119.897 1.226 . . . . 3.93 112.415 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.306 35.3 mt-30 58.31 150.75 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.959 2.904 . . . . 4.07 115.775 -173.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -71.12 40.89 0.06 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 117.203 2.297 . . . . 3.82 117.203 -167.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.47 17.77 0.43 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.627 1.584 . . . . 1.01 115.712 178.201 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.52 170.23 8.27 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.831 1.315 . . . . 3.15 113.392 170.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.2 mt -122.02 131.8 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.454 1.502 . . . . 1.19 109.004 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.96 131.58 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.717 1.607 . . . . 0.74 111.02 -169.44 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -84.52 125.72 32.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.913 0.779 . . . . 2.17 112.23 171.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.79 133.04 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.233 1.413 . . . . 0.68 110.935 172.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 m -93.2 168.26 12.5 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 124.036 0.935 . . . . 0.9 112.982 -176.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.92 132.38 47.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.583 2.188 . . . . 1.02 110.324 168.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.77 -6.17 27.12 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.614 1.102 . . . . 1.0 115.395 -172.038 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.26 162.71 53.69 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.149 1.474 . . . . 0.99 114.112 -179.072 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -104.84 146.34 29.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.299 1.04 . . . . 2.21 111.692 175.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -71.57 130.91 86.74 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.696 -0.669 . . . . 1.8 109.538 169.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -94.83 -18.03 0.41 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.481 2.12 . . . . 0.94 115.065 -171.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 m -144.09 175.63 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 127.277 2.231 . . . . 1.2 110.086 -178.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -94.91 136.25 35.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.97 0.805 . . . . 1.98 112.027 168.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.46 -173.44 46.28 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 121.545 -0.722 . . . . 0.68 114.243 -169.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -109.22 134.65 51.48 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.143 0.977 . . . . 4.93 113.218 -175.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.8 126.88 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.907 2.083 . . . . 0.81 108.048 174.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.8 pt -140.39 33.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 118.614 0.643 . . . . 1.01 112.12 176.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -165.82 128.54 2.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.714 1.606 . . . . 3.88 108.594 169.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.78 165.93 40.67 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.745 1.164 . . . . 1.3 114.697 -179.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -141.53 130.16 22.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.293 1.037 . . . . 1.93 112.38 178.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.46 ' HB2' HD21 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -143.69 163.36 33.49 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.49 1.116 . . . . 1.37 112.657 173.222 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.0 ttm -90.61 141.94 28.26 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.489 0.716 . . . . 0.93 109.298 168.161 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.2 t -134.55 142.56 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.997 1.319 . . . . 0.64 112.724 -168.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -89.07 116.36 27.29 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.257 1.023 . . . . 2.15 112.211 173.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -109.62 10.69 24.92 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.504 1.522 . . . . 1.75 111.951 169.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 t -58.47 -39.29 79.53 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.939 1.296 . . . . 2.47 114.043 -172.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.88 -31.47 27.91 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 120.391 1.451 . . . . 1.62 111.576 177.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.8 mm -62.03 -57.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.028 0.931 . . . . 1.58 110.762 178.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 p -119.58 -5.11 10.27 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.161 1.171 . . . . 2.11 114.161 -169.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.42 11.69 77.33 Favored Glycine 0 CA--C 1.539 1.572 0 CA-C-O 118.504 -1.164 . . . . 1.79 115.295 -179.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -49.97 -53.51 26.0 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.842 1.821 . . . . 2.8 114.17 -175.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.256 . . 59.66 13.94 3.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.09 1.756 . . . . 1.57 114.739 -173.498 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 52.3 ttp -132.81 131.84 22.23 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 128.308 2.643 . . . . 3.79 106.876 169.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.98 152.33 46.11 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.161 2.574 . . . . 1.92 112.949 -171.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -109.48 133.24 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.752 1.621 . . . . 0.72 110.632 -171.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.16 132.35 36.52 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.57 -0.706 . . . . 0.78 111.206 174.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -120.58 144.62 48.0 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.365 1.466 . . . . 0.79 110.122 173.085 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 167.28 13.51 Favored Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 127.699 2.4 . . . . 4.45 110.526 -169.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -58.72 132.03 45.59 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 CA-C-N 121.628 1.617 . . . . 0.85 111.354 174.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.5 29.56 35.84 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.451 1.024 . . . . 0.74 114.21 -169.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.9 t -116.4 152.6 33.63 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.788 1.635 . . . . 1.57 111.658 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.2 p -107.15 150.15 26.9 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.931 1.241 . . . . 0.79 113.142 178.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.4 m -140.27 163.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.448 1.499 . . . . 0.6 112.285 -174.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.93 156.78 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.535 1.534 . . . . 1.26 112.549 173.418 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.75 148.12 49.99 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.487 0.921 . . . . 0.58 113.487 -177.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.49 -1.62 70.88 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 115.198 0.839 . . . . 0.89 115.198 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.8 p -78.11 151.43 33.36 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.425 1.113 . . . . 1.44 109.433 166.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.88 132.87 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.509 0.724 . . . . 0.73 111.835 -168.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -95.28 137.65 34.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.221 1.808 . . . . 1.56 112.671 -176.176 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -85.53 -92.94 0.09 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 115.488 1.662 . . . . 3.32 115.488 -169.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -109.22 -30.65 7.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 117.143 2.275 . . . . 3.94 117.143 -167.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.8 150.72 16.93 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.065 1.317 . . . . 1.96 113.379 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 t -98.15 139.65 33.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.275 1.83 . . . . 2.5 112.443 -174.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 62' ' ' SER . 1.0 OUTLIER -132.85 162.68 30.91 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.717 1.607 . . . . 1.32 112.208 -168.447 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.36 127.95 54.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.073 0.949 . . . . 1.96 112.248 172.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.53 132.21 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.326 1.451 . . . . 1.21 111.875 -172.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.1 m -84.97 118.27 24.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.81 1.244 . . . . 2.08 111.187 -179.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.95 117.0 21.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.45 0.7 . . . . 0.99 111.79 176.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.4 t -112.53 5.34 17.88 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.926 1.29 . . . . 2.82 114.253 174.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -151.3 144.29 24.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.498 2.319 . . . . 2.18 108.808 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.6 m -82.59 162.31 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.271 -1.011 . . . . 2.08 108.271 164.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.98 -39.15 56.54 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-N 119.555 1.071 . . . . 1.39 114.976 -168.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.71 80.63 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.265 1.026 . . . . 1.86 113.537 173.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.85 -9.46 58.7 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.563 1.545 . . . . 4.04 114.958 -179.145 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.3 p -69.7 160.94 30.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.777 1.028 . . . . 1.66 113.777 -175.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.8 t -63.07 -33.03 74.56 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.71 0.804 . . . . 1.89 112.112 172.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.59 -45.25 92.46 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.054 -1.029 . . . . 1.45 111.368 176.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 64.8 m -71.46 -33.32 69.23 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.906 0.882 . . . . 2.14 112.54 173.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -61.97 -42.23 98.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.276 1.03 . . . . 2.01 111.17 177.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.29 -55.63 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.079 1.352 . . . . 1.38 110.808 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 113.404 0.89 . . . . 1.39 113.404 -175.588 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.687 0 N-CA-C 112.367 0.506 . . . . 1.55 112.367 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 tp -61.7 -32.55 72.76 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.572 0.749 . . . . 1.69 111.884 175.248 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.47 -41.79 45.98 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.507 0.723 . . . . 1.47 112.391 168.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -61.06 -36.85 80.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.803 1.241 . . . . 2.57 113.143 -174.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.45 -33.19 72.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.389 0.995 . . . . 1.16 113.449 178.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.98 -39.85 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.25 -0.906 . . . . 1.61 111.853 168.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.2 m -63.99 -32.77 74.43 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.097 -1.002 . . . . 1.07 113.128 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.14 -24.02 67.53 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.0 2.52 . . . . 1.87 114.132 177.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -80.24 121.48 25.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.391 0.677 . . . . 2.37 109.291 -177.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.78 66.56 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 116.527 2.047 . . . . 2.43 116.527 -166.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m 67.16 -21.13 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 115.613 1.709 . . . . 3.49 115.613 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -128.05 152.19 48.26 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.146 -1.596 . . . . 3.04 114.171 176.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.7 144.62 49.25 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.086 1.355 . . . . 1.68 111.112 -177.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.5 m -119.08 98.23 6.07 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.919 0.887 . . . . 1.97 112.049 -171.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.6 mt -81.68 136.91 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 127.013 2.125 . . . . 0.94 111.46 -171.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.61 142.79 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.679 0.792 . . . . 1.99 112.49 168.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.0 m . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 126.388 1.875 . . . . 3.29 111.849 -169.895 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.8 tp . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 113.258 0.836 . . . . 3.37 113.258 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.5 m -78.15 153.81 31.75 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.311 1.044 . . . . 2.59 110.826 -178.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -124.2 146.96 48.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.51 0.724 . . . . 2.59 112.707 176.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -137.42 139.76 40.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.789 2.036 . . . . 2.66 110.255 -172.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -107.56 130.28 54.89 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.258 0.936 . . . . 2.84 112.665 175.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 m -132.97 174.71 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.644 1.578 . . . . 1.45 111.503 -177.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.87 145.58 31.28 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.939 0.895 . . . . 4.95 111.761 169.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.31 -8.02 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 114.189 1.181 . . . . 1.84 114.189 -176.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -85.46 -28.12 25.25 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.166 -1.583 . . . . 4.56 112.315 167.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.58 -20.06 22.07 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.441 1.496 . . . . 2.13 113.515 -169.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.58 -46.07 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.48 1.112 . . . . 3.82 112.352 178.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 59.56 164.94 0.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.408 1.883 . . . . 3.85 115.863 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -74.34 27.34 0.08 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 117.002 2.223 . . . . 4.19 117.002 -168.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.75 -8.3 5.29 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 117.012 1.565 . . . . 1.17 117.012 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.11 175.76 5.37 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.63 1.715 . . . . 3.08 114.308 -174.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.9 mt -123.27 135.33 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.481 1.913 . . . . 1.64 110.411 -178.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.4 mm -124.9 123.59 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.349 1.859 . . . . 0.76 110.186 -170.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -100.01 122.0 42.24 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.273 -0.892 . . . . 3.24 112.79 177.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.7 p -100.72 142.57 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.557 1.543 . . . . 0.71 112.117 -173.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 m -88.95 163.58 34.29 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 124.417 1.087 . . . . 1.03 113.136 -177.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.95 132.6 48.39 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.446 2.097 . . . . 1.25 110.902 169.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.17 -1.99 62.62 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 115.854 1.102 . . . . 1.1 115.854 -172.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.17 174.99 46.27 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-N 119.517 1.659 . . . . 1.1 114.923 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -122.37 145.89 47.85 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.505 1.522 . . . . 2.41 111.132 -177.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -86.35 129.66 52.56 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 118.697 -0.668 . . . . 2.21 112.443 -177.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.12 -19.83 0.85 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.124 2.55 . . . . 0.91 115.825 -172.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.7 m -148.57 165.71 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 126.87 2.068 . . . . 1.21 109.466 -177.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -88.29 127.88 35.47 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.288 0.949 . . . . 2.13 111.976 169.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.19 -167.83 29.41 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.592 1.091 . . . . 0.65 112.918 -169.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -117.33 135.36 53.9 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.042 0.937 . . . . 5.12 113.326 -175.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.8 t -83.45 129.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 128.522 2.729 . . . . 0.76 109.14 176.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.17 32.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.216 1.006 . . . . 0.88 113.165 -179.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -168.55 137.91 2.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.004 1.722 . . . . 3.52 108.675 166.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.11 -177.08 51.93 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.593 0.997 . . . . 0.79 115.593 169.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -145.89 120.73 9.94 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.282 1.433 . . . . 5.42 110.972 -169.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.22 171.76 14.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.462 1.105 . . . . 1.31 111.267 172.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.6 ttm -108.01 149.15 28.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.99 1.316 . . . . 0.81 111.043 170.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.92 133.72 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.743 1.217 . . . . 0.69 112.573 -169.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -100.45 106.06 17.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.412 1.485 . . . . 2.21 110.409 177.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.29 6.07 10.71 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.741 1.616 . . . . 2.17 114.912 -172.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.3 p -45.69 -26.04 0.57 Allowed 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 117.127 2.269 . . . . 1.36 117.127 -175.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.34 -42.16 19.09 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.558 1.526 . . . . 0.99 112.664 175.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.9 mm -72.68 -60.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.974 0.91 . . . . 1.01 110.278 -170.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 p -93.25 -11.11 33.36 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.877 2.071 . . . . 1.16 112.455 -176.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.1 31.85 57.06 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 121.246 -0.909 . . . . 1.55 113.275 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -68.24 178.83 1.77 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.691 0.796 . . . . 2.58 110.96 168.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.03 7.13 1.59 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.193 1.183 . . . . 2.11 114.193 177.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 ptp -149.19 153.55 37.93 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.669 1.988 . . . . 3.07 107.806 169.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.9 159.64 37.88 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.138 1.892 . . . . 1.34 112.652 -177.087 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.88 138.37 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.211 1.804 . . . . 1.19 112.024 -168.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.6 150.86 36.43 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.382 -0.823 . . . . 0.83 113.119 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -132.32 155.1 48.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.628 1.971 . . . . 1.56 112.699 175.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -153.94 -179.15 0.99 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 129.044 2.938 . . . . 2.62 109.79 178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.72 150.4 82.73 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.748 1.632 . . . . 1.46 113.788 170.468 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.34 19.88 70.95 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-N 114.569 -1.196 . . . . 1.1 114.357 -171.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.7 t -107.84 153.88 22.37 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 119.324 1.562 . . . . 1.18 111.1 -176.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.3 p -118.44 143.43 46.69 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.282 -1.511 . . . . 1.23 112.948 -169.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 m -134.01 156.95 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.768 1.627 . . . . 0.64 112.399 -169.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.526 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -112.7 153.51 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.236 1.814 . . . . 1.44 112.816 174.669 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.38 150.45 48.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.148 0.796 . . . . 0.68 113.148 175.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.84 -6.0 56.26 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.489 1.042 . . . . 0.78 115.451 176.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.4 p -77.72 159.82 28.85 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.274 1.03 . . . . 1.43 111.361 169.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mm -113.77 127.24 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.432 0.693 . . . . 0.82 111.782 -169.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -86.48 140.12 30.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.445 1.898 . . . . 1.67 111.987 -178.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -100.46 -125.34 0.17 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.402 1.081 . . . . 3.44 113.509 -172.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -90.13 63.61 5.89 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.983 1.265 . . . . 3.71 113.844 -166.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.92 157.23 9.23 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.431 -0.793 . . . . 1.9 114.989 169.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -92.36 133.3 36.0 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.475 1.11 . . . . 2.12 112.259 -175.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.76 153.7 39.14 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.601 1.56 . . . . 0.92 111.587 -176.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.1 tp -108.62 119.81 40.61 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.617 1.167 . . . . 2.34 110.356 174.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mp -117.53 127.94 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.319 1.048 . . . . 1.23 111.04 -175.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.3 p -81.52 128.65 34.13 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.722 -0.611 . . . . 1.39 110.654 171.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.09 126.17 34.6 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.499 -0.751 . . . . 1.07 110.864 176.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 p -133.97 -3.96 2.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.926 1.69 . . . . 2.27 113.698 -170.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -148.03 150.3 33.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.237 2.215 . . . . 2.09 108.887 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.74 173.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.246 1.018 . . . . 1.65 111.416 169.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.75 -35.78 47.55 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.17 -0.956 . . . . 1.85 115.027 -170.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.63 -31.97 71.14 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.322 1.231 . . . . 2.31 114.322 176.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.84 -14.11 60.28 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.05 1.295 . . . . 3.88 114.19 172.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 60.1 p -68.47 144.59 54.6 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.138 -1.601 . . . . 2.04 113.152 -169.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 t -63.48 -33.04 74.7 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.77 0.428 . . . . 2.86 110.821 171.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.7 mp -53.3 -53.01 57.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.58 1.152 . . . . 1.61 111.886 175.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.4 m -71.73 -26.54 62.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.022 0.929 . . . . 2.02 111.77 177.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -70.64 -42.66 70.55 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.761 -0.587 . . . . 1.61 111.826 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.91 -53.34 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.746 1.219 . . . . 2.11 110.287 177.65 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 113.607 0.966 . . . . 1.78 113.607 -176.561 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.081 0.771 . . . . 1.4 113.081 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.9 tp -67.58 -28.86 68.13 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.327 -0.858 . . . . 1.45 112.243 177.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.77 -45.31 29.48 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.019 0.528 . . . . 1.23 111.312 167.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -53.62 -43.69 68.88 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.462 1.905 . . . . 2.28 113.22 -175.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -48.04 -48.1 33.24 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.003 0.921 . . . . 0.98 112.229 176.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.6 mm -73.88 -34.59 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.23 -0.919 . . . . 1.81 113.408 177.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -77.17 -24.16 51.52 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.417 1.266 . . . . 1.96 114.417 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.6 mt -58.63 -21.07 52.7 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.232 1.413 . . . . 1.95 113.769 174.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -78.09 141.7 38.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.858 1.263 . . . . 2.54 113.589 -174.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.9 154.51 33.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.283 1.033 . . . . 1.78 112.732 175.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.61 -12.93 35.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.498 1.519 . . . . 2.58 113.549 175.18 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -143.42 164.74 29.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.794 2.038 . . . . 3.17 113.3 -175.497 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.15 163.59 32.31 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.343 1.457 . . . . 0.73 111.524 171.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.4 m -114.75 106.8 14.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.017 1.327 . . . . 0.8 110.062 170.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.52 133.12 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.084 -1.08 . . . . 0.65 108.084 174.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.61 118.43 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.519 0.728 . . . . 2.28 110.451 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.8 m . . . . . 0 N--CA 1.466 0.349 0 C-N-CA 125.183 1.393 . . . . 2.42 109.765 -171.711 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 120.537 0.208 . . . . 3.09 111.128 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 t -139.5 96.81 3.15 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.678 1.191 . . . . 1.69 110.447 -177.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -91.14 150.14 21.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.769 1.025 . . . . 2.51 113.769 -179.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -124.18 140.55 52.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.308 1.843 . . . . 2.82 111.182 169.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -98.05 126.02 43.29 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.71 0.804 . . . . 1.94 109.099 169.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 m -136.28 164.78 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.698 1.199 . . . . 0.8 112.625 -172.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.36 151.14 31.17 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.663 0.785 . . . . 3.41 111.741 169.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.05 -24.87 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.385 0.883 . . . . 1.09 113.385 175.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -69.4 -27.88 65.68 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.843 -1.161 . . . . 3.13 113.199 170.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.9 mt -100.74 -7.78 23.42 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.872 1.669 . . . . 1.29 114.434 -168.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.67 141.83 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.631 0.773 . . . . 1.55 110.341 169.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -126.07 159.67 32.17 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.78 1.632 . . . . 3.69 111.962 -170.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.266 16.8 ptt85 -75.53 15.82 0.43 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.957 1.836 . . . . 2.78 115.957 -174.217 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.31 -2.58 15.48 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.651 2.072 . . . . 1.04 113.539 168.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -84.02 155.84 22.54 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 118.731 1.266 . . . . 2.99 111.735 178.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 mt -118.69 128.95 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.55 1.14 . . . . 1.17 109.167 169.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.6 mm -107.09 168.45 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 128.018 2.527 . . . . 1.26 111.022 -167.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -129.13 136.52 50.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.775 1.23 . . . . 1.78 109.832 170.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.07 132.69 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.393 1.077 . . . . 0.73 110.405 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.9 m -90.15 166.52 19.84 Favored Pre-proline 0 N--CA 1.482 1.127 0 N-CA-C 113.427 0.899 . . . . 1.24 113.427 -170.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -61.8 128.01 23.16 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.76 2.307 . . . . 1.03 110.598 169.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.42 8.46 59.54 Favored Glycine 0 CA--C 1.539 1.583 0 O-C-N 121.278 -0.889 . . . . 0.88 114.884 -170.573 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.47 169.02 54.9 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.636 1.588 . . . . 0.96 114.791 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -125.61 140.35 52.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.964 1.305 . . . . 1.96 110.979 -175.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -79.06 127.39 79.66 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 112.671 0.619 . . . . 1.74 112.671 -173.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -87.0 -24.59 1.3 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.397 2.731 . . . . 0.64 114.875 -174.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 m -149.86 171.45 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 127.877 2.471 . . . . 0.72 108.988 -177.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.54 139.77 38.41 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.428 1.013 . . . . 1.79 113.111 178.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.44 -154.86 14.5 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 114.701 0.641 . . . . 0.65 114.701 -170.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -120.73 141.45 50.43 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.125 1.157 . . . . 5.2 114.125 -173.147 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.1 t -89.83 132.64 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 128.647 2.779 . . . . 0.65 108.997 174.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 pt -139.09 35.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 113.456 0.91 . . . . 0.84 113.456 171.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -165.75 137.4 3.92 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.673 1.189 . . . . 3.09 111.149 166.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.1 -164.73 26.21 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 117.469 1.748 . . . . 0.95 117.469 168.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -151.48 109.03 3.62 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.321 1.449 . . . . 2.06 111.97 -172.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.13 170.21 16.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.726 0.774 . . . . 1.24 112.024 172.108 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 ttm -117.43 144.11 45.33 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.911 1.284 . . . . 1.19 110.092 176.203 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.0 t -130.29 139.74 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.851 1.26 . . . . 0.63 111.259 -169.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -98.11 127.51 44.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.384 0.674 . . . . 2.32 112.427 175.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -127.95 20.7 6.42 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.515 1.526 . . . . 2.06 112.879 -173.336 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 p -64.55 -22.2 66.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.878 1.807 . . . . 1.43 115.878 -169.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.68 -42.65 11.23 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.752 0.821 . . . . 1.06 109.543 168.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.77 -59.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.802 1.241 . . . . 1.09 112.505 -171.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.0 p -106.91 -10.56 15.96 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.548 1.539 . . . . 1.23 113.361 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.58 13.01 76.88 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 119.151 -0.805 . . . . 1.31 114.574 176.693 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -58.32 -47.39 83.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.718 1.207 . . . . 2.83 113.407 -174.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 61.75 19.76 10.82 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.507 1.299 . . . . 1.34 114.507 178.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.4 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 28.6 ttt -150.68 136.93 10.97 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 128.466 2.706 . . . . 4.49 106.729 168.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 74' ' ' MET . 46.0 Cg_exo -59.13 151.73 64.57 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.288 3.325 . . . . 1.29 115.2 -176.038 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.23 134.38 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.555 1.942 . . . . 0.86 111.597 -169.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.97 141.87 32.9 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.054 1.131 . . . . 0.95 114.054 -173.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -124.72 142.35 51.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.4 1.88 . . . . 0.76 111.496 173.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -142.03 174.71 3.51 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 128.968 2.907 . . . . 3.48 109.84 -176.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.76 126.65 19.48 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 CA-C-N 121.577 1.599 . . . . 0.85 110.493 167.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.39 9.55 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.045 1.307 . . . . 0.76 114.315 -169.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.3 m -120.41 153.14 36.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 119.233 1.517 . . . . 1.45 111.749 177.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 p -101.5 152.28 20.95 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.344 1.429 . . . . 0.89 113.358 175.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.1 m -136.41 155.03 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.803 1.641 . . . . 0.54 111.41 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.91 143.97 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.487 1.515 . . . . 0.91 112.802 -179.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.45 147.91 29.97 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.394 1.078 . . . . 0.6 112.663 -178.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.98 -6.26 49.76 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.599 -1.112 . . . . 0.76 115.705 178.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.8 p -79.26 163.37 25.0 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.964 1.382 . . . . 1.29 111.844 169.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mm -110.93 129.93 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.351 1.06 . . . . 0.68 111.253 -173.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -92.03 135.21 34.14 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.816 1.646 . . . . 1.86 110.858 176.303 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -88.77 -107.01 0.08 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.215 1.191 . . . . 3.44 114.215 -173.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -82.24 -45.44 15.02 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 116.722 2.119 . . . . 3.14 116.722 -166.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.41 140.72 15.19 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.069 0.849 . . . . 1.93 113.539 -172.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.1 p -82.93 137.15 34.32 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.652 0.726 . . . . 1.6 112.53 171.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.1 mt -130.03 156.17 44.93 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.953 1.301 . . . . 0.94 112.079 -170.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.97 122.21 42.53 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.366 1.067 . . . . 2.67 110.82 174.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -115.6 123.02 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.799 1.239 . . . . 1.48 111.895 -173.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 74.8 m -79.51 120.24 23.61 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.674 -1.267 . . . . 2.28 108.956 168.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.88 118.24 20.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.644 -0.502 . . . . 0.78 109.644 173.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.7 p -108.72 -0.28 20.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.39 1.076 . . . . 2.15 113.31 175.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -137.96 139.65 39.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.093 1.357 . . . . 1.65 111.618 176.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 m -78.84 157.18 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.702 -0.851 . . . . 1.56 108.702 165.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.74 -35.24 73.45 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 120.954 -1.091 . . . . 1.36 115.569 -169.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.22 64.43 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.629 1.344 . . . . 1.8 114.629 174.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -80.18 -8.18 59.31 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.814 1.646 . . . . 2.54 115.274 173.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 37.4 p -58.86 158.22 8.56 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.609 1.337 . . . . 1.61 114.609 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.7 m -60.68 -35.65 76.79 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.711 0.804 . . . . 3.25 111.035 170.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.63 -43.64 96.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.208 1.003 . . . . 1.47 112.101 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.9 p -72.95 -21.84 60.81 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.901 1.074 . . . . 2.17 113.901 170.092 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -70.44 -38.28 74.5 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.606 -1.309 . . . . 2.04 112.01 174.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.22 -52.39 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.848 1.259 . . . . 1.35 110.741 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.481 1.088 0 CA-C-N 119.285 0.948 . . . . 1.39 112.951 179.289 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 111.28 0.104 . . . . 2.28 111.28 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.9 tp -42.01 -31.04 0.31 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.533 2.733 . . . . 1.89 115.861 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.97 -32.67 65.37 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.187 1.18 . . . . 2.05 114.187 177.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.98 -30.55 68.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.822 1.249 . . . . 5.65 112.497 -170.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -53.16 -37.29 61.74 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.803 1.641 . . . . 0.97 112.51 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -75.84 -35.93 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.962 1.305 . . . . 1.52 112.821 175.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.1 m -72.82 -39.74 66.37 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.039 1.126 . . . . 1.29 114.039 -175.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.21 -18.01 65.06 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.301 1.223 . . . . 2.19 114.301 -173.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -70.09 141.33 52.77 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.273 1.029 . . . . 2.28 112.829 -172.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.04 139.1 30.79 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.583 0.957 . . . . 2.23 113.583 -176.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -90.69 -8.18 50.61 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.565 1.546 . . . . 1.78 113.868 -171.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.01 160.85 38.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.142 1.377 . . . . 3.66 113.896 -179.236 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.04 166.37 24.89 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.812 1.645 . . . . 0.94 112.005 176.03 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.9 m -117.62 105.38 11.98 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.624 1.17 . . . . 1.12 111.322 169.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.0 mt -82.87 130.44 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.482 1.113 . . . . 0.81 108.925 177.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -126.52 128.11 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 121.501 -0.749 . . . . 1.86 112.139 -176.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 124.737 1.215 . . . . 2.98 109.56 169.67 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.548 0.881 0 N-CA-C 115.351 1.612 . . . . 3.87 115.351 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.6 t -112.58 109.82 19.6 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.373 1.069 . . . . 1.7 108.409 166.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -107.9 145.01 34.34 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.622 0.971 . . . . 2.76 113.622 -168.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -124.02 128.53 49.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.511 1.924 . . . . 3.17 109.97 173.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -91.86 124.05 35.7 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.208 -0.932 . . . . 2.12 109.228 173.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 m -136.51 162.75 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.505 1.298 . . . . 1.12 114.505 -169.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.47 147.99 35.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.001 1.321 . . . . 2.7 111.653 169.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -57.68 -22.81 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.694 0.998 . . . . 1.25 113.694 -178.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.52 -12.79 61.56 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.624 -1.298 . . . . 3.74 113.258 175.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.87 -2.07 21.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.318 1.447 . . . . 1.55 113.863 -171.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.39 148.26 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.862 1.265 . . . . 1.47 110.571 170.109 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -137.56 165.68 25.74 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.176 1.391 . . . . 2.85 113.379 -178.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.0 ptt85 -67.51 25.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 118.463 2.764 . . . . 2.61 118.463 -168.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.32 9.7 1.28 Allowed Glycine 0 CA--C 1.54 1.629 0 C-N-CA 126.122 1.82 . . . . 1.06 114.387 171.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -83.83 155.79 22.79 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.039 1.42 . . . . 2.72 112.408 175.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 mt -111.8 124.99 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.51 0.724 . . . . 1.33 110.254 172.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.1 mm -121.61 129.28 75.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 127.268 2.227 . . . . 0.78 110.452 -169.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -92.04 128.7 37.98 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.339 -0.851 . . . . 2.21 110.536 171.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -102.76 135.4 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.837 1.255 . . . . 0.76 110.346 -177.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.0 m -89.2 156.05 48.94 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.288 1.035 . . . . 1.24 112.433 -178.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -59.19 143.28 99.82 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.929 1.753 . . . . 1.27 111.641 168.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.05 -6.85 3.58 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.313 0.958 . . . . 1.33 114.427 -169.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.7 151.16 50.28 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 119.246 1.523 . . . . 1.15 113.054 177.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -103.03 142.8 33.49 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.826 1.25 . . . . 1.97 110.875 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -75.49 125.25 88.92 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.881 -0.512 . . . . 2.32 112.059 -179.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.3 -25.46 3.88 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.88 2.387 . . . . 0.94 113.922 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.3 m -151.97 171.95 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 127.711 2.404 . . . . 0.8 109.057 -176.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.22 151.26 19.93 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.646 0.778 . . . . 2.27 112.229 177.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.74 -172.08 41.85 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 116.139 1.216 . . . . 0.75 116.139 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -108.37 129.26 55.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.66 1.584 . . . . 4.33 111.703 -175.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.2 t -87.29 127.96 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.115 2.166 . . . . 0.76 109.218 -176.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.4 pt -142.12 29.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 113.728 1.01 . . . . 1.01 113.728 -172.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.22 141.45 1.61 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.784 1.634 . . . . 2.92 109.534 165.093 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.75 -174.75 41.4 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 122.433 1.018 . . . . 0.75 114.98 170.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.43 103.96 3.19 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.135 0.974 . . . . 2.91 111.07 -167.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -144.44 172.73 12.54 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.212 0.819 . . . . 1.07 113.212 -172.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.5 ttm -124.71 133.64 53.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.981 1.312 . . . . 1.03 110.04 -176.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -123.28 137.34 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.27 1.428 . . . . 0.82 111.637 -169.063 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -95.71 103.63 15.52 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.87 1.268 . . . . 2.18 110.682 -176.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -108.6 -1.5 19.55 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.669 1.588 . . . . 2.06 113.677 -170.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 p -53.4 -33.06 52.41 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.552 2.056 . . . . 1.42 116.552 -169.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.23 -44.34 22.0 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.652 1.569 . . . . 1.14 110.775 173.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mm -62.04 -49.11 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.215 1.806 . . . . 1.2 111.621 -174.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.9 p -118.27 -2.68 11.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.009 1.114 . . . . 1.37 114.009 -171.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.24 18.91 70.55 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.924 1.249 . . . . 1.13 114.732 178.027 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -61.08 -179.12 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.543 1.137 . . . . 2.77 111.138 168.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.05 -20.35 0.88 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.322 1.449 . . . . 1.72 114.141 177.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -125.58 153.22 72.73 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.827 2.051 . . . . 3.04 110.336 167.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.0 165.83 31.43 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.237 2.625 . . . . 1.67 114.019 -174.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.17 133.43 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 127.047 2.139 . . . . 0.95 112.191 -168.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.88 141.03 36.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.35 1.06 . . . . 0.73 113.567 178.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -126.08 150.0 48.49 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.662 1.985 . . . . 0.82 111.38 178.254 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 17.5 ptpt -144.41 176.29 2.33 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.543 2.337 . . . . 2.36 110.257 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 37.5 Cg_endo -60.47 131.01 36.02 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 CA-C-N 122.047 1.767 . . . . 0.84 110.463 167.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.05 28.68 33.48 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 118.092 -1.393 . . . . 0.84 114.805 -171.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.3 m -108.02 174.14 6.01 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.853 1.826 . . . . 1.58 110.959 174.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -125.79 156.44 39.5 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.437 -1.414 . . . . 0.89 112.831 175.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.09 146.16 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.716 1.606 . . . . 0.58 112.648 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.85 152.3 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.73 2.412 . . . . 0.99 112.42 170.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.46 155.19 38.25 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.733 0.813 . . . . 0.9 112.158 177.02 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.53 -1.37 52.05 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.519 1.057 . . . . 0.95 115.543 176.467 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 p -76.86 162.81 27.32 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.066 1.433 . . . . 1.61 112.306 172.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.76 137.98 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.722 1.209 . . . . 0.77 111.082 -174.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -84.31 134.73 34.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.199 1.0 . . . . 2.52 111.152 170.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.26 50.92 1.49 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.135 1.532 . . . . 3.74 115.135 179.214 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -163.97 -36.43 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.1 1.518 . . . . 3.38 115.1 171.12 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.26 169.74 28.22 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-N 120.197 1.362 . . . . 1.97 115.411 -171.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.0 m -69.56 137.46 52.42 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.547 1.314 . . . . 1.94 114.547 -171.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.49 159.98 31.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.547 1.939 . . . . 1.08 110.415 171.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.4 tp -114.07 126.51 55.18 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.037 0.935 . . . . 2.77 110.778 173.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.36 132.43 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.842 1.257 . . . . 1.14 111.272 -170.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 46.7 t -87.18 121.17 29.28 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.529 -0.915 . . . . 3.32 108.529 168.008 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.93 130.48 35.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.083 0.953 . . . . 0.83 110.604 -178.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.9 p -120.72 9.05 10.67 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.555 1.317 . . . . 2.13 114.555 -175.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -149.04 155.15 40.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.428 1.491 . . . . 2.41 111.575 168.499 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.33 164.03 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 108.71 -0.848 . . . . 1.58 108.71 163.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 -39.66 95.55 Favored Glycine 0 N--CA 1.473 1.155 0 O-C-N 120.719 -1.238 . . . . 1.4 113.536 -170.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.72 77.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.417 1.109 . . . . 1.82 113.27 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -77.37 -6.65 54.09 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.127 1.528 . . . . 2.63 115.127 175.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.0 p -63.62 148.21 49.52 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.686 -1.259 . . . . 1.67 111.182 174.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.6 m -65.27 -34.38 78.22 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.506 -0.746 . . . . 3.65 110.312 169.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.1 tp -49.34 -51.87 31.73 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.435 1.494 . . . . 1.68 112.565 172.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.2 m -74.37 -24.15 59.11 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.1 1.148 . . . . 2.47 114.1 177.071 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -71.45 -40.5 70.32 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.879 1.271 . . . . 2.44 112.75 173.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.2 mt -51.63 -46.48 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.271 1.028 . . . . 1.47 111.71 -178.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 113.936 1.087 . . . . 1.3 113.936 179.488 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 113.18 0.808 . . . . 2.73 113.18 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -82.83 -38.79 22.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.666 0.787 . . . . 4.7 110.735 169.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.44 -42.31 87.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.357 0.663 . . . . 1.6 111.631 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.9 tp -51.42 -34.24 33.93 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.706 1.602 . . . . 2.58 114.341 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.32 -44.86 20.78 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.395 0.887 . . . . 2.14 113.395 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -61.38 -34.51 75.46 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.587 1.155 . . . . 3.1 113.299 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.25 -49.76 6.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.511 1.524 . . . . 0.97 112.117 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -74.37 -30.42 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.836 1.05 . . . . 2.22 113.836 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -67.3 -27.62 67.32 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.544 -0.722 . . . . 1.99 112.265 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.73 -14.58 59.27 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.998 1.481 . . . . 2.6 114.998 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -63.4 129.3 39.67 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 120.55 1.523 . . . . 3.09 112.142 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.46 158.6 33.39 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.993 1.317 . . . . 1.87 112.159 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.1 p -98.34 -24.54 15.17 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 116.061 1.874 . . . . 3.15 116.061 -168.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.27 159.48 37.72 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.88 1.067 . . . . 4.21 113.88 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.86 149.39 40.22 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.596 1.558 . . . . 1.07 111.762 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 m -95.01 109.18 21.25 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.502 0.721 . . . . 1.57 112.649 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.7 mt -81.09 140.18 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.646 1.178 . . . . 1.33 108.616 169.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.72 127.01 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.102 0.953 . . . . 2.05 112.173 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 92.9 m -120.23 134.28 55.29 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.67 2.388 . . . . 2.13 109.979 -170.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.35 145.79 28.44 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.082 1.353 . . . . 2.99 109.926 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.11 5.13 1.29 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.638 2.088 . . . . 3.53 116.638 -167.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.5 m -133.34 -60.11 0.85 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.116 1.367 . . . . 4.55 110.428 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -158.7 -169.51 2.74 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.772 2.829 . . . . 4.41 106.265 168.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -55.37 -13.98 1.67 Allowed 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 113.616 0.969 . . . . 4.3 113.616 168.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 pt -68.46 -22.56 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 127.158 2.183 . . . . 3.83 114.433 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 tt -116.32 128.52 55.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.374 0.988 . . . . 3.06 111.458 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mp -130.25 127.66 40.05 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.787 1.235 . . . . 3.17 111.063 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.4 t -133.04 140.05 47.51 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.725 2.01 . . . . 2.0 110.009 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.08 149.15 39.41 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.796 0.838 . . . . 2.67 112.506 -168.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.85 126.31 30.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.849 1.66 . . . . 2.69 110.765 169.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -87.01 126.82 34.99 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.851 -1.155 . . . . 2.05 108.761 167.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.48 162.19 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.211 1.405 . . . . 1.21 111.763 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.97 147.53 42.95 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.29 0.567 . . . . 3.91 111.124 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -56.26 -23.91 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 114.686 1.365 . . . . 1.4 114.686 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.57 -13.71 60.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.549 1.315 . . . . 3.84 114.549 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.7 mt -106.67 -13.38 15.3 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.956 1.302 . . . . 1.47 113.818 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.97 142.36 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.052 1.341 . . . . 1.56 110.647 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -114.71 161.24 18.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.483 1.113 . . . . 2.96 113.333 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -76.27 31.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.499 1.666 . . . . 4.31 115.499 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.7 0.21 4.96 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 127.834 2.635 . . . . 1.11 113.725 169.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -89.68 160.41 16.62 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.339 1.456 . . . . 2.19 112.139 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.4 mt -118.77 128.55 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.583 1.553 . . . . 1.22 108.368 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.4 mm -120.3 136.54 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.304 1.441 . . . . 0.85 113.933 -166.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -78.14 143.75 37.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.774 1.23 . . . . 2.36 112.303 172.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.13 132.68 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.695 0.798 . . . . 0.78 110.808 167.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.436 ' HB ' ' HD2' ' A' ' 47' ' ' PRO . 10.9 m -102.47 166.97 11.07 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 125.278 1.431 . . . . 1.17 112.282 -169.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 46' ' ' VAL . 36.3 Cg_endo -61.13 120.83 8.73 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.885 1.723 . . . . 0.97 111.626 171.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.63 -6.17 82.18 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 126.638 2.066 . . . . 0.95 115.159 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.18 154.4 46.24 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 119.123 1.461 . . . . 1.01 114.285 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -109.14 152.92 24.46 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.929 1.292 . . . . 1.99 111.852 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -89.13 126.8 57.75 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.813 1.042 . . . . 2.29 113.813 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.18 -22.24 3.45 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.028 3.152 . . . . 1.47 114.532 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.4 m -143.64 170.54 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 127.206 2.202 . . . . 1.32 109.41 -176.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.31 166.64 17.27 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.072 0.549 . . . . 2.54 110.811 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.98 -175.53 47.08 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 115.936 1.134 . . . . 1.07 115.936 170.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -105.29 142.33 35.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.617 1.567 . . . . 3.72 111.277 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.08 131.17 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.367 2.267 . . . . 1.17 110.27 -171.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.07 30.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 113.549 0.944 . . . . 1.0 113.549 -175.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -170.62 144.97 2.45 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.119 2.568 . . . . 3.15 107.213 168.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.48 179.61 46.51 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 116.612 1.405 . . . . 1.53 116.612 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -152.1 41.76 0.66 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.902 1.815 . . . . 2.98 115.902 -166.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.683 ' H ' HD21 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -75.88 156.53 34.25 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.409 -1.432 . . . . 1.2 113.19 -178.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 42.7 ttm -96.67 127.21 42.44 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.928 -0.767 . . . . 1.31 108.928 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.9 t -112.95 129.05 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 124.58 1.152 . . . . 1.05 110.685 -170.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -91.66 105.64 17.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.538 0.735 . . . . 2.25 110.775 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -117.8 23.61 11.58 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.888 2.075 . . . . 2.41 113.004 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 93.0 p -63.82 -18.58 64.26 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 116.659 2.096 . . . . 1.68 116.659 -169.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.84 -48.86 7.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.441 1.096 . . . . 1.42 109.907 169.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.88 -58.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.82 1.248 . . . . 1.64 111.722 -172.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.4 p -103.9 -12.35 16.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.298 1.039 . . . . 1.75 112.66 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.63 -3.02 85.05 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.484 -1.176 . . . . 1.79 114.737 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -63.94 103.47 0.59 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.585 1.192 . . . . 3.13 110.693 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.97 -17.51 61.46 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.815 -1.178 . . . . 1.62 111.577 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.69 103.9 42.82 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 128.099 2.56 . . . . 5.12 107.947 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -55.35 147.13 58.14 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.725 2.95 . . . . 2.35 114.19 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.5 t -94.21 125.26 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.744 1.218 . . . . 1.24 111.944 -167.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.18 141.29 38.76 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.709 -0.619 . . . . 1.13 111.72 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -115.08 169.54 9.03 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.796 1.638 . . . . 1.54 111.526 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -157.15 169.33 10.8 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 127.714 2.406 . . . . 3.89 110.727 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.18 135.1 48.93 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 CA-C-N 121.451 1.554 . . . . 1.35 108.41 165.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.88 39.37 17.13 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.28 0.943 . . . . 1.17 113.253 -168.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 t -124.76 174.26 8.02 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.624 1.57 . . . . 1.95 111.254 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 p -133.26 150.59 51.92 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.518 -1.363 . . . . 1.27 112.566 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.06 161.84 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 125.411 1.485 . . . . 0.94 112.79 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.0 150.31 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.298 1.839 . . . . 1.32 113.435 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.67 148.33 24.86 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.038 1.335 . . . . 1.06 112.944 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.88 -4.1 67.19 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 115.333 0.893 . . . . 0.96 115.333 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 97.6 p -84.61 160.02 20.5 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.498 1.149 . . . . 1.34 111.969 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mm -113.21 127.13 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.469 1.107 . . . . 0.95 112.203 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -93.9 144.0 25.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.238 1.415 . . . . 1.91 113.083 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -157.6 145.95 19.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.884 1.274 . . . . 3.86 111.332 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 46.54 87.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.504 2.322 . . . . 3.9 113.585 168.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.38 -13.42 2.28 Favored Glycine 0 CA--C 1.542 1.761 0 N-CA-C 116.251 1.26 . . . . 3.89 116.251 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.2 m 40.1 108.61 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 130.964 3.706 . . . . 2.61 117.322 170.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.683 HD21 ' H ' ' A' ' 62' ' ' SER . 57.4 mt -106.33 160.37 15.42 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.987 1.106 . . . . 1.88 113.987 -169.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.68 121.28 41.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.332 1.853 . . . . 3.11 108.476 168.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.45 126.23 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.653 0.781 . . . . 1.41 111.167 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.81 121.51 30.31 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.375 -0.828 . . . . 1.61 109.999 168.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.65 129.95 35.04 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.2 0.6 . . . . 0.96 112.147 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.9 p -117.77 -6.12 11.07 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.85 1.66 . . . . 2.35 113.968 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -138.98 148.78 43.93 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.649 1.98 . . . . 2.29 110.242 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.5 m -92.42 -174.05 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.583 1.153 . . . . 1.94 112.638 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.65 -33.16 83.58 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.857 -1.152 . . . . 2.78 113.557 -171.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.52 -51.67 11.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.265 1.426 . . . . 2.51 112.888 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.29 -8.13 53.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.499 1.919 . . . . 3.58 115.551 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 109' ' ' SER . 4.6 t -48.17 146.56 2.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.974 2.109 . . . . 2.8 114.872 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 t -62.1 -21.77 65.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.079 0.552 . . . . 2.66 111.992 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.5 tp -59.89 -41.18 91.03 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.647 -1.283 . . . . 1.71 111.897 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.515 ' H ' HG23 ' A' ' 106' ' ' THR . 8.8 t -73.26 -27.38 61.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.475 1.11 . . . . 2.68 111.564 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -70.06 -39.6 75.58 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.408 -0.807 . . . . 2.43 112.146 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.8 mt -60.04 -44.68 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.668 1.587 . . . . 2.27 111.657 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -68.02 -9.19 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 115.249 1.574 . . . . 2.12 115.249 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -75.19 -38.92 60.58 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.318 -0.863 . . . . 4.88 111.617 166.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.94 -41.41 36.38 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.628 2.371 . . . . 4.45 113.161 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.8 t -70.74 -22.44 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.325 1.45 . . . . 3.86 112.243 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.28 -59.46 5.29 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.256 1.022 . . . . 5.42 110.74 170.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -65.9 -5.34 8.92 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.988 1.847 . . . . 7.27 115.988 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.63 -32.47 69.79 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.999 1.272 . . . . 7.95 112.718 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 116.865 -1.54 . . . . 8.04 115.105 -179.521 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.9 p . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 114.322 1.23 . . . . 3.77 114.322 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -75.95 -36.73 59.2 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.962 0.905 . . . . 4.74 110.042 169.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.06 77.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.552 0.741 . . . . 2.14 111.095 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.8 tp -53.28 -32.16 47.35 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.378 1.071 . . . . 2.05 113.405 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.51 -54.21 7.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.759 0.824 . . . . 2.1 112.63 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -54.53 -36.98 64.84 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.463 1.505 . . . . 2.52 113.002 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.77 -38.96 67.87 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.457 1.103 . . . . 1.24 113.491 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.8 mm -74.66 -34.07 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 118.954 0.797 . . . . 1.49 112.811 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -69.52 -25.34 63.99 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.247 -0.908 . . . . 1.35 112.43 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.31 -15.77 63.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.36 2.264 . . . . 2.43 114.873 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -73.56 140.72 46.47 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.692 1.197 . . . . 2.22 112.257 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.42 165.39 15.6 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.578 1.151 . . . . 1.79 112.47 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -93.7 -41.99 9.4 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.354 0.872 . . . . 2.53 113.354 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -125.37 158.97 32.96 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.135 1.531 . . . . 4.29 115.135 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -137.55 149.83 47.02 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.646 1.578 . . . . 0.92 111.311 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.7 m -106.43 108.8 20.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.233 1.013 . . . . 0.94 112.052 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.7 mt -90.09 132.9 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.217 1.807 . . . . 0.92 109.576 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.23 139.55 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.609 0.719 . . . . 1.98 112.442 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.9 m -129.28 138.5 51.67 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.733 2.013 . . . . 1.86 110.402 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.4 mt -93.62 73.21 4.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.841 0.856 . . . . 2.89 109.381 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.03 -12.52 39.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.62 1.168 . . . . 3.55 113.772 -173.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.6 m -148.42 139.43 23.14 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.901 1.281 . . . . 3.37 110.858 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 25' ' ' ILE . 22.9 t70 -8.96 58.78 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.002 1 C-N-CA 134.125 4.97 . . . . 4.52 118.396 -171.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.38 -9.78 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 125.593 1.557 . . . . 4.01 113.938 -167.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 23' ' ' ASP . 22.6 pt -82.8 -18.01 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 130.011 3.324 . . . . 3.47 116.123 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 tt -125.42 120.93 32.38 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.841 0.856 . . . . 2.76 110.802 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -98.64 127.27 44.51 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.009 -0.996 . . . . 2.29 109.533 175.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 t -123.48 122.04 37.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.413 1.485 . . . . 1.95 108.991 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -116.41 141.42 48.19 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.519 1.128 . . . . 2.28 110.012 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -136.02 132.94 36.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.903 1.281 . . . . 2.85 110.616 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -100.1 134.56 42.85 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 119.344 0.974 . . . . 1.66 110.506 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -138.75 163.47 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.656 1.182 . . . . 0.86 112.104 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.19 146.63 43.23 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.9 -0.778 . . . . 3.13 108.9 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -63.75 -1.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 114.997 1.48 . . . . 1.19 114.997 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -83.48 -17.17 42.92 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.648 1.579 . . . . 3.95 114.855 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.4 -9.32 14.95 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.937 1.458 . . . . 1.33 114.937 -165.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 p -83.35 151.21 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 125.677 1.591 . . . . 1.46 109.743 168.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.71 160.26 24.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.099 1.148 . . . . 3.81 114.099 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -74.71 47.13 0.31 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.25 1.82 . . . . 4.86 113.892 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.27 23.12 0.23 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.312 1.434 . . . . 1.18 113.545 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -129.36 172.57 11.36 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.032 1.733 . . . . 2.86 111.316 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 mm -108.29 123.89 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.566 1.946 . . . . 1.42 110.038 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.1 mm -117.16 126.45 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.406 1.482 . . . . 0.9 110.1 -170.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HE3' HD11 ' A' ' 96' ' ' LEU . 44.7 mtpt -94.06 139.98 30.3 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.936 0.717 . . . . 2.9 112.936 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.11 153.24 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.689 1.196 . . . . 1.16 112.133 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.94 165.52 23.42 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 125.654 1.581 . . . . 1.83 112.693 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.5 124.16 14.89 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.069 2.513 . . . . 1.41 112.156 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.68 -13.68 61.94 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.154 1.835 . . . . 1.6 115.728 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.56 -8.52 76.5 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 116.992 1.557 . . . . 4.39 116.992 -172.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.0 mttt 61.88 158.87 0.06 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 127.871 2.469 . . . . 1.63 115.463 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -92.51 119.02 68.25 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.144 0.977 . . . . 2.13 111.01 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -87.45 -13.16 4.33 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.914 2.409 . . . . 0.77 114.618 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -147.47 168.26 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.496 1.918 . . . . 1.09 110.503 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.57 145.39 30.38 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.707 0.803 . . . . 1.7 113.117 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.05 -159.11 32.39 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 114.484 0.554 . . . . 0.7 114.484 -173.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -108.84 140.19 42.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.033 1.333 . . . . 3.6 112.925 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.85 132.14 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 127.878 2.471 . . . . 0.69 107.789 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.9 pt -140.05 29.34 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 119.378 0.99 . . . . 1.16 112.914 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -166.97 137.6 3.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.06 1.344 . . . . 3.51 108.984 169.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.83 -178.71 53.17 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 122.549 1.083 . . . . 0.81 114.717 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.28 136.57 31.75 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.487 1.515 . . . . 2.52 111.502 -174.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 m -148.32 156.75 42.91 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.05 1.129 . . . . 1.65 114.05 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 29.4 ttm -104.79 133.87 48.88 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.665 -1.235 . . . . 0.99 107.665 167.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.1 t -126.47 138.99 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.927 1.291 . . . . 0.82 112.48 -167.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -93.09 103.03 15.36 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.585 1.554 . . . . 2.25 109.984 173.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -128.2 3.31 5.79 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.906 1.682 . . . . 1.82 115.115 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.6 p -47.33 -29.62 2.65 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.256 1.822 . . . . 1.63 115.399 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.86 -38.07 46.86 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.635 1.174 . . . . 1.44 112.115 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.95 -62.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.87 2.068 . . . . 1.23 111.198 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 p -88.85 -12.73 41.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.74 1.616 . . . . 1.37 112.577 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.74 19.24 60.13 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.76 1.171 . . . . 1.75 114.209 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -74.8 -167.73 0.62 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.336 1.455 . . . . 2.93 111.333 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.91 13.35 1.67 Allowed 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 115.001 1.482 . . . . 2.29 115.001 -171.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -158.23 154.24 23.5 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.672 1.589 . . . . 3.8 111.061 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -58.97 141.26 98.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.54 2.827 . . . . 1.72 113.048 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.2 t -114.04 137.05 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.833 2.053 . . . . 1.09 111.735 -169.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.6 133.56 33.7 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.221 -0.924 . . . . 0.86 112.746 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -129.21 140.84 51.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.127 2.171 . . . . 1.17 109.921 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 15.1 ptpt -148.82 -177.19 0.63 Allowed Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 126.223 1.809 . . . . 3.96 110.287 -169.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 59.5 Cg_endo -69.31 132.96 25.19 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 122.703 2.001 . . . . 1.04 110.674 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.09 7.22 68.22 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 126.222 1.867 . . . . 1.18 114.784 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.3 t -101.56 152.35 20.89 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.105 1.952 . . . . 1.66 111.86 -170.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.0 p -105.22 145.91 29.99 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.877 -1.139 . . . . 0.74 113.356 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 m -137.54 161.41 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.902 1.681 . . . . 0.53 112.183 -172.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.95 147.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.138 1.775 . . . . 0.93 113.419 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.17 150.36 30.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.701 1.2 . . . . 0.59 112.604 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.16 -3.63 51.48 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.239 0.924 . . . . 0.77 115.227 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.8 p -80.97 156.86 25.74 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.331 1.066 . . . . 1.38 111.85 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mm -107.77 123.52 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.503 0.721 . . . . 0.81 110.763 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -83.12 128.29 34.35 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.825 -0.806 . . . . 2.0 108.825 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.86 43.9 2.68 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.28 1.215 . . . . 3.68 114.28 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -157.92 -38.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.494 2.405 . . . . 3.69 117.494 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -156.38 -175.87 27.84 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 120.626 1.557 . . . . 2.25 116.743 -168.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -116.02 122.68 45.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.624 1.169 . . . . 1.69 111.944 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.1 mt -125.78 165.4 18.72 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.047 1.339 . . . . 0.97 113.823 -170.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.467 HD11 ' HE3' ' A' ' 44' ' ' LYS . 8.5 mp -112.37 122.7 48.46 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.507 1.523 . . . . 2.34 109.006 167.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.28 129.63 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.65 1.18 . . . . 1.28 110.952 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 29.2 p -86.51 120.08 27.45 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.466 -0.771 . . . . 1.65 109.945 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.93 131.18 37.34 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.306 -0.871 . . . . 1.03 111.159 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.91 -12.33 11.41 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.65 0.981 . . . . 3.3 113.65 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -141.58 143.47 33.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.372 1.469 . . . . 2.22 109.227 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.5 p -75.93 158.99 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 107.755 -1.202 . . . . 3.43 107.755 166.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.16 -39.64 71.43 Favored Glycine 0 N--CA 1.477 1.411 0 CA-C-N 121.231 1.832 . . . . 1.84 115.196 -167.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -34.17 77.15 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.621 0.971 . . . . 2.67 113.621 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -77.87 -10.33 59.51 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.759 2.424 . . . . 2.85 115.392 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.7 p -66.49 156.19 35.51 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.355 0.872 . . . . 1.59 113.355 -174.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.2 t -57.62 -33.8 68.62 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.741 -0.6 . . . . 1.98 112.174 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.1 tp -56.14 -49.56 73.59 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.937 1.295 . . . . 1.58 111.963 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -72.98 -24.16 60.74 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.324 1.45 . . . . 2.57 113.515 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -70.69 -48.16 56.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.397 1.079 . . . . 1.37 112.04 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.2 mt -53.05 -51.97 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.909 0.883 . . . . 1.42 111.832 -169.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.6 m -69.66 -24.63 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.044 1.127 . . . . 1.31 114.044 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -75.27 -34.72 61.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 118.764 -0.636 . . . . 4.21 112.381 171.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.06 -46.17 65.52 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.047 1.339 . . . . 2.2 110.966 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.7 t -59.61 -43.37 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.519 -0.738 . . . . 2.25 111.334 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.13 -28.85 68.48 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.551 0.945 . . . . 3.49 113.551 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -73.9 -30.38 62.57 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.822 1.045 . . . . 4.32 113.822 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.19 72.13 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.095 0.958 . . . . 4.64 112.333 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.502 1.921 . . . . 4.74 113.121 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.3 p . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 112.059 0.392 . . . . 3.07 112.059 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -82.09 -30.24 31.36 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.27 -0.894 . . . . 5.3 112.169 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.42 -29.85 68.04 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.455 -0.778 . . . . 1.68 112.927 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.33 -29.15 69.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.671 0.788 . . . . 1.66 112.924 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.82 -25.68 49.01 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.981 1.104 . . . . 1.59 113.981 169.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.81 -42.97 80.71 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.864 1.266 . . . . 2.67 112.971 -167.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -49.85 -42.48 47.6 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.195 1.398 . . . . 1.06 112.417 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.6 mm -72.47 -35.56 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.362 1.065 . . . . 1.82 112.564 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.3 m -70.69 -27.76 64.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.093 0.957 . . . . 1.44 113.331 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 mp -66.39 -25.73 66.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.177 0.806 . . . . 2.28 113.177 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -61.64 131.16 49.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.338 0.972 . . . . 2.59 112.209 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.31 159.47 23.87 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.96 1.096 . . . . 1.82 113.96 -169.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.5 m -86.84 -30.32 21.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.72 1.208 . . . . 3.11 112.338 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -141.88 161.0 39.07 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.712 1.745 . . . . 4.08 115.712 -168.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.23 162.73 34.78 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.826 2.05 . . . . 1.08 111.97 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.6 m -121.89 104.55 9.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.102 1.361 . . . . 1.05 112.237 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.0 mt -83.43 133.49 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.109 1.364 . . . . 0.67 110.503 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.7 m -126.33 144.66 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.358 1.614 . . . . 2.03 115.358 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.8 m -140.83 135.5 31.45 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.527 1.531 . . . . 2.73 111.432 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.82 87.2 6.81 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.836 -1.165 . . . . 3.77 109.441 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.48 -18.14 59.93 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.308 1.043 . . . . 3.97 112.699 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -148.14 132.9 17.94 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.295 1.438 . . . . 5.49 108.856 166.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 25' ' ' ILE . 44.3 t0 -32.56 75.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 131.021 3.728 . . . . 6.41 117.556 -166.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 60.19 -23.25 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.693 2.397 . . . . 5.32 114.779 -170.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.405 ' H ' ' C ' ' A' ' 23' ' ' ASP . 19.6 pt -65.1 -17.51 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 129.245 3.018 . . . . 4.75 115.382 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -117.56 -80.19 0.6 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.108 1.363 . . . . 5.09 110.15 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.5 tt 61.26 135.57 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.853 2.061 . . . . 2.93 112.295 -168.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -126.41 143.6 51.12 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.603 1.561 . . . . 1.61 110.739 -173.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -128.17 132.58 48.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.54 1.136 . . . . 2.78 110.843 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -108.96 132.99 53.55 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.835 1.254 . . . . 2.8 110.392 170.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -101.54 114.92 29.38 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.687 1.13 . . . . 2.69 110.69 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.23 159.2 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.235 1.414 . . . . 1.46 113.567 -168.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.83 154.41 33.9 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.441 1.097 . . . . 3.61 111.025 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.62 -21.91 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 114.145 1.165 . . . . 1.46 114.145 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -73.29 -15.19 61.41 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.487 -1.383 . . . . 3.33 113.587 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.4 mt -99.84 -1.08 38.41 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.512 1.525 . . . . 2.17 114.422 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.33 146.37 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.579 1.552 . . . . 1.59 111.359 173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -120.53 165.75 14.56 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.848 1.659 . . . . 3.36 112.711 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -68.69 26.03 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.224 1.935 . . . . 2.7 116.224 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.69 14.58 1.99 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 126.565 2.031 . . . . 1.1 114.073 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -97.91 162.75 13.09 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 119.176 1.488 . . . . 2.61 112.845 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 87.6 mt -118.56 130.94 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.257 1.423 . . . . 1.21 109.912 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.9 mm -121.19 130.89 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.824 1.649 . . . . 0.65 112.413 -168.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HE3' HD21 ' A' ' 96' ' ' LEU . 32.2 ttmt -93.68 124.26 37.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.606 0.762 . . . . 2.16 112.089 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.97 137.18 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.351 1.06 . . . . 0.73 112.414 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.8 m -86.53 158.47 54.32 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.455 1.102 . . . . 1.27 113.361 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -62.6 126.91 19.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.724 2.283 . . . . 1.83 111.377 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.66 -5.81 72.66 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.685 1.612 . . . . 1.09 114.786 -169.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.51 159.04 53.22 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.764 1.173 . . . . 1.04 114.431 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -112.69 141.9 45.94 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.547 1.139 . . . . 2.51 111.745 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -76.07 129.99 79.24 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 119.214 -0.422 . . . . 1.78 112.06 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -90.32 -21.7 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.391 2.727 . . . . 0.8 114.924 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.56 166.93 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 127.405 2.282 . . . . 0.96 109.049 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.21 140.86 29.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.081 0.855 . . . . 2.03 111.845 173.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.61 -173.57 44.83 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 114.737 0.655 . . . . 0.84 114.737 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -110.27 144.43 38.99 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.48 1.112 . . . . 6.43 113.204 -170.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.11 129.13 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.574 2.35 . . . . 0.93 109.755 -172.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.7 pt -142.86 30.21 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 114.225 1.194 . . . . 1.2 114.225 -171.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -168.81 143.83 3.28 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.608 1.963 . . . . 3.11 109.367 166.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.84 -170.91 44.31 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.08 0.792 . . . . 0.96 115.08 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -155.11 121.62 5.32 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.361 0.664 . . . . 2.94 112.098 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.9 t -143.57 168.79 19.03 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.633 1.173 . . . . 1.14 112.631 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.1 ttm -115.1 137.0 52.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.817 0.847 . . . . 1.2 111.458 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.93 142.47 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.302 1.841 . . . . 0.75 111.705 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.93 114.53 26.65 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.837 1.255 . . . . 1.9 110.96 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -114.22 14.2 18.08 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 114.379 1.252 . . . . 2.03 114.379 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.5 p -67.02 -3.35 6.98 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 117.922 2.564 . . . . 1.69 117.922 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.62 -41.62 3.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.937 1.695 . . . . 1.24 109.865 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.3 mm -76.01 -58.5 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.362 1.065 . . . . 1.17 111.453 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.1 p -102.03 -11.74 18.67 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.185 0.994 . . . . 1.33 112.958 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.65 16.22 75.91 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.735 1.159 . . . . 1.39 115.083 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -56.08 -38.12 70.24 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.396 1.098 . . . . 2.58 113.393 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 63.49 19.42 11.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.263 1.425 . . . . 1.32 114.134 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.6 ttm -148.29 134.42 9.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 129.589 3.156 . . . . 3.22 105.213 169.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.41 161.79 43.37 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.29 1.993 . . . . 1.43 112.81 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.5 t -124.7 122.28 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.279 1.432 . . . . 0.89 110.911 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.5 145.21 33.34 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.705 0.802 . . . . 1.04 112.628 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -124.32 159.74 29.62 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.021 2.128 . . . . 0.86 111.399 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -157.14 174.26 4.2 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 126.995 2.118 . . . . 2.73 110.732 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.25 130.1 32.69 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 CA-C-N 121.909 1.717 . . . . 1.23 109.497 166.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.18 43.21 10.9 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.713 0.673 . . . . 1.03 113.087 -169.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -131.76 167.03 20.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.265 1.426 . . . . 1.56 110.85 175.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.8 p -124.41 150.55 45.49 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 120.554 1.524 . . . . 1.26 113.034 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 m -135.01 163.03 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.945 1.298 . . . . 0.81 112.348 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.5 150.72 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.383 2.273 . . . . 1.03 110.67 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.76 150.88 47.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.411 0.684 . . . . 0.83 112.521 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.75 -5.94 55.9 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 115.355 0.902 . . . . 0.9 115.355 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.88 157.64 21.91 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.255 1.528 . . . . 2.73 111.456 169.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -110.12 131.21 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.438 1.095 . . . . 0.93 111.025 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -96.93 132.02 43.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.309 1.444 . . . . 1.97 111.211 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -84.89 -72.96 0.45 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.128 -0.982 . . . . 3.64 113.245 -170.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -157.85 142.95 16.75 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.556 2.343 . . . . 4.68 107.42 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.46 11.19 1.18 Allowed Glycine 0 CA--C 1.542 1.72 0 N-CA-C 117.452 1.741 . . . . 3.3 117.452 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.6 m 32.29 85.37 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.435 2.694 . . . . 1.8 117.036 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.8 mt -103.98 156.13 18.1 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.887 1.275 . . . . 1.38 113.524 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.477 HD21 ' HE3' ' A' ' 44' ' ' LYS . 65.1 mt -108.85 123.89 49.77 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.425 1.09 . . . . 2.54 110.492 167.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.55 124.66 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.485 1.514 . . . . 1.5 109.542 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.7 p -82.44 120.36 25.37 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.346 -0.846 . . . . 1.77 109.586 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.5 115.29 19.04 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.355 -0.841 . . . . 1.05 109.254 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.3 p -119.29 6.35 11.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.692 1.197 . . . . 2.08 113.524 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -147.66 145.48 28.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.109 1.763 . . . . 1.58 110.321 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.8 m -83.64 159.6 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.74 -0.837 . . . . 1.73 108.74 164.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.18 -38.87 79.29 Favored Glycine 0 N--CA 1.475 1.262 0 O-C-N 121.025 -1.047 . . . . 1.54 114.913 -168.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.16 90.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.355 1.077 . . . . 1.94 112.814 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -77.26 -9.21 58.66 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.249 1.574 . . . . 2.52 115.249 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.7 p -64.47 159.04 22.35 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.336 0.865 . . . . 1.66 113.336 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -66.1 -29.29 69.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.969 -0.56 . . . . 2.04 111.627 170.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.12 -46.3 88.68 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.657 -1.277 . . . . 1.65 112.255 171.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.6 m -68.41 -23.01 64.59 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.492 0.552 . . . . 1.63 112.492 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.429 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 6.4 tp-100 -71.24 -40.39 71.08 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.995 1.271 . . . . 2.5 112.033 169.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 82.4 mt -54.96 -50.23 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 120.26 1.391 . . . . 1.51 110.772 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.4 m -64.91 -32.23 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 118.102 -0.951 . . . . 1.61 113.027 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 110' ' ' GLN . 47.1 mtmt -70.71 -37.6 73.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.724 1.147 . . . . 3.23 113.12 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.1 -48.13 83.02 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.951 2.1 . . . . 3.4 110.049 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.4 -44.13 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 119.095 -0.479 . . . . 1.97 110.962 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -58.47 -32.15 68.49 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.384 0.993 . . . . 4.39 113.437 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.06 -24.46 62.33 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.605 1.162 . . . . 4.86 113.935 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.92 -39.67 79.52 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.209 0.603 . . . . 3.81 110.395 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 126.037 1.735 . . . . 4.81 112.714 169.818 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 113.439 0.904 . . . . 2.69 113.439 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -76.9 -26.08 53.73 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.531 1.06 . . . . 6.49 112.542 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.48 -30.97 68.91 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.56 0.744 . . . . 1.65 112.309 171.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.12 -33.12 71.43 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.911 1.284 . . . . 1.6 112.662 172.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.9 -29.77 58.56 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.827 0.677 . . . . 1.38 112.827 171.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.79 -41.1 77.11 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.111 -0.993 . . . . 2.45 112.001 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.58 -30.41 65.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.284 0.947 . . . . 1.6 113.112 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.2 mm -75.25 -45.46 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.747 1.219 . . . . 2.05 112.409 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 m -75.66 -15.51 60.31 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.508 1.123 . . . . 1.52 113.401 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.0 tp -72.88 -24.49 60.86 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.579 2.751 . . . . 2.89 112.949 170.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -77.61 148.48 35.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.189 0.995 . . . . 2.45 113.407 -173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 163.4 27.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.397 1.479 . . . . 2.41 114.514 -171.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.7 p -109.0 -38.11 5.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.21 1.404 . . . . 2.47 112.965 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.84 154.76 51.08 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.613 1.565 . . . . 3.06 113.366 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.35 161.99 36.55 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.823 1.649 . . . . 0.73 113.358 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -118.61 103.2 9.48 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.462 1.105 . . . . 0.93 112.303 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.3 mt -83.56 134.71 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.888 1.275 . . . . 0.59 110.25 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.86 141.01 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.604 1.162 . . . . 1.71 110.283 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m -133.27 139.06 46.72 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.381 1.872 . . . . 1.74 110.118 -169.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.1 mt -100.36 125.5 46.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.517 0.727 . . . . 2.98 110.097 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -118.17 6.85 12.02 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 117.343 2.349 . . . . 4.29 117.343 -166.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -135.2 -73.35 0.46 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 120.688 1.586 . . . . 4.04 113.223 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -164.25 64.39 0.15 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.42 2.288 . . . . 4.68 106.438 174.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.283 12.1 p30 54.98 -11.11 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 128.751 2.821 . . . . 5.07 118.145 -169.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 pt -76.09 -3.68 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.979 1.712 . . . . 4.44 115.253 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 tp -130.9 120.56 23.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.834 1.654 . . . . 3.58 111.419 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 mp -111.41 129.35 56.05 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.115 1.766 . . . . 3.05 111.998 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 t -138.92 140.04 38.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.35 1.86 . . . . 1.63 110.319 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -123.18 148.81 45.38 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.921 1.452 . . . . 2.39 114.921 -170.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -121.36 146.66 46.63 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.509 2.324 . . . . 3.4 110.325 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -111.83 132.09 54.92 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.422 1.01 . . . . 1.68 111.641 171.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.2 m -135.9 161.27 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.199 1.0 . . . . 0.74 113.03 -170.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.7 148.7 36.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.479 0.711 . . . . 3.39 109.786 168.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.22 -24.95 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 113.948 1.092 . . . . 1.17 113.948 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -64.4 -22.86 67.09 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.45 1.1 . . . . 4.24 113.566 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.3 mt -103.79 -6.83 21.06 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.742 1.617 . . . . 1.13 114.747 -168.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.02 140.48 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.147 0.979 . . . . 1.5 110.356 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -121.26 165.51 15.35 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.024 1.73 . . . . 3.05 111.312 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -75.02 11.48 1.1 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.722 1.749 . . . . 3.24 115.722 -175.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.38 6.31 16.81 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 126.562 2.029 . . . . 0.98 114.483 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -87.91 152.47 22.05 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 119.891 1.846 . . . . 2.97 112.777 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.0 mm -111.5 128.65 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.163 1.785 . . . . 1.74 109.813 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.8 mm -119.68 128.44 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.511 1.124 . . . . 0.67 112.903 -168.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -88.34 121.97 31.33 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 121.225 -0.922 . . . . 1.89 112.532 170.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.21 134.33 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.293 1.437 . . . . 0.68 111.3 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 m -97.32 163.69 19.3 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 124.61 1.164 . . . . 0.92 113.26 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.35 133.9 52.07 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.231 1.954 . . . . 0.91 111.334 167.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.46 -8.21 54.73 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.775 2.131 . . . . 0.92 115.098 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.76 161.77 54.28 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 118.536 1.168 . . . . 1.06 114.379 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -113.24 140.69 47.75 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.749 1.219 . . . . 1.69 111.006 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.49 123.16 88.96 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-O 118.257 -0.878 . . . . 1.79 111.834 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.64 -24.09 4.45 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.971 2.447 . . . . 0.77 115.818 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.19 152.56 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 126.608 1.963 . . . . 0.96 109.116 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 138.8 35.62 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.873 1.064 . . . . 1.87 113.873 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.94 -157.79 20.85 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 123.728 0.68 . . . . 0.66 114.431 -171.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.5 ttp-105 -119.87 146.31 45.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.097 1.359 . . . . 4.01 113.062 -170.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.6 t -98.99 130.74 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 128.247 2.619 . . . . 0.79 109.467 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.7 31.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 114.143 1.164 . . . . 0.78 114.143 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -167.42 139.62 3.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.427 1.491 . . . . 2.68 110.29 169.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.61 -164.8 36.33 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 116.845 1.498 . . . . 1.06 116.845 167.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -145.69 132.68 20.25 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.689 1.196 . . . . 2.87 111.523 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.1 -179.21 6.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.882 0.873 . . . . 1.19 112.831 168.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.43 135.32 54.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.793 2.037 . . . . 1.22 110.358 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 72.4 t -126.31 142.76 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.48 1.112 . . . . 0.82 113.071 -169.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.94 106.24 16.13 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.544 1.138 . . . . 2.42 112.582 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -100.64 30.15 4.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.961 2.105 . . . . 1.78 114.103 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.3 p -48.7 -28.81 3.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.016 2.598 . . . . 2.35 118.016 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.41 -56.03 2.34 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.493 1.517 . . . . 2.12 110.637 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.3 mm -67.77 -51.98 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.783 0.66 . . . . 1.67 112.783 -167.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.7 p -95.52 -20.18 19.23 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.665 0.786 . . . . 1.49 112.474 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.51 83.37 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.182 1.372 . . . . 1.28 115.374 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.43 -47.57 83.5 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.573 1.323 . . . . 2.35 114.573 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 64.86 30.71 12.0 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.656 1.982 . . . . 1.82 112.861 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -149.12 154.26 39.05 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 127.529 2.332 . . . . 4.7 109.879 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -63.13 133.74 42.43 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.449 2.766 . . . . 2.03 115.168 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -116.16 136.16 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 127.063 2.145 . . . . 0.87 110.848 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.13 133.73 34.28 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.971 -1.081 . . . . 0.85 112.717 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -124.25 137.09 54.55 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.89 1.276 . . . . 0.96 111.677 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -148.48 179.15 1.24 Allowed Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 127.52 2.328 . . . . 2.74 108.667 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -56.3 139.38 86.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 CA-C-N 123.289 2.21 . . . . 0.82 112.319 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.05 11.73 83.37 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.456 -1.191 . . . . 0.77 115.105 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.2 m -102.2 166.53 10.54 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.581 1.69 . . . . 1.71 110.949 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.7 p -117.4 152.77 34.28 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.244 -1.535 . . . . 0.79 112.855 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.15 157.06 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.763 1.625 . . . . 0.61 112.159 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.73 143.08 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.758 1.623 . . . . 1.17 111.675 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.68 153.99 37.93 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.47 0.915 . . . . 0.75 113.47 -170.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.68 -1.0 59.7 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 114.893 0.717 . . . . 0.87 114.893 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 m -88.97 156.4 18.91 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.303 1.051 . . . . 2.45 111.447 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.05 145.33 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.576 1.15 . . . . 0.84 111.117 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -115.97 137.13 52.39 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.958 2.103 . . . . 1.77 112.227 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -153.93 139.73 18.07 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.401 -1.437 . . . . 3.01 113.084 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.314 30.1 t30 87.89 -1.48 0.49 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.285 3.434 . . . . 3.14 116.006 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.67 163.45 29.0 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 120.437 -1.414 . . . . 1.94 115.257 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -98.95 144.01 28.6 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.121 1.769 . . . . 1.98 112.128 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.9 mt -135.57 160.02 39.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.948 1.299 . . . . 1.07 111.361 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.9 mt -107.99 127.63 53.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.691 0.796 . . . . 2.26 110.435 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.3 mm -117.24 124.62 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.923 1.689 . . . . 1.7 110.306 -173.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -87.19 111.22 20.77 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.424 -0.797 . . . . 1.57 109.533 169.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.17 119.13 22.53 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.622 0.769 . . . . 0.92 109.806 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 t -119.86 8.71 11.15 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.594 0.961 . . . . 2.56 113.594 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -138.36 139.31 38.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.612 1.965 . . . . 1.73 108.058 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 m -85.98 174.58 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.737 0.815 . . . . 1.64 111.802 170.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.25 -36.57 91.15 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 121.08 -1.012 . . . . 1.3 114.795 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.71 -36.9 70.67 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.852 1.326 . . . . 1.63 112.615 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -78.49 -10.25 59.64 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.798 1.777 . . . . 2.27 115.798 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -76.6 156.17 32.95 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.646 -1.283 . . . . 2.87 112.379 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.9 t -56.88 -34.39 67.83 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.38 0.882 . . . . 1.94 113.38 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.5 mp -56.93 -48.68 77.7 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.541 -1.349 . . . . 1.44 112.52 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.9 m -70.74 -27.99 64.38 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.02 1.328 . . . . 1.9 112.203 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -70.76 -44.74 66.12 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.394 0.678 . . . . 2.07 111.974 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.5 mt -56.37 -49.57 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.94 1.296 . . . . 1.22 111.267 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.52 -19.74 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.251 1.204 . . . . 1.33 114.251 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -72.27 -29.97 64.4 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.6 1.091 . . . . 3.14 112.67 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tt -75.03 -58.92 2.98 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.095 1.358 . . . . 2.85 111.328 170.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.6 t -69.66 -18.11 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.364 -0.835 . . . . 1.88 112.885 -169.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -65.41 -30.98 71.84 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.133 -1.604 . . . . 3.41 112.147 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -75.04 -18.86 60.25 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.187 1.395 . . . . 3.9 113.293 172.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.06 -7.79 57.38 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.654 1.582 . . . . 4.62 114.636 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.173 -1.394 . . . . 4.8 114.115 179.412 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 119.088 -0.482 . . . . 3.16 111.769 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.55 -23.91 53.58 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.221 0.919 . . . . 4.63 112.672 170.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.18 -8.27 37.27 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.135 1.161 . . . . 2.03 114.135 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.4 tp -56.41 -53.96 51.3 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.193 0.997 . . . . 2.62 111.301 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.37 -7.99 47.2 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.436 1.643 . . . . 2.15 115.436 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -64.88 -43.89 91.45 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 121.486 1.948 . . . . 2.12 111.003 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -48.76 -48.96 40.51 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.281 1.432 . . . . 1.24 111.048 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.9 mm -70.16 -34.01 57.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.79 1.236 . . . . 1.52 112.034 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 m -76.64 -24.77 53.32 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.153 1.381 . . . . 1.14 113.053 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 mp -68.22 -26.79 65.89 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.889 0.768 . . . . 2.04 112.621 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -70.72 139.78 51.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.409 1.004 . . . . 2.68 113.013 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.87 152.39 44.59 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.102 -0.499 . . . . 2.02 111.188 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -106.23 -2.66 22.18 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.911 1.284 . . . . 1.94 112.128 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -142.59 153.5 43.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.326 2.25 . . . . 3.91 112.282 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.85 162.0 36.62 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.194 1.398 . . . . 0.71 112.991 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.8 m -115.07 108.16 16.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.929 1.292 . . . . 0.86 111.916 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.0 mt -83.32 130.33 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.104 -0.702 . . . . 0.67 109.104 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.31 138.42 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.04 0.936 . . . . 2.51 112.37 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.4 m -140.19 139.29 35.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.178 0.991 . . . . 1.99 111.747 -169.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.4 mt -104.35 141.22 36.7 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.953 1.301 . . . . 3.45 109.199 168.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.36 20.77 1.2 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.333 1.975 . . . . 4.88 116.333 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.8 m -142.04 -73.83 0.31 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.401 -0.812 . . . . 4.22 112.573 173.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -160.99 50.28 0.25 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.491 1.916 . . . . 6.79 109.052 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.7 -18.59 0.08 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.55 2.34 . . . . 6.41 114.471 -167.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.5 pt -69.62 -33.39 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.422 1.489 . . . . 4.62 113.284 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 tp -86.83 92.46 8.99 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.213 1.005 . . . . 2.99 108.61 168.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.5 tp -106.55 125.79 51.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.826 2.051 . . . . 3.32 109.5 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 t -135.22 129.35 33.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.637 1.175 . . . . 1.71 110.966 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -130.74 129.44 42.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.446 1.098 . . . . 2.41 111.822 -169.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -119.51 118.97 32.47 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.486 1.914 . . . . 2.84 109.746 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -89.24 121.54 31.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.576 1.08 . . . . 2.13 109.93 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.31 171.28 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.124 1.37 . . . . 0.97 112.612 -169.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -79.7 146.17 32.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.634 1.174 . . . . 3.21 110.506 168.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.96 -24.05 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.608 0.966 . . . . 1.07 113.608 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.16 -22.48 61.29 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.815 -1.178 . . . . 2.92 113.062 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.77 -15.18 42.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.305 1.042 . . . . 1.24 113.231 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 p -86.7 93.54 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 122.715 1.245 . . . . 1.89 109.9 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -78.32 158.3 28.89 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.42 2.288 . . . . 4.19 109.218 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -69.74 134.26 48.41 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.015 -1.053 . . . . 2.73 112.966 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.42 12.18 4.32 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.207 1.385 . . . . 0.88 115.999 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -116.48 168.86 9.79 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.288 2.044 . . . . 2.71 113.861 175.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.2 mm -101.86 129.04 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.31 1.844 . . . . 1.55 109.607 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.1 mm -122.75 129.14 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.119 1.768 . . . . 0.8 110.465 -171.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -83.13 135.71 34.72 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.765 1.226 . . . . 2.85 112.365 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.36 136.8 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.822 1.249 . . . . 0.82 111.949 169.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.35 159.14 65.29 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.018 0.927 . . . . 1.16 112.886 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.28 136.12 66.31 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.78 2.32 . . . . 1.24 110.757 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.18 3.79 57.87 Favored Glycine 0 CA--C 1.542 1.735 0 N-CA-C 114.914 0.726 . . . . 0.99 114.914 -169.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.1 178.89 48.54 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 118.928 1.364 . . . . 0.98 115.686 -174.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.81 145.26 51.24 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.419 1.888 . . . . 1.64 111.096 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -88.07 129.5 49.79 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 112.863 0.69 . . . . 1.73 112.863 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -86.27 -22.22 2.23 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.275 2.65 . . . . 0.73 115.661 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.6 m -151.08 175.82 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 127.843 2.457 . . . . 0.76 109.147 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -99.94 140.99 33.36 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.357 0.98 . . . . 1.68 113.474 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.51 -177.73 46.58 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 123.545 0.593 . . . . 0.62 114.38 -169.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -103.24 138.81 39.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.838 1.255 . . . . 4.47 112.178 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.8 t -83.45 130.55 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.255 2.222 . . . . 0.75 108.657 173.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.1 pt -140.37 33.48 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-O 122.394 1.093 . . . . 0.77 112.379 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -166.6 129.5 1.89 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.155 2.182 . . . . 2.81 108.084 168.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.33 176.0 50.5 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 122.701 1.167 . . . . 1.03 115.03 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -153.31 120.96 5.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.417 1.487 . . . . 2.07 112.572 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.8 t -141.69 159.73 41.63 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.445 1.498 . . . . 1.46 112.024 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.4 ttm -90.67 130.18 36.7 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.761 -0.587 . . . . 0.88 110.341 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.7 t -113.85 140.77 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.524 1.13 . . . . 0.61 111.781 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -108.32 102.46 11.58 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.334 1.453 . . . . 1.76 111.427 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 19.86 17.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.624 1.969 . . . . 4.0 113.096 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.2 p -54.6 -29.09 50.76 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.331 1.604 . . . . 1.3 115.331 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.59 -30.46 26.97 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.825 1.193 . . . . 1.02 111.708 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 mm -72.76 -53.57 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.554 1.542 . . . . 1.06 110.176 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.2 p -102.92 -22.04 13.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.313 1.845 . . . . 1.66 113.691 -171.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.75 -2.23 87.7 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.277 1.418 . . . . 1.28 114.328 -170.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -64.9 110.16 2.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.502 1.651 . . . . 2.86 110.296 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.59 -3.38 58.44 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.983 -1.073 . . . . 1.47 112.596 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.8 mmt -95.79 138.7 21.71 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.99 2.516 . . . . 3.63 108.952 167.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.36 161.09 22.78 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.155 2.57 . . . . 1.93 112.347 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.8 t -124.03 119.82 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.463 0.705 . . . . 0.82 111.369 -168.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.57 130.79 35.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.021 0.928 . . . . 0.87 112.086 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -108.74 157.68 18.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.015 1.726 . . . . 0.76 111.866 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -146.73 168.97 10.25 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 127.581 2.352 . . . . 3.5 111.624 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -59.14 123.22 12.98 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 121.578 1.519 . . . . 0.93 109.356 166.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.43 57.15 3.01 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.866 1.222 . . . . 1.21 112.426 -168.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -141.3 150.31 42.38 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.696 1.598 . . . . 1.28 112.427 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.9 p -101.05 150.76 22.57 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 120.861 1.664 . . . . 0.85 113.522 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.05 162.61 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.464 1.506 . . . . 0.53 111.823 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -126.97 150.06 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.768 2.027 . . . . 0.93 111.363 176.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.59 142.23 49.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.033 0.933 . . . . 0.66 112.71 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.49 -5.77 72.07 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.125 1.345 . . . . 0.79 116.305 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.4 p -73.93 162.22 29.3 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.711 1.256 . . . . 1.39 111.896 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mm -110.79 143.88 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.52 1.128 . . . . 0.64 111.61 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -105.45 142.62 34.89 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.467 1.907 . . . . 1.91 112.341 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -85.73 -125.69 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.639 1.175 . . . . 3.52 112.316 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -78.99 -38.16 37.43 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.001 1.852 . . . . 3.4 116.001 -166.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.4 128.78 13.68 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 118.794 0.725 . . . . 1.93 112.538 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.2 t -83.97 121.43 27.38 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.875 -1.158 . . . . 2.28 107.875 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.4 mt -117.99 157.73 26.23 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.715 1.206 . . . . 1.12 111.321 -169.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -117.31 125.52 51.2 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.482 0.658 . . . . 2.06 109.75 169.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.79 138.17 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.64 1.576 . . . . 1.31 110.573 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.6 p -79.03 106.62 11.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.021 0.915 . . . . 1.85 111.185 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.73 82.4 4.13 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.202 1.001 . . . . 1.68 109.097 171.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 t -101.51 9.32 41.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.585 1.954 . . . . 3.04 111.874 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -144.49 152.86 41.21 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.159 1.783 . . . . 2.15 111.451 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -106.7 170.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.211 1.404 . . . . 1.77 111.579 168.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.6 -24.24 46.56 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.366 1.306 . . . . 2.22 116.366 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.38 96.91 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.595 1.698 . . . . 2.85 112.529 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.18 -22.98 59.17 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.272 1.582 . . . . 3.83 115.272 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 109' ' ' SER . 3.2 t -71.58 142.74 50.01 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.463 1.283 . . . . 2.96 114.463 -166.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m -60.95 -27.14 68.03 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.499 -0.751 . . . . 3.52 112.275 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.0 tp -58.4 -46.22 86.83 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.367 -0.833 . . . . 1.5 112.093 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.474 ' H ' HG23 ' A' ' 106' ' ' THR . 75.9 p -73.03 -27.33 61.7 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.881 0.872 . . . . 2.6 113.012 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -66.64 -40.06 88.54 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.164 -0.96 . . . . 1.88 112.461 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 67.8 mt -53.91 -52.22 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.392 1.077 . . . . 1.4 110.301 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.404 ' HA ' HG12 ' A' ' 115' ' ' VAL . 21.9 m -70.01 -24.4 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 113.686 0.995 . . . . 1.13 113.686 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -70.07 -48.37 58.06 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.229 0.922 . . . . 2.81 111.849 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mt -72.68 -37.93 67.75 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.597 0.962 . . . . 2.45 113.597 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 112' ' ' VAL . 2.3 p -70.85 -18.83 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.142 -0.974 . . . . 2.72 112.649 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -71.96 -36.49 69.86 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.927 0.891 . . . . 3.73 111.012 168.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -73.17 -11.52 60.56 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.07 -1.019 . . . . 3.58 113.121 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.62 -56.06 6.57 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.165 -0.96 . . . . 3.65 110.237 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.257 0 CA-C-O 116.665 -1.636 . . . . 4.28 114.767 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 113.681 0.993 . . . . 2.67 113.681 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -99.06 -39.99 8.24 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.945 1.698 . . . . 5.29 111.381 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.27 90.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.158 0.983 . . . . 1.91 111.785 172.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.5 tp -55.05 -35.82 64.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.254 1.022 . . . . 2.1 112.386 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.07 -47.34 37.26 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.359 0.527 . . . . 2.06 112.208 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.08 -32.46 70.97 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.211 1.005 . . . . 3.04 113.384 -172.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.0 -35.73 77.6 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 120.228 1.377 . . . . 1.31 113.267 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.6 mm -73.99 -40.29 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.498 -0.751 . . . . 1.89 111.591 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -66.86 -30.38 70.53 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.391 0.886 . . . . 1.63 113.391 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.31 -17.33 62.43 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.555 1.942 . . . . 2.38 113.941 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -86.4 147.04 26.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.538 1.135 . . . . 2.46 112.835 -170.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.23 154.41 22.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.557 1.543 . . . . 2.04 112.98 -172.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 m -100.53 -27.39 13.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.331 1.452 . . . . 2.13 113.314 -172.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.84 150.76 50.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.228 1.411 . . . . 3.42 113.678 -170.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.4 172.32 12.93 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.608 1.563 . . . . 1.02 113.37 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 93.1 m -119.4 105.3 11.15 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.501 1.52 . . . . 0.99 112.125 170.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.89 140.31 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.016 0.927 . . . . 0.6 109.402 174.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.93 124.98 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.469 -0.769 . . . . 1.89 110.551 172.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -128.04 144.47 51.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.604 1.162 . . . . 1.78 110.681 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.8 mt -112.56 123.5 50.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.183 0.993 . . . . 2.54 110.938 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -105.79 1.57 27.09 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 117.567 2.432 . . . . 4.2 117.567 -165.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 m -128.89 -93.47 0.44 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.815 1.246 . . . . 4.09 111.454 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -142.01 58.45 1.48 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.618 1.967 . . . . 4.47 108.995 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.337 12.7 p30 56.81 -9.55 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.649 2.779 . . . . 4.55 117.899 -170.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.4 pt -77.33 -13.14 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.876 2.07 . . . . 3.36 115.472 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.7 tp -117.82 105.54 12.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.298 1.439 . . . . 2.91 109.683 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.86 129.13 36.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.28 1.032 . . . . 2.35 110.642 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 t -141.42 84.69 1.92 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.601 1.56 . . . . 1.56 109.431 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -81.02 154.15 27.03 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.033 -1.042 . . . . 2.72 112.926 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -121.74 130.72 53.63 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.181 1.792 . . . . 2.7 110.958 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -88.58 120.56 30.08 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.671 -0.863 . . . . 2.1 108.671 168.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.24 159.23 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.051 0.94 . . . . 0.99 113.13 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -78.04 143.22 37.65 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.903 -0.777 . . . . 3.18 108.903 166.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.09 -20.24 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.609 1.164 . . . . 1.12 113.585 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -70.24 -20.02 63.1 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.707 -1.246 . . . . 3.43 113.637 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.2 mt -89.83 -5.55 56.76 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.455 1.28 . . . . 1.72 114.455 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.1 p -94.13 144.65 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.762 0.825 . . . . 1.69 112.508 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -121.25 163.3 18.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.943 2.497 . . . . 3.17 110.124 170.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 ptt85 -72.29 147.15 46.66 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.181 -0.95 . . . . 3.77 110.784 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.43 28.49 7.11 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-N 119.142 0.883 . . . . 1.76 113.93 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.5 166.34 25.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.333 1.853 . . . . 3.53 111.523 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.4 mt -122.95 132.16 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.945 1.298 . . . . 1.84 111.937 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 mm -118.65 129.98 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.692 1.997 . . . . 0.72 110.623 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -84.45 130.39 34.77 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.639 -0.663 . . . . 2.09 112.19 172.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.43 136.89 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.888 1.275 . . . . 0.61 110.227 169.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.93 161.91 39.71 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.118 1.367 . . . . 0.87 112.39 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -57.5 134.27 62.31 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.674 1.583 . . . . 1.08 108.618 166.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.64 -9.04 38.25 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 118.702 -1.054 . . . . 0.93 115.557 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.92 177.94 37.53 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 119.645 1.723 . . . . 0.95 114.237 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.88 151.37 38.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.684 1.593 . . . . 2.09 111.234 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -90.14 116.55 66.63 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 118.496 -0.764 . . . . 1.83 109.965 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -89.16 -11.22 3.72 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.936 2.424 . . . . 0.74 114.896 -171.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -147.8 172.82 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 128.55 2.74 . . . . 0.89 108.834 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.2 139.39 37.88 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.164 0.893 . . . . 2.66 112.518 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.75 -158.67 22.58 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 115.253 0.861 . . . . 0.79 115.253 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -118.3 129.1 55.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.74 1.216 . . . . 4.34 112.647 -170.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.3 t -88.69 127.23 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.881 1.672 . . . . 0.89 108.93 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.7 pt -141.52 30.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 113.438 0.903 . . . . 0.96 113.438 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -169.08 132.01 1.29 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.615 1.966 . . . . 3.17 108.975 166.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.71 173.34 46.83 Favored Glycine 0 CA--C 1.539 1.578 0 N-CA-C 116.102 1.201 . . . . 1.1 116.102 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -140.28 127.36 20.9 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.099 1.36 . . . . 3.03 113.806 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.8 m -151.46 172.15 16.42 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.362 1.616 . . . . 1.22 115.362 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.9 ttm -106.46 133.78 50.61 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.625 1.17 . . . . 1.46 110.497 168.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.85 132.82 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.479 1.112 . . . . 1.16 113.743 -167.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -91.23 98.7 11.88 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.269 1.828 . . . . 2.28 111.386 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -128.98 8.61 5.68 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.135 1.774 . . . . 1.77 115.57 -172.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.3 p -59.73 -4.81 0.75 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 116.248 1.944 . . . . 2.1 116.248 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -94.62 -35.6 12.14 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.153 1.342 . . . . 1.63 111.449 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.8 mm -79.73 -62.88 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.797 1.239 . . . . 1.61 111.612 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 p -84.99 -8.15 58.85 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.206 1.403 . . . . 2.24 112.999 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.02 25.9 70.19 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.556 1.074 . . . . 2.9 113.241 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -64.3 -177.33 0.28 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.671 1.589 . . . . 3.17 110.876 169.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.5 -9.64 5.7 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.843 -1.161 . . . . 2.83 113.612 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -149.26 151.25 33.55 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.099 1.36 . . . . 2.93 110.793 169.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -48.8 153.87 3.42 Favored 'Trans proline' 0 CA--C 1.538 0.712 1 C-N-CA 125.405 4.07 . . . . 2.95 116.245 -178.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.3 t -113.25 134.07 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.722 1.609 . . . . 1.16 111.354 -170.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.38 137.22 38.6 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.614 0.765 . . . . 0.87 112.188 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -130.14 143.87 51.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.167 2.187 . . . . 1.03 110.179 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 16.5 ptmt -148.61 -172.61 0.32 Allowed Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 126.611 1.964 . . . . 3.41 109.526 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 74.1 Cg_endo -66.45 142.92 67.43 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 CA-C-N 123.492 2.283 . . . . 1.16 111.347 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.02 8.73 87.4 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.512 1.53 . . . . 0.98 114.895 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.2 m -89.52 163.83 15.05 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.851 1.826 . . . . 1.65 112.234 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.3 p -112.33 147.1 37.06 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 120.911 -1.118 . . . . 1.16 111.218 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 m -139.46 156.31 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.553 1.141 . . . . 0.7 112.754 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.53 150.53 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.169 1.788 . . . . 1.23 113.225 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.02 149.59 47.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.044 0.937 . . . . 0.85 113.168 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.3 -2.52 56.85 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.712 1.148 . . . . 0.89 114.966 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 89.9 p -76.59 155.0 33.91 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.629 1.214 . . . . 1.54 111.657 169.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.09 136.95 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.273 1.029 . . . . 1.14 110.669 -171.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -93.19 149.78 20.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.853 1.661 . . . . 1.5 113.412 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -160.47 115.27 2.22 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.989 0.916 . . . . 3.97 111.88 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.5 t30 147.79 -46.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 131.658 3.983 . . . . 3.22 110.829 166.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.1 179.78 42.74 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 121.084 -1.01 . . . . 2.11 114.884 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -85.34 132.59 34.22 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.213 1.005 . . . . 2.25 112.276 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.86 163.56 24.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.838 1.655 . . . . 1.76 112.304 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.1 mt -118.46 127.29 53.51 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.209 1.004 . . . . 2.52 112.011 172.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.95 126.99 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.11 1.364 . . . . 1.25 110.893 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 44.2 t -83.09 125.46 31.51 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.094 0.558 . . . . 2.75 110.307 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.24 104.12 14.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.188 0.995 . . . . 1.16 109.754 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.8 p -94.22 -3.81 50.1 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.558 1.143 . . . . 2.73 112.13 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -136.47 136.9 39.84 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.474 1.91 . . . . 2.57 109.856 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 p -88.69 170.08 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.573 1.149 . . . . 2.49 110.474 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.17 -35.68 85.36 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.31 -1.494 . . . . 1.9 114.875 -171.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.79 -31.84 73.15 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.947 1.374 . . . . 2.5 113.227 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.16 -5.92 44.67 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.118 1.367 . . . . 3.75 113.738 172.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.0 p -80.71 147.16 30.72 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.529 -1.357 . . . . 1.72 112.77 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -70.67 -23.37 62.49 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.295 1.22 . . . . 2.69 114.295 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 mp -59.37 -58.14 9.91 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 119.809 -1.807 . . . . 1.54 115.762 -167.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.7 m -73.18 -15.22 61.46 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.859 0.754 . . . . 3.4 112.7 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.5 -42.92 64.31 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.001 0.92 . . . . 2.38 111.461 172.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 54.9 mt -57.63 -45.76 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.067 1.347 . . . . 1.77 112.499 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.73 -18.7 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 114.514 1.301 . . . . 1.98 114.514 -172.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -73.34 -31.26 63.87 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.372 -0.83 . . . . 2.79 112.428 173.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -56.11 5.02 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.072 1.749 . . . . 3.92 111.41 172.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.68 -27.24 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.614 0.766 . . . . 2.93 112.466 -170.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.12 -30.16 71.24 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.173 -0.954 . . . . 3.83 112.888 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.32 -19.27 58.39 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.241 -1.537 . . . . 6.04 112.722 174.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.21 -30.13 57.85 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.631 1.345 . . . . 5.53 114.631 -169.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 124.921 1.288 . . . . 6.44 111.371 175.055 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 112.84 0.682 . . . . 2.37 112.84 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -73.49 -36.08 65.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.97 0.908 . . . . 5.25 111.103 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.17 -21.2 63.08 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.606 -1.309 . . . . 2.68 113.496 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.9 tp -64.49 -31.95 73.38 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.03 0.932 . . . . 1.98 111.134 171.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.19 -17.3 61.94 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.122 -0.986 . . . . 1.27 113.532 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -67.39 -28.52 68.0 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.755 0.822 . . . . 2.55 112.207 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.8 -38.9 83.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.838 0.855 . . . . 1.27 111.319 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.3 mm -70.14 -41.28 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.275 0.63 . . . . 2.15 110.954 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 m -67.44 -24.74 65.67 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.024 0.93 . . . . 1.14 113.256 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.5 mt -73.32 -27.8 61.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.979 1.712 . . . . 1.66 113.889 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -64.45 140.44 58.87 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.877 0.762 . . . . 3.3 111.003 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.51 165.26 18.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.562 1.145 . . . . 2.53 113.475 -172.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.1 m -121.11 -29.31 4.57 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.108 1.363 . . . . 2.08 112.411 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.21 150.05 43.68 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.227 1.411 . . . . 2.95 112.728 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.86 145.95 38.72 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.866 1.267 . . . . 1.06 112.507 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.5 m -98.54 100.92 12.21 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.638 1.175 . . . . 1.4 112.323 -174.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 35.1 mt -76.72 139.58 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 108.83 -0.804 . . . . 1.09 108.83 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.42 125.58 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.712 0.768 . . . . 2.38 112.254 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.0 m -140.19 141.72 35.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.844 1.658 . . . . 2.03 111.323 -167.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 24' ' ' ASN . 2.9 mm? -93.3 112.94 25.0 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.994 0.917 . . . . 4.84 109.034 173.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.99 -3.64 48.09 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.768 1.025 . . . . 5.13 113.768 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.6 m -161.1 146.37 14.1 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 129.843 3.257 . . . . 5.02 111.178 168.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 25' ' ' ILE . 24.2 t70 -23.88 61.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 1 C-N-CA 133.568 4.747 . . . . 6.0 118.622 -169.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.514 ' HA ' HD12 ' A' ' 20' ' ' LEU . 28.8 t-20 63.74 -26.64 0.08 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.083 2.153 . . . . 6.6 114.456 -166.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.409 ' H ' ' C ' ' A' ' 23' ' ' ASP . 33.0 pt -62.2 -13.36 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 128.639 2.776 . . . . 5.04 115.391 175.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.2 tp -131.02 56.33 1.8 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.209 1.404 . . . . 3.78 110.841 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.51 ' HA ' HD13 ' A' ' 20' ' ' LEU . 6.9 tt -65.44 116.14 6.42 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.098 -1.41 . . . . 2.86 109.0 167.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.1 p -135.92 152.27 50.83 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.884 1.274 . . . . 2.46 110.985 -168.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.67 149.07 40.38 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.969 0.908 . . . . 3.25 111.487 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -139.64 113.56 8.75 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.661 1.184 . . . . 2.56 111.588 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -79.83 115.61 19.52 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.918 -1.114 . . . . 2.7 109.303 167.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.78 166.08 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.239 1.416 . . . . 0.92 111.166 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -76.6 142.0 40.88 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.921 -0.487 . . . . 3.95 110.342 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.41 -23.57 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.289 1.218 . . . . 1.29 114.289 -171.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -60.68 -27.43 67.85 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.88 1.272 . . . . 4.44 113.206 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.2 mt -101.57 -7.63 22.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.9 2.08 . . . . 1.36 115.816 -167.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.74 144.71 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.151 0.887 . . . . 1.56 111.151 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -121.33 154.78 35.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.204 1.802 . . . . 4.13 112.881 -170.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -77.64 23.8 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 117.215 2.302 . . . . 3.28 117.215 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.78 6.81 12.28 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.682 1.611 . . . . 1.47 115.564 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -124.01 173.31 8.33 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.75 1.775 . . . . 3.56 115.256 -168.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.4 mt -113.84 126.31 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.057 1.743 . . . . 2.13 110.491 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.3 mm -116.08 124.14 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.495 1.918 . . . . 0.73 110.109 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.489 ' HE3' HD11 ' A' ' 96' ' ' LEU . 65.2 tttt -87.07 141.36 28.72 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.737 1.215 . . . . 2.17 111.676 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -116.59 137.09 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.489 0.716 . . . . 0.73 112.287 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.13 159.25 54.33 Favored Pre-proline 0 N--CA 1.481 1.075 0 C-N-CA 124.387 1.075 . . . . 1.32 113.234 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -60.95 136.94 68.91 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.888 1.726 . . . . 1.8 109.772 167.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.89 -2.27 26.37 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 115.429 0.932 . . . . 1.02 115.429 -171.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.66 -177.17 41.19 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 119.062 1.431 . . . . 1.08 115.31 -176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -123.67 154.74 38.95 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.093 1.357 . . . . 2.04 112.043 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -88.69 122.12 69.47 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 118.608 -0.71 . . . . 1.79 110.34 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.18 -19.54 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.565 2.176 . . . . 0.76 115.426 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.48 164.89 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 127.987 2.515 . . . . 0.9 108.051 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -81.14 149.23 29.23 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.039 0.923 . . . . 2.36 113.286 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -167.07 38.73 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.785 -0.643 . . . . 0.86 113.906 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -114.96 132.6 56.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.742 0.817 . . . . 3.84 112.504 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.0 t -79.02 131.58 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 127.078 2.151 . . . . 0.65 107.636 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.06 31.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.039 0.836 . . . . 0.76 112.277 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -169.07 146.71 3.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.378 2.271 . . . . 3.24 109.258 168.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.08 -179.55 32.51 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 118.847 0.749 . . . . 0.94 114.842 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -143.53 32.4 1.31 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.445 1.646 . . . . 3.15 115.445 -167.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.806 ' H ' HD21 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -83.36 165.84 18.94 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.361 1.615 . . . . 1.28 115.361 -168.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.0 ttm -110.8 138.36 47.29 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.819 0.847 . . . . 1.06 110.95 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.33 134.66 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.092 1.357 . . . . 0.88 112.805 -168.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -86.03 108.54 18.29 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.107 1.363 . . . . 2.53 110.924 174.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -103.94 -10.79 17.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.0 1.32 . . . . 2.51 113.89 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.5 p -43.23 -35.45 1.43 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 117.995 2.591 . . . . 1.79 117.995 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -84.86 -27.45 26.69 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.62 1.1 . . . . 1.41 112.016 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mm -89.52 -55.55 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.944 0.898 . . . . 1.39 110.922 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.0 p -85.79 -18.35 33.2 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.191 0.996 . . . . 1.8 113.132 -176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.71 9.91 80.25 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.448 1.499 . . . . 1.79 114.439 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.02 -177.59 0.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.365 1.466 . . . . 2.83 112.512 171.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.69 -20.68 0.59 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.148 1.379 . . . . 1.9 114.492 -176.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.9 mtp -119.2 140.47 28.97 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.7 1.2 . . . . 4.23 111.354 172.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -59.28 144.93 99.22 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.556 2.837 . . . . 2.18 113.973 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 t -106.72 131.99 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 127.3 2.24 . . . . 0.83 111.982 -168.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.13 134.84 37.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.267 0.627 . . . . 0.83 111.85 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -110.37 155.47 22.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.4 1.88 . . . . 0.87 111.652 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -151.93 172.07 5.88 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 127.343 2.257 . . . . 2.28 108.285 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -54.9 142.08 76.3 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 CA-C-N 122.149 1.803 . . . . 0.83 112.279 171.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.63 13.33 82.62 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-O 117.7 -1.611 . . . . 1.09 115.635 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -96.83 144.7 26.55 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.209 2.505 . . . . 1.42 111.392 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.5 p -90.42 157.17 17.73 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 121.305 1.866 . . . . 1.01 112.933 172.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 m -140.34 156.85 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.457 1.903 . . . . 0.79 112.035 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -113.47 151.65 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 127.573 2.349 . . . . 1.1 111.636 173.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.34 155.86 23.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.29 0.636 . . . . 0.88 112.369 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.69 0.12 53.15 Favored Glycine 0 CA--C 1.536 1.402 0 O-C-N 121.447 -0.783 . . . . 1.15 114.974 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.9 p -78.22 153.51 31.87 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.557 1.179 . . . . 1.72 110.899 168.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mm -113.3 131.73 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.811 0.844 . . . . 1.32 111.011 -171.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -94.27 148.32 22.32 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.696 1.598 . . . . 1.68 112.653 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -96.95 -88.08 0.3 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.291 1.036 . . . . 3.42 112.712 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -154.17 146.92 24.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.628 2.771 . . . . 4.41 107.865 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.64 23.97 2.7 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 120.602 1.546 . . . . 2.99 115.158 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 t 18.19 97.94 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 130.169 3.388 . . . . 1.74 116.837 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.806 HD21 ' H ' ' A' ' 62' ' ' SER . 54.9 mt -102.5 154.03 19.49 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.629 1.171 . . . . 1.07 112.948 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.489 HD11 ' HE3' ' A' ' 44' ' ' LYS . 7.2 mp -117.75 126.02 51.69 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.501 1.12 . . . . 2.34 108.566 166.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.54 125.9 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.127 1.371 . . . . 1.14 110.086 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.2 p -81.2 119.88 24.17 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.627 -0.67 . . . . 1.53 109.538 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.95 130.92 35.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.293 0.637 . . . . 1.27 109.665 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.46 3.55 9.05 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.897 1.073 . . . . 3.04 113.897 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -141.18 151.5 43.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.998 1.319 . . . . 2.16 111.86 169.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -89.45 173.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.769 1.628 . . . . 2.15 111.223 171.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.94 -36.41 87.76 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 121.061 -1.024 . . . . 1.6 114.843 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.39 -28.12 69.02 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.582 1.327 . . . . 2.09 114.582 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.71 -13.02 60.03 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.962 1.467 . . . . 3.35 114.962 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.1 p -66.45 132.92 49.35 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.215 -0.928 . . . . 2.1 112.608 -168.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.8 t -63.24 -23.77 67.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.487 1.291 . . . . 2.23 114.487 -167.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.7 -43.74 80.84 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.917 -1.114 . . . . 1.83 111.795 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.2 p -68.03 -28.5 67.45 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.158 0.983 . . . . 2.02 112.712 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -75.27 -48.65 22.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.969 1.307 . . . . 1.55 111.91 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 53.4 mt -53.62 -49.23 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.862 1.665 . . . . 1.45 110.5 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.55 -20.08 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.876 1.435 . . . . 1.61 114.876 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -74.86 -38.52 61.92 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.888 1.222 . . . . 3.0 112.842 170.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.38 -52.71 8.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.198 2.199 . . . . 3.27 112.656 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.3 t -71.32 -21.71 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.65 1.18 . . . . 3.1 111.819 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.83 -34.13 71.2 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.419 -1.426 . . . . 5.33 112.18 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.89 -17.51 59.76 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.974 0.91 . . . . 6.21 113.349 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.54 -26.4 50.97 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.7 1.37 . . . . 6.6 114.7 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 127.033 2.133 . . . . 7.67 113.685 179.664 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 111.481 0.178 . . . . 3.59 111.481 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -76.69 -31.21 57.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.757 1.223 . . . . 4.29 111.699 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.26 61.96 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.277 -0.889 . . . . 1.79 112.639 170.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.25 -40.73 86.86 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.636 1.174 . . . . 2.98 111.205 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.32 -14.25 61.27 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.456 0.91 . . . . 1.18 113.456 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -67.3 -33.31 75.01 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.649 -1.282 . . . . 2.39 111.505 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.91 -28.03 69.78 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.489 1.115 . . . . 1.13 111.885 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.8 mm -74.11 -39.47 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.694 0.798 . . . . 1.74 111.772 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -65.79 -31.52 72.54 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.803 -1.186 . . . . 1.79 112.288 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.7 mt -71.23 -11.55 60.99 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.488 1.915 . . . . 2.16 113.685 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -87.03 158.34 19.25 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.762 1.225 . . . . 2.29 112.873 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.13 161.3 14.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.499 1.519 . . . . 2.28 114.326 -169.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p -90.98 -47.72 7.41 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.474 1.51 . . . . 2.76 113.203 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -142.08 157.4 44.95 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.336 1.454 . . . . 4.12 112.782 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.17 157.38 44.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.383 1.473 . . . . 0.88 112.525 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.1 m -100.4 107.02 18.67 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.896 0.878 . . . . 0.87 111.589 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.8 mt -78.84 142.26 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.684 1.193 . . . . 0.72 108.443 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.23 135.63 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.643 0.735 . . . . 2.02 111.924 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.0 m -128.83 141.26 51.35 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.747 2.419 . . . . 1.66 110.959 -169.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.6 mt -99.54 130.7 45.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.886 0.874 . . . . 2.82 109.783 168.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.04 23.01 6.6 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.287 1.035 . . . . 3.39 113.457 -169.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -151.1 -82.13 0.1 Allowed 'General case' 0 N--CA 1.484 1.233 0 O-C-N 119.733 -1.854 . . . . 3.8 114.541 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -160.91 55.38 0.3 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.574 1.549 . . . . 5.29 108.941 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.67 -26.33 0.07 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.828 2.451 . . . . 5.18 115.463 -169.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.7 pt -63.02 -5.56 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.422 1.889 . . . . 3.71 115.717 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.24 126.37 26.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.367 1.467 . . . . 2.6 111.62 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.6 mp -114.73 137.5 51.85 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.063 2.145 . . . . 2.49 111.149 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.7 t -140.13 139.11 35.71 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.079 2.152 . . . . 1.34 109.46 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -126.11 151.69 46.9 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.096 -1.002 . . . . 2.84 112.183 -174.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -129.4 128.45 43.04 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.133 1.373 . . . . 2.8 111.25 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -93.46 108.16 19.89 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.263 -0.898 . . . . 2.13 109.571 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 m -118.95 154.55 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.179 0.992 . . . . 0.95 112.263 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -72.7 148.27 44.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.686 -0.486 . . . . 3.21 109.686 171.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.41 -17.86 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.387 1.625 . . . . 1.08 115.387 -168.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -70.94 -20.65 62.44 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.41 -1.431 . . . . 4.26 113.833 170.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.7 mt -98.35 -3.66 36.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.644 1.578 . . . . 1.23 114.078 -168.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -89.14 139.36 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.676 1.591 . . . . 1.54 109.959 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -108.95 164.45 12.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.864 1.266 . . . . 3.85 111.166 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -70.56 37.45 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.726 1.38 . . . . 2.85 114.726 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.47 11.5 0.15 Allowed Glycine 0 CA--C 1.54 1.62 0 C-N-CA 127.824 2.63 . . . . 0.87 114.395 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -97.3 165.4 12.05 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.829 1.815 . . . . 2.33 112.505 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.7 mm -113.21 123.08 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.822 1.649 . . . . 1.55 110.49 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.7 mm -116.24 128.52 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.011 1.324 . . . . 0.77 112.174 -170.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -85.91 140.04 30.71 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.455 1.102 . . . . 2.06 112.926 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.62 136.57 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.65 1.18 . . . . 0.66 112.118 174.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.69 160.93 30.33 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.637 1.175 . . . . 0.9 113.818 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.18 123.6 13.49 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.571 2.18 . . . . 1.17 111.526 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.02 -2.36 87.7 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.619 2.057 . . . . 1.08 115.242 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.84 171.71 54.62 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 119.246 1.523 . . . . 1.08 114.049 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -111.24 152.44 27.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.047 1.339 . . . . 2.41 112.235 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -76.66 131.94 73.02 Favored Pre-proline 0 CA--C 1.553 1.066 0 CA-C-O 118.629 -0.701 . . . . 2.3 111.587 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -96.1 -17.13 0.35 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.264 2.642 . . . . 0.8 115.787 -173.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.49 171.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 127.07 2.148 . . . . 0.75 108.976 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.6 137.38 40.9 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.935 0.789 . . . . 1.9 112.652 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.13 -156.48 20.4 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 114.548 0.579 . . . . 0.8 114.548 -171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.6 ttp85 -114.78 140.3 49.03 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.631 1.172 . . . . 3.85 112.939 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.9 t -88.85 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.685 1.994 . . . . 0.73 108.971 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.9 pt -140.92 33.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.84 0.829 . . . . 0.96 112.376 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -166.12 137.23 3.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.22 1.808 . . . . 2.71 109.662 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.52 -176.1 51.11 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 123.691 0.662 . . . . 0.82 114.74 171.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -156.8 92.27 1.27 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.06 0.944 . . . . 3.11 112.13 -168.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.63 165.86 19.17 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.85 1.66 . . . . 1.18 112.675 -169.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.0 ttm -112.28 130.75 55.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.455 1.102 . . . . 1.48 110.544 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.3 t -123.4 142.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.311 1.444 . . . . 0.9 113.365 -167.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -104.03 107.72 18.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.835 1.254 . . . . 1.86 112.288 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -103.01 27.21 7.32 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 126.09 1.756 . . . . 2.38 114.109 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 p -51.53 -9.36 0.07 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 119.206 3.039 . . . . 2.14 119.206 -169.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.36 -49.28 1.92 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.023 1.329 . . . . 1.4 111.128 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.2 mm -67.04 -55.99 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 119.309 0.959 . . . . 1.2 111.917 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.8 p -95.59 -13.24 24.55 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.028 0.931 . . . . 1.37 111.75 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.58 11.43 84.41 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.198 1.38 . . . . 1.31 115.569 169.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.54 -40.34 82.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.209 1.004 . . . . 2.46 113.235 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.04 43.78 8.64 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.35 1.46 . . . . 1.52 112.246 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.0 ptm -161.98 159.4 21.88 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 128.979 2.912 . . . . 4.4 109.602 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.82 139.25 17.48 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.577 2.185 . . . . 2.31 112.534 172.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.49 139.09 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.871 1.669 . . . . 1.12 110.578 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.37 137.08 32.64 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.132 -0.98 . . . . 0.82 112.499 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -117.36 157.2 26.57 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.659 1.584 . . . . 0.72 111.027 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -160.1 172.99 5.27 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 127.536 2.335 . . . . 2.26 110.511 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -53.57 135.2 60.93 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 CA-C-N 122.201 1.822 . . . . 1.04 111.656 167.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.31 38.87 44.95 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.356 0.503 . . . . 0.88 113.284 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 t -125.52 139.29 53.74 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 118.088 0.944 . . . . 1.46 111.396 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.6 p -91.05 145.02 25.04 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.902 1.228 . . . . 0.98 112.475 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.2 m -135.88 156.45 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.63 1.572 . . . . 0.61 112.095 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -130.01 144.02 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.487 1.515 . . . . 1.13 112.984 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.92 147.44 50.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.757 0.823 . . . . 0.9 112.912 -175.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.27 -6.64 63.11 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 115.245 0.858 . . . . 1.04 115.245 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.5 p -76.12 158.03 32.21 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.441 1.121 . . . . 1.41 110.395 167.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -108.76 140.26 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.383 1.073 . . . . 1.11 110.996 -171.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -109.09 147.72 31.97 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.803 1.241 . . . . 1.68 113.475 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -150.95 140.35 21.43 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.983 1.313 . . . . 3.49 112.045 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 t30 43.85 88.09 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.219 2.608 . . . . 3.15 113.708 168.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.47 -10.37 0.14 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 117.665 1.826 . . . . 3.75 117.665 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.3 m 45.31 85.48 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 127.732 2.413 . . . . 2.52 115.946 169.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.2 mt -106.99 160.72 15.33 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.17 1.544 . . . . 0.93 115.17 -169.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.0 135.55 51.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.332 1.053 . . . . 2.43 110.604 165.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.56 129.72 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.257 1.823 . . . . 1.66 110.396 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.3 p -83.1 119.27 24.29 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.484 -0.76 . . . . 1.52 109.034 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.32 124.99 28.62 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.813 -0.554 . . . . 0.8 110.244 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 p -118.16 -0.65 11.53 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.353 1.861 . . . . 2.38 112.884 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -142.97 136.23 28.29 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.842 2.057 . . . . 1.87 110.054 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.38 162.93 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.404 -0.961 . . . . 1.64 108.404 164.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.1 91.08 Favored Glycine 0 N--CA 1.479 1.562 0 O-C-N 120.4 -1.437 . . . . 1.33 114.215 -169.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.94 -32.73 74.37 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.803 1.241 . . . . 1.63 113.997 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -79.41 -9.76 59.66 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.962 2.105 . . . . 2.28 115.142 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.0 p -70.1 154.69 41.62 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.067 -1.646 . . . . 1.47 112.93 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.8 t -57.7 -30.25 65.35 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.387 -0.821 . . . . 1.86 112.889 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.03 -49.88 75.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.931 -1.106 . . . . 1.6 112.044 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.3 m -64.24 -34.11 77.35 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.11 0.964 . . . . 1.72 110.922 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.19 -40.48 82.18 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.923 -0.486 . . . . 1.68 111.882 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.0 mt -58.32 -54.69 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.478 1.111 . . . . 1.18 110.604 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.11 -22.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.178 1.177 . . . . 1.45 114.178 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -71.68 -46.4 58.98 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.842 0.857 . . . . 2.65 112.116 172.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.72 -43.73 65.39 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.786 0.834 . . . . 2.35 112.217 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.42 -17.87 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 120.557 -1.34 . . . . 2.71 113.53 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -67.97 -28.75 67.72 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.854 1.262 . . . . 4.05 112.012 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -70.38 -19.81 62.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.518 1.127 . . . . 3.64 113.471 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.98 -58.97 2.93 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.171 1.388 . . . . 4.31 111.821 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 125.438 1.495 . . . . 4.38 113.453 179.666 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.5 p . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 114.007 1.114 . . . . 5.3 114.007 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -99.51 -10.44 22.12 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.298 1.039 . . . . 5.39 113.052 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.4 -38.07 35.71 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.628 1.344 . . . . 2.06 114.628 169.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.79 -46.28 70.98 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 117.22 2.304 . . . . 1.77 117.22 -165.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.37 -31.81 60.62 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.721 1.146 . . . . 1.35 113.06 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -69.0 -31.78 70.86 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.966 1.706 . . . . 2.84 113.333 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.97 -41.77 71.57 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.295 0.952 . . . . 1.47 111.998 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.37 -38.06 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 122.942 0.497 . . . . 2.07 111.285 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.8 m -66.89 -24.16 66.08 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.604 -1.31 . . . . 1.8 113.639 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.02 -15.53 62.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.258 1.423 . . . . 2.36 113.453 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -72.55 118.9 16.03 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.167 0.894 . . . . 3.38 109.506 172.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.25 177.98 2.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.278 1.831 . . . . 2.59 115.445 -168.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.2 m -112.59 -39.37 4.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.967 1.707 . . . . 2.45 113.006 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -141.18 157.14 45.67 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.49 1.293 . . . . 2.9 114.49 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.08 170.98 14.7 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.691 1.597 . . . . 0.93 112.822 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.7 m -131.08 112.94 13.33 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.287 1.435 . . . . 1.3 111.654 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.8 mt -85.16 142.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.317 1.447 . . . . 1.1 109.632 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -102.05 121.62 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 121.18 0.514 . . . . 2.09 111.254 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.4 m -121.93 144.34 48.92 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.252 1.421 . . . . 1.8 110.078 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.7 mt -109.88 150.57 28.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.122 1.369 . . . . 2.57 112.828 -168.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.53 -22.34 0.81 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 116.184 1.92 . . . . 4.38 116.184 -174.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.3 m -109.93 3.76 20.84 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.847 1.203 . . . . 4.69 113.994 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t0 88.94 78.46 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 129.841 3.256 . . . . 5.23 111.704 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.317 14.6 p30 54.98 -6.12 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.979 2.912 . . . . 4.26 118.24 -169.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.0 pt -91.27 -8.1 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 115.796 1.776 . . . . 4.71 115.796 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 tt -129.6 137.43 50.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.738 1.215 . . . . 3.61 111.046 169.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.41 136.94 52.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.814 1.646 . . . . 2.76 111.596 174.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -135.52 111.29 9.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.94 1.696 . . . . 2.05 108.104 170.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.04 143.84 26.28 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.905 1.076 . . . . 2.51 113.905 -169.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -113.69 126.11 54.89 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.862 1.665 . . . . 3.85 110.141 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -98.98 122.32 42.08 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.558 1.072 . . . . 2.41 111.535 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.19 158.0 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.931 1.085 . . . . 0.93 113.931 -168.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -78.36 145.1 35.42 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.711 -0.848 . . . . 3.55 108.711 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 p -62.42 -18.48 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 114.386 1.254 . . . . 1.55 114.386 -168.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -61.42 -27.67 68.71 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.589 -1.319 . . . . 3.61 113.309 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.3 mt -93.17 -5.72 49.47 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.283 1.833 . . . . 1.44 115.008 -169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.76 140.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.831 1.652 . . . . 1.45 109.663 171.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -114.98 160.47 19.53 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.394 1.478 . . . . 3.0 111.968 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -67.43 137.57 56.0 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.349 -0.982 . . . . 3.21 108.349 167.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.69 -4.35 56.4 Favored Glycine 0 CA--C 1.543 1.803 0 C-N-CA 124.339 0.971 . . . . 1.61 114.115 -168.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -93.43 158.65 15.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.168 1.387 . . . . 2.49 112.527 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.97 120.12 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.868 1.267 . . . . 1.55 110.229 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 mm -122.1 132.54 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.882 1.673 . . . . 0.86 111.47 -168.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.22 130.0 34.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.623 0.769 . . . . 1.88 112.654 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.8 p -116.33 132.99 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.106 1.362 . . . . 0.75 111.282 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.94 161.86 42.83 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 125.479 1.511 . . . . 0.9 113.318 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.74 139.81 70.99 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.691 1.594 . . . . 1.13 109.997 166.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.85 -14.72 41.29 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 126.164 1.84 . . . . 1.21 115.366 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.82 159.86 44.37 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.546 1.673 . . . . 1.07 114.878 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -92.68 139.65 30.35 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.978 1.311 . . . . 4.02 111.502 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.34 130.13 94.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.396 -0.812 . . . . 2.39 111.371 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -89.8 -13.42 2.67 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.706 2.271 . . . . 0.87 114.908 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.11 175.2 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 127.503 2.321 . . . . 1.47 109.903 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.255 1.2 p30 -111.55 147.23 35.85 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.159 0.8 . . . . 1.87 113.159 172.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.25 -159.37 32.5 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 115.002 0.761 . . . . 0.58 115.002 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 ttp-105 -111.43 140.62 45.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.229 1.412 . . . . 4.25 112.564 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.91 128.4 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 127.436 2.294 . . . . 0.73 108.377 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.76 32.83 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.234 0.827 . . . . 0.68 113.234 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -168.03 134.01 1.96 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.655 1.582 . . . . 3.4 108.51 167.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.78 178.96 52.58 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 122.086 0.826 . . . . 0.81 114.623 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -148.72 124.38 10.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.605 0.762 . . . . 2.55 112.78 -172.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -145.45 169.49 18.24 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.292 1.437 . . . . 1.14 113.499 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.3 ttm -110.79 132.28 54.34 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.266 1.427 . . . . 0.88 110.454 174.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -118.98 140.22 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.979 1.311 . . . . 0.85 111.968 -169.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -107.19 92.89 4.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.498 1.119 . . . . 2.13 111.068 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -87.2 22.62 2.04 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.418 1.887 . . . . 1.88 113.999 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.9 p -55.49 -8.76 0.39 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 118.973 2.953 . . . . 2.1 118.973 -169.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -126.24 -38.12 2.17 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.916 1.686 . . . . 1.49 111.501 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.6 mm -76.84 -61.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.211 0.604 . . . . 1.56 111.191 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.3 p -98.58 -12.97 20.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.938 0.895 . . . . 1.63 112.616 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.04 87.29 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.329 1.442 . . . . 1.43 115.971 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -56.1 -45.15 79.52 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.34 1.056 . . . . 3.43 111.68 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 69.81 -14.67 0.35 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.559 2.744 . . . . 2.22 114.764 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 58.3 ttm -87.87 149.28 45.43 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.292 1.837 . . . . 3.06 110.089 168.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.09 133.83 34.61 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.324 2.683 . . . . 1.48 112.606 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.04 135.2 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 125.987 1.715 . . . . 0.86 111.863 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.39 135.3 36.66 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.034 0.934 . . . . 1.08 113.494 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -128.53 144.71 51.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.016 1.726 . . . . 0.75 111.358 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -146.55 174.74 3.16 Favored Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 128.929 2.892 . . . . 2.64 109.072 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.66 132.88 45.17 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 122.105 1.787 . . . . 0.77 110.526 169.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.45 33.68 21.9 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.012 1.291 . . . . 0.75 114.248 -169.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 57.2 m -123.41 152.42 41.6 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.883 1.273 . . . . 1.44 111.258 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.9 p -102.37 152.15 21.43 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.983 1.265 . . . . 0.84 113.959 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.08 161.65 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.472 1.909 . . . . 0.5 112.292 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.89 149.9 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.585 1.954 . . . . 1.12 112.542 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.88 154.39 30.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.8 1.24 . . . . 0.7 114.191 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.6 -11.26 14.22 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.879 1.228 . . . . 0.8 115.43 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 m -81.8 160.2 23.6 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.426 1.09 . . . . 2.75 111.047 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.03 145.37 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.114 0.966 . . . . 1.26 111.655 -171.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -107.99 139.68 42.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.855 2.062 . . . . 1.82 111.228 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -152.08 145.24 24.61 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.715 -1.241 . . . . 4.51 112.049 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 53.2 t30 122.53 -55.81 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.099 1 C-N-CA 132.004 4.122 . . . . 3.44 111.228 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -165.74 175.24 41.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.568 1.08 . . . . 1.82 114.891 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.5 m -77.71 137.97 38.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.847 1.259 . . . . 1.87 112.193 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.8 mt -127.08 162.55 25.79 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.594 1.158 . . . . 1.05 112.111 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.6 127.46 54.53 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.653 0.781 . . . . 2.58 110.343 168.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 mm -114.05 124.51 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 125.468 1.507 . . . . 1.59 109.981 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.1 p -91.38 121.57 33.22 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.844 0.747 . . . . 1.46 109.412 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.25 138.02 37.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.344 0.658 . . . . 1.29 111.819 -173.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -112.35 -12.3 13.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.062 0.945 . . . . 2.75 112.919 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -142.64 141.65 31.93 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.196 1.399 . . . . 1.64 110.948 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.89 161.84 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.494 1.117 . . . . 1.75 111.443 170.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.9 -35.96 91.48 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.4 -0.813 . . . . 2.31 113.899 -169.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.74 84.34 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.149 0.974 . . . . 2.93 111.661 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.3 -4.69 31.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.389 1.625 . . . . 3.49 115.389 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.4 p -59.79 147.94 36.25 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.923 1.238 . . . . 2.03 111.704 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.7 t -57.67 -19.8 29.25 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.203 1.186 . . . . 1.9 114.203 -174.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -48.55 -46.08 38.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.591 1.556 . . . . 1.65 112.438 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.6 p -69.11 -29.08 67.08 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.281 1.033 . . . . 2.22 112.839 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -74.64 -42.5 58.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.724 1.21 . . . . 1.33 111.917 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 69.1 mt -54.72 -46.19 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.69 1.196 . . . . 1.34 110.861 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m -70.03 -20.89 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.606 -1.309 . . . . 1.46 114.176 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -75.2 -29.1 60.24 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.13 0.972 . . . . 2.39 113.235 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.0 mt -73.74 -58.32 3.38 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.921 1.288 . . . . 2.6 111.479 168.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 85.4 t -65.73 -22.08 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.862 0.865 . . . . 2.48 112.775 -169.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.8 -33.97 75.84 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.041 -1.662 . . . . 3.45 112.912 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.87 -14.31 60.28 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.36 -1.462 . . . . 5.74 113.376 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.02 -36.65 64.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.152 0.981 . . . . 5.65 112.778 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 124.746 1.218 . . . . 6.02 110.776 169.189 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 112.481 0.549 . . . . 2.43 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -70.97 -43.4 68.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.376 0.67 . . . . 4.42 109.723 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.65 74.37 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.723 1.209 . . . . 1.38 112.454 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.81 -33.06 73.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.706 0.803 . . . . 1.66 111.673 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.39 -48.02 21.28 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.701 0.682 . . . . 1.28 111.245 168.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.32 -40.13 61.49 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.745 2.018 . . . . 2.63 113.983 -174.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -43.42 -51.91 6.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.7 1.2 . . . . 1.74 111.695 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.2 mm -72.69 -28.02 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.498 1.119 . . . . 2.66 113.125 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -74.0 -24.02 59.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.405 1.082 . . . . 1.19 112.894 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.47 -16.9 61.97 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.636 0.976 . . . . 2.04 113.636 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.4 154.43 42.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.501 1.143 . . . . 2.88 113.466 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.58 160.79 26.3 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.638 -1.165 . . . . 1.9 110.855 168.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.6 m -108.65 -6.43 15.99 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.507 1.523 . . . . 1.9 112.272 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.21 159.51 41.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.199 1.8 . . . . 3.37 113.012 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.19 156.65 44.4 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.209 1.404 . . . . 0.69 113.092 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -109.66 108.61 19.07 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 113.279 0.844 . . . . 0.88 113.279 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.9 mt -86.82 125.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.894 1.278 . . . . 0.77 110.064 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.04 125.3 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 119.571 1.078 . . . . 2.18 112.539 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 m -142.26 149.21 39.28 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.893 1.277 . . . . 2.76 113.647 -172.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.69 148.67 49.83 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.729 1.611 . . . . 2.65 112.792 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -147.44 16.75 1.16 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.071 1.508 . . . . 6.1 115.071 -173.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 m -130.11 -120.61 0.22 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.322 1.449 . . . . 3.91 109.135 -175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -117.8 60.1 0.78 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.245 1.818 . . . . 7.77 109.266 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t30 66.72 -39.55 0.35 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 128.734 2.814 . . . . 6.41 114.865 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.6 pt -45.85 -30.33 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 127.862 2.465 . . . . 5.31 117.143 -174.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.02 -39.71 79.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.054 1.341 . . . . 3.79 113.509 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.7 tp 12.46 63.43 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 129.379 3.072 . . . . 2.79 114.245 -173.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 m -77.64 136.02 38.18 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.943 1.297 . . . . 1.85 111.394 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -122.39 127.27 49.51 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.065 0.946 . . . . 2.41 110.241 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -114.45 119.86 38.34 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.959 1.303 . . . . 4.21 108.891 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -93.97 124.0 37.69 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.582 -0.896 . . . . 1.91 108.582 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 m -137.63 170.71 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.734 1.214 . . . . 0.73 112.265 -169.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.17 147.35 36.54 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.769 0.828 . . . . 3.4 110.601 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.88 -17.67 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 113.734 1.013 . . . . 1.13 113.734 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.52 -17.62 26.72 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 120.351 -1.468 . . . . 4.68 113.511 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.62 -16.68 28.24 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.246 1.419 . . . . 1.43 113.441 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -76.53 147.54 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.289 -0.882 . . . . 1.63 110.065 169.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -121.81 162.41 20.95 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.324 1.45 . . . . 3.21 111.852 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.4 ptt-85 -72.84 139.2 46.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.576 -0.738 . . . . 5.0 109.931 170.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.54 -3.43 10.23 Favored Glycine 0 CA--C 1.541 1.713 0 N-CA-C 115.666 1.027 . . . . 1.09 115.666 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -119.25 -174.42 2.72 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.592 1.696 . . . . 3.42 112.979 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.68 130.25 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.894 1.678 . . . . 1.8 109.933 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -115.89 129.35 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.738 2.015 . . . . 0.71 110.144 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HE3' HD11 ' A' ' 96' ' ' LEU . 41.9 mtpt -92.15 133.95 35.31 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 121.627 -0.671 . . . . 2.15 112.611 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 p -116.02 133.39 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.049 1.34 . . . . 0.7 111.44 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 m -100.67 162.2 21.47 Favored Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 124.414 1.086 . . . . 0.87 113.095 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.25 137.61 71.13 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.064 2.51 . . . . 1.07 112.472 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.14 -7.37 4.56 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.569 0.987 . . . . 1.03 115.569 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.12 160.88 50.31 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.193 1.497 . . . . 0.94 113.542 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -99.14 152.09 20.26 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.704 1.202 . . . . 1.96 112.146 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -81.04 125.03 80.73 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.021 0.929 . . . . 1.78 110.823 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.35 -20.8 2.59 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.987 2.458 . . . . 0.7 115.496 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 m -151.17 168.78 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 127.921 2.488 . . . . 0.85 108.834 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -89.32 148.03 23.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.122 0.874 . . . . 2.19 111.793 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.8 -149.42 10.0 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 114.416 0.526 . . . . 1.01 114.416 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.3 ttm105 -132.26 144.5 50.65 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.711 1.205 . . . . 5.02 113.058 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.93 132.77 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.185 2.194 . . . . 0.86 109.78 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.7 pt -140.67 30.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 114.144 1.165 . . . . 0.86 114.144 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -168.51 140.3 2.75 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.488 -1.383 . . . . 3.38 110.048 168.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.15 -165.12 32.66 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.604 1.097 . . . . 0.99 114.641 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -150.27 123.22 8.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.383 1.473 . . . . 1.87 111.423 -175.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.06 171.89 15.13 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.18 1.178 . . . . 1.1 114.18 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.0 ttm -121.05 132.93 55.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.207 1.403 . . . . 0.84 109.643 172.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.86 134.81 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.903 1.281 . . . . 0.63 112.0 -168.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -94.98 113.4 25.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.465 1.906 . . . . 2.16 110.642 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -114.72 22.76 13.25 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.621 1.568 . . . . 2.22 112.964 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.7 p -57.06 -22.92 42.9 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 118.176 2.658 . . . . 2.03 118.176 -167.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -105.04 -31.03 9.38 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.516 1.527 . . . . 1.3 111.415 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.0 mm -74.36 -67.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.534 1.134 . . . . 1.3 110.919 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.1 p -99.13 -4.85 31.28 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.444 1.497 . . . . 1.52 112.306 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.13 2.79 85.56 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.801 1.191 . . . . 2.09 114.757 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -73.81 108.23 6.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.412 1.085 . . . . 3.61 112.263 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.94 -16.49 56.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.47 1.108 . . . . 2.12 112.963 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.4 ttp -109.85 121.08 43.03 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.675 1.59 . . . . 3.4 108.052 169.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.82 165.66 28.99 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.604 2.869 . . . . 1.5 114.275 -168.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.14 130.45 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.545 1.538 . . . . 0.8 111.02 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.58 137.4 38.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.08 0.552 . . . . 0.7 111.66 174.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.18 147.26 46.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.807 1.643 . . . . 0.85 110.404 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -145.63 171.65 6.26 Favored Pre-proline 0 N--CA 1.48 1.048 0 C-N-CA 127.639 2.376 . . . . 2.8 110.248 -171.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.14 127.15 23.82 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.973 1.74 . . . . 1.02 111.556 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.01 35.29 18.88 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.539 1.066 . . . . 0.9 113.902 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.9 t -118.47 154.7 32.07 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.427 1.613 . . . . 1.55 112.252 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -107.1 144.03 34.39 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.657 1.183 . . . . 1.02 112.536 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 m -138.72 153.71 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.187 0.995 . . . . 0.73 113.555 -172.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -118.37 146.25 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.001 1.32 . . . . 0.9 114.031 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.1 143.82 31.47 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.207 1.403 . . . . 0.76 112.154 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.62 -4.04 66.21 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.845 1.098 . . . . 0.68 115.845 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.4 p -74.25 159.38 32.56 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.074 1.437 . . . . 1.4 111.758 169.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.58 140.58 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.397 1.079 . . . . 0.8 111.507 -173.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -81.86 139.29 34.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.502 1.121 . . . . 2.68 111.475 172.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -146.35 56.88 1.18 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.5 1.296 . . . . 3.22 114.5 168.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -160.03 -59.36 0.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.374 1.25 . . . . 3.4 114.374 167.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -164.21 168.96 38.87 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.701 1.143 . . . . 1.99 113.497 -168.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.8 p -84.15 148.18 26.91 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.789 1.033 . . . . 1.79 113.789 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -137.5 161.3 36.76 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.993 1.717 . . . . 1.29 111.629 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.479 HD11 ' HE3' ' A' ' 44' ' ' LYS . 9.7 mp -108.42 119.86 40.74 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.075 1.35 . . . . 2.04 110.348 174.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.9 mt -107.13 119.74 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.267 1.427 . . . . 2.12 110.153 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.6 p -79.97 117.11 20.52 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.856 -1.153 . . . . 1.49 110.248 170.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.63 121.83 28.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.616 0.722 . . . . 0.93 112.701 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -115.31 -9.77 12.14 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.558 1.543 . . . . 2.13 113.471 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -138.26 146.0 41.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.5 1.52 . . . . 1.61 111.474 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 m -100.4 160.75 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.47 1.508 . . . . 1.78 110.1 167.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.96 -39.13 56.33 Favored Glycine 0 N--CA 1.472 1.074 0 N-CA-C 116.556 1.382 . . . . 1.28 116.556 -166.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.22 -36.37 71.83 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.654 1.227 . . . . 1.73 113.346 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.66 -9.06 58.26 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.322 1.23 . . . . 2.33 114.322 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.8 p -58.8 152.64 18.64 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.158 -0.964 . . . . 1.65 113.148 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 t -56.82 -39.22 73.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.756 1.222 . . . . 1.89 110.567 169.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.39 -43.36 99.01 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.014 1.726 . . . . 1.47 112.362 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.7 t -67.4 -35.14 78.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.498 0.719 . . . . 2.14 111.839 176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.29 -43.37 70.53 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.364 0.529 . . . . 1.57 111.739 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.6 mt -54.06 -51.4 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.143 0.977 . . . . 1.73 111.589 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.8 m -66.45 -32.14 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 120.99 -1.069 . . . . 1.41 113.04 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -73.61 -27.09 61.1 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.413 1.085 . . . . 2.84 112.633 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.6 mt -70.41 -53.23 17.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.722 1.209 . . . . 3.21 110.654 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.23 -50.38 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.76 0.824 . . . . 2.01 111.777 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -54.47 -41.14 69.15 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.754 1.02 . . . . 3.79 113.754 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.33 -30.91 54.19 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.731 1.012 . . . . 4.03 113.731 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.27 -25.03 62.28 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 115.284 1.587 . . . . 4.37 115.284 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.777 1.631 . . . . 4.89 111.865 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 114.337 1.236 . . . . 2.38 114.337 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.99 -43.58 24.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.771 0.714 . . . . 5.5 109.947 169.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.98 -42.9 81.07 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.753 -0.592 . . . . 1.87 111.797 171.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.39 -33.29 65.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.9 0.88 . . . . 2.25 113.25 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.36 -44.65 35.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.791 0.723 . . . . 1.61 112.581 169.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -64.15 -34.13 77.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.317 0.858 . . . . 2.5 113.317 -174.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.23 -36.38 73.1 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.497 1.044 . . . . 1.25 113.047 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.0 mm -67.01 -37.24 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 118.764 0.711 . . . . 2.38 111.304 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.0 m -72.9 -23.81 60.76 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.387 -0.821 . . . . 1.23 112.754 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.7 mt -72.38 -25.6 61.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.909 1.284 . . . . 2.09 112.905 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -68.49 106.09 2.43 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.721 1.146 . . . . 3.26 110.76 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 155.31 28.23 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.173 1.389 . . . . 2.2 113.467 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.7 m -95.78 -31.14 13.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.388 1.475 . . . . 1.95 114.281 -169.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.35 159.83 41.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.184 0.994 . . . . 2.85 113.33 -169.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.45 163.49 32.96 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.567 1.547 . . . . 0.73 112.776 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.5 m -119.65 97.52 5.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.559 1.544 . . . . 0.8 110.704 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.2 mt -84.89 133.92 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.369 1.068 . . . . 0.79 110.008 -172.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -107.81 127.34 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.506 1.122 . . . . 1.78 111.111 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.6 m -121.8 146.22 47.28 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.4 1.48 . . . . 1.63 111.388 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.5 mt -77.11 113.75 15.17 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.718 0.807 . . . . 3.49 110.625 171.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -99.23 -5.83 29.18 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.349 1.24 . . . . 5.4 114.349 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 m -133.3 -58.7 0.89 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.499 1.52 . . . . 3.89 110.755 169.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -163.1 -158.7 0.49 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.958 2.903 . . . . 4.68 104.728 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -61.26 -1.3 0.47 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.353 1.861 . . . . 5.43 114.588 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.4 pt -91.84 -16.59 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 128.433 2.693 . . . . 4.13 113.747 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -135.34 123.48 22.94 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.736 1.214 . . . . 3.73 111.711 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.97 132.23 56.04 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.621 1.568 . . . . 3.4 111.015 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -142.2 145.66 34.37 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.179 1.392 . . . . 2.06 110.959 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -118.48 149.06 41.92 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.495 1.665 . . . . 2.51 115.495 -168.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -104.07 139.0 39.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.577 1.951 . . . . 2.92 109.65 169.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -98.73 121.23 40.41 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.043 0.937 . . . . 2.23 109.408 172.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.62 159.86 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 115.288 1.588 . . . . 0.82 115.288 -167.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.09 150.74 30.17 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.434 1.093 . . . . 3.17 109.761 166.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.05 -21.27 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.334 1.054 . . . . 1.03 113.646 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.47 -20.14 62.81 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.361 -1.462 . . . . 2.88 112.95 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.1 mt -107.22 -8.93 16.25 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.253 1.575 . . . . 1.42 115.253 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.15 148.89 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.297 1.039 . . . . 1.49 111.051 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -122.3 165.07 16.81 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.121 1.368 . . . . 4.09 114.204 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -69.09 26.19 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 127.011 2.124 . . . . 2.78 116.213 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.79 9.65 2.32 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.003 1.764 . . . . 1.01 113.776 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -89.47 165.07 14.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.126 1.37 . . . . 2.91 112.821 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.1 mt -122.21 128.28 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.143 1.377 . . . . 1.17 110.167 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.1 mm -118.06 130.54 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.407 1.483 . . . . 0.75 113.348 -167.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -82.77 128.08 34.05 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.525 1.13 . . . . 2.58 112.408 172.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -120.39 125.26 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.666 1.186 . . . . 0.78 111.856 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.81 158.57 42.03 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.506 1.522 . . . . 1.16 113.205 -175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.82 123.08 9.11 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.268 3.312 . . . . 1.14 113.489 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.72 -0.75 88.13 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.879 1.228 . . . . 0.96 115.022 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.9 -169.03 30.21 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 118.757 1.278 . . . . 1.05 114.116 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -130.18 158.85 38.57 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.12 1.768 . . . . 2.45 111.462 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -86.68 118.66 70.53 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.621 0.768 . . . . 2.39 109.277 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -89.68 -13.84 2.61 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.04 1.827 . . . . 1.01 115.865 -168.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.0 159.82 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 128.992 2.917 . . . . 1.07 107.699 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.0 147.51 25.7 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.653 0.983 . . . . 2.0 113.653 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.45 -159.3 32.21 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 114.946 0.738 . . . . 0.87 114.946 -173.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -109.12 145.43 35.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.702 1.601 . . . . 5.12 113.541 -169.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 t -106.89 119.88 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 127.396 2.279 . . . . 1.12 108.276 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 pt -136.61 34.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 119.224 0.92 . . . . 1.52 113.399 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.15 127.97 2.21 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.024 1.73 . . . . 3.59 107.454 167.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.88 178.03 40.76 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 122.874 1.263 . . . . 0.89 115.402 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -154.95 110.65 3.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.279 1.032 . . . . 2.4 112.737 -166.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.0 p -137.74 175.05 9.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.609 1.964 . . . . 2.9 113.936 -168.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 38.6 ttm -114.72 145.13 42.41 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.321 1.048 . . . . 1.04 109.619 165.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.37 142.91 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.067 1.347 . . . . 0.64 111.771 -172.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -113.13 113.23 25.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.915 1.686 . . . . 1.88 110.747 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -134.39 14.37 3.79 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.084 1.754 . . . . 2.52 114.336 -170.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.6 p -58.49 -13.95 6.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 117.543 2.423 . . . . 1.34 117.543 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -93.86 -33.32 13.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.999 1.32 . . . . 1.1 111.684 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.0 mm -73.79 -62.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.575 -0.703 . . . . 1.08 110.047 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.6 p -94.23 -13.19 26.84 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.007 1.323 . . . . 1.38 113.382 -171.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.43 10.31 78.93 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.659 1.6 . . . . 1.49 113.827 -172.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.88 98.87 0.58 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.684 1.742 . . . . 2.71 109.385 170.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.64 28.41 0.26 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.988 1.315 . . . . 1.89 112.496 -171.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.2 ptm -155.16 145.0 15.55 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.377 2.271 . . . . 3.27 109.301 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.42 148.92 21.22 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.111 2.541 . . . . 1.35 112.095 -172.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.55 136.21 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.829 1.252 . . . . 0.99 112.416 -168.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.0 150.15 29.0 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.079 0.952 . . . . 0.78 113.125 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -132.26 150.87 52.06 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.131 1.772 . . . . 1.16 111.598 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -143.78 173.88 4.06 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 129.146 2.978 . . . . 3.25 108.784 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -58.06 138.77 87.68 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 CA-C-N 121.058 1.414 . . . . 1.12 110.862 168.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.22 14.61 74.0 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.205 1.383 . . . . 1.04 115.083 -170.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.8 m -97.74 164.87 12.22 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.391 1.596 . . . . 1.81 110.72 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.8 p -124.03 159.96 28.73 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.107 -0.996 . . . . 1.48 113.334 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.65 161.06 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.616 1.966 . . . . 0.7 112.151 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.537 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -116.84 154.86 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.847 2.059 . . . . 1.29 112.026 172.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.2 150.45 48.29 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.37 0.878 . . . . 0.78 113.37 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.64 -5.12 62.01 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.661 1.124 . . . . 0.79 115.219 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.0 p -77.68 157.46 30.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.792 1.237 . . . . 1.51 111.663 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mm -108.39 137.2 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.884 0.874 . . . . 0.74 111.482 -170.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.66 155.13 21.24 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.877 1.671 . . . . 3.45 112.905 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -129.77 124.49 33.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.642 1.577 . . . . 3.02 109.075 166.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.465 ' ND2' ' H ' ' A' ' 93' ' ' GLY . 34.4 t30 45.94 -132.37 1.03 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.101 2.161 . . . . 3.85 110.294 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.465 ' H ' ' ND2' ' A' ' 92' ' ' ASN . . . 88.98 -60.23 3.85 Favored Glycine 0 CA--C 1.527 0.8 0 O-C-N 120.069 -1.644 . . . . 3.42 116.488 166.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.4 m 47.44 77.16 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.398 1.479 . . . . 2.32 111.781 -168.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.2 164.2 12.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.402 1.081 . . . . 1.36 113.421 -166.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mp -119.54 128.7 54.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.158 0.983 . . . . 2.0 110.527 168.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.5 mm -115.74 122.55 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.835 1.654 . . . . 1.43 110.955 -170.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.07 103.34 16.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.756 1.222 . . . . 3.02 110.141 176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.07 131.35 36.23 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.355 1.062 . . . . 0.87 112.001 -174.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.35 6.01 7.0 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.01 1.485 . . . . 2.21 115.01 -175.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -142.05 147.31 36.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.492 1.117 . . . . 1.53 111.842 170.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 p -86.64 163.25 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.442 1.097 . . . . 3.02 110.389 170.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.05 -37.67 94.29 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 120.241 -1.537 . . . . 1.43 114.712 -169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.67 -32.06 71.27 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.244 1.018 . . . . 1.68 112.822 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.42 -16.74 60.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.78 1.232 . . . . 2.64 113.946 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.9 p -68.37 159.87 30.64 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 119.902 1.228 . . . . 1.72 113.714 -169.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.3 t -66.27 -31.12 71.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.396 -0.82 . . . . 2.32 111.539 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.3 mp -57.44 -53.09 62.05 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.839 -1.163 . . . . 1.62 111.828 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.6 p -70.5 -24.69 62.88 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.196 0.998 . . . . 1.81 111.901 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -72.76 -42.61 63.82 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.478 0.918 . . . . 2.15 113.478 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.3 mt -56.68 -49.19 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.031 -1.043 . . . . 1.71 110.259 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 m -65.92 -25.16 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.379 0.881 . . . . 1.58 113.379 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -71.88 -46.44 57.81 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.81 0.844 . . . . 2.4 112.056 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.0 mt -70.07 -36.49 74.98 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.521 1.528 . . . . 2.36 113.65 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.32 -52.14 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.776 -0.453 . . . . 2.29 109.776 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.22 -23.49 63.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.571 1.323 . . . . 4.42 114.571 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.53 -25.48 59.36 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.039 -1.038 . . . . 3.7 113.024 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.14 -50.6 21.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.44 1.018 . . . . 3.93 112.136 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.183 0 C-N-CA 124.943 1.297 . . . . 4.16 113.728 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 112.05 0.389 . . . . 2.98 112.05 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -76.28 -49.15 17.78 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.225 -0.922 . . . . 4.91 110.136 168.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.45 -15.25 62.8 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.149 1.537 . . . . 1.71 115.149 -170.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.9 tp -68.17 -31.64 71.33 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.608 -1.308 . . . . 1.93 113.731 -169.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.89 -21.01 55.56 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.894 -1.129 . . . . 1.34 113.532 169.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -69.39 -41.41 76.49 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.813 -1.179 . . . . 2.63 111.366 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.19 -43.56 82.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.241 1.016 . . . . 1.02 112.162 177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.02 -33.64 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.294 -0.879 . . . . 1.6 111.998 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.9 m -75.77 -19.62 58.87 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.285 1.034 . . . . 1.12 113.177 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mt -68.12 -32.13 72.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.585 1.954 . . . . 2.07 113.006 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -57.11 131.76 50.88 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.853 1.206 . . . . 3.43 111.952 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.08 144.93 53.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.835 -0.621 . . . . 2.3 109.489 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 p -78.52 -20.98 49.55 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.118 1.155 . . . . 3.15 114.118 -174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -137.76 158.65 43.91 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.61 1.337 . . . . 3.97 114.61 -169.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.86 172.8 12.19 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.595 1.958 . . . . 1.17 112.476 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.6 m -131.45 102.41 5.93 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.135 1.774 . . . . 1.2 111.141 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.5 mt -80.38 128.62 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.045 1.338 . . . . 0.76 109.387 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.51 132.97 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.804 0.842 . . . . 2.18 112.533 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.4 m -140.52 150.98 44.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.611 1.165 . . . . 2.15 113.403 -169.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mt -104.07 132.54 50.22 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.861 0.864 . . . . 3.1 108.784 166.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.66 174.44 10.12 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.276 1.431 . . . . 4.09 112.74 -168.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.4 t 68.26 -61.53 0.39 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.155 2.582 . . . . 6.7 113.801 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -164.82 46.61 0.1 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.685 3.194 . . . . 6.34 107.026 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.277 0.6 OUTLIER 59.21 -8.54 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 128.453 2.701 . . . . 6.83 115.919 -165.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.5 pt -68.73 -19.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.322 1.849 . . . . 5.29 115.425 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.7 tp -107.84 98.92 8.44 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.085 1.354 . . . . 3.78 109.074 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mp -81.35 121.93 26.83 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.42 -0.8 . . . . 3.62 109.051 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 t -124.93 144.33 50.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.138 1.375 . . . . 2.03 111.207 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -141.79 127.25 18.86 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.947 1.299 . . . . 2.34 110.054 -171.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.4 133.35 53.43 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.723 -1.236 . . . . 3.28 111.12 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.69 123.47 43.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.082 0.856 . . . . 2.9 110.965 176.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -129.61 165.41 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.243 1.417 . . . . 1.28 112.808 -168.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -80.18 151.1 29.9 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.115 1.366 . . . . 3.69 110.165 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.35 -23.09 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 120.968 -1.083 . . . . 1.76 113.117 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -70.05 -18.16 63.27 Favored 'General case' 0 CA--C 1.552 1.053 0 O-C-N 120.813 -1.179 . . . . 3.78 113.741 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -110.52 -3.36 16.04 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.093 1.516 . . . . 1.73 115.093 -169.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -94.63 145.33 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.931 1.692 . . . . 1.97 111.067 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -122.79 166.72 14.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.713 2.405 . . . . 3.4 114.041 -175.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -73.86 16.18 0.24 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.787 2.143 . . . . 3.45 116.787 -169.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.97 11.25 3.64 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.218 1.865 . . . . 1.33 113.829 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -79.64 152.74 29.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.332 1.566 . . . . 3.54 112.508 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.24 120.08 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.116 1.366 . . . . 1.8 108.922 173.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.6 mm -118.76 125.25 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.031 0.932 . . . . 0.62 113.198 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.563 ' HE3' HD11 ' A' ' 96' ' ' LEU . 17.7 ttmt -80.03 128.69 33.78 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.378 0.671 . . . . 1.93 110.632 167.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 p -103.14 137.07 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.137 0.975 . . . . 0.66 111.113 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -88.58 160.66 44.18 Favored Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 113.35 0.87 . . . . 1.16 113.35 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.01 136.29 64.52 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.67 2.247 . . . . 1.31 110.41 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.64 -3.97 23.49 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.443 1.497 . . . . 0.96 116.408 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.97 178.26 53.9 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.203 1.382 . . . . 0.98 114.9 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -126.65 148.0 49.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.659 1.584 . . . . 2.38 112.616 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -82.73 126.68 72.6 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.394 0.677 . . . . 1.86 112.601 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -90.89 -22.6 0.61 Allowed 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.122 3.215 . . . . 1.0 114.713 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 m -147.67 170.3 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 128.524 2.73 . . . . 0.8 108.721 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -99.22 156.35 17.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.106 1.15 . . . . 1.68 114.106 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.8 -168.1 39.87 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 115.845 1.098 . . . . 0.65 115.845 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -112.17 138.72 48.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.43 1.892 . . . . 4.15 111.552 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.82 127.84 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 127.016 2.126 . . . . 0.67 109.399 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.2 pt -140.61 31.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.494 0.718 . . . . 0.7 112.844 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -167.3 133.59 2.2 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.415 1.486 . . . . 2.57 109.821 169.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.41 -177.8 48.86 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.075 1.19 . . . . 0.79 116.075 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -147.75 113.02 5.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.864 1.266 . . . . 2.31 112.402 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.79 167.27 22.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.488 1.115 . . . . 1.28 111.607 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.7 ttm -105.3 145.57 30.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.955 0.902 . . . . 0.96 109.945 169.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.57 136.0 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.215 1.006 . . . . 0.7 112.054 -170.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -100.89 132.66 46.19 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.067 1.347 . . . . 2.21 111.631 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -133.62 16.46 3.98 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.101 1.519 . . . . 1.82 115.101 -169.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' A' ' 73' ' ' ALA . 98.0 p -44.38 -32.45 1.35 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 119.628 3.196 . . . . 1.8 119.628 -166.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -95.09 -41.82 8.92 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.648 1.113 . . . . 1.51 111.202 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.4 mm -69.04 -64.32 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.889 1.276 . . . . 1.05 111.498 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.4 p -93.69 -11.3 31.85 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.202 1.401 . . . . 1.32 112.327 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.54 2.16 87.29 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.021 1.296 . . . . 1.23 115.083 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -55.68 -46.46 77.58 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.174 0.987 . . . . 2.33 113.542 -170.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' A' ' 67' ' ' SER . . . 55.94 27.25 10.85 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.679 1.592 . . . . 2.07 113.369 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.7 ttt -152.79 136.85 10.36 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 131.158 3.783 . . . . 3.68 105.312 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.32 153.51 35.71 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.719 2.28 . . . . 1.35 112.881 -172.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.8 t -128.39 134.38 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.735 1.614 . . . . 1.01 112.073 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.55 134.12 36.48 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.545 1.138 . . . . 0.9 113.488 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -117.7 143.52 46.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.635 1.974 . . . . 0.87 110.655 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -142.93 175.34 2.94 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 127.358 2.263 . . . . 3.59 109.465 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -59.18 127.82 25.42 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 CA-C-N 122.182 1.815 . . . . 0.99 111.325 170.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.29 33.59 11.63 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.659 1.123 . . . . 1.03 114.749 -169.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -121.09 170.82 9.17 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.166 1.386 . . . . 1.76 111.173 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.8 p -122.74 151.22 41.8 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.493 -1.379 . . . . 0.81 113.449 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.72 156.37 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.936 1.694 . . . . 0.69 112.272 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -123.97 159.06 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.213 1.805 . . . . 0.97 112.355 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.14 149.99 49.43 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.769 -0.582 . . . . 0.65 112.479 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.7 -2.42 83.0 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 115.293 0.877 . . . . 1.03 115.293 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.88 153.14 32.92 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 117.783 0.792 . . . . 1.96 112.05 168.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mm -108.89 129.84 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.988 1.315 . . . . 0.73 110.493 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -94.77 142.38 27.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.04 1.736 . . . . 1.66 111.856 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.65 -101.33 0.11 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.242 1.201 . . . . 5.1 114.242 -174.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -98.42 -41.36 7.84 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.324 1.602 . . . . 3.66 115.324 -167.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.49 140.37 18.11 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 119.487 1.04 . . . . 1.85 114.041 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.1 t -84.93 129.35 34.82 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.735 0.814 . . . . 2.62 110.413 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.2 mt -120.69 158.72 26.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.375 1.47 . . . . 0.96 110.902 -173.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.563 HD11 ' HE3' ' A' ' 44' ' ' LYS . 7.8 mp -112.97 129.75 56.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.166 0.587 . . . . 1.76 109.88 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.31 128.19 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.596 1.558 . . . . 1.12 110.222 -173.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 23.4 p -81.84 111.16 17.8 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.288 -1.004 . . . . 1.51 108.288 168.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.29 142.96 37.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.869 0.868 . . . . 1.06 110.848 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -132.21 3.5 3.99 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.876 1.806 . . . . 2.99 115.876 -169.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -145.16 150.81 37.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.842 1.257 . . . . 1.98 111.473 170.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.8 m -81.88 171.41 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.206 1.002 . . . . 1.81 110.85 168.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.75 -28.89 73.3 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 120.756 -1.215 . . . . 1.73 114.699 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.91 -42.75 60.2 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.792 1.296 . . . . 1.79 113.572 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -78.73 -10.2 59.69 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 116.497 2.036 . . . . 2.91 116.497 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.9 t -83.95 156.48 22.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.464 1.505 . . . . 2.57 113.417 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.8 m -39.33 -44.28 1.28 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.99 2.116 . . . . 2.31 114.308 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.17 -46.73 85.8 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.756 1.162 . . . . 1.41 111.847 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.3 t -70.19 -35.65 74.09 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.851 0.861 . . . . 2.38 111.088 173.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -64.25 -35.73 81.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.377 0.671 . . . . 1.92 112.288 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.6 mt -64.69 -58.99 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.466 1.506 . . . . 1.43 110.728 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m -65.37 -20.99 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 113.539 0.941 . . . . 1.48 113.539 -171.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -69.58 -55.53 9.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.171 0.988 . . . . 2.68 111.744 169.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -30.24 56.06 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 115.151 1.538 . . . . 3.22 115.151 -173.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.73 -54.46 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.952 -0.759 . . . . 2.4 108.952 171.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -59.96 -14.71 17.22 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.383 1.994 . . . . 4.35 116.383 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -72.41 -37.28 68.68 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.423 1.465 . . . . 4.55 112.636 169.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.08 -65.1 1.05 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.362 0.665 . . . . 3.81 111.552 169.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 128.348 2.659 . . . . 5.37 112.268 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 112.161 0.43 . . . . 2.7 112.161 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -57.33 -33.21 67.5 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.475 1.51 . . . . 4.46 113.211 173.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.48 -17.79 60.03 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.632 1.345 . . . . 1.51 114.632 172.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 35.3 tp -63.63 -42.62 98.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.903 1.229 . . . . 1.41 113.313 -168.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.8 -21.61 57.17 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.597 -1.314 . . . . 2.19 113.161 169.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -67.17 -39.56 86.47 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.776 1.171 . . . . 2.58 111.446 -170.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -49.47 -46.15 47.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.315 0.646 . . . . 1.43 110.998 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.2 mm -71.52 -27.99 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.652 1.181 . . . . 2.36 113.294 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.9 m -70.91 -37.09 72.92 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.307 1.043 . . . . 1.24 112.83 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.05 -17.34 51.88 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.092 1.145 . . . . 2.39 114.092 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.65 135.52 55.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.691 1.596 . . . . 2.19 113.185 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.13 150.36 48.29 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.399 0.679 . . . . 1.97 112.104 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 m -100.56 -28.55 12.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.765 1.226 . . . . 1.87 112.193 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -140.64 152.93 45.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.054 1.342 . . . . 3.3 112.096 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.08 157.84 44.16 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.638 1.575 . . . . 1.2 113.272 -169.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 m -94.5 109.67 21.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.784 0.834 . . . . 1.48 112.849 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.7 mt -84.48 125.09 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.067 0.947 . . . . 0.81 109.55 169.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.72 130.17 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.986 0.914 . . . . 1.83 110.691 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -140.21 136.24 33.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.594 1.158 . . . . 1.98 111.09 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.3 mt -81.32 92.08 6.33 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.297 -1.001 . . . . 3.33 108.297 169.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.84 -5.38 40.6 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.952 0.901 . . . . 3.6 113.259 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.2 m -158.72 142.46 15.23 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.838 2.055 . . . . 3.99 111.655 167.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 25' ' ' ILE . 1.5 m-20 -3.6 50.49 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.266 1 C-N-CA 134.995 5.318 . . . . 5.86 117.725 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.4 -22.61 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 126.737 2.015 . . . . 5.25 113.339 -166.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.432 ' H ' ' C ' ' A' ' 23' ' ' ASP . 44.7 pt -61.55 -11.44 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 129.106 2.962 . . . . 3.97 116.332 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.5 tp -136.49 103.88 5.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.693 1.197 . . . . 2.68 110.988 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.85 127.65 33.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.081 0.952 . . . . 3.5 109.108 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t -140.59 138.44 34.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.81 0.844 . . . . 1.65 111.588 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -137.39 132.0 32.86 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.195 0.998 . . . . 3.03 110.915 -173.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.2 140.36 48.62 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.243 1.417 . . . . 3.46 109.925 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -100.45 117.77 35.29 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.308 0.958 . . . . 2.05 109.22 168.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.99 156.96 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.857 1.263 . . . . 1.43 111.946 -168.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -76.84 151.62 35.8 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.46 -0.775 . . . . 3.78 111.273 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.0 -19.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 115.037 1.495 . . . . 1.15 115.037 -172.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -78.95 -19.28 52.13 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 120.333 -1.479 . . . . 3.97 113.668 173.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.8 mt -91.36 -6.85 52.32 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.107 1.763 . . . . 1.72 113.43 -174.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.26 143.03 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.218 1.807 . . . . 1.49 110.255 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.32 172.73 10.8 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.17 0.988 . . . . 4.39 112.316 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -65.66 21.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 117.487 2.403 . . . . 3.74 117.487 -172.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.7 42.95 0.81 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.219 1.866 . . . . 1.4 111.714 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -122.66 159.32 28.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.894 1.678 . . . . 2.19 110.584 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 53.7 mt -116.22 125.79 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.18 0.992 . . . . 1.2 109.834 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.5 mm -116.92 127.19 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.936 1.295 . . . . 0.7 112.195 -168.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -79.37 121.66 25.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.693 0.797 . . . . 3.2 109.209 168.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.8 124.44 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.247 1.019 . . . . 1.14 109.29 170.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.8 m -85.99 156.68 57.74 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 123.323 0.649 . . . . 1.3 112.654 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.05 130.71 35.66 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.746 2.297 . . . . 1.35 111.848 171.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.1 -7.44 29.34 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 124.812 1.196 . . . . 1.03 115.07 -171.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.51 -177.83 50.62 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.341 1.448 . . . . 1.09 114.234 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -125.65 158.18 35.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.22 1.408 . . . . 1.81 112.29 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -88.78 129.08 49.97 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.901 0.881 . . . . 2.22 111.859 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.99 -25.59 1.41 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.747 2.965 . . . . 0.88 115.207 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -147.85 167.33 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.833 2.453 . . . . 0.99 108.749 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.21 149.11 24.83 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.023 0.828 . . . . 1.95 111.429 174.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.73 -165.15 35.72 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 114.552 0.581 . . . . 0.96 114.552 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -111.5 144.49 40.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.473 1.509 . . . . 3.56 112.314 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.13 134.03 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.863 2.465 . . . . 1.04 108.225 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 pt -138.35 30.31 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 122.253 1.025 . . . . 1.14 112.42 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -168.54 144.44 3.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.582 1.953 . . . . 3.38 109.552 167.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.29 177.18 38.94 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 117.268 1.667 . . . . 1.06 117.268 167.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -143.78 37.6 1.32 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 115.619 1.711 . . . . 2.21 115.619 -168.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.645 ' H ' HD21 ' A' ' 95' ' ' LEU . 34.7 m -77.3 157.61 30.63 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.718 -1.239 . . . . 1.72 112.247 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.3 ttm -92.89 140.13 29.82 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.841 -0.618 . . . . 1.16 110.083 168.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.5 t -126.24 143.48 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.355 1.462 . . . . 0.73 111.905 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -106.22 111.09 23.55 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.014 1.725 . . . . 2.14 111.429 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.3 16.24 5.01 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.792 1.637 . . . . 1.9 114.662 -172.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.5 p -65.6 -26.92 68.06 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.659 1.726 . . . . 1.46 115.659 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -79.43 -48.21 14.35 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.36 0.982 . . . . 1.51 110.686 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.5 mm -65.73 -55.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.657 0.783 . . . . 1.63 110.499 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.7 p -93.57 -11.63 31.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.407 1.083 . . . . 1.68 113.708 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.07 13.48 82.95 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 119.312 -0.716 . . . . 1.43 113.785 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.58 175.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.14 2.176 . . . . 2.91 113.581 171.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -142.77 6.45 1.61 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.224 1.565 . . . . 2.24 115.224 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -149.55 148.83 27.08 Favored Pre-proline 0 C--O 1.24 0.604 0 O-C-N 120.825 -1.172 . . . . 4.09 109.272 168.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.08 157.85 60.13 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.565 2.176 . . . . 1.27 111.395 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.8 t -117.25 127.81 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.832 1.253 . . . . 0.94 112.353 -167.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.21 130.17 35.2 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.274 0.629 . . . . 1.01 111.213 173.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.12 162.92 12.56 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.684 1.194 . . . . 0.81 111.649 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -150.6 165.17 18.0 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 127.571 2.349 . . . . 3.7 110.342 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.1 129.79 31.66 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 CA-C-N 121.075 1.42 . . . . 1.08 108.697 165.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.37 44.67 6.85 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.344 0.973 . . . . 1.01 113.576 -169.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.2 t -131.39 151.2 51.75 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.346 1.458 . . . . 1.74 111.698 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.0 p -101.4 147.58 26.17 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.788 1.631 . . . . 1.45 113.151 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 m -139.48 151.71 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.197 1.399 . . . . 0.76 112.64 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -112.88 147.08 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.94 1.296 . . . . 1.21 112.736 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.66 144.31 14.24 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.864 -1.062 . . . . 0.74 111.719 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.57 -7.58 57.49 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 116.203 1.241 . . . . 0.85 116.203 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.6 p -68.98 160.73 30.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.398 1.599 . . . . 1.48 110.962 168.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.55 146.18 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.115 0.966 . . . . 0.87 110.624 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -108.45 153.04 23.89 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.832 1.253 . . . . 1.6 113.465 -174.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -115.28 -167.7 1.28 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.662 1.985 . . . . 3.61 109.805 170.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -77.66 140.5 39.6 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 119.649 -1.907 . . . . 4.79 111.574 -174.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.05 11.31 0.42 Allowed Glycine 0 CA--C 1.542 1.741 0 C-N-CA 124.978 1.275 . . . . 3.51 114.012 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m 23.8 85.67 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 129.58 3.152 . . . . 1.64 115.846 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.645 HD21 ' H ' ' A' ' 62' ' ' SER . 57.7 mt -87.33 150.69 23.68 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.402 0.681 . . . . 1.38 112.761 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.73 128.93 51.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.679 0.792 . . . . 1.95 110.244 167.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.0 mm -111.86 126.47 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.837 1.655 . . . . 1.75 110.449 -169.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.2 p -79.41 104.5 10.06 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.899 0.857 . . . . 1.69 109.718 169.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.94 113.69 14.91 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.178 -0.951 . . . . 1.12 109.393 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.5 p -120.21 16.2 12.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.708 1.203 . . . . 2.44 113.026 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -148.86 146.32 27.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.075 1.75 . . . . 1.78 110.417 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 m -100.56 164.16 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.701 0.8 . . . . 1.55 109.625 165.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -51.45 -45.09 53.63 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 114.523 0.569 . . . . 1.49 114.523 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.2 -23.57 67.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.325 1.232 . . . . 1.77 114.325 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -78.7 -25.96 44.81 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.986 1.476 . . . . 2.58 114.986 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 p -52.36 143.21 15.51 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.838 1.792 . . . . 1.72 115.838 -164.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.6 t -60.04 -32.22 70.71 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.067 0.947 . . . . 2.03 111.499 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.3 tp -52.97 -44.62 67.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.424 1.49 . . . . 1.63 112.195 168.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.0 p -71.87 -24.5 61.69 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.154 0.798 . . . . 2.94 113.154 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -71.25 -39.56 71.54 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.826 -1.171 . . . . 2.72 112.014 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 96.3 mt -53.49 -55.14 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.506 0.722 . . . . 1.71 109.968 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.77 -18.9 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 114.251 1.204 . . . . 1.53 114.251 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -71.12 -41.45 70.51 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.837 -1.164 . . . . 3.5 110.764 168.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.7 mt -70.86 -40.68 72.19 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.78 1.232 . . . . 2.51 113.646 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.4 t -65.94 -28.75 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.44 1.018 . . . . 1.92 111.368 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -73.83 -30.89 62.95 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.575 1.15 . . . . 4.2 112.94 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.66 -29.1 63.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.433 1.093 . . . . 4.41 113.884 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.07 -52.42 42.33 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.917 0.78 . . . . 3.7 110.881 -173.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 126.274 1.829 . . . . 3.92 114.366 169.668 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 113.899 1.074 . . . . 3.42 113.899 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -70.56 -39.06 74.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.358 1.435 . . . . 5.28 109.054 167.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.64 56.11 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.797 1.036 . . . . 1.8 113.797 173.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 47.3 tp -67.84 -35.05 77.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.797 1.18 . . . . 1.41 112.507 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.63 -36.37 62.9 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.374 0.534 . . . . 1.74 111.481 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -56.54 -36.9 69.77 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.801 1.24 . . . . 2.85 114.255 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -48.62 -49.51 36.73 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.753 1.16 . . . . 1.66 111.489 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.97 -29.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.625 1.17 . . . . 2.35 112.039 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -73.01 -26.35 61.29 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.475 -0.766 . . . . 1.28 112.907 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.36 -33.01 72.44 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.239 0.927 . . . . 1.94 112.362 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -62.02 147.1 48.24 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.167 0.894 . . . . 3.65 111.655 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.9 -21.01 64.37 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.235 2.309 . . . . 3.79 117.235 -167.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 m 66.73 -28.17 0.13 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.233 1.813 . . . . 2.65 114.545 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -137.82 156.62 47.74 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.127 2.171 . . . . 2.8 112.981 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.12 165.73 26.63 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.495 1.518 . . . . 0.88 113.7 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.2 m -116.29 108.13 15.71 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.966 1.706 . . . . 0.83 111.274 170.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.8 mt -85.94 141.08 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.674 1.189 . . . . 0.73 109.727 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 m -114.63 133.39 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.195 0.998 . . . . 1.75 113.285 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.3 m -134.19 136.42 43.72 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.985 1.714 . . . . 1.86 110.093 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.3 mt -91.5 86.69 6.12 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.214 0.606 . . . . 2.64 110.632 -174.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.69 -3.37 34.3 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.052 0.941 . . . . 3.79 112.821 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.9 m -160.76 142.05 11.97 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 128.029 2.532 . . . . 3.82 110.803 167.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -20.99 66.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 1 C-N-CA 132.552 4.341 . . . . 4.32 117.917 -168.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.33 11.2 p30 49.39 2.73 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.642 2.377 . . . . 4.34 116.442 -167.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 pt -82.38 -11.45 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 129.262 3.025 . . . . 3.5 114.603 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.7 tp -135.58 95.14 3.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.181 1.392 . . . . 2.87 111.625 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.89 78.78 7.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.026 1.73 . . . . 2.37 110.6 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -78.87 125.82 29.88 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.656 1.182 . . . . 1.75 110.407 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -103.0 160.79 14.31 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.951 -1.093 . . . . 3.32 113.055 -174.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.94 125.28 35.1 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.05 1.34 . . . . 4.53 109.486 168.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -91.82 121.75 33.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.859 -1.164 . . . . 1.67 107.859 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 m -136.32 157.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.077 0.951 . . . . 1.12 113.538 -167.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.8 145.6 32.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.775 0.83 . . . . 2.97 110.29 167.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.63 -29.65 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 113.287 0.847 . . . . 1.27 113.287 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -74.35 -3.77 32.35 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.895 1.278 . . . . 3.95 113.551 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.8 -13.52 12.61 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.535 1.934 . . . . 1.93 114.617 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.51 147.85 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 119.556 1.071 . . . . 1.77 111.246 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.76 163.76 20.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.016 1.726 . . . . 3.66 114.298 -176.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -71.52 18.82 0.07 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 117.621 2.452 . . . . 3.51 117.621 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.17 4.33 6.35 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.019 1.295 . . . . 1.22 115.548 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -111.29 169.67 8.63 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.633 1.173 . . . . 2.27 112.565 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.8 mt -123.75 130.75 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.666 1.586 . . . . 1.17 110.427 -170.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -117.99 136.04 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.438 1.495 . . . . 0.7 113.871 -166.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -87.09 143.14 27.44 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.567 0.951 . . . . 2.61 113.567 169.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.9 p -132.25 134.74 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.439 1.095 . . . . 0.82 111.479 169.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.14 170.41 5.36 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 125.339 1.456 . . . . 1.34 112.847 -170.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.33 132.07 50.02 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.785 2.323 . . . . 1.3 112.547 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.11 -8.27 39.35 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.939 1.733 . . . . 0.91 114.992 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.78 166.56 54.57 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 118.933 1.366 . . . . 0.98 113.813 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -119.61 153.34 35.64 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.037 1.335 . . . . 2.77 112.255 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -79.29 134.97 58.09 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.374 0.669 . . . . 1.81 112.45 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.14 -32.58 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.983 2.456 . . . . 0.9 115.313 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 m -145.85 171.32 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 126.984 2.114 . . . . 0.9 109.183 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.96 144.5 25.4 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.089 0.859 . . . . 2.39 112.399 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.62 -164.82 35.89 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.013 1.165 . . . . 0.78 116.013 -175.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -107.94 145.64 33.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.738 2.015 . . . . 5.19 112.693 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.66 133.76 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 127.581 2.352 . . . . 0.97 110.443 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.73 37.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.936 1.087 . . . . 1.21 113.936 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -165.29 136.53 3.98 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.839 -1.163 . . . . 2.37 110.159 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.41 -174.31 50.39 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.844 1.212 . . . . 0.76 115.992 168.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -149.67 112.0 4.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.27 1.028 . . . . 1.99 112.222 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.55 154.95 45.78 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.238 1.015 . . . . 1.25 112.814 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.4 ttm -104.32 128.87 52.19 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.689 1.195 . . . . 0.84 108.969 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 86.1 t -115.99 136.6 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.68 1.592 . . . . 0.62 113.147 -166.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -91.04 100.68 13.49 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.348 -0.845 . . . . 1.98 111.607 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -93.65 4.74 53.48 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.318 1.447 . . . . 2.05 113.963 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -38.97 -45.59 1.22 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.923 2.489 . . . . 1.9 116.842 -169.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.74 -32.01 28.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.024 0.829 . . . . 1.09 111.924 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.15 -58.13 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.796 1.639 . . . . 1.07 111.642 -171.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.9 p -102.7 -5.5 23.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.757 1.223 . . . . 1.22 113.036 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.98 18.82 79.75 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.445 1.498 . . . . 1.15 113.955 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -67.15 -53.29 31.96 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.782 0.833 . . . . 2.42 112.035 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 64.18 29.26 14.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.433 1.893 . . . . 1.85 112.882 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.2 ptp -157.77 128.77 3.68 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 130.21 3.404 . . . . 4.1 106.489 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.98 156.95 51.87 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.032 1.821 . . . . 1.32 114.104 -167.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.9 t -120.02 129.55 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 126.96 2.104 . . . . 0.7 111.299 -168.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.7 134.63 36.41 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.34 -0.85 . . . . 0.66 112.809 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -120.34 151.3 39.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.302 1.841 . . . . 0.74 110.841 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -149.24 174.66 3.27 Favored Pre-proline 0 N--CA 1.483 1.175 0 C-N-CA 127.866 2.466 . . . . 2.4 111.491 -168.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.24 129.67 24.84 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 CA-C-N 122.045 1.766 . . . . 0.84 110.592 167.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.24 46.77 9.78 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.59 1.09 . . . . 1.1 111.918 -168.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.8 t -126.34 160.27 30.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.615 1.566 . . . . 1.33 111.365 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.0 p -121.0 146.09 47.06 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.887 -1.133 . . . . 0.93 111.817 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.05 155.0 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.064 1.345 . . . . 0.67 112.952 -171.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.434 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -114.76 147.81 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.575 1.95 . . . . 1.03 112.503 169.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.66 151.46 33.54 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.902 1.281 . . . . 0.71 113.136 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.03 -6.6 59.0 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.928 1.251 . . . . 0.75 115.715 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.5 p -76.53 159.84 30.0 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.763 1.282 . . . . 1.37 111.758 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -110.24 125.77 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.138 0.975 . . . . 0.71 112.112 -169.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -95.5 127.53 41.61 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.251 1.82 . . . . 1.68 112.099 -175.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -150.69 76.9 1.27 Allowed 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.087 1.884 . . . . 3.44 116.087 -171.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -171.59 -60.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.393 1.877 . . . . 3.35 110.592 167.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.17 175.07 24.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.076 2.274 . . . . 1.9 112.285 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.0 m -87.15 141.37 28.7 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.672 1.189 . . . . 1.82 112.296 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.4 mt -127.73 165.51 19.93 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.224 1.81 . . . . 0.9 112.339 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.1 tp -124.02 113.52 18.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.048 1.739 . . . . 2.81 111.573 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.87 130.04 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.113 0.965 . . . . 1.67 112.588 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 82.8 m -86.67 106.4 17.59 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.813 0.845 . . . . 2.52 109.939 169.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.25 116.41 19.5 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.451 -0.78 . . . . 0.94 111.108 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -115.86 10.42 15.28 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.339 1.056 . . . . 3.3 113.384 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -141.09 138.51 33.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.694 1.598 . . . . 1.69 110.795 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 m -84.59 162.27 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 108.903 -0.777 . . . . 1.63 108.903 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.31 -43.33 75.59 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.009 -1.057 . . . . 1.73 114.257 -169.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.41 -31.41 72.1 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.888 1.07 . . . . 1.79 113.888 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.18 -17.02 58.86 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.025 1.73 . . . . 2.8 114.19 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.0 p -68.86 151.8 46.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.022 0.929 . . . . 1.81 113.245 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.6 t -55.44 -37.45 67.72 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.281 0.632 . . . . 2.07 112.051 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.7 tp -61.57 -49.46 76.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.416 1.086 . . . . 1.73 112.256 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 t -71.89 -25.99 62.15 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.444 0.697 . . . . 1.63 112.2 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.83 -41.15 75.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.73 1.212 . . . . 1.63 112.778 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.69 -50.09 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.804 0.842 . . . . 1.66 110.651 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.14 -18.27 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 114.005 1.113 . . . . 1.48 114.005 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.84 -45.95 73.19 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.768 1.167 . . . . 2.67 110.448 167.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -41.72 99.07 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.819 1.247 . . . . 2.35 112.57 -177.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.76 -33.13 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.901 0.88 . . . . 2.33 112.467 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -71.14 -27.52 63.62 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.774 0.829 . . . . 3.81 112.538 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -67.26 -32.25 73.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.986 0.914 . . . . 4.24 112.453 172.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.78 -43.44 46.45 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.425 1.09 . . . . 4.88 113.474 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.714 1.606 . . . . 5.5 113.264 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 112.609 0.596 . . . . 2.64 112.609 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -73.94 -46.15 45.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.771 1.228 . . . . 4.12 109.818 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.4 -33.06 74.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.794 1.238 . . . . 1.51 113.175 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.15 -28.3 69.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.3 0.64 . . . . 1.63 112.331 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.34 -47.51 33.92 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.693 -0.629 . . . . 1.42 110.852 167.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -48.91 -41.48 33.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.301 1.44 . . . . 3.46 114.779 -169.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -53.42 -45.33 69.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.944 0.793 . . . . 1.57 111.992 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.7 mm -72.91 -29.24 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.551 1.14 . . . . 2.01 112.521 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -74.29 -24.21 59.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.408 0.892 . . . . 1.47 113.408 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.31 -19.73 65.62 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.77 1.026 . . . . 2.07 113.77 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.33 157.79 36.32 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 115.178 1.547 . . . . 2.33 115.178 -169.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.11 154.4 17.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.893 1.677 . . . . 1.81 112.721 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -88.55 -23.29 23.2 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.552 1.141 . . . . 2.3 112.736 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.75 168.26 20.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.779 1.232 . . . . 3.52 114.075 -169.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.65 161.3 38.08 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.408 1.483 . . . . 0.73 112.472 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.0 m -121.55 95.95 4.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.748 1.619 . . . . 0.82 110.873 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.32 146.22 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.219 1.408 . . . . 0.83 110.002 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.19 120.59 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.518 1.054 . . . . 1.72 111.967 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.1 m -122.1 146.97 46.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.17 1.388 . . . . 1.94 111.277 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 mp -110.48 88.9 2.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.635 1.174 . . . . 3.22 110.607 -171.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.03 -7.93 20.14 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.767 1.765 . . . . 3.75 115.767 -169.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.6 m -113.36 -96.0 0.45 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.083 1.353 . . . . 4.1 111.594 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -152.72 56.38 0.8 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.994 1.717 . . . . 4.6 109.873 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 60.9 -7.68 0.08 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 129.623 3.169 . . . . 5.07 118.095 -172.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.4 pt -80.15 -9.05 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.559 1.543 . . . . 4.26 114.103 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tt -127.69 140.58 51.99 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.303 2.241 . . . . 3.19 110.99 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.14 127.16 47.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.934 1.693 . . . . 2.85 111.926 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.7 t -132.3 110.65 10.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.149 1.78 . . . . 1.61 110.072 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -108.51 136.64 47.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.176 1.176 . . . . 2.89 114.176 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -108.11 132.55 53.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.671 1.588 . . . . 2.67 110.106 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -104.51 122.79 46.29 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.524 -0.917 . . . . 2.03 108.524 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.3 m -139.68 156.66 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.974 0.91 . . . . 0.93 113.007 -169.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -74.06 146.48 43.63 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.618 -0.512 . . . . 4.03 109.618 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.41 -27.92 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.681 1.363 . . . . 1.28 114.681 -168.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -73.3 -7.67 52.54 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 120.495 -1.378 . . . . 3.35 113.431 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.0 -1.04 32.68 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.258 1.823 . . . . 1.69 114.882 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -109.76 148.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.918 1.287 . . . . 1.92 110.736 172.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -123.65 175.9 6.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.908 2.083 . . . . 3.41 110.811 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -68.92 156.65 38.16 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 121.36 -0.838 . . . . 2.84 111.093 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.36 22.78 21.17 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 119.132 0.878 . . . . 1.2 113.858 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.15 167.28 20.95 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.539 1.535 . . . . 2.1 112.305 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.03 129.69 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.159 1.383 . . . . 1.2 110.646 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 mm -120.52 129.13 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.241 1.816 . . . . 0.67 110.499 -169.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -78.68 133.69 37.18 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.101 -1.0 . . . . 2.12 111.171 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.96 128.09 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.008 1.323 . . . . 0.8 110.539 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.85 171.08 5.8 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.622 1.169 . . . . 1.1 112.48 -169.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.32 127.81 25.24 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.483 2.122 . . . . 1.04 112.537 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.22 -1.96 73.12 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.79 1.185 . . . . 1.0 116.006 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.22 -176.82 50.3 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 118.897 1.348 . . . . 0.94 114.064 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -124.57 159.79 29.87 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.074 1.749 . . . . 2.57 112.152 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -84.03 118.8 72.25 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.125 0.97 . . . . 2.31 109.554 170.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -83.49 -17.66 6.22 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.258 1.972 . . . . 0.8 115.482 -169.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -153.04 160.93 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 127.915 2.486 . . . . 1.2 108.312 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.03 140.88 33.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.154 0.888 . . . . 1.92 112.768 -177.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.16 -148.75 9.39 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.642 -0.661 . . . . 0.81 114.603 -171.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -131.85 145.57 51.62 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.896 1.278 . . . . 4.02 113.939 -170.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.5 t -96.46 125.48 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.949 2.5 . . . . 0.75 108.916 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.49 32.73 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 113.641 0.978 . . . . 0.78 113.641 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -168.11 136.21 2.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.364 1.866 . . . . 3.56 108.26 166.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.29 179.4 52.62 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 122.448 1.027 . . . . 0.91 114.726 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -154.67 123.44 6.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.972 0.909 . . . . 2.04 112.743 -170.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.9 p -137.5 -179.04 5.5 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.345 1.858 . . . . 3.18 113.588 -168.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.9 ttm -128.4 135.14 49.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.971 1.708 . . . . 0.81 108.888 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.76 139.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.215 1.406 . . . . 0.67 112.076 -168.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -102.24 110.57 22.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.386 1.475 . . . . 1.91 111.401 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.75 22.05 11.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.21 1.804 . . . . 2.49 113.145 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.5 p -53.1 -28.18 24.17 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.7 1.741 . . . . 1.6 115.7 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.83 -34.91 16.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.369 0.986 . . . . 1.2 111.667 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.3 mm -70.46 -47.8 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.617 0.767 . . . . 1.25 110.687 -177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.2 p -119.92 -4.33 10.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.77 1.228 . . . . 1.74 114.172 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.37 3.07 89.86 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.606 1.098 . . . . 1.85 115.331 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -56.32 -52.92 62.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.298 1.221 . . . . 2.72 114.298 -169.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.19 33.63 23.35 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 122.201 1.0 . . . . 1.9 111.868 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -154.78 113.21 2.37 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 128.745 2.818 . . . . 3.82 106.068 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -62.33 153.03 73.2 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.994 2.462 . . . . 1.48 114.251 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.4 t -115.96 137.27 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.99 1.316 . . . . 0.72 110.949 -171.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.95 142.05 28.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.636 0.774 . . . . 0.64 112.483 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -123.43 152.19 41.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.289 1.436 . . . . 0.68 111.717 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -146.23 170.16 8.38 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 129.148 2.979 . . . . 3.5 107.864 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.33 132.79 54.33 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 CA-C-N 121.82 1.686 . . . . 0.78 111.63 168.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.11 25.77 28.07 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.239 1.399 . . . . 0.76 114.815 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.2 t -117.56 158.61 24.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.231 1.412 . . . . 1.37 111.826 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.6 p -116.6 146.95 42.32 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.005 1.275 . . . . 0.84 113.22 -172.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.6 156.04 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.703 1.601 . . . . 0.74 113.08 -172.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -115.24 147.35 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.702 2.001 . . . . 1.03 112.558 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.14 148.29 44.9 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.886 1.274 . . . . 0.84 112.897 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.86 -4.96 51.06 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.617 1.103 . . . . 0.74 115.42 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.3 p -74.61 154.49 38.52 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.477 1.638 . . . . 1.29 111.363 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.94 124.9 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.095 0.558 . . . . 0.74 111.618 -169.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -86.73 139.64 30.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.469 1.107 . . . . 1.54 111.763 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -88.49 -70.49 0.64 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.255 -0.903 . . . . 3.46 112.206 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -131.9 -160.66 1.06 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.746 1.618 . . . . 4.47 109.208 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.86 -26.52 11.48 Favored Glycine 0 CA--C 1.529 0.908 0 O-C-N 119.684 -1.885 . . . . 3.41 116.128 169.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.0 m 44.74 67.89 0.63 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.686 1.594 . . . . 1.97 112.163 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mt -97.8 159.47 14.91 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.706 1.203 . . . . 0.99 113.115 -166.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.93 128.96 54.91 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.567 0.698 . . . . 2.0 110.487 168.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.56 122.5 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.45 1.9 . . . . 1.52 109.952 -169.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 21.0 p -82.46 119.29 24.01 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.936 0.789 . . . . 1.65 110.316 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -97.45 113.96 25.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.457 1.103 . . . . 0.91 111.195 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.1 p -108.37 4.8 24.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.24 1.816 . . . . 1.87 112.77 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -137.69 136.52 37.48 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.922 1.289 . . . . 1.62 109.702 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -91.54 176.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.331 1.053 . . . . 2.53 109.602 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.18 -31.95 66.55 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 120.835 1.652 . . . . 1.65 113.952 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -45.1 65.08 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.633 1.216 . . . . 2.14 113.353 171.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.32 -14.41 59.43 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.961 1.837 . . . . 2.78 115.961 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.5 t -77.76 143.33 38.07 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.057 -1.027 . . . . 3.06 112.829 -170.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.0 t -63.0 -31.77 72.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.917 0.71 . . . . 1.9 112.917 -172.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.67 -51.33 65.82 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.315 1.046 . . . . 1.44 112.491 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 p -72.92 -31.82 64.88 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.542 0.571 . . . . 2.13 112.542 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.4 -42.13 98.78 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.428 0.558 . . . . 1.65 111.71 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.99 -56.15 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.31 1.044 . . . . 1.72 110.153 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.34 -21.78 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 114.181 1.178 . . . . 1.36 114.181 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -71.85 -43.5 65.39 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.218 0.917 . . . . 4.47 111.917 170.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.35 -34.25 72.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.399 0.68 . . . . 2.89 111.713 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.19 -24.93 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.009 -1.057 . . . . 2.17 111.917 171.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.88 -27.72 65.05 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.853 -1.154 . . . . 3.0 111.874 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -72.37 -16.23 61.86 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.953 1.094 . . . . 4.97 113.953 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.57 -60.6 2.14 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.977 -1.077 . . . . 4.35 110.612 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 126.389 1.876 . . . . 5.22 114.537 176.115 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 112.208 0.447 . . . . 2.88 112.208 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -72.11 -38.59 69.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.353 1.061 . . . . 5.61 110.953 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.28 -44.73 94.24 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.102 1.361 . . . . 2.23 111.838 169.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tp -52.56 -33.79 47.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.92 0.888 . . . . 1.67 112.819 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.88 -50.07 14.21 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.704 0.802 . . . . 1.23 112.919 168.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -58.73 -32.83 69.57 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.726 1.211 . . . . 3.01 114.032 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.83 -30.24 65.58 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.947 0.721 . . . . 1.38 112.947 173.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.4 mm -72.76 -42.22 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.844 0.858 . . . . 2.02 111.718 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.6 m -68.38 -21.56 64.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.438 1.095 . . . . 1.11 113.224 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.1 mt -73.01 -14.02 61.34 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.961 2.104 . . . . 1.86 114.671 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -87.04 149.76 24.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.425 1.011 . . . . 2.33 113.184 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.13 173.79 11.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.73 1.612 . . . . 2.63 114.61 -169.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.3 m -99.91 -43.88 6.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.809 1.644 . . . . 3.1 110.706 168.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -139.18 165.42 27.22 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.601 1.56 . . . . 3.66 113.04 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.72 173.38 11.55 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.053 1.741 . . . . 1.03 112.3 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.2 m -131.32 111.3 11.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.899 1.279 . . . . 0.95 111.334 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.7 mt -98.84 145.42 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.478 1.911 . . . . 0.98 109.884 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.5 133.61 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.373 -0.829 . . . . 2.02 112.608 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 85.7 m -113.26 135.76 53.48 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.374 1.47 . . . . 1.77 112.245 -172.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.9 mt -129.32 91.83 3.25 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.486 -1.301 . . . . 3.01 107.486 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.69 4.94 45.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.81 1.244 . . . . 5.28 111.67 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.2 m -149.86 127.6 11.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.822 3.249 . . . . 4.02 106.988 176.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -35.24 68.56 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.196 1 C-N-CA 133.021 4.528 . . . . 6.29 118.484 -167.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.63 30.3 19.91 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.236 2.214 . . . . 4.44 114.062 -174.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.5 pt -122.63 -23.07 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.247 1.819 . . . . 4.64 113.927 -174.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.66 -60.27 3.31 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.883 1.068 . . . . 3.88 113.883 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 63.26 91.38 0.07 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.326 1.45 . . . . 4.96 112.88 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.6 t -139.16 154.4 48.08 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.598 1.559 . . . . 1.51 111.562 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.81 138.76 45.86 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.127 1.371 . . . . 2.83 111.71 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -119.74 129.31 54.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.063 1.745 . . . . 3.35 110.051 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.8 133.86 39.43 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.45 -1.406 . . . . 2.13 110.608 168.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -135.08 158.15 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.332 1.053 . . . . 0.87 112.835 -171.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.94 149.04 36.03 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.478 1.111 . . . . 4.18 109.414 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.49 -29.49 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.291 1.589 . . . . 1.57 115.291 -168.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -76.46 -7.15 54.5 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.369 -1.457 . . . . 3.47 113.599 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.9 mt -100.74 -6.32 25.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.096 1.758 . . . . 1.29 113.357 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 p -95.63 129.9 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.687 1.195 . . . . 2.33 109.013 169.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -141.32 -175.21 4.26 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.229 1.011 . . . . 5.51 112.016 -169.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -65.9 15.53 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.475 2.769 . . . . 3.2 118.475 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.07 9.87 3.59 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.282 1.42 . . . . 1.17 115.344 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -94.32 148.55 22.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.063 1.431 . . . . 3.1 113.818 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.1 mm -105.26 124.67 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.24 1.016 . . . . 1.62 110.03 171.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.5 mm -99.82 162.93 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.927 2.091 . . . . 1.41 111.276 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HE2' HD11 ' A' ' 96' ' ' LEU . 37.5 ttmt -132.39 129.6 39.57 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.188 1.395 . . . . 2.01 110.328 170.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.25 144.04 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.354 1.062 . . . . 1.06 112.554 -173.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -99.02 163.9 17.85 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.246 1.418 . . . . 1.97 113.104 -174.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.34 106.58 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.826 2.351 . . . . 2.28 109.385 166.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.45 68.26 1.16 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.255 1.407 . . . . 2.91 110.311 -168.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.86 164.08 33.51 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 127.407 2.432 . . . . 1.06 109.497 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -125.34 153.09 43.86 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.521 1.16 . . . . 1.6 112.798 -172.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -87.46 136.71 32.92 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 123.968 0.907 . . . . 1.68 112.29 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -98.48 -18.03 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.934 3.09 . . . . 0.72 115.587 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.86 166.88 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 127.936 2.494 . . . . 1.08 108.422 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.18 142.35 27.72 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.185 0.902 . . . . 2.04 113.405 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.66 -160.33 27.67 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.581 0.61 . . . . 0.67 114.06 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.3 ttp-105 -116.19 136.25 53.18 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.567 1.147 . . . . 3.82 112.888 -171.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -82.74 130.36 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 126.531 1.932 . . . . 0.8 108.26 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.69 34.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.395 0.678 . . . . 0.85 112.328 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -166.71 132.67 2.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.088 1.355 . . . . 2.82 109.709 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.95 -170.77 50.08 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 116.363 1.305 . . . . 0.82 116.363 172.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 123.43 13.21 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.804 1.642 . . . . 2.08 112.306 -173.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.57 176.68 9.64 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.169 0.988 . . . . 1.11 112.428 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 34.0 ttm -120.98 133.72 55.28 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.624 1.57 . . . . 1.09 110.126 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.06 143.45 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.792 1.237 . . . . 0.7 111.514 -169.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -106.95 86.11 2.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.064 1.346 . . . . 2.01 111.099 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -87.74 34.01 0.71 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.955 1.702 . . . . 1.89 113.578 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -58.92 -34.34 71.61 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 117.182 2.29 . . . . 2.05 117.182 -168.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.75 -48.59 4.66 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.805 1.184 . . . . 1.12 111.468 -174.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.7 mm -67.63 -48.89 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.739 0.816 . . . . 1.14 111.634 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.1 m -101.15 -32.84 10.36 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.946 1.298 . . . . 2.71 110.715 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.74 5.41 61.35 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.67 1.129 . . . . 1.22 115.541 171.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.14 -51.02 71.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.027 1.331 . . . . 2.65 111.603 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.21 35.8 15.26 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.9 1.68 . . . . 2.31 112.793 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -154.19 154.53 29.89 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 129.923 3.289 . . . . 4.9 109.08 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -64.19 136.63 52.66 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.5 2.8 . . . . 1.71 113.604 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.6 t -130.56 129.81 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 125.471 1.509 . . . . 1.36 111.999 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.73 146.44 32.37 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.06 1.134 . . . . 0.78 114.06 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -125.7 152.36 45.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.886 2.074 . . . . 0.82 111.164 175.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -141.82 -176.38 0.56 Allowed Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 128.688 2.795 . . . . 3.19 107.782 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.84 148.89 90.8 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 CA-C-N 122.141 1.8 . . . . 1.27 114.094 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.17 25.45 74.54 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.959 1.266 . . . . 1.34 114.455 -172.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -115.01 147.69 39.78 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.753 1.277 . . . . 1.57 111.034 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.1 p -99.08 147.67 24.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.183 1.356 . . . . 1.0 113.286 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.0 168.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 126.4 1.88 . . . . 0.61 111.152 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.7 156.32 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.448 1.499 . . . . 1.55 111.651 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.67 157.51 32.42 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.136 1.162 . . . . 1.02 114.136 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.87 -7.2 15.8 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.159 0.885 . . . . 0.99 115.113 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 m -90.92 156.98 17.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.716 1.206 . . . . 2.73 110.417 172.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mm -102.42 141.47 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.938 0.895 . . . . 1.07 111.39 -169.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -101.59 135.74 42.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.594 1.957 . . . . 1.94 110.84 173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -153.57 140.45 19.16 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.91 1.284 . . . . 3.22 111.143 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.321 9.0 t30 95.98 -17.61 0.07 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 129.136 2.974 . . . . 3.86 116.832 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.25 161.83 34.97 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 120.66 1.573 . . . . 1.86 114.629 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.2 m -87.97 133.72 33.88 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.285 1.034 . . . . 1.91 112.979 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.1 mt -128.96 162.52 27.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.988 1.715 . . . . 0.98 112.814 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.522 HD11 ' HE2' ' A' ' 44' ' ' LYS . 7.4 mp -117.89 132.78 56.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.86 0.864 . . . . 2.01 109.923 167.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.76 131.16 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.708 1.203 . . . . 1.62 111.468 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 29.9 p -85.05 115.08 22.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.662 0.665 . . . . 1.58 109.607 168.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.53 118.16 21.13 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.637 0.775 . . . . 0.96 109.526 173.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.7 p -119.19 11.91 12.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.537 1.135 . . . . 2.04 113.275 -174.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -145.44 146.96 31.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.903 1.681 . . . . 1.84 111.149 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 103' ' ' GLY . 1.3 p -112.07 -175.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.717 1.607 . . . . 3.0 111.869 176.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.452 ' H ' HG22 ' A' ' 102' ' ' VAL . . . -61.36 -18.27 55.12 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 119.826 -1.797 . . . . 2.88 116.329 -172.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.62 -58.01 3.87 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.314 1.046 . . . . 3.72 111.74 169.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.41 -32.11 64.24 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.769 1.396 . . . . 3.91 114.769 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.8 t -50.13 126.55 14.85 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.81 1.244 . . . . 2.47 112.789 -168.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.4 t -54.06 -35.41 62.0 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.892 1.071 . . . . 2.48 113.892 -168.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.06 -50.47 73.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.726 -1.234 . . . . 1.78 112.241 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -71.56 -23.17 61.7 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.354 1.062 . . . . 2.17 112.194 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -74.05 -43.91 56.12 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.828 1.251 . . . . 2.4 113.077 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.7 mt -55.9 -49.17 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.405 1.482 . . . . 1.45 110.644 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.67 -18.65 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 114.324 1.231 . . . . 1.23 114.324 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -72.55 -42.61 64.49 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.753 -0.642 . . . . 2.6 111.28 168.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -54.04 10.7 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.411 1.484 . . . . 2.48 112.382 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.92 -21.97 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.451 1.1 . . . . 1.97 112.25 -173.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.14 -30.94 67.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.006 1.322 . . . . 3.33 113.027 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -77.32 -9.6 58.93 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.817 -1.177 . . . . 4.6 114.041 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.16 -63.4 1.23 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.479 1.036 . . . . 3.55 110.568 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.256 1.397 0 C-N-CA 125.796 1.638 . . . . 3.95 114.133 -178.205 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 112.905 0.705 . . . . 4.19 112.905 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -82.9 -26.91 31.06 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.313 -0.867 . . . . 6.33 112.236 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.42 68.28 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.959 -1.088 . . . . 1.86 110.354 168.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.22 -30.36 71.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.649 1.179 . . . . 1.59 112.439 172.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.19 -26.95 59.42 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.257 -0.902 . . . . 1.19 113.317 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.91 -41.15 87.6 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.278 1.031 . . . . 2.33 112.228 -169.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -50.02 -44.2 51.11 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.842 1.257 . . . . 1.4 111.992 173.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -73.08 -35.3 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.355 1.062 . . . . 1.74 112.104 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -70.38 -22.06 62.8 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.864 -1.147 . . . . 1.33 113.313 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.33 -19.95 65.52 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.955 1.094 . . . . 2.06 113.955 170.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -70.99 169.51 14.76 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.696 1.135 . . . . 2.65 113.843 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.02 -24.94 9.63 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.769 1.396 . . . . 3.25 114.769 -174.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 m 67.76 -11.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 126.283 1.833 . . . . 2.84 115.818 175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -130.03 157.86 41.2 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.284 1.833 . . . . 2.82 112.061 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.45 162.69 34.73 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.006 0.923 . . . . 0.78 113.166 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.4 m -123.44 100.62 6.91 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.657 1.583 . . . . 0.95 110.364 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.6 mt -85.29 146.14 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.47 1.508 . . . . 0.83 110.615 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.412 HG12 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -107.45 127.56 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.955 0.902 . . . . 1.99 110.387 166.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.5 m -134.38 139.54 45.67 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.285 1.434 . . . . 2.16 111.089 -170.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.47 114.17 23.83 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.362 -0.836 . . . . 3.65 108.776 167.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -94.76 -11.17 29.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.681 1.192 . . . . 4.99 111.378 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.8 m -156.4 140.63 16.54 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.662 1.985 . . . . 4.52 110.248 167.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -42.87 69.42 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 130.61 3.564 . . . . 5.43 119.493 -166.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 63.65 23.58 13.59 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.198 1.799 . . . . 5.43 112.643 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 pt -124.61 -16.34 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 126.82 2.048 . . . . 5.49 112.104 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.8 tp -136.97 80.5 1.82 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.725 2.01 . . . . 3.99 108.767 169.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -85.41 123.68 31.14 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.14 -1.059 . . . . 3.39 108.14 169.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -138.81 153.33 48.38 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.53 1.132 . . . . 1.54 110.832 -169.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' HG2' HG12 ' A' ' 18' ' ' VAL . 29.4 mt-10 -121.26 134.89 55.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.748 0.819 . . . . 2.37 110.24 -170.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -123.92 129.07 50.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.507 1.523 . . . . 3.46 110.858 -169.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.51 130.66 45.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.589 1.086 . . . . 2.78 110.476 170.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.8 m -141.42 168.27 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.039 1.336 . . . . 1.11 112.844 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -78.15 139.28 38.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.402 0.681 . . . . 3.13 109.593 168.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.89 -22.67 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.708 1.744 . . . . 1.57 115.708 -168.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -64.31 -21.06 66.48 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.609 -1.307 . . . . 5.14 112.94 172.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.2 mt -99.2 -4.93 30.92 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.611 1.965 . . . . 1.72 114.502 -169.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.3 m -74.35 -42.5 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.486 0.714 . . . . 4.01 112.635 -171.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.319 32.1 mt-30 60.54 146.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 128.248 2.619 . . . . 3.49 116.043 -171.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -80.11 25.03 0.39 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 116.831 2.16 . . . . 3.16 116.831 -167.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.25 8.25 12.37 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.107 1.337 . . . . 1.03 113.662 170.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.24 169.9 8.23 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.253 1.421 . . . . 2.9 114.173 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.7 mt -121.56 127.92 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.261 2.224 . . . . 1.26 109.69 -178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.1 mm -116.3 133.69 62.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.729 2.012 . . . . 0.77 110.552 -170.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HE3' HD11 ' A' ' 96' ' ' LEU . 14.0 mmmm -79.52 142.7 35.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.296 1.438 . . . . 2.53 113.202 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 p -133.12 131.42 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.365 0.666 . . . . 0.68 112.039 168.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.58 162.68 49.88 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 125.003 1.321 . . . . 1.25 113.182 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -60.12 131.14 37.5 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.427 2.085 . . . . 1.04 110.733 166.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.37 -3.86 61.31 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.738 1.637 . . . . 0.89 114.717 -170.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.17 170.08 53.52 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 118.48 1.14 . . . . 0.96 113.829 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -115.25 144.4 43.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.565 1.146 . . . . 1.57 110.973 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -79.44 120.73 81.38 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-O 118.722 -0.656 . . . . 1.66 109.868 175.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.35 -12.5 6.69 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.601 2.201 . . . . 0.76 114.095 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.9 m -148.95 165.1 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.478 2.711 . . . . 1.26 109.446 -173.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -103.51 145.59 29.79 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.349 0.87 . . . . 2.25 113.349 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.95 -153.19 23.23 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.647 0.619 . . . . 0.62 114.647 -172.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -117.31 132.45 56.6 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.704 1.202 . . . . 4.23 112.734 -169.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.3 t -82.7 127.13 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.935 2.094 . . . . 0.66 108.422 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 pt -140.71 32.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 122.745 1.26 . . . . 0.94 113.017 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -168.21 126.66 1.17 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.746 2.419 . . . . 2.98 106.711 167.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.45 178.25 46.89 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 117.004 1.562 . . . . 1.06 117.004 174.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -148.02 128.45 13.99 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.863 1.265 . . . . 2.15 112.328 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 m -148.12 167.74 24.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.346 1.059 . . . . 1.21 113.133 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.3 ttm -111.4 108.39 17.94 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.822 1.249 . . . . 1.32 109.939 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.7 t -87.64 158.35 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.465 1.906 . . . . 0.81 112.536 -169.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -113.55 92.22 3.92 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.374 1.87 . . . . 1.92 110.134 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.89 16.52 21.22 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.943 1.697 . . . . 2.11 112.884 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -56.56 -29.39 61.96 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.252 1.821 . . . . 1.37 114.713 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -81.58 -32.18 32.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.256 1.389 . . . . 1.25 111.866 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mm -77.76 -45.95 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.087 0.955 . . . . 1.27 111.14 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 m -109.08 -12.58 14.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.336 1.454 . . . . 2.65 112.751 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.28 6.47 80.15 Favored Glycine 0 CA--C 1.544 1.889 0 C-N-CA 125.219 1.39 . . . . 1.53 116.011 174.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.77 -38.22 89.75 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.693 1.197 . . . . 2.94 113.995 -169.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 72.81 -17.77 0.38 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.949 2.5 . . . . 1.45 113.886 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -92.08 150.07 39.81 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.14 1.776 . . . . 5.67 110.665 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.53 153.6 30.7 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.356 2.704 . . . . 2.02 112.243 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.73 124.85 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.586 1.154 . . . . 1.1 111.851 -169.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.73 138.89 37.45 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.699 0.8 . . . . 1.05 112.821 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -127.13 145.76 50.63 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.019 2.127 . . . . 0.88 110.451 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -144.04 172.31 5.69 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 128.618 2.767 . . . . 2.44 109.605 -169.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -57.74 137.08 79.42 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.673 1.582 . . . . 0.99 110.943 168.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.0 17.81 79.83 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.954 1.264 . . . . 1.28 114.57 -172.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 t -101.79 161.02 13.97 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.006 1.903 . . . . 1.6 111.414 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 p -112.43 146.57 38.16 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.841 1.2 . . . . 0.79 113.648 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 m -138.64 159.35 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.204 1.802 . . . . 0.55 111.964 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.474 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -117.35 152.1 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.896 1.678 . . . . 1.62 112.176 173.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.96 149.99 39.07 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.737 -0.665 . . . . 0.66 112.52 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.69 -10.57 55.98 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.583 1.087 . . . . 0.78 115.53 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.3 p -76.51 161.51 28.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.516 1.158 . . . . 1.35 111.262 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -106.77 142.23 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.917 0.887 . . . . 0.7 110.913 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -99.74 143.23 30.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.714 1.606 . . . . 1.7 112.543 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -155.94 141.4 17.71 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.026 -1.046 . . . . 3.32 112.15 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.26 17.3 t30 111.8 -42.07 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 1 C-N-CA 131.863 4.065 . . . . 3.83 113.556 -178.279 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.16 -174.58 37.12 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 119.76 1.164 . . . . 2.01 114.661 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.0 m -92.29 136.8 32.89 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.731 1.612 . . . . 1.85 111.373 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 mt -130.81 160.97 32.81 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.553 1.141 . . . . 1.05 113.294 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.427 HD11 ' HE3' ' A' ' 44' ' ' LYS . 7.0 mp -113.97 123.05 48.77 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.83 1.252 . . . . 1.93 109.97 170.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.15 126.21 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.653 1.181 . . . . 1.22 110.714 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 32.0 p -79.38 126.94 31.48 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.495 -0.753 . . . . 1.58 110.235 169.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.32 129.21 34.24 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.568 0.747 . . . . 1.03 110.393 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.7 p -107.9 -8.86 15.84 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.657 0.984 . . . . 3.1 113.657 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -145.82 150.29 35.9 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.31 1.444 . . . . 2.19 110.909 170.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 m -74.74 160.19 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 118.69 0.677 . . . . 2.15 109.174 166.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.77 -39.66 77.57 Favored Glycine 0 N--CA 1.475 1.242 0 N-CA-C 116.285 1.274 . . . . 2.17 116.285 -165.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.49 -39.31 62.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.688 1.244 . . . . 3.17 113.581 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -72.11 -6.02 39.55 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.402 1.481 . . . . 3.31 114.106 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.0 p -51.48 151.29 3.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.381 1.473 . . . . 1.73 114.035 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.19 -33.62 67.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.178 1.391 . . . . 2.69 111.173 169.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.82 -51.48 68.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.673 1.989 . . . . 1.6 112.549 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.8 m -70.66 -18.19 62.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.441 0.534 . . . . 2.5 112.441 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -73.93 -39.25 63.93 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.497 -0.752 . . . . 1.75 112.613 169.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 87.4 mt -49.75 -51.9 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 119.892 1.224 . . . . 1.67 111.441 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.3 m -63.39 -29.41 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.273 -0.892 . . . . 1.5 113.276 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -74.73 -33.52 62.38 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.838 0.855 . . . . 4.19 112.556 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -39.47 75.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.978 1.711 . . . . 2.79 110.528 174.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.4 t -61.18 -45.68 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.027 0.931 . . . . 2.24 110.404 169.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.58 -9.97 40.74 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 116.293 1.96 . . . . 4.15 116.293 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -71.13 -26.58 63.07 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 121.107 1.776 . . . . 6.79 111.848 168.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.28 -57.62 3.78 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.588 -0.695 . . . . 3.59 111.463 173.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 C--O 1.252 1.192 0 N-CA-C 113.427 0.899 . . . . 4.97 113.427 178.447 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 112.882 0.697 . . . . 4.23 112.882 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 68.61 -49.33 0.57 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 128.224 2.609 . . . . 4.94 112.818 -167.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.35 -11.82 60.86 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 121.134 -0.979 . . . . 2.01 113.599 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 tp -59.41 -37.85 79.09 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.888 1.675 . . . . 1.9 111.714 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.21 -18.82 63.18 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.075 0.768 . . . . 1.34 113.075 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -61.15 -36.76 80.65 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.943 1.247 . . . . 3.0 112.237 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.16 -42.24 96.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.877 0.871 . . . . 1.26 111.355 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -72.1 -36.29 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.167 0.587 . . . . 1.51 111.704 172.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -69.02 -30.95 69.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.333 1.053 . . . . 1.31 112.881 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.8 mt -64.0 -32.84 74.52 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.695 1.998 . . . . 2.33 112.979 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -77.48 129.89 36.3 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.94 0.791 . . . . 3.32 112.395 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.97 156.42 36.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.124 0.97 . . . . 2.25 112.787 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -108.75 -4.83 16.64 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.092 1.515 . . . . 2.1 115.092 -167.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.29 160.54 39.9 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.285 -1.509 . . . . 3.95 113.806 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.16 159.06 43.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.977 1.311 . . . . 0.8 112.988 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 90.0 m -119.08 106.15 12.11 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.441 1.497 . . . . 0.88 111.148 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mt -97.4 138.53 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.838 1.655 . . . . 0.82 110.842 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -124.74 126.45 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.796 1.18 . . . . 1.97 111.737 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 m -138.25 150.14 46.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.342 1.457 . . . . 2.4 111.055 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -89.25 146.41 24.76 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.112 -0.992 . . . . 3.21 112.181 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.87 -8.47 9.4 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.481 1.112 . . . . 3.88 112.639 169.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -150.82 135.11 16.96 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.113 2.165 . . . . 3.31 107.989 168.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -51.6 84.79 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 117.61 2.448 . . . . 4.64 117.61 -165.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 62.48 23.58 14.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.508 2.323 . . . . 4.12 113.557 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.8 pt -128.96 -19.88 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.883 1.673 . . . . 3.81 112.359 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 tt -136.26 115.56 12.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.779 1.231 . . . . 3.3 110.393 165.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 mp -98.83 148.63 23.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.257 1.423 . . . . 2.99 111.606 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 t -141.0 133.62 28.66 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.016 1.726 . . . . 2.45 109.871 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -127.41 139.28 52.94 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.265 -0.897 . . . . 3.89 112.146 -176.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -114.61 145.82 41.54 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.277 1.431 . . . . 2.67 112.166 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -117.23 110.73 18.48 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.0 1.32 . . . . 2.45 108.283 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.9 m -127.86 164.65 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 114.531 1.308 . . . . 0.78 114.531 -166.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.79 146.41 37.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.549 -0.751 . . . . 3.1 110.379 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.71 -23.61 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 113.26 0.837 . . . . 1.05 113.26 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.36 -17.17 61.85 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 120.817 -1.177 . . . . 3.76 112.984 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.7 mt -105.05 -12.26 16.24 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.404 1.882 . . . . 1.28 114.525 -169.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.41 143.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.101 0.96 . . . . 1.5 109.321 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -119.29 163.29 17.36 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.557 1.143 . . . . 3.24 112.327 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.64 135.64 50.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.67 -0.863 . . . . 3.06 108.67 167.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.9 -10.85 32.12 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 124.86 1.219 . . . . 0.9 114.225 -169.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -88.15 152.07 22.25 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.334 1.454 . . . . 2.8 113.773 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.5 mm -105.26 118.92 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.546 1.539 . . . . 1.2 110.321 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 mm -118.51 128.6 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.105 1.362 . . . . 0.67 111.922 -169.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -90.99 139.97 30.27 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.209 -0.932 . . . . 1.87 112.437 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.05 133.6 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.374 1.47 . . . . 0.72 110.998 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 m -107.69 170.5 5.52 Favored Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 124.683 1.193 . . . . 1.09 113.751 -167.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -52.49 134.59 52.9 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.224 2.616 . . . . 1.0 112.89 169.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.54 -13.68 3.75 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 116.017 1.167 . . . . 1.03 116.017 -175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.9 162.99 53.93 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 118.77 1.285 . . . . 0.96 114.454 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -107.3 154.12 21.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.702 1.201 . . . . 2.15 112.374 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -88.15 119.48 70.35 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.779 0.832 . . . . 2.09 111.512 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.29 -15.2 5.47 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.363 2.709 . . . . 0.73 114.924 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 m -152.45 171.47 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.988 2.515 . . . . 0.71 108.234 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.27 144.89 30.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.313 0.857 . . . . 1.72 113.313 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.16 -160.98 25.91 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 114.78 0.672 . . . . 0.71 114.78 -173.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -115.89 140.54 49.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.156 1.382 . . . . 5.54 112.408 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.41 127.67 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.792 2.437 . . . . 0.87 109.198 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.5 pt -141.0 32.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.636 0.976 . . . . 0.91 113.636 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -165.15 132.44 3.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.154 1.382 . . . . 3.8 108.07 167.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.88 -172.71 48.28 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 116.297 1.279 . . . . 0.82 116.297 169.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -150.85 126.54 10.25 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.237 1.015 . . . . 1.91 111.838 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.96 169.53 17.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.903 1.681 . . . . 1.27 113.067 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.8 ttm -112.62 124.26 52.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.711 0.805 . . . . 1.23 111.279 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.36 140.44 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.885 1.274 . . . . 0.68 111.294 -170.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -104.93 111.96 24.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.001 1.32 . . . . 1.86 109.461 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.47 15.25 5.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.883 2.073 . . . . 2.0 113.95 -169.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.5 p -51.73 -31.35 26.08 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 116.728 2.121 . . . . 1.68 116.728 -170.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.51 -34.09 35.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.265 1.393 . . . . 1.72 110.684 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 108' ' ' LEU . 9.0 mm -78.4 -58.3 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.763 0.825 . . . . 1.7 111.206 -175.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 p -95.68 0.46 52.65 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.113 1.365 . . . . 2.07 113.779 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.07 20.73 79.66 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.215 1.388 . . . . 1.81 113.983 174.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -72.65 -168.23 0.43 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.839 1.655 . . . . 2.63 111.097 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.2 -34.19 0.17 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.232 1.813 . . . . 1.72 110.917 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.4 mmt -85.06 157.84 59.26 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 125.494 1.517 . . . . 4.86 110.852 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -68.68 160.49 49.3 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.246 2.631 . . . . 1.6 112.677 167.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.4 t -125.27 130.14 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.958 1.703 . . . . 1.03 111.728 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.59 131.35 36.7 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.964 0.906 . . . . 1.07 113.209 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -113.13 152.26 29.84 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.861 2.064 . . . . 0.86 110.855 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -141.3 177.72 1.82 Allowed Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 128.642 2.777 . . . . 3.08 109.917 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -66.84 128.57 19.09 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 CA-C-N 121.679 1.635 . . . . 1.27 109.703 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.65 25.27 28.16 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.457 1.503 . . . . 1.11 114.945 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.5 m -108.12 174.56 5.83 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.903 1.351 . . . . 2.07 110.855 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.2 p -130.75 150.37 51.96 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.081 -1.637 . . . . 1.23 112.581 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.49 147.75 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.769 1.227 . . . . 0.74 112.089 -172.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -112.87 148.28 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.837 1.655 . . . . 1.23 112.868 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.83 144.8 54.28 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.821 0.849 . . . . 0.9 112.484 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.31 -3.16 73.81 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.109 1.338 . . . . 0.77 115.886 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.3 p -78.77 162.47 26.11 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.605 1.202 . . . . 1.43 111.725 171.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.73 136.37 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.093 0.957 . . . . 0.79 111.708 -171.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -91.01 146.12 24.12 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.814 1.646 . . . . 1.49 111.981 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -93.49 -93.36 0.16 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.325 1.05 . . . . 3.67 111.396 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -136.83 131.43 33.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.958 1.703 . . . . 4.58 108.935 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.13 114.41 1.63 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 108.848 -1.701 . . . . 1.85 108.848 -167.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -94.31 114.74 26.86 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.961 0.904 . . . . 1.98 110.108 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.9 mt -112.74 153.31 27.94 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.297 1.039 . . . . 0.98 112.078 -169.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 tp -114.83 121.2 42.53 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.941 0.897 . . . . 2.58 110.049 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 mm -113.62 129.09 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.646 1.578 . . . . 1.68 110.981 -169.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.9 p -86.79 116.67 25.03 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.064 -1.023 . . . . 1.48 109.973 168.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.89 122.89 31.38 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.48 -0.762 . . . . 0.93 110.111 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.8 t -124.1 10.85 8.81 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.52 0.933 . . . . 3.03 113.52 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -137.19 140.29 41.65 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.545 1.138 . . . . 2.03 110.929 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.5 p -97.11 170.53 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.013 1.325 . . . . 2.76 111.212 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.33 -27.45 65.52 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 119.699 -1.876 . . . . 1.57 116.092 -169.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.86 -27.87 68.55 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.96 1.38 . . . . 2.44 113.842 174.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.45 -16.62 60.31 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.42 1.267 . . . . 4.03 114.42 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 74.0 p -63.01 125.02 22.6 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.66 0.985 . . . . 2.24 113.66 -166.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.405 HG23 HD12 ' A' ' 108' ' ' LEU . 11.4 t -60.31 -35.66 76.12 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.238 0.615 . . . . 2.32 111.925 -174.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.484 HD11 HD12 ' A' ' 69' ' ' ILE . 8.0 mp -56.27 -50.5 71.17 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.469 1.107 . . . . 1.77 112.298 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 91.9 p -70.78 -28.44 64.66 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.903 0.481 . . . . 1.7 112.014 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -70.43 -43.29 70.24 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.859 -0.526 . . . . 2.01 111.595 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 53.6 mt -54.71 -51.22 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.118 1.367 . . . . 1.66 110.876 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.03 -25.21 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 113.752 1.019 . . . . 1.51 113.752 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -73.34 -36.76 66.22 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.745 0.702 . . . . 3.14 112.281 169.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.1 -33.33 73.32 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.637 0.775 . . . . 2.54 112.111 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.32 -59.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.839 1.256 . . . . 2.87 112.089 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -68.22 -25.1 65.04 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.505 1.298 . . . . 4.46 114.505 -170.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.52 -12.62 61.15 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.417 1.462 . . . . 5.27 114.492 170.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.86 -49.01 50.75 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.372 0.987 . . . . 5.68 110.996 170.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.214 0 C-N-CA 126.203 1.801 . . . . 5.63 113.239 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 113.0 0.741 . . . . 2.54 113.0 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -74.19 -31.01 62.48 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.012 1.278 . . . . 4.35 112.193 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.33 88.17 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.184 0.994 . . . . 1.39 112.549 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.95 -28.71 70.0 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.639 0.776 . . . . 1.5 112.153 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.12 -37.25 58.3 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.326 0.65 . . . . 1.21 111.956 167.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -63.05 -32.92 74.4 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.589 1.556 . . . . 3.72 114.235 -176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 10' ' ' LEU . 4.2 mm? -60.3 -31.65 70.47 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.992 1.269 . . . . 1.5 111.738 172.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.4 mm -73.6 -45.26 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.728 0.811 . . . . 1.71 110.973 166.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 m -68.39 -16.66 64.0 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 121.052 1.751 . . . . 1.48 114.654 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 7' ' ' LEU . 22.5 mt -69.97 -30.23 67.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.396 1.478 . . . . 3.2 112.446 169.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -77.92 130.75 36.97 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.771 0.828 . . . . 2.32 110.694 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.9 167.59 20.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.839 1.256 . . . . 2.21 112.661 -176.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -106.15 -25.51 11.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.601 1.334 . . . . 2.22 114.601 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.66 152.69 44.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.941 1.296 . . . . 3.57 113.969 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.33 171.8 13.56 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.484 1.514 . . . . 0.83 112.396 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.2 m -125.49 108.46 11.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.735 1.214 . . . . 0.9 111.856 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.2 mt -82.06 140.64 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.19 1.396 . . . . 0.63 109.349 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.1 t -127.31 123.48 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.881 0.872 . . . . 1.92 111.109 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.1 m -136.83 151.27 48.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.104 1.362 . . . . 1.99 110.92 -171.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.4 mt -94.89 127.24 40.78 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.722 0.809 . . . . 2.77 110.42 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB3' HD23 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -100.47 -12.23 19.51 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.272 1.029 . . . . 3.41 111.983 177.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.4 m -146.15 135.89 23.3 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.085 2.154 . . . . 3.78 107.975 169.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.94 84.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 127.58 2.352 . . . . 5.03 116.681 -166.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 57.87 35.55 25.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.74 1.616 . . . . 4.05 112.732 -175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.5 pt -141.96 -22.21 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.819 1.648 . . . . 3.4 113.121 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' A' ' 21' ' ' ASP . 48.9 tp -130.31 124.79 33.16 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.774 1.229 . . . . 2.72 111.297 169.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.5 mp -107.94 138.79 43.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.896 1.679 . . . . 2.48 111.179 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.4 t -142.63 128.63 19.6 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.312 1.045 . . . . 1.38 111.444 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -111.4 138.13 48.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.446 1.099 . . . . 2.95 111.566 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -106.88 146.43 31.0 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.615 1.566 . . . . 4.0 110.958 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -113.34 126.08 54.98 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.809 0.731 . . . . 1.63 109.796 169.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.8 160.12 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 115.098 1.518 . . . . 0.76 115.098 -166.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -75.74 147.99 38.88 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.687 0.795 . . . . 3.47 109.085 167.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.31 -9.52 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 114.536 1.31 . . . . 1.01 114.536 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -79.79 -19.01 49.57 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.168 -1.583 . . . . 3.54 113.861 170.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.7 mt -96.48 -4.59 41.27 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.859 1.264 . . . . 1.24 113.644 -173.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.51 141.26 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.433 1.493 . . . . 1.52 109.465 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -127.49 168.39 14.98 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.026 1.731 . . . . 2.99 111.38 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -72.59 23.7 0.06 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.737 1.615 . . . . 3.16 114.958 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.26 11.38 2.27 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.968 2.223 . . . . 0.89 113.855 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -87.47 163.39 16.73 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.669 1.734 . . . . 2.66 112.371 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 98.7 mt -118.29 126.45 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.185 1.394 . . . . 1.45 109.216 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.2 mm -118.2 129.58 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.964 1.706 . . . . 0.68 112.044 -168.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -88.57 131.48 34.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.022 0.929 . . . . 2.12 112.566 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 p -108.02 140.74 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.333 1.453 . . . . 0.66 111.649 175.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 m -102.96 159.5 29.1 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 124.39 1.076 . . . . 0.84 113.324 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.75 138.76 40.98 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.444 2.762 . . . . 0.97 112.287 169.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.08 -7.28 8.01 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.995 1.158 . . . . 1.09 115.995 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.19 -179.38 48.79 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.423 1.487 . . . . 1.17 115.023 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -123.43 151.98 42.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.493 1.517 . . . . 2.56 112.62 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -78.01 122.38 85.36 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.093 0.957 . . . . 1.87 110.179 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -88.3 -17.97 2.27 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.661 2.24 . . . . 0.82 115.004 -170.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.72 170.83 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 128.586 2.755 . . . . 0.71 108.082 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.49 151.55 20.13 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.694 0.998 . . . . 2.15 113.694 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.63 -160.26 33.69 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.4 0.524 . . . . 0.79 114.081 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -113.32 143.86 43.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.135 0.974 . . . . 4.2 112.913 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.26 124.54 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 126.169 1.788 . . . . 1.1 107.237 169.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.79 33.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.256 1.022 . . . . 1.12 110.959 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -167.85 122.74 0.99 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.613 1.965 . . . . 2.91 108.511 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.02 177.28 43.65 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 116.22 1.248 . . . . 0.94 116.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -146.81 127.69 14.45 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.072 1.349 . . . . 2.03 112.315 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.8 t -145.7 171.48 14.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.925 1.29 . . . . 1.45 112.685 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.7 ttm -115.68 125.56 53.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.508 1.523 . . . . 1.35 108.88 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -122.99 140.54 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.721 1.208 . . . . 0.97 112.443 -168.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -102.04 124.62 47.96 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.03 2.132 . . . . 2.1 111.347 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -125.05 20.25 8.28 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.681 1.193 . . . . 2.57 113.477 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.2 p -62.51 -3.56 1.5 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 117.742 2.497 . . . . 1.32 117.742 -169.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.34 -45.6 4.63 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.685 1.194 . . . . 1.44 109.403 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.7 mm -74.92 -56.77 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.567 1.147 . . . . 1.58 112.321 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.4 p -107.64 -0.95 21.58 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.328 1.451 . . . . 2.02 112.621 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.21 6.07 78.62 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.27 1.414 . . . . 1.78 114.937 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -71.32 106.17 3.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.207 1.003 . . . . 3.38 111.733 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.48 -16.35 60.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.827 0.851 . . . . 1.82 112.375 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.7 ttt -113.42 136.85 21.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.041 1.736 . . . . 5.4 108.971 172.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.07 165.74 25.7 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.63 2.22 . . . . 1.78 114.17 -168.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.06 138.68 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.142 1.777 . . . . 1.58 111.065 -170.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.23 126.72 33.42 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.732 -0.605 . . . . 1.48 112.017 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -98.62 151.04 21.12 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.29 1.436 . . . . 0.94 110.067 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -137.08 175.79 3.24 Favored Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 126.112 1.765 . . . . 2.88 109.679 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.82 65.96 4.91 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 123.395 2.73 . . . . 2.49 111.631 172.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.02 29.98 0.02 OUTLIER Glycine 0 CA--C 1.538 1.479 0 C-N-CA 127.14 2.305 . . . . 1.35 112.806 -176.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.8 m -126.94 150.44 49.34 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.172 1.389 . . . . 1.82 111.273 -170.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.1 p -98.29 148.81 23.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.793 0.837 . . . . 1.15 112.631 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 m -140.08 148.24 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.751 1.621 . . . . 0.93 111.796 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.64 148.66 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.253 1.421 . . . . 1.38 112.51 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.38 142.0 55.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.141 0.976 . . . . 0.75 112.454 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.51 2.44 89.59 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 115.619 1.008 . . . . 1.23 115.619 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 76.0 p -79.22 153.37 30.02 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.012 1.406 . . . . 1.64 111.118 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 mm -112.56 132.51 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.127 0.971 . . . . 1.01 112.796 -168.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -84.45 133.97 34.47 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.668 1.587 . . . . 2.95 111.282 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.82 -72.66 0.44 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.437 0.637 . . . . 3.98 110.071 168.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -143.91 155.93 44.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.425 2.29 . . . . 3.99 107.877 172.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.93 108.04 2.88 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 127.45 2.452 . . . . 1.98 111.803 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.7 t -86.64 127.89 34.96 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.491 1.146 . . . . 2.2 110.844 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.7 mt -126.12 162.64 24.9 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.835 1.254 . . . . 0.97 111.562 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.5 mp -114.81 126.78 55.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.426 0.691 . . . . 1.95 109.44 167.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.62 125.65 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.804 1.642 . . . . 1.28 110.292 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.7 p -87.25 108.03 18.76 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.671 0.748 . . . . 1.52 109.744 168.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.26 135.66 36.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.61 0.764 . . . . 0.87 111.574 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.04 -0.14 9.54 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.586 1.328 . . . . 2.15 114.586 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -143.78 144.68 31.91 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.296 1.438 . . . . 1.52 111.827 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 m -83.6 162.92 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.024 0.93 . . . . 1.68 110.974 169.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.63 -34.49 90.04 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 120.728 -1.233 . . . . 1.37 114.984 -168.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.25 -28.0 64.89 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.11 -1.229 . . . . 1.71 113.056 175.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.27 -7.81 56.57 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.16 1.784 . . . . 2.76 114.545 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.4 p -68.55 158.03 34.76 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.885 -1.135 . . . . 1.94 112.688 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 t -64.59 -33.19 75.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.19 0.596 . . . . 2.43 111.254 170.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mp -55.66 -50.98 68.79 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.983 -1.073 . . . . 1.95 111.107 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.0 m -69.29 -31.56 70.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.417 1.087 . . . . 1.71 111.928 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -63.19 -40.8 98.56 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.671 -0.643 . . . . 1.69 111.718 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 70.0 mt -65.18 -50.7 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.843 1.657 . . . . 2.04 111.108 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.2 m -65.21 -25.46 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 113.52 0.933 . . . . 1.97 113.52 -175.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -72.72 -38.46 67.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.12 0.873 . . . . 4.16 113.197 169.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.25 -52.12 13.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.459 1.904 . . . . 3.14 113.482 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.8 t -69.47 -22.98 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.627 -1.295 . . . . 2.34 111.762 -176.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.56 -24.58 64.63 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.556 1.142 . . . . 4.02 112.642 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.86 -27.62 63.97 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.915 -1.116 . . . . 4.42 113.775 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.74 -50.72 48.38 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.622 1.101 . . . . 5.0 110.298 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 125.045 1.338 . . . . 5.22 113.088 170.028 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.131 1.16 . . . . 2.38 114.131 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -74.16 -39.34 63.32 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.9 0.88 . . . . 4.42 109.737 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.68 83.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.871 1.268 . . . . 2.0 112.644 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.0 tp -65.06 -30.19 71.14 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.601 -0.687 . . . . 2.37 111.891 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.69 61.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.583 0.753 . . . . 1.33 112.439 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -58.84 -35.96 73.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.013 1.325 . . . . 2.73 112.914 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -48.98 -49.97 38.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.892 0.877 . . . . 1.53 112.236 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.8 mm -74.09 -36.84 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.672 0.789 . . . . 2.16 112.622 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m -58.91 -30.31 67.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.116 0.966 . . . . 1.16 113.053 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -22.06 61.72 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.938 1.295 . . . . 2.31 114.308 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -62.84 162.84 10.38 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.997 1.48 . . . . 2.36 114.997 -171.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.7 -31.08 12.86 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.97 1.308 . . . . 3.55 114.291 -171.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 m 64.32 -12.78 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 127.946 2.499 . . . . 2.48 116.437 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -140.9 149.05 41.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.212 1.805 . . . . 2.86 111.204 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.21 173.06 11.92 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.504 1.122 . . . . 0.75 112.837 -172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.4 m -124.33 120.88 33.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.611 1.165 . . . . 0.84 111.967 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.9 mt -94.42 144.5 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.785 2.034 . . . . 0.6 110.37 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.7 t -111.92 126.0 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.223 1.009 . . . . 2.06 110.878 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.6 m -135.88 152.77 51.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.791 1.636 . . . . 1.87 111.331 -172.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -78.71 141.31 38.0 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.122 0.874 . . . . 4.77 111.493 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.46 -9.39 10.87 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.746 1.218 . . . . 4.73 113.143 172.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.1 m -152.7 145.53 24.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.495 1.918 . . . . 3.51 110.528 169.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -39.29 78.8 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 130.713 3.605 . . . . 6.48 116.725 -167.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 66.05 -22.71 0.09 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.812 2.445 . . . . 8.04 114.563 -170.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 pt -82.24 -15.57 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 128.586 2.755 . . . . 4.66 115.138 -170.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tt -138.3 132.6 31.89 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.048 1.129 . . . . 2.95 114.048 170.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mp -106.14 147.76 28.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.337 2.255 . . . . 3.39 111.594 172.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.0 t -136.75 145.47 44.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.729 1.612 . . . . 1.82 110.5 169.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -109.79 130.1 55.56 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.143 0.497 . . . . 2.82 111.68 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -118.27 132.52 56.29 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.384 2.273 . . . . 3.92 110.19 -170.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -93.52 139.17 31.05 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.097 1.317 . . . . 1.61 112.312 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.96 166.09 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.68 1.592 . . . . 0.88 114.02 -171.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.79 150.58 24.95 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.375 1.47 . . . . 3.21 109.621 166.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.45 -19.48 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 114.295 1.22 . . . . 1.11 114.295 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.32 -21.73 60.5 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.703 -1.248 . . . . 3.82 113.866 172.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.8 mt -101.87 -7.43 22.48 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.806 1.242 . . . . 1.31 113.808 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -86.23 142.35 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.835 1.254 . . . . 1.43 109.631 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -117.19 168.36 10.37 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.471 1.108 . . . . 4.42 113.292 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -67.62 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.98 2.112 . . . . 2.69 115.711 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.77 12.22 0.63 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.484 1.993 . . . . 0.84 114.277 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -92.42 152.31 19.78 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.739 1.769 . . . . 2.71 112.702 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -102.0 121.99 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.716 1.206 . . . . 1.4 110.281 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.0 mm -104.56 159.95 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.796 1.638 . . . . 1.37 112.273 -172.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HE2' HD11 ' A' ' 96' ' ' LEU . 34.3 ttmt -129.47 132.89 47.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.688 1.595 . . . . 2.03 111.332 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.57 140.8 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.225 1.01 . . . . 0.79 112.542 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 m -95.03 159.34 33.27 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 125.233 1.413 . . . . 0.98 112.859 176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.0 133.96 43.9 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.058 2.505 . . . . 1.06 111.891 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.29 -12.04 61.63 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.539 1.542 . . . . 0.95 114.7 -172.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.61 173.76 52.85 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.216 1.389 . . . . 0.99 114.726 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -108.45 154.07 22.4 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.55 1.54 . . . . 2.7 113.259 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -84.03 121.75 75.78 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.887 0.875 . . . . 1.81 110.818 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.79 -21.06 2.82 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.974 2.449 . . . . 0.83 115.816 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.4 m -152.04 163.08 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 128.08 2.552 . . . . 0.96 108.906 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 136.78 32.84 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 112.818 0.673 . . . . 1.7 112.818 -172.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.3 -161.86 32.89 Favored Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.635 -0.666 . . . . 0.72 114.148 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.7 ttp85 -109.91 134.01 52.54 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.204 1.801 . . . . 4.06 112.976 -172.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.5 133.53 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.524 2.329 . . . . 0.94 108.77 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.62 32.46 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.951 0.901 . . . . 0.99 112.817 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -167.16 136.17 2.74 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.222 1.809 . . . . 3.04 109.005 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.18 -177.19 51.85 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 122.417 1.01 . . . . 0.96 115.559 170.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -144.01 124.71 14.13 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.653 1.181 . . . . 1.95 111.746 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m -149.28 166.49 28.77 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.23 1.567 . . . . 1.15 115.23 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.6 ttm -114.67 119.57 37.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.142 1.377 . . . . 1.31 108.884 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.39 134.37 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.882 1.673 . . . . 1.09 112.363 -167.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -86.73 75.79 9.59 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.702 1.601 . . . . 2.2 110.316 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.67 4.62 53.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.205 1.402 . . . . 1.98 113.718 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.1 -23.87 66.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 115.511 1.671 . . . . 3.01 115.511 -169.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.72 -21.13 57.82 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.434 1.015 . . . . 1.58 112.029 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -86.94 -49.84 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.935 0.894 . . . . 1.4 110.968 176.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.4 p -100.19 -7.7 24.43 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.436 1.273 . . . . 1.42 114.436 -172.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.98 -1.06 56.77 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.336 1.446 . . . . 1.61 115.186 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.94 -6.76 1.41 Allowed 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 119.822 1.811 . . . . 2.89 115.094 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 45.24 26.37 0.25 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 130.746 3.618 . . . . 1.97 115.537 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 ttm -166.49 135.39 2.38 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.618 1.967 . . . . 3.87 108.779 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.88 162.84 40.58 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.215 3.277 . . . . 1.75 114.474 -169.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.99 135.57 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 126.198 1.799 . . . . 1.34 110.991 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.8 141.98 35.74 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.826 0.85 . . . . 1.3 112.977 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -128.87 149.54 50.72 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.829 2.052 . . . . 1.05 111.04 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -151.46 171.67 6.25 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 128.757 2.823 . . . . 2.84 108.977 -173.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.78 134.57 63.6 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 CA-C-N 122.36 1.879 . . . . 1.12 111.699 169.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.78 31.14 45.38 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.052 0.834 . . . . 1.1 114.19 -170.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.2 t -122.05 159.82 26.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.835 1.254 . . . . 1.9 110.827 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.0 p -118.77 155.43 31.14 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.547 1.521 . . . . 1.19 113.732 -172.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.1 m -132.2 152.41 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 126.61 1.964 . . . . 1.26 111.568 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.637 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -100.71 -1.26 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.844 2.058 . . . . 4.06 116.041 -176.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 70.07 159.98 0.2 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.171 1.788 . . . . 0.87 114.484 -167.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.7 -44.27 2.5 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.011 1.291 . . . . 1.68 113.277 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.5 p -51.33 151.29 3.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.373 1.069 . . . . 1.3 113.741 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.59 136.13 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.229 1.012 . . . . 1.04 110.462 -172.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -83.3 129.9 35.03 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.05 0.94 . . . . 1.9 109.121 169.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -134.49 63.6 1.62 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.911 0.708 . . . . 3.55 112.911 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -158.31 -56.1 0.07 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.51 1.67 . . . . 4.24 115.51 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.9 -174.43 31.77 Favored Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.247 1.259 . . . . 2.12 116.247 -167.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.4 p -94.31 126.46 39.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.857 1.263 . . . . 2.52 112.54 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 mt -136.0 161.79 34.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.333 1.053 . . . . 1.05 113.255 -173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.503 HD11 ' HE2' ' A' ' 44' ' ' LYS . 7.5 mp -120.61 139.0 53.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.291 1.036 . . . . 1.93 111.591 168.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.36 133.07 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.209 1.404 . . . . 1.56 111.244 -173.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.6 p -90.28 118.76 30.03 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.145 -0.972 . . . . 1.42 111.307 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.46 121.0 24.64 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.083 -1.011 . . . . 0.92 110.782 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.4 p -125.95 11.21 7.69 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.818 1.247 . . . . 2.43 113.612 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -139.6 135.29 33.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.163 1.785 . . . . 1.61 108.137 171.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 p -78.66 160.65 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 122.962 0.505 . . . . 2.73 109.697 169.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.28 -32.86 68.62 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 120.819 -1.176 . . . . 1.4 115.875 -168.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.48 -40.12 73.82 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.356 1.578 . . . . 1.63 113.243 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.33 -7.67 53.63 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.703 2.001 . . . . 2.42 114.385 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 67.6 p -58.48 149.25 25.71 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.988 -1.07 . . . . 1.7 113.547 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.0 t -60.09 -36.57 77.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.663 0.785 . . . . 2.34 111.309 171.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.2 tp -58.48 -47.01 85.46 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.841 -1.162 . . . . 1.49 112.792 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 t -70.9 -26.96 63.46 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.337 0.655 . . . . 1.92 112.404 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -71.25 -42.77 68.41 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.516 1.126 . . . . 1.56 111.818 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.4 mt -54.31 -50.68 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.158 0.983 . . . . 1.79 110.574 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.7 m -68.62 -29.47 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 120.958 -1.089 . . . . 1.68 113.292 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -70.81 -29.28 65.41 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.286 -0.884 . . . . 2.35 112.285 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.0 mt -76.56 -51.77 11.01 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.73 1.612 . . . . 2.78 112.649 168.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.65 -28.19 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.317 1.047 . . . . 2.7 112.507 -171.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -65.08 -34.47 78.48 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.701 -1.25 . . . . 4.1 111.636 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -80.73 -14.0 58.5 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.134 1.161 . . . . 3.75 114.134 173.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.26 -24.26 59.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.543 1.137 . . . . 5.35 113.586 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 128.436 2.694 . . . . 5.21 114.249 177.896 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.9 p . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 113.763 1.023 . . . . 3.18 113.763 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -77.03 -33.79 57.34 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.714 -1.242 . . . . 4.37 110.946 168.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.93 -35.78 80.77 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.514 0.725 . . . . 1.52 111.893 176.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.8 tp -49.25 -43.14 42.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.587 1.555 . . . . 1.64 111.797 171.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.93 -35.97 62.16 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.276 0.843 . . . . 1.27 113.276 172.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -64.57 -31.24 72.38 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.941 0.792 . . . . 3.07 112.801 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.44 -32.65 70.41 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.97 1.259 . . . . 1.75 112.569 172.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.6 mm -73.08 -40.71 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.397 -0.814 . . . . 2.3 111.725 169.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.5 m -70.83 -21.06 62.49 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.142 1.164 . . . . 1.17 114.142 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -72.84 -9.97 59.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.653 1.581 . . . . 2.12 113.807 173.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -89.28 132.92 34.69 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.071 0.85 . . . . 2.76 113.094 -172.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.48 161.13 31.52 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.445 1.498 . . . . 2.86 114.43 -169.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 p -123.6 -26.3 4.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.587 1.555 . . . . 2.05 113.833 -179.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.58 153.19 43.3 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.438 1.095 . . . . 3.35 113.242 177.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.63 165.66 26.88 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.211 1.404 . . . . 0.78 112.786 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -118.61 98.41 6.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.658 1.183 . . . . 1.04 112.159 -178.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.2 mt -83.24 129.6 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 121.252 -0.905 . . . . 0.66 110.496 -177.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -90.94 109.28 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 108.478 -0.934 . . . . 1.76 108.478 169.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -104.41 149.94 24.97 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.803 1.641 . . . . 2.17 110.144 -177.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.44 103.49 14.85 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.387 -0.82 . . . . 3.22 109.971 178.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.81 -1.53 58.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.454 1.502 . . . . 4.44 113.68 -174.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.6 m -156.13 133.21 10.59 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.496 1.918 . . . . 3.51 107.933 167.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 t70 18.04 -117.09 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 130.025 3.33 . . . . 6.23 110.667 -166.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.01 12.44 34.16 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.565 1.146 . . . . 5.48 110.201 163.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.5 pt -94.78 -29.83 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.931 2.492 . . . . 4.33 116.939 -167.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.44 108.82 17.38 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.935 1.243 . . . . 2.69 111.417 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 mp -88.29 120.16 29.39 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.998 1.319 . . . . 2.63 109.559 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 t -137.93 127.96 25.74 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.333 1.053 . . . . 1.79 110.476 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -102.76 146.94 27.49 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.478 -0.764 . . . . 2.61 112.459 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -127.75 138.37 52.74 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.965 1.706 . . . . 3.53 110.41 -169.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -99.69 116.75 32.53 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.487 0.715 . . . . 2.51 109.334 178.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.95 166.07 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.008 0.923 . . . . 0.87 113.146 -172.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -88.13 160.82 17.61 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.582 1.553 . . . . 3.83 112.565 169.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.55 -28.36 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 115.472 1.656 . . . . 1.67 115.472 -171.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -75.99 -17.23 59.78 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.272 -1.517 . . . . 4.39 112.554 172.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -94.78 -8.78 36.54 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.176 1.39 . . . . 1.54 113.723 -172.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.73 139.02 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.945 1.698 . . . . 1.45 109.392 168.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -136.63 168.04 20.26 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.281 1.432 . . . . 2.88 112.597 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -68.91 4.84 1.32 Allowed 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 117.531 2.419 . . . . 4.38 117.531 -167.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -117.16 7.35 16.63 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.667 1.603 . . . . 1.37 114.21 172.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -90.04 152.78 21.01 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.058 1.429 . . . . 2.71 112.929 -177.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.1 mm -113.45 122.47 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.927 1.691 . . . . 1.32 109.86 177.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.3 mm -113.28 125.04 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.992 1.317 . . . . 0.88 111.562 -172.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -78.74 132.48 36.96 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.443 -0.786 . . . . 2.43 110.508 169.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 p -121.85 133.86 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.337 1.455 . . . . 0.66 111.206 176.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 m -89.06 162.22 38.42 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.766 1.226 . . . . 1.05 113.389 -173.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -61.28 133.7 47.95 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.695 1.597 . . . . 1.21 109.196 167.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.96 -10.69 46.05 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 118.515 -1.158 . . . . 1.12 115.426 -172.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.53 175.17 44.07 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 119.038 1.419 . . . . 1.06 114.403 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -111.63 153.34 26.49 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.463 1.505 . . . . 1.74 112.055 175.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -84.17 128.67 61.45 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-O 118.101 -0.952 . . . . 2.31 109.717 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -96.9 -14.46 0.4 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.912 2.408 . . . . 0.8 115.482 -173.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.37 164.62 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 127.716 2.406 . . . . 1.03 108.336 -176.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -88.46 155.09 19.87 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.412 1.264 . . . . 2.47 114.412 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.74 -131.26 2.4 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.362 -0.835 . . . . 1.06 113.735 177.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -135.72 146.39 47.65 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.233 1.197 . . . . 3.6 114.233 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.77 122.77 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 105.628 -1.99 . . . . 1.21 105.628 166.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.2 pt -137.0 33.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.816 0.817 . . . . 0.88 112.109 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -167.62 128.54 1.46 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.069 2.148 . . . . 2.81 107.75 166.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.66 -178.12 54.09 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 122.842 1.246 . . . . 0.8 115.374 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -149.13 137.04 20.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.391 1.476 . . . . 2.57 111.414 -176.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -150.76 176.68 10.81 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.481 0.919 . . . . 1.33 113.481 176.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.5 ttm -112.89 126.95 56.02 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.334 1.054 . . . . 1.27 110.678 171.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -114.33 140.77 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.206 1.402 . . . . 0.73 112.774 -168.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -97.38 107.67 20.23 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.456 1.502 . . . . 1.95 109.554 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . 0.256 11.2 pt-20 -123.75 30.15 6.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.483 1.513 . . . . 1.86 113.063 -178.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.3 p -60.63 -24.22 65.36 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.966 1.839 . . . . 1.51 115.966 -175.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -95.47 -33.61 12.38 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.079 1.351 . . . . 1.32 111.352 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.0 mm -76.5 -49.34 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.531 -0.731 . . . . 1.23 110.632 178.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 m -106.85 -21.5 13.0 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.535 1.134 . . . . 2.2 113.277 -169.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.59 -13.69 64.87 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.584 1.564 . . . . 1.22 115.78 172.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -63.86 118.31 8.19 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.475 1.138 . . . . 3.1 110.215 174.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.25 35.05 0.32 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.187 1.395 . . . . 1.54 112.829 -178.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 ptp -154.14 137.13 10.12 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.367 1.867 . . . . 4.04 110.239 -174.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -63.23 154.93 64.69 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.861 2.374 . . . . 1.58 115.193 -179.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.4 t -122.76 132.23 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.999 1.72 . . . . 0.99 111.04 -170.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.25 35.56 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.964 0.887 . . . . 1.01 113.289 -175.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -125.01 150.57 46.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.539 1.936 . . . . 0.76 110.61 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -150.09 173.9 3.92 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 129.621 3.169 . . . . 2.57 108.415 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -56.14 136.81 77.08 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 CA-C-N 121.702 1.644 . . . . 0.8 111.573 170.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.94 25.98 72.33 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.602 1.096 . . . . 0.89 114.465 -171.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.4 m -102.05 146.98 27.15 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 119.139 1.469 . . . . 1.45 110.575 174.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.7 p -88.83 151.76 22.17 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.184 1.357 . . . . 0.8 113.148 178.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -138.52 157.04 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.04 1.336 . . . . 0.7 112.01 176.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.75 150.18 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.095 2.158 . . . . 1.3 111.282 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.86 148.54 49.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.913 0.885 . . . . 0.66 113.334 -174.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.44 -3.46 62.96 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.348 0.975 . . . . 0.76 115.106 179.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 93.2 p -79.5 157.2 27.5 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.951 1.375 . . . . 1.43 111.07 169.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mm -115.13 130.52 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.551 0.74 . . . . 0.81 112.645 -168.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -90.07 149.26 22.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.882 1.673 . . . . 1.66 113.669 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -157.67 142.9 16.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.403 1.081 . . . . 4.07 112.61 171.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 t30 117.47 -40.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 131.255 3.822 . . . . 4.11 113.514 175.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.62 -179.79 46.35 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 120.031 1.287 . . . . 1.89 115.281 173.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.4 m -82.35 134.21 35.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.416 1.086 . . . . 2.13 112.616 -177.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.39 165.16 20.29 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.128 1.771 . . . . 1.34 111.619 -176.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.43 132.96 55.91 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.607 0.718 . . . . 2.15 111.026 168.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.7 mm -118.14 125.12 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.053 1.741 . . . . 1.54 110.283 -169.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -82.73 114.65 21.23 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.383 -0.823 . . . . 1.5 109.065 168.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.04 112.67 15.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.338 -0.986 . . . . 1.01 108.338 174.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -104.6 2.56 30.79 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.932 0.893 . . . . 2.45 112.746 -172.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -147.76 154.39 40.46 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.7 1.6 . . . . 2.06 111.665 173.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.06 165.63 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.896 1.278 . . . . 1.96 112.181 170.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 -35.21 85.42 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 120.906 -1.121 . . . . 1.5 114.283 -172.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.91 -31.69 72.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.455 1.128 . . . . 1.89 113.64 176.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -75.19 -17.63 60.32 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.127 -0.983 . . . . 2.95 113.58 174.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 81.6 p -64.65 144.6 57.11 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.899 -1.126 . . . . 1.83 112.566 -169.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -64.55 -22.85 67.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.899 0.879 . . . . 1.94 113.065 -169.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.64 -49.33 78.19 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.68 1.192 . . . . 1.59 113.107 -177.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.8 m -72.83 -17.34 61.56 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.533 0.938 . . . . 2.75 113.533 173.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -76.92 -40.89 45.58 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.736 0.643 . . . . 1.48 112.736 172.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.13 -47.31 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.6 1.56 . . . . 1.46 110.386 177.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.13 -18.7 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 114.479 1.288 . . . . 1.5 114.479 -178.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -72.03 -33.25 67.87 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.562 1.074 . . . . 4.03 112.504 171.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 mt -75.32 -50.73 15.11 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.405 1.082 . . . . 3.19 111.603 170.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -66.44 -29.1 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.03 0.932 . . . . 2.79 112.122 -174.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -60.16 -38.85 84.41 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.417 -1.427 . . . . 4.52 112.524 173.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.04 -13.54 59.71 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.52 -1.363 . . . . 6.54 114.478 171.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.43 -27.43 62.33 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.704 1.001 . . . . 6.34 113.704 -176.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 124.523 1.129 . . . . 5.56 111.268 169.249 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 114.174 1.175 . . . . 3.67 114.174 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -87.17 -24.49 24.45 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.795 1.238 . . . . 6.57 111.741 168.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.9 -27.15 60.11 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.011 0.924 . . . . 2.37 112.48 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.25 -44.85 84.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.253 1.421 . . . . 1.54 111.797 176.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.82 -8.61 56.33 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.286 1.217 . . . . 1.59 114.286 175.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -65.25 -43.01 92.71 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.818 1.19 . . . . 2.49 110.607 -177.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -45.86 -52.93 10.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.246 1.818 . . . . 1.68 112.246 172.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.1 mm -69.78 -31.32 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.11 0.964 . . . . 2.14 112.183 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.9 m -75.46 -28.3 59.23 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.01 1.324 . . . . 1.27 113.627 -175.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.32 -24.14 67.73 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.265 0.938 . . . . 2.0 113.519 175.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -68.25 139.47 56.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.886 1.275 . . . . 2.49 113.465 -175.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.87 157.28 29.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.604 1.161 . . . . 2.21 112.561 173.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.54 -2.25 17.72 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.7 1.741 . . . . 1.97 115.7 -169.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.31 156.74 48.21 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.862 1.665 . . . . 3.9 112.526 -178.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.72 147.3 37.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.034 0.934 . . . . 0.82 113.108 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.2 m -107.98 106.45 16.71 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.597 1.159 . . . . 0.81 111.369 175.225 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.8 mt -83.48 147.22 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.178 1.791 . . . . 0.59 109.486 176.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.16 140.24 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.636 1.347 . . . . 2.11 114.636 169.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 p -126.22 142.49 51.51 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.575 1.55 . . . . 2.66 114.4 -178.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.55 82.81 8.11 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.287 1.042 . . . . 3.0 108.268 169.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.401 ' HB2' HD23 ' A' ' 26' ' ' LEU . 15.0 m-20 -78.15 -33.65 50.22 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.869 1.268 . . . . 4.66 112.07 178.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -142.59 125.04 15.65 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.577 1.951 . . . . 4.33 109.502 170.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -10.51 62.43 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.219 1 C-N-CA 135.942 5.697 . . . . 5.76 117.168 -178.958 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 59.19 -21.16 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.349 2.26 . . . . 4.07 115.41 -168.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.404 ' H ' ' C ' ' A' ' 23' ' ' ASP . 8.0 pt -58.45 -27.53 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 128.751 2.82 . . . . 4.02 115.499 177.048 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 21' ' ' ASP . 2.4 tp -105.65 -55.96 2.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.586 0.754 . . . . 4.11 112.495 177.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.8 tp 40.61 80.9 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.08 2.152 . . . . 3.28 112.388 -173.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -79.08 153.6 30.05 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.231 1.013 . . . . 1.67 112.501 -172.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -116.08 131.63 56.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.111 1.364 . . . . 2.65 110.214 176.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -126.33 136.07 52.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.214 1.806 . . . . 3.98 110.171 -176.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -110.2 130.98 55.45 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.466 -1.396 . . . . 1.97 112.252 -175.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.81 169.14 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.922 1.289 . . . . 0.76 113.62 -173.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -79.58 152.42 30.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.24 1.416 . . . . 3.38 112.494 171.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.77 -18.76 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 115.189 1.552 . . . . 1.16 115.189 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -85.46 -19.92 30.54 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 120.623 1.556 . . . . 3.04 113.503 169.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.16 -17.7 21.55 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.046 1.338 . . . . 1.21 113.558 -173.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.54 138.69 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.766 0.827 . . . . 1.6 109.235 168.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -118.82 159.27 24.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.196 0.998 . . . . 3.53 111.123 178.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.2 ptt85 -69.59 146.6 51.62 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.899 -0.501 . . . . 2.7 109.984 169.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.12 2.8 56.9 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-N 118.852 0.751 . . . . 1.08 114.077 -171.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -112.98 172.87 6.67 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.612 1.565 . . . . 2.37 112.102 173.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.3 mm -112.69 122.95 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.734 1.614 . . . . 1.3 110.483 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.6 mm -119.5 132.89 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.458 1.503 . . . . 0.87 111.429 -169.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HE3' HD11 ' A' ' 96' ' ' LEU . 13.7 mmmm -86.74 142.24 28.3 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.322 1.449 . . . . 2.44 112.456 174.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 p -121.35 145.4 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.58 0.752 . . . . 0.72 111.749 170.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.78 156.75 35.17 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 124.98 1.312 . . . . 1.09 113.323 -177.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -59.64 140.18 92.41 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.352 2.035 . . . . 1.27 110.679 168.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.57 -5.34 11.21 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.748 1.166 . . . . 1.05 114.906 -172.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.64 169.99 53.81 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 118.817 1.308 . . . . 0.99 114.241 177.032 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -123.25 152.05 41.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.07 1.748 . . . . 1.95 110.606 -178.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -81.05 127.51 74.13 Favored Pre-proline 0 CA--C 1.551 0.988 0 O-C-N 121.629 -0.669 . . . . 1.9 111.575 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.13 -20.66 2.76 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.581 2.854 . . . . 1.12 113.493 177.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 m -147.99 170.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.872 2.469 . . . . 0.92 108.978 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.84 152.47 20.48 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.059 0.763 . . . . 1.71 113.059 177.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.74 -174.61 46.17 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 115.397 0.919 . . . . 0.73 115.397 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.0 ttt85 -102.75 139.46 38.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.66 1.184 . . . . 5.9 111.912 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.3 t -99.91 133.96 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 127.307 2.243 . . . . 0.8 109.268 -173.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.1 pt -139.87 28.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.017 1.117 . . . . 0.76 114.017 -177.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.73 150.18 3.95 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.941 1.697 . . . . 3.27 110.114 166.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.57 -173.92 34.35 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.704 1.145 . . . . 0.82 115.29 169.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -151.33 121.13 7.04 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.185 1.394 . . . . 2.52 110.965 -175.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.6 m -147.5 155.2 41.66 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.111 -0.993 . . . . 1.41 113.009 172.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.1 ttm -102.06 121.13 41.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.598 1.159 . . . . 1.15 108.436 169.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 68.7 t -118.59 146.33 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.539 1.936 . . . . 1.0 112.831 -165.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -108.41 115.84 30.85 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.351 1.86 . . . . 2.01 110.541 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -127.12 26.21 6.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.611 1.564 . . . . 1.74 112.271 179.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 87.5 p -55.58 -31.04 61.86 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.006 1.854 . . . . 1.43 116.006 -172.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.0 -39.44 13.7 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.607 1.094 . . . . 1.1 111.189 176.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.6 mm -70.29 -62.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.733 1.213 . . . . 1.05 111.332 -173.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.7 p -98.21 -7.49 29.2 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.552 1.141 . . . . 1.25 112.946 -175.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.61 17.66 65.6 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.839 1.209 . . . . 1.43 113.331 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -82.53 96.81 8.16 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.32 1.06 . . . . 3.06 112.108 -176.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.88 20.18 0.26 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.27 1.028 . . . . 1.48 113.565 177.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.5 ttt -146.69 132.54 9.4 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 128.419 2.688 . . . . 4.21 107.385 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -69.64 153.53 69.34 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.052 2.501 . . . . 1.9 112.62 -170.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.1 t -111.87 132.5 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.971 1.708 . . . . 0.98 111.207 -168.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.09 137.68 34.0 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.435 -0.791 . . . . 0.78 111.398 174.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -122.75 146.91 47.09 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.364 1.465 . . . . 0.8 110.938 176.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -150.23 170.98 6.89 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 126.871 2.068 . . . . 2.86 111.375 -170.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -59.01 118.94 5.92 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 121.982 1.788 . . . . 0.87 109.634 167.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.3 48.33 4.34 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.534 1.54 . . . . 0.88 113.689 -169.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.6 m -126.44 166.62 16.89 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.861 1.33 . . . . 1.44 112.804 173.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.7 p -111.0 149.63 30.43 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.271 0.941 . . . . 0.87 112.842 174.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.03 157.12 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.371 1.468 . . . . 0.54 111.898 175.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -119.34 149.42 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.839 2.056 . . . . 0.91 113.078 176.193 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.84 143.83 46.23 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.891 0.876 . . . . 0.63 111.843 176.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.33 -7.67 60.28 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 116.272 1.269 . . . . 0.7 116.272 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 t -73.7 157.14 37.08 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.137 1.468 . . . . 2.19 111.329 169.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.41 136.32 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.753 1.621 . . . . 0.99 111.697 -169.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -99.59 134.42 42.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.249 1.019 . . . . 2.23 110.745 172.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -135.9 53.65 1.94 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.041 1.126 . . . . 3.42 114.041 175.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -153.17 -54.21 0.11 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.415 1.635 . . . . 2.98 115.415 173.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.07 -156.17 11.33 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-N 119.367 0.985 . . . . 2.5 114.946 -169.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -83.9 155.47 22.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.223 1.009 . . . . 3.06 112.783 177.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.1 mt -147.55 152.28 37.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.839 2.056 . . . . 1.12 107.766 167.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD11 ' HE3' ' A' ' 44' ' ' LYS . 10.1 mp -111.58 114.86 28.21 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.189 0.995 . . . . 2.13 109.399 175.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.67 126.43 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.259 1.023 . . . . 1.18 111.397 -173.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 30.0 p -82.37 119.65 24.43 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.579 -0.701 . . . . 1.55 109.249 169.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.8 123.53 28.32 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.275 -0.891 . . . . 0.88 110.973 -175.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.6 p -115.81 -8.14 12.0 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.736 1.013 . . . . 2.56 113.736 -174.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -142.24 151.0 41.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.569 1.548 . . . . 1.48 110.603 173.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 m -100.65 171.21 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.863 1.265 . . . . 1.88 109.614 167.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.51 63.52 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.61 -1.306 . . . . 1.64 114.663 -174.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.13 -47.06 63.34 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.27 -1.135 . . . . 1.62 112.951 169.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -79.1 -16.73 56.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.091 2.156 . . . . 2.53 116.174 -174.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 109' ' ' SER . 10.0 t -71.54 148.37 46.78 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.485 -1.385 . . . . 2.78 113.614 -170.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.3 t -51.62 -35.89 43.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.033 1.333 . . . . 1.92 112.869 171.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.9 tp -60.29 -46.36 90.11 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.204 -0.935 . . . . 1.72 112.128 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.403 ' H ' HG23 ' A' ' 106' ' ' THR . 53.1 p -73.91 -30.83 62.8 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.991 0.916 . . . . 2.13 113.411 173.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -61.54 -43.1 99.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.18 0.9 . . . . 1.59 111.343 175.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.83 -54.69 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.547 1.139 . . . . 1.8 110.475 178.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.21 -29.75 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.338 -0.851 . . . . 1.3 112.84 -178.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -66.1 -39.62 90.11 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.288 0.949 . . . . 2.57 112.006 174.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.15 -35.84 74.31 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.569 1.148 . . . . 3.27 113.385 174.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.2 t -69.41 -42.52 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.427 0.691 . . . . 2.07 111.113 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -65.29 -36.16 83.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.193 1.397 . . . . 3.83 112.999 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -69.49 -30.06 67.85 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.994 -1.066 . . . . 4.69 112.927 171.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.05 -59.73 2.57 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.66 0.784 . . . . 4.31 112.491 173.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.202 0 C-N-CA 127.402 2.281 . . . . 4.84 114.008 -173.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 113.537 0.94 . . . . 3.79 113.537 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -89.23 -26.54 21.15 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.032 0.933 . . . . 6.14 111.523 170.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.77 -33.47 75.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.816 0.846 . . . . 2.14 111.638 169.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 tp -50.2 -41.41 49.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.242 1.417 . . . . 1.92 113.36 177.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.22 61.04 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.928 0.714 . . . . 1.93 112.928 171.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.23 -35.18 73.19 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.029 0.931 . . . . 3.06 112.551 178.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.32 -31.94 69.61 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 119.301 0.955 . . . . 1.36 112.973 173.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.2 mm -72.17 -40.2 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.027 0.931 . . . . 2.83 111.786 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m -71.26 -23.74 62.04 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.824 -1.173 . . . . 1.91 113.882 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.0 mt -73.4 -20.98 60.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.102 1.361 . . . . 2.4 113.57 173.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -85.37 143.18 28.79 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.178 0.991 . . . . 2.92 113.326 -176.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.56 165.69 12.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.746 1.619 . . . . 3.15 114.568 -178.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -120.55 -6.3 9.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.287 1.035 . . . . 3.59 113.041 169.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.49 155.23 45.03 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.558 -1.339 . . . . 2.79 113.725 -175.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.78 162.38 35.63 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.864 1.666 . . . . 1.28 113.003 177.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.2 m -125.51 111.97 15.68 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.637 1.175 . . . . 1.42 112.811 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 mt -96.75 133.1 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.788 1.235 . . . . 0.74 110.439 -175.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.2 t -126.54 115.1 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.218 1.407 . . . . 2.65 110.614 -177.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.5 m -133.51 149.21 51.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.865 1.266 . . . . 2.59 110.561 -169.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.09 143.87 25.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.781 0.833 . . . . 3.5 111.197 175.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.04 -12.03 8.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.481 1.112 . . . . 3.68 113.686 170.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.5 m -144.42 139.77 28.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.224 1.41 . . . . 5.02 109.998 168.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -32.96 72.58 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 131.288 3.835 . . . . 5.89 118.203 -166.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 61.48 -17.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.439 2.296 . . . . 7.02 114.589 -168.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.0 pt -72.83 -18.18 18.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 127.324 2.249 . . . . 4.62 115.696 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 tt -130.06 124.98 34.13 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.515 1.052 . . . . 3.05 112.851 175.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -102.58 131.89 49.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.047 1.739 . . . . 4.1 110.404 177.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.7 t -126.78 120.0 28.26 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.759 1.224 . . . . 1.61 109.301 172.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -117.88 152.46 35.35 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.293 1.037 . . . . 3.24 111.14 -173.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -142.09 138.39 31.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.968 1.707 . . . . 2.93 111.18 -176.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -108.41 130.61 55.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.407 1.003 . . . . 1.94 109.664 168.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.7 167.86 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.588 1.155 . . . . 1.17 112.9 -168.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.88 149.87 32.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.261 1.425 . . . . 4.89 110.712 168.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.02 -9.05 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.599 1.333 . . . . 1.63 114.599 -173.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -96.64 -15.51 21.47 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.274 -1.516 . . . . 4.41 112.803 169.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.01 -5.67 59.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.219 1.408 . . . . 1.66 113.936 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -100.12 142.85 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.504 1.522 . . . . 1.55 111.207 170.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -117.83 168.97 10.0 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.76 2.024 . . . . 3.44 111.468 175.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -68.83 144.82 54.17 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.841 -0.537 . . . . 4.74 110.586 169.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.0 -7.37 31.13 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.264 1.411 . . . . 1.8 114.984 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.6 165.69 11.5 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.404 1.602 . . . . 3.06 113.343 178.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -116.39 132.49 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.653 1.181 . . . . 1.93 112.302 -173.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.52 118.57 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 127.599 2.36 . . . . 1.09 109.225 -169.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -94.68 115.59 27.72 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.613 -0.679 . . . . 3.14 111.699 172.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.6 p -94.04 146.93 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.343 1.057 . . . . 1.02 112.254 -170.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.6 m -92.04 160.39 35.75 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.65 1.18 . . . . 1.11 112.598 169.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -55.86 146.5 67.29 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.116 1.877 . . . . 1.84 110.939 167.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.52 0.95 41.95 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.722 1.153 . . . . 1.75 115.299 -174.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.63 148.2 50.62 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.263 1.531 . . . . 1.53 112.819 172.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -117.68 9.72 13.15 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.478 1.658 . . . . 3.97 115.478 -169.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 51.88 115.11 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 129.095 2.958 . . . . 2.27 116.794 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.71 -14.81 9.94 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.065 2.51 . . . . 0.96 115.346 -176.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 m -153.11 173.72 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 128.296 2.638 . . . . 0.88 108.639 -178.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -92.62 147.87 22.53 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.505 0.928 . . . . 2.46 113.505 173.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.56 173.78 44.44 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 115.134 0.814 . . . . 1.4 115.134 -170.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -113.28 133.16 55.25 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.125 1.37 . . . . 5.17 111.621 -174.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.25 127.92 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 126.821 2.048 . . . . 0.86 109.286 -169.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 pt -142.49 30.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.784 1.031 . . . . 1.06 113.784 -173.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -169.51 143.08 2.72 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.459 1.903 . . . . 3.46 109.747 168.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -171.6 37.9 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 116.285 1.274 . . . . 1.26 116.285 169.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -142.63 123.78 14.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.142 0.977 . . . . 2.77 111.929 177.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.4 m -148.22 151.41 35.45 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.862 -1.149 . . . . 1.31 113.915 169.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.8 ttm -95.24 138.42 32.97 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.638 -0.664 . . . . 1.07 109.688 168.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.5 t -129.31 132.2 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.421 1.488 . . . . 1.03 111.035 -170.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.76 121.14 30.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.918 1.287 . . . . 2.31 111.651 176.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -116.12 14.21 15.93 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.054 1.742 . . . . 1.96 113.224 -178.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 86.7 p -60.74 -0.85 0.32 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 119.211 3.041 . . . . 1.41 119.211 -167.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -115.1 -40.51 3.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.938 1.295 . . . . 1.57 110.299 169.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.5 mm -69.46 -49.95 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.831 0.853 . . . . 1.61 112.109 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 p -106.09 -13.47 15.44 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.3 1.04 . . . . 1.44 113.108 175.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.68 -0.17 84.55 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 124.85 1.214 . . . . 1.25 115.162 169.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.18 121.98 27.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.04 1.336 . . . . 3.02 111.916 179.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.01 14.52 4.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.955 1.302 . . . . 1.32 113.301 -173.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 71.7 mtp -126.75 105.86 23.13 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 127.887 2.475 . . . . 3.25 108.002 -174.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.33 152.97 36.22 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.222 2.615 . . . . 1.96 114.387 -173.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.82 127.98 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 126.275 1.83 . . . . 0.99 111.054 -167.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.83 129.07 34.18 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.713 -0.617 . . . . 0.81 111.639 -178.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -121.65 144.88 48.51 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.454 1.902 . . . . 0.86 110.2 -177.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -155.8 -177.77 0.79 Allowed Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 128.452 2.701 . . . . 3.8 108.78 -174.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.82 133.35 54.05 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.119 1.88 . . . . 1.04 112.308 168.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.25 28.9 59.27 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.166 1.365 . . . . 0.91 114.567 -171.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.1 m -111.33 170.27 8.23 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.668 1.734 . . . . 1.85 110.661 175.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.3 p -127.06 148.29 50.13 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 120.463 -1.398 . . . . 1.09 111.986 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.0 149.05 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.371 1.069 . . . . 1.06 112.019 179.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -119.4 150.54 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.428 1.891 . . . . 1.43 110.763 177.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.19 138.59 57.88 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.967 -0.56 . . . . 0.82 111.654 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.66 3.73 88.02 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.143 0.817 . . . . 1.7 115.143 -176.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.6 p -88.44 142.82 27.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.815 1.308 . . . . 1.75 110.2 167.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mm -109.44 120.39 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.092 0.775 . . . . 1.18 113.092 -167.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -76.16 129.32 36.58 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.445 1.098 . . . . 2.0 111.037 178.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -106.4 -29.67 9.58 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.223 1.194 . . . . 5.44 114.223 -172.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -104.62 -45.36 4.64 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 116.521 2.045 . . . . 3.15 116.521 -165.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.96 -142.65 5.22 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 118.204 2.042 . . . . 2.52 118.204 -167.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 t -90.09 144.28 26.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.369 1.468 . . . . 2.04 112.412 -174.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 73.7 mt -147.82 159.44 43.83 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.72 1.608 . . . . 1.11 109.538 169.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 tp -116.39 123.52 47.78 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.486 1.114 . . . . 2.36 110.331 169.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.57 129.47 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.275 1.03 . . . . 1.6 110.845 -170.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 52.8 t -86.46 123.9 32.2 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.379 -0.826 . . . . 3.11 109.671 168.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.89 121.83 25.35 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.898 0.879 . . . . 1.1 109.424 176.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.3 t -114.73 0.23 13.79 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.93 1.085 . . . . 2.46 113.93 -169.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -146.84 150.64 35.67 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.955 2.102 . . . . 1.85 111.178 175.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.1 m -83.47 166.56 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.767 0.827 . . . . 1.95 112.615 169.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.87 -31.4 75.88 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 120.932 -1.105 . . . . 1.49 114.681 -174.033 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.19 -25.39 64.31 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.174 1.175 . . . . 1.98 114.174 174.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.19 -19.92 59.57 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.269 -0.894 . . . . 3.14 113.081 171.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.1 p -68.49 141.96 55.43 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.564 -0.71 . . . . 1.71 111.809 -169.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 t -70.15 -18.18 63.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.097 0.777 . . . . 2.47 113.097 -170.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.4 mp -59.42 -52.14 66.9 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.297 -1.502 . . . . 1.76 112.588 -175.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.6 p -73.76 -17.48 61.09 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.91 0.884 . . . . 1.88 113.379 174.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -72.0 -42.72 66.11 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.12 0.968 . . . . 2.09 111.723 173.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.3 mt -61.18 -52.75 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.616 1.566 . . . . 1.63 111.16 -177.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m -63.92 -15.26 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.347 1.61 . . . . 1.9 115.347 -172.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -71.15 -42.57 68.96 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.186 0.995 . . . . 2.62 111.697 169.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.54 -47.62 22.03 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.853 1.661 . . . . 3.71 111.306 177.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.9 t -68.66 -21.81 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 118.631 -0.699 . . . . 2.82 112.225 -176.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -53.4 -36.81 61.87 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 120.743 1.611 . . . . 4.12 111.328 167.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.84 -8.32 55.6 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.428 -1.42 . . . . 5.13 113.565 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.99 -27.86 57.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.397 1.079 . . . . 6.31 113.7 171.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.609 1.564 . . . . 5.56 113.141 -178.749 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 111.975 0.361 . . . . 3.21 111.975 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -72.72 -39.44 66.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.006 1.323 . . . . 4.39 111.181 175.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.56 -11.33 60.61 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.098 1.518 . . . . 1.56 115.098 174.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.0 tp -59.75 -40.81 89.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.962 1.256 . . . . 1.98 113.928 -168.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.25 -20.7 60.78 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.3 1.222 . . . . 1.75 114.3 173.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -70.73 -42.99 69.81 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.109 1.322 . . . . 2.42 111.426 -169.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -47.52 -50.55 23.29 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.834 1.254 . . . . 1.52 111.564 173.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.54 -28.87 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.396 1.078 . . . . 2.23 112.635 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -74.42 -25.64 59.57 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.874 -1.141 . . . . 1.06 112.973 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.01 -22.5 63.11 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.036 0.835 . . . . 2.13 112.89 169.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -68.46 135.19 51.27 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.855 1.207 . . . . 3.01 111.469 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.26 151.13 47.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.642 0.777 . . . . 1.86 112.422 179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.8 p -87.36 -21.95 25.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.827 1.651 . . . . 2.53 113.355 177.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.75 157.08 47.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.871 1.268 . . . . 3.53 112.788 -175.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.75 157.38 45.11 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.73 1.212 . . . . 0.71 112.179 177.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 m -115.11 110.35 19.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.372 1.069 . . . . 0.83 111.385 177.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.7 mt -91.75 135.2 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 126.091 1.756 . . . . 0.77 109.495 -178.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 m -96.53 115.02 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 119.385 0.993 . . . . 2.47 109.372 167.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.0 m -78.99 135.37 36.89 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.813 0.845 . . . . 2.71 110.273 -177.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 mt -120.51 59.15 0.91 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.42 1.488 . . . . 5.1 109.195 179.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.65 -8.04 44.19 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.544 -0.722 . . . . 6.08 112.291 177.374 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.4 m -136.45 128.44 29.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.91 2.884 . . . . 5.44 108.006 176.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -19.96 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 1 C-N-CA 134.403 5.081 . . . . 8.03 116.705 -169.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . 0.277 16.7 p30 46.74 21.56 0.14 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.852 1.797 . . . . 7.08 115.852 -170.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.8 pt -110.05 -26.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 127.204 2.201 . . . . 6.22 114.256 -175.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.92 -53.9 52.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.199 0.908 . . . . 5.29 113.285 -169.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 mp 53.77 43.42 31.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.033 1.333 . . . . 3.88 113.117 178.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.0 t -92.42 111.43 23.01 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.939 0.896 . . . . 1.83 109.607 176.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -81.53 138.29 35.45 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.349 0.87 . . . . 2.94 113.349 -170.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -127.83 125.3 39.5 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.847 2.059 . . . . 2.7 109.795 178.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -95.5 132.0 41.07 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 120.419 -1.425 . . . . 3.65 109.864 174.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.81 167.79 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.768 1.627 . . . . 0.87 112.846 -169.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.9 148.95 31.07 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.217 -0.66 . . . . 3.35 109.217 165.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.97 -7.36 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 114.954 1.465 . . . . 1.15 114.954 -177.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.78 -30.5 56.52 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 119.791 -1.818 . . . . 3.3 112.691 167.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -90.69 4.04 52.58 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.798 1.639 . . . . 1.3 114.117 -168.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 p -101.1 135.75 36.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 126.416 1.886 . . . . 1.67 110.62 173.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.82 166.58 10.91 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.219 1.808 . . . . 4.05 111.45 178.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -65.29 -12.87 56.08 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.718 1.377 . . . . 3.93 114.718 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.19 7.56 75.85 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.262 1.41 . . . . 1.2 115.938 174.352 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -91.82 155.84 17.94 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.782 1.791 . . . . 2.9 112.649 176.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.0 mm -110.9 123.83 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.753 1.621 . . . . 1.83 109.172 176.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -120.95 133.83 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.424 1.089 . . . . 0.71 113.375 -167.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.529 ' HE3' ' CG ' ' A' ' 96' ' ' LEU . 10.9 mmmm -101.04 148.2 25.32 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.601 0.76 . . . . 3.65 112.563 178.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 p -124.22 134.53 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.424 1.089 . . . . 0.6 111.691 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.2 m -79.94 163.57 57.3 Favored Pre-proline 0 N--CA 1.482 1.15 0 N-CA-C 113.303 0.853 . . . . 0.97 113.303 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.36 120.33 7.45 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.242 1.961 . . . . 1.43 108.451 168.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.02 84.2 Favored Glycine 0 CA--C 1.54 1.655 0 C-N-CA 124.634 1.112 . . . . 1.22 115.467 -170.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.46 178.51 52.9 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 119.633 1.717 . . . . 1.07 115.404 -177.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -120.87 145.3 47.78 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.614 1.165 . . . . 1.76 112.211 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -81.99 124.22 79.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.763 0.825 . . . . 1.72 111.901 -178.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -91.98 -20.14 0.66 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.194 2.596 . . . . 0.77 115.932 -170.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.73 166.94 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 126.849 2.06 . . . . 0.71 109.79 -177.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.313 0.3 OUTLIER -88.98 142.96 27.2 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.983 0.811 . . . . 1.9 112.698 174.327 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' A' ' 100' ' ' THR . . . 170.61 -166.75 39.94 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.533 0.973 . . . . 0.6 115.533 -173.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.6 ttp85 -109.76 143.54 39.44 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.68 1.592 . . . . 4.37 112.053 -171.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.2 128.87 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.1 1.76 . . . . 0.92 109.668 -172.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.7 pt -140.27 36.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 114.001 1.111 . . . . 0.97 114.001 -172.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -166.27 142.14 4.78 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.14 1.376 . . . . 3.17 111.283 168.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.15 -163.84 34.74 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.049 1.309 . . . . 1.21 115.907 169.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.98 126.46 5.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.329 1.233 . . . . 2.59 114.329 174.035 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 m -145.95 166.67 25.35 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.849 -1.157 . . . . 1.37 112.828 174.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.9 ttm -107.73 124.44 50.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.018 0.927 . . . . 0.96 109.286 172.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.08 143.61 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.064 1.746 . . . . 0.59 112.981 -167.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -98.25 96.28 7.96 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.22 1.408 . . . . 1.94 111.309 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -93.01 -10.58 35.72 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.082 1.353 . . . . 1.74 113.268 177.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 t -38.12 -46.4 1.03 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.51 2.411 . . . . 2.34 117.51 -167.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.3 -33.48 61.19 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.46 1.482 . . . . 1.2 112.167 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 mm -73.23 -47.49 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.406 1.482 . . . . 1.03 111.075 -177.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.4 p -110.44 -13.19 14.31 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.037 1.335 . . . . 1.2 114.125 -170.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.36 2.84 90.24 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.512 1.529 . . . . 1.12 114.752 -177.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -51.44 -49.91 60.77 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.921 1.36 . . . . 2.49 114.419 -172.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 57.76 31.53 20.59 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.334 1.454 . . . . 1.59 114.605 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.2 ttm -162.55 136.08 4.64 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 130.212 3.405 . . . . 3.14 105.242 169.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.18 164.9 34.12 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.95 2.433 . . . . 1.38 113.321 -170.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.3 t -120.22 129.83 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.383 1.473 . . . . 0.73 111.454 -169.427 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.27 139.7 36.54 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.479 -0.763 . . . . 0.81 111.943 177.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -125.03 150.97 46.21 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.664 1.586 . . . . 0.88 111.449 -178.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -149.57 172.86 4.77 Favored Pre-proline 0 N--CA 1.483 1.224 0 C-N-CA 129.312 3.045 . . . . 3.21 109.053 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -59.52 140.2 92.86 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 CA-C-N 121.588 1.603 . . . . 0.91 110.994 167.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.42 44.76 15.91 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.811 -0.555 . . . . 1.05 112.45 -170.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.9 t -126.67 170.14 12.41 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.69 1.596 . . . . 1.47 111.111 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.4 p -129.69 149.43 51.45 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 120.777 -1.202 . . . . 0.82 112.411 -176.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.89 159.06 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.09 1.356 . . . . 0.54 113.804 -176.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -120.05 152.84 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.798 2.439 . . . . 1.17 111.46 169.922 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.32 152.14 44.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.774 0.829 . . . . 0.63 112.906 178.427 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.23 4.72 89.87 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.42 0.528 . . . . 0.91 114.42 -175.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 m -82.15 153.52 25.98 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.286 -1.126 . . . . 1.49 110.563 169.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mm -108.3 143.59 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.698 1.199 . . . . 0.85 110.236 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -108.21 139.8 42.37 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.832 1.653 . . . . 1.54 113.086 -175.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -152.22 115.73 4.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.508 1.049 . . . . 3.78 113.808 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 51.5 t30 152.04 -51.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 131.341 3.856 . . . . 3.12 109.245 167.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.51 -178.65 36.54 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.768 1.651 . . . . 2.0 112.454 -174.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.4 p -89.53 135.39 33.63 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.713 -0.875 . . . . 1.86 113.286 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.6 mt -122.5 165.7 15.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.454 1.101 . . . . 1.29 112.921 -176.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.529 ' CG ' ' HE3' ' A' ' 44' ' ' LYS . 6.8 tt -116.24 117.45 30.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.367 1.467 . . . . 3.62 111.478 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.12 120.48 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.948 1.299 . . . . 1.34 111.49 178.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 20.4 p -84.57 120.82 26.79 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.035 -1.098 . . . . 1.48 108.035 166.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.28 157.38 34.49 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.921 -0.487 . . . . 1.63 110.481 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.418 HG22 ' HA2' ' A' ' 55' ' ' GLY . 8.4 t -141.46 -9.22 0.96 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.671 1.36 . . . . 2.54 114.671 176.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -140.51 144.27 35.89 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.589 1.156 . . . . 1.62 110.451 169.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 m -69.97 161.02 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.641 -0.503 . . . . 1.52 109.641 167.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.48 -36.61 89.96 Favored Glycine 0 N--CA 1.476 1.355 0 O-C-N 121.114 -0.991 . . . . 1.52 113.811 -171.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.87 -38.51 91.21 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 113.754 1.02 . . . . 1.88 113.754 171.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -77.31 -6.71 54.2 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.043 2.137 . . . . 2.47 114.861 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 81.3 p -65.3 157.91 27.81 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.604 -1.31 . . . . 1.55 113.194 178.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 90.9 m -64.48 -35.68 81.73 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.622 0.769 . . . . 2.95 111.36 175.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.19 -47.56 68.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.866 1.266 . . . . 1.63 111.7 171.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 m -68.41 -30.44 69.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.479 1.112 . . . . 1.94 113.584 176.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -70.08 -41.05 74.59 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.085 0.857 . . . . 1.77 111.663 172.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.49 -48.55 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.845 0.858 . . . . 1.6 110.904 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.21 -27.11 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 113.439 0.903 . . . . 1.31 113.439 177.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -71.72 -48.74 45.09 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.726 1.148 . . . . 2.6 111.691 171.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.16 -40.99 82.82 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.436 1.094 . . . . 2.77 112.954 178.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 p -75.36 -33.87 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 113.981 1.104 . . . . 2.56 113.981 176.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -74.63 -46.58 37.37 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.007 0.822 . . . . 4.22 112.071 179.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -74.76 -9.98 59.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 5.59 113.9 -179.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.12 -52.95 43.78 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.578 0.751 . . . . 4.54 111.163 170.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.29 -1.338 . . . . 4.46 114.185 178.091 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 112.233 0.457 . . . . 3.99 112.233 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -63.97 -47.56 79.89 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.412 1.885 . . . . 4.83 109.791 169.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.35 76.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.075 1.35 . . . . 1.94 113.535 174.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.5 tp -70.92 -34.31 71.38 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.641 1.177 . . . . 1.47 113.17 170.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.07 -32.04 68.61 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.194 -0.941 . . . . 1.46 111.567 174.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -54.56 -37.9 66.01 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 124.968 1.307 . . . . 2.04 113.354 -170.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.05 -43.79 91.74 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.346 1.058 . . . . 1.18 112.578 -178.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.3 mm -72.43 -33.18 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.25 -0.906 . . . . 1.8 112.237 175.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m -77.43 -17.31 58.22 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.383 0.882 . . . . 1.57 113.383 176.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mt -71.88 -43.39 65.5 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.602 2.361 . . . . 1.77 112.749 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -49.57 134.7 19.36 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.63 0.772 . . . . 3.01 110.764 175.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.59 -14.34 41.6 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.041 1.497 . . . . 3.66 115.041 -172.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 m 69.11 -24.79 0.14 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 128.29 2.636 . . . . 3.01 115.024 173.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -125.38 152.97 44.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.176 1.39 . . . . 3.26 111.262 169.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.84 151.35 45.62 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.716 1.206 . . . . 1.02 111.88 -177.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.2 m -111.45 104.09 12.5 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.283 1.033 . . . . 1.07 111.876 -176.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.1 mt -91.26 134.67 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.705 1.602 . . . . 1.04 110.795 -173.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.69 130.27 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 120.719 -1.238 . . . . 2.54 110.483 169.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m -125.78 153.9 43.34 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.726 1.61 . . . . 3.18 110.873 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.3 mt -111.85 108.25 17.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.624 1.17 . . . . 4.44 110.044 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.13 3.1 38.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 116.372 1.989 . . . . 5.21 116.372 -168.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.4 m -128.71 -63.13 0.99 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.134 1.374 . . . . 6.76 110.163 169.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -157.89 -170.12 3.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 130.111 3.364 . . . . 8.29 105.829 169.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -15.77 1.72 Allowed 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 114.178 1.177 . . . . 6.33 114.178 173.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.6 pt -67.93 -29.87 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 126.194 1.797 . . . . 5.18 114.078 175.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tt -115.2 118.27 32.86 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.12 0.968 . . . . 3.09 110.891 -171.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 mp -91.98 130.75 37.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.625 0.726 . . . . 2.84 111.502 173.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.1 t -134.97 95.12 3.26 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.992 2.517 . . . . 1.95 107.406 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.78 145.21 25.74 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.121 -0.987 . . . . 3.66 110.573 -176.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -127.49 156.53 42.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.345 2.658 . . . . 2.93 111.274 -167.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -121.11 140.2 52.3 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.238 0.926 . . . . 2.03 112.746 169.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.97 166.24 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.257 1.423 . . . . 1.36 113.478 -177.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.44 147.66 32.21 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.694 1.198 . . . . 3.96 110.443 166.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.77 -13.06 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.461 1.282 . . . . 1.57 114.461 -176.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -82.87 -12.67 57.21 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 120.141 -1.599 . . . . 5.01 113.565 170.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.9 mt -103.75 -10.22 18.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.151 1.78 . . . . 1.95 114.282 -172.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.63 143.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.693 1.197 . . . . 1.79 110.664 173.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -121.23 164.63 16.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.502 1.921 . . . . 3.09 111.067 176.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.0 ptt-85 -72.22 153.3 41.67 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.707 -1.246 . . . . 2.82 110.743 172.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.57 25.37 9.32 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 119.25 -0.75 . . . . 1.28 114.213 -176.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -140.14 162.24 35.72 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.49 1.516 . . . . 2.74 112.05 176.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.45 125.72 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.307 1.443 . . . . 1.13 110.199 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.8 mm -115.43 128.71 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.99 1.316 . . . . 0.87 111.401 -171.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -80.87 146.77 30.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.339 1.055 . . . . 2.47 112.667 175.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.8 137.0 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.524 0.729 . . . . 0.56 111.81 168.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 m -89.75 164.29 29.5 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.068 1.347 . . . . 0.89 113.38 -178.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.66 132.25 32.26 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.238 1.959 . . . . 1.07 109.445 168.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.74 -8.8 47.47 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.183 0.897 . . . . 1.01 115.187 -169.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.74 163.9 43.32 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 118.616 1.208 . . . . 1.02 114.092 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -111.6 149.07 31.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.422 1.489 . . . . 1.67 110.437 175.083 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -81.39 130.14 63.37 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 121.85 -0.531 . . . . 2.08 111.918 177.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.96 -25.66 1.4 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.446 2.764 . . . . 0.72 114.792 -178.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.4 176.59 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.22 2.208 . . . . 0.88 109.323 -178.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -102.84 148.04 26.14 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.647 0.779 . . . . 2.36 111.816 174.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.2 -160.14 32.87 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.521 0.568 . . . . 0.76 114.521 -172.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -116.91 135.6 53.59 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.412 1.485 . . . . 3.45 113.268 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.47 135.36 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.111 2.164 . . . . 1.03 108.935 170.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.4 pt -137.03 31.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 113.386 0.884 . . . . 0.82 113.386 175.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -166.46 139.45 3.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.707 1.603 . . . . 2.88 109.098 166.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.13 177.38 49.91 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 122.684 1.158 . . . . 0.82 115.259 174.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -145.52 133.22 21.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.043 1.337 . . . . 1.83 112.23 -174.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.3 m -150.66 176.03 11.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.625 1.17 . . . . 1.18 112.853 172.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 35.8 ttm -117.96 129.84 55.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.711 1.204 . . . . 0.94 110.397 168.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t -117.38 136.05 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.78 1.232 . . . . 0.66 113.223 -167.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -88.6 108.2 19.31 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.58 1.152 . . . . 1.85 111.227 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -110.18 16.36 21.82 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.225 1.41 . . . . 1.68 114.117 -178.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -60.57 -19.91 58.89 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.986 1.847 . . . . 1.6 115.986 -169.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -91.94 -40.82 10.92 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.112 0.869 . . . . 0.99 111.663 172.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 27.5 mm -78.34 -61.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.016 0.926 . . . . 1.02 112.246 -171.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.9 p -96.74 -7.75 33.08 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.499 1.12 . . . . 1.2 112.651 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.35 16.03 74.97 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.446 1.498 . . . . 1.25 113.833 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -83.66 105.01 14.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.391 1.476 . . . . 2.98 111.763 -176.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.31 -13.26 59.76 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.398 -0.814 . . . . 1.53 111.643 177.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -100.06 111.92 63.05 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 126.745 2.018 . . . . 4.53 107.889 169.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.86 148.93 35.63 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.869 3.046 . . . . 1.55 114.162 -178.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.79 130.23 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.516 1.526 . . . . 0.72 110.879 -169.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.2 142.89 37.63 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.271 0.629 . . . . 0.65 112.516 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.07 147.3 46.87 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.414 1.886 . . . . 0.74 110.603 177.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -147.25 170.6 7.49 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 128.504 2.721 . . . . 2.69 109.664 -174.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -59.38 124.37 15.39 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 121.566 1.595 . . . . 0.87 109.593 168.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.94 55.25 3.18 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.938 0.78 . . . . 1.34 112.308 -168.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 t -139.49 141.36 37.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.417 1.087 . . . . 1.38 111.147 178.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.8 p -97.09 144.8 26.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.51 1.05 . . . . 0.72 112.497 -178.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.58 156.59 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.323 1.849 . . . . 0.59 111.49 -173.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.29 146.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.672 1.589 . . . . 1.01 111.92 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.47 153.12 28.14 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.81 0.844 . . . . 0.72 113.218 -175.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.45 -5.08 17.05 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.594 0.997 . . . . 0.82 115.594 178.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -75.79 153.03 37.2 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.787 1.294 . . . . 1.33 109.869 168.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 mm -109.14 132.3 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.658 0.783 . . . . 0.66 110.668 -169.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -91.95 151.89 20.29 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.694 1.597 . . . . 1.58 113.198 -173.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -156.65 139.33 15.08 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.029 -1.044 . . . . 3.04 111.774 176.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . 0.311 57.8 t30 99.23 -21.67 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.001 3.321 . . . . 3.0 116.932 172.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.32 178.81 38.8 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 119.928 -1.733 . . . . 2.18 114.215 -174.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.1 t -120.78 125.7 48.24 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.627 1.171 . . . . 2.36 110.942 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.66 161.85 21.77 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.627 1.571 . . . . 1.17 112.438 -167.298 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.21 119.58 37.54 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.944 1.298 . . . . 1.75 110.154 174.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.98 123.3 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.052 1.341 . . . . 1.54 109.747 175.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.8 p -82.28 108.45 15.74 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.544 -0.722 . . . . 1.57 110.077 170.02 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.87 113.88 17.33 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.127 -0.983 . . . . 1.02 110.707 -172.038 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -111.34 -2.33 15.68 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.07 1.348 . . . . 2.92 112.478 179.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -138.32 142.33 39.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.954 2.102 . . . . 1.72 109.391 178.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.34 178.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 124.707 1.203 . . . . 1.85 112.554 172.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.63 -39.49 97.63 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.594 -1.316 . . . . 1.39 113.615 -178.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.01 -31.89 72.31 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 118.411 1.105 . . . . 1.83 113.176 172.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -75.71 -4.37 39.98 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 128.132 2.573 . . . . 3.04 113.464 175.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 76.3 p -70.57 141.44 51.83 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.588 -1.945 . . . . 1.64 114.275 -177.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -62.17 -31.93 72.49 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.71 -0.619 . . . . 1.9 112.19 176.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -56.03 -48.05 76.7 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.777 -1.202 . . . . 1.47 111.8 171.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.8 m -64.97 -36.56 84.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.094 0.557 . . . . 1.82 110.43 175.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.32 -40.59 85.97 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.664 -0.647 . . . . 1.6 112.303 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 67.9 mt -59.03 -51.41 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.355 1.062 . . . . 1.26 109.945 177.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 m -71.19 -32.35 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 117.903 -1.046 . . . . 1.18 113.084 179.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -56.21 -46.69 79.38 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.59 1.086 . . . . 3.14 110.9 171.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.67 -41.07 88.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.591 1.157 . . . . 2.49 113.499 178.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.4 t -65.16 -46.98 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 118.97 0.804 . . . . 2.53 110.405 175.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -59.23 -37.87 78.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.829 1.252 . . . . 4.04 112.065 -178.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.38 -26.83 64.84 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.374 1.25 . . . . 4.37 114.374 176.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.7 86.92 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.517 0.599 . . . . 4.72 111.199 -171.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.253 1.243 0 C-N-CA 126.148 1.779 . . . . 5.23 112.691 172.013 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 114.112 1.152 . . . . 4.34 114.112 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -84.91 -27.83 26.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 5.41 112.181 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.38 -39.0 93.32 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.069 0.948 . . . . 1.77 111.97 171.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 tp -56.56 -34.41 67.09 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.71 0.804 . . . . 1.56 112.92 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.23 -41.76 39.94 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.915 0.709 . . . . 1.33 112.915 168.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -60.19 -35.11 74.65 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.953 1.301 . . . . 2.18 112.709 -175.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.72 -36.68 72.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.691 0.796 . . . . 1.26 112.866 173.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.4 mm -72.88 -38.66 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.872 0.76 . . . . 1.85 111.621 173.13 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -65.54 -25.75 67.58 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.174 -0.954 . . . . 1.23 112.783 177.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.9 mt -73.33 -17.84 61.25 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.633 1.973 . . . . 1.87 114.892 174.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -74.48 144.76 44.04 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.085 1.311 . . . . 3.32 112.105 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.49 156.49 21.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.845 1.258 . . . . 2.98 112.839 -176.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 p -94.76 -30.45 14.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.599 1.16 . . . . 2.73 113.7 171.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -140.47 162.13 36.08 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.245 1.818 . . . . 3.56 113.014 -173.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.16 159.61 41.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.948 1.299 . . . . 1.56 112.873 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.4 m -104.53 124.49 49.38 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.266 1.026 . . . . 1.32 111.833 176.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.78 130.25 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.325 1.45 . . . . 0.96 110.932 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -110.83 133.96 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.366 1.066 . . . . 2.48 111.897 177.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -140.39 133.43 29.39 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.457 0.703 . . . . 1.62 112.279 -175.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.82 143.73 32.73 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.306 1.442 . . . . 4.85 111.217 175.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -145.2 19.33 1.57 Allowed 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.652 2.093 . . . . 4.62 116.652 -171.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 m -144.04 -74.38 0.26 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.856 1.058 . . . . 4.03 113.856 175.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -157.63 37.92 0.27 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.659 1.984 . . . . 7.31 109.229 -168.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.42 -17.27 0.1 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 127.194 2.197 . . . . 6.16 114.168 -166.214 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 pt -66.77 -37.56 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 O-C-N 119.975 -1.703 . . . . 4.81 113.438 176.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.1 tp -84.17 76.87 10.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.545 1.538 . . . . 3.11 111.19 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 tt -97.24 120.5 37.72 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.734 1.613 . . . . 4.27 111.427 176.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.2 t -130.63 131.16 44.76 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.618 1.567 . . . . 1.88 109.605 -177.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.36 143.63 49.1 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.703 1.201 . . . . 3.03 112.366 -170.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.96 143.65 50.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.954 1.302 . . . . 3.39 111.177 -178.054 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -108.35 125.98 52.33 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.823 -0.806 . . . . 2.42 108.823 166.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.29 161.29 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.605 1.162 . . . . 1.68 112.357 -170.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -74.06 143.3 45.53 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.025 -0.732 . . . . 4.3 109.025 172.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.59 -2.34 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 114.463 1.283 . . . . 1.74 114.463 -171.48 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -81.05 -23.4 38.58 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.33 2.252 . . . . 4.77 113.13 168.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.6 mt -103.12 -10.76 18.58 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.644 1.578 . . . . 1.94 114.009 -168.125 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.4 p -87.01 145.06 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.74 2.016 . . . . 1.75 108.646 168.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.24 159.48 16.08 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.198 0.999 . . . . 4.8 112.415 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -73.49 33.04 0.08 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 115.615 1.709 . . . . 4.55 115.615 -178.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.26 15.95 1.31 Allowed Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.481 2.467 . . . . 1.55 113.756 171.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -81.96 158.37 23.91 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.968 1.384 . . . . 2.35 113.216 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -106.91 125.85 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.418 1.487 . . . . 1.69 112.333 -172.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.7 mm -127.3 119.1 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.899 1.28 . . . . 0.91 111.492 -169.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HE3' ' HG ' ' A' ' 96' ' ' LEU . 21.2 mmtp -85.44 120.16 26.59 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.744 -1.223 . . . . 3.63 110.287 169.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.7 p -96.97 138.41 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.758 0.708 . . . . 1.12 111.795 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 m -87.68 150.44 48.36 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.678 1.191 . . . . 1.1 112.886 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -59.44 142.83 99.57 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.755 2.303 . . . . 1.72 111.07 170.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.31 -13.08 8.24 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 115.855 1.102 . . . . 1.91 115.855 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.31 -172.64 40.62 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-N 119.058 1.429 . . . . 1.44 115.214 -175.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -113.25 158.01 21.03 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.006 1.322 . . . . 1.75 111.521 171.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -91.54 125.26 58.4 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.234 1.013 . . . . 2.43 111.437 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -92.66 -13.29 1.48 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.311 2.674 . . . . 1.41 115.444 -175.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.48 162.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 126.613 1.965 . . . . 1.5 109.433 178.193 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.273 0.5 OUTLIER -93.51 137.67 32.56 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.684 0.754 . . . . 2.09 112.33 175.595 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.41 177.32 41.95 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 123.975 0.798 . . . . 1.01 114.6 -169.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.7 ttm-85 -100.89 146.02 27.86 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.203 1.401 . . . . 6.28 111.578 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.4 t -101.06 126.57 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.135 2.174 . . . . 1.17 109.135 -174.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 pt -140.87 29.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 113.973 1.101 . . . . 1.17 113.973 -175.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -170.17 146.67 3.02 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.882 2.073 . . . . 3.9 109.158 166.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.4 -174.24 48.63 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.43 1.014 . . . . 1.33 115.227 169.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -150.22 118.78 6.5 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.353 1.061 . . . . 2.24 111.064 -174.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.4 t -142.71 163.98 31.36 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.282 1.433 . . . . 1.59 112.27 -175.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.2 ttm -116.05 129.69 56.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.06 1.344 . . . . 0.79 110.435 174.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.6 t -121.59 143.33 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.766 1.627 . . . . 0.61 112.061 -168.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -99.45 90.4 4.51 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.281 1.832 . . . . 1.8 111.359 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -90.03 9.58 27.47 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.862 1.265 . . . . 2.32 113.762 -175.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.8 t -50.35 -47.35 56.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.188 2.195 . . . . 1.88 115.612 -169.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.98 -36.99 48.32 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.593 -1.317 . . . . 1.14 111.777 -175.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.3 mm -73.61 -48.28 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.727 -0.608 . . . . 1.03 110.207 -177.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.1 p -107.33 -11.37 15.57 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.352 1.241 . . . . 1.26 114.352 -170.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.61 -5.81 72.39 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 126.011 1.767 . . . . 1.51 115.943 174.117 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.25 -47.2 81.98 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.529 1.165 . . . . 2.85 113.254 -169.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.268 . . 58.61 45.61 15.86 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.442 1.897 . . . . 1.93 111.847 -176.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptp -153.02 134.95 8.81 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 128.98 2.912 . . . . 4.07 109.068 172.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -62.2 145.64 96.19 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.712 2.275 . . . . 1.35 113.952 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.34 128.51 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.502 1.521 . . . . 0.76 111.303 -174.117 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.87 144.79 28.17 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.628 0.771 . . . . 0.76 112.977 -179.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -122.23 159.44 27.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.176 1.79 . . . . 1.31 112.274 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -151.98 171.76 6.24 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 127.791 2.437 . . . . 3.64 110.643 -176.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.5 123.98 13.79 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 CA-C-N 121.341 1.515 . . . . 1.42 108.84 166.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.83 44.4 5.75 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.057 0.837 . . . . 1.27 113.01 -168.367 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.9 m -124.96 169.05 12.48 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.245 1.418 . . . . 1.36 109.362 168.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.4 p -121.46 156.79 32.0 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.825 -1.172 . . . . 0.98 112.868 169.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.28 160.48 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.884 1.674 . . . . 0.76 111.924 -178.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.466 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -127.62 154.51 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 126.47 1.908 . . . . 1.6 112.514 -176.952 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.73 159.84 33.17 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.432 0.901 . . . . 1.17 113.432 -177.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -6.96 11.88 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.797 1.189 . . . . 1.07 115.113 179.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -84.65 162.69 19.64 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.167 1.387 . . . . 2.46 111.601 174.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 mm -111.33 140.86 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.271 1.028 . . . . 0.97 111.547 -169.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -90.61 136.09 33.28 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.178 1.791 . . . . 2.79 109.371 169.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -83.64 -73.32 0.42 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.702 0.801 . . . . 3.52 110.663 169.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -140.55 161.27 38.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.241 1.816 . . . . 3.63 107.969 170.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.88 138.66 6.48 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.506 2.479 . . . . 1.83 111.572 177.436 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.9 m -114.61 95.77 5.41 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.825 1.25 . . . . 2.56 110.167 -169.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.3 mt -104.44 152.7 22.01 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.043 1.337 . . . . 1.68 113.684 -170.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.416 ' HG ' ' HE3' ' A' ' 44' ' ' LYS . 4.2 tt -104.25 117.75 34.96 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.891 1.276 . . . . 3.58 109.731 171.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.3 mm -113.41 129.02 69.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.022 1.329 . . . . 1.96 111.422 -173.493 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.3 p -101.69 124.94 48.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.414 -0.804 . . . . 1.45 110.109 168.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.96 151.02 31.88 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.692 0.627 . . . . 1.39 112.692 -174.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.7 p -129.43 -3.23 4.89 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.775 1.398 . . . . 2.8 114.775 169.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -140.97 141.87 34.37 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.66 1.184 . . . . 2.73 111.09 169.067 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.85 165.8 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 109.233 -0.655 . . . . 2.21 109.233 166.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.7 -39.74 91.67 Favored Glycine 0 N--CA 1.475 1.294 0 CA-C-N 119.528 1.058 . . . . 2.45 114.673 -168.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.16 82.58 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.142 0.971 . . . . 3.24 112.875 174.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -74.33 -8.34 55.9 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.213 2.605 . . . . 3.74 114.275 176.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.0 p -64.13 159.07 21.27 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 120.789 -1.194 . . . . 2.05 113.525 -174.526 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.6 t -52.21 -24.04 6.57 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.22 1.193 . . . . 2.53 114.22 175.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.69 -44.92 93.46 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.251 -1.531 . . . . 1.93 112.87 174.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.2 p -70.92 -21.35 62.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 117.945 0.339 . . . . 2.14 111.785 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -71.02 -38.55 72.61 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.672 -0.643 . . . . 2.41 111.149 174.024 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 94.1 mt -59.98 -54.21 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.405 0.682 . . . . 1.72 110.829 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.37 -23.49 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 113.303 0.853 . . . . 1.31 113.303 -178.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -74.45 -39.94 62.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.803 0.841 . . . . 2.78 113.215 170.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.5 mt -65.25 -36.91 85.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.612 1.096 . . . . 3.18 112.606 178.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.82 -52.25 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.991 0.516 . . . . 2.37 110.627 174.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.49 -19.4 62.21 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.493 1.664 . . . . 4.77 115.493 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -71.55 -33.93 69.55 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.51 1.505 . . . . 4.81 111.906 168.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.03 -54.82 9.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.105 0.962 . . . . 4.37 111.755 176.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.104 0 C-N-CA 127.079 2.152 . . . . 5.14 115.451 177.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 112.137 0.421 . . . . 2.71 112.137 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -67.37 -39.53 85.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.067 1.347 . . . . 4.4 112.005 175.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.05 73.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.764 0.426 . . . . 1.67 111.604 176.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.0 tp -70.56 -30.95 67.81 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.122 1.369 . . . . 1.6 112.234 174.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.21 -34.13 61.45 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.991 0.516 . . . . 1.45 112.343 177.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -64.31 -28.46 69.73 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.359 -0.838 . . . . 2.41 112.88 -177.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.28 -28.63 69.86 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.064 0.946 . . . . 1.25 113.237 173.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.62 -37.85 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.169 -0.957 . . . . 1.81 111.31 169.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 m -70.48 -31.39 68.5 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.253 1.021 . . . . 1.52 113.138 179.322 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.72 -22.79 64.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.166 2.186 . . . . 2.23 114.165 -178.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -76.78 155.58 33.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.21 1.404 . . . . 2.49 113.926 -169.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.78 -28.07 14.44 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.391 1.256 . . . . 3.03 114.391 -168.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m 66.93 -29.47 0.14 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.805 2.15 . . . . 2.99 116.805 171.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.22 145.9 41.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.087 1.755 . . . . 3.53 111.455 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.25 160.66 41.14 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.94 1.089 . . . . 0.77 113.94 -169.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.8 m -112.43 112.64 24.35 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.309 1.044 . . . . 1.19 112.395 174.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.42 146.18 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 126.742 2.017 . . . . 0.7 109.932 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.56 115.0 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.024 -1.102 . . . . 1.76 108.024 166.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m -107.2 139.85 41.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.238 1.815 . . . . 1.89 109.917 -176.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.45 95.25 8.73 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.739 -0.837 . . . . 3.75 108.739 174.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -15.58 60.64 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.526 0.935 . . . . 4.07 113.526 -173.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.9 m -150.51 146.12 26.41 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.979 2.112 . . . . 3.68 111.509 168.097 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -19.63 64.49 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 1 C-N-CA 133.814 4.846 . . . . 6.19 118.108 -169.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.26 -14.27 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 127.157 2.183 . . . . 5.45 114.329 -168.426 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 pt -75.66 -26.25 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 128.09 2.556 . . . . 4.94 115.221 -178.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.1 tp -125.41 128.63 48.41 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.851 1.26 . . . . 3.16 111.793 -172.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.8 mp -108.4 137.83 45.72 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.697 1.199 . . . . 2.74 112.311 177.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.3 t -142.07 131.88 24.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.914 1.285 . . . . 1.46 110.507 168.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -99.34 135.67 40.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.091 0.956 . . . . 2.75 110.878 -179.035 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -131.99 132.58 43.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.5 1.92 . . . . 3.42 111.642 -167.088 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -104.08 130.0 51.76 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.251 -1.531 . . . . 1.93 112.706 -172.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -142.6 -179.77 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 125.7 1.6 . . . . 0.93 113.749 -171.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.93 147.43 23.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.671 1.188 . . . . 2.67 110.69 166.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.38 -21.53 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.943 1.09 . . . . 2.07 113.943 -176.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.16 -23.88 67.23 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.119 -0.988 . . . . 3.15 112.448 168.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.4 mt -106.62 -10.23 16.26 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.838 1.655 . . . . 2.05 114.384 -169.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.7 m -60.78 -37.34 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 119.897 1.226 . . . . 3.93 112.415 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.306 35.3 mt-30 58.31 150.75 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.959 2.904 . . . . 4.07 115.775 -173.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -71.12 40.89 0.06 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 117.203 2.297 . . . . 3.82 117.203 -167.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.47 17.77 0.43 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.627 1.584 . . . . 1.01 115.712 178.201 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.52 170.23 8.27 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.831 1.315 . . . . 3.15 113.392 170.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.2 mt -122.02 131.8 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.454 1.502 . . . . 1.19 109.004 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.96 131.58 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.717 1.607 . . . . 0.74 111.02 -169.44 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -84.52 125.72 32.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.913 0.779 . . . . 2.17 112.23 171.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.79 133.04 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.233 1.413 . . . . 0.68 110.935 172.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.1 m -93.2 168.26 12.5 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 124.036 0.935 . . . . 0.9 112.982 -176.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.92 132.38 47.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.583 2.188 . . . . 1.02 110.324 168.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.77 -6.17 27.12 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.614 1.102 . . . . 1.0 115.395 -172.038 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.26 162.71 53.69 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.149 1.474 . . . . 0.99 114.112 -179.072 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -104.84 146.34 29.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.299 1.04 . . . . 2.21 111.692 175.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -71.57 130.91 86.74 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.696 -0.669 . . . . 1.8 109.538 169.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -94.83 -18.03 0.41 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.481 2.12 . . . . 0.94 115.065 -171.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 m -144.09 175.63 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 127.277 2.231 . . . . 1.2 110.086 -178.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -94.91 136.25 35.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.97 0.805 . . . . 1.98 112.027 168.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.46 -173.44 46.28 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 121.545 -0.722 . . . . 0.68 114.243 -169.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -109.22 134.65 51.48 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.143 0.977 . . . . 4.93 113.218 -175.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.8 126.88 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.907 2.083 . . . . 0.81 108.048 174.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.8 pt -140.39 33.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 118.614 0.643 . . . . 1.01 112.12 176.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -165.82 128.54 2.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.714 1.606 . . . . 3.88 108.594 169.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.78 165.93 40.67 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.745 1.164 . . . . 1.3 114.697 -179.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -141.53 130.16 22.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.293 1.037 . . . . 1.93 112.38 178.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.46 ' HB2' HD21 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -143.69 163.36 33.49 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.49 1.116 . . . . 1.37 112.657 173.222 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.0 ttm -90.61 141.94 28.26 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.489 0.716 . . . . 0.93 109.298 168.161 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.2 t -134.55 142.56 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.997 1.319 . . . . 0.64 112.724 -168.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -89.07 116.36 27.29 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.257 1.023 . . . . 2.15 112.211 173.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -109.62 10.69 24.92 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.504 1.522 . . . . 1.75 111.951 169.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 t -58.47 -39.29 79.53 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.939 1.296 . . . . 2.47 114.043 -172.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -82.88 -31.47 27.91 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 120.391 1.451 . . . . 1.62 111.576 177.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.8 mm -62.03 -57.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.028 0.931 . . . . 1.58 110.762 178.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 p -119.58 -5.11 10.27 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.161 1.171 . . . . 2.11 114.161 -169.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.42 11.69 77.33 Favored Glycine 0 CA--C 1.539 1.572 0 CA-C-O 118.504 -1.164 . . . . 1.79 115.295 -179.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -49.97 -53.51 26.0 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.842 1.821 . . . . 2.8 114.17 -175.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . 0.256 . . 59.66 13.94 3.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.09 1.756 . . . . 1.57 114.739 -173.498 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 52.3 ttp -132.81 131.84 22.23 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 128.308 2.643 . . . . 3.79 106.876 169.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.98 152.33 46.11 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.161 2.574 . . . . 1.92 112.949 -171.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -109.48 133.24 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.752 1.621 . . . . 0.72 110.632 -171.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.16 132.35 36.52 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.57 -0.706 . . . . 0.78 111.206 174.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -120.58 144.62 48.0 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.365 1.466 . . . . 0.79 110.122 173.085 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 167.28 13.51 Favored Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 127.699 2.4 . . . . 4.45 110.526 -169.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -58.72 132.03 45.59 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 CA-C-N 121.628 1.617 . . . . 0.85 111.354 174.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.5 29.56 35.84 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.451 1.024 . . . . 0.74 114.21 -169.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.9 t -116.4 152.6 33.63 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.788 1.635 . . . . 1.57 111.658 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.2 p -107.15 150.15 26.9 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.931 1.241 . . . . 0.79 113.142 178.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.4 m -140.27 163.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.448 1.499 . . . . 0.6 112.285 -174.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.93 156.78 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.535 1.534 . . . . 1.26 112.549 173.418 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.75 148.12 49.99 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.487 0.921 . . . . 0.58 113.487 -177.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.49 -1.62 70.88 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 115.198 0.839 . . . . 0.89 115.198 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.8 p -78.11 151.43 33.36 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.425 1.113 . . . . 1.44 109.433 166.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 mm -112.88 132.87 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.509 0.724 . . . . 0.73 111.835 -168.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -95.28 137.65 34.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.221 1.808 . . . . 1.56 112.671 -176.176 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -85.53 -92.94 0.09 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 115.488 1.662 . . . . 3.32 115.488 -169.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -109.22 -30.65 7.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 117.143 2.275 . . . . 3.94 117.143 -167.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.8 150.72 16.93 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.065 1.317 . . . . 1.96 113.379 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 t -98.15 139.65 33.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.275 1.83 . . . . 2.5 112.443 -174.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 62' ' ' SER . 1.0 OUTLIER -132.85 162.68 30.91 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.717 1.607 . . . . 1.32 112.208 -168.447 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.36 127.95 54.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.073 0.949 . . . . 1.96 112.248 172.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.53 132.21 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.326 1.451 . . . . 1.21 111.875 -172.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.1 m -84.97 118.27 24.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.81 1.244 . . . . 2.08 111.187 -179.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.95 117.0 21.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.45 0.7 . . . . 0.99 111.79 176.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.4 t -112.53 5.34 17.88 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.926 1.29 . . . . 2.82 114.253 174.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -151.3 144.29 24.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.498 2.319 . . . . 2.18 108.808 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.6 m -82.59 162.31 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.271 -1.011 . . . . 2.08 108.271 164.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.98 -39.15 56.54 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-N 119.555 1.071 . . . . 1.39 114.976 -168.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.71 80.63 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.265 1.026 . . . . 1.86 113.537 173.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.85 -9.46 58.7 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.563 1.545 . . . . 4.04 114.958 -179.145 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.3 p -69.7 160.94 30.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.777 1.028 . . . . 1.66 113.777 -175.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.8 t -63.07 -33.03 74.56 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.71 0.804 . . . . 1.89 112.112 172.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.6 tp -59.59 -45.25 92.46 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.054 -1.029 . . . . 1.45 111.368 176.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 64.8 m -71.46 -33.32 69.23 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.906 0.882 . . . . 2.14 112.54 173.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -61.97 -42.23 98.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.276 1.03 . . . . 2.01 111.17 177.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.29 -55.63 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.079 1.352 . . . . 1.38 110.808 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.0 m -66.92 -24.01 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 113.404 0.89 . . . . 1.39 113.404 -175.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -72.71 -49.09 33.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.88 1.272 . . . . 2.78 112.241 170.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.4 mt -66.24 -27.88 68.3 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.37 0.878 . . . . 3.45 113.37 179.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.53 -53.63 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.279 0.632 . . . . 2.3 109.727 169.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.54 -33.04 67.69 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.492 1.293 . . . . 3.85 114.492 -177.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.85 -29.79 69.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.154 0.982 . . . . 4.86 112.866 175.261 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.95 -59.02 2.91 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.798 0.839 . . . . 4.44 112.529 -169.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--O 1.255 1.386 0 C-N-CA 125.033 1.333 . . . . 4.09 113.698 -176.629 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 114.417 1.266 . . . . 3.7 114.417 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.0 -32.51 24.9 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.493 1.042 . . . . 4.1 110.678 169.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.88 71.51 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.516 -0.74 . . . . 1.55 112.367 170.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 tp -61.7 -32.55 72.76 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.572 0.749 . . . . 1.69 111.884 175.248 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.47 -41.79 45.98 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.507 0.723 . . . . 1.47 112.391 168.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -61.06 -36.85 80.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.803 1.241 . . . . 2.57 113.143 -174.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.45 -33.19 72.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.389 0.995 . . . . 1.16 113.449 178.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.98 -39.85 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.25 -0.906 . . . . 1.61 111.853 168.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.2 m -63.99 -32.77 74.43 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.097 -1.002 . . . . 1.07 113.128 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.14 -24.02 67.53 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.0 2.52 . . . . 1.87 114.132 177.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -80.24 121.48 25.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.391 0.677 . . . . 2.37 109.291 -177.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.31 -20.78 66.56 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 116.527 2.047 . . . . 2.43 116.527 -166.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m 67.16 -21.13 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 115.613 1.709 . . . . 3.49 115.613 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -128.05 152.19 48.26 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.146 -1.596 . . . . 3.04 114.171 176.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.7 144.62 49.25 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.086 1.355 . . . . 1.68 111.112 -177.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.5 m -119.08 98.23 6.07 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.919 0.887 . . . . 1.97 112.049 -171.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.6 mt -81.68 136.91 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 127.013 2.125 . . . . 0.94 111.46 -171.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.61 142.79 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.679 0.792 . . . . 1.99 112.49 168.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.0 m -138.58 115.84 11.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.388 1.875 . . . . 3.29 111.849 -169.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mp -102.62 77.56 1.62 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.558 1.143 . . . . 3.82 110.004 177.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -17.34 62.59 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.91 0.707 . . . . 4.28 112.91 176.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.9 m -144.79 131.48 20.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.377 2.271 . . . . 5.27 110.078 176.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 25' ' ' ILE . 2.5 t70 -21.06 63.65 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.424 1 C-N-CA 133.875 4.87 . . . . 5.86 117.649 -169.907 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 60.73 -25.47 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.825 2.45 . . . . 4.94 114.473 -167.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 23' ' ' ASP . 26.7 pt -58.74 5.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 131.6 3.96 . . . . 5.05 117.08 179.076 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.8 tp -129.51 -40.67 1.41 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.364 1.866 . . . . 5.44 113.249 179.298 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.8 tp 22.57 68.05 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 128.687 2.795 . . . . 3.37 113.258 -176.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.5 m -78.15 153.81 31.75 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.311 1.044 . . . . 2.59 110.826 -178.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -124.2 146.96 48.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.51 0.724 . . . . 2.59 112.707 176.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -137.42 139.76 40.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.789 2.036 . . . . 2.66 110.255 -172.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -107.56 130.28 54.89 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.258 0.936 . . . . 2.84 112.665 175.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 m -132.97 174.71 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.644 1.578 . . . . 1.45 111.503 -177.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.87 145.58 31.28 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.939 0.895 . . . . 4.95 111.761 169.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.31 -8.02 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 114.189 1.181 . . . . 1.84 114.189 -176.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -85.46 -28.12 25.25 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.166 -1.583 . . . . 4.56 112.315 167.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.58 -20.06 22.07 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.441 1.496 . . . . 2.13 113.515 -169.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.58 -46.07 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.48 1.112 . . . . 3.82 112.352 178.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 59.56 164.94 0.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.408 1.883 . . . . 3.85 115.863 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -74.34 27.34 0.08 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 117.002 2.223 . . . . 4.19 117.002 -168.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.75 -8.3 5.29 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 117.012 1.565 . . . . 1.17 117.012 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.11 175.76 5.37 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.63 1.715 . . . . 3.08 114.308 -174.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.9 mt -123.27 135.33 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.481 1.913 . . . . 1.64 110.411 -178.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.4 mm -124.9 123.59 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.349 1.859 . . . . 0.76 110.186 -170.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -100.01 122.0 42.24 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.273 -0.892 . . . . 3.24 112.79 177.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.7 p -100.72 142.57 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.557 1.543 . . . . 0.71 112.117 -173.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 m -88.95 163.58 34.29 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 124.417 1.087 . . . . 1.03 113.136 -177.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.95 132.6 48.39 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.446 2.097 . . . . 1.25 110.902 169.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.17 -1.99 62.62 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 115.854 1.102 . . . . 1.1 115.854 -172.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.17 174.99 46.27 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-N 119.517 1.659 . . . . 1.1 114.923 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -122.37 145.89 47.85 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.505 1.522 . . . . 2.41 111.132 -177.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -86.35 129.66 52.56 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 118.697 -0.668 . . . . 2.21 112.443 -177.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -91.12 -19.83 0.85 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.124 2.55 . . . . 0.91 115.825 -172.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.7 m -148.57 165.71 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 126.87 2.068 . . . . 1.21 109.466 -177.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -88.29 127.88 35.47 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.288 0.949 . . . . 2.13 111.976 169.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.19 -167.83 29.41 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.592 1.091 . . . . 0.65 112.918 -169.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -117.33 135.36 53.9 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.042 0.937 . . . . 5.12 113.326 -175.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.8 t -83.45 129.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 128.522 2.729 . . . . 0.76 109.14 176.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.4 pt -141.17 32.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.216 1.006 . . . . 0.88 113.165 -179.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -168.55 137.91 2.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.004 1.722 . . . . 3.52 108.675 166.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.11 -177.08 51.93 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.593 0.997 . . . . 0.79 115.593 169.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -145.89 120.73 9.94 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.282 1.433 . . . . 5.42 110.972 -169.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.22 171.76 14.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.462 1.105 . . . . 1.31 111.267 172.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.6 ttm -108.01 149.15 28.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.99 1.316 . . . . 0.81 111.043 170.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.92 133.72 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.743 1.217 . . . . 0.69 112.573 -169.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -100.45 106.06 17.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.412 1.485 . . . . 2.21 110.409 177.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.29 6.07 10.71 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.741 1.616 . . . . 2.17 114.912 -172.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.3 p -45.69 -26.04 0.57 Allowed 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 117.127 2.269 . . . . 1.36 117.127 -175.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.34 -42.16 19.09 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.558 1.526 . . . . 0.99 112.664 175.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.9 mm -72.68 -60.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.974 0.91 . . . . 1.01 110.278 -170.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 p -93.25 -11.11 33.36 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.877 2.071 . . . . 1.16 112.455 -176.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.1 31.85 57.06 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 121.246 -0.909 . . . . 1.55 113.275 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -68.24 178.83 1.77 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.691 0.796 . . . . 2.58 110.96 168.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.03 7.13 1.59 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.193 1.183 . . . . 2.11 114.193 177.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 ptp -149.19 153.55 37.93 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.669 1.988 . . . . 3.07 107.806 169.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.9 159.64 37.88 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.138 1.892 . . . . 1.34 112.652 -177.087 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.88 138.37 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 126.211 1.804 . . . . 1.19 112.024 -168.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.6 150.86 36.43 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.382 -0.823 . . . . 0.83 113.119 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -132.32 155.1 48.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.628 1.971 . . . . 1.56 112.699 175.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -153.94 -179.15 0.99 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 129.044 2.938 . . . . 2.62 109.79 178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.72 150.4 82.73 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.748 1.632 . . . . 1.46 113.788 170.468 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.34 19.88 70.95 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-N 114.569 -1.196 . . . . 1.1 114.357 -171.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.7 t -107.84 153.88 22.37 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 119.324 1.562 . . . . 1.18 111.1 -176.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.3 p -118.44 143.43 46.69 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.282 -1.511 . . . . 1.23 112.948 -169.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 m -134.01 156.95 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.768 1.627 . . . . 0.64 112.399 -169.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.526 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -112.7 153.51 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.236 1.814 . . . . 1.44 112.816 174.669 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.38 150.45 48.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.148 0.796 . . . . 0.68 113.148 175.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.84 -6.0 56.26 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.489 1.042 . . . . 0.78 115.451 176.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.4 p -77.72 159.82 28.85 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.274 1.03 . . . . 1.43 111.361 169.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mm -113.77 127.24 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.432 0.693 . . . . 0.82 111.782 -169.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -86.48 140.12 30.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.445 1.898 . . . . 1.67 111.987 -178.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -100.46 -125.34 0.17 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.402 1.081 . . . . 3.44 113.509 -172.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -90.13 63.61 5.89 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.983 1.265 . . . . 3.71 113.844 -166.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.92 157.23 9.23 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.431 -0.793 . . . . 1.9 114.989 169.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -92.36 133.3 36.0 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.475 1.11 . . . . 2.12 112.259 -175.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.76 153.7 39.14 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.601 1.56 . . . . 0.92 111.587 -176.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.1 tp -108.62 119.81 40.61 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.617 1.167 . . . . 2.34 110.356 174.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mp -117.53 127.94 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.319 1.048 . . . . 1.23 111.04 -175.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.3 p -81.52 128.65 34.13 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.722 -0.611 . . . . 1.39 110.654 171.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.09 126.17 34.6 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.499 -0.751 . . . . 1.07 110.864 176.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 p -133.97 -3.96 2.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.926 1.69 . . . . 2.27 113.698 -170.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -148.03 150.3 33.7 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.237 2.215 . . . . 2.09 108.887 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.74 173.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.246 1.018 . . . . 1.65 111.416 169.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.75 -35.78 47.55 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.17 -0.956 . . . . 1.85 115.027 -170.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.63 -31.97 71.14 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.322 1.231 . . . . 2.31 114.322 176.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.84 -14.11 60.28 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.05 1.295 . . . . 3.88 114.19 172.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 60.1 p -68.47 144.59 54.6 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.138 -1.601 . . . . 2.04 113.152 -169.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 t -63.48 -33.04 74.7 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.77 0.428 . . . . 2.86 110.821 171.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.7 mp -53.3 -53.01 57.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.58 1.152 . . . . 1.61 111.886 175.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.4 m -71.73 -26.54 62.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.022 0.929 . . . . 2.02 111.77 177.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -70.64 -42.66 70.55 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.761 -0.587 . . . . 1.61 111.826 -179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.91 -53.34 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.746 1.219 . . . . 2.11 110.287 177.65 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.5 m -67.47 -23.25 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 113.607 0.966 . . . . 1.78 113.607 -176.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -73.35 -51.96 15.56 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.908 0.776 . . . . 2.67 112.068 168.596 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.0 mt -62.22 -43.17 99.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.146 0.978 . . . . 2.95 112.925 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.39 -50.75 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.492 0.717 . . . . 2.62 110.517 178.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -56.95 -37.25 71.26 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.72 1.007 . . . . 3.82 113.72 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -74.65 -21.56 59.37 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.104 1.15 . . . . 5.61 114.104 176.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.98 -44.33 63.69 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.84 0.856 . . . . 4.55 112.093 -174.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.691 1.196 . . . . 5.04 113.409 170.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 119.163 -0.446 . . . . 2.34 110.249 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.34 -42.47 98.74 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.015 0.825 . . . . 4.59 109.979 167.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.81 -34.91 65.76 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.252 -0.905 . . . . 1.4 113.081 175.278 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.9 tp -67.58 -28.86 68.13 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.327 -0.858 . . . . 1.45 112.243 177.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.77 -45.31 29.48 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.019 0.528 . . . . 1.23 111.312 167.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -53.62 -43.69 68.88 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.462 1.905 . . . . 2.28 113.22 -175.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -48.04 -48.1 33.24 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.003 0.921 . . . . 0.98 112.229 176.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.6 mm -73.88 -34.59 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.23 -0.919 . . . . 1.81 113.408 177.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -77.17 -24.16 51.52 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.417 1.266 . . . . 1.96 114.417 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.6 mt -58.63 -21.07 52.7 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.232 1.413 . . . . 1.95 113.769 174.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -78.09 141.7 38.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.858 1.263 . . . . 2.54 113.589 -174.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.9 154.51 33.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.283 1.033 . . . . 1.78 112.732 175.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.61 -12.93 35.46 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.498 1.519 . . . . 2.58 113.549 175.18 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -143.42 164.74 29.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.794 2.038 . . . . 3.17 113.3 -175.497 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.15 163.59 32.31 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.343 1.457 . . . . 0.73 111.524 171.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.4 m -114.75 106.8 14.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.017 1.327 . . . . 0.8 110.062 170.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.6 mt -81.52 133.12 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.084 -1.08 . . . . 0.65 108.084 174.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.61 118.43 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.519 0.728 . . . . 2.28 110.451 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.8 m -131.85 144.16 50.69 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.183 1.393 . . . . 2.42 109.765 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.7 mt -105.23 124.23 49.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.187 0.995 . . . . 3.75 108.701 -176.27 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.39 10.77 23.37 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.772 2.138 . . . . 3.72 116.772 -166.58 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.0 m -125.77 -96.97 0.43 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.024 0.929 . . . . 3.88 109.789 175.076 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -139.4 56.39 1.67 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.878 2.071 . . . . 5.21 107.572 -179.343 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 65.0 -23.78 0.08 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.615 2.766 . . . . 4.23 116.711 -168.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.0 pt -71.84 -8.32 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 115.735 1.754 . . . . 4.18 115.735 -172.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tt -119.42 125.35 48.75 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.329 1.852 . . . . 2.83 110.292 -177.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -101.52 131.86 47.45 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.246 1.418 . . . . 3.09 111.128 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 t -139.5 96.81 3.15 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.678 1.191 . . . . 1.69 110.447 -177.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -91.14 150.14 21.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.769 1.025 . . . . 2.51 113.769 -179.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -124.18 140.55 52.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.308 1.843 . . . . 2.82 111.182 169.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -98.05 126.02 43.29 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.71 0.804 . . . . 1.94 109.099 169.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 m -136.28 164.78 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.698 1.199 . . . . 0.8 112.625 -172.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.36 151.14 31.17 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.663 0.785 . . . . 3.41 111.741 169.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.05 -24.87 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.385 0.883 . . . . 1.09 113.385 175.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -69.4 -27.88 65.68 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.843 -1.161 . . . . 3.13 113.199 170.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.9 mt -100.74 -7.78 23.42 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.872 1.669 . . . . 1.29 114.434 -168.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.67 141.83 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.631 0.773 . . . . 1.55 110.341 169.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -126.07 159.67 32.17 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.78 1.632 . . . . 3.69 111.962 -170.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.266 16.8 ptt85 -75.53 15.82 0.43 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.957 1.836 . . . . 2.78 115.957 -174.217 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.31 -2.58 15.48 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 126.651 2.072 . . . . 1.04 113.539 168.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -84.02 155.84 22.54 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 118.731 1.266 . . . . 2.99 111.735 178.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 mt -118.69 128.95 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.55 1.14 . . . . 1.17 109.167 169.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.6 mm -107.09 168.45 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 128.018 2.527 . . . . 1.26 111.022 -167.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -129.13 136.52 50.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.775 1.23 . . . . 1.78 109.832 170.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.07 132.69 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.393 1.077 . . . . 0.73 110.405 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.9 m -90.15 166.52 19.84 Favored Pre-proline 0 N--CA 1.482 1.127 0 N-CA-C 113.427 0.899 . . . . 1.24 113.427 -170.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -61.8 128.01 23.16 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.76 2.307 . . . . 1.03 110.598 169.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.42 8.46 59.54 Favored Glycine 0 CA--C 1.539 1.583 0 O-C-N 121.278 -0.889 . . . . 0.88 114.884 -170.573 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.47 169.02 54.9 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.636 1.588 . . . . 0.96 114.791 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -125.61 140.35 52.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.964 1.305 . . . . 1.96 110.979 -175.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -79.06 127.39 79.66 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 112.671 0.619 . . . . 1.74 112.671 -173.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -87.0 -24.59 1.3 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.397 2.731 . . . . 0.64 114.875 -174.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 m -149.86 171.45 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 127.877 2.471 . . . . 0.72 108.988 -177.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.54 139.77 38.41 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.428 1.013 . . . . 1.79 113.111 178.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.44 -154.86 14.5 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 114.701 0.641 . . . . 0.65 114.701 -170.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -120.73 141.45 50.43 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.125 1.157 . . . . 5.2 114.125 -173.147 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.1 t -89.83 132.64 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 128.647 2.779 . . . . 0.65 108.997 174.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.0 pt -139.09 35.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 113.456 0.91 . . . . 0.84 113.456 171.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -165.75 137.4 3.92 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.673 1.189 . . . . 3.09 111.149 166.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.1 -164.73 26.21 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 117.469 1.748 . . . . 0.95 117.469 168.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -151.48 109.03 3.62 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.321 1.449 . . . . 2.06 111.97 -172.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.13 170.21 16.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.726 0.774 . . . . 1.24 112.024 172.108 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.3 ttm -117.43 144.11 45.33 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.911 1.284 . . . . 1.19 110.092 176.203 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.0 t -130.29 139.74 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.851 1.26 . . . . 0.63 111.259 -169.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -98.11 127.51 44.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.384 0.674 . . . . 2.32 112.427 175.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -127.95 20.7 6.42 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.515 1.526 . . . . 2.06 112.879 -173.336 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 p -64.55 -22.2 66.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.878 1.807 . . . . 1.43 115.878 -169.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.68 -42.65 11.23 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.752 0.821 . . . . 1.06 109.543 168.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.77 -59.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.802 1.241 . . . . 1.09 112.505 -171.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.0 p -106.91 -10.56 15.96 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.548 1.539 . . . . 1.23 113.361 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.58 13.01 76.88 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 119.151 -0.805 . . . . 1.31 114.574 176.693 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -58.32 -47.39 83.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.718 1.207 . . . . 2.83 113.407 -174.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 61.75 19.76 10.82 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.507 1.299 . . . . 1.34 114.507 178.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.4 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 28.6 ttt -150.68 136.93 10.97 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 128.466 2.706 . . . . 4.49 106.729 168.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 74' ' ' MET . 46.0 Cg_exo -59.13 151.73 64.57 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.288 3.325 . . . . 1.29 115.2 -176.038 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.23 134.38 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.555 1.942 . . . . 0.86 111.597 -169.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.97 141.87 32.9 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.054 1.131 . . . . 0.95 114.054 -173.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -124.72 142.35 51.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.4 1.88 . . . . 0.76 111.496 173.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -142.03 174.71 3.51 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 128.968 2.907 . . . . 3.48 109.84 -176.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -61.76 126.65 19.48 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 CA-C-N 121.577 1.599 . . . . 0.85 110.493 167.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.39 9.55 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.045 1.307 . . . . 0.76 114.315 -169.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.3 m -120.41 153.14 36.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 119.233 1.517 . . . . 1.45 111.749 177.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 p -101.5 152.28 20.95 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.344 1.429 . . . . 0.89 113.358 175.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.1 m -136.41 155.03 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.803 1.641 . . . . 0.54 111.41 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.91 143.97 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.487 1.515 . . . . 0.91 112.802 -179.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.45 147.91 29.97 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.394 1.078 . . . . 0.6 112.663 -178.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.98 -6.26 49.76 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.599 -1.112 . . . . 0.76 115.705 178.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.8 p -79.26 163.37 25.0 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.964 1.382 . . . . 1.29 111.844 169.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mm -110.93 129.93 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.351 1.06 . . . . 0.68 111.253 -173.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -92.03 135.21 34.14 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.816 1.646 . . . . 1.86 110.858 176.303 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -88.77 -107.01 0.08 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.215 1.191 . . . . 3.44 114.215 -173.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -82.24 -45.44 15.02 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 116.722 2.119 . . . . 3.14 116.722 -166.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.41 140.72 15.19 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.069 0.849 . . . . 1.93 113.539 -172.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.1 p -82.93 137.15 34.32 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.652 0.726 . . . . 1.6 112.53 171.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.1 mt -130.03 156.17 44.93 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.953 1.301 . . . . 0.94 112.079 -170.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.97 122.21 42.53 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.366 1.067 . . . . 2.67 110.82 174.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -115.6 123.02 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.799 1.239 . . . . 1.48 111.895 -173.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 74.8 m -79.51 120.24 23.61 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 120.674 -1.267 . . . . 2.28 108.956 168.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.88 118.24 20.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.644 -0.502 . . . . 0.78 109.644 173.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.7 p -108.72 -0.28 20.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.39 1.076 . . . . 2.15 113.31 175.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -137.96 139.65 39.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.093 1.357 . . . . 1.65 111.618 176.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 m -78.84 157.18 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.702 -0.851 . . . . 1.56 108.702 165.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.74 -35.24 73.45 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 120.954 -1.091 . . . . 1.36 115.569 -169.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.22 64.43 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.629 1.344 . . . . 1.8 114.629 174.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -80.18 -8.18 59.31 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.814 1.646 . . . . 2.54 115.274 173.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 37.4 p -58.86 158.22 8.56 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.609 1.337 . . . . 1.61 114.609 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.7 m -60.68 -35.65 76.79 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.711 0.804 . . . . 3.25 111.035 170.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.63 -43.64 96.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.208 1.003 . . . . 1.47 112.101 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.9 p -72.95 -21.84 60.81 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.901 1.074 . . . . 2.17 113.901 170.092 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -70.44 -38.28 74.5 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.606 -1.309 . . . . 2.04 112.01 174.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.22 -52.39 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.848 1.259 . . . . 1.35 110.741 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -65.63 -28.28 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.285 0.948 . . . . 1.39 112.951 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -63.17 -40.75 98.44 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.281 0.946 . . . . 3.28 111.019 172.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.19 -46.28 61.62 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.672 1.189 . . . . 2.65 112.718 178.697 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.91 -26.44 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.239 -0.913 . . . . 1.82 113.096 -178.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.63 -25.9 63.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.003 -1.061 . . . . 3.77 112.167 175.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -71.8 -19.93 61.92 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.258 1.023 . . . . 4.27 113.327 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.95 -57.17 4.24 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.842 -1.162 . . . . 3.59 112.711 -176.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 124.265 1.026 . . . . 4.34 112.483 -177.477 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 117.249 2.314 . . . . 4.02 117.249 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -98.21 -36.2 10.12 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 120.174 -1.579 . . . . 5.56 111.961 173.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.06 86.24 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.795 0.838 . . . . 2.28 111.28 168.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.9 tp -42.01 -31.04 0.31 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.533 2.733 . . . . 1.89 115.861 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.97 -32.67 65.37 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.187 1.18 . . . . 2.05 114.187 177.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.98 -30.55 68.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.822 1.249 . . . . 5.65 112.497 -170.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -53.16 -37.29 61.74 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.803 1.641 . . . . 0.97 112.51 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -75.84 -35.93 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.962 1.305 . . . . 1.52 112.821 175.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.1 m -72.82 -39.74 66.37 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.039 1.126 . . . . 1.29 114.039 -175.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.21 -18.01 65.06 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.301 1.223 . . . . 2.19 114.301 -173.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -70.09 141.33 52.77 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.273 1.029 . . . . 2.28 112.829 -172.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.04 139.1 30.79 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.583 0.957 . . . . 2.23 113.583 -176.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -90.69 -8.18 50.61 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.565 1.546 . . . . 1.78 113.868 -171.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.01 160.85 38.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.142 1.377 . . . . 3.66 113.896 -179.236 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.04 166.37 24.89 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.812 1.645 . . . . 0.94 112.005 176.03 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.9 m -117.62 105.38 11.98 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.624 1.17 . . . . 1.12 111.322 169.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.0 mt -82.87 130.44 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.482 1.113 . . . . 0.81 108.925 177.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -126.52 128.11 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 121.501 -0.749 . . . . 1.86 112.139 -176.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.4 m -91.16 130.48 37.05 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.737 1.215 . . . . 2.98 109.56 169.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.91 3.01 8.08 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.545 1.313 . . . . 6.06 114.545 -169.376 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 t70 20.77 -92.61 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 130.65 3.58 . . . . 8.72 114.252 -177.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 m -29.61 -52.63 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.288 2.635 . . . . 7.71 115.853 178.465 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -164.92 -85.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.191 1.396 . . . . 11.02 107.848 176.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -130.99 10.31 4.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.092 1.757 . . . . 8.31 112.073 175.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 pt -111.71 -11.27 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 117.942 2.571 . . . . 8.13 117.942 -164.348 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -69.23 -32.18 71.25 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.164 1.347 . . . . 4.81 114.074 -172.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.4 mp 53.49 66.18 1.3 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.351 1.612 . . . . 3.87 115.351 174.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.6 t -112.58 109.82 19.6 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.373 1.069 . . . . 1.7 108.409 166.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -107.9 145.01 34.34 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.622 0.971 . . . . 2.76 113.622 -168.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -124.02 128.53 49.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.511 1.924 . . . . 3.17 109.97 173.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -91.86 124.05 35.7 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.208 -0.932 . . . . 2.12 109.228 173.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 m -136.51 162.75 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.505 1.298 . . . . 1.12 114.505 -169.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.47 147.99 35.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.001 1.321 . . . . 2.7 111.653 169.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -57.68 -22.81 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.694 0.998 . . . . 1.25 113.694 -178.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.52 -12.79 61.56 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.624 -1.298 . . . . 3.74 113.258 175.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.87 -2.07 21.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.318 1.447 . . . . 1.55 113.863 -171.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.39 148.26 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.862 1.265 . . . . 1.47 110.571 170.109 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -137.56 165.68 25.74 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.176 1.391 . . . . 2.85 113.379 -178.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.0 ptt85 -67.51 25.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 118.463 2.764 . . . . 2.61 118.463 -168.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.32 9.7 1.28 Allowed Glycine 0 CA--C 1.54 1.629 0 C-N-CA 126.122 1.82 . . . . 1.06 114.387 171.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -83.83 155.79 22.79 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.039 1.42 . . . . 2.72 112.408 175.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 mt -111.8 124.99 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.51 0.724 . . . . 1.33 110.254 172.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.1 mm -121.61 129.28 75.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 127.268 2.227 . . . . 0.78 110.452 -169.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -92.04 128.7 37.98 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.339 -0.851 . . . . 2.21 110.536 171.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.2 p -102.76 135.4 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.837 1.255 . . . . 0.76 110.346 -177.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.0 m -89.2 156.05 48.94 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.288 1.035 . . . . 1.24 112.433 -178.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -59.19 143.28 99.82 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.929 1.753 . . . . 1.27 111.641 168.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.05 -6.85 3.58 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.313 0.958 . . . . 1.33 114.427 -169.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.7 151.16 50.28 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 119.246 1.523 . . . . 1.15 113.054 177.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -103.03 142.8 33.49 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.826 1.25 . . . . 1.97 110.875 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -75.49 125.25 88.92 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.881 -0.512 . . . . 2.32 112.059 -179.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.3 -25.46 3.88 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.88 2.387 . . . . 0.94 113.922 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.3 m -151.97 171.95 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 127.711 2.404 . . . . 0.8 109.057 -176.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.22 151.26 19.93 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.646 0.778 . . . . 2.27 112.229 177.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.74 -172.08 41.85 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 116.139 1.216 . . . . 0.75 116.139 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -108.37 129.26 55.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.66 1.584 . . . . 4.33 111.703 -175.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.2 t -87.29 127.96 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.115 2.166 . . . . 0.76 109.218 -176.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.4 pt -142.12 29.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 113.728 1.01 . . . . 1.01 113.728 -172.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.22 141.45 1.61 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.784 1.634 . . . . 2.92 109.534 165.093 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.75 -174.75 41.4 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 122.433 1.018 . . . . 0.75 114.98 170.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.43 103.96 3.19 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.135 0.974 . . . . 2.91 111.07 -167.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -144.44 172.73 12.54 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.212 0.819 . . . . 1.07 113.212 -172.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.5 ttm -124.71 133.64 53.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.981 1.312 . . . . 1.03 110.04 -176.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -123.28 137.34 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.27 1.428 . . . . 0.82 111.637 -169.063 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -95.71 103.63 15.52 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.87 1.268 . . . . 2.18 110.682 -176.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -108.6 -1.5 19.55 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.669 1.588 . . . . 2.06 113.677 -170.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 p -53.4 -33.06 52.41 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.552 2.056 . . . . 1.42 116.552 -169.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.23 -44.34 22.0 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.652 1.569 . . . . 1.14 110.775 173.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mm -62.04 -49.11 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.215 1.806 . . . . 1.2 111.621 -174.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.9 p -118.27 -2.68 11.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.009 1.114 . . . . 1.37 114.009 -171.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.24 18.91 70.55 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.924 1.249 . . . . 1.13 114.732 178.027 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -61.08 -179.12 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.543 1.137 . . . . 2.77 111.138 168.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.05 -20.35 0.88 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.322 1.449 . . . . 1.72 114.141 177.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -125.58 153.22 72.73 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.827 2.051 . . . . 3.04 110.336 167.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.0 165.83 31.43 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.237 2.625 . . . . 1.67 114.019 -174.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.17 133.43 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 127.047 2.139 . . . . 0.95 112.191 -168.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.88 141.03 36.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.35 1.06 . . . . 0.73 113.567 178.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -126.08 150.0 48.49 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.662 1.985 . . . . 0.82 111.38 178.254 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 17.5 ptpt -144.41 176.29 2.33 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.543 2.337 . . . . 2.36 110.257 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 37.5 Cg_endo -60.47 131.01 36.02 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 CA-C-N 122.047 1.767 . . . . 0.84 110.463 167.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.05 28.68 33.48 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 118.092 -1.393 . . . . 0.84 114.805 -171.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.3 m -108.02 174.14 6.01 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.853 1.826 . . . . 1.58 110.959 174.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -125.79 156.44 39.5 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.437 -1.414 . . . . 0.89 112.831 175.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.09 146.16 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.716 1.606 . . . . 0.58 112.648 -179.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.85 152.3 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.73 2.412 . . . . 0.99 112.42 170.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.46 155.19 38.25 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.733 0.813 . . . . 0.9 112.158 177.02 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.53 -1.37 52.05 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.519 1.057 . . . . 0.95 115.543 176.467 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 p -76.86 162.81 27.32 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.066 1.433 . . . . 1.61 112.306 172.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.76 137.98 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.722 1.209 . . . . 0.77 111.082 -174.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -84.31 134.73 34.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.199 1.0 . . . . 2.52 111.152 170.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.26 50.92 1.49 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.135 1.532 . . . . 3.74 115.135 179.214 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -163.97 -36.43 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.1 1.518 . . . . 3.38 115.1 171.12 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.26 169.74 28.22 Favored Glycine 0 N--CA 1.479 1.501 0 CA-C-N 120.197 1.362 . . . . 1.97 115.411 -171.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.0 m -69.56 137.46 52.42 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.547 1.314 . . . . 1.94 114.547 -171.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.49 159.98 31.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.547 1.939 . . . . 1.08 110.415 171.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.4 tp -114.07 126.51 55.18 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.037 0.935 . . . . 2.77 110.778 173.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.36 132.43 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.842 1.257 . . . . 1.14 111.272 -170.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 46.7 t -87.18 121.17 29.28 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.529 -0.915 . . . . 3.32 108.529 168.008 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.93 130.48 35.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.083 0.953 . . . . 0.83 110.604 -178.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.9 p -120.72 9.05 10.67 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.555 1.317 . . . . 2.13 114.555 -175.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -149.04 155.15 40.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.428 1.491 . . . . 2.41 111.575 168.499 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 m -84.33 164.03 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 108.71 -0.848 . . . . 1.58 108.71 163.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 -39.66 95.55 Favored Glycine 0 N--CA 1.473 1.155 0 O-C-N 120.719 -1.238 . . . . 1.4 113.536 -170.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.72 77.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.417 1.109 . . . . 1.82 113.27 174.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -77.37 -6.65 54.09 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.127 1.528 . . . . 2.63 115.127 175.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.0 p -63.62 148.21 49.52 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.686 -1.259 . . . . 1.67 111.182 174.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.6 m -65.27 -34.38 78.22 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.506 -0.746 . . . . 3.65 110.312 169.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.1 tp -49.34 -51.87 31.73 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.435 1.494 . . . . 1.68 112.565 172.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.2 m -74.37 -24.15 59.11 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.1 1.148 . . . . 2.47 114.1 177.071 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -71.45 -40.5 70.32 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.879 1.271 . . . . 2.44 112.75 173.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.2 mt -51.63 -46.48 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.271 1.028 . . . . 1.47 111.71 -178.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.8 m -66.49 -22.93 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.936 1.087 . . . . 1.3 113.936 179.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -74.17 -44.85 51.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.104 0.962 . . . . 2.99 112.006 169.014 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.8 mt -70.16 -46.47 64.61 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.849 1.66 . . . . 3.38 112.74 -173.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.32 -48.17 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.029 0.532 . . . . 2.25 109.901 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.18 -31.05 68.65 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.018 1.118 . . . . 3.06 114.018 179.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -76.23 -36.37 58.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.966 1.099 . . . . 3.77 113.966 169.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.32 -17.21 62.46 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.281 1.586 . . . . 4.59 115.281 -169.374 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 126.241 1.817 . . . . 5.87 111.951 175.877 . . . . . . . . 0 0 . 1 stop_ save_